Citrus Sinensis ID: 022132

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300--
Protein Sequence
MHSITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Secondary Structure (PSIPRED)
cccccHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEccccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccHHHHHHHcHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccHHHHcc
Secondary Structure Prediction (SSPRO)
ccccccHHHHHHHHHHHHHHHHcccccEEEEHHccccccHHHcccEEEEHHHHHccHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEHEccHcccccccHHHHcccHHHHcccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccHHHHHHcHHHHHHHccccccccccHHHccccccHHHHHHHHHHccccHHHcccHHHHHccHHHcccccHHHccccccccccccccccccHHHHHHHHHHHHcccccccccc
Coil and Loop (DISEMBL)
MHSITKlmqrghfvrsscfdtwIMKTSVVAIrdiipppqresfnDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAnvlhrdlkpsnlllnancdlkicdfglarvtsetdFMTEYVVTrwyrapelllnssdytaAIDVWSVGCIFMelmdrkplfpgrdhVHQLRLLIELigtpseaelgFLNENAKKYICqlpryqrqsftekfpnvhpsAIDLVEKMltfdprqritvedalahpylgslhdisdepvcmspfsfdfeQHALTEGQMKELIYQEALafnpeyrqq
Flexible Loop (DISEMBL)
mhsitklmqrghfvrsscfdTWIMKTSVVAirdiipppqrESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Low Complexity Region (SEG)
MHSITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Disordered region (IsUnstruct)
*******MQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAF*******
Disordered Region (DISOPRED)
MHSITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP*****SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP*****
Disordered Region (DISEMBL)
********QRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Disordered Region (DISPRO)
*HSITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MHSITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	302	2.2.26 [Sep-21-2011]
Q06060	394	Mitogen-activated protein	N/A	no	0.910	0.697	0.930	1e-152
Q07176	387	Mitogen-activated protein	N/A	no	0.910	0.710	0.930	1e-152
Q40532	393	Mitogen-activated protein	N/A	no	0.910	0.699	0.912	1e-150
Q84UI5	398	Mitogen-activated protein	yes	no	0.907	0.688	0.901	1e-148
Q39026	395	Mitogen-activated protein	yes	no	0.910	0.696	0.890	1e-139
Q39023	370	Mitogen-activated protein	no	no	0.903	0.737	0.759	1e-125
Q10N20	369	Mitogen-activated protein	no	no	0.907	0.742	0.741	1e-125
A2XFC8	369	Mitogen-activated protein	N/A	no	0.907	0.742	0.741	1e-125
Q39024	376	Mitogen-activated protein	no	no	0.900	0.723	0.714	1e-120
Q9M1Z5	393	Mitogen-activated protein	no	no	0.900	0.692	0.738	1e-119

>sp|Q06060|MAPK_PEA Mitogen-activated protein kinase homolog D5 OS=Pisum sativum PE=2 SV=1

 Score =  538 bits (1386), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 256/275 (93%), Positives = 267/275 (97%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 120 NVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 179

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 180 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 239

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK+YI 
Sbjct: 240 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAKRYIR 299

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPRQRITVE+ALAHPYL SLHDISDEPVC
Sbjct: 300 QLPLYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRQRITVENALAHPYLTSLHDISDEPVC 359

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 301
            +PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 360 TTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 394

Pisum sativum (taxid: 3888)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q07176|MMK1_MEDSA Mitogen-activated protein kinase homolog MMK1 OS=Medicago sativa GN=MMK1 PE=1 SV=1

 Score =  537 bits (1384), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 256/275 (93%), Positives = 267/275 (97%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 113 NVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 172

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 173 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 232

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE +LGFLNENAK+YI 
Sbjct: 233 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEDDLGFLNENAKRYIR 292

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISDEPVC
Sbjct: 293 QLPPYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISDEPVC 352

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 301
           M+PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 353 MTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 387

May play a role in the mitogenic induction of symbiotic root nodules on Alfalfa by Rhizobium signal molecules.

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40532|NTF4_TOBAC Mitogen-activated protein kinase homolog NTF4 OS=Nicotiana tabacum GN=NTF4 PE=2 SV=1

 Score =  531 bits (1368), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 251/275 (91%), Positives = 266/275 (96%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           ++VAIRDIIPPPQRE+FNDVYIAYELMDTDLHQIIRSNQ LSEEHCQYFLYQILRGLKYI
Sbjct: 118 NIVAIRDIIPPPQREAFNDVYIAYELMDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYI 177

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 178 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 237

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEAE+ FLNENAK+YI 
Sbjct: 238 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEAEMEFLNENAKRYIR 297

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP Y+RQSF EKFP+V+P+AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISDEPVC
Sbjct: 298 QLPLYRRQSFVEKFPHVNPAAIDLVEKMLTFDPRRRITVEDALAHPYLTSLHDISDEPVC 357

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 301
           M+PF+FDFEQHALTE QMKELIY+E LAFNPEY+ 
Sbjct: 358 MTPFNFDFEQHALTEEQMKELIYREGLAFNPEYQH 392

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q84UI5|MPK1_ORYSJ Mitogen-activated protein kinase 1 OS=Oryza sativa subsp. japonica GN=MPK1 PE=1 SV=1

 Score =  523 bits (1347), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 247/274 (90%), Positives = 262/274 (95%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           ++VAIRDIIPPPQR SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 125 NIVAIRDIIPPPQRNSFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 184

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLAR TSETDFMTEYVVTRWYRAPELLLNSS+
Sbjct: 185 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWYRAPELLLNSSE 244

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTP+EA+L F+NENA++YI 
Sbjct: 245 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPNEADLDFVNENARRYIR 304

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLPR+ RQSF EKFP+VHP AIDLVEKMLTFDPRQRITVE ALAHPYL SLHDISDEPVC
Sbjct: 305 QLPRHARQSFPEKFPHVHPLAIDLVEKMLTFDPRQRITVEGALAHPYLASLHDISDEPVC 364

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
            SPFSFDFEQHAL+E QMK+LIYQE LAFNP+Y+
Sbjct: 365 SSPFSFDFEQHALSEEQMKDLIYQEGLAFNPDYQ 398

Involved in sphingolipid elicitor (SE)-dependent defense signaling pathway. Acts downstream of heterotrimeric G protein alpha subunit and small GTPase RAC1. May regulate the expression of various genes involved in biotic and abiotic stress response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39026|MPK6_ARATH Mitogen-activated protein kinase 6 OS=Arabidopsis thaliana GN=MPK6 PE=1 SV=1

 Score =  495 bits (1274), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 245/275 (89%), Positives = 258/275 (93%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           ++VAIRDIIPPP R +FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 121 NIVAIRDIIPPPLRNAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 180

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE+DFMTEYVVTRWYRAPELLLNSSD
Sbjct: 181 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSESDFMTEYVVTRWYRAPELLLNSSD 240

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE EL FLNENAK+YI 
Sbjct: 241 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEELEFLNENAKRYIR 300

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP Y RQS T+KFP VHP AIDL+EKMLTFDPR+RITV DALAHPYL SLHDISDEP C
Sbjct: 301 QLPPYPRQSITDKFPTVHPLAIDLIEKMLTFDPRRRITVLDALAHPYLNSLHDISDEPEC 360

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 301
             PF+FDFE HAL+E QMKELIY+EALAFNPEY+Q
Sbjct: 361 TIPFNFDFENHALSEEQMKELIYREALAFNPEYQQ 395

Involved in oxidative stress-mediated signaling cascade (such as ozone). Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in hypersensitive response (HR)-mediated signaling cascade. May phosphorylate regulators of WRKY transcription factors. Phosphorylates 1-aminocyclopropane-1-carboxylic acid synthases (ACS2 and ACS6) and may be involved in the regulation of bacterial elicitor flagellin-induced ethylene production. Regulates locally gene-mediated and basal resitance response to certain pathogens. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39023|MPK3_ARATH Mitogen-activated protein kinase 3 OS=Arabidopsis thaliana GN=MPK3 PE=1 SV=2

 Score =  448 bits (1153), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 208/274 (75%), Positives = 241/274 (87%), Gaps = 1/274 (0%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++AIRD++PPP R  F+DVYI+ ELMDTDLHQIIRSNQ+LSEEHCQYFLYQ+LRGLKYI
Sbjct: 96  NIIAIRDVVPPPLRRQFSDVYISTELMDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYI 155

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSAN++HRDLKPSNLLLNANCDLKICDFGLAR TSE DFMTEYVVTRWYRAPELLLNSSD
Sbjct: 156 HSANIIHRDLKPSNLLLNANCDLKICDFGLARPTSENDFMTEYVVTRWYRAPELLLNSSD 215

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
           YTAAIDVWSVGCIFMELM+RKPLFPG+DHVHQ+RLL EL+GTP+E++LGF  NE+AK+YI
Sbjct: 216 YTAAIDVWSVGCIFMELMNRKPLFPGKDHVHQMRLLTELLGTPTESDLGFTHNEDAKRYI 275

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
            QLP + RQ   + F +V+P AIDLV++MLTFDP +RITVE AL H YL  LHD +DEP+
Sbjct: 276 RQLPNFPRQPLAKLFSHVNPMAIDLVDRMLTFDPNRRITVEQALNHQYLAKLHDPNDEPI 335

Query: 266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY 299
           C  PFSF+FEQ  L E Q+KE+IYQEA+A NP Y
Sbjct: 336 CQKPFSFEFEQQPLDEEQIKEMIYQEAIALNPTY 369

Involved in oxidative stress-mediated signaling cascade to oxidative (such as ozone). Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in hypersensitive response (HR)-mediated signaling cascade. May phosphorylate regulators of WRKY transcription factors. Mediates the phosphorylation of VIP1 and subsequent stress genes transcription in response to Agrobacterium.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q10N20|MPK5_ORYSJ Mitogen-activated protein kinase 5 OS=Oryza sativa subsp. japonica GN=MPK5 PE=1 SV=1

 Score =  446 bits (1147), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 204/275 (74%), Positives = 243/275 (88%), Gaps = 1/275 (0%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ IRD+IPPP  ++FNDVYIA ELMDTDLH IIRSNQ LSEEHCQYFLYQILRGLKYI
Sbjct: 94  NIIGIRDVIPPPIPQAFNDVYIATELMDTDLHHIIRSNQELSEEHCQYFLYQILRGLKYI 153

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANV+HRDLKPSNLLLNANCDLKICDFGLAR +SE+D MTEYVVTRWYRAPELLLNS+D
Sbjct: 154 HSANVIHRDLKPSNLLLNANCDLKICDFGLARPSSESDMMTEYVVTRWYRAPELLLNSTD 213

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
           Y+AAIDVWSVGCIFMEL++R+PLFPGRDH+HQ+RL+ E+IGTP++ ELGF+ NE+A+KY+
Sbjct: 214 YSAAIDVWSVGCIFMELINRQPLFPGRDHMHQMRLITEVIGTPTDDELGFIRNEDARKYM 273

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
             LP+Y R++F   FP V P+A+DL+E+MLTF+P QRITVE+AL HPYL  LHDI+DEP+
Sbjct: 274 RHLPQYPRRTFASMFPRVQPAALDLIERMLTFNPLQRITVEEALDHPYLERLHDIADEPI 333

Query: 266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           C+ PFSFDFEQ AL E QMK+LI+ EA+  NP  R
Sbjct: 334 CLEPFSFDFEQKALNEDQMKQLIFNEAIEMNPNIR 368

Involved in disease resistance and abiotic stress tolerance signaling pathways. Acts as a positive regulator of drought, salt and cold tolerance. Negatively modulates pathogenesis-related (PR) gene expression and broad-spectrum disease resistance.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|A2XFC8|MPK5_ORYSI Mitogen-activated protein kinase 5 OS=Oryza sativa subsp. indica GN=MPK5 PE=1 SV=2

 Score =  446 bits (1147), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 204/275 (74%), Positives = 243/275 (88%), Gaps = 1/275 (0%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ IRD+IPPP  ++FNDVYIA ELMDTDLH IIRSNQ LSEEHCQYFLYQILRGLKYI
Sbjct: 94  NIIGIRDVIPPPIPQAFNDVYIATELMDTDLHHIIRSNQELSEEHCQYFLYQILRGLKYI 153

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANV+HRDLKPSNLLLNANCDLKICDFGLAR +SE+D MTEYVVTRWYRAPELLLNS+D
Sbjct: 154 HSANVIHRDLKPSNLLLNANCDLKICDFGLARPSSESDMMTEYVVTRWYRAPELLLNSTD 213

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
           Y+AAIDVWSVGCIFMEL++R+PLFPGRDH+HQ+RL+ E+IGTP++ ELGF+ NE+A+KY+
Sbjct: 214 YSAAIDVWSVGCIFMELINRQPLFPGRDHMHQMRLITEVIGTPTDDELGFIRNEDARKYM 273

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
             LP+Y R++F   FP V P+A+DL+E+MLTF+P QRITVE+AL HPYL  LHDI+DEP+
Sbjct: 274 RHLPQYPRRTFASMFPRVQPAALDLIERMLTFNPLQRITVEEALDHPYLERLHDIADEPI 333

Query: 266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           C+ PFSFDFEQ AL E QMK+LI+ EA+  NP  R
Sbjct: 334 CLEPFSFDFEQKALNEDQMKQLIFNEAIEMNPNIR 368

Involved in disease resistance and abiotic stress tolerance signaling pathways.

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39024|MPK4_ARATH Mitogen-activated protein kinase 4 OS=Arabidopsis thaliana GN=MPK4 PE=1 SV=2

 Score =  431 bits (1108), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 195/273 (71%), Positives = 239/273 (87%), Gaps = 1/273 (0%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +V+A++DII PPQRE+FNDVYI YELMDTDLHQIIRSNQ L+++HC++FLYQ+LRGLKY+
Sbjct: 101 NVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYV 160

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLK+ DFGLAR  SETDFMTEYVVTRWYRAPELLLN S+
Sbjct: 161 HSANVLHRDLKPSNLLLNANCDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSE 220

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
           YTAAID+WSVGCI  E M R+PLFPG+D+VHQLRL+ ELIG+P ++ LGFL ++NA++Y+
Sbjct: 221 YTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYV 280

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
            QLP+Y RQ+F  +FPN+   A+DL+EKML FDP +RITV++AL HPYL  LHDI++EPV
Sbjct: 281 RQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPV 340

Query: 266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPE 298
           C+ PF+FDFEQ  LTE  +KELIY+E + FNP+
Sbjct: 341 CVRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Involved in root hair development process. Negative regulator of systemic acquired resistance (SAR) and salicylic acid- (SA) mediated defense response. Required for jasmonic acid- (JA) mediated defense gene expression. May regulate activity of transcription factor controlling pathogenesis-related (PR) gene expression. Seems to act independently of the SAR regulatory protein NPR1 (Nonexpresser of PR1). Phosphorylates MKS1 and transcription factors WRKY25 and WRKY33. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). May act as negative regulator of salt tolerance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9M1Z5|MPK10_ARATH Mitogen-activated protein kinase 10 OS=Arabidopsis thaliana GN=MPK10 PE=1 SV=1

 Score =  427 bits (1099), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 201/272 (73%), Positives = 236/272 (86%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           ++VAIRD+I PPQR+SF DVYI  ELM+ DL++ ++S+Q L+++H  YF+YQILRGLKYI
Sbjct: 118 NIVAIRDVILPPQRDSFEDVYIVNELMEFDLYRTLKSDQELTKDHGMYFMYQILRGLKYI 177

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLL+  CDLKICDFGLAR T E++ MTEYVVTRWYRAPELLL SSD
Sbjct: 178 HSANVLHRDLKPSNLLLSTQCDLKICDFGLARATPESNLMTEYVVTRWYRAPELLLGSSD 237

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFME+M+R+PLFPG+D V+QLRLL+ELIGTPSE ELG L+E AK+YI 
Sbjct: 238 YTAAIDVWSVGCIFMEIMNREPLFPGKDQVNQLRLLLELIGTPSEEELGSLSEYAKRYIR 297

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP   RQSFTEKFPNV P AIDLVEKMLTFDP+QRI+V++ALAHPYL S HDI+DEP C
Sbjct: 298 QLPTLPRQSFTEKFPNVPPLAIDLVEKMLTFDPKQRISVKEALAHPYLSSFHDITDEPEC 357

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPE 298
             PF+FD ++H  +E Q +ELIY EALAFNPE
Sbjct: 358 SEPFNFDLDEHPFSEEQFRELIYCEALAFNPE 389

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	302
255567750	402	big map kinase/bmk, putative [Ricinus co	0.913	0.686	0.938	1e-152
7649153	389	mitogen-activated protein kinase [Euphor	0.913	0.709	0.931	1e-151
224095467	363	predicted protein [Populus trichocarpa]	0.910	0.757	0.927	1e-151
449452881	405	PREDICTED: mitogen-activated protein kin	0.913	0.681	0.934	1e-151
351721680	391	mitogen-activated protein kinase 2 [Glyc	0.910	0.703	0.927	1e-150
585454	394	RecName: Full=Mitogen-activated protein	0.910	0.697	0.930	1e-150
357475629	387	Mitogen-activated protein kinase [Medica	0.910	0.710	0.930	1e-150
585519	387	RecName: Full=Mitogen-activated protein	0.910	0.710	0.930	1e-150
71068415	397	mitogen-activated protein kinase 1 [Arac	0.907	0.690	0.927	1e-150
356521451	433	PREDICTED: mitogen-activated protein kin	0.910	0.635	0.927	1e-150

>gi|255567750|ref|XP_002524853.1| big map kinase/bmk, putative [Ricinus communis] gi|223535816|gb|EEF37477.1| big map kinase/bmk, putative [Ricinus communis]

 Score =  543 bits (1400), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 259/276 (93%), Positives = 269/276 (97%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VVAIRDIIPPP+RE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 127 NVVAIRDIIPPPKRELFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 186

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 187 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 246

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEAELGFLNENAK+YI 
Sbjct: 247 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEAELGFLNENAKRYIR 306

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP Y+RQSFT+KFPNVHP+AIDLVEKMLTFDPR RITVEDALAHPYL SLHDISDEPVC
Sbjct: 307 QLPLYRRQSFTDKFPNVHPAAIDLVEKMLTFDPRLRITVEDALAHPYLTSLHDISDEPVC 366

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 302
            +PFSFDFEQHALTE QMKELIY+EALAFNPEY+QQ
Sbjct: 367 TTPFSFDFEQHALTEDQMKELIYREALAFNPEYQQQ 402

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7649153|gb|AAF65766.1|AF242308_1 mitogen-activated protein kinase [Euphorbia esula]

 Score =  541 bits (1395), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 257/276 (93%), Positives = 268/276 (97%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 114 NVVAIRDIMPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 173

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 174 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 233

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE ELGFLNENAK+YI 
Sbjct: 234 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEELGFLNENAKRYIR 293

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           Q+  ++RQSFTEKFP VHP+AIDLVEKMLTFDPRQRITVEDALAHPYL SLHDISDEPVC
Sbjct: 294 QMSVFRRQSFTEKFPTVHPAAIDLVEKMLTFDPRQRITVEDALAHPYLTSLHDISDEPVC 353

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 302
           M+PFSFDFEQHALTE QMKELIY+EALAFNPEY+QQ
Sbjct: 354 MTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQQ 389

Source: Euphorbia esula

Species: Euphorbia esula

Genus: Euphorbia

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224095467|ref|XP_002310398.1| predicted protein [Populus trichocarpa] gi|222853301|gb|EEE90848.1| predicted protein [Populus trichocarpa]

 Score =  540 bits (1392), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 255/275 (92%), Positives = 268/275 (97%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ LSEEHCQYFLYQILRGLKYI
Sbjct: 89  NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQVLSEEHCQYFLYQILRGLKYI 148

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 149 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 208

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGC+FMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEAELGFLNENAK+YI 
Sbjct: 209 YTAAIDVWSVGCVFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEAELGFLNENAKRYIR 268

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP ++RQSFTEKFP VHP+AIDL+EKMLTFDPRQRITVE+ALAHPYL SLHDISDEP+C
Sbjct: 269 QLPLHRRQSFTEKFPTVHPAAIDLIEKMLTFDPRQRITVEEALAHPYLTSLHDISDEPIC 328

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 301
           M+PFSFDFEQHALTE QMKELIY+EALAFNPEY+ 
Sbjct: 329 MTPFSFDFEQHALTEEQMKELIYREALAFNPEYQN 363

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452881|ref|XP_004144187.1| PREDICTED: mitogen-activated protein kinase homolog MMK1-like [Cucumis sativus] gi|449511404|ref|XP_004163946.1| PREDICTED: mitogen-activated protein kinase homolog MMK1-like [Cucumis sativus]

 Score =  539 bits (1389), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 258/276 (93%), Positives = 266/276 (96%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VVAIRDIIPPP RE+FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 130 NVVAIRDIIPPPLRETFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 189

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 190 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 249

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK+YI 
Sbjct: 250 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLLELIGTPSEADLGFLNENAKRYIR 309

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP Y RQSFTEKFP+VHP+AIDLVEKMLTFDP QRITVEDALAHPYL SLHDISDEPVC
Sbjct: 310 QLPHYHRQSFTEKFPHVHPAAIDLVEKMLTFDPGQRITVEDALAHPYLTSLHDISDEPVC 369

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 302
           M+PFSFDFEQHALTE QMKELIY EALAFNPEY  Q
Sbjct: 370 MTPFSFDFEQHALTEEQMKELIYLEALAFNPEYHHQ 405

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351721680|ref|NP_001235426.1| mitogen-activated protein kinase 2 [Glycine max] gi|33340593|gb|AAQ14867.1|AF329506_1 mitogen-activated protein kinase 2 [Glycine max]

 Score =  538 bits (1386), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 255/275 (92%), Positives = 267/275 (97%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQ LSEEHCQYFLYQILRGLKYI
Sbjct: 117 NVVAIRDIVPPPQREIFNDVYIAYELMDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYI 176

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 177 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 236

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK+YI 
Sbjct: 237 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAKRYIR 296

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISDEPVC
Sbjct: 297 QLPLYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISDEPVC 356

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 301
           M+PF+FDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 357 MTPFNFDFEQHALTEEQMKELIYREALAFNPEYQQ 391

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|585454|sp|Q06060.1|MAPK_PEA RecName: Full=Mitogen-activated protein kinase homolog D5 gi|20808|emb|CAA50036.1| MAP kinase homologue [Pisum sativum]

 Score =  538 bits (1386), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 256/275 (93%), Positives = 267/275 (97%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 120 NVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 179

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 180 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 239

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK+YI 
Sbjct: 240 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAKRYIR 299

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPRQRITVE+ALAHPYL SLHDISDEPVC
Sbjct: 300 QLPLYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRQRITVENALAHPYLTSLHDISDEPVC 359

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 301
            +PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 360 TTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 394

Source: Pisum sativum

Species: Pisum sativum

Genus: Pisum

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357475629|ref|XP_003608100.1| Mitogen-activated protein kinase [Medicago truncatula] gi|355509155|gb|AES90297.1| Mitogen-activated protein kinase [Medicago truncatula]

 Score =  538 bits (1385), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 256/275 (93%), Positives = 266/275 (96%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 113 NVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 172

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 173 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 232

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE +LGFLNENAK+YI 
Sbjct: 233 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEDDLGFLNENAKRYIR 292

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP Y+RQSF EKFP VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISDEPVC
Sbjct: 293 QLPPYRRQSFQEKFPQVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISDEPVC 352

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 301
           M+PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 353 MTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 387

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|585519|sp|Q07176.1|MMK1_MEDSA RecName: Full=Mitogen-activated protein kinase homolog MMK1; AltName: Full=MAP kinase ERK1; AltName: Full=MAP kinase MSK7 gi|289125|gb|AAB41548.1| MAP kinase [Medicago sativa] gi|298019|emb|CAA47099.1| MAP Kinase [Medicago sativa]

 Score =  537 bits (1384), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 256/275 (93%), Positives = 267/275 (97%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 113 NVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 172

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 173 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 232

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE +LGFLNENAK+YI 
Sbjct: 233 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEDDLGFLNENAKRYIR 292

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISDEPVC
Sbjct: 293 QLPPYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISDEPVC 352

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 301
           M+PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 353 MTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 387

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|71068415|gb|AAZ23128.1| mitogen-activated protein kinase 1 [Arachis hypogaea]

 Score =  537 bits (1383), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 254/274 (92%), Positives = 267/274 (97%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VVAIRDI+PPPQRE+FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 124 NVVAIRDIVPPPQREAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 183

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET+FMTEYVVTRWYRAPELLLNSSD
Sbjct: 184 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETNFMTEYVVTRWYRAPELLLNSSD 243

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK+YI 
Sbjct: 244 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAKRYIR 303

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP Y+RQSF EKFP VHP+AIDLVEKMLTFDPRQRITVEDALAHPYL SLHDISDEPVC
Sbjct: 304 QLPLYRRQSFQEKFPQVHPAAIDLVEKMLTFDPRQRITVEDALAHPYLTSLHDISDEPVC 363

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           M+PF+FDFE HALTE QMKELIY+EALAFNPEY+
Sbjct: 364 MTPFNFDFEHHALTEEQMKELIYREALAFNPEYQ 397

Source: Arachis hypogaea

Species: Arachis hypogaea

Genus: Arachis

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356521451|ref|XP_003529369.1| PREDICTED: mitogen-activated protein kinase homolog MMK1-like isoform 1 [Glycine max]

 Score =  536 bits (1382), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 255/275 (92%), Positives = 267/275 (97%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct: 159 NVVAIRDIVPPPQREIFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 218

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD
Sbjct: 219 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 278

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK+YI 
Sbjct: 279 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAKRYIR 338

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISDEPVC
Sbjct: 339 QLPLYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISDEPVC 398

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 301
           ++PFSFDFEQHALTE QMKELIY+EALAFN EY+Q
Sbjct: 399 LTPFSFDFEQHALTEEQMKELIYREALAFNLEYQQ 433

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	302
TAIR|locus:2043904	395	MPK6 "MAP kinase 6" [Arabidops	0.910	0.696	0.890	2.1e-132
TAIR|locus:2085632	370	MPK3 "mitogen-activated protei	0.903	0.737	0.759	1.5e-115
TAIR|locus:2124943	376	MPK4 "MAP kinase 4" [Arabidops	0.900	0.723	0.714	2.3e-110
TAIR|locus:2080457	393	MPK10 "MAP kinase 10" [Arabido	0.900	0.692	0.738	4.3e-109
TAIR|locus:2128263	376	MPK5 "MAP kinase 5" [Arabidops	0.897	0.720	0.698	2.2e-105
TAIR|locus:2025341	369	MPK11 "MAP kinase 11" [Arabido	0.897	0.734	0.694	2.8e-105
TAIR|locus:2026484	363	ATMPK13 [Arabidopsis thaliana	0.890	0.741	0.688	2e-104
TAIR|locus:2062897	372	MPK12 "mitogen-activated prote	0.903	0.733	0.631	1e-98
DICTYBASE|DDB_G0286353	529	erkA "mitogen-activated protei	0.900	0.514	0.6	3.6e-89
TAIR|locus:2053119	368	MPK7 "MAP kinase 7" [Arabidops	0.897	0.736	0.536	1.2e-81

TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1298 (462.0 bits), Expect = 2.1e-132, P = 2.1e-132
 Identities = 245/275 (89%), Positives = 258/275 (93%)

Query:    27 SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
             ++VAIRDIIPPP R +FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
Sbjct:   121 NIVAIRDIIPPPLRNAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 180

Query:    87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
             HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE+DFMTEYVVTRWYRAPELLLNSSD
Sbjct:   181 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSESDFMTEYVVTRWYRAPELLLNSSD 240

Query:   147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
             YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE EL FLNENAK+YI 
Sbjct:   241 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEELEFLNENAKRYIR 300

Query:   207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
             QLP Y RQS T+KFP VHP AIDL+EKMLTFDPR+RITV DALAHPYL SLHDISDEP C
Sbjct:   301 QLPPYPRQSITDKFPTVHPLAIDLIEKMLTFDPRRRITVLDALAHPYLNSLHDISDEPEC 360

Query:   267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 301
               PF+FDFE HAL+E QMKELIY+EALAFNPEY+Q
Sbjct:   361 TIPFNFDFENHALSEEQMKELIYREALAFNPEYQQ 395

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0006979 "response to oxidative stress" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0007165 "signal transduction" evidence=IC

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0009723 "response to ethylene stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=IGI;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0009574 "preprophase band" evidence=IDA

GO:0048364 "root development" evidence=IMP

GO:0051301 "cell division" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1139 (406.0 bits), Expect = 1.5e-115, P = 1.5e-115
 Identities = 208/274 (75%), Positives = 241/274 (87%)

Query:    27 SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
             +++AIRD++PPP R  F+DVYI+ ELMDTDLHQIIRSNQ+LSEEHCQYFLYQ+LRGLKYI
Sbjct:    96 NIIAIRDVVPPPLRRQFSDVYISTELMDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYI 155

Query:    87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
             HSAN++HRDLKPSNLLLNANCDLKICDFGLAR TSE DFMTEYVVTRWYRAPELLLNSSD
Sbjct:   156 HSANIIHRDLKPSNLLLNANCDLKICDFGLARPTSENDFMTEYVVTRWYRAPELLLNSSD 215

Query:   147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
             YTAAIDVWSVGCIFMELM+RKPLFPG+DHVHQ+RLL EL+GTP+E++LGF  NE+AK+YI
Sbjct:   216 YTAAIDVWSVGCIFMELMNRKPLFPGKDHVHQMRLLTELLGTPTESDLGFTHNEDAKRYI 275

Query:   206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
              QLP + RQ   + F +V+P AIDLV++MLTFDP +RITVE AL H YL  LHD +DEP+
Sbjct:   276 RQLPNFPRQPLAKLFSHVNPMAIDLVDRMLTFDPNRRITVEQALNHQYLAKLHDPNDEPI 335

Query:   266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY 299
             C  PFSF+FEQ  L E Q+KE+IYQEA+A NP Y
Sbjct:   336 CQKPFSFEFEQQPLDEEQIKEMIYQEAIALNPTY 369

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0006979 "response to oxidative stress" evidence=IEP;TAS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=IC

GO:0000169 "activation of MAPK activity involved in osmosensory signaling pathway" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009611 "response to wounding" evidence=IEP

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0009617 "response to bacterium" evidence=IEP;RCA

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0001666 "response to hypoxia" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1090 (388.8 bits), Expect = 2.3e-110, P = 2.3e-110
 Identities = 195/273 (71%), Positives = 239/273 (87%)

Query:    27 SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
             +V+A++DII PPQRE+FNDVYI YELMDTDLHQIIRSNQ L+++HC++FLYQ+LRGLKY+
Sbjct:   101 NVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYV 160

Query:    87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
             HSANVLHRDLKPSNLLLNANCDLK+ DFGLAR  SETDFMTEYVVTRWYRAPELLLN S+
Sbjct:   161 HSANVLHRDLKPSNLLLNANCDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSE 220

Query:   147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
             YTAAID+WSVGCI  E M R+PLFPG+D+VHQLRL+ ELIG+P ++ LGFL ++NA++Y+
Sbjct:   221 YTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYV 280

Query:   206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
              QLP+Y RQ+F  +FPN+   A+DL+EKML FDP +RITV++AL HPYL  LHDI++EPV
Sbjct:   281 RQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPV 340

Query:   266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPE 298
             C+ PF+FDFEQ  LTE  +KELIY+E + FNP+
Sbjct:   341 CVRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0009868 "jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA;IMP;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=RCA;IDA

GO:0006972 "hyperosmotic response" evidence=RCA;IMP

GO:0042539 "hypotonic salinity response" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0009620 "response to fungus" evidence=IMP

GO:0009861 "jasmonic acid and ethylene-dependent systemic resistance" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007112 "male meiosis cytokinesis" evidence=IMP

GO:0009555 "pollen development" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2080457 MPK10 "MAP kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1078 (384.5 bits), Expect = 4.3e-109, P = 4.3e-109
 Identities = 201/272 (73%), Positives = 236/272 (86%)

Query:    27 SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
             ++VAIRD+I PPQR+SF DVYI  ELM+ DL++ ++S+Q L+++H  YF+YQILRGLKYI
Sbjct:   118 NIVAIRDVILPPQRDSFEDVYIVNELMEFDLYRTLKSDQELTKDHGMYFMYQILRGLKYI 177

Query:    87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
             HSANVLHRDLKPSNLLL+  CDLKICDFGLAR T E++ MTEYVVTRWYRAPELLL SSD
Sbjct:   178 HSANVLHRDLKPSNLLLSTQCDLKICDFGLARATPESNLMTEYVVTRWYRAPELLLGSSD 237

Query:   147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
             YTAAIDVWSVGCIFME+M+R+PLFPG+D V+QLRLL+ELIGTPSE ELG L+E AK+YI 
Sbjct:   238 YTAAIDVWSVGCIFMEIMNREPLFPGKDQVNQLRLLLELIGTPSEEELGSLSEYAKRYIR 297

Query:   207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
             QLP   RQSFTEKFPNV P AIDLVEKMLTFDP+QRI+V++ALAHPYL S HDI+DEP C
Sbjct:   298 QLPTLPRQSFTEKFPNVPPLAIDLVEKMLTFDPKQRISVKEALAHPYLSSFHDITDEPEC 357

Query:   267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPE 298
               PF+FD ++H  +E Q +ELIY EALAFNPE
Sbjct:   358 SEPFNFDLDEHPFSEEQFRELIYCEALAFNPE 389

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1043 (372.2 bits), Expect = 2.2e-105, P = 2.2e-105
 Identities = 190/272 (69%), Positives = 238/272 (87%)

Query:    27 SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
             +VV I+DII PP++E F DVYI +ELMDTDLHQIIRSNQ+L+++HCQYFLYQILRGLKYI
Sbjct:   101 NVVVIKDIIRPPKKEDFVDVYIVFELMDTDLHQIIRSNQSLNDDHCQYFLYQILRGLKYI 160

Query:    87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
             HSANVLHRDLKPSNLLLN+NCDLKI DFGLAR TSET++MTEYVVTRWYRAPELLLNSS+
Sbjct:   161 HSANVLHRDLKPSNLLLNSNCDLKITDFGLARTTSETEYMTEYVVTRWYRAPELLLNSSE 220

Query:   147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE-NAKKYI 205
             YT+AIDVWSVGCIF E+M R+PLFPG+D+VHQL+L+ ELIG+P  A L FL   NA+KY+
Sbjct:   221 YTSAIDVWSVGCIFAEIMTREPLFPGKDYVHQLKLITELIGSPDGASLEFLRSANARKYV 280

Query:   206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
              +LP++ RQ+F+ +FP+++ +AIDL+EKML FDP +RITVE+AL +PYL +LHD++DEPV
Sbjct:   281 KELPKFPRQNFSARFPSMNSTAIDLLEKMLVFDPVKRITVEEALCYPYLSALHDLNDEPV 340

Query:   266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
             C + FSF FE  + TE ++KEL++ E++ FNP
Sbjct:   341 CSNHFSFHFEDPSSTEEEIKELVWLESVKFNP 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 1042 (371.9 bits), Expect = 2.8e-105, P = 2.8e-105
 Identities = 189/272 (69%), Positives = 235/272 (86%)

Query:    27 SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
             +V+AI DII PPQ ++FNDV+I YELMDTDLH IIRSNQ L+++H ++FLYQ+LRGLKY+
Sbjct:    98 NVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHIIRSNQPLTDDHSRFFLYQLLRGLKYV 157

Query:    87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
             HSANVLHRDLKPSNLLLNANCDLKI DFGLAR  SETDFMTEYVVTRWYRAPELLLN S+
Sbjct:   158 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSE 217

Query:   147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
             YTAAID+WSVGCI  E+M R+PLFPGRD+V QLRL+ ELIG+P ++ LGFL ++NA++Y+
Sbjct:   218 YTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLRLITELIGSPDDSSLGFLRSDNARRYV 277

Query:   206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
              QLP+Y RQ+F  +FPN+  +A+DL++KML FDP +RITV++AL HPYL  LH+ ++EPV
Sbjct:   278 RQLPQYPRQNFAARFPNMSVNAVDLLQKMLVFDPNRRITVDEALCHPYLAPLHEYNEEPV 337

Query:   266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
             C+ PF FDFEQ +LTE  +KELIY+E++ FNP
Sbjct:   338 CVRPFHFDFEQPSLTEENIKELIYRESVKFNP 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)]

 Score = 1034 (369.0 bits), Expect = 2.0e-104, P = 2.0e-104
 Identities = 186/270 (68%), Positives = 232/270 (85%)

Query:    27 SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
             +V+ I+DII  P++E F DVYI YELMDTDLHQIIRS Q L+++HCQYFLYQILRGLKYI
Sbjct:    91 NVIKIKDIIELPEKERFEDVYIVYELMDTDLHQIIRSTQTLTDDHCQYFLYQILRGLKYI 150

Query:    87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
             HSANVLHRDLKPSNL+LN NCDLKICDFGLAR ++ET+ MTEYVVTRWYRAPELLLNSS+
Sbjct:   151 HSANVLHRDLKPSNLVLNTNCDLKICDFGLARTSNETEIMTEYVVTRWYRAPELLLNSSE 210

Query:   147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
             YT AID+WSVGCIFME++ R+ LFPG+D+V QL+L+ EL+G+P +++L FL ++NA+KY+
Sbjct:   211 YTGAIDIWSVGCIFMEILRRETLFPGKDYVQQLKLITELLGSPDDSDLDFLRSDNARKYV 270

Query:   206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
              QLP  Q+QSF EKFPN+ P A+DL EKML FDP +RITV++AL  PYL SLH+I++EP 
Sbjct:   271 KQLPHVQKQSFREKFPNISPMALDLAEKMLVFDPSKRITVDEALKQPYLASLHEINEEPT 330

Query:   266 CMSPFSFDFEQHALTEGQMKELIYQEALAF 295
             C +PFSFDFE+ AL E  +KEL+++E+L F
Sbjct:   331 CPTPFSFDFEETALDEQDIKELVWRESLHF 360

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2062897 MPK12 "mitogen-activated protein kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
 Identities = 173/274 (63%), Positives = 228/274 (83%)

Query:    27 SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
             +V+ I+DI+ PPQR+ FNDVYI YELMDTDL +I+RSNQ L+ + C++ +YQ+LRGLKY+
Sbjct:    99 NVITIKDIVRPPQRDIFNDVYIVYELMDTDLQRILRSNQTLTSDQCRFLVYQLLRGLKYV 158

Query:    87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
             HSAN+LHRDL+PSN+LLN+  +LKI DFGLAR TS+TDFMTEYVVTRWYRAPELLLN S+
Sbjct:   159 HSANILHRDLRPSNVLLNSKNELKIGDFGLARTTSDTDFMTEYVVTRWYRAPELLLNCSE 218

Query:   147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
             YTAAID+WSVGCI  E+M  +PLFPG+D+VHQLRL+ EL+G+P  + LGFL ++NA++Y+
Sbjct:   219 YTAAIDIWSVGCILGEIMTGQPLFPGKDYVHQLRLITELVGSPDNSSLGFLRSDNARRYV 278

Query:   206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
              QLPRY +Q F  +FP +  +AIDL+E+ML FDP +RI+V++AL H YL   HD++ EPV
Sbjct:   279 RQLPRYPKQQFAARFPKMPTTAIDLLERMLVFDPNRRISVDEALGHAYLSPHHDVAKEPV 338

Query:   266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY 299
             C +PFSFDFE  + TE  +KELIY+E++ FNP++
Sbjct:   339 CSTPFSFDFEHPSCTEEHIKELIYKESVKFNPDH 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

GO:0007243 "intracellular protein kinase cascade" evidence=IC

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0080026 "response to indolebutyric acid stimulus" evidence=IMP

DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 890 (318.4 bits), Expect = 3.6e-89, P = 3.6e-89
 Identities = 165/275 (60%), Positives = 211/275 (76%)

Query:    27 SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
             ++++I+DI+ P  +E F DVYI  ELMDTDLHQII S Q LS++HCQYF+YQ+LRGLK+I
Sbjct:   207 NLISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHI 266

Query:    87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNS 144
             HSANVLHRDLKPSNLL+N +C LKICD GLARV   T   FMTEYV TRWYRAPE++L+ 
Sbjct:   267 HSANVLHRDLKPSNLLINEDCLLKICDLGLARVEDATHQGFMTEYVATRWYRAPEVILSW 326

Query:   145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKK 203
             + YT AID+WSVGCIF EL+ RKPLF G+D++HQ+ L+IE IG+PSE ++    NE A++
Sbjct:   327 NKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNIANEQARQ 386

Query:   204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
             +I  +    + +F   FP  +P AIDL+E+ML FDP +R+TVE+ALAHPY  SLHD SDE
Sbjct:   387 FIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYFQSLHDPSDE 446

Query:   264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE 298
             P+C+  FS +FE   L    +KELIY E LA++PE
Sbjct:   447 PICLHKFSLNFEAWDLNRDLLKELIYNEMLAYHPE 481

GO:0030587 "sorocarp development" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2053119 MPK7 "MAP kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 819 (293.4 bits), Expect = 1.2e-81, P = 1.2e-81
 Identities = 147/274 (53%), Positives = 208/274 (75%)

Query:    27 SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
             +V+A++D++ P  R SF DVY+ YELMDTDLHQII+S+Q+LS++HC+YFL+Q+LRGLKY+
Sbjct:    90 NVIALKDVMLPANRSSFKDVYLVYELMDTDLHQIIKSSQSLSDDHCKYFLFQLLRGLKYL 149

Query:    87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSS 145
             HSAN+LHRDLKP NLL+NANCDLKICDFGLAR +   + FMTEYVVTRWYRAPELLL   
Sbjct:   150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSQGNEQFMTEYVVTRWYRAPELLLCCD 209

Query:   146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
             +Y  +IDVWSVGCIF E++ RKP+FPG + ++QL+L+I ++G+  E+++ F+ N  A+++
Sbjct:   210 NYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIINVVGSQQESDIRFIDNPKARRF 269

Query:   205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
             I  LP  +    +  +P  +P AIDL+++ML FDP +RI+V DAL HPY+  L D    P
Sbjct:   270 IKSLPYSRGTHLSNLYPQANPLAIDLLQRMLVFDPTKRISVTDALLHPYMAGLFDPGSNP 329

Query:   265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE 298
                 P S D +++ + E  ++E+++ E L ++PE
Sbjct:   330 PAHVPISLDIDEN-MEEPVIREMMWNEMLYYHPE 362

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0007623 "circadian rhythm" evidence=TAS

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q06060	MAPK_PEA	2, ., 7, ., 1, 1, ., 2, 4	0.9309	0.9105	0.6979	N/A	no
Q84UI5	MPK1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.9014	0.9072	0.6884	yes	no
P40417	ERKA_DROME	2, ., 7, ., 1, 1, ., 2, 4	0.5145	0.8874	0.6291	yes	no
Q40531	NTF6_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.7132	0.8973	0.7304	N/A	no
P28482	MK01_HUMAN	2, ., 7, ., 1, 1, ., 2, 4	0.5340	0.9039	0.7583	yes	no
Q40532	NTF4_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.9127	0.9105	0.6997	N/A	no
Q39026	MPK6_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8909	0.9105	0.6962	yes	no
A2XFC8	MPK5_ORYSI	2, ., 7, ., 1, 1, ., 2, 4	0.7418	0.9072	0.7425	N/A	no
P27638	SPK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 4	0.5218	0.8741	0.7096	yes	no
P63085	MK01_MOUSE	2, ., 7, ., 1, 1, ., 2, 4	0.5340	0.9039	0.7625	yes	no
Q07176	MMK1_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.9309	0.9105	0.7105	N/A	no
P63086	MK01_RAT	2, ., 7, ., 1, 1, ., 2, 4	0.5340	0.9039	0.7625	yes	no
Q40353	MMK2_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.7032	0.9006	0.7331	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.991
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	302
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.0
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-162
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-144
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-129
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-121
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-119
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-117
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-101
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-101
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-95
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-94
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-89
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-88
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-87
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-87
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-82
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-81
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-78
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-77
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-75
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-74
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-72
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-72
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-70
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-69
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-67
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-66
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-65
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-65
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-62
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-62
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-61
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-61
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-60
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-60
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-60
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-60
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-58
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-57
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-57
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-56
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-55
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-54
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-54
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-53
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-52
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-50
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-50
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-49
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-47
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-46
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-46
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-43
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-42
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-40
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-39
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-37
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-34
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-33
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-31
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-28
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-27
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-26
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-23
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-22
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-22
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-19
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-18
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-18
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-18
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-18
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-17
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-17
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-17
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-16
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-14
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-14
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-14
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-14
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-13
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-13
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-13
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-10
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-09
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	2e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	5e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	6e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	0.002

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  550 bits (1420), Expect = 0.0
 Identities = 208/272 (76%), Positives = 238/272 (87%), Gaps = 2/272 (0%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           V+AI+DI+PPP RE+FNDVYI YELMDTDLHQIIRS+Q LS++HCQYFLYQ+LRGLKYIH
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125

Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSD 146
           SANVLHRDLKPSNLLLNANCDLKICDFGLAR TSE  DFMTEYVVTRWYRAPELLLN S+
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE 185

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
           YT AIDVWSVGCIF EL+ RKPLFPG+D+VHQL+L+ EL+G+PSE +LGF+ NE A++YI
Sbjct: 186 YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYI 245

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
             LP   RQSF   FP+ +P AIDL+EKML FDP +RITVE+ALAHPYL SLHD SDEPV
Sbjct: 246 RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV 305

Query: 266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           C +PFSFDFE+ ALTE  +KELIY E LA++P
Sbjct: 306 CQTPFSFDFEEDALTEEDIKELIYNEMLAYHP 337

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  454 bits (1171), Expect = e-162
 Identities = 168/270 (62%), Positives = 211/270 (78%), Gaps = 6/270 (2%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++ + DI+ PP  E FNDVYI  ELM+TDLH++I+S Q L+++H QYFLYQILRGLKY+H
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120

Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARVT----SETDFMTEYVVTRWYRAPELLLN 143
           SANV+HRDLKPSN+L+N+NCDLKICDFGLAR       E  F+TEYVVTRWYRAPELLL+
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF-LNENAK 202
           SS YT AID+WSVGCIF EL+ RKPLFPGRD++ QL L++E++GTPSE +L F  +E A+
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240

Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 262
            Y+  LP+  ++  ++ FP   P AIDL+EKML FDP++RIT ++ALAHPYL  LHD  D
Sbjct: 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300

Query: 263 EPVCMSPFSFDFEQHA-LTEGQMKELIYQE 291
           EPV   PF FDF     LTE ++KELIY+E
Sbjct: 301 EPVAKPPFDFDFFDDDELTEEELKELIYEE 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  408 bits (1052), Expect = e-144
 Identities = 163/272 (59%), Positives = 207/272 (76%), Gaps = 7/272 (2%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++ I DII PP  ESFNDVYI  ELM+TDL+++I++ Q LS +H QYFLYQILRGLKYIH
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIH 123

Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE----TDFMTEYVVTRWYRAPELLLN 143
           SANVLHRDLKPSNLLLN NCDLKICDFGLAR+       T F+TEYV TRWYRAPE++LN
Sbjct: 124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAK 202
           S  YT AID+WSVGCI  E++  +PLFPG+D++HQL L++ ++GTPS+ +L   ++  A+
Sbjct: 184 SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRAR 243

Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 262
            YI  LP   +  + + FPN  P A+DL++KMLTF+P +RITVE+ALAHPYL   HD SD
Sbjct: 244 NYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303

Query: 263 EPVCMSPFSFDFEQH-ALTEGQMKELIYQEAL 293
           EPV   PF FDFE    L + ++KELI++E +
Sbjct: 304 EPVAEEPFPFDFELFDDLPKEKLKELIFEEIM 335

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  370 bits (952), Expect = e-129
 Identities = 154/273 (56%), Positives = 202/273 (73%), Gaps = 13/273 (4%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++AIRDI+ PP  + F DVY+  +LM++DLH II S+Q L+EEH +YFLYQ+LRGLKYIH
Sbjct: 66  IIAIRDILRPPGAD-FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124

Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETD---FMTEYVVTRWYRAPELLL 142
           SANV+HRDLKPSNLL+N +C+L+I DFG+AR   +S T+   FMTEYV TRWYRAPELLL
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN---- 198
           +  +YT AID+WSVGCIF E++ R+ LFPG+++VHQL+L++ ++G+PSE     LN    
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE---EVLNRIGS 241

Query: 199 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 258
           +  +KYI  LPR Q   +++ FP   P A+DL+ +ML FDP +RITVE AL HP+L   H
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301

Query: 259 DISDEPVCMSPFSFDFEQHALTEGQMKELIYQE 291
           D  DEP C  PF FDFE   L+  Q+KE I +E
Sbjct: 302 DPDDEPTCPPPFDFDFEAIELSREQLKEAIVKE 334

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  350 bits (901), Expect = e-121
 Identities = 147/265 (55%), Positives = 189/265 (71%), Gaps = 10/265 (3%)

Query: 33  DIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVL 92
           DI+ P    +FN++Y+  ELM+ DLHQIIRS Q L++ H Q F+YQIL GLKYIHSANVL
Sbjct: 71  DIVFP---GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVL 127

Query: 93  HRDLKPSNLLLNANCDLKICDFGLARVTSE-----TDFMTEYVVTRWYRAPELLLNSSDY 147
           HRDLKP NLL+NA+C+LKICDFGLAR  SE       FMTEYV TRWYRAPE++L+   Y
Sbjct: 128 HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSY 187

Query: 148 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENAKKYIC 206
           T AIDVWSVGCI  EL+ RKP+F G+D+V QL  +++++GTP E  L    +  A+ YI 
Sbjct: 188 TKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIR 247

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
            LP   ++ F   FPN +P A+DL+EK+L FDP +RI+VE+AL HPYL   HD  DEPVC
Sbjct: 248 SLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVC 307

Query: 267 MSPFSFDFEQHALTEGQMKELIYQE 291
             PF F FE    +  +++++I +E
Sbjct: 308 QKPFDFSFE-SEDSMEELRDMIIEE 331

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  344 bits (885), Expect = e-119
 Identities = 136/263 (51%), Positives = 177/263 (67%), Gaps = 5/263 (1%)

Query: 36  PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRD 95
           P    E F DVY+   LM  DL+ I++  Q LS++H Q+ +YQILRGLKYIHSA ++HRD
Sbjct: 85  PASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRD 143

Query: 96  LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
           LKPSN+ +N +C+LKI DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WS
Sbjct: 144 LKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201

Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQ 214
           VGCI  EL+  K LFPG DH+ QL+ ++ L+GTP E  L  ++ E+A+ YI  LP+  ++
Sbjct: 202 VGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKK 261

Query: 215 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDF 274
            F E F   +P AIDL+EKML  DP +RIT  +ALAHPYL   HD  DEPV   P+   F
Sbjct: 262 DFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVA-PPYDQSF 320

Query: 275 EQHALTEGQMKELIYQEALAFNP 297
           E   LT  + KEL+Y+E + F P
Sbjct: 321 ESRDLTVDEWKELVYKEIMNFKP 343

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  340 bits (873), Expect = e-117
 Identities = 143/278 (51%), Positives = 195/278 (70%), Gaps = 8/278 (2%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           +V I+ I+ PP R  F D+Y+ +ELM++DLHQ+I++N  L+ EH Q+FLYQ+LR LKYIH
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120

Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARV----TSETDFMTEYVVTRWYRAPELLLN 143
           +ANV HRDLKP N+L NA+C LKICDFGLARV    T    F T+YV TRWYRAPEL  +
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180

Query: 144 -SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS-EAELGFLNENA 201
             S YT AID+WS+GCIF E++  KPLFPG++ VHQL L+ +L+GTPS E      NE A
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240

Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           ++Y+  + + Q   F++KFPN  P A+ L+E++L FDP+ R T E+ALA PY   L  + 
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300

Query: 262 DEPVC--MSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
            EP    ++   F+FE+  LT+  ++ELIY+E L ++P
Sbjct: 301 REPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  300 bits (770), Expect = e-101
 Identities = 131/266 (49%), Positives = 182/266 (68%), Gaps = 8/266 (3%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++++ DI   P      D+Y   EL+ TDLH+++ S + L ++  QYFLYQILRGLKY+
Sbjct: 70  NIISLSDIFISP----LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYV 124

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSA V+HRDLKPSN+L+N NCDLKICDFGLAR+      MT YV TR+YRAPE++L    
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQK 182

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
           Y   +D+WS GCIF E+++ KPLFPG+DHV+Q  ++ +L+GTP +  +  + +EN  +++
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
             LP+ +   F+EKF N  PSAIDL+EKML FDP++RI+  +ALAHPYL   HD +DEPV
Sbjct: 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPV 302

Query: 266 CMSPFSFDFEQHALTEGQMKELIYQE 291
               F + F    L     K ++Y E
Sbjct: 303 AEEKFDWSFNDADLPVDTWKVMMYSE 328

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  299 bits (768), Expect = e-101
 Identities = 115/256 (44%), Positives = 167/256 (65%), Gaps = 9/256 (3%)

Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
            D+Y+ +E M+TDLH +IR+N  L + H +Y +YQ+L+ LKYIHS NV+HRDLKPSN+LL
Sbjct: 82  KDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL 140

Query: 104 NANCDLKICDFGLARVTSETD------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           N++C +K+ DFGLAR  SE +       +T+YV TRWYRAPE+LL S+ YT  +D+WSVG
Sbjct: 141 NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVG 200

Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN-AKKYICQLPRYQRQSF 216
           CI  E++  KPLFPG   ++QL  +IE+IG PS  ++  +    A   +  LP   R+  
Sbjct: 201 CILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPL 260

Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDF-E 275
            E  P     A+DL++K+L F+P +R+T E+AL HPY+   H+ SDEPV   P +    +
Sbjct: 261 DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDD 320

Query: 276 QHALTEGQMKELIYQE 291
              L+  + +  +Y+E
Sbjct: 321 NVKLSVAEYRNKLYEE 336

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  283 bits (726), Expect = 1e-95
 Identities = 102/229 (44%), Positives = 138/229 (60%), Gaps = 7/229 (3%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYI 86
           ++ + D+          D+Y+ +E MDTDL+++I+  Q  L E   + +LYQ+L+GL + 
Sbjct: 60  IIKLLDVFRHKG-----DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC 114

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  +LHRDLKP NLL+N    LK+ DFGLAR   S     T YVVTRWYRAPELLL   
Sbjct: 115 HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y+  +D+WSVGCIF EL+ R+PLFPG+  + QL  +   +GTP           A+ Y 
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              P+       + FPN  P A+DL+ +ML +DP +RIT E ALAHPY 
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  283 bits (725), Expect = 3e-94
 Identities = 127/288 (44%), Positives = 179/288 (62%), Gaps = 26/288 (9%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           V++  DI+ PP  + F ++Y+  ELM +DLH+II S Q LS +H + FLYQILRGLKY+H
Sbjct: 61  VLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120

Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTS--ETDFMTEYVVTRWYRAPELLLNSS 145
           SA +LHRD+KP NLL+N+NC LKICDFGLARV    E+  MT+ VVT++YRAPE+L+ S 
Sbjct: 121 SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSR 180

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            YT+A+D+WSVGCIF EL+ R+ LF  +  + QL L+ +L+GTPS   +    E A+ +I
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI 240

Query: 206 CQLPRYQ--RQS-FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL-------- 254
            + P         +T      H  A+ L+ +ML FDP +RI+  DALAHPYL        
Sbjct: 241 LRGPHKPPSLPVLYTLSSQATH-EAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYH 299

Query: 255 ------------GSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQ 290
                       G ++    EP    PF  ++E++  +  Q+KE ++Q
Sbjct: 300 TCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELHQ 347

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  269 bits (688), Expect = 4e-89
 Identities = 130/273 (47%), Positives = 177/273 (64%), Gaps = 6/273 (2%)

Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 135

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T +   MT YV TRWYRAPE++LN  
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWM 193

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+A+ Y
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253

Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DEP
Sbjct: 254 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 313

Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           V   P+   FE   L   + K L Y E ++F P
Sbjct: 314 VA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 345

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  263 bits (676), Expect = 6e-88
 Identities = 91/229 (39%), Positives = 134/229 (58%), Gaps = 8/229 (3%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYI 86
           +V + D+I      +   +Y+ +E  D DL + +      LS    +  +YQ+LRGL Y 
Sbjct: 60  IVKLLDVIH-----TERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  +LHRDLKP N+L+N +  LK+ DFGLAR         T  VVT WYRAPE+LL S 
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK 174

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y+ A+D+WSVGCIF E++  KPLFPG   + QL  + +++GTP+E     + +    Y 
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL-PDYK 233

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              P++  +   +  P + P  IDL+ KML ++P +RI+ ++AL HPY 
Sbjct: 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  263 bits (674), Expect = 5e-87
 Identities = 121/273 (44%), Positives = 179/273 (65%), Gaps = 6/273 (2%)

Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P    + F+D Y+    M TDL ++++ ++ LSE+  Q+ +YQ+L+GLKY
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKY 133

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IH+A ++HRDLKP NL +N +C+LKI DFGLAR T     MT YVVTRWYRAPE++LN  
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWM 191

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
            YT  +D+WSVGCI  E++  KPLF G DH+ QL  ++++ GTPS+  +  L +E+AK Y
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNY 251

Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           + +LPR++++ F    PN +P A++++EKML  D   RIT  +ALAHPY    HD  DE 
Sbjct: 252 VKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET 311

Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
               P+   F++   +  + K L + E L+F P
Sbjct: 312 E-APPYDDSFDEVDQSLEEWKRLTFTEILSFQP 343

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  263 bits (672), Expect = 9e-87
 Identities = 130/273 (47%), Positives = 178/273 (65%), Gaps = 6/273 (2%)

Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P    E+FN+VY+   LM  DL+ I++  Q LS+EH Q+ +YQ+LRGLKY
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKY 133

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA ++HRDLKPSN+ +N +C+L+I DFGLAR     D MT YV TRWYRAPE++LN  
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD--DEMTGYVATRWYRAPEIMLNWM 191

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
            Y   +D+WSVGCI  EL+  K LFPG D++ QL+ ++E++GTPS   L  + +E+A+KY
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKY 251

Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  LP   +Q   + F   +P AIDL+EKML  D  +RI+  +ALAHPY    HD  DEP
Sbjct: 252 IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEP 311

Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
               P+    E    T  + KEL Y+E  +F P
Sbjct: 312 EA-EPYDESPENKERTIEEWKELTYEEVSSFKP 343

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  250 bits (641), Expect = 4e-82
 Identities = 118/273 (43%), Positives = 165/273 (60%), Gaps = 7/273 (2%)

Query: 27  SVVAIRDI-IPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+       + F D Y+    M TDL +I+     LSE+  QY +YQ+L GLKY
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKY 132

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA ++HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++LN  
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWM 190

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE-NAKKY 204
            Y   +D+WSVGCI  E++  K LF G+D++ QL  ++++ G P    +  L +  AK Y
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY 250

Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  LP+Y R+ F+  FP   P A+DL+EKML  D  +R+T  +AL HPY  S  D  +E 
Sbjct: 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310

Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
               P+    E   L+  + K+ IY+E  +F+P
Sbjct: 311 E-QQPYDDSLENEKLSVDEWKKHIYKEVKSFSP 342

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  250 bits (639), Expect = 1e-81
 Identities = 119/275 (43%), Positives = 163/275 (59%), Gaps = 29/275 (10%)

Query: 38  PQR--ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRD 95
           PQ+  E F DVY+  ELMD +L Q+I     L  E   Y LYQ+L G+K++HSA ++HRD
Sbjct: 86  PQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRD 143

Query: 96  LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
           LKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WS
Sbjct: 144 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWS 202

Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           VGCI  E++    LFPG DH+ Q   +IE +GTPS+  +  L    + Y+   P+Y   S
Sbjct: 203 VGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYS 262

Query: 216 FTEKFPNV-------HPS------AIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 262
           F E FP+V         +      A DL+ KML  DP +RI+V+DAL HPY+   +D S+
Sbjct: 263 FEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE 322

Query: 263 EPVCMSP------FSFDFEQHALTEGQMKELIYQE 291
                +P       S D  +H + E   KELIY+E
Sbjct: 323 ---VEAPPPAPYDHSIDEREHTVEE--WKELIYKE 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  239 bits (612), Expect = 3e-78
 Identities = 85/239 (35%), Positives = 139/239 (58%), Gaps = 23/239 (9%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKY 85
           ++V +++I+    +     +Y+ +E MD DL  ++ S +   +E   + ++ Q+L GL+Y
Sbjct: 59  NIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS--ETDFMTEYVVTRWYRAPELLLN 143
           +HS  +LHRD+K SN+L+N +  LK+ DFGLAR  +   +   T  V+T WYR PELLL 
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
           ++ Y   +D+WSVGCI  EL   KP+F G   + QL  + EL G+P         +    
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP--------TDENWP 227

Query: 204 YICQLPRYQ--------RQSFTEKFPNVH-PSAIDLVEKMLTFDPRQRITVEDALAHPY 253
            + +LP ++        ++   E F ++  PSA+DL++K+LT DP++RI+ + AL H Y
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  238 bits (610), Expect = 2e-77
 Identities = 105/239 (43%), Positives = 151/239 (63%), Gaps = 6/239 (2%)

Query: 42  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
             N VYI  E M+TDL  ++     LSEEH + F+YQ+LRGLKYIHSANVLHRDLKP+N+
Sbjct: 87  ELNSVYIVQEYMETDLANVLEQGP-LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANV 145

Query: 102 LLNA-NCDLKICDFGLARVT----SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
            +N  +  LKI DFGLAR+     S   +++E +VT+WYR+P LLL+ ++YT AID+W+ 
Sbjct: 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 205

Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           GCIF E++  KPLF G   + Q++L++E +    E +   L      ++       R+  
Sbjct: 206 GCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPL 265

Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFE 275
            +  P V+P A+D +E++LTF+P  R+T E+AL HPY+       DEPV + PF  + E
Sbjct: 266 RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDE 324

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  230 bits (590), Expect = 2e-75
 Identities = 80/228 (35%), Positives = 120/228 (52%), Gaps = 33/228 (14%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +V + D+      E  + +Y+  E  +  DL  +++    LSE+  +++L QIL  L+Y+
Sbjct: 59  IVRLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL 113

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HS  ++HRDLKP N+LL+ +  +K+ DFGLAR     + +T +V T  Y APE+LL    
Sbjct: 114 HSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKG- 172

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           Y  A+D+WS+G I  EL+  KP FPG D   QL  L + IG P                 
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKP--------------- 214

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                    F     ++ P A DL+ K+L  DP +R+T E+AL HP+ 
Sbjct: 215 --------PFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  229 bits (586), Expect = 4e-74
 Identities = 88/216 (40%), Positives = 123/216 (56%), Gaps = 16/216 (7%)

Query: 46  VYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           + + +E M+TDL ++I+     L+    + ++   LRGL+Y+HS  +LHRDLKP+NLL+ 
Sbjct: 77  INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA 136

Query: 105 ANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           ++  LK+ DFGLAR   S    MT  VVTRWYRAPELL  +  Y   +D+WSVGCIF EL
Sbjct: 137 SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAEL 196

Query: 164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY------QRQSFT 217
           + R P  PG   + QL  + E +GTP+E                LP Y            
Sbjct: 197 LLRVPFLPGDSDIDQLGKIFEALGTPTEEN----WPGVTS----LPDYVEFKPFPPTPLK 248

Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
           + FP     A+DL++++LT +P +RIT   AL HPY
Sbjct: 249 QIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  224 bits (573), Expect = 2e-72
 Identities = 89/238 (37%), Positives = 138/238 (57%), Gaps = 24/238 (10%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYI 86
           VV + D+ P           +  E M +DL +++R   + L E   + ++  +L+G+ Y+
Sbjct: 61  VVKLLDVFPHGSG-----FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNS 144
           H+  ++HRDLKP+NLL++A+  LKI DFGLAR+ SE +    +  V TRWYRAPELL  +
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
             Y   +D+W+VGCIF EL++  PLFPG + + QL ++   +GTP+E     L       
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT------ 229

Query: 205 ICQLPRYQRQSFTEK--------FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              LP Y + +F E         FP+  P A+DL++ +L +DP +R++  +AL HPY 
Sbjct: 230 --SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  223 bits (570), Expect = 6e-72
 Identities = 90/239 (37%), Positives = 140/239 (58%), Gaps = 27/239 (11%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKY 85
           +V ++++     RE+ +++Y  +E M+ +L+Q+++  +    SE   +  +YQIL+GL +
Sbjct: 60  IVKLKEVF----REN-DELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IH     HRDLKP NLL++    +KI DFGLAR        T+YV TRWYRAPE+LL S+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST 174

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE----------LG 195
            Y++ +D+W++GCI  EL   +PLFPG   + QL  +  ++GTP++ +          LG
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234

Query: 196 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           F          + P++   S  +  PN  P AIDL++ ML +DP++R T   AL HPY 
Sbjct: 235 F----------RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  219 bits (561), Expect = 1e-70
 Identities = 91/229 (39%), Positives = 132/229 (57%), Gaps = 6/229 (2%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR--SNQALSEEHCQYFLYQILRGLKY 85
           +V + D+   P+ +    + + +E +D DL   +       L  E  +  + Q+LRG+ +
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HS  ++HRDLKP N+L+ ++  +KI DFGLAR+ S    +T  VVT WYRAPE+LL SS
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS 182

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCIF EL  R+PLF G     QL  + ++IG PSE E      N     
Sbjct: 183 -YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE---WPRNVSLPR 238

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              P Y  +SF    P +    +DL++KMLTF+P +RI+  +AL HPY 
Sbjct: 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  216 bits (553), Expect = 2e-69
 Identities = 96/216 (44%), Positives = 133/216 (61%), Gaps = 8/216 (3%)

Query: 44  NDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           + +Y+  E ++ DL  ++    Q   +   +  + Q+L G+ ++H   +LHRDLK SNLL
Sbjct: 79  DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLL 138

Query: 103 LNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
           LN    LKICDFGLAR   S     T+ VVT WYRAPELLL + +Y+ AID+WSVGCIF 
Sbjct: 139 LNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFA 198

Query: 162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLN-ENAKKYICQLPRYQRQSFTEK 219
           EL+ +KPLFPG+  + QL  + +L+GTP+E    GF     AKK      +Y      +K
Sbjct: 199 ELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK--KTFTKYPYNQLRKK 256

Query: 220 FPNVHPS--AIDLVEKMLTFDPRQRITVEDALAHPY 253
           FP +  S    DL+ ++LT+DP +RI+ EDAL HPY
Sbjct: 257 FPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  213 bits (544), Expect = 3e-67
 Identities = 115/273 (42%), Positives = 163/273 (59%), Gaps = 22/273 (8%)

Query: 38  PQR--ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRD 95
           PQ+  E F DVY+  ELMD +L Q+I  +  L  E   Y LYQ+L G+K++HSA ++HRD
Sbjct: 91  PQKSLEEFQDVYLVMELMDANLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 148

Query: 96  LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
           LKPSN+++ ++C LKI DFGLAR       MT YVVTR+YRAPE++L    Y   +D+WS
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWS 207

Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           VGCI  EL+    +F G DH+ Q   +IE +GTPS   +  L    + Y+   P+Y   S
Sbjct: 208 VGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGIS 267

Query: 216 FTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           F E FP+ + PS           A DL+ KML  DP +RI+V++AL HPY+   +D ++ 
Sbjct: 268 FEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEA 327

Query: 264 ---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
              P  +     +  +HA+   + KELIY+E +
Sbjct: 328 EAPPPQIYDAQLEEREHAIE--EWKELIYKEVM 358

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  209 bits (534), Expect = 9e-66
 Identities = 114/273 (41%), Positives = 158/273 (57%), Gaps = 20/273 (7%)

Query: 36  PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRD 95
           P    E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++HSA ++HRD
Sbjct: 94  PQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151

Query: 96  LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
           LKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WS
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWS 210

Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           VGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    + Y+   P+Y   S
Sbjct: 211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYS 270

Query: 216 FTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           F + FP+V               A DL+ KML  D  +RI+V++AL HPY+   +D S+ 
Sbjct: 271 FEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEA 330

Query: 264 ---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
              P  +     D  +H + E   KELIY+E +
Sbjct: 331 EAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  205 bits (524), Expect = 2e-65
 Identities = 77/216 (35%), Positives = 115/216 (53%), Gaps = 25/216 (11%)

Query: 41  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E  + +Y+  E  +  DL   +     LSE+  +    QILRGL+Y+HS  ++HRDLKP 
Sbjct: 68  EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPE 127

Query: 100 NLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           N+LL+ N  +KI DFGLA+   ++   +T +V T WY APE+LL  + Y   +DVWS+G 
Sbjct: 128 NILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGV 187

Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           I  EL+  KP F G + + QL+L+  ++G P E +                         
Sbjct: 188 ILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDE-----------------------P 224

Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           K+ +    A DL++K L  DP +R T E+ L HP+ 
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  208 bits (530), Expect = 3e-65
 Identities = 113/283 (39%), Positives = 170/283 (60%), Gaps = 21/283 (7%)

Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 77  NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 134

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 195 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253

Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V++AL HPY
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313

Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 314 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 354

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  198 bits (506), Expect = 2e-62
 Identities = 91/233 (39%), Positives = 137/233 (58%), Gaps = 12/233 (5%)

Query: 26  TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---QALSEEHCQYFLYQILRG 82
            ++V + D+I      + N + + +E MD DL + + ++    AL     + F YQ+L+G
Sbjct: 58  ENIVRLHDVI-----HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKG 112

Query: 83  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMTEYVVTRWYRAPEL 140
           + + H   VLHRDLKP NLL+N   +LK+ DFGLAR        F  E VVT WYRAP++
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE-VVTLWYRAPDV 171

Query: 141 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 200
           LL S  Y+ +ID+WSVGCI  E++  +PLFPG ++  QL  +  ++GTP+E+    ++  
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-Q 230

Query: 201 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
             +Y    PRY  Q   + FP+  P  IDL+ ++L  +P  RI+  DAL HP+
Sbjct: 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  198 bits (506), Expect = 3e-62
 Identities = 88/232 (37%), Positives = 133/232 (57%), Gaps = 10/232 (4%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 86
           +V + DII    +++   V+   E +DTDL Q +      LS  + + FL+Q+LRGL Y 
Sbjct: 65  IVTLHDIIH--TKKTLTLVF---EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSS 145
           H   VLHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P++LL S+
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPG-RDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
           +Y+ ++D+W VGCIF E+   +PLFPG  D   QL  +  ++GTP+E     ++ N +  
Sbjct: 180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239

Query: 205 ICQLPRYQRQSFTEKFPNV--HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
               P Y  +      P +   P   +L  K L ++P++RI+  +A+ HPY 
Sbjct: 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  196 bits (501), Expect = 1e-61
 Identities = 95/235 (40%), Positives = 138/235 (58%), Gaps = 19/235 (8%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKY 85
           +V + D++      S N +Y+ +E +D DL + + S     L     + +LYQ+L+G+ Y
Sbjct: 60  IVRLLDVV-----HSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---VTSETDFMTEYVVTRWYRAPELLL 142
            HS  VLHRDLKP NLL++    LK+ DFGLAR   V   T   T  VVT WYRAPE+LL
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILL 172

Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEA---ELGFLNE 199
            S  Y+  +D+WS+GCIF E+++R+PLFPG   + QL  +   +GTP E     +  L +
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232

Query: 200 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
               Y    P++ RQ  ++  PN+    +DL+ KML +DP +RI+ + AL HPY 
Sbjct: 233 ----YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  197 bits (502), Expect = 2e-61
 Identities = 86/252 (34%), Positives = 131/252 (51%), Gaps = 34/252 (13%)

Query: 27  SVVAIRDII---PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQY--FLYQILR 81
           +VV + D+    P   +     VY+    MD DL  ++  N ++     Q   ++ Q+L 
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-ENPSVKLTESQIKCYMLQLLE 126

Query: 82  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-------------TSETDFMTE 128
           G+ Y+H  ++LHRD+K +N+L++    LKI DFGLAR                   + T 
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY-TN 185

Query: 129 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT 188
            VVTRWYR PELLL    YT A+D+W +GC+F E+  R+P+  G+  + QL L+ +L GT
Sbjct: 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245

Query: 189 PSEAEL-------GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ 241
           P+E          G    ++         Y R +  E+F  + P  +DL+ K+L+ DP +
Sbjct: 246 PTEETWPGWRSLPGCEGVHSF------TNYPR-TLEERFGKLGPEGLDLLSKLLSLDPYK 298

Query: 242 RITVEDALAHPY 253
           R+T  DAL HPY
Sbjct: 299 RLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  193 bits (493), Expect = 2e-60
 Identities = 74/214 (34%), Positives = 128/214 (59%), Gaps = 5/214 (2%)

Query: 46  VYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           +Y+ +E ++  L +++ ++   L  +  + +++Q+L+ + Y HS N++HRD+KP N+L++
Sbjct: 75  LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS 134

Query: 105 ANCDLKICDFGLARVTSE--TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
            +  LK+CDFG AR         +T+YV TRWYRAPELL+  ++Y   +DVW++GCI  E
Sbjct: 135 ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAE 194

Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR-YQRQSFTEKFP 221
           L+D +PLFPG   + QL L+ + +G    +     + N +      P   Q +S   ++P
Sbjct: 195 LLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYP 254

Query: 222 NVHPS-AIDLVEKMLTFDPRQRITVEDALAHPYL 254
               S A+D ++  L  DP++R+T ++ L HPY 
Sbjct: 255 GKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  194 bits (494), Expect = 2e-60
 Identities = 88/232 (37%), Positives = 136/232 (58%), Gaps = 9/232 (3%)

Query: 26  TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLK 84
            ++V +++++     +  + +++  E  + DL  ++ +     SE   +  + Q+LRGL+
Sbjct: 66  PNIVELKEVV---VGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122

Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLN 143
           Y+H   ++HRDLK SNLLL     LKI DFGLAR        MT  VVT WYRAPELLL 
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE--NA 201
            + YT AID+W+VGCI  EL+  KPL PG+  + QL L+I+L+GTP+E+     ++    
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242

Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
            K+   LP+    +   KFP +  + + L+  +L +DP++R T E+AL   Y
Sbjct: 243 GKFT--LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  193 bits (491), Expect = 3e-60
 Identities = 88/232 (37%), Positives = 135/232 (58%), Gaps = 13/232 (5%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 60  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---VTSETDFMTEYVVTRWYRAPELL 141
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR   V   T   T  VVT WYRAPE+L
Sbjct: 115 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEIL 172

Query: 142 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 201
           L    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +    
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS-L 231

Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
             Y    P++ RQ F++  P +     DL+ +ML +DP +RI+ + ALAHP+
Sbjct: 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  192 bits (490), Expect = 6e-60
 Identities = 74/204 (36%), Positives = 119/204 (58%), Gaps = 3/204 (1%)

Query: 51  ELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 109
           ELMD +L+++I+   + L E+  + ++YQ+L+ L ++H   + HRD+KP N+L+  +  L
Sbjct: 80  ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDI-L 138

Query: 110 KICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 169
           K+ DFG  R        TEY+ TRWYRAPE LL    Y   +D+W+VGC+F E++   PL
Sbjct: 139 KLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPL 198

Query: 170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 229
           FPG + + Q+  + +++GTP    L    ++        P  +     +  PN     +D
Sbjct: 199 FPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY-NFPSKKGTGLRKLLPNASAEGLD 257

Query: 230 LVEKMLTFDPRQRITVEDALAHPY 253
           L++K+L +DP +RIT + AL HPY
Sbjct: 258 LLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  189 bits (482), Expect = 3e-58
 Identities = 86/234 (36%), Positives = 124/234 (52%), Gaps = 30/234 (12%)

Query: 45  DVY-------IAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           DVY       +  ++M +DL +++     L+E   +  L QIL GL  +H    +HRDL 
Sbjct: 87  DVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLS 146

Query: 98  PSNLLLNANCDLKICDFGLAR---------------VTSETDFMTEYVVTRWYRAPELLL 142
           P+N+ +N+    KI DFGLAR                    + MT  VVT WYRAPELL+
Sbjct: 147 PANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLM 206

Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 202
            +  Y  A+D+WSVGCIF EL+  KPLFPG + + QL  + EL+GTP+E      N    
Sbjct: 207 GAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNED-----NWPQA 261

Query: 203 KYI---CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
           K +    +    + +     FPN    AIDL++ +L  +P +RI+ ++AL H Y
Sbjct: 262 KKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315

Length = 335

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  186 bits (474), Expect = 1e-57
 Identities = 86/231 (37%), Positives = 132/231 (57%), Gaps = 10/231 (4%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQI---IRSNQALSEEHCQYFLYQILRGLK 84
           +V ++D++    R     +Y+ +E +  DL +    +   Q +  E  + +LYQIL+G+ 
Sbjct: 61  IVCLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL++    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
           S  Y+  +D+WS+G IF E+  +KPLF G   + QL  +  ++GTP+E     +  +   
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV-TSLPD 234

Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++++ S      N+    +DL+EKML +DP +RI+ + AL HPY 
Sbjct: 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  184 bits (469), Expect = 8e-57
 Identities = 84/216 (38%), Positives = 132/216 (61%), Gaps = 11/216 (5%)

Query: 46  VYIAYELMDTDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
           +Y+ +E +D+DL + + SN     + L  +  + F+YQ+L+G+ + H   V+HRDLKP N
Sbjct: 81  LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQN 140

Query: 101 LLLNANCD-LKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           LL++     LKI D GL R  +      T  +VT WYRAPE+LL S+ Y+  +D+WSVGC
Sbjct: 141 LLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200

Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKYICQLPRYQRQSFT 217
           IF E+  ++PLFPG   + QL  + +L+GTP+E    G       +   + P+++ Q  +
Sbjct: 201 IFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK---LRDWHEFPQWKPQDLS 257

Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P++ P  +DL++KML +DP +RI+ + AL HPY
Sbjct: 258 RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  184 bits (468), Expect = 1e-56
 Identities = 92/238 (38%), Positives = 139/238 (58%), Gaps = 10/238 (4%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEH--CQYFLYQILRGLK 84
           ++V ++D++   +R     +Y+ +E +D DL + + S+   ++     + +LYQILRG+ 
Sbjct: 62  NIVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 85  YIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLL 142
           Y HS  VLHRDLKP NLL++   + LK+ DFGLAR         T  VVT WYRAPE+LL
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 202
            S  Y+  +D+WSVGCIF E++++KPLFPG   + +L  +  ++GTP+E     +  +  
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT-SLP 235

Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 260
            Y    P++  +      P + P+ +DL+ KML  DP +RIT   AL H Y   L D 
Sbjct: 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293

Length = 294

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  181 bits (460), Expect = 3e-55
 Identities = 93/242 (38%), Positives = 134/242 (55%), Gaps = 20/242 (8%)

Query: 27  SVVAIRDIIPPPQ-----RESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQIL 80
           ++V +++I+   Q     ++     Y+ +E MD DL  ++ S     SE+H + F+ Q+L
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126

Query: 81  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMTEYVVTRWYRAP 138
            GL Y H  N LHRD+K SN+LLN    +K+ DFGLAR+  + E+   T  V+T WYR P
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186

Query: 139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEA------ 192
           ELLL    Y  AIDVWS GCI  EL  +KP+F     + QL L+  L G+P  A      
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVI 246

Query: 193 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
           +L + N    K      +  R+   E+F  +   A+DL++ MLT DP +R T E+AL  P
Sbjct: 247 KLPYFNTMKPK------KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP 300

Query: 253 YL 254
           +L
Sbjct: 301 WL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  177 bits (450), Expect = 6e-54
 Identities = 95/235 (40%), Positives = 133/235 (56%), Gaps = 11/235 (4%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEH-CQYFLYQILRGLKY 85
           ++V + DII      +   + + +E +D DL Q +         H  + FL+Q+LRGL Y
Sbjct: 65  NIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNY 119

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNS 144
            H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++LL S
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS 179

Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFL-NENAK 202
           +DY+  ID+W VGCIF E+   +PLFPG     QL  +  ++GTP+E    G L NE  K
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239

Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
            Y    P+Y+        P +     +L+ K+L F+ R+RI+ E+A+ HPY   L
Sbjct: 240 SY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  177 bits (449), Expect = 9e-54
 Identities = 92/233 (39%), Positives = 135/233 (57%), Gaps = 7/233 (3%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKY 85
           ++V + DI+      +   + + +E +D DL Q +      +S  + + FLYQILRGL Y
Sbjct: 65  NIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNS 144
            H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++LL S
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 179

Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
           S+Y+  ID+W VGCIF E+   +PLFPG     +L L+  L+GTP+E     ++ N +  
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239

Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
               P+Y+ Q      P +    I+L+ K L ++ ++RI+ E+A+ H Y  SL
Sbjct: 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  174 bits (444), Expect = 4e-53
 Identities = 86/220 (39%), Positives = 124/220 (56%), Gaps = 26/220 (11%)

Query: 48  IAYELMDTDLHQIIRSNQALSEEH-CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           + +E  D DL +   S     +    + F++Q+L+GL + HS NVLHRDLKP NLL+N N
Sbjct: 76  LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135

Query: 107 CDLKICDFGLAR-----VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
            +LK+ DFGLAR     V     +  E VVT WYR P++L  +  Y+ +ID+WS GCIF 
Sbjct: 136 GELKLADFGLARAFGIPVRC---YSAE-VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 191

Query: 162 ELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ-------R 213
           EL +  +PLFPG D   QL+ +  L+GTP         E +   + +LP Y+        
Sbjct: 192 ELANAGRPLFPGNDVDDQLKRIFRLLGTP--------TEESWPGVSKLPDYKPYPMYPAT 243

Query: 214 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
            S     P ++ +  DL++ +L  +P QRI+ E+AL HPY
Sbjct: 244 TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  173 bits (440), Expect = 4e-52
 Identities = 91/263 (34%), Positives = 136/263 (51%), Gaps = 48/263 (18%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII---RSNQA--LSEEHCQYFLYQILRG 82
           VV++ ++      +S   VY+ ++  + DL QII   R  +   +     +  L+QIL G
Sbjct: 64  VVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 83  LKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARVTSE--TDFMTE--YVVTRW 134
           + Y+HS  VLHRDLKP+N+L+         +KI D GLAR+ +            VVT W
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD---------HVHQLRLLIEL 185
           YRAPELLL +  YT AID+W++GCIF EL+  +P+F GR+            QL  + E+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240

Query: 186 IGTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPN------VH------PSAIDL 230
           +GTP+E +           I ++P Y        T+ +P+      +           DL
Sbjct: 241 LGTPTEKDW--------PDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292

Query: 231 VEKMLTFDPRQRITVEDALAHPY 253
           + K+L +DP +RIT E+AL HPY
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  168 bits (427), Expect = 1e-50
 Identities = 85/231 (36%), Positives = 131/231 (56%), Gaps = 7/231 (3%)

Query: 26  TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLK 84
            ++V + DII      +   + + +E +D+DL Q + +    +S  + + F++Q+LRGL 
Sbjct: 63  ANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLS 117

Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           Y H   +LHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++LL 
Sbjct: 118 YCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 177

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
           S++Y+  ID+W VGCI  E+   +P+FPG     +L L+  L+GTP+E     +  N + 
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237

Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                P+Y+ Q      P +    IDL+  +L ++ + RI+ E AL H Y 
Sbjct: 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  168 bits (427), Expect = 1e-50
 Identities = 73/208 (35%), Positives = 121/208 (58%), Gaps = 5/208 (2%)

Query: 50  YELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD 108
           +E  D T L+++ ++ + + E   +  ++Q L+ + + H  N +HRD+KP N+L+     
Sbjct: 79  FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ 138

Query: 109 LKICDFGLARVTSETDFM-TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK 167
           +K+CDFG AR+ +      T+YV TRWYRAPELL+  + Y   +DVW++GC+F EL+  +
Sbjct: 139 IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198

Query: 168 PLFPGRDHVHQLRLLIELIG--TPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP 225
           PL+PG+  V QL L+ + +G   P   ++   N+  K      P   R+    KFPN+  
Sbjct: 199 PLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPE-TREPLESKFPNISS 257

Query: 226 SAIDLVEKMLTFDPRQRITVEDALAHPY 253
            A+  ++  L  DP +R++ E+ L HPY
Sbjct: 258 PALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  164 bits (418), Expect = 3e-49
 Identities = 73/210 (34%), Positives = 122/210 (58%), Gaps = 3/210 (1%)

Query: 47  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           Y+ +E +D T L  + +    L E   + +L+QILRG+++ HS N++HRD+KP N+L++ 
Sbjct: 76  YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135

Query: 106 NCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  +K+CDFG AR + +  +  T+YV TRWYRAPELL+  + Y  A+D+W+VGC+  E++
Sbjct: 136 SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML 195

Query: 165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ-RQSFTEKFPNV 223
             +PLFPG   + QL  +I+ +G           +N      +LP  +  +   ++FP +
Sbjct: 196 TGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKL 255

Query: 224 HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
               +DL ++ L  DP  R +    L H +
Sbjct: 256 SGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  160 bits (406), Expect = 2e-47
 Identities = 90/241 (37%), Positives = 137/241 (56%), Gaps = 26/241 (10%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQ-IIRSNQALSEEHCQYFLYQILRGLKY 85
           ++V + DII   +  +F      +E M TDL Q +I+    L   + + F++Q+LRGL Y
Sbjct: 64  NIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAY 118

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNS 144
           IH  ++LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P++LL +
Sbjct: 119 IHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178

Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKK 203
           +DY++A+D+W  GCIF+E++  +P FPG   V  QL  +  ++G P+        E+   
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT--------EDTWP 230

Query: 204 YICQLPRYQRQSFT-EKFPNVH---------PSAIDLVEKMLTFDPRQRITVEDALAHPY 253
            + +LP Y+ + F   K   +          P A DL  +ML   P+ RI+ +DAL HPY
Sbjct: 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Query: 254 L 254
            
Sbjct: 291 F 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  157 bits (400), Expect = 3e-46
 Identities = 78/226 (34%), Positives = 117/226 (51%), Gaps = 26/226 (11%)

Query: 45  DVYIAYELMDTDLHQIIRSNQAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
             Y+ +E  + DL  ++ SN+ +  +    +  +  +L GL YIH   +LHRD+K +N+L
Sbjct: 93  SFYLVFEFCEHDLAGLL-SNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANIL 151

Query: 103 LNANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           +  +  LK+ DFGLAR  S +     +  T  VVT WYR PELLL   DY   ID+W  G
Sbjct: 152 ITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211

Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIG--TPSEAELGFLNENAKKY----ICQLPRY 211
           CI  E+  R P+  G    HQL L+ +L G  TP       +     K       +LP+ 
Sbjct: 212 CIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE------VWPGVDKLELFKKMELPQG 265

Query: 212 QRQSFTEK----FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
           Q++   E+      + H  A+DL++K+L  DP +RI  + AL H +
Sbjct: 266 QKRKVKERLKPYVKDPH--ALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  156 bits (396), Expect = 4e-46
 Identities = 84/230 (36%), Positives = 125/230 (54%), Gaps = 6/230 (2%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLK 84
           ++V + D+    + +    V + +E +D DL   +       L  E  +  + Q LRGL 
Sbjct: 63  NIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 144
           ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +T  VVT WYRAPE+LL S
Sbjct: 123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS 182

Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
           + Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +  +  +     
Sbjct: 183 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD--WPRDVTLPR 239

Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
               PR  R       P +  S   L+ +MLTF+P +RI+   AL HP+ 
Sbjct: 240 GAFSPRGPR-PVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  151 bits (383), Expect = 9e-43
 Identities = 77/200 (38%), Positives = 119/200 (59%), Gaps = 4/200 (2%)

Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVT 120
           R+N AL     + + YQ+ R L YIHS  + HRDLKP NLL++ N   LK+CDFG A+  
Sbjct: 162 RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221

Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
                   Y+ +R+YRAPEL+L +++YT  ID+WS+GCI  E++   P+F G+  V QL 
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281

Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP-SAIDLVEKMLTFDP 239
            +I+++GTP+E +L  +N N      + P  + +   + FP   P  AI+ + + L ++P
Sbjct: 282 RIIQVLGTPTEDQLKEMNPNYAD--IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP 339

Query: 240 RQRITVEDALAHPYLGSLHD 259
            +R+   +ALA P+   L D
Sbjct: 340 LKRLNPIEALADPFFDDLRD 359

Length = 440

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  145 bits (368), Expect = 6e-42
 Identities = 85/229 (37%), Positives = 131/229 (57%), Gaps = 6/229 (2%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLK 84
           +VV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LRGL 
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 144
           ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+LL S
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 184

Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
           S Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E +  +  + A   
Sbjct: 185 S-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED--WPRDVALPR 241

Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
                +   Q   +   ++     DL+ K LTF+P +RI+   AL+HPY
Sbjct: 242 QAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  142 bits (359), Expect = 2e-40
 Identities = 89/258 (34%), Positives = 139/258 (53%), Gaps = 28/258 (10%)

Query: 14  VRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHC 72
           +R +     +   ++V + DII      +   + + +E + TDL Q +  +   L  E+ 
Sbjct: 51  IREASLLKGLKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENV 105

Query: 73  QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVV 131
           + FL+Q+LRGL YIH   +LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VV
Sbjct: 106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165

Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG-RDHVHQLRLLIELIGTPS 190
           T WYR P++LL S++Y+  +D+W VGCIF+E++     FPG +D   QL  +  ++GTP 
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTP- 224

Query: 191 EAELGFLNENAKKYICQLPRYQRQSFT-----------EKFPNVHPSAIDLVEKMLTFDP 239
                  NE+    +  LP ++ + FT            K   V+  A DL  K+L   P
Sbjct: 225 -------NEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVN-HAEDLASKLLQCFP 276

Query: 240 RQRITVEDALAHPYLGSL 257
           + R++ + AL+H Y   L
Sbjct: 277 KNRLSAQAALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  140 bits (353), Expect = 1e-39
 Identities = 73/213 (34%), Positives = 122/213 (57%), Gaps = 8/213 (3%)

Query: 46  VYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +Y+ +E ++ ++ +++    N    E+  + ++YQ+++ + + H  +++HRD+KP NLL+
Sbjct: 75  LYLVFEYVEKNMLELLEEMPNGVPPEK-VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI 133

Query: 104 NANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
           + N  LK+CDFG AR  SE      TEYV TRWYR+PELLL +  Y  A+D+WSVGCI  
Sbjct: 134 SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILG 192

Query: 162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR-QSFTEKF 220
           EL D +PLFPG   + QL  + +++G     ++     N + +  + P     QS   ++
Sbjct: 193 ELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRY 252

Query: 221 PNVHPSA-IDLVEKMLTFDPRQRITVEDALAHP 252
             +     +DL++ +L  +P  R   E  L HP
Sbjct: 253 LGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  136 bits (345), Expect = 3e-39
 Identities = 50/129 (38%), Positives = 78/129 (60%), Gaps = 4/129 (3%)

Query: 41  ESFNDVYIAYELMD-TDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           E  N +Y+  E  +   L  +++ N+  LSE+     L QIL GL+Y+HS  ++HRDLKP
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 99  SNLLLNANCD-LKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
            N+LL+++   +K+ DFGL++ +TS+   +   V T  Y APE+LL    Y+   D+WS+
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180

Query: 157 GCIFMELMD 165
           G I  EL +
Sbjct: 181 GVILYELPE 189

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  133 bits (337), Expect = 2e-37
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 31/201 (15%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L  +++    L E   + +  QIL GL Y+HS  ++HRD+K +N+L++++  +K+ DFG 
Sbjct: 88  LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGC 147

Query: 117 ARV--TSETDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 173
           A+     ET   T  V  T ++ APE ++   +Y  A D+WS+GC  +E+   KP +   
Sbjct: 148 AKRLGDIETGEGTGSVRGTPYWMAPE-VIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206

Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
            +       I   G P                 ++P            ++   A D + K
Sbjct: 207 GNPMAALYKIGSSGEPP----------------EIP-----------EHLSEEAKDFLRK 239

Query: 234 MLTFDPRQRITVEDALAHPYL 254
            L  DP++R T ++ L HP+L
Sbjct: 240 CLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  125 bits (317), Expect = 2e-34
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 41/225 (18%)

Query: 40  RESFND---VYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANV 91
            ESF +   + I  E  D  DL Q I+      +   EE    +  Q+   LKY+HS  +
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKI 124

Query: 92  LHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-TRWYRAPELLLNSSDYTAA 150
           LHRD+KP N+ L +N  +K+ DFG+++V S T  + + VV T +Y +PEL  N   Y   
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP-YNYK 183

Query: 151 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 210
            D+WS+GC+  EL   K  F G +++ +L L I                           
Sbjct: 184 SDIWSLGCVLYELCTLKHPFEG-ENLLELALKI--------------------------- 215

Query: 211 YQRQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 254
             +  +    P+ + S + +LV  +L  DP +R ++   L  P++
Sbjct: 216 -LKGQY-PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  128 bits (322), Expect = 2e-34
 Identities = 61/247 (24%), Positives = 105/247 (42%), Gaps = 31/247 (12%)

Query: 41  ESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDL 96
           +    +Y+  E +D   L  +++       LSE    + L QIL  L+Y+HS  ++HRD+
Sbjct: 68  QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDI 127

Query: 97  KPSNLLLNAN-CDLKICDFGLARVTSETD-------FMTEYVVTRWYRAPELLLNSSD-- 146
           KP N+LL+ +   +K+ DFGLA++  +           +  V T  Y APE+LL  S   
Sbjct: 128 KPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY 187

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
            +++ D+WS+G    EL+   P F G  +       +++I                    
Sbjct: 188 ASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII-----------------LEL 230

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
             P             +  +A DL++K+L  DP+ R++    L+H  L  L     +   
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290

Query: 267 MSPFSFD 273
           +      
Sbjct: 291 LLKPDDS 297

Length = 384

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  123 bits (310), Expect = 4e-33
 Identities = 84/247 (34%), Positives = 129/247 (52%), Gaps = 42/247 (17%)

Query: 46  VYIAYELMDTDLHQIIRSNQA---------LSEEHCQYFLYQILRGLKYIHSANVLHRDL 96
           V++ ++  + DL  II+ ++A         L     +  LYQIL G+ Y+H+  VLHRDL
Sbjct: 75  VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 134

Query: 97  KPSNLLLNANCD----LKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYT 148
           KP+N+L+         +KI D G AR+ +        +   VVT WYRAPELLL +  YT
Sbjct: 135 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 194

Query: 149 AAIDVWSVGCIFMELMDRKPLFPGRD---------HVHQLRLLIELIGTPSEAELGFLNE 199
            AID+W++GCIF EL+  +P+F  R          H  QL  +  ++G P++ +     E
Sbjct: 195 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDW----E 250

Query: 200 NAKK---YICQLPRYQRQSFTE----KFPNVH-----PSAIDLVEKMLTFDPRQRITVED 247
           + KK   +   +  ++R ++T     K+   H       A  L++K+LT DP +RIT E 
Sbjct: 251 DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 310

Query: 248 ALAHPYL 254
           A+  PY 
Sbjct: 311 AMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  121 bits (304), Expect = 3e-32
 Identities = 84/247 (34%), Positives = 127/247 (51%), Gaps = 42/247 (17%)

Query: 46  VYIAYELMDTDLHQIIRSNQA---------LSEEHCQYFLYQILRGLKYIHSANVLHRDL 96
           V++ ++  + DL  II+ ++A         L     +  LYQIL G+ Y+H+  VLHRDL
Sbjct: 75  VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDL 134

Query: 97  KPSNLLLNANCD----LKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYT 148
           KP+N+L+         +KI D G AR+ +        +   VVT WYRAPELLL +  YT
Sbjct: 135 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 194

Query: 149 AAIDVWSVGCIFMELMDRKPLFPGRD---------HVHQLRLLIELIGTPSEAELGFLNE 199
            AID+W++GCIF EL+  +P+F  R          H  QL  +  ++G P++ +     E
Sbjct: 195 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDW----E 250

Query: 200 NAKK---YICQLPRYQRQSFTE----KFPNVHPSAID-----LVEKMLTFDPRQRITVED 247
           + +K   Y      ++R ++      K+   H    D     L++K+LT DP +RIT E 
Sbjct: 251 DIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ 310

Query: 248 ALAHPYL 254
           AL  PY 
Sbjct: 311 ALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  119 bits (301), Expect = 7e-32
 Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 49/223 (21%)

Query: 44  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           +++++  E MD    TD+  I ++   ++E    Y   ++L+GL+Y+HS NV+HRD+K  
Sbjct: 88  DELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSD 145

Query: 100 NLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           N+LL+ +  +K+ DFG  A++T E       V T ++ APE++    DY   +D+WS+G 
Sbjct: 146 NILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK-RKDYGPKVDIWSLGI 204

Query: 159 IFMEL-------MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY 211
           + +E+       +   PL        +   LI   G P    L    +N +K        
Sbjct: 205 MCIEMAEGEPPYLREPPL--------RALFLITTKGIP---PL----KNPEK-------- 241

Query: 212 QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                        P   D + K L  DP +R + E+ L HP+L
Sbjct: 242 -----------WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 9e-32
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 37/203 (18%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   +      SEE  +++  +I+  L+Y+HS  +++RDLKP N+LL+A+  +K+ DFG
Sbjct: 79  ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFG 138

Query: 116 LAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
           LA+ ++SE      +  T  Y APE+LL    Y  A+D WS+G +  E++  KP F   D
Sbjct: 139 LAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197

Query: 175 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEK 233
                  + E I                                +FP  + P A DL+  
Sbjct: 198 RK----EIYEKI---------------------------LKDPLRFPEFLSPEARDLISG 226

Query: 234 MLTFDPRQRIT---VEDALAHPY 253
           +L  DP +R+     E+  AHP+
Sbjct: 227 LLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  116 bits (292), Expect = 7e-31
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 35/216 (16%)

Query: 45  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLL 102
           ++ I  E MD   L  +++    + E    Y   QIL+GL Y+H+  +++HRD+KPSNLL
Sbjct: 73  EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLL 132

Query: 103 LNANCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
           +N+  ++KI DFG+++V   T      +V T  Y +PE +   S Y+ A D+WS+G   +
Sbjct: 133 INSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES-YSYAADIWSLGLTLL 191

Query: 162 EL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ--LPRYQRQSFTE 218
           E  + + P  P               G PS  EL        + IC    P    + F+ 
Sbjct: 192 ECALGKFPFLPP--------------GQPSFFEL-------MQAICDGPPPSLPAEEFSP 230

Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +F        D +   L  DP++R +  + L HP++
Sbjct: 231 EF-------RDFISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  113 bits (286), Expect = 5e-30
 Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 42/228 (18%)

Query: 44  NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
            ++Y+  E +   DL  ++ +  +L E+  + ++ +I+  L+Y+HS  ++HRDLKP N+L
Sbjct: 66  KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL 125

Query: 103 LNANCDLKICDFGLARV--TSETDFM-------TEYVVTRWYRAPELLLNSSDYTAAIDV 153
           +++N  LK+ DFGL++V        +          V T  Y APE++L    ++  +D 
Sbjct: 126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDW 184

Query: 154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 213
           WS+GCI  E +   P F G               TP E     + +N      + P    
Sbjct: 185 WSLGCILYEFLVGIPPFHGE--------------TPEE-----IFQNILNGKIEWP---- 221

Query: 214 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSLH 258
                +   V   AIDL+ K+L  DP +R+   ++E+   HP+   + 
Sbjct: 222 -----EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  113 bits (284), Expect = 9e-30
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 30/212 (14%)

Query: 44  NDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           ++++I  E      L  +++S NQ L+E    Y   ++L+GL+Y+HS  ++HRD+K +N+
Sbjct: 70  DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANI 129

Query: 102 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
           LL ++ ++K+ DFGL+   S+T      V T ++ APE ++N   Y    D+WS+G   +
Sbjct: 130 LLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPE-VINGKPYDYKADIWSLGITAI 188

Query: 162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 221
           EL + KP +       +    I   G P     G  N          P      F     
Sbjct: 189 ELAEGKPPY-SELPPMKALFKIATNGPP-----GLRN----------PEKWSDEFK---- 228

Query: 222 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
                  D ++K L  +P +R T E  L HP+
Sbjct: 229 -------DFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  108 bits (272), Expect = 7e-28
 Identities = 69/241 (28%), Positives = 105/241 (43%), Gaps = 60/241 (24%)

Query: 42  SFND---VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           +F D   +Y   E   + +L Q IR   +L E+  +++  +IL  L+Y+HS  ++HRDLK
Sbjct: 70  TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLK 129

Query: 98  PSNLLLNANCDLKICDFGLARVTSETDFMTE---------------------YVVTRWYR 136
           P N+LL+ +  +KI DFG A+V                              +V T  Y 
Sbjct: 130 PENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYV 189

Query: 137 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 196
           +PELL        + D+W++GCI  +++  KP F G                 +E    F
Sbjct: 190 SPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRG----------------SNEYLT-F 231

Query: 197 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL----AHP 252
                 +Y          SF   FP   P A DL+EK+L  DP+ R+ V +      AHP
Sbjct: 232 QKILKLEY----------SFPPNFP---PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278

Query: 253 Y 253
           +
Sbjct: 279 F 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  105 bits (264), Expect = 7e-27
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 36/222 (16%)

Query: 40  RESFNDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRD 95
             SF D    Y ++D     DL   +      SEE  ++++ +I+  L+Y+HS  ++HRD
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRD 125

Query: 96  LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
           +KP N+LL+    + I DF +A   +     T    T  Y APE +L    Y+ A+D WS
Sbjct: 126 IKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE-VLCRQGYSVAVDWWS 184

Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           +G    E +  K  + G       R + + I                       R ++++
Sbjct: 185 LGVTAYECLRGKRPYRGHS-----RTIRDQI-----------------------RAKQET 216

Query: 216 FTEKFPNVHPS-AIDLVEKMLTFDPRQRI--TVEDALAHPYL 254
               +P    + AID + K+L  DP++R+   ++D   HPY 
Sbjct: 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  105 bits (263), Expect = 9e-27
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 34/219 (15%)

Query: 39  QRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           +RE  N +YI  EL+    L ++++   +  E   + +  QIL GL+Y+H  N +HRD+K
Sbjct: 71  EREEDN-LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIK 129

Query: 98  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
            +N+L++ N  +K+ DFG+A+   E  F   +  + ++ APE++     Y  A D+WS+G
Sbjct: 130 GANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLG 189

Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIEL--IGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           C  +E+   KP +       QL  +  +  IG   E                +P      
Sbjct: 190 CTVLEMATGKPPW------SQLEGVAAVFKIGRSKELPP-------------IPD----- 225

Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                 ++   A D + K L  DP  R T  + L HP++
Sbjct: 226 ------HLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  104 bits (262), Expect = 2e-26
 Identities = 69/234 (29%), Positives = 104/234 (44%), Gaps = 46/234 (19%)

Query: 32  RDIIPPPQRESFNDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYI 86
           R I    Q      +YI  E  +  DL Q+I    +  + + EE     L Q+L  L   
Sbjct: 67  RIIDRSNQT-----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121

Query: 87  H-----SANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPEL 140
           H        VLHRDLKP+N+ L+AN ++K+ DFGLA++   ++ F   YV T +Y +PE 
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ 181

Query: 141 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 200
           L + S Y    D+WS+GC+  EL    P F  R+ + QL   I+                
Sbjct: 182 LNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQL-QLASKIK---------------- 223

Query: 201 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             K+     RY  +               +++ ML  DP +R + E+ L  P +
Sbjct: 224 EGKFRRIPYRYSSELNE------------VIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (260), Expect = 3e-26
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 34/219 (15%)

Query: 44  NDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
             VYI  E      L +++   + L E   + +  Q+L GL Y+HS  ++HRD+KP+N+ 
Sbjct: 72  EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIF 131

Query: 103 LNANCDLKICDFGLARV-----TSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWS 155
           L+ N  +K+ DFG A       T+  + +     T  Y APE++       +  A D+WS
Sbjct: 132 LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWS 191

Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           +GC+ +E+   K  +   D+  Q+   +     P                  +P   + S
Sbjct: 192 LGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-----------------PIPDSLQLS 234

Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                    P   D +++ L  DP++R T  + L HP++
Sbjct: 235 ---------PEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 99.7 bits (249), Expect = 1e-24
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 35/207 (16%)

Query: 55  TDLHQ-IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           TDL + + +  + L EE   Y L + LRGL Y+H   V+HRD+K  N+LL  N ++K+ D
Sbjct: 97  TDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156

Query: 114 FGLAR-VTSETDFMTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMDRKP 168
           FG++  + S       ++ T ++ APE++         Y A  DVWS+G   +EL D KP
Sbjct: 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216

Query: 169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR-YQRQSFTEKFPNVHPSA 227
             P  D +H +R L ++   P                   P     +++++KF       
Sbjct: 217 --PLCD-MHPMRALFKIPRNPP------------------PTLKSPENWSKKF------- 248

Query: 228 IDLVEKMLTFDPRQRITVEDALAHPYL 254
            D + + L  +  QR  +E+ L HP++
Sbjct: 249 NDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 4e-24
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 36/212 (16%)

Query: 47  YIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           YI  E  +   L QII+      E     ++YQ+L+GL Y+H   V+HRD+K +N+L   
Sbjct: 75  YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK 134

Query: 106 NCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  +K+ DFG+A ++   +      V T ++ APE ++  S  + A D+WS+GC  +EL+
Sbjct: 135 DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE-VIEMSGASTASDIWSLGCTVIELL 193

Query: 165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY-ICQLPRYQRQSFTEKFP-N 222
              P +   + +  L                        + I Q             P  
Sbjct: 194 TGNPPYYDLNPMAAL------------------------FRIVQDDHP-------PLPEG 222

Query: 223 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           + P   D + +    DP  R T +  L HP++
Sbjct: 223 ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 97.9 bits (244), Expect = 4e-24
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 33/205 (16%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           D   +I++   L E+  + ++ +++ G++ +H   ++HRD+KP NLL++    LK+ DFG
Sbjct: 83  DCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFG 142

Query: 116 LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 175
           L+R   E     ++V T  Y APE +L   D     D WS+GC+  E             
Sbjct: 143 LSRNGLEN---KKFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEF------------ 186

Query: 176 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 235
                    L G P      F  E        +   +     E      P A+DL+ ++L
Sbjct: 187 ---------LFGYPP-----FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232

Query: 236 TFDPRQRI---TVEDALAHPYLGSL 257
             DP +R+     ++  +HP+  S+
Sbjct: 233 CMDPAKRLGANGYQEIKSHPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 98.2 bits (245), Expect = 4e-24
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 32/216 (14%)

Query: 44  NDVYIAYELMD-TDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN 100
            D+ I  E MD   L +I+      + E         +L+GL Y+H    ++HRD+KPSN
Sbjct: 72  GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131

Query: 101 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
           +L+N+   +K+CDFG++     +   T +V T  Y APE  +  +DY+   D+WS+G   
Sbjct: 132 ILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE-RIQGNDYSVKSDIWSLGLSL 189

Query: 161 MEL-MDRKPL-FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +EL   R P             LL  ++  P                 +LP       + 
Sbjct: 190 IELATGRFPYPPENDPPDGIFELLQYIVNEPPP---------------RLP-------SG 227

Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           KF    P   D V   L  DPR+R + ++ L HP++
Sbjct: 228 KFS---PDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.7 bits (244), Expect = 5e-24
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 33/201 (16%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           D+ +I   N+ L+EE     LYQ L+GL+Y+HS   +HRD+K  N+LLN     K+ DFG
Sbjct: 87  DIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG 144

Query: 116 LARVTSETDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
           ++   ++T      V+ T ++ APE++     Y    D+WS+G   +E+ + KP  P   
Sbjct: 145 VSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKP--P-YS 200

Query: 175 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEK 233
            +H +R +  +   P                         + ++  P    P   D V+K
Sbjct: 201 DIHPMRAIFMIPNKPP-----------------------PTLSD--PEKWSPEFNDFVKK 235

Query: 234 MLTFDPRQRITVEDALAHPYL 254
            L  DP +R +    L HP++
Sbjct: 236 CLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.3 bits (243), Expect = 1e-23
 Identities = 51/189 (26%), Positives = 91/189 (48%), Gaps = 30/189 (15%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDF 125
           L E +  + L ++L GL+Y+H    +HRD+K +N+LL+   D+K+ DFG++ ++TS    
Sbjct: 95  LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154

Query: 126 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 185
              +V T ++ APE++  S  Y    D+WS+G   +EL   +P  P    +H +R+L  +
Sbjct: 155 RNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEP--P-LSDLHPMRVLFLI 210

Query: 186 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 245
                                  P  +   F++ F        D V   L  DP++R + 
Sbjct: 211 PKNNP------------------PSLEGNKFSKPFK-------DFVSLCLNKDPKERPSA 245

Query: 246 EDALAHPYL 254
           ++ L H ++
Sbjct: 246 KELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 94.1 bits (235), Expect = 1e-22
 Identities = 47/127 (37%), Positives = 63/127 (49%), Gaps = 13/127 (10%)

Query: 46  VYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +YI  E M+  DL   +R N+  LS      F  QI RG++Y+ S N +HRDL   N L+
Sbjct: 76  LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 135

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 157
             N  +KI DFGL+R   + D    Y         RW  APE L     +T+  DVWS G
Sbjct: 136 GENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWM-APESLKEGK-FTSKSDVWSFG 190

Query: 158 CIFMELM 164
            +  E+ 
Sbjct: 191 VLLWEIF 197

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.1 bits (234), Expect = 1e-22
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 39/222 (17%)

Query: 41  ESFNDVYIAYELM----DTDLHQIIRSNQA----LSEEHCQYFLYQILRGLKYIHSANVL 92
           E+F D      +M      DL + I   +     + E+       Q+LRGL+ +H   +L
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125

Query: 93  HRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAID 152
           HRDLK +N+LL AN  +KI D G+++V  +    T+ + T  Y APE +     Y+   D
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPE-VWKGRPYSYKSD 183

Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+GC+  E+    P F  R  +  LR                             + Q
Sbjct: 184 IWSLGCLLYEMATFAPPFEARS-MQDLRY----------------------------KVQ 214

Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           R  +    P       + +  ML   P+ R   +  LA P +
Sbjct: 215 RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 93.8 bits (234), Expect = 1e-22
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)

Query: 39  QRESFNDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHR 94
              +F D    Y LM+     +L  I+R      E   ++++  ++   +Y+H+  +++R
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117

Query: 95  DLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 154
           DLKP NLLL++N  +K+ DFG A+          +  T  Y APE++LN   Y  ++D W
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG-YDFSVDYW 176

Query: 155 SVGCIFMELMDRKPLFPGRDH----VHQLRL-LIELIGTPSEAELGFLNENAKKYICQL 208
           S+G +  EL+  +P F   D     ++   L     +  P+     ++++ AK  I QL
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN-----YIDKAAKDLIKQL 230

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 93.4 bits (233), Expect = 2e-22
 Identities = 47/128 (36%), Positives = 62/128 (48%), Gaps = 14/128 (10%)

Query: 46  VYIAYELMDT-DLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           + I  E M   DL   +R N+   LS      F  QI RG++Y+ S N +HRDL   N L
Sbjct: 76  LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL 135

Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSV 156
           +  N  +KI DFGL+R   + D    Y V       RW  APE L     +T+  DVWS 
Sbjct: 136 VGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWM-APESLKEGK-FTSKSDVWSF 190

Query: 157 GCIFMELM 164
           G +  E+ 
Sbjct: 191 GVLLWEIF 198

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.0 bits (226), Expect = 2e-21
 Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 30/199 (15%)

Query: 60  IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV 119
            +R+     E+  ++F  Q+L GL Y+HS  +LHRDLK  NLL++A+   KI DFG+++ 
Sbjct: 98  CLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK 157

Query: 120 TSE---TDFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELM-DRKPLFPGRD 174
           + +    D       + ++ APE++ + S  Y+A +D+WS+GC+ +E+   R+P     +
Sbjct: 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW--SDE 215

Query: 175 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 234
                   +  +G    A               +P        +   N+ P A+D +   
Sbjct: 216 EAIA---AMFKLGNKRSAP-------------PIP-------PDVSMNLSPVALDFLNAC 252

Query: 235 LTFDPRQRITVEDALAHPY 253
            T +P  R T  + L HP+
Sbjct: 253 FTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 89.4 bits (222), Expect = 7e-21
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 33/201 (16%)

Query: 57  LHQII--RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 114
           L+  I  +  Q   EE   ++L+QI+  + YIH A +LHRD+K  N+ L     +K+ DF
Sbjct: 86  LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDF 145

Query: 115 GLARVTSETDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 173
           G++++      M E VV T +Y +PE L     Y    D+W++GC+  EL+  K  F   
Sbjct: 146 GISKILGSEYSMAETVVGTPYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTF--- 201

Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
           D  + L L+++++                 Y   +  Y  +             I LV  
Sbjct: 202 DATNPLNLVVKIV--------------QGNYTPVVSVYSSE------------LISLVHS 235

Query: 234 MLTFDPRQRITVEDALAHPYL 254
           +L  DP +R T ++ L  P L
Sbjct: 236 LLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.3 bits (219), Expect = 3e-20
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 24/178 (13%)

Query: 79  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE--TDFMTEYVVTRWYR 136
           +L+GL Y+HS  ++HRD+KPSN+LL     +K+CDFG   V+ E        +  T +Y 
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG---VSGELVNSLAGTFTGTSFYM 170

Query: 137 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 196
           APE +     Y+   DVWS+G   +E             V Q R      G P    +  
Sbjct: 171 APERIQGKP-YSITSDVWSLGLTLLE-------------VAQNRFPFPPEGEPPLGPIEL 216

Query: 197 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           L+     YI  +P  + +              D +++ L  DP +R T  D L HP++
Sbjct: 217 LS-----YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 85.3 bits (211), Expect = 2e-19
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 37/221 (16%)

Query: 41  ESFNDVYIAYELMD----TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHR 94
           ESF D      +M+     DLH++++    + L E+    F  QIL GL ++HS  +LHR
Sbjct: 66  ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125

Query: 95  DLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDV 153
           D+K  NL L+A  ++KI D G+A++ S  T+F    V T +Y +PE L     Y    DV
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCEDKPYNEKSDV 184

Query: 154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 213
           W++G +  E    K  F   +    +  +I  +  P              Y  QL     
Sbjct: 185 WALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ----------MYSQQL----- 229

Query: 214 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                           L+++ LT D RQR      L +P L
Sbjct: 230 --------------AQLIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 2e-19
 Identities = 40/128 (31%), Positives = 71/128 (55%), Gaps = 6/128 (4%)

Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           + I  E M    +   +++  AL+E   + +  QIL G++Y+HS  ++HRD+K +N+L +
Sbjct: 79  LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD 138

Query: 105 ANCDLKICDFG----LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
           +  ++K+ DFG    L  + S    M     T ++ +PE +++   Y    DVWSVGC  
Sbjct: 139 SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE-VISGEGYGRKADVWSVGCTV 197

Query: 161 MELMDRKP 168
           +E++  KP
Sbjct: 198 VEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 6e-19
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 34/199 (17%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 125
           L+E   +Y   Q+L  L ++HS  V+HRDLK  N+LL  + D+K+ DFG+ A+  S    
Sbjct: 100 LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159

Query: 126 MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 181
              ++ T ++ APE++      D  Y    D+WS+G   +EL   +P  P  + ++ +R+
Sbjct: 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMRV 216

Query: 182 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQS-FTEKFPNVHPSAIDLVEKMLTFDPR 240
           L++++ +                    P   + S ++  F        D ++  L  DP 
Sbjct: 217 LLKILKSEP------------------PTLDQPSKWSSSFN-------DFLKSCLVKDPD 251

Query: 241 QRITVEDALAHPYLGSLHD 259
            R T  + L HP++    D
Sbjct: 252 DRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 6e-19
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 32/203 (15%)

Query: 55  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 114
            D++Q+ R    LSE    Y   + L+GL Y+H    +HRD+K +N+LL  + D+K+ DF
Sbjct: 88  QDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADF 145

Query: 115 GL-ARVTSETDFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFP 171
           G+ A++T+       ++ T ++ APE+        Y    D+W++G   +EL + +P  P
Sbjct: 146 GVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP--P 203

Query: 172 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS-FTEKFPNVHPSAIDL 230
             D +H +R L  LI                K     P+ + +  ++  F        D 
Sbjct: 204 MFD-LHPMRALF-LIS---------------KSNFPPPKLKDKEKWSPVF-------HDF 239

Query: 231 VEKMLTFDPRQRITVEDALAHPY 253
           ++K LT DP++R T    L HP+
Sbjct: 240 IKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 84.4 bits (209), Expect = 7e-19
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 37/218 (16%)

Query: 45  DVYIAYELMDTDLH----QIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS 99
           DV+I  E+MDT L     ++      + E+        I++ L+Y+HS  +V+HRD+KPS
Sbjct: 74  DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS 133

Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSV 156
           N+L+N N  +K+CDFG++    ++   T     + Y APE +   LN   Y    DVWS+
Sbjct: 134 NVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSL 193

Query: 157 GCIFMEL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           G   +EL   R P    +    QL+ ++E    PS                  P+   + 
Sbjct: 194 GITMIELATGRFPYDSWKTPFQQLKQVVE---EPS------------------PQLPAEK 232

Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
           F+ +F        D V K L  + ++R    + L HP+
Sbjct: 233 FSPEF-------QDFVNKCLKKNYKERPNYPELLQHPF 263

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.0 bits (208), Expect = 8e-19
 Identities = 42/186 (22%), Positives = 84/186 (45%), Gaps = 29/186 (15%)

Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSET 123
             ++E++    + ++L  LKYIH   V+HRD+K +N+L+    ++K+CDFG+ A +   +
Sbjct: 96  GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155

Query: 124 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 183
              + +V T ++ APE++     Y    D+WS+G    E+    P +   D    + L+ 
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP 215

Query: 184 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
           +                      + PR +   ++           + V   L  +P++R+
Sbjct: 216 K---------------------SKPPRLEDNGYS-------KLLREFVAACLDEEPKERL 247

Query: 244 TVEDAL 249
           + E+ L
Sbjct: 248 SAEELL 253

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 83.9 bits (207), Expect = 1e-18
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 39/214 (18%)

Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARV 119
           I S   L+EE        +L+ L Y+HS  V+HRD+K  ++LL  +  +K+ DFG  A++
Sbjct: 108 IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167

Query: 120 TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 179
           + +       V T ++ APE +++ + Y   +D+WS+G + +E++D +P +     V  +
Sbjct: 168 SKDVPKRKSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226

Query: 180 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH---PSAIDLVEKMLT 236
           + L                              R S   K  N H   P   D +E+MLT
Sbjct: 227 KRL------------------------------RDSPPPKLKNAHKISPVLRDFLERMLT 256

Query: 237 FDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 270
            +P++R T ++ L HP+L      +  P C+ P 
Sbjct: 257 REPQERATAQELLDHPFLLQ----TGLPECLVPL 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.4 bits (206), Expect = 1e-18
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 10/128 (7%)

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLA-----RVTSETDFMTE 128
           +  Q+LRGL Y+H   ++HRD+K +NLL+++    L+I DFG A     + T   +F  +
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 129 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL--- 185
            + T  + APE+L     Y  + DVWSVGC+ +E+   KP +    H + L L+ ++   
Sbjct: 168 LLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA 226

Query: 186 IGTPSEAE 193
              PS  E
Sbjct: 227 TTAPSIPE 234

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 83.4 bits (207), Expect = 1e-18
 Identities = 40/120 (33%), Positives = 67/120 (55%), Gaps = 7/120 (5%)

Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     +L   +R +    E   +++  Q++  L+Y+HS ++++RDLK
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLK 128

Query: 98  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           P NLLL+++  +KI DFG A+      +      T  Y APE++L S  Y  A+D W++G
Sbjct: 129 PENLLLDSDGYIKITDFGFAKRVKGRTYTL--CGTPEYLAPEIIL-SKGYGKAVDWWALG 185

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 32/221 (14%)

Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           D   H     N    EE   ++  +IL GL+ +H  N ++RDLKP N+LL+    ++I D
Sbjct: 86  DLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISD 145

Query: 114 FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 173
            GLA    E + +   V T  Y APE +LN+  YT + D W +GC+  E+++ +  F GR
Sbjct: 146 LGLAVKIPEGESIRGRVGTVGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204

Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
               +   +   +    E      +E AK  IC++                         
Sbjct: 205 KEKVKREEVDRRVLETEEVYSAKFSEEAKS-ICKM------------------------- 238

Query: 234 MLTFDPRQRITVEDALA-----HPYLGSLHDISDEPVCMSP 269
           +LT DP+QR+  ++  A     HP+  +++    E   + P
Sbjct: 239 LLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDP 279

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)

Query: 42  SFND---VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           +F D   +Y+A E +   D   ++ +   LSE+H ++++ ++   +  +H    +HRDLK
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128

Query: 98  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           P N L++A+  +K+ DFGL++      +    V +  Y APE +L    Y   +D WS+G
Sbjct: 129 PENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPE-VLRGKGYDFTVDYWSLG 185

Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
           C+  E +   P F G               TP+E       EN K +   L   QR  + 
Sbjct: 186 CMLYEFLCGFPPFSG--------------STPNETW-----ENLKYWKETL---QRPVYD 223

Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 258
           +   N+   A DL+ K++    R+  ++ED   HP+   + 
Sbjct: 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 82.6 bits (205), Expect = 2e-18
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 14/128 (10%)

Query: 46  VYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +YI  E M   DL   +R + + L+ +       QI +G++Y+ S N +HRDL   N L+
Sbjct: 76  LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLV 135

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
             N  +KI DFGL+R   E D    Y          +W  APE L +   +T+  DVWS 
Sbjct: 136 TENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWM-APESLKDGK-FTSKSDVWSF 190

Query: 157 GCIFMELM 164
           G +  E+ 
Sbjct: 191 GVLLWEIF 198

Length = 258

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.9 bits (205), Expect = 2e-18
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 22/228 (9%)

Query: 42  SFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI---HSANVLHRDLK 97
           S  ++ I  E MD   L Q+++    + E         +LRGL Y+   H   ++HRD+K
Sbjct: 70  SDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVK 127

Query: 98  PSNLLLNANCDLKICDFGLARVTSE-TDFM-TEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
           PSN+L+N+  ++K+CDFG   V+ +  D M   +V TR Y +PE  L  + YT   D+WS
Sbjct: 128 PSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSYMSPE-RLQGTHYTVQSDIWS 183

Query: 156 VGCIFMEL-MDRKPLFPGRDHVHQLRLL------IELIGTPSEAELGFLNENAKKYICQL 208
           +G   +E+ + R P+ P  D      +        E   +         +      I +L
Sbjct: 184 LGLSLVEMAIGRYPI-PPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFEL 242

Query: 209 PRYQRQSFTEKFPNVH--PSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             Y       K P+        D V+K L  +P++R  +++   HP++
Sbjct: 243 LDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 82.2 bits (203), Expect = 4e-18
 Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 27/191 (14%)

Query: 79  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETDFMTEYVVTRWYR 136
           +++GL Y+ S  +LHRD+KPSN+L+N    +K+CDFG++   V S       YV T  Y 
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYM 160

Query: 137 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 196
           APE +     Y    DVWS+G  FMEL   +  +P         + ++L+          
Sbjct: 161 APERIS-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-------I 212

Query: 197 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           ++E+        P      F+EKF       +  + + +   P++R   E+ + HP++  
Sbjct: 213 VDEDP-------PVLPVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPFIVQ 258

Query: 257 LHDISDEPVCM 267
            +D + E V M
Sbjct: 259 YNDGNAEVVSM 269

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 81.6 bits (201), Expect = 5e-18
 Identities = 55/185 (29%), Positives = 96/185 (51%), Gaps = 21/185 (11%)

Query: 76  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRW 134
           L +IL+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T +
Sbjct: 107 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
           + APE++  S+ Y +  D+WS+G   +EL   +P  P  D +H +R+L  +         
Sbjct: 167 WMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNPPTLT 222

Query: 195 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           G  ++  K++I         +   K P+  P+A +L+        + +  V++A    YL
Sbjct: 223 GEFSKPFKEFI--------DACLNKDPSFRPTAKELL--------KHKFIVKNAKKTSYL 266

Query: 255 GSLHD 259
             L D
Sbjct: 267 TELID 271

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 82.0 bits (202), Expect = 5e-18
 Identities = 54/231 (23%), Positives = 106/231 (45%), Gaps = 39/231 (16%)

Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 90  DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL 149

Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +  +K+ DFG  A+V+ E       V T ++ APEL+ +   Y   +D+WS+G + +E
Sbjct: 150 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIE 208

Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 222
           ++D +P +     +  ++++                              R +   K  N
Sbjct: 209 MVDGEPPYFNEPPLKAMKMI------------------------------RDNLPPKLKN 238

Query: 223 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 270
           +H   PS    ++++L  DP QR T  + L HP+L      +  P C+ P 
Sbjct: 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK----AGPPSCIVPL 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 81.1 bits (200), Expect = 7e-18
 Identities = 55/192 (28%), Positives = 83/192 (43%), Gaps = 31/192 (16%)

Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R N  L E+   +F  QIL  L ++H+  +LHRDLK  N+LL+ +   +KI DFG++++ 
Sbjct: 93  RCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152

Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
           S        V T  Y +PE L     Y    D+W++GC+  EL   K  F   +    L 
Sbjct: 153 SSKSKAYTVVGTPCYISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN----LP 207

Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR 240
            L+  I + + A +               RY             P    L+  ML  DP 
Sbjct: 208 ALVLKIMSGTFAPIS-------------DRYS------------PDLRQLILSMLNLDPS 242

Query: 241 QRITVEDALAHP 252
           +R  +   +A P
Sbjct: 243 KRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 80.8 bits (199), Expect = 8e-18
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 34/204 (16%)

Query: 53  MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 112
           +D  L ++  + + LSE     +  Q+L G+ Y+H   +LHRDLK  N+ L  N  LKI 
Sbjct: 89  LDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIG 147

Query: 113 DFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP 171
           DFG++R +    D  T +  T +Y +PE  L    Y +  D+WS+GCI  E+      F 
Sbjct: 148 DFGVSRLLMGSCDLATTFTGTPYYMSPE-ALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206

Query: 172 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 231
           G++    L +++ ++  P                           T   P  +   ++ +
Sbjct: 207 GQNF---LSVVLRIVEGP---------------------------TPSLPETYSRQLNSI 236

Query: 232 -EKMLTFDPRQRITVEDALAHPYL 254
            + ML  DP  R +  + L +P++
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 80.8 bits (199), Expect = 9e-18
 Identities = 51/138 (36%), Positives = 71/138 (51%), Gaps = 8/138 (5%)

Query: 40  RESFN---DVYIAYELMDT-DLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLH 93
           +ESF     +YI  E  D  DL Q I+  +     E+    +  Q+  G+++IH   VLH
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123

Query: 94  RDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAID 152
           RD+K  N+ L  N  +K+ DFG AR+ TS   +   YV T +Y  PE+  N   Y    D
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP-YNNKSD 182

Query: 153 VWSVGCIFMELMDRKPLF 170
           +WS+GCI  EL   K  F
Sbjct: 183 IWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.9 bits (200), Expect = 9e-18
 Identities = 42/127 (33%), Positives = 72/127 (56%), Gaps = 9/127 (7%)

Query: 44  NDVYIAYELMDT-DLHQII---RSNQALSEEHC--QYFLYQILRGLKYIHSANVLHRDLK 97
           N++ I  EL D  DL ++I   +  + L  E    +YF  Q+   L+++HS  ++HRD+K
Sbjct: 75  NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLCSALEHMHSKRIMHRDIK 133

Query: 98  PSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P+N+ + A   +K+ D GL R  +S+T      V T +Y +PE  ++ + Y    D+WS+
Sbjct: 134 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSL 192

Query: 157 GCIFMEL 163
           GC+  E+
Sbjct: 193 GCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 39/204 (19%)

Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV- 119
           +   +  SE+  +++  +I+  L Y+HS +V++RDLK  NL+L+ +  +KI DFGL +  
Sbjct: 86  LSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145

Query: 120 TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 179
            S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH    
Sbjct: 146 ISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---- 200

Query: 180 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFD 238
             L ELI          L E                   +FP  + P A  L+  +L  D
Sbjct: 201 EKLFELI----------LMEEI-----------------RFPRTLSPEAKSLLAGLLKKD 233

Query: 239 PRQRI--TVEDAL---AHPYLGSL 257
           P+QR+    EDA     H +  S+
Sbjct: 234 PKQRLGGGPEDAKEIMEHRFFASI 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (198), Expect = 2e-17
 Identities = 66/264 (25%), Positives = 114/264 (43%), Gaps = 46/264 (17%)

Query: 6   KLMQRGHFV-RSSCFDTWIMKTSVVAIRDIIPPPQRESFND---VYIAYELMDT-DLHQI 60
           K +++ H V RS    T   +T +  +      P + SF     +Y+    ++  +L   
Sbjct: 24  KTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHH 83

Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 120
           ++          +++  ++L  L+ +H  NV++RDLKP N+LL+    + +CDFGL ++ 
Sbjct: 84  LQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLN 143

Query: 121 -SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 179
             + D    +  T  Y APELLL    YT A+D W++G +  E+                
Sbjct: 144 MKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEM---------------- 186

Query: 180 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE--KFP-NVHPSAIDLVEKMLT 236
                L G P      F +EN       +    R+   E  +FP      A DL+  +L+
Sbjct: 187 -----LTGLPP-----FYDEN-------VNEMYRKILQEPLRFPDGFDRDAKDLLIGLLS 229

Query: 237 FDPRQRITV---EDALAHPYLGSL 257
            DP +R+     ++   HP+   L
Sbjct: 230 RDPTRRLGYNGAQEIKNHPFFSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.5 bits (196), Expect = 3e-17
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 37/196 (18%)

Query: 66  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF 125
           A  E   + F+ QIL+GL Y+H+  ++HRD+K +N+L++    +KI DFG+++       
Sbjct: 102 AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161

Query: 126 MTEYVVTR-------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+    R       ++ APE++  +S YT   D+WS+GC+ +E++  K  FP       
Sbjct: 162 STKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFP------- 213

Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD 238
                              +    + I ++             N+   AID +EK    D
Sbjct: 214 -------------------DCTQLQAIFKIGENASPEIPS---NISSEAIDFLEKTFEID 251

Query: 239 PRQRITVEDALAHPYL 254
             +R T  + L HP+L
Sbjct: 252 HNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 79.5 bits (196), Expect = 3e-17
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 34/210 (16%)

Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           D   H     N    EE   ++  +I  GL+ +H   +++RDLKP N+LL+    ++I D
Sbjct: 86  DLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISD 145

Query: 114 FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 173
            GLA    E + +   V T  Y APE ++ +  YT + D W +GC+  E+++ K  F  R
Sbjct: 146 LGLAVEIPEGETIRGRVGTVGYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204

Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKK-YICQLPRYQRQSFTEKFPNVHPSAIDLVE 232
                                    E  K+  + +  +  ++ ++EKF     +A  +  
Sbjct: 205 ------------------------KEKVKREEVERRVKEDQEEYSEKFS---EAARSICR 237

Query: 233 KMLTFDPRQRI-----TVEDALAHPYLGSL 257
           ++LT DP  R+       E+  AHP+  + 
Sbjct: 238 QLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 79.3 bits (195), Expect = 4e-17
 Identities = 57/228 (25%), Positives = 109/228 (47%), Gaps = 33/228 (14%)

Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E ++      I ++  ++EE        +LR L Y+H+  V+HRD+K  ++LL
Sbjct: 92  DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL 151

Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
            ++  +K+ DFG  A+V+ E       V T ++ APE++ +   Y   +D+WS+G + +E
Sbjct: 152 TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIE 210

Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 222
           ++D +P +     +  +R + +                       LP   + S   K  +
Sbjct: 211 MIDGEPPYFNEPPLQAMRRIRD----------------------NLPPRVKDS--HKVSS 246

Query: 223 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 270
           V    +DL   ML  +P QR T ++ L HP+L     ++  P C+ P 
Sbjct: 247 VLRGFLDL---MLVREPSQRATAQELLQHPFL----KLAGPPSCIVPL 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 79.0 bits (195), Expect = 5e-17
 Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 29/189 (15%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 125
           ++EE        +L+ L ++H+  V+HRD+K  ++LL ++  +K+ DFG  A+V+ E   
Sbjct: 112 MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171

Query: 126 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 185
               V T ++ APE +++   Y   +D+WS+G + +E++D +P +     +  ++ + + 
Sbjct: 172 RKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230

Query: 186 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 245
                                 LP   +         V P     +++ML  DP QR T 
Sbjct: 231 ----------------------LPPKLKNLH-----KVSPRLRSFLDRMLVRDPAQRATA 263

Query: 246 EDALAHPYL 254
            + L HP+L
Sbjct: 264 AELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.8 bits (194), Expect = 5e-17
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 35/216 (16%)

Query: 44  NDVYIAYELMDT-DLHQIIRSNQAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
             ++I  E  D  DL + I   + +  SE+    +  QI  GLK+IH   +LHRD+K  N
Sbjct: 72  GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQN 131

Query: 101 LLLNANCDL-KICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           + L+ N  + K+ DFG+AR  +++ +     V T +Y +PE+  N   Y    D+WS+GC
Sbjct: 132 IFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGC 190

Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  EL   K  F G +++HQL L                       ICQ        F  
Sbjct: 191 VLYELCTLKHPFEG-NNLHQLVL----------------------KICQ------GYFAP 221

Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             PN       L+ ++    PR R ++   L  P+L
Sbjct: 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (196), Expect = 5e-17
 Identities = 32/98 (32%), Positives = 62/98 (63%), Gaps = 1/98 (1%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT-SETDF 125
            SE+  ++++ +++  L+++H  ++++RDLKP N+LL+A   + +CDFGL++   ++   
Sbjct: 93  FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152

Query: 126 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
              +  T  Y APE+LL+   YT  +D WS+G +  E+
Sbjct: 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.3 bits (193), Expect = 9e-17
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 43/223 (19%)

Query: 44  NDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPSNL 101
           N++ +  E MD   L +I +    +  E        ++ GL Y+++ + ++HRD+KPSN+
Sbjct: 76  NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNI 135

Query: 102 LLNANCDLKICDFGLA--RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           L+N+   +K+CDFG++   + S  D    +V T  Y +PE  +    YT   DVWS+G  
Sbjct: 136 LVNSRGQIKLCDFGVSGELINSIAD---TFVGTSTYMSPE-RIQGGKYTVKSDVWSLGIS 191

Query: 160 FMELMDRKPLFP---------GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 210
            +EL   K  FP         G+D    +  L++ I          + E   +    LP 
Sbjct: 192 IIELALGK--FPFAFSNIDDDGQDDPMGILDLLQQI----------VQEPPPR----LP- 234

Query: 211 YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
                 +  FP       D V+  L  DP +R T +   A P 
Sbjct: 235 ------SSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMPP 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 78.0 bits (193), Expect = 9e-17
 Identities = 42/136 (30%), Positives = 63/136 (46%), Gaps = 22/136 (16%)

Query: 46  VYIAYELMD-TDLHQIIRSN---------QALSEEHCQYFLYQILRGLKYIHSANVLHRD 95
           +Y+  E M+  DL   +R +           LS +    F  QI +G++Y+ S   +HRD
Sbjct: 71  LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRD 130

Query: 96  LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYT 148
           L   N L+  +  +KI DFGL+R   + D+   Y          RW  APE  L    +T
Sbjct: 131 LAARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPIRWM-APE-SLKDGIFT 185

Query: 149 AAIDVWSVGCIFMELM 164
           +  DVWS G +  E+ 
Sbjct: 186 SKSDVWSFGVLLWEIF 201

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.8 bits (191), Expect = 1e-16
 Identities = 57/189 (30%), Positives = 96/189 (50%), Gaps = 31/189 (16%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           L E +    L +IL+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T   
Sbjct: 98  LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157

Query: 127 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 185
              +V T ++ APE++  S+ Y    D+WS+G   +EL   +P  P  D +H +R+L   
Sbjct: 158 RNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVLF-- 211

Query: 186 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 245
                      + +N+       P  + Q +++ F        + VE  L  DPR R T 
Sbjct: 212 ----------LIPKNSP------PTLEGQ-YSKPFK-------EFVEACLNKDPRFRPTA 247

Query: 246 EDALAHPYL 254
           ++ L H ++
Sbjct: 248 KELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 77.3 bits (190), Expect = 2e-16
 Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 31/191 (16%)

Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSET 123
           + L E     +  QI   L+Y+H  ++LHRDLK  N+ L     +K+ D G+ARV  ++ 
Sbjct: 97  KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156

Query: 124 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 183
           D  +  + T +Y +PEL  N   Y    DVW++GC   E+   K  F  +D    +  +I
Sbjct: 157 DMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII 215

Query: 184 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
           E          G L    K Y  +L                    +L+  ML+  P +R 
Sbjct: 216 E----------GKLPPMPKDYSPEL-------------------GELIATMLSKRPEKRP 246

Query: 244 TVEDALAHPYL 254
           +V+  L  PY+
Sbjct: 247 SVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 35/225 (15%)

Query: 41  ESFNDVYIAYELMDT-DLH-QIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           E+ +D+ +   LM+  DL   I    +    E    ++  QI+ GL+++H   +++RDLK
Sbjct: 63  ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK 122

Query: 98  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           P N+LL+ + +++I D GLA        +     T  Y APE+L     Y  ++D +++G
Sbjct: 123 PENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVYDFSVDWFALG 181

Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
           C   E++  +   P R                 E       E  K+   ++       F+
Sbjct: 182 CTLYEMIAGRS--PFRQR-----------KEKVE------KEELKRRTLEMAVEYPDKFS 222

Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL 257
                  P A DL E +L  DP +R+     + ++   HP    L
Sbjct: 223 -------PEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.2 bits (190), Expect = 2e-16
 Identities = 41/131 (31%), Positives = 66/131 (50%), Gaps = 7/131 (5%)

Query: 46  VYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 99
           +YI  +L++   L +   S     Q  +EE       Q++  L+Y+H    ++HRDL P+
Sbjct: 84  LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN 143

Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N++L  +  + I DFGLA+       +T  V T  Y  PE++ N   Y    DVW+ GCI
Sbjct: 144 NIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCI 202

Query: 160 FMELMDRKPLF 170
             ++   +P F
Sbjct: 203 LYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 28/200 (14%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L  I      LSE    Y   + L+GL Y+HS   +HRD+K +N+LL  N D+K+ DFG+
Sbjct: 93  LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGV 152

Query: 117 -ARVTSETDFMTEYVVTRWYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 173
            A++T+       ++ T ++ APE+  +  +  Y    D+W+VG   +EL + +P  P  
Sbjct: 153 AAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP--PMF 210

Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
           D +H +R L             FL     K   Q P+ + +  T+     H    + V+ 
Sbjct: 211 D-LHPMRAL-------------FL---MSKSNFQPPKLKDK--TKWSSTFH----NFVKI 247

Query: 234 MLTFDPRQRITVEDALAHPY 253
            LT +P++R T E  L H +
Sbjct: 248 SLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.9 bits (189), Expect = 3e-16
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 35/203 (17%)

Query: 59  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 118
            I+     L E     +  QIL G+ Y+H+  V+HRD+K +N++L  N  +K+ DFG AR
Sbjct: 91  SILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150

Query: 119 V-------TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP 171
                    + ++ +     T ++ APE ++N S Y    D+WS+GC   E+   KP   
Sbjct: 151 RLAWVGLHGTHSNMLKSMHGTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKPPLA 209

Query: 172 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 231
             D +  +                F     +  + +LP     SF+        +AID V
Sbjct: 210 SMDRLAAM----------------FYIGAHRGLMPRLP----DSFSA-------AAIDFV 242

Query: 232 EKMLTFDPRQRITVEDALAHPYL 254
              LT D  +R +    L H +L
Sbjct: 243 TSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 76.7 bits (188), Expect = 3e-16
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 34/205 (16%)

Query: 55  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 114
           TDL +  + N  L EE   Y   +ILRGL ++H   V+HRD+K  N+LL  N ++K+ DF
Sbjct: 97  TDLIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 155

Query: 115 GL-ARVTSETDFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMDRKPL 169
           G+ A++         ++ T ++ APE++    +    Y    D+WS+G   +E+ +  P 
Sbjct: 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP- 214

Query: 170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 229
            P  D +H +R L  +   P+                  PR + + +++KF +       
Sbjct: 215 -PLCD-MHPMRALFLIPRNPA------------------PRLKSKKWSKKFQS------- 247

Query: 230 LVEKMLTFDPRQRITVEDALAHPYL 254
            +E  L  +  QR T E  + HP++
Sbjct: 248 FIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 77.0 bits (189), Expect = 4e-16
 Identities = 56/192 (29%), Positives = 100/192 (52%), Gaps = 13/192 (6%)

Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSE 122
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +  ++  
Sbjct: 90  RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 149

Query: 123 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL- 181
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH     L 
Sbjct: 150 AT-MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207

Query: 182 LIELIGTP----SEAE---LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 234
           L+E I  P     EA+    G L ++ K+ +   P   ++    +F     +  D+V+K 
Sbjct: 208 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL-SINWQDVVQKK 266

Query: 235 LTFDPRQRITVE 246
           L    + ++T E
Sbjct: 267 LLPPFKPQVTSE 278

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.0 bits (187), Expect = 4e-16
 Identities = 43/138 (31%), Positives = 72/138 (52%), Gaps = 8/138 (5%)

Query: 40  RESFNDVYIAYELMD----TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLH 93
           +ESF +    Y +MD     DL++ I + +     E+    +  QI   LK++H   +LH
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124

Query: 94  RDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAID 152
           RD+K  N+ L  +  +K+ DFG+ARV + T +     + T +Y +PE+  N   Y    D
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP-YNNKSD 183

Query: 153 VWSVGCIFMELMDRKPLF 170
           +W++GC+  E+   K  F
Sbjct: 184 IWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 76.3 bits (188), Expect = 5e-16
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 31/215 (14%)

Query: 45  DVYIAYELMDTDLHQI-IRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLL 102
           DV+I  ELM T L ++  R    + E+        I++ L Y+     V+HRD+KPSN+L
Sbjct: 88  DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNIL 147

Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCI 159
           L+A+ ++K+CDFG++    ++   T       Y APE +     +  Y    DVWS+G  
Sbjct: 148 LDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGIS 207

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
            +EL      FP ++   +  +L ++           L E        LP    + F+  
Sbjct: 208 LVELA--TGQFPYKNCKTEFEVLTKI-----------LQEEPPS----LP--PNEGFSPD 248

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           F          V+  LT D R+R    + L HP++
Sbjct: 249 F-------CSFVDLCLTKDHRKRPKYRELLQHPFI 276

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 75.5 bits (186), Expect = 7e-16
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 8/154 (5%)

Query: 46  VYIAYELMDT-DLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           VYI  ELM+   L   +RS   Q L          Q+  G+ Y+   N +HRDL   N+L
Sbjct: 77  VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL 136

Query: 103 LNANCDLKICDFGLARVTSETDFMTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
           +  +   K+ DFGLAR+  E  +++    +  +W  APE   +   ++   DVWS G + 
Sbjct: 137 VGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPE-AASHGTFSTKSDVWSFGILL 194

Query: 161 MELMDRKPL-FPGRDHVHQLRLLIELIGTPSEAE 193
            E+     + +PG ++      +      P  A+
Sbjct: 195 YEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAK 228

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 75.3 bits (185), Expect = 1e-15
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 34/217 (15%)

Query: 64  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 123
           N    E    ++  QI+ GL+++H   +++RDLKP N+LL+ + +++I D GLA    + 
Sbjct: 91  NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150

Query: 124 DFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 182
              T+ Y  T  + APELL    +Y  ++D +++G    E++  +  F  R         
Sbjct: 151 QSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRAR--------- 200

Query: 183 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 242
               G   E      N+  K+ I         ++ +KF    P++    E +L  DP +R
Sbjct: 201 ----GEKVE------NKELKQRILNDS----VTYPDKFS---PASKSFCEALLAKDPEKR 243

Query: 243 ITVEDA-----LAHPYLGSLH-DISDEPVCMSPFSFD 273
           +   D        HP    L+    +  +   PF  D
Sbjct: 244 LGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.9 bits (186), Expect = 1e-15
 Identities = 44/130 (33%), Positives = 76/130 (58%), Gaps = 5/130 (3%)

Query: 45  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPSNLL 102
           ++ I  E MD   L Q+++  + + EE        +LRGL Y+   + ++HRD+KPSN+L
Sbjct: 77  EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136

Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
           +N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVE 194

Query: 163 L-MDRKPLFP 171
           L + R P+ P
Sbjct: 195 LAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 42/102 (41%), Positives = 63/102 (61%), Gaps = 6/102 (5%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYR 136
           QIL G+ Y+H  +++HRD+KPSNLL+N+  ++KI DFG++R+ ++T D     V T  Y 
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYM 235

Query: 137 APELL---LNSSDYTA-AIDVWSVGCIFMEL-MDRKPLFPGR 173
           +PE +   LN   Y   A D+WS+G   +E  + R P   GR
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277

Length = 353

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.0 bits (184), Expect = 1e-15
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 34/205 (16%)

Query: 55  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 114
           TDL +  + N AL E+   Y   +ILRGL ++H+  V+HRD+K  N+LL  N ++K+ DF
Sbjct: 107 TDLVKNTKGN-ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF 165

Query: 115 GL-ARVTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMDRKPL 169
           G+ A++         ++ T ++ APE++       + Y    D+WS+G   +E+ +  P 
Sbjct: 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP- 224

Query: 170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 229
            P  D +H +R L  +   P                   P+ + + +++KF       ID
Sbjct: 225 -PLCD-MHPMRALFLIPRNPP------------------PKLKSKKWSKKF-------ID 257

Query: 230 LVEKMLTFDPRQRITVEDALAHPYL 254
            +E  L  +   R + E  L HP++
Sbjct: 258 FIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.1 bits (182), Expect = 2e-15
 Identities = 57/181 (31%), Positives = 85/181 (46%), Gaps = 40/181 (22%)

Query: 69  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMT 127
           E+   ++  QIL GLKY+H   ++HRD+K  N+L+N     +KI DFG ++  +  +  T
Sbjct: 107 EQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166

Query: 128 E-YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 185
           E +  T  Y APE++      Y A  D+WS+GC  +E+   KP F            IEL
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF------------IEL 214

Query: 186 IGTPSEA--ELGF----------LNENAKKYI--CQLPRYQRQSFTEKFPNVHPSAIDLV 231
            G P  A  ++G           L+  AK +I  C  P           P+   SA DL+
Sbjct: 215 -GEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPD----------PDKRASAHDLL 263

Query: 232 E 232
           +
Sbjct: 264 Q 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.5 bits (180), Expect = 6e-15
 Identities = 37/91 (40%), Positives = 57/91 (62%), Gaps = 5/91 (5%)

Query: 80  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 139
           L+GL Y+HS N++HRD+K  N+LL     +K+ DFG A  +S  +    +V T ++ APE
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPE 187

Query: 140 LLL--NSSDYTAAIDVWSVGCIFMELMDRKP 168
           ++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 73.3 bits (180), Expect = 7e-15
 Identities = 38/96 (39%), Positives = 57/96 (59%), Gaps = 6/96 (6%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 137
             L+GL Y+HS   +HRD+K  N+LL     +K+ DFG A + S  +    +V T ++ A
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMA 179

Query: 138 PELLL--NSSDYTAAIDVWSVGCIFMELMDRK-PLF 170
           PE++L  +   Y   +DVWS+G   +EL +RK PLF
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 73.8 bits (181), Expect = 7e-15
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 27/195 (13%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYR 136
           QIL GL+Y+H+  ++HRD+K  N+ +N    + I D G A+       F+     T    
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAGTVETN 223

Query: 137 APELLLNSSDYTAAIDVWSVGCIFMELM----------DRKPLFPGRD-HVHQLRLLIEL 185
           APE+L     Y +  D+WS G +  E++             P    +  H H L+++  L
Sbjct: 224 APEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282

Query: 186 IGTPSEAELGFLNENAKKYICQLPRY---QRQSFTEKFP-----NVHPSAIDLVEKMLTF 237
              P E    F  +   + +     Y   +RQ +T ++P     N+      LV KMLTF
Sbjct: 283 KVHPEE----FPRDPGSRLVRGFIEYASLERQPYT-RYPCFQRVNLPIDGEFLVHKMLTF 337

Query: 238 DPRQRITVEDALAHP 252
           D   R + E+ L +P
Sbjct: 338 DAAMRPSAEEILNYP 352

Length = 357

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.4 bits (177), Expect = 8e-15
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 28/200 (14%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L  I      LSE    Y   + L+GL Y+HS   +HRD+K +N+LL  N  +K+ DFG+
Sbjct: 93  LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGV 152

Query: 117 -ARVTSETDFMTEYVVTRWYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 173
            A++T+       ++ T ++ APE+  +     Y    D+W+VG   +EL + +P  P  
Sbjct: 153 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP--PMF 210

Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
           D +H +R L   + T S  +   L +  K             ++  F +        V+ 
Sbjct: 211 D-LHPMRAL--FLMTKSNFQPPKLKDKMK-------------WSNSFHH-------FVKM 247

Query: 234 MLTFDPRQRITVEDALAHPY 253
            LT +P++R T E  L HP+
Sbjct: 248 ALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 72.8 bits (178), Expect = 1e-14
 Identities = 37/91 (40%), Positives = 57/91 (62%), Gaps = 5/91 (5%)

Query: 80  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 139
           L+GL Y+HS N++HRD+K  N+LL     +K+ DFG A + S  +    +V T ++ APE
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPE 191

Query: 140 LLL--NSSDYTAAIDVWSVGCIFMELMDRKP 168
           ++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 29/178 (16%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYR 136
           + L+ L+++HS  V+HRD+K  N+LL  +  +K+ DFG  A++T E    +  V T ++ 
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 137 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 196
           APE++   + Y   +D+WS+G + +E+++ +P +   + +  L  LI   GTP       
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP------- 233

Query: 197 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                     +L   ++ S             D + + L  D  +R + ++ L HP+L
Sbjct: 234 ----------ELQNPEKLS---------AIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 72.8 bits (178), Expect = 1e-14
 Identities = 39/120 (32%), Positives = 68/120 (56%), Gaps = 2/120 (1%)

Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSET 123
           +  SE+  +++  +I+  L Y+HS  +++RDLK  NL+L+ +  +KI DFGL +   ++ 
Sbjct: 90  RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA 149

Query: 124 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 183
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH     L++
Sbjct: 150 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 45/137 (32%), Positives = 72/137 (52%), Gaps = 10/137 (7%)

Query: 60  IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-AR 118
           ++   Q L E    Y LY  L GL+++H+  ++HRD+K +N+LL     +K+ DFG+ A+
Sbjct: 118 LLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177

Query: 119 VTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMD-RKPLFPGR 173
           +TS        V T ++ APE++         Y A  DVWS+G   +EL D   PLF   
Sbjct: 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF--- 234

Query: 174 DHVHQLRLLIELIGTPS 190
             +H ++ L ++   P 
Sbjct: 235 -DMHPVKTLFKIPRNPP 250

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 44/229 (19%)

Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNAN------------- 106
           I  +   S  H    ++Q    L Y H+  +++H DLKP N+L+  +             
Sbjct: 222 IMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281

Query: 107 ---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
              C ++ICD G      E    T  V TR YR+PE++L    +  + D+WS+GCI  EL
Sbjct: 282 PDPCRVRICDLG--GCCDERHSRTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYEL 338

Query: 164 MDRKPLFPGRDHVHQLRLLIELIGT-PSEAELGFLNENAK---------------KYICQ 207
              K L+   D++  L L+ + +G  PSE       E A+               K++ +
Sbjct: 339 YTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLAR 398

Query: 208 LPRYQ--RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           + R +  R+   +          DL+  +L +D ++R+       HPY+
Sbjct: 399 IARARPVREVIRDDL------LCDLIYGLLHYDRQKRLNARQMTTHPYV 441

Length = 467

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 51/198 (25%)

Query: 69  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 128
           E+   ++L +I   L+++H   +++RDLKP N+LL+A   +K+ DFGL + +     +T 
Sbjct: 99  EDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158

Query: 129 -YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG 187
            +  T  Y APE+L+ S  +  A+D WS+G +  ++                     L G
Sbjct: 159 TFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDM---------------------LTG 196

Query: 188 TPSEAELGFLNENAKKYI-------CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR 240
            P      F  EN KK I         LP Y           + P A DL++K+L  +P 
Sbjct: 197 APP-----FTAENRKKTIDKILKGKLNLPPY-----------LTPEARDLLKKLLKRNPS 240

Query: 241 QRI--TVEDAL---AHPY 253
            R+     DA    +HP+
Sbjct: 241 SRLGAGPGDAAEVQSHPF 258

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 71.7 bits (175), Expect = 2e-14
 Identities = 37/113 (32%), Positives = 68/113 (60%), Gaps = 3/113 (2%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYR 136
           + L+ L+++HS  V+HRD+K  N+LL  +  +K+ DFG  A++T E    +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183

Query: 137 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 189
           APE++   + Y   +D+WS+G + +E+++ +P +   + +  L  LI   GTP
Sbjct: 184 APEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTP 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 71.2 bits (175), Expect = 3e-14
 Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 13/147 (8%)

Query: 45  DVYIAYELMDTDL-------HQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDL 96
           D +I  ELMD  L       +++++S   + EE         ++ L Y+     ++HRD+
Sbjct: 77  DCWICMELMDISLDKFYKYVYEVLKSV--IPEEILGKIAVATVKALNYLKEELKIIHRDV 134

Query: 97  KPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVW 154
           KPSN+LL+ N ++K+CDFG++    ++   T     R Y APE +  S+   Y    DVW
Sbjct: 135 KPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVW 194

Query: 155 SVGCIFMELMDRKPLFPGRDHV-HQLR 180
           S+G    E+   K  +P  + V  QL 
Sbjct: 195 SLGITLYEVATGKFPYPKWNSVFDQLT 221

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 27/207 (13%)

Query: 79  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWY--- 135
           +LR ++Y+H   ++HRD+K  N+ +N   D+ + DFG A       F  +    ++Y   
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC------FPVDINANKYYGWA 244

Query: 136 -----RAPELLLNSSDYTAAIDVWSVGCIFME-------LMDRKPLFPGRDHVHQLRLLI 183
                 APELL     Y  A+D+WS G +  E       L ++  L    D   Q++L+I
Sbjct: 245 GTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303

Query: 184 ELIGT-PSEAELGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAID---LVEKMLTFD 238
              GT P+E  +       + YI    +  R+  +   + N++   ID   L+ KML FD
Sbjct: 304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD 363

Query: 239 PRQRITVEDALAHPYLGSLHDISDEPV 265
              R + E  L       + D    P+
Sbjct: 364 AHHRPSAEALLDFAAFQDIPDPYPNPM 390

Length = 391

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.4 bits (175), Expect = 3e-14
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 53/230 (23%)

Query: 46  VYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN 100
           VY+  E MD      L+    + + + E+  +   Y +++GLK++    N++HRD+KP+N
Sbjct: 74  VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133

Query: 101 LLLNANCDLKICDFG----LARVTSETDFMTEYVVTRWYRAPELL--LNSSD---YTAAI 151
           +L+N N  +K+CDFG    L    ++T+     +  + Y APE +     +    YT   
Sbjct: 134 VLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYMAPERIKSGGPNQNPTYTVQS 188

Query: 152 DVWSVGCIFMEL-MDRKPLFPGRDHVH---QLRLLIELIGTPSEAELGFLNENAKKYICQ 207
           DVWS+G   +E+ + R P +P   + +   QL  +++  G P                  
Sbjct: 189 DVWSLGLSILEMALGRYP-YPPETYANIFAQLSAIVD--GDPP----------------T 229

Query: 208 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
           LP                 A D V K L   P +R T    L HP+L   
Sbjct: 230 LP-----------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 70.8 bits (174), Expect = 3e-14
 Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 36/224 (16%)

Query: 42  SF---NDVYIAYELMDT-DLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHR 94
           SF   +++++    +    L  I++S      L E      L ++L+GL+Y+HS   +HR
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHR 126

Query: 95  DLKPSNLLLNANCDLKICDFGLARVTSETDFMTE-----YVVTRWYRAPELLLNSSDYTA 149
           D+K  N+LL  +  +KI DFG++   ++    T      +V T  + APE++     Y  
Sbjct: 127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDF 186

Query: 150 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 209
             D+WS G   +EL       P   +     L++ L   P   E      + KKY     
Sbjct: 187 KADIWSFGITAIELATGAA--PYSKYPPMKVLMLTLQNDPPSLE---TGADYKKY----- 236

Query: 210 RYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
               +SF             ++   L  DP +R T E+ L H +
Sbjct: 237 ---SKSFR-----------KMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 70.8 bits (173), Expect = 3e-14
 Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 44/227 (19%)

Query: 44  NDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           N++ I  EL D  DL Q+I    +  + + E     +  Q+   ++++HS  V+HRD+KP
Sbjct: 75  NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKP 134

Query: 99  SNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           +N+ + A   +K+ D GL R  +S+T      V T +Y +PE  ++ + Y    D+WS+G
Sbjct: 135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLG 193

Query: 158 CIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           C+  E+   + P +  + ++  L   IE                     C  P    + +
Sbjct: 194 CLLYEMAALQSPFYGDKMNLFSLCQKIEQ--------------------CDYPPLPTEHY 233

Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           +EK         +LV   +  DP QR         P +G +H I+ +
Sbjct: 234 SEKLR-------ELVSMCIYPDPDQR---------PDIGYVHQIAKQ 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 71.1 bits (174), Expect = 3e-14
 Identities = 43/130 (33%), Positives = 74/130 (56%), Gaps = 12/130 (9%)

Query: 51  ELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 109
           +LM+  DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  +
Sbjct: 77  DLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHV 136

Query: 110 KICDFGLARVTSETDFMTE----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
           +I D GLA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+ 
Sbjct: 137 RISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL- 190

Query: 166 RKPLFPGRDH 175
            +   P R H
Sbjct: 191 -RGHSPFRQH 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 36/91 (39%), Positives = 58/91 (63%), Gaps = 5/91 (5%)

Query: 80  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 139
           L+GL Y+HS N++HRD+K  N+LL+    +K+ DFG A + +  +    +V T ++ APE
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPE 181

Query: 140 LLL--NSSDYTAAIDVWSVGCIFMELMDRKP 168
           ++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.9 bits (173), Expect = 4e-14
 Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 21/194 (10%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 98  LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157

Query: 127 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 185
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +   P    +H +++L  +
Sbjct: 158 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGE---PPHSELHPMKVLFLI 213

Query: 186 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 245
                    G  ++  K+++        ++   K P+  P+A +L+        + +  V
Sbjct: 214 PKNNPPTLEGNYSKPLKEFV--------EACLNKEPSFRPTAKELL--------KHKFIV 257

Query: 246 EDALAHPYLGSLHD 259
             A    YL  L D
Sbjct: 258 RFAKKTSYLTELID 271

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 33/182 (18%)

Query: 64  NQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARV-TS 121
            +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    
Sbjct: 89  ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148

Query: 122 ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 181
           +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      
Sbjct: 149 DGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EK 203

Query: 182 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ 241
           L ELI          L E  +      PR            + P A  L+  +L  DP+Q
Sbjct: 204 LFELI----------LMEEIR-----FPR-----------TLSPEAKSLLSGLLKKDPKQ 237

Query: 242 RI 243
           R+
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 59/231 (25%), Positives = 108/231 (46%), Gaps = 20/231 (8%)

Query: 42  SFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 99
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 74  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 133

Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 134 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 191

Query: 160 FMEL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-------------FLNENAKKYI 205
            +E+ + R P+ P      +L     + G P+E+E                 +      I
Sbjct: 192 LVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAI 251

Query: 206 CQLPRYQRQSFTEKFPNVHPSA--IDLVEKMLTFDPRQRITVEDALAHPYL 254
            +L  Y       K P+    A   D V K L  +P +R  ++  + H ++
Sbjct: 252 FELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.5 bits (172), Expect = 6e-14
 Identities = 49/178 (27%), Positives = 91/178 (51%), Gaps = 29/178 (16%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYR 136
           + L+ L+++H+  V+HRD+K  N+LL  +  +K+ DFG  A++T E    +  V T ++ 
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 137 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 196
           APE++   + Y   +D+WS+G + +E+++ +P +   + +  L  LI   GTP   EL  
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP---EL-- 235

Query: 197 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             +N +K                   + P   D + + L  D  +R + ++ L HP+L
Sbjct: 236 --QNPEK-------------------LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.1 bits (171), Expect = 6e-14
 Identities = 42/135 (31%), Positives = 74/135 (54%), Gaps = 7/135 (5%)

Query: 44  NDVYIAYELMDT-DLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           N++ I  EL D  DL ++I+      + + E+    +  Q+   L+++HS  V+HRD+KP
Sbjct: 75  NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKP 134

Query: 99  SNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           +N+ + A   +K+ D GL R  +S+T      V T +Y +PE  ++ + Y    D+WS+G
Sbjct: 135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLG 193

Query: 158 CIFMELMDRKPLFPG 172
           C+  E+   +  F G
Sbjct: 194 CLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 70.4 bits (172), Expect = 6e-14
 Identities = 51/227 (22%), Positives = 97/227 (42%), Gaps = 38/227 (16%)

Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           D   H     N    E+   ++  ++  GL+ +    +++RDLKP N+LL+    ++I D
Sbjct: 86  DLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISD 145

Query: 114 FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 173
            GLA    E + +   V T  Y APE++ N   YT + D W +GC+  E++  +   P R
Sbjct: 146 LGLAVQIPEGETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQS--PFR 202

Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
               +++                  E   + + +     ++ ++EKF      A  +   
Sbjct: 203 KRKERVK-----------------REEVDRRVKE----DQEEYSEKFSE---DAKSICRM 238

Query: 234 MLTFDPRQRITVEDALA-----HPYLGSLH------DISDEPVCMSP 269
           +LT +P++R+      A     HP   +++      ++ + P C  P
Sbjct: 239 LLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 70.0 bits (171), Expect = 6e-14
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 35/207 (16%)

Query: 55  TDLHQ-IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           TDL +  ++  + + E    Y L++ L GL+++H    +HRD+K +N+LL     +K+ D
Sbjct: 108 TDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167

Query: 114 FGL-ARVTSETDFMTEYVVTRWYRAPELL-----LNSSDYTAAIDVWSVGCIFMELMDRK 167
           FG+ A++TS        V T ++ APE++     L+S+ Y A  DVWS+G   +EL D  
Sbjct: 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGD 226

Query: 168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSA 227
           P  P  D +H +R L ++   P                   P      F           
Sbjct: 227 P--PLAD-LHPMRALFKIPRNPPPT-------------LHQPELWSNEFN---------- 260

Query: 228 IDLVEKMLTFDPRQRITVEDALAHPYL 254
            D + K LT D  +R TV D L H ++
Sbjct: 261 -DFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 70.0 bits (171), Expect = 7e-14
 Identities = 38/113 (33%), Positives = 68/113 (60%), Gaps = 9/113 (7%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DLH  +  +   SE+  +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 83  DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142

Query: 116 LARVTSETDFMTE----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA      DF  +     V T  Y APE+L   + Y ++ D +S+GC+  +L+
Sbjct: 143 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.1 bits (171), Expect = 8e-14
 Identities = 48/178 (26%), Positives = 88/178 (49%), Gaps = 29/178 (16%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYR 136
           + L+ L ++HS  V+HRD+K  N+LL  +  +K+ DFG  A++T E    +  V T ++ 
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 137 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 196
           APE++   + Y   +D+WS+G + +E+++ +P +   + +  L  LI   GTP       
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP------- 233

Query: 197 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                     +L   +R S   +         D + + L  D  +R + ++ L HP+L
Sbjct: 234 ----------ELQNPERLSAVFR---------DFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 36/125 (28%), Positives = 65/125 (52%), Gaps = 12/125 (9%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   I+ +    E   +++  +I+ GL+++H   +++RDLK  N+LL++   +KI DFG
Sbjct: 82  DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFG 141

Query: 116 LARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 169
           + +     + +   V T        Y APE+L     Y  A+D W++G +  E++  +  
Sbjct: 142 MCK-----EGILGGVTTSTFCGTPDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSP 195

Query: 170 FPGRD 174
           F G D
Sbjct: 196 FEGDD 200

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 69.3 bits (169), Expect = 1e-13
 Identities = 47/181 (25%), Positives = 88/181 (48%), Gaps = 28/181 (15%)

Query: 64  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSE 122
           ++ L+E   Q    Q+L  L+Y+HS  ++HRDLK  N+LL  + D+K+ DFG+ A+    
Sbjct: 104 DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163

Query: 123 TDFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
                 ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P    ++ 
Sbjct: 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 220

Query: 179 LRLLIEL-------IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 231
           +R+L+++       +  PS+  + F  +  K  +            +K P   PSA  L+
Sbjct: 221 MRVLLKIAKSEPPTLSQPSKWSMEF-RDFLKTAL------------DKHPETRPSAAQLL 267

Query: 232 E 232
           E
Sbjct: 268 E 268

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 37/202 (18%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   I+S+    E   +++  +I+ GL+++H   +++RDLK  N+LL+ +  +KI DFG
Sbjct: 82  DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFG 141

Query: 116 LARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
           + +     +     +  T  Y APE+L     Y  ++D WS G +  E++  +  F G D
Sbjct: 142 MCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGED 200

Query: 175 HVHQLRLLIELIGTPSEAEL--GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 232
                           E EL    LN+         PR+           +   A D + 
Sbjct: 201 ----------------EDELFDSILNDRP-----HFPRW-----------ISKEAKDCLS 228

Query: 233 KMLTFDPRQRITVE-DALAHPY 253
           K+   DP +R+ V+ D   HP+
Sbjct: 229 KLFERDPTKRLGVDGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 42/206 (20%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   I ++   SE    ++   ++ GL+Y+H   +++RDLK  NLLL+    +KI DFG
Sbjct: 88  DLMMHIHTDV-FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFG 146

Query: 116 LARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
           L +      D  + +  T  + APE+L  +S YT A+D W +G +  E++  +  FPG D
Sbjct: 147 LCKEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDD 205

Query: 175 HVHQLRLLIELIGTPSEAEL--GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 232
                           E E+    +N+          RY R    E        AI ++ 
Sbjct: 206 ----------------EEEVFDSIVNDE--------VRYPRFLSRE--------AISIMR 233

Query: 233 KMLTFDPRQRI-----TVEDALAHPY 253
           ++L  +P +R+       ED    P+
Sbjct: 234 RLLRRNPERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 54/261 (20%), Positives = 98/261 (37%), Gaps = 80/261 (30%)

Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     D+  ++      +EE  ++++ + +  +  IH    +HRD+K
Sbjct: 69  SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIK 128

Query: 98  PSNLLLNANCDLKICDFGL-----------------------ARVTSETDFMTEYVVTRW 134
           P NLLL+A   +K+ DFGL                                 ++     W
Sbjct: 129 PDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETW 188

Query: 135 ----------------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
                           Y APE+ L +  Y    D WS+G I  E+               
Sbjct: 189 KRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEM--------------- 232

Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP---NVHPSAIDLVEKML 235
                 L+G P      F ++N ++   +     ++  T +FP    + P A DL++++ 
Sbjct: 233 ------LVGYPP-----FCSDNPQE-TYRKIINWKE--TLQFPDEVPLSPEAKDLIKRLC 278

Query: 236 TFDPRQRI---TVEDALAHPY 253
             +  +R+    V +  +HP+
Sbjct: 279 C-EAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 68.1 bits (166), Expect = 3e-13
 Identities = 35/112 (31%), Positives = 65/112 (58%), Gaps = 5/112 (4%)

Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-- 118
           ++S  AL+E   + +  QIL G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++  
Sbjct: 97  LKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156

Query: 119 --VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 168
             +      M     T ++ +PE +++   Y    D+WSVGC  +E++  KP
Sbjct: 157 QTICLSGTGMKSVTGTPYWMSPE-VISGEGYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 39/133 (29%), Positives = 69/133 (51%), Gaps = 7/133 (5%)

Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           + +D    Y LM+     +L   +R++   S     ++  +I+  L+Y+HS  +++RDLK
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128

Query: 98  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           P N+LL+    +K+ DFG A+     D       T  Y APE ++ S  +  A+D W++G
Sbjct: 129 PENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPE-VIQSKGHNKAVDWWALG 185

Query: 158 CIFMELMDRKPLF 170
            +  E++   P F
Sbjct: 186 ILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 43/136 (31%), Positives = 71/136 (52%), Gaps = 9/136 (6%)

Query: 33  DIIPPPQRESF-NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV 91
           DI        +   +  A E    D   +I  + ALS      F YQ+  G++++ S N 
Sbjct: 203 DIESSNYESPYDQYLPSAPERTRRDT--LINESPALSYMDLVGFSYQVANGMEFLASKNC 260

Query: 92  LHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDY 147
           +HRDL   N+L+     +KICDFGLAR +  +++++++   ++  +W  APE + N+  Y
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM-APESIFNNL-Y 318

Query: 148 TAAIDVWSVGCIFMEL 163
           T   DVWS G +  E+
Sbjct: 319 TTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 4e-13
 Identities = 35/113 (30%), Positives = 68/113 (60%), Gaps = 7/113 (6%)

Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 120
           +++  AL+E   + +  QIL+G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++  
Sbjct: 97  LKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156

Query: 121 SETDFMTEYVV-----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 168
            +T  M+   +     T ++ +PE +++   Y    DVWSV C  +E++  KP
Sbjct: 157 -QTICMSGTGIKSVTGTPYWMSPE-VISGEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 6/104 (5%)

Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 124
           + L+++    F YQ+ RG++++ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 125 FMTEYVVTR----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  +    R    W  APE L +   YT   DVWS G +  E+ 
Sbjct: 187 YYRKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.4 bits (164), Expect = 6e-13
 Identities = 34/112 (30%), Positives = 64/112 (57%), Gaps = 5/112 (4%)

Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG----L 116
           +++  AL+E   + +  QIL G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG    L
Sbjct: 97  LKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156

Query: 117 ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 168
             +      +     T ++ +PE +++   Y    DVWS+GC  +E++  KP
Sbjct: 157 QTICMSGTGIRSVTGTPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 67.7 bits (165), Expect = 6e-13
 Identities = 36/120 (30%), Positives = 67/120 (55%), Gaps = 3/120 (2%)

Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV- 119
           ++  ++  E   +++  +I   L Y+HS N+++RDLKP N+LL++   + + DFGL +  
Sbjct: 87  LQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146

Query: 120 TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 179
            +++D  T +  T  Y APE ++    Y   +D W +G +  E++   P F  RD V ++
Sbjct: 147 IAQSDTTTTFCGTPEYLAPE-VIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-VAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 67.5 bits (165), Expect = 6e-13
 Identities = 45/119 (37%), Positives = 61/119 (51%), Gaps = 18/119 (15%)

Query: 56  DLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           DL   +R  +   L+ E    F YQ+ +G+ ++ S N +HRDL   N+LL     +KICD
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184

Query: 114 FGLARVTSETDFMTE--YVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           FGLAR     D M +  YVV        +W  APE + N   YT   DVWS G +  E+
Sbjct: 185 FGLAR-----DIMNDSNYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 68.0 bits (166), Expect = 7e-13
 Identities = 49/152 (32%), Positives = 72/152 (47%), Gaps = 25/152 (16%)

Query: 24  MKTSVVAI----RDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQI 79
           MK  V  +     D     +  S+ D  +  E+++ D         AL  E    F YQ+
Sbjct: 171 MKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEED-------ELALDTEDLLSFSYQV 223

Query: 80  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVV------- 131
            +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++    YVV       
Sbjct: 224 AKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN----YVVKGNARLP 279

Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            +W  APE + N   YT   DVWS G +  E+
Sbjct: 280 VKWM-APESIFNCV-YTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.0 bits (163), Expect = 8e-13
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 32/210 (15%)

Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           D   H          E    ++  +I  GL+ +H   +++RDLKP N+LL+ +  ++I D
Sbjct: 86  DLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISD 145

Query: 114 FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 173
            GLA    E   +   V T  Y APE++ N   YT + D W++GC+  E++       G+
Sbjct: 146 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIA------GQ 198

Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
               Q +  I+              E  ++ + ++     + ++EKF    P A  L + 
Sbjct: 199 SPFQQRKKKIK-------------REEVERLVKEVQ----EEYSEKFS---PDARSLCKM 238

Query: 234 MLTFDPRQRI-----TVEDALAHPYLGSLH 258
           +L  DP++R+        +   HP    ++
Sbjct: 239 LLCKDPKERLGCQGGGAREVKEHPLFKQIN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 42/131 (32%), Positives = 72/131 (54%), Gaps = 13/131 (9%)

Query: 37  PPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL 96
           P   +  ND  +   L+  D  + + +   LS      F YQ+ RG++++ S N +HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263

Query: 97  KPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAID 152
              N+LL     +KICDFGLAR +  +++++++   ++  +W  APE + ++  YT   D
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APESIFDNL-YTTLSD 321

Query: 153 VWSVGCIFMEL 163
           VWS G +  E+
Sbjct: 322 VWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 43/218 (19%)

Query: 44  NDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           N VY   E ++  +L   +R       +  +++  +++   +Y+HS ++++RDLKP NLL
Sbjct: 91  NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLL 150

Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
           L+    +K+ DFG A+   +  F      T  Y APE ++ S  +  A+D W++G +  E
Sbjct: 151 LDNKGHVKVTDFGFAKKVPDRTFT--LCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYE 207

Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR-QSFTEKFP 221
                                 + G P      F ++   +       Y++  +   KFP
Sbjct: 208 F---------------------IAGYPP-----FFDDTPFRI------YEKILAGRLKFP 235

Query: 222 N-VHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 253
           N     A DLV+ +L  D  +R+      V D   HPY
Sbjct: 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273

Length = 329

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 35/109 (32%), Positives = 58/109 (53%), Gaps = 2/109 (1%)

Query: 68  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFM 126
            E   +++  +I   L Y+HS N+++RDLKP N+LL++   + + DFGL +   E +   
Sbjct: 94  PEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153

Query: 127 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 175
           + +  T  Y APE+L     Y   +D W +G +  E++   P F  RD 
Sbjct: 154 STFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 1e-12
 Identities = 48/145 (33%), Positives = 69/145 (47%), Gaps = 14/145 (9%)

Query: 46  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +YI  E M    L   ++S   + L          QI  G+ Y+ S N +HRDL   N+L
Sbjct: 76  IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNIL 135

Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCI 159
           +  N   KI DFGLAR+  E D  T     ++   + APE   N   +T   DVWS G +
Sbjct: 136 VGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPE-AANYGRFTIKSDVWSFGIL 193

Query: 160 FMELMD--RKPLFPG---RDHVHQL 179
             E++   R P +PG   R+ + Q+
Sbjct: 194 LTEIVTYGRVP-YPGMTNREVLEQV 217

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.5 bits (162), Expect = 1e-12
 Identities = 41/138 (29%), Positives = 75/138 (54%), Gaps = 7/138 (5%)

Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           ++  QI  G+ ++HS ++++RD+KP N+LL+   + ++ D GLA    +   +T+   T 
Sbjct: 99  HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 193
            Y APE+L     Y+  +D +++GC   E++  +   P +DH  ++    EL     E E
Sbjct: 159 GYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRT--PFKDHKEKVAKE-ELKRRTLEDE 214

Query: 194 LGFLNEN---AKKYICQL 208
           + F ++N     K IC+L
Sbjct: 215 VKFEHQNFTEESKDICRL 232

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 41/145 (28%), Positives = 79/145 (54%), Gaps = 12/145 (8%)

Query: 68  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT 127
           +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+ DFGL++ + + +   
Sbjct: 96  TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155

Query: 128 -EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 186
             +  T  Y APE ++N   +T + D WS G +  E++     F G+D    + +++   
Sbjct: 156 YSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--- 211

Query: 187 GTPSEAELG---FLNENAKKYICQL 208
               +A+LG   FL+  A+  +  L
Sbjct: 212 ----KAKLGMPQFLSPEAQSLLRAL 232

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 47/133 (35%), Positives = 67/133 (50%), Gaps = 17/133 (12%)

Query: 43  FNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRG----LKYIHSANVLHRDLK 97
           F    I  E M+   L + +R +     E   Y L  +LRG    +KY+   N +HRDL 
Sbjct: 78  FKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLA 134

Query: 98  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAI 151
             N+L+N+N + K+ DFGL+RV  E D    Y  +      RW  APE  +    +T+A 
Sbjct: 135 ARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRW-TAPE-AIAYRKFTSAS 191

Query: 152 DVWSVGCIFMELM 164
           DVWS G +  E+M
Sbjct: 192 DVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 51/223 (22%), Positives = 108/223 (48%), Gaps = 30/223 (13%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 141

Query: 116 LARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 142 MCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 196

Query: 175 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 234
                    +++G+    +     +N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 197 ---------DIVGSSDNPD-----QNTEDYLFQVI-LEKQIRIPRSLSVKAASV--LKSF 239

Query: 235 LTFDPRQRITV------EDALAHPYLGSLH-DISDEPVCMSPF 270
           L  DP++R+         D   HP+  ++  D+ ++   + PF
Sbjct: 240 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPF 282

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 37/100 (37%), Positives = 52/100 (52%), Gaps = 13/100 (13%)

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           F  QI +G+ Y+ S   +HRDL   N+L+ +   +KI DFGLA+V  E     +Y   + 
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK---DYYYVKE 170

Query: 134 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 166
                  WY APE  L +S +++A DVWS G    EL   
Sbjct: 171 PGESPIFWY-APE-CLRTSKFSSASDVWSFGVTLYELFTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 35/109 (32%), Positives = 58/109 (53%), Gaps = 5/109 (4%)

Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSET 123
           + L+E   +    Q L  L Y+H   ++HRDLK  N+L   + D+K+ DFG+ A+ T   
Sbjct: 98  RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157

Query: 124 DFMTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKP 168
                ++ T ++ APE+++   S D  Y    DVWS+G   +E+   +P
Sbjct: 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 65.2 bits (159), Expect = 4e-12
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 2/107 (1%)

Query: 69  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 128
           E H  ++  +I  GL ++HS  +++RDLK  N++L+A   +KI DFG+ +        T 
Sbjct: 100 EPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159

Query: 129 -YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
            +  T  Y APE++     Y  ++D W+ G +  E++  +P F G D
Sbjct: 160 TFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 72/230 (31%)

Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA--- 117
           IR +    EE  ++++ +++  L  +H    +HRD+KP N+L++A+  +K+ DFGL    
Sbjct: 93  IRKDV-FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151

Query: 118 ---------RVTSETDFMTEYVVTRW------------------YRAPELLLNSSDYTAA 150
                       S      + V+ R                   Y APE+L   + Y   
Sbjct: 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLE 210

Query: 151 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP---SEAELGFLNENAKKYICQ 207
            D WS+G I  E+                     L G P   S+     L E   K I  
Sbjct: 211 CDWWSLGVILYEM---------------------LYGFPPFYSDT----LQETYNKII-- 243

Query: 208 LPRYQRQSFTEKFP---NVHPSAIDLVEKMLTFDPRQRIT-VEDALAHPY 253
                ++S    FP    V P AIDL+ ++L  DP  R+   E+  +HP+
Sbjct: 244 ---NWKESLR--FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 64.7 bits (157), Expect = 5e-12
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 11/145 (7%)

Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQY--FLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +YI  E M    L   ++S++   +   +   F  QI  G+ +I   N +HRDL+ +N+L
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 134

Query: 103 LNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           ++A+   KI DFGLARV  + ++          +W  APE  +N   +T   DVWS G +
Sbjct: 135 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIKSDVWSFGIL 192

Query: 160 FMELMD--RKPLFPGRDHVHQLRLL 182
            ME++   R P +PG  +   +R L
Sbjct: 193 LMEIVTYGRIP-YPGMSNPEVIRAL 216

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.7 bits (160), Expect = 5e-12
 Identities = 39/126 (30%), Positives = 68/126 (53%), Gaps = 8/126 (6%)

Query: 56  DLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 111
           DL Q I+S    N+   E        Q+L  + ++HS +++HRD+K +N+LL +N  +K+
Sbjct: 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 112 CDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 168
            DFG +++ + T   D    +  T +Y APE +     Y+   D++S+G +  EL+  K 
Sbjct: 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKR 243

Query: 169 LFPGRD 174
            F G +
Sbjct: 244 PFDGEN 249

Length = 496

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 125
           L+ E    + +Q+ +G++++ S   +HRDL   N+LL+ N  +KICDFGLAR +  + D+
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235

Query: 126 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 236 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 63.9 bits (156), Expect = 7e-12
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 10/95 (10%)

Query: 76  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT--- 132
           L  I  G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R   +++    Y      
Sbjct: 112 LRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYTTKGGK 169

Query: 133 ---RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
              RW  APE  +    +T+A DVWS G +  E+M
Sbjct: 170 IPIRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 34/115 (29%), Positives = 61/115 (53%), Gaps = 2/115 (1%)

Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 120
           ++  +   E   +++  ++   + Y+HS N+++RDLKP N+LL++   + + DFGL +  
Sbjct: 87  LQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146

Query: 121 SETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
            E +  T  +  T  Y APE +L    Y   +D W +G +  E++   P F  RD
Sbjct: 147 VEPEETTSTFCGTPEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.6 bits (157), Expect = 8e-12
 Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 16/196 (8%)

Query: 42  SFND---VYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D   +Y+  E ++  +    +R N+    +   ++  QI+   +Y+ S N+++RDLK
Sbjct: 99  SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLK 158

Query: 98  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           P NLLL+ +  +K+ DFG A+V     +      T  Y APE+LLN     AA D W++G
Sbjct: 159 PENLLLDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYIAPEILLNVGHGKAA-DWWTLG 215

Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIE-LIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
               E++   P F   + +   + ++E +I  P      FL+ N K  + +L  +     
Sbjct: 216 IFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK-----FLDNNCKHLMKKLLSH---DL 267

Query: 217 TEKFPNVHPSAIDLVE 232
           T+++ N+   A ++ E
Sbjct: 268 TKRYGNLKKGAQNVKE 283

Length = 340

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 2/107 (1%)

Query: 69  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 128
           E   +++  +I   L Y+HS N+++RDLKP N+LL++   + + DFGL +   E +  T 
Sbjct: 95  EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154

Query: 129 -YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
            +  T  Y APE +L+   Y   +D W +G +  E++   P F  R+
Sbjct: 155 TFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 1e-11
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203

Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 204 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 44/203 (21%), Positives = 91/203 (44%), Gaps = 36/203 (17%)

Query: 63  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VT 120
             +  +E   + ++ +I+  L ++H   +++RD+K  N+LL++   + + DFGL++  + 
Sbjct: 98  QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157

Query: 121 SETDFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 179
            E +    +  T  Y APE++   S  +  A+D WS+G +  EL+     F         
Sbjct: 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG----- 212

Query: 180 RLLIELIGTPSEAELGFLNENAKKYI-CQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTF 237
                     S++E+      +++ +  + P          FP  +   A D ++K+L  
Sbjct: 213 -------EQNSQSEI------SRRILKSKPP----------FPKTMSAEARDFIQKLLEK 249

Query: 238 DPRQRITVEDA---LAHPYLGSL 257
           DP++R+    A     HP+   +
Sbjct: 250 DPKKRLGANGADEIKNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 35/116 (30%), Positives = 65/116 (56%), Gaps = 3/116 (2%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   ++  + L EEH +++  +I   L ++H   +++RDLK  N+LL+A+  +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYG 141

Query: 116 LARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPL 169
           + +      D  + +  T  Y APE +L   +Y  ++D W++G +  E+M  R P 
Sbjct: 142 MCKEGLGPGDTTSTFCGTPNYIAPE-ILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 50/218 (22%), Positives = 98/218 (44%), Gaps = 37/218 (16%)

Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y++   M T L+Q        SE+  +++  +I+  L+++H   +++RD+K  N+LL++ 
Sbjct: 86  YVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE 141

Query: 107 CDLKICDFGLAR--VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
             + + DFGL++  ++ E +    +  T  Y APE++     +  A+D WS+G +  EL+
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201

Query: 165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 224
                F                    E E    +E +++ +   P +           + 
Sbjct: 202 TGASPF------------------TLEGERNTQSEVSRRILKCDPPFP--------SFIG 235

Query: 225 PSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL 257
           P A DL+ K+L  DP++R+        +   HP+   L
Sbjct: 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 39/120 (32%), Positives = 64/120 (53%), Gaps = 2/120 (1%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   I+S          ++  +I+ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 82  DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFG 141

Query: 116 LARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
           + +     D  T  +  T  Y APE+LL    Y  ++D WS G +  E++  +  F G D
Sbjct: 142 MCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 34/93 (36%), Positives = 56/93 (60%), Gaps = 6/93 (6%)

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFM---TEYV 130
           + +Q+ RG++++ S   +HRDL   N+LL+ N  +KICDFGLAR +  + D++   +  +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 131 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
             +W  APE + +   YT   DVWS G +  E+
Sbjct: 239 PLKWM-APESIFDKV-YTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 57/217 (26%), Positives = 87/217 (40%), Gaps = 31/217 (14%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   +  +  L  E       ++L  L Y+H   ++HRD+K  N+ L+   +  + DFG
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG 230

Query: 116 LARVTSETDFMTE---YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFME-LMDRKPLF 170
            A          +   +  T    +PELL L+   Y A  D+WS G +  E  +    LF
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDP--YCAKTDIWSAGLVLFEMSVKNVTLF 288

Query: 171 PGRDHV--HQLRLLIELIGTPSEAELGF-LNENA------KKYICQL------PRYQRQS 215
             +      QLR +I  +       L F  N +       K+Y   L      P   R+ 
Sbjct: 289 GKQVKSSSSQLRSIIRCMQV---HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKY 345

Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
                  +H     L+ KMLTFD   R + +D L+ P
Sbjct: 346 ------GMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376

Length = 392

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 40/109 (36%), Positives = 57/109 (52%), Gaps = 19/109 (17%)

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE--YVV- 131
           F  Q+ +G+ ++ S N +HRD+   N+LL      KICDFGLAR     D M +  YVV 
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVK 271

Query: 132 ------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 172
                  +W  APE + +   YT   DVWS G +  E+  + + P +PG
Sbjct: 272 GNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP-YPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.0 bits (150), Expect = 3e-11
 Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 6/103 (5%)

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 131
           F  QI  G+ YI   N +HRDL+ +N+L++ +   KI DFGLARV  + ++         
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 167

Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGR 173
            +W  APE  +N   +T   DVWS G +  E++   K  +PG 
Sbjct: 168 IKW-TAPE-AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 34/110 (30%), Positives = 62/110 (56%), Gaps = 2/110 (1%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   ++  + L EEH +++  +I   L ++H   +++RDLK  N+LL+A   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 141

Query: 116 LARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M
Sbjct: 142 MCKEGIRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMM 190

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.0 bits (151), Expect = 4e-11
 Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 6/108 (5%)

Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 120
             + QALS +   +   QI  G+ Y+H   V+H+D+   N +++    +KI D  L+R  
Sbjct: 108 ANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Query: 121 SETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
              D+      E    +W  A E L+N  +Y++A DVWS G +  ELM
Sbjct: 168 FPMDYHCLGDNENRPVKWM-ALESLVN-KEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 36/100 (36%), Positives = 52/100 (52%), Gaps = 5/100 (5%)

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200

Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
            + APE L +   YT   DVWS G +  E+       +PG
Sbjct: 201 KWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR   + D+  +    R   
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPV 200

Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 201 KWMAPEALFDRV-YTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 61.8 bits (151), Expect = 5e-11
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 38/206 (18%)

Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKIC 112
           D DL  +++    LSE   +  + Q++  L  +H  N++H D+K  N+L +   D + +C
Sbjct: 93  DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 113 DFGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 169
           D+GL ++    S  D   +Y       +PE  +   +Y  + D W+VG +  EL+  K  
Sbjct: 153 DYGLCKIIGTPSCYDGTLDYF------SPE-KIKGHNYDVSFDWWAVGVLTYELLTGK-- 203

Query: 170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 229
            P ++   +     EL                      L + Q++       NV  +A D
Sbjct: 204 HPFKEDEDE-----EL--DLES----------------LLKRQQKKLP-FIKNVSKNAND 239

Query: 230 LVEKMLTFDPRQR-ITVEDALAHPYL 254
            V+ ML ++   R     + + HP+L
Sbjct: 240 FVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 4/123 (3%)

Query: 53  MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 112
           ++  + Q ++ +    E       YQI+  L  +HS  ++HRDLK +N+ L     +K+ 
Sbjct: 152 LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211

Query: 113 DFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 169
           DFG ++  S++   D  + +  T +Y APE L     Y+   D+WS+G I  EL+     
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRP 270

Query: 170 FPG 172
           F G
Sbjct: 271 FKG 273

Length = 478

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 61.5 bits (149), Expect = 6e-11
 Identities = 37/95 (38%), Positives = 50/95 (52%), Gaps = 9/95 (9%)

Query: 76  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT--- 132
           L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV  E D    Y      
Sbjct: 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGK 170

Query: 133 ---RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
              RW  APE  +    +T+A DVWS G +  E+M
Sbjct: 171 IPIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 36/101 (35%), Positives = 59/101 (58%), Gaps = 6/101 (5%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 125
           L+ E    + +Q+ RG++++ S   +HRDL   N+LL+ N  +KICDFGLAR +  + D+
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 229

Query: 126 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 230 VRKGDARLPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 60.7 bits (147), Expect = 8e-11
 Identities = 32/110 (29%), Positives = 62/110 (56%), Gaps = 5/110 (4%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L++ ++ N+ ++E++    ++Q+  G+KY+   N +HRDL   N+LL      KI DFGL
Sbjct: 82  LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGL 141

Query: 117 AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 162
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 142 SKALGADENYYKAKTHGKWPVKWYAPE-CMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 61.2 bits (148), Expect = 9e-11
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 206

Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 207 KWMAPEALFDRI-YTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 8/101 (7%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLFPGR 173
             APE  +N   +T   DVWS G +  E++   R P +PG 
Sbjct: 170 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTYGRIP-YPGM 207

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 40/151 (26%), Positives = 77/151 (50%), Gaps = 13/151 (8%)

Query: 41  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           ++ + +Y   E ++  DL   I+      E H  ++  +I  GL ++HS  +++RDLK  
Sbjct: 71  QTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLD 130

Query: 100 NLLLNANCDLKICDFGLAR------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDV 153
           N++L++   +KI DFG+ +      VT++T     +  T  Y APE ++    Y  ++D 
Sbjct: 131 NVMLDSEGHIKIADFGMCKENMWDGVTTKT-----FCGTPDYIAPE-IIAYQPYGKSVDW 184

Query: 154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 184
           W+ G +  E++  +  F G D     + ++E
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 26/195 (13%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY--VVTRWY 135
           Q+L  ++YIH   ++HRD+K  N+ LN +  + + DFG A    +     +Y  V T   
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334

Query: 136 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRK--PLFPGRDHVH-QLRLLIELIGTPSEA 192
            +PE+L     Y    D+WS G I ++++     P+  G      QL  +I+        
Sbjct: 335 NSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID-------- 385

Query: 193 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI-----------DLVEKMLTFDPRQ 241
            L   +E      C+L  Y   +  +   +  P  I            LV KMLTFD   
Sbjct: 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLV-KMLTFDWHL 444

Query: 242 RITVEDALAHPYLGS 256
           R    + LA P   +
Sbjct: 445 RPGAAELLALPLFSA 459

Length = 501

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 38/224 (16%)

Query: 44  NDVYIAYELM-DTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           +++Y+  E     DL  ++ R      E+  Q++L +++  +  +H    +HRD+KP N+
Sbjct: 74  DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133

Query: 102 LLNANCDLKICDFG-LARVTSE-TDFMTEYVVTRWYRAPELL--LNSSD---YTAAIDVW 154
           L++    +K+ DFG  AR+T+         V T  Y APE+L  +N      Y    D W
Sbjct: 134 LIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWW 193

Query: 155 SVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 213
           S+G I  E++  R P   G        ++                 N ++++        
Sbjct: 194 SLGVIAYEMIYGRSPFHEGTSAKTYNNIM-----------------NFQRFL-------- 228

Query: 214 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
             F E  P V    +DL++ +L    ++R+  E    HP+   +
Sbjct: 229 -KFPED-PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 39/104 (37%), Positives = 55/104 (52%), Gaps = 15/104 (14%)

Query: 70  EHCQYFLY--QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT 127
           +H +  LY  QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGL +V  +     
Sbjct: 106 DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD---K 162

Query: 128 EYVVTR--------WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           EY   R        WY APE  L  S ++ A DVWS G +  EL
Sbjct: 163 EYYKVREPGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 34/116 (29%), Positives = 61/116 (52%), Gaps = 2/116 (1%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   I+ ++   E   +++  ++   L ++H   V++RDLK  N+LL+A    K+ DFG
Sbjct: 82  DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFG 141

Query: 116 LARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           + +        T  +  T  Y APE +L   +Y  ++D W++G +  E+M  +P F
Sbjct: 142 MCKEGILNGVTTTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 12/99 (12%)

Query: 72  CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV 131
           C Y + QI  G++Y+ S   +HRDL   N+LL ++  +KI DFGL R   + +   ++ V
Sbjct: 100 CDYAV-QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE---DHYV 155

Query: 132 TRWYR-------APELLLNSSDYTAAIDVWSVGCIFMEL 163
              +        APE  L +  ++ A DVW  G    E+
Sbjct: 156 MEEHLKVPFAWCAPE-SLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 45/194 (23%), Positives = 91/194 (46%), Gaps = 37/194 (19%)

Query: 55  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 114
           T L Q  R      E+  Q +  +I+  L+++H   +++RD+K  N+LL++N  + + DF
Sbjct: 94  THLSQRER----FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 149

Query: 115 GLAR--VTSETDFMTEYVVTRWYRAPELLL-NSSDYTAAIDVWSVGCIFMELMDRKPLFP 171
           GL++     E +    +  T  Y AP+++      +  A+D WS+G +  EL+     F 
Sbjct: 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209

Query: 172 --GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 229
             G  +              S+AE+      +++ +   P Y ++        +   A D
Sbjct: 210 VDGEKN--------------SQAEI------SRRILKSEPPYPQE--------MSALAKD 241

Query: 230 LVEKMLTFDPRQRI 243
           +++++L  DP++R+
Sbjct: 242 IIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 35/131 (26%), Positives = 60/131 (45%), Gaps = 20/131 (15%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICD 113
           L +++ ++ AL        + Q+L  L   H+  ++HRDLKP N++++        K+ D
Sbjct: 66  LREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLD 125

Query: 114 FGL------------ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
           FG+            A +T      TE + T  Y APE L      T   D+++ G IF+
Sbjct: 126 FGIGTLLPGVRDADVATLTRT----TEVLGTPTYCAPEQLRGEP-VTPNSDLYAWGLIFL 180

Query: 162 ELMDRKPLFPG 172
           E +  + +  G
Sbjct: 181 ECLTGQRVVQG 191

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 11/108 (10%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L + ++  + +     +   +Q+  G+ Y+ S + +HRDL   N+LL      KI DFG+
Sbjct: 82  LLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGM 141

Query: 117 ARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVG 157
           +R          Y  T       +WY APE  +N   +++  DVWS G
Sbjct: 142 SRALGAGS--DYYRATTAGRWPLKWY-APE-CINYGKFSSKSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 59.9 bits (145), Expect = 2e-10
 Identities = 38/100 (38%), Positives = 50/100 (50%), Gaps = 13/100 (13%)

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           F  QI  G+ Y+HS + +HRDL   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 168

Query: 134 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 166
                  WY A E L  +    A+ DVWS G    EL+  
Sbjct: 169 DGDSPVFWY-AVECLKENKFSYAS-DVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 59.9 bits (145), Expect = 2e-10
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 9/96 (9%)

Query: 76  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-------TDFMTE 128
           L  I  G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R   +       T  +  
Sbjct: 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171

Query: 129 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +  RW  APE  +    +T+A DVWS G +  E+M
Sbjct: 172 KIPIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 8/100 (8%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW--- 134
           Q+  G+ Y+ + N +HRDL   N+L+  N   K+ DFGLARV  E  +       ++   
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIK 169

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLFPG 172
           + APE     + ++   DVWS G +  E++   R P +PG
Sbjct: 170 WTAPE-AALYNRFSIKSDVWSFGILLTEIVTYGRMP-YPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 38/95 (40%), Positives = 51/95 (53%), Gaps = 13/95 (13%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 133
           QI +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +   ETD   EY   +    
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETD--KEYYTVKDDLD 173

Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
               WY APE L+ S  Y A+ DVWS G    EL+
Sbjct: 174 SPVFWY-APECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 34/103 (33%), Positives = 60/103 (58%), Gaps = 4/103 (3%)

Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETDFMTEYVV 131
           ++  +I+ GL+++HS  +++RDLK  N++L+ +  +KI DFG+ +  V  +    T +  
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCG 158

Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
           T  Y APE+L     YT ++D WS G +  E++  +  F G D
Sbjct: 159 TPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 59.0 bits (143), Expect = 3e-10
 Identities = 33/128 (25%), Positives = 59/128 (46%), Gaps = 17/128 (13%)

Query: 46  VYIAYELMDTD-LHQIIRSNQALSE-----EHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           ++I  E M    L   +R  +         + C      +   ++Y+ S   +HRDL   
Sbjct: 74  IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS----DVCEAMEYLESNGFIHRDLAAR 129

Query: 100 NLLLNANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
           N L+  +  +K+ DFGLAR   +  +     T++ V +W  AP  + + S +++  DVWS
Sbjct: 130 NCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV-KW--APPEVFDYSRFSSKSDVWS 186

Query: 156 VGCIFMEL 163
            G +  E+
Sbjct: 187 FGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 47/206 (22%)

Query: 32  RDIIPPPQRE-------SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQIL 80
           RDI+     E       +F D    Y +M+     DL  ++ SN  + E+  +++  +++
Sbjct: 94  RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVV 152

Query: 81  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-------ARVTSETDFMTEYVVTR 133
             L  IHS   +HRD+KP N+LL+ +  LK+ DFG          V  +T      V T 
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-----VGTP 207

Query: 134 WYRAPELLLN---SSDYTAAIDVWSVGCIFMELMDRKPLFPGR----------DHVHQLR 180
            Y +PE+L +      Y    D WSVG    E++     F             DH + L 
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT 267

Query: 181 LLIELIGTPSEAELGFLNENAKKYIC 206
                   P + E   +++ AK  IC
Sbjct: 268 F-------PDDIE---ISKQAKDLIC 283

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 59.3 bits (143), Expect = 3e-10
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 134
           QI  G+ YI   N +HRDL+ +N+L+  N   KI DFGLAR+  + ++          +W
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL+ +  + +PG
Sbjct: 170 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 59.2 bits (143), Expect = 3e-10
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 6/102 (5%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 134
           Q+  G+ YI   N +HRDL+ +N+L+      KI DFGLAR+  + ++          +W
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDH 175
             APE  L    +T   DVWS G +  EL+ +  + +PG ++
Sbjct: 170 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNN 209

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 59.3 bits (143), Expect = 3e-10
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 6/102 (5%)

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VV 131
              QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++         
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166

Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
            +W  APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 167 IKW-TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 48/183 (26%), Positives = 90/183 (49%), Gaps = 22/183 (12%)

Query: 6   KLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPP---QRES-FNDVYIAYELMD----TDL 57
           K++++   ++    +  +++  V+A++D   PP   Q  S F  V   Y +M+     DL
Sbjct: 31  KILKKDVVIQDDDVECTMVEKRVLALQD--KPPFLTQLHSCFQTVDRLYFVMEYVNGGDL 88

Query: 58  HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 117
              I+      E    ++  +I  GL ++H   +++RDLK  N++L++   +KI DFG+ 
Sbjct: 89  MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMC 148

Query: 118 RVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP 171
           +     + M + V TR       Y APE++     Y  ++D W+ G +  E++  +P F 
Sbjct: 149 K-----EHMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFD 202

Query: 172 GRD 174
           G D
Sbjct: 203 GED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 59.2 bits (143), Expect = 4e-10
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YV 130
           F +QI RG++Y+    ++HRDL   N+L+     +KI DFGL+R   E D   +     +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191

Query: 131 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
             +W  A E L +   YT   DVWS G +  E++
Sbjct: 192 PVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 59.0 bits (143), Expect = 5e-10
 Identities = 38/114 (33%), Positives = 61/114 (53%), Gaps = 19/114 (16%)

Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-------------- 119
           YF   +L  L+Y+H+  ++HRDLKP NLL+ +   +K+ DFGL+++              
Sbjct: 106 YFAETVL-ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164

Query: 120 TSET-DFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFME-LMDRKPLF 170
             +T +F+ + V  T  Y APE++L    Y   +D W++G I  E L+   P F
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFF 217

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 59.8 bits (144), Expect = 7e-10
 Identities = 42/127 (33%), Positives = 56/127 (44%), Gaps = 25/127 (19%)

Query: 78  QILRGLKYIHS-------ANVLHRDLKPSNLLL-----------------NANCDLKICD 113
           Q+L  L Y H+         VLHRDLKP N+ L                 N     KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 114 FGLARVTSETDFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPG 172
           FGL++           V T +Y +PELLL+ +  Y    D+W++GCI  EL   K  F  
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 173 RDHVHQL 179
            ++  QL
Sbjct: 246 ANNFSQL 252

Length = 1021

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.4 bits (141), Expect = 7e-10
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 133
           QI  G+KY+ S N +HRDL   N L+  N  +KI DFG++R     D+        +  R
Sbjct: 138 QIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR 197

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           W     +LL    +T A DVW+ G    E++
Sbjct: 198 WMSWESILLGK--FTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 57.7 bits (139), Expect = 9e-10
 Identities = 36/124 (29%), Positives = 65/124 (52%), Gaps = 9/124 (7%)

Query: 46  VYIAYELMDTD-LHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + + +E M+   L   +R+ +   S+E        +  G+ Y+ S+NV+HRDL   N L+
Sbjct: 74  ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV 133

Query: 104 NANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
             N  +K+ DFG+ R   +  +     T++ V +W  +PE + + S Y++  DVWS G +
Sbjct: 134 GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV-KW-SSPE-VFSFSKYSSKSDVWSFGVL 190

Query: 160 FMEL 163
             E+
Sbjct: 191 MWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 40/125 (32%), Positives = 65/125 (52%), Gaps = 7/125 (5%)

Query: 46  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS  ++HRD+KP N+LL+
Sbjct: 118 LYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 176

Query: 105 ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 159
            +  LK+ DFG      ET  +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 177 KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 160 FMELM 164
             E++
Sbjct: 237 LFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 49/194 (25%), Positives = 79/194 (40%), Gaps = 42/194 (21%)

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV--- 131
           + YQ+   L Y+ S   +HRD+   N+L+++   +K+ DFGL+R   +  +         
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171

Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR--KPLFPGRDHVHQLRLLIELIGTP 189
            +W  APE  +N   +T+A DVW  G    E++    KP                  G  
Sbjct: 172 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ----------------GVK 213

Query: 190 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
           +   +G + EN ++    LP           PN  P+   L+ K   +DP +R    +  
Sbjct: 214 NNDVIGRI-ENGER----LP---------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELK 259

Query: 250 AHPYLGSLHDISDE 263
           A      L DI  E
Sbjct: 260 A-----QLSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 42/130 (32%), Positives = 67/130 (51%), Gaps = 8/130 (6%)

Query: 44  NDVYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
           N +YI  ELM   +L   +R+     +S      F   +  G++Y+ S  ++HRDL   N
Sbjct: 71  NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARN 130

Query: 101 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
           +L++ +   K+ DFGLARV S     ++  V +W  APE L +   +++  DVWS G + 
Sbjct: 131 ILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-KW-TAPEALKHKK-FSSKSDVWSYGVLL 187

Query: 161 MELMD--RKP 168
            E+    R P
Sbjct: 188 WEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 10/87 (11%)

Query: 82  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM------TEYVVTRWY 135
           G++Y+ S N +HRDL   N L+  N  LKI DFG++R   E   +       + +  +W 
Sbjct: 105 GMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKW- 161

Query: 136 RAPELLLNSSDYTAAIDVWSVGCIFME 162
            APE  LN   YT+  DVWS G +  E
Sbjct: 162 TAPE-ALNYGRYTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.5 bits (139), Expect = 1e-09
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 34/181 (18%)

Query: 4   ITKLMQRGHFVRSSCFDTWIMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQ 59
           IT L +   F++       IMK     +V+++  I  P   E    V + Y +   DL  
Sbjct: 34  ITDLEEVEQFLKEGI----IMKDFSHPNVLSLLGICLPS--EGSPLVVLPY-MKHGDLRN 86

Query: 60  IIRSNQALSEEHCQY------FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
            IRS     E H         F  Q+ +G++Y+ S   +HRDL   N +L+ +  +K+ D
Sbjct: 87  FIRS-----ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVAD 141

Query: 114 FGLARVTSETDFMTEYVVTRWYRAPEL--------LLNSSDYTAAIDVWSVGCIFMELMD 165
           FGLAR   +     EY     +   +L         L +  +T   DVWS G +  ELM 
Sbjct: 142 FGLARDIYD----KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Query: 166 R 166
           R
Sbjct: 198 R 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 12/93 (12%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT----- 132
           +I  G+ Y+ +   +HRDL   N ++  +  +KI DFG+ R   ETD+   Y        
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY---YRKGGKGLL 183

Query: 133 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
             RW  APE  L    +T   DVWS G +  E+
Sbjct: 184 PVRWM-APE-SLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F+  I  G++Y+ S N +HRDL   N +LN N  + + DFGL++     D+  +   +  
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 133 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 166
             +W     L  N   YT   DVW+ G    E+M R
Sbjct: 178 PVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 37/112 (33%), Positives = 53/112 (47%), Gaps = 15/112 (13%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT----- 132
           QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    +   EY        
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE--KEYHAEGGKVP 174

Query: 133 -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPL--FPGRDHVHQL 179
            +W  A E +L+   YT   DVWS G    ELM    KP    P  + +  L
Sbjct: 175 IKWM-ALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPDL 223

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 4e-09
 Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 59/207 (28%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA--------- 117
           LSEE  +++  ++L  L+Y+H   +++RDLKP N+LL+ +  + + DF L+         
Sbjct: 100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159

Query: 118 --------------------RVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
                                 + E  F +  +V T  Y APE +++   + +A+D W++
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTL 218

Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           G +  E+     L+ G               TP      F   N  +    + + +  +F
Sbjct: 219 GILLYEM-----LY-GT--------------TP------FKGSNRDETFSNILK-KEVTF 251

Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRI 243
               P V  SA DL+ K+L  DP +R+
Sbjct: 252 PGS-PPVSSSARDLIRKLLVKDPSKRL 277

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 74/312 (23%), Positives = 117/312 (37%), Gaps = 101/312 (32%)

Query: 28  VVAIRDIIPPPQRE-------SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFL 76
           V A RDI+     E       SF D    Y +MD     D+  ++       E+  ++++
Sbjct: 48  VKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYI 107

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSET---------- 123
            ++   ++ +H    +HRD+KP N+L++ +  +K+ DFGL    R T ++          
Sbjct: 108 AELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVR 167

Query: 124 ----DFMTEY-------------------------------VVTRWYRAPELLLNSSDYT 148
               DF  E+                               V T  Y APE+LL +  YT
Sbjct: 168 QDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YT 226

Query: 149 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL 208
              D WSVG I  E++  +P F              L  TP E ++  +N     +I   
Sbjct: 227 QLCDWWSVGVILYEMLVGQPPF--------------LAQTPLETQMKVINWQTSLHI--- 269

Query: 209 PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSLHDISDEPV 265
           P   + S         P A DL+ K L   P  R+     ++  AHP+  ++        
Sbjct: 270 PPQAKLS---------PEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFKTID------- 312

Query: 266 CMSPFSFDFEQH 277
               FS D  Q 
Sbjct: 313 ----FSSDLRQQ 320

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 45/169 (26%), Positives = 69/169 (40%), Gaps = 41/169 (24%)

Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     D+  ++     LSEE  Q+++ + +  +  IH    +HRD+K
Sbjct: 69  SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIK 128

Query: 98  PSNLLLNANCDLKICDFGLA---RVTSETDFMTEY------------------------- 129
           P NLLL+A   +K+ DFGL    +    T+F                             
Sbjct: 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188

Query: 130 --------VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
                   V T  Y APE+ + +  Y    D WS+G I  E++   P F
Sbjct: 189 RRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 5e-09
 Identities = 39/123 (31%), Positives = 61/123 (49%), Gaps = 6/123 (4%)

Query: 44  NDVYIAYELMDT-DLHQIIRS-NQALSEEHCQY-FLYQILRGLKYIHSANVLHRDLKPSN 100
           N +YI  E M    L   +RS  +A+     Q  F   +  G++Y+   N +HRDL   N
Sbjct: 73  NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARN 132

Query: 101 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
           +L++ +   K+ DFGLA+  S+     +  V +W  APE L     ++   DVWS G + 
Sbjct: 133 VLVSEDLVAKVSDFGLAKEASQGQDSGKLPV-KW-TAPEALREKK-FSTKSDVWSFGILL 189

Query: 161 MEL 163
            E+
Sbjct: 190 WEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.8 bits (134), Expect = 6e-09
 Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 6/102 (5%)

Query: 66  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF 125
           ++S  +  Y   QI  G+KY+ S N +HRDL   N L+  +  +KI DFG++R     D+
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 126 M----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
                   +  RW     +LL    +T A DVW+ G    E+
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 55.4 bits (133), Expect = 6e-09
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 10/105 (9%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMTE--YVVTR 133
           QI +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR+    ET++  +   V  +
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPL--FPGRD 174
           W  A E +L+   +T   DVWS G    ELM    KP    P R+
Sbjct: 177 WM-ALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.4 bits (133), Expect = 6e-09
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 5/102 (4%)

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW 134
           F+  I  G++Y+ S + +HRDL   N +LN N ++ + DFGL++     D+  +  + + 
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 135 ---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPG 172
              + A E L +   YT   DVWS G    E+  R +  +PG
Sbjct: 177 PVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.2 bits (133), Expect = 7e-09
 Identities = 34/123 (27%), Positives = 61/123 (49%), Gaps = 7/123 (5%)

Query: 46  VYIAYELMDTD-LHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +YI  E M+   L   +R  Q  LS++        +  G++Y+   + +HRDL   N L+
Sbjct: 74  LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV 133

Query: 104 NANCDLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
           ++   +K+ DFG+ R   + ++ +        +W   PE + N S Y++  DVWS G + 
Sbjct: 134 SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPPE-VFNFSKYSSKSDVWSFGVLM 191

Query: 161 MEL 163
            E+
Sbjct: 192 WEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 55.8 bits (134), Expect = 7e-09
 Identities = 72/307 (23%), Positives = 114/307 (37%), Gaps = 93/307 (30%)

Query: 28  VVAIRDIIPPPQRE-------SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFL 76
           V A RDI+     E       SF D    Y +MD     D+  ++   +   E   ++++
Sbjct: 48  VKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYI 107

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-------------------- 116
            ++   ++ +H    +HRD+KP N+L++ +  +K+ DFGL                    
Sbjct: 108 AELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIR 167

Query: 117 ----------------------------ARVTSETDFMTEYVVTRWYRAPELLLNSSDYT 148
                                       A    +       V T  Y APE+LL    YT
Sbjct: 168 QDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YT 226

Query: 149 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN-ENAKKYICQ 207
              D WSVG I  E++  +P F              L  TP+E +L  +N EN       
Sbjct: 227 QLCDWWSVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENT----LH 268

Query: 208 LPRYQRQSFTEKFPNVHPSAIDLVEKM-LTFDPR-QRITVEDALAHPYLGSL---HDISD 262
           +P   + S         P A+DL+ K+  + + R  R   +D  AHP+   +    DI  
Sbjct: 269 IPPQVKLS---------PEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRT 319

Query: 263 EPVCMSP 269
           +P    P
Sbjct: 320 QPAPYVP 326

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 55.0 bits (132), Expect = 8e-09
 Identities = 38/122 (31%), Positives = 58/122 (47%), Gaps = 7/122 (5%)

Query: 46  VYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +YI  EL+     L  + +    L  +    F      G+ Y+ S N +HRDL   N L+
Sbjct: 67  IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV 126

Query: 104 NANCDLKICDFGLARVTSETDFMT---EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
             N  LKI DFG++R   +  + +   + +  +W  APE  LN   Y++  DVWS G + 
Sbjct: 127 GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-TAPE-ALNYGRYSSESDVWSYGILL 184

Query: 161 ME 162
            E
Sbjct: 185 WE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 39/125 (31%), Positives = 56/125 (44%), Gaps = 16/125 (12%)

Query: 56  DLHQIIRSNQALSEEHC-----QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 110
           DL   +RS +            Q    +I  GL ++H  N +H DL   N LL A+  +K
Sbjct: 81  DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVK 140

Query: 111 ICDFGLARVTSETDFMTE----YVVTRWYRAPELL------LNSSDYTAAIDVWSVGCIF 160
           I D+GL+    + D+       +V  RW  APEL+      L   D T   +VWS+G   
Sbjct: 141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTI 199

Query: 161 MELMD 165
            EL +
Sbjct: 200 WELFE 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 41/169 (24%)

Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     D+  ++     L+EE  Q+++ + +  +  IH    +HRD+K
Sbjct: 69  SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIK 128

Query: 98  PSNLLLNANCDLKICDFGLARVTSE---------------TDFMTEYVVTR-----WYR- 136
           P NLLL++   +K+ DFGL     +               +DF  + + ++     W R 
Sbjct: 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188

Query: 137 ---------------APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
                          APE+ + +  Y    D WS+G I  E++   P F
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 28/171 (16%)

Query: 47  YIAYELMDT-DLHQIIRSN--------------QALSEEHCQYFLYQILRGLKYIHSANV 91
            + +E M+  DL++ +RS+                L+         QI  G+ Y+ S + 
Sbjct: 84  IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHF 143

Query: 92  LHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDY 147
           +HRDL   N L+  +  +KI DFG++R    TD+        +  RW   PE ++    +
Sbjct: 144 VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM-PPESIMYRK-F 201

Query: 148 TAAIDVWSVGCIFMELMD--RKPLFPGRD-----HVHQLRLLIELIGTPSE 191
           T   DVWS G +  E+    ++P +   +      + Q RLL      PSE
Sbjct: 202 TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSE 252

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 39/125 (31%), Positives = 57/125 (45%), Gaps = 16/125 (12%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQ-----ILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 110
           DL   +RSN+ +  +  Q  + Q     +  GL ++H A+ +H DL   N  L A+  +K
Sbjct: 81  DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVK 140

Query: 111 ICDFGLARVTSETDFMT----EYVVTRWYRAPELL------LNSSDYTAAIDVWSVGCIF 160
           I D+GLA      D+        V  RW  APEL+      L   D T   ++WS+G   
Sbjct: 141 IGDYGLALEQYPEDYYITKDCHAVPLRWL-APELVEIRGQDLLPKDQTKKSNIWSLGVTM 199

Query: 161 MELMD 165
            EL  
Sbjct: 200 WELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 32/88 (36%), Positives = 47/88 (53%), Gaps = 4/88 (4%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG---LARVTSETDFMTEYVVTRW 134
           Q+L  + YIH   ++HRD+K  N+L+N   D+ + DFG    AR +  T F      T  
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFME 162
             APE+L     YT ++D+WS G +  E
Sbjct: 328 TNAPEVLAGDP-YTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.8 bits (129), Expect = 2e-08
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 7/106 (6%)

Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS 121
            +   LS +   +F   + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R   
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--G 173

Query: 122 ETDFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  ++ +    +  RW       LN S YT   DVWS G +  E++
Sbjct: 174 QEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 55/242 (22%), Positives = 94/242 (38%), Gaps = 46/242 (19%)

Query: 44  NDVYIAYELMD----TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           +++Y+   LM      DL   ++++  + L E    + L  +L  L YIHS   +HR +K
Sbjct: 72  SELYVVSPLMAYGSCEDL---LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVK 128

Query: 98  PSNLLLNANCDLKICDFGLA--------RVTSETDFMTEYVVTRWYRAPELL-LNSSDYT 148
            S++LL+ +  + +     +        R     DF    V    + +PE+L  N   Y 
Sbjct: 129 ASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYN 188

Query: 149 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP----------------SEA 192
              D++SVG    EL +     P +D      LL ++ GT                 S++
Sbjct: 189 EKSDIYSVGITACELAN--GHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS 246

Query: 193 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
                + N +     +     ++F+E F   H      VE  L  DP  R +    L H 
Sbjct: 247 RSSNEHPNNRD---SVDHPYTRTFSEHF---H----QFVELCLQRDPESRPSASQLLNHS 296

Query: 253 YL 254
           + 
Sbjct: 297 FF 298

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 37/118 (31%), Positives = 56/118 (47%), Gaps = 8/118 (6%)

Query: 59  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 118
           Q  ++   L      +   QI  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Query: 119 VTSETDFMT----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLF 170
               TD+        +  RW   PE ++    +T   DVWS G I  E+    ++P F
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 6/90 (6%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 133
           Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     D+      + +  R
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           W     +  N   YT   DVW+ G +  E+
Sbjct: 198 WMPPESIFYNR--YTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 32/94 (34%), Positives = 46/94 (48%), Gaps = 12/94 (12%)

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV----- 131
            QI  G++Y+ S + +HRDL   N L+     +KI DFGL+R     D+   Y V     
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY---YRVQSKSL 187

Query: 132 --TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
              RW   PE +L    +T   D+WS G +  E+
Sbjct: 188 LPVRWM-PPEAIL-YGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 40/230 (17%)

Query: 42  SFNDVYIAYELMD----TDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL 96
           +F D    Y +MD     DL  ++ +    L E+  ++++ +++  +  IH  + +HRD+
Sbjct: 69  AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDI 128

Query: 97  KPSNLLLNANCDLKICDFG--LARVTSETDFMTEYVVTRWYRAPELLLNSSD----YTAA 150
           KP N+LL+ N  +++ DFG  L      T   +  V T  Y +PE+L    D    Y   
Sbjct: 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 188

Query: 151 IDVWSVG-CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 209
            D WS+G C++  L    P +           L+E  G     E                
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYA--------ESLVETYGKIMNHE---------------- 224

Query: 210 RYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLGSL 257
             +R  F     +V   A DL+++++    R+  +  +ED   H +   +
Sbjct: 225 --ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 7/109 (6%)

Query: 61  IRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV 119
           +R ++  +  ++   +  QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++
Sbjct: 99  VREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158

Query: 120 --TSETDFMTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
               E ++  E   V  +W  A E +L+   YT   DVWS G    ELM
Sbjct: 159 LGADEKEYHAEGGKVPIKWM-ALESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 27/81 (33%), Positives = 48/81 (59%), Gaps = 1/81 (1%)

Query: 41  ESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           +S N+VY+  E L+  D+  ++       EE    ++ ++   L Y+H   ++HRDLKP 
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPD 133

Query: 100 NLLLNANCDLKICDFGLARVT 120
           N+L++    +K+ DFGL++VT
Sbjct: 134 NMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 7/125 (5%)

Query: 46  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS   +HRD+KP N+LL+
Sbjct: 118 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176

Query: 105 ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 159
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 177 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 160 FMELM 164
             E++
Sbjct: 237 LYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 52.7 bits (126), Expect = 5e-08
 Identities = 32/86 (37%), Positives = 47/86 (54%), Gaps = 8/86 (9%)

Query: 82  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-----VTSETDFMTEYVVTRWYR 136
           G++Y+ S + +HRDL   N L+     LKI DFG++R     V + T  M + +  +W  
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ-IPVKW-T 163

Query: 137 APELLLNSSDYTAAIDVWSVGCIFME 162
           APE  LN   Y++  DVWS G +  E
Sbjct: 164 APE-ALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 53.0 bits (127), Expect = 5e-08
 Identities = 31/115 (26%), Positives = 58/115 (50%), Gaps = 12/115 (10%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   I+ ++   E   +++  +I   L ++H   +++RDLK  N+LL+     K+ DFG
Sbjct: 82  DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 141

Query: 116 LAR------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           + +       T+ T     +  T  Y APE +L    Y  ++D W++G +  E++
Sbjct: 142 MCKEGIFNGKTTST-----FCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 36/213 (16%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG--LARVTSETD 124
           L E+  +++L +++  +  +H  + +HRD+KP N+L++ N  +++ DFG  L  +   T 
Sbjct: 99  LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158

Query: 125 FMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMDRKPLFPGRDHVHQL 179
             +  V T  Y +PE+L    D    Y    D WS+G C++  L    P +         
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-------- 210

Query: 180 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 239
             L+E  G               K +    R+Q   F  +  +V   A DL+ +++    
Sbjct: 211 ESLVETYG---------------KIMNHKERFQ---FPAQVTDVSEDAKDLIRRLICSRE 252

Query: 240 RQ--RITVEDALAHPYLGSLHDISDEPVCMSPF 270
            +  +  +ED   HP+   + D  +   C +P+
Sbjct: 253 HRLGQNGIEDFKQHPFFTGI-DWDNIRNCEAPY 284

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 52.2 bits (125), Expect = 6e-08
 Identities = 28/91 (30%), Positives = 50/91 (54%), Gaps = 7/91 (7%)

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVT 132
             +  G+ Y+ S   +HRDL   N L++    +K+ DFGL+R   + ++     +++ V 
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV- 165

Query: 133 RWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           RW   PE+LL S  +++  DVW+ G +  E+
Sbjct: 166 RW-SPPEVLLYSK-FSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 52.2 bits (125), Expect = 8e-08
 Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 8/123 (6%)

Query: 47  YIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           YI  E M   +L   +R    Q ++     Y   QI   ++Y+   N +HRDL   N L+
Sbjct: 78  YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 137

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 160
             N  +K+ DFGL+R+ +  D  T +   ++   + APE L  +  ++   DVW+ G + 
Sbjct: 138 GENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLL 195

Query: 161 MEL 163
            E+
Sbjct: 196 WEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 52.2 bits (125), Expect = 8e-08
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 133
           QI  G+KY+ S N +HRDL   N L+  N  +KI DFG++R     D+        +  R
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR 205

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           W     +L+    +T A DVW+ G    E++
Sbjct: 206 WMAWECILMGK--FTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 52.0 bits (124), Expect = 9e-08
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 6/102 (5%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           L++    +   QI  G+ Y+ S + +HRDL   N L+  N  +KI DFG++R    TD+ 
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176

Query: 127 T----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
                  +  RW   PE ++    +T   DVWS+G +  E+ 
Sbjct: 177 RVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 184
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 187 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGMSNEQVLRFVME 236

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 33/96 (34%), Positives = 46/96 (47%), Gaps = 13/96 (13%)

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
            ++Q+  G+KY+   N +HRDL   N+LL      KI DFGL++     D    Y   R 
Sbjct: 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD---SYYKARS 156

Query: 134 -------WYRAPELLLNSSDYTAAIDVWSVGCIFME 162
                  WY APE  +N   +++  DVWS G    E
Sbjct: 157 AGKWPLKWY-APE-CINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 38/127 (29%), Positives = 58/127 (45%), Gaps = 23/127 (18%)

Query: 56  DLHQIIRSNQALSEEHCQY--------FLY---QILRGLKYIHSANVLHRDLKPSNLLLN 104
           DL+Q ++ + A +               LY   QI  G++Y+ S N +HRDL   N L+ 
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164

Query: 105 ANCDLKICDFGLARVTSETDFMTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVG 157
            N  +KI DFG++R    +D+   Y V        RW     +LL    +T   DVW+ G
Sbjct: 165 KNYTIKIADFGMSRNLYSSDY---YRVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFG 219

Query: 158 CIFMELM 164
               E++
Sbjct: 220 VTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 7/101 (6%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           L+ +    F   +  G++Y+     +HRDL   N+L+  N   KI DFGL+R   E  ++
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYV 173

Query: 127 TEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +    +  RW       LN S YT   DVWS G +  E++
Sbjct: 174 KKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 64/289 (22%), Positives = 107/289 (37%), Gaps = 88/289 (30%)

Query: 28  VVAIRDIIPPPQRE-------SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFL 76
           V A RDI+     E       SF D    Y +MD     D+  ++       E+  ++++
Sbjct: 48  VKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYI 107

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL------------------AR 118
            ++   ++ +H    +HRD+KP N+L++ +  +K+ DFGL                   R
Sbjct: 108 AELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167

Query: 119 VTSETDFMTEY---------------------------VVTRWYRAPELLLNSSDYTAAI 151
             S  +   E+                           V T  Y APE+LL +  YT   
Sbjct: 168 QDS-MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLC 225

Query: 152 DVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY 211
           D WSVG I  E++  +P F              L  TP+E +L  +N     +I      
Sbjct: 226 DWWSVGVILYEMLVGQPPF--------------LADTPAETQLKVINWETTLHI----PS 267

Query: 212 QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSL 257
           Q          +   A DL+ ++       R+     ++  AHP+   +
Sbjct: 268 Q--------AKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 50.7 bits (121), Expect = 2e-07
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           W  APE L +   +T + D+WS G +  E+
Sbjct: 187 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.5 bits (120), Expect = 3e-07
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           LS +   +F   + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R   +  ++
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYV 166

Query: 127 TEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +    +  RW       LN S YT   DVWS G +  E++
Sbjct: 167 KKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.2 bits (120), Expect = 3e-07
 Identities = 33/130 (25%), Positives = 60/130 (46%), Gaps = 15/130 (11%)

Query: 47  YIAYELMD-TDLHQIIRSNQA---------LSEEHCQYFLYQILRGLKYIHSANVLHRDL 96
           Y+  E  D  DL Q +R+ ++         LS +       QI  G+ ++ +A  +HRDL
Sbjct: 84  YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDL 143

Query: 97  KPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDV 153
              N L+++  ++K+    L++    ++        +  RW  APE +    D++   DV
Sbjct: 144 AARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL-APEAVQE-DDFSTKSDV 201

Query: 154 WSVGCIFMEL 163
           WS G +  E+
Sbjct: 202 WSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 50.2 bits (120), Expect = 3e-07
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 8/97 (8%)

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW 134
           F+  I  G++Y+ + N +HRDL   N +L  +  + + DFGL++     D+   Y   R 
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY---YRQGRI 174

Query: 135 YRAPE--LLLNS-SD--YTAAIDVWSVGCIFMELMDR 166
            + P   + + S +D  YT+  DVW+ G    E+  R
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.8 bits (119), Expect = 5e-07
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 21/156 (13%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-LARVTSETDF 125
           L E+  +++L +++  +  +H    +HRD+KP N+LL+ N  +++ DFG   R+ ++   
Sbjct: 99  LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158

Query: 126 MTEYVV-TRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMDRKPLFP-------G 172
            +   V T  Y +PE+L    D    Y    D WS+G C++  L    P +        G
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218

Query: 173 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL 208
           +   H+          P +     ++E AK  I +L
Sbjct: 219 KIMNHKEHFQF-----PPDVTD--VSEEAKDLIRRL 247

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 49.6 bits (118), Expect = 5e-07
 Identities = 30/102 (29%), Positives = 49/102 (48%), Gaps = 3/102 (2%)

Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS 121
           R    L  +    F   +   ++Y+ + N +HRDL   N+L++ +   K+ DFGL +  S
Sbjct: 94  RGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153

Query: 122 ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            T    +  V +W  APE  L    ++   DVWS G +  E+
Sbjct: 154 STQDTGKLPV-KW-TAPE-ALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 19/42 (45%), Positives = 29/42 (69%)

Query: 76  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 117
           + Q+L GL+ +H   ++HRD+KP NLL+  +  +KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 52/217 (23%), Positives = 79/217 (36%), Gaps = 33/217 (15%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--- 123
           +SE    Y L  +L+ L YIH    +HR +K S++L++   D K+   GL    S     
Sbjct: 98  MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMINHG 155

Query: 124 -------DFMTEYVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 175
                  DF    V    + +PE+L  N   Y A  D++SVG    EL +     P +D 
Sbjct: 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDM 213

Query: 176 VHQLRLLIELIGT-----------PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 224
                LL +L GT             E  +      A   + +         +    + H
Sbjct: 214 PATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSH 273

Query: 225 P-------SAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           P            VE+ L  +P  R +    L H + 
Sbjct: 274 PYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 28/98 (28%), Positives = 50/98 (51%), Gaps = 11/98 (11%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT----EYVVTR 133
           +I  G+ ++H  N LH DL   N  L ++  +K+ D+G+     + D++     + V  R
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166

Query: 134 WYRAPELL------LNSSDYTAAIDVWSVGCIFMELMD 165
           W  APEL+      L +++ T   +VW++G    EL +
Sbjct: 167 WL-APELVGEFHGGLITAEQTKPSNVWALGVTLWELFE 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 4/80 (5%)

Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     DL  ++      SE+  ++++ + +  ++ +H    +HRD+K
Sbjct: 69  SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIK 128

Query: 98  PSNLLLNANCDLKICDFGLA 117
           P N+L++    +K+ DFGL+
Sbjct: 129 PDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 133
           QI  G+ Y+ S + +HRDL   N L+     +KI DFG++R    TD+        +  R
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           W   PE +L    +T   D+WS G +  E+
Sbjct: 190 WM-PPESILYRK-FTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.2 bits (112), Expect = 3e-06
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 3/101 (2%)

Query: 69  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 128
           EE  + +  +++  L  +H   ++ RDL P+N+LL+    +++  F   R +   D    
Sbjct: 84  EECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDG 141

Query: 129 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 169
             V   Y APE +   S+ T A D WS+G I  EL+  K L
Sbjct: 142 EAVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS--ETDFMTE--YVVTR 133
           QI +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR+    E ++  +   +  +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           W       ++   +T   DVWS G    ELM
Sbjct: 177 WMALE--CIHYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 4/90 (4%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRW 134
           QI +G+ Y+    ++HR+L   N+LL ++  ++I DFG+A +    D   F +E+     
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           + A E +L    YT   DVWS G    E+M
Sbjct: 177 WMALESILFGR-YTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 42/136 (30%), Positives = 65/136 (47%), Gaps = 19/136 (13%)

Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQIL-------RGLKYIHSANVLHRDLK 97
            YI  ELM+  DL   +R  +          L ++L       +G  Y+   + +HRDL 
Sbjct: 74  QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLA 133

Query: 98  PSNLLLNA---NCD--LKICDFGLARVTSETDFMTE----YVVTRWYRAPELLLNSSDYT 148
             N L++    + D  +KI DFGLAR   ++D+  +     +  RW  APE LL+   +T
Sbjct: 134 ARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM-APESLLDGK-FT 191

Query: 149 AAIDVWSVGCIFMELM 164
              DVWS G +  E++
Sbjct: 192 TQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 44/191 (23%), Positives = 71/191 (37%), Gaps = 47/191 (24%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR------------------- 118
           +I   ++Y+HS  VLHRDLKP N+LL    ++ I D+G A                    
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
             S      + V T  Y APE LL     + + D++++G I  +++     FP R    +
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLS--FPYRRKKGR 237

Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD 238
                ++I +P E                            +  + P    +  K L  D
Sbjct: 238 KISYRDVILSPIE-------------------------VAPYREIPPFLSQIAMKALAVD 272

Query: 239 PRQRITVEDAL 249
           P +R +    L
Sbjct: 273 PAERYSSVQEL 283

Length = 932

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 29/130 (22%), Positives = 48/130 (36%), Gaps = 19/130 (14%)

Query: 57  LHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           L  I+    + L+EE       Q L  L+ +H        L   + LL           G
Sbjct: 3   LADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL--------DG 54

Query: 116 -LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
            +A  T E      Y +     APE++     YT   D++S+G    E +D +      +
Sbjct: 55  SVAFKTPEQSRPDPYFM-----APEVIQGQ-SYTEKADIYSLGITLYEALDYE---LPYN 105

Query: 175 HVHQLRLLIE 184
              +L  ++E
Sbjct: 106 EERELSAILE 115

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 26/90 (28%), Positives = 45/90 (50%), Gaps = 6/90 (6%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 133
           QI  G++Y+ S   +H+DL   N+L+     +KI D GL+R     D+        +  R
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           W   PE ++    +++  D+WS G +  E+
Sbjct: 192 WM-PPEAIMYGK-FSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 43.5 bits (102), Expect = 6e-05
 Identities = 26/90 (28%), Positives = 47/90 (52%), Gaps = 6/90 (6%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 133
           QI  G++++ S +V+H+DL   N+L+    ++KI D GL R     D+        +  R
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           W  +PE ++    ++   D+WS G +  E+
Sbjct: 192 WM-SPEAIMYGK-FSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 41.4 bits (97), Expect = 2e-04
 Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 5/92 (5%)

Query: 76  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-LARVTSETDF--MTEYVVT 132
           L  +  G+KY+     +H+ L    +L+N++   KI  F  L    SE  +  M+     
Sbjct: 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPV 172

Query: 133 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            W  APE  +    +++A DVWS G +  E+M
Sbjct: 173 LW-AAPE-AIQYHHFSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 15/92 (16%)

Query: 31  IRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN 90
           I D+ P           +   +   DL  ++  N  L  +        +   +  +H A 
Sbjct: 403 IYDVDP------EEKTIVMEYIGGKDLKDVLEGNPELVRK--------VGEIVAKLHKAG 448

Query: 91  VLHRDLKPSNLLLNANCDLKICDFGLARVTSE 122
           ++H DL  SN ++  +  L + DFGL + +  
Sbjct: 449 IVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 40.3 bits (95), Expect = 5e-04
 Identities = 19/66 (28%), Positives = 33/66 (50%), Gaps = 5/66 (7%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L  +I SN     E  +     + +    +HSA ++H DL  SN++L+    + + DFGL
Sbjct: 86  LKDLINSNGMEELELSREIGRLVGK----LHSAGIIHGDLTTSNMILSGG-KIYLIDFGL 140

Query: 117 ARVTSE 122
           A  + +
Sbjct: 141 AEFSKD 146

Length = 211

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 39.9 bits (94), Expect = 6e-04
 Identities = 13/37 (35%), Positives = 23/37 (62%), Gaps = 1/37 (2%)

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 122
           +H A ++H DL  SN+++  +  L + DFGL + + E
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSDE 141

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 40.5 bits (95), Expect = 6e-04
 Identities = 37/133 (27%), Positives = 56/133 (42%), Gaps = 17/133 (12%)

Query: 47  YIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR-------GLKYIHSANVLHRDLKP 98
           +I  ELM   DL   +R N+   E      +  +L        G KY+   + +HRD+  
Sbjct: 85  FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAA 144

Query: 99  SNLLLNANCD---LKICDFGLARVTSETDFMTE----YVVTRWYRAPELLLNSSDYTAAI 151
            N LL         KI DFG+AR      +  +     +  +W   PE  L+   +T+  
Sbjct: 145 RNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM-PPEAFLDGI-FTSKT 202

Query: 152 DVWSVGCIFMELM 164
           DVWS G +  E+ 
Sbjct: 203 DVWSFGVLLWEIF 215

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 53/218 (24%), Positives = 83/218 (38%), Gaps = 60/218 (27%)

Query: 73  QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETDFMT---- 127
           Q  + QIL  L  +HS  ++HRD+KP N++ +      KI D G A      D       
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA-----ADLRVGINY 312

Query: 128 ---EYVVTRWYRAPELLLNSSDYTAA---------------------IDVWSVGCIFMEL 163
              E+++   Y APE  + S+   +A                      D++S G IF+++
Sbjct: 313 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372

Query: 164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV 223
                 FP       LR    LI      +L   + +   +   +           F   
Sbjct: 373 A-----FPN------LRSDSNLIQF--NRQLKRNDYDLVAWRKLVEPRASPDLRRGF--- 416

Query: 224 HPSAID--------LVEKMLTFDPRQRITVEDALAHPY 253
               +D        L++ M+ F  RQRI+ + ALAHPY
Sbjct: 417 --EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPY 452

Length = 566

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 38.4 bits (90), Expect = 0.002
 Identities = 11/28 (39%), Positives = 16/28 (57%)

Query: 225 PSAIDLVEKMLTFDPRQRITVEDALAHP 252
           P   DL+ KML  DP +R + ++ L H 
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	302
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.98
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.98
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.98
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.94
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.79
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
PRK09188	365	serine/threonine protein kinase; Provisional	99.77
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.77
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.74
PRK10345	210	hypothetical protein; Provisional	99.73
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.69
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.67
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.64
PRK14879	211	serine/threonine protein kinase; Provisional	99.58
smart00090	237	RIO RIO-like kinase.	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.54
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.54
KOG1243	690	consensus Protein kinase [General function predict	99.53
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.45
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.38
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.3
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.29
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.28
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.24
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.17
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.16
KOG3087	229	consensus Serine/threonine protein kinase [General	99.15
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.11
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.07
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.06
COG4248	637	Uncharacterized protein with protein kinase and he	99.04
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.02
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.97
PRK09902	216	hypothetical protein; Provisional	98.9
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.84
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.67
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.65
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.64
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.58
KOG1093	725	consensus Predicted protein kinase (contains TBC a	98.32
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.22
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.08
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.03
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.92
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.88
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.65
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.64
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.54
PLN02876	822	acyl-CoA dehydrogenase	97.46
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.31
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.24
PF01636	239	APH: Phosphotransferase enzyme family This family	97.21
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.5
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.32
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.15
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.7
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.58
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.5
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	95.47
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	95.39
PRK05231	319	homoserine kinase; Provisional	95.33
PTZ00384	383	choline kinase; Provisional	95.3
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	95.19
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.18
PRK10271	188	thiK thiamine kinase; Provisional	95.14
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	95.13
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.99
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	94.38
KOG2270	520	consensus Serine/threonine protein kinase involved	94.31
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	94.24
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.21
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.12
COG2334	331	Putative homoserine kinase type II (protein kinase	93.72
PLN02236	344	choline kinase	93.6
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	93.53
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	92.04
PHA03111	444	Ser/Thr kinase; Provisional	92.03
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	91.57
PRK11768	325	serine/threonine protein kinase; Provisional	91.47
PRK06148	1013	hypothetical protein; Provisional	91.07
PRK06149	972	hypothetical protein; Provisional	89.95
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	89.78
PRK14559	645	putative protein serine/threonine phosphatase; Pro	88.97

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-66  Score=432.35  Aligned_cols=292  Identities=60%  Similarity=1.062  Sum_probs=273.0

Q ss_pred             HhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...++..||+++|+.++|+||+.+++++..+....++++|+|+|+|+.+|.+.++.+..|+++.++.+++|++.||+|+|
T Consensus        63 ~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH  142 (359)
T KOG0660|consen   63 IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH  142 (359)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh
Confidence            35568889999999999999999999999977788899999999999999999999888999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCC---CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      +.||+|||+||.|++++.+..+||||||+|+....   ....+.++.|.+|+|||++.....|+.+.||||+|||++||+
T Consensus       143 SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL  222 (359)
T KOG0660|consen  143 SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEML  222 (359)
T ss_pred             cccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHH
Confidence            99999999999999999999999999999998753   455688899999999999998889999999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhh-hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      +|++.|+|.+...++..|.+.+|+|+++.+... +..+..+..+.+...+.++...|++.++.+.+|+.+||..||.+|+
T Consensus       223 ~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRi  302 (359)
T KOG0660|consen  223 TGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRI  302 (359)
T ss_pred             cCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccC
Confidence            999999999999999999999999999998877 5778889999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccChhhhc
Q 022132          244 TVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ  301 (302)
Q Consensus       244 t~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (302)
                      |++|+|+|||+..++++.++|++...+.. .+. .++.+++++++|.|+..|+|..++
T Consensus       303 ta~eAL~hPYl~~~hdp~dEP~~~~~~~~-~~~-~~~~~~~r~~i~~e~~~~~~~~~~  358 (359)
T KOG0660|consen  303 TAEEALAHPYLAPYHDPEDEPVCQPIFDS-FEH-ELTEEELRELIYKEILDFHPDVSK  358 (359)
T ss_pred             CHHHHhcChhhhhhcCCccCCCCCCCCcc-ccc-cccHHHHHHHHHHHHHhhCccccC
Confidence            99999999999999999999988876654 333 399999999999999999998653

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.1e-57  Score=375.80  Aligned_cols=291  Identities=31%  Similarity=0.592  Sum_probs=248.2

Q ss_pred             hhHHHHhcCchh-hHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc----CCCCCHHHHHHHHH
Q 022132            3 SITKLMQRGHFV-RSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS----NQALSEEHCQYFLY   77 (302)
Q Consensus         3 ~~~~~~~~~~~~-~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~   77 (302)
                      ||||..+++++. +|+.+|+.+.|||||++..+|......+--...+||||++.+|.++++.    +..++.-.++.+++
T Consensus        53 AIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~  132 (364)
T KOG0658|consen   53 AIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTY  132 (364)
T ss_pred             EEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHH
Confidence            889999999998 8999999999999999999998764322235668999999999999984    57899999999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCCEEEecC-CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHH
Q 022132           78 QILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  156 (302)
Q Consensus        78 qll~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  156 (302)
                      ||++||.|||+.|||||||||.|+|+|.+ |.+||||||.|+.........++..|++|+|||.+.+...|+.+.||||.
T Consensus       133 Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSa  212 (364)
T KOG0658|consen  133 QLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSA  212 (364)
T ss_pred             HHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhh
Confidence            99999999999999999999999999987 99999999999998888888999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccc-cCCCCCHHHHHHHHHcc
Q 022132          157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE-KFPNVHPSAIDLVEKML  235 (302)
Q Consensus       157 G~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L  235 (302)
                      ||+++||+.|++.|+|.+..+++..|.+.+|.|+.+.+..++.+..  ....+.....++.+ .+...+++..+|+.++|
T Consensus       213 GCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~--~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L  290 (364)
T KOG0658|consen  213 GCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT--EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLL  290 (364)
T ss_pred             hHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc--cccCcccccccceeecccCCCHHHHHHHHHHh
Confidence            9999999999999999999999999999999999999988876654  34566666677766 66788999999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCcCCccCCCCCCCC----CCCCCcchhhcccCHHHHHHHHHHHHHcc
Q 022132          236 TFDPRQRITVEDALAHPYLGSLHDISDEPVC----MSPFSFDFEQHALTEGQMKELIYQEALAF  295 (302)
Q Consensus       236 ~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (302)
                      .++|.+|.|+.|+|.||||..++++...-.+    ..-|++...+.....+-+..++-.++..+
T Consensus       291 ~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~f~~~e~~~~~~~~~~l~p~~~~~~  354 (364)
T KOG0658|consen  291 QYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFNFKRAELGISPELVNVLIPEHLREQ  354 (364)
T ss_pred             ccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccCchHHHhccchHHHHhhccHhhhhh
Confidence            9999999999999999999999877422211    23345554444444455555555444443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-56  Score=377.54  Aligned_cols=254  Identities=34%  Similarity=0.626  Sum_probs=233.4

Q ss_pred             hhHHHHhcC------chhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHH
Q 022132            3 SITKLMQRG------HFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQY   74 (302)
Q Consensus         3 ~~~~~~~~~------~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~   74 (302)
                      |||+++.+=      --.||++.|++++ |||||+|.+++.+..    +.+|+|||||+.+|+++++.+ +.|++..++.
T Consensus        39 AIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~L~fVfE~Md~NLYqLmK~R~r~fse~~irn  114 (538)
T KOG0661|consen   39 AIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RILYFVFEFMDCNLYQLMKDRNRLFSESDIRN  114 (538)
T ss_pred             eHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHH
Confidence            677666543      4459999999997 999999999999972    399999999999999999864 6799999999


Q ss_pred             HHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHH
Q 022132           75 FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW  154 (302)
Q Consensus        75 i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  154 (302)
                      |++||+.||+|+|++|+.|||+||+|||+.....+||+|||+|+........+.++.|++|+|||++.....|+.+.|+|
T Consensus       115 im~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~w  194 (538)
T KOG0661|consen  115 IMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMW  194 (538)
T ss_pred             HHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHH
Confidence            99999999999999999999999999999988899999999999988888889999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHc
Q 022132          155 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  234 (302)
Q Consensus       155 slG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (302)
                      ++|||++|+.+-+|.|+|.+..+++-+|.+++|+|....|..-........-.+|.....++...++..++++.++|.+|
T Consensus       195 A~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~l  274 (538)
T KOG0661|consen  195 AVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERL  274 (538)
T ss_pred             HHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHH
Confidence            99999999999999999999999999999999999999887766666666677888888899999999999999999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCcCCccCC
Q 022132          235 LTFDPRQRITVEDALAHPYLGSLHDI  260 (302)
Q Consensus       235 L~~dP~~R~t~~ell~h~~~~~~~~~  260 (302)
                      |.+||.+||||.++|+||||+.....
T Consensus       275 l~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  275 LAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             hcCCCccCccHHHHhcCccccccccc
Confidence            99999999999999999999876443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.9e-55  Score=356.80  Aligned_cols=242  Identities=31%  Similarity=0.645  Sum_probs=214.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      -..||+++|++++|||+|.+.++|...     ..+++|+|||+.++.+.++.. ..++.+.++.+++|++.|+.|+|+++
T Consensus        47 IAlREIrmLKqLkH~NLVnLiEVFrrk-----rklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n  121 (396)
T KOG0593|consen   47 IALREIRMLKQLKHENLVNLIEVFRRK-----RKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN  121 (396)
T ss_pred             HHHHHHHHHHhcccchHHHHHHHHHhc-----ceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC
Confidence            467999999999999999999999998     899999999999888888754 45899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ++||||||+||+++.+|.+||||||+|+..+ +.+..+.++.|++|+|||.+.+...|+..+||||+||++.||++|.+.
T Consensus       122 ~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL  201 (396)
T KOG0593|consen  122 CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPL  201 (396)
T ss_pred             eecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcC
Confidence            9999999999999999999999999999877 667778899999999999999988999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccc-ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |+|.++.+++-.|...+|...+....-+..+..=.--.+|.. ...+++..+|+++..+.||+++||+.||.+|+|.+++
T Consensus       202 ~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql  281 (396)
T KOG0593|consen  202 WPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL  281 (396)
T ss_pred             CCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH
Confidence            999999999999999999888776654433311111112222 3457888899999999999999999999999999999


Q ss_pred             hcCCCcCCcc
Q 022132          249 LAHPYLGSLH  258 (302)
Q Consensus       249 l~h~~~~~~~  258 (302)
                      |.|+||.++.
T Consensus       282 l~H~yFd~~~  291 (396)
T KOG0593|consen  282 LHHPYFDGFI  291 (396)
T ss_pred             hcChHHHHHH
Confidence            9999997764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.2e-54  Score=341.39  Aligned_cols=242  Identities=37%  Similarity=0.702  Sum_probs=214.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ...||++.|+.++||||+.+.|+|...     +.+.+|+||++.+|..+++.+ ..++...++.++.+++.||+|||++.
T Consensus        47 talREIK~Lqel~h~nIi~LiD~F~~~-----~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~  121 (318)
T KOG0659|consen   47 TALREIKLLQELKHPNIIELIDVFPHK-----SNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW  121 (318)
T ss_pred             HHHHHHHHHHHccCcchhhhhhhccCC-----CceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh
Confidence            567999999999999999999999998     899999999999999999854 67999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |.|||+||.|+|++.+|.+||+|||+++..+... .....+-|++|+|||.+++...|+..+|+||.|||++||+.|.|.
T Consensus       122 IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~  201 (318)
T KOG0659|consen  122 ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF  201 (318)
T ss_pred             hhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC
Confidence            9999999999999999999999999999876553 334447899999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |+|.++.+++..++..+|+|.+..|..+.....-.  ++..++..+....|+..+.++.||+.+||.+||.+|+|+.|+|
T Consensus       202 fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~--~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL  279 (318)
T KOG0659|consen  202 FPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV--KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL  279 (318)
T ss_pred             CCCCchHHHHHHHHHHcCCCCcccCccccccccHH--HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence            99999999999999999999999988764322111  1113344455558889999999999999999999999999999


Q ss_pred             cCCCcCCccCC
Q 022132          250 AHPYLGSLHDI  260 (302)
Q Consensus       250 ~h~~~~~~~~~  260 (302)
                      +|+||++...+
T Consensus       280 ~~~yf~~~P~p  290 (318)
T KOG0659|consen  280 KHPYFKSLPLP  290 (318)
T ss_pred             cchhhhcCCCC
Confidence            99999975433

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-53  Score=364.64  Aligned_cols=241  Identities=36%  Similarity=0.635  Sum_probs=209.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      -..|||.||++|+||||++|.++..+...   +.+|||+|||+.+|..++... -.|++.+++.++.||+.||+|+|++|
T Consensus       162 t~~REI~ILr~l~HpNIikL~eivt~~~~---~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g  238 (560)
T KOG0600|consen  162 TAIREIKILRRLDHPNIIKLEEIVTSKLS---GSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG  238 (560)
T ss_pred             HHHHHHHHHHhcCCCcccceeeEEEecCC---ceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC
Confidence            35699999999999999999999988632   789999999999999999863 47999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccC--CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTS--ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |.|||||.+|||+|.+|.+||+|||+|+...  .....+..+.|.+|+|||++++...|+.++|+||.|||+.||+.|+|
T Consensus       239 vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP  318 (560)
T KOG0600|consen  239 VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP  318 (560)
T ss_pred             eeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence            9999999999999999999999999999543  33456778899999999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      +|.|.+..+++..|++.+|.|.+..|................+ ...+.+.+..+++...+|+.+||..||.+|.||.++
T Consensus       319 I~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y-~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~a  397 (560)
T KOG0600|consen  319 ILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPY-KRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSA  397 (560)
T ss_pred             CcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcc-cchHHHHhccCCHHHHHHHHHHhccCccccccHHHH
Confidence            9999999999999999999999998872222111111111111 234566688899999999999999999999999999


Q ss_pred             hcCCCcCC
Q 022132          249 LAHPYLGS  256 (302)
Q Consensus       249 l~h~~~~~  256 (302)
                      |.|.||..
T Consensus       398 L~seyF~t  405 (560)
T KOG0600|consen  398 LQSEYFTT  405 (560)
T ss_pred             hcCccccc
Confidence            99999954

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-54  Score=363.32  Aligned_cols=215  Identities=29%  Similarity=0.534  Sum_probs=186.3

Q ss_pred             hhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022132           13 FVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV   91 (302)
Q Consensus        13 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i   91 (302)
                      ..+|++||+.|+|||||+++++|..+     ...||||||++ |+|.+.+-.++.+.+...+.+++|++.|+.|||++||
T Consensus       223 v~~EieILkkL~HP~IV~~~d~f~~~-----ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI  297 (475)
T KOG0615|consen  223 VQNEIEILKKLSHPNIVRIKDFFEVP-----DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGI  297 (475)
T ss_pred             hHHHHHHHHhcCCCCEEEEeeeeecC-----CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCc
Confidence            35899999999999999999999998     88899999996 7999999999999999999999999999999999999


Q ss_pred             eecCCCCCCEEEecC---CCEEEeecccccccCCCCcccccccccccCchhhhhCCC--CCCCchhHHHHHHHHHHHHhC
Q 022132           92 LHRDLKPSNLLLNAN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        92 ~H~dikp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~i~~~ll~g  166 (302)
                      +||||||+|||++.+   ..+||+|||+|+..++.......+||+.|.|||++...+  .+..++|+||+||++|.+++|
T Consensus       298 ~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG  377 (475)
T KOG0615|consen  298 IHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSG  377 (475)
T ss_pred             ccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEecc
Confidence            999999999999876   669999999999999999999999999999999996543  245689999999999999999


Q ss_pred             CCCCCCCChHH-HHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          167 KPLFPGRDHVH-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       167 ~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      .+||.+..... ....|.+.--                          .-.+..|..++.++++||.+||..||++|||+
T Consensus       378 ~pPFS~~~~~~sl~eQI~~G~y--------------------------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~  431 (475)
T KOG0615|consen  378 YPPFSEEYTDPSLKEQILKGRY--------------------------AFGPLQWDRISEEALDLINWMLVVDPENRPSA  431 (475)
T ss_pred             CCCcccccCCccHHHHHhcCcc--------------------------cccChhhhhhhHHHHHHHHHhhEeCcccCcCH
Confidence            99998765443 3333322110                          01123344788999999999999999999999


Q ss_pred             HHHhcCCCcCCcc
Q 022132          246 EDALAHPYLGSLH  258 (302)
Q Consensus       246 ~ell~h~~~~~~~  258 (302)
                      +|+|+||||+...
T Consensus       432 ~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  432 DEALNHPWFKDAP  444 (475)
T ss_pred             HHHhcChhhhccc
Confidence            9999999999654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-53  Score=346.92  Aligned_cols=288  Identities=40%  Similarity=0.696  Sum_probs=255.0

Q ss_pred             HhcCchhhHHHHHHhcCCCCccccceeeCCCC-CCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      +..++..||+..+..++|+||++++.+|.... ...+..+|+|||+|+.+|.+++..  .++.+.+.++++|++.|+++|
T Consensus        57 ~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~--elDH~tis~i~yq~~~~ik~l  134 (369)
T KOG0665|consen   57 THAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVILM--ELDHETISYILYQMLCGIKHL  134 (369)
T ss_pred             ccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHHH--hcchHHHHHHHHHHHHHHHHH
Confidence            34567889999999999999999999999865 456788999999999999999883  588999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |+.||+||||||+||+++.++.+||+|||+++.....-..+.++.+++|+|||++.+.+ +...+||||+|||+.+|++|
T Consensus       135 hs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~  213 (369)
T KOG0665|consen  135 HSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILG  213 (369)
T ss_pred             HhcceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhc
Confidence            99999999999999999999999999999998877666778899999999999998877 89999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCC------------CHHHHHHHHHc
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKM  234 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~  234 (302)
                      +..|+|.+..+++.++.+.+|.|.+..+.++......+....+.++..++.+.+|+.            +..+++++.+|
T Consensus       214 ~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~M  293 (369)
T KOG0665|consen  214 TVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKM  293 (369)
T ss_pred             eEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHh
Confidence            999999999999999999999999999999999999999999999888888888743            24689999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCcCCccCCCCCCCC-CCCCCcchhhcccCHHHHHHHHHHHHHccChh
Q 022132          235 LTFDPRQRITVEDALAHPYLGSLHDISDEPVC-MSPFSFDFEQHALTEGQMKELIYQEALAFNPE  298 (302)
Q Consensus       235 L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (302)
                      |..||++|.|++++|+|||++-|.....-.-. ..+.....+..+.+.++|+++||.|++.|+++
T Consensus       294 Lvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~  358 (369)
T KOG0665|consen  294 LVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEF  358 (369)
T ss_pred             hccChhhcccHHHHhcCCeeeeecccccccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhccc
Confidence            99999999999999999999977543321111 11343445666777999999999999999984

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-53  Score=369.43  Aligned_cols=227  Identities=30%  Similarity=0.488  Sum_probs=200.9

Q ss_pred             hhHHHHhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHH
Q 022132            3 SITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR   81 (302)
Q Consensus         3 ~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~   81 (302)
                      +|+|-.++....+|++|.++|+|||||+++++|+++     +.+|||+|+|. ++|..+++.++.++|.+++++++||+.
T Consensus        55 ~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-----~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~  129 (592)
T KOG0575|consen   55 LLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-----NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVE  129 (592)
T ss_pred             HhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-----CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHH
Confidence            345667777888999999999999999999999999     99999999998 799999998899999999999999999


Q ss_pred             HHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           82 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        82 ~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      ||.|||++||+|||||..|++++++..+||+|||+|...... ....+.+||+.|.|||++.+. ..+..+||||+|||+
T Consensus       130 GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvm  208 (592)
T KOG0575|consen  130 GLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVM  208 (592)
T ss_pred             HHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccC-CCCCchhhhhhhhHH
Confidence            999999999999999999999999999999999999876633 556778999999999999754 489999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      |.||.|+|||...+..+.+..|...--.                              ....+|.++++||.+||++||.
T Consensus       209 YtLL~G~PPFetk~vkety~~Ik~~~Y~------------------------------~P~~ls~~A~dLI~~lL~~~P~  258 (592)
T KOG0575|consen  209 YTLLVGRPPFETKTVKETYNKIKLNEYS------------------------------MPSHLSAEAKDLIRKLLRPNPS  258 (592)
T ss_pred             HhhhhCCCCcccchHHHHHHHHHhcCcc------------------------------cccccCHHHHHHHHHHhcCCcc
Confidence            9999999999999888888877652211                              1126889999999999999999


Q ss_pred             CCCCHHHHhcCCCcCCccCCCCCCC
Q 022132          241 QRITVEDALAHPYLGSLHDISDEPV  265 (302)
Q Consensus       241 ~R~t~~ell~h~~~~~~~~~~~~~~  265 (302)
                      +|||++++|.|+||++-..+...+.
T Consensus       259 ~Rpsl~~vL~h~Ff~~g~~p~~lp~  283 (592)
T KOG0575|consen  259 ERPSLDEVLDHPFFKSGFTPARLPS  283 (592)
T ss_pred             cCCCHHHHhcCHhhhCCCcCCCCCc
Confidence            9999999999999965555544443

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-52  Score=344.55  Aligned_cols=243  Identities=38%  Similarity=0.644  Sum_probs=219.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ...|||.+|.+++|||||.+..+..-+.-   +.+|||||||+.+|..++..- .+++..+++.++.|++.|++|||.+.
T Consensus       121 tsLREIniLl~~~H~NIV~vkEVVvG~~~---d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w  197 (419)
T KOG0663|consen  121 TSLREINILLKARHPNIVEVKEVVVGSNM---DKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW  197 (419)
T ss_pred             hhHHHHHHHHhcCCCCeeeeEEEEecccc---ceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce
Confidence            35699999999999999999999977643   789999999999999999864 58999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+|||+|++|+|++..|.+||+|||+|+..++. ...+..+-|.+|+|||.+.+...|+.++|+||+|||+.+|+++.|.
T Consensus       198 ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPl  277 (419)
T KOG0663|consen  198 ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPL  277 (419)
T ss_pred             eEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCC
Confidence            999999999999999999999999999987765 4567778899999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCC--HHHHHHHHHccCCCCCCCCCHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH--PSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      |+|....+++..|+..+|+|++..|..+..........++......+...|+..+  ....+|+.++|.+||.+|.||+|
T Consensus       278 f~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~  357 (419)
T KOG0663|consen  278 FPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED  357 (419)
T ss_pred             CCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence            9999999999999999999999999888665444444556666666777777654  89999999999999999999999


Q ss_pred             HhcCCCcCCc
Q 022132          248 ALAHPYLGSL  257 (302)
Q Consensus       248 ll~h~~~~~~  257 (302)
                      +|.|.||...
T Consensus       358 ~L~h~~F~e~  367 (419)
T KOG0663|consen  358 GLKHEYFRET  367 (419)
T ss_pred             hhcccccccC
Confidence            9999999874

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-52  Score=348.23  Aligned_cols=216  Identities=26%  Similarity=0.473  Sum_probs=186.1

Q ss_pred             HhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCC-cEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFN-DVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~-~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..++++.||++|++.++|||||++|+.|...     + .++|+||||+ |+|.+++..-+++++..+..++.+|+.||.|
T Consensus       119 ~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~-----~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~Y  193 (364)
T KOG0581|consen  119 ALQKQILRELEILRSCQSPYIVGFYGAFYSN-----GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSY  193 (364)
T ss_pred             HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC-----CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            3445778999999999999999999999998     6 4999999997 7999999988999999999999999999999


Q ss_pred             HHh-CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           86 IHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        86 LH~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ||. .+|+||||||+|||++..|.+||||||.++..... ...+++||..|||||.+.+. .|+.++||||||++++|++
T Consensus       194 Lh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a  271 (364)
T KOG0581|consen  194 LHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELA  271 (364)
T ss_pred             HhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHh
Confidence            995 89999999999999999999999999999876544 56788999999999999655 5999999999999999999


Q ss_pred             hCCCCCCCC-----ChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC-CCCHHHHHHHHHccCCC
Q 022132          165 DRKPLFPGR-----DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       165 ~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~d  238 (302)
                      +|+.||...     +..+.+..|..   .|+                          +.... .+|+++++||..||++|
T Consensus       272 ~GrfP~~~~~~~~~~~~~Ll~~Iv~---~pp--------------------------P~lP~~~fS~ef~~FV~~CL~Kd  322 (364)
T KOG0581|consen  272 IGRFPYPPPNPPYLDIFELLCAIVD---EPP--------------------------PRLPEGEFSPEFRSFVSCCLRKD  322 (364)
T ss_pred             hCCCCCCCcCCCCCCHHHHHHHHhc---CCC--------------------------CCCCcccCCHHHHHHHHHHhcCC
Confidence            999999764     23333333332   111                          11222 38899999999999999


Q ss_pred             CCCCCCHHHHhcCCCcCCccC
Q 022132          239 PRQRITVEDALAHPYLGSLHD  259 (302)
Q Consensus       239 P~~R~t~~ell~h~~~~~~~~  259 (302)
                      |.+|+|+.++++|||+.....
T Consensus       323 p~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  323 PSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             cccCCCHHHHhcCHHHhhccc
Confidence            999999999999999998654

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.6e-50  Score=332.22  Aligned_cols=247  Identities=36%  Similarity=0.729  Sum_probs=215.3

Q ss_pred             hhhHHHHHHhcCCCC-ccccceeeCCCC-CCCCCcEEEEEecCCccHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHH
Q 022132           13 FVRSSCFDTWIMKTS-VVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQ----ALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        13 ~~~E~~il~~l~h~n-iv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~----~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..||+.+|+.++|+| |+.+++++.... ..+...+|+|+||++.+|.+++....    .++...++.+++||+.||+||
T Consensus        57 aiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~  136 (323)
T KOG0594|consen   57 AIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL  136 (323)
T ss_pred             hhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH
Confidence            479999999999999 999999998873 12334899999999999999998754    578899999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      |++||+||||||.||+++.+|.+||+|||+|+..+ +....+..+.|.+|+|||++.+...|+...||||+|||++||++
T Consensus       137 H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~  216 (323)
T KOG0594|consen  137 HSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT  216 (323)
T ss_pred             HhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh
Confidence            99999999999999999999999999999999776 34456778899999999999999889999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccc-cccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ-RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +.+.|+|....+++..|...+|+|++..|......... ....+... ...+....+..+++..+++.+||+++|.+|.|
T Consensus       217 ~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~-k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S  295 (323)
T KOG0594|consen  217 RRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDY-KAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS  295 (323)
T ss_pred             CCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccc-cccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC
Confidence            99999999999999999999999999988765432211 11333333 45566777777889999999999999999999


Q ss_pred             HHHHhcCCCcCCccCC
Q 022132          245 VEDALAHPYLGSLHDI  260 (302)
Q Consensus       245 ~~ell~h~~~~~~~~~  260 (302)
                      ++.+|.||||......
T Consensus       296 a~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  296 AKGALTHPYFSELPEK  311 (323)
T ss_pred             HHHHhcChhhcccccc
Confidence            9999999999986543

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-48  Score=343.55  Aligned_cols=286  Identities=49%  Similarity=0.941  Sum_probs=235.9

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV   91 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i   91 (302)
                      .+.+|+.+++.++||||+++++++......+...+|+||||++++|.+++...+.+++..+..++.||+.||.|||++||
T Consensus        45 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  124 (338)
T cd07859          45 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANV  124 (338)
T ss_pred             HHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            57789999999999999999999876544445679999999999999999888889999999999999999999999999


Q ss_pred             eecCCCCCCEEEecCCCEEEeecccccccCCC----CcccccccccccCchhhhhCC-CCCCCchhHHHHHHHHHHHHhC
Q 022132           92 LHRDLKPSNLLLNANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        92 ~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      +||||||+||+++.++.++|+|||++......    .......++..|+|||++.+. ..++.++||||+||++|+|++|
T Consensus       125 vH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg  204 (338)
T cd07859         125 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG  204 (338)
T ss_pred             ecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcC
Confidence            99999999999999999999999998754221    112345789999999988542 4578999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhh-HhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      ++||.+.+....+..+....+.|......... .....+..........++...++..++.+.++|.+||+.||.+|||+
T Consensus       205 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  284 (338)
T cd07859         205 KPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA  284 (338)
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH
Confidence            99999998888888888888888877665442 22333333333334445566677889999999999999999999999


Q ss_pred             HHHhcCCCcCCccCCCCCCCCC--CCCCcchhhcccCHHHHHHHHHHHHHccCh
Q 022132          246 EDALAHPYLGSLHDISDEPVCM--SPFSFDFEQHALTEGQMKELIYQEALAFNP  297 (302)
Q Consensus       246 ~ell~h~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (302)
                      +|+++||||+........+...  +...+.++...++.++++..++.+...++|
T Consensus       285 ~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (338)
T cd07859         285 EEALADPYFKGLAKVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP  338 (338)
T ss_pred             HHHhcCchhhhcCccccccccCccccccccHHHHhcCHHHHHHHHHHHHHhcCC
Confidence            9999999999876544333222  334566788899999999999999887775

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-48  Score=342.26  Aligned_cols=287  Identities=73%  Similarity=1.221  Sum_probs=248.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ..+.+|+.+++.++||||+++++++.......+..+|+|+||++++|.+++...+++++..+..++.|++.||.|||+.|
T Consensus        49 ~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  128 (337)
T cd07858          49 KRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN  128 (337)
T ss_pred             HHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            35668999999999999999999988764444567999999999999999988889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+...++.++|+||+||++++|++|.+|
T Consensus       129 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  208 (337)
T cd07858         129 VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL  208 (337)
T ss_pred             EecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCC
Confidence            999999999999999999999999998765433 2233456788899999986655588999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhh-hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |.+.+.......+....+.+....+... .....++....+......+....+.+++.+.++|++||++||.+|||++++
T Consensus       209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el  288 (337)
T cd07858         209 FPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA  288 (337)
T ss_pred             CCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence            9999888888888888888887766433 333444445555555555556667889999999999999999999999999


Q ss_pred             hcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccCh
Q 022132          249 LAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  297 (302)
Q Consensus       249 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (302)
                      ++||||..+.....++....++.+++++...+.++++++|+.|+++++|
T Consensus       289 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (337)
T cd07858         289 LAHPYLASLHDPSDEPVCQTPFSFDFEEDALTEEDIKELIYNEMLAYHP  337 (337)
T ss_pred             HcCcchhhhcCcccCccCCCccchhhhhhhcCHHHHHHHHHHHHhhcCC
Confidence            9999999999999999999999999999999999999999999999876

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-49  Score=341.11  Aligned_cols=221  Identities=29%  Similarity=0.483  Sum_probs=193.9

Q ss_pred             CchhHHHHhc-------Cchh-hHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHH
Q 022132            1 MHSITKLMQR-------GHFV-RSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEE   70 (302)
Q Consensus         1 ~~~~~~~~~~-------~~~~-~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~   70 (302)
                      ++|||.+..+       ..++ +|-.+|.+| +||.|++|+..|.+.     ..+|+|+||++ |+|.+++.+.+.|++.
T Consensus       100 eYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-----~sLYFvLe~A~nGdll~~i~K~Gsfde~  174 (604)
T KOG0592|consen  100 EYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-----ESLYFVLEYAPNGDLLDLIKKYGSFDET  174 (604)
T ss_pred             eeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc-----cceEEEEEecCCCcHHHHHHHhCcchHH
Confidence            3677665433       2333 789999999 899999999999998     89999999997 8999999999999999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--------------cccccccccccC
Q 022132           71 HCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--------------FMTEYVVTRWYR  136 (302)
Q Consensus        71 ~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--------------~~~~~~~~~~y~  136 (302)
                      ..++++.||+.||+|||++||+||||||+|||++.++.++|+|||.|+..++..              ....++||-.|.
T Consensus       175 caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYV  254 (604)
T KOG0592|consen  175 CARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYV  254 (604)
T ss_pred             HHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeeccc
Confidence            999999999999999999999999999999999999999999999997654221              125589999999


Q ss_pred             chhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccc
Q 022132          137 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF  216 (302)
Q Consensus       137 aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  216 (302)
                      +||++.. ...+..+|+|+||||+|+|+.|.|||.+.+.....++|++.--.                            
T Consensus       255 SPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~----------------------------  305 (604)
T KOG0592|consen  255 SPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE----------------------------  305 (604)
T ss_pred             CHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc----------------------------
Confidence            9999854 45899999999999999999999999999999998888874321                            


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       217 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                        ..+++++.++|||+++|..||++|+|+.++-+||||.++
T Consensus       306 --fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  306 --FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             --CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence              123678999999999999999999999999999999976

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-49  Score=348.12  Aligned_cols=217  Identities=29%  Similarity=0.475  Sum_probs=197.3

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+-||+.+.|||++++|+++.+.     .++|+|.||++ |.|++++..+|++++.++.++++||+.|+.|+|..+
T Consensus        58 ~IerEIviMkLi~HpnVl~LydVwe~~-----~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~  132 (786)
T KOG0588|consen   58 GIEREIVIMKLIEHPNVLRLYDVWENK-----QHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN  132 (786)
T ss_pred             chhhhhHHHHHhcCCCeeeeeeeeccC-----ceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc
Confidence            567999999999999999999999998     89999999996 799999999999999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      |||||+||+|+|++..+++||+|||+|....++......||++.|+|||++.+..+.+.++||||+|||+|.||+|+.||
T Consensus       133 icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPF  212 (786)
T KOG0588|consen  133 ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPF  212 (786)
T ss_pred             ceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCC
Confidence            99999999999999999999999999998888888999999999999999998887899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      ++.+....+.+......                              +....+++++++||++||..||.+|+|.+|+++
T Consensus       213 dDdNir~LLlKV~~G~f------------------------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  213 DDDNIRVLLLKVQRGVF------------------------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             CCccHHHHHHHHHcCcc------------------------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            97776655544432111                              122378999999999999999999999999999


Q ss_pred             CCCcCCccCCCCC
Q 022132          251 HPYLGSLHDISDE  263 (302)
Q Consensus       251 h~~~~~~~~~~~~  263 (302)
                      |||+.........
T Consensus       263 HP~l~g~~~~~~~  275 (786)
T KOG0588|consen  263 HPFLSGYTSLPSS  275 (786)
T ss_pred             CchhhcCCCCChh
Confidence            9999998776655

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-48  Score=324.98  Aligned_cols=211  Identities=27%  Similarity=0.487  Sum_probs=188.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      +...|..||..++||+||+++..|.+.     .++|+|+||+. |.|...++..+.++++.++.++..|+.||.|||+.|
T Consensus        71 ~~~~Er~IL~~v~hPFiv~l~ysFQt~-----~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g  145 (357)
T KOG0598|consen   71 HTKAERNILSKIKHPFIVKLIYSFQTE-----EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG  145 (357)
T ss_pred             HHHHHHHHHHhCCCCcEeeeEEecccC-----CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC
Confidence            566799999999999999999999998     89999999996 699999999999999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeeccccccc-CCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+|||+||+|||+|.+|.++|+|||+|+.. .........+||+.|+|||++.+.+ ++.++|.||||+++|+|++|.+|
T Consensus       146 IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pP  224 (357)
T KOG0598|consen  146 IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPP  224 (357)
T ss_pred             eeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCC
Confidence            999999999999999999999999999853 3445556689999999999997765 89999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC----CH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI----TV  245 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----t~  245 (302)
                      |.+.+....+..+...-.                             ......++.+++++++++|..||.+|.    .+
T Consensus       225 F~~~~~~~~~~~I~~~k~-----------------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~  275 (357)
T KOG0598|consen  225 FYAEDVKKMYDKILKGKL-----------------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDA  275 (357)
T ss_pred             CcCccHHHHHHHHhcCcC-----------------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCCh
Confidence            999998888887765221                             111124789999999999999999995    68


Q ss_pred             HHHhcCCCcCCc
Q 022132          246 EDALAHPYLGSL  257 (302)
Q Consensus       246 ~ell~h~~~~~~  257 (302)
                      +++-+||||...
T Consensus       276 ~~ik~HpfF~~i  287 (357)
T KOG0598|consen  276 EEIKRHPFFKGI  287 (357)
T ss_pred             HHhhcCcccccC
Confidence            999999999875

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.4e-49  Score=316.46  Aligned_cols=216  Identities=29%  Similarity=0.524  Sum_probs=193.5

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ...+|+.||+++ .||+|+++.|+|..+     ..+++|+|.|+ |.|.+++.+.-.++++..+.|++|+++|+.|||..
T Consensus        68 aT~~Ev~ILRqv~GHP~II~l~D~yes~-----sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~  142 (411)
T KOG0599|consen   68 ATRQEISILRQVMGHPYIIDLQDVYESD-----AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR  142 (411)
T ss_pred             HHHHHHHHHHHhcCCCcEEEeeeeccCc-----chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh
Confidence            456899999999 899999999999998     88999999997 89999999988999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCC-----CCCCCchhHHHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS-----SDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~i~~~ll  164 (302)
                      +|+|||+||+|||++++.+++|+|||++....++......+||+.|.|||.+.+.     ..|+..+|+|++|+|||.++
T Consensus       143 ~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL  222 (411)
T KOG0599|consen  143 NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL  222 (411)
T ss_pred             hhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHH
Confidence            9999999999999999999999999999999888888999999999999998543     35788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      .|.+||..+...-++..|++.--.-..                          ..|.++|...+|||++||+.||.+|.|
T Consensus       223 aGcpPFwHRkQmlMLR~ImeGkyqF~s--------------------------peWadis~~~KdLIsrlLqVdp~~Rit  276 (411)
T KOG0599|consen  223 AGCPPFWHRKQMLMLRMIMEGKYQFRS--------------------------PEWADISATVKDLISRLLQVDPTKRIT  276 (411)
T ss_pred             cCCCchhHHHHHHHHHHHHhcccccCC--------------------------cchhhccccHHHHHHHHHeeCchhccc
Confidence            999999888777777777653322222                          223478889999999999999999999


Q ss_pred             HHHHhcCCCcCCcc
Q 022132          245 VEDALAHPYLGSLH  258 (302)
Q Consensus       245 ~~ell~h~~~~~~~  258 (302)
                      ++|+|+||||.+.-
T Consensus       277 ake~LaHpff~q~~  290 (411)
T KOG0599|consen  277 AKEALAHPFFIQIA  290 (411)
T ss_pred             HHHHhcChHHHHHH
Confidence            99999999997653

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=335.45  Aligned_cols=211  Identities=29%  Similarity=0.497  Sum_probs=188.1

Q ss_pred             CchhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.||+.+++.++ ||||+++++++...     .++|+||||+. |+|.+++.+.+++.+..++.++.|+++||+|||+
T Consensus        64 ~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-----~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~  138 (370)
T KOG0583|consen   64 ELIKREISILRRLRSHPNIIRLLEVFATP-----TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHS  138 (370)
T ss_pred             hhhHHHHHHHHHhccCCCEeEEEEEEecC-----CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh
Confidence            35558999999998 99999999999998     78999999997 5999999999999999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecC-CCEEEeeccccccc-CCCCcccccccccccCchhhhhCCC-CCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNAN-CDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~i~~~ll~  165 (302)
                      +||+||||||+||+++.+ +.+||+|||++... .........+||+.|+|||++.+.. .-+.++||||+|+++|.|++
T Consensus       139 ~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~  218 (370)
T KOG0583|consen  139 RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLC  218 (370)
T ss_pred             CCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHh
Confidence            999999999999999999 99999999999887 5667788899999999999998766 45799999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCC-CHHHHHHHHHccCCCCCCCCC
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV-HPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~R~t  244 (302)
                      |..||...+.......+.+.--                              .....+ |+++++|+++||..||.+|+|
T Consensus       219 G~~PF~d~~~~~l~~ki~~~~~------------------------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t  268 (370)
T KOG0583|consen  219 GRLPFDDSNVPNLYRKIRKGEF------------------------------KIPSYLLSPEARSLIEKMLVPDPSTRIT  268 (370)
T ss_pred             CCCCCCCccHHHHHHHHhcCCc------------------------------cCCCCcCCHHHHHHHHHHcCCCcccCCC
Confidence            9999998777666666433100                              111134 899999999999999999999


Q ss_pred             HHHHhcCCCcCC
Q 022132          245 VEDALAHPYLGS  256 (302)
Q Consensus       245 ~~ell~h~~~~~  256 (302)
                      +.+++.||||+.
T Consensus       269 ~~~i~~h~w~~~  280 (370)
T KOG0583|consen  269 LLEILEHPWFQK  280 (370)
T ss_pred             HHHHhhChhhcc
Confidence            999999999997

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.1e-46  Score=331.31  Aligned_cols=281  Identities=40%  Similarity=0.709  Sum_probs=228.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++..... .....+|+||||++++|.+.+..  .+++..+..++.|++.||+|||++
T Consensus        68 ~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~  145 (364)
T cd07875          68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA  145 (364)
T ss_pred             HHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC
Confidence            356789999999999999999999876532 33457899999999999988864  588999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.++|+|||+++............++..|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus       146 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~p  224 (364)
T cd07875         146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL  224 (364)
T ss_pred             CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCC
Confidence            9999999999999999999999999999876555444566789999999998654 489999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC------------CCCHHHHHHHHHccCC
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP------------NVHPSAIDLVEKMLTF  237 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~L~~  237 (302)
                      |.+.+....+..+....+.|..............+....+.+....+...++            ..+..+++||.+||+.
T Consensus       225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  304 (364)
T cd07875         225 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI  304 (364)
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCc
Confidence            9999999999999999999888777666665555555544443332222221            2356789999999999


Q ss_pred             CCCCCCCHHHHhcCCCcCCccCCCCCCCCCCCC-CcchhhcccCHHHHHHHHHHHHHc
Q 022132          238 DPRQRITVEDALAHPYLGSLHDISDEPVCMSPF-SFDFEQHALTEGQMKELIYQEALA  294 (302)
Q Consensus       238 dP~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  294 (302)
                      ||.+|||++++|+||||..+..+.......... ....+....+.+++++.++.++++
T Consensus       305 dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (364)
T cd07875         305 DASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMD  362 (364)
T ss_pred             CcccCCCHHHHhcCcccccccCcccCCCCCCCCCCccchhhhccHHHHHHHHHHHHHc
Confidence            999999999999999999877665443222212 223455678888999999999865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.3e-46  Score=323.40  Aligned_cols=238  Identities=36%  Similarity=0.705  Sum_probs=200.3

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +..|+||||++++|.+++... ..+++..+..++.||+.||+|||++|
T Consensus        49 ~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~  123 (288)
T cd07871          49 TAIREVSLLKNLKHANIVTLHDIIHTE-----RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK  123 (288)
T ss_pred             hHHHHHHHHHhCCCCCEeeEEEEEcCC-----CeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            566899999999999999999999887     789999999999999988754 45789999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.++|+|||++...... .......++..|+|||.+.+...++.++|+||+||++|+|++|.+|
T Consensus       124 ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p  203 (288)
T cd07871         124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPM  203 (288)
T ss_pred             cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998754322 2223456788999999987666689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+..+.+..+....+.|....+........-.....+.....+.....+..++++++||++||++||.+|||++|+|
T Consensus       204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l  283 (288)
T cd07871         204 FPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL  283 (288)
T ss_pred             CCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence            99999999999999999999888776543322111112223333334445567889999999999999999999999999


Q ss_pred             cCCCc
Q 022132          250 AHPYL  254 (302)
Q Consensus       250 ~h~~~  254 (302)
                      +||||
T Consensus       284 ~hp~f  288 (288)
T cd07871         284 RHSYF  288 (288)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.3e-46  Score=327.24  Aligned_cols=283  Identities=46%  Similarity=0.832  Sum_probs=233.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCC-CCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++.... ......+|+++++++++|.+++.. +.+++..+..++.||+.||.|||+.
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~  137 (343)
T cd07878          59 RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSA  137 (343)
T ss_pred             HHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            35668999999999999999999987543 233456899999999999888764 5799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.++|+|||++......  .....++..|+|||.+.+...++.++||||+||++|+|++|.+|
T Consensus       138 ~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  215 (343)
T cd07878         138 GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL  215 (343)
T ss_pred             CeecccCChhhEEECCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCC
Confidence            9999999999999999999999999998765433  34457899999999987656688999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhh-HhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |.+.+..+.+..+.+..+.+......... .....+....+......+...+...++.+.+||.+||+.||.+|||+.|+
T Consensus       216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el  295 (343)
T cd07878         216 FPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA  295 (343)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            99998888888888888888776554442 23334444444444445555566778899999999999999999999999


Q ss_pred             hcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccCh
Q 022132          249 LAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  297 (302)
Q Consensus       249 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (302)
                      |+||||.....+...+. ..+............+++++..+.+..+|.|
T Consensus       296 l~hp~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07878         296 LAHPYFSQYHDPEDEPE-AEPYDESPENKERTIEEWKELTYEEVSSFKP  343 (343)
T ss_pred             hcCcchhccCCCccccc-cCccccchhhhhccHHHHHHHHHHHHHhcCC
Confidence            99999998876654443 3345555566788889999999999988875

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8.2e-46  Score=329.47  Aligned_cols=285  Identities=44%  Similarity=0.728  Sum_probs=227.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      +.+.+|+.+++.++||||+++++++.......+..+|+||||++++|.+.+...+.+++..++.++.||+.||+|||+.|
T Consensus        44 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~  123 (372)
T cd07853          44 KRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG  123 (372)
T ss_pred             HHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            46779999999999999999999998764334448999999999999999988888999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC--CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ++||||||+||+++.++.++|+|||++......  .......++..|+|||.+.+...++.++||||+||++++|++|++
T Consensus       124 ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~  203 (372)
T cd07853         124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI  203 (372)
T ss_pred             eeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCC
Confidence            999999999999999999999999998754322  223344678899999998776668899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccc--cccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ--SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ||.+.+....+..+.+.++.|....+..............+.....  .........++.+.+||.+||++||.+|||++
T Consensus       204 pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~  283 (372)
T cd07853         204 LFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAA  283 (372)
T ss_pred             CCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHH
Confidence            9999999999999999999988776554433333322222111111  11122345688999999999999999999999


Q ss_pred             HHhcCCCcCCccC--------------------CCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHcc
Q 022132          247 DALAHPYLGSLHD--------------------ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAF  295 (302)
Q Consensus       247 ell~h~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (302)
                      |+|+||||.....                    ...++....++..+.+....+..++++.++.++..+
T Consensus       284 e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (372)
T cd07853         284 DALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELHQFILEQ  352 (372)
T ss_pred             HHhcCHhhCCCcchhccccccccccccccccCCcccCCCCCCCCCcccccccCCHHHHHHHHHHHHHHh
Confidence            9999999987421                    112333344556666777788899999999887654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-47  Score=332.86  Aligned_cols=213  Identities=24%  Similarity=0.497  Sum_probs=186.4

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      +.-...|+.+|+..+|+|||.+++.|...     +.+|+||||++ |+|.+++... .++|.++..|+++++.||+|||.
T Consensus       314 keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~  387 (550)
T KOG0578|consen  314 KELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHA  387 (550)
T ss_pred             hhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHh
Confidence            33455899999999999999999999998     89999999997 6988888764 59999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||+|||||.+|||++.+|.+||+|||+|....+.. .....+||++|||||++.. ..|+.++||||||+++.||+.|+
T Consensus       388 ~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGE  466 (550)
T KOG0578|consen  388 RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGE  466 (550)
T ss_pred             cceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCC
Confidence            999999999999999999999999999998766553 6677899999999999954 45999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      |||-..+....+..|... |.|.                          -.....+|+.+++|+.+||+.|+.+|+||.|
T Consensus       467 PPYlnE~PlrAlyLIa~n-g~P~--------------------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~e  519 (550)
T KOG0578|consen  467 PPYLNENPLRALYLIATN-GTPK--------------------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKE  519 (550)
T ss_pred             CCccCCChHHHHHHHhhc-CCCC--------------------------cCCccccCHHHHHHHHHHhhcchhcCCCHHH
Confidence            999887777666665542 2222                          1233478999999999999999999999999


Q ss_pred             HhcCCCcCC
Q 022132          248 ALAHPYLGS  256 (302)
Q Consensus       248 ll~h~~~~~  256 (302)
                      ||.||||+.
T Consensus       520 LL~HpFl~~  528 (550)
T KOG0578|consen  520 LLEHPFLKM  528 (550)
T ss_pred             HhcChhhhh
Confidence            999999954

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-45  Score=326.47  Aligned_cols=280  Identities=40%  Similarity=0.704  Sum_probs=219.7

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++||||+++++++..... .....+|+||||++++|.+.+..  .+++..+..++.|++.||+|||+
T Consensus        64 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~  141 (359)
T cd07876          64 AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHS  141 (359)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHh
Confidence            3456789999999999999999999976532 23356899999999999888753  58899999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      +||+||||||+||+++.++.++|+|||++.............++..|+|||.+.+. .++.++||||+||++|+|++|.+
T Consensus       142 ~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~  220 (359)
T cd07876         142 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSV  220 (359)
T ss_pred             CCcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999998765444444556789999999998654 48899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC------------CCCHHHHHHHHHccC
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP------------NVHPSAIDLVEKMLT  236 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~L~  236 (302)
                      ||.+.+....+..+.+..+.|..............+....+......+.+.++            ..++.+++||.+||+
T Consensus       221 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~  300 (359)
T cd07876         221 IFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLV  300 (359)
T ss_pred             CCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhc
Confidence            99999988899999999999888766655555555544444433333332222            246789999999999


Q ss_pred             CCCCCCCCHHHHhcCCCcCCccCCCCCCCCCCCCC-cchhhcccCHHHHHHHHHHHH
Q 022132          237 FDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFS-FDFEQHALTEGQMKELIYQEA  292 (302)
Q Consensus       237 ~dP~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  292 (302)
                      +||.+|||+.|+|+||||..+..+........... ...+......+.++++|+.++
T Consensus       301 ~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (359)
T cd07876         301 IDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEV  357 (359)
T ss_pred             cCcccCCCHHHHhcCchhhhhcCcccccCCCccccccccccccccHHHHHHHHHHHh
Confidence            99999999999999999998776553322221111 122344555666777776655

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=304.68  Aligned_cols=215  Identities=28%  Similarity=0.464  Sum_probs=193.7

Q ss_pred             HHHHhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHH
Q 022132            5 TKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGL   83 (302)
Q Consensus         5 ~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l   83 (302)
                      =++.+-.+...|..||+.+.||+++++++.+.+.     +.+||||||.+ |.|..++++.+++++..++.++.||+.||
T Consensus        83 VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-----~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAl  157 (355)
T KOG0616|consen   83 VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-----SNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLAL  157 (355)
T ss_pred             HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-----CeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHH
Confidence            3456666888999999999999999999999998     99999999996 69999999999999999999999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           84 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      +|||+++|++||+||+|||+|.+|.+||+|||+|+.....  ....+||+.|+|||++.. +.++.++|.||||+++|||
T Consensus       158 eylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEM  234 (355)
T KOG0616|consen  158 EYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEM  234 (355)
T ss_pred             HHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHH
Confidence            9999999999999999999999999999999999887765  567799999999999964 4589999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      +.|.+||.+.+..+.+.+|.+.-                              ....+.+++++++||+++|+.|-.+|.
T Consensus       235 laG~pPF~~~~~~~iY~KI~~~~------------------------------v~fP~~fs~~~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  235 LAGYPPFYDDNPIQIYEKILEGK------------------------------VKFPSYFSSDAKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             HcCCCCCcCCChHHHHHHHHhCc------------------------------ccCCcccCHHHHHHHHHHHhhhhHhhh
Confidence            99999999999988888887621                              112236889999999999999999993


Q ss_pred             -----CHHHHhcCCCcCCc
Q 022132          244 -----TVEDALAHPYLGSL  257 (302)
Q Consensus       244 -----t~~ell~h~~~~~~  257 (302)
                           ..+++.+||||++.
T Consensus       285 gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  285 GNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             cCcCCCccccccCcccccc
Confidence                 57899999999965

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.6e-46  Score=335.56  Aligned_cols=287  Identities=30%  Similarity=0.545  Sum_probs=216.3

Q ss_pred             hhHHHHhcCc-hhhHHHHHHhcCCCCccccceeeCCCCC---CCCCcEEEEEecCCccHHHHHH----cCCCCCHHHHHH
Q 022132            3 SITKLMQRGH-FVRSSCFDTWIMKTSVVAIRDIIPPPQR---ESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQY   74 (302)
Q Consensus         3 ~~~~~~~~~~-~~~E~~il~~l~h~niv~l~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~   74 (302)
                      |||++..+.. ..+|+.+++.++||||+++++++.....   .....+++||||++++|.+++.    ....+++..++.
T Consensus        95 AiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~  174 (440)
T PTZ00036         95 AIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL  174 (440)
T ss_pred             EEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHH
Confidence            4555544443 3479999999999999999998754321   1123577999999999887765    346799999999


Q ss_pred             HHHHHHHHHHHHHhCCceecCCCCCCEEEecCC-CEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhH
Q 022132           75 FLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDV  153 (302)
Q Consensus        75 i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  153 (302)
                      ++.||+.||+|||+.||+||||||+||+++.++ .+||+|||+++............+++.|+|||++.+...++.++||
T Consensus       175 ~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  254 (440)
T PTZ00036        175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDL  254 (440)
T ss_pred             HHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHH
Confidence            999999999999999999999999999998665 6999999999866544444556789999999998776668999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC-CCCHHHHHHHH
Q 022132          154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVE  232 (302)
Q Consensus       154 wslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~  232 (302)
                      ||+||++|+|++|.+||.+.+..+.+..+...++.|....+..........  ..+......+...++ ..++++++||.
T Consensus       255 wSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~p~~~~~~~~~li~  332 (440)
T PTZ00036        255 WSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI--KFPDVKPKDLKKVFPKGTPDDAINFIS  332 (440)
T ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcc--cCCccCchhHHHHhccCCCHHHHHHHH
Confidence            999999999999999999999999999999999998877665443221111  112222222222222 46789999999


Q ss_pred             HccCCCCCCCCCHHHHhcCCCcCCccCCCCC-----CCCCCCCCcchhh-cccCHHHHHHHHHHH
Q 022132          233 KMLTFDPRQRITVEDALAHPYLGSLHDISDE-----PVCMSPFSFDFEQ-HALTEGQMKELIYQE  291 (302)
Q Consensus       233 ~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  291 (302)
                      +||.+||.+|||+.|+|+||||..+.+....     ......+.+...+ ..+..+..+.++...
T Consensus       333 ~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (440)
T PTZ00036        333 QFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPKC  397 (440)
T ss_pred             HHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHhhCCHHHHHHHhhHH
Confidence            9999999999999999999999987653321     1122234443332 356666666655443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=316.21  Aligned_cols=212  Identities=27%  Similarity=0.473  Sum_probs=185.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      -...|+.||+.++|||||.+++++..+     +.+|+|||||+ |+|.+++..++.+++..++.++.||+.|+++||+++
T Consensus        55 ~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~  129 (429)
T KOG0595|consen   55 LLLSEIKILKELKHPNIVRLLDCIEDD-----DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN  129 (429)
T ss_pred             HHHHHHHHHHhcCCcceeeEEEEEecC-----CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            446899999999999999999999998     89999999997 799999999999999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecC------CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           91 VLHRDLKPSNLLLNAN------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        91 i~H~dikp~Nil~~~~------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      |+||||||+|||++..      ..+||+|||+|+...+.......+|++.|||||++.. ..|+.|+|+||+|+|+|+|+
T Consensus       130 IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l  208 (429)
T KOG0595|consen  130 IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCL  208 (429)
T ss_pred             eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHH
Confidence            9999999999999865      5689999999999998888899999999999999954 45999999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|.+||...+..+....+...-...+                           ......++...+|+...|..||.+|.+
T Consensus       209 ~g~~Pf~a~t~~eL~~~~~k~~~~~~---------------------------~~~~~~s~~~~~Ll~~ll~~~~~~~~~  261 (429)
T KOG0595|consen  209 TGKPPFDAETPKELLLYIKKGNEIVP---------------------------VLPAELSNPLRELLISLLQRNPKDRIS  261 (429)
T ss_pred             hCCCCccccCHHHHHHHHhccccccC---------------------------chhhhccCchhhhhhHHHhcCccccCc
Confidence            99999998887776654332111110                           011134566779999999999999999


Q ss_pred             HHHHhcCCCcCC
Q 022132          245 VEDALAHPYLGS  256 (302)
Q Consensus       245 ~~ell~h~~~~~  256 (302)
                      ..+-+.|+++..
T Consensus       262 ~~~~~~~~~l~~  273 (429)
T KOG0595|consen  262 FEDFFDHPFLAA  273 (429)
T ss_pred             hHHhhhhhhccc
Confidence            999999999976

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-46  Score=334.20  Aligned_cols=247  Identities=33%  Similarity=0.605  Sum_probs=204.1

Q ss_pred             hhHHHHhcCchh----hHHHHHHhcC-C-----CCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHH
Q 022132            3 SITKLMQRGHFV----RSSCFDTWIM-K-----TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEE   70 (302)
Q Consensus         3 ~~~~~~~~~~~~----~E~~il~~l~-h-----~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~   70 (302)
                      |||.+..++.|.    .|+.||..++ |     -|+|+++|+|...     +|+|||+|.++.+|+++++.+  ..++..
T Consensus       215 AIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr-----~HlciVfELL~~NLYellK~n~f~Glsl~  289 (586)
T KOG0667|consen  215 AIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR-----NHLCIVFELLSTNLYELLKNNKFRGLSLP  289 (586)
T ss_pred             EEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc-----cceeeeehhhhhhHHHHHHhcCCCCCCHH
Confidence            677777777666    4899999997 5     4899999999998     999999999999999999865  468999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCC
Q 022132           71 HCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYT  148 (302)
Q Consensus        71 ~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  148 (302)
                      .++.++.||+.||.+||+.||||+||||+|||+..-  ..+||+|||.+...+....  .++-+++|+|||++++.. |+
T Consensus       290 ~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlp-Y~  366 (586)
T KOG0667|consen  290 LVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLP-YD  366 (586)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce--eeeeccccccchhhccCC-CC
Confidence            999999999999999999999999999999999654  4699999999988776644  788999999999998876 89


Q ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhh--hcccc---------------
Q 022132          149 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC--QLPRY---------------  211 (302)
Q Consensus       149 ~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---------------  211 (302)
                      .+.||||||||++||++|.|.|+|.+..++++.|++.+|.|+...+.......+-+..  ..+..               
T Consensus       367 ~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~  446 (586)
T KOG0667|consen  367 TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEV  446 (586)
T ss_pred             CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhh
Confidence            9999999999999999999999999999999999999999998877654332111111  00000               


Q ss_pred             ---------------ccccccccCC-CCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          212 ---------------QRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       212 ---------------~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                                     ...++....+ .....+.|||++||++||.+|+|+.++|+||||...
T Consensus       447 ~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  447 RKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             hhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence                           0001111111 122468999999999999999999999999999954

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.7e-45  Score=322.15  Aligned_cols=280  Identities=39%  Similarity=0.700  Sum_probs=221.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++..... .....+|+||||++++|.+.+..  .+++..+..++.|++.||+|||+.
T Consensus        61 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~  138 (355)
T cd07874          61 KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA  138 (355)
T ss_pred             HHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC
Confidence            356689999999999999999999876532 33457899999999999888764  588999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.++|+|||+++............++..|+|||.+.+. .++.++|+||+||++++|++|..|
T Consensus       139 givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p  217 (355)
T cd07874         139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL  217 (355)
T ss_pred             CcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999999876655445566789999999998654 489999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccc------------cCCCCCHHHHHHHHHccCC
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE------------KFPNVHPSAIDLVEKMLTF  237 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~li~~~L~~  237 (302)
                      |.+.+..+.+....+.++.+..+...........+....+.+....+..            .....+..+++||.+||..
T Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~  297 (355)
T cd07874         218 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI  297 (355)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcC
Confidence            9999988999999999998887776665555444444433332211111            1122456789999999999


Q ss_pred             CCCCCCCHHHHhcCCCcCCccCCCCCCCCC-CCCCcchhhcccCHHHHHHHHHHHHH
Q 022132          238 DPRQRITVEDALAHPYLGSLHDISDEPVCM-SPFSFDFEQHALTEGQMKELIYQEAL  293 (302)
Q Consensus       238 dP~~R~t~~ell~h~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (302)
                      ||.+|||++|+|+||||+.+.++....... ..+..+.++...+.+++++.++.+++
T Consensus       298 dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (355)
T cd07874         298 DPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM  354 (355)
T ss_pred             CchhcCCHHHHhcCcchhcccChhhccCCCccccccchhhhhccHHHHHHHHHHHhh
Confidence            999999999999999999876543322211 12333444556677888888887764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.8e-45  Score=320.16  Aligned_cols=283  Identities=49%  Similarity=0.898  Sum_probs=239.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++..... ..+...|+|+||++++|.+++.. +++++..+..++.|++.||+|||+.
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~  137 (343)
T cd07851          59 KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA  137 (343)
T ss_pred             HHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            346689999999999999999998876532 34456999999999999999876 5799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||+|+||+++.++.++|+|||.+......  .....++..|+|||.+.+...++.++|+||+||++++|++|.+|
T Consensus       138 gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~p  215 (343)
T cd07851         138 GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTL  215 (343)
T ss_pred             CeecCCCCHHHeEECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999998765433  33446788899999986554578999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhh-hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |.+.+....+..+.+..+.+.+..+... ......+....+......+...++..++.+.++|.+||+.||.+|||+.++
T Consensus       216 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el  295 (343)
T cd07851         216 FPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA  295 (343)
T ss_pred             CCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH
Confidence            9998888888888888888777655444 333444555555555555566666779999999999999999999999999


Q ss_pred             hcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccCh
Q 022132          249 LAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  297 (302)
Q Consensus       249 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (302)
                      ++||||..+....+++. ...++.+++...+..++|++++|.++..|.|
T Consensus       296 l~h~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07851         296 LAHPYLAEYHDPEDEPV-APPYDQSFESRDLTVDEWKELVYKEIMNFKP  343 (343)
T ss_pred             hcCCCccccCCCccccc-ccccCcchhhhhcCHHHHHHHhHHHHHhccC
Confidence            99999999988776654 6777788899999999999999999998875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=318.35  Aligned_cols=217  Identities=28%  Similarity=0.437  Sum_probs=177.3

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ...+|+.+|++++|||||++++.......   ..+++.|||+. |+|.+++.+.+ .+++..++.+.+||++||+|||++
T Consensus        60 ~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~  136 (313)
T KOG0198|consen   60 SLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK  136 (313)
T ss_pred             HHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            36899999999999999999998665521   36999999996 79999999876 899999999999999999999999


Q ss_pred             CceecCCCCCCEEEec-CCCEEEeecccccccCC----CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSE----TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ||+|+||||+|||++. ++.+||+|||.+.....    ........||+.|+|||++..+.....++||||+||++.+|+
T Consensus       137 g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~  216 (313)
T KOG0198|consen  137 GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEML  216 (313)
T ss_pred             CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEecc
Confidence            9999999999999999 69999999998876553    223446789999999999975333345999999999999999


Q ss_pred             hCCCCCCCC-ChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 DRKPLFPGR-DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      +|++||... ....   .+.......                         ..+.....+|.++++||.+|+..||.+||
T Consensus       217 Tg~~PW~~~~~~~~---~~~~ig~~~-------------------------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rp  268 (313)
T KOG0198|consen  217 TGKPPWSEFFEEAE---ALLLIGRED-------------------------SLPEIPDSLSDEAKDFLRKCFKRDPEKRP  268 (313)
T ss_pred             CCCCcchhhcchHH---HHHHHhccC-------------------------CCCCCCcccCHHHHHHHHHHhhcCcccCc
Confidence            999999763 2222   121111110                         11133346899999999999999999999


Q ss_pred             CHHHHhcCCCcCCccC
Q 022132          244 TVEDALAHPYLGSLHD  259 (302)
Q Consensus       244 t~~ell~h~~~~~~~~  259 (302)
                      ||+++|+|||......
T Consensus       269 ta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  269 TAEELLEHPFLKQNSI  284 (313)
T ss_pred             CHHHHhhChhhhcccc
Confidence            9999999999987543

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-46  Score=293.49  Aligned_cols=213  Identities=29%  Similarity=0.500  Sum_probs=187.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ...||++|-+.|+||||+++++.+...     +..|+|+|++. ++|..-+-.+.-.++..+-..++||++||.|+|.+|
T Consensus        56 ~l~rEarIC~~LqHP~IvrL~~ti~~~-----~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~  130 (355)
T KOG0033|consen   56 KLEREARICRKLQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG  130 (355)
T ss_pred             HHHHHHHHHHhcCCCcEeehhhhhccc-----ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC
Confidence            556999999999999999999999887     88999999997 588777766677899999999999999999999999


Q ss_pred             ceecCCCCCCEEEec---CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           91 VLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        91 i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |+|||+||.|+++-+   ..-+||+|||++...+....-....||+.|+|||++... .++..+|||+.|+|+|-++.|.
T Consensus       131 IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~  209 (355)
T KOG0033|consen  131 IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGY  209 (355)
T ss_pred             ceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCC
Confidence            999999999999954   355999999999888877667788999999999999654 5899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+....+..|+...-..+                          ...++++++++++|+++||..||.+|+|+.|
T Consensus       210 ~PF~~~~~~rlye~I~~g~yd~~--------------------------~~~w~~is~~Ak~LvrrML~~dP~kRIta~E  263 (355)
T KOG0033|consen  210 PPFWDEDQHRLYEQIKAGAYDYP--------------------------SPEWDTVTPEAKSLIRRMLTVNPKKRITADE  263 (355)
T ss_pred             CCCCCccHHHHHHHHhccccCCC--------------------------CcccCcCCHHHHHHHHHHhccChhhhccHHH
Confidence            99999888888887775322211                          2346689999999999999999999999999


Q ss_pred             HhcCCCcCC
Q 022132          248 ALAHPYLGS  256 (302)
Q Consensus       248 ll~h~~~~~  256 (302)
                      +|+|||+.+
T Consensus       264 AL~HpWi~~  272 (355)
T KOG0033|consen  264 ALKHPWICN  272 (355)
T ss_pred             HhCCchhcc
Confidence            999999976

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-45  Score=320.83  Aligned_cols=281  Identities=59%  Similarity=1.070  Sum_probs=242.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      +.+.+|+.+++.++||||+++++++......+++.+|++|||++++|.+++...+.+++..+..++.||+.||++||+.|
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g  123 (330)
T cd07834          44 KRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN  123 (330)
T ss_pred             hhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            46788999999999999999999998874445568999999999999999988789999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ++|+||||+||+++.++.++|+|||.+.......    ......++..|+|||.+.+...++.++|+||+|+++++|++|
T Consensus       124 i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g  203 (330)
T cd07834         124 VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR  203 (330)
T ss_pred             eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcC
Confidence            9999999999999999999999999987655432    234456788899999987664689999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhh-hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      .+||.+.+..+.+..+....+.+....+... ......+..........++....+.+++.+.++|.+||++||.+|||+
T Consensus       204 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  283 (330)
T cd07834         204 KPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA  283 (330)
T ss_pred             CCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCH
Confidence            9999999999999999998888887766532 333344444444445555666677889999999999999999999999


Q ss_pred             HHHhcCCCcCCccCCCCCCCCCCCCCc-chhhcccCHHHHHHHHHHH
Q 022132          246 EDALAHPYLGSLHDISDEPVCMSPFSF-DFEQHALTEGQMKELIYQE  291 (302)
Q Consensus       246 ~ell~h~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  291 (302)
                      ++++.||||+++..+.++++...++++ .++...+++++.+++|+.|
T Consensus       284 ~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (330)
T cd07834         284 DEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTEEELKELIYEE  330 (330)
T ss_pred             HHHHhCccHHhhcccccCCCCCCcccccccchhhcCHHHHhHHhhcC
Confidence            999999999999999999988888887 5788899999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.8e-45  Score=320.01  Aligned_cols=279  Identities=54%  Similarity=0.986  Sum_probs=237.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ..+.+|+.+++.++||||+++++++.... .....+|+||||++++|.+++...+.+++..+..++.||+.||.|||+.|
T Consensus        49 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  127 (334)
T cd07855          49 KRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN  127 (334)
T ss_pred             HHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            35668999999999999999999987643 23368999999999999999988788999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-----CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||||||+||+++.++.++|+|||.+......     .......++..|+|||.+.+...++.++|+||+||++++|++
T Consensus       128 ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~  207 (334)
T cd07855         128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLG  207 (334)
T ss_pred             eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHc
Confidence            999999999999999999999999998654322     112334678899999998665567899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhH-hHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE-NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      |.+||.+.+....+..+....+.|+......... ...+.....+......+....+..++++.++|++||+.||.+|||
T Consensus       208 g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt  287 (334)
T cd07855         208 RRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT  287 (334)
T ss_pred             CCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC
Confidence            9999999998889999999999888776554432 233333344444445556666788999999999999999999999


Q ss_pred             HHHHhcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHH
Q 022132          245 VEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQ  290 (302)
Q Consensus       245 ~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (302)
                      +++++.||||.+...+..++.+..++.++++....+.+.+.+.|..
T Consensus       288 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (334)
T cd07855         288 VEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAIELSREQLKEAIVK  333 (334)
T ss_pred             HHHHHhChhhhhccCCcccccCCCCCCCChhhhhcChhhHHHHhhc
Confidence            9999999999999999999999999999999999999999988753

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-44  Score=316.39  Aligned_cols=281  Identities=58%  Similarity=1.018  Sum_probs=229.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV   91 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i   91 (302)
                      .+.+|+.+++.++||||+++++++......+...+|+|+||++++|.+.+.. +.+++..++.++.|++.||++||+.||
T Consensus        49 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~i  127 (336)
T cd07849          49 RTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANV  127 (336)
T ss_pred             HHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4668999999999999999999987664444467999999999999988865 579999999999999999999999999


Q ss_pred             eecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           92 LHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        92 ~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||||||+||+++.++.++|+|||++.......    ......++..|+|||.+.+...++.++|+||+||++++|++|+
T Consensus       128 vH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~  207 (336)
T cd07849         128 LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR  207 (336)
T ss_pred             eccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999987543321    1223467888999998766556789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhH-hHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNE-NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      +||.+.+.......+...++.|..+.+..... ....+....+.....++....+..++.+.++|.+||+.||.+|||+.
T Consensus       208 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~  287 (336)
T cd07849         208 PLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE  287 (336)
T ss_pred             CCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHH
Confidence            99999888888888888888887766544322 22223333333333444445567789999999999999999999999


Q ss_pred             HHhcCCCcCCccCCCCCCCCCCCCCcchh-hcccCHHHHHHHHHHHHH
Q 022132          247 DALAHPYLGSLHDISDEPVCMSPFSFDFE-QHALTEGQMKELIYQEAL  293 (302)
Q Consensus       247 ell~h~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  293 (302)
                      ++++||||......++++....++.++++ ...+..+..|++|+.+++
T Consensus       288 e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (336)
T cd07849         288 EALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIM  335 (336)
T ss_pred             HHhcCccccccCCCCCcccCCCCCChhhccccccCHHHHHHHHHHHhc
Confidence            99999999999988888877655555443 356779999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=299.23  Aligned_cols=237  Identities=27%  Similarity=0.444  Sum_probs=196.2

Q ss_pred             chhHHHHhcCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC--CCHHHHHHHHH
Q 022132            2 HSITKLMQRGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA--LSEEHCQYFLY   77 (302)
Q Consensus         2 ~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--l~~~~~~~i~~   77 (302)
                      .|+|.+.......||++..=.. .|||||+++|+|...- .+-..+.+|||.|+ |.|+..+..++.  +++.++..|++
T Consensus        90 fALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~  168 (400)
T KOG0604|consen   90 FALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMK  168 (400)
T ss_pred             hHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHH
Confidence            4899999999999999976666 7999999999998752 23378999999997 699999987754  99999999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCCEEEec---CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHH
Q 022132           78 QILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW  154 (302)
Q Consensus        78 qll~~l~~LH~~~i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  154 (302)
                      ||..|+.|||+.+|.||||||+|+|.+.   +..+||+|||+|+...........+.|++|.|||++ +...|+...|+|
T Consensus       169 qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmw  247 (400)
T KOG0604|consen  169 QIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMW  247 (400)
T ss_pred             HHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHh-CchhcCCCCCcc
Confidence            9999999999999999999999999965   466999999999988766667788999999999998 556699999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          155 SVGCIFMELMDRKPLFPGRDHV----HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       155 slG~i~~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      |+|||+|-|++|.|||......    .....|...--..+                          ...|..+|.+.+|+
T Consensus       248 SlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP--------------------------~pEWs~VSe~aKdl  301 (400)
T KOG0604|consen  248 SLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP--------------------------EPEWSCVSEAAKDL  301 (400)
T ss_pred             chhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC--------------------------ChhHhHHHHHHHHH
Confidence            9999999999999999755432    12222222111111                          12234678899999


Q ss_pred             HHHccCCCCCCCCCHHHHhcCCCcCCccCCCCCCCC
Q 022132          231 VEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC  266 (302)
Q Consensus       231 i~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~  266 (302)
                      |+++|..+|.+|.|++++++|||+++.....+-+.+
T Consensus       302 IR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~  337 (400)
T KOG0604|consen  302 IRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS  337 (400)
T ss_pred             HHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence            999999999999999999999999997766555443

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.7e-45  Score=314.75  Aligned_cols=242  Identities=38%  Similarity=0.724  Sum_probs=204.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +..|+||||++++|.+.+... ..+++..+..++.||+.||+|||+.|
T Consensus        50 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~  124 (309)
T cd07872          50 TAIREVSLLKDLKHANIVTLHDIVHTD-----KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK  124 (309)
T ss_pred             hHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            567899999999999999999999887     889999999999999988754 45899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.++|+|||++...... .......++..|+|||.+.+...++.++||||+||++++|++|.+|
T Consensus       125 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~p  204 (309)
T cd07872         125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPL  204 (309)
T ss_pred             eecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998754322 2223446788999999987666688999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+..+.+..+....+.|....+..............+......+....+.+++++++||.+||+.||.+|||++|++
T Consensus       205 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l  284 (309)
T cd07872         205 FPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM  284 (309)
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence            99999999999999999999888776554332222223333333344455567899999999999999999999999999


Q ss_pred             cCCCcCCcc
Q 022132          250 AHPYLGSLH  258 (302)
Q Consensus       250 ~h~~~~~~~  258 (302)
                      +||||+.+.
T Consensus       285 ~h~~~~~~~  293 (309)
T cd07872         285 KHAYFRSLG  293 (309)
T ss_pred             cChhhhhcc
Confidence            999999865

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.4e-45  Score=300.39  Aligned_cols=252  Identities=37%  Similarity=0.648  Sum_probs=208.2

Q ss_pred             chhHHHHhcC-------chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-----CCCCH
Q 022132            2 HSITKLMQRG-------HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-----QALSE   69 (302)
Q Consensus         2 ~~~~~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-----~~l~~   69 (302)
                      +||||+...+       ...||+-+++.++|||++++..+|..-.    ..+++++||.+.+|..+++-+     +.++.
T Consensus        56 yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d----~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~  131 (438)
T KOG0666|consen   56 YAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD----KKVWLLFDYAEHDLWHIIKFHRASKAKQLPR  131 (438)
T ss_pred             hHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC----ceEEEEehhhhhhHHHHHHHhccchhccCCH
Confidence            6889988873       5679999999999999999999998731    899999999999999999632     46889


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC----CCEEEeecccccccCCC----CcccccccccccCchhhh
Q 022132           70 EHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN----CDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELL  141 (302)
Q Consensus        70 ~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~----~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~  141 (302)
                      ..++.|+.||+.|+.|||++-|+|||+||.||++..+    |.+||+|||+++.....    ......+-|.+|+|||.+
T Consensus       132 ~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELL  211 (438)
T KOG0666|consen  132 SMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELL  211 (438)
T ss_pred             HHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHh
Confidence            9999999999999999999999999999999999888    99999999999875543    223456779999999999


Q ss_pred             hCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHHHhCCCChHHHhhhhHhHH--HHhhhcc-
Q 022132          142 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR---------DHVHQLRLLIELIGTPSEAELGFLNENAK--KYICQLP-  209 (302)
Q Consensus       142 ~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-  209 (302)
                      .+...|+.+.|+|++|||+.||++-.|.|.+.         -..+++..|++.+|.|+...|..+.....  .....+. 
T Consensus       212 LGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~  291 (438)
T KOG0666|consen  212 LGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRR  291 (438)
T ss_pred             cccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHH
Confidence            99999999999999999999999999999764         24678999999999999998887643211  1111111 


Q ss_pred             ----ccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          210 ----RYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       210 ----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                          ......+-.....-++...+|+.+||.+||.+|.|++++|+|+||..-
T Consensus       292 ~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d  343 (438)
T KOG0666|consen  292 HYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED  343 (438)
T ss_pred             hhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence                111112223333445668999999999999999999999999999874

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3e-44  Score=317.25  Aligned_cols=278  Identities=41%  Similarity=0.758  Sum_probs=225.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++..... .+..++|+||||++++|.+.+...  +++..+..++.|++.||+|||++|
T Consensus        61 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g  138 (353)
T cd07850          61 RAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG  138 (353)
T ss_pred             HHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC
Confidence            56689999999999999999999876532 344678999999999999988754  899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      ++||||||+||+++.++.++|+|||.+.............++..|+|||.+.+. .++.++|+||+||++++|++|..||
T Consensus       139 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf  217 (353)
T cd07850         139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLF  217 (353)
T ss_pred             eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCC
Confidence            999999999999999999999999999876554444455678899999998654 4899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC-------------CCCHHHHHHHHHccCC
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-------------NVHPSAIDLVEKMLTF  237 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~li~~~L~~  237 (302)
                      .+.+....+..+.+.++.|.......+......+....+.....++...++             ..++.++++|.+||+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  297 (353)
T cd07850         218 PGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI  297 (353)
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCC
Confidence            999988889999999999888766665555555544444333322222221             2456789999999999


Q ss_pred             CCCCCCCHHHHhcCCCcCCccCCCCCCC-CCCCCCcchhhcccCHHHHHHHHHHHH
Q 022132          238 DPRQRITVEDALAHPYLGSLHDISDEPV-CMSPFSFDFEQHALTEGQMKELIYQEA  292 (302)
Q Consensus       238 dP~~R~t~~ell~h~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (302)
                      ||++|||+.|+|.||||..|....+... ....+....+....+.++|+..+|.++
T Consensus       298 dP~~R~t~~eiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (353)
T cd07850         298 DPEKRISVDDALQHPYINVWYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV  353 (353)
T ss_pred             ChhhCcCHHHHhcChhHhhccCCccCCCCCCCccccccccccccHHHHHHHHHhhC
Confidence            9999999999999999998876654333 233444455677888899999888763

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.6e-45  Score=314.23  Aligned_cols=242  Identities=34%  Similarity=0.628  Sum_probs=189.9

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++.+.     ...|+||||++++|.+.+... +.+++..+..++.|++.||+|||+.|
T Consensus        49 ~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  123 (303)
T cd07869          49 TAIREASLLKGLKHANIVLLHDIIHTK-----ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY  123 (303)
T ss_pred             hHHHHHHHHhhCCCCCcCeEEEEEecC-----CeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            467899999999999999999999887     889999999999999888754 57899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.++|+|||++...... .......++..|+|||++.+...++.++|+||+||++++|++|.+|
T Consensus       124 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  203 (303)
T cd07869         124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA  203 (303)
T ss_pred             eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998654322 2233456789999999987666688999999999999999999999


Q ss_pred             CCCCCh-HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC--CCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          170 FPGRDH-VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       170 f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      |.+..+ ...+..+....+.|....+.....................+...+.  ..++.+.+|+.+||++||.+|||++
T Consensus       204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~  283 (303)
T cd07869         204 FPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ  283 (303)
T ss_pred             CCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHH
Confidence            987644 4566777777777765544332211000000000111111111111  3457899999999999999999999


Q ss_pred             HHhcCCCcCCcc
Q 022132          247 DALAHPYLGSLH  258 (302)
Q Consensus       247 ell~h~~~~~~~  258 (302)
                      |+|+||||+...
T Consensus       284 ~~l~h~~f~~~~  295 (303)
T cd07869         284 AALSHEYFSDLP  295 (303)
T ss_pred             HHhcCcccccCC
Confidence            999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-46  Score=301.22  Aligned_cols=210  Identities=28%  Similarity=0.468  Sum_probs=172.5

Q ss_pred             cCchhhHHHHHHhcCCCCccccce-eeCCCCCCCCCcEEEEEecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRD-IIPPPQRESFNDVYIAYELMD-TDLHQIIR----SNQALSEEHCQYFLYQILRGL   83 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~-~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qll~~l   83 (302)
                      +.....|+.+|++|+|||||++++ .|....    .-++||||||+ |+|.+.++    .++.+++..+++++.|++.||
T Consensus        62 rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~----evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL  137 (375)
T KOG0591|consen   62 RQDCVKEISLLKQLNHPNIVQYYAHSFIEDN----EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRAL  137 (375)
T ss_pred             HHHHHHHHHHHHhcCCchHHHHHHHhhhccc----hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHH
Confidence            345678999999999999999999 444431    44999999997 89999986    356899999999999999999


Q ss_pred             HHHHh--CC--ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHH
Q 022132           84 KYIHS--AN--VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC  158 (302)
Q Consensus        84 ~~LH~--~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  158 (302)
                      ..+|+  ..  |+||||||.||+++.+|.+||+|||+++..+.. ....+.+||++||+||.+.+. .|+.++||||+||
T Consensus       138 ~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGC  216 (375)
T KOG0591|consen  138 YHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGC  216 (375)
T ss_pred             HHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHH
Confidence            99999  34  999999999999999999999999999976654 456778999999999999655 4999999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCC
Q 022132          159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       159 i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  238 (302)
                      ++|||..-++||.|++-.+...+|.. ...|+.+                         .  ..+|.++..+|..|+..|
T Consensus       217 llyEMcaL~~PF~g~n~~~L~~KI~q-gd~~~~p-------------------------~--~~YS~~l~~li~~ci~vd  268 (375)
T KOG0591|consen  217 LLYEMCALQSPFYGDNLLSLCKKIEQ-GDYPPLP-------------------------D--EHYSTDLRELINMCIAVD  268 (375)
T ss_pred             HHHHHHhcCCCcccccHHHHHHHHHc-CCCCCCc-------------------------H--HHhhhHHHHHHHHHccCC
Confidence            99999999999999855444444432 2222110                         0  156788999999999999


Q ss_pred             CCCCCCHHHHhcCCCcCCc
Q 022132          239 PRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       239 P~~R~t~~ell~h~~~~~~  257 (302)
                      |.+||+.     +|++...
T Consensus       269 ~~~RP~t-----~~~v~di  282 (375)
T KOG0591|consen  269 PEQRPDT-----VPYVQDI  282 (375)
T ss_pred             cccCCCc-----chHHHHH
Confidence            9999986     5555444

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-45  Score=309.95  Aligned_cols=232  Identities=22%  Similarity=0.353  Sum_probs=188.3

Q ss_pred             hHHHHhc-CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHH
Q 022132            4 ITKLMQR-GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQI   79 (302)
Q Consensus         4 ~~~~~~~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~ql   79 (302)
                      |.+...+ +.+.+|+..++.++||||++++..|...     ..+|+||.||. |++.+++...  ..++|..+..|++++
T Consensus        61 LEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-----~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~  135 (516)
T KOG0582|consen   61 LEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-----SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREV  135 (516)
T ss_pred             hhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-----ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHH
Confidence            4555556 5777999999999999999999999998     89999999997 7999999753  459999999999999


Q ss_pred             HHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC----Cc-ccccccccccCchhh-hhCCCCCCCchhH
Q 022132           80 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET----DF-MTEYVVTRWYRAPEL-LLNSSDYTAAIDV  153 (302)
Q Consensus        80 l~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~----~~-~~~~~~~~~y~aPE~-~~~~~~~~~~~Di  153 (302)
                      ++||.|||.+|.+|||||+.|||++.+|.++|+|||.+....+.    .. +....++++|+|||+ ......|+.|+||
T Consensus       136 LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDI  215 (516)
T KOG0582|consen  136 LKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADI  215 (516)
T ss_pred             HHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhh
Confidence            99999999999999999999999999999999999987543221    11 156689999999999 4445569999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHH
Q 022132          154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  233 (302)
Q Consensus       154 wslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  233 (302)
                      ||||++..||.+|..||......+.+-.  +.-+.|+..........                  .....+..++.+|..
T Consensus       216 wSfGITA~ELA~G~aPf~k~pPmkvLl~--tLqn~pp~~~t~~~~~d------------------~~k~~~ksf~e~i~~  275 (516)
T KOG0582|consen  216 WSFGITACELAHGHAPFSKYPPMKVLLL--TLQNDPPTLLTSGLDKD------------------EDKKFSKSFREMIAL  275 (516)
T ss_pred             hhhhHHHHHHhcCCCCcccCChHHHHHH--HhcCCCCCcccccCChH------------------HhhhhcHHHHHHHHH
Confidence            9999999999999999988877665432  22344432221111111                  111456689999999


Q ss_pred             ccCCCCCCCCCHHHHhcCCCcCCccCC
Q 022132          234 MLTFDPRQRITVEDALAHPYLGSLHDI  260 (302)
Q Consensus       234 ~L~~dP~~R~t~~ell~h~~~~~~~~~  260 (302)
                      ||++||.+|||++++|+|+||+.....
T Consensus       276 CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  276 CLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             HhhcCcccCCCHHHHhccHHHhhccch
Confidence            999999999999999999999976543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.5e-45  Score=320.90  Aligned_cols=215  Identities=30%  Similarity=0.524  Sum_probs=190.4

Q ss_pred             hhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 022132           13 FVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVL   92 (302)
Q Consensus        13 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~   92 (302)
                      ..+|++|++.++||||+.+++.|+.+     .++++|+|||.|+|++++...+.++++.++.+..+++.||.|||+++|.
T Consensus        48 l~~ev~i~r~lkHpniv~m~esfEt~-----~~~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~ril  122 (808)
T KOG0597|consen   48 LRQEVRILRSLKHPNIVEMLESFETS-----AHLWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRIL  122 (808)
T ss_pred             HHHHHHHHHhcCCcchhhHHHhhccc-----ceEEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcc
Confidence            67899999999999999999999998     9999999999999999999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022132           93 HRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  171 (302)
Q Consensus        93 H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~  171 (302)
                      |||+||.||++...|.+|+||||+++..+... ..+...||+.|||||++. ...|+..+|.||+|||+||+..|+|||.
T Consensus       123 hrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~  201 (808)
T KOG0597|consen  123 HRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFY  201 (808)
T ss_pred             cccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCch
Confidence            99999999999999999999999999887653 456678999999999986 5569999999999999999999999997


Q ss_pred             CCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          172 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      ..........|.+-.-.|                              .+.+++.++.|+..+|.+||.+|.|..+++.|
T Consensus       202 a~si~~Lv~~I~~d~v~~------------------------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  202 ARSITQLVKSILKDPVKP------------------------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             HHHHHHHHHHHhcCCCCC------------------------------cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            776665555554321111                              12678899999999999999999999999999


Q ss_pred             CCcCCccCCCCC
Q 022132          252 PYLGSLHDISDE  263 (302)
Q Consensus       252 ~~~~~~~~~~~~  263 (302)
                      ||.++-....+.
T Consensus       252 pF~k~~~~~~~~  263 (808)
T KOG0597|consen  252 PFWKGKINIAEL  263 (808)
T ss_pred             hHHhhhhhhhcc
Confidence            999876544433

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.6e-44  Score=308.31  Aligned_cols=239  Identities=35%  Similarity=0.627  Sum_probs=195.8

Q ss_pred             chhhHHHHHHhc---CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWI---MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~il~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+|+.+++.+   +||||+++++++..........+++||||++++|.+++...  ..+++..+..++.|++.||.||
T Consensus        47 ~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l  126 (290)
T cd07862          47 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL  126 (290)
T ss_pred             HHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            456788887776   69999999999865433333679999999999999998753  4589999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |+.||+||||||+||+++.++.++|+|||.+.............++..|+|||.+.+. .++.++||||+||++|+|++|
T Consensus       127 H~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g  205 (290)
T cd07862         127 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRR  205 (290)
T ss_pred             HHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcC
Confidence            9999999999999999999999999999999766544444556789999999998654 478999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+..+.+..+.+..+.|....+........   .........++....+.+++.+++++.+||+.||++|||+.
T Consensus       206 ~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~  282 (290)
T cd07862         206 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY  282 (290)
T ss_pred             CCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccc---hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHH
Confidence            999999999999999998888777665433211111   11112233344455567889999999999999999999999


Q ss_pred             HHhcCCCc
Q 022132          247 DALAHPYL  254 (302)
Q Consensus       247 ell~h~~~  254 (302)
                      |+|+||||
T Consensus       283 ~~l~hp~f  290 (290)
T cd07862         283 SALSHPYF  290 (290)
T ss_pred             HHhcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=276.75  Aligned_cols=239  Identities=39%  Similarity=0.728  Sum_probs=210.9

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ...||+.+|+.++|.|||+++++....     +.+.+|+|||+.+|..+..+ ++.++.+.++.++.|++.||.++|+++
T Consensus        47 salreicllkelkhknivrl~dvlhsd-----kkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn  121 (292)
T KOG0662|consen   47 SALREICLLKELKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN  121 (292)
T ss_pred             HHHHHHHHHHHhhhcceeehhhhhccC-----ceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh
Confidence            467999999999999999999999988     89999999999999999875 688999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKP  168 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g~~  168 (302)
                      +.|||+||.|++++.+|.+|+.|||+++..+-.. ..+..+-|.+|++|.++++.+.|+...|+||.|||+.|+.. |.|
T Consensus       122 vlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp  201 (292)
T KOG0662|consen  122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_pred             hhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence            9999999999999999999999999999877553 45666789999999999999999999999999999999985 899


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccc-cccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ-RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      .|+|.+..+++..|+..+|.|++..|..+.... .| ...|-+. ..+|....|+++...+|+++++|.-+|.+|+++++
T Consensus       202 lfpg~dvddqlkrif~~lg~p~ed~wps~t~lp-dy-k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaea  279 (292)
T KOG0662|consen  202 LFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP-DY-KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEA  279 (292)
T ss_pred             CCCCCcHHHHHHHHHHHhCCCccccCCccccCC-CC-cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHH
Confidence            999999999999999999999998876543210 00 1112222 23577778889999999999999999999999999


Q ss_pred             HhcCCCcCCc
Q 022132          248 ALAHPYLGSL  257 (302)
Q Consensus       248 ll~h~~~~~~  257 (302)
                      +++||||...
T Consensus       280 alqhpyf~d~  289 (292)
T KOG0662|consen  280 ALQHPYFSDF  289 (292)
T ss_pred             HhcCcccccc
Confidence            9999999864

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.8e-43  Score=309.82  Aligned_cols=279  Identities=52%  Similarity=0.917  Sum_probs=229.9

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++++ +||||+++++...... .+...+|++++|++++|.+.+.....+++..++.++.||+.||+|||++|
T Consensus        47 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g  125 (332)
T cd07857          47 RALRELKLLRHFRGHKNITCLYDMDIVFP-GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN  125 (332)
T ss_pred             HHHHHHHHHHHhcCCCChheeeeeeeecc-ccCCcEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            567899999999 6999999998754321 22367899999999999999988888999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC-----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||||||+||+++.++.++|+|||.+.......     ......++..|+|||.+.+...++.++|+||+||++++|++
T Consensus       126 ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~  205 (332)
T cd07857         126 VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG  205 (332)
T ss_pred             cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999987543221     12334678899999988665567899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhH-hHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE-NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      |.+||.+.+....+..+....+.|....+..+.. ................+....+..+..+.+++.+||+.||.+|||
T Consensus       206 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t  285 (332)
T cd07857         206 RKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS  285 (332)
T ss_pred             CCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC
Confidence            9999999998899999999999888766544422 222222333333334445555677899999999999999999999


Q ss_pred             HHHHhcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHH
Q 022132          245 VEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEA  292 (302)
Q Consensus       245 ~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (302)
                      +++++.|||++.++++...+.|..++.++++. +-+.++++.+|..++
T Consensus       286 ~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  332 (332)
T cd07857         286 VEEALEHPYLAIWHDPDDEPVCQKPFDFSFES-EDSMEELRDMIIEEV  332 (332)
T ss_pred             HHHHhcChhhhhhcCccccccccccccCCccc-cccHHHHHHHHhhcC
Confidence            99999999999999998999999998888765 557788888887653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-44  Score=313.53  Aligned_cols=211  Identities=26%  Similarity=0.475  Sum_probs=184.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ++...|-.+|..-.+|.|||+|..|.+.     ..+|+||||++ |++.++|.+.+.|+++.++.++.+++.|+..||+.
T Consensus       186 ~hV~aERdiL~~~ds~~vVKLyYsFQD~-----~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~  260 (550)
T KOG0605|consen  186 EHVRAERDILAEVDSPWVVKLYYSFQDK-----EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL  260 (550)
T ss_pred             HHHHHHHHHhhhcCCCcEEEEEEEecCC-----CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc
Confidence            4677899999999999999999999998     99999999996 69999999999999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC----------------------C--C---------------------
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE----------------------T--D---------------------  124 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~----------------------~--~---------------------  124 (302)
                      |++||||||+|+|||..|.+||+|||+|.....                      .  .                     
T Consensus       261 gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~n  340 (550)
T KOG0605|consen  261 GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRN  340 (550)
T ss_pred             CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhh
Confidence            999999999999999999999999999842110                      0  0                     


Q ss_pred             ---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh---CCCChHHHhhhh
Q 022132          125 ---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI---GTPSEAELGFLN  198 (302)
Q Consensus       125 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  198 (302)
                         ...+.+||+.|+|||++.+.+ |+..+|.||||||+||||.|.|||.+.+..+.++.|+.--   ..|..       
T Consensus       341 rr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~-------  412 (550)
T KOG0605|consen  341 RRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE-------  412 (550)
T ss_pred             hhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc-------
Confidence               002347899999999998766 8999999999999999999999999999999999887521   11111       


Q ss_pred             HhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC---HHHHhcCCCcCCc
Q 022132          199 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSL  257 (302)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ell~h~~~~~~  257 (302)
                                            ...+++++|||.+||. ||.+|..   ++|+-+||||+.+
T Consensus       413 ----------------------~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  413 ----------------------VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             ----------------------CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence                                  1467899999999999 9999984   8999999999976

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.2e-45  Score=305.48  Aligned_cols=209  Identities=27%  Similarity=0.479  Sum_probs=192.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ++.||+.|+..|+||||+++|++|+.+     +.+.|||||.. |.|++++..++.|++.+.+.+++||++|+.|+|+++
T Consensus        99 hIRREIeIMSsLNHPhII~IyEVFENk-----dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr  173 (668)
T KOG0611|consen   99 HIRREIEIMSSLNHPHIIQIYEVFENK-----DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR  173 (668)
T ss_pred             HHHHHHHHHhhcCCCceeehhhhhcCC-----ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc
Confidence            677999999999999999999999998     89999999996 799999999999999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      ++|||+|.+|||+|.++++||.|||++...........++|++-|.+||++.+...-++.+|.||||+++|.+..|..||
T Consensus       174 VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF  253 (668)
T KOG0611|consen  174 VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF  253 (668)
T ss_pred             ceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc
Confidence            99999999999999999999999999999888889999999999999999977776689999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      +|.+....+..|....-.-                               |.-+.++.-||+.||-.||.+|.|++|+-+
T Consensus       254 DG~Dhk~lvrQIs~GaYrE-------------------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  254 DGRDHKRLVRQISRGAYRE-------------------------------PETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             CCchHHHHHHHhhcccccC-------------------------------CCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence            9999888777776422111                               234567889999999999999999999999


Q ss_pred             CCCcCC
Q 022132          251 HPYLGS  256 (302)
Q Consensus       251 h~~~~~  256 (302)
                      |=|++=
T Consensus       303 HWWvNw  308 (668)
T KOG0611|consen  303 HWWVNW  308 (668)
T ss_pred             hheeec
Confidence            999873

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-45  Score=311.55  Aligned_cols=215  Identities=27%  Similarity=0.456  Sum_probs=181.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ....+||.||++|.|||||+|+++..++..   +++|||+|||. |.+.. ....++ +++.+++.++++++.||+|||.
T Consensus       153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s---~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~  228 (576)
T KOG0585|consen  153 EKVRREIAILKKLHHPNVVKLIEVLDDPES---DKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHY  228 (576)
T ss_pred             HHHHHHHHHHHhcCCcCeeEEEEeecCccc---CceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHh
Confidence            367899999999999999999999988744   88999999997 44433 333345 9999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeeccccccc------CCCCcccccccccccCchhhhhCC---CCCCCchhHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVT------SETDFMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCI  159 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~i  159 (302)
                      +||+||||||+|+|++.+|++||+|||.+...      +........+||+.|+|||.+.+.   ...+.+.||||+||+
T Consensus       229 QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVT  308 (576)
T KOG0585|consen  229 QGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVT  308 (576)
T ss_pred             cCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhh
Confidence            99999999999999999999999999998754      233445568999999999998663   234789999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHh-CCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCC
Q 022132          160 FMELMDRKPLFPGRDHVHQLRLLIELI-GTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       160 ~~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  238 (302)
                      +|.|+.|+.||-+....+...+|++.. ..|.                             .+.+..+++|||.+||++|
T Consensus       309 LYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~-----------------------------~pe~~e~~kDli~~lL~Kd  359 (576)
T KOG0585|consen  309 LYCLLFGQLPFFDDFELELFDKIVNDPLEFPE-----------------------------NPEINEDLKDLIKRLLEKD  359 (576)
T ss_pred             HHHhhhccCCcccchHHHHHHHHhcCcccCCC-----------------------------cccccHHHHHHHHHHhhcC
Confidence            999999999999888888888777532 1111                             1246788999999999999


Q ss_pred             CCCCCCHHHHhcCCCcCCcc
Q 022132          239 PRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       239 P~~R~t~~ell~h~~~~~~~  258 (302)
                      |.+|+|+.++..|||.....
T Consensus       360 P~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  360 PEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             hhheeehhhheecceeccCC
Confidence            99999999999999998753

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.1e-44  Score=317.34  Aligned_cols=252  Identities=22%  Similarity=0.286  Sum_probs=192.3

Q ss_pred             hhHHHHhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHH
Q 022132            3 SITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG   82 (302)
Q Consensus         3 ~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~   82 (302)
                      |||+. .+..+.+|+.++++++||||+++++++...     ...++|+|+++++|..++...+.+++..+..++.||+.|
T Consensus       121 aiK~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~a  194 (391)
T PHA03212        121 VIKAG-QRGGTATEAHILRAINHPSIIQLKGTFTYN-----KFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRA  194 (391)
T ss_pred             EEech-hhhhhHHHHHHHHhCCCCCCCCEeEEEEEC-----CeeEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Confidence            44443 345678999999999999999999999887     789999999999999999888889999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC--CcccccccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      |+|||++||+||||||+||+++.++.++|+|||++......  .......||+.|+|||++.+. .++.++||||+||++
T Consensus       195 L~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil  273 (391)
T PHA03212        195 IQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVL  273 (391)
T ss_pred             HHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHH
Confidence            99999999999999999999999999999999998643221  223345789999999998654 589999999999999


Q ss_pred             HHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCChHHHhhhhHhHHHHh----hhccc-cccccccccCCCCCHHHH
Q 022132          161 MELMDRKPLFPGR-------DHVHQLRLLIELIGTPSEAELGFLNENAKKYI----CQLPR-YQRQSFTEKFPNVHPSAI  228 (302)
Q Consensus       161 ~~ll~g~~pf~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~~  228 (302)
                      |+|++|..||.+.       +....+..+....+.++...............    ..... ....+.......++.++.
T Consensus       274 ~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  353 (391)
T PHA03212        274 FEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLE  353 (391)
T ss_pred             HHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHH
Confidence            9999999776433       23456777777777654332211111111100    00000 000011111224567899


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcCCCcCCccCCC
Q 022132          229 DLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  261 (302)
Q Consensus       229 ~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~  261 (302)
                      +||.+||++||.+|||++|+|+||||+.+..+.
T Consensus       354 ~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~  386 (391)
T PHA03212        354 YLICKMLAFDAHHRPSAEALLDFAAFQDIPDPY  386 (391)
T ss_pred             HHHHHHhcCChhhCCCHHHHhcChhhccCCCCC
Confidence            999999999999999999999999998865443

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-43  Score=307.42  Aligned_cols=282  Identities=43%  Similarity=0.821  Sum_probs=232.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++..... .....+++||||++++|.+++.. ..+++..+..++.|++.||+|||+.|
T Consensus        60 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g  138 (343)
T cd07880          60 RAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG  138 (343)
T ss_pred             HHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            46789999999999999999999976532 23346799999999899888764 57999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      |+||||+|+||+++.++.++|+|||.+......  .....++..|+|||.+.+...++.++|+||+||+++++++|.+||
T Consensus       139 i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  216 (343)
T cd07880         139 IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF  216 (343)
T ss_pred             eecCCCCHHHEEEcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999998765432  233456888999999865455789999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhh-hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      .+.+.......+....+.+.......+ ......+....+......+....+..++.+.++|.+||+.||.+|||+.+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         217 KGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence            988887777777776666655443333 2223444455555544445555667889999999999999999999999999


Q ss_pred             cCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccCh
Q 022132          250 AHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  297 (302)
Q Consensus       250 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (302)
                      .||||+.+.....++ ...++..+.+..+.+-++|+.+.+.|+++|+|
T Consensus       297 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07880         297 AHPYFEEFHDPEDET-EAPPYDDSFDEVDQSLEEWKRLTFTEILSFQP  343 (343)
T ss_pred             cCccHhhhcCccccc-CCCCccccHHhhccchHHHHHHHHHHHHhcCC
Confidence            999999987766554 34567778899999999999999999999986

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.6e-43  Score=306.01  Aligned_cols=242  Identities=37%  Similarity=0.719  Sum_probs=199.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+||||++++|.+++.. ...+++..+..++.|++.||+|||+.|
T Consensus        50 ~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~  124 (301)
T cd07873          50 TAIREVSLLKDLKHANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK  124 (301)
T ss_pred             HHHHHHHHHHhcCCCCcceEEEEEecC-----CeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            466899999999999999999999887     88999999999999998875 356899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ++|+||||+||+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++++|++|.+|
T Consensus       125 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~  204 (301)
T cd07873         125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPL  204 (301)
T ss_pred             eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998754322 1223345688899999987666678999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+..+....+....+.+....+..............+...........+.+++.+.+||.+||+.||.+|||++|+|
T Consensus       205 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil  284 (301)
T cd07873         205 FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM  284 (301)
T ss_pred             CCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence            99998888888888888888776655432221111112222222222334457888999999999999999999999999


Q ss_pred             cCCCcCCcc
Q 022132          250 AHPYLGSLH  258 (302)
Q Consensus       250 ~h~~~~~~~  258 (302)
                      +||||..+.
T Consensus       285 ~h~~f~~~~  293 (301)
T cd07873         285 KHPYFHCLG  293 (301)
T ss_pred             cCccccccc
Confidence            999998765

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-42  Score=306.30  Aligned_cols=283  Identities=46%  Similarity=0.853  Sum_probs=230.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++..... ...+.+|+++++++++|.+++.. +.+++..++.++.|++.||+|||+.
T Consensus        61 ~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~  139 (345)
T cd07877          61 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA  139 (345)
T ss_pred             HHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            457789999999999999999999875432 23356899999999999888765 4699999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |++||||||+||+++.++.++|+|||++......  .....++..|+|||.+.+...++.++|+||+||++++|++|.+|
T Consensus       140 ~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  217 (345)
T cd07877         140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL  217 (345)
T ss_pred             CeeecCCChHHEEEcCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999998765432  23456788899999986655678899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHh-HHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNEN-AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |.+.+.......+....+.+........... ...+....+......+...+...++.+.++|.+||++||.+|||+.++
T Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~  297 (345)
T cd07877         218 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  297 (345)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH
Confidence            9988888888888887777766655444322 233333444444444444444678899999999999999999999999


Q ss_pred             hcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccCh
Q 022132          249 LAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  297 (302)
Q Consensus       249 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (302)
                      ++||||.++..+..++. ..++...+..+.+-.++++...|.|+.+|.|
T Consensus       298 l~h~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (345)
T cd07877         298 LAHAYFAQYHDPDDEPV-ADPYDQSFESRDLLIDEWKSLTYDEVISFVP  345 (345)
T ss_pred             hcChhhhhcCCCCcccc-CCCccCcchhcccCHHHHHHHHHHHHHhcCC
Confidence            99999999887776664 3456666677777789999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-43  Score=306.67  Aligned_cols=281  Identities=42%  Similarity=0.794  Sum_probs=228.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++..... .....+|+|+||+..+|.....  ..+++..+..++.|++.||+|||+.|
T Consensus        60 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~  137 (342)
T cd07879          60 RAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG  137 (342)
T ss_pred             HHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            46789999999999999999999876532 2335689999999988877653  46899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      ++||||+|+||+++.++.++|+|||++......  .....++..|+|||.+.+...++.++|+||+||++++|++|+.||
T Consensus       138 i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf  215 (342)
T cd07879         138 IIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF  215 (342)
T ss_pred             cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999998764332  234466888999999866555789999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhhhH-hHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFLNE-NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      .+.+....+..+....+.+.......... ....+....+......+...++..++.+.+||.+||+.||.+|||+++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l  295 (342)
T cd07879         216 KGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL  295 (342)
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            99888888888888777776655443322 12233333444444455556677889999999999999999999999999


Q ss_pred             cCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccCh
Q 022132          250 AHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  297 (302)
Q Consensus       250 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (302)
                      .||||..+++...++ +..+++...+...+..+++..-||.|+++|-|
T Consensus       296 ~h~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (342)
T cd07879         296 EHPYFDSFRDADEET-EQQPYDDSLENEKLSVDEWKKHIYKEVKSFSP  342 (342)
T ss_pred             cCcchhhcccccccC-CCCcccchhhhhhCCHHHHHHHhhhhhhccCC
Confidence            999999987654433 45666666677788899999999999988865

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.5e-43  Score=302.69  Aligned_cols=238  Identities=31%  Similarity=0.622  Sum_probs=187.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~-~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||+++++.+.+. ....+++..++.++.|++.||+|||+.
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~  119 (287)
T cd07848          45 ETTLRELKMLRTLKQENIVELKEAFRRR-----GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN  119 (287)
T ss_pred             hhHHHHHHHHHhCCCccccchhhhEecC-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3567899999999999999999999887     8899999999876655554 346799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC--CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |++||||||+||+++.++.++|+|||.+......  .......++..|+|||.+.+.. ++.++|+||+||++|+|++|+
T Consensus       120 ~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~  198 (287)
T cd07848         120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQ  198 (287)
T ss_pred             CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCC
Confidence            9999999999999999999999999998765432  1223456889999999986544 789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccc-cc-cccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ-RQ-SFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      +||.+.+..+....+....+..+...+..............+... .. ......+.+++++.+||++||++||.+|||+
T Consensus       199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~  278 (287)
T cd07848         199 PLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT  278 (287)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH
Confidence            999998887777777777766655544332111100000000000 00 0111223478899999999999999999999


Q ss_pred             HHHhcCCCc
Q 022132          246 EDALAHPYL  254 (302)
Q Consensus       246 ~ell~h~~~  254 (302)
                      +++|+||||
T Consensus       279 ~~~l~hp~f  287 (287)
T cd07848         279 EQCLNHPAF  287 (287)
T ss_pred             HHHhcCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3e-43  Score=306.48  Aligned_cols=240  Identities=33%  Similarity=0.623  Sum_probs=185.9

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC---------CCCCHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---------QALSEEHCQYFLYQILRG   82 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qll~~   82 (302)
                      .+.+|+.+++.++||||+++++++.....   ..+|++|||++++|.+++...         ..+++..++.++.||+.|
T Consensus        44 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  120 (317)
T cd07868          44 SACREIALLRELKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG  120 (317)
T ss_pred             HHHHHHHHHHhcCCCCCcceeeeEecCCC---cEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence            56789999999999999999999865422   679999999999999887532         258999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEE----ecCCCEEEeecccccccCCC----CcccccccccccCchhhhhCCCCCCCchhHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVW  154 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~----~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  154 (302)
                      |+|||+.||+||||||+||++    +.++.+||+|||++......    .......+|..|+|||.+.+...++.++|+|
T Consensus       121 l~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  200 (317)
T cd07868         121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  200 (317)
T ss_pred             HHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHH
Confidence            999999999999999999999    45578999999999765432    1223457789999999997766689999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHHhCCCChHHHhhhhHhHHH--Hhhhcc--ccccc----ccc
Q 022132          155 SVGCIFMELMDRKPLFPGRD---------HVHQLRLLIELIGTPSEAELGFLNENAKK--YICQLP--RYQRQ----SFT  217 (302)
Q Consensus       155 slG~i~~~ll~g~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~----~~~  217 (302)
                      |+||++++|++|.+||.+..         ...++..+...++.|....+.........  ......  .....    ...
T Consensus       201 slG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (317)
T cd07868         201 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME  280 (317)
T ss_pred             HHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHH
Confidence            99999999999999997543         24667788888888887766544221100  000000  00000    011


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCc
Q 022132          218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  254 (302)
Q Consensus       218 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~  254 (302)
                      ......+..+.+||++||++||.+|||++|+|+||||
T Consensus       281 ~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         281 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            1112345679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-43  Score=303.70  Aligned_cols=211  Identities=23%  Similarity=0.362  Sum_probs=180.3

Q ss_pred             hcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ....+.+|+.+++.++||||+++++++.+.     +.+|+||||+. ++|.+++...+.+++..+..++.|++.||+|||
T Consensus        44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  118 (291)
T cd05612          44 QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-----RFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH  118 (291)
T ss_pred             HHHHHHHHHHHHHhCCCCcHhhhHhhhccC-----CeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            344677899999999999999999999887     89999999996 699999998889999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      ++||+||||||+||+++.+|.++|+|||++......  .....+++.|+|||.+.+. .++.++|||||||++|+|++|.
T Consensus       119 ~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~  195 (291)
T cd05612         119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGY  195 (291)
T ss_pred             HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999998765433  2345688999999998554 4789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC---
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---  244 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---  244 (302)
                      .||.+.+.......+....                              .......++.+++||++||+.||.+|++   
T Consensus       196 ~pf~~~~~~~~~~~i~~~~------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  245 (291)
T cd05612         196 PPFFDDNPFGIYEKILAGK------------------------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMK  245 (291)
T ss_pred             CCCCCCCHHHHHHHHHhCC------------------------------cCCCccCCHHHHHHHHHHcCCCHHHccCCcc
Confidence            9998877655544433210                              0111245788999999999999999995   


Q ss_pred             --HHHHhcCCCcCCc
Q 022132          245 --VEDALAHPYLGSL  257 (302)
Q Consensus       245 --~~ell~h~~~~~~  257 (302)
                        ++++++||||...
T Consensus       246 ~~~~~~l~h~~~~~~  260 (291)
T cd05612         246 NGADDVKNHRWFKSV  260 (291)
T ss_pred             CCHHHHhcCccccCC
Confidence              9999999999865

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.2e-43  Score=300.76  Aligned_cols=239  Identities=35%  Similarity=0.614  Sum_probs=193.7

Q ss_pred             chhhHHHHHHhc---CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWI---MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~il~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+|+.+++.+   +||||+++++++..........+++||||++++|.+++...  ..+++..+..++.|++.||+||
T Consensus        45 ~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l  124 (288)
T cd07863          45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL  124 (288)
T ss_pred             HHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            355788877766   69999999999876543334679999999999999988753  3589999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |+.|++||||||+||+++.++.++|+|||++.............++..|+|||.+.+. .++.++||||+||++++|++|
T Consensus       125 H~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g  203 (288)
T cd07863         125 HANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRR  203 (288)
T ss_pred             HhCCeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhC
Confidence            9999999999999999999999999999998766544444456778899999998654 489999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+....+.+..+....+.+....+.......   ................+.++..+.++|.+||++||.+|||+.
T Consensus       204 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  280 (288)
T cd07863         204 KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP---RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAF  280 (288)
T ss_pred             CcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc---ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHH
Confidence            99999988888888888888777655443211100   001111222334455567888999999999999999999999


Q ss_pred             HHhcCCCc
Q 022132          247 DALAHPYL  254 (302)
Q Consensus       247 ell~h~~~  254 (302)
                      |++.||||
T Consensus       281 ~~l~hp~f  288 (288)
T cd07863         281 RALQHPFF  288 (288)
T ss_pred             HHhcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.3e-42  Score=303.73  Aligned_cols=274  Identities=48%  Similarity=0.914  Sum_probs=230.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ..+.+|+.+++.++||||+++++++....    ...|+++||++++|.+++.. .++++..+..++.|+++||+|||+.|
T Consensus        54 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~  128 (328)
T cd07856          54 KRTYRELKLLKHLRHENIISLSDIFISPL----EDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG  128 (328)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEeeeEecCC----CcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            46778999999999999999999987632    67899999999999888765 46889999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      ++|+||+|+||+++.++.++|+|||.+......  .....++..|+|||.+.+...++.++|+||+||++++|++|.+||
T Consensus       129 iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f  206 (328)
T cd07856         129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF  206 (328)
T ss_pred             cccCCCCHHHEeECCCCCEEeCccccccccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999998754332  233456788999998765456889999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhh-hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      .+.........+.+.++.++....... ......+....+.....+.....+.+++.+.++|++||+.||.+|||+++++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell  286 (328)
T cd07856         207 PGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL  286 (328)
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            998888888888888888876654432 2222333333333333445556667889999999999999999999999999


Q ss_pred             cCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHH
Q 022132          250 AHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQE  291 (302)
Q Consensus       250 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (302)
                      .||||..+..+..++...+.|++.++..++..+.||-+.|.|
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (328)
T cd07856         287 AHPYLAPYHDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE  328 (328)
T ss_pred             cCCccccccCCccccCchhhcCCchhcccCCHHHHHHHhcCC
Confidence            999999999999999988999999999999999999988754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.1e-43  Score=308.16  Aligned_cols=211  Identities=26%  Similarity=0.453  Sum_probs=179.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+.+...+.+++..+..++.||+.||+|||++
T Consensus        40 ~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~  114 (323)
T cd05571          40 AHTLTESRVLQNTRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC  114 (323)
T ss_pred             HHHHHHHHHHHhCCCCCCCCEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3567899999999999999999999887     89999999997 69999998888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||+++... .........|+..|+|||++.+ ..++.++||||+||++|+|++|..
T Consensus       115 ~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~  193 (323)
T cd05571         115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRL  193 (323)
T ss_pred             CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCC
Confidence            99999999999999999999999999987532 2223344578999999999864 448999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----  243 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----  243 (302)
                      ||.+.+.......+...  .                            ......+++.+.+||++||+.||.+||     
T Consensus       194 Pf~~~~~~~~~~~~~~~--~----------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~  243 (323)
T cd05571         194 PFYNQDHEKLFELILME--E----------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPE  243 (323)
T ss_pred             CCCCCCHHHHHHHHHcC--C----------------------------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCC
Confidence            99877654443332210  0                            011225788999999999999999999     


Q ss_pred             CHHHHhcCCCcCCc
Q 022132          244 TVEDALAHPYLGSL  257 (302)
Q Consensus       244 t~~ell~h~~~~~~  257 (302)
                      ++.++++||||.+.
T Consensus       244 ~~~~ll~h~~f~~~  257 (323)
T cd05571         244 DAKEIMEHRFFASI  257 (323)
T ss_pred             CHHHHHcCCCcCCC
Confidence            89999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-43  Score=304.25  Aligned_cols=207  Identities=27%  Similarity=0.384  Sum_probs=178.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCC-cEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFN-DVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~-~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..|.+|+.+|+.++|||||++++++...     . .+.+||||++ |+|.+++..  .+.++...+..++.||+.|+.||
T Consensus        84 ~~f~~E~~il~~l~HpNIV~f~G~~~~~-----~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YL  158 (362)
T KOG0192|consen   84 KAFRREASLLSRLRHPNIVQFYGACTSP-----PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYL  158 (362)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence            4899999999999999999999999987     4 7999999997 799999987  68899999999999999999999


Q ss_pred             HhCC-ceecCCCCCCEEEecCC-CEEEeecccccccCCC-CcccccccccccCchhhhhC-CCCCCCchhHHHHHHHHHH
Q 022132           87 HSAN-VLHRDLKPSNLLLNANC-DLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        87 H~~~-i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~i~~~  162 (302)
                      |+++ |+||||||+|||++.++ .+||+|||+++..... ...+...||..|||||++.+ ...++.++||||||+++||
T Consensus       159 H~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWE  238 (362)
T KOG0192|consen  159 HSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWE  238 (362)
T ss_pred             hcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHH
Confidence            9999 99999999999999997 9999999999876654 33455789999999999974 3569999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      |++|..||.+...............+|..                            ....++.+..++..||+.||.+|
T Consensus       239 l~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~----------------------------p~~~~~~l~~l~~~CW~~dp~~R  290 (362)
T KOG0192|consen  239 LLTGEIPFEDLAPVQVASAVVVGGLRPPI----------------------------PKECPPHLSSLMERCWLVDPSRR  290 (362)
T ss_pred             HHHCCCCCCCCCHHHHHHHHHhcCCCCCC----------------------------CccCCHHHHHHHHHhCCCCCCcC
Confidence            99999999998874444443332222221                            11378899999999999999999


Q ss_pred             CCHHHHhc
Q 022132          243 ITVEDALA  250 (302)
Q Consensus       243 ~t~~ell~  250 (302)
                      |+..+++.
T Consensus       291 P~f~ei~~  298 (362)
T KOG0192|consen  291 PSFLEIVS  298 (362)
T ss_pred             CCHHHHHH
Confidence            99998765

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-43  Score=293.59  Aligned_cols=217  Identities=23%  Similarity=0.417  Sum_probs=183.0

Q ss_pred             HhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~   84 (302)
                      ..-.+...|-.||+.++||.++.||+.|+.+     ...|+|||||. |+|..++++  .+.++++.++.++..|+.||+
T Consensus       119 kKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~-----~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALE  193 (459)
T KOG0610|consen  119 KKLKRAQTEREILSLLDHPFLPTLYASFETD-----KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALE  193 (459)
T ss_pred             hHHHHHHHHHHHHHhcCCCccchhhheeecc-----ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHH
Confidence            3334566799999999999999999999998     89999999996 699999875  468999999999999999999


Q ss_pred             HHHhCCceecCCCCCCEEEecCCCEEEeecccccccC----------------------------------C-C------
Q 022132           85 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----------------------------------E-T------  123 (302)
Q Consensus        85 ~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~----------------------------------~-~------  123 (302)
                      |||..||++|||||+||||.++|.+.|+||.++....                                  . .      
T Consensus       194 YLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~  273 (459)
T KOG0610|consen  194 YLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKD  273 (459)
T ss_pred             HHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccc
Confidence            9999999999999999999999999999998863110                                  0 0      


Q ss_pred             ----------------CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 022132          124 ----------------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG  187 (302)
Q Consensus       124 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~  187 (302)
                                      .....++||-.|.|||++.+.+ .+.++|.|+||+.+|||+.|..||+|.+..+.+..++..  
T Consensus       274 ~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~--  350 (459)
T KOG0610|consen  274 ESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ--  350 (459)
T ss_pred             ccccccchhhhcCCCCccccccccccccccceeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC--
Confidence                            0112356788899999997766 799999999999999999999999999998887766542  


Q ss_pred             CCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC----HHHHhcCCCcCCcc
Q 022132          188 TPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT----VEDALAHPYLGSLH  258 (302)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~ell~h~~~~~~~  258 (302)
                       +.                        .+++ .+.++.+++|||+++|.+||++|..    |.|+-+||||++++
T Consensus       351 -~l------------------------~Fp~-~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn  399 (459)
T KOG0610|consen  351 -PL------------------------KFPE-EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN  399 (459)
T ss_pred             -CC------------------------cCCC-CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence             11                        0111 1256789999999999999999998    99999999999874

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3e-42  Score=295.54  Aligned_cols=237  Identities=37%  Similarity=0.699  Sum_probs=194.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      .+.+|+.++++++||||+++++++.+.     +.+|+||||++++|.+++...   ..+++..++.++.||+.||+|||+
T Consensus        45 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~  119 (285)
T cd07861          45 TAIREISLLKELQHPNIVCLQDVLMQE-----SRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS  119 (285)
T ss_pred             HHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh
Confidence            467899999999999999999999887     899999999999999888642   568999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      .|++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+...++.++|+||+||++++|++|.
T Consensus       120 ~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~  199 (285)
T cd07861         120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK  199 (285)
T ss_pred             CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999999999998754432 11233456788999999866666789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.........+....+.+....+..... ...+....+.............++++++++|++||+.||.+|||+.+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~  278 (285)
T cd07861         200 PLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS-LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK  278 (285)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCChhhhhcchh-hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence            99998888877777777777776655543321 12222233333333334445568999999999999999999999999


Q ss_pred             HhcCCCc
Q 022132          248 ALAHPYL  254 (302)
Q Consensus       248 ll~h~~~  254 (302)
                      ++.||||
T Consensus       279 ll~~~~~  285 (285)
T cd07861         279 ALNHPYF  285 (285)
T ss_pred             HhcCCCC
Confidence            9999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.2e-43  Score=306.88  Aligned_cols=208  Identities=25%  Similarity=0.410  Sum_probs=179.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++.+.     +.+|+||||+. |+|.+++...+.+++..+..++.|++.||.|||+.|
T Consensus        77 ~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~  151 (340)
T PTZ00426         77 HVFSERKILNYINHPFCVNLYGSFKDE-----SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN  151 (340)
T ss_pred             HHHHHHHHHHhCCCCCCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            567899999999999999999999887     88999999995 799999998889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      |+||||||+||+++.++.++|+|||++......  .....||+.|+|||++.+. .++.++|+||+||++|+|++|.+||
T Consensus       152 ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf  228 (340)
T PTZ00426        152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPF  228 (340)
T ss_pred             eEccCCCHHHEEECCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCC
Confidence            999999999999999999999999998765433  2345789999999998654 4789999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CH
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TV  245 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~  245 (302)
                      .+.+.......+....                              ....+.+++.+.++|++||+.||.+|+     |+
T Consensus       229 ~~~~~~~~~~~i~~~~------------------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~  278 (340)
T PTZ00426        229 YANEPLLIYQKILEGI------------------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGA  278 (340)
T ss_pred             CCCCHHHHHHHHhcCC------------------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCH
Confidence            8877655444433211                              011125678899999999999999995     89


Q ss_pred             HHHhcCCCcCCc
Q 022132          246 EDALAHPYLGSL  257 (302)
Q Consensus       246 ~ell~h~~~~~~  257 (302)
                      +++++||||+..
T Consensus       279 ~~~~~hp~f~~~  290 (340)
T PTZ00426        279 QNVKEHPWFGNI  290 (340)
T ss_pred             HHHHcCCCcCCC
Confidence            999999999875

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.7e-43  Score=306.17  Aligned_cols=209  Identities=23%  Similarity=0.394  Sum_probs=178.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++...     +.+|+||||+. ++|.+.+.+.+.+++..+..++.||+.||+|||++
T Consensus        63 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~  137 (329)
T PTZ00263         63 QHVAQEKSILMELSHPFIVNMMCSFQDE-----NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK  137 (329)
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEcC-----CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4577899999999999999999999887     89999999996 69999999888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.++|+|||++.......  ....|++.|+|||.+.+. .++.++|+|||||++|+|++|.+|
T Consensus       138 ~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p  214 (329)
T PTZ00263        138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPP  214 (329)
T ss_pred             CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCC
Confidence            99999999999999999999999999987654432  345789999999998654 478999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----  244 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----  244 (302)
                      |.+.+.......+...  .+                            .....++..+++||++||+.||.+|++     
T Consensus       215 f~~~~~~~~~~~i~~~--~~----------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~  264 (329)
T PTZ00263        215 FFDDTPFRIYEKILAG--RL----------------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGG  264 (329)
T ss_pred             CCCCCHHHHHHHHhcC--Cc----------------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCC
Confidence            9877655444333220  00                            011246788999999999999999997     


Q ss_pred             HHHHhcCCCcCCc
Q 022132          245 VEDALAHPYLGSL  257 (302)
Q Consensus       245 ~~ell~h~~~~~~  257 (302)
                      ++++++||||...
T Consensus       265 ~~~ll~hp~f~~~  277 (329)
T PTZ00263        265 VADVKNHPYFHGA  277 (329)
T ss_pred             HHHHhcCCccCCC
Confidence            7999999999863

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.9e-42  Score=295.51  Aligned_cols=237  Identities=37%  Similarity=0.681  Sum_probs=192.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++.+.     +.+|+|+||++++|.+.+.. .+.+++..+..++.||+.||.|||+.
T Consensus        44 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~  118 (284)
T cd07839          44 SSALREICLLKELKHKNIVRLYDVLHSD-----KKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH  118 (284)
T ss_pred             cchhHHHHHHHhcCCCCeeeHHHHhccC-----CceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3567899999999999999999999887     88999999999999988864 56799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |++||||+|+||+++.++.++|+|||.+...+.. .......++..|+|||.+.+...++.++||||+||++++|++|..
T Consensus       119 ~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~  198 (284)
T cd07839         119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR  198 (284)
T ss_pred             CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCC
Confidence            9999999999999999999999999998765432 222334567889999998766667899999999999999999876


Q ss_pred             C-CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccc-cccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          169 L-FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ-RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       169 p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      | |.+.+....+..+....+.+....+.........  ...+... ...+....+.++++++++|.+||..||.+|||++
T Consensus       199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~  276 (284)
T cd07839         199 PLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY--KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE  276 (284)
T ss_pred             CCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc--cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHH
Confidence            6 5667777788888888887776655433211110  0111111 1122344567889999999999999999999999


Q ss_pred             HHhcCCCc
Q 022132          247 DALAHPYL  254 (302)
Q Consensus       247 ell~h~~~  254 (302)
                      +++.||||
T Consensus       277 ~il~h~~f  284 (284)
T cd07839         277 EALQHPYF  284 (284)
T ss_pred             HHhcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-43  Score=302.54  Aligned_cols=211  Identities=25%  Similarity=0.493  Sum_probs=179.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++...     +.+|+||||++ |+|.+++...+.+++..+..++.||+.||.|||+.
T Consensus        38 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~  112 (312)
T cd05585          38 THTLAERTVLAQVNCPFIVPLKFSFQSP-----EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF  112 (312)
T ss_pred             HHHHHHHHHHHhCCCCcEeceeeEEecC-----CeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3567899999999999999999999887     89999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++..... ........|+..|+|||.+.+. .++.++||||+||++|+|++|.+
T Consensus       113 ~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~  191 (312)
T cd05585         113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLP  191 (312)
T ss_pred             CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCC
Confidence            999999999999999999999999999875322 2223445789999999998654 48999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC---CH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TV  245 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~  245 (302)
                      ||.+.+.......+..   .+                           ......+++.+.++|.+||..||.+||   ++
T Consensus       192 pf~~~~~~~~~~~~~~---~~---------------------------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~  241 (312)
T cd05585         192 PFYDENVNEMYRKILQ---EP---------------------------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGA  241 (312)
T ss_pred             CcCCCCHHHHHHHHHc---CC---------------------------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence            9987765544433321   00                           011235788999999999999999997   58


Q ss_pred             HHHhcCCCcCCc
Q 022132          246 EDALAHPYLGSL  257 (302)
Q Consensus       246 ~ell~h~~~~~~  257 (302)
                      .++++||||...
T Consensus       242 ~e~l~hp~~~~~  253 (312)
T cd05585         242 QEIKNHPFFSQL  253 (312)
T ss_pred             HHHHcCCCcCCC
Confidence            999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-42  Score=297.63  Aligned_cols=216  Identities=22%  Similarity=0.367  Sum_probs=178.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++|+||+++++++...     +.+++||||++ |+|.+.+..  ...+++..+..++.|++.||+|||
T Consensus        45 ~~~~~E~~il~~l~~~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  119 (285)
T cd05631          45 AMALNEKRILEKVNSRFVVSLAYAYETK-----DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ  119 (285)
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEccC-----CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999887     88999999997 689877753  346899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +.||+||||||+||+++.++.++|+|||++.............++..|+|||.+.+. .++.++||||+||++|+|++|.
T Consensus       120 ~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~  198 (285)
T cd05631         120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQ  198 (285)
T ss_pred             hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCC
Confidence            999999999999999999999999999999775544434456789999999998644 5899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC---
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---  244 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---  244 (302)
                      +||.+.+.......+......+                          .......+++++.+||++||+.||.+|||   
T Consensus       199 ~pf~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~  252 (285)
T cd05631         199 SPFRKRKERVKREEVDRRVKED--------------------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRG  252 (285)
T ss_pred             CCCCCCCcchhHHHHHHHhhcc--------------------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCC
Confidence            9998765433222222111110                          01122357889999999999999999997   


Q ss_pred             --HHHHhcCCCcCCcc
Q 022132          245 --VEDALAHPYLGSLH  258 (302)
Q Consensus       245 --~~ell~h~~~~~~~  258 (302)
                        ++++++||||....
T Consensus       253 ~~~~~~~~h~~~~~~~  268 (285)
T cd05631         253 NGAAGVKQHPIFKNIN  268 (285)
T ss_pred             CCHHHHhcCHhhcCCC
Confidence              89999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-42  Score=309.78  Aligned_cols=247  Identities=22%  Similarity=0.265  Sum_probs=190.4

Q ss_pred             hHHHHhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHH
Q 022132            4 ITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGL   83 (302)
Q Consensus         4 ~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l   83 (302)
                      +|.+.......+|+.+|+.++||||+++++++...     +.+|+|||+++++|.+++...+.+++..+..++.||+.||
T Consensus       124 vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL  198 (392)
T PHA03207        124 VKAVTGGKTPGREIDILKTISHRAIINLIHAYRWK-----STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEAL  198 (392)
T ss_pred             EEeccccccHHHHHHHHHhcCCCCccceeeeEeeC-----CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Confidence            44455555667999999999999999999999877     8899999999999999998778899999999999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           84 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      .|||+.||+||||||+||+++.++.++|+|||++.......   ......+|..|+|||++.+. .++.++||||+||++
T Consensus       199 ~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil  277 (392)
T PHA03207        199 AYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVL  277 (392)
T ss_pred             HHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHH
Confidence            99999999999999999999999999999999986544322   12345689999999998544 488999999999999


Q ss_pred             HHHHhCCCCCCCCC---hHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccc--cccccC--CCCCHHHHHHHHH
Q 022132          161 MELMDRKPLFPGRD---HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ--SFTEKF--PNVHPSAIDLVEK  233 (302)
Q Consensus       161 ~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~  233 (302)
                      |+|++|..||.+..   ....+..+.+.++...................+.....+.  ..+..+  ...+.++.++|++
T Consensus       278 ~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  357 (392)
T PHA03207        278 FEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAK  357 (392)
T ss_pred             HHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHH
Confidence            99999999997654   3455666666665443322111111111111111111111  111111  1456789999999


Q ss_pred             ccCCCCCCCCCHHHHhcCCCcCC
Q 022132          234 MLTFDPRQRITVEDALAHPYLGS  256 (302)
Q Consensus       234 ~L~~dP~~R~t~~ell~h~~~~~  256 (302)
                      ||.+||.+|||+.|+|+||||..
T Consensus       358 ml~~dp~~Rpsa~e~l~~p~f~~  380 (392)
T PHA03207        358 MLTFDQEFRPSAQDILSLPLFTK  380 (392)
T ss_pred             HhccChhhCCCHHHHhhCchhhc
Confidence            99999999999999999999976

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-41  Score=298.81  Aligned_cols=277  Identities=43%  Similarity=0.802  Sum_probs=224.0

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++++ +||||+++++++.....   ...|+||||++++|.+++... .+++..+..++.||+.||+|||+.
T Consensus        51 ~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~---~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~  126 (337)
T cd07852          51 QRTFREIMFLQELGDHPNIVKLLNVIKAEND---KDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG  126 (337)
T ss_pred             hhhhHHHHHHHHhcCCCCccceeeeeccCCC---ceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3566899999999 99999999999876421   578999999999999998775 789999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC------cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      ||+|+||+|+||+++.++.++|+|||.+.......      ......++..|+|||.+.+...++.++|+||+||++++|
T Consensus       127 ~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el  206 (337)
T cd07852         127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEM  206 (337)
T ss_pred             CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHH
Confidence            99999999999999999999999999987543221      223346788899999886666678899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhH-HHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA-KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      ++|.+||.+.........+....+.+....+..+.... ...................+..+..+.++|.+||+.||++|
T Consensus       207 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R  286 (337)
T cd07852         207 LLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKR  286 (337)
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccc
Confidence            99999999998888888888888888776665543222 22223333344445556666789999999999999999999


Q ss_pred             CCHHHHhcCCCcCCccCCCCCCCCCCCCCc-chhhcccCHHHHHHHHHHH
Q 022132          243 ITVEDALAHPYLGSLHDISDEPVCMSPFSF-DFEQHALTEGQMKELIYQE  291 (302)
Q Consensus       243 ~t~~ell~h~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  291 (302)
                      ||+.++++||||+.+.....++....++.. -.....++..+.+..+|.|
T Consensus       287 ps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (337)
T cd07852         287 LTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSVAEYRNKLYEE  336 (337)
T ss_pred             cCHHHHhhChhhhhhccCCCCCCCCCCccCCccccceeeHHHHHhhhhhc
Confidence            999999999999998777666655444332 3356677777777777765

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-43  Score=276.67  Aligned_cols=216  Identities=22%  Similarity=0.400  Sum_probs=192.6

Q ss_pred             hHHHHhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHH--cCCCCCHHHHHHHHHHHH
Q 022132            4 ITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR--SNQALSEEHCQYFLYQIL   80 (302)
Q Consensus         4 ~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~--~~~~l~~~~~~~i~~qll   80 (302)
                      |.+.....++.||+.|...|+||||+++|++|.++     ..+|+++||.. |+|...+.  ..+++++.....+++|++
T Consensus        60 i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-----~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A  134 (281)
T KOG0580|consen   60 ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-----KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLA  134 (281)
T ss_pred             HHHhcchhhhhheeEeecccCCccHHhhhhheecc-----ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHH
Confidence            34555667889999999999999999999999998     89999999996 89999998  567899999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           81 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        81 ~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      .|+.|+|..+++||||||+|+|++..|.+|++|||.+.... .......+||..|.|||...+. ..+..+|+|++|++.
T Consensus       135 ~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~  212 (281)
T KOG0580|consen  135 NALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLC  212 (281)
T ss_pred             HHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHH
Confidence            99999999999999999999999999999999999987655 4446778999999999998654 479999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      |+++.|.+||......+.++.|.+.--.-                              ...++..++|+|.+||.++|.
T Consensus       213 yeflvg~ppFes~~~~etYkrI~k~~~~~------------------------------p~~is~~a~dlI~~ll~~~p~  262 (281)
T KOG0580|consen  213 YEFLVGLPPFESQSHSETYKRIRKVDLKF------------------------------PSTISGGAADLISRLLVKNPI  262 (281)
T ss_pred             HHHHhcCCchhhhhhHHHHHHHHHccccC------------------------------CcccChhHHHHHHHHhccCcc
Confidence            99999999999988888888887642211                              137889999999999999999


Q ss_pred             CCCCHHHHhcCCCcCC
Q 022132          241 QRITVEDALAHPYLGS  256 (302)
Q Consensus       241 ~R~t~~ell~h~~~~~  256 (302)
                      +|.+..|++.|||+..
T Consensus       263 ~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  263 ERLALTEVMDHPWIVA  278 (281)
T ss_pred             ccccHHHHhhhHHHHh
Confidence            9999999999999865

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=302.65  Aligned_cols=216  Identities=33%  Similarity=0.543  Sum_probs=188.6

Q ss_pred             chhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ...+|+.||+++. ||||+.++++|.+.     ..+|+|||+|. |.|.+.+.+. .+++..+..++.|++.|++|||+.
T Consensus        81 ~v~~Ev~il~~l~~hpniv~l~~~~e~~-----~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~  154 (382)
T KOG0032|consen   81 DVRREVAILQQLSGHPNIVQLKDAFEDP-----DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL  154 (382)
T ss_pred             HHHHHHHHHHhccCCCCEEEEEEEEEcC-----CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC
Confidence            6779999999997 99999999999998     89999999996 7999999876 599999999999999999999999


Q ss_pred             CceecCCCCCCEEEecC----CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           90 NVLHRDLKPSNLLLNAN----CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ||+|||+||+|+++...    +.++++|||++............+||+.|+|||++.. ..|+..+|+||+|+++|.|++
T Consensus       155 gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~  233 (382)
T KOG0032|consen  155 GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLS  233 (382)
T ss_pred             CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhh
Confidence            99999999999999643    5799999999998877667888899999999999954 458999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+.......+...--                          .-....|+.++..+++||++||..||.+|+|+
T Consensus       234 G~~PF~~~~~~~~~~~i~~~~~--------------------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta  287 (382)
T KOG0032|consen  234 GVPPFWGETEFEIFLAILRGDF--------------------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTA  287 (382)
T ss_pred             CCCCCcCCChhHHHHHHHcCCC--------------------------CCCCCCccccCHHHHHHHHHhcccCcccCCCH
Confidence            9999998887666554433111                          11134566889999999999999999999999


Q ss_pred             HHHhcCCCcCCccCC
Q 022132          246 EDALAHPYLGSLHDI  260 (302)
Q Consensus       246 ~ell~h~~~~~~~~~  260 (302)
                      .++|+|||+++....
T Consensus       288 ~~~L~HpWi~~~~~~  302 (382)
T KOG0032|consen  288 AQALQHPWIKSIGEA  302 (382)
T ss_pred             HHHhcCccccCCccc
Confidence            999999999876433

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.1e-41  Score=295.64  Aligned_cols=246  Identities=36%  Similarity=0.635  Sum_probs=197.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++|+||+++++++.....   +.+|+||||++++|.+++.. ...+++..+..++.|++.||+|||+.|
T Consensus        52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  128 (309)
T cd07845          52 SSLREITLLLNLRHPNIVELKEVVVGKHL---DSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF  128 (309)
T ss_pred             hhhHHHHHHHhCCCCCCcceEEEEecCCC---CeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34589999999999999999999876422   56899999999999988875 467999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ++||||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++|+|++|.+|
T Consensus       129 i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~  208 (309)
T cd07845         129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPL  208 (309)
T ss_pred             eecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998765433 1223334577899999987666678999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+....+..+....+.+....+..............+......+...++..++.+.++|.+||++||.+|||+++++
T Consensus       209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il  288 (309)
T cd07845         209 LPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL  288 (309)
T ss_pred             CCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence            99999999999999988887766554332211100001111111222333445688999999999999999999999999


Q ss_pred             cCCCcCCccCC
Q 022132          250 AHPYLGSLHDI  260 (302)
Q Consensus       250 ~h~~~~~~~~~  260 (302)
                      +||||....-+
T Consensus       289 ~h~~f~~~~~~  299 (309)
T cd07845         289 ESSYFKEKPLP  299 (309)
T ss_pred             cChhhccCCCC
Confidence            99999875433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.9e-42  Score=293.32  Aligned_cols=240  Identities=36%  Similarity=0.713  Sum_probs=199.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++...     +.+|+|+||++++|.+++.. ...+++..++.++.||+.||+|||+.
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  118 (286)
T cd07832          44 NQALREIKALQACQHPYVVKLLDVFPHG-----SGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN  118 (286)
T ss_pred             HHHHHHHHHHHhCCCCCCcceeeEEecC-----CeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577899999999999999999999887     88999999998899999864 46799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |++|+||+|+||+++.++.++|+|||.+.......  ......++..|+|||.+.+...++.++||||+||++++|++|.
T Consensus       119 ~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~  198 (286)
T cd07832         119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS  198 (286)
T ss_pred             CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC
Confidence            99999999999999999999999999987654332  2334567889999998866666789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+......+..+....+.+....+..............+......+...++..+..+.++|.+||.+||.+|||+++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  278 (286)
T cd07832         199 PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE  278 (286)
T ss_pred             cCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHH
Confidence            99999888888888888888887765554322111111112222223344556677899999999999999999999999


Q ss_pred             HhcCCCcC
Q 022132          248 ALAHPYLG  255 (302)
Q Consensus       248 ll~h~~~~  255 (302)
                      +|+||||.
T Consensus       279 ~l~h~~~~  286 (286)
T cd07832         279 ALRHPYFT  286 (286)
T ss_pred             HhhCcCcC
Confidence            99999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.9e-42  Score=300.95  Aligned_cols=210  Identities=26%  Similarity=0.448  Sum_probs=178.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|...+...+.+++..++.++.||+.||+|||++|
T Consensus        41 ~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~  115 (323)
T cd05595          41 HTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD  115 (323)
T ss_pred             HHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            566899999999999999999999887     88999999997 699999988888999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.++|+|||++.... .........|+..|+|||.+.+. .++.++|+||+||++|+|++|..|
T Consensus       116 ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~P  194 (323)
T cd05595         116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLP  194 (323)
T ss_pred             eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCC
Confidence            9999999999999999999999999986532 22223345689999999998544 479999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----C
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----T  244 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t  244 (302)
                      |.+.+.......+....                              ......+++.+.++|.+||+.||.+|+     +
T Consensus       195 f~~~~~~~~~~~~~~~~------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~  244 (323)
T cd05595         195 FYNQDHERLFELILMEE------------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD  244 (323)
T ss_pred             CCCCCHHHHHHHHhcCC------------------------------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCC
Confidence            98776554443332100                              011125788999999999999999998     8


Q ss_pred             HHHHhcCCCcCCc
Q 022132          245 VEDALAHPYLGSL  257 (302)
Q Consensus       245 ~~ell~h~~~~~~  257 (302)
                      +.++++|+||.+.
T Consensus       245 ~~~~l~h~~~~~~  257 (323)
T cd05595         245 AKEVMEHRFFLSI  257 (323)
T ss_pred             HHHHHcCCCcCCC
Confidence            9999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.1e-42  Score=298.12  Aligned_cols=240  Identities=34%  Similarity=0.614  Sum_probs=183.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC---------CCCCHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---------QALSEEHCQYFLYQILRG   82 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qll~~   82 (302)
                      .+.+|+.+++.++||||+++++++.....   ..+|+||||++++|.+++...         ..+++..+..++.||+.|
T Consensus        44 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  120 (317)
T cd07867          44 SACREIALLRELKHPNVIALQKVFLSHSD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG  120 (317)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEeccCC---CeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence            56789999999999999999999865322   678999999999998887521         258899999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEE----ecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVW  154 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~----~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  154 (302)
                      |+|||+.||+||||||+||++    +.++.++|+|||+++......    ......++..|+|||.+.+...++.++|||
T Consensus       121 L~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  200 (317)
T cd07867         121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  200 (317)
T ss_pred             HHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHH
Confidence            999999999999999999999    456789999999997654321    223456788999999987666689999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHHhCCCChHHHhhhhHhHH--HHhhh--cccccccc----cc
Q 022132          155 SVGCIFMELMDRKPLFPGRD---------HVHQLRLLIELIGTPSEAELGFLNENAK--KYICQ--LPRYQRQS----FT  217 (302)
Q Consensus       155 slG~i~~~ll~g~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~----~~  217 (302)
                      |+||++++|++|.+||....         ...++..+...++.+....+........  .....  ........    ..
T Consensus       201 SlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (317)
T cd07867         201 AIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYME  280 (317)
T ss_pred             hHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhh
Confidence            99999999999999997543         2355667777778777666544321100  00000  00000000    11


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCc
Q 022132          218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  254 (302)
Q Consensus       218 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~  254 (302)
                      ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       281 ~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         281 KHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             cccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            1112346679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.2e-42  Score=301.24  Aligned_cols=211  Identities=24%  Similarity=0.430  Sum_probs=178.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ |+|...+...+.+++..+..++.||+.||+|||++
T Consensus        40 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~  114 (328)
T cd05593          40 AHTLTESRVLKNTRHPFLTSLKYSFQTK-----DRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG  114 (328)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEEcC-----CEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3567899999999999999999999887     89999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++..... ........|+..|+|||.+.+. .++.++||||+||++|+|++|..
T Consensus       115 ~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~  193 (328)
T cd05593         115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRL  193 (328)
T ss_pred             CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCC
Confidence            999999999999999999999999999875322 2223345689999999998644 47999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----  243 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----  243 (302)
                      ||.+.+.......+...  .                            ......+++++.+||++||++||.+|+     
T Consensus       194 Pf~~~~~~~~~~~~~~~--~----------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~  243 (328)
T cd05593         194 PFYNQDHEKLFELILME--D----------------------------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPD  243 (328)
T ss_pred             CCCCCCHHHHHHHhccC--C----------------------------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCC
Confidence            99876654443332110  0                            011225788999999999999999997     


Q ss_pred             CHHHHhcCCCcCCc
Q 022132          244 TVEDALAHPYLGSL  257 (302)
Q Consensus       244 t~~ell~h~~~~~~  257 (302)
                      ++.++++||||...
T Consensus       244 ~~~~il~h~~~~~~  257 (328)
T cd05593         244 DAKEIMRHSFFTGV  257 (328)
T ss_pred             CHHHHhcCCCcCCC
Confidence            89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.7e-41  Score=292.16  Aligned_cols=240  Identities=38%  Similarity=0.718  Sum_probs=195.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++.....   +.+|+||||++++|.+++... ..+++..+..++.||+.||+|||+.|
T Consensus        50 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  126 (293)
T cd07843          50 TSLREINILLKLQHPNIVTVKEVVVGSNL---DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW  126 (293)
T ss_pred             hHHHHHHHHHhcCCCCEEEEEEEEEecCC---CcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            35689999999999999999999876422   689999999999999998764 45999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+|+++++|++|.+|
T Consensus       127 i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~  206 (293)
T cd07843         127 ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPL  206 (293)
T ss_pred             eeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998765543 2233445678899999986655578899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCC--CCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN--VHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      |.+......+..+....+.|....+.....................+...++.  +++.+.++|++||+.||++|||++|
T Consensus       207 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~e  286 (293)
T cd07843         207 FPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED  286 (293)
T ss_pred             CCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHH
Confidence            99999888888888888888877665443211111111111222223344444  4888999999999999999999999


Q ss_pred             HhcCCCc
Q 022132          248 ALAHPYL  254 (302)
Q Consensus       248 ll~h~~~  254 (302)
                      +|.||||
T Consensus       287 ll~~~~f  293 (293)
T cd07843         287 ALKHPYF  293 (293)
T ss_pred             HhcCCCC
Confidence            9999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-42  Score=274.95  Aligned_cols=245  Identities=30%  Similarity=0.547  Sum_probs=203.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCC---CCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRES---FNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~---~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...||++||..++|+|++.+.+++...+...   -..+|+|+++|+.+|..++... .+++..+++.++.++++||.|+|
T Consensus        62 talreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH  141 (376)
T KOG0669|consen   62 TALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH  141 (376)
T ss_pred             HHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHH
Confidence            4579999999999999999999998765332   2459999999999999999765 68999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      ++.|+|||+||.|++|+.+|.++|.|||+++..+...     ..+..+-|.+|++||.+.+...++++.|||+.|||+.+
T Consensus       142 r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimae  221 (376)
T KOG0669|consen  142 RNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAE  221 (376)
T ss_pred             HhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHH
Confidence            9999999999999999999999999999997655332     22334568999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhh---ccccccccccccCC--CCCHHHHHHHHHccCC
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ---LPRYQRQSFTEKFP--NVHPSAIDLVEKMLTF  237 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~  237 (302)
                      |++|.+.+.+.....++..|...+|.-+.+-|...........-.   ++..+.........  .-.+++.||+.+||..
T Consensus       222 Mwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~  301 (376)
T KOG0669|consen  222 MWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKL  301 (376)
T ss_pred             HHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhcc
Confidence            999999999999999999999999998888887664322111111   22222222222211  1246899999999999


Q ss_pred             CCCCCCCHHHHhcCCCcCC
Q 022132          238 DPRQRITVEDALAHPYLGS  256 (302)
Q Consensus       238 dP~~R~t~~ell~h~~~~~  256 (302)
                      ||.+|++++++|+|.||..
T Consensus       302 DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  302 DPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CcccCcchHhhhchhhhhc
Confidence            9999999999999999965

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=292.02  Aligned_cols=238  Identities=37%  Similarity=0.713  Sum_probs=191.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++.+.     +..|+||||++++|.+++... ..+++..++.++.|++.||.|||+.|
T Consensus        49 ~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~  123 (291)
T cd07844          49 TAIREASLLKDLKHANIVTLHDIIHTK-----KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR  123 (291)
T ss_pred             hHHHHHHHHhhCCCcceeeEEEEEecC-----CeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            456899999999999999999999887     899999999999999988753 46899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+||++++|++|.+|
T Consensus       124 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~  203 (291)
T cd07844         124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL  203 (291)
T ss_pred             eecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999986543221 112234577899999987656678999999999999999999999


Q ss_pred             CCCCC-hHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCC--HHHHHHHHHccCCCCCCCCCHH
Q 022132          170 FPGRD-HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH--PSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       170 f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      |.+.. ..+.+..+.+.++.+....+....................+.....+..+  ..+.+++.+||++||.+|||++
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~  283 (291)
T cd07844         204 FPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAA  283 (291)
T ss_pred             CCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHH
Confidence            97766 56677777888888777665444322111111222222233334444455  7899999999999999999999


Q ss_pred             HHhcCCCc
Q 022132          247 DALAHPYL  254 (302)
Q Consensus       247 ell~h~~~  254 (302)
                      +++.||||
T Consensus       284 e~l~~~~f  291 (291)
T cd07844         284 EAMKHPYF  291 (291)
T ss_pred             HHhcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.2e-41  Score=290.13  Aligned_cols=237  Identities=37%  Similarity=0.710  Sum_probs=195.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.++++++||||+++++++...     +..|+||||++++|..++..  ...+++..+..++.|++.||+|||+.
T Consensus        45 ~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~  119 (284)
T cd07860          45 TAIREISLLKELNHPNIVKLLDVIHTE-----NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH  119 (284)
T ss_pred             HHHHHHHHHHhcCCCCCcchhhhcccC-----CcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            577899999999999999999999877     88999999999899988865  35689999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++++|++|..
T Consensus       120 ~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~  199 (284)
T cd07860         120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA  199 (284)
T ss_pred             CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            9999999999999999999999999998754432 122333567889999988665556889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||.+.+.......+....+.+....+..... ...+....+......+....+.+++.++++|.+||+.||.+|||++++
T Consensus       200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~  278 (284)
T cd07860         200 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS-LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA  278 (284)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChhhhhhhhH-HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHH
Confidence            9998888888888888888777654433222 222222333333344444556788999999999999999999999999


Q ss_pred             hcCCCc
Q 022132          249 LAHPYL  254 (302)
Q Consensus       249 l~h~~~  254 (302)
                      +.||||
T Consensus       279 l~~~~f  284 (284)
T cd07860         279 LAHPFF  284 (284)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.3e-42  Score=299.36  Aligned_cols=211  Identities=24%  Similarity=0.448  Sum_probs=179.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+.+...+.+++..+..++.||+.||+|||++
T Consensus        45 ~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  119 (323)
T cd05584          45 AHTKAERNILEAVKHPFIVDLIYAFQTG-----GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ  119 (323)
T ss_pred             HHHHHHHHHHHhCCCCchhceeeEEecC-----CeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3566899999999999999999999887     88999999997 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++.... .........++..|+|||.+.+. .++.++|||||||++|+|++|.+
T Consensus       120 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~  198 (323)
T cd05584         120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAP  198 (323)
T ss_pred             CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCC
Confidence            99999999999999999999999999986432 22223445789999999998654 47899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----  243 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----  243 (302)
                      ||.+.+.......+....                              ....+.+++.+.++|++||++||.+||     
T Consensus       199 pf~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~  248 (323)
T cd05584         199 PFTAENRKKTIDKILKGK------------------------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPG  248 (323)
T ss_pred             CCCCCCHHHHHHHHHcCC------------------------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCC
Confidence            998777655444332210                              011235678999999999999999999     


Q ss_pred             CHHHHhcCCCcCCc
Q 022132          244 TVEDALAHPYLGSL  257 (302)
Q Consensus       244 t~~ell~h~~~~~~  257 (302)
                      +++++++||||...
T Consensus       249 ~~~~l~~h~~~~~~  262 (323)
T cd05584         249 DAAEVQSHPFFRHV  262 (323)
T ss_pred             CHHHHhcCCCcCCC
Confidence            89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.2e-42  Score=312.17  Aligned_cols=241  Identities=23%  Similarity=0.379  Sum_probs=186.4

Q ss_pred             chhhHHHHHHhcCCC------CccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKT------SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        12 ~~~~E~~il~~l~h~------niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      .+.+|+.+++.++|.      +++++++++....    +++|+|||+++++|.+++.+.+.+++..+..++.||+.||+|
T Consensus       171 ~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~----~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~y  246 (467)
T PTZ00284        171 DAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET----GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDY  246 (467)
T ss_pred             HHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC----ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence            455688888887654      5888999887642    679999999999999999888899999999999999999999


Q ss_pred             HHh-CCceecCCCCCCEEEecCC----------------CEEEeecccccccCCCCcccccccccccCchhhhhCCCCCC
Q 022132           86 IHS-ANVLHRDLKPSNLLLNANC----------------DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYT  148 (302)
Q Consensus        86 LH~-~~i~H~dikp~Nil~~~~~----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  148 (302)
                      ||+ .||+||||||+||+++.++                .+||+|||.+......  .....+|..|+|||++.+. .++
T Consensus       247 LH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~~~-~~~  323 (467)
T PTZ00284        247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVLGL-GWM  323 (467)
T ss_pred             HHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc--cccccCCccccCcHHhhcC-CCC
Confidence            998 5999999999999998765                4999999987543222  3456789999999999654 489


Q ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhH-hHHHHhhhccc----ccccccccc----
Q 022132          149 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE-NAKKYICQLPR----YQRQSFTEK----  219 (302)
Q Consensus       149 ~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~----  219 (302)
                      .++|||||||++|+|++|++||.+.+..+.+..+.+.++.++......... ....+......    .....+...    
T Consensus       324 ~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
T PTZ00284        324 YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARAR  403 (467)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhccc
Confidence            999999999999999999999999998888888888888876654432211 11111111100    000000000    


Q ss_pred             -C--CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccC
Q 022132          220 -F--PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  259 (302)
Q Consensus       220 -~--~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  259 (302)
                       .  ...++.++|||.+||++||.+|||++|+|+||||..+..
T Consensus       404 ~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        404 PVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             chhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence             0  012467889999999999999999999999999998654

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-42  Score=300.08  Aligned_cols=217  Identities=26%  Similarity=0.446  Sum_probs=182.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.
T Consensus        46 ~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~  120 (333)
T cd05600          46 RHVLTERDILTTTKSEWLVKLLYAFQDD-----EYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL  120 (333)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEEcC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4577899999999999999999999887     89999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.++|+|||++.....  ......++..|+|||.+.+. .++.++||||+||++|+|++|.+|
T Consensus       121 ~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~p  197 (333)
T cd05600         121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPP  197 (333)
T ss_pred             CccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCC
Confidence            999999999999999999999999999876543  23455789999999998655 589999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+..+....+.......                      ...........+++++.+||.+||..+|.+|||+++++
T Consensus       198 f~~~~~~~~~~~i~~~~~~~----------------------~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll  255 (333)
T cd05600         198 FSGSTPNETWENLKYWKETL----------------------QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIK  255 (333)
T ss_pred             CCCCCHHHHHHHHHhccccc----------------------cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHH
Confidence            98877665554443211100                      00000111125688999999999999999999999999


Q ss_pred             cCCCcCCc
Q 022132          250 AHPYLGSL  257 (302)
Q Consensus       250 ~h~~~~~~  257 (302)
                      +||||...
T Consensus       256 ~h~~~~~~  263 (333)
T cd05600         256 NHPFFKEV  263 (333)
T ss_pred             hCcccCCC
Confidence            99999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-43  Score=302.49  Aligned_cols=212  Identities=27%  Similarity=0.453  Sum_probs=192.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCc-EEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFND-VYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~-~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ....|+.++++++|||||.+++.|..+     +. ++|||+||+ |+|.+.+.+.  ..++++.+..|+.|++.|+.|||
T Consensus        49 ~A~~E~~lis~~~hP~iv~y~ds~~~~-----~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH  123 (426)
T KOG0589|consen   49 SAIQEMDLLSKLLHPNIVEYKDSFEED-----GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH  123 (426)
T ss_pred             HHHHHHHHHHhccCCCeeeeccchhcC-----CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            557899999999999999999999998     66 999999997 6999999753  57999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      +++|.|||||+.||+++.++.++|+|||+|+..+... ......||++|++||++.+ .+|+.++|||||||++|+|++-
T Consensus       124 ~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~l  202 (426)
T KOG0589|consen  124 ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTL  202 (426)
T ss_pred             hhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhc
Confidence            9999999999999999999999999999999988776 7788999999999998854 5599999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      +++|.+.+......++......|...                             ..+.+++.+|+.||..+|..||++.
T Consensus       203 k~aF~a~~m~~Li~ki~~~~~~Plp~-----------------------------~ys~el~~lv~~~l~~~P~~RPsa~  253 (426)
T KOG0589|consen  203 KPAFKASNMSELILKINRGLYSPLPS-----------------------------MYSSELRSLVKSMLRKNPEHRPSAL  253 (426)
T ss_pred             ccccCccchHHHHHHHhhccCCCCCc-----------------------------cccHHHHHHHHHHhhcCCccCCCHH
Confidence            99999999888888887766444432                             6788999999999999999999999


Q ss_pred             HHhcCCCcCCcc
Q 022132          247 DALAHPYLGSLH  258 (302)
Q Consensus       247 ell~h~~~~~~~  258 (302)
                      ++|.+|.+....
T Consensus       254 ~LL~~P~l~~~~  265 (426)
T KOG0589|consen  254 ELLRRPHLLRYL  265 (426)
T ss_pred             HHhhChhhhhHH
Confidence            999999888554

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.2e-42  Score=297.43  Aligned_cols=210  Identities=20%  Similarity=0.382  Sum_probs=178.0

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|..+++.+ +||||+++++++...     +.+|+||||++ |+|.+.+.+.+.+++..+..++.|++.||+|||+.
T Consensus        41 ~~~~e~~~l~~~~~h~~iv~~~~~~~~~-----~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~  115 (320)
T cd05590          41 CTMTEKRILSLARNHPFLTQLYCCFQTP-----DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK  115 (320)
T ss_pred             HHHHHHHHHHhccCCCchhceeeEEEcC-----CEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            456788888877 799999999999887     88999999997 69999998888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++.... .........|+..|+|||.+.+ ..++.++|+||+||++|+|++|..
T Consensus       116 ~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~  194 (320)
T cd05590         116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHA  194 (320)
T ss_pred             CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCC
Confidence            99999999999999999999999999986532 2223344578999999999854 447899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH---
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV---  245 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---  245 (302)
                      ||.+.+.......+....                              ......+++++.++|++||+.||.+|+++   
T Consensus       195 Pf~~~~~~~~~~~i~~~~------------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~  244 (320)
T cd05590         195 PFEAENEDDLFEAILNDE------------------------------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTL  244 (320)
T ss_pred             CCCCCCHHHHHHHHhcCC------------------------------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence            998887665554443210                              01112467899999999999999999998   


Q ss_pred             ---HHHhcCCCcCCc
Q 022132          246 ---EDALAHPYLGSL  257 (302)
Q Consensus       246 ---~ell~h~~~~~~  257 (302)
                         +++++||||..+
T Consensus       245 ~~~~~~~~h~~f~~~  259 (320)
T cd05590         245 GGEEAILRHPFFKEL  259 (320)
T ss_pred             CCHHHHHcCCCcCCC
Confidence               999999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.5e-41  Score=294.72  Aligned_cols=261  Identities=41%  Similarity=0.764  Sum_probs=200.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCC---------CCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRES---------FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR   81 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~---------~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~   81 (302)
                      +.+.+|+.+++.++||||+++++++.......         ....|+||||++++|.+.+.. +.+++..++.++.||++
T Consensus        47 ~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~  125 (342)
T cd07854          47 KHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLR  125 (342)
T ss_pred             HHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHH
Confidence            45778999999999999999999887653211         246899999999999988865 57999999999999999


Q ss_pred             HHHHHHhCCceecCCCCCCEEEec-CCCEEEeecccccccCCC----CcccccccccccCchhhhhCCCCCCCchhHHHH
Q 022132           82 GLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  156 (302)
Q Consensus        82 ~l~~LH~~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  156 (302)
                      ||.|||+.|++||||||+||+++. ++.++|+|||.+......    .......++..|+|||.+.+...++.++|||||
T Consensus       126 aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSl  205 (342)
T cd07854         126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA  205 (342)
T ss_pred             HHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHH
Confidence            999999999999999999999975 457899999998754322    112234568889999987665567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccC
Q 022132          157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  236 (302)
Q Consensus       157 G~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  236 (302)
                      ||++++|++|..||.+.+.......+.+....+.........................+.....+.++.++++||.+||+
T Consensus       206 Gvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  285 (342)
T cd07854         206 GCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILT  285 (342)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhC
Confidence            99999999999999988887777777666555444333322211111111111222233444556788999999999999


Q ss_pred             CCCCCCCCHHHHhcCCCcCCccCCCCCCCCCCCCCc
Q 022132          237 FDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSF  272 (302)
Q Consensus       237 ~dP~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~~~  272 (302)
                      .||.+|||+++++.||||+.+..+.+.++...++..
T Consensus       286 ~dP~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~~~  321 (342)
T cd07854         286 FNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHI  321 (342)
T ss_pred             CCchhccCHHHHhCCCccccccCCccccCCCCCccc
Confidence            999999999999999999988777677666555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.2e-41  Score=290.38  Aligned_cols=243  Identities=36%  Similarity=0.691  Sum_probs=197.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++|+||+++++++.+.     +..|+||||++++|.+++.... .+++..+..++.||++||.|||++|
T Consensus        48 ~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  122 (298)
T cd07841          48 TALREIKLLQELKHPNIIGLLDVFGHK-----SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW  122 (298)
T ss_pred             HHHHHHHHHhhcCCCCChhhhheeecC-----CEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            456799999999999999999999886     8999999999889999998765 7999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++++|++|.+|
T Consensus       123 i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~  202 (298)
T cd07841         123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPF  202 (298)
T ss_pred             eeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcc
Confidence            999999999999999999999999998765433 2223335677899999886656678999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+....+..+....+.|....+....... .+ .........+....+...+..+.++|.+||.+||++|||+.|++
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l  280 (298)
T cd07841         203 LPGDSDIDQLGKIFEALGTPTEENWPGVTSLP-DY-VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL  280 (298)
T ss_pred             ccCCccHHHHHHHHHHcCCCchhhhhhccccc-cc-ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHh
Confidence            99888888788887777777665543221110 00 11111122233344556788999999999999999999999999


Q ss_pred             cCCCcCCccCCC
Q 022132          250 AHPYLGSLHDIS  261 (302)
Q Consensus       250 ~h~~~~~~~~~~  261 (302)
                      .|+||.....+.
T Consensus       281 ~~~~~~~~~~~~  292 (298)
T cd07841         281 EHPYFSNDPAPT  292 (298)
T ss_pred             hCccccCCCCCC
Confidence            999999865443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-41  Score=300.46  Aligned_cols=241  Identities=24%  Similarity=0.355  Sum_probs=178.9

Q ss_pred             hcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ......+|+.+++.++||||+++++++...     +..++||||+.++|.+++.. .+.+++..+..++.||+.||.|||
T Consensus       100 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH  174 (357)
T PHA03209        100 QKGTTLIEAMLLQNVNHPSVIRMKDTLVSG-----AITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH  174 (357)
T ss_pred             CccccHHHHHHHHhCCCCCCcChhheEEeC-----CeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            344567899999999999999999999887     78999999999999998864 467999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC-
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g-  166 (302)
                      +.||+||||||+||+++.++.++|+|||.+.............++..|+|||.+.+. .++.++|+||+||++|+|+++ 
T Consensus       175 ~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~  253 (357)
T PHA03209        175 AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYP  253 (357)
T ss_pred             HCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcC
Confidence            999999999999999999999999999998754433334456789999999998654 489999999999999999974 


Q ss_pred             CCCCCCCCh---------HHHHHHHHHHhCCCChHHHhhh-hHhHHHHhhhccccccccccc----cCCCCCHHHHHHHH
Q 022132          167 KPLFPGRDH---------VHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTE----KFPNVHPSAIDLVE  232 (302)
Q Consensus       167 ~~pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~  232 (302)
                      .++|.....         ...+..+...++..+....... ......+.. .......++..    ....++.++.+||.
T Consensus       254 ~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~  332 (357)
T PHA03209        254 STIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIE-YASLERQPYTRYPCFQRVNLPIDGEFLVH  332 (357)
T ss_pred             CccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHh-hcccCCCcccccHHHhccCCCchHHHHHH
Confidence            455543221         2233333444443222211000 000011100 00001111100    11256778899999


Q ss_pred             HccCCCCCCCCCHHHHhcCCCcCC
Q 022132          233 KMLTFDPRQRITVEDALAHPYLGS  256 (302)
Q Consensus       233 ~~L~~dP~~R~t~~ell~h~~~~~  256 (302)
                      +||++||.+|||+.|+|+||||++
T Consensus       333 ~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        333 KMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHcCCcccCcCHHHHhcCchhcc
Confidence            999999999999999999999986

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.2e-41  Score=299.99  Aligned_cols=214  Identities=23%  Similarity=0.377  Sum_probs=175.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++.+.+.     +.+|+||||++ |+|.+++.+.+.+++..++.++.|++.||+|||++
T Consensus        46 ~~~~~E~~il~~~~~~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~  120 (363)
T cd05628          46 GHIRAERDILVEADSLWVVKMFYSFQDK-----LNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL  120 (363)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecC-----CeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3567899999999999999999999987     89999999996 69999998888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC------------------------------------ccccccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD------------------------------------FMTEYVVTR  133 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~------------------------------------~~~~~~~~~  133 (302)
                      ||+||||||+||+++.++.++|+|||+++......                                    .....+||.
T Consensus       121 givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~  200 (363)
T cd05628         121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTP  200 (363)
T ss_pred             CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCc
Confidence            99999999999999999999999999986432110                                    012347899


Q ss_pred             ccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccc
Q 022132          134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR  213 (302)
Q Consensus       134 ~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (302)
                      .|+|||++.+. .++.++|+||+||++|+|++|.+||.+.+.......+.......                        
T Consensus       201 ~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------------------  255 (363)
T cd05628         201 DYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETL------------------------  255 (363)
T ss_pred             cccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcc------------------------
Confidence            99999998654 48899999999999999999999998877666555444311100                        


Q ss_pred             ccccccCCCCCHHHHHHHHHccCCCCC---CCCCHHHHhcCCCcCCc
Q 022132          214 QSFTEKFPNVHPSAIDLVEKMLTFDPR---QRITVEDALAHPYLGSL  257 (302)
Q Consensus       214 ~~~~~~~~~~~~~~~~li~~~L~~dP~---~R~t~~ell~h~~~~~~  257 (302)
                       .++. ...++++++++|.+|+. +|.   .||+++|+++||||++.
T Consensus       256 -~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         256 -IFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             -cCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence             0000 11467899999999775 444   46899999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=292.47  Aligned_cols=242  Identities=26%  Similarity=0.440  Sum_probs=205.9

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..++..|++-++.++|||||++|++....     ..+|+|+|+=+ |+|++++.++ ..+.++..++++.||+.|+.|+|
T Consensus        61 t~hlfqEVRCMKLVQHpNiVRLYEViDTQ-----TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH  135 (864)
T KOG4717|consen   61 TGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-----TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH  135 (864)
T ss_pred             hhHHHHHHHHHHHhcCcCeeeeeehhccc-----ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh
Confidence            34788999999999999999999999887     88999999986 6999999875 56999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEe-cCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           88 SANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      +..++|||+||+|+++. .-|-+||+|||++....++......+|+..|-|||++.+....-+++||||||+|+|.+++|
T Consensus       136 qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCG  215 (864)
T KOG4717|consen  136 QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCG  215 (864)
T ss_pred             hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhC
Confidence            99999999999998765 45899999999998888888889999999999999999988777899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ++||...++.+.+..|++.--+                              ...+++.++++||..||..||++|.|++
T Consensus       216 q~PFqeANDSETLTmImDCKYt------------------------------vPshvS~eCrdLI~sMLvRdPkkRAslE  265 (864)
T KOG4717|consen  216 QPPFQEANDSETLTMIMDCKYT------------------------------VPSHVSKECRDLIQSMLVRDPKKRASLE  265 (864)
T ss_pred             CCccccccchhhhhhhhccccc------------------------------CchhhhHHHHHHHHHHHhcCchhhccHH
Confidence            9999999988888877763221                              1126788999999999999999999999


Q ss_pred             HHhcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHH
Q 022132          247 DALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEA  292 (302)
Q Consensus       247 ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (302)
                      |+..|+|++.......-   .-|+.   ..+.+.+++...+|.+.+
T Consensus       266 eI~s~~Wlq~~D~~~sT---~iPLv---sr~~L~ee~Ha~IIq~Mv  305 (864)
T KOG4717|consen  266 EIVSTSWLQAGDRGLST---AIPLV---SRHHLPEEAHATIIQQMV  305 (864)
T ss_pred             HHhccccccCCCCCccc---cCcee---ehhhCChHHHHHHHHHHh
Confidence            99999999986543222   12322   234566666666665544

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=307.91  Aligned_cols=209  Identities=24%  Similarity=0.446  Sum_probs=182.0

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.|.+|+... +||.++.++.+|.++     .++|+||||+. |++..+ ...+.+++..++.++..|+.||+|||++
T Consensus       414 ~~~~EkrI~~la~~HPFL~~L~~~fQT~-----~~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~  487 (694)
T KOG0694|consen  414 SLMCEKRIFELANRHPFLVNLFSCFQTK-----EHLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHEN  487 (694)
T ss_pred             HHHHHHHHHHHhccCCeEeecccccccC-----CeEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhc
Confidence            345799999988 599999999999998     99999999996 573333 3447899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeeccccccc-CCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+|||||.+|||+|.+|.+||+|||+|+.. .......+.+||+.|+|||++.+. .|+.++|.|||||++|+|+.|.+
T Consensus       488 ~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~  566 (694)
T KOG0694|consen  488 GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGES  566 (694)
T ss_pred             CceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999999854 355667889999999999999654 59999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT----  244 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----  244 (302)
                      ||+|.+..+....|..---                              .....+|.++.++++++|.+||.+|..    
T Consensus       567 PF~gddEee~FdsI~~d~~------------------------------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~  616 (694)
T KOG0694|consen  567 PFPGDDEEEVFDSIVNDEV------------------------------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGER  616 (694)
T ss_pred             CCCCCCHHHHHHHHhcCCC------------------------------CCCCcccHHHHHHHHHHhccCcccccCCCCC
Confidence            9999999988887765110                              111257889999999999999999985    


Q ss_pred             -HHHHhcCCCcCCc
Q 022132          245 -VEDALAHPYLGSL  257 (302)
Q Consensus       245 -~~ell~h~~~~~~  257 (302)
                       ++++..||||+.+
T Consensus       617 d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  617 DAEDIKKHPFFRSI  630 (694)
T ss_pred             CchhhhhCCccccC
Confidence             5899999999976

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.2e-42  Score=299.18  Aligned_cols=210  Identities=26%  Similarity=0.448  Sum_probs=177.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-A   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~-~   89 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|...+...+.+++..+..++.||+.||+|||+ .
T Consensus        41 ~~~~e~~~l~~~~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~  115 (325)
T cd05594          41 HTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK  115 (325)
T ss_pred             HHHHHHHHHHhCCCCCCCceEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence            456899999999999999999999887     88999999997 6999998888889999999999999999999997 7


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++.... .........++..|+|||.+.+. .++.++||||+||++|+|++|..
T Consensus       116 ~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~  194 (325)
T cd05594         116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRL  194 (325)
T ss_pred             CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCC
Confidence            99999999999999999999999999986532 22233445689999999998554 47999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----  243 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----  243 (302)
                      ||.+.+.......+....                              ......+++++.+||.+||++||.+|+     
T Consensus       195 Pf~~~~~~~~~~~i~~~~------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~  244 (325)
T cd05594         195 PFYNQDHEKLFELILMEE------------------------------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPD  244 (325)
T ss_pred             CCCCCCHHHHHHHHhcCC------------------------------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCC
Confidence            998776544433322100                              001125788999999999999999997     


Q ss_pred             CHHHHhcCCCcCCc
Q 022132          244 TVEDALAHPYLGSL  257 (302)
Q Consensus       244 t~~ell~h~~~~~~  257 (302)
                      ++.++++||||...
T Consensus       245 ~~~~il~h~~~~~~  258 (325)
T cd05594         245 DAKEIMQHKFFAGI  258 (325)
T ss_pred             CHHHHhcCCCcCCC
Confidence            99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.2e-41  Score=296.46  Aligned_cols=238  Identities=23%  Similarity=0.358  Sum_probs=179.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++...     +.+++||||++ ++|.+++...+.+++..+..++.|++.||.|||+.
T Consensus        48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~  122 (331)
T cd06649          48 NQIIRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK  122 (331)
T ss_pred             HHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence            4688999999999999999999999887     88999999997 59999998888899999999999999999999986


Q ss_pred             -CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 -NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 -~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                       +|+||||||+||+++.++.++|+|||++...... ......++..|+|||.+.+. .++.++||||+||++|+|++|..
T Consensus       123 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~  200 (331)
T cd06649         123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRY  200 (331)
T ss_pred             CCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCC
Confidence             6999999999999999999999999998765432 23445689999999998654 48999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhh--------------------hHhHHHHhhhccccccccccccCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFL--------------------NENAKKYICQLPRYQRQSFTEKFPNVHPSAI  228 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (302)
                      ||...+..+....+...............                    ...............  .........+++++
T Consensus       201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~  278 (331)
T cd06649         201 PIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEP--PPKLPNGVFTPDFQ  278 (331)
T ss_pred             CCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCC--CcCCCCccccHHHH
Confidence            99876654432221110000000000000                    000000000000000  00001124678999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          229 DLVEKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       229 ~li~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                      +||.+||++||.+|||++|+++||||+..
T Consensus       279 ~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         279 EFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             HHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence            99999999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5e-41  Score=287.80  Aligned_cols=237  Identities=38%  Similarity=0.751  Sum_probs=196.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      .+.+|+.++++++||||+++++++.+.     +..|+||||++++|.+++...   ..+++..+..++.|++.||+|||+
T Consensus        44 ~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  118 (284)
T cd07836          44 TAIREISLMKELKHENIVRLHDVIHTE-----NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE  118 (284)
T ss_pred             HHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence            556899999999999999999999987     889999999999999988653   368999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      .|++||||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++++|++|.
T Consensus       119 ~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~  198 (284)
T cd07836         119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR  198 (284)
T ss_pred             CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999998754332 11233456788999999866656789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+..+....+....+.|....+.... ....+....+...........+..++.+++++.+||+.||.+|||+.+
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~  277 (284)
T cd07836         199 PLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD  277 (284)
T ss_pred             CCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence            9999999888888888888888776654433 111222222222223333444567889999999999999999999999


Q ss_pred             HhcCCCc
Q 022132          248 ALAHPYL  254 (302)
Q Consensus       248 ll~h~~~  254 (302)
                      +++||||
T Consensus       278 ~l~~~~f  284 (284)
T cd07836         278 ALQHPWF  284 (284)
T ss_pred             HhcCCCC
Confidence            9999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.2e-41  Score=296.66  Aligned_cols=216  Identities=20%  Similarity=0.331  Sum_probs=175.8

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.+ +||||+++++++...     +.+|+||||++ |+|.+.+..++.+++..+..++.||+.||+|||+
T Consensus        49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~  123 (332)
T cd05614          49 EHTRTERNVLEHVRQSPFLVTLHYAFQTE-----AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK  123 (332)
T ss_pred             HHHHHHHHHHHhccCCCCcccEEEEEecC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3567899999999 699999999999887     88999999997 6999999888889999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC--CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      .||+||||||+||+++.++.++|+|||++......  .......||..|+|||.+.+...++.++|||||||++|+|++|
T Consensus       124 ~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg  203 (332)
T cd05614         124 LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG  203 (332)
T ss_pred             CCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcC
Confidence            99999999999999999999999999998754322  2223457899999999987655578899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC---
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---  243 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---  243 (302)
                      ..||...........+...+..                  ..        ....+.+++.+.++|.+||+.||.+||   
T Consensus       204 ~~pf~~~~~~~~~~~~~~~~~~------------------~~--------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  257 (332)
T cd05614         204 ASPFTLEGERNTQSEVSRRILK------------------CD--------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAG  257 (332)
T ss_pred             CCCCCCCCCCCCHHHHHHHHhc------------------CC--------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence            9999644321111111110000                  00        011235788999999999999999999   


Q ss_pred             --CHHHHhcCCCcCCc
Q 022132          244 --TVEDALAHPYLGSL  257 (302)
Q Consensus       244 --t~~ell~h~~~~~~  257 (302)
                        +++++++||||+..
T Consensus       258 ~~~~~~~l~h~~~~~~  273 (332)
T cd05614         258 PQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCCHHHHHcCCCcCCC
Confidence              88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.7e-42  Score=298.55  Aligned_cols=210  Identities=22%  Similarity=0.424  Sum_probs=178.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++...     +.+|+||||++ ++|.+.+.+...+++..+..++.||+.||+|||+.|
T Consensus        44 ~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  118 (318)
T cd05582          44 RTKMERDILAEVNHPFIVKLHYAFQTE-----GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG  118 (318)
T ss_pred             HHHHHHHHHHhCCCCCcccEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            456899999999999999999999887     88999999996 799999988888999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.++|+|||++...... .......|+..|+|||.+.+ ..++.++||||+||++|+|++|..|
T Consensus       119 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p  197 (318)
T cd05582         119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLP  197 (318)
T ss_pred             EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCC
Confidence            999999999999999999999999998754433 22344578899999999865 4478999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----  244 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----  244 (302)
                      |.+.+.......+....                              ......+++.+.++|++||+.||.+|||     
T Consensus       198 ~~~~~~~~~~~~i~~~~------------------------------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~  247 (318)
T cd05582         198 FQGKDRKETMTMILKAK------------------------------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDG  247 (318)
T ss_pred             CCCCCHHHHHHHHHcCC------------------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCC
Confidence            98776655444332210                              0111256789999999999999999999     


Q ss_pred             HHHHhcCCCcCCc
Q 022132          245 VEDALAHPYLGSL  257 (302)
Q Consensus       245 ~~ell~h~~~~~~  257 (302)
                      +++++.||||...
T Consensus       248 ~~~~~~~~~~~~~  260 (318)
T cd05582         248 VEEIKRHPFFSTI  260 (318)
T ss_pred             HHHHhCCCCcCCC
Confidence            7889999999864

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.5e-41  Score=294.83  Aligned_cols=210  Identities=20%  Similarity=0.373  Sum_probs=178.2

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+..|..+++.+ +||||+++++++...     +.+|+||||++ ++|...+...+.+++..+..++.||+.||.|||++
T Consensus        41 ~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~  115 (321)
T cd05591          41 CTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH  115 (321)
T ss_pred             HHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            466789999877 899999999999887     88999999997 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++.... .........|+..|+|||.+.+ ..++.++|+||+||++|+|++|.+
T Consensus       116 ~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~  194 (321)
T cd05591         116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQP  194 (321)
T ss_pred             CeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCC
Confidence            99999999999999999999999999986532 2222344568999999999854 458999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----  243 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----  243 (302)
                      ||.+.+....+..+....                              ......+++++.++|.+||+.||.+|+     
T Consensus       195 Pf~~~~~~~~~~~i~~~~------------------------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~  244 (321)
T cd05591         195 PFEADNEDDLFESILHDD------------------------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVAS  244 (321)
T ss_pred             CCCCCCHHHHHHHHHcCC------------------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCC
Confidence            998887666554443210                              001124678999999999999999999     


Q ss_pred             --CHHHHhcCCCcCCc
Q 022132          244 --TVEDALAHPYLGSL  257 (302)
Q Consensus       244 --t~~ell~h~~~~~~  257 (302)
                        +++++++||||...
T Consensus       245 ~~~~~~~~~hp~~~~~  260 (321)
T cd05591         245 QGGEDAIKQHPFFKEI  260 (321)
T ss_pred             CCCHHHHhcCCccCCC
Confidence              99999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-41  Score=286.55  Aligned_cols=239  Identities=42%  Similarity=0.790  Sum_probs=202.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+|+||++++|.+.+.. ...+++..+..++.|++.||.+||+.
T Consensus        43 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~  117 (283)
T cd05118          43 KTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH  117 (283)
T ss_pred             HHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3567899999999999999999999887     89999999999999988876 36899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+|+++++|++|++
T Consensus       118 ~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~  197 (283)
T cd05118         118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP  197 (283)
T ss_pred             CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987655432 22334577889999998765468899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||.+.+..+.+..+...++.+....+..............+...........+.++..++++|.+||.+||.+||+++++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l  277 (283)
T cd05118         198 LFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA  277 (283)
T ss_pred             CCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence            99999988888888888888877766655443333333344444444445556788999999999999999999999999


Q ss_pred             hcCCCc
Q 022132          249 LAHPYL  254 (302)
Q Consensus       249 l~h~~~  254 (302)
                      ++||||
T Consensus       278 l~~~~~  283 (283)
T cd05118         278 LAHPYF  283 (283)
T ss_pred             hhCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=301.22  Aligned_cols=214  Identities=25%  Similarity=0.450  Sum_probs=177.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||+.
T Consensus        46 ~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~  120 (364)
T cd05599          46 AHVRAERDILAEADNPWVVKLYYSFQDE-----NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL  120 (364)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEEcC-----CeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3467899999999999999999999987     89999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC---------------------------------------cccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---------------------------------------FMTEYV  130 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---------------------------------------~~~~~~  130 (302)
                      ||+||||||+||+++.++.++|+|||++.......                                       .....+
T Consensus       121 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (364)
T cd05599         121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV  200 (364)
T ss_pred             CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccc
Confidence            99999999999999999999999999986432110                                       011246


Q ss_pred             cccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccc
Q 022132          131 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR  210 (302)
Q Consensus       131 ~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (302)
                      ||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.......+......                      
T Consensus       201 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~----------------------  257 (364)
T cd05599         201 GTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKET----------------------  257 (364)
T ss_pred             cCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCc----------------------
Confidence            8999999999854 44899999999999999999999999887765554443321000                      


Q ss_pred             cccccccccCCCCCHHHHHHHHHccCCCCCCCCC---HHHHhcCCCcCCc
Q 022132          211 YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSL  257 (302)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ell~h~~~~~~  257 (302)
                      .   .+.. ...+++.+.+||++||. +|.+|++   ++++++||||+..
T Consensus       258 ~---~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         258 L---QFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             c---CCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            0   0000 11468899999999997 9999998   9999999999875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=285.49  Aligned_cols=237  Identities=39%  Similarity=0.754  Sum_probs=196.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.+++.++|||++++++++.+.     +..|++|||++++|.+++....  .+++..+..++.|++.||+|||+.
T Consensus        44 ~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~  118 (283)
T cd07835          44 TAIREISLLKELNHPNIVRLLDVVHSE-----NKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH  118 (283)
T ss_pred             HHHHHHHHHHhcCCCCccCHhheeccC-----CeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            567899999999999999999999887     8999999999999999987655  789999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+|+++++|++|.+
T Consensus       119 ~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~  198 (283)
T cd07835         119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP  198 (283)
T ss_pred             CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999998654322 112233557889999988665557889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||.+.+.......+....+.|....+.... ....+....+...........+.++..+.++|.+||+.||.+|||++|+
T Consensus       199 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i  277 (283)
T cd07835         199 LFPGDSEIDQLFRIFRTLGTPDEDVWPGVT-SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAA  277 (283)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChHHhhhhh-hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            999888888888888888877766553321 1122223333333444445566788999999999999999999999999


Q ss_pred             hcCCCc
Q 022132          249 LAHPYL  254 (302)
Q Consensus       249 l~h~~~  254 (302)
                      +.||||
T Consensus       278 l~~~~~  283 (283)
T cd07835         278 LQHPYF  283 (283)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.3e-40  Score=284.82  Aligned_cols=237  Identities=32%  Similarity=0.659  Sum_probs=190.4

Q ss_pred             hhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           13 FVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        13 ~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ..+|+.+++++ +|||++++++++.+...   +.+++||||++++|.+.+.. .+.+++..+..++.|++.||+|||+.|
T Consensus        44 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~  120 (282)
T cd07831          44 NLREIQALRRLSPHPNILRLIEVLFDRKT---GRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG  120 (282)
T ss_pred             HHHHHHHHhhcCCCCCccceEEEEecCCC---CcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34789999999 59999999999986522   57899999999999988875 357899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      ++||||+|+||+++. +.++|+|||.+.............++..|+|||.+.....++.++|+||+||++++|++|.+||
T Consensus       121 i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~  199 (282)
T cd07831         121 IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF  199 (282)
T ss_pred             ceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC
Confidence            999999999999999 9999999999976654433444567889999998766555788999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      .+.+..+....+.+..+.+............ ......+......+....+..+..++++|.+||.+||.+|||++++++
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         200 PGTNELDQIAKIHDVLGTPDAEVLKKFRKSR-HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CCCCHHHHHHHHHHHcCCCCHHHHHhhcccc-cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            9999888888888888877765422211110 000011111112223334467899999999999999999999999999


Q ss_pred             CCCc
Q 022132          251 HPYL  254 (302)
Q Consensus       251 h~~~  254 (302)
                      ||||
T Consensus       279 ~~~~  282 (282)
T cd07831         279 HPYF  282 (282)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.8e-41  Score=300.36  Aligned_cols=215  Identities=24%  Similarity=0.390  Sum_probs=174.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||+.
T Consensus        46 ~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~  120 (381)
T cd05626          46 AHVKAERDILAEADNEWVVKLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM  120 (381)
T ss_pred             HHHHHHHHHHHhcCCCCeeeeEEEEecC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3577899999999999999999999987     88999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC----------------------------------------------
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET----------------------------------------------  123 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~----------------------------------------------  123 (302)
                      ||+||||||+||+++.++.++|+|||++......                                              
T Consensus       121 givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (381)
T cd05626         121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQH  200 (381)
T ss_pred             CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccc
Confidence            9999999999999999999999999987432100                                              


Q ss_pred             --CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhH
Q 022132          124 --DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA  201 (302)
Q Consensus       124 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (302)
                        .......||..|+|||.+.+. .++.++||||+||++|+|++|.+||.+.+.......+........           
T Consensus       201 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------  268 (381)
T cd05626         201 QRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH-----------  268 (381)
T ss_pred             cccccccccCCccccCHHHHcCC-CCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC-----------
Confidence              001234689999999998654 488999999999999999999999987765544433322100000           


Q ss_pred             HHHhhhccccccccccccCCCCCHHHHHHHHHcc--CCCCCCCCCHHHHhcCCCcCCc
Q 022132          202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML--TFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L--~~dP~~R~t~~ell~h~~~~~~  257 (302)
                                     ......+++++++||.+|+  ..+|..|+|++++++||||+..
T Consensus       269 ---------------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         269 ---------------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence                           0011257889999999965  4555569999999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.1e-41  Score=302.25  Aligned_cols=214  Identities=23%  Similarity=0.411  Sum_probs=175.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++.+.+.     +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++
T Consensus        46 ~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~  120 (382)
T cd05625          46 AHVKAERDILAEADNEWVVRLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM  120 (382)
T ss_pred             HHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4677899999999999999999999887     88999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC----------------------------------------------
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET----------------------------------------------  123 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~----------------------------------------------  123 (302)
                      ||+||||||+||+++.+|.++|+|||++......                                              
T Consensus       121 ~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (382)
T cd05625         121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQH  200 (382)
T ss_pred             CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccc
Confidence            9999999999999999999999999987421100                                              


Q ss_pred             --CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhH
Q 022132          124 --DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA  201 (302)
Q Consensus       124 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (302)
                        .......||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+.......+........           
T Consensus       201 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------  268 (382)
T cd05625         201 QRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH-----------  268 (382)
T ss_pred             ccccccccccCcccCCHHHhcCC-CCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC-----------
Confidence              001224689999999998654 489999999999999999999999988776554443332111000           


Q ss_pred             HHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC---HHHHhcCCCcCCc
Q 022132          202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSL  257 (302)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ell~h~~~~~~  257 (302)
                                     ......+++++.++|.+|+ .||.+|++   ++++++||||...
T Consensus       269 ---------------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         269 ---------------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             ---------------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence                           0011257889999999986 59999997   9999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9e-41  Score=285.91  Aligned_cols=215  Identities=23%  Similarity=0.389  Sum_probs=174.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR----SNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+..|+.+++.++||||+++.+++...     +.+|+||||++ |+|.+.+.    ....+++..+..++.||+.||+||
T Consensus        39 ~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l  113 (280)
T cd05608          39 GAMVEKRILAKVHSRFIVSLAYAFQTK-----TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL  113 (280)
T ss_pred             HHHHHHHHHHhCCCCcEeeeeEEEcCC-----CeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            456899999999999999999999887     88999999996 68987764    345799999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      |+.||+||||||+||+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+||++|+|++
T Consensus       114 H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~  192 (280)
T cd05608         114 HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIA  192 (280)
T ss_pred             HHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHh
Confidence            99999999999999999999999999999987544332 22345688999999998654 47899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC--
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI--  243 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~--  243 (302)
                      |..||...................                          .....+.+++.+.+++.+||+.||.+||  
T Consensus       193 g~~pf~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (280)
T cd05608         193 ARGPFRARGEKVENKELKQRILND--------------------------SVTYPDKFSPASKSFCEALLAKDPEKRLGF  246 (280)
T ss_pred             CCCCCCCCCcchhHHHHHHhhccc--------------------------CCCCcccCCHHHHHHHHHHhcCCHHHhcCC
Confidence            999997654322111111111000                          0111235788999999999999999999  


Q ss_pred             ---CHHHHhcCCCcCCcc
Q 022132          244 ---TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 ---t~~ell~h~~~~~~~  258 (302)
                         |++++++||||++..
T Consensus       247 ~~~~~~~~l~h~~~~~~~  264 (280)
T cd05608         247 RDGNCDGLRTHPLFRDLN  264 (280)
T ss_pred             CCCCHHHHhcChhhhcCC
Confidence               889999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.7e-40  Score=284.66  Aligned_cols=238  Identities=30%  Similarity=0.644  Sum_probs=185.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++...     +.+++||||+++ +|..+......+++..+..++.|++.||+|||+.|
T Consensus        46 ~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~  120 (286)
T cd07847          46 IALREIRMLKQLKHPNLVNLIEVFRRK-----RKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN  120 (286)
T ss_pred             HHHHHHHHHHhCCCCCEeeeeeEEeeC-----CEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            466899999999999999999999887     889999999986 55555555567999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+|+++++|++|.+|
T Consensus       121 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p  200 (286)
T cd07847         121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPL  200 (286)
T ss_pred             ceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987654432 223345678899999987656678999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccc-cccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR-YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |.+.+..+....+....+...............-.....+. ....+....++.++..+.+|+.+||++||++|||+.|+
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei  280 (286)
T cd07847         201 WPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL  280 (286)
T ss_pred             CCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH
Confidence            99888777666666555443332111110000000000000 11112233455778999999999999999999999999


Q ss_pred             hcCCCc
Q 022132          249 LAHPYL  254 (302)
Q Consensus       249 l~h~~~  254 (302)
                      +.||||
T Consensus       281 l~~~~f  286 (286)
T cd07847         281 LEHPYF  286 (286)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.4e-40  Score=291.82  Aligned_cols=241  Identities=36%  Similarity=0.626  Sum_probs=197.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV   91 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i   91 (302)
                      .+.+|+.+++.++||||+++++++...     +..|+||||++++|.+++.....+++..+..++.|++.||++||+.|+
T Consensus        66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i  140 (335)
T PTZ00024         66 TTLRELKIMNEIKHENIMGLVDVYVEG-----DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYF  140 (335)
T ss_pred             hHHHHHHHHHhCCCcceeeeeEEEecC-----CcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            467899999999999999999999887     889999999999999999888889999999999999999999999999


Q ss_pred             eecCCCCCCEEEecCCCEEEeecccccccCC---------------CCcccccccccccCchhhhhCCCCCCCchhHHHH
Q 022132           92 LHRDLKPSNLLLNANCDLKICDFGLARVTSE---------------TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  156 (302)
Q Consensus        92 ~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  156 (302)
                      +|+||+|+||+++.++.++|+|||.+.....               ........++..|+|||.+.+...++.++|+||+
T Consensus       141 ~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  220 (335)
T PTZ00024        141 MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV  220 (335)
T ss_pred             ecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence            9999999999999999999999999865441               1111223457789999998765557899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccC
Q 022132          157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  236 (302)
Q Consensus       157 G~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  236 (302)
                      ||++++|++|.+||.+.+....+..+....+.|....+...... ..+ ...............+..+..+.++|.+||+
T Consensus       221 G~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  298 (335)
T PTZ00024        221 GCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKL-PLY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLK  298 (335)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhc-ccc-cccCcCCcccHHHhCcCCChHHHHHHHHHcC
Confidence            99999999999999999988888888888888776544322110 000 0011111122333445678899999999999


Q ss_pred             CCCCCCCCHHHHhcCCCcCCccC
Q 022132          237 FDPRQRITVEDALAHPYLGSLHD  259 (302)
Q Consensus       237 ~dP~~R~t~~ell~h~~~~~~~~  259 (302)
                      .||.+|||++|+|.||||+....
T Consensus       299 ~~P~~R~s~~~~l~~~~~~~~~~  321 (335)
T PTZ00024        299 LNPLERISAKEALKHEYFKSDPL  321 (335)
T ss_pred             CCchhccCHHHHhcCcccCCCCC
Confidence            99999999999999999997643

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=301.27  Aligned_cols=214  Identities=23%  Similarity=0.386  Sum_probs=175.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..++.++.|++.||+|||+.
T Consensus        46 ~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~  120 (377)
T cd05629          46 AHVKAERDVLAESDSPWVVSLYYSFQDA-----QYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL  120 (377)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEcC-----CeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3567899999999999999999999887     89999999996 79999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-------------C--------------------------------
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-------------D--------------------------------  124 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-------------~--------------------------------  124 (302)
                      ||+||||||+||+++.++.++|+|||+++.....             .                                
T Consensus       121 givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (377)
T cd05629         121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKN  200 (377)
T ss_pred             CeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc
Confidence            9999999999999999999999999988522110             0                                


Q ss_pred             ---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhH
Q 022132          125 ---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA  201 (302)
Q Consensus       125 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (302)
                         ......||..|+|||++.+. .++.++||||+||++|+|++|.+||.+.+....+..+.......            
T Consensus       201 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------  267 (377)
T cd05629         201 RRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL------------  267 (377)
T ss_pred             ccccccccCCCccccCHHHHccC-CCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc------------
Confidence               00124689999999998654 48999999999999999999999998877655554443211000            


Q ss_pred             HHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC---CCHHHHhcCCCcCCc
Q 022132          202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR---ITVEDALAHPYLGSL  257 (302)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---~t~~ell~h~~~~~~  257 (302)
                                   .++ ....++.++++||.+||. +|.+|   +|+.|++.||||...
T Consensus       268 -------------~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         268 -------------YFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             -------------CCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence                         000 112467899999999998 77765   599999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.9e-41  Score=291.71  Aligned_cols=210  Identities=21%  Similarity=0.407  Sum_probs=177.1

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|..+++.+ +||||+++++++...     +.+|+||||++ ++|...+...+.+++..+..++.|++.||+|||+.
T Consensus        41 ~~~~e~~il~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~  115 (318)
T cd05570          41 CTMTEKRVLALAGKHPFLTQLHSCFQTK-----DRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER  115 (318)
T ss_pred             HHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            456788999888 799999999999887     88999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++.... .........++..|+|||.+.+. .++.++|+||+||++++|++|..
T Consensus       116 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~  194 (318)
T cd05570         116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQS  194 (318)
T ss_pred             CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCC
Confidence            99999999999999999999999999986432 22223345688999999998654 48899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH---
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV---  245 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---  245 (302)
                      ||.+.+.......+....                              ......++..+.+||++||+.||.+|||+   
T Consensus       195 pf~~~~~~~~~~~i~~~~------------------------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~  244 (318)
T cd05570         195 PFEGDDEDELFQSILEDE------------------------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPT  244 (318)
T ss_pred             CCCCCCHHHHHHHHHcCC------------------------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCC
Confidence            998776554443332100                              00112467899999999999999999999   


Q ss_pred             --HHHhcCCCcCCc
Q 022132          246 --EDALAHPYLGSL  257 (302)
Q Consensus       246 --~ell~h~~~~~~  257 (302)
                        .++++||||...
T Consensus       245 ~~~~ll~~~~~~~~  258 (318)
T cd05570         245 GEQDIKGHPFFREI  258 (318)
T ss_pred             CHHHHhcCCCcCCC
Confidence              999999999875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.1e-41  Score=293.35  Aligned_cols=219  Identities=21%  Similarity=0.405  Sum_probs=173.3

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|..+++.+ +||||+++++++...     +.+|+||||++ |+|.+.+...+++++..+..++.||+.||+|||++
T Consensus        41 ~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~  115 (329)
T cd05588          41 WVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER  115 (329)
T ss_pred             HHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            466899999999 799999999999887     88999999996 69999988888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeeccccccc-CCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |++||||||+||+++.++.++|+|||++... ..........|+..|+|||++.+ ..++.++|+||+||++|+|++|..
T Consensus       116 ~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~  194 (329)
T cd05588         116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS  194 (329)
T ss_pred             CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCC
Confidence            9999999999999999999999999998642 22223345678999999999865 447899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT----  244 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----  244 (302)
                      ||.......          .+............   ...        .......+++.+.++|++||++||.+|+|    
T Consensus       195 Pf~~~~~~~----------~~~~~~~~~~~~~~---~~~--------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~  253 (329)
T cd05588         195 PFDIVGMSD----------NPDQNTEDYLFQVI---LEK--------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQ  253 (329)
T ss_pred             Ccccccccc----------cccccchHHHHHHH---HcC--------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCC
Confidence            996322110          00000000000000   000        00112357889999999999999999987    


Q ss_pred             --HHHHhcCCCcCCc
Q 022132          245 --VEDALAHPYLGSL  257 (302)
Q Consensus       245 --~~ell~h~~~~~~  257 (302)
                        ++++++||||...
T Consensus       254 ~~~~~i~~hp~~~~~  268 (329)
T cd05588         254 TGFRDIKSHPFFRNI  268 (329)
T ss_pred             CCHHHHhcCCCCCCC
Confidence              7899999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8e-41  Score=291.01  Aligned_cols=210  Identities=22%  Similarity=0.405  Sum_probs=175.0

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ....|..++... +||||+++++++...     +.+|+||||+. ++|...+...+.+++..+..++.||+.||+|||++
T Consensus        41 ~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~  115 (316)
T cd05620          41 CTMVEKRVLALAWENPFLTHLYCTFQTK-----EHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK  115 (316)
T ss_pred             HHHHHHHHHHhccCCCCccCeeEEEEeC-----CEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            455788888765 899999999999887     89999999997 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++..... ........|+..|+|||.+.+. .++.++||||+||++|+|++|..
T Consensus       116 ~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~  194 (316)
T cd05620         116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQS  194 (316)
T ss_pred             CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCC
Confidence            999999999999999999999999999864321 2223445689999999998654 48999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH-HH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-ED  247 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~e  247 (302)
                      ||.+.+.......+..  +.+                            .....++.+++++|.+||+.||.+|+|+ ++
T Consensus       195 Pf~~~~~~~~~~~~~~--~~~----------------------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~  244 (316)
T cd05620         195 PFHGDDEDELFESIRV--DTP----------------------------HYPRWITKESKDILEKLFERDPTRRLGVVGN  244 (316)
T ss_pred             CCCCCCHHHHHHHHHh--CCC----------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHH
Confidence            9987765544333321  000                            1112467899999999999999999997 58


Q ss_pred             HhcCCCcCCc
Q 022132          248 ALAHPYLGSL  257 (302)
Q Consensus       248 ll~h~~~~~~  257 (302)
                      +++||||...
T Consensus       245 ~~~h~~f~~~  254 (316)
T cd05620         245 IRGHPFFKTI  254 (316)
T ss_pred             HHcCCCcCCC
Confidence            9999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=298.13  Aligned_cols=214  Identities=26%  Similarity=0.465  Sum_probs=180.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +.+|+||||+. ++|.+++.+.+.+++..++.++.||+.||+|||+.
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~  120 (350)
T cd05573          46 AHVRAERDILADADSPWIVKLYYSFQDE-----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL  120 (350)
T ss_pred             HHHHHHHHHHHhcCCCCccchhhheecC-----CeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577899999999999999999999887     89999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC------------------------------cccccccccccCchh
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD------------------------------FMTEYVVTRWYRAPE  139 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~------------------------------~~~~~~~~~~y~aPE  139 (302)
                      ||+||||||+||+++.++.++|+|||++.......                              ......||..|+|||
T Consensus       121 giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  200 (350)
T cd05573         121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE  200 (350)
T ss_pred             CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence            99999999999999999999999999987544322                              223456899999999


Q ss_pred             hhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccccccc
Q 022132          140 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK  219 (302)
Q Consensus       140 ~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (302)
                      .+.+. .++.++|||||||++|+|++|..||.+.+.......+.......                         .+ ..
T Consensus       201 ~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~-p~  253 (350)
T cd05573         201 VLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESL-------------------------RF-PP  253 (350)
T ss_pred             HHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcc-------------------------cC-CC
Confidence            98655 58999999999999999999999998877655544443211000                         00 01


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCC-HHHHhcCCCcCCc
Q 022132          220 FPNVHPSAIDLVEKMLTFDPRQRIT-VEDALAHPYLGSL  257 (302)
Q Consensus       220 ~~~~~~~~~~li~~~L~~dP~~R~t-~~ell~h~~~~~~  257 (302)
                      ...+++++.+||.+||. ||.+|++ ++++++||||...
T Consensus       254 ~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         254 DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            11368899999999997 9999999 9999999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=276.14  Aligned_cols=255  Identities=44%  Similarity=0.762  Sum_probs=215.1

Q ss_pred             hhHHHHhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHH
Q 022132            3 SITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG   82 (302)
Q Consensus         3 ~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~   82 (302)
                      .++.+.+-+.+.||+++|.-++|.|++..+|+.......-+..+|+++|.+..+|...+-+...++.+.++-+++||+.|
T Consensus        89 vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRG  168 (449)
T KOG0664|consen   89 VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRG  168 (449)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhh
Confidence            45677888899999999999999999999999998766666779999999999999999998999999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC--CcccccccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      |+|||+.||.||||||.|++++++..+||||||+++.....  ...+..+-|.+|+|||++.+...|+.+.||||.|||+
T Consensus       169 LKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIF  248 (449)
T KOG0664|consen  169 LKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIF  248 (449)
T ss_pred             hHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHH
Confidence            99999999999999999999999999999999999876543  3445667799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC-----CCCHHHHHHHHHcc
Q 022132          161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-----NVHPSAIDLVEKML  235 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L  235 (302)
                      .|++..+..|...+..+++..|.+.+|+|+-+.+..--+-.+..+-..+..+ .++...+.     +-.....+++.+||
T Consensus       249 aELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~-Ps~~vLYtlsS~~~~~heav~~~~~~l  327 (449)
T KOG0664|consen  249 AELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRA-PDTQRLYKIASPDDKNHEAVDLLQKLL  327 (449)
T ss_pred             HHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCC-CCccceeeecCCcccchHHHHHHHHHh
Confidence            9999999999999999999999999999998876543333333222111111 11111111     22346788999999


Q ss_pred             CCCCCCCCCHHHHhcCCCcCCcc
Q 022132          236 TFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       236 ~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      .+||++|.+.++++.|+|....+
T Consensus       328 ~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  328 HFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             CCCCcccccHhhhcccccccccc
Confidence            99999999999999999997653

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-43  Score=296.87  Aligned_cols=211  Identities=24%  Similarity=0.390  Sum_probs=182.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ...+|+.+|.+++++||.++|+.|...     ..++++||||+ |++.+.++....+++..+..++++++.|+.|||+.+
T Consensus        57 diqqei~~Ls~~~~~~it~yygsyl~g-----~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~  131 (467)
T KOG0201|consen   57 DIQQEISVLSQCDSPNITEYYGSYLKG-----TKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK  131 (467)
T ss_pred             HHHHHHHHHHhcCcchHHhhhhheeec-----ccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc
Confidence            345799999999999999999999998     88999999997 699999998877899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      .+|||||+.||++..+|.++|+|||.+....... ....++||++|||||++. ...|+.++||||||++.++|++|.||
T Consensus       132 kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP  210 (467)
T KOG0201|consen  132 KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPP  210 (467)
T ss_pred             eecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCC
Confidence            9999999999999999999999999987665543 347889999999999997 44599999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      +........+-.|.                             +...+..-..+++.+++|+..||++||..||||.+||
T Consensus       211 ~s~~hPmrvlflIp-----------------------------k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LL  261 (467)
T KOG0201|consen  211 HSKLHPMRVLFLIP-----------------------------KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELL  261 (467)
T ss_pred             CcccCcceEEEecc-----------------------------CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence            98776532222111                             1111222226789999999999999999999999999


Q ss_pred             cCCCcCCc
Q 022132          250 AHPYLGSL  257 (302)
Q Consensus       250 ~h~~~~~~  257 (302)
                      +|+|++..
T Consensus       262 Kh~FIk~a  269 (467)
T KOG0201|consen  262 KHKFIKRA  269 (467)
T ss_pred             hhHHHHhc
Confidence            99999873

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=283.29  Aligned_cols=237  Identities=39%  Similarity=0.739  Sum_probs=200.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+|+||++++|.+++... ..+++..+..++.|++.||++||+.|
T Consensus        44 ~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~  118 (282)
T cd07829          44 TALREISLLKELKHPNIVKLLDVIHTE-----RKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR  118 (282)
T ss_pred             HHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            456799999999999999999999987     899999999999999999875 58999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ++||||+|+||+++.++.++|+|||.+....... .......+..|+|||.+.+...++.++|+||+||++++|++|.+|
T Consensus       119 i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~  198 (282)
T cd07829         119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPL  198 (282)
T ss_pred             cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987654332 223345577899999987665688999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+..+.+..+....+.+....+....... .+....+..........++..+..+.++|++||..||.+|||+++++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l  277 (282)
T cd07829         199 FPGDSEIDQLFKIFQILGTPTEESWPGVTKLP-DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL  277 (282)
T ss_pred             CCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHh
Confidence            99999888999999988888877665443322 22223344444444555667789999999999999999999999999


Q ss_pred             cCCCc
Q 022132          250 AHPYL  254 (302)
Q Consensus       250 ~h~~~  254 (302)
                      .||||
T Consensus       278 ~~p~~  282 (282)
T cd07829         278 KHPYF  282 (282)
T ss_pred             hCcCC
Confidence            99998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.6e-41  Score=297.41  Aligned_cols=213  Identities=23%  Similarity=0.367  Sum_probs=177.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++.+.     +.+|+||||++ |+|.+++.. ..+++..+..++.||+.||+|||+.|
T Consensus        89 ~~~~e~~il~~~~h~~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~  162 (370)
T cd05596          89 FFWEERDIMAHANSEWIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMG  162 (370)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEecC-----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            466899999999999999999999887     89999999996 699998865 46899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCC---CCCCCchhHHHHHHHHHHHHh
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~i~~~ll~  165 (302)
                      |+||||||+||+++.++.++|+|||.+.......  ......|++.|+|||++.+.   ..++.++|+|||||++|+|++
T Consensus       163 ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt  242 (370)
T cd05596         163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV  242 (370)
T ss_pred             eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh
Confidence            9999999999999999999999999987654321  22345789999999998543   236889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC--CC
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RI  243 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~  243 (302)
                      |.+||.+.+....+..+.......                         .+ .....++..+.+||.+||..+|.+  |+
T Consensus       243 G~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~  296 (370)
T cd05596         243 GDTPFYADSLVGTYSKIMDHKNSL-------------------------TF-PDDIEISKQAKDLICAFLTDREVRLGRN  296 (370)
T ss_pred             CCCCcCCCCHHHHHHHHHcCCCcC-------------------------CC-CCcCCCCHHHHHHHHHHccChhhccCCC
Confidence            999998877665554443211100                         00 011256889999999999999998  99


Q ss_pred             CHHHHhcCCCcCC
Q 022132          244 TVEDALAHPYLGS  256 (302)
Q Consensus       244 t~~ell~h~~~~~  256 (302)
                      |++|+++||||+.
T Consensus       297 s~~ell~h~~~~~  309 (370)
T cd05596         297 GVDEIKSHPFFKN  309 (370)
T ss_pred             CHHHHhcCcccCC
Confidence            9999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.4e-41  Score=292.54  Aligned_cols=210  Identities=24%  Similarity=0.461  Sum_probs=175.2

Q ss_pred             chhhHHH-HHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSC-FDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|.. +++.++||||+++++.+...     +.+|+||||+. ++|..++...+.+++..+..++.||+.||+|||++
T Consensus        41 ~~~~e~~~~~~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~  115 (323)
T cd05575          41 HIMAERNVLLKNVKHPFLVGLHYSFQTA-----DKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL  115 (323)
T ss_pred             HHHHHHHHHHhhCCCCCCCCeeEEEEeC-----CEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3444544 46778999999999999887     88999999997 69999998888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++..... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|.+
T Consensus       116 givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~  194 (323)
T cd05575         116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLP  194 (323)
T ss_pred             CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCC
Confidence            999999999999999999999999999865322 223344568999999999865 448899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH---
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV---  245 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---  245 (302)
                      ||.+.+..+....+...   +                           ....+..++.+.++|++||+.||.+||++   
T Consensus       195 pf~~~~~~~~~~~i~~~---~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~  244 (323)
T cd05575         195 PFYSRDTAEMYDNILNK---P---------------------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDD  244 (323)
T ss_pred             CCCCCCHHHHHHHHHcC---C---------------------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCC
Confidence            99887665544433220   0                           11223578899999999999999999987   


Q ss_pred             -HHHhcCCCcCCc
Q 022132          246 -EDALAHPYLGSL  257 (302)
Q Consensus       246 -~ell~h~~~~~~  257 (302)
                       .++++||||...
T Consensus       245 ~~~il~~~~~~~~  257 (323)
T cd05575         245 FLEIKNHVFFSSI  257 (323)
T ss_pred             HHHHHcCCCcCCC
Confidence             699999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.7e-40  Score=283.97  Aligned_cols=242  Identities=38%  Similarity=0.733  Sum_probs=193.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.++++++||||+++++++...     +.+|+||||++++|.+.+....  .+++..+..++.||+.||+|||++
T Consensus        47 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~  121 (294)
T PLN00009         47 TAIREISLLKEMQHGNIVRLQDVVHSE-----KRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH  121 (294)
T ss_pred             HHHHHHHHHHhccCCCEeeEEEEEecC-----CeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence            567899999999999999999999887     8999999999999988886543  357888999999999999999999


Q ss_pred             CceecCCCCCCEEEec-CCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           90 NVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |++|+||+|+||+++. ++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++++|++|.
T Consensus       122 ~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~  201 (294)
T PLN00009        122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK  201 (294)
T ss_pred             CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999999985 457999999998754332 12233456788999999866556789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+..+.+..+....+.|....+..... ...+....+...........+..++.+.+++.+||+.||.+|||+++
T Consensus       202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~  280 (294)
T PLN00009        202 PLFPGDSEIDELFKIFRILGTPNEETWPGVTS-LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA  280 (294)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCChhhcccccc-chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHH
Confidence            99998888888888888788777665442211 11111111222222222334567889999999999999999999999


Q ss_pred             HhcCCCcCCccC
Q 022132          248 ALAHPYLGSLHD  259 (302)
Q Consensus       248 ll~h~~~~~~~~  259 (302)
                      ++.||||..+..
T Consensus       281 ~l~~~~~~~~~~  292 (294)
T PLN00009        281 ALEHEYFKDLGD  292 (294)
T ss_pred             HhcCchHhHHhc
Confidence            999999988653

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.5e-40  Score=282.94  Aligned_cols=243  Identities=36%  Similarity=0.696  Sum_probs=192.0

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-----QALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qll~~l~   84 (302)
                      ..+.+|+.+++.+ +||||+++++++......+....|+||||++++|.+++...     ..+++..+..++.||+.||.
T Consensus        45 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~  124 (295)
T cd07837          45 PTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA  124 (295)
T ss_pred             hHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHH
Confidence            3567899999999 56999999999987633222458999999999999988642     35899999999999999999


Q ss_pred             HHHhCCceecCCCCCCEEEec-CCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           85 YIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        85 ~LH~~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      |||+.|++||||+|+||+++. ++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+|+++++
T Consensus       125 ~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~  204 (295)
T cd07837         125 HCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAE  204 (295)
T ss_pred             HHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHH
Confidence            999999999999999999998 889999999998754322 112233567789999988665667899999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      |++|.+||.+.+.......+...++.|....+.........  ...+...........+.+++.+.+||.+||.+||.+|
T Consensus       205 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R  282 (295)
T cd07837         205 MSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDW--HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKR  282 (295)
T ss_pred             HHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccch--hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhc
Confidence            99999999998888888888887777766544322111000  0112222223334455788999999999999999999


Q ss_pred             CCHHHHhcCCCcC
Q 022132          243 ITVEDALAHPYLG  255 (302)
Q Consensus       243 ~t~~ell~h~~~~  255 (302)
                      ||++|++.||||+
T Consensus       283 ~~~~eil~~~~~~  295 (295)
T cd07837         283 ISAKAALTHPYFD  295 (295)
T ss_pred             CCHHHHhcCCCcC
Confidence            9999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=284.92  Aligned_cols=215  Identities=26%  Similarity=0.395  Sum_probs=177.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++.+...     +.+|+||||++ ++|.+.+...  ..+++..+..++.|++.||.|||
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  119 (285)
T cd05605          45 AMALNEKQILEKVNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH  119 (285)
T ss_pred             HHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999999887     88999999996 6898887543  46999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +.|++||||+|+||+++.++.++|+|||++.............++..|+|||.+.+ ..++.++|+||+||++|+|++|.
T Consensus       120 ~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~  198 (285)
T cd05605         120 RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGK  198 (285)
T ss_pred             HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCC
Confidence            99999999999999999999999999999876544433344578899999999865 44789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC----
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI----  243 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----  243 (302)
                      .||.+.+.......+...+....                          ....+.++..+.+||.+||..||.+||    
T Consensus       199 ~pf~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~  252 (285)
T cd05605         199 SPFRQRKEKVKREEVERRVKEDQ--------------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRG  252 (285)
T ss_pred             CCCCCCchhhHHHHHHHHhhhcc--------------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCC
Confidence            99987655433322222111000                          111235788899999999999999999    


Q ss_pred             -CHHHHhcCCCcCCc
Q 022132          244 -TVEDALAHPYLGSL  257 (302)
Q Consensus       244 -t~~ell~h~~~~~~  257 (302)
                       +++++++||||...
T Consensus       253 ~~~~~l~~~~~~~~~  267 (285)
T cd05605         253 EGAEEVKAHPFFRTA  267 (285)
T ss_pred             CCHHHHhcCcCccCC
Confidence             99999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-41  Score=292.29  Aligned_cols=209  Identities=26%  Similarity=0.413  Sum_probs=181.3

Q ss_pred             HHhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHH
Q 022132            7 LMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGL   83 (302)
Q Consensus         7 ~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l   83 (302)
                      .++...|.+|+++|++|+|+|||++++++...     ..+|||||||. |+|.++|..  ++.+.......++.||++|.
T Consensus       242 ~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM  316 (468)
T KOG0197|consen  242 SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGM  316 (468)
T ss_pred             ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHH
Confidence            44557889999999999999999999999987     67999999997 899999986  57899999999999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCccc--ccccccccCchhhhhCCCCCCCchhHHHHHHHHH
Q 022132           84 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT--EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~  161 (302)
                      +||++++++||||.+.||||++++.+||+|||+|+...+..+..  ...-...|+|||.+..+. ++.+|||||||++++
T Consensus       317 ~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~  395 (468)
T KOG0197|consen  317 AYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLW  395 (468)
T ss_pred             HHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHH
Confidence            99999999999999999999999999999999999766553322  222345699999996554 999999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          162 ELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       162 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      ||+| |+.||++.+..+.+..+.+..+-|-+                             +.+|+.+-+++..||+.+|+
T Consensus       396 E~fT~G~~py~~msn~ev~~~le~GyRlp~P-----------------------------~~CP~~vY~lM~~CW~~~P~  446 (468)
T KOG0197|consen  396 ELFTYGRVPYPGMSNEEVLELLERGYRLPRP-----------------------------EGCPDEVYELMKSCWHEDPE  446 (468)
T ss_pred             HHhccCCCCCCCCCHHHHHHHHhccCcCCCC-----------------------------CCCCHHHHHHHHHHhhCCcc
Confidence            9997 99999999998888877664443332                             37899999999999999999


Q ss_pred             CCCCHHHHhc
Q 022132          241 QRITVEDALA  250 (302)
Q Consensus       241 ~R~t~~ell~  250 (302)
                      +|||++.+..
T Consensus       447 ~RPtF~~L~~  456 (468)
T KOG0197|consen  447 DRPTFETLRE  456 (468)
T ss_pred             cCCCHHHHHH
Confidence            9999997643

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.7e-41  Score=300.00  Aligned_cols=214  Identities=22%  Similarity=0.379  Sum_probs=175.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++.+.+.     +.+|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++
T Consensus        46 ~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~  120 (376)
T cd05598          46 AHVKAERDILAEADNEWVVKLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM  120 (376)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4567899999999999999999999887     89999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC--------------------------------------------CCc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE--------------------------------------------TDF  125 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~--------------------------------------------~~~  125 (302)
                      ||+||||||+||+++.++.++|+|||++.....                                            ...
T Consensus       121 ~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (376)
T cd05598         121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCL  200 (376)
T ss_pred             CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccccc
Confidence            999999999999999999999999998742110                                            000


Q ss_pred             ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHh
Q 022132          126 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI  205 (302)
Q Consensus       126 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (302)
                      .....||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.......+.......                
T Consensus       201 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~----------------  263 (376)
T cd05598         201 AHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL----------------  263 (376)
T ss_pred             ccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccc----------------
Confidence            113468999999999865 447899999999999999999999998876554433322100000                


Q ss_pred             hhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC---CHHHHhcCCCcCCc
Q 022132          206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSL  257 (302)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~ell~h~~~~~~  257 (302)
                               . ......+++.+.++|.+|+ .+|.+|+   |++++++||||...
T Consensus       264 ---------~-~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         264 ---------H-IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             ---------c-CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence                     0 0111257889999999976 5999999   99999999999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.7e-40  Score=289.02  Aligned_cols=209  Identities=23%  Similarity=0.421  Sum_probs=174.6

Q ss_pred             hhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           13 FVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        13 ~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      +..|..++... +||||+++++++...     +.+|+||||++ |+|.+.+...+.+++..+..++.||+.||+|||+.|
T Consensus        42 ~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~  116 (316)
T cd05592          42 TMVERRVLALAWEHPFLTHLFCTFQTK-----EHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG  116 (316)
T ss_pred             HHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45677777765 899999999999887     88999999996 699999988888999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.++|+|||++..... ........||..|+|||.+.+. .++.++|+||+||++++|++|..|
T Consensus       117 ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~P  195 (316)
T cd05592         117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSP  195 (316)
T ss_pred             EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCC
Confidence            99999999999999999999999999875432 2233445789999999998654 478999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH-HHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-EDA  248 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-~el  248 (302)
                      |.+.+.......+...  .+                            .....++.++.++|.+||+.||.+||++ .++
T Consensus       196 f~~~~~~~~~~~i~~~--~~----------------------------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l  245 (316)
T cd05592         196 FHGEDEDELFDSILND--RP----------------------------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDI  245 (316)
T ss_pred             CCCCCHHHHHHHHHcC--CC----------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence            9887765544433210  00                            0112467889999999999999999986 589


Q ss_pred             hcCCCcCCc
Q 022132          249 LAHPYLGSL  257 (302)
Q Consensus       249 l~h~~~~~~  257 (302)
                      +.||||...
T Consensus       246 ~~h~~~~~~  254 (316)
T cd05592         246 RQHPFFRGI  254 (316)
T ss_pred             HcCcccCCC
Confidence            999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.4e-40  Score=282.84  Aligned_cols=217  Identities=21%  Similarity=0.319  Sum_probs=174.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+..|+.+++.++||||+++++++...     ..+|+||||++ ++|.+.+...  ..+++..+..++.|++.||+|||
T Consensus        38 ~~~~~E~~il~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH  112 (277)
T cd05607          38 KMALLEKEILEKVNSPFIVNLAYAFESK-----THLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH  112 (277)
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEecC-----CeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3456799999999999999999999887     88999999996 6998887543  35889999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +.|++||||||+||+++.++.++|+|||++.............++..|+|||.+.+.. ++.++|+||+||++|+|++|.
T Consensus       113 ~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~  191 (277)
T cd05607         113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGR  191 (277)
T ss_pred             HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999999987665443344457888999999986554 899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH--
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV--  245 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--  245 (302)
                      .||.+................                         .........+++++++++.+||++||.+|||+  
T Consensus       192 ~p~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~  246 (277)
T cd05607         192 TPFKDHKEKVAKEELKRRTLE-------------------------DEVKFEHQNFTEESKDICRLFLAKKPEDRLGSRE  246 (277)
T ss_pred             CCCCCCcchhhHHHHHHHhhc-------------------------cccccccccCCHHHHHHHHHHhccCHhhCCCCcc
Confidence            999754322111111110000                         00011122578899999999999999999999  


Q ss_pred             --HHHhcCCCcCCcc
Q 022132          246 --EDALAHPYLGSLH  258 (302)
Q Consensus       246 --~ell~h~~~~~~~  258 (302)
                        ++++.|+||+.+.
T Consensus       247 ~~~~~~~h~~f~~~~  261 (277)
T cd05607         247 KNDDPRKHEFFKTIN  261 (277)
T ss_pred             chhhhhcChhhcCCC
Confidence              6788999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-40  Score=288.50  Aligned_cols=222  Identities=26%  Similarity=0.432  Sum_probs=176.1

Q ss_pred             chhHHHHhcC-------chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCC-CCHHHH
Q 022132            2 HSITKLMQRG-------HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHC   72 (302)
Q Consensus         2 ~~~~~~~~~~-------~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-l~~~~~   72 (302)
                      +|++|.....       -|..|+..|.+| .|.+||+|+||-...     +.+||||||=+.+|..+|.++.. +..-.+
T Consensus       388 yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d-----~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~l  462 (677)
T KOG0596|consen  388 YALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD-----GYLYMVMECGDIDLNKILKKKKSIDPDWFL  462 (677)
T ss_pred             hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC-----ceEEEEeecccccHHHHHHhccCCCchHHH
Confidence            4555554443       688999999999 699999999999887     89999999999999999987654 333489


Q ss_pred             HHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCC----
Q 022132           73 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSS----  145 (302)
Q Consensus        73 ~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~----  145 (302)
                      +.+..|+|.|+.++|..||+|.||||.|+++- .|.+||+|||.|..+....   .....+||..|||||.+....    
T Consensus       463 k~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~  541 (677)
T KOG0596|consen  463 KFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRE  541 (677)
T ss_pred             HHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhcccccc
Confidence            99999999999999999999999999999886 5689999999998766543   345678999999999985332    


Q ss_pred             ------CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccccccc
Q 022132          146 ------DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK  219 (302)
Q Consensus       146 ------~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (302)
                            ..+.++||||||||+|+|+.|++||..-..   ....+..+..|..                         +..
T Consensus       542 ~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---~~aKl~aI~~P~~-------------------------~Ie  593 (677)
T KOG0596|consen  542 NGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---QIAKLHAITDPNH-------------------------EIE  593 (677)
T ss_pred             CCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---HHHHHHhhcCCCc-------------------------ccc
Confidence                  256799999999999999999999943211   1111222223321                         112


Q ss_pred             CCCCC--HHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          220 FPNVH--PSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       220 ~~~~~--~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                      ||..+  .++.++++.||.+||++|||+.|||+|||++..
T Consensus       594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            23332  238999999999999999999999999999874

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-40  Score=304.10  Aligned_cols=212  Identities=23%  Similarity=0.331  Sum_probs=177.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||+. |+|.+.+..    ..++++..+..++.||+.||.|
T Consensus       110 ~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  184 (478)
T PTZ00267        110 AYARSELHCLAACDHFGIVKHFDDFKSD-----DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDE  184 (478)
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence            3566899999999999999999999887     89999999996 699887753    4579999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      ||+.||+||||||+||+++.++.++|+|||++.......   ......||+.|+|||.+.+ ..++.++||||+||++++
T Consensus       185 lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~e  263 (478)
T PTZ00267        185 VHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYE  263 (478)
T ss_pred             HHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHH
Confidence            999999999999999999999999999999997654321   2344568999999998855 458999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      |++|..||.+.+....+..+......                             .....+++.+.++|.+||..||.+|
T Consensus       264 l~tg~~Pf~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~s~~~~~li~~~L~~dP~~R  314 (478)
T PTZ00267        264 LLTLHRPFKGPSQREIMQQVLYGKYD-----------------------------PFPCPVSSGMKALLDPLLSKNPALR  314 (478)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHhCCCC-----------------------------CCCccCCHHHHHHHHHHhccChhhC
Confidence            99999999877665544443321100                             0112567889999999999999999


Q ss_pred             CCHHHHhcCCCcCCc
Q 022132          243 ITVEDALAHPYLGSL  257 (302)
Q Consensus       243 ~t~~ell~h~~~~~~  257 (302)
                      ||+++++.|+|++..
T Consensus       315 ps~~~~l~~~~~~~~  329 (478)
T PTZ00267        315 PTTQQLLHTEFLKYV  329 (478)
T ss_pred             cCHHHHHhCHHHHHH
Confidence            999999999998754

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-41  Score=294.71  Aligned_cols=211  Identities=22%  Similarity=0.431  Sum_probs=175.1

Q ss_pred             hhhHHHHHHhc---CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           13 FVRSSCFDTWI---MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        13 ~~~E~~il~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+|..++..+   +||||+++++++...     +.+|+||||+. |+|...+.+.+.+++..+..++.||+.||+|||+
T Consensus        40 ~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~  114 (330)
T cd05586          40 TIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK  114 (330)
T ss_pred             HHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            44566777665   699999999999887     89999999996 6999999888899999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||+||||||+||+++.++.++|+|||++..... ........|+..|+|||.+.+...++.++||||+||++|+|++|.
T Consensus       115 ~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~  194 (330)
T cd05586         115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW  194 (330)
T ss_pred             CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCC
Confidence            9999999999999999999999999999865322 223345678999999999876555789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC----
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI----  243 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----  243 (302)
                      .||.+.+.......+.....                           .+.  ...+++++.+||++||++||.+||    
T Consensus       195 ~Pf~~~~~~~~~~~i~~~~~---------------------------~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~  245 (330)
T cd05586         195 SPFYAEDTQQMYRNIAFGKV---------------------------RFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHR  245 (330)
T ss_pred             CCCCCCCHHHHHHHHHcCCC---------------------------CCC--CccCCHHHHHHHHHHcCCCHHHCCCCCC
Confidence            99987765544433321000                           000  013678899999999999999998    


Q ss_pred             CHHHHhcCCCcCCc
Q 022132          244 TVEDALAHPYLGSL  257 (302)
Q Consensus       244 t~~ell~h~~~~~~  257 (302)
                      +++++++||||...
T Consensus       246 ~~~~ll~h~~~~~~  259 (330)
T cd05586         246 DAVELKEHPFFADI  259 (330)
T ss_pred             CHHHHhcCccccCC
Confidence            79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.2e-41  Score=294.58  Aligned_cols=215  Identities=21%  Similarity=0.396  Sum_probs=178.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +.+|+||||++ ++|.+++... +.+++..+..++.|++.||+|||+
T Consensus        46 ~~~~~e~~i~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~  120 (330)
T cd05601          46 SFFEEERDILSISNSPWIPQLQYAFQDK-----DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ  120 (330)
T ss_pred             HHHHHHHHHHHhCCCCCCcceeeEEecC-----CeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999999887     88999999996 6999999875 689999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhC-----CCCCCCchhHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLN-----SSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~i~~  161 (302)
                      .||+||||||+||+++.++.++|+|||++.......  ......++..|+|||.+..     ...++.++||||+||++|
T Consensus       121 ~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~  200 (330)
T cd05601         121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY  200 (330)
T ss_pred             CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceee
Confidence            999999999999999999999999999987654332  1223468899999999853     344678999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       162 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      +|++|..||.+.+....+..+.+.....                         .+ ...+.+++.+.+||.+||. ||.+
T Consensus       201 el~~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~-~~~~~~~~~~~~li~~ll~-~p~~  253 (330)
T cd05601         201 EMIYGRSPFHEGTSAKTYNNIMNFQRFL-------------------------KF-PEDPKVSSDFLDLIQSLLC-GQKE  253 (330)
T ss_pred             eeccCCCCCCCCCHHHHHHHHHcCCCcc-------------------------CC-CCCCCCCHHHHHHHHHHcc-Chhh
Confidence            9999999998777655544443211000                         00 0113578899999999998 9999


Q ss_pred             CCCHHHHhcCCCcCCc
Q 022132          242 RITVEDALAHPYLGSL  257 (302)
Q Consensus       242 R~t~~ell~h~~~~~~  257 (302)
                      |||++++++||||...
T Consensus       254 R~t~~~l~~h~~~~~~  269 (330)
T cd05601         254 RLGYEGLCCHPFFSKI  269 (330)
T ss_pred             CCCHHHHhCCCCcCCC
Confidence            9999999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-40  Score=297.33  Aligned_cols=239  Identities=23%  Similarity=0.311  Sum_probs=177.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+|++++||||+++++++...     +..++|||++.++|.+++... +.+++..+..++.||+.||.|||+.
T Consensus       205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~  279 (461)
T PHA03211        205 ASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE  279 (461)
T ss_pred             cCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4567899999999999999999999887     789999999999999988754 5799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ||+||||||+||+++.++.++|+|||+++......   ......||..|+|||++.+. .++.++|||||||++|+|++|
T Consensus       280 gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g  358 (461)
T PHA03211        280 GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVH  358 (461)
T ss_pred             CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHc
Confidence            99999999999999999999999999987543221   12235689999999998654 489999999999999999987


Q ss_pred             CCC-CCCCC------hHHHHHHHHHHhCCCChHHHh----hhhHhHHH--HhhhccccccccccccCCCCCHHHHHHHHH
Q 022132          167 KPL-FPGRD------HVHQLRLLIELIGTPSEAELG----FLNENAKK--YICQLPRYQRQSFTEKFPNVHPSAIDLVEK  233 (302)
Q Consensus       167 ~~p-f~~~~------~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  233 (302)
                      ..+ |....      ....+..++...+........    .+......  .....+......|.. +...+.++.+||.+
T Consensus       359 ~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~  437 (461)
T PHA03211        359 TASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCR  437 (461)
T ss_pred             CCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhh-hccccchHHHHHHH
Confidence            754 33221      123344444433322111000    00000000  001111122222222 23567789999999


Q ss_pred             ccCCCCCCCCCHHHHhcCCCcCC
Q 022132          234 MLTFDPRQRITVEDALAHPYLGS  256 (302)
Q Consensus       234 ~L~~dP~~R~t~~ell~h~~~~~  256 (302)
                      ||+.||.+|||+.|+|+||||++
T Consensus       438 mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        438 ALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HcccChhhCcCHHHHhhCcccCC
Confidence            99999999999999999999975

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-40  Score=281.49  Aligned_cols=238  Identities=37%  Similarity=0.698  Sum_probs=197.2

Q ss_pred             chhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh
Q 022132           12 HFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        12 ~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+|+..++.++ ||||+++++++...     +..|+||||++++|.+.+....  .+++..+..++.|++.||.|||+
T Consensus        43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~  117 (283)
T cd07830          43 MNLREVKSLRKLNEHPNIVKLKEVFREN-----DELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK  117 (283)
T ss_pred             HHHHHHHHHHhccCCCCchhHHHHhhcC-----CcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH
Confidence            3457999999998 99999999999886     8999999999999999987654  78999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      +|++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+...++.++|+||+|+++++|++|.+
T Consensus       118 ~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~  197 (283)
T cd07830         118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP  197 (283)
T ss_pred             CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCC
Confidence            99999999999999999999999999998766554444455678889999988666667899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||.+....+....+...++.+....+..............+..........++..+..++++|++||+.||.+|||++|+
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  277 (283)
T cd07830         198 LFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA  277 (283)
T ss_pred             ccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHH
Confidence            99999988888888888888876654433222222111222222222334444557899999999999999999999999


Q ss_pred             hcCCCc
Q 022132          249 LAHPYL  254 (302)
Q Consensus       249 l~h~~~  254 (302)
                      +.||||
T Consensus       278 ~~~~~~  283 (283)
T cd07830         278 LQHPYF  283 (283)
T ss_pred             hhCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.5e-40  Score=288.93  Aligned_cols=210  Identities=22%  Similarity=0.402  Sum_probs=176.4

Q ss_pred             chhhHHHHHHhcCC-CCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMK-TSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|..+++.+.| ++|+++++++...     +.+|+||||++ |+|.+.+...+.+++..+..++.||+.||+|||+.
T Consensus        46 ~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~  120 (324)
T cd05587          46 CTMVEKRVLALPGKPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK  120 (324)
T ss_pred             HHHHHHHHHHhcCCCCceeeeEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            56789999999966 5688899999887     88999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++.... .........|+..|+|||.+.+. .++.++|+||+||++|+|++|.+
T Consensus       121 ~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~  199 (324)
T cd05587         121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQP  199 (324)
T ss_pred             CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCC
Confidence            99999999999999999999999999986432 22223445689999999998654 47899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH---
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV---  245 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---  245 (302)
                      ||.+.+.......+....                              ......+++.+.+++++||.+||.+|++.   
T Consensus       200 pf~~~~~~~~~~~i~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~  249 (324)
T cd05587         200 PFDGEDEDELFQSIMEHN------------------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPT  249 (324)
T ss_pred             CCCCCCHHHHHHHHHcCC------------------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCC
Confidence            998877665554443210                              01112578899999999999999999986   


Q ss_pred             --HHHhcCCCcCCc
Q 022132          246 --EDALAHPYLGSL  257 (302)
Q Consensus       246 --~ell~h~~~~~~  257 (302)
                        +++++||||...
T Consensus       250 ~~~~~~~hp~~~~~  263 (324)
T cd05587         250 GERDIREHAFFRRI  263 (324)
T ss_pred             CHHHHhcCCCcCCC
Confidence              899999999874

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.7e-40  Score=286.79  Aligned_cols=211  Identities=23%  Similarity=0.413  Sum_probs=175.4

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|..+++.. +||||+++++++.+.     +.+|+||||++ |+|.+.+.....+++..+..++.|++.||+|||+.
T Consensus        41 ~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~  115 (316)
T cd05619          41 CTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK  115 (316)
T ss_pred             HHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            355688888765 999999999999887     88999999996 69999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++..... ........++..|+|||.+.+. .++.++|+||+||++|+|++|..
T Consensus       116 ~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~  194 (316)
T cd05619         116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQS  194 (316)
T ss_pred             CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCC
Confidence            999999999999999999999999999865321 2223445689999999998654 48999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH-H
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE-D  247 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-e  247 (302)
                      ||.+.+.......+..  ..+                            .....++.+++++|.+||+.||.+||++. +
T Consensus       195 pf~~~~~~~~~~~i~~--~~~----------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~  244 (316)
T cd05619         195 PFHGHDEEELFQSIRM--DNP----------------------------CYPRWLTREAKDILVKLFVREPERRLGVKGD  244 (316)
T ss_pred             CCCCCCHHHHHHHHHh--CCC----------------------------CCCccCCHHHHHHHHHHhccCHhhcCCChHH
Confidence            9987765544433221  000                            01124677899999999999999999996 9


Q ss_pred             HhcCCCcCCcc
Q 022132          248 ALAHPYLGSLH  258 (302)
Q Consensus       248 ll~h~~~~~~~  258 (302)
                      +++||||....
T Consensus       245 l~~h~~~~~~~  255 (316)
T cd05619         245 IRQHPFFREID  255 (316)
T ss_pred             HHcCcccCCCC
Confidence            99999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-40  Score=295.04  Aligned_cols=213  Identities=25%  Similarity=0.382  Sum_probs=175.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++.+.     +.+|+||||++ |+|.+++.. ..+++..+..++.||+.||+|||+.|
T Consensus        89 ~~~~e~~i~~~~~hp~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~  162 (370)
T cd05621          89 FFWEERDIMAFANSPWVVQLFCAFQDD-----KYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMG  162 (370)
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            466899999999999999999999887     89999999996 699998865 46899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCC---CCCCchhHHHHHHHHHHHHh
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSS---DYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~i~~~ll~  165 (302)
                      |+||||||+||+++.++.++|+|||++.......  ......||..|+|||++.+..   .++.++|+||+||++|+|++
T Consensus       163 IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~  242 (370)
T cd05621         163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV  242 (370)
T ss_pred             eEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh
Confidence            9999999999999999999999999997654322  123457899999999986432   36789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC--CC
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RI  243 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~  243 (302)
                      |.+||.+.+....+..+........                         ++. ...++..+++++.+||..++.+  |+
T Consensus       243 G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~p~-~~~~s~~~~~li~~~L~~~~~r~~R~  296 (370)
T cd05621         243 GDTPFYADSLVGTYSKIMDHKNSLN-------------------------FPE-DVEISKHAKNLICAFLTDREVRLGRN  296 (370)
T ss_pred             CCCCCCCCCHHHHHHHHHhCCcccC-------------------------CCC-cccCCHHHHHHHHHHccCchhccCCC
Confidence            9999988876655554443111100                         000 1146788999999999866544  89


Q ss_pred             CHHHHhcCCCcCC
Q 022132          244 TVEDALAHPYLGS  256 (302)
Q Consensus       244 t~~ell~h~~~~~  256 (302)
                      |++|+++||||+.
T Consensus       297 ~~~e~l~hp~~~~  309 (370)
T cd05621         297 GVEEIKQHPFFKN  309 (370)
T ss_pred             CHHHHhcCcccCC
Confidence            9999999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.8e-40  Score=288.62  Aligned_cols=209  Identities=24%  Similarity=0.417  Sum_probs=172.4

Q ss_pred             chhhHHHHH---HhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFD---TWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il---~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      .+.+|+.++   +.++||||+++++++...     +.+|+||||++ ++|...+.. +.+++..+..++.||+.||+|||
T Consensus        45 ~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH  118 (324)
T cd05589          45 SLMCEKRIFETANSERHPFLVNLFACFQTE-----DHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLH  118 (324)
T ss_pred             HHHHHHHHHHhccccCCCChhceeeEEEcC-----CEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence            455666655   566799999999999887     89999999997 588877754 57999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ++||+||||||+||+++.++.++|+|||++..... ........|+..|+|||.+.+ ..++.++|+|||||++|+|++|
T Consensus       119 ~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G  197 (324)
T cd05589         119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVG  197 (324)
T ss_pred             hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhC
Confidence            99999999999999999999999999999864322 222344678999999999865 4478999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC---
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---  243 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---  243 (302)
                      ..||.+.+.......+....                              ......+++.+.++|.+||+.||.+||   
T Consensus       198 ~~pf~~~~~~~~~~~i~~~~------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~  247 (324)
T cd05589         198 ESPFPGDDEEEVFDSIVNDE------------------------------VRYPRFLSREAISIMRRLLRRNPERRLGSG  247 (324)
T ss_pred             CCCCCCCCHHHHHHHHHhCC------------------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence            99998877655444332210                              011125688999999999999999999   


Q ss_pred             --CHHHHhcCCCcCCc
Q 022132          244 --TVEDALAHPYLGSL  257 (302)
Q Consensus       244 --t~~ell~h~~~~~~  257 (302)
                        ++.++++||||...
T Consensus       248 ~~~~~~l~~~~~f~~~  263 (324)
T cd05589         248 EKDAEDVKKQPFFRDI  263 (324)
T ss_pred             CCCHHHHhhCCCcCCC
Confidence              79999999999875

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-41  Score=295.04  Aligned_cols=214  Identities=23%  Similarity=0.410  Sum_probs=180.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII--RSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l--~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .|+-||.||..|.||+|++|++.|.-.     +.++|+.|+|+|.-.+.+  .-...|++.++..+++|++.||.|||++
T Consensus        75 DylVEIeILa~CdHP~ivkLl~ayy~e-----nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~  149 (1187)
T KOG0579|consen   75 DYLVEIEILAECDHPVIVKLLSAYYFE-----NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ  149 (1187)
T ss_pred             hhhhhhhhhhcCCChHHHHHHHHHhcc-----CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc
Confidence            678899999999999999999999887     899999999987554443  2357899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeeccccccc-CCCCcccccccccccCchhhhhCC----CCCCCchhHHHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~i~~~ll  164 (302)
                      +|+|||+|+.|||++-+|.++|.|||.+... +.......+.||++|||||+..+.    .+|+.++||||||+++.+|.
T Consensus       150 ~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMA  229 (1187)
T KOG0579|consen  150 NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMA  229 (1187)
T ss_pred             chhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHh
Confidence            9999999999999999999999999987543 333445678999999999998543    46889999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      .+.||....+..-.+-++.+. ..|+                          .-...+.+..+.||+.+||.+||..||+
T Consensus       230 qiEPPHhelnpMRVllKiaKS-ePPT--------------------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~  282 (1187)
T KOG0579|consen  230 QIEPPHHELNPMRVLLKIAKS-EPPT--------------------------LLQPSHWSRSFSDFLKRCLVKNPRNRPP  282 (1187)
T ss_pred             ccCCCccccchHHHHHHHhhc-CCCc--------------------------ccCcchhhhHHHHHHHHHHhcCCccCCC
Confidence            999999888777666555431 1111                          1112366788999999999999999999


Q ss_pred             HHHHhcCCCcCCc
Q 022132          245 VEDALAHPYLGSL  257 (302)
Q Consensus       245 ~~ell~h~~~~~~  257 (302)
                      +.++|.||||+..
T Consensus       283 aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  283 AAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHhhCcccccC
Confidence            9999999999864

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.6e-40  Score=289.27  Aligned_cols=214  Identities=22%  Similarity=0.400  Sum_probs=172.1

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.++.++ +||||+++++++...     +.+|+||||++ ++|...+...+.+++..++.++.||+.||+|||++
T Consensus        41 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~  115 (329)
T cd05618          41 WVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER  115 (329)
T ss_pred             HHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            456788888887 899999999999887     89999999997 69999888888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++.... .........|+..|+|||.+.+. .++.++|+||+||++|+|++|..
T Consensus       116 ~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~  194 (329)
T cd05618         116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRS  194 (329)
T ss_pred             CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCC
Confidence            99999999999999999999999999986532 22223445789999999998654 47899999999999999999999


Q ss_pred             CCCCCChHH-----HHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          169 LFPGRDHVH-----QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       169 pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ||.......     ....+.+.+.                  .        .........+..+.++|++||+.||.+|+
T Consensus       195 Pf~~~~~~~~~~~~~~~~~~~~i~------------------~--------~~~~~p~~~~~~~~~ll~~~L~~dP~~R~  248 (329)
T cd05618         195 PFDIVGSSDNPDQNTEDYLFQVIL------------------E--------KQIRIPRSLSVKAASVLKSFLNKDPKERL  248 (329)
T ss_pred             CCccCCCcCCcccccHHHHHHHHh------------------c--------CCCCCCCCCCHHHHHHHHHHhcCCHHHcC
Confidence            995321100     0000000000                  0        00012235778899999999999999999


Q ss_pred             C------HHHHhcCCCcCCc
Q 022132          244 T------VEDALAHPYLGSL  257 (302)
Q Consensus       244 t------~~ell~h~~~~~~  257 (302)
                      |      ++++++||||...
T Consensus       249 ~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         249 GCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             CCCCCCCHHHHhcCCCCCCC
Confidence            8      5899999999865

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.7e-40  Score=288.38  Aligned_cols=210  Identities=22%  Similarity=0.429  Sum_probs=173.4

Q ss_pred             chhhHHH-HHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSC-FDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|.. +++.++||||+++++++.+.     +.+|+||||++ ++|...+...+.+++..+..++.||+.||+|||+.
T Consensus        41 ~~~~e~~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~  115 (321)
T cd05603          41 HIMAERNVLLKNLKHPFLVGLHYSFQTA-----EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL  115 (321)
T ss_pred             HHHHHHHHHHHhCCCCCccceeeEEEcC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3445544 67888999999999999887     88999999997 69998888878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++..... ........++..|+|||.+.+ ..++.++|+||+||++|+|++|.+
T Consensus       116 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~  194 (321)
T cd05603         116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLP  194 (321)
T ss_pred             CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCC
Confidence            999999999999999999999999999875322 222344578999999999854 448899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH---
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV---  245 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---  245 (302)
                      ||.+.+.......+..   .+                           ....+..+..+.++|.+||+.||.+|+++   
T Consensus       195 pf~~~~~~~~~~~i~~---~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~  244 (321)
T cd05603         195 PFYSRDVSQMYDNILH---KP---------------------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKAD  244 (321)
T ss_pred             CCCCCCHHHHHHHHhc---CC---------------------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCC
Confidence            9988765544333221   00                           01123567889999999999999999975   


Q ss_pred             -HHHhcCCCcCCc
Q 022132          246 -EDALAHPYLGSL  257 (302)
Q Consensus       246 -~ell~h~~~~~~  257 (302)
                       .++++|+||...
T Consensus       245 ~~~~~~~~~~~~~  257 (321)
T cd05603         245 FLEIKNHVFFSPI  257 (321)
T ss_pred             HHHHhCCCCcCCC
Confidence             599999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.4e-40  Score=289.17  Aligned_cols=210  Identities=24%  Similarity=0.463  Sum_probs=174.9

Q ss_pred             chhhHHH-HHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSC-FDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|.. +++.++||||+++++++...     +.+|+||||++ ++|...+.+.+.+++..+..++.||+.||+|||+.
T Consensus        41 ~~~~e~~~~l~~~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~  115 (325)
T cd05604          41 HIMAERNVLLKNVKHPFLVGLHYSFQTT-----EKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI  115 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEecC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3445554 46778999999999999887     89999999997 69999998888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++.... .........|+..|+|||.+.+. .++.++||||+||++|+|++|.+
T Consensus       116 givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~  194 (325)
T cd05604         116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLP  194 (325)
T ss_pred             CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCC
Confidence            99999999999999999999999999987532 22233455789999999998654 47899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH---
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV---  245 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---  245 (302)
                      ||.+.+.......+...   +                           ....+..+..+.++|++||..||.+||++   
T Consensus       195 pf~~~~~~~~~~~~~~~---~---------------------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         195 PFYCRDVAEMYDNILHK---P---------------------------LVLRPGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             CCCCCCHHHHHHHHHcC---C---------------------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence            99877655544433220   0                           11223577889999999999999999976   


Q ss_pred             -HHHhcCCCcCCc
Q 022132          246 -EDALAHPYLGSL  257 (302)
Q Consensus       246 -~ell~h~~~~~~  257 (302)
                       .+++.||||...
T Consensus       245 ~~~i~~h~~f~~~  257 (325)
T cd05604         245 FLEIQEHPFFESL  257 (325)
T ss_pred             HHHHhcCCCcCCC
Confidence             599999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.9e-40  Score=287.01  Aligned_cols=210  Identities=20%  Similarity=0.363  Sum_probs=177.2

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+..|..++..+ +||+|+++++++...     +.+|+||||++ |+|.+.+...+.+++..+..++.||+.||+|||+.
T Consensus        46 ~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~  120 (323)
T cd05616          46 CTMVEKRVLALSGKPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK  120 (323)
T ss_pred             HHHHHHHHHHhccCCCeEeeEEEEEecC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            456788888888 689999999999887     88999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++..... ........|++.|+|||.+.+ ..++.++|+||+||++|+|++|..
T Consensus       121 ~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~  199 (323)
T cd05616         121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQA  199 (323)
T ss_pred             CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCC
Confidence            999999999999999999999999999875332 222345578999999999865 458999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT----  244 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----  244 (302)
                      ||.+.+.......+.....                              ......+.++.+++.+||+.||.+|++    
T Consensus       200 Pf~~~~~~~~~~~i~~~~~------------------------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~  249 (323)
T cd05616         200 PFEGEDEDELFQSIMEHNV------------------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPE  249 (323)
T ss_pred             CCCCCCHHHHHHHHHhCCC------------------------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCC
Confidence            9988776655554443110                              011256789999999999999999998    


Q ss_pred             -HHHHhcCCCcCCc
Q 022132          245 -VEDALAHPYLGSL  257 (302)
Q Consensus       245 -~~ell~h~~~~~~  257 (302)
                       ..++++||||+..
T Consensus       250 ~~~~i~~h~~~~~~  263 (323)
T cd05616         250 GERDIKEHAFFRYI  263 (323)
T ss_pred             CHHHHhcCCCcCCC
Confidence             4899999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.7e-40  Score=288.00  Aligned_cols=209  Identities=23%  Similarity=0.455  Sum_probs=174.6

Q ss_pred             hhhHH-HHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           13 FVRSS-CFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        13 ~~~E~-~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      +.+|. .+++.++||||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.||+.||+|||++|
T Consensus        42 ~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g  116 (325)
T cd05602          42 IMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN  116 (325)
T ss_pred             HHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34444 356788999999999999887     88999999997 599999988888999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.++|+|||++..... ........|+..|+|||++.+ ..++.++||||+||++|+|++|.+|
T Consensus       117 iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~p  195 (325)
T cd05602         117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPP  195 (325)
T ss_pred             eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCC
Confidence            99999999999999999999999999865322 222345578999999999865 4588999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH---
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE---  246 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~---  246 (302)
                      |.+.+....+..+...   +                           ....+.+++.+.++|.+||+.||.+|+++.   
T Consensus       196 f~~~~~~~~~~~i~~~---~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         196 FYSRNTAEMYDNILNK---P---------------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCHHHHHHHHHhC---C---------------------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            9887766554443321   0                           012236788999999999999999999876   


Q ss_pred             -HHhcCCCcCCc
Q 022132          247 -DALAHPYLGSL  257 (302)
Q Consensus       247 -ell~h~~~~~~  257 (302)
                       ++++|+||...
T Consensus       246 ~~i~~~~~~~~~  257 (325)
T cd05602         246 MEIKNHIFFSPI  257 (325)
T ss_pred             HHHhcCcccCCC
Confidence             89999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.5e-39  Score=278.89  Aligned_cols=238  Identities=31%  Similarity=0.655  Sum_probs=186.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +..|+|+||+++ +|..+......+++..+..++.|++.||+|||+.|
T Consensus        46 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~  120 (286)
T cd07846          46 IAMREIRMLKQLRHENLVNLIEVFRRK-----KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN  120 (286)
T ss_pred             HHHHHHHHHHhcCCcchhhHHHhcccC-----CeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            467899999999999999999999877     889999999985 56666555567999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+...++.++|+||+|+++++|++|.+|
T Consensus       121 i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~  200 (286)
T cd07846         121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPL  200 (286)
T ss_pred             ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCC
Confidence            999999999999999999999999998754332 2223345788899999986655578899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccc-ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |.+.+..+....+....+.....................+.. .........+.++..+++|+.+||+.||.+|||+.++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  280 (286)
T cd07846         201 FPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL  280 (286)
T ss_pred             CCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence            988877777777776665543322221111110000011111 1112233456788999999999999999999999999


Q ss_pred             hcCCCc
Q 022132          249 LAHPYL  254 (302)
Q Consensus       249 l~h~~~  254 (302)
                      +.||||
T Consensus       281 l~~~~~  286 (286)
T cd07846         281 LHHEFF  286 (286)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.8e-40  Score=293.97  Aligned_cols=214  Identities=27%  Similarity=0.426  Sum_probs=175.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++.+++||||+++++.+.+.     +.+|+||||++ |+|.+++.+.+.+++..++.++.|++.||+|||+.
T Consensus        46 ~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~  120 (360)
T cd05627          46 AHIRAERDILVEADGAWVVKMFYSFQDK-----RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL  120 (360)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3566899999999999999999999887     89999999996 69999998888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC------------------------------------ccccccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD------------------------------------FMTEYVVTR  133 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~------------------------------------~~~~~~~~~  133 (302)
                      ||+||||||+||+++.+|.++|+|||++.......                                    .....+||.
T Consensus       121 givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  200 (360)
T cd05627         121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTP  200 (360)
T ss_pred             CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCc
Confidence            99999999999999999999999999986432110                                    012346899


Q ss_pred             ccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccc
Q 022132          134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR  213 (302)
Q Consensus       134 ~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (302)
                      .|+|||++.+. .++.++|+||+||++|+|++|.+||.+.+.......+......                         
T Consensus       201 ~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~-------------------------  254 (360)
T cd05627         201 DYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKET-------------------------  254 (360)
T ss_pred             cccCHHHHcCC-CCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCc-------------------------
Confidence            99999998654 4899999999999999999999999887766554444321000                         


Q ss_pred             ccccccCCCCCHHHHHHHHHccCCCCCCCC---CHHHHhcCCCcCCc
Q 022132          214 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSL  257 (302)
Q Consensus       214 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~ell~h~~~~~~  257 (302)
                      ..++. ...+++.+++||.+|+. ||.+|+   +++++++||||...
T Consensus       255 ~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         255 LVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             eecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            00000 01367899999999874 999998   58999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-39  Score=282.71  Aligned_cols=243  Identities=34%  Similarity=0.639  Sum_probs=191.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCC---CCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQR---ESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      .+.+|+.+++.++||||+++++++.....   .....+|+|+||++++|...+.. ...+++..+..++.|+++||+|||
T Consensus        53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH  132 (311)
T cd07866          53 TALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH  132 (311)
T ss_pred             hHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            45789999999999999999998866431   22356899999999988888765 457999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc------------ccccccccccCchhhhhCCCCCCCchhHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF------------MTEYVVTRWYRAPELLLNSSDYTAAIDVWS  155 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  155 (302)
                      +.|++|+||+|+||+++.++.++|+|||++........            .....++..|+|||.+.+...++.++|+||
T Consensus       133 ~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s  212 (311)
T cd07866         133 ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWG  212 (311)
T ss_pred             hCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHH
Confidence            99999999999999999999999999999865432211            122345778999999876666789999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHcc
Q 022132          156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  235 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  235 (302)
                      +||++++|++|.+||.+.+.......+....+.+....+.........................+...++.+.++|.+||
T Consensus       213 lG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  292 (311)
T cd07866         213 IGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLL  292 (311)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHc
Confidence            99999999999999999999888888888888776655433211110000000011112233344566788999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCc
Q 022132          236 TFDPRQRITVEDALAHPYL  254 (302)
Q Consensus       236 ~~dP~~R~t~~ell~h~~~  254 (302)
                      ..||.+|||+.|++.||||
T Consensus       293 ~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         293 SLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             ccCcccCcCHHHHhcCCCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.9e-40  Score=286.73  Aligned_cols=238  Identities=22%  Similarity=0.362  Sum_probs=177.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+++++.++||||+++++++.+.     +.+|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+.
T Consensus        48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~  122 (333)
T cd06650          48 NQIIRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK  122 (333)
T ss_pred             HHHHHHHHHHHHCCCCcccceeEEEEEC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence            4578999999999999999999999987     89999999996 69999998888899999999999999999999975


Q ss_pred             -CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 -NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 -~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                       +++|+||||+||+++.++.++|+|||++...... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..
T Consensus       123 ~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~  200 (333)
T cd06650         123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRY  200 (333)
T ss_pred             CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCC
Confidence             7999999999999999999999999998654322 2234468889999999865 447899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHH-hCCCChHHHhh-----------hhH------hHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          169 LFPGRDHVHQLRLLIEL-IGTPSEAELGF-----------LNE------NAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~-~~~~~~~~~~~-----------~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      ||............... .+.+.......           ...      ................  ......+.++++|
T Consensus       201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l  278 (333)
T cd06650         201 PIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPK--LPSGVFGAEFQDF  278 (333)
T ss_pred             CCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCcc--CCCCCcCHHHHHH
Confidence            99766543332211100 00000000000           000      0000000000000000  0011357889999


Q ss_pred             HHHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          231 VEKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       231 i~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                      |.+||++||.+|||++|++.||||+..
T Consensus       279 i~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         279 VNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             HHHhccCCcccCcCHHHHhhCHHHhcC
Confidence            999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7e-40  Score=286.43  Aligned_cols=214  Identities=21%  Similarity=0.386  Sum_probs=173.3

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.++.++ +||||+++++++...     +.+|+||||++ ++|...+...+.+++..+..++.||+.||+|||++
T Consensus        41 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~  115 (327)
T cd05617          41 WVQTEKHVFEQASSNPFLVGLHSCFQTT-----SRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER  115 (327)
T ss_pred             HHHHHHHHHHhhcCCCCEeeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            466899999998 799999999999887     88999999996 69999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++.... .........|+..|+|||.+.+ ..++.++|+||+||++|+|++|..
T Consensus       116 ~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~  194 (327)
T cd05617         116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRS  194 (327)
T ss_pred             CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCC
Confidence            99999999999999999999999999987532 2233345678999999999865 457899999999999999999999


Q ss_pred             CCCCCChHH---HHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC-
Q 022132          169 LFPGRDHVH---QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-  244 (302)
Q Consensus       169 pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-  244 (302)
                      ||.......   ....+......                          ........++..+.++|.+||+.||.+|++ 
T Consensus       195 pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         195 PFDIITDNPDMNTEDYLFQVILE--------------------------KPIRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCccCCCcccccHHHHHHHHHh--------------------------CCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            996432110   00000000000                          000112256788999999999999999998 


Q ss_pred             -----HHHHhcCCCcCCc
Q 022132          245 -----VEDALAHPYLGSL  257 (302)
Q Consensus       245 -----~~ell~h~~~~~~  257 (302)
                           ++++++||||...
T Consensus       249 ~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         249 QPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             CCCCCHHHHHcCCCCCCC
Confidence                 5799999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=276.60  Aligned_cols=210  Identities=21%  Similarity=0.374  Sum_probs=174.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++...     ..+|+|+||++ ++|.+.+...+.+++..+..++.|++.||.+||+.
T Consensus        49 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~  123 (263)
T cd06625          49 NALECEIQLLKNLQHERIVQYYGCLRDD-----ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN  123 (263)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEEEEccC-----CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3577899999999999999999999887     79999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcc----cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      |++|+||+|+||+++.++.++|+|||.+.........    ....++..|+|||.+.+.. ++.++|+||+|+++++|++
T Consensus       124 ~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~  202 (263)
T cd06625         124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLT  202 (263)
T ss_pred             CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHh
Confidence            9999999999999999999999999998654332111    2345678899999986544 7899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||...+.............                            ........+..+.++|.+||..||.+|||+
T Consensus       203 g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  254 (263)
T cd06625         203 EKPPWAEFEAMAAIFKIATQPT----------------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSA  254 (263)
T ss_pred             CCCCccccchHHHHHHHhccCC----------------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCH
Confidence            9999976554433222211000                            011122567889999999999999999999


Q ss_pred             HHHhcCCCc
Q 022132          246 EDALAHPYL  254 (302)
Q Consensus       246 ~ell~h~~~  254 (302)
                      .++++||||
T Consensus       255 ~~ll~~~~~  263 (263)
T cd06625         255 EELLRHFFV  263 (263)
T ss_pred             HHHhhCCCC
Confidence            999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.8e-40  Score=288.46  Aligned_cols=215  Identities=25%  Similarity=0.338  Sum_probs=169.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++|+||+++++++...     +.+|+||||+. ++|.+.    ...++..+..++.||+.||+|||++
T Consensus       117 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~  187 (353)
T PLN00034        117 RQICREIEILRDVNHPNVVKCHDMFDHN-----GEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRR  187 (353)
T ss_pred             HHHHHHHHHHHhCCCCCcceeeeEeccC-----CeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4577999999999999999999999887     88999999997 476542    3467888999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCC----CCCCCchhHHHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~i~~~ll  164 (302)
                      ||+||||||+||+++.++.++|+|||++...... .......|+..|+|||.+...    ...+.++|||||||++|+|+
T Consensus       188 ~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~  267 (353)
T PLN00034        188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFY  267 (353)
T ss_pred             CEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHH
Confidence            9999999999999999999999999998765432 222345789999999987421    22456899999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|+.||......+..........                          .........++..+++||.+||..||.+|||
T Consensus       268 ~g~~pf~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt  321 (353)
T PLN00034        268 LGRFPFGVGRQGDWASLMCAICM--------------------------SQPPEAPATASREFRHFISCCLQREPAKRWS  321 (353)
T ss_pred             hCCCCCCCCCCccHHHHHHHHhc--------------------------cCCCCCCCccCHHHHHHHHHHccCChhhCcC
Confidence            99999974332221111111000                          0001122357889999999999999999999


Q ss_pred             HHHHhcCCCcCCccCC
Q 022132          245 VEDALAHPYLGSLHDI  260 (302)
Q Consensus       245 ~~ell~h~~~~~~~~~  260 (302)
                      +.|+|+||||......
T Consensus       322 ~~ell~hp~~~~~~~~  337 (353)
T PLN00034        322 AMQLLQHPFILRAQPG  337 (353)
T ss_pred             HHHHhcCcccccCCcc
Confidence            9999999999886433

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.3e-39  Score=280.83  Aligned_cols=243  Identities=32%  Similarity=0.554  Sum_probs=184.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCC---CCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQR---ESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      .+.+|+.++++++||||+++++++.....   ......|+||||++++|.+.+... ..+++..+..++.|++.||+|||
T Consensus        57 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH  136 (310)
T cd07865          57 TALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH  136 (310)
T ss_pred             HHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            34679999999999999999999876531   123467999999999999888754 37899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      ++|++|+||+|+||+++.++.++|+|||.+.......     ......++..|+|||.+.+...++.++|+||+|+++++
T Consensus       137 ~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~e  216 (310)
T cd07865         137 RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAE  216 (310)
T ss_pred             HCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHH
Confidence            9999999999999999999999999999987543221     11234567789999988665557889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccccccc--CCCCCHHHHHHHHHccCCCCC
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK--FPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~  240 (302)
                      |++|.+||.+.+.......+....+..+...+..............+..........  ....++.+.+||.+||..||.
T Consensus       217 l~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~  296 (310)
T cd07865         217 MWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA  296 (310)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChh
Confidence            999999999888777777777766655544332221100000000111111111110  012357789999999999999


Q ss_pred             CCCCHHHHhcCCCc
Q 022132          241 QRITVEDALAHPYL  254 (302)
Q Consensus       241 ~R~t~~ell~h~~~  254 (302)
                      +|||++++|+||||
T Consensus       297 ~R~t~~e~l~h~~f  310 (310)
T cd07865         297 KRIDADTALNHDFF  310 (310)
T ss_pred             hccCHHHHhcCCCC
Confidence            99999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-39  Score=299.07  Aligned_cols=239  Identities=21%  Similarity=0.282  Sum_probs=177.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+|+.+|++++||||+++++++...     +..|+|+++++++|..++...     .......+..++.||+.||+||
T Consensus       209 ~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yL  283 (501)
T PHA03210        209 QLENEILALGRLNHENILKIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI  283 (501)
T ss_pred             HHHHHHHHHHhCCCCCcCcEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999887     789999999999998887542     2344677889999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      |++||+||||||+||+++.++.++|+|||++.......  ......|+..|+|||.+.+. .++.++|||||||++|+|+
T Consensus       284 H~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell  362 (501)
T PHA03210        284 HDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDML  362 (501)
T ss_pred             HhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999997654332  22345789999999998654 4899999999999999999


Q ss_pred             hCCC-CCCC--CChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcc-ccccccccccC--CCCCHHHHHHHHHccCCC
Q 022132          165 DRKP-LFPG--RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP-RYQRQSFTEKF--PNVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       165 ~g~~-pf~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~li~~~L~~d  238 (302)
                      +|.. |+.+  .+....+..+...++.+..+. .........+..... ......+...+  ..++.++.++|.+||++|
T Consensus       363 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D  441 (501)
T PHA03210        363 SHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEF-PDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD  441 (501)
T ss_pred             HCCCCCccCCCCCHHHHHHHHHHhcccChhhc-CCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC
Confidence            9875 4432  234455555555554433221 111111111111100 00001111111  145778999999999999


Q ss_pred             CCCCCCHHHHhcCCCcCCc
Q 022132          239 PRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       239 P~~R~t~~ell~h~~~~~~  257 (302)
                      |.+|||+.|+|+||||...
T Consensus       442 P~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        442 WHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             cccCcCHHHHhhChhhhcC
Confidence            9999999999999999864

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.5e-39  Score=277.47  Aligned_cols=238  Identities=35%  Similarity=0.643  Sum_probs=182.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++|+||+++++++...     +..|+|+||++++|.+.+.. ...+++..+..++.|++.||.|||+.|
T Consensus        49 ~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~  123 (291)
T cd07870          49 TAIREASLLKGLKHANIVLLHDIIHTK-----ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH  123 (291)
T ss_pred             HHHHHHHHHHhcCCCCEeEEEEEEecC-----CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            456899999999999999999999876     78999999999988887754 356888999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ++|+||||+||+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++++|++|.+|
T Consensus       124 i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~  203 (291)
T cd07870         124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA  203 (291)
T ss_pred             cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999988654322 1123345688899999886555578899999999999999999999


Q ss_pred             CCCCCh-HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC--CCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          170 FPGRDH-VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       170 f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      |.+.+. .+.+..+....+.|..............................+.  ..++.+.+++.+||..||.+|||++
T Consensus       204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~  283 (291)
T cd07870         204 FPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQ  283 (291)
T ss_pred             CCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHH
Confidence            976654 3455566666666665544332211000000000111111111111  2367899999999999999999999


Q ss_pred             HHhcCCCc
Q 022132          247 DALAHPYL  254 (302)
Q Consensus       247 ell~h~~~  254 (302)
                      |++.||||
T Consensus       284 ~~l~h~~~  291 (291)
T cd07870         284 DALLHPYF  291 (291)
T ss_pred             HHhcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=278.36  Aligned_cols=240  Identities=35%  Similarity=0.654  Sum_probs=192.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++|||++++++++....   .+..|+|+||++++|.+++... ..+++..+..++.||+.||++||+.|
T Consensus        44 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~  120 (287)
T cd07840          44 TAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG  120 (287)
T ss_pred             HHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4678999999999999999999997652   2689999999999999998765 57999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ++|+||+|+||+++.++.++|+|||.+.......  ......++..|+|||.+.+...++.++|+||+|+++++|++|.+
T Consensus       121 ~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~  200 (287)
T cd07840         121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKP  200 (287)
T ss_pred             ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999987654432  12334567789999987665567899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCC-CHHHHHHHHHccCCCCCCCCCHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV-HPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      ||...+....+..+.+..+.+....+.....................+...+... ++.+.+++++||..||.+|||+++
T Consensus       201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~  280 (287)
T cd07840         201 IFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQ  280 (287)
T ss_pred             CCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            9999988888888888888777665543222100000000000011122233343 889999999999999999999999


Q ss_pred             HhcCCCc
Q 022132          248 ALAHPYL  254 (302)
Q Consensus       248 ll~h~~~  254 (302)
                      ++.||||
T Consensus       281 ~l~~~~~  287 (287)
T cd07840         281 ALQHEYF  287 (287)
T ss_pred             HhhCcCC
Confidence            9999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-39  Score=278.76  Aligned_cols=209  Identities=18%  Similarity=0.180  Sum_probs=171.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~-   88 (302)
                      +.+.+|+.++++++||||+++++++.+.. .+...+++||||++ |+|.+++.+.+.+++.....++.|++.|+.+||+ 
T Consensus        63 ~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~  141 (283)
T PHA02988         63 DITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY  141 (283)
T ss_pred             HHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc
Confidence            34569999999999999999999987621 11267899999997 6999999988889999999999999999999998 


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCC-CCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      .+++||||||+||+++.++.+||+|||++......  .....++..|+|||.+.+. ..++.++|||||||++|+|++|.
T Consensus       142 ~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~  219 (283)
T PHA02988        142 TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK  219 (283)
T ss_pred             CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCC
Confidence            49999999999999999999999999998765433  2344678899999998642 45899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      .||.+.+..+....+......+                            ......++.+.+++.+||+.||.+|||++|
T Consensus       220 ~Pf~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~e  271 (283)
T PHA02988        220 IPFENLTTKEIYDLIINKNNSL----------------------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKE  271 (283)
T ss_pred             CCCCCCCHHHHHHHHHhcCCCC----------------------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHH
Confidence            9998776555544433211111                            011256788999999999999999999999


Q ss_pred             Hhc
Q 022132          248 ALA  250 (302)
Q Consensus       248 ll~  250 (302)
                      +++
T Consensus       272 ll~  274 (283)
T PHA02988        272 ILY  274 (283)
T ss_pred             HHH
Confidence            985

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.4e-39  Score=289.00  Aligned_cols=214  Identities=23%  Similarity=0.341  Sum_probs=174.9

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+||||++ |+|.+++.. ..+++..+..++.||+.||+|||++|
T Consensus        89 ~~~~e~~i~~~~~hp~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~  162 (371)
T cd05622          89 FFWEERDIMAFANSPWVVQLFYAFQDD-----RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG  162 (371)
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            466899999999999999999999887     88999999996 699998865 46899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCC---CCCCchhHHHHHHHHHHHHh
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSS---DYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~i~~~ll~  165 (302)
                      |+||||||+||+++.++.++|+|||++.......  ......||+.|+|||++.+..   .++.++||||+||++|+|++
T Consensus       163 ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~  242 (371)
T cd05622         163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV  242 (371)
T ss_pred             EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh
Confidence            9999999999999999999999999987654321  223457899999999986432   36889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC--CC
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RI  243 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~  243 (302)
                      |.+||.+.+.......+.......                         .+ ...+.++..++++|.+||..++.+  |+
T Consensus       243 G~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~-~~~~~~s~~~~~li~~~L~~~~~r~~r~  296 (371)
T cd05622         243 GDTPFYADSLVGTYSKIMNHKNSL-------------------------TF-PDDNDISKEAKNLICAFLTDREVRLGRN  296 (371)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCcc-------------------------cC-CCcCCCCHHHHHHHHHHcCChhhhcCCC
Confidence            999998877655554443211100                         00 112367889999999999844443  78


Q ss_pred             CHHHHhcCCCcCCc
Q 022132          244 TVEDALAHPYLGSL  257 (302)
Q Consensus       244 t~~ell~h~~~~~~  257 (302)
                      +++++++|+||...
T Consensus       297 ~~~ei~~h~~~~~~  310 (371)
T cd05622         297 GVEEIKRHLFFKND  310 (371)
T ss_pred             CHHHHhcCcccCCC
Confidence            99999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=280.12  Aligned_cols=240  Identities=37%  Similarity=0.668  Sum_probs=183.9

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+|+.+++.++||||+++++++.+...   +.+|+||||++++|.+.+...     ..+++..++.++.|++.||+||
T Consensus        48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l  124 (316)
T cd07842          48 SACREIALLRELKHENVVSLVEVFLEHAD---KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL  124 (316)
T ss_pred             HHHHHHHHHHhcCCCCccceEEEEeCCCC---ceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH
Confidence            56789999999999999999999987532   679999999999888877532     3689999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEec----CCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLLNA----NCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC  158 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~----~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  158 (302)
                      |+.||+||||+|+||+++.    ++.++|+|||++.......    ......++..|+|||.+.+...++.++|+||+||
T Consensus       125 H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  204 (316)
T cd07842         125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGC  204 (316)
T ss_pred             HhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHH
Confidence            9999999999999999999    8999999999987643321    1223456788999999876666789999999999


Q ss_pred             HHHHHHhCCCCCCCCChH---------HHHHHHHHHhCCCChHHHhhhhHh--HHHHh--hhcccccccc---ccccCCC
Q 022132          159 IFMELMDRKPLFPGRDHV---------HQLRLLIELIGTPSEAELGFLNEN--AKKYI--CQLPRYQRQS---FTEKFPN  222 (302)
Q Consensus       159 i~~~ll~g~~pf~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~~---~~~~~~~  222 (302)
                      ++++|++|.+||.+....         ..+..+...++.+....+......  .....  .....+....   +.+....
T Consensus       205 ~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (316)
T cd07842         205 IFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKK  284 (316)
T ss_pred             HHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccC
Confidence            999999999999765432         356666677776666544332111  00000  0000000001   1111125


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhcCCCc
Q 022132          223 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  254 (302)
Q Consensus       223 ~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~  254 (302)
                      .+..+.+++.+||++||.+|||+.|++.||||
T Consensus       285 ~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         285 PDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            67889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.8e-39  Score=282.10  Aligned_cols=210  Identities=20%  Similarity=0.367  Sum_probs=176.3

Q ss_pred             chhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|..+++.+. |++|+++++++...     +.+|+||||++ |+|.+++...+.+++..+..++.||+.||+|||+.
T Consensus        46 ~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~  120 (323)
T cd05615          46 CTMVEKRVLALQDKPPFLTQLHSCFQTV-----DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR  120 (323)
T ss_pred             HHHHHHHHHHhccCCCchhheeeEEecC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4667899998885 57888999999887     88999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++...... .......|+..|+|||.+.+ ..++.++|+||+||++++|++|.+
T Consensus       121 ~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~  199 (323)
T cd05615         121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQP  199 (323)
T ss_pred             CeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCC
Confidence            9999999999999999999999999998754322 22334568999999999854 458899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT----  244 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----  244 (302)
                      ||.+.+.......+.....                              .....++.++.+++.+||+.||.+|++    
T Consensus       200 pf~~~~~~~~~~~i~~~~~------------------------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~  249 (323)
T cd05615         200 PFDGEDEDELFQSIMEHNV------------------------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPE  249 (323)
T ss_pred             CCCCCCHHHHHHHHHhCCC------------------------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCC
Confidence            9988776555444432100                              111256788999999999999999997    


Q ss_pred             -HHHHhcCCCcCCc
Q 022132          245 -VEDALAHPYLGSL  257 (302)
Q Consensus       245 -~~ell~h~~~~~~  257 (302)
                       .+++++||||...
T Consensus       250 ~~~~i~~h~~f~~~  263 (323)
T cd05615         250 GERDIREHAFFRRI  263 (323)
T ss_pred             CHHHHhcCcccCCC
Confidence             5799999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.3e-39  Score=279.47  Aligned_cols=215  Identities=25%  Similarity=0.394  Sum_probs=174.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++|+||+++++.+.+.     +.+|+||||+. ++|.+.+...  ..+++..+..++.|++.||.|||
T Consensus        45 ~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH  119 (285)
T cd05630          45 SMALNEKQILEKVNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH  119 (285)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3466899999999999999999999887     88999999996 6999888543  35899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +.||+||||||+||+++.++.++|+|||++.............++..|+|||.+.+. .++.++|+||+||++++|++|.
T Consensus       120 ~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~  198 (285)
T cd05630         120 QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQ  198 (285)
T ss_pred             hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCC
Confidence            999999999999999999999999999998765443333445788999999998654 4889999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC---
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---  244 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---  244 (302)
                      +||.+.................                          ........++++.+|+.+||+.||.+|||   
T Consensus       199 ~Pf~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~  252 (285)
T cd05630         199 SPFQQRKKKIKREEVERLVKEV--------------------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQG  252 (285)
T ss_pred             CCCCCCCccchHHHHHhhhhhh--------------------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCC
Confidence            9997653221111111000000                          00112356788999999999999999999   


Q ss_pred             --HHHHhcCCCcCCc
Q 022132          245 --VEDALAHPYLGSL  257 (302)
Q Consensus       245 --~~ell~h~~~~~~  257 (302)
                        ++|+++||||.+.
T Consensus       253 ~~~~~~~~h~~~~~~  267 (285)
T cd05630         253 GGAREVKEHPLFKQI  267 (285)
T ss_pred             CchHHHHcChhhhcc
Confidence              9999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-39  Score=275.54  Aligned_cols=213  Identities=32%  Similarity=0.538  Sum_probs=176.4

Q ss_pred             hhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 022132           14 VRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVL   92 (302)
Q Consensus        14 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~   92 (302)
                      .+|+.++++++||||+++++++...     +..++||||+++ +|.+++...+.+++..+..++.|++.||++||+.|++
T Consensus        46 ~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~  120 (260)
T PF00069_consen   46 IREIKILRRLRHPNIVQILDVFQDD-----NYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIV  120 (260)
T ss_dssp             HHHHHHHHHHTBTTBCHEEEEEEES-----SEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhhcccccccccccccccccccc-----cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4599999999999999999999987     899999999986 9999999778899999999999999999999999999


Q ss_pred             ecCCCCCCEEEecCCCEEEeeccccccc-CCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022132           93 HRDLKPSNLLLNANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  171 (302)
Q Consensus        93 H~dikp~Nil~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~  171 (302)
                      |+||||+||+++.++.++|+|||.+... ..........++..|+|||.+......+.++|+||+|+++++|++|..||.
T Consensus       121 H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~  200 (260)
T PF00069_consen  121 HRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFE  200 (260)
T ss_dssp             ESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSST
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999999999999998753 333345566788999999998635568999999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          172 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      ..........+......+......                       .....+..+.++|.+||+.||++|||++++++|
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  201 ESNSDDQLEIIEKILKRPLPSSSQ-----------------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             TSSHHHHHHHHHHHHHTHHHHHTT-----------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccchhhhhhhhhccccccccccc-----------------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            774444444433322211111000                       000123689999999999999999999999999


Q ss_pred             CCc
Q 022132          252 PYL  254 (302)
Q Consensus       252 ~~~  254 (302)
                      |||
T Consensus       258 ~~~  260 (260)
T PF00069_consen  258 PWF  260 (260)
T ss_dssp             GGG
T ss_pred             CCC
Confidence            997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-39  Score=276.73  Aligned_cols=239  Identities=32%  Similarity=0.690  Sum_probs=187.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQI-IRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~-l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+||||+++++.+. ..+...+++..+..++.||+.||.|||+.
T Consensus        45 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~  119 (288)
T cd07833          45 KTALREVKVLRQLRHENIVNLKEAFRRK-----GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH  119 (288)
T ss_pred             hHHHHHHHHHHhcCCCCeeehhheEEEC-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577899999999999999999999886     88999999998755554 44556799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |++|+|++|+||+++.++.++|+|||.+.......  ......++..|+|||.+.+...++.++|+||+|+++++|++|.
T Consensus       120 ~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~  199 (288)
T cd07833         120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE  199 (288)
T ss_pred             CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999987654432  2334567888999999876646889999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccc-ccccccccCCC-CCHHHHHHHHHccCCCCCCCCCH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      +||.+....+.+..+...++.....................+.. ....+...++. +++.+++||++||..||++|||+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  279 (288)
T cd07833         200 PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC  279 (288)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH
Confidence            99998887777777777666555433322211100000000000 11112222333 48899999999999999999999


Q ss_pred             HHHhcCCCc
Q 022132          246 EDALAHPYL  254 (302)
Q Consensus       246 ~ell~h~~~  254 (302)
                      ++++.||||
T Consensus       280 ~~il~~~~f  288 (288)
T cd07833         280 DELLQHPYF  288 (288)
T ss_pred             HHHhcCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.5e-39  Score=277.40  Aligned_cols=211  Identities=26%  Similarity=0.476  Sum_probs=179.5

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecC-CccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+++++++.||||+++++++...     +.+|+||||+ +++|.+++...+.+++..+..++.|++.||.|||+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~  119 (290)
T cd05580          45 VEHVLNEKRILQSIRHPFLVNLYGSFQDD-----SNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS  119 (290)
T ss_pred             HHHHHHHHHHHHhCCCCCccceeeEEEcC-----CeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34677899999999999999999999887     8899999999 57999999888899999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      .|++|+||+|.||+++.++.++|+|||++......  .....++..|+|||.+.+. ..+.++|+||||+++++|++|..
T Consensus       120 ~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~  196 (290)
T cd05580         120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYP  196 (290)
T ss_pred             CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999998766544  3344678889999988544 47889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----  243 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----  243 (302)
                      ||...+.......+..  +.+                            ......++.++++|.+||..||.+|+     
T Consensus       197 p~~~~~~~~~~~~~~~--~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~  246 (290)
T cd05580         197 PFFDDNPIQIYEKILE--GKV----------------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKN  246 (290)
T ss_pred             CCCCCCHHHHHHHHhc--CCc----------------------------cCCccCCHHHHHHHHHHccCCHHHccCcccC
Confidence            9987764433333221  000                            11124578899999999999999999     


Q ss_pred             CHHHHhcCCCcCCcc
Q 022132          244 TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 t~~ell~h~~~~~~~  258 (302)
                      +++|+++||||+.+.
T Consensus       247 ~~~~l~~~~~~~~~~  261 (290)
T cd05580         247 GVNDIKNHPWFAGID  261 (290)
T ss_pred             CHHHHHcCcccccCC
Confidence            999999999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=282.13  Aligned_cols=216  Identities=20%  Similarity=0.359  Sum_probs=175.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.+++.++||||+++++++...     +++|+||||+. ++|.+++.+ ...+++..++.++.||+.||+|||++
T Consensus        47 ~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  121 (331)
T cd05597          47 CFREERDVLVNGDRRWITNLHYAFQDE-----NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL  121 (331)
T ss_pred             HHHHHHHHHHhCCCCCCCceEEEEecC-----CeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            467899999999999999999999887     89999999995 699999976 46799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhC----CCCCCCchhHHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~i~~~l  163 (302)
                      ||+||||||+||+++.++.++|+|||++........  .....+++.|+|||++.+    ...++.++||||+||++|+|
T Consensus       122 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el  201 (331)
T cd05597         122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM  201 (331)
T ss_pred             CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHH
Confidence            999999999999999999999999999865443221  223468999999999863    23467899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC--
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--  241 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--  241 (302)
                      ++|..||.+.+..+....+.....                         ...+....+.++..++++|++||..++.+  
T Consensus       202 ~~g~~Pf~~~~~~~~~~~i~~~~~-------------------------~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~  256 (331)
T cd05597         202 LYGETPFYAESLVETYGKIMNHKE-------------------------HFQFPPDVTDVSEEAKDLIRRLICSPETRLG  256 (331)
T ss_pred             hhCCCCCCCCCHHHHHHHHHcCCC-------------------------cccCCCccCCCCHHHHHHHHHHccCcccccC
Confidence            999999987766555444332110                         00112222357889999999999765544  


Q ss_pred             CCCHHHHhcCCCcCCc
Q 022132          242 RITVEDALAHPYLGSL  257 (302)
Q Consensus       242 R~t~~ell~h~~~~~~  257 (302)
                      |++++++++||||...
T Consensus       257 r~~~~~~l~hp~~~~~  272 (331)
T cd05597         257 RNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CCCHHHHhcCCCCCCC
Confidence            8899999999999875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.2e-39  Score=273.47  Aligned_cols=209  Identities=26%  Similarity=0.477  Sum_probs=173.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      +.+.+|+.++++++||||+++++++...     +..++||||++ ++|.+++...+.+++..+..++.|++.||++||++
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~  125 (267)
T cd06628          51 DALAREIALLKELQHENIVQYLGSSLDA-----DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR  125 (267)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEEeC-----CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc
Confidence            4577899999999999999999999887     88999999996 59999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC-------cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      |++||||+|+||+++.++.++|+|||.+.......       ......++..|+|||.+.+. .++.++|+||+||++++
T Consensus       126 ~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~  204 (267)
T cd06628         126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVE  204 (267)
T ss_pred             CcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHH
Confidence            99999999999999999999999999987554211       11223467889999988544 47889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      |++|..||.+.+....+..+....                             ........+..+.++|++||++||.+|
T Consensus       205 l~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R  255 (267)
T cd06628         205 MLTGKHPFPDCTQLQAIFKIGENA-----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKR  255 (267)
T ss_pred             HhhCCCCCCCccHHHHHHHHhccC-----------------------------CCcCCcccCHHHHHHHHHHccCCchhC
Confidence            999999998765443332221100                             011112567889999999999999999


Q ss_pred             CCHHHHhcCCCc
Q 022132          243 ITVEDALAHPYL  254 (302)
Q Consensus       243 ~t~~ell~h~~~  254 (302)
                      ||+.++++||||
T Consensus       256 p~~~~il~~~~~  267 (267)
T cd06628         256 PTAAELLKHPFL  267 (267)
T ss_pred             cCHHHHhhCCCC
Confidence            999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.8e-39  Score=277.05  Aligned_cols=243  Identities=37%  Similarity=0.639  Sum_probs=189.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCC-----CCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQ-----RESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~   85 (302)
                      .+.+|+.+++.++||||+++++++.+..     ..+.+.+|+|+||+++++.+.+... ..+++..+..++.|++.||+|
T Consensus        52 ~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~  131 (302)
T cd07864          52 TAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNY  131 (302)
T ss_pred             HHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence            4568999999999999999999997752     0112479999999999888888754 468999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      ||+.||+|+||+|+||+++.++.++|+|||.+.......  ......++..|+|||.+.+...++.++|+||+||++++|
T Consensus       132 LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el  211 (302)
T cd07864         132 CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL  211 (302)
T ss_pred             HHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHH
Confidence            999999999999999999999999999999987544322  112234577899999886555578899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|.+||...+....+..+....+.+....+.....................+...+..+++.+.+++.+||..||++||
T Consensus       212 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  291 (302)
T cd07864         212 FTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC  291 (302)
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC
Confidence            99999999888888888888877777665443221100000000000000122233445788999999999999999999


Q ss_pred             CHHHHhcCCCc
Q 022132          244 TVEDALAHPYL  254 (302)
Q Consensus       244 t~~ell~h~~~  254 (302)
                      |+++++.||||
T Consensus       292 ~~~~il~~~~~  302 (302)
T cd07864         292 TAEEALNSPWL  302 (302)
T ss_pred             CHHHHhcCCCC
Confidence            99999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.4e-39  Score=273.35  Aligned_cols=213  Identities=24%  Similarity=0.440  Sum_probs=177.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++.+.+.     +.+|+++||++ ++|.+++.+...+++..+..++.||+.||+|||++
T Consensus        38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~  112 (262)
T cd05572          38 EHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR  112 (262)
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            4678899999999999999999999877     88999999986 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.. ..++.++|+||+|+++|+|++|..|
T Consensus       113 ~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p  191 (262)
T cd05572         113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPP  191 (262)
T ss_pred             CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCC
Confidence            999999999999999999999999999877654433344567888999998754 4478999999999999999999999


Q ss_pred             CCCCC--hHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC---
Q 022132          170 FPGRD--HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---  244 (302)
Q Consensus       170 f~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---  244 (302)
                      |....  .......+......                            .......++.+.++|.+||..||.+|||   
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~  243 (262)
T cd05572         192 FGEDDEDPMEIYNDILKGNGK----------------------------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLK  243 (262)
T ss_pred             cCCCCCCHHHHHHHHhccCCC----------------------------CCCCcccCHHHHHHHHHHccCChhhCcCCcc
Confidence            97665  22222222210000                            0111134778999999999999999999   


Q ss_pred             --HHHHhcCCCcCCc
Q 022132          245 --VEDALAHPYLGSL  257 (302)
Q Consensus       245 --~~ell~h~~~~~~  257 (302)
                        ++|+++||||+++
T Consensus       244 ~~~~~l~~~~~~~~~  258 (262)
T cd05572         244 GGIKDIKKHKWFNGF  258 (262)
T ss_pred             cCHHHHhcChhhhCC
Confidence              9999999999875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-39  Score=287.52  Aligned_cols=212  Identities=21%  Similarity=0.371  Sum_probs=180.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+|..|+.+|+.|+||||+++|+.+.+...   ..+-+|+|.+. |+|..++++.++++.+.++.|++||+.||.|||++
T Consensus        86 eR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~  162 (632)
T KOG0584|consen   86 ERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ  162 (632)
T ss_pred             HHHHHHHHHHccCCCCceeeeeeheecCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC
Confidence            368899999999999999999999988743   67899999996 89999999999999999999999999999999999


Q ss_pred             C--ceecCCCCCCEEEecC-CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           90 N--VLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        90 ~--i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      .  |+|||||-+||+|+.+ |.+||+|+|+|....... .....||+.|||||++.  ..|...+||||||+.|+||+|+
T Consensus       163 ~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~  239 (632)
T KOG0584|consen  163 DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTS  239 (632)
T ss_pred             CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhc
Confidence            6  9999999999999876 999999999998765432 34479999999999995  4599999999999999999999


Q ss_pred             CCCCCCCChHH-HHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          167 KPLFPGRDHVH-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       167 ~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      ..||....... .+++..+  |..+...                          ..--.|++++||.+||.. .+.|+|+
T Consensus       240 eYPYsEC~n~AQIYKKV~S--GiKP~sl--------------------------~kV~dPevr~fIekCl~~-~~~R~sa  290 (632)
T KOG0584|consen  240 EYPYSECTNPAQIYKKVTS--GIKPAAL--------------------------SKVKDPEVREFIEKCLAT-KSERLSA  290 (632)
T ss_pred             cCChhhhCCHHHHHHHHHc--CCCHHHh--------------------------hccCCHHHHHHHHHHhcC-chhccCH
Confidence            99998665554 4444433  2221110                          012257899999999999 9999999


Q ss_pred             HHHhcCCCcCCc
Q 022132          246 EDALAHPYLGSL  257 (302)
Q Consensus       246 ~ell~h~~~~~~  257 (302)
                      .|||.||||..-
T Consensus       291 ~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  291 KELLKDPFFDED  302 (632)
T ss_pred             HHHhhChhhccc
Confidence            999999999874

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.4e-39  Score=283.17  Aligned_cols=241  Identities=19%  Similarity=0.272  Sum_probs=173.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      .+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++..  .+.+++..+..++.|++.||+|||+
T Consensus        45 ~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  119 (327)
T cd08227          45 FLQGELHVSKLFNHPNIVPYRATFIAD-----NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH  119 (327)
T ss_pred             HHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            456799999999999999999999887     88999999997 699999865  3468999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC--------CcccccccccccCchhhhhCC-CCCCCchhHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCI  159 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~i  159 (302)
                      +||+||||||+||+++.++.++++||+.+......        .......++..|+|||.+.+. ..++.++||||+||+
T Consensus       120 ~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~i  199 (327)
T cd08227         120 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT  199 (327)
T ss_pred             CCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHH
Confidence            99999999999999999999999999864322111        011223456779999998653 357899999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHH--------------HHh---hhccccccccccccCCC
Q 022132          160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK--------------KYI---CQLPRYQRQSFTEKFPN  222 (302)
Q Consensus       160 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~---~~~~~~~~~~~~~~~~~  222 (302)
                      +++|++|..||............... ..+.............              ...   ...+.............
T Consensus       200 l~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (327)
T cd08227         200 ACELANGHVPFKDMPATQMLLEKLNG-TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRT  278 (327)
T ss_pred             HHHHHHCCCCCCCcchhHHHHHHhcC-CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccc
Confidence            99999999999765544332222110 0000000000000000              000   00000000011111224


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          223 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       223 ~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      +++.+.+||.+||++||.+|||++++++||||+...
T Consensus       279 ~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         279 FSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             cCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence            578899999999999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=274.07  Aligned_cols=214  Identities=23%  Similarity=0.394  Sum_probs=180.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~-~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      +++.|+.|+++|+.|++|++|+.|.-.     .+++||||||+ |+..+.++ .+++|++.++..+++..+.||+|||..
T Consensus        74 EIIKEISIMQQC~S~yVVKYYGSYFK~-----sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~  148 (502)
T KOG0574|consen   74 EIIKEISIMQQCKSKYVVKYYGSYFKH-----SDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL  148 (502)
T ss_pred             HHHHHHHHHHHcCCchhhhhhhhhccC-----CceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH
Confidence            567899999999999999999999876     89999999998 89999987 457899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      .-+|||||..|||++.+|..||.|||.+....+. .......||+.|+|||++...+ |..++||||||++..+|..|+|
T Consensus       149 ~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~P  227 (502)
T KOG0574|consen  149 KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRP  227 (502)
T ss_pred             HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCC
Confidence            9999999999999999999999999999765543 4556778999999999997655 8999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||..-...   +.|+-....|++.                        -......|.++-||+++||.++|.+|.|+.++
T Consensus       228 PYsDIHPM---RAIFMIPT~PPPT------------------------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L  280 (502)
T KOG0574|consen  228 PYSDIHPM---RAIFMIPTKPPPT------------------------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRL  280 (502)
T ss_pred             Cccccccc---ceeEeccCCCCCC------------------------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHH
Confidence            99654432   1111111111110                        01112467889999999999999999999999


Q ss_pred             hcCCCcCCcc
Q 022132          249 LAHPYLGSLH  258 (302)
Q Consensus       249 l~h~~~~~~~  258 (302)
                      ++|||++...
T Consensus       281 ~~H~FiknA~  290 (502)
T KOG0574|consen  281 CEHTFIKNAP  290 (502)
T ss_pred             hhhhhhcCCC
Confidence            9999998754

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=265.86  Aligned_cols=225  Identities=23%  Similarity=0.368  Sum_probs=179.7

Q ss_pred             hcCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus         9 ~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ++++..||+.++.++ .|+||++++++|++.     ..+|+|||.|. |.|...+.+++.+++.++..++..|+.||.||
T Consensus       118 sR~RvfREVe~f~~Cqgh~nilqLiefFEdd-----~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFl  192 (463)
T KOG0607|consen  118 SRSRVFREVETFYQCQGHKNILQLIEFFEDD-----TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFL  192 (463)
T ss_pred             HHHHHHHHHHHHHHhcCCccHHHHHHHhccc-----ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHH
Confidence            456788999999999 799999999999998     88999999995 79999999999999999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecC---CCEEEeecccccccCC--------CCcccccccccccCchhhhh----CCCCCCCch
Q 022132           87 HSANVLHRDLKPSNLLLNAN---CDLKICDFGLARVTSE--------TDFMTEYVVTRWYRAPELLL----NSSDYTAAI  151 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~---~~~kl~dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~  151 (302)
                      |.+||.|||+||+|||-..-   .-+|||||.+......        .....+.+|+..|||||+..    ....|+.+.
T Consensus       193 H~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrC  272 (463)
T KOG0607|consen  193 HTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRC  272 (463)
T ss_pred             hhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccc
Confidence            99999999999999998654   3489999987643211        12344567888999999863    234578899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccC
Q 022132          152 DVWSVGCIFMELMDRKPLFPGRDH-----------VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF  220 (302)
Q Consensus       152 DiwslG~i~~~ll~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (302)
                      |.||||+|+|-||+|.+||.|.=.           ..--..+++.+..               .       ...-..+.|
T Consensus       273 DlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE---------------G-------kYeFPdkdW  330 (463)
T KOG0607|consen  273 DLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE---------------G-------KYEFPDKDW  330 (463)
T ss_pred             cHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc---------------c-------CCcCChhhh
Confidence            999999999999999999965411           1111122221110               0       011112445


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccCC
Q 022132          221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  260 (302)
Q Consensus       221 ~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  260 (302)
                      .++|.+.+|+++++|..|+.+|.++..+++|||++.....
T Consensus       331 ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  331 AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            5789999999999999999999999999999999987644

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.7e-39  Score=275.04  Aligned_cols=214  Identities=26%  Similarity=0.415  Sum_probs=177.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      .+.+|+.+++.++|+||+++++.+...     +..++||||+. ++|.+.+..  ...+++..+..++.|++.||.|||+
T Consensus        46 ~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~  120 (285)
T cd05632          46 MALNEKQILEKVNSQFVVNLAYAYETK-----DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR  120 (285)
T ss_pred             HHHHHHHHHHHcCCcCceeEEEEEecC-----CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            467899999999999999999999887     88999999997 588887754  3469999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      .||+||||+|+||+++.++.++|+|||++.............++..|+|||.+.+. .++.++|+||+||++++|++|..
T Consensus       121 ~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~  199 (285)
T cd05632         121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQS  199 (285)
T ss_pred             CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999998765444333455789999999998654 48899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT----  244 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----  244 (302)
                      ||.+.........+........                          ....+.+++.+.+|+.+||+.||.+|||    
T Consensus       200 P~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~  253 (285)
T cd05632         200 PFRGRKEKVKREEVDRRVLETE--------------------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEE  253 (285)
T ss_pred             CCCCCCHHHHHHHHHHhhhccc--------------------------cccCccCCHHHHHHHHHHccCCHhHcCCCccc
Confidence            9987665444333322211110                          0112356788999999999999999999    


Q ss_pred             -HHHHhcCCCcCCc
Q 022132          245 -VEDALAHPYLGSL  257 (302)
Q Consensus       245 -~~ell~h~~~~~~  257 (302)
                       +++++.|+||...
T Consensus       254 ~~~~l~~~~~~~~~  267 (285)
T cd05632         254 GAGEVKRHPFFRNM  267 (285)
T ss_pred             ChHHHHcChhhhcC
Confidence             8999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.2e-39  Score=282.10  Aligned_cols=216  Identities=21%  Similarity=0.378  Sum_probs=177.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.++..++|+||+++++++.+.     +.+|+||||+. |+|.+++.+ .+.+++..++.++.||+.||+|||+.
T Consensus        47 ~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~  121 (332)
T cd05623          47 CFREERDVLVNGDNQWITTLHYAFQDE-----NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL  121 (332)
T ss_pred             HHHHHHHHHhhCCCCCEeeEEEEEecC-----CEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            467899999999999999999999887     89999999996 799999976 46799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhC----CCCCCCchhHHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~i~~~l  163 (302)
                      ||+||||||+||+++.++.++|+|||++.......  ......||..|+|||++.+    ...++.++|+||+||++|+|
T Consensus       122 ~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~el  201 (332)
T cd05623         122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM  201 (332)
T ss_pred             CeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHH
Confidence            99999999999999999999999999986543221  1223568999999999853    34478899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC--
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--  241 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--  241 (302)
                      ++|..||.+.+....+..+.....                         ...++.....+++++++||++||..++.+  
T Consensus       202 l~g~~Pf~~~~~~~~~~~i~~~~~-------------------------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~  256 (332)
T cd05623         202 LYGETPFYAESLVETYGKIMNHKE-------------------------RFQFPAQVTDVSEDAKDLIRRLICSREHRLG  256 (332)
T ss_pred             hcCCCCCCCCCHHHHHHHHhCCCc-------------------------cccCCCccccCCHHHHHHHHHHccChhhhcC
Confidence            999999988776665554432110                         01112223467899999999999765554  


Q ss_pred             CCCHHHHhcCCCcCCc
Q 022132          242 RITVEDALAHPYLGSL  257 (302)
Q Consensus       242 R~t~~ell~h~~~~~~  257 (302)
                      |+|++++++||||...
T Consensus       257 r~~~~~~~~h~~f~~~  272 (332)
T cd05623         257 QNGIEDFKQHPFFTGI  272 (332)
T ss_pred             CCCHHHHhCCCCcCCC
Confidence            6899999999999874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-38  Score=268.86  Aligned_cols=210  Identities=27%  Similarity=0.407  Sum_probs=175.3

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ...+.+|+.+++.++||||+++++++...     +..|+||||+. ++|.+++...  ..+++..+..++.|++.||.||
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~l  117 (256)
T cd08529          43 REEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL  117 (256)
T ss_pred             HHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            34677899999999999999999999887     88999999996 6999998763  5789999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      |+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+|||||++++|++
T Consensus       118 H~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~  196 (256)
T cd08529         118 HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCT  196 (256)
T ss_pred             HHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHh
Confidence            99999999999999999999999999999987654332 22334678889999988654 47899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||...+.......+.....                             ......++.++.+++.+||+.+|++||++
T Consensus       197 g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~  247 (256)
T cd08529         197 GKHPFDANNQGALILKIIRGVF-----------------------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDT  247 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCccccCHHHHHHHHHHccCCcccCcCH
Confidence            9999987765444333322110                             01111467889999999999999999999


Q ss_pred             HHHhcCCCc
Q 022132          246 EDALAHPYL  254 (302)
Q Consensus       246 ~ell~h~~~  254 (302)
                      .+++.|||+
T Consensus       248 ~~ll~~~~~  256 (256)
T cd08529         248 FQLLRNPSL  256 (256)
T ss_pred             HHHhhCCCC
Confidence            999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.1e-39  Score=273.71  Aligned_cols=217  Identities=24%  Similarity=0.384  Sum_probs=176.8

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ...+.+|+.++++++||||+++++++...     +..|+||||++ ++|.+++.+.+  .+++..+..++.|++.||.||
T Consensus        37 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~l  111 (277)
T cd05577          37 EQMALNEKKILEKVSSRFIVSLAYAFETK-----DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHL  111 (277)
T ss_pred             hHHHHHHHHHHHhCCCCCEeeeeeEEecC-----CeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            34557899999999999999999999887     88999999997 69999987655  799999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |+.|++||||+|+||+++.++.++|+|||.+.............++..|+|||.+.+.. ++.++|+||+||++++|++|
T Consensus       112 H~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g  190 (277)
T cd05577         112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAG  190 (277)
T ss_pred             HhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhC
Confidence            99999999999999999999999999999987655443344456778899999986544 78999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC---
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---  243 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---  243 (302)
                      ..||...........+.....                          .......+..++.+.++|.+||+.||.+||   
T Consensus       191 ~~p~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  244 (277)
T cd05577         191 RSPFRQRKEKVEKEELKRRTL--------------------------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCR  244 (277)
T ss_pred             CCCCCCCcccccHHHHHhccc--------------------------cccccCCccCCHHHHHHHHHHccCChhHccCCC
Confidence            999976543211111111000                          000112235688999999999999999999   


Q ss_pred             --CHHHHhcCCCcCCcc
Q 022132          244 --TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 --t~~ell~h~~~~~~~  258 (302)
                        ++.++++||||..+.
T Consensus       245 ~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         245 GGSADEVREHPLFKDLN  261 (277)
T ss_pred             cccHHHHHhChhhhcCC
Confidence              999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.4e-39  Score=277.40  Aligned_cols=235  Identities=23%  Similarity=0.373  Sum_probs=177.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~-   88 (302)
                      ..+.+|++++++++||||+++++++...     +.+|+||||++ ++|.+++.+.+.+++..+..++.|++.||.|||+ 
T Consensus        44 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~  118 (308)
T cd06615          44 NQIIRELKVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK  118 (308)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh
Confidence            3577899999999999999999999887     89999999997 6999999888889999999999999999999997 


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      .|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+ ..++.++|+||+||++++|++|..
T Consensus       119 ~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~  196 (308)
T cd06615         119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRY  196 (308)
T ss_pred             CCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCC
Confidence            69999999999999999999999999988654322 2234567889999998854 447899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChH--------------HHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHc
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEA--------------ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  234 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (302)
                      ||...+.......+..........              ...............      .........++.++++|+.+|
T Consensus       197 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~  270 (308)
T cd06615         197 PIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE------PPPKLPSGAFSDEFQDFVDKC  270 (308)
T ss_pred             CCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcC------CCccCcCcccCHHHHHHHHHH
Confidence            997665333222221110000000              000000000000000      000001113678899999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          235 LTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       235 L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      |..||++|||++++++||||..+.
T Consensus       271 l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         271 LKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             ccCChhhCcCHHHHhcChhhhhcc
Confidence            999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-40  Score=287.18  Aligned_cols=217  Identities=18%  Similarity=0.302  Sum_probs=183.1

Q ss_pred             hhHHHHhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHH
Q 022132            3 SITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR   81 (302)
Q Consensus         3 ~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~   81 (302)
                      ||||...-+  ..+|+-|++|+||||+.+.+++...     ..++||||||. |-|.++|+....++......|..+|+.
T Consensus       151 AVKKV~elk--ETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~  223 (904)
T KOG4721|consen  151 AVKKVRELK--ETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAG  223 (904)
T ss_pred             hhHHHhhhh--hhhHHHHHhccCcceeeEeeeecCC-----ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhh
Confidence            556654433  2588999999999999999999998     89999999997 899999999999999999999999999


Q ss_pred             HHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHH
Q 022132           82 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        82 ~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~  161 (302)
                      |+.|||.+.|+|||||.-||||+.+..+||+|||.++..++....-.++||..|||||++.. ..++.++|||||||++|
T Consensus       224 GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLW  302 (904)
T KOG4721|consen  224 GMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLW  302 (904)
T ss_pred             hhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHH
Confidence            99999999999999999999999999999999999988877766667899999999999954 55899999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       162 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      |||||..||...+....+    ...|..+.                        -......++..++-||++||+-.|..
T Consensus       303 EmLT~EiPYkdVdssAII----wGVGsNsL------------------------~LpvPstcP~GfklL~Kqcw~sKpRN  354 (904)
T KOG4721|consen  303 EMLTGEIPYKDVDSSAII----WGVGSNSL------------------------HLPVPSTCPDGFKLLLKQCWNSKPRN  354 (904)
T ss_pred             HHHhcCCCccccchheeE----EeccCCcc------------------------cccCcccCchHHHHHHHHHHhcCCCC
Confidence            999999999766543221    11111110                        00112256778999999999999999


Q ss_pred             CCCHHHHhcCCCcC
Q 022132          242 RITVEDALAHPYLG  255 (302)
Q Consensus       242 R~t~~ell~h~~~~  255 (302)
                      ||++.++|.|-=+.
T Consensus       355 RPSFrqil~HldIa  368 (904)
T KOG4721|consen  355 RPSFRQILLHLDIA  368 (904)
T ss_pred             CccHHHHHHHHhhc
Confidence            99999999986443

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.4e-38  Score=270.08  Aligned_cols=211  Identities=26%  Similarity=0.390  Sum_probs=174.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++|+||+++++++.+.     +.+|+++||+. ++|.+++.+.+++++..+..++.|++.||+|||+.
T Consensus        47 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~  121 (265)
T cd06631          47 EKLQEEVDLLKSLKHVNIVQYLGTCLDD-----NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN  121 (265)
T ss_pred             HHHHHHHHHHHhcCCCCEeeEeeEeecC-----CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3577899999999999999999999887     89999999996 69999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC-------CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-------TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      |++|+||+|+||+++.++.++|+|||.+.....       ........++..|+|||.+.+ ..++.++|+||+||++++
T Consensus       122 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~  200 (265)
T cd06631         122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFE  200 (265)
T ss_pred             CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHH
Confidence            999999999999999999999999998865321       111233467888999998854 447899999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      |++|..||...+.......+....+                           ......+.++..+.++|++||..||.+|
T Consensus       201 l~~g~~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R  253 (265)
T cd06631         201 MATGKPPLASMDRLAAMFYIGAHRG---------------------------LMPRLPDSFSAAAIDFVTSCLTRDQHER  253 (265)
T ss_pred             HHhCCCccccCChHHHHHHhhhccC---------------------------CCCCCCCCCCHHHHHHHHHHhcCCcccC
Confidence            9999999976654333222211100                           0111223577889999999999999999


Q ss_pred             CCHHHHhcCCCc
Q 022132          243 ITVEDALAHPYL  254 (302)
Q Consensus       243 ~t~~ell~h~~~  254 (302)
                      ||+.+++.||||
T Consensus       254 p~~~~~l~~~~~  265 (265)
T cd06631         254 PSALQLLRHDFL  265 (265)
T ss_pred             CCHHHHhcCCCC
Confidence            999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.8e-39  Score=281.50  Aligned_cols=207  Identities=24%  Similarity=0.380  Sum_probs=163.8

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC------------------------
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN------------------------   64 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------   64 (302)
                      ..+.+|+.+++.+ +||||+++++++....    +.+|+||||++ |+|.+++...                        
T Consensus        55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  130 (338)
T cd05102          55 KALMSELKILIHIGNHLNVVNLLGACTKPN----GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ  130 (338)
T ss_pred             HHHHHHHHHHHHhccCcceeeEEeEecCCC----CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhh
Confidence            3577899999999 8999999999887642    56899999997 7999988642                        


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC
Q 022132           65 --------------------------------------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN  106 (302)
Q Consensus        65 --------------------------------------~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~  106 (302)
                                                            .++++..+..++.||+.||+|||+.||+||||||+||+++.+
T Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~  210 (338)
T cd05102         131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN  210 (338)
T ss_pred             hccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC
Confidence                                                  247888999999999999999999999999999999999999


Q ss_pred             CCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022132          107 CDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLL  182 (302)
Q Consensus       107 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~  182 (302)
                      +.++|+|||+++......   ......++..|+|||.+.+. .++.++||||+||++|+|++ |.+||.+..........
T Consensus       211 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~  289 (338)
T cd05102         211 NVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR  289 (338)
T ss_pred             CcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH
Confidence            999999999987543221   11223445779999998654 47999999999999999996 99999876543322221


Q ss_pred             HHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          183 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      ......                            .......++.+.+++.+||+.||.+|||+.|+++
T Consensus       290 ~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         290 LKDGTR----------------------------MRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             HhcCCC----------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            110000                            0111256788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-40  Score=283.71  Aligned_cols=216  Identities=25%  Similarity=0.448  Sum_probs=197.8

Q ss_pred             HhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecC-CccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+..+...|-.||..+..|.||++|..|.++     ..+|++||.| +|.|+..+++++.+++...+.++..+++|++||
T Consensus       462 kQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~-----kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYL  536 (732)
T KOG0614|consen  462 KQQEHVFSERNIMMECRSDFIVRLYRTFRDS-----KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYL  536 (732)
T ss_pred             hHHHHHHhHHHHHHhcCchHHHHHHHHhccc-----hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHH
Confidence            3445788899999999999999999999998     8999999997 789999999999999999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |++||++||+||+|++++.+|.+||.|||+|+..+.......++||+.|.|||++...+ ...++|.||||+++||+++|
T Consensus       537 H~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G  615 (732)
T KOG0614|consen  537 HRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTG  615 (732)
T ss_pred             HhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcC
Confidence            99999999999999999999999999999999999888899999999999999998766 68999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC--
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT--  244 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t--  244 (302)
                      .|||.+.+....+..|.+.+..-                            +....++....+||+++-..+|.+|..  
T Consensus       616 ~pPFs~~dpmktYn~ILkGid~i----------------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~  667 (732)
T KOG0614|consen  616 SPPFSGVDPMKTYNLILKGIDKI----------------------------EFPRRITKTATDLIKKLCRDNPTERLGYQ  667 (732)
T ss_pred             CCCCCCCchHHHHHHHHhhhhhh----------------------------hcccccchhHHHHHHHHHhcCcHhhhccc
Confidence            99999999999999998755321                            111257778999999999999999985  


Q ss_pred             ---HHHHhcCCCcCCc
Q 022132          245 ---VEDALAHPYLGSL  257 (302)
Q Consensus       245 ---~~ell~h~~~~~~  257 (302)
                         +.|+-.|.||.++
T Consensus       668 ~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  668 KGGINDIKKHRWFEGF  683 (732)
T ss_pred             cCChHHHHhhhhhhcC
Confidence               8999999999876

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-38  Score=270.56  Aligned_cols=212  Identities=25%  Similarity=0.380  Sum_probs=171.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++.+...     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||+|||+.|
T Consensus        52 ~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  126 (267)
T cd06645          52 VVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG  126 (267)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            456899999999999999999999887     88999999997 699999988889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhh--CCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      ++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.  ....++.++|+||+||++++|++|.
T Consensus       127 i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~  206 (267)
T cd06645         127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQ  206 (267)
T ss_pred             eecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCC
Confidence            999999999999999999999999998654332 1223456888999999874  2334788999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||..................                        ... ......++..+.++|.+||..||++|||+++
T Consensus       207 ~p~~~~~~~~~~~~~~~~~~~------------------------~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~  261 (267)
T cd06645         207 PPMFDLHPMRALFLMTKSNFQ------------------------PPK-LKDKMKWSNSFHHFVKMALTKNPKKRPTAEK  261 (267)
T ss_pred             CCcccccchhhHHhhhccCCC------------------------CCc-ccccCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence            998655433222211110000                        000 0111246778999999999999999999999


Q ss_pred             HhcCCC
Q 022132          248 ALAHPY  253 (302)
Q Consensus       248 ll~h~~  253 (302)
                      +++|||
T Consensus       262 ll~~~~  267 (267)
T cd06645         262 LLQHPF  267 (267)
T ss_pred             HhcCCC
Confidence            999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.9e-38  Score=271.74  Aligned_cols=215  Identities=21%  Similarity=0.361  Sum_probs=174.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+|+||++ ++|...+.. .+++++..+..++.|++.||.|||+
T Consensus        47 ~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~  121 (282)
T cd06643          47 EDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE  121 (282)
T ss_pred             HHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999887     88999999997 588777654 4679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhC----CCCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~i~~~l  163 (302)
                      .|++||||+|+||+++.++.++|+|||++...... .......++..|+|||.+..    ...++.++|+||+||++++|
T Consensus       122 ~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el  201 (282)
T cd06643         122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM  201 (282)
T ss_pred             CCeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHH
Confidence            99999999999999999999999999998654322 12234467889999998742    23467899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|.+||...+.......+......                           .......++..+.++|.+||+.||.+||
T Consensus       202 ~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp  254 (282)
T cd06643         202 AQIEPPHHELNPMRVLLKIAKSEPP---------------------------TLAQPSRWSSEFKDFLKKCLEKNVDARW  254 (282)
T ss_pred             ccCCCCccccCHHHHHHHHhhcCCC---------------------------CCCCccccCHHHHHHHHHHccCChhhCc
Confidence            9999999776654443333221000                           0011124678899999999999999999


Q ss_pred             CHHHHhcCCCcCCc
Q 022132          244 TVEDALAHPYLGSL  257 (302)
Q Consensus       244 t~~ell~h~~~~~~  257 (302)
                      |++++++||||...
T Consensus       255 ~~~~il~~~~~~~~  268 (282)
T cd06643         255 TTTQLLQHPFVTVN  268 (282)
T ss_pred             CHHHHhcCCCEecc
Confidence            99999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=271.60  Aligned_cols=239  Identities=38%  Similarity=0.689  Sum_probs=188.6

Q ss_pred             chhhHHHHHHhc---CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWI---MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~il~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+|+.+++++   +||||+++++++......+...++++|||++++|.+++...  ..+++..+..++.|++.||++|
T Consensus        44 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~L  123 (287)
T cd07838          44 STLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL  123 (287)
T ss_pred             hHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            455788887777   59999999999988633233459999999999999988754  3589999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |+.|++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+. .++.++|+||+||++++|++|
T Consensus       124 H~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~  202 (287)
T cd07838         124 HSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRR  202 (287)
T ss_pred             HHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhC
Confidence            9999999999999999999999999999998776544333445578889999998654 478999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+....+.+..+......+....+........   ...+...........+..++.+.++|.+||+.||++|||++
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  279 (287)
T cd07838         203 RPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR---SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAF  279 (287)
T ss_pred             CCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch---hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHH
Confidence            999999888888888877766655433221110000   01111122223344456678899999999999999999999


Q ss_pred             HHhcCCCc
Q 022132          247 DALAHPYL  254 (302)
Q Consensus       247 ell~h~~~  254 (302)
                      +++.||||
T Consensus       280 ~il~~~~~  287 (287)
T cd07838         280 EALQHPYF  287 (287)
T ss_pred             HHhcCcCC
Confidence            99999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.7e-39  Score=254.61  Aligned_cols=247  Identities=27%  Similarity=0.573  Sum_probs=198.3

Q ss_pred             HhcCchhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      -.++.+.||++||+.|. ||||++++++..++.+   ....+++||.+. ++..+..   .|+.-.++.++++++.||.|
T Consensus        74 VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S---ktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdy  147 (338)
T KOG0668|consen   74 VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES---KTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDY  147 (338)
T ss_pred             HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc---cCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhH
Confidence            34567899999999995 9999999999998754   778899999985 6666654   48899999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecC-CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      +|+.||+|||+||.|++++.. -.++|+|+|+|..-.+.....-.+.+++|--||.+..-..|.-+-|+|||||+++.|+
T Consensus       148 CHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~mi  227 (338)
T KOG0668|consen  148 CHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI  227 (338)
T ss_pred             HHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHH
Confidence            999999999999999999976 4599999999987776655566678899999999988888999999999999999998


Q ss_pred             hCC-CCCCCCChHHHHHHHHHHhCCCChHHHhhh-h-HhHHHHhhhccccccccccccCC-----CCCHHHHHHHHHccC
Q 022132          165 DRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFL-N-ENAKKYICQLPRYQRQSFTEKFP-----NVHPSAIDLVEKMLT  236 (302)
Q Consensus       165 ~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L~  236 (302)
                      ..+ |.|.|.+..+++.+|.+++|+-.-...-.- . ....++..-+....+.+|+...+     -.++++.||+.++|.
T Consensus       228 FrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLr  307 (338)
T KOG0668|consen  228 FRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLR  307 (338)
T ss_pred             hccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHh
Confidence            866 556789999999999999987433221110 0 11112222222334444443332     356999999999999


Q ss_pred             CCCCCCCCHHHHhcCCCcCCccCC
Q 022132          237 FDPRQRITVEDALAHPYLGSLHDI  260 (302)
Q Consensus       237 ~dP~~R~t~~ell~h~~~~~~~~~  260 (302)
                      +|.++|+||.|++.||||....+.
T Consensus       308 YDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  308 YDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             hccccccchHHHhcCchHHHHHHH
Confidence            999999999999999999887643

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=271.74  Aligned_cols=215  Identities=26%  Similarity=0.440  Sum_probs=175.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++.+...     +.+|+||||++ ++|.+++.+. +.+++..+..++.|++.||.|||+
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~  121 (280)
T cd06611          47 EDFMVEIDILSECKHPNIVGLYEAYFYE-----NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS  121 (280)
T ss_pred             HHHHHHHHHHHhCCCCceeEEEEEEecC-----CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999887     88999999997 5998888763 579999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhC----CCCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~i~~~l  163 (302)
                      .||+|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+..    ...++.++|+||+||++|+|
T Consensus       122 ~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l  201 (280)
T cd06611         122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL  201 (280)
T ss_pred             CCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHH
Confidence            99999999999999999999999999987654332 22234467888999998752    23467799999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|.+||.+.+....+..+..  +.+                         +.......++..+.++|.+||+.||.+||
T Consensus       202 ~~g~~p~~~~~~~~~~~~~~~--~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  254 (280)
T cd06611         202 AQMEPPHHELNPMRVLLKILK--SEP-------------------------PTLDQPSKWSSSFNDFLKSCLVKDPDDRP  254 (280)
T ss_pred             HhCCCCcccCCHHHHHHHHhc--CCC-------------------------CCcCCcccCCHHHHHHHHHHhccChhhCc
Confidence            999999977654433322211  000                         00011125678899999999999999999


Q ss_pred             CHHHHhcCCCcCCc
Q 022132          244 TVEDALAHPYLGSL  257 (302)
Q Consensus       244 t~~ell~h~~~~~~  257 (302)
                      |++++++||||...
T Consensus       255 s~~~il~~~~~~~~  268 (280)
T cd06611         255 TAAELLKHPFVSDQ  268 (280)
T ss_pred             CHHHHhcChhhccc
Confidence            99999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=302.73  Aligned_cols=217  Identities=26%  Similarity=0.395  Sum_probs=175.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.++++++||||++++++|.....   ..+||||||++ ++|.+++..    .+.+++..++.|+.||+.||.|
T Consensus        57 ~~~~~EI~IL~~L~HPNIVrl~d~f~de~~---~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaY  133 (1021)
T PTZ00266         57 SQLVIEVNVMRELKHKNIVRYIDRFLNKAN---QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY  133 (1021)
T ss_pred             HHHHHHHHHHHHcCCCCcCeEEEEEEecCC---CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            457789999999999999999999865422   67999999997 699998864    3579999999999999999999


Q ss_pred             HHhC-------CceecCCCCCCEEEec-----------------CCCEEEeecccccccCCCCcccccccccccCchhhh
Q 022132           86 IHSA-------NVLHRDLKPSNLLLNA-----------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL  141 (302)
Q Consensus        86 LH~~-------~i~H~dikp~Nil~~~-----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~  141 (302)
                      ||+.       +|+||||||+|||++.                 .+.++|+|||++.............+++.|+|||++
T Consensus       134 LHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL  213 (1021)
T PTZ00266        134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELL  213 (1021)
T ss_pred             HHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHH
Confidence            9985       4999999999999964                 345899999999876554444556789999999998


Q ss_pred             hCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccC
Q 022132          142 LNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF  220 (302)
Q Consensus       142 ~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (302)
                      .+. ..++.++||||||||+|+|++|.+||...+....+......  .|.                           ...
T Consensus       214 ~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~--~p~---------------------------lpi  264 (1021)
T PTZ00266        214 LHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKR--GPD---------------------------LPI  264 (1021)
T ss_pred             hccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhc--CCC---------------------------CCc
Confidence            643 34789999999999999999999999766544433222211  000                           011


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccC
Q 022132          221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  259 (302)
Q Consensus       221 ~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  259 (302)
                      +..++++.+||..||..+|.+|||+.++|.|+|+.....
T Consensus       265 ~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        265 KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            246788999999999999999999999999999986543

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=270.73  Aligned_cols=212  Identities=23%  Similarity=0.401  Sum_probs=176.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++.+.     ..+|+|+||++ ++|.+++... ++++..+..++.|++.|+.|||+.|
T Consensus        45 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~  118 (274)
T cd06609          45 DIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG  118 (274)
T ss_pred             HHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            567899999999999999999999887     88999999997 5999998765 8999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+.. ++.++|+||+||++|+|++|.+|
T Consensus       119 i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p  197 (274)
T cd06609         119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPP  197 (274)
T ss_pred             cccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998766543 2234456778899999986554 89999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |...+.......+.... .                         ..+..  ..++.++.+++.+||..||++|||+++++
T Consensus       198 ~~~~~~~~~~~~~~~~~-~-------------------------~~~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il  249 (274)
T cd06609         198 LSDLHPMRVLFLIPKNN-P-------------------------PSLEG--NKFSKPFKDFVSLCLNKDPKERPSAKELL  249 (274)
T ss_pred             cccCchHHHHHHhhhcC-C-------------------------CCCcc--cccCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence            97665433322222110 0                         00000  12678899999999999999999999999


Q ss_pred             cCCCcCCcc
Q 022132          250 AHPYLGSLH  258 (302)
Q Consensus       250 ~h~~~~~~~  258 (302)
                      +||||....
T Consensus       250 ~~~~~~~~~  258 (274)
T cd06609         250 KHKFIKKAK  258 (274)
T ss_pred             hChhhcCCC
Confidence            999998743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.5e-38  Score=266.88  Aligned_cols=212  Identities=26%  Similarity=0.449  Sum_probs=174.0

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.+++.++||||+++++++...     ..+|+++||++ ++|.+++.. ...+++..+..++.|++.|+.|||
T Consensus        42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh  116 (256)
T cd06612          42 LQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH  116 (256)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH
Confidence            45688999999999999999999999887     88999999997 599999875 457899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      +.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++++|++|
T Consensus       117 ~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g  195 (256)
T cd06612         117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEG  195 (256)
T ss_pred             HCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999987655432 22334567889999998554 578999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||...+.......+..   .+                       . ......+.++..+.++|.+||+.||.+|||+.
T Consensus       196 ~~p~~~~~~~~~~~~~~~---~~-----------------------~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~  248 (256)
T cd06612         196 KPPYSDIHPMRAIFMIPN---KP-----------------------P-PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAI  248 (256)
T ss_pred             CCCCCCcchhhhhhhhcc---CC-----------------------C-CCCCchhhcCHHHHHHHHHHHhcChhhCcCHH
Confidence            999976544332211110   00                       0 00011124667899999999999999999999


Q ss_pred             HHhcCCCc
Q 022132          247 DALAHPYL  254 (302)
Q Consensus       247 ell~h~~~  254 (302)
                      |+|.||||
T Consensus       249 ~il~~~~~  256 (256)
T cd06612         249 QLLQHPFI  256 (256)
T ss_pred             HHhcCCCC
Confidence            99999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-39  Score=284.31  Aligned_cols=204  Identities=26%  Similarity=0.467  Sum_probs=170.8

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ....+|+.++... +||||+++++.+.+.     .+.|+|||++.| -+.+.+...+.+. ..+..|+.+|+.|+.|||+
T Consensus       360 ~~~~~e~~~~~~~~~h~niv~~~~v~~~~-----~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~  433 (612)
T KOG0603|consen  360 DDNQDEIPISLLVRDHPNIVKSHDVYEDG-----KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHE  433 (612)
T ss_pred             cccccccchhhhhcCCCcceeecceecCC-----ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHh
Confidence            3455788777777 899999999999998     899999999974 6666666655454 7888899999999999999


Q ss_pred             CCceecCCCCCCEEE-ecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLL-NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +|++|||+||+|||+ +..|+++|+|||.+......  ....+.|..|.|||++. ...++.++|+||||+++|+||+|.
T Consensus       434 ~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~  510 (612)
T KOG0603|consen  434 QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGR  510 (612)
T ss_pred             cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCC
Confidence            999999999999999 68899999999998765544  33457788999999996 556999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      .||......   ..+...++.|...                            ..+|..+++||++||+.||.+|+++++
T Consensus       511 tp~~~~P~~---~ei~~~i~~~~~s----------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~  559 (612)
T KOG0603|consen  511 TLFAAHPAG---IEIHTRIQMPKFS----------------------------ECVSDEAKDLLQQLLQVDPALRLGADE  559 (612)
T ss_pred             CccccCCch---HHHHHhhcCCccc----------------------------cccCHHHHHHHHHhccCChhhCcChhh
Confidence            999766544   3344444443321                            268999999999999999999999999


Q ss_pred             HhcCCCc
Q 022132          248 ALAHPYL  254 (302)
Q Consensus       248 ll~h~~~  254 (302)
                      ++.||||
T Consensus       560 i~~h~w~  566 (612)
T KOG0603|consen  560 IGAHPWF  566 (612)
T ss_pred             hccCcch
Confidence            9999999

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.8e-38  Score=265.40  Aligned_cols=209  Identities=27%  Similarity=0.455  Sum_probs=171.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      .+.+|+.++++++|||++++++.+....    +.+|++|||++ ++|.+.+..  ...+++..+..++.|++.||++||+
T Consensus        45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~  120 (257)
T cd08223          45 AAEQEAQLLSQLKHPNIVAYRESWEGED----GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE  120 (257)
T ss_pred             HHHHHHHHHHhCCCCCeeeeeeeecCCC----CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            5678999999999999999999876431    56899999997 699998875  3468999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      .|++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+. .++.++|+||+||++++|++|.
T Consensus       121 ~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~  199 (257)
T cd08223         121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLK  199 (257)
T ss_pred             CCeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCC
Confidence            99999999999999999999999999998755322 223344678889999988544 4788999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      .||.+.+.......+.....                             .......++.+.+++.+||+.||.+|||+.+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  250 (257)
T cd08223         200 HAFNAKDMNSLVYRIIEGKL-----------------------------PPMPKDYSPELGELIATMLSKRPEKRPSVKS  250 (257)
T ss_pred             CCCCCCCHHHHHHHHHhcCC-----------------------------CCCccccCHHHHHHHHHHhccCcccCCCHHH
Confidence            99987665443332222100                             0111256788999999999999999999999


Q ss_pred             HhcCCCc
Q 022132          248 ALAHPYL  254 (302)
Q Consensus       248 ll~h~~~  254 (302)
                      +++||||
T Consensus       251 ~l~~~~~  257 (257)
T cd08223         251 ILRQPYI  257 (257)
T ss_pred             HhcCCCC
Confidence            9999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=270.36  Aligned_cols=238  Identities=27%  Similarity=0.512  Sum_probs=186.3

Q ss_pred             chhhHHHHHHhcCC--CC----ccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMK--TS----VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGL   83 (302)
Q Consensus        12 ~~~~E~~il~~l~h--~n----iv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~~l   83 (302)
                      ..+-|+++|+++++  |+    ++++.++|.-.     ++.+||+|.++-++++++.++  .+++...++.+.+|++.++
T Consensus       131 Aa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr-----ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv  205 (415)
T KOG0671|consen  131 AALIEIEVLQKINESDPNGKFRCVQMRDWFDYR-----GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESV  205 (415)
T ss_pred             HHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc-----CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHH
Confidence            33469999999943  33    78888889887     999999999999999999875  4788999999999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEec--------------------CCCEEEeecccccccCCCCcccccccccccCchhhhhC
Q 022132           84 KYIHSANVLHRDLKPSNLLLNA--------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN  143 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~--------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  143 (302)
                      ++||+.+++|.|+||+||++.+                    +..++++|||.|+...+.  ....+.|..|+|||++.+
T Consensus       206 ~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLg  283 (415)
T KOG0671|consen  206 AFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILG  283 (415)
T ss_pred             HHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheec
Confidence            9999999999999999999842                    345899999999876554  356688999999999998


Q ss_pred             CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccc----c------
Q 022132          144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ----R------  213 (302)
Q Consensus       144 ~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~------  213 (302)
                      .+ ++..+||||+|||++|+.+|...|.+.++.+.++-+-..+|..+..++.... ..+-+.....++.    .      
T Consensus       284 LG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~-~~Kyf~~~rldw~e~~~~~~~k~v  361 (415)
T KOG0671|consen  284 LG-WSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTR-KEKYFRRGRLDWPEVSSKGKSKYV  361 (415)
T ss_pred             cC-cCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhh-hHhhhhcccccCccccccccchhh
Confidence            77 9999999999999999999999999999999887777778855554443321 1111111110100    0      


Q ss_pred             ----ccccccCC---CCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          214 ----QSFTEKFP---NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       214 ----~~~~~~~~---~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                          .++.....   .....+.|||++||.+||.+|+|+.|+|.||||+...
T Consensus       362 ~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  362 FEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             hcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence                00111111   1123689999999999999999999999999998754

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.6e-38  Score=273.64  Aligned_cols=218  Identities=23%  Similarity=0.435  Sum_probs=177.2

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++||||+++++.+...     +..|+||||++ ++|.+++.. +.+++..+..++.||+.||+|||+
T Consensus        63 ~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~  136 (292)
T cd06658          63 RELLFNEVVIMRDYHHENVVDMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHN  136 (292)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHHheecC-----CeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34577999999999999999999999887     88999999997 588887754 578999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      .|++||||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+|+++++|++|.
T Consensus       137 ~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~  215 (292)
T cd06658         137 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGE  215 (292)
T ss_pred             CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999998654322 22233567889999998854 44789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      .||.+.+....+..+......                           ........+..+.+++.+||..||.+|||+++
T Consensus       216 ~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  268 (292)
T cd06658         216 PPYFNEPPLQAMRRIRDNLPP---------------------------RVKDSHKVSSVLRGFLDLMLVREPSQRATAQE  268 (292)
T ss_pred             CCCCCCCHHHHHHHHHhcCCC---------------------------ccccccccCHHHHHHHHHHccCChhHCcCHHH
Confidence            999876654443332211100                           00111246778999999999999999999999


Q ss_pred             HhcCCCcCCccCCC
Q 022132          248 ALAHPYLGSLHDIS  261 (302)
Q Consensus       248 ll~h~~~~~~~~~~  261 (302)
                      +++||||.....++
T Consensus       269 il~~~~~~~~~~~~  282 (292)
T cd06658         269 LLQHPFLKLAGPPS  282 (292)
T ss_pred             HhhChhhhccCCcc
Confidence            99999998765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.6e-38  Score=276.32  Aligned_cols=242  Identities=18%  Similarity=0.246  Sum_probs=175.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|++|||++ ++|.+++...  ..+++..+..++.|++.||+|||
T Consensus        44 ~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH  118 (314)
T cd08216          44 KLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH  118 (314)
T ss_pred             HHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3678999999999999999999999887     88999999997 6899988753  46899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--------cccccccccccCchhhhhCC-CCCCCchhHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGC  158 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~  158 (302)
                      ++||+||||+|+||+++.++.++++|||.+.......        ......++..|+|||.+.+. ..++.++|+||+||
T Consensus       119 ~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~  198 (314)
T cd08216         119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGI  198 (314)
T ss_pred             HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHH
Confidence            9999999999999999999999999999876432211        12233466789999998653 34788999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhh------ccccccccccccCCCCCHHHHHHHH
Q 022132          159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ------LPRYQRQSFTEKFPNVHPSAIDLVE  232 (302)
Q Consensus       159 i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~  232 (302)
                      ++++|++|.+||..............  +....................      .+.............++.++.+|+.
T Consensus       199 il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  276 (314)
T cd08216         199 TACELANGHVPFKDMPATQMLLEKVR--GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVE  276 (314)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHh--ccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHH
Confidence            99999999999987654433222111  111000000000000000000      0000000000111134568899999


Q ss_pred             HccCCCCCCCCCHHHHhcCCCcCCccC
Q 022132          233 KMLTFDPRQRITVEDALAHPYLGSLHD  259 (302)
Q Consensus       233 ~~L~~dP~~R~t~~ell~h~~~~~~~~  259 (302)
                      +||.+||++|||++++|+||||+..+.
T Consensus       277 ~~l~~~P~~Rpt~~~ll~~p~~~~~~~  303 (314)
T cd08216         277 LCLQRDPESRPSASQLLNHSFFKQCKR  303 (314)
T ss_pred             HHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence            999999999999999999999998763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-40  Score=258.52  Aligned_cols=223  Identities=24%  Similarity=0.326  Sum_probs=172.3

Q ss_pred             chhHHHH-----hcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHH
Q 022132            2 HSITKLM-----QRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEH   71 (302)
Q Consensus         2 ~~~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~   71 (302)
                      ||+||+.     +.....+|++..++++|||+++++++...+..++....|++++|+. |+|.+.++.    +..+++..
T Consensus        49 YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~  128 (302)
T KOG2345|consen   49 YALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQ  128 (302)
T ss_pred             hhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHH
Confidence            5666653     3447789999999999999999999988766556678999999996 899999863    34799999


Q ss_pred             HHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEecCCCEEEeecccccccCCCC----------cccccccccccCchh
Q 022132           72 CQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----------FMTEYVVTRWYRAPE  139 (302)
Q Consensus        72 ~~~i~~qll~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~~y~aPE  139 (302)
                      +..|+.+|++||++||+..  ++||||||.||++++++.++++|||.+....-..          .-.....|..|+|||
T Consensus       129 iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPE  208 (302)
T KOG2345|consen  129 ILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPE  208 (302)
T ss_pred             HHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCch
Confidence            9999999999999999999  9999999999999999999999999986432110          112345688999999


Q ss_pred             hhhCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccc-ccccc
Q 022132          140 LLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY-QRQSF  216 (302)
Q Consensus       140 ~~~~~~--~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  216 (302)
                      .+....  ..++++|||||||++|.|+.|..||...-         ...+..                 ...-. ...++
T Consensus       209 Lf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~GgSl-----------------aLAv~n~q~s~  262 (302)
T KOG2345|consen  209 LFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQGGSL-----------------ALAVQNAQISI  262 (302)
T ss_pred             heecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcCCeE-----------------EEeeecccccc
Confidence            984332  25789999999999999999999994210         000000                 00000 01122


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       217 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +... .+|..+.++|+.||+.||.+||++.+++.+
T Consensus       263 P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  263 PNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             CCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            2222 378899999999999999999999999874

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.2e-38  Score=270.11  Aligned_cols=216  Identities=23%  Similarity=0.456  Sum_probs=178.2

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++||||+++++++...     +..|+++||+. ++|.+++.. +++++..+..++.|++.||++||+
T Consensus        60 ~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~  133 (285)
T cd06648          60 RELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHA  133 (285)
T ss_pred             HHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34577899999999999999999999877     88999999996 699998877 679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +|++||||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+||++++|++|.
T Consensus       134 ~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~  212 (285)
T cd06648         134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGE  212 (285)
T ss_pred             CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999876543321 22334578899999998544 4789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      .||.+.+.......+... ..+                          .......++..+.+++.+||..||++|||+.+
T Consensus       213 ~p~~~~~~~~~~~~~~~~-~~~--------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  265 (285)
T cd06648         213 PPYFNEPPLQAMKRIRDN-LPP--------------------------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAE  265 (285)
T ss_pred             CCCcCCCHHHHHHHHHhc-CCC--------------------------CCcccccCCHHHHHHHHHHcccChhhCcCHHH
Confidence            999776654444333221 000                          01111246788999999999999999999999


Q ss_pred             HhcCCCcCCccC
Q 022132          248 ALAHPYLGSLHD  259 (302)
Q Consensus       248 ll~h~~~~~~~~  259 (302)
                      +++||||.....
T Consensus       266 il~~~~~~~~~~  277 (285)
T cd06648         266 LLNHPFLAKAGP  277 (285)
T ss_pred             HccCcccccCCC
Confidence            999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.3e-38  Score=266.38  Aligned_cols=211  Identities=26%  Similarity=0.466  Sum_probs=176.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+++||++ ++|.+++.+.+.+++..+..++.|++.||++||+.
T Consensus        47 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  121 (258)
T cd06632          47 KQLEQEIALLSKLQHPNIVQYLGTEREE-----DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR  121 (258)
T ss_pred             HHHHHHHHHHHhcCCCCchheeeeEecC-----CeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577899999999999999999999877     88999999997 59999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.....++.++|+||+||++++|++|.+|
T Consensus       122 ~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~p  201 (258)
T cd06632         122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP  201 (258)
T ss_pred             CcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999987654443334556788899999885444478999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |...........+....                            ......+.+++.+.+++++||..||.+|||+++++
T Consensus       202 f~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l  253 (258)
T cd06632         202 WSQLEGVAAVFKIGRSK----------------------------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELL  253 (258)
T ss_pred             cccCcHHHHHHHHHhcc----------------------------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence            97655333222211100                            00112235678999999999999999999999999


Q ss_pred             cCCCc
Q 022132          250 AHPYL  254 (302)
Q Consensus       250 ~h~~~  254 (302)
                      .|||+
T Consensus       254 ~~~~~  258 (258)
T cd06632         254 EHPFV  258 (258)
T ss_pred             cCCCC
Confidence            99996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-38  Score=268.85  Aligned_cols=209  Identities=27%  Similarity=0.455  Sum_probs=175.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      +.+.+|+.++++++||||+++++++...     +.+|+|+||+. ++|.+.+.....+++..+..++.|+++||.|||++
T Consensus        45 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~  119 (258)
T cd05578          45 RNVLNERRILQELNHPFLVNLWYSFQDE-----ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK  119 (258)
T ss_pred             HHHHHHHHHHHhCCCCChHHHHHhhcCC-----CeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence            4678899999999999999999999887     88999999996 69999998777899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+... .++.++|+||+|+++++|++|..|
T Consensus       120 ~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p  198 (258)
T cd05578         120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRP  198 (258)
T ss_pred             CeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCC
Confidence            9999999999999999999999999998766544334455678889999998554 478999999999999999999999


Q ss_pred             CCCCChH--HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH--
Q 022132          170 FPGRDHV--HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV--  245 (302)
Q Consensus       170 f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--  245 (302)
                      |...+..  ..+.....   .                          ......+..+.++.++|.+||..||.+|||+  
T Consensus       199 ~~~~~~~~~~~~~~~~~---~--------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~  249 (258)
T cd05578         199 YRGHSRTIRDQIRAKQE---T--------------------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNL  249 (258)
T ss_pred             CCCCCccHHHHHHHHhc---c--------------------------ccccCcccCcHHHHHHHHHHccCChhHcCCccH
Confidence            9876642  11111110   0                          0011122567899999999999999999999  


Q ss_pred             HHHhcCCCc
Q 022132          246 EDALAHPYL  254 (302)
Q Consensus       246 ~ell~h~~~  254 (302)
                      .|+++||||
T Consensus       250 ~~l~~~~~~  258 (258)
T cd05578         250 KDLKNHPYF  258 (258)
T ss_pred             HHHhcCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.6e-38  Score=267.78  Aligned_cols=211  Identities=22%  Similarity=0.409  Sum_probs=169.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++.....   +.+++++||++ ++|.+.+...+.+++..+..++.|++.||+|||+.|
T Consensus        50 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~  126 (266)
T cd06651          50 ALECEIQLLKNLQHERIVQYYGCLRDRAE---KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM  126 (266)
T ss_pred             HHHHHHHHHHHcCCCCeeeEEEEEEcCCC---CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            46789999999999999999999876422   67899999997 699999988788999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC----CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ++|+||+|+||+++.++.++|+|||++......    .......++..|+|||.+.+ ..++.++|+||+||++++|++|
T Consensus       127 i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g  205 (266)
T cd06651         127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTE  205 (266)
T ss_pred             eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHC
Confidence            999999999999999999999999998654321    11123456788999998855 4478999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||...+.......+..   .+..                         .......++.+.+++ +||..||.+|||++
T Consensus       206 ~~pf~~~~~~~~~~~~~~---~~~~-------------------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~  256 (266)
T cd06651         206 KPPWAEYEAMAAIFKIAT---QPTN-------------------------PQLPSHISEHARDFL-GCIFVEARHRPSAE  256 (266)
T ss_pred             CCCccccchHHHHHHHhc---CCCC-------------------------CCCchhcCHHHHHHH-HHhcCChhhCcCHH
Confidence            999976654433322211   1000                         011124567888898 57778999999999


Q ss_pred             HHhcCCCcC
Q 022132          247 DALAHPYLG  255 (302)
Q Consensus       247 ell~h~~~~  255 (302)
                      |+++||||+
T Consensus       257 eil~hp~~~  265 (266)
T cd06651         257 ELLRHPFAQ  265 (266)
T ss_pred             HHhcCcccc
Confidence            999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-38  Score=269.65  Aligned_cols=218  Identities=24%  Similarity=0.417  Sum_probs=175.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN---QALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..+.+|+.++++++||||+++++.+...     +.+|+||||++ ++|..++...   ..+++..+..++.|++.||.||
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L  118 (286)
T cd06622          44 NQIIMELDILHKAVSPYIVDFYGAFFIE-----GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL  118 (286)
T ss_pred             HHHHHHHHHHHhcCCCcHHhhhhheecC-----CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999887     89999999997 5888887753   3799999999999999999999


Q ss_pred             Hh-CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCC-----CCCCchhHHHHHHHH
Q 022132           87 HS-ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS-----DYTAAIDVWSVGCIF  160 (302)
Q Consensus        87 H~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~i~  160 (302)
                      |+ .|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+..     .++.++|+||+||++
T Consensus       119 H~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il  197 (286)
T cd06622         119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSI  197 (286)
T ss_pred             HhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHH
Confidence            97 59999999999999999999999999998654322 223345778899999875432     247899999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      ++|++|..||...........+......+                          .....+.+++++.++|.+||..||+
T Consensus       198 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~  251 (286)
T cd06622         198 LEMALGRYPYPPETYANIFAQLSAIVDGD--------------------------PPTLPSGYSDDAQDFVAKCLNKIPN  251 (286)
T ss_pred             HHHHhCCCCCCCcchhhHHHHHHHHhhcC--------------------------CCCCCcccCHHHHHHHHHHcccCcc
Confidence            99999999997654333222221111110                          1122235788999999999999999


Q ss_pred             CCCCHHHHhcCCCcCCccCC
Q 022132          241 QRITVEDALAHPYLGSLHDI  260 (302)
Q Consensus       241 ~R~t~~ell~h~~~~~~~~~  260 (302)
                      +|||++++++||||......
T Consensus       252 ~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         252 RRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             cCCCHHHHhcChhhhhccCC
Confidence            99999999999999887643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-39  Score=286.98  Aligned_cols=213  Identities=22%  Similarity=0.371  Sum_probs=188.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ++.||+++++.++|||||+++.+....     ..+|+||||+. |.+++++.++++..+..++.++.|++.|++|||+++
T Consensus       101 k~~rev~imk~l~HPnIvkl~~v~~t~-----~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~  175 (596)
T KOG0586|consen  101 KLGREVDIMKSLNHPNIVKLFSVIETE-----ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN  175 (596)
T ss_pred             HHHHHHHHHHhcCCcceeeeeeeeeec-----ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc
Confidence            368999999999999999999999998     89999999985 799999999999999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      |+|||||++||+++.+..+||+|||++............+|++.|.|||++.+....++.+|+||+|+++|.|+.|..||
T Consensus       176 ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPF  255 (596)
T KOG0586|consen  176 IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPF  255 (596)
T ss_pred             eeccccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccccc
Confidence            99999999999999999999999999998888888889999999999999998887899999999999999999999999


Q ss_pred             CCCChHHHHHH-HHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          171 PGRDHVHQLRL-LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       171 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      +|.+-...-.. +....+.                               .--++.++.++|+++|.++|.+|++.+++.
T Consensus       256 DG~~lk~Lr~rvl~gk~rI-------------------------------p~~ms~dce~lLrk~lvl~Pskr~~~dqim  304 (596)
T KOG0586|consen  256 DGQNLKELRPRVLRGKYRI-------------------------------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIM  304 (596)
T ss_pred             CCcccccccchheeeeecc-------------------------------cceeechhHHHHHHhhccCccccCCHHHhh
Confidence            87763321110 0000000                               013567899999999999999999999999


Q ss_pred             cCCCcCCccCC
Q 022132          250 AHPYLGSLHDI  260 (302)
Q Consensus       250 ~h~~~~~~~~~  260 (302)
                      .|.|.+..+..
T Consensus       305 ~~~W~n~~~~~  315 (596)
T KOG0586|consen  305 KDRWRNDLLEA  315 (596)
T ss_pred             hhcccchhhhh
Confidence            99999988765

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.3e-38  Score=270.30  Aligned_cols=216  Identities=22%  Similarity=0.385  Sum_probs=173.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++.+...     +.+|+||||++ ++|..++.. ...+++..+..++.|++.||+|||+
T Consensus        54 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~  128 (292)
T cd06644          54 EDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS  128 (292)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            3567899999999999999999999877     78999999997 577776643 4678999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhC----CCCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~i~~~l  163 (302)
                      .|++||||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+    ...++.++|+||+||++|+|
T Consensus       129 ~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el  208 (292)
T cd06644         129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM  208 (292)
T ss_pred             CCeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHH
Confidence            99999999999999999999999999987653322 12234457788999998742    23467899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|.+||...+.......+..   ...                        +.......++.++.++|.+||..||++||
T Consensus       209 ~~g~~p~~~~~~~~~~~~~~~---~~~------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  261 (292)
T cd06644         209 AQIEPPHHELNPMRVLLKIAK---SEP------------------------PTLSQPSKWSMEFRDFLKTALDKHPETRP  261 (292)
T ss_pred             hcCCCCCccccHHHHHHHHhc---CCC------------------------ccCCCCcccCHHHHHHHHHHhcCCcccCc
Confidence            999999976654333222211   000                        00011225677899999999999999999


Q ss_pred             CHHHHhcCCCcCCcc
Q 022132          244 TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 t~~ell~h~~~~~~~  258 (302)
                      |++++++||||....
T Consensus       262 ~~~~il~~~~~~~~~  276 (292)
T cd06644         262 SAAQLLEHPFVSSVT  276 (292)
T ss_pred             CHHHHhcCccccccc
Confidence            999999999998765

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.1e-38  Score=271.61  Aligned_cols=217  Identities=22%  Similarity=0.447  Sum_probs=178.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+|+||+. ++|..++.. ..+++..+..++.|++.||++||+.
T Consensus        61 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~  134 (296)
T cd06655          61 ELIINEILVMKELKNPNIVNFLDSFLVG-----DELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHAN  134 (296)
T ss_pred             HHHHHHHHHHHhcCCCceeeeeeeEecC-----ceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4567899999999999999999999887     88999999996 588888765 4689999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|.+
T Consensus       135 ~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~  213 (296)
T cd06655         135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEP  213 (296)
T ss_pred             CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987654332 2233467888999998854 447899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||.+.+.......+... +.+.                          ......+++.+.++|++||..||.+|||+.++
T Consensus       214 pf~~~~~~~~~~~~~~~-~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~i  266 (296)
T cd06655         214 PYLNENPLRALYLIATN-GTPE--------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKEL  266 (296)
T ss_pred             CCCCCCHHHHHHHHHhc-CCcc--------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence            99877654433322110 1100                          11122577889999999999999999999999


Q ss_pred             hcCCCcCCccCCC
Q 022132          249 LAHPYLGSLHDIS  261 (302)
Q Consensus       249 l~h~~~~~~~~~~  261 (302)
                      +.||||+......
T Consensus       267 l~~~~~~~~~~~~  279 (296)
T cd06655         267 LQHPFLKLAKPLS  279 (296)
T ss_pred             hhChHhhhccccc
Confidence            9999998766433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.7e-38  Score=265.38  Aligned_cols=209  Identities=26%  Similarity=0.476  Sum_probs=176.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.++++++|+||+++++++.+.     +.++++|||++ ++|.+.+...  ..+++..+..++.|++.||.|||
T Consensus        44 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh  118 (256)
T cd08221          44 RDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH  118 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3577999999999999999999999887     88999999997 6999999764  56899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      +.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+.. ++.++|+||+|+++++|++|
T Consensus       119 ~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g  197 (256)
T cd08221         119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTL  197 (256)
T ss_pred             hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHC
Confidence            9999999999999999999999999999987654332 233456788999999886543 78899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||.+.+..+....+..  +.+                           ....+..+..+.+++.+||..||.+|||++
T Consensus       198 ~~~~~~~~~~~~~~~~~~--~~~---------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~  248 (256)
T cd08221         198 KRTFDATNPLNLVVKIVQ--GNY---------------------------TPVVSVYSSELISLVHSLLQQDPEKRPTAD  248 (256)
T ss_pred             CCCCCCCCHHHHHHHHHc--CCC---------------------------CCCccccCHHHHHHHHHHcccCcccCCCHH
Confidence            999987765554444332  110                           011135678899999999999999999999


Q ss_pred             HHhcCCCc
Q 022132          247 DALAHPYL  254 (302)
Q Consensus       247 ell~h~~~  254 (302)
                      ++++|+|+
T Consensus       249 ~ll~~~~l  256 (256)
T cd08221         249 EVLDQPLL  256 (256)
T ss_pred             HHhhCcCC
Confidence            99999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.3e-38  Score=271.49  Aligned_cols=214  Identities=21%  Similarity=0.412  Sum_probs=174.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.+.||||+++++.+...     ...|+||||+. ++|.+++.. ..+++..+..++.|++.||+|||+.
T Consensus        62 ~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~  135 (296)
T cd06654          62 ELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN  135 (296)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4577899999999999999999999876     88999999996 699998865 4689999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+||++++|++|.+
T Consensus       136 gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~  214 (296)
T cd06654         136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEP  214 (296)
T ss_pred             CcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999887543322 2233467889999998854 447899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||...+.......+.. .+.+.                          ....+.+++.+.+++.+||..||.+|||++++
T Consensus       215 pf~~~~~~~~~~~~~~-~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ei  267 (296)
T cd06654         215 PYLNENPLRALYLIAT-NGTPE--------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL  267 (296)
T ss_pred             CCCCCCHHHhHHHHhc-CCCCC--------------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHH
Confidence            9976654332221110 01000                          01122567889999999999999999999999


Q ss_pred             hcCCCcCCcc
Q 022132          249 LAHPYLGSLH  258 (302)
Q Consensus       249 l~h~~~~~~~  258 (302)
                      ++||||...+
T Consensus       268 l~~~~~~~~~  277 (296)
T cd06654         268 LQHQFLKIAK  277 (296)
T ss_pred             hhChhhhccC
Confidence            9999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.9e-38  Score=266.97  Aligned_cols=214  Identities=24%  Similarity=0.449  Sum_probs=173.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +++++|+||+. ++|.+++...+++++..+..++.|++.||.+||++
T Consensus        48 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~  122 (268)
T cd06630          48 EALRKEIRLMARLNHPHIIRMLGATCED-----SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN  122 (268)
T ss_pred             HHHHHHHHHHHHcCCCceehhhceeccC-----CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4678899999999999999999999887     89999999997 59999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCC-CEEEeecccccccCCCC-----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      |++|+||+|+||+++.++ .++|+|||.+.......     ......++..|+|||.+.+ ..++.++|+||+||++++|
T Consensus       123 ~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l  201 (268)
T cd06630         123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEM  201 (268)
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHH
Confidence            999999999999998776 59999999986544321     1223456788999999854 4478999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|..||...........+......                         .......+..++++.+++.+||..||++||
T Consensus       202 ~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~  256 (268)
T cd06630         202 ATAKPPWNAEKHSNHLALIFKIASA-------------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRP  256 (268)
T ss_pred             HhCCCCCCCCCCcchHHHHHHHhcc-------------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCc
Confidence            9999999655433222222111000                         000112225678999999999999999999


Q ss_pred             CHHHHhcCCCcC
Q 022132          244 TVEDALAHPYLG  255 (302)
Q Consensus       244 t~~ell~h~~~~  255 (302)
                      |+.++++||||+
T Consensus       257 ~~~~ll~~~~~~  268 (268)
T cd06630         257 PSRELLKHPVFR  268 (268)
T ss_pred             CHHHHhcCcccC
Confidence            999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.3e-38  Score=269.20  Aligned_cols=213  Identities=24%  Similarity=0.388  Sum_probs=169.8

Q ss_pred             hhhHHHHHHh---cCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           13 FVRSSCFDTW---IMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        13 ~~~E~~il~~---l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      +.+|..+++.   .+||||+++++++...     +..|+||||++ ++|.+++..++.+++..+..++.|++.||+|||+
T Consensus        41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~  115 (279)
T cd05633          41 ALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN  115 (279)
T ss_pred             HHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3455544444   4799999999999887     78999999997 6999999888889999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      .|++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+.....++.++|+||+||++++|++|..
T Consensus       116 ~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~  194 (279)
T cd05633         116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHS  194 (279)
T ss_pred             CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence            999999999999999999999999999986544322 2334688999999988654557899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----  243 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----  243 (302)
                      ||.......... +......                          ......+.+++++.++|.+||..||.+|+     
T Consensus       195 pf~~~~~~~~~~-~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~  247 (279)
T cd05633         195 PFRQHKTKDKHE-IDRMTLT--------------------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGR  247 (279)
T ss_pred             CcCCCCCcCHHH-HHHHhhc--------------------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCC
Confidence            997543221110 0000000                          00112235788999999999999999999     


Q ss_pred             CHHHHhcCCCcCCcc
Q 022132          244 TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 t~~ell~h~~~~~~~  258 (302)
                      |+.++++||||+...
T Consensus       248 ~~~~~~~h~~~~~~~  262 (279)
T cd05633         248 GAQEVKEHVFFKGID  262 (279)
T ss_pred             CHHHHHhCccccCCC
Confidence            699999999998854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-38  Score=266.07  Aligned_cols=213  Identities=25%  Similarity=0.397  Sum_probs=173.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|++|||++ ++|.+++... ..+++..+..++.|++.||+|||+
T Consensus        45 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~  119 (262)
T cd06613          45 EIIQQEISMLKECRHPNIVAYFGSYLRR-----DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE  119 (262)
T ss_pred             HHHHHHHHHHHhCCCCChhceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4677899999999999999999999887     88999999997 5999888765 789999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCC--CCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+.  ..++.++|+||+||++++|++
T Consensus       120 ~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~t  199 (262)
T cd06613         120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE  199 (262)
T ss_pred             CCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHh
Confidence            999999999999999999999999999987544321 22344678889999988544  247889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+.......+....-.+.                         .....+..+.++.+++.+||..||.+|||+
T Consensus       200 g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  254 (262)
T cd06613         200 LQPPMFDLHPMRALFLISKSNFPPP-------------------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTA  254 (262)
T ss_pred             CCCCCCCCCHHHHHHHHHhccCCCc-------------------------cccchhhhhHHHHHHHHHHcCCChhhCCCH
Confidence            9999987665443332221100000                         000112356789999999999999999999


Q ss_pred             HHHhcCCC
Q 022132          246 EDALAHPY  253 (302)
Q Consensus       246 ~ell~h~~  253 (302)
                      .+++.|+|
T Consensus       255 ~~il~~~~  262 (262)
T cd06613         255 TKLLQHPF  262 (262)
T ss_pred             HHHhcCCC
Confidence            99999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-38  Score=273.26  Aligned_cols=214  Identities=22%  Similarity=0.422  Sum_probs=175.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++.+...     +..|+||||+. ++|.+++...  ..+++..+..++.|++.||+|||
T Consensus        46 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH  120 (316)
T cd05574          46 KRVLTEQEILATLDHPFLPTLYASFQTE-----TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH  120 (316)
T ss_pred             HHHHHHHHHHHhCCCCCchhheeeeecC-----CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999887     88999999996 5999998753  57999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC------------------------------cccccccccccCc
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD------------------------------FMTEYVVTRWYRA  137 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~------------------------------~~~~~~~~~~y~a  137 (302)
                      +.|++|+||||+||+++.++.++|+|||++.......                              ......++..|+|
T Consensus       121 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~a  200 (316)
T cd05574         121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIA  200 (316)
T ss_pred             HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcC
Confidence            9999999999999999999999999999876432211                              1112356788999


Q ss_pred             hhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccccc
Q 022132          138 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT  217 (302)
Q Consensus       138 PE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (302)
                      ||.+.+. .++.++||||||+++|+|++|..||.+.+....+..+....   .                        .+.
T Consensus       201 PE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~---~------------------------~~~  252 (316)
T cd05574         201 PEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE---V------------------------TFP  252 (316)
T ss_pred             HHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCC---c------------------------cCC
Confidence            9998654 47899999999999999999999998776554443332100   0                        000


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCC----HHHHhcCCCcCCcc
Q 022132          218 EKFPNVHPSAIDLVEKMLTFDPRQRIT----VEDALAHPYLGSLH  258 (302)
Q Consensus       218 ~~~~~~~~~~~~li~~~L~~dP~~R~t----~~ell~h~~~~~~~  258 (302)
                       .....+..+.++|.+||..||.+|||    ++++|+||||++..
T Consensus       253 -~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         253 -GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             -CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence             01136789999999999999999999    99999999998764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.1e-38  Score=276.49  Aligned_cols=216  Identities=21%  Similarity=0.363  Sum_probs=176.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|..+++.++|+||+++++++...     +..|+||||+. |+|.+++.. .+.+++..+..++.|++.||+|||+.
T Consensus        47 ~~~~e~~~l~~~~~~~i~~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~  121 (331)
T cd05624          47 CFREERNVLVNGDCQWITTLHYAFQDE-----NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL  121 (331)
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            467899999999999999999999887     89999999996 799999976 46899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhCC----CCCCCchhHHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~i~~~l  163 (302)
                      ||+||||||+||+++.++.++|+|||++........  .....|+..|+|||.+.+.    ..++.++|+||+||++|+|
T Consensus       122 ~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~el  201 (331)
T cd05624         122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM  201 (331)
T ss_pred             CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhh
Confidence            999999999999999999999999999876543321  1234689999999998542    3468899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC--
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--  241 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--  241 (302)
                      ++|..||.+.+..+....+.....                         ..+++.....++..++++|.+||..++.+  
T Consensus       202 l~g~~Pf~~~~~~~~~~~i~~~~~-------------------------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~  256 (331)
T cd05624         202 LYGETPFYAESLVETYGKIMNHEE-------------------------RFQFPSHITDVSEEAKDLIQRLICSRERRLG  256 (331)
T ss_pred             hhCCCCccCCCHHHHHHHHHcCCC-------------------------cccCCCccccCCHHHHHHHHHHccCchhhcC
Confidence            999999987766555444332110                         01122233457889999999999976655  


Q ss_pred             CCCHHHHhcCCCcCCc
Q 022132          242 RITVEDALAHPYLGSL  257 (302)
Q Consensus       242 R~t~~ell~h~~~~~~  257 (302)
                      |++++++++||||...
T Consensus       257 ~~~~~~~~~h~~f~~~  272 (331)
T cd05624         257 QNGIEDFKKHAFFEGI  272 (331)
T ss_pred             CCCHHHHhcCCCcCCC
Confidence            5699999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.3e-38  Score=269.29  Aligned_cols=218  Identities=24%  Similarity=0.372  Sum_probs=172.6

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR----SNQALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qll~~l~   84 (302)
                      ..+.+|+.+++.+ +|||++++++++........+.+|+||||++ ++|.+++.    ....+++..++.++.|++.||+
T Consensus        63 ~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~  142 (291)
T cd06639          63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ  142 (291)
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Confidence            3566899999999 8999999999997653333367999999996 59988875    3467899999999999999999


Q ss_pred             HHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCC----CCCCchhHHHHHHH
Q 022132           85 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCI  159 (302)
Q Consensus        85 ~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~i  159 (302)
                      +||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+....    .++.++|+||+||+
T Consensus       143 ~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi  222 (291)
T cd06639         143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT  222 (291)
T ss_pred             HHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHH
Confidence            9999999999999999999999999999999987654322 122345788899999875432    25789999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC
Q 022132          160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       160 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      +++|++|.+||...+....+..+..   .+..                       . .......+..+.++|.+||++||
T Consensus       223 ~~el~~g~~p~~~~~~~~~~~~~~~---~~~~-----------------------~-~~~~~~~~~~l~~li~~~l~~~p  275 (291)
T cd06639         223 AIELGDGDPPLFDMHPVKTLFKIPR---NPPP-----------------------T-LLHPEKWCRSFNHFISQCLIKDF  275 (291)
T ss_pred             HHHHhhCCCCCCCCcHHHHHHHHhc---CCCC-----------------------C-CCcccccCHHHHHHHHHHhhcCh
Confidence            9999999999977654443332211   1000                       0 00112456789999999999999


Q ss_pred             CCCCCHHHHhcCCCcC
Q 022132          240 RQRITVEDALAHPYLG  255 (302)
Q Consensus       240 ~~R~t~~ell~h~~~~  255 (302)
                      .+|||+.|+++||||+
T Consensus       276 ~~Rps~~~il~~~~~~  291 (291)
T cd06639         276 EARPSVTHLLEHPFIK  291 (291)
T ss_pred             hhCcCHHHHhcCcccC
Confidence            9999999999999994

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3e-38  Score=267.86  Aligned_cols=215  Identities=27%  Similarity=0.473  Sum_probs=174.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+++||++ ++|.+++... ..+++..+..++.|++.|+++||+
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  118 (265)
T cd06605          44 KQILRELDILHKCNSPYIVGFYGAFYNN-----GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE  118 (265)
T ss_pred             HHHHHHHHHHHHCCCCchhhhheeeecC-----CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC
Confidence            4678999999999999999999999887     89999999998 6999999865 789999999999999999999999


Q ss_pred             -CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 -ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 -~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                       .|++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+. .++.++|+||+||++++|++|.
T Consensus       119 ~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~  196 (265)
T cd06605         119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGR  196 (265)
T ss_pred             CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-hcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCC
Confidence             9999999999999999999999999999865543221 125678889999988554 5889999999999999999999


Q ss_pred             CCCCCCCh--HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCC-CCHHHHHHHHHccCCCCCCCCC
Q 022132          168 PLFPGRDH--VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       168 ~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      .||...+.  .............+.                          ...... +++.+.++|.+||..||.+|||
T Consensus       197 ~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  250 (265)
T cd06605         197 FPYPPENDPPDGIFELLQYIVNEPP--------------------------PRLPSGKFSPDFQDFVNLCLIKDPRERPS  250 (265)
T ss_pred             CCCCccccccccHHHHHHHHhcCCC--------------------------CCCChhhcCHHHHHHHHHHcCCCchhCcC
Confidence            99965431  111111111111000                          011112 6788999999999999999999


Q ss_pred             HHHHhcCCCcCCcc
Q 022132          245 VEDALAHPYLGSLH  258 (302)
Q Consensus       245 ~~ell~h~~~~~~~  258 (302)
                      +.+++.||||+.+.
T Consensus       251 ~~~ll~~~~~~~~~  264 (265)
T cd06605         251 YKELLEHPFIKKYE  264 (265)
T ss_pred             HHHHhhCchhhccc
Confidence            99999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.4e-38  Score=266.50  Aligned_cols=216  Identities=22%  Similarity=0.378  Sum_probs=171.1

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCC-CCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRE-SFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~-~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.+++.+ +||||+++++++...... ....+|+||||++ ++|.+++...  ..+++..+..++.|++.|++|
T Consensus        47 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~  126 (272)
T cd06637          47 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH  126 (272)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Confidence            3577899999999 799999999998764322 1256899999997 6999988753  468999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCC----CCCCCchhHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIF  160 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~i~  160 (302)
                      ||+.||+|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+.    ..++.++|+||+||++
T Consensus       127 LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l  206 (272)
T cd06637         127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA  206 (272)
T ss_pred             HHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHH
Confidence            99999999999999999999999999999998754322 223345678899999998532    2467899999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      ++|++|..||..............   .                       ...  .......+..+.+|+.+||..||.
T Consensus       207 ~el~~g~~p~~~~~~~~~~~~~~~---~-----------------------~~~--~~~~~~~~~~~~~li~~~l~~~p~  258 (272)
T cd06637         207 IEMAEGAPPLCDMHPMRALFLIPR---N-----------------------PAP--RLKSKKWSKKFQSFIESCLVKNHS  258 (272)
T ss_pred             HHHHhCCCCccccCHHHHHHHHhc---C-----------------------CCC--CCCCCCcCHHHHHHHHHHcCCChh
Confidence            999999999965543322211110   0                       000  011124678899999999999999


Q ss_pred             CCCCHHHHhcCCCc
Q 022132          241 QRITVEDALAHPYL  254 (302)
Q Consensus       241 ~R~t~~ell~h~~~  254 (302)
                      +|||+++++.||||
T Consensus       259 ~Rpt~~~il~~~~~  272 (272)
T cd06637         259 QRPTTEQLMKHPFI  272 (272)
T ss_pred             hCCCHHHHhhCCCC
Confidence            99999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5e-38  Score=271.14  Aligned_cols=216  Identities=25%  Similarity=0.460  Sum_probs=177.2

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.+.||||+++++++...     +..|+|+||++ ++|..++.. ..+++..+..++.|++.||++||+
T Consensus        62 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~  135 (297)
T cd06659          62 RELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHS  135 (297)
T ss_pred             HHHHHHHHHHHHhCCCCchhhhhhheeeC-----CeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34577899999999999999999999887     88999999997 588887654 578999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||+||++++|++|.
T Consensus       136 ~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~  214 (297)
T cd06659         136 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGE  214 (297)
T ss_pred             CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999986543321 22345678899999998554 4789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||...+....+..+..   .+                        ..........+..+.++|.+||+.||.+|||+++
T Consensus       215 ~p~~~~~~~~~~~~~~~---~~------------------------~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~  267 (297)
T cd06659         215 PPYFSDSPVQAMKRLRD---SP------------------------PPKLKNAHKISPVLRDFLERMLTREPQERATAQE  267 (297)
T ss_pred             CCCCCCCHHHHHHHHhc---cC------------------------CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence            99976665444332211   00                        0011122356788999999999999999999999


Q ss_pred             HhcCCCcCCccC
Q 022132          248 ALAHPYLGSLHD  259 (302)
Q Consensus       248 ll~h~~~~~~~~  259 (302)
                      +++||||.....
T Consensus       268 ll~~~~~~~~~~  279 (297)
T cd06659         268 LLDHPFLLQTGL  279 (297)
T ss_pred             HhhChhhccCCC
Confidence            999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=264.02  Aligned_cols=219  Identities=26%  Similarity=0.434  Sum_probs=191.2

Q ss_pred             chhHHHHhcC--------chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHH
Q 022132            2 HSITKLMQRG--------HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHC   72 (302)
Q Consensus         2 ~~~~~~~~~~--------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~   72 (302)
                      +|||.+..+.        +-..|-++|+.++||.+..+.-.|...     +.+++||||.. |.|.-.+...+.++++..
T Consensus       196 YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~-----drlCFVMeyanGGeLf~HLsrer~FsE~Rt  270 (516)
T KOG0690|consen  196 YAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ-----DRLCFVMEYANGGELFFHLSRERVFSEDRT  270 (516)
T ss_pred             eehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC-----ceEEEEEEEccCceEeeehhhhhcccchhh
Confidence            5666555443        556789999999999999999999887     89999999995 688888887788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccc-cCCCCcccccccccccCchhhhhCCCCCCCch
Q 022132           73 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAI  151 (302)
Q Consensus        73 ~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  151 (302)
                      +.+...|+.||.|||+++|++||+|.+|++++.+|.+||.|||+|+. +.........+||+.|.|||++. ...|+.++
T Consensus       271 RFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraV  349 (516)
T KOG0690|consen  271 RFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAV  349 (516)
T ss_pred             hhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhc-ccccccee
Confidence            99999999999999999999999999999999999999999999975 44556678899999999999995 45699999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          152 DVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL-IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       152 DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      |.|.+|++||+|++|+.||...+.......|.-. +..                               ...++++++.|
T Consensus       350 DWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kF-------------------------------Pr~ls~eAktL  398 (516)
T KOG0690|consen  350 DWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKF-------------------------------PRTLSPEAKTL  398 (516)
T ss_pred             ehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccC-------------------------------CccCCHHHHHH
Confidence            9999999999999999999999888777666531 111                               12689999999


Q ss_pred             HHHccCCCCCCCC-----CHHHHhcCCCcCCc
Q 022132          231 VEKMLTFDPRQRI-----TVEDALAHPYLGSL  257 (302)
Q Consensus       231 i~~~L~~dP~~R~-----t~~ell~h~~~~~~  257 (302)
                      +..+|.+||.+|.     .+.|+.+|+||.++
T Consensus       399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v  430 (516)
T KOG0690|consen  399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV  430 (516)
T ss_pred             HHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence            9999999999997     47899999999976

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-40  Score=286.63  Aligned_cols=246  Identities=24%  Similarity=0.356  Sum_probs=195.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+..|++.|++++|||+|.+.++|.-.     .+.|+|||||=|+-.+++.- ++++.+.+|..|+.+.+.||+|||+.+
T Consensus        72 DIlKEVrFL~~l~HPntieYkgCyLre-----~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~  146 (948)
T KOG0577|consen   72 DILKEVRFLRQLRHPNTIEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN  146 (948)
T ss_pred             HHHHHHHHHHhccCCCcccccceeecc-----chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh
Confidence            467899999999999999999999987     88999999998887777763 468999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhC--CCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      .+|||||..|||+++.|.+||+|||.+....+   ..+++||++|||||++..  .+.|+-++||||||++..++...+|
T Consensus       147 ~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkP  223 (948)
T KOG0577|consen  147 RIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  223 (948)
T ss_pred             HHhhhccccceEecCCCeeeeccccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCC
Confidence            99999999999999999999999999876554   467899999999999853  3568999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |+-..+....+-.|...                     ..|..+       .+..|..++.|+..||++-|..|||.+++
T Consensus       224 PlFnMNAMSALYHIAQN---------------------esPtLq-------s~eWS~~F~~Fvd~CLqKipqeRptse~l  275 (948)
T KOG0577|consen  224 PLFNMNAMSALYHIAQN---------------------ESPTLQ-------SNEWSDYFRNFVDSCLQKIPQERPTSEEL  275 (948)
T ss_pred             CccCchHHHHHHHHHhc---------------------CCCCCC-------CchhHHHHHHHHHHHHhhCcccCCcHHHH
Confidence            98777766555444321                     111111       23567789999999999999999999999


Q ss_pred             hcCCCcCCccCCCCC-CCCCCCCCcchhhcccCHHHHHHHHHHHHH
Q 022132          249 LAHPYLGSLHDISDE-PVCMSPFSFDFEQHALTEGQMKELIYQEAL  293 (302)
Q Consensus       249 l~h~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (302)
                      |.|+|+...+.+.-. .+...--+.-.+-.++....+++++|+++.
T Consensus       276 l~H~fv~R~Rp~tvi~dLIqRTKdaVrELDNlqYrKMkKilf~e~~  321 (948)
T KOG0577|consen  276 LKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQEAP  321 (948)
T ss_pred             hhcchhccCCCchHHHHHHHHHHHHHHHhhhhhHHHHHHHHhhccC
Confidence            999999875432210 000001111223445666777777777653

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.9e-38  Score=288.67  Aligned_cols=218  Identities=24%  Similarity=0.389  Sum_probs=176.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCC---CCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQR---ESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRG   82 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~---~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~   82 (302)
                      ..+.+|+.++..++|+||+++++.+.....   .....+++||||+. |+|.+.+..    ...+++..+..++.|++.|
T Consensus        76 ~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~a  155 (496)
T PTZ00283         76 NRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA  155 (496)
T ss_pred             HHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHH
Confidence            356789999999999999999988764321   11124789999997 799998864    3568999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCCCCchhHHHHHHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  159 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  159 (302)
                      |.|||+.||+||||||+||+++.++.++|+|||+++.....   .......||..|+|||.+.+. .++.++|||||||+
T Consensus       156 L~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvi  234 (496)
T PTZ00283        156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVL  234 (496)
T ss_pred             HHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHH
Confidence            99999999999999999999999999999999998754322   223445789999999998654 48999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC
Q 022132          160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       160 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      +|+|++|..||.+.+....+..+....                             .....+.+++.+.+++.+||+.||
T Consensus       235 lyeLltG~~Pf~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~L~~dP  285 (496)
T PTZ00283        235 LYELLTLKRPFDGENMEEVMHKTLAGR-----------------------------YDPLPPSISPEMQEIVTALLSSDP  285 (496)
T ss_pred             HHHHHHCCCCCCCCCHHHHHHHHhcCC-----------------------------CCCCCCCCCHHHHHHHHHHcccCh
Confidence            999999999998776555444332210                             011223678899999999999999


Q ss_pred             CCCCCHHHHhcCCCcCCcc
Q 022132          240 RQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       240 ~~R~t~~ell~h~~~~~~~  258 (302)
                      .+|||+.++++|||++...
T Consensus       286 ~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        286 KRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             hhCcCHHHHHhCHHHHHhh
Confidence            9999999999999987643

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.3e-37  Score=269.68  Aligned_cols=214  Identities=22%  Similarity=0.363  Sum_probs=174.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++.+...     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||+|||+.
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~  120 (305)
T cd05609          46 QQVFVERDILTFAENPFVVSMFCSFETK-----RHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY  120 (305)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEEEEecC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4567899999999999999999999877     88999999997 59999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC----------------cccccccccccCchhhhhCCCCCCCchhH
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----------------FMTEYVVTRWYRAPELLLNSSDYTAAIDV  153 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  153 (302)
                      |++||||+|+||+++.++.++|+|||.++......                ......++..|+|||.+.+. .++.++|+
T Consensus       121 ~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di  199 (305)
T cd05609         121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDW  199 (305)
T ss_pred             CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhH
Confidence            99999999999999999999999999876321000                01123467789999988654 47899999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHH
Q 022132          154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  233 (302)
Q Consensus       154 wslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  233 (302)
                      ||+||++++|++|..||.+.+..+..........                           ......+..++++.++|.+
T Consensus       200 ~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~  252 (305)
T cd05609         200 WAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI---------------------------EWPEGDEALPADAQDLISR  252 (305)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------------------------CCCCccccCCHHHHHHHHH
Confidence            9999999999999999987765544333322100                           0011112567889999999


Q ss_pred             ccCCCCCCCCC---HHHHhcCCCcCCc
Q 022132          234 MLTFDPRQRIT---VEDALAHPYLGSL  257 (302)
Q Consensus       234 ~L~~dP~~R~t---~~ell~h~~~~~~  257 (302)
                      ||+.||.+|||   +.++|+||||...
T Consensus       253 ~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         253 LLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             HhccChhhccCccCHHHHHhCccccCC
Confidence            99999999998   7999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.6e-38  Score=263.95  Aligned_cols=209  Identities=24%  Similarity=0.364  Sum_probs=173.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++.+...     +..++||||++ ++|.+++...  ..+++..+..++.|++.|+++||
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh  118 (256)
T cd08220          44 LAAQNECQVLKLLSHPNIIEYYENFLED-----KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH  118 (256)
T ss_pred             HHHHHHHHHHhhCCCCchhheeeeEecC-----CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999876     88999999996 5999999763  45899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecC-CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           88 SANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ++|++|+||+|+||+++.+ +.++|+|||.+.............++..|+|||.+.+ ...+.++|+||+|+++++|++|
T Consensus       119 ~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~  197 (256)
T cd08220         119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASL  197 (256)
T ss_pred             hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhC
Confidence            9999999999999999865 4579999999987665544445567889999998854 3478899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||.+.+.......+.....                             .......++.+.+++.+||..||++|||++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  248 (256)
T cd08220         198 KRAFEAANLPALVLKIMSGTF-----------------------------APISDRYSPDLRQLILSMLNLDPSKRPQLS  248 (256)
T ss_pred             CCCcccCchHHHHHHHHhcCC-----------------------------CCCCCCcCHHHHHHHHHHccCChhhCCCHH
Confidence            999987765444333322110                             011124678899999999999999999999


Q ss_pred             HHhcCCCc
Q 022132          247 DALAHPYL  254 (302)
Q Consensus       247 ell~h~~~  254 (302)
                      |+++||||
T Consensus       249 ~ll~~p~~  256 (256)
T cd08220         249 QIMAQPIC  256 (256)
T ss_pred             HHhhCCCC
Confidence            99999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.8e-38  Score=269.97  Aligned_cols=219  Identities=24%  Similarity=0.398  Sum_probs=172.2

Q ss_pred             CchhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHH-----cCCCCCHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-----SNQALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus        11 ~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~-----~~~~l~~~~~~~i~~qll~~l~   84 (302)
                      ..+.+|+.++.++. ||||+++++++...     +..+++|||+++++.++..     ..+.+++..+..++.|++.||+
T Consensus        47 ~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~  121 (288)
T cd06616          47 KRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN  121 (288)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHH
Confidence            46778999999995 99999999999876     7899999999876655432     2467999999999999999999


Q ss_pred             HHHhC-CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCC--CCCCCchhHHHHHHHHH
Q 022132           85 YIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        85 ~LH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~i~~  161 (302)
                      |||+. |++||||||+||+++.++.++|+|||++.............++..|+|||.+.+.  ..++.++|+||+||+++
T Consensus       122 ~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~  201 (288)
T cd06616         122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLY  201 (288)
T ss_pred             HHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHH
Confidence            99975 9999999999999999999999999998765443333444678889999998655  35789999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       162 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      +|++|.+||.....  ....+........                  +..    .......++..+.+|+.+||++||.+
T Consensus       202 el~~g~~p~~~~~~--~~~~~~~~~~~~~------------------~~~----~~~~~~~~~~~l~~li~~~l~~~p~~  257 (288)
T cd06616         202 EVATGKFPYPKWNS--VFDQLTQVVKGDP------------------PIL----SNSEEREFSPSFVNFINLCLIKDESK  257 (288)
T ss_pred             HHHhCCCCchhcch--HHHHHhhhcCCCC------------------CcC----CCcCCCccCHHHHHHHHHHccCChhh
Confidence            99999999965541  1111111111000                  000    00111357889999999999999999


Q ss_pred             CCCHHHHhcCCCcCCcc
Q 022132          242 RITVEDALAHPYLGSLH  258 (302)
Q Consensus       242 R~t~~ell~h~~~~~~~  258 (302)
                      |||+++++.||||....
T Consensus       258 Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         258 RPKYKELLEHPFIKDYE  274 (288)
T ss_pred             CcCHHHHhcChhhhchh
Confidence            99999999999998743

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-38  Score=266.93  Aligned_cols=217  Identities=25%  Similarity=0.423  Sum_probs=172.2

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCC-CCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGL   83 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l   83 (302)
                      ..+.+|+.+++.+ .||||+++++++..... .....+|+||||++ ++|.+++..    +..+++..+..++.|++.||
T Consensus        47 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al  126 (275)
T cd06608          47 EEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL  126 (275)
T ss_pred             HHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence            4678899999999 79999999999987532 23367999999997 588888764    35799999999999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCC----CCCCCchhHHHHHH
Q 022132           84 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGC  158 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~  158 (302)
                      .|||+.|++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+...    ..++.++|+||+||
T Consensus       127 ~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~  206 (275)
T cd06608         127 AYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGI  206 (275)
T ss_pred             HHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHH
Confidence            9999999999999999999999999999999998654332 222345678889999987432    34678899999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCC
Q 022132          159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       159 i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  238 (302)
                      ++++|++|.+||...........+..   .+..                       . .......+..+.++|.+||..|
T Consensus       207 il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-----------------------~-~~~~~~~~~~~~~li~~~l~~d  259 (275)
T cd06608         207 TAIELADGKPPLCDMHPMRALFKIPR---NPPP-----------------------T-LKSPENWSKKFNDFISECLIKN  259 (275)
T ss_pred             HHHHHHhCCCCccccchHHHHHHhhc---cCCC-----------------------C-CCchhhcCHHHHHHHHHHhhcC
Confidence            99999999999976544333322221   0000                       0 0001136778999999999999


Q ss_pred             CCCCCCHHHHhcCCCc
Q 022132          239 PRQRITVEDALAHPYL  254 (302)
Q Consensus       239 P~~R~t~~ell~h~~~  254 (302)
                      |++|||++++++|||+
T Consensus       260 p~~Rpt~~~ll~~~~~  275 (275)
T cd06608         260 YEQRPFMEELLEHPFI  275 (275)
T ss_pred             hhhCcCHHHHhcCCCC
Confidence            9999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5e-38  Score=266.89  Aligned_cols=212  Identities=26%  Similarity=0.385  Sum_probs=170.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||+|||+.|
T Consensus        52 ~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  126 (267)
T cd06646          52 LIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG  126 (267)
T ss_pred             HHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            466899999999999999999999877     88999999997 699999987788999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhC--CCCCCCchhHHHHHHHHHHHHhCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |+|||++|+||+++.++.++|+|||++....... ......++..|+|||.+..  ...++.++|+||+||++++|++|.
T Consensus       127 i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~  206 (267)
T cd06646         127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQ  206 (267)
T ss_pred             ccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999987553321 2234467888999998742  334678999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||...+.......+...                        .... +.......++..+.++|++||..||.+|||+++
T Consensus       207 ~p~~~~~~~~~~~~~~~~------------------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~  261 (267)
T cd06646         207 PPMFDLHPMRALFLMSKS------------------------NFQP-PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAER  261 (267)
T ss_pred             CCccccchhhhheeeecC------------------------CCCC-CCCccccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence            998654432211111000                        0000 000111246789999999999999999999999


Q ss_pred             HhcCCC
Q 022132          248 ALAHPY  253 (302)
Q Consensus       248 ll~h~~  253 (302)
                      +++|+|
T Consensus       262 il~~l~  267 (267)
T cd06646         262 LLTHLF  267 (267)
T ss_pred             HhcCCC
Confidence            999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.3e-38  Score=266.96  Aligned_cols=205  Identities=22%  Similarity=0.413  Sum_probs=166.2

Q ss_pred             HHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 022132           16 SSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLH   93 (302)
Q Consensus        16 E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H   93 (302)
                      |+.+...+ +||||+++++.+...     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||.+||+.|++|
T Consensus        58 e~~~~~~~~~h~~iv~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H  132 (267)
T PHA03390         58 EPMVHQLMKDNPNFIKLYYSVTTL-----KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIH  132 (267)
T ss_pred             hHHHHHHhhcCCCEEEEEEEEecC-----CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            44444434 799999999999987     78999999996 699999988778999999999999999999999999999


Q ss_pred             cCCCCCCEEEecCC-CEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022132           94 RDLKPSNLLLNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG  172 (302)
Q Consensus        94 ~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~  172 (302)
                      |||+|+||+++.++ .++|+|||.+......   ....++..|+|||.+.+. .++.++|+||+|+++++|++|..||..
T Consensus       133 ~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~  208 (267)
T PHA03390        133 NDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKE  208 (267)
T ss_pred             CCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            99999999999998 9999999998765433   234578889999998654 478999999999999999999999975


Q ss_pred             CChHHH-HHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC-HHHHhc
Q 022132          173 RDHVHQ-LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-VEDALA  250 (302)
Q Consensus       173 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~ell~  250 (302)
                      ...... .........                           ......+..++.+.+||.+||++||.+|++ ++++|+
T Consensus       209 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        209 DEDEELDLESLLKRQQ---------------------------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             CCcchhhHHHHHHhhc---------------------------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            433221 111111000                           001222367899999999999999999996 699999


Q ss_pred             CCCcCC
Q 022132          251 HPYLGS  256 (302)
Q Consensus       251 h~~~~~  256 (302)
                      ||||..
T Consensus       262 h~~~~~  267 (267)
T PHA03390        262 HPFLKI  267 (267)
T ss_pred             CCcccC
Confidence            999963

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-40  Score=308.16  Aligned_cols=217  Identities=24%  Similarity=0.376  Sum_probs=188.4

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      -+.+.+|.++|..++|||+|++|++-...     ..+||.||||+ |+|.+.+...+..++...+.+..|++.|++|||+
T Consensus      1278 ~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~ 1352 (1509)
T KOG4645|consen 1278 FKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHE 1352 (1509)
T ss_pred             CcchHHHHHHHHhccCccccccCceeecH-----HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHh
Confidence            35677999999999999999999999887     88999999996 7999999988888999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC-----cccccccccccCchhhhhCCC--CCCCchhHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFM  161 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~i~~  161 (302)
                      +||+||||||.||+++.+|.+|++|||.|.......     ......||+.|||||++.+.+  ...-++|||||||++.
T Consensus      1353 ~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVl 1432 (1509)
T KOG4645|consen 1353 HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVL 1432 (1509)
T ss_pred             cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEE
Confidence            999999999999999999999999999997655432     234568999999999996653  2457899999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       162 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      ||+||+.||...+..-++...+.....|..+                            ..+|++.+|||..||+.||.+
T Consensus      1433 EM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P----------------------------~~ls~~g~dFle~Cl~~dP~~ 1484 (1509)
T KOG4645|consen 1433 EMATGKRPWAELDNEWAIMYHVAAGHKPQIP----------------------------ERLSSEGRDFLEHCLEQDPKM 1484 (1509)
T ss_pred             EeecCCCchhhccchhHHHhHHhccCCCCCc----------------------------hhhhHhHHHHHHHHHhcCchh
Confidence            9999999998887776666666554444322                            258899999999999999999


Q ss_pred             CCCHHHHhcCCCcCCccC
Q 022132          242 RITVEDALAHPYLGSLHD  259 (302)
Q Consensus       242 R~t~~ell~h~~~~~~~~  259 (302)
                      |.++.++|.|.|-+...+
T Consensus      1485 Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1485 RWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred             hhHHHHHHHhhccccccc
Confidence            999999999999887554

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-37  Score=265.05  Aligned_cols=214  Identities=25%  Similarity=0.438  Sum_probs=173.3

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++|||++++++++...     +.+++||||+. ++|.+++...+.+++..+..++.|++.||.+||+.|
T Consensus        54 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  128 (272)
T cd06629          54 ALRSEIETLKDLDHLNIVQYLGFETTE-----EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG  128 (272)
T ss_pred             HHHHHHHHHHhcCCCCcceEEEEeccC-----CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            467899999999999999999999887     88999999996 699999988888999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCC-CCCCchhHHHHHHHHHHHHhC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ++|+||+|+||+++.++.++|+|||.+......   .......++..|+|||.+.... .++.++|+||+|++++++++|
T Consensus       129 i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  208 (272)
T cd06629         129 ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG  208 (272)
T ss_pred             eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhC
Confidence            999999999999999999999999998654322   1122345778899999986543 368899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||...+....+..+......                        ........+.++..+.++|.+||.+||++|||++
T Consensus       209 ~~p~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  264 (272)
T cd06629         209 RRPWSDEEAIAAMFKLGNKRSA------------------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTAR  264 (272)
T ss_pred             CCCCcCcchHHHHHHhhccccC------------------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHH
Confidence            9999654433222211100000                        0001122245688999999999999999999999


Q ss_pred             HHhcCCCc
Q 022132          247 DALAHPYL  254 (302)
Q Consensus       247 ell~h~~~  254 (302)
                      ++|+||||
T Consensus       265 ~il~~~~~  272 (272)
T cd06629         265 ELLQHPFI  272 (272)
T ss_pred             HHhhCCCC
Confidence            99999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.9e-38  Score=265.35  Aligned_cols=215  Identities=23%  Similarity=0.378  Sum_probs=175.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN---QALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..+.+|+.+++.++||||+++++.+...     +..|+|+|+++ ++|.+++...   ..+++..+..++.|++.||++|
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l  118 (267)
T cd06610          44 DELRKEVQAMSQCNHPNVVKYYTSFVVG-----DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL  118 (267)
T ss_pred             HHHHHHHHHHHhcCCCCEEEEEEEEeeC-----CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence            4677899999999999999999999887     89999999996 6999998753   4589999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~  161 (302)
                      |+.|++|+||+|+||+++.++.++|+|||++.......     ......++..|+|||.+.....++.++|+||+||+++
T Consensus       119 h~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~  198 (267)
T cd06610         119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAI  198 (267)
T ss_pred             HhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHH
Confidence            99999999999999999999999999999986544322     1233457888999999866545789999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       162 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      +|++|..||...+...........   ...                     ..........+++.+.+++.+||..||.+
T Consensus       199 ~l~~g~~p~~~~~~~~~~~~~~~~---~~~---------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~  254 (267)
T cd06610         199 ELATGAAPYSKYPPMKVLMLTLQN---DPP---------------------SLETGADYKKYSKSFRKMISLCLQKDPSK  254 (267)
T ss_pred             HHHhCCCCccccChhhhHHHHhcC---CCC---------------------CcCCccccccccHHHHHHHHHHcCCChhh
Confidence            999999999766554333322211   000                     00001112367789999999999999999


Q ss_pred             CCCHHHHhcCCCc
Q 022132          242 RITVEDALAHPYL  254 (302)
Q Consensus       242 R~t~~ell~h~~~  254 (302)
                      |||+++++.||||
T Consensus       255 Rp~~~~ll~~p~~  267 (267)
T cd06610         255 RPTAEELLKHKFF  267 (267)
T ss_pred             CcCHHHHhhCCCC
Confidence            9999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.6e-38  Score=263.50  Aligned_cols=209  Identities=23%  Similarity=0.410  Sum_probs=173.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+|+||+. ++|.+.+...  ..+++..+..++.|++.|+.+||
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh  118 (256)
T cd08218          44 EESRKEVAVLSNMKHPNIVQYQESFEEN-----GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH  118 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEeeecCC-----CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3678999999999999999999999887     89999999996 6999988753  35889999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ++|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+. ..+.++|+||+||++++|++|
T Consensus       119 ~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g  197 (256)
T cd08218         119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTL  197 (256)
T ss_pred             hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcC
Confidence            9999999999999999999999999999987654332 12234567889999998544 478899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||...+..+....+.....                             .......+.++.++|.+||+.+|++||++.
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  248 (256)
T cd08218         198 KHAFEAGNMKNLVLKIIRGSY-----------------------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVN  248 (256)
T ss_pred             CCCccCCCHHHHHHHHhcCCC-----------------------------CCCcccCCHHHHHHHHHHhhCChhhCcCHH
Confidence            999977665544433321100                             111225678899999999999999999999


Q ss_pred             HHhcCCCc
Q 022132          247 DALAHPYL  254 (302)
Q Consensus       247 ell~h~~~  254 (302)
                      +++.||||
T Consensus       249 ~vl~~~~~  256 (256)
T cd08218         249 SILEKNFI  256 (256)
T ss_pred             HHhhCcCC
Confidence            99999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.4e-38  Score=270.51  Aligned_cols=217  Identities=22%  Similarity=0.421  Sum_probs=176.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++.+ ..+++..+..++.|++.||.|||+.
T Consensus        61 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~  134 (297)
T cd06656          61 ELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN  134 (297)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecC-----CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4567899999999999999999999887     88999999996 699998865 5689999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |++||||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+||++++|++|.+
T Consensus       135 ~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~  213 (297)
T cd06656         135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEP  213 (297)
T ss_pred             CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987644332 2233467888999998854 447899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||.+.+.......+.. .+.+.                          ......++..+.+++.+||..||.+|||++++
T Consensus       214 pf~~~~~~~~~~~~~~-~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  266 (297)
T cd06656         214 PYLNENPLRALYLIAT-NGTPE--------------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKEL  266 (297)
T ss_pred             CCCCCCcchheeeecc-CCCCC--------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9976543322111110 01110                          11122567889999999999999999999999


Q ss_pred             hcCCCcCCccCCC
Q 022132          249 LAHPYLGSLHDIS  261 (302)
Q Consensus       249 l~h~~~~~~~~~~  261 (302)
                      +.||||...+...
T Consensus       267 l~~~~~~~~~~~~  279 (297)
T cd06656         267 LQHPFLKLAKPLS  279 (297)
T ss_pred             hcCchhccccccc
Confidence            9999998865433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.1e-37  Score=267.05  Aligned_cols=205  Identities=20%  Similarity=0.335  Sum_probs=169.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQY   74 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~   74 (302)
                      .+.+|+.+++.++||||+++++++...     +..|++|||++ ++|.+++...                ..+++..+..
T Consensus        54 ~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  128 (283)
T cd05048          54 EFRQEAELMSDLQHPNIVCLLGVCTKE-----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH  128 (283)
T ss_pred             HHHHHHHHHHhcCCcccceEEEEEcCC-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHH
Confidence            577899999999999999999999877     78999999997 6999998754                4588899999


Q ss_pred             HHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCch
Q 022132           75 FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAI  151 (302)
Q Consensus        75 i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~  151 (302)
                      ++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+. .++.++
T Consensus       129 ~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~s  207 (283)
T cd05048         129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTES  207 (283)
T ss_pred             HHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhh
Confidence            99999999999999999999999999999999999999999987543321   12334557789999988554 479999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          152 DVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       152 DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      |+|||||++++|++ |..||.+.+..+....+.+...                             ......+++.+.+|
T Consensus       208 Dv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~~~~l  258 (283)
T cd05048         208 DIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-----------------------------LPCPEDCPARVYAL  258 (283)
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-----------------------------CCCcccCCHHHHHH
Confidence            99999999999997 9999987765544433322110                             11123678899999


Q ss_pred             HHHccCCCCCCCCCHHHHhcC
Q 022132          231 VEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       231 i~~~L~~dP~~R~t~~ell~h  251 (302)
                      +.+||+.||.+|||+.|++++
T Consensus       259 ~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         259 MIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.4e-37  Score=263.37  Aligned_cols=211  Identities=30%  Similarity=0.489  Sum_probs=173.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.+++.++||||+++++++.....   ..+|++|||++ ++|.+++..    ..++++..+..++.||+.||.+
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~  120 (265)
T cd08217          44 QQLVSEVNILRELKHPNIVRYYDRIIDRSN---QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE  120 (265)
T ss_pred             HHHHHHHHHHHhcCCCccceeeeeeecCCC---CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            356789999999999999999998865422   67899999996 699988865    4679999999999999999999


Q ss_pred             HH-----hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc-ccccccccccCchhhhhCCCCCCCchhHHHHHHH
Q 022132           86 IH-----SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  159 (302)
Q Consensus        86 LH-----~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  159 (302)
                      ||     +.+++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||||++
T Consensus       121 lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~i  199 (265)
T cd08217         121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCL  199 (265)
T ss_pred             HhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHH
Confidence            99     89999999999999999999999999999887654432 3345678899999998554 47889999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC
Q 022132          160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       160 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      +++|++|..||...+.......+...                             .........+..+.+++.+||..+|
T Consensus       200 l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~~~l~~~p  250 (265)
T cd08217         200 IYELCALSPPFTARNQLQLASKIKEG-----------------------------KFRRIPYRYSSELNEVIKSMLNVDP  250 (265)
T ss_pred             HHHHHHCCCcccCcCHHHHHHHHhcC-----------------------------CCCCCccccCHHHHHHHHHHccCCc
Confidence            99999999999876643332222110                             0111222567899999999999999


Q ss_pred             CCCCCHHHHhcCCCc
Q 022132          240 RQRITVEDALAHPYL  254 (302)
Q Consensus       240 ~~R~t~~ell~h~~~  254 (302)
                      .+|||+.++++|||+
T Consensus       251 ~~Rp~~~~il~~~~~  265 (265)
T cd08217         251 DKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCCCHHHHhhCCCC
Confidence            999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-37  Score=266.89  Aligned_cols=216  Identities=23%  Similarity=0.387  Sum_probs=170.6

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCC-CCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+..|+.+++.+ +||||+++++++..... ...+.+|++|||++ ++|.+++..  ...+++..+..++.||+.|++|
T Consensus        57 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~  136 (282)
T cd06636          57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH  136 (282)
T ss_pred             HHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHH
Confidence            4567899999999 79999999999875422 23367999999997 599998865  3458899999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhC----CCCCCCchhHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~i~  160 (302)
                      ||+.|++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+..    ...++.++|+||+||++
T Consensus       137 LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l  216 (282)
T cd06636         137 LHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITA  216 (282)
T ss_pred             HHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHH
Confidence            99999999999999999999999999999998654322 22234567889999998753    23467899999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      ++|++|.+||...........+..   .+                         ........++..+.+||.+||..||.
T Consensus       217 ~el~~g~~p~~~~~~~~~~~~~~~---~~-------------------------~~~~~~~~~~~~~~~li~~cl~~~p~  268 (282)
T cd06636         217 IEMAEGAPPLCDMHPMRALFLIPR---NP-------------------------PPKLKSKKWSKKFIDFIEGCLVKNYL  268 (282)
T ss_pred             HHHHhCCCCccccCHHhhhhhHhh---CC-------------------------CCCCcccccCHHHHHHHHHHhCCChh
Confidence            999999999966543322211110   00                         00011125678999999999999999


Q ss_pred             CCCCHHHHhcCCCc
Q 022132          241 QRITVEDALAHPYL  254 (302)
Q Consensus       241 ~R~t~~ell~h~~~  254 (302)
                      +|||+.|+|.||||
T Consensus       269 ~Rp~~~ell~~~~~  282 (282)
T cd06636         269 SRPSTEQLLKHPFI  282 (282)
T ss_pred             hCcCHHHHhcCCCC
Confidence            99999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-37  Score=270.37  Aligned_cols=211  Identities=24%  Similarity=0.388  Sum_probs=173.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+|+||++|++.+.+.. .+.+++..+..++.|++.||.|||+.
T Consensus        60 ~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~  134 (307)
T cd06607          60 QDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH  134 (307)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEEeC-----CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577899999999999999999999887     78999999999998888763 46799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhC--CCCCCCchhHHHHHHHHHHHHhCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |++|+||+|+||+++.++.++|+|||.+......   ....++..|+|||.+.+  ...++.++||||+|+++++|++|.
T Consensus       135 ~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~  211 (307)
T cd06607         135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  211 (307)
T ss_pred             CceecCCCcccEEECCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCC
Confidence            9999999999999999999999999998655433   23467788999998742  344788999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+.......+...  .++                          .......+..+.++|.+||..||.+|||+.+
T Consensus       212 ~p~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  263 (307)
T cd06607         212 PPLFNMNAMSALYHIAQN--DSP--------------------------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEE  263 (307)
T ss_pred             CCCCCccHHHHHHHHhcC--CCC--------------------------CCCchhhCHHHHHHHHHHhcCChhhCcCHHH
Confidence            999776544432222110  000                          0001135678999999999999999999999


Q ss_pred             HhcCCCcCCc
Q 022132          248 ALAHPYLGSL  257 (302)
Q Consensus       248 ll~h~~~~~~  257 (302)
                      ++.||||..-
T Consensus       264 il~~~~~~~~  273 (307)
T cd06607         264 LLKHRFVLRE  273 (307)
T ss_pred             HhcChhhccc
Confidence            9999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.4e-37  Score=263.49  Aligned_cols=214  Identities=28%  Similarity=0.445  Sum_probs=178.2

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++.....+++..+..++.|++.|+++||+
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~  117 (264)
T cd06623          43 RKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT  117 (264)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            34688999999999999999999999887     89999999998 7999999887889999999999999999999999


Q ss_pred             -CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc-cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           89 -ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM-TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        89 -~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                       .|++|+||+|+||+++.++.++|+|||.+......... ....++..|+|||.+... .++.++|+||||+++++|++|
T Consensus       118 ~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg  196 (264)
T cd06623         118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALG  196 (264)
T ss_pred             cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhC
Confidence             99999999999999999999999999998765543322 245678889999988544 578999999999999999999


Q ss_pred             CCCCCCCCh---HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCC-CCHHHHHHHHHccCCCCCCC
Q 022132          167 KPLFPGRDH---VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       167 ~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R  242 (302)
                      .+||.....   ......+.   ...                          ....... ++..+.++|.+||..+|++|
T Consensus       197 ~~p~~~~~~~~~~~~~~~~~---~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R  247 (264)
T cd06623         197 KFPFLPPGQPSFFELMQAIC---DGP--------------------------PPSLPAEEFSPEFRDFISACLQKDPKKR  247 (264)
T ss_pred             CCCCccccccCHHHHHHHHh---cCC--------------------------CCCCCcccCCHHHHHHHHHHccCChhhC
Confidence            999976642   11111111   100                          0111123 67899999999999999999


Q ss_pred             CCHHHHhcCCCcCCcc
Q 022132          243 ITVEDALAHPYLGSLH  258 (302)
Q Consensus       243 ~t~~ell~h~~~~~~~  258 (302)
                      ||+.++++||||+...
T Consensus       248 ~~~~~ll~~~~~~~~~  263 (264)
T cd06623         248 PSAAELLQHPFIKKAD  263 (264)
T ss_pred             CCHHHHHhCHHHHhcc
Confidence            9999999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=268.97  Aligned_cols=219  Identities=24%  Similarity=0.371  Sum_probs=183.9

Q ss_pred             HhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~   84 (302)
                      ....-...|..||..++.+.||.+--.|+++     +.+++|+..|. |+|.-.+...+  .+++..+..++.+|+.||+
T Consensus       227 ~ge~maLnEk~iL~kV~s~FiVslaYAfeTk-----d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLe  301 (591)
T KOG0986|consen  227 KGETMALNEKQILEKVSSPFIVSLAYAFETK-----DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLE  301 (591)
T ss_pred             hhhHHhhHHHHHHHHhccCcEEEEeeeecCC-----CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHH
Confidence            3334667899999999999999999999998     99999999996 69987776655  7999999999999999999


Q ss_pred             HHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           85 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        85 ~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      +||+.+|++||+||+|||+|+.|.++|+|+|+|....+.......+||..|||||++.+.. |+...|.|||||++|+|+
T Consensus       302 hlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi  380 (591)
T KOG0986|consen  302 HLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMI  380 (591)
T ss_pred             HHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHH
Confidence            9999999999999999999999999999999999988887777889999999999996655 999999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-  243 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-  243 (302)
                      .|+.||.......-...+-....                          ..-.+....+|++++++++.+|.+||.+|. 
T Consensus       381 ~G~sPFr~~KeKvk~eEvdrr~~--------------------------~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  381 AGHSPFRQRKEKVKREEVDRRTL--------------------------EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             cccCchhhhhhhhhHHHHHHHHh--------------------------cchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            99999965432221111111000                          001122237899999999999999999997 


Q ss_pred             ----CHHHHhcCCCcCCcc
Q 022132          244 ----TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 ----t~~ell~h~~~~~~~  258 (302)
                          ++.++-+||||+.++
T Consensus       435 crg~ga~evk~HpfFk~ln  453 (591)
T KOG0986|consen  435 CRGEGAQEVKEHPFFKDLN  453 (591)
T ss_pred             CCCcCcchhhhCcccccCC
Confidence                567999999999763

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-37  Score=266.56  Aligned_cols=213  Identities=24%  Similarity=0.391  Sum_probs=168.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++.+...     +..++||||+++ +|..+    ..+++..+..++.|++.||.|||+.
T Consensus        44 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~  114 (279)
T cd06619          44 KQIMSELEILYKCDSPYIIGFYGAFFVE-----NRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSL  114 (279)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4577899999999999999999999987     889999999985 66443    3578999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+|+||||+||+++.++.++|+|||++...... ......++..|+|||.+.+. .++.++|+||+||++++|++|..|
T Consensus       115 ~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p  192 (279)
T cd06619         115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFP  192 (279)
T ss_pred             CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999998765432 23345788899999988654 478999999999999999999999


Q ss_pred             CCCCChHHHH---HHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          170 FPGRDHVHQL---RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       170 f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      |.........   .........+                        ..........++++.+++.+||+.||.+||+++
T Consensus       193 f~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~  248 (279)
T cd06619         193 YPQIQKNQGSLMPLQLLQCIVDE------------------------DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPE  248 (279)
T ss_pred             chhhcccccccchHHHHHHHhcc------------------------CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHH
Confidence            9643211100   0000000000                        000011124678899999999999999999999


Q ss_pred             HHhcCCCcCCcc
Q 022132          247 DALAHPYLGSLH  258 (302)
Q Consensus       247 ell~h~~~~~~~  258 (302)
                      |++.||||....
T Consensus       249 eil~~~~~~~~~  260 (279)
T cd06619         249 NLMDHPFIVQYN  260 (279)
T ss_pred             HHhcCccccccc
Confidence            999999998753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=255.95  Aligned_cols=217  Identities=24%  Similarity=0.375  Sum_probs=177.9

Q ss_pred             cCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      .+++.+.+.+.... .+|+||+.+++|...     .+++|.||.|...+..++.. .++++|..+-++...++.||.||.
T Consensus       134 ~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK  208 (391)
T KOG0983|consen  134 NKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLK  208 (391)
T ss_pred             HHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH
Confidence            44556666666666 489999999999988     88999999999776666653 478999999999999999999999


Q ss_pred             h-CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCC--CCCCCchhHHHHHHHHHHHH
Q 022132           88 S-ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        88 ~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~i~~~ll  164 (302)
                      . +||+|||+||+|||+|..|.+||||||.+...-+....+...|-+.|||||.+.-.  ..|..++||||||++++++.
T Consensus       209 eKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLa  288 (391)
T KOG0983|consen  209 EKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELA  288 (391)
T ss_pred             HhcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhh
Confidence            5 58999999999999999999999999999877666556667788889999998533  45889999999999999999


Q ss_pred             hCCCCCCCCChH-HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 DRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ||+.||.+.+.. +.+.++.+  ..|+.                         ..-..++|+++++|+..||.+|+.+||
T Consensus       289 Tg~yPy~~c~tdFe~ltkvln--~ePP~-------------------------L~~~~gFSp~F~~fv~~CL~kd~r~RP  341 (391)
T KOG0983|consen  289 TGQYPYKGCKTDFEVLTKVLN--EEPPL-------------------------LPGHMGFSPDFQSFVKDCLTKDHRKRP  341 (391)
T ss_pred             cccCCCCCCCccHHHHHHHHh--cCCCC-------------------------CCcccCcCHHHHHHHHHHhhcCcccCc
Confidence            999999986544 44444443  11110                         011114899999999999999999999


Q ss_pred             CHHHHhcCCCcCCcc
Q 022132          244 TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 t~~ell~h~~~~~~~  258 (302)
                      ...+||+|||+....
T Consensus       342 ~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  342 KYNKLLEHPFIKRYE  356 (391)
T ss_pred             chHHHhcCcceeecc
Confidence            999999999998754

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.5e-37  Score=263.09  Aligned_cols=213  Identities=29%  Similarity=0.523  Sum_probs=175.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++.+...     +..|+++||+. ++|.+++.+.+.+++..+..++.||+.||+|||+.
T Consensus        38 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~  112 (265)
T cd05579          38 DQVLTERDILSQAQSPYVVKLYYSFQGK-----KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN  112 (265)
T ss_pred             HHHHHHHHHHHhCCCcchhHHHHheecC-----cEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence            4577899999999999999999999876     88999999996 69999998877899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC---------cccccccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      |++|+||+|+||+++.++.++|+|||++.......         ......++..|+|||...... .+.++|+||||+++
T Consensus       113 ~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~  191 (265)
T cd05579         113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCIL  191 (265)
T ss_pred             CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHH
Confidence            99999999999999999999999999886543221         122345677899999986544 78899999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      +++++|..||...........+..  +..                         .+... ...++.+.+++.+||+.+|.
T Consensus       192 ~~l~~g~~p~~~~~~~~~~~~~~~--~~~-------------------------~~~~~-~~~~~~~~~~i~~~l~~~p~  243 (265)
T cd05579         192 YEFLVGIPPFHGETPEEIFQNILN--GKI-------------------------EWPED-VEVSDEAIDLISKLLVPDPE  243 (265)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHhc--CCc-------------------------CCCcc-ccCCHHHHHHHHHHhcCCHh
Confidence            999999999987765444333221  000                         00000 12478899999999999999


Q ss_pred             CCCCH---HHHhcCCCcCCc
Q 022132          241 QRITV---EDALAHPYLGSL  257 (302)
Q Consensus       241 ~R~t~---~ell~h~~~~~~  257 (302)
                      +|||+   .++|+||||+..
T Consensus       244 ~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         244 KRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             hcCCCccHHHHhcCccccCC
Confidence            99999   999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.6e-38  Score=271.79  Aligned_cols=211  Identities=24%  Similarity=0.390  Sum_probs=172.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++|||++++++++...     +..|+||||+.|+|.+.+.. ..++++..+..++.|++.|+.|||+.|
T Consensus        61 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~  135 (308)
T cd06634          61 DIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN  135 (308)
T ss_pred             HHHHHHHHHHhCCCCCcccEEEEEEcC-----CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            466899999999999999999999887     88999999999998887753 456899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhC--CCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ++||||+|+||+++.++.++|+|||.+......   ....++..|+|||.+.+  ...++.++||||+||++++|++|..
T Consensus       136 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~  212 (308)
T cd06634         136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  212 (308)
T ss_pred             cccCCCCHHhEEECCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCC
Confidence            999999999999999999999999988755432   23457788999999753  2346889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||...+.......+... ..+                           .......+..+.++|.+||..+|.+|||++++
T Consensus       213 p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l  264 (308)
T cd06634         213 PLFNMNAMSALYHIAQN-ESP---------------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL  264 (308)
T ss_pred             CCccccHHHHHHHHhhc-CCC---------------------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHH
Confidence            98665433322222110 000                           00112467789999999999999999999999


Q ss_pred             hcCCCcCCcc
Q 022132          249 LAHPYLGSLH  258 (302)
Q Consensus       249 l~h~~~~~~~  258 (302)
                      +.|||+....
T Consensus       265 l~~~~~~~~~  274 (308)
T cd06634         265 LKHRFVLRER  274 (308)
T ss_pred             hhCccccccC
Confidence            9999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.9e-37  Score=261.96  Aligned_cols=211  Identities=22%  Similarity=0.426  Sum_probs=170.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++.+...   ..+|++|||++ ++|.+++...+.+++..+..++.|++.||++||++|
T Consensus        50 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  126 (265)
T cd06652          50 ALECEIQLLKNLLHERIVQYYGCLRDPME---RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM  126 (265)
T ss_pred             HHHHHHHHHHhcCCCCeeeEEeEeccCCC---ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            56789999999999999999999876421   56889999996 699999988778999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC----CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ++|+||+|+||+++.++.++|+|||.+......    .......++..|+|||.+.+ ..++.++|+|||||++|+|++|
T Consensus       127 i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g  205 (265)
T cd06652         127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTE  205 (265)
T ss_pred             EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhC
Confidence            999999999999999999999999988754321    11223457888999999865 4478999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||...+.......+.   ..+..                         ....+..+..+.++|++|+. +|.+|||++
T Consensus       206 ~~p~~~~~~~~~~~~~~---~~~~~-------------------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~  256 (265)
T cd06652         206 KPPWAEFEAMAAIFKIA---TQPTN-------------------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSAD  256 (265)
T ss_pred             CCCCCccchHHHHHHHh---cCCCC-------------------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHH
Confidence            99997654443332211   11100                         01122456788999999995 999999999


Q ss_pred             HHhcCCCcC
Q 022132          247 DALAHPYLG  255 (302)
Q Consensus       247 ell~h~~~~  255 (302)
                      |+++|||++
T Consensus       257 ~il~~~~~~  265 (265)
T cd06652         257 ELLRHTFVH  265 (265)
T ss_pred             HHhcCcccC
Confidence            999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.1e-37  Score=261.48  Aligned_cols=212  Identities=25%  Similarity=0.433  Sum_probs=168.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCC--CHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QAL--SEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l--~~~~~~~i~~qll~~l~~L   86 (302)
                      ..+.+|+.+++.++||||+++++++...     +..++|+||++ ++|.+++... ..+  ++..+..++.|++.||+||
T Consensus        50 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~l  124 (268)
T cd06624          50 QPLHEEIALHSYLKHRNIVQYLGSDSEN-----GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL  124 (268)
T ss_pred             HHHHHHHHHHHhcCCCCeeeeeeeeccC-----CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHH
Confidence            3677999999999999999999999887     88999999997 6999998754 455  8889999999999999999


Q ss_pred             HhCCceecCCCCCCEEEec-CCCEEEeecccccccCCC-CcccccccccccCchhhhhCC-CCCCCchhHHHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~i~~~l  163 (302)
                      |+.||+||||+|+||+++. ++.++|+|||.+...... .......++..|+|||.+.+. ..++.++|+||+|+++++|
T Consensus       125 H~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l  204 (268)
T cd06624         125 HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEM  204 (268)
T ss_pred             HHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHH
Confidence            9999999999999999976 678999999998654322 222334578889999988543 2368899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|.+||.................                           ........+++.+.+++.+||+.+|.+||
T Consensus       205 ~~g~~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  257 (268)
T cd06624         205 ATGKPPFIELGEPQAAMFKVGMFK---------------------------IHPEIPESLSAEAKNFILRCFEPDPDKRA  257 (268)
T ss_pred             HhCCCCCccccChhhhHhhhhhhc---------------------------cCCCCCcccCHHHHHHHHHHcCCCchhCC
Confidence            999999965432211110000000                           00111225678899999999999999999


Q ss_pred             CHHHHhcCCCc
Q 022132          244 TVEDALAHPYL  254 (302)
Q Consensus       244 t~~ell~h~~~  254 (302)
                      |+.+++.||||
T Consensus       258 t~~~ll~~~~~  268 (268)
T cd06624         258 SAHDLLQDPFL  268 (268)
T ss_pred             CHHHHHhCCCC
Confidence            99999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.5e-37  Score=266.14  Aligned_cols=216  Identities=23%  Similarity=0.454  Sum_probs=177.0

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++.. +.+++..+..++.|++.||+|||+
T Consensus        61 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~  134 (292)
T cd06657          61 RELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHA  134 (292)
T ss_pred             HHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34577899999999999999999999887     89999999997 588877654 578999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      .|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|.
T Consensus       135 ~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~  213 (292)
T cd06657         135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGE  213 (292)
T ss_pred             CCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999886543321 2233457888999998754 44788999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+.......+.....                           .........++.+.+++.+||+.||.+|||+.+
T Consensus       214 ~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~  266 (292)
T cd06657         214 PPYFNEPPLKAMKMIRDNLP---------------------------PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE  266 (292)
T ss_pred             CCCCCCCHHHHHHHHHhhCC---------------------------cccCCcccCCHHHHHHHHHHHhCCcccCcCHHH
Confidence            99987665544333221110                           001112356788999999999999999999999


Q ss_pred             HhcCCCcCCccC
Q 022132          248 ALAHPYLGSLHD  259 (302)
Q Consensus       248 ll~h~~~~~~~~  259 (302)
                      ++.||||.....
T Consensus       267 ll~~~~~~~~~~  278 (292)
T cd06657         267 LLKHPFLAKAGP  278 (292)
T ss_pred             HhcChHHhccCC
Confidence            999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=291.82  Aligned_cols=211  Identities=25%  Similarity=0.421  Sum_probs=186.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      -|..|-.||..-+.+=|++++-.|.+.     +++|+|||||. |+|..++.+.++++++.+++++..|+.||.-||+.|
T Consensus       121 ~F~EERDimv~~ns~Wiv~LhyAFQD~-----~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg  195 (1317)
T KOG0612|consen  121 CFREERDIMVFGNSEWIVQLHYAFQDE-----RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG  195 (1317)
T ss_pred             HHHHHhHHHHcCCcHHHHHHHHHhcCc-----cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc
Confidence            566788999988999999999999998     99999999985 799999999889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC--CcccccccccccCchhhhhC----CCCCCCchhHHHHHHHHHHHH
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ++||||||+|||+|..|.+||.|||.|-.....  ......+|||.|.|||++..    .+.|+..+|.||+||++|+|+
T Consensus       196 yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMl  275 (1317)
T KOG0612|consen  196 YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEML  275 (1317)
T ss_pred             ceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHH
Confidence            999999999999999999999999998765522  23455689999999999852    245899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHH---hCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIEL---IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      .|..||...+-.+.+.+|++.   ++.|.+                             ..+|..+++||.+++. +|..
T Consensus       276 yG~TPFYadslveTY~KIm~hk~~l~FP~~-----------------------------~~VSeeakdLI~~ll~-~~e~  325 (1317)
T KOG0612|consen  276 YGETPFYADSLVETYGKIMNHKESLSFPDE-----------------------------TDVSEEAKDLIEALLC-DREV  325 (1317)
T ss_pred             cCCCcchHHHHHHHHHHHhchhhhcCCCcc-----------------------------cccCHHHHHHHHHHhc-Chhh
Confidence            999999999999999998875   222211                             1589999999999886 8999


Q ss_pred             CCC---HHHHhcCCCcCCc
Q 022132          242 RIT---VEDALAHPYLGSL  257 (302)
Q Consensus       242 R~t---~~ell~h~~~~~~  257 (302)
                      |..   ++|+-+||||.+.
T Consensus       326 RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  326 RLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             hcccccHHHHHhCccccCC
Confidence            998   9999999999865

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.4e-37  Score=261.10  Aligned_cols=214  Identities=25%  Similarity=0.455  Sum_probs=174.0

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++|+||+++++++...     +.+++|+||++ ++|.+++...+.+++..+..++.|++.||.|||+
T Consensus        43 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~  117 (264)
T cd06626          43 IKEIADEMKVLELLKHPNLVKYYGVEVHR-----EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS  117 (264)
T ss_pred             HHHHHHHHHHHHhCCCCChhheeeeEecC-----CEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH
Confidence            34677999999999999999999998876     88999999997 6999999887789999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc-----ccccccccccCchhhhhCCC--CCCCchhHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-----MTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFM  161 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~i~~  161 (302)
                      .|++|+||+|+||+++.++.++|+|||.+........     .....++..|+|||.+.+..  ..+.++|+||+|++++
T Consensus       118 ~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~  197 (264)
T cd06626         118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL  197 (264)
T ss_pred             CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHH
Confidence            9999999999999999999999999999876543322     11245678899999986443  2688999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       162 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      ++++|..||...+........... +.+.                        .+ .....+++.+.++|.+||+.||.+
T Consensus       198 ~l~~g~~pf~~~~~~~~~~~~~~~-~~~~------------------------~~-~~~~~~~~~~~~li~~~l~~~p~~  251 (264)
T cd06626         198 EMATGKRPWSELDNEFQIMFHVGA-GHKP------------------------PI-PDSLQLSPEGKDFLDRCLESDPKK  251 (264)
T ss_pred             HHHhCCCCccCCcchHHHHHHHhc-CCCC------------------------CC-CcccccCHHHHHHHHHHccCCccc
Confidence            999999999765433222222111 1000                        00 111245788999999999999999


Q ss_pred             CCCHHHHhcCCCc
Q 022132          242 RITVEDALAHPYL  254 (302)
Q Consensus       242 R~t~~ell~h~~~  254 (302)
                      |||+++++.|||+
T Consensus       252 R~~~~~i~~~~~~  264 (264)
T cd06626         252 RPTASELLQHPFV  264 (264)
T ss_pred             CCCHHHHhcCCCC
Confidence            9999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=261.71  Aligned_cols=209  Identities=25%  Similarity=0.435  Sum_probs=169.8

Q ss_pred             hhHHHHH-HhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022132           14 VRSSCFD-TWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV   91 (302)
Q Consensus        14 ~~E~~il-~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i   91 (302)
                      ..|..++ ...+|||++++++++...     +.+|+|+||++ ++|.+++...+.+++..+..++.|++.||.|||+.|+
T Consensus        44 ~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i  118 (260)
T cd05611          44 KAERAIMMIQGESPYVAKLYYSFQSK-----DYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI  118 (260)
T ss_pred             HHHHHHHhhcCCCCCeeeeeeeEEcC-----CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3444443 445899999999999887     89999999996 6999999887889999999999999999999999999


Q ss_pred             eecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022132           92 LHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  171 (302)
Q Consensus        92 ~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~  171 (302)
                      +|+||+|+||+++.++.++|+|||.+.....   .....++..|+|||.+.+.. ++.++|+||+|+++++|++|.+||.
T Consensus       119 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~  194 (260)
T cd05611         119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFH  194 (260)
T ss_pred             ecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCC
Confidence            9999999999999999999999998875443   22345678899999986554 7899999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC---HHHH
Q 022132          172 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDA  248 (302)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~el  248 (302)
                      ..+.......+......                          ........+++.+.++|.+||+.||++|||   ++|+
T Consensus       195 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         195 AETPDAVFDNILSRRIN--------------------------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             CCCHHHHHHHHHhcccC--------------------------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            77655443332211000                          001112257889999999999999999994   5799


Q ss_pred             hcCCCcCCc
Q 022132          249 LAHPYLGSL  257 (302)
Q Consensus       249 l~h~~~~~~  257 (302)
                      +.||||...
T Consensus       249 l~~~~~~~~  257 (260)
T cd05611         249 KSHPFFKSI  257 (260)
T ss_pred             HcChHhhcC
Confidence            999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-37  Score=266.35  Aligned_cols=211  Identities=25%  Similarity=0.379  Sum_probs=172.9

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++.. +.+++..+..++.|++.|+.|||+.|
T Consensus        48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~  121 (277)
T cd06642          48 DIQQEITVLSQCDSPYITRYYGSYLKG-----TKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER  121 (277)
T ss_pred             HHHHHHHHHHcCCCCccHhhhcccccC-----CceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            577999999999999999999999887     88999999997 588888765 57899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||+||++++|++|.+|
T Consensus       122 ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p  200 (277)
T cd06642         122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPP  200 (277)
T ss_pred             eeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987654332 12234567889999998544 478899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |...........+..                             ..........+..+.+++.+||..+|.+|||+.+++
T Consensus       201 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il  251 (277)
T cd06642         201 NSDLHPMRVLFLIPK-----------------------------NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELL  251 (277)
T ss_pred             CcccchhhHHhhhhc-----------------------------CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHH
Confidence            865543322211100                             000111124677899999999999999999999999


Q ss_pred             cCCCcCCcc
Q 022132          250 AHPYLGSLH  258 (302)
Q Consensus       250 ~h~~~~~~~  258 (302)
                      +||||..+.
T Consensus       252 ~~~~~~~~~  260 (277)
T cd06642         252 KHKFITRYT  260 (277)
T ss_pred             HhHHHHHHh
Confidence            999998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.1e-37  Score=262.12  Aligned_cols=205  Identities=17%  Similarity=0.222  Sum_probs=166.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++...     +..|+||||++ |+|.+++... +.+++..+..++.|++.||+|||+
T Consensus        51 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~  125 (266)
T cd05064          51 RGFLAEALTLGQFDHSNIVRLEGVITRG-----NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE  125 (266)
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEecC-----CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999877     88999999997 5899888763 578999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc--cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH-h
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-D  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll-~  165 (302)
                      .|++||||||+||+++.++.++++|||.+.........  ....++..|+|||.+.+ ..++.++||||+||++++++ +
T Consensus       126 ~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~  204 (266)
T cd05064         126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSY  204 (266)
T ss_pred             CCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcC
Confidence            99999999999999999999999999987543322111  12234567999998855 45899999999999999976 4


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+.......+......                             ...+.++..+.+++.+||+.||.+|||+
T Consensus       205 g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~  255 (266)
T cd05064         205 GERPYWDMSGQDVIKAVEDGFRL-----------------------------PAPRNCPNLLHQLMLDCWQKERGERPRF  255 (266)
T ss_pred             CCCCcCcCCHHHHHHHHHCCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCCchhCCCH
Confidence            99999877655544333211100                             1123567889999999999999999999


Q ss_pred             HHHhc
Q 022132          246 EDALA  250 (302)
Q Consensus       246 ~ell~  250 (302)
                      +++++
T Consensus       256 ~~i~~  260 (266)
T cd05064         256 SQIHS  260 (266)
T ss_pred             HHHHH
Confidence            99875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.1e-37  Score=263.01  Aligned_cols=207  Identities=26%  Similarity=0.411  Sum_probs=167.6

Q ss_pred             HHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 022132           19 FDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   97 (302)
Q Consensus        19 il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dik   97 (302)
                      .++...||||+++++++...     +.+|+||||+. ++|.+++...+.+++..+..++.|++.||+|||+.|++||||+
T Consensus        50 ~~~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~  124 (278)
T cd05606          50 LVSTGDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLK  124 (278)
T ss_pred             HHHhCCCCcEeeeeeeeecC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCC
Confidence            34445799999999999887     88999999996 6999999888889999999999999999999999999999999


Q ss_pred             CCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022132           98 PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  177 (302)
Q Consensus        98 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~  177 (302)
                      |+||+++.++.++|+|||.+....... .....++..|+|||.+.+...++.++|+||+||++++|++|..||.+.....
T Consensus       125 p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~  203 (278)
T cd05606         125 PANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD  203 (278)
T ss_pred             HHHEEECCCCCEEEccCcCccccCccC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc
Confidence            999999999999999999986543322 2344688999999998655557899999999999999999999997653221


Q ss_pred             HHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCC
Q 022132          178 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHP  252 (302)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~h~  252 (302)
                      ..... .....                          .........++.+.+++.+||..||.+||     |+.++++||
T Consensus       204 ~~~~~-~~~~~--------------------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~  256 (278)
T cd05606         204 KHEID-RMTLT--------------------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP  256 (278)
T ss_pred             hHHHH-HHhhc--------------------------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence            11100 00000                          00011224678999999999999999999     999999999


Q ss_pred             CcCCcc
Q 022132          253 YLGSLH  258 (302)
Q Consensus       253 ~~~~~~  258 (302)
                      ||+...
T Consensus       257 ~~~~~~  262 (278)
T cd05606         257 FFRSLD  262 (278)
T ss_pred             cccCCC
Confidence            998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-37  Score=259.01  Aligned_cols=208  Identities=29%  Similarity=0.508  Sum_probs=175.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecC-CccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++.+...     +.+|+||||+ +++|.+++...+.+++..+..++.|++.||.+||+.
T Consensus        38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~  112 (250)
T cd05123          38 EHTLTERNILSRINHPFIVKLHYAFQTE-----EKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL  112 (250)
T ss_pred             HHHHHHHHHHHHcCCCcHHHHHHHeecC-----CeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3678899999999999999999999887     8999999999 579999998877899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||...+. ..+.++|+||||++++++++|..
T Consensus       113 ~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~  191 (250)
T cd05123         113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKP  191 (250)
T ss_pred             CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCC
Confidence            9999999999999999999999999998765443 223445678889999988554 37889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH---
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV---  245 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---  245 (302)
                      ||...+.......+..  ..                            .......+..+.+++++||..||++|||+   
T Consensus       192 p~~~~~~~~~~~~~~~--~~----------------------------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~  241 (250)
T cd05123         192 PFYAEDRKEIYEKILK--DP----------------------------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGA  241 (250)
T ss_pred             CCCCCCHHHHHHHHhc--CC----------------------------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccH
Confidence            9977765433333221  00                            01112347889999999999999999999   


Q ss_pred             HHHhcCCCc
Q 022132          246 EDALAHPYL  254 (302)
Q Consensus       246 ~ell~h~~~  254 (302)
                      +++++||||
T Consensus       242 ~~l~~~~~f  250 (250)
T cd05123         242 EEIKAHPFF  250 (250)
T ss_pred             HHHHhCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.9e-37  Score=265.53  Aligned_cols=214  Identities=27%  Similarity=0.421  Sum_probs=169.2

Q ss_pred             chhhHHHH-HHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCF-DTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS----NQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+..|+.+ ++.++||||+++++++...     +.+|++|||++++|.+++..    ...+++..+..++.|++.||+||
T Consensus        45 ~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l  119 (283)
T cd06617          45 RLLMDLDISMRSVDCPYTVTFYGALFRE-----GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL  119 (283)
T ss_pred             HHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            45556665 5566999999999999887     78999999999998888754    34689999999999999999999


Q ss_pred             HhC-CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCC---CCCCCchhHHHHHHHHHH
Q 022132           87 HSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        87 H~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~i~~~  162 (302)
                      |++ +++||||||+||+++.++.++|+|||.+.............++..|+|||.+.+.   ..++.++|+||+||++++
T Consensus       120 H~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~  199 (283)
T cd06617         120 HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE  199 (283)
T ss_pred             hhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence            997 9999999999999999999999999998765443333335678889999987542   336789999999999999


Q ss_pred             HHhCCCCCCCCC-hHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          163 LMDRKPLFPGRD-HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       163 ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      |++|..||.... ..+.+......   ..                       ..  .....+|.++.++|.+||..||.+
T Consensus       200 l~~g~~p~~~~~~~~~~~~~~~~~---~~-----------------------~~--~~~~~~~~~l~~li~~~l~~~p~~  251 (283)
T cd06617         200 LATGRFPYDSWKTPFQQLKQVVEE---PS-----------------------PQ--LPAEKFSPEFQDFVNKCLKKNYKE  251 (283)
T ss_pred             HHhCCCCCCccccCHHHHHHHHhc---CC-----------------------CC--CCccccCHHHHHHHHHHccCChhh
Confidence            999999996432 22222221110   00                       00  001146788999999999999999


Q ss_pred             CCCHHHHhcCCCcCCcc
Q 022132          242 RITVEDALAHPYLGSLH  258 (302)
Q Consensus       242 R~t~~ell~h~~~~~~~  258 (302)
                      |||+++++.||||....
T Consensus       252 Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         252 RPNYPELLQHPFFELHL  268 (283)
T ss_pred             CcCHHHHhcCchhhhcc
Confidence            99999999999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.5e-37  Score=264.13  Aligned_cols=211  Identities=24%  Similarity=0.367  Sum_probs=173.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.+.||||+++++++...     +.+|+||||++ ++|.+++.. +++++..+..++.|++.||++||+.
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~  120 (277)
T cd06640          47 EDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSE  120 (277)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3577899999999999999999999887     89999999997 599998875 5789999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |++|+||+|+||+++.++.++++|||.+....... ......++..|+|||.+.+. ..+.++|+||+||++++|++|.+
T Consensus       121 ~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~  199 (277)
T cd06640         121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEP  199 (277)
T ss_pred             CccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCC
Confidence            99999999999999999999999999986654332 22334567889999988544 47899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||.+.+.......+.. ..                            ........+..+.+++.+||+.||.+|||++++
T Consensus       200 p~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  250 (277)
T cd06640         200 PNSDMHPMRVLFLIPK-NN----------------------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKEL  250 (277)
T ss_pred             CCCCcChHhHhhhhhc-CC----------------------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHH
Confidence            9976654433221110 00                            011122456789999999999999999999999


Q ss_pred             hcCCCcCCc
Q 022132          249 LAHPYLGSL  257 (302)
Q Consensus       249 l~h~~~~~~  257 (302)
                      +.|+||...
T Consensus       251 l~~~~~~~~  259 (277)
T cd06640         251 LKHKFIVKN  259 (277)
T ss_pred             HhChHhhhc
Confidence            999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=6.2e-37  Score=266.27  Aligned_cols=210  Identities=24%  Similarity=0.407  Sum_probs=174.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++|||++++++++.+.     +..|+||||+.++|.+.+.. ..++++..+..++.|++.||.|||++|
T Consensus        67 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g  141 (313)
T cd06633          67 DIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN  141 (313)
T ss_pred             HHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            567899999999999999999999887     88999999999999888864 457899999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhC--CCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ++|+||+|+||+++.++.++|+|||.+.....   .....++..|+|||.+..  ...++.++|+||+||++++|++|.+
T Consensus       142 i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~  218 (313)
T cd06633         142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  218 (313)
T ss_pred             eecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999998864332   234567888999998742  3447889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||...+.......+... ..+                           ....+..+..+.+|+.+||+++|.+|||++++
T Consensus       219 p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~  270 (313)
T cd06633         219 PLFNMNAMSALYHIAQN-DSP---------------------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAEL  270 (313)
T ss_pred             CCCCCChHHHHHHHHhc-CCC---------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            99777654444332210 000                           01112456789999999999999999999999


Q ss_pred             hcCCCcCCc
Q 022132          249 LAHPYLGSL  257 (302)
Q Consensus       249 l~h~~~~~~  257 (302)
                      +.||||...
T Consensus       271 l~~~~~~~~  279 (313)
T cd06633         271 LRHDFVRRD  279 (313)
T ss_pred             hcCcccCCC
Confidence            999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.2e-37  Score=262.96  Aligned_cols=205  Identities=23%  Similarity=0.373  Sum_probs=168.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--------------CCCCHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--------------QALSEEHCQYF   75 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--------------~~l~~~~~~~i   75 (302)
                      ..+.+|+.+++.++||||+++++++...     ...|+||||++ ++|.+++...              ..+++..+..+
T Consensus        53 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~  127 (280)
T cd05049          53 KDFEREAELLTNFQHENIVKFYGVCTEG-----DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI  127 (280)
T ss_pred             HHHHHHHHHHHhcCCCCchheeeEEecC-----CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHH
Confidence            4678999999999999999999999887     88999999996 6999998754              24788999999


Q ss_pred             HHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchh
Q 022132           76 LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAID  152 (302)
Q Consensus        76 ~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~D  152 (302)
                      +.|++.||++||++|++||||||+||+++.++.++|+|||.+.......   ......++..|+|||.+.+. .++.++|
T Consensus       128 ~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~D  206 (280)
T cd05049         128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESD  206 (280)
T ss_pred             HHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-Ccchhhh
Confidence            9999999999999999999999999999999999999999987543221   12233456789999998654 4899999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHH
Q 022132          153 VWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV  231 (302)
Q Consensus       153 iwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  231 (302)
                      ||||||++++|++ |..||.+.+.......+....                             ........+..+.+++
T Consensus       207 i~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li  257 (280)
T cd05049         207 VWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR-----------------------------LLQRPRTCPSEVYDIM  257 (280)
T ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------------------------cCCCCCCCCHHHHHHH
Confidence            9999999999998 999997776555443332100                             0111125678999999


Q ss_pred             HHccCCCCCCCCCHHHHhc
Q 022132          232 EKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       232 ~~~L~~dP~~R~t~~ell~  250 (302)
                      ++||+.||.+|||+.|+++
T Consensus       258 ~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         258 LGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHcCCCcccCCCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-37  Score=276.23  Aligned_cols=205  Identities=22%  Similarity=0.326  Sum_probs=163.2

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------------------------
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------------------------   64 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------------------------   64 (302)
                      .+.+|+.+++.+ +||||+++++++...     +.+|+||||+. |+|.+++...                         
T Consensus        87 ~~~~E~~il~~l~~h~nIv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (374)
T cd05106          87 ALMSELKILSHLGQHKNIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNIT  161 (374)
T ss_pred             HHHHHHHHHHhhccCCceeeEeeEecCC-----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccc
Confidence            577899999999 899999999999887     88999999996 6999888532                         


Q ss_pred             ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 022132           65 ---------------------------------------------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   99 (302)
Q Consensus        65 ---------------------------------------------~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~   99 (302)
                                                                   .++++..+..++.||+.||+|||++||+||||||+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~  241 (374)
T cd05106         162 LEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAAR  241 (374)
T ss_pred             hhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchh
Confidence                                                         24788899999999999999999999999999999


Q ss_pred             CEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 022132          100 NLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  175 (302)
Q Consensus       100 Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~  175 (302)
                      ||+++.++.++|+|||++........   .....++..|+|||++.+ ..++.++||||+||++|+|++ |.+||.....
T Consensus       242 Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~  320 (374)
T cd05106         242 NVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILV  320 (374)
T ss_pred             eEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence            99999999999999999875432211   112234567999999854 448999999999999999997 9999976543


Q ss_pred             HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          176 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      .............+                            ......++++.+++.+||+.||.+|||+.++++
T Consensus       321 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         321 NSKFYKMVKRGYQM----------------------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             cHHHHHHHHcccCc----------------------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            33222222110000                            011235789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.1e-37  Score=263.73  Aligned_cols=204  Identities=22%  Similarity=0.353  Sum_probs=167.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-------------CCCHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-------------ALSEEHCQYFLY   77 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-------------~l~~~~~~~i~~   77 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...+             .+++..+..++.
T Consensus        53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  127 (288)
T cd05093          53 DFHREAELLTNLQHEHIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ  127 (288)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEecC-----CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHH
Confidence            578999999999999999999999877     88999999997 69999987543             489999999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHH
Q 022132           78 QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVW  154 (302)
Q Consensus        78 qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  154 (302)
                      |++.||+|||+.|++||||||+||+++.++.++|+|||.+.......   ......++..|+|||.+.+ ..++.++|+|
T Consensus       128 ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiw  206 (288)
T cd05093         128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVW  206 (288)
T ss_pred             HHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHH
Confidence            99999999999999999999999999999999999999987543221   1122334667999998854 4578999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHH
Q 022132          155 SVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  233 (302)
Q Consensus       155 slG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  233 (302)
                      ||||++++|++ |.+||.+.........+.....                             .......++++.+|+.+
T Consensus       207 slG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~l~~li~~  257 (288)
T cd05093         207 SLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-----------------------------LQRPRTCPKEVYDLMLG  257 (288)
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc-----------------------------CCCCCCCCHHHHHHHHH
Confidence            99999999998 9999977765544333322100                             01112467889999999


Q ss_pred             ccCCCCCCCCCHHHHhc
Q 022132          234 MLTFDPRQRITVEDALA  250 (302)
Q Consensus       234 ~L~~dP~~R~t~~ell~  250 (302)
                      ||+.||.+|||+.+++.
T Consensus       258 ~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         258 CWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HccCChhhCCCHHHHHH
Confidence            99999999999999954

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-37  Score=259.68  Aligned_cols=206  Identities=25%  Similarity=0.376  Sum_probs=172.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecC-CccHHHHHHcC---------CCCCHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSN---------QALSEEHCQYFLYQIL   80 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---------~~l~~~~~~~i~~qll   80 (302)
                      ..+.+|+.+++.++|+||+++++++...     ..+++||||+ +++|.+++...         ..+++..+..++.|++
T Consensus        41 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~  115 (262)
T cd00192          41 KDFLKEARVMKKLGHPNVVRLLGVCTEE-----EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA  115 (262)
T ss_pred             HHHHHHHHHHhhcCCCChheeeeeecCC-----CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHH
Confidence            4677899999999999999999999886     8899999999 57999999875         7899999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCCCCchhHHHHH
Q 022132           81 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG  157 (302)
Q Consensus        81 ~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  157 (302)
                      .||++||++|++|+||+|+||+++.++.++|+|||.+......   .......++..|+|||.+... .++.++|+||+|
T Consensus       116 ~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG  194 (262)
T cd00192         116 KGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFG  194 (262)
T ss_pred             HHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHH
Confidence            9999999999999999999999999999999999999765543   122344567789999988654 588999999999


Q ss_pred             HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccC
Q 022132          158 CIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  236 (302)
Q Consensus       158 ~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  236 (302)
                      |++++|++ |..||...........+....                             .......+++++.+++.+||.
T Consensus       195 ~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~  245 (262)
T cd00192         195 VLLWEIFTLGATPYPGLSNEEVLEYLRKGY-----------------------------RLPKPEYCPDELYELMLSCWQ  245 (262)
T ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------------------------CCCCCccCChHHHHHHHHHcc
Confidence            99999998 699998776554444333200                             011123568899999999999


Q ss_pred             CCCCCCCCHHHHhcC
Q 022132          237 FDPRQRITVEDALAH  251 (302)
Q Consensus       237 ~dP~~R~t~~ell~h  251 (302)
                      .||.+|||+.+++++
T Consensus       246 ~~p~~Rps~~~l~~~  260 (262)
T cd00192         246 LDPEDRPTFSELVER  260 (262)
T ss_pred             CCcccCcCHHHHHHh
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.9e-37  Score=262.90  Aligned_cols=217  Identities=24%  Similarity=0.354  Sum_probs=169.9

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR----SNQALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qll~~l~   84 (302)
                      ..+.+|+.+++.+ +||||+++++++........+.+|+||||++ ++|.+++.    ....+++..+..++.|++.||.
T Consensus        59 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~  138 (286)
T cd06638          59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ  138 (286)
T ss_pred             HHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHH
Confidence            3566899999999 7999999999986543333367999999996 69988765    2356899999999999999999


Q ss_pred             HHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCC----CCCCCchhHHHHHHH
Q 022132           85 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCI  159 (302)
Q Consensus        85 ~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~i  159 (302)
                      |||+.|++||||+|+||+++.++.++|+|||++....... ......++..|+|||.+...    ..++.++|+||+||+
T Consensus       139 ~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi  218 (286)
T cd06638         139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT  218 (286)
T ss_pred             HHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHH
Confidence            9999999999999999999999999999999987654322 22334678899999987432    336889999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC
Q 022132          160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       160 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      +++|++|.+||...+....+......  .+                         +........+..+.+++.+||+.||
T Consensus       219 ~~el~~g~~p~~~~~~~~~~~~~~~~--~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p  271 (286)
T cd06638         219 AIELGDGDPPLADLHPMRALFKIPRN--PP-------------------------PTLHQPELWSNEFNDFIRKCLTKDY  271 (286)
T ss_pred             HHHHhcCCCCCCCCchhHHHhhcccc--CC-------------------------CcccCCCCcCHHHHHHHHHHccCCc
Confidence            99999999999765443322111100  00                         0000111356789999999999999


Q ss_pred             CCCCCHHHHhcCCCc
Q 022132          240 RQRITVEDALAHPYL  254 (302)
Q Consensus       240 ~~R~t~~ell~h~~~  254 (302)
                      ++|||+.|+++|+||
T Consensus       272 ~~Rps~~ell~~~~~  286 (286)
T cd06638         272 EKRPTVSDLLQHVFI  286 (286)
T ss_pred             ccCCCHHHHhhcccC
Confidence            999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.7e-37  Score=265.00  Aligned_cols=212  Identities=24%  Similarity=0.361  Sum_probs=165.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------------------CCCCHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------------------QALSEE   70 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------------------~~l~~~   70 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +..++||||++ ++|.+++...                   ..+++.
T Consensus        64 ~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (304)
T cd05096          64 NDFLKEVKILSRLKDPNIIRLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYS  138 (304)
T ss_pred             HHHHHHHHHHhhcCCCCeeEEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHH
Confidence            4678999999999999999999999887     78999999996 6999988643                   136778


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCC
Q 022132           71 HCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDY  147 (302)
Q Consensus        71 ~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~  147 (302)
                      .+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........   .....++..|+|||.+.+. .+
T Consensus       139 ~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~  217 (304)
T cd05096         139 SLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KF  217 (304)
T ss_pred             HHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CC
Confidence            8999999999999999999999999999999999999999999999875433221   1223446789999998654 48


Q ss_pred             CCchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCH
Q 022132          148 TAAIDVWSVGCIFMELMD--RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP  225 (302)
Q Consensus       148 ~~~~DiwslG~i~~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (302)
                      +.++|||||||++++|++  +..||.+.+..+.............                      ........+..+.
T Consensus       218 ~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~  275 (304)
T cd05096         218 TTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQG----------------------RQVYLFRPPPCPQ  275 (304)
T ss_pred             CchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcc----------------------ccccccCCCCCCH
Confidence            999999999999999986  5678876655444433222111000                      0001112235678


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          226 SAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       226 ~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      .+.+|+.+||..||.+|||++++.+
T Consensus       276 ~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         276 GLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHHH
Confidence            8999999999999999999999943

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.9e-37  Score=258.93  Aligned_cols=206  Identities=18%  Similarity=0.316  Sum_probs=167.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+
T Consensus        44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~  118 (256)
T cd05113          44 DEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES  118 (256)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3578999999999999999999999876     77899999996 6999998763 478999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc--cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      .|++|+||+|+||+++.++.++|+|||.+.........  ....++..|+|||.+.+. .++.++|+|||||++++|++ 
T Consensus       119 ~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~  197 (256)
T cd05113         119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSL  197 (256)
T ss_pred             CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcC
Confidence            99999999999999999999999999998755433211  122345679999988544 47899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||...+.......+......                             ......+..+++++.+||+.||.+|||+
T Consensus       198 g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~  248 (256)
T cd05113         198 GKMPYERFNNSETVEKVSQGLRL-----------------------------YRPHLASEKVYAIMYSCWHEKAEERPTF  248 (256)
T ss_pred             CCCCcCcCCHHHHHHHHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence            99999776655444333221110                             0011357789999999999999999999


Q ss_pred             HHHhcC
Q 022132          246 EDALAH  251 (302)
Q Consensus       246 ~ell~h  251 (302)
                      .+++.+
T Consensus       249 ~~ll~~  254 (256)
T cd05113         249 QQLLSS  254 (256)
T ss_pred             HHHHHh
Confidence            999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.6e-37  Score=258.29  Aligned_cols=205  Identities=20%  Similarity=0.342  Sum_probs=164.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++... ..+++..+..++.|++.||.|||+
T Consensus        38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~  112 (252)
T cd05084          38 AKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES  112 (252)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4688999999999999999999999887     88999999996 6999998654 468999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCccc---ccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT---EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      .|++|+||+|+||+++.++.++|+|||.+..........   ....+..|+|||.+.+. .++.++|+||+||++++|++
T Consensus       113 ~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~  191 (252)
T cd05084         113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFS  191 (252)
T ss_pred             CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHh
Confidence            999999999999999999999999999987544321111   11223469999988544 47899999999999999997


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||...........+.....                             .......+..+.+++.+||+.||++|||
T Consensus       192 ~~~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps  242 (252)
T cd05084         192 LGAVPYANLSNQQTREAIEQGVR-----------------------------LPCPELCPDAVYRLMERCWEYDPGQRPS  242 (252)
T ss_pred             CCCCCccccCHHHHHHHHHcCCC-----------------------------CCCcccCCHHHHHHHHHHcCCChhhCcC
Confidence             8899966544332222211000                             0111245788999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      +.++++
T Consensus       243 ~~~~~~  248 (252)
T cd05084         243 FSTVHQ  248 (252)
T ss_pred             HHHHHH
Confidence            999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.5e-37  Score=267.52  Aligned_cols=206  Identities=24%  Similarity=0.298  Sum_probs=165.2

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHC   72 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~   72 (302)
                      ..+.+|+.++.++ +||||+++++++...     +.+|+||||++ ++|.+++...+                .+++..+
T Consensus        52 ~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  126 (303)
T cd05088          52 RDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL  126 (303)
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEECCC-----CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHH
Confidence            3577899999999 899999999999887     78999999996 69999986532                5789999


Q ss_pred             HHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchh
Q 022132           73 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAID  152 (302)
Q Consensus        73 ~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  152 (302)
                      ..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..............+..|+|||.+.+ ..++.++|
T Consensus       127 ~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  205 (303)
T cd05088         127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSD  205 (303)
T ss_pred             HHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCccccc
Confidence            99999999999999999999999999999999999999999999864322111112233567999998854 44789999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHH
Q 022132          153 VWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV  231 (302)
Q Consensus       153 iwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  231 (302)
                      |||+||++++|++ |.+||.+.+..+....+....                             ........++++.+++
T Consensus       206 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li  256 (303)
T cd05088         206 VWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-----------------------------RLEKPLNCDDEVYDLM  256 (303)
T ss_pred             chhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-----------------------------cCCCCCCCCHHHHHHH
Confidence            9999999999998 999997665544332221100                             0001124678899999


Q ss_pred             HHccCCCCCCCCCHHHHhcC
Q 022132          232 EKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       232 ~~~L~~dP~~R~t~~ell~h  251 (302)
                      .+||+.||++|||+++++.+
T Consensus       257 ~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         257 RQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999885

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.6e-37  Score=258.31  Aligned_cols=204  Identities=21%  Similarity=0.307  Sum_probs=166.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.+.||||+++++++..      ...++||||++ ++|.+++...+.+++..+..++.|++.||++||++
T Consensus        41 ~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~  114 (257)
T cd05116          41 DELLREANVMQQLDNPYIVRMIGICEA------ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET  114 (257)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            467889999999999999999998754      56789999997 68999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCc----ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      |++||||||.||+++.++.++|+|||.+........    .....++..|+|||.+.. ..++.++|+|||||++|+|++
T Consensus       115 ~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t  193 (257)
T cd05116         115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFS  193 (257)
T ss_pred             CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHh
Confidence            999999999999999999999999999876543321    112233568999998843 447889999999999999997


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.+.......+.+...                             ....+..++++.++|.+||+.||.+|||
T Consensus       194 ~g~~p~~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~  244 (257)
T cd05116         194 YGQKPYKGMKGNEVTQMIESGER-----------------------------MECPQRCPPEMYDLMKLCWTYGVDERPG  244 (257)
T ss_pred             CCCCCCCCCCHHHHHHHHHCCCC-----------------------------CCCCCCCCHHHHHHHHHHhccCchhCcC
Confidence             9999987765544433321100                             0112357889999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++++..
T Consensus       245 ~~~i~~  250 (257)
T cd05116         245 FAVVEL  250 (257)
T ss_pred             HHHHHH
Confidence            998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.1e-37  Score=263.22  Aligned_cols=205  Identities=23%  Similarity=0.360  Sum_probs=167.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQ   73 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~   73 (302)
                      +.+.+|+.+++.++||||+++++++...     +..++||||++ ++|.+++..+                +.+++..+.
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  126 (291)
T cd05094          52 KDFQREAELLTNLQHEHIVKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML  126 (291)
T ss_pred             HHHHHHHHHHhcCCCCCcceEEEEEccC-----CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHH
Confidence            4677999999999999999999999876     78999999996 7999998753                238899999


Q ss_pred             HHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCc
Q 022132           74 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAA  150 (302)
Q Consensus        74 ~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~  150 (302)
                      .++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.......   ......++..|+|||.+.+ ..++.+
T Consensus       127 ~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  205 (291)
T cd05094         127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTE  205 (291)
T ss_pred             HHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCch
Confidence            999999999999999999999999999999999999999999987554322   1223445778999998865 447889


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHH
Q 022132          151 IDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID  229 (302)
Q Consensus       151 ~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (302)
                      +||||+||++++|++ |.+||...+.......+...                             .........+..+.+
T Consensus       206 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~  256 (291)
T cd05094         206 SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG-----------------------------RVLERPRVCPKEVYD  256 (291)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC-----------------------------CCCCCCccCCHHHHH
Confidence            999999999999998 99999776654433322110                             001112246788999


Q ss_pred             HHHHccCCCCCCCCCHHHHhc
Q 022132          230 LVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       230 li~~~L~~dP~~R~t~~ell~  250 (302)
                      ++.+||+.||++|||++++++
T Consensus       257 li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         257 IMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHcccChhhCcCHHHHHH
Confidence            999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-37  Score=262.17  Aligned_cols=213  Identities=20%  Similarity=0.419  Sum_probs=173.4

Q ss_pred             chhhHHHHHHhcC---CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIM---KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      .+.+|+.+++.+.   |||++++++++...     ...|+||||++ ++|.+++.. +.+++..+..++.|++.||.|||
T Consensus        45 ~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh  118 (277)
T cd06917          45 DIQREVALLSQLRQSQPPNITKYYGSYLKG-----PRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIH  118 (277)
T ss_pred             HHHHHHHHHHHhccCCCCCeeeEeeeeeeC-----CEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH
Confidence            5678999999997   99999999999876     78999999996 599988866 47999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      +.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+||++++|++|
T Consensus       119 ~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g  198 (277)
T cd06917         119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG  198 (277)
T ss_pred             hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999987654332 223346788899999986555578899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+.......+.. .                         ....+.  ....+.++.+++.+||..||++|||+.
T Consensus       199 ~~p~~~~~~~~~~~~~~~-~-------------------------~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~  250 (277)
T cd06917         199 NPPYSDVDAFRAMMLIPK-S-------------------------KPPRLE--DNGYSKLLREFVAACLDEEPKERLSAE  250 (277)
T ss_pred             CCCCCCCChhhhhhcccc-C-------------------------CCCCCC--cccCCHHHHHHHHHHcCCCcccCcCHH
Confidence            999976554322211100 0                         000000  012677899999999999999999999


Q ss_pred             HHhcCCCcCCcc
Q 022132          247 DALAHPYLGSLH  258 (302)
Q Consensus       247 ell~h~~~~~~~  258 (302)
                      +++.|+||+...
T Consensus       251 ~il~~~~~~~~~  262 (277)
T cd06917         251 ELLKSKWIKAHS  262 (277)
T ss_pred             HHhhChHhhccc
Confidence            999999997643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.6e-37  Score=261.77  Aligned_cols=224  Identities=23%  Similarity=0.332  Sum_probs=174.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~-   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++.+.+.+++..+..++.|++.||.|||+ 
T Consensus        48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~  122 (284)
T cd06620          48 KQILRELQIMHECRSPYIVSFYGAFLNE-----NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV  122 (284)
T ss_pred             HHHHHHHHHHHHcCCCCcceEeeeEecC-----CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            4577899999999999999999999987     89999999997 6999998887889999999999999999999997 


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      .|++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+. .++.++|+||+||+++++++|..
T Consensus       123 ~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~  200 (284)
T cd06620         123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKF  200 (284)
T ss_pred             cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCC
Confidence            69999999999999999999999999988654322 12344678899999988654 57899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||............        ...   .........    ......+.  ...++..+.+|+.+||+.||.+|||++|+
T Consensus       201 p~~~~~~~~~~~~~--------~~~---~~~~~~~~~----~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~  263 (284)
T cd06620         201 PFAFSNIDDDGQDD--------PMG---ILDLLQQIV----QEPPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQL  263 (284)
T ss_pred             CCcccchhhhhhhh--------hhH---HHHHHHHHh----hccCCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            99765432110000        000   000000000    00000000  01366789999999999999999999999


Q ss_pred             hcCCCcCCcc
Q 022132          249 LAHPYLGSLH  258 (302)
Q Consensus       249 l~h~~~~~~~  258 (302)
                      ++|+||.+-.
T Consensus       264 ~~~~~~~~~~  273 (284)
T cd06620         264 CAMPPFIQAL  273 (284)
T ss_pred             hcCccccccc
Confidence            9999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.7e-37  Score=259.34  Aligned_cols=210  Identities=23%  Similarity=0.345  Sum_probs=170.0

Q ss_pred             hhHHHHhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHH
Q 022132            3 SITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR   81 (302)
Q Consensus         3 ~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~   81 (302)
                      |+|++.....+.+|...+....||||+++++++...     +.+|+||||++ ++|.+.+.+...+++..+..++.|++.
T Consensus        22 ~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~   96 (237)
T cd05576          22 ILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV   96 (237)
T ss_pred             EEEeecchhhhhhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHH
Confidence            455665555666777777777899999999999887     88999999997 699999988778999999999999999


Q ss_pred             HHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHH
Q 022132           82 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        82 ~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~  161 (302)
                      ||+|||+.|++||||||+||+++.++.++++|||.+......  .....++..|+|||.+.. ..++.++|+||+||+++
T Consensus        97 ~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~  173 (237)
T cd05576          97 ALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGI-SEETEACDWWSLGAILF  173 (237)
T ss_pred             HHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcccCC-CCCCchhhHHHHHHHHH
Confidence            999999999999999999999999999999999987655433  223345677999998743 44788999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       162 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      +|++|..|+.......         ..                      ..  . ....+.+++.++++|.+||+.||++
T Consensus       174 el~~g~~~~~~~~~~~---------~~----------------------~~--~-~~~~~~~~~~~~~li~~~l~~dp~~  219 (237)
T cd05576         174 ELLTGKTLVECHPSGI---------NT----------------------HT--T-LNIPEWVSEEARSLLQQLLQFNPTE  219 (237)
T ss_pred             HHHHCcchhhcCchhc---------cc----------------------cc--c-cCCcccCCHHHHHHHHHHccCCHHH
Confidence            9999998874321100         00                      00  0 0111246788999999999999999


Q ss_pred             CCCH-----HHHhcCCCc
Q 022132          242 RITV-----EDALAHPYL  254 (302)
Q Consensus       242 R~t~-----~ell~h~~~  254 (302)
                      |+|+     +++++||||
T Consensus       220 R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         220 RLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             hcCCCccchHHHHcCCCC
Confidence            9985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.5e-37  Score=257.71  Aligned_cols=209  Identities=27%  Similarity=0.466  Sum_probs=174.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+++++.++|||++++++.+...     ...++|+||++ ++|.+.+...    ..+++..+..++.|++.||.+
T Consensus        44 ~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~  118 (258)
T cd08215          44 EDALNEVKILKKLNHPNIIKYYESFEEK-----GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY  118 (258)
T ss_pred             HHHHHHHHHHHhcCCCChhheEEEEecC-----CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999887     88999999997 5999998763    779999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++++|+
T Consensus       119 lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~  197 (258)
T cd08215         119 LHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELC  197 (258)
T ss_pred             HHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHH
Confidence            999999999999999999999999999999987654432 23345678889999987554 4788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|..||...+............                             ........+..+.+++.+||..||++|||
T Consensus       198 ~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  248 (258)
T cd08215         198 TLKHPFEGENLLELALKILKGQ-----------------------------YPPIPSQYSSELRNLVSSLLQKDPEERPS  248 (258)
T ss_pred             cCCCCCCCCcHHHHHHHHhcCC-----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence            9999997766443333222110                             01111256788999999999999999999


Q ss_pred             HHHHhcCCCc
Q 022132          245 VEDALAHPYL  254 (302)
Q Consensus       245 ~~ell~h~~~  254 (302)
                      +.++|+||||
T Consensus       249 ~~~ll~~~~~  258 (258)
T cd08215         249 IAQILQSPFI  258 (258)
T ss_pred             HHHHhcCCCC
Confidence            9999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.9e-37  Score=257.87  Aligned_cols=209  Identities=27%  Similarity=0.459  Sum_probs=171.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++.+...     +.+|+|+||+. ++|.+++....  .+++..+..++.|++.||.|||
T Consensus        44 ~~~~~E~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh  118 (257)
T cd08225          44 EASKKEVILLAKMKHPNIVTFFASFQEN-----GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH  118 (257)
T ss_pred             HHHHHHHHHHHhCCCCChhhhhheeccC-----CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4667899999999999999999999887     88999999996 69999887543  5799999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCC-EEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~-~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +.|++|+||+|+||+++.++. ++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++++|++
T Consensus       119 ~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~  197 (257)
T cd08225         119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCT  197 (257)
T ss_pred             HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHh
Confidence            999999999999999998865 6999999887654332 22234578889999988544 47899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||...+.......+...                             ......+..+.+++++|.+||..+|++|||+
T Consensus       198 g~~p~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~  248 (257)
T cd08225         198 LKHPFEGNNLHQLVLKICQG-----------------------------YFAPISPNFSRDLRSLISQLFKVSPRDRPSI  248 (257)
T ss_pred             CCCCCCCccHHHHHHHHhcc-----------------------------cCCCCCCCCCHHHHHHHHHHhccChhhCcCH
Confidence            99999766544433222110                             0111223567889999999999999999999


Q ss_pred             HHHhcCCCc
Q 022132          246 EDALAHPYL  254 (302)
Q Consensus       246 ~ell~h~~~  254 (302)
                      .|+++||||
T Consensus       249 ~~ll~~~~~  257 (257)
T cd08225         249 TSILKRPFL  257 (257)
T ss_pred             HHHhhCCCC
Confidence            999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-36  Score=257.26  Aligned_cols=205  Identities=19%  Similarity=0.336  Sum_probs=168.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+++||||++ |+|.+++.. .+.+++..+..++.|++.||+|||+
T Consensus        44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  118 (256)
T cd05114          44 EDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER  118 (256)
T ss_pred             HHHHHHHHHHHHCCCCCceeEEEEEccC-----CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3678899999999999999999999887     78999999996 799999875 3568999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc--cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      .|++|+||+|+||+++.++.++|+|||.+.........  ....++..|+|||.+.+ ..++.++|+||+|+++++|++ 
T Consensus       119 ~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~  197 (256)
T cd05114         119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTE  197 (256)
T ss_pred             CCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcC
Confidence            99999999999999999999999999988754332211  12234567999998854 458899999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||...+..+....+......                             ......+..+.+++.+||..||.+|||+
T Consensus       198 g~~p~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~  248 (256)
T cd05114         198 GKMPFEKKSNYEVVEMISRGFRL-----------------------------YRPKLASMTVYEVMYSCWHEKPEGRPTF  248 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHCCCCC-----------------------------CCCCCCCHHHHHHHHHHccCCcccCcCH
Confidence            99999877765554444321100                             0011356789999999999999999999


Q ss_pred             HHHhc
Q 022132          246 EDALA  250 (302)
Q Consensus       246 ~ell~  250 (302)
                      +++++
T Consensus       249 ~~l~~  253 (256)
T cd05114         249 AELLR  253 (256)
T ss_pred             HHHHH
Confidence            99985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.2e-37  Score=263.93  Aligned_cols=205  Identities=22%  Similarity=0.290  Sum_probs=165.2

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHH
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQ   73 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~   73 (302)
                      .+.+|+.+++++ +||||+++++++...     +.+|+|+||++ ++|.+++.+.+                .+++..+.
T Consensus        48 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  122 (297)
T cd05089          48 DFAGELEVLCKLGHHPNIINLLGACENR-----GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL  122 (297)
T ss_pred             HHHHHHHHHHhhcCCCchhheEEEEccC-----CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHH
Confidence            577899999999 799999999999887     78999999996 69999986532                48889999


Q ss_pred             HHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhH
Q 022132           74 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDV  153 (302)
Q Consensus        74 ~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  153 (302)
                      .++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..............+..|+|||.+.+ ..++.++||
T Consensus       123 ~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv  201 (297)
T cd05089         123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDV  201 (297)
T ss_pred             HHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhH
Confidence            9999999999999999999999999999999999999999999864322111112223456999998854 447899999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHH
Q 022132          154 WSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE  232 (302)
Q Consensus       154 wslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  232 (302)
                      |||||++++|++ |.+||.+.........+.....                             ......++..+.+|+.
T Consensus       202 wSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~  252 (297)
T cd05089         202 WSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-----------------------------MEKPRNCDDEVYELMR  252 (297)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-----------------------------CCCCCCCCHHHHHHHH
Confidence            999999999997 9999987765544333221100                             0111257789999999


Q ss_pred             HccCCCCCCCCCHHHHhcC
Q 022132          233 KMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       233 ~~L~~dP~~R~t~~ell~h  251 (302)
                      +||..||.+|||++++++.
T Consensus       253 ~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         253 QCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             HHcCCChhhCcCHHHHHHH
Confidence            9999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.2e-36  Score=257.90  Aligned_cols=204  Identities=23%  Similarity=0.398  Sum_probs=166.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      .+.+|+.+++.++||||+++++++...     +.++++|||++ ++|.+++...  ..+++..+..++.|++.||+|||+
T Consensus        48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~  122 (263)
T cd05052          48 EFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK  122 (263)
T ss_pred             HHHHHHHHHHhCCCCChhheEEEEcCC-----CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            577899999999999999999999887     78999999996 6999998653  468999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCccc--ccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT--EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      .|++||||||+||+++.++.++|+|||.+..........  ....+..|+|||.+.+ ..++.++|+|||||++++|++ 
T Consensus       123 ~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~  201 (263)
T cd05052         123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY  201 (263)
T ss_pred             CCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcC
Confidence            999999999999999999999999999987654332111  1223557999998854 447899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||.+.+..+....+.....                             .......++.+.+++.+||..||++|||+
T Consensus       202 g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~  252 (263)
T cd05052         202 GMSPYPGIDLSQVYELLEKGYR-----------------------------MERPEGCPPKVYELMRACWQWNPSDRPSF  252 (263)
T ss_pred             CCCCCCCCCHHHHHHHHHCCCC-----------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCH
Confidence            9999987765444333221000                             01123578899999999999999999999


Q ss_pred             HHHhc
Q 022132          246 EDALA  250 (302)
Q Consensus       246 ~ell~  250 (302)
                      .++++
T Consensus       253 ~~l~~  257 (263)
T cd05052         253 AEIHQ  257 (263)
T ss_pred             HHHHH
Confidence            99975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.5e-37  Score=272.34  Aligned_cols=206  Identities=24%  Similarity=0.344  Sum_probs=163.7

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------------------------
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------------------------   64 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------------------------   64 (302)
                      .+.+|+.+++.+ +||||+++++++...     +..|+||||++ |+|.+++...                         
T Consensus        84 ~~~~Ei~il~~l~~HpnIv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (375)
T cd05104          84 ALMSELKVLSYLGNHINIVNLLGACTVG-----GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQR  158 (375)
T ss_pred             HHHHHHHHHHHhcCCcceeeeeeeeccC-----CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhh
Confidence            577899999999 899999999999887     78999999997 6999888642                         


Q ss_pred             --------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 022132           65 --------------------------------------------------QALSEEHCQYFLYQILRGLKYIHSANVLHR   94 (302)
Q Consensus        65 --------------------------------------------------~~l~~~~~~~i~~qll~~l~~LH~~~i~H~   94 (302)
                                                                        ..+++..+..++.||+.||+|||+.||+||
T Consensus       159 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~  238 (375)
T cd05104         159 EMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHR  238 (375)
T ss_pred             cccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence                                                              147888999999999999999999999999


Q ss_pred             CCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 022132           95 DLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLF  170 (302)
Q Consensus        95 dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf  170 (302)
                      ||||+||+++.++.++|+|||++........   .....++..|+|||.+.+. .++.++|||||||++++|++ |.+||
T Consensus       239 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~  317 (375)
T cd05104         239 DLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPY  317 (375)
T ss_pred             CCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence            9999999999999999999999875543221   1122345679999998654 48999999999999999997 89999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      .+................                            .......+.++.+|+.+||+.||.+|||+.|+++
T Consensus       318 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  369 (375)
T cd05104         318 PGMPVDSKFYKMIKEGYR----------------------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ  369 (375)
T ss_pred             CCCCchHHHHHHHHhCcc----------------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            765443322222110000                            0011235678999999999999999999999986


Q ss_pred             C
Q 022132          251 H  251 (302)
Q Consensus       251 h  251 (302)
                      .
T Consensus       370 ~  370 (375)
T cd05104         370 L  370 (375)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.7e-37  Score=260.76  Aligned_cols=206  Identities=23%  Similarity=0.361  Sum_probs=165.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------QALSEEHCQYFLYQI   79 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~ql   79 (302)
                      ..+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++.+.          ..++...+..++.|+
T Consensus        54 ~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  128 (277)
T cd05062          54 IEFLNEASVMKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI  128 (277)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHH
Confidence            3577899999999999999999999877     78999999997 6999998652          235778899999999


Q ss_pred             HHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHHH
Q 022132           80 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  156 (302)
Q Consensus        80 l~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  156 (302)
                      +.||+|||+.|++|+||||+||+++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++|+|||
T Consensus       129 ~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~sl  207 (277)
T cd05062         129 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSF  207 (277)
T ss_pred             HHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHH
Confidence            9999999999999999999999999999999999999865433221   112234667999999865 447999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHcc
Q 022132          157 GCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  235 (302)
Q Consensus       157 G~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  235 (302)
                      ||++++|++ |..||.+.+.......+.... .                            .......++.+.+++.+||
T Consensus       208 G~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~----------------------------~~~~~~~~~~~~~li~~~l  258 (277)
T cd05062         208 GVVLWEIATLAEQPYQGMSNEQVLRFVMEGG-L----------------------------LDKPDNCPDMLFELMRMCW  258 (277)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c----------------------------CCCCCCCCHHHHHHHHHHc
Confidence            999999998 789998776554443322210 0                            0111246778999999999


Q ss_pred             CCCCCCCCCHHHHhcC
Q 022132          236 TFDPRQRITVEDALAH  251 (302)
Q Consensus       236 ~~dP~~R~t~~ell~h  251 (302)
                      +.||++|||+.|++++
T Consensus       259 ~~~p~~Rps~~e~l~~  274 (277)
T cd05062         259 QYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCChhhCcCHHHHHHH
Confidence            9999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.4e-36  Score=264.62  Aligned_cols=210  Identities=24%  Similarity=0.397  Sum_probs=174.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++|||++++++++...     +..|+||||+.|+|.+.+.. ..++++..+..++.|++.|+.|||+.|
T Consensus        71 ~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~  145 (317)
T cd06635          71 DIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN  145 (317)
T ss_pred             HHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            577899999999999999999999887     78999999999998888754 467999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhC--CCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ++|+||+|+||+++.++.++|+|||.+......   ....++..|+|||.+..  ...++.++|+||+||++++|++|.+
T Consensus       146 i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~  222 (317)
T cd06635         146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  222 (317)
T ss_pred             cccCCCCcccEEECCCCCEEEecCCCccccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999988654432   33467888999998742  2447889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||.+.+.......+......+                            ......++.+.+++.+||+.+|.+|||+.++
T Consensus       223 p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i  274 (317)
T cd06635         223 PLFNMNAMSALYHIAQNESPT----------------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEEL  274 (317)
T ss_pred             CCCCccHHHHHHHHHhccCCC----------------------------CCCccccHHHHHHHHHHccCCcccCcCHHHH
Confidence            997765444443333211100                            0112456789999999999999999999999


Q ss_pred             hcCCCcCCc
Q 022132          249 LAHPYLGSL  257 (302)
Q Consensus       249 l~h~~~~~~  257 (302)
                      ++|+|+...
T Consensus       275 l~~~~~~~~  283 (317)
T cd06635         275 LKHMFVLRE  283 (317)
T ss_pred             HhChhhhcc
Confidence            999999653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.6e-37  Score=269.51  Aligned_cols=244  Identities=16%  Similarity=0.239  Sum_probs=174.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      +.+.+|+.+++.++||||+++++++...     +..|+|+||+. ++|.+++...  ..+++..+..++.|++.||+|||
T Consensus        44 ~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH  118 (328)
T cd08226          44 KALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH  118 (328)
T ss_pred             HHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999887     88999999997 5999888753  35899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCC----Cc----ccccccccccCchhhhhCC-CCCCCchhHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET----DF----MTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGC  158 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~----~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~  158 (302)
                      +.|++||||||+||+++.++.++++||+.+......    ..    .....++..|+|||.+.+. ..++.++|+||+||
T Consensus       119 ~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~  198 (328)
T cd08226         119 QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI  198 (328)
T ss_pred             hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHH
Confidence            999999999999999999999999999754322111    00    0112235569999998653 34688999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcc-----------------cccccc-ccccC
Q 022132          159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP-----------------RYQRQS-FTEKF  220 (302)
Q Consensus       159 i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~-~~~~~  220 (302)
                      ++++|++|.+||.+.................+.... ..............                 ...... .....
T Consensus       199 ~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (328)
T cd08226         199 TACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT-TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSS  277 (328)
T ss_pred             HHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc-ccchhhhhhccchhhhhcccccchhccccccccccccccchhh
Confidence            999999999999877655444333221110000000 00000000000000                 000000 00111


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccCC
Q 022132          221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  260 (302)
Q Consensus       221 ~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  260 (302)
                      ...++.+.+|+++||+.||.+|||++|+|+||||......
T Consensus       278 ~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         278 KTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence            2456789999999999999999999999999999887653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.4e-37  Score=261.17  Aligned_cols=209  Identities=31%  Similarity=0.558  Sum_probs=175.3

Q ss_pred             cCchhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecC-CccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|..+++++. ||||+++++++...     +..++||||+ +++|.+++.+.+.+++..+..++.|++.||.+||
T Consensus        45 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh  119 (280)
T cd05581          45 VKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH  119 (280)
T ss_pred             HHHHHHHHHHHHhcccCCCchhHHHHhcCC-----ceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            346778999999998 99999999999887     8899999999 5799999998889999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---------------------cccccccccccCchhhhhCCCC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---------------------FMTEYVVTRWYRAPELLLNSSD  146 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---------------------~~~~~~~~~~y~aPE~~~~~~~  146 (302)
                      +.|++|+||+|+||+++.++.++++|||.+.......                     ......++..|+|||..... .
T Consensus       120 ~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~  198 (280)
T cd05581         120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-P  198 (280)
T ss_pred             HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-C
Confidence            9999999999999999999999999999987544322                     11223467889999988544 4


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHH
Q 022132          147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPS  226 (302)
Q Consensus       147 ~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (302)
                      .+.++|+||+|++++++++|..||...+.......+....                              ......+++.
T Consensus       199 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~  248 (280)
T cd05581         199 AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE------------------------------YSFPPNFPPD  248 (280)
T ss_pred             CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC------------------------------CCCCCccCHH
Confidence            7889999999999999999999998776444333322100                              0111256788


Q ss_pred             HHHHHHHccCCCCCCCCCH----HHHhcCCCc
Q 022132          227 AIDLVEKMLTFDPRQRITV----EDALAHPYL  254 (302)
Q Consensus       227 ~~~li~~~L~~dP~~R~t~----~ell~h~~~  254 (302)
                      +.++|.+||+.||++|||+    +++++||||
T Consensus       249 ~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         249 AKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            9999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-36  Score=261.44  Aligned_cols=219  Identities=25%  Similarity=0.449  Sum_probs=169.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.+++.++||||+++++++.....   +.+|+||||++ ++|.+++..    ...+++..+..++.||+.||.|
T Consensus        44 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~  120 (287)
T cd06621          44 KQILRELEINKSCKSPYIVKYYGAFLDESS---SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY  120 (287)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeEEEccCC---CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            457899999999999999999999865422   57999999997 588877642    4568999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ||+.|++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+ ..++.++|+||+||++|+|++
T Consensus       121 lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~  198 (287)
T cd06621         121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQ  198 (287)
T ss_pred             HHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999999999986544322 123456788999998854 457899999999999999999


Q ss_pred             CCCCCCCCCh-----HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          166 RKPLFPGRDH-----VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       166 g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      |..||.....     .+....+.   ....                  +.....  ...-...++.+.+++.+||.+||.
T Consensus       199 g~~p~~~~~~~~~~~~~~~~~~~---~~~~------------------~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~  255 (287)
T cd06621         199 NRFPFPPEGEPPLGPIELLSYIV---NMPN------------------PELKDE--PGNGIKWSEEFKDFIKQCLEKDPT  255 (287)
T ss_pred             CCCCCCcccCCCCChHHHHHHHh---cCCc------------------hhhccC--CCCCCchHHHHHHHHHHHcCCCcc
Confidence            9999976532     11111110   0000                  000000  000012457899999999999999


Q ss_pred             CCCCHHHHhcCCCcCCc
Q 022132          241 QRITVEDALAHPYLGSL  257 (302)
Q Consensus       241 ~R~t~~ell~h~~~~~~  257 (302)
                      +|||+.|++.||||...
T Consensus       256 ~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         256 RRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             cCCCHHHHHhCcccccc
Confidence            99999999999999653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-36  Score=259.93  Aligned_cols=206  Identities=21%  Similarity=0.381  Sum_probs=166.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-------CCCHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-------ALSEEHCQYFLYQILRG   82 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-------~l~~~~~~~i~~qll~~   82 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+||||+. ++|.+++...+       .+++..+..++.||+.|
T Consensus        54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~  128 (277)
T cd05036          54 SDFLMEALIMSKFNHQNIVRLIGVSFER-----LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG  128 (277)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHH
Confidence            3578899999999999999999999887     77899999995 69999987643       58999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEecCC---CEEEeecccccccCCCCcc---cccccccccCchhhhhCCCCCCCchhHHHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNANC---DLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSV  156 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~~~---~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  156 (302)
                      |+|||+.|++|+||+|+||+++.++   .++|+|||.+.........   .....+..|+|||.+.+. .++.++|||||
T Consensus       129 l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  207 (277)
T cd05036         129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSF  207 (277)
T ss_pred             HHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHH
Confidence            9999999999999999999998765   5899999998765322211   122234579999998654 48999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHcc
Q 022132          157 GCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  235 (302)
Q Consensus       157 G~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  235 (302)
                      ||++++|++ |..||.+.+.......+... ..                            ......++..+.+++.+||
T Consensus       208 G~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~~~i~~cl  258 (277)
T cd05036         208 GVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GR----------------------------LDPPKGCPGPVYRIMTDCW  258 (277)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc----------------------------CCCCCCCCHHHHHHHHHHc
Confidence            999999996 99999877655443322210 00                            0112356789999999999


Q ss_pred             CCCCCCCCCHHHHhcC
Q 022132          236 TFDPRQRITVEDALAH  251 (302)
Q Consensus       236 ~~dP~~R~t~~ell~h  251 (302)
                      +.||++|||+.++++|
T Consensus       259 ~~~p~~Rps~~~vl~~  274 (277)
T cd05036         259 QHTPEDRPNFATILER  274 (277)
T ss_pred             CCCcccCcCHHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=9.2e-37  Score=261.80  Aligned_cols=214  Identities=28%  Similarity=0.510  Sum_probs=176.8

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.+++.++|+|++++++++...     +..|+|+||++ ++|.+++.... .++...+..++.|++.||.+||
T Consensus        59 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH  133 (286)
T cd06614          59 KELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH  133 (286)
T ss_pred             HHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH
Confidence            34677899999999999999999999887     89999999998 79999998876 8999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      +.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|
T Consensus       134 ~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g  212 (286)
T cd06614         134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEG  212 (286)
T ss_pred             hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhC
Confidence            9999999999999999999999999999876543221 1223346778999998854 4478999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||...+.......+... +.+.                          ......++..+.++|.+||+.+|.+|||++
T Consensus       213 ~~p~~~~~~~~~~~~~~~~-~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  265 (286)
T cd06614         213 EPPYLREPPLRALFLITTK-GIPP--------------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAE  265 (286)
T ss_pred             CCCCCCCCHHHHHHHHHhc-CCCC--------------------------CcchhhCCHHHHHHHHHHhccChhhCcCHH
Confidence            9999776654433322211 0000                          011123678899999999999999999999


Q ss_pred             HHhcCCCcCC
Q 022132          247 DALAHPYLGS  256 (302)
Q Consensus       247 ell~h~~~~~  256 (302)
                      +++.|+||..
T Consensus       266 ~il~~~~~~~  275 (286)
T cd06614         266 ELLQHPFLKK  275 (286)
T ss_pred             HHhhChHhhc
Confidence            9999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.6e-37  Score=263.70  Aligned_cols=218  Identities=22%  Similarity=0.422  Sum_probs=176.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+|+||++ ++|.+++.+ ..+++..+..++.|++.||.|||++
T Consensus        61 ~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~  134 (293)
T cd06647          61 ELIINEILVMRENKHPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN  134 (293)
T ss_pred             HHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4577899999999999999999999887     88999999996 699998875 4588999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+||+++++++|.+
T Consensus       135 gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~  213 (293)
T cd06647         135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEP  213 (293)
T ss_pred             CEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999876543322 2233457788999998855 447899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||...+.......+.. .+.+.                          ......++..+.++|++||..||.+|||++++
T Consensus       214 pf~~~~~~~~~~~~~~-~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i  266 (293)
T cd06647         214 PYLNENPLRALYLIAT-NGTPE--------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL  266 (293)
T ss_pred             CCCCCChhhheeehhc-CCCCC--------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9976654332211110 00000                          01112457789999999999999999999999


Q ss_pred             hcCCCcCCccCCCC
Q 022132          249 LAHPYLGSLHDISD  262 (302)
Q Consensus       249 l~h~~~~~~~~~~~  262 (302)
                      +.|+||...+....
T Consensus       267 l~h~~~~~~~~~~~  280 (293)
T cd06647         267 LQHPFLKIAKPLSS  280 (293)
T ss_pred             hcCHHHhcCccccc
Confidence            99999998765444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2e-36  Score=254.16  Aligned_cols=210  Identities=27%  Similarity=0.481  Sum_probs=174.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++|||++++++++...     +..++++||++ ++|.+++... +.+++..+..++.|++.||.+||+
T Consensus        42 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~  116 (253)
T cd05122          42 EKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS  116 (253)
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc
Confidence            4678999999999999999999999887     88999999998 6999998775 689999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      .|++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+.. .+.++|+||+|+++++|++|..
T Consensus       117 ~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~  195 (253)
T cd05122         117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKP  195 (253)
T ss_pred             CCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999999987765543234556788899999986544 7889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||...+.......... ...+.                         . .....++..+.++|.+||+.||++|||+.++
T Consensus       196 p~~~~~~~~~~~~~~~-~~~~~-------------------------~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~  248 (253)
T cd05122         196 PYSELPPMKALFKIAT-NGPPG-------------------------L-RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQL  248 (253)
T ss_pred             CCCCCchHHHHHHHHh-cCCCC-------------------------c-CcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence            9976653333222211 00000                         0 0001237789999999999999999999999


Q ss_pred             hcCCC
Q 022132          249 LAHPY  253 (302)
Q Consensus       249 l~h~~  253 (302)
                      +.|||
T Consensus       249 l~~~~  253 (253)
T cd05122         249 LKHPF  253 (253)
T ss_pred             hcCCC
Confidence            99998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-36  Score=256.78  Aligned_cols=206  Identities=18%  Similarity=0.288  Sum_probs=167.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++.. .+.+++..+..++.|++.||+|||+
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~  118 (256)
T cd05059          44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES  118 (256)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEcCC-----CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3678899999999999999999999877     78999999996 699999875 3578999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCccc--ccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT--EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      .|++||||+|+||+++.++.++|+|||.++.........  ...++..|+|||.+.+ ..++.++|+||+|+++|+|++ 
T Consensus       119 ~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~  197 (256)
T cd05059         119 NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSE  197 (256)
T ss_pred             CCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhcc
Confidence            999999999999999999999999999987654322111  1123456999998864 447899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+..+....+.....                             .......+..+.+++.+||..+|++|||+
T Consensus       198 g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~  248 (256)
T cd05059         198 GKMPYERFSNSEVVESVSAGYR-----------------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAF  248 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCc-----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence            8999977665544333221100                             01112468899999999999999999999


Q ss_pred             HHHhcC
Q 022132          246 EDALAH  251 (302)
Q Consensus       246 ~ell~h  251 (302)
                      .|+++.
T Consensus       249 ~~~l~~  254 (256)
T cd05059         249 KKLLSQ  254 (256)
T ss_pred             HHHHHH
Confidence            999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=254.76  Aligned_cols=209  Identities=26%  Similarity=0.470  Sum_probs=175.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++|||++++++++...     +.+|++|||++ ++|.+++...+.+++..+..++.|++.||.+||+.
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~  118 (254)
T cd06627          44 KSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ  118 (254)
T ss_pred             HHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            4678999999999999999999999887     88999999997 59999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCc-ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||...+.. .+.++|+||+|+++++|++|.+
T Consensus       119 ~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~  197 (254)
T cd06627         119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNP  197 (254)
T ss_pred             CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999999876554322 23346788899999885544 7899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||...+..........   .                          ......+.++..+.+++.+||..+|++|||+.++
T Consensus       198 p~~~~~~~~~~~~~~~---~--------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~  248 (254)
T cd06627         198 PYYDLNPMAALFRIVQ---D--------------------------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQL  248 (254)
T ss_pred             CCCCccHHHHHHHHhc---c--------------------------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHH
Confidence            9976554332222110   0                          0011123567899999999999999999999999


Q ss_pred             hcCCCc
Q 022132          249 LAHPYL  254 (302)
Q Consensus       249 l~h~~~  254 (302)
                      +.||||
T Consensus       249 l~~~~~  254 (254)
T cd06627         249 LKHPWI  254 (254)
T ss_pred             hcCCCC
Confidence            999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=8.8e-37  Score=263.26  Aligned_cols=216  Identities=25%  Similarity=0.405  Sum_probs=170.5

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS-   88 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~-   88 (302)
                      .+.+|+.++... .||||+++++++.+.     ...|++|||++++|.+++.. .+.+++..+..++.|++.|++|||+ 
T Consensus        59 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~  133 (296)
T cd06618          59 RILMDLDVVLKSHDCPYIVKCYGYFITD-----SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK  133 (296)
T ss_pred             HHHHHHHHHHhccCCCchHhhheeeecC-----CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh
Confidence            456677777677 599999999999887     88999999999888887765 4579999999999999999999997 


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCC---CCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~i~~~ll~  165 (302)
                      .||+||||+|+||+++.++.++|+|||.+.............++..|+|||.+.+.   ..++.++|+||+|+++++|++
T Consensus       134 ~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~  213 (296)
T cd06618         134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT  213 (296)
T ss_pred             CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHh
Confidence            59999999999999999999999999998765443333344567789999998543   236789999999999999999


Q ss_pred             CCCCCCCCChH-HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 RKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      |..||...... +.+.....   ...                  +     .+ .....++.++.+|+.+||..||.+|||
T Consensus       214 g~~p~~~~~~~~~~~~~~~~---~~~------------------~-----~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~  266 (296)
T cd06618         214 GQFPYKNCKTEFEVLTKILQ---EEP------------------P-----SL-PPNEGFSPDFCSFVDLCLTKDHRKRPK  266 (296)
T ss_pred             CCCCCCcchhHHHHHHHHhc---CCC------------------C-----CC-CCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            99999654322 12111111   000                  0     00 011146778999999999999999999


Q ss_pred             HHHHhcCCCcCCccC
Q 022132          245 VEDALAHPYLGSLHD  259 (302)
Q Consensus       245 ~~ell~h~~~~~~~~  259 (302)
                      +++++.||||..+..
T Consensus       267 ~~~il~~~~~~~~~~  281 (296)
T cd06618         267 YRELLQHPFIRRYET  281 (296)
T ss_pred             HHHHhcChhhhccch
Confidence            999999999987654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-36  Score=256.89  Aligned_cols=201  Identities=17%  Similarity=0.265  Sum_probs=160.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.+++.++||||+++++++...     ...++||||++ ++|..++.. ...+++..+..++.||+.||+|||+.
T Consensus        50 ~~~~~~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  124 (262)
T cd05077          50 AFFETASMMRQVSHKHIVLLYGVCVRD-----VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK  124 (262)
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEecC-----CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC
Confidence            567889999999999999999999877     77899999997 578777764 45799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCC-------EEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCD-------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~-------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      ||+||||||+||+++.++.       ++++|||.+......   ....++..|+|||.+.....++.++||||+||++|+
T Consensus       125 ~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~e  201 (262)
T cd05077         125 DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE  201 (262)
T ss_pred             CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHH
Confidence            9999999999999987664       899999988654322   234567789999988655668899999999999999


Q ss_pred             HH-hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          163 LM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       163 ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      |+ .|.+||......+... ...   ..                           .......+.++.+|+.+||+.||.+
T Consensus       202 l~~~~~~p~~~~~~~~~~~-~~~---~~---------------------------~~~~~~~~~~~~~li~~cl~~dp~~  250 (262)
T cd05077         202 ICYNGEIPLKDKTLAEKER-FYE---GQ---------------------------CMLVTPSCKELADLMTHCMNYDPNQ  250 (262)
T ss_pred             HHhCCCCCCCCcchhHHHH-HHh---cC---------------------------ccCCCCChHHHHHHHHHHcCCChhh
Confidence            97 5888886654322211 000   00                           0001123567899999999999999


Q ss_pred             CCCHHHHhcC
Q 022132          242 RITVEDALAH  251 (302)
Q Consensus       242 R~t~~ell~h  251 (302)
                      |||+.+++.+
T Consensus       251 Rp~~~~il~~  260 (262)
T cd05077         251 RPFFRAIMRD  260 (262)
T ss_pred             CcCHHHHHHh
Confidence            9999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.3e-36  Score=254.74  Aligned_cols=208  Identities=25%  Similarity=0.416  Sum_probs=173.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.+++.++||||+++++++...     ...|+|+||++ ++|.+++..    ...+++..+..++.|++.||++
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~  118 (256)
T cd08530          44 EDAVNEIRILASVNHPNIISYKEAFLDG-----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA  118 (256)
T ss_pred             HHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999887     88999999996 599988865    4578999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ||+.|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+ ..++.++|+||+|+++++|++
T Consensus       119 lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~  196 (256)
T cd08530         119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMAT  196 (256)
T ss_pred             HhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999999999998766544 2334567888999999854 447889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||...+.......+...                             .+.......+.++++++.+||..+|.+|||+
T Consensus       197 g~~p~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  247 (256)
T cd08530         197 FAPPFEARSMQDLRYKVQRG-----------------------------KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNC  247 (256)
T ss_pred             CCCCCCCCCHHHHHHHHhcC-----------------------------CCCCCchhhCHHHHHHHHHHcCCCcccCCCH
Confidence            99999876644332222110                             0011112467789999999999999999999


Q ss_pred             HHHhcCCCc
Q 022132          246 EDALAHPYL  254 (302)
Q Consensus       246 ~ell~h~~~  254 (302)
                      .++++||++
T Consensus       248 ~~~l~~p~~  256 (256)
T cd08530         248 DKILASPAV  256 (256)
T ss_pred             HHHhcCCCC
Confidence            999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-36  Score=258.65  Aligned_cols=204  Identities=24%  Similarity=0.303  Sum_probs=163.4

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHH
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQ   73 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~   73 (302)
                      .+.+|+.+++.+ +||||+++++++...     +.+|+||||+. ++|.+++...+                .+++..+.
T Consensus        41 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~  115 (270)
T cd05047          41 DFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL  115 (270)
T ss_pred             HHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHH
Confidence            567899999999 899999999999887     78999999996 79999987542                47899999


Q ss_pred             HHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhH
Q 022132           74 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDV  153 (302)
Q Consensus        74 ~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  153 (302)
                      .++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++..............+..|+|||.+.. ..++.++|+
T Consensus       116 ~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di  194 (270)
T cd05047         116 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDV  194 (270)
T ss_pred             HHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhH
Confidence            9999999999999999999999999999999999999999999853322111112233556999998854 457899999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHH
Q 022132          154 WSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE  232 (302)
Q Consensus       154 wslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  232 (302)
                      |||||++++|++ |..||.+.+.......+....                             ........+.++.+++.
T Consensus       195 ~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~  245 (270)
T cd05047         195 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-----------------------------RLEKPLNCDDEVYDLMR  245 (270)
T ss_pred             HHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-----------------------------CCCCCCcCCHHHHHHHH
Confidence            999999999996 999997765444333221100                             00111246778999999


Q ss_pred             HccCCCCCCCCCHHHHhc
Q 022132          233 KMLTFDPRQRITVEDALA  250 (302)
Q Consensus       233 ~~L~~dP~~R~t~~ell~  250 (302)
                      +||..||.+|||+.+++.
T Consensus       246 ~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         246 QCWREKPYERPSFAQILV  263 (270)
T ss_pred             HHcccChhhCCCHHHHHH
Confidence            999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=255.70  Aligned_cols=205  Identities=18%  Similarity=0.275  Sum_probs=166.8

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.+.||||+++++++..      +.+++||||+. ++|.+++...+.+++..+..++.|++.||++||.
T Consensus        40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~  113 (257)
T cd05060          40 KKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES  113 (257)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            3467889999999999999999998753      56899999986 6999999888889999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc----cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .|++|+||||+||+++.++.++|+|||.+.........    ....++..|+|||.+.+ ..++.++|+|||||++++|+
T Consensus       114 ~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~  192 (257)
T cd05060         114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAF  192 (257)
T ss_pred             cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHH
Confidence            99999999999999999999999999998755433211    11122456999998854 44899999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |.+||...+..+....+....                             ........+..+++++.+||..||.+||
T Consensus       193 ~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp  243 (257)
T cd05060         193 SYGAKPYGEMKGAEVIAMLESGE-----------------------------RLPRPEECPQEIYSIMLSCWKYRPEDRP  243 (257)
T ss_pred             cCCCCCcccCCHHHHHHHHHcCC-----------------------------cCCCCCCCCHHHHHHHHHHhcCChhhCc
Confidence            7 999997766544433322110                             0012235678899999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |+.++++
T Consensus       244 ~~~~l~~  250 (257)
T cd05060         244 TFSELES  250 (257)
T ss_pred             CHHHHHH
Confidence            9999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.1e-36  Score=260.13  Aligned_cols=218  Identities=19%  Similarity=0.343  Sum_probs=175.2

Q ss_pred             cCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..++.+|+.+++++ +||||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH  122 (290)
T cd05613          48 TEHTRTERQVLEHIRQSPFLVTLHYAFQTD-----TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH  122 (290)
T ss_pred             HHHHHHHHHHHHhcccCCChhceeeEeecC-----CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            35677899999999 699999999999887     78999999997 699999988888999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCC-CCCCCchhHHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~i~~~ll  164 (302)
                      +.|++||||+|+||+++.++.++|+|||++.......  ......++..|+|||.+.+. ..++.++|+||+|+++++|+
T Consensus       123 ~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll  202 (290)
T cd05613         123 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL  202 (290)
T ss_pred             hCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHh
Confidence            9999999999999999999999999999987654321  12234578889999988543 23678999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-  243 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-  243 (302)
                      +|..||...........+.......                  .        ....+.+++.+.+++++||..||.+|| 
T Consensus       203 ~g~~p~~~~~~~~~~~~~~~~~~~~------------------~--------~~~~~~~~~~~~~ll~~~l~~~p~~R~~  256 (290)
T cd05613         203 TGASPFTVDGEKNSQAEISRRILKS------------------E--------PPYPQEMSALAKDIIQRLLMKDPKKRLG  256 (290)
T ss_pred             cCCCCCCcCCccccHHHHHHHhhcc------------------C--------CCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence            9999996443222222121111000                  0        001124678899999999999999997 


Q ss_pred             ----CHHHHhcCCCcCCcc
Q 022132          244 ----TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 ----t~~ell~h~~~~~~~  258 (302)
                          ++++++.||||+...
T Consensus       257 ~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         257 CGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             CCCCCHHHHHcCcccccCC
Confidence                899999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4e-37  Score=260.39  Aligned_cols=206  Identities=26%  Similarity=0.398  Sum_probs=165.1

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ...+.+|++++++++||||+++++++...     +..++|+||+. |+|.+++...  ..++...+..|+.|++.||.||
T Consensus        45 ~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~L  119 (259)
T PF07714_consen   45 EEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYL  119 (259)
T ss_dssp             HHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHH
T ss_pred             ceeeeeccccccccccccccccccccccc-----cccccccccccccccccccccccccccccccccccccccccccccc
Confidence            46788999999999999999999999966     67999999997 7999999876  7899999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      |+.+++|++|+++||+++.++.+||+|||++.......   ..........|+|||.+.... ++.++||||||++++++
T Consensus       120 h~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei  198 (259)
T PF07714_consen  120 HSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEI  198 (259)
T ss_dssp             HHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc
Confidence            99999999999999999999999999999987763221   123345667899999986554 79999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          164 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       164 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      ++ |..||...+..+....+.+...                             ......++..+.++|.+||..||.+|
T Consensus       199 ~~~~~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~C~~~~p~~R  249 (259)
T PF07714_consen  199 LTLGKFPFSDYDNEEIIEKLKQGQR-----------------------------LPIPDNCPKDIYSLIQQCWSHDPEKR  249 (259)
T ss_dssp             HTTSSGTTTTSCHHHHHHHHHTTEE-----------------------------TTSBTTSBHHHHHHHHHHT-SSGGGS
T ss_pred             ccccccccccccccccccccccccc-----------------------------ceeccchhHHHHHHHHHHcCCChhhC
Confidence            99 7899987766554444422111                             11123578899999999999999999


Q ss_pred             CCHHHHhc
Q 022132          243 ITVEDALA  250 (302)
Q Consensus       243 ~t~~ell~  250 (302)
                      ||+.++++
T Consensus       250 Ps~~~i~~  257 (259)
T PF07714_consen  250 PSFQEILQ  257 (259)
T ss_dssp             --HHHHHH
T ss_pred             cCHHHHHh
Confidence            99999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.6e-36  Score=259.31  Aligned_cols=211  Identities=23%  Similarity=0.389  Sum_probs=169.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------QALSEEHCQYFLYQIL   80 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qll   80 (302)
                      .+.+|+.+++.++||||+++++++...     +..|+||||++ |+|.+++...          ..++...+..++.|++
T Consensus        55 ~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  129 (288)
T cd05061          55 EFLNEASVMKGFTCHHVVRLLGVVSKG-----QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA  129 (288)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHH
Confidence            567899999999999999999999877     78999999996 7999999642          2356778899999999


Q ss_pred             HHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHHHH
Q 022132           81 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG  157 (302)
Q Consensus        81 ~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  157 (302)
                      .||.|||++|++||||||+||+++.++.++|+|||+++.......   .....++..|+|||.+.+. .++.++|+||+|
T Consensus       130 ~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG  208 (288)
T cd05061         130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFG  208 (288)
T ss_pred             HHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHH
Confidence            999999999999999999999999999999999999875433211   1122345679999988544 478999999999


Q ss_pred             HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccC
Q 022132          158 CIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  236 (302)
Q Consensus       158 ~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  236 (302)
                      |++++|++ |.+||.+.+..+....+.... .                            .......++.+.+++.+||+
T Consensus       209 ~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~----------------------------~~~~~~~~~~~~~li~~~l~  259 (288)
T cd05061         209 VVLWEITSLAEQPYQGLSNEQVLKFVMDGG-Y----------------------------LDQPDNCPERVTDLMRMCWQ  259 (288)
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C----------------------------CCCCCCCCHHHHHHHHHHcC
Confidence            99999998 789998766554433322100 0                            00112456789999999999


Q ss_pred             CCCCCCCCHHHHhc------CCCcCCc
Q 022132          237 FDPRQRITVEDALA------HPYLGSL  257 (302)
Q Consensus       237 ~dP~~R~t~~ell~------h~~~~~~  257 (302)
                      .||++|||+.++++      ||||.+.
T Consensus       260 ~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         260 FNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            99999999999987      8988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=283.98  Aligned_cols=208  Identities=24%  Similarity=0.383  Sum_probs=163.7

Q ss_pred             chhhHHHHHHhc-CCCCcccccee-eCCCCCCC-CCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDI-IPPPQRES-FNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~-~~~~~~~~-~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ...+|+.++++| .|+|||.++|. .......+ .-.++|+||||. |+|.++++.+  .+|++.++.+|+.|+++||++
T Consensus        80 ~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~  159 (738)
T KOG1989|consen   80 AVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAA  159 (738)
T ss_pred             HHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHH
Confidence            456899999999 59999999994 33322222 356899999998 6999999853  569999999999999999999


Q ss_pred             HHhCC--ceecCCCCCCEEEecCCCEEEeecccccccCCCCcc----------cccccccccCchhhhh--CCCCCCCch
Q 022132           86 IHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----------TEYVVTRWYRAPELLL--NSSDYTAAI  151 (302)
Q Consensus        86 LH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~y~aPE~~~--~~~~~~~~~  151 (302)
                      ||..+  |+|||||-+|||++.+|..||||||.+.........          -....|+.|+|||.+.  .+...+.|+
T Consensus       160 mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKs  239 (738)
T KOG1989|consen  160 MHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKS  239 (738)
T ss_pred             HhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchh
Confidence            99998  999999999999999999999999998543221101          1124588999999873  344579999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHH
Q 022132          152 DVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV  231 (302)
Q Consensus       152 DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  231 (302)
                      |||+|||++|-|+.+..||++......+.-                            .+..    ..++.++..+.+||
T Consensus       240 DIWALGclLYkLCy~t~PFe~sg~laIlng----------------------------~Y~~----P~~p~ys~~l~~LI  287 (738)
T KOG1989|consen  240 DIWALGCLLYKLCYFTTPFEESGKLAILNG----------------------------NYSF----PPFPNYSDRLKDLI  287 (738)
T ss_pred             HHHHHHHHHHHHHHhCCCcCcCcceeEEec----------------------------cccC----CCCccHHHHHHHHH
Confidence            999999999999999999975532211110                            0111    11246788999999


Q ss_pred             HHccCCCCCCCCCHHHHhcC
Q 022132          232 EKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       232 ~~~L~~dP~~R~t~~ell~h  251 (302)
                      +.||+.||.+||++-+++.+
T Consensus       288 ~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  288 RTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             HHHhccCcccCCCHHHHHHH
Confidence            99999999999999888764

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-36  Score=255.73  Aligned_cols=205  Identities=24%  Similarity=0.348  Sum_probs=167.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecC-CccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.++++++||||+++++++...     +..|++|||+ +++|.+++....  .+++..+..++.|++.||.+||
T Consensus        46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH  120 (261)
T cd05068          46 KDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE  120 (261)
T ss_pred             HHHHHHHHHHHHCCCCCccceeEEEecC-----CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3578899999999999999999999887     7899999999 579999997643  6899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc--cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +.|++|+||||+||+++.++.++|+|||.+.........  .....+..|+|||.+.+ ..++.++|+||||+++++|++
T Consensus       121 ~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t  199 (261)
T cd05068         121 AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVT  199 (261)
T ss_pred             hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999999998765533211  11122357999998754 457899999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |..||.+.+.......+......                             ......+..+.+++.+||+.||.+|||
T Consensus       200 ~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~  250 (261)
T cd05068         200 YGRMPYPGMTNAEVLQQVDQGYRM-----------------------------PCPPGCPKELYDIMLDCWKEDPDDRPT  250 (261)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCCcCCHHHHHHHHHHhhcCcccCCC
Confidence             99999877655444333221100                             011246788999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      +++++.
T Consensus       251 ~~~l~~  256 (261)
T cd05068         251 FETLQW  256 (261)
T ss_pred             HHHHHH
Confidence            999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=276.24  Aligned_cols=214  Identities=25%  Similarity=0.420  Sum_probs=176.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCC--CHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQAL--SEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l--~~~~~~~i~~qll~~l~~LH   87 (302)
                      ....||.+.++|+|.|||++++.+...     +.+-|.||-.+ |+|..+++. .|++  .+..+.++.+||++||.|||
T Consensus       618 PLhEEIaLH~~LrHkNIVrYLGs~sen-----Gf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH  692 (1226)
T KOG4279|consen  618 PLHEEIALHSTLRHKNIVRYLGSVSEN-----GFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH  692 (1226)
T ss_pred             cHHHHHHHHHHHhhHhHHHHhhccCCC-----CeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh
Confidence            455799999999999999999998877     78889999986 799999975 5888  89999999999999999999


Q ss_pred             hCCceecCCCCCCEEEec-CCCEEEeeccccccc-CCCCcccccccccccCchhhhhCC-CCCCCchhHHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNA-NCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~i~~~ll  164 (302)
                      .+.|+|||||.+|++|+. .|.+||.|||.++.. +-......+.||.-|||||++..+ ..|+.++|||||||++.||.
T Consensus       693 en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMA  772 (1226)
T KOG4279|consen  693 ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMA  772 (1226)
T ss_pred             hcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeec
Confidence            999999999999999975 689999999998754 344566778999999999999654 35899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      ||+|||......+             ..+.            ++-.+...  +.....++.+++.||.+|+.+||.+||+
T Consensus       773 TGrPPF~Elgspq-------------AAMF------------kVGmyKvH--P~iPeelsaeak~FilrcFepd~~~R~s  825 (1226)
T KOG4279|consen  773 TGRPPFVELGSPQ-------------AAMF------------KVGMYKVH--PPIPEELSAEAKNFILRCFEPDPCDRPS  825 (1226)
T ss_pred             cCCCCeeecCChh-------------Hhhh------------hhcceecC--CCCcHHHHHHHHHHHHHHcCCCcccCcc
Confidence            9999996443222             1111            01111111  1122246778999999999999999999


Q ss_pred             HHHHhcCCCcCCc
Q 022132          245 VEDALAHPYLGSL  257 (302)
Q Consensus       245 ~~ell~h~~~~~~  257 (302)
                      |.++|..||++.-
T Consensus       826 A~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  826 AKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHhccCcccccC
Confidence            9999999999865

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-36  Score=256.53  Aligned_cols=207  Identities=26%  Similarity=0.422  Sum_probs=170.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++.+...     +.+|+||||++ ++|.+.+..  ...+++..+..++.|++.||.+||
T Consensus        43 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH  117 (255)
T cd08219          43 EDSRKEAVLLAKMKHPNIVAFKESFEAD-----GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH  117 (255)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence            4567899999999999999999999887     89999999996 699988864  346899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ++|++|+||+|+||+++.++.++++|||.+...... .......++..|+|||.+.+. .++.++|+||+|+++++|++|
T Consensus       118 ~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g  196 (255)
T cd08219         118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTL  196 (255)
T ss_pred             hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhc
Confidence            999999999999999999999999999998755432 222345678889999998544 478999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||...+.......+.....                             ......++..+.++|.+||+.||.+|||+.
T Consensus       197 ~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~  247 (255)
T cd08219         197 KHPFQANSWKNLILKVCQGSY-----------------------------KPLPSHYSYELRSLIKQMFKRNPRSRPSAT  247 (255)
T ss_pred             cCCCCCCCHHHHHHHHhcCCC-----------------------------CCCCcccCHHHHHHHHHHHhCCcccCCCHH
Confidence            999987665444333221000                             011124677899999999999999999999


Q ss_pred             HHhcCC
Q 022132          247 DALAHP  252 (302)
Q Consensus       247 ell~h~  252 (302)
                      ++++-.
T Consensus       248 ~il~~~  253 (255)
T cd08219         248 TILSRG  253 (255)
T ss_pred             HHhhcc
Confidence            998743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.4e-36  Score=255.43  Aligned_cols=201  Identities=14%  Similarity=0.238  Sum_probs=162.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+..|..+++.+.||||+++++++...     +..++||||++ |+|.+++..+ ..+++..+..++.||+.||+|||+.
T Consensus        45 ~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  119 (258)
T cd05078          45 SFFEAASMMSQLSHKHLVLNYGVCVCG-----DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK  119 (258)
T ss_pred             HHHHHHHHHHhCCCCChhheeeEEEeC-----CCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            567899999999999999999999887     78999999997 6999999764 3589999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCC--------EEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCD--------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~  161 (302)
                      ||+||||||+||+++.++.        ++++|||.+......   ....++..|+|||.+.+...++.++|+||+||++|
T Consensus       120 ~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~  196 (258)
T cd05078         120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLW  196 (258)
T ss_pred             CeecCCCccceEEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHH
Confidence            9999999999999987765        699999988654432   23456778999999876556789999999999999


Q ss_pred             HHHhC-CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          162 ELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       162 ~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      +|++| .+||...+...........                               .......+.++.+++.+||+.||+
T Consensus       197 ~l~~g~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~  245 (258)
T cd05078         197 EIFSGGDKPLSALDSQKKLQFYEDR-------------------------------HQLPAPKWTELANLINQCMDYEPD  245 (258)
T ss_pred             HHHcCCCCChhhccHHHHHHHHHcc-------------------------------ccCCCCCcHHHHHHHHHHhccChh
Confidence            99998 5676554433222111100                               011113456799999999999999


Q ss_pred             CCCCHHHHhcC
Q 022132          241 QRITVEDALAH  251 (302)
Q Consensus       241 ~R~t~~ell~h  251 (302)
                      +|||++++++.
T Consensus       246 ~Rps~~~il~~  256 (258)
T cd05078         246 FRPSFRAIIRD  256 (258)
T ss_pred             hCCCHHHHHHh
Confidence            99999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.1e-36  Score=257.05  Aligned_cols=202  Identities=18%  Similarity=0.242  Sum_probs=162.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+||||++ ++|..++.. .+.+++..+..++.|++.||+|||+
T Consensus        61 ~~~~~~~~~~~~l~h~niv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~  135 (274)
T cd05076          61 LAFFETASLMSQVSHIHLAFVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED  135 (274)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc
Confidence            4677899999999999999999999887     78999999997 688888864 5678999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCC-------CEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANC-------DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~  161 (302)
                      .||+||||||+||+++..+       .++++|||.+......   ....++..|+|||.+.+...++.++|+|||||++|
T Consensus       136 ~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~  212 (274)
T cd05076         136 KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLL  212 (274)
T ss_pred             CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHH
Confidence            9999999999999997643       3899999987543222   22356777999998866556799999999999999


Q ss_pred             HHH-hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          162 ELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       162 ~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      +|+ +|.+||.+...............                               .....++.+.++|.+||+.||.
T Consensus       213 el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~cl~~~p~  261 (274)
T cd05076         213 EICFDGEVPLKERTPSEKERFYEKKHR-------------------------------LPEPSCKELATLISQCLTYEPT  261 (274)
T ss_pred             HHHhCCCCCccccChHHHHHHHHhccC-------------------------------CCCCCChHHHHHHHHHcccChh
Confidence            984 79999976654332221111000                               0012356799999999999999


Q ss_pred             CCCCHHHHhcC
Q 022132          241 QRITVEDALAH  251 (302)
Q Consensus       241 ~R~t~~ell~h  251 (302)
                      +|||+.++|++
T Consensus       262 ~Rps~~~il~~  272 (274)
T cd05076         262 QRPSFRTILRD  272 (274)
T ss_pred             hCcCHHHHHHh
Confidence            99999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.6e-36  Score=255.48  Aligned_cols=205  Identities=23%  Similarity=0.372  Sum_probs=167.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|++|||+. ++|.+++..  ...+++..+..++.|++.||+|||
T Consensus        46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH  120 (261)
T cd05072          46 QAFLEEANLMKTLQHDKLVRLYAVVTKE-----EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE  120 (261)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4677899999999999999999999877     78999999996 699999864  356889999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +.|++|+||+|+||+++.++.++|+|||.+........  .....++..|+|||.+.+ ..++.++|+||+||++|+|++
T Consensus       121 ~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t  199 (261)
T cd05072         121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVT  199 (261)
T ss_pred             HCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHc
Confidence            99999999999999999999999999999976543221  122334567999998854 447889999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |..||.+.+.......+......                             .....++.++.+++.+||..||++|||
T Consensus       200 ~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~  250 (261)
T cd05072         200 YGKIPYPGMSNSDVMSALQRGYRM-----------------------------PRMENCPDELYDIMKTCWKEKAEERPT  250 (261)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHccCCcccCcC
Confidence             99999877655444333221100                             112356788999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++++++
T Consensus       251 ~~~i~~  256 (261)
T cd05072         251 FDYLQS  256 (261)
T ss_pred             HHHHHH
Confidence            999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.8e-36  Score=258.07  Aligned_cols=204  Identities=23%  Similarity=0.381  Sum_probs=166.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC---------------CCCHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---------------ALSEEHCQYF   75 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---------------~l~~~~~~~i   75 (302)
                      .+.+|+.+++.+.||||+++++++...     +.++++|||++ ++|.+++...+               .+++..+..+
T Consensus        53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  127 (280)
T cd05092          53 DFQREAELLTVLQHQHIVRFYGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI  127 (280)
T ss_pred             HHHHHHHHHhcCCCCCCceEEEEEecC-----CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHH
Confidence            678899999999999999999999887     78999999996 69999987542               4889999999


Q ss_pred             HHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchh
Q 022132           76 LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAID  152 (302)
Q Consensus        76 ~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~D  152 (302)
                      +.|++.|++|||+.|++||||||+||++++++.++|+|||++........   .....++..|+|||.+.+. .++.++|
T Consensus       128 ~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~D  206 (280)
T cd05092         128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESD  206 (280)
T ss_pred             HHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhh
Confidence            99999999999999999999999999999999999999999865432211   1222345679999988554 4789999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHH
Q 022132          153 VWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV  231 (302)
Q Consensus       153 iwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  231 (302)
                      +|||||++++|++ |.+||...........+.....                             ......+++.+.+++
T Consensus       207 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li  257 (280)
T cd05092         207 IWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE-----------------------------LERPRTCPPEVYAIM  257 (280)
T ss_pred             HHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc-----------------------------CCCCCCCCHHHHHHH
Confidence            9999999999998 9999976655444333221100                             011125678899999


Q ss_pred             HHccCCCCCCCCCHHHHhc
Q 022132          232 EKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       232 ~~~L~~dP~~R~t~~ell~  250 (302)
                      .+||+.||.+|||++|++.
T Consensus       258 ~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         258 QGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHccCChhhCCCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4e-36  Score=253.28  Aligned_cols=214  Identities=26%  Similarity=0.419  Sum_probs=175.7

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecC-CccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.++++++||||+++++.+....   .+.+++++||+ +++|.+++.....+++..+..++.|++.||+|||+
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  119 (260)
T cd06606          43 LEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS  119 (260)
T ss_pred             HHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            346789999999999999999999998753   25799999999 47999999887799999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      .|++|+|++|+||+++.++.++|+|||.+........   .....++..|+|||.+.+.. .+.++|+||+|+++++|++
T Consensus       120 ~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~  198 (260)
T cd06606         120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMAT  198 (260)
T ss_pred             CCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999999877655432   34456788899999885544 7899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||...+.....  ......                         ...........+..+.+++.+||..||++|||+
T Consensus       199 g~~p~~~~~~~~~~--~~~~~~-------------------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~  251 (260)
T cd06606         199 GKPPWSELGNPMAA--LYKIGS-------------------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTA  251 (260)
T ss_pred             CCCCCCCCCchHHH--HHhccc-------------------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCH
Confidence            99999776522111  111000                         001111222457899999999999999999999


Q ss_pred             HHHhcCCCc
Q 022132          246 EDALAHPYL  254 (302)
Q Consensus       246 ~ell~h~~~  254 (302)
                      .+++.||||
T Consensus       252 ~~ll~~~~~  260 (260)
T cd06606         252 DELLQHPFL  260 (260)
T ss_pred             HHHhhCCCC
Confidence            999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.7e-36  Score=261.02  Aligned_cols=205  Identities=26%  Similarity=0.437  Sum_probs=166.6

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----------------CCCCCHHHHH
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----------------NQALSEEHCQ   73 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----------------~~~l~~~~~~   73 (302)
                      .+.+|+.+++.+ +||||+++++++...     +.+|++|||+. ++|..++..                .+.+++..+.
T Consensus        61 ~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  135 (293)
T cd05053          61 DLVSEMEMMKMIGKHKNIINLLGVCTQE-----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV  135 (293)
T ss_pred             HHHHHHHHHHhhcCCCCeeeEEEEEcCC-----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHH
Confidence            477899999999 899999999999887     78999999996 699999854                2468999999


Q ss_pred             HHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCc
Q 022132           74 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAA  150 (302)
Q Consensus        74 ~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~  150 (302)
                      .++.|++.||+|||+.||+||||||+||+++.++.++|+|||.+........   .....++..|+|||.+.+ ..++.+
T Consensus       136 ~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  214 (293)
T cd05053         136 SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQ  214 (293)
T ss_pred             HHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcc
Confidence            9999999999999999999999999999999999999999999876543221   112234567999998854 447899


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHH
Q 022132          151 IDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID  229 (302)
Q Consensus       151 ~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (302)
                      +||||+||++|++++ |..||.+....+....+.....                             .......+..+.+
T Consensus       215 ~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~  265 (293)
T cd05053         215 SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR-----------------------------MEKPQNCTQELYH  265 (293)
T ss_pred             cceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-----------------------------CCCCCCCCHHHHH
Confidence            999999999999997 9999987765544433221100                             0111256788999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcC
Q 022132          230 LVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       230 li~~~L~~dP~~R~t~~ell~h  251 (302)
                      |+.+||..||++|||+.|++++
T Consensus       266 li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         266 LMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHcccCcccCcCHHHHHHH
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-36  Score=254.52  Aligned_cols=210  Identities=22%  Similarity=0.418  Sum_probs=170.9

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++.+...   +.+++++||++ ++|.+++...+.+++..+..++.|++.||.|||++|
T Consensus        50 ~~~~ei~~l~~l~h~~i~~~~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~  126 (264)
T cd06653          50 ALECEIQLLKNLRHDRIVQYYGCLRDPEE---KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM  126 (264)
T ss_pred             HHHHHHHHHHHcCCCCcceEEEEEEcCCC---CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            67789999999999999999999876422   56899999996 699999988778999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC----CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ++|+||+|+||+++.++.++|+|||.+......    .......++..|+|||.+.+. .++.++|+||+||++++|++|
T Consensus       127 i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g  205 (264)
T cd06653         127 IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTE  205 (264)
T ss_pred             EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999998754321    112234578889999988654 478999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||...........+   ...+..                         ....+.+++.+.+++.+||. +|.+|||+.
T Consensus       206 ~~p~~~~~~~~~~~~~---~~~~~~-------------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~  256 (264)
T cd06653         206 KPPWAEYEAMAAIFKI---ATQPTK-------------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAE  256 (264)
T ss_pred             CCCCCccCHHHHHHHH---HcCCCC-------------------------CCCCcccCHHHHHHHHHHhc-CcccCccHH
Confidence            9999765444333222   111110                         11223577889999999999 579999999


Q ss_pred             HHhcCCCc
Q 022132          247 DALAHPYL  254 (302)
Q Consensus       247 ell~h~~~  254 (302)
                      +++.|||+
T Consensus       257 ~~~~~~~~  264 (264)
T cd06653         257 FLLRHPFV  264 (264)
T ss_pred             HHhcCCCC
Confidence            99999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=272.43  Aligned_cols=213  Identities=30%  Similarity=0.566  Sum_probs=184.7

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR--SNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~--~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ......|+.||+++.||.||.+--.|+.+     ..+|+|||.+.|+..+.+.  +.++|++...+.++.||+.||+|||
T Consensus       607 esqlR~EVaILq~l~HPGiV~le~M~ET~-----ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH  681 (888)
T KOG4236|consen  607 ESQLRNEVAILQNLHHPGIVNLECMFETP-----ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH  681 (888)
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEeecCC-----ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh
Confidence            34667899999999999999999999998     8999999999999998885  4589999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecC---CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNAN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      -+||+|+|+||+|||+.+.   .++||||||+|+.+++.......+||+.|.|||++...+ |...-|+||.|+|+|.-+
T Consensus       682 ~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsL  760 (888)
T KOG4236|consen  682 FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSL  760 (888)
T ss_pred             hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEe
Confidence            9999999999999999765   568999999999999999999999999999999997655 899999999999999999


Q ss_pred             hCCCCCCCC-ChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 DRKPLFPGR-DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      +|..||... +..++++.. ..+                        ++    +.-|..+++.+.|||.++|+..=.+|.
T Consensus       761 SGTFPFNEdEdIndQIQNA-aFM------------------------yP----p~PW~eis~~AidlIn~LLqVkm~kRy  811 (888)
T KOG4236|consen  761 SGTFPFNEDEDINDQIQNA-AFM------------------------YP----PNPWSEISPEAIDLINNLLQVKMRKRY  811 (888)
T ss_pred             cccccCCCccchhHHhhcc-ccc------------------------cC----CCchhhcCHHHHHHHHHHHHHHHHHhc
Confidence            999999644 333333211 111                        11    122346789999999999999999999


Q ss_pred             CHHHHhcCCCcCCc
Q 022132          244 TVEDALAHPYLGSL  257 (302)
Q Consensus       244 t~~ell~h~~~~~~  257 (302)
                      |++..|.|||++..
T Consensus       812 svdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  812 SVDKSLSHPWLQDY  825 (888)
T ss_pred             chHhhccchhhhcc
Confidence            99999999999875

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.2e-36  Score=254.18  Aligned_cols=205  Identities=21%  Similarity=0.350  Sum_probs=169.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++.+  ...+++..+..++.|++.||.|||
T Consensus        47 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH  121 (261)
T cd05148          47 QDFQKEVQALKRLRHKHLISLFAVCSVG-----EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE  121 (261)
T ss_pred             HHHHHHHHHHhcCCCcchhheeeeEecC-----CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999887     78999999997 599999975  346899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc-ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      +.|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.. ..++.++|+||||+++++|++ 
T Consensus       122 ~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~  200 (261)
T cd05148         122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTY  200 (261)
T ss_pred             HCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcC
Confidence            99999999999999999999999999999876543321 122334567999998854 457899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||.+.+.......+......                             ......++.+.+++.+||+.||.+|||+
T Consensus       201 g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~  251 (261)
T cd05148         201 GQVPYPGMNNHEVYDQITAGYRM-----------------------------PCPAKCPQEIYKIMLECWAAEPEDRPSF  251 (261)
T ss_pred             CCCCCCcCCHHHHHHHHHhCCcC-----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence            89999877755555444321111                             1113567889999999999999999999


Q ss_pred             HHHhc
Q 022132          246 EDALA  250 (302)
Q Consensus       246 ~ell~  250 (302)
                      .++++
T Consensus       252 ~~l~~  256 (261)
T cd05148         252 KALRE  256 (261)
T ss_pred             HHHHH
Confidence            99875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-36  Score=256.93  Aligned_cols=205  Identities=23%  Similarity=0.371  Sum_probs=167.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------QALSEEHCQYFLYQI   79 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~ql   79 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++...          ..+++..+..++.|+
T Consensus        54 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i  128 (277)
T cd05032          54 IEFLNEASVMKEFNCHHVVRLLGVVSTG-----QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI  128 (277)
T ss_pred             HHHHHHHHHHHhCCCCceeEEEEEEcCC-----CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHH
Confidence            3577899999999999999999999887     88999999996 7999998642          236788999999999


Q ss_pred             HHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHH
Q 022132           80 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  156 (302)
Q Consensus        80 l~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  156 (302)
                      +.||.|||+.|++|+||+|+||+++.++.++|+|||.++......   ......++..|+|||.+.+. .++.++|||||
T Consensus       129 ~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~sl  207 (277)
T cd05032         129 ADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSF  207 (277)
T ss_pred             HHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHH
Confidence            999999999999999999999999999999999999987544322   12233456789999988544 47899999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHcc
Q 022132          157 GCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  235 (302)
Q Consensus       157 G~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  235 (302)
                      ||+++++++ |.+||.+.+.......+.. ...                            .......+..+.+++.+||
T Consensus       208 G~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~----------------------------~~~~~~~~~~~~~li~~~l  258 (277)
T cd05032         208 GVVLWEMATLAEQPYQGLSNEEVLKFVID-GGH----------------------------LDLPENCPDKLLELMRMCW  258 (277)
T ss_pred             HHHHHHhhccCCCCCccCCHHHHHHHHhc-CCC----------------------------CCCCCCCCHHHHHHHHHHc
Confidence            999999998 9999987765544333321 000                            0111245788999999999


Q ss_pred             CCCCCCCCCHHHHhc
Q 022132          236 TFDPRQRITVEDALA  250 (302)
Q Consensus       236 ~~dP~~R~t~~ell~  250 (302)
                      +.+|++|||+.++++
T Consensus       259 ~~~p~~Rpt~~~l~~  273 (277)
T cd05032         259 QYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCChhhCCCHHHHHH
Confidence            999999999999976

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.8e-36  Score=256.94  Aligned_cols=205  Identities=18%  Similarity=0.339  Sum_probs=166.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQY   74 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~   74 (302)
                      .+.+|+.+++.++||||+++++++...     +..++++||+. ++|.+++...                ..+++..+..
T Consensus        54 ~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  128 (283)
T cd05091          54 EFKHEAMMRSRLQHPNIVCLLGVVTKE-----QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH  128 (283)
T ss_pred             HHHHHHHHHhcCCCCCcCeEEEEEcCC-----CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHH
Confidence            467899999999999999999999887     78999999997 6899888532                3478889999


Q ss_pred             HHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCch
Q 022132           75 FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAI  151 (302)
Q Consensus        75 i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~  151 (302)
                      ++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++.......   .....++..|+|||.+.+.. ++.++
T Consensus       129 ~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~  207 (283)
T cd05091         129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDS  207 (283)
T ss_pred             HHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcch
Confidence            999999999999999999999999999999999999999999875433221   12334567899999986544 78999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          152 DVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       152 DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      |+||+||++++|++ |.+||.+....+....+......                             .....++..+.++
T Consensus       208 Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~~~~l  258 (283)
T cd05091         208 DIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL-----------------------------PCPDDCPAWVYTL  258 (283)
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHH
Confidence            99999999999997 88899876655444433321110                             1112578889999


Q ss_pred             HHHccCCCCCCCCCHHHHhcC
Q 022132          231 VEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       231 i~~~L~~dP~~R~t~~ell~h  251 (302)
                      +.+||+.||.+|||+++++..
T Consensus       259 i~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         259 MLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHhCCCcccCCCHHHHHHH
Confidence            999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5e-36  Score=255.25  Aligned_cols=211  Identities=22%  Similarity=0.338  Sum_probs=165.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCC-CCCCCcEEEEEecCC-ccHHHHHHc------CCCCCHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQ-RESFNDVYIAYELMD-TDLHQIIRS------NQALSEEHCQYFLYQILRG   82 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~~~~~~lv~e~~~-~~L~~~l~~------~~~l~~~~~~~i~~qll~~   82 (302)
                      ..+.+|+.+++.++||||+++++++.... .......+++|||+. |+|.+++..      ...+++..+..++.|++.|
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  124 (272)
T cd05075          45 EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG  124 (272)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHH
Confidence            46778999999999999999999875432 223356899999997 699888742      2358899999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHHHHHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  159 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  159 (302)
                      |+|||+.||+||||||+||+++.++.++|+|||++........   .....++..|+|||...+ ..++.++|+||+||+
T Consensus       125 l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~i  203 (272)
T cd05075         125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVT  203 (272)
T ss_pred             HHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHH
Confidence            9999999999999999999999999999999999876543221   112234567999998854 447899999999999


Q ss_pred             HHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCC
Q 022132          160 FMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       160 ~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  238 (302)
                      +++|++ |.+||.+.........+....                             .....+..+..+.++|.+||+.|
T Consensus       204 l~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~  254 (272)
T cd05075         204 MWEIATRGQTPYPGVENSEIYDYLRQGN-----------------------------RLKQPPDCLDGLYSLMSSCWLLN  254 (272)
T ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHHcCC-----------------------------CCCCCCCCCHHHHHHHHHHcCCC
Confidence            999998 899998766544333222100                             00112356778999999999999


Q ss_pred             CCCCCCHHHHhcC
Q 022132          239 PRQRITVEDALAH  251 (302)
Q Consensus       239 P~~R~t~~ell~h  251 (302)
                      |.+|||+++++++
T Consensus       255 p~~Rps~~~l~~~  267 (272)
T cd05075         255 PKDRPSFETLRCE  267 (272)
T ss_pred             cccCcCHHHHHHH
Confidence            9999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6e-36  Score=252.94  Aligned_cols=204  Identities=17%  Similarity=0.269  Sum_probs=164.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      +.+.+|+.++++++||||+++++++..      +..++||||++ ++|.+++.. ...+++..+..++.|++.||+|||+
T Consensus        40 ~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~  113 (257)
T cd05115          40 DEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG  113 (257)
T ss_pred             HHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            357799999999999999999998853      56899999996 699998874 4679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc----ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      +|++||||||+||+++.++.++|+|||.+........    .....++..|+|||.+.. ..++.++|+|||||++++++
T Consensus       114 ~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~  192 (257)
T cd05115         114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAF  192 (257)
T ss_pred             cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHh
Confidence            9999999999999999999999999999875433211    111223467999998854 34788999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |.+||.+....+....+.... .                            ....+..++++.+++.+||..||.+||
T Consensus       193 ~~g~~p~~~~~~~~~~~~~~~~~-~----------------------------~~~~~~~~~~l~~li~~c~~~~~~~Rp  243 (257)
T cd05115         193 SYGQKPYKKMKGPEVMSFIEQGK-R----------------------------LDCPAECPPEMYALMKDCWIYKWEDRP  243 (257)
T ss_pred             cCCCCCcCcCCHHHHHHHHHCCC-C----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence            6 999998776554433222110 0                            011235678999999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      ++.++.+
T Consensus       244 ~~~~i~~  250 (257)
T cd05115         244 NFAKVEE  250 (257)
T ss_pred             CHHHHHH
Confidence            9999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6e-36  Score=252.66  Aligned_cols=203  Identities=21%  Similarity=0.346  Sum_probs=164.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      .+.+|+.+++.++|+|++++++++....    +.+|++|||++ ++|.+++.+.+  .+++..+..++.|++.||+|||+
T Consensus        45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  120 (256)
T cd05082          45 AFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA  120 (256)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEEcCC----CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            5778999999999999999999765431    67999999997 69999987643  48899999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-CC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g~  167 (302)
                      +|++||||||+||+++.++.++|+|||++.......  .....+..|+|||.+.+ ..++.++|+||+||++|+|++ |.
T Consensus       121 ~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~  197 (256)
T cd05082         121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGR  197 (256)
T ss_pred             CCEeccccchheEEEcCCCcEEecCCccceeccccC--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCC
Confidence            999999999999999999999999999987544322  22334567999998854 447899999999999999997 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||...+.......+....                             .....+..++.+.+++.+||..||.+|||+.+
T Consensus       198 ~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  248 (256)
T cd05082         198 VPYPRIPLKDVVPRVEKGY-----------------------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQ  248 (256)
T ss_pred             CCCCCCCHHHHHHHHhcCC-----------------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence            9997665443332221100                             01122367889999999999999999999999


Q ss_pred             Hhc
Q 022132          248 ALA  250 (302)
Q Consensus       248 ll~  250 (302)
                      +++
T Consensus       249 l~~  251 (256)
T cd05082         249 LRE  251 (256)
T ss_pred             HHH
Confidence            975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.6e-36  Score=257.10  Aligned_cols=206  Identities=19%  Similarity=0.382  Sum_probs=165.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-----------------CCCCHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-----------------QALSEEHC   72 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----------------~~l~~~~~   72 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++...                 ..+++..+
T Consensus        52 ~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  126 (283)
T cd05090          52 GEFQQEASLMAELHHPNIVCLLGVVTQE-----QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF  126 (283)
T ss_pred             HHHHHHHHHHhhCCCCCeeeEEEEEecC-----CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHH
Confidence            3577899999999999999999999887     78999999997 6999998532                 24788899


Q ss_pred             HHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCC
Q 022132           73 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTA  149 (302)
Q Consensus        73 ~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~  149 (302)
                      ..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+. .++.
T Consensus       127 ~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~  205 (283)
T cd05090         127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSS  205 (283)
T ss_pred             HHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCc
Confidence            9999999999999999999999999999999999999999999987543221   12223345679999988554 4799


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHH
Q 022132          150 AIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  228 (302)
Q Consensus       150 ~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (302)
                      ++|+|||||++++|++ |.+||.+.+.......+....                             .......+++.+.
T Consensus       206 ~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~  256 (283)
T cd05090         206 DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ-----------------------------LLPCSEDCPPRMY  256 (283)
T ss_pred             hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-----------------------------cCCCCCCCCHHHH
Confidence            9999999999999998 999997765433332222100                             0011225678999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcC
Q 022132          229 DLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       229 ~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +++.+||+.||.+||++.+++++
T Consensus       257 ~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         257 SLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHcccCcccCcCHHHHHHH
Confidence            99999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-36  Score=254.80  Aligned_cols=206  Identities=21%  Similarity=0.339  Sum_probs=167.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+++||||++ ++|.+++.. .+.+++..+..++.|++.||+|||+
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~  124 (266)
T cd05033          50 LDFLTEASIMGQFDHPNIIRLEGVVTKS-----RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE  124 (266)
T ss_pred             HHHHHHHHHHHhCCCCCcceEeEEEecC-----CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3577899999999999999999999876     78999999996 699999865 3578999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-Cc--ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      .||+|+||+|+||+++.++.++|+|||.+...... ..  .....++..|+|||.+.+ ..++.++|+||+|+++++|++
T Consensus       125 ~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~  203 (266)
T cd05033         125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMS  203 (266)
T ss_pred             CCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHc
Confidence            99999999999999999999999999998765421 11  112234567999998854 447899999999999999997


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |..||...........+......+                             .....+..+.+++.+||+.||++|||
T Consensus       204 ~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~  254 (266)
T cd05033         204 YGERPYWDMSNQDVIKAVEDGYRLP-----------------------------PPMDCPSALYQLMLDCWQKDRNERPT  254 (266)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CCCCCCHHHHHHHHHHcCCCcccCcC
Confidence             999997665554433332211111                             11256788999999999999999999


Q ss_pred             HHHHhcC
Q 022132          245 VEDALAH  251 (302)
Q Consensus       245 ~~ell~h  251 (302)
                      +++++++
T Consensus       255 ~~ei~~~  261 (266)
T cd05033         255 FSQIVST  261 (266)
T ss_pred             HHHHHHH
Confidence            9999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.2e-36  Score=258.71  Aligned_cols=205  Identities=24%  Similarity=0.354  Sum_probs=165.4

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      .+.+|+.+++++ +||||+++++++...     +.+|+||||+. ++|.+++....  .+++..+..++.|++.||+|||
T Consensus        84 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH  158 (302)
T cd05055          84 ALMSELKIMSHLGNHENIVNLLGACTIG-----GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA  158 (302)
T ss_pred             HHHHHHHHHHhccCCCCcceEEEEEecC-----CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            577899999999 899999999999887     78999999996 79999987532  3899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ++|++|+||||+||+++.++.++++|||.+........   .....++..|+|||.+.+. .++.++||||+||++++|+
T Consensus       159 ~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~  237 (302)
T cd05055         159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIF  237 (302)
T ss_pred             HCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHH
Confidence            99999999999999999999999999999875443211   1123456779999988654 4789999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |.+||.+................                            .......++.+.+++.+||.++|++||
T Consensus       238 t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp  289 (302)
T cd05055         238 SLGSNPYPGMPVDSKFYKLIKEGYR----------------------------MAQPEHAPAEIYDIMKTCWDADPLKRP  289 (302)
T ss_pred             hCCCCCcCCCCchHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCchhCc
Confidence            8 99999766543332222110000                            001124578899999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |+.+++.
T Consensus       290 t~~ell~  296 (302)
T cd05055         290 TFKQIVQ  296 (302)
T ss_pred             CHHHHHH
Confidence            9999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-36  Score=252.34  Aligned_cols=203  Identities=22%  Similarity=0.360  Sum_probs=167.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      +++.+|+.+++.++|+||+++++++.+.     +..|+||||++ ++|.+++....  .+++..+..++.|++.||.|||
T Consensus        45 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh  119 (256)
T cd05039          45 QAFLAEASVMTTLRHPNLVQLLGVVLQG-----NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE  119 (256)
T ss_pred             HHHHHHHHHHHhcCCcceeeeEEEEcCC-----CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4678899999999999999999999886     88999999997 69999997655  7999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-C
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-R  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g  166 (302)
                      +.|++|+||+|+||+++.++.++|+|||.+.......  .....+..|+|||.+.. ..++.++|+||+|+++++|++ |
T Consensus       120 ~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g  196 (256)
T cd05039         120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFG  196 (256)
T ss_pred             hCCccchhcccceEEEeCCCCEEEccccccccccccc--ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcC
Confidence            9999999999999999999999999999987664332  12344567999998854 447889999999999999997 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||...........+....                             ........++.+.++|.+||..+|.+|||++
T Consensus       197 ~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  247 (256)
T cd05039         197 RVPYPRIPLKDVVPHVEKGY-----------------------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFK  247 (256)
T ss_pred             CCCCCCCCHHHHHHHHhcCC-----------------------------CCCCccCCCHHHHHHHHHHhccChhhCcCHH
Confidence            99997665443322221100                             0011125678999999999999999999999


Q ss_pred             HHhc
Q 022132          247 DALA  250 (302)
Q Consensus       247 ell~  250 (302)
                      |+++
T Consensus       248 ~l~~  251 (256)
T cd05039         248 QLRE  251 (256)
T ss_pred             HHHH
Confidence            9976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9e-36  Score=259.12  Aligned_cols=204  Identities=25%  Similarity=0.410  Sum_probs=165.6

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHH
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQ   73 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~   73 (302)
                      .+.+|+.+++.+ +||||+++++++...     +.+|++|||+. |+|.+++...                ..+++..+.
T Consensus        63 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~  137 (314)
T cd05099          63 DLISEMELMKLIGKHKNIINLLGVCTQE-----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV  137 (314)
T ss_pred             HHHHHHHHHHhccCCCCeeeEEEEEccC-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHH
Confidence            467899999999 699999999999876     78999999996 6999999653                348899999


Q ss_pred             HHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCc
Q 022132           74 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAA  150 (302)
Q Consensus        74 ~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~  150 (302)
                      .++.|++.||.|||++|++||||||+||+++.++.++|+|||.++.......   .....++..|+|||.+.+ ..++.+
T Consensus       138 ~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  216 (314)
T cd05099         138 SCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQ  216 (314)
T ss_pred             HHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCcc
Confidence            9999999999999999999999999999999999999999999975543211   112233457999998865 457899


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHH
Q 022132          151 IDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID  229 (302)
Q Consensus       151 ~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (302)
                      +|+||+||++|+|++ |..||.+....+....+....                             ........+.++.+
T Consensus       217 ~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~  267 (314)
T cd05099         217 SDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH-----------------------------RMDKPSNCTHELYM  267 (314)
T ss_pred             chhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------------------CCCCCCCCCHHHHH
Confidence            999999999999998 899997776554443332100                             00112356778999


Q ss_pred             HHHHccCCCCCCCCCHHHHhc
Q 022132          230 LVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       230 li~~~L~~dP~~R~t~~ell~  250 (302)
                      ++.+||..||.+|||+.++++
T Consensus       268 li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         268 LMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.8e-36  Score=256.24  Aligned_cols=211  Identities=24%  Similarity=0.377  Sum_probs=173.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      +.+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++.. ..+++..+..++.|++.|+.+||+.
T Consensus        47 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~  120 (277)
T cd06641          47 EDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE  120 (277)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccC
Confidence            3577899999999999999999999887     88999999997 588888865 5789999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ ...+.++|+||+||++++|++|.+
T Consensus       121 ~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~  199 (277)
T cd06641         121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEP  199 (277)
T ss_pred             CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999886544322 1223456788999998854 447889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||...........+.. ..                            .......++..+.+++.+||+.||.+||++.++
T Consensus       200 p~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~  250 (277)
T cd06641         200 PHSELHPMKVLFLIPK-NN----------------------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL  250 (277)
T ss_pred             CCCccchHHHHHHHhc-CC----------------------------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9976554333322211 00                            011112467889999999999999999999999


Q ss_pred             hcCCCcCCc
Q 022132          249 LAHPYLGSL  257 (302)
Q Consensus       249 l~h~~~~~~  257 (302)
                      ++||||...
T Consensus       251 l~~~~~~~~  259 (277)
T cd06641         251 LKHKFIVRF  259 (277)
T ss_pred             HhCHHHhhh
Confidence            999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7e-36  Score=256.89  Aligned_cols=204  Identities=24%  Similarity=0.357  Sum_probs=164.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC------------------------CC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN------------------------QA   66 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------~~   66 (302)
                      .+.+|+.+++.++||||+++++.+...     +..|+++||+. ++|.+++...                        ..
T Consensus        49 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  123 (290)
T cd05045          49 DLLSEFNLLKQVNHPHVIKLYGACSQD-----GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA  123 (290)
T ss_pred             HHHHHHHHHhhCCCCCEeeEEEEEecC-----CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccc
Confidence            577899999999999999999999877     78999999997 7999987642                        34


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhC
Q 022132           67 LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLN  143 (302)
Q Consensus        67 l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~  143 (302)
                      +++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||++........   .....++..|+|||.+.+
T Consensus       124 l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~  203 (290)
T cd05045         124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD  203 (290)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc
Confidence            78899999999999999999999999999999999999999999999999875432211   122234567999998854


Q ss_pred             CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCC
Q 022132          144 SSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN  222 (302)
Q Consensus       144 ~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (302)
                       ..++.++||||||+++++|++ |.+||.+................                             .....
T Consensus       204 -~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~  253 (290)
T cd05045         204 -HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM-----------------------------ERPEN  253 (290)
T ss_pred             -CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-----------------------------CCCCC
Confidence             447899999999999999998 99999876654433322110000                             01125


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          223 VHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       223 ~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      .+.++.+++..||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         254 CSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            6789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9.4e-36  Score=252.03  Aligned_cols=204  Identities=25%  Similarity=0.378  Sum_probs=164.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++|||++++++++..      ...|++|||++ ++|.+++...  ..+++..+..++.|++.||+|||
T Consensus        46 ~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH  119 (260)
T cd05070          46 ESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE  119 (260)
T ss_pred             HHHHHHHHHHHhcCCCceEEEEeEECC------CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357899999999999999999998853      56899999996 6999998753  45899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +.|++|+||+|+||+++.++.++|+|||.+........  .....++..|+|||.+.+ ..++.++|+||||+++++|++
T Consensus       120 ~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~  198 (260)
T cd05070         120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVT  198 (260)
T ss_pred             HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHh
Confidence            99999999999999999999999999999876543221  112234567999998854 447899999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.+..+....+......                             ......+..+.+++.+||.+||++|||
T Consensus       199 ~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt  249 (260)
T cd05070         199 KGRVPYPGMNNREVLEQVERGYRM-----------------------------PCPQDCPISLHELMLQCWKKDPEERPT  249 (260)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCCcCCHHHHHHHHHHcccCcccCcC
Confidence             89999877655444433211000                             111256788999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++++++
T Consensus       250 ~~~l~~  255 (260)
T cd05070         250 FEYLQS  255 (260)
T ss_pred             HHHHHH
Confidence            999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.4e-36  Score=256.67  Aligned_cols=212  Identities=22%  Similarity=0.346  Sum_probs=169.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-----------CCCHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-----------ALSEEHCQYFLYQ   78 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~l~~~~~~~i~~q   78 (302)
                      ..+.+|+.++++++||||+++++++...     +.++++|||+. ++|.+++....           .+++..+..++.|
T Consensus        64 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (296)
T cd05051          64 EDFLKEVKILSRLSDPNIARLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQ  138 (296)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHH
Confidence            4677899999999999999999999887     78999999996 69999987655           6899999999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHH
Q 022132           79 ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWS  155 (302)
Q Consensus        79 ll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  155 (302)
                      ++.||+|||+.|++|+||||+||+++.++.++|+|||.+.......   ......++..|+|||.+.+. .++.++||||
T Consensus       139 i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s  217 (296)
T cd05051         139 IASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWA  217 (296)
T ss_pred             HHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhh
Confidence            9999999999999999999999999999999999999987543321   12233456789999988654 4899999999


Q ss_pred             HHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHH
Q 022132          156 VGCIFMELMD--RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  233 (302)
Q Consensus       156 lG~i~~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  233 (302)
                      +||++|+|++  |..||...+....+...........                      ........+..+.++.+++.+
T Consensus       218 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~li~~  275 (296)
T cd05051         218 FGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDG----------------------RQIYLPRPPNCPKDIYELMLE  275 (296)
T ss_pred             hHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccc----------------------ccccCCCccCCCHHHHHHHHH
Confidence            9999999987  7788876665554443332111100                      000111123567899999999


Q ss_pred             ccCCCCCCCCCHHHHhc
Q 022132          234 MLTFDPRQRITVEDALA  250 (302)
Q Consensus       234 ~L~~dP~~R~t~~ell~  250 (302)
                      ||+.||.+|||+.++++
T Consensus       276 cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         276 CWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HhccChhcCCCHHHHHH
Confidence            99999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9.8e-36  Score=255.70  Aligned_cols=218  Identities=19%  Similarity=0.320  Sum_probs=172.7

Q ss_pred             cCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.+++++ +||||+++++.+...     ..+|+||||++ ++|.+.+...+.+++..+..++.|++.||.|||
T Consensus        48 ~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH  122 (288)
T cd05583          48 AEHTRTERQVLEAVRRCPFLVTLHYAFQTD-----TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH  122 (288)
T ss_pred             HHHHHHHHHHHHhccCCcchhhhheeeecC-----CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHH
Confidence            34577899999999 699999999999877     78999999997 699999987778999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCC-CCCCchhHHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~i~~~ll  164 (302)
                      +.|++|+||+|+||+++.++.++|+|||++.......  ......++..|+|||.+.+.. ..+.++|+||+|+++++|+
T Consensus       123 ~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~  202 (288)
T cd05583         123 QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL  202 (288)
T ss_pred             HCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHH
Confidence            9999999999999999999999999999986543321  122345788899999875432 2578999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|..||...........+......                  .        .......+++.+.+++.+||+.||++|||
T Consensus       203 tg~~p~~~~~~~~~~~~~~~~~~~------------------~--------~~~~~~~~~~~l~~li~~~l~~~p~~R~t  256 (288)
T cd05583         203 TGASPFTVDGEQNSQSEISRRILK------------------S--------KPPFPKTMSAEARDFIQKLLEKDPKKRLG  256 (288)
T ss_pred             hCCCCcccCcccchHHHHHHHHHc------------------c--------CCCCCcccCHHHHHHHHHHhcCCHhhccC
Confidence            999999643322111111110000                  0        00112246788999999999999999998


Q ss_pred             ---HHHHhcCCCcCCcc
Q 022132          245 ---VEDALAHPYLGSLH  258 (302)
Q Consensus       245 ---~~ell~h~~~~~~~  258 (302)
                         +.++|+||||+.+.
T Consensus       257 ~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         257 ANGADEIKNHPFFQGID  273 (288)
T ss_pred             cchHHHHhcCcccccCC
Confidence               57889999998864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.4e-36  Score=252.41  Aligned_cols=204  Identities=25%  Similarity=0.377  Sum_probs=164.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++.+..      +..|+||||++ ++|.+++.+.  ..+++..+..++.|++.||++||
T Consensus        46 ~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH  119 (262)
T cd05071          46 EAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE  119 (262)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEECC------CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            357899999999999999999998754      45799999997 6999999753  45899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc--cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +.|++|+||+|+||+++.++.++|+|||.+.........  ....++..|+|||...+ ..++.++|+||+||++++|++
T Consensus       120 ~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt  198 (262)
T cd05071         120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT  198 (262)
T ss_pred             HCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHc
Confidence            999999999999999999999999999998765433211  22345667999998754 447999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.........+......                             ......+..+.+++.+||++||.+|||
T Consensus       199 ~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~  249 (262)
T cd05071         199 KGRVPYPGMVNREVLDQVERGYRM-----------------------------PCPPECPESLHDLMCQCWRKEPEERPT  249 (262)
T ss_pred             CCCCCCCCCChHHHHHHHhcCCCC-----------------------------CCccccCHHHHHHHHHHccCCcccCCC
Confidence             88999877655443332211000                             011256788999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      +.++++
T Consensus       250 ~~~~~~  255 (262)
T cd05071         250 FEYLQA  255 (262)
T ss_pred             HHHHHH
Confidence            999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.9e-36  Score=275.04  Aligned_cols=211  Identities=23%  Similarity=0.409  Sum_probs=180.3

Q ss_pred             hhHHHHhcC------chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-----------
Q 022132            3 SITKLMQRG------HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-----------   64 (302)
Q Consensus         3 ~~~~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----------   64 (302)
                      |||.++.++      .|.||+.++..|+|||||++++++...     +.+|+|+|||. |||.++|..+           
T Consensus       520 AVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~-----~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~  594 (774)
T KOG1026|consen  520 AVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG-----DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQ  594 (774)
T ss_pred             hHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC-----CeeEEEEEecccccHHHHHHhhCCccccccCCC
Confidence            455555444      789999999999999999999999998     89999999998 8999999743           


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCccc---ccccccccCch
Q 022132           65 ---QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT---EYVVTRWYRAP  138 (302)
Q Consensus        65 ---~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aP  138 (302)
                         .+|+..+...|+.||+.|.+||-++.++||||-..|+||+++-.+||+|||+++..-..++..   .......||||
T Consensus       595 ~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMpp  674 (774)
T KOG1026|consen  595 DTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPP  674 (774)
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCH
Confidence               238899999999999999999999999999999999999999999999999998654333222   23345679999


Q ss_pred             hhhhCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccccc
Q 022132          139 ELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT  217 (302)
Q Consensus       139 E~~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (302)
                      |.+..++ ++.++||||+||++||+++ |..||.+..+.+.+..+...                             ...
T Consensus       675 EsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g-----------------------------~lL  724 (774)
T KOG1026|consen  675 ESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG-----------------------------QLL  724 (774)
T ss_pred             HHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC-----------------------------Ccc
Confidence            9997654 9999999999999999986 99999999988888777542                             112


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       218 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ....+.|..+.+|+..||+.+|++|||+.|+
T Consensus       725 ~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  725 SCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             cCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            3334789999999999999999999999997

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-36  Score=250.56  Aligned_cols=206  Identities=22%  Similarity=0.339  Sum_probs=166.2

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|++++++++||||+++++++.+.     ...|+||||++ ++|.+++.. ...+++..+..++.|++.||+|||
T Consensus        36 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH  110 (251)
T cd05041          36 KRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE  110 (251)
T ss_pred             HHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            44678999999999999999999999887     88999999996 699999865 456899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc---cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ++|++||||+|+||+++.++.++|+|||.+.........   .....+..|+|||.+.+. .++.++|+||+||++++|+
T Consensus       111 ~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~  189 (251)
T cd05041         111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETF  189 (251)
T ss_pred             hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHH
Confidence            999999999999999999999999999998754422111   112234569999988544 5889999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |..||.+.........+......                             ......+..+.+++.+||..+|++||
T Consensus       190 t~~~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp  240 (251)
T cd05041         190 SLGDTPYPGMSNQQTRERIESGYRM-----------------------------PAPQLCPEEIYRLMLQCWAYDPENRP  240 (251)
T ss_pred             hccCCCCccCCHHHHHHHHhcCCCC-----------------------------CCCccCCHHHHHHHHHHhccChhhCc
Confidence            8 88999776544333222110000                             01124678899999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |++|+++
T Consensus       241 ~~~ell~  247 (251)
T cd05041         241 SFSEIYN  247 (251)
T ss_pred             CHHHHHH
Confidence            9999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-36  Score=252.07  Aligned_cols=205  Identities=26%  Similarity=0.396  Sum_probs=168.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++++...     ...++||||++ ++|.+++...  ..+++..+..++.|++.|+.|||
T Consensus        46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh  120 (261)
T cd05034          46 EAFLQEAQIMKKLRHDKLVQLYAVCSEE-----EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE  120 (261)
T ss_pred             HHHHHHHHHHhhCCCCCEeeeeeeeecC-----CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999999876     78999999996 6999999764  36899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++|++|+||+|+||+++.++.++|+|||.+........  ......+..|+|||.+.+ ..++.++|+||+||+++++++
T Consensus       121 ~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t  199 (261)
T cd05034         121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVT  199 (261)
T ss_pred             hCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999876543211  112233567999998864 447899999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |..||.+.+....+..+......+                             .....+..+.+++.+||..||.+|||
T Consensus       200 ~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~  250 (261)
T cd05034         200 YGRVPYPGMTNREVLEQVERGYRMP-----------------------------RPPNCPEELYDLMLQCWDKDPEERPT  250 (261)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CCCCCCHHHHHHHHHHcccCcccCCC
Confidence             999998776655555443211111                             11245778999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++++++
T Consensus       251 ~~~l~~  256 (261)
T cd05034         251 FEYLQS  256 (261)
T ss_pred             HHHHHH
Confidence            999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.7e-35  Score=251.57  Aligned_cols=204  Identities=25%  Similarity=0.400  Sum_probs=164.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------QALSEEHCQYFLYQILRGL   83 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qll~~l   83 (302)
                      .+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++...       ..+++..+..++.|++.||
T Consensus        45 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l  119 (269)
T cd05044          45 EFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC  119 (269)
T ss_pred             HHHHHHHHHHhcCCCCeeeEeeeecCC-----CCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHH
Confidence            677899999999999999999999877     78999999996 6999998642       3478899999999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEecCC-----CEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHH
Q 022132           84 KYIHSANVLHRDLKPSNLLLNANC-----DLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWS  155 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~~~-----~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  155 (302)
                      +|||+.|++|+||+|+||+++.++     .++++|||++........   .....++..|+|||.+.+. .++.++|+||
T Consensus       120 ~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s  198 (269)
T cd05044         120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWS  198 (269)
T ss_pred             HHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHH
Confidence            999999999999999999999887     899999999865432211   1122345679999988654 4799999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHc
Q 022132          156 VGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  234 (302)
Q Consensus       156 lG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (302)
                      |||++|+|++ |..||...+.......+... .                            ........+..+.++|.+|
T Consensus       199 lG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~----------------------------~~~~~~~~~~~~~~li~~~  249 (269)
T cd05044         199 FGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G----------------------------RLQKPENCPDKIYQLMTNC  249 (269)
T ss_pred             HHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C----------------------------ccCCcccchHHHHHHHHHH
Confidence            9999999997 99999876654433322110 0                            0011235678899999999


Q ss_pred             cCCCCCCCCCHHHHhc
Q 022132          235 LTFDPRQRITVEDALA  250 (302)
Q Consensus       235 L~~dP~~R~t~~ell~  250 (302)
                      |..+|.+|||++++++
T Consensus       250 l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         250 WAQDPSERPTFDRIQE  265 (269)
T ss_pred             cCCCcccCCCHHHHHH
Confidence            9999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-35  Score=260.87  Aligned_cols=207  Identities=23%  Similarity=0.368  Sum_probs=163.3

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------------------------
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------------------------   64 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------------------------   64 (302)
                      .+.+|+.+++++ +||||+++++++....    ..++++|||+. ++|.+++...                         
T Consensus        56 ~~~~E~~~~~~l~~h~niv~~~~~~~~~~----~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  131 (337)
T cd05054          56 ALMTELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ  131 (337)
T ss_pred             HHHHHHHHHHhhccCcchhheeeeEecCC----CCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccccc
Confidence            466899999999 8999999999886542    67999999997 6998888532                         


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC
Q 022132           65 ------------------------------------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD  108 (302)
Q Consensus        65 ------------------------------------~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~  108 (302)
                                                          .++++..+..++.||+.||+|||++||+||||||+||+++.++.
T Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~  211 (337)
T cd05054         132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV  211 (337)
T ss_pred             ccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc
Confidence                                                26889999999999999999999999999999999999999999


Q ss_pred             EEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022132          109 LKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIE  184 (302)
Q Consensus       109 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~  184 (302)
                      ++|+|||++.......   ......++..|+|||.+.+. .++.++||||+||++++|++ |.+||.+....+.+.....
T Consensus       212 vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~  290 (337)
T cd05054         212 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK  290 (337)
T ss_pred             EEEeccccchhcccCcchhhccCCCCCccccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh
Confidence            9999999987643221   11223446679999988654 48999999999999999997 9999976543322222111


Q ss_pred             HhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          185 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      ....                            .......++++.+++.+||+.+|.+|||++|+++|
T Consensus       291 ~~~~----------------------------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         291 EGTR----------------------------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ccCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            0000                            00112457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=9.3e-36  Score=251.99  Aligned_cols=207  Identities=26%  Similarity=0.465  Sum_probs=168.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+|+.+++.++||||+++++++.+.     ...++|+||++ ++|.+.+..    ...+++..+..++.|++.||.||
T Consensus        48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l  122 (260)
T cd08222          48 QANQEAQLLSKLDHPAIVKFHASFLER-----DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM  122 (260)
T ss_pred             HHHHHHHHHHhCCCCcHHHHHHHHhcC-----CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH
Confidence            455799999999999999999999877     78999999997 588887753    45799999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      |+.|++|+||+|+||+++. +.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||+|+++++|++
T Consensus       123 H~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~  200 (260)
T cd08222         123 HQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCC  200 (260)
T ss_pred             HHcCccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999975 57999999988654332 22234456788999998854 447889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||.+.........+..   .+                          ........+.++.++|.+||..||++||++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~---~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  251 (260)
T cd08222         201 LAHAFEGQNFLSVVLRIVE---GP--------------------------TPSLPETYSRQLNSIMQSMLNKDPSLRPSA  251 (260)
T ss_pred             CCCCCCCccHHHHHHHHHc---CC--------------------------CCCCcchhcHHHHHHHHHHhcCChhhCcCH
Confidence            9999976654433332221   00                          011112567889999999999999999999


Q ss_pred             HHHhcCCCc
Q 022132          246 EDALAHPYL  254 (302)
Q Consensus       246 ~ell~h~~~  254 (302)
                      .++++||||
T Consensus       252 ~~il~~~~~  260 (260)
T cd08222         252 AEILRNPFI  260 (260)
T ss_pred             HHHhhCCCC
Confidence            999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.4e-35  Score=251.93  Aligned_cols=205  Identities=22%  Similarity=0.351  Sum_probs=167.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+..|+.+++.++||||+++++++...     +..|+||||++ ++|.+++.. .+.+++..+..++.|++.|++|||+
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~  125 (268)
T cd05063          51 QDFLSEASIMGQFSHHNIIRLEGVVTKF-----KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD  125 (268)
T ss_pred             HHHHHHHHHHhcCCCCCeeEEEEEEccC-----CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999887     78999999997 599999865 3678999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc----cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .|++|+||||+||+++.++.++|+|||++.........    .....+..|+|||.+.+ ..++.++|+||+||++|+|+
T Consensus       126 ~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell  204 (268)
T cd05063         126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVM  204 (268)
T ss_pred             CCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHH
Confidence            99999999999999999999999999998755432111    11122446999998854 44789999999999999998


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |..||...+..+....+......|.                             ....+..+.+++.+||..||++||
T Consensus       205 ~~g~~p~~~~~~~~~~~~i~~~~~~~~-----------------------------~~~~~~~~~~li~~c~~~~p~~Rp  255 (268)
T cd05063         205 SFGERPYWDMSNHEVMKAINDGFRLPA-----------------------------PMDCPSAVYQLMLQCWQQDRARRP  255 (268)
T ss_pred             hCCCCCCCcCCHHHHHHHHhcCCCCCC-----------------------------CCCCCHHHHHHHHHHcCCCcccCc
Confidence            7 9999977765554444432111111                             114678899999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      ++.++++
T Consensus       256 ~~~~i~~  262 (268)
T cd05063         256 RFVDIVN  262 (268)
T ss_pred             CHHHHHH
Confidence            9999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-35  Score=256.96  Aligned_cols=206  Identities=25%  Similarity=0.398  Sum_probs=167.0

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHC   72 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~   72 (302)
                      ..+.+|+.+++.+ +||||+++++++...     +.+|++|||+. ++|.+++...                ..++...+
T Consensus        65 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  139 (304)
T cd05101          65 SDLVSEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL  139 (304)
T ss_pred             HHHHHHHHHHHhhccCCCchheeEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHH
Confidence            3577899999999 899999999999887     78999999997 6999998753                24778889


Q ss_pred             HHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCC
Q 022132           73 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTA  149 (302)
Q Consensus        73 ~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~  149 (302)
                      ..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+........   .....++..|+|||.+.+ ..++.
T Consensus       140 ~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  218 (304)
T cd05101         140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTH  218 (304)
T ss_pred             HHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCc
Confidence            99999999999999999999999999999999999999999999876543221   122334567999998855 44789


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHH
Q 022132          150 AIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  228 (302)
Q Consensus       150 ~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (302)
                      ++||||||+++++|++ |..||.+.+..+....+.....                             .......+..+.
T Consensus       219 ~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~  269 (304)
T cd05101         219 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR-----------------------------MDKPANCTNELY  269 (304)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-----------------------------CCCCCCCCHHHH
Confidence            9999999999999998 8889977765544433221000                             011125678999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcC
Q 022132          229 DLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       229 ~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +++.+||..+|.+|||+.|+++.
T Consensus       270 ~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         270 MMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHcccChhhCCCHHHHHHH
Confidence            99999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.9e-35  Score=250.20  Aligned_cols=203  Identities=25%  Similarity=0.377  Sum_probs=164.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      .+.+|+.+++.++|||++++++++..      +..|+||||+. ++|.+++...  ..+++..+..++.|++.||.|||+
T Consensus        47 ~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~  120 (260)
T cd05069          47 AFLQEAQIMKKLRHDKLVPLYAVVSE------EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER  120 (260)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEcC------CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            56789999999999999999998853      45789999997 5999999753  348899999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      .|++|+||+|+||+++.++.++|+|||.+........  .....++..|+|||...+ ...+.++|+||+|+++|+|++ 
T Consensus       121 ~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~  199 (260)
T cd05069         121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTK  199 (260)
T ss_pred             CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999876543221  122334567999998754 447899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.........+......                             ......+..+.+++++||.+||.+|||+
T Consensus       200 g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~  250 (260)
T cd05069         200 GRVPYPGMVNREVLEQVERGYRM-----------------------------PCPQGCPESLHELMKLCWKKDPDERPTF  250 (260)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCcccCHHHHHHHHHHccCCcccCcCH
Confidence            99999877655444333221000                             1112567889999999999999999999


Q ss_pred             HHHhc
Q 022132          246 EDALA  250 (302)
Q Consensus       246 ~ell~  250 (302)
                      +++++
T Consensus       251 ~~i~~  255 (260)
T cd05069         251 EYIQS  255 (260)
T ss_pred             HHHHH
Confidence            99875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.8e-35  Score=251.60  Aligned_cols=209  Identities=22%  Similarity=0.282  Sum_probs=162.3

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-----ALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~l~~~~~~~i~~qll~~l~~   85 (302)
                      .+.+|+.+++.++||||+++++.+...     ..+|+||||++ |+|.+++....     ..++..+..++.||+.||+|
T Consensus        41 ~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  115 (269)
T cd05042          41 LFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW  115 (269)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHH
Confidence            567899999999999999999999887     88999999997 69999987542     34678889999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhC------CCCCCCchhHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLN------SSDYTAAIDVWSV  156 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~------~~~~~~~~Diwsl  156 (302)
                      ||++||+||||||+||+++.++.++|+|||.+........   .....++..|+|||++..      ...++.++||||+
T Consensus       116 lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl  195 (269)
T cd05042         116 LHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSL  195 (269)
T ss_pred             HHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHH
Confidence            9999999999999999999999999999999864322211   122334567999998743      2346789999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHcc
Q 022132          157 GCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  235 (302)
Q Consensus       157 G~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  235 (302)
                      ||++++|++ |.+||......+............                        .+........+..+.+++..|+
T Consensus       196 G~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~  251 (269)
T cd05042         196 GVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK------------------------LPKPQLDLKYSDRWYEVMQFCW  251 (269)
T ss_pred             HHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc------------------------CCCCcccccCCHHHHHHHHHHh
Confidence            999999998 788997766554443332211100                        0001112356778899999998


Q ss_pred             CCCCCCCCCHHHHhc
Q 022132          236 TFDPRQRITVEDALA  250 (302)
Q Consensus       236 ~~dP~~R~t~~ell~  250 (302)
                       .||.+|||++++++
T Consensus       252 -~dp~~Rpt~~~v~~  265 (269)
T cd05042         252 -LDPETRPTAEEVHE  265 (269)
T ss_pred             -cCcccccCHHHHHH
Confidence             59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-35  Score=252.82  Aligned_cols=210  Identities=20%  Similarity=0.294  Sum_probs=166.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCC-ccHHHHHHcC------CCCCHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRSN------QALSEEHCQYFLYQILRGL   83 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~-~~L~~~l~~~------~~l~~~~~~~i~~qll~~l   83 (302)
                      .+.+|+.+++.++||||+++++++..... .+....++++||+. ++|..++...      ..+++..+..++.|++.||
T Consensus        47 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL  126 (273)
T cd05035          47 EFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM  126 (273)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHH
Confidence            57789999999999999999998876532 33346899999997 6998887432      3689999999999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           84 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      +|||+.|++||||||+||++++++.++|+|||.++.......   ......+..|+|||.+. ...++.++|+||+||++
T Consensus       127 ~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~SlG~il  205 (273)
T cd05035         127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTM  205 (273)
T ss_pred             HHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcc-cCCCCcccchHHHHHHH
Confidence            999999999999999999999999999999999875433211   11223456799999874 34578999999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC
Q 022132          161 MELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       161 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      ++|++ |.+||.+....+....+....                             ........+..+.+++.+||+.||
T Consensus       206 ~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p  256 (273)
T cd05035         206 WEIATRGQTPYPGVENHEIYDYLRHGN-----------------------------RLKQPEDCLDELYDLMYSCWRADP  256 (273)
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------------------CCCCCcCCCHHHHHHHHHHcCCCh
Confidence            99998 899997766544433322110                             011123567899999999999999


Q ss_pred             CCCCCHHHHhcC
Q 022132          240 RQRITVEDALAH  251 (302)
Q Consensus       240 ~~R~t~~ell~h  251 (302)
                      ++|||+.|++.+
T Consensus       257 ~~Rp~~~e~~~~  268 (273)
T cd05035         257 KDRPTFTKLREV  268 (273)
T ss_pred             hhCcCHHHHHHH
Confidence            999999999863

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2e-35  Score=248.47  Aligned_cols=204  Identities=21%  Similarity=0.348  Sum_probs=165.3

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.+++.++||||+++++++...     +..++||||++ ++|.+++.. ...+++..+..++.|++.||.|||+.
T Consensus        38 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  112 (250)
T cd05085          38 KFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK  112 (250)
T ss_pred             HHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            577899999999999999999999887     78999999996 699998865 35689999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcc--cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-C
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-R  166 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g  166 (302)
                      |++|+||+|+||+++.++.++|+|||++.........  ....++..|+|||.+.+ ..++.++|+||+|++++++++ |
T Consensus       113 ~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g  191 (250)
T cd05085         113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLG  191 (250)
T ss_pred             CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCC
Confidence            9999999999999999999999999998654332211  11233456999998854 447899999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||.+.........+.....                             .......+..+.+++.+||..||++|||+.
T Consensus       192 ~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  242 (250)
T cd05085         192 VCPYPGMTNQQAREQVEKGYR-----------------------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFS  242 (250)
T ss_pred             CCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence            999977655443322211000                             011235678999999999999999999999


Q ss_pred             HHhc
Q 022132          247 DALA  250 (302)
Q Consensus       247 ell~  250 (302)
                      |+++
T Consensus       243 ~l~~  246 (250)
T cd05085         243 ELQK  246 (250)
T ss_pred             HHHH
Confidence            9975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.1e-36  Score=259.30  Aligned_cols=205  Identities=21%  Similarity=0.285  Sum_probs=164.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...      ..++++||+. |+|.+++... ..++...+..++.||+.||+|||+
T Consensus        54 ~~~~~e~~~l~~l~h~niv~~~g~~~~~------~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~  127 (316)
T cd05108          54 KEILDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE  127 (316)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEcCC------CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            3577899999999999999999998763      4679999986 7999998764 468899999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc---cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      .||+||||||+||+++.++.++|+|||+++........   .....+..|+|||.+.+ ..++.++|||||||++|+|++
T Consensus       128 ~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t  206 (316)
T cd05108         128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMT  206 (316)
T ss_pred             cCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHc
Confidence            99999999999999999999999999999865433211   12233567999998854 447899999999999999987


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+....+... +......                            ....+..+.++.+++.+||..||.+|||
T Consensus       207 ~g~~p~~~~~~~~~~~-~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps  257 (316)
T cd05108         207 FGSKPYDGIPASEISS-ILEKGER----------------------------LPQPPICTIDVYMIMVKCWMIDADSRPK  257 (316)
T ss_pred             CCCCCCCCCCHHHHHH-HHhCCCC----------------------------CCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence             999997765443322 1111000                            0111245678999999999999999999


Q ss_pred             HHHHhcC
Q 022132          245 VEDALAH  251 (302)
Q Consensus       245 ~~ell~h  251 (302)
                      +.+++.+
T Consensus       258 ~~~l~~~  264 (316)
T cd05108         258 FRELIIE  264 (316)
T ss_pred             HHHHHHH
Confidence            9999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.9e-35  Score=249.55  Aligned_cols=206  Identities=20%  Similarity=0.322  Sum_probs=167.9

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+.+|+.++++++||||+++++++..      +..++||||++ ++|.+.+....  .+++..+..++.|++.||+||
T Consensus        40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~l  113 (257)
T cd05040          40 MDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL  113 (257)
T ss_pred             HHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHH
Confidence            3467789999999999999999999876      57899999996 79999997653  689999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      |+.|++|+||+|+||+++.++.++|+|||.+.......    ......++..|+|||.+.. ..++.++|+||+||++++
T Consensus       114 H~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~e  192 (257)
T cd05040         114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWE  192 (257)
T ss_pred             HhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHH
Confidence            99999999999999999999999999999987654321    1112345678999998754 447899999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          163 LMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       163 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      |++ |.+||.+.+..+....+......                            .......+..+.+++.+||..+|.+
T Consensus       193 l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~  244 (257)
T cd05040         193 MFTYGEEPWAGLSGSQILKKIDKEGER----------------------------LERPEACPQDIYNVMLQCWAHNPAD  244 (257)
T ss_pred             HHhCCCCCCCCCCHHHHHHHHHhcCCc----------------------------CCCCccCCHHHHHHHHHHCCCCccc
Confidence            998 99999877665544443321000                            0011245788999999999999999


Q ss_pred             CCCHHHHhc
Q 022132          242 RITVEDALA  250 (302)
Q Consensus       242 R~t~~ell~  250 (302)
                      |||+.++++
T Consensus       245 Rps~~~~~~  253 (257)
T cd05040         245 RPTFAALRE  253 (257)
T ss_pred             CCCHHHHHH
Confidence            999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-35  Score=257.84  Aligned_cols=205  Identities=25%  Similarity=0.395  Sum_probs=165.2

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHH
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQ   73 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~   73 (302)
                      .+.+|+.+++.+ +||||+++++++...     +..|+||||++ ++|.+++...+                .++...+.
T Consensus        69 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~  143 (307)
T cd05098          69 DLISEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV  143 (307)
T ss_pred             HHHHHHHHHHHhcCCCCEeeEEEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHH
Confidence            467899999999 799999999999887     78999999997 69999997532                48889999


Q ss_pred             HHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCc
Q 022132           74 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAA  150 (302)
Q Consensus        74 ~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~  150 (302)
                      .++.|++.||+|||+.|++||||||+||+++.++.++|+|||.+........   .....++..|+|||.+.+. .++.+
T Consensus       144 ~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~  222 (307)
T cd05098         144 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQ  222 (307)
T ss_pred             HHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcH
Confidence            9999999999999999999999999999999999999999999875443211   1122334679999988654 47899


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHH
Q 022132          151 IDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID  229 (302)
Q Consensus       151 ~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (302)
                      +|+||+||++|+|++ |.+||.+.+..+....+....                             ........+.++.+
T Consensus       223 ~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~  273 (307)
T cd05098         223 SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-----------------------------RMDKPSNCTNELYM  273 (307)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC-----------------------------CCCCCCcCCHHHHH
Confidence            999999999999998 889997665433332221100                             00112256789999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcC
Q 022132          230 LVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       230 li~~~L~~dP~~R~t~~ell~h  251 (302)
                      ++.+||..+|.+|||+.+++++
T Consensus       274 li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         274 MMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHcccChhhCcCHHHHHHH
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.3e-35  Score=252.08  Aligned_cols=205  Identities=21%  Similarity=0.325  Sum_probs=166.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++...     +.+|+||||++ ++|.+++... +.++...+..++.|++.||++||+
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  124 (267)
T cd05066          50 RDFLSEASIMGQFDHPNIIHLEGVVTKS-----KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD  124 (267)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecC-----CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4678899999999999999999999876     78999999996 6999998764 568999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc----ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .|++|+||||+||+++.++.++|+|||.+........    .....++..|+|||.+.+. .++.++|+||+||++++++
T Consensus       125 ~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell  203 (267)
T cd05066         125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVM  203 (267)
T ss_pred             CCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHh
Confidence            9999999999999999999999999999876543211    1112234579999998543 4799999999999999988


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |..||.+.+..+....+.+....                             ......++.+.+++.+||+.+|.+||
T Consensus       204 ~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp  254 (267)
T cd05066         204 SYGERPYWEMSNQDVIKAIEEGYRL-----------------------------PAPMDCPAALHQLMLDCWQKDRNERP  254 (267)
T ss_pred             cCCCCCcccCCHHHHHHHHhCCCcC-----------------------------CCCCCCCHHHHHHHHHHcccCchhCC
Confidence            6 99999777655444333221110                             01125678899999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |+.++++
T Consensus       255 ~~~~i~~  261 (267)
T cd05066         255 KFEQIVS  261 (267)
T ss_pred             CHHHHHH
Confidence            9999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-35  Score=252.15  Aligned_cols=207  Identities=26%  Similarity=0.391  Sum_probs=165.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+|+||++ ++|.+++..    ...+++..+..++.|++.||+|
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  121 (267)
T cd08228          47 QDCVKEIDLLKQLNHPNVIKYLDSFIED-----NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH  121 (267)
T ss_pred             HHHHHHHHHHHhCCCcceeeeeeeEEEC-----CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999887     88999999997 599888752    3458999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc-ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ||++|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||+|+++++|+
T Consensus       122 LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~  200 (267)
T cd08228         122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMA  200 (267)
T ss_pred             HhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHh
Confidence            9999999999999999999999999999998876543221 2234577889999988654 4788999999999999999


Q ss_pred             hCCCCCCCCChH-HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 DRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      +|..||...... ..........+.|+                           ......+..+.+++.+||..||++||
T Consensus       201 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp  253 (267)
T cd08228         201 ALQSPFYGDKMNLFSLCQKIEQCDYPP---------------------------LPTEHYSEKLRELVSMCIYPDPDQRP  253 (267)
T ss_pred             cCCCCCccccccHHHHHHHHhcCCCCC---------------------------CChhhcCHHHHHHHHHHCCCCcccCc
Confidence            999998654321 11211111111111                           00114567899999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |+.++++
T Consensus       254 ~~~~vl~  260 (267)
T cd08228         254 DIGYVHQ  260 (267)
T ss_pred             CHHHHHH
Confidence            9999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-35  Score=249.24  Aligned_cols=206  Identities=28%  Similarity=0.432  Sum_probs=169.8

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--l~~~~~~~i~~qll~~l~~L   86 (302)
                      ...+.+|+.+++.++||||+++++++.+.     +..|++|||+. ++|.+++.....  +++..+..++.|++.||++|
T Consensus        45 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l  119 (258)
T smart00219       45 IEEFLREARIMRKLDHPNIVKLLGVCTEE-----EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL  119 (258)
T ss_pred             HHHHHHHHHHHHhcCCCchheEEEEEcCC-----CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHH
Confidence            34677899999999999999999999987     88999999996 699999976544  99999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCccc--ccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT--EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      |+.|++|+||+|+||+++.++.++|+|||.+..........  ...++..|+|||.+. ...++.++|+||+|+++++|+
T Consensus       120 h~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~  198 (258)
T smart00219      120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIF  198 (258)
T ss_pred             hcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHH
Confidence            99999999999999999999999999999987655432221  123567899999884 445799999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |.+||...+.......+.....                             .......+.++.+++.+||..||.+||
T Consensus       199 ~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp  249 (258)
T smart00219      199 TLGESPYPGMSNEEVLEYLKKGYR-----------------------------LPKPENCPPEIYKLMLQCWAEDPEDRP  249 (258)
T ss_pred             hCCCCCCCCCCHHHHHHHHhcCCC-----------------------------CCCCCcCCHHHHHHHHHHCcCChhhCc
Confidence            8 8899977665544443322110                             111224678999999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |+.++++
T Consensus       250 t~~~ll~  256 (258)
T smart00219      250 TFSELVE  256 (258)
T ss_pred             CHHHHHh
Confidence            9999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-35  Score=253.93  Aligned_cols=220  Identities=20%  Similarity=0.256  Sum_probs=163.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.....   ..+|++|||+. ++|.+++.. ..+++..+..++.|++.||+|||++
T Consensus        51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~  126 (283)
T cd05080          51 SGWKKEINILKTLYHENIVKYKGCCSEQGG---KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQ  126 (283)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCCC---ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            456789999999999999999998765421   56899999997 699998876 4699999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCc----ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      |++||||||+||+++.++.++|+|||++........    .....++..|+|||.+.+ ..++.++|||||||++++|++
T Consensus       127 ~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~t  205 (283)
T cd05080         127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLT  205 (283)
T ss_pred             CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHh
Confidence            999999999999999999999999999876543211    122344567999998854 447899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHH-hCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 RKPLFPGRDHVHQLRLLIEL-IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      |..||.......  ...... .+......       .......   ...   .......+..+.+++.+||+.||++|||
T Consensus       206 g~~p~~~~~~~~--~~~~~~~~~~~~~~~-------~~~~~~~---~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps  270 (283)
T cd05080         206 HCDSKQSPPKKF--EEMIGPKQGQMTVVR-------LIELLER---GMR---LPCPKNCPQEVYILMKNCWETEAKFRPT  270 (283)
T ss_pred             CCCCCCCCcchh--hhhhcccccccchhh-------hhhhhhc---CCC---CCCCCCCCHHHHHHHHHHhccChhhCCC
Confidence            999985443211  000000 00000000       0000000   000   0112356789999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++++++
T Consensus       271 ~~~i~~  276 (283)
T cd05080         271 FRSLIP  276 (283)
T ss_pred             HHHHHH
Confidence            999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.3e-35  Score=250.93  Aligned_cols=205  Identities=21%  Similarity=0.329  Sum_probs=165.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..|.+|+.+++.++||||+++++++...     ..+++||||++ ++|.+++.. .+.+++..+..++.|++.||+|||+
T Consensus        50 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~  124 (269)
T cd05065          50 RDFLSEASIMGQFDHPNIIHLEGVVTKS-----RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE  124 (269)
T ss_pred             HHHHHHHHHHHhCCCcCcceEEEEECCC-----CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4678899999999999999999999887     78999999997 589998875 4568999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc---c-c--cccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM---T-E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~-~--~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      +|++|+||+|+||+++.++.++|+|||.+.........   . .  ...+..|+|||.+.+ ..++.++|+||+||++++
T Consensus       125 ~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e  203 (269)
T cd05065         125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWE  203 (269)
T ss_pred             CCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHH
Confidence            99999999999999999999999999988654322111   1 1  112346999998854 447899999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          163 LMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       163 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      |++ |..||...+.......+......|                             ..+..+..+.+++.+||..+|.+
T Consensus       204 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~  254 (269)
T cd05065         204 VMSYGERPYWDMSNQDVINAIEQDYRLP-----------------------------PPMDCPTALHQLMLDCWQKDRNA  254 (269)
T ss_pred             HhcCCCCCCCCCCHHHHHHHHHcCCcCC-----------------------------CcccCCHHHHHHHHHHcCCChhh
Confidence            886 999997766554433332111000                             11256788999999999999999


Q ss_pred             CCCHHHHhc
Q 022132          242 RITVEDALA  250 (302)
Q Consensus       242 R~t~~ell~  250 (302)
                      |||+++++.
T Consensus       255 Rp~~~~i~~  263 (269)
T cd05065         255 RPKFGQIVS  263 (269)
T ss_pred             CcCHHHHHH
Confidence            999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.3e-35  Score=250.45  Aligned_cols=207  Identities=25%  Similarity=0.391  Sum_probs=165.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.+++.++||||+++++++...     +..+++|||++ ++|.+++..    ...+++..++.++.||+.||.|
T Consensus        47 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  121 (267)
T cd08229          47 ADCIKEIDLLKQLNHPNVIKYYASFIED-----NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH  121 (267)
T ss_pred             HHHHHHHHHHHHccCCchhhhhheeEeC-----CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence            4678899999999999999999999887     88999999997 599888763    4568999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ||++|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++++|+
T Consensus       122 LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~  200 (267)
T cd08229         122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMA  200 (267)
T ss_pred             HHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHH
Confidence            999999999999999999999999999999887654332 2233467888999998854 44788999999999999999


Q ss_pred             hCCCCCCCCChHH-HHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 DRKPLFPGRDHVH-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      +|..||.+..... ...........+                           .......++.+.+++.+||..||++||
T Consensus       201 ~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp  253 (267)
T cd08229         201 ALQSPFYGDKMNLYSLCKKIEQCDYP---------------------------PLPSDHYSEELRQLVNMCINPDPEKRP  253 (267)
T ss_pred             hCCCCcccccchHHHHhhhhhcCCCC---------------------------CCCcccccHHHHHHHHHhcCCCcccCC
Confidence            9999996543221 111110000000                           001124677899999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |+.+++.
T Consensus       254 t~~~i~~  260 (267)
T cd08229         254 DITYVYD  260 (267)
T ss_pred             CHHHHHH
Confidence            9997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.2e-35  Score=258.80  Aligned_cols=206  Identities=25%  Similarity=0.400  Sum_probs=166.8

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHC   72 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~   72 (302)
                      ..+.+|+.+++++ +||||+++++++...     +.+|+++||++ |+|.+++....                .++...+
T Consensus        62 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  136 (334)
T cd05100          62 SDLVSEMEMMKMIGKHKNIINLLGACTQD-----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL  136 (334)
T ss_pred             HHHHHHHHHHHhhcCCCCeeeeeEEEccC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHH
Confidence            3677899999999 899999999999887     78999999996 69999987532                4778889


Q ss_pred             HHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCC
Q 022132           73 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTA  149 (302)
Q Consensus        73 ~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~  149 (302)
                      ..++.|++.||+|||++|++||||||+||+++.++.++|+|||.++.......   .....++..|+|||.+.+. .++.
T Consensus       137 ~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~  215 (334)
T cd05100         137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTH  215 (334)
T ss_pred             HHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCc
Confidence            99999999999999999999999999999999999999999999876543221   1222334579999998554 4789


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHH
Q 022132          150 AIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  228 (302)
Q Consensus       150 ~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (302)
                      ++|||||||++++|++ |.+||.+.+..+....+.....                             .......+..+.
T Consensus       216 ~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~  266 (334)
T cd05100         216 QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR-----------------------------MDKPANCTHELY  266 (334)
T ss_pred             hhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCCCCCHHHH
Confidence            9999999999999998 8899987765544333321100                             011225677899


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcC
Q 022132          229 DLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       229 ~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +++.+||+.+|.+|||+.|++++
T Consensus       267 ~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         267 MIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHcccChhhCcCHHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.7e-35  Score=264.42  Aligned_cols=206  Identities=25%  Similarity=0.340  Sum_probs=162.9

Q ss_pred             CchhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC------------------------
Q 022132           11 GHFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN------------------------   64 (302)
Q Consensus        11 ~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------   64 (302)
                      ..+.+|+.+++.+. ||||+++++++...     +.+|+|||||. |+|.+++...                        
T Consensus        85 ~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (400)
T cd05105          85 QALMSELKIMTHLGPHLNIVNLLGACTKS-----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPA  159 (400)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcc
Confidence            35778999999995 99999999999887     88999999996 6998887542                        


Q ss_pred             ------------------------------------------------------------------------CCCCHHHH
Q 022132           65 ------------------------------------------------------------------------QALSEEHC   72 (302)
Q Consensus        65 ------------------------------------------------------------------------~~l~~~~~   72 (302)
                                                                                              ..+++..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~  239 (400)
T cd05105         160 DESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDL  239 (400)
T ss_pred             cccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHH
Confidence                                                                                    24778888


Q ss_pred             HHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCC
Q 022132           73 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTA  149 (302)
Q Consensus        73 ~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~  149 (302)
                      ..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+. .++.
T Consensus       240 ~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~  318 (400)
T cd05105         240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTT  318 (400)
T ss_pred             HHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCc
Confidence            9999999999999999999999999999999999999999999987543221   11223456779999988654 4789


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHH
Q 022132          150 AIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  228 (302)
Q Consensus       150 ~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (302)
                      ++|||||||++++|++ |..||.+................                            .......+..+.
T Consensus       319 ~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~  370 (400)
T cd05105         319 LSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR----------------------------MAKPDHATQEVY  370 (400)
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCC----------------------------CCCCccCCHHHH
Confidence            9999999999999996 99999765433222111110000                            011125678899


Q ss_pred             HHHHHccCCCCCCCCCHHHHhc
Q 022132          229 DLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       229 ~li~~~L~~dP~~R~t~~ell~  250 (302)
                      +++.+||+.||++|||+.++.+
T Consensus       371 ~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         371 DIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHCccCHhHCcCHHHHHH
Confidence            9999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-35  Score=253.08  Aligned_cols=211  Identities=22%  Similarity=0.366  Sum_probs=165.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC------------CCCHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ------------ALSEEHCQYFLYQ   78 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------------~l~~~~~~~i~~q   78 (302)
                      .+.+|+++++.++||||+++++++...     +..++||||+. ++|.+++....            .+++..+..++.|
T Consensus        63 ~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  137 (295)
T cd05097          63 DFLKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQ  137 (295)
T ss_pred             HHHHHHHHHHhCCCCCcCeEEEEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHH
Confidence            577899999999999999999999887     88999999997 69999886431            3688899999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHH
Q 022132           79 ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWS  155 (302)
Q Consensus        79 ll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  155 (302)
                      ++.||+|||+.|++|+||||+||+++.++.++|+|||++........   .....++..|+|||.+.+. .++.++|+||
T Consensus       138 i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS  216 (295)
T cd05097         138 IASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWA  216 (295)
T ss_pred             HHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHH
Confidence            99999999999999999999999999999999999999875432211   1222346679999988654 4799999999


Q ss_pred             HHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHH
Q 022132          156 VGCIFMELMD--RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  233 (302)
Q Consensus       156 lG~i~~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  233 (302)
                      |||++++|++  |..||...+...............                      .........+..++.+.+|+.+
T Consensus       217 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~li~~  274 (295)
T cd05097         217 FGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQ----------------------GRQIYLSQTPLCPSPVFKLMMR  274 (295)
T ss_pred             HHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhc----------------------cccccCCCCCCCCHHHHHHHHH
Confidence            9999999987  677887766555444332211100                      0000111223467899999999


Q ss_pred             ccCCCCCCCCCHHHHhc
Q 022132          234 MLTFDPRQRITVEDALA  250 (302)
Q Consensus       234 ~L~~dP~~R~t~~ell~  250 (302)
                      ||..||.+|||++++++
T Consensus       275 ~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         275 CWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HcCCCchhCcCHHHHHH
Confidence            99999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.6e-35  Score=253.06  Aligned_cols=205  Identities=21%  Similarity=0.327  Sum_probs=164.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------------CCC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------------QAL   67 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------------~~l   67 (302)
                      ..+.+|+.+++.+.||||+++++++...     ..+|++|||++ ++|.+++...                      ..+
T Consensus        53 ~~~~~ei~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l  127 (288)
T cd05050          53 ADFQREAALMAEFDHPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL  127 (288)
T ss_pred             HHHHHHHHHHHhcCCCchheEEEEEcCC-----CccEEEEecCCCCCHHHHHHHcCcccccccccccccccccccccccc
Confidence            4578899999999999999999999887     78999999997 6999998743                      247


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCC
Q 022132           68 SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNS  144 (302)
Q Consensus        68 ~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~  144 (302)
                      ++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........   ......+..|+|||.+.+.
T Consensus       128 ~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  207 (288)
T cd05050         128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN  207 (288)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC
Confidence            7888999999999999999999999999999999999999999999999875433211   1122345669999988544


Q ss_pred             CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCC
Q 022132          145 SDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV  223 (302)
Q Consensus       145 ~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (302)
                       .++.++|+|||||++|+|++ |..||.+.+..+....+....                             .....+..
T Consensus       208 -~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~  257 (288)
T cd05050         208 -RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN-----------------------------VLSCPDNC  257 (288)
T ss_pred             -CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----------------------------CCCCCCCC
Confidence             48999999999999999997 888887665544333222100                             00111246


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          224 HPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       224 ~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      +..+.+++.+||+.||.+|||++|+++
T Consensus       258 ~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         258 PLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.5e-35  Score=248.71  Aligned_cols=206  Identities=21%  Similarity=0.361  Sum_probs=167.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|++++++++|||++++++++...     ...++||||+. ++|.+++... +.++++.+..++.|++.|+++||+
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  118 (256)
T cd05112          44 EDFIEEAQVMMKLSHPKLVQLYGVCTER-----SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES  118 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEccC-----CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999887     78999999997 6999888753 568999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      .|++|+||+|+||+++.++.++|+|||.+........  .....++..|+|||.+.+ ..++.++|+||+|+++|+|++ 
T Consensus       119 ~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~  197 (256)
T cd05112         119 SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSE  197 (256)
T ss_pred             CCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcC
Confidence            9999999999999999999999999999875543321  112234567999998864 447899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||...........+......                             ......+..+.+|+.+||+.+|++|||+
T Consensus       198 g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~  248 (256)
T cd05112         198 GKTPYENRSNSEVVETINAGFRL-----------------------------YKPRLASQSVYELMQHCWKERPEDRPSF  248 (256)
T ss_pred             CCCCCCcCCHHHHHHHHhCCCCC-----------------------------CCCCCCCHHHHHHHHHHcccChhhCCCH
Confidence            99999776655444333211000                             0011356789999999999999999999


Q ss_pred             HHHhcC
Q 022132          246 EDALAH  251 (302)
Q Consensus       246 ~ell~h  251 (302)
                      .++++.
T Consensus       249 ~~~l~~  254 (256)
T cd05112         249 SLLLHQ  254 (256)
T ss_pred             HHHHHh
Confidence            999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.9e-35  Score=250.41  Aligned_cols=204  Identities=24%  Similarity=0.372  Sum_probs=165.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.+.||||+++++++.+      +..|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+
T Consensus        52 ~~~~~e~~~l~~~~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~  125 (270)
T cd05056          52 EKFLQEAYIMRQFDHPHIVKLIGVITE------NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES  125 (270)
T ss_pred             HHHHHHHHHHHhCCCCchhceeEEEcC------CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            467889999999999999999999875      45789999996 6999999764 468999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc--cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      .|++|+||+|+||+++.++.++|+|||++.........  ....++..|+|||.+.. ..++.++|+|||||+++++++ 
T Consensus       126 ~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~  204 (270)
T cd05056         126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILML  204 (270)
T ss_pred             CCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHc
Confidence            99999999999999999999999999998765433211  12233457999998754 457899999999999999986 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||.+.+..+....+....                             .....+.+++.+.+++.+|+..+|.+|||+
T Consensus       205 g~~pf~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  255 (270)
T cd05056         205 GVKPFQGVKNNDVIGRIENGE-----------------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRF  255 (270)
T ss_pred             CCCCCCCCCHHHHHHHHHcCC-----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            999998776554433322100                             001223678899999999999999999999


Q ss_pred             HHHhc
Q 022132          246 EDALA  250 (302)
Q Consensus       246 ~ell~  250 (302)
                      .+++.
T Consensus       256 ~~~~~  260 (270)
T cd05056         256 TELKA  260 (270)
T ss_pred             HHHHH
Confidence            99876

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.7e-35  Score=251.19  Aligned_cols=207  Identities=20%  Similarity=0.311  Sum_probs=167.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC---------CCCHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---------ALSEEHCQYFLYQIL   80 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---------~l~~~~~~~i~~qll   80 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +..|+||||++ ++|.+++....         .+++..+..++.|++
T Consensus        53 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~  127 (275)
T cd05046          53 SEFRRELDMFRKLSHKNVVRLLGLCREA-----EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA  127 (275)
T ss_pred             HHHHHHHHHHHhcCCcceeeeEEEECCC-----CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHH
Confidence            3578899999999999999999999887     78999999997 79999997655         689999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC--CcccccccccccCchhhhhCCCCCCCchhHHHHHH
Q 022132           81 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC  158 (302)
Q Consensus        81 ~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  158 (302)
                      .||+|||+.||+||||||+||+++.++.++++|||++......  .......++..|+|||.+.+. ..+.++||||||+
T Consensus       128 ~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~  206 (275)
T cd05046         128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGV  206 (275)
T ss_pred             HHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHH
Confidence            9999999999999999999999999999999999987643222  112233456779999988544 4788999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCC
Q 022132          159 IFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTF  237 (302)
Q Consensus       159 i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  237 (302)
                      ++++|++ |..||.+.........+...  .                         .. .......+..+.+++.+||+.
T Consensus       207 ~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~-------------------------~~-~~~~~~~~~~l~~~i~~~l~~  258 (275)
T cd05046         207 LMWEVFTQGELPFYGLSDEEVLNRLQAG--K-------------------------LE-LPVPEGCPSRLYKLMTRCWAV  258 (275)
T ss_pred             HHHHHHhCCCCCccccchHHHHHHHHcC--C-------------------------cC-CCCCCCCCHHHHHHHHHHcCC
Confidence            9999998 88899765544333322110  0                         00 011225678999999999999


Q ss_pred             CCCCCCCHHHHhcC
Q 022132          238 DPRQRITVEDALAH  251 (302)
Q Consensus       238 dP~~R~t~~ell~h  251 (302)
                      ||.+|||+.+++..
T Consensus       259 ~p~~Rp~~~~~l~~  272 (275)
T cd05046         259 NPKDRPSFSELVSA  272 (275)
T ss_pred             CcccCCCHHHHHHH
Confidence            99999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.8e-35  Score=250.92  Aligned_cols=203  Identities=22%  Similarity=0.285  Sum_probs=163.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.+++.++||||+++++++..      ...++++||++ |+|.+.+.. .+.+++..+..++.|++.||+|||+.
T Consensus        55 ~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~  128 (279)
T cd05109          55 EILDEAYVMAGVGSPYVCRLLGICLT------STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV  128 (279)
T ss_pred             HHHHHHHHHHhcCCCCCceEEEEEcC------CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            56789999999999999999999875      45789999996 799999876 45799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      |++||||||+||+++.++.++|+|||+++.......   .....++..|+|||...+. .++.++|||||||++|+|++ 
T Consensus       129 ~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~  207 (279)
T cd05109         129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTF  207 (279)
T ss_pred             CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcC
Confidence            999999999999999999999999999876543221   1122345679999998544 47899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||...........+.. ...+                            ...+..+.++.+++.+||..||.+|||+
T Consensus       208 g~~p~~~~~~~~~~~~~~~-~~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~  258 (279)
T cd05109         208 GAKPYDGIPAREIPDLLEK-GERL----------------------------PQPPICTIDVYMIMVKCWMIDSECRPRF  258 (279)
T ss_pred             CCCCCCCCCHHHHHHHHHC-CCcC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCH
Confidence            9999976654333222211 1000                            1122567889999999999999999999


Q ss_pred             HHHhc
Q 022132          246 EDALA  250 (302)
Q Consensus       246 ~ell~  250 (302)
                      .+++.
T Consensus       259 ~~l~~  263 (279)
T cd05109         259 RELVD  263 (279)
T ss_pred             HHHHH
Confidence            99985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3e-35  Score=249.09  Aligned_cols=206  Identities=23%  Similarity=0.352  Sum_probs=161.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++....    +..++||||+. ++|.+++... ..++...+..++.|++.||+|||+
T Consensus        41 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  116 (262)
T cd05058          41 EQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS  116 (262)
T ss_pred             HHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            36778999999999999999999776431    56889999996 7999998753 456788889999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC-----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      .|++||||||+||+++.++.++|+|||.+.......     ......++..|+|||.+.+ ..++.++|||||||++++|
T Consensus       117 ~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el  195 (262)
T cd05058         117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWEL  195 (262)
T ss_pred             CCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHH
Confidence            999999999999999999999999999987543221     1122344667999998854 4478999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          164 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       164 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      ++ |.+||...+........... ..+                            ......++.+.+++.+||..+|++|
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~-~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~R  246 (262)
T cd05058         196 MTRGAPPYPDVDSFDITVYLLQG-RRL----------------------------LQPEYCPDPLYEVMLSCWHPKPEMR  246 (262)
T ss_pred             HcCCCCCCCCCCHHHHHHHHhcC-CCC----------------------------CCCCcCCHHHHHHHHHHcCCChhhC
Confidence            99 56778665543332221110 000                            0011457789999999999999999


Q ss_pred             CCHHHHhc
Q 022132          243 ITVEDALA  250 (302)
Q Consensus       243 ~t~~ell~  250 (302)
                      ||+.+++.
T Consensus       247 p~~~~il~  254 (262)
T cd05058         247 PTFSELVS  254 (262)
T ss_pred             CCHHHHHH
Confidence            99999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.9e-35  Score=250.29  Aligned_cols=203  Identities=22%  Similarity=0.287  Sum_probs=161.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+..|+.+++.+.||||+++++++..      ...++++||+. |+|.+++.. .+.+++..+..++.||+.||+|||+.
T Consensus        55 ~~~~~~~~l~~l~h~~iv~~~~~~~~------~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  128 (279)
T cd05111          55 EITDHMLAMGSLDHAYIVRLLGICPG------ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH  128 (279)
T ss_pred             HHHHHHHHHhcCCCCCcceEEEEECC------CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            45567778899999999999998753      45788999986 799999975 46789999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      |++|+||||+||+++.++.++|+|||.++......   ......++..|+|||.+.+. .++.++|+|||||++|++++ 
T Consensus       129 ~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~  207 (279)
T cd05111         129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSY  207 (279)
T ss_pred             CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcC
Confidence            99999999999999999999999999987543221   11233456679999988654 48999999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||.+.........+ .....+                            ......+.++.+++.+||..||.+|||+
T Consensus       208 g~~p~~~~~~~~~~~~~-~~~~~~----------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~  258 (279)
T cd05111         208 GAEPYAGMRPHEVPDLL-EKGERL----------------------------AQPQICTIDVYMVMVKCWMIDENVRPTF  258 (279)
T ss_pred             CCCCCCCCCHHHHHHHH-HCCCcC----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence            99999776544322221 110000                            0011346688999999999999999999


Q ss_pred             HHHhc
Q 022132          246 EDALA  250 (302)
Q Consensus       246 ~ell~  250 (302)
                      .|+++
T Consensus       259 ~el~~  263 (279)
T cd05111         259 KELAN  263 (279)
T ss_pred             HHHHH
Confidence            99976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4e-35  Score=248.18  Aligned_cols=204  Identities=23%  Similarity=0.370  Sum_probs=165.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++++..      +.+|++|||+. ++|.+++..  ...+++..+..++.|++.||+|||
T Consensus        46 ~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH  119 (260)
T cd05067          46 EAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE  119 (260)
T ss_pred             HHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh
Confidence            367889999999999999999998743      56899999996 699998864  346899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +.|++|+||+|+||+++.++.++|+|||.+........  .....++..|+|||.+.. ..++.++|+||+|++++++++
T Consensus       120 ~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~  198 (260)
T cd05067         120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVT  198 (260)
T ss_pred             cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHh
Confidence            99999999999999999999999999999876542211  122334567999998854 447889999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.+.......+......                             ......+..+.+++.+||..||++|||
T Consensus       199 ~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~  249 (260)
T cd05067         199 YGRIPYPGMTNPEVIQNLERGYRM-----------------------------PRPDNCPEELYELMRLCWKEKPEERPT  249 (260)
T ss_pred             CCCCCCCCCChHHHHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHccCChhhCCC
Confidence             99999877655544333211110                             111246778999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++++++
T Consensus       250 ~~~l~~  255 (260)
T cd05067         250 FEYLRS  255 (260)
T ss_pred             HHHHHH
Confidence            999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.4e-35  Score=248.20  Aligned_cols=210  Identities=20%  Similarity=0.257  Sum_probs=161.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-----QALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----~~l~~~~~~~i~~qll~~l~   84 (302)
                      ..+.+|+.++++++||||+++++++.+.     ..+++||||++ |+|.+++...     ...++..+..++.|++.|++
T Consensus        40 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~  114 (269)
T cd05087          40 MKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL  114 (269)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHH
Confidence            3677899999999999999999999887     78999999997 7999998642     24567788899999999999


Q ss_pred             HHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCC------CCCCchhHHH
Q 022132           85 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSS------DYTAAIDVWS  155 (302)
Q Consensus        85 ~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~------~~~~~~Diws  155 (302)
                      |||+.|++|+||||+||+++.++.++|+|||.+........   .....++..|+|||.+.+..      .++.++|+||
T Consensus       115 ~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws  194 (269)
T cd05087         115 HLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS  194 (269)
T ss_pred             HHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHH
Confidence            99999999999999999999999999999999865432211   12234567799999885321      2478999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHc
Q 022132          156 VGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  234 (302)
Q Consensus       156 lG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (302)
                      +||++++|++ |.+||......+...........                     ..   .........+..+.+++..|
T Consensus       195 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~---~~~~~~~~~~~~~~~l~~~c  250 (269)
T cd05087         195 LGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL---------------------KL---PKPRLKLPLSDRWYEVMQFC  250 (269)
T ss_pred             HHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC---------------------CC---CCCccCCCCChHHHHHHHHH
Confidence            9999999996 99999766554433222110000                     00   00111123567889999999


Q ss_pred             cCCCCCCCCCHHHHhc
Q 022132          235 LTFDPRQRITVEDALA  250 (302)
Q Consensus       235 L~~dP~~R~t~~ell~  250 (302)
                      + .+|++|||++|++.
T Consensus       251 ~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         251 W-LQPEQRPSAEEVHL  265 (269)
T ss_pred             h-cCcccCCCHHHHHH
Confidence            8 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.9e-35  Score=251.45  Aligned_cols=212  Identities=22%  Similarity=0.354  Sum_probs=164.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-----------CCCHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-----------ALSEEHCQYFLYQ   78 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~l~~~~~~~i~~q   78 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++....           .+++..+..++.|
T Consensus        64 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (296)
T cd05095          64 NDFLKEIKIMSRLKDPNIIRLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQ  138 (296)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHH
Confidence            3677999999999999999999999887     78999999996 69999987542           3677889999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHH
Q 022132           79 ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWS  155 (302)
Q Consensus        79 ll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  155 (302)
                      ++.||+|||+.|++|+||||+||+++.++.++|+|||.+........   ......+..|+|||...+. .++.++|+||
T Consensus       139 i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwS  217 (296)
T cd05095         139 IASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWA  217 (296)
T ss_pred             HHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhH
Confidence            99999999999999999999999999999999999999875433211   1122335679999987654 4899999999


Q ss_pred             HHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHH
Q 022132          156 VGCIFMELMD--RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  233 (302)
Q Consensus       156 lG~i~~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  233 (302)
                      |||++|+|++  |..||...+..+.+........                   ..   .........+..++.+.+|+.+
T Consensus       218 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~-------------------~~---~~~~~~~~~~~~~~~~~~li~~  275 (296)
T cd05095         218 FGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFR-------------------DQ---GRQVYLPKPALCPDSLYKLMLS  275 (296)
T ss_pred             HHHHHHHHHHhCCCCCccccChHHHHHHHHHHHh-------------------hc---cccccCCCCCCCCHHHHHHHHH
Confidence            9999999997  7788876655443322211000                   00   0000011123467889999999


Q ss_pred             ccCCCCCCCCCHHHHhc
Q 022132          234 MLTFDPRQRITVEDALA  250 (302)
Q Consensus       234 ~L~~dP~~R~t~~ell~  250 (302)
                      ||+.||.+|||+.++++
T Consensus       276 cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         276 CWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HcCCCcccCCCHHHHHH
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=8e-37  Score=264.12  Aligned_cols=237  Identities=31%  Similarity=0.550  Sum_probs=191.7

Q ss_pred             hhhHHHHHHhcCC------CCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCC---CCCHHHHHHHHHHHHHHH
Q 022132           13 FVRSSCFDTWIMK------TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ---ALSEEHCQYFLYQILRGL   83 (302)
Q Consensus        13 ~~~E~~il~~l~h------~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~l~~~~~~~i~~qll~~l   83 (302)
                      -.+|+.||+.|+.      -|+++++..|...     +++|||+|-+.-+|.+++.+.|   .|....++.++.|++.||
T Consensus       475 Gl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk-----nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflAL  549 (752)
T KOG0670|consen  475 GLKELEILKKLNDADPEDKFHCLRLFRHFKHK-----NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLAL  549 (752)
T ss_pred             hhHHHHHHHHhhccCchhhhHHHHHHHHhhhc-----ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHH
Confidence            4579999999974      3789999999888     9999999999999999998754   588999999999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEecC-CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           84 KYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      ..|..+||+|.||||+||||+.. ..+||||||.|...++.. .+.+.-+.+|+|||++.+.. |+...|+||+||++|+
T Consensus       550 klLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYE  627 (752)
T KOG0670|consen  550 KLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYE  627 (752)
T ss_pred             HHHHhcCeeecccCccceEeccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEE
Confidence            99999999999999999999976 558999999998877654 46677889999999998766 8999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHh--hhc-----cccccc-------------cccccC--
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI--CQL-----PRYQRQ-------------SFTEKF--  220 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-----~~~~~~-------------~~~~~~--  220 (302)
                      +.+|+..|+|....+++...++.-|..+..++..-.....-|-  +.+     ...+..             .+....  
T Consensus       628 lYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~  707 (752)
T KOG0670|consen  628 LYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA  707 (752)
T ss_pred             eeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc
Confidence            9999999999999999999999999887776542211100000  000     000000             000000  


Q ss_pred             -CCCC-------HHHHHHHHHccCCCCCCCCCHHHHhcCCCcCC
Q 022132          221 -PNVH-------PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  256 (302)
Q Consensus       221 -~~~~-------~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  256 (302)
                       +.++       ..+++|+.+||..||.+|.|+.++|.||||+.
T Consensus       708 ~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  708 VQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             cCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence             0122       46899999999999999999999999999974

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.2e-35  Score=246.64  Aligned_cols=202  Identities=24%  Similarity=0.387  Sum_probs=163.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++|||++++++++..      +..|+||||+. ++|.+++...  ..+++..+..++.|++.||.|||
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH  117 (254)
T cd05083          44 QAFLEETAVMTKLHHKNLVRLLGVILH------NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE  117 (254)
T ss_pred             HHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999865      34799999997 6999999754  35889999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-C
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-R  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g  166 (302)
                      +.|++||||+|+||+++.++.++|+|||.+......  ......+..|+|||.+.+ ..++.++|+||+||++++|++ |
T Consensus       118 ~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g  194 (254)
T cd05083         118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYG  194 (254)
T ss_pred             hCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999998754322  122234567999998854 447899999999999999997 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+.......+....                          .   ....+..+..+.+++.+||+.+|.+|||++
T Consensus       195 ~~p~~~~~~~~~~~~~~~~~--------------------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  245 (254)
T cd05083         195 RAPYPKMSLKEVKECVEKGY--------------------------R---MEPPEGCPADVYVLMTSCWETEPKKRPSFH  245 (254)
T ss_pred             CCCCccCCHHHHHHHHhCCC--------------------------C---CCCCCcCCHHHHHHHHHHcCCChhhCcCHH
Confidence            99997766543322221100                          0   011125678899999999999999999999


Q ss_pred             HHhc
Q 022132          247 DALA  250 (302)
Q Consensus       247 ell~  250 (302)
                      +++.
T Consensus       246 ~l~~  249 (254)
T cd05083         246 KLRE  249 (254)
T ss_pred             HHHH
Confidence            9875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.1e-35  Score=247.11  Aligned_cols=201  Identities=17%  Similarity=0.239  Sum_probs=160.4

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.+++.++||||+++++++..      +..++||||++ ++|.+++...+ .++...+..++.||+.||+|||
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH  118 (259)
T cd05037          45 SLAFFETASLMSQLSHKHLVKLYGVCVR------DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE  118 (259)
T ss_pred             HHHHHHHHHHHHcCCCcchhheeeEEec------CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh
Confidence            3467799999999999999999998866      24689999997 69999998755 7999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCC-------CEEEeecccccccCCCCcccccccccccCchhhhhCC-CCCCCchhHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANC-------DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCI  159 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~i  159 (302)
                      ++||+||||||+||+++.++       .++|+|||++......   ....++..|+|||.+.+. ..++.++|+||+||+
T Consensus       119 ~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~  195 (259)
T cd05037         119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTT  195 (259)
T ss_pred             hCCeecccCccceEEEecCccccCCceeEEeCCCCcccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHH
Confidence            99999999999999999887       7999999998765432   233456679999998655 357899999999999


Q ss_pred             HHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCC
Q 022132          160 FMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       160 ~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  238 (302)
                      +++|++ |..||...+..........    +.                           .........+.+++.+||..|
T Consensus       196 ~~~l~~~~~~p~~~~~~~~~~~~~~~----~~---------------------------~~~~~~~~~~~~li~~~l~~~  244 (259)
T cd05037         196 LLEICSNGEEPLSTLSSSEKERFYQD----QH---------------------------RLPMPDCAELANLINQCWTYD  244 (259)
T ss_pred             HHHHHhCCCCCcccCCchhHHHHHhc----CC---------------------------CCCCCCchHHHHHHHHHhccC
Confidence            999998 5778866543221111110    00                           000012268999999999999


Q ss_pred             CCCCCCHHHHhc
Q 022132          239 PRQRITVEDALA  250 (302)
Q Consensus       239 P~~R~t~~ell~  250 (302)
                      |.+|||+.++++
T Consensus       245 p~~Rpt~~~il~  256 (259)
T cd05037         245 PTKRPSFRAILR  256 (259)
T ss_pred             hhhCCCHHHHHH
Confidence            999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.3e-35  Score=246.90  Aligned_cols=207  Identities=24%  Similarity=0.393  Sum_probs=165.5

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~   84 (302)
                      ...+.+|++++++++|+|++++++++...     +..++||||++ ++|.+++..    ...+++..+..++.|++.||.
T Consensus        46 ~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~  120 (267)
T cd08224          46 RQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE  120 (267)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeeeecC-----CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999887     88999999997 699988853    345899999999999999999


Q ss_pred             HHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           85 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        85 ~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      |||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+||++++|
T Consensus       121 ~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l  199 (267)
T cd08224         121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEM  199 (267)
T ss_pred             HHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHH
Confidence            9999999999999999999999999999999987544322 2233467888999998854 4478999999999999999


Q ss_pred             HhCCCCCCCCChH--HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          164 MDRKPLFPGRDHV--HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       164 l~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      ++|..||......  .....+....                          ..+..  .+..+..+.++|.+||..+|++
T Consensus       200 ~~g~~p~~~~~~~~~~~~~~~~~~~--------------------------~~~~~--~~~~~~~~~~~i~~cl~~~p~~  251 (267)
T cd08224         200 AALQSPFYGDKMNLYSLCKKIEKCD--------------------------YPPLP--ADHYSEELRDLVSRCINPDPEK  251 (267)
T ss_pred             HHCCCCcccCCccHHHHHhhhhcCC--------------------------CCCCC--hhhcCHHHHHHHHHHcCCCccc
Confidence            9999999654311  1111111000                          00000  1145678999999999999999


Q ss_pred             CCCHHHHhc
Q 022132          242 RITVEDALA  250 (302)
Q Consensus       242 R~t~~ell~  250 (302)
                      |||+.++++
T Consensus       252 Rp~~~~il~  260 (267)
T cd08224         252 RPDISYVLQ  260 (267)
T ss_pred             CCCHHHHHH
Confidence            999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.1e-35  Score=246.69  Aligned_cols=204  Identities=25%  Similarity=0.392  Sum_probs=165.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++|+||+++++++..      ...|++|||++ ++|.+++.+  ...+++..+..++.|++.||.+||
T Consensus        46 ~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH  119 (260)
T cd05073          46 EAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE  119 (260)
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999865      46899999996 699999975  346788899999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +.|++|+||+|+||+++.++.++|+|||.+........  .....++..|+|||.+.. ..++.++|+||+||+++++++
T Consensus       120 ~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t  198 (260)
T cd05073         120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVT  198 (260)
T ss_pred             hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHh
Confidence            99999999999999999999999999998875433211  122234567999998854 447889999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.+.......+.....                             ....+..+..+.+++.+||++||++|||
T Consensus       199 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  249 (260)
T cd05073         199 YGRIPYPGMSNPEVIRALERGYR-----------------------------MPRPENCPEELYNIMMRCWKNRPEERPT  249 (260)
T ss_pred             cCCCCCCCCCHHHHHHHHhCCCC-----------------------------CCCcccCCHHHHHHHHHHcccCcccCcC
Confidence             9999987765544433321100                             0112356788999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++++++
T Consensus       250 ~~~l~~  255 (260)
T cd05073         250 FEYIQS  255 (260)
T ss_pred             HHHHHH
Confidence            998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.6e-35  Score=248.77  Aligned_cols=206  Identities=22%  Similarity=0.340  Sum_probs=164.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--------CCCCHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--------QALSEEHCQYFLYQILR   81 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--------~~l~~~~~~~i~~qll~   81 (302)
                      ..+.+|+.+++.++||||+++++++....    ...++++||++ ++|.+++...        ..+++..+..++.|++.
T Consensus        53 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~  128 (280)
T cd05043          53 TLLLQESCLLYGLSHQNILPILHVCIEDG----EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC  128 (280)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEecCC----CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHH
Confidence            45778999999999999999999876642    67899999997 7999998653        45899999999999999


Q ss_pred             HHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHHHHH
Q 022132           82 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC  158 (302)
Q Consensus        82 ~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  158 (302)
                      ||+|||+.|++|+||+|+||+++.++.++|+|||+++.......   .....++..|+|||.+.+. .++.++||||+||
T Consensus       129 ~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~  207 (280)
T cd05043         129 GMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGV  207 (280)
T ss_pred             HHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHH
Confidence            99999999999999999999999999999999999875433211   1123346679999988554 4789999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCC
Q 022132          159 IFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTF  237 (302)
Q Consensus       159 i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  237 (302)
                      +++++++ |.+||...+..+....+.... .                            ......+++.+.+++.+||..
T Consensus       208 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~----------------------------~~~~~~~~~~~~~li~~~l~~  258 (280)
T cd05043         208 LLWELMTLGQTPYVEIDPFEMAAYLKDGY-R----------------------------LAQPINCPDELFAVMACCWAL  258 (280)
T ss_pred             HHHHHhcCCCCCcCcCCHHHHHHHHHcCC-C----------------------------CCCCCcCCHHHHHHHHHHcCC
Confidence            9999998 999997765544322221100 0                            001124678899999999999


Q ss_pred             CCCCCCCHHHHhc
Q 022132          238 DPRQRITVEDALA  250 (302)
Q Consensus       238 dP~~R~t~~ell~  250 (302)
                      ||++|||+.++++
T Consensus       259 ~p~~Rps~~~~~~  271 (280)
T cd05043         259 DPEERPSFSQLVQ  271 (280)
T ss_pred             ChhhCCCHHHHHH
Confidence            9999999999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.3e-34  Score=246.15  Aligned_cols=210  Identities=17%  Similarity=0.240  Sum_probs=162.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.+++.++||||+++++.+...     ...|+||||++ |+|.+++...    ..++...+..++.||+.||+|
T Consensus        40 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~  114 (268)
T cd05086          40 NEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH  114 (268)
T ss_pred             HHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999887     78999999997 6999998753    346777889999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCC------CCCCCchhHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNS------SDYTAAIDVWSV  156 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~------~~~~~~~Diwsl  156 (302)
                      ||+.|++||||||+||+++.++.++|+|||.+......   .......++..|+|||.+...      ..++.++||||+
T Consensus       115 lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl  194 (268)
T cd05086         115 MHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWAL  194 (268)
T ss_pred             HHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHH
Confidence            99999999999999999999999999999987542211   112234567889999987431      124678999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHcc
Q 022132          157 GCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  235 (302)
Q Consensus       157 G~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  235 (302)
                      ||++++|++ |.+||...+....+..+.......                     ...   .......++.+.+++..|+
T Consensus       195 G~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---------------------~~~---~~~~~~~~~~~~~l~~~c~  250 (268)
T cd05086         195 GVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---------------------LFK---PQLELPYSERWYEVLQFCW  250 (268)
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc---------------------cCC---CccCCCCcHHHHHHHHHHh
Confidence            999999986 678887766555444432211000                     000   1111246778999999999


Q ss_pred             CCCCCCCCCHHHHhc
Q 022132          236 TFDPRQRITVEDALA  250 (302)
Q Consensus       236 ~~dP~~R~t~~ell~  250 (302)
                       .+|.+|||++++++
T Consensus       251 -~~P~~Rp~~~~i~~  264 (268)
T cd05086         251 -LSPEKRATAEEVHR  264 (268)
T ss_pred             -hCcccCCCHHHHHH
Confidence             68999999999865

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=264.36  Aligned_cols=208  Identities=23%  Similarity=0.357  Sum_probs=176.4

Q ss_pred             HhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~~l~~   85 (302)
                      .+..++.+|.+++++++|||||++||+....     ..+|+|||+|. |+|.+++.+.+ .++..+...++.+.+.||+|
T Consensus       203 ~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~-----~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~Y  277 (474)
T KOG0194|consen  203 EQIKEFMKEARVMRQLNHPNVVRFYGVAVLE-----EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEY  277 (474)
T ss_pred             HHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHH
Confidence            3455889999999999999999999999998     88999999996 69999999876 59999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCccc-ccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ||+++++||||-..|+|++.++.+||+|||+++......... ...-...|+|||.+... .++.++||||+||++||++
T Consensus       278 Lh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif  356 (474)
T KOG0194|consen  278 LHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIF  356 (474)
T ss_pred             HHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeee
Confidence            999999999999999999999999999999988765332222 22345679999999655 6899999999999999998


Q ss_pred             h-CCCCCCCCChHHHHHHHHH-HhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIE-LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      + |..||.+....+..+.+.. ....+.                             ....+..+..++.+|+..||.+|
T Consensus       357 ~~g~~Py~g~~~~~v~~kI~~~~~r~~~-----------------------------~~~~p~~~~~~~~~c~~~~p~~R  407 (474)
T KOG0194|consen  357 ENGAEPYPGMKNYEVKAKIVKNGYRMPI-----------------------------PSKTPKELAKVMKQCWKKDPEDR  407 (474)
T ss_pred             ccCCCCCCCCCHHHHHHHHHhcCccCCC-----------------------------CCCCHHHHHHHHHHhccCChhhc
Confidence            7 8889999998877777733 222111                             11456778889999999999999


Q ss_pred             CCHHHHhc
Q 022132          243 ITVEDALA  250 (302)
Q Consensus       243 ~t~~ell~  250 (302)
                      ||..++.+
T Consensus       408 ~tm~~i~~  415 (474)
T KOG0194|consen  408 PTMSTIKK  415 (474)
T ss_pred             cCHHHHHH
Confidence            99988865

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8e-35  Score=275.65  Aligned_cols=207  Identities=24%  Similarity=0.370  Sum_probs=162.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-----------CCCCHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-----------QALSEEHCQYFLYQ   78 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----------~~l~~~~~~~i~~q   78 (302)
                      .++.+|+.+++.++||||+++++++.+.     +..|+||||++ ++|.+++...           ..++...+..++.|
T Consensus        47 ~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~Q  121 (932)
T PRK13184         47 KRFLREAKIAADLIHPGIVPVYSICSDG-----DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK  121 (932)
T ss_pred             HHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHH
Confidence            4688999999999999999999999887     88999999997 6999888631           23566778899999


Q ss_pred             HHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC-------------------CcccccccccccCchh
Q 022132           79 ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-------------------DFMTEYVVTRWYRAPE  139 (302)
Q Consensus        79 ll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-------------------~~~~~~~~~~~y~aPE  139 (302)
                      |+.||+|||+.||+||||||+||+++.++.++|+|||++......                   .......||+.|+|||
T Consensus       122 Ia~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE  201 (932)
T PRK13184        122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE  201 (932)
T ss_pred             HHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHH
Confidence            999999999999999999999999999999999999998754110                   0112246899999999


Q ss_pred             hhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccccccc
Q 022132          140 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK  219 (302)
Q Consensus       140 ~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (302)
                      .+.+. .++.++||||+||++++|++|.+||.+.+.......  .....|..                         ...
T Consensus       202 ~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i~~P~~-------------------------~~p  253 (932)
T PRK13184        202 RLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--DVILSPIE-------------------------VAP  253 (932)
T ss_pred             HhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhccChhh-------------------------ccc
Confidence            98654 479999999999999999999999976543322111  11111100                         011


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          220 FPNVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       220 ~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      ...+++.+.+++.+||..||++|++..+.+.
T Consensus       254 ~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        254 YREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2357888999999999999999987665554

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=249.79  Aligned_cols=220  Identities=22%  Similarity=0.383  Sum_probs=190.0

Q ss_pred             chhHHHHhcCch--------hhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHH
Q 022132            2 HSITKLMQRGHF--------VRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEH   71 (302)
Q Consensus         2 ~~~~~~~~~~~~--------~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~   71 (302)
                      +|||.+..+.-+        +.|.++|... +-|.+++++.+|...     +.+|+||||+. |+|--.+..-+++-+..
T Consensus       377 yAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm-----DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~  451 (683)
T KOG0696|consen  377 YAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGKFKEPV  451 (683)
T ss_pred             hhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh-----hheeeEEEEecCchhhhHHHHhcccCCch
Confidence            577776655432        3688888888 568999999999988     89999999996 69988888889999999


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccc-cCCCCcccccccccccCchhhhhCCCCCCCc
Q 022132           72 CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAA  150 (302)
Q Consensus        72 ~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  150 (302)
                      +..++..|+.||-+||++||++||+|.+||+++.+|.+||.|||+++. .-+.......+||+.|+|||++. ..+|+.+
T Consensus       452 AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgks  530 (683)
T KOG0696|consen  452 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKS  530 (683)
T ss_pred             hhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEE-ecccccc
Confidence            999999999999999999999999999999999999999999999974 33344567789999999999884 4569999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          151 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       151 ~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      +|.||+|+++|||+.|++||+|.+..+..+.|.+.--.                              ....+|.++.++
T Consensus       531 vDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs------------------------------yPKslSkEAv~i  580 (683)
T KOG0696|consen  531 VDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS------------------------------YPKSLSKEAVAI  580 (683)
T ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc------------------------------CcccccHHHHHH
Confidence            99999999999999999999999999998888763221                              122578899999


Q ss_pred             HHHccCCCCCCCCCH-----HHHhcCCCcCCc
Q 022132          231 VEKMLTFDPRQRITV-----EDALAHPYLGSL  257 (302)
Q Consensus       231 i~~~L~~dP~~R~t~-----~ell~h~~~~~~  257 (302)
                      ++..|.+.|.+|..+     .++-.||||+.+
T Consensus       581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~i  612 (683)
T KOG0696|consen  581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRI  612 (683)
T ss_pred             HHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence            999999999999854     689999999865

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-34  Score=248.39  Aligned_cols=223  Identities=21%  Similarity=0.348  Sum_probs=164.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++.....   ..+|+||||++ ++|.+++.+. ..+++..+..++.|++.||+|||+
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~  127 (284)
T cd05079          51 ADLKKEIEILRNLYHENIVKYKGICTEDGG---NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS  127 (284)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeEEecCCC---CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            357789999999999999999999876422   57899999996 6999998654 468999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .|++||||||+||+++.++.++|+|||.+.......    ......++..|+|||.+.+. .++.++||||+||++++|+
T Consensus       128 ~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ell  206 (284)
T cd05079         128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELL  206 (284)
T ss_pred             CCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhh
Confidence            999999999999999999999999999987644321    11234456679999988654 4789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      ++..|+.....     ...+..+........  .. ........      ........++..+.+|+.+||+.||.+|||
T Consensus       207 t~~~~~~~~~~-----~~~~~~~~~~~~~~~--~~-~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  272 (284)
T cd05079         207 TYCDSESSPMT-----LFLKMIGPTHGQMTV--TR-LVRVLEEG------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTT  272 (284)
T ss_pred             cCCCCCccccc-----hhhhhcccccccccH--HH-HHHHHHcC------ccCCCCCCCCHHHHHHHHHHccCCcccCcC
Confidence            98766432211     111111111100000  00 00000000      011122357889999999999999999999


Q ss_pred             HHHHhcC
Q 022132          245 VEDALAH  251 (302)
Q Consensus       245 ~~ell~h  251 (302)
                      +++++.+
T Consensus       273 ~~~il~~  279 (284)
T cd05079         273 FQNLIEG  279 (284)
T ss_pred             HHHHHHH
Confidence            9999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.2e-34  Score=244.73  Aligned_cols=206  Identities=24%  Similarity=0.418  Sum_probs=167.2

Q ss_pred             chhhHHHHHHh-cCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTW-IMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR----SNQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        12 ~~~~E~~il~~-l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      .+.+|+.+++. ++||||+++++++...     +..+++|||++ ++|.+++.    ....+++..++.++.|++.||.+
T Consensus        54 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~  128 (269)
T cd08528          54 DIVSEVTIIKEQLRHPNIVRYYKTFLEN-----DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY  128 (269)
T ss_pred             HHHHHHHHHhhcCCCCCeeeEEeeEccC-----CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence            35678888875 6999999999999887     89999999997 58888763    34578999999999999999999


Q ss_pred             HHh-CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           86 IHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        86 LH~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ||+ .|++|+||+|.||+++.++.++|+|||.+.............++..|+|||.+.+ ..++.++|+||+|+++++|+
T Consensus       129 lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~  207 (269)
T cd08528         129 LHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMC  207 (269)
T ss_pred             hccCCceeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHH
Confidence            996 7899999999999999999999999999876655443445567888999999865 44789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|.+||...+.......+......|.                            .....++.+.+++.+||+.||++|||
T Consensus       208 ~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~  259 (269)
T cd08528         208 TLQPPFYSTNMLSLATKIVEAVYEPL----------------------------PEGMYSEDVTDVITSCLTPDAEARPD  259 (269)
T ss_pred             hCCCcccccCHHHHHHHHhhccCCcC----------------------------CcccCCHHHHHHHHHHCCCCCccCCC
Confidence            99999976654443333322111110                            01145788999999999999999999


Q ss_pred             HHHHhcC
Q 022132          245 VEDALAH  251 (302)
Q Consensus       245 ~~ell~h  251 (302)
                      +.|+.++
T Consensus       260 ~~e~~~~  266 (269)
T cd08528         260 IIQVSAM  266 (269)
T ss_pred             HHHHHHH
Confidence            9998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=257.77  Aligned_cols=218  Identities=22%  Similarity=0.348  Sum_probs=165.2

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCC-cEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFN-DVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~-~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~   85 (302)
                      .++|.+|+.++.+++|||+|+|+|||.+.     + ..++|+||+. |+|.+.+....  +++|..+.+|+.+++.||+|
T Consensus       115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~-----~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~y  189 (361)
T KOG1187|consen  115 EREFLNEVEILSRLRHPNLVKLLGYCLEG-----GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAY  189 (361)
T ss_pred             hhHHHHHHHHHhcCCCcCcccEEEEEecC-----CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence            45699999999999999999999999987     6 5999999997 89999998654  89999999999999999999


Q ss_pred             HHhCC---ceecCCCCCCEEEecCCCEEEeecccccccCC-CCccccc-ccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           86 IHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEY-VVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        86 LH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      ||...   |+||||||+|||+|.+...||+|||+|+.... ....... .||..|+|||.... +..+.++||||+|+++
T Consensus       190 LH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvl  268 (361)
T KOG1187|consen  190 LHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVL  268 (361)
T ss_pred             HccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHH
Confidence            99864   99999999999999999999999999976654 3323333 78999999998854 4589999999999999


Q ss_pred             HHHHhCCCCCCCCChH---HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccccc-ccCC--CCCHHHHHHHHHc
Q 022132          161 MELMDRKPLFPGRDHV---HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT-EKFP--NVHPSAIDLVEKM  234 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~li~~~  234 (302)
                      +|+++|+.+.+.....   .........+...          ...+       .-...+. ...+  ..-..+..+...|
T Consensus       269 lElitgr~~~d~~~~~~~~~l~~w~~~~~~~~----------~~~e-------iiD~~l~~~~~~~~~~~~~~~~~a~~C  331 (361)
T KOG1187|consen  269 LELITGRKAVDQSRPRGELSLVEWAKPLLEEG----------KLRE-------IVDPRLKEGEYPDEKEVKKLAELALRC  331 (361)
T ss_pred             HHHHhCCcccCCCCCcccccHHHHHHHHHHCc----------chhh-------eeCCCccCCCCChHHHHHHHHHHHHHH
Confidence            9999999887643211   1111111111111          0000       0000110 0000  0112367788999


Q ss_pred             cCCCCCCCCCHHHHhc
Q 022132          235 LTFDPRQRITVEDALA  250 (302)
Q Consensus       235 L~~dP~~R~t~~ell~  250 (302)
                      ++.+|.+||+..+++.
T Consensus       332 ~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  332 LRPDPKERPTMSQVVK  347 (361)
T ss_pred             cCcCCCcCcCHHHHHH
Confidence            9999999999998754

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-34  Score=245.30  Aligned_cols=204  Identities=24%  Similarity=0.302  Sum_probs=164.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++..      ...++||||+. |+|.+++... ..+++..+..++.|++.||+|||+
T Consensus        54 ~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~  127 (279)
T cd05057          54 KEILDEAYVMASVDHPHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE  127 (279)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEec------CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            357789999999999999999999875      56889999996 7999998763 579999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc---cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      .|++|+||+|+||+++.++.++|+|||.+.........   ....++..|+|||.+.. ..++.++|+||+||+++++++
T Consensus       128 ~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~  206 (279)
T cd05057         128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMT  206 (279)
T ss_pred             CCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhc
Confidence            99999999999999999999999999998765432211   11223457999998854 447899999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.+..+....+... ..                            ....+..+.++.+++.+||..||.+|||
T Consensus       207 ~g~~p~~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~  257 (279)
T cd05057         207 FGAKPYEGIPAVEIPDLLEKG-ER----------------------------LPQPPICTIDVYMVLVKCWMIDAESRPT  257 (279)
T ss_pred             CCCCCCCCCCHHHHHHHHhCC-CC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCC
Confidence             99999876654433322210 00                            0111245678999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      +.++++
T Consensus       258 ~~~l~~  263 (279)
T cd05057         258 FKELIN  263 (279)
T ss_pred             HHHHHH
Confidence            999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.7e-34  Score=239.50  Aligned_cols=213  Identities=37%  Similarity=0.658  Sum_probs=176.1

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+..+++++|+||+++++++...     ...++++||+++ +|.+++.....++...+..++.+++.++.+||+
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  105 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHS  105 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35778999999999999999999999887     789999999986 999999876669999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      .|++|+||+|.||+++.++.++++|||.+.............++..|+|||.+.+ ..++.++|+||+|++++++++|..
T Consensus       106 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~  184 (244)
T smart00220      106 NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKP  184 (244)
T ss_pred             cCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999999987665444455677888999998854 447889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||..................                          ........++..+.+++.+||..||++||++.++
T Consensus       185 p~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~  238 (244)
T smart00220      185 PFPGDDQLLELFKKIGKPKP--------------------------PFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA  238 (244)
T ss_pred             CCCCCCcHHHHHHHHhccCC--------------------------CCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence            99774333222221111000                          0001111167789999999999999999999999


Q ss_pred             hcCCCc
Q 022132          249 LAHPYL  254 (302)
Q Consensus       249 l~h~~~  254 (302)
                      ++||||
T Consensus       239 ~~~~~~  244 (244)
T smart00220      239 LQHPFF  244 (244)
T ss_pred             hhCCCC
Confidence            999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.2e-34  Score=274.30  Aligned_cols=103  Identities=23%  Similarity=0.436  Sum_probs=96.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||+.
T Consensus        49 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~  123 (669)
T cd05610          49 HQVQAERDALALSKSPFIVHLYYSLQSA-----NNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH  123 (669)
T ss_pred             HHHHHHHHHHHhcCCCCcCeEEEEEEEC-----CEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4577899999999999999999999877     88999999995 69999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                      ||+||||||+||+++.++.++|+|||+++
T Consensus       124 gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         124 GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.9e-34  Score=247.60  Aligned_cols=204  Identities=22%  Similarity=0.293  Sum_probs=162.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.+++.++||||+++++++...      ..++++||++ |+|.+++..+ ..+++..+..++.|++.||+|||++
T Consensus        55 ~~~~e~~~~~~l~h~niv~~~~~~~~~------~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~  128 (303)
T cd05110          55 EFMDEALIMASMDHPHLVRLLGVCLSP------TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER  128 (303)
T ss_pred             HHHHHHHHHHhCCCCCcccEEEEEcCC------CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc
Confidence            567899999999999999999998653      4679999997 7999998764 4689999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      ||+|+||||+||+++.++.++|+|||.+........   .....++..|+|||.+.+ ..++.++||||+||++|+|++ 
T Consensus       129 ~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~  207 (303)
T cd05110         129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTF  207 (303)
T ss_pred             CeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhC
Confidence            999999999999999999999999999876432211   122334667999998854 447899999999999999987 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||.+.........+ .....+                            ...+..+.++.+++.+||..||.+|||+
T Consensus       208 g~~p~~~~~~~~~~~~~-~~~~~~----------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~  258 (303)
T cd05110         208 GGKPYDGIPTREIPDLL-EKGERL----------------------------PQPPICTIDVYMVMVKCWMIDADSRPKF  258 (303)
T ss_pred             CCCCCCCCCHHHHHHHH-HCCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            89999766543322211 110000                            0112456789999999999999999999


Q ss_pred             HHHhcC
Q 022132          246 EDALAH  251 (302)
Q Consensus       246 ~ell~h  251 (302)
                      ++++..
T Consensus       259 ~~l~~~  264 (303)
T cd05110         259 KELAAE  264 (303)
T ss_pred             HHHHHH
Confidence            998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.4e-34  Score=245.56  Aligned_cols=221  Identities=20%  Similarity=0.322  Sum_probs=162.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++.....   ..+++||||++ ++|.+++... ..+++..+..++.|++.||+|||+
T Consensus        50 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~  126 (284)
T cd05081          50 RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS  126 (284)
T ss_pred             HHHHHHHHHHHhCCCCCeeEEEEEEccCCC---CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH
Confidence            367789999999999999999998765321   56899999996 7999998753 568999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc----ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .|++||||||+||+++.++.++|+|||++........    .....++..|+|||.+.+. .++.++|+||+||++++|+
T Consensus       127 ~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~  205 (284)
T cd05081         127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELF  205 (284)
T ss_pred             CCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999876533211    1122234569999988544 4789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCh--HHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSE--AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      +|..++...... .    ....+....  .....+    .+.....      ........++..+.+|+.+||..||.+|
T Consensus       206 ~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~----~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~R  270 (284)
T cd05081         206 TYSDKSCSPPAE-F----MRMMGNDKQGQMIVYHL----IELLKNN------GRLPAPPGCPAEIYAIMKECWNNDPSQR  270 (284)
T ss_pred             hcCCcCCCcchh-h----hhhcccccccccchHHH----HHHHhcC------CcCCCCCCCCHHHHHHHHHHccCChhhC
Confidence            987765433211 0    111111000  000000    0000000      0011223577899999999999999999


Q ss_pred             CCHHHHhc
Q 022132          243 ITVEDALA  250 (302)
Q Consensus       243 ~t~~ell~  250 (302)
                      ||+.|+++
T Consensus       271 pt~~ei~~  278 (284)
T cd05081         271 PSFSELAL  278 (284)
T ss_pred             CCHHHHHH
Confidence            99999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4e-34  Score=251.73  Aligned_cols=207  Identities=24%  Similarity=0.374  Sum_probs=160.4

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------------------------
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------------------------   64 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------------------------   64 (302)
                      .+.+|+.++.++ +||||+++++++....    ..+++||||++ |+|.+++...                         
T Consensus        56 ~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  131 (343)
T cd05103          56 ALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDIS  131 (343)
T ss_pred             HHHHHHHHHHhccCCccHhhhcceeecCC----CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchh
Confidence            467899999999 7899999999886542    57899999997 6999888642                         


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q 022132           65 ------------------------------------------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL  102 (302)
Q Consensus        65 ------------------------------------------~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil  102 (302)
                                                                ..++...+..++.|++.||+|||+.||+||||||+||+
T Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  211 (343)
T cd05103         132 EDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNIL  211 (343)
T ss_pred             hhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEE
Confidence                                                      23678888999999999999999999999999999999


Q ss_pred             EecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 022132          103 LNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  178 (302)
Q Consensus       103 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~  178 (302)
                      ++.++.++|+|||++.......   ......++..|+|||.+.+ ..++.++|+||+|+++++|++ |..||.+......
T Consensus       212 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  290 (343)
T cd05103         212 LSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  290 (343)
T ss_pred             EcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH
Confidence            9999999999999987543221   1112234567999998854 447899999999999999996 9999976543222


Q ss_pred             HHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      ..........                            .......++.+.+++.+||+.||.+|||+.|+++|
T Consensus       291 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         291 FCRRLKEGTR----------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHHhccCC----------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1111110000                            00011356789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.8e-34  Score=255.08  Aligned_cols=206  Identities=24%  Similarity=0.310  Sum_probs=164.3

Q ss_pred             chhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC------------------------
Q 022132           12 HFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ------------------------   65 (302)
Q Consensus        12 ~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------------------------   65 (302)
                      .+.+|+.+|.++. ||||+++++++...     +.+|+||||+. |+|.+++...+                        
T Consensus        86 ~~~~E~~~l~~l~~H~niv~~~~~~~~~-----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (401)
T cd05107          86 ALMSELKIMSHLGPHLNIVNLLGACTKG-----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTP  160 (401)
T ss_pred             HHHHHHHHHHhcCCCCCeEEEEEEEccC-----CCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccc
Confidence            5778999999997 99999999999887     78999999997 79999986431                        


Q ss_pred             --------------------------------------------------------------------------CCCHHH
Q 022132           66 --------------------------------------------------------------------------ALSEEH   71 (302)
Q Consensus        66 --------------------------------------------------------------------------~l~~~~   71 (302)
                                                                                                .+++..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  240 (401)
T cd05107         161 LSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMD  240 (401)
T ss_pred             ccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHH
Confidence                                                                                      356777


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCC
Q 022132           72 CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYT  148 (302)
Q Consensus        72 ~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~  148 (302)
                      +..++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++......   ......++..|+|||.+.+. .++
T Consensus       241 ~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~  319 (401)
T cd05107         241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYT  319 (401)
T ss_pred             HHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCC
Confidence            88999999999999999999999999999999999999999999987543221   11223456789999988654 478


Q ss_pred             CchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHH
Q 022132          149 AAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSA  227 (302)
Q Consensus       149 ~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (302)
                      .++|+||+||++++|++ |..||......+...........                            ......++..+
T Consensus       320 ~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~----------------------------~~~p~~~~~~l  371 (401)
T cd05107         320 TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR----------------------------MAKPAHASDEI  371 (401)
T ss_pred             cHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCC----------------------------CCCCCCCCHHH
Confidence            99999999999999998 88999765544433222211000                            01122567899


Q ss_pred             HHHHHHccCCCCCCCCCHHHHhcC
Q 022132          228 IDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       228 ~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      .+++.+||..||.+|||++|++..
T Consensus       372 ~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         372 YEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=258.05  Aligned_cols=205  Identities=21%  Similarity=0.368  Sum_probs=174.5

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...|..|..+++.++||||+++.|++.+      ...+||||++. |.|..+++.+ ..|+......+++||+.||+|||
T Consensus       435 tekflqEa~iMrnfdHphIikLIGv~~e------~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe  508 (974)
T KOG4257|consen  435 TEKFLQEASIMRNFDHPHIIKLIGVCVE------QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE  508 (974)
T ss_pred             HHHHHHHHHHHHhCCCcchhheeeeeec------cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH
Confidence            3478999999999999999999999988      57999999998 9999999854 57999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCccccccc--ccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV--TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +.+++||||...|||+.+...+||+|||+++...+..+.....+  ..-|+|||.+. -..++.++|||.||+.|||++.
T Consensus       509 SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~  587 (974)
T KOG4257|consen  509 SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILS  587 (974)
T ss_pred             hhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHH
Confidence            99999999999999999999999999999998887755444333  45599999884 4458999999999999999985


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |..||.|..+.+.+..+-+.-+.                             ...+++|+.+-.|+.+||.+||.+||+
T Consensus       588 lGvkPfqgvkNsDVI~~iEnGeRl-----------------------------P~P~nCPp~LYslmskcWayeP~kRPr  638 (974)
T KOG4257|consen  588 LGVKPFQGVKNSDVIGHIENGERL-----------------------------PCPPNCPPALYSLMSKCWAYEPSKRPR  638 (974)
T ss_pred             hcCCccccccccceEEEecCCCCC-----------------------------CCCCCCChHHHHHHHHHhccCcccCCc
Confidence             99999988777665444332222                             233588999999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      +.++..
T Consensus       639 ftei~~  644 (974)
T KOG4257|consen  639 FTEIKA  644 (974)
T ss_pred             HHHHHH
Confidence            877643

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-33  Score=240.27  Aligned_cols=209  Identities=22%  Similarity=0.340  Sum_probs=162.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCC-CCcEEEEEecCC-ccHHHHHHcC------CCCCHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRES-FNDVYIAYELMD-TDLHQIIRSN------QALSEEHCQYFLYQILRGL   83 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~-~~~~~lv~e~~~-~~L~~~l~~~------~~l~~~~~~~i~~qll~~l   83 (302)
                      .+.+|+++++.++||||+++++++......+ ....++++||+. |+|.+++...      ..++...+..++.|++.||
T Consensus        47 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l  126 (273)
T cd05074          47 EFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM  126 (273)
T ss_pred             HHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Confidence            4778999999999999999999987653221 123578999986 7888876421      2578999999999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           84 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      +|||+.||+||||||+||+++.++.++|+|||.++......   ......++..|++||.+... .++.++||||+||++
T Consensus       127 ~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il  205 (273)
T cd05074         127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTM  205 (273)
T ss_pred             HHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHH
Confidence            99999999999999999999999999999999987653321   11223345679999988544 478899999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC
Q 022132          161 MELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       161 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      ++|++ |.+||.+.+.......+... ..                            ....+..+..+.+++.+||..+|
T Consensus       206 ~el~~~g~~p~~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~~l~~~~l~~~p  256 (273)
T cd05074         206 WEIMTRGQTPYAGVENSEIYNYLIKG-NR----------------------------LKQPPDCLEDVYELMCQCWSPEP  256 (273)
T ss_pred             HHHhhCCCCCCCCCCHHHHHHHHHcC-Cc----------------------------CCCCCCCCHHHHHHHHHHcCCCh
Confidence            99998 89999776554433322210 00                            01112567889999999999999


Q ss_pred             CCCCCHHHHhc
Q 022132          240 RQRITVEDALA  250 (302)
Q Consensus       240 ~~R~t~~ell~  250 (302)
                      ++|||+.+++.
T Consensus       257 ~~Rps~~~~~~  267 (273)
T cd05074         257 KCRPSFQHLRD  267 (273)
T ss_pred             hhCcCHHHHHH
Confidence            99999999976

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=237.37  Aligned_cols=219  Identities=25%  Similarity=0.372  Sum_probs=174.0

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHH-----cCCCCCHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-----SNQALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~-----~~~~l~~~~~~~i~~qll~~l~   84 (302)
                      +++..|.....+- ++||||++|+.....     ++.||.||+|+.+|..+.+     ....+++..+-.|.-..+.||.
T Consensus       107 ~rll~e~d~~mks~~cp~IVkfyGa~F~E-----GdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~  181 (361)
T KOG1006|consen  107 KRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALD  181 (361)
T ss_pred             HHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----CceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHH
Confidence            3566677665555 789999999999888     8999999999987765543     3467999999999999999999


Q ss_pred             HHHhC-CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCC-CCCchhHHHHHHHHHH
Q 022132           85 YIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFME  162 (302)
Q Consensus        85 ~LH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~i~~~  162 (302)
                      ||... .|+|||+||+|||++..|.+||||||.+....+.--.+...|-..|+|||.+..... |..++|+||||++++|
T Consensus       182 yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~E  261 (361)
T KOG1006|consen  182 YLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYE  261 (361)
T ss_pred             HHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEee
Confidence            99964 899999999999999999999999999976554433445567778999999965544 8899999999999999


Q ss_pred             HHhCCCCCCCCChH-HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          163 LMDRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       163 ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      +.+|..||.+.+.. +++...+  .|.|+...                      ....--+.+..++.+|..||.+|-+.
T Consensus       262 vAtG~fPyr~w~svfeql~~Vv--~gdpp~l~----------------------~~~~~~~~s~~~~~fintCl~Kd~~~  317 (361)
T KOG1006|consen  262 VATGNFPYRKWDSVFEQLCQVV--IGDPPILL----------------------FDKECVHYSFSMVRFINTCLIKDRSD  317 (361)
T ss_pred             eecCCCCcchHHHHHHHHHHHH--cCCCCeec----------------------CcccccccCHHHHHHHHHHhhccccc
Confidence            99999999876543 3333322  23333210                      00111157889999999999999999


Q ss_pred             CCCHHHHhcCCCcCCcc
Q 022132          242 RITVEDALAHPYLGSLH  258 (302)
Q Consensus       242 R~t~~ell~h~~~~~~~  258 (302)
                      ||...+|+.+||+...-
T Consensus       318 Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  318 RPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             CcchhhhhcCchhhhhh
Confidence            99999999999998753

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-34  Score=268.79  Aligned_cols=206  Identities=23%  Similarity=0.383  Sum_probs=175.6

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------QALSEEHCQYFLYQILR   81 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qll~   81 (302)
                      ...|.+|..+++.++||||+++++++.+.     ...+|++|||. |+|..+|++.       ..++......++.||+.
T Consensus       739 ~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~-----~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~  813 (1025)
T KOG1095|consen  739 VSDFLKEALLMSKFDHPNIVSLIGVCLDS-----GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAK  813 (1025)
T ss_pred             HHHHHHHHHHHhcCCCcceeeEEEeecCC-----CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhh
Confidence            34789999999999999999999999997     88999999996 7999999875       45899999999999999


Q ss_pred             HHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccc---cccccccCchhhhhCCCCCCCchhHHHHHH
Q 022132           82 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGC  158 (302)
Q Consensus        82 ~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  158 (302)
                      |..||++++++||||...|+|++....+||+|||+|+.+-...+...   ......|||||.+.. ..++.++|||||||
T Consensus       814 G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGV  892 (1025)
T KOG1095|consen  814 GMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGV  892 (1025)
T ss_pred             hhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHH
Confidence            99999999999999999999999999999999999995543322211   123467999999975 45999999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCC
Q 022132          159 IFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTF  237 (302)
Q Consensus       159 i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  237 (302)
                      ++||+++ |..||++.+..+.+....+.-+-                             ...+.++..+-+++..||+.
T Consensus       893 llWEifslG~~PY~~~~n~~v~~~~~~ggRL-----------------------------~~P~~CP~~ly~lM~~CW~~  943 (1025)
T KOG1095|consen  893 LLWEIFSLGATPYPSRSNFEVLLDVLEGGRL-----------------------------DPPSYCPEKLYQLMLQCWKH  943 (1025)
T ss_pred             HHHHHHhCCCCCCCCcchHHHHHHHHhCCcc-----------------------------CCCCCCChHHHHHHHHHccC
Confidence            9999997 99999999888776544432211                             12236888899999999999


Q ss_pred             CCCCCCCHHHHhc
Q 022132          238 DPRQRITVEDALA  250 (302)
Q Consensus       238 dP~~R~t~~ell~  250 (302)
                      +|.+||++..+++
T Consensus       944 ~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  944 DPEDRPSFRTIVE  956 (1025)
T ss_pred             ChhhCccHHHHHh
Confidence            9999999999988

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=263.20  Aligned_cols=220  Identities=27%  Similarity=0.350  Sum_probs=168.8

Q ss_pred             hhHHHHhcCc--hhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCC----CCCHHHHHHH
Q 022132            3 SITKLMQRGH--FVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ----ALSEEHCQYF   75 (302)
Q Consensus         3 ~~~~~~~~~~--~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~----~l~~~~~~~i   75 (302)
                      |+|.+...-.  +.||+..|+.. +|||||++|+.-.+.     +..||+.|.|..+|.++++..+    .......+.+
T Consensus       537 AVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~-----qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~  611 (903)
T KOG1027|consen  537 AVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDR-----QFLYIALELCACSLQDLIESSGLDVEMQSDIDPISV  611 (903)
T ss_pred             hHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCC-----ceEEEEehHhhhhHHHHHhccccchhhcccccHHHH
Confidence            5566655543  45999999999 899999999988877     8999999999999999998741    1111345788


Q ss_pred             HHHHHHHHHHHHhCCceecCCCCCCEEEec---C--CCEEEeecccccccCCC----CcccccccccccCchhhhhCCCC
Q 022132           76 LYQILRGLKYIHSANVLHRDLKPSNLLLNA---N--CDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSD  146 (302)
Q Consensus        76 ~~qll~~l~~LH~~~i~H~dikp~Nil~~~---~--~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~  146 (302)
                      +.|+++||++||+.+|+|||+||.||||+.   +  ..++|.|||+|+.....    .......||..|+|||++.... 
T Consensus       612 l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-  690 (903)
T KOG1027|consen  612 LSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-  690 (903)
T ss_pred             HHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccc-
Confidence            999999999999999999999999999976   3  46899999999865433    2345678999999999997655 


Q ss_pred             CCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCH
Q 022132          147 YTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP  225 (302)
Q Consensus       147 ~~~~~DiwslG~i~~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (302)
                      -+.++||||+||++|+.++| ..||...-..+.  .|..                   ....        +...-+....
T Consensus       691 ~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~-------------------~~~~--------L~~L~~~~d~  741 (903)
T KOG1027|consen  691 KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILT-------------------GNYT--------LVHLEPLPDC  741 (903)
T ss_pred             cCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhc-------------------Cccc--------eeeeccCchH
Confidence            47799999999999999875 899964432221  0110                   0000        0011111112


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          226 SAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       226 ~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                      .+.|||.+||++||..||||.++|.||+|=.+
T Consensus       742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            78999999999999999999999999999543

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=262.77  Aligned_cols=220  Identities=22%  Similarity=0.386  Sum_probs=181.0

Q ss_pred             cCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        10 ~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      +.+..-|..||+.. .|||++..|++|.-....+.+.+|+|||||+ |+.-++++.  ..++.|+.+.+|++.++.|+.+
T Consensus        59 deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~H  138 (953)
T KOG0587|consen   59 EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAH  138 (953)
T ss_pred             cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHH
Confidence            34566788999998 8999999999998766666688999999997 688888764  5789999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCC----CCCchhHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVGCIF  160 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~----~~~~~DiwslG~i~  160 (302)
                      ||.+.++|||||-.|||++.+|.+||+|||.+...... .......||++|||||++.+...    |+..+|+||||++.
T Consensus       139 LH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITa  218 (953)
T KOG0587|consen  139 LHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITA  218 (953)
T ss_pred             HhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhcccee
Confidence            99999999999999999999999999999998655433 44567799999999999965543    57799999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      .||..|.||+-......   .++.....|+..                        ...+...+..+.+||..||.+|..
T Consensus       219 IEladG~PPl~DmHPmr---aLF~IpRNPPPk------------------------Lkrp~kWs~~FndFIs~cL~Kd~e  271 (953)
T KOG0587|consen  219 IEMAEGAPPLCDMHPMR---ALFLIPRNPPPK------------------------LKRPKKWSKKFNDFISTCLVKDYE  271 (953)
T ss_pred             ehhcCCCCCccCcchhh---hhccCCCCCCcc------------------------ccchhhHHHHHHHHHHHHHhhccc
Confidence            99999999986554332   222222223221                        112235677899999999999999


Q ss_pred             CCCCHHHHhcCCCcCC
Q 022132          241 QRITVEDALAHPYLGS  256 (302)
Q Consensus       241 ~R~t~~ell~h~~~~~  256 (302)
                      +||+..++|.|||+..
T Consensus       272 ~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  272 QRPSTEELLKHPFITE  287 (953)
T ss_pred             cCcchhhhccCCcccc
Confidence            9999999999999983

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-33  Score=241.25  Aligned_cols=222  Identities=23%  Similarity=0.347  Sum_probs=164.3

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.+++.+.||||+++++++.....   ...+++|||++ ++|.+++.... .+++..+..++.|++.||+|||
T Consensus        50 ~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH  126 (284)
T cd05038          50 RSDFEREIEILRTLDHENIVKYKGVCEKPGG---RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG  126 (284)
T ss_pred             HHHHHHHHHHHHhCCCCChheEEeeeecCCC---CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH
Confidence            3468899999999999999999999876421   67999999996 69999997644 6999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc----ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      +.|++|+||+|+||+++.++.++|+|||.+........    .....++..|+|||.+.+. .++.++|+||+||++++|
T Consensus       127 ~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el  205 (284)
T cd05038         127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYEL  205 (284)
T ss_pred             hCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhhee
Confidence            99999999999999999999999999999876552211    1122345569999988554 478999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCC-ChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTP-SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      ++|..|+........     ...+.. ........    .........      .......+..+.+++.+||.+||.+|
T Consensus       206 ~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~----~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~R  270 (284)
T cd05038         206 FTYGDPSQSPPAEFL-----RMIGIAQGQMIVTRL----LELLKEGER------LPRPPSCPDEVYDLMKLCWEAEPQDR  270 (284)
T ss_pred             eccCCCcccccchhc-----cccccccccccHHHH----HHHHHcCCc------CCCCccCCHHHHHHHHHHhccChhhC
Confidence            999988854322110     000000 00000000    000000000      01112456789999999999999999


Q ss_pred             CCHHHHhc
Q 022132          243 ITVEDALA  250 (302)
Q Consensus       243 ~t~~ell~  250 (302)
                      ||+.|+++
T Consensus       271 pt~~ei~~  278 (284)
T cd05038         271 PSFADLIL  278 (284)
T ss_pred             CCHHHHHH
Confidence            99999976

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.5e-33  Score=239.93  Aligned_cols=212  Identities=17%  Similarity=0.146  Sum_probs=158.7

Q ss_pred             hHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 022132           15 RSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHR   94 (302)
Q Consensus        15 ~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~   94 (302)
                      .++..++.+.|+|+++++++...... .....|++++++..++.+.+......++..+..++.|++.||+|||+.||+||
T Consensus        72 ~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr  150 (294)
T PHA02882         72 ALWKNIHNIDHLGIPKYYGCGSFKRC-RMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHG  150 (294)
T ss_pred             HHHHHhccCCCCCCCcEEEeeeEecC-CceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            44455667789999999997665421 11245788999888888887765567899999999999999999999999999


Q ss_pred             CCCCCCEEEecCCCEEEeecccccccCCC--------CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           95 DLKPSNLLLNANCDLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        95 dikp~Nil~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ||||+||+++.++.++|+|||+++.....        .......+|+.|+|||.+.+ ..++.++||||+||++++|++|
T Consensus       151 DiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g  229 (294)
T PHA02882        151 DIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGI  229 (294)
T ss_pred             CCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhC
Confidence            99999999999999999999998754221        11223468999999998864 4489999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.............                 .+......     -....+..++.+.+++..|+..+|.+||+.+
T Consensus       230 ~~P~~~~~~~~~~~~~~~~-----------------~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~  287 (294)
T PHA02882        230 KLPWKGFGHNGNLIHAAKC-----------------DFIKRLHE-----GKIKIKNANKFIYDFIECVTKLSYEEKPDYD  287 (294)
T ss_pred             CCCCCccccchHHHHHhHH-----------------HHHHHhhh-----hhhccCCCCHHHHHHHHHHHhCCCCCCCCHH
Confidence            9999876432222111110                 00000000     0011235678899999999999999999999


Q ss_pred             HHhc
Q 022132          247 DALA  250 (302)
Q Consensus       247 ell~  250 (302)
                      ++++
T Consensus       288 ~l~~  291 (294)
T PHA02882        288 ALIK  291 (294)
T ss_pred             HHHH
Confidence            9875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-34  Score=251.89  Aligned_cols=217  Identities=23%  Similarity=0.409  Sum_probs=173.3

Q ss_pred             hcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      +-++.+-|-.||..-.++-||+||-.|.++     +.+|+||||+. |++-.+|-.-+.|.|+.+++++..+.+|+++.|
T Consensus       672 QvaHVKAERDILAEADn~WVVrLyySFQDk-----dnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH  746 (1034)
T KOG0608|consen  672 QVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH  746 (1034)
T ss_pred             hhhhhhhhhhhHhhcCCcceEEEEEEeccC-----CceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH
Confidence            344677899999999999999999999999     99999999996 699999888899999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccC---------CCC----------------------------------
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---------ETD----------------------------------  124 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~---------~~~----------------------------------  124 (302)
                      +.|++||||||+|||||.+|.+||+|||+|....         +..                                  
T Consensus       747 kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~  826 (1034)
T KOG0608|consen  747 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRI  826 (1034)
T ss_pred             hccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhh
Confidence            9999999999999999999999999999984210         000                                  


Q ss_pred             cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHH
Q 022132          125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY  204 (302)
Q Consensus       125 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (302)
                      .....+||..|+|||++...+ ++..+|.||.|||+|+|+.|++||-.......-.++++                ..++
T Consensus       827 ~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n----------------w~~~  889 (1034)
T KOG0608|consen  827 LAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN----------------WRNF  889 (1034)
T ss_pred             hhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee----------------hhhc
Confidence            002346899999999997655 89999999999999999999999966554332111111                0000


Q ss_pred             hhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC---CHHHHhcCCCcCCcc
Q 022132          205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSLH  258 (302)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~ell~h~~~~~~~  258 (302)
                          ..+      ..-.++++++.++|.++. -+++.|.   .++++-+||||+.+.
T Consensus       890 ----l~~------~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  890 ----LHI------PYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             ----ccc------ccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccc
Confidence                000      001268899999999755 4888887   467899999999763

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=244.43  Aligned_cols=221  Identities=24%  Similarity=0.431  Sum_probs=177.3

Q ss_pred             HhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .--++..||.+|.+.|.||.||++||+|..+.    +.++-|+|||+| +|.-+++.++.+++.+++.|+.||+.||.||
T Consensus       509 NYhKHAcREyrIHKeLDHpRIVKlYDyfslDt----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YL  584 (775)
T KOG1151|consen  509 NYHKHACREYRIHKELDHPRIVKLYDYFSLDT----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYL  584 (775)
T ss_pred             hHHHHHHHHHhhhhccCcceeeeeeeeeeecc----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHH
Confidence            33457789999999999999999999998763    779999999986 8888888889999999999999999999999


Q ss_pred             HhCC--ceecCCCCCCEEEec---CCCEEEeecccccccCCCC--------cccccccccccCchhhhhCC---CCCCCc
Q 022132           87 HSAN--VLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNS---SDYTAA  150 (302)
Q Consensus        87 H~~~--i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~---~~~~~~  150 (302)
                      ....  |+|-|+||.|||+-.   .|.+||+|||+++......        ......||.+|.+||.+.-.   ...+.+
T Consensus       585 NEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnK  664 (775)
T KOG1151|consen  585 NEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNK  664 (775)
T ss_pred             hccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccc
Confidence            9875  999999999999854   4789999999998765432        33567899999999988543   356889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          151 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       151 ~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      +||||+|||+|.++.|+.||...-....+-.....+..               ..-++        + .-|.+++++++|
T Consensus       665 VDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA---------------tEVqF--------P-~KPvVsseAkaF  720 (775)
T KOG1151|consen  665 VDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA---------------TEVQF--------P-PKPVVSSEAKAF  720 (775)
T ss_pred             eeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc---------------eeccC--------C-CCCccCHHHHHH
Confidence            99999999999999999999654322211111110000               00011        1 113688999999


Q ss_pred             HHHccCCCCCCCCCHHHHhcCCCcCC
Q 022132          231 VEKMLTFDPRQRITVEDALAHPYLGS  256 (302)
Q Consensus       231 i~~~L~~dP~~R~t~~ell~h~~~~~  256 (302)
                      |++||.+--.+|..+-+|-.||||..
T Consensus       721 IRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  721 IRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             HHHHHHhhhhhhhhHHHHccCccccc
Confidence            99999999999999999999999975

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.6e-33  Score=264.15  Aligned_cols=184  Identities=33%  Similarity=0.525  Sum_probs=136.7

Q ss_pred             cEEEEEecCCccHH-HHHHcCCCC-CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeeccccccc--
Q 022132           45 DVYIAYELMDTDLH-QIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT--  120 (302)
Q Consensus        45 ~~~lv~e~~~~~L~-~~l~~~~~l-~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~--  120 (302)
                      .+||=||||+.++. +++..+... .....+.++++|++||.|+|++||+||||||.||+++.++.+||+|||++...  
T Consensus       670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~  749 (1351)
T KOG1035|consen  670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKE  749 (1351)
T ss_pred             EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhh
Confidence            37889999996555 444444333 47889999999999999999999999999999999999999999999998651  


Q ss_pred             -----------------CCCCcccccccccccCchhhhhCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 022132          121 -----------------SETDFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  181 (302)
Q Consensus       121 -----------------~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~  181 (302)
                                       +.....+..+||.-|+|||++.+..  .|+.++|+||||+|++||+.-   |...  .+ ...
T Consensus       750 ~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~Ts--ME-Ra~  823 (1351)
T KOG1035|consen  750 NLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTS--ME-RAS  823 (1351)
T ss_pred             hhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCch--HH-HHH
Confidence                             1112456678999999999997666  699999999999999999843   5322  11 122


Q ss_pred             HHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCC
Q 022132          182 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  256 (302)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  256 (302)
                      +...++.+..+..                      ...+..--+.-..+|+.||+.||++||||.|||++.||-.
T Consensus       824 iL~~LR~g~iP~~----------------------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  824 ILTNLRKGSIPEP----------------------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             HHHhcccCCCCCC----------------------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence            2222222221100                      0111122345678999999999999999999999999964

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=252.67  Aligned_cols=210  Identities=20%  Similarity=0.329  Sum_probs=168.5

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRS-NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      -+.|+.|+.+|++-+|.||+=+.+++..+     . +.||+-+|+| +|+.+++- ...|.....+.|+.||+.|+.|||
T Consensus       432 lqaFKnEVa~lkkTRH~NIlLFMG~~~~p-----~-~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH  505 (678)
T KOG0193|consen  432 LQAFKNEVAVLKKTRHENILLFMGACMNP-----P-LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH  505 (678)
T ss_pred             HHHHHHHHHHHhhcchhhheeeehhhcCC-----c-eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh
Confidence            34789999999999999999999999886     4 4999999986 99999874 356899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeeccccccc---CCCCcccccccccccCchhhhhC--CCCCCCchhHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~---~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i~~~  162 (302)
                      .++|+|||+|..||++.++++++|+|||++..-   ..........+...|+|||++..  ...|++.+|||||||++||
T Consensus       506 AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YE  585 (678)
T KOG0193|consen  506 AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYE  585 (678)
T ss_pred             hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHH
Confidence            999999999999999999999999999998542   22333445567888999999853  3458999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      |++|..||.... .+++--.+   |..                     +..........+.+.++++|+..||.+++++|
T Consensus       586 Lltg~lPysi~~-~dqIifmV---GrG---------------------~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eR  640 (678)
T KOG0193|consen  586 LLTGELPYSIQN-RDQIIFMV---GRG---------------------YLMPDLSKIRSNCPKAMKRLLSDCWKFDREER  640 (678)
T ss_pred             HHhCcCCcCCCC-hhheEEEe---ccc---------------------ccCccchhhhccCHHHHHHHHHHHHhcCcccC
Confidence            999999998443 33321111   110                     00111122223567799999999999999999


Q ss_pred             CCHHHHhc
Q 022132          243 ITVEDALA  250 (302)
Q Consensus       243 ~t~~ell~  250 (302)
                      |++.++|.
T Consensus       641 P~F~~il~  648 (678)
T KOG0193|consen  641 PLFPQLLS  648 (678)
T ss_pred             ccHHHHHH
Confidence            99999887

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-33  Score=237.56  Aligned_cols=243  Identities=28%  Similarity=0.464  Sum_probs=175.4

Q ss_pred             hhhHHHHHHhcC-C-------CCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHH
Q 022132           13 FVRSSCFDTWIM-K-------TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRG   82 (302)
Q Consensus        13 ~~~E~~il~~l~-h-------~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~~   82 (302)
                      .+.||++|++++ +       ..||+|+|.|..+...+ .|++||+|+++.+|..++...  +.++...++.|++|||.|
T Consensus       121 AlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG-~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~G  199 (590)
T KOG1290|consen  121 ALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG-QHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTG  199 (590)
T ss_pred             HHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC-cEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHH
Confidence            457999999994 2       36999999999875444 899999999999999999753  569999999999999999


Q ss_pred             HHHHHh-CCceecCCCCCCEEEecC-------------------------------------------------------
Q 022132           83 LKYIHS-ANVLHRDLKPSNLLLNAN-------------------------------------------------------  106 (302)
Q Consensus        83 l~~LH~-~~i~H~dikp~Nil~~~~-------------------------------------------------------  106 (302)
                      |.|||+ .||+|.||||+|||+-..                                                       
T Consensus       200 LdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r  279 (590)
T KOG1290|consen  200 LDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKR  279 (590)
T ss_pred             HHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhh
Confidence            999995 599999999999998300                                                       


Q ss_pred             --------------------------------------------------------------------------------
Q 022132          107 --------------------------------------------------------------------------------  106 (302)
Q Consensus       107 --------------------------------------------------------------------------------  106 (302)
                                                                                                      
T Consensus       280 ~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t  359 (590)
T KOG1290|consen  280 QAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSAT  359 (590)
T ss_pred             hhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccc
Confidence                                                                                            


Q ss_pred             -------------------------------CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHH
Q 022132          107 -------------------------------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS  155 (302)
Q Consensus       107 -------------------------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  155 (302)
                                                     .++||.|||.|......  ++....|+-|+|||++.+.+ |+..+||||
T Consensus       360 ~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh--FT~DIQTRQYRapEVllGsg-Y~~~ADiWS  436 (590)
T KOG1290|consen  360 PSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH--FTEDIQTRQYRAPEVLLGSG-YSTSADIWS  436 (590)
T ss_pred             cccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhh--hchhhhhhhccCcceeecCC-CCCchhHHH
Confidence                                           01223333322211111  12234477899999999877 899999999


Q ss_pred             HHHHHHHHHhCCCCCCC------CChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhh---------cccccccc-cccc
Q 022132          156 VGCIFMELMDRKPLFPG------RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ---------LPRYQRQS-FTEK  219 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~-~~~~  219 (302)
                      ++|+++||+||...|..      ..+.+.++.|++.+|..+......- ..-+++...         +..+.... +.+.
T Consensus       437 ~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~G-k~SRdFFnr~G~LrhI~~LK~WpL~~VL~eK  515 (590)
T KOG1290|consen  437 TACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGG-KYSRDFFNRRGELRHIRRLKPWPLYEVLIEK  515 (590)
T ss_pred             HHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcC-cchHhhhccccceecccccCCCcHHHHHHHH
Confidence            99999999999999853      2467899999999998765532110 001111111         11111100 0000


Q ss_pred             C---CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccCC
Q 022132          220 F---PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  260 (302)
Q Consensus       220 ~---~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  260 (302)
                      +   .....++.+||.-||+.+|.+||||.++|+|||++..-.+
T Consensus       516 Y~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  516 YEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             hCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence            0   0123578899999999999999999999999999976544

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=254.30  Aligned_cols=163  Identities=26%  Similarity=0.384  Sum_probs=142.6

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCC-ccHHHHHHcC---CCCCHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRSN---QALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qll~~l~   84 (302)
                      ...+.+|+++|++++|||||+++++-.+... --.....+|||||. |+|..++++.   ..|++.++..++..+..|+.
T Consensus        55 ~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~  134 (732)
T KOG4250|consen   55 RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALR  134 (732)
T ss_pred             HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHH
Confidence            4467799999999999999999998776531 11256779999996 7999999753   46999999999999999999


Q ss_pred             HHHhCCceecCCCCCCEEEe--cCCC--EEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           85 YIHSANVLHRDLKPSNLLLN--ANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        85 ~LH~~~i~H~dikp~Nil~~--~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      |||.+||+||||||.||++-  .+|+  .||+|||.|+...+.....+.+||..|.+||++...+.|+..+|.||+||++
T Consensus       135 ~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gvtl  214 (732)
T KOG4250|consen  135 HLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTL  214 (732)
T ss_pred             HHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHH
Confidence            99999999999999999874  3344  6999999999999998999999999999999997556799999999999999


Q ss_pred             HHHHhCCCCCCC
Q 022132          161 MELMDRKPLFPG  172 (302)
Q Consensus       161 ~~ll~g~~pf~~  172 (302)
                      |+++||..||..
T Consensus       215 Y~caTG~lPF~p  226 (732)
T KOG4250|consen  215 YECATGELPFIP  226 (732)
T ss_pred             HHHhccCCCCCc
Confidence            999999999953

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.5e-32  Score=252.81  Aligned_cols=207  Identities=23%  Similarity=0.325  Sum_probs=140.8

Q ss_pred             CCcEEEEEecCC-ccHHHHHHcCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q 022132           43 FNDVYIAYELMD-TDLHQIIRSNQA--------------------LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL  101 (302)
Q Consensus        43 ~~~~~lv~e~~~-~~L~~~l~~~~~--------------------l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Ni  101 (302)
                      ...+++|+||++ ++|.+++.....                    .....+..++.||+.||+|||+.||+||||||+||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI  286 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI  286 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence            378999999997 689988865321                    12345778999999999999999999999999999


Q ss_pred             EEec-CCCEEEeecccccccCCC--CcccccccccccCchhhhhCCC---------------------CCCCchhHHHHH
Q 022132          102 LLNA-NCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSS---------------------DYTAAIDVWSVG  157 (302)
Q Consensus       102 l~~~-~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DiwslG  157 (302)
                      |++. ++.+||+|||++......  .......+++.|+|||.+....                     .+..++||||+|
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            9986 578999999999754322  2234567889999999764322                     123456999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCC
Q 022132          158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTF  237 (302)
Q Consensus       158 ~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  237 (302)
                      |++|+|+++..++  .+....+.......+...........        ...........+.+...+....+||.+||++
T Consensus       367 viL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        367 LIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVE--------PRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhc--------cccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            9999999866543  33333333333333222111100000        0000000000111223345678999999999


Q ss_pred             CCCCCCCHHHHhcCCCcCCccC
Q 022132          238 DPRQRITVEDALAHPYLGSLHD  259 (302)
Q Consensus       238 dP~~R~t~~ell~h~~~~~~~~  259 (302)
                      ||.+|||++++|+||||+....
T Consensus       437 dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        437 KGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             CcccCCCHHHHhCCcCcCCCCc
Confidence            9999999999999999987543

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=242.78  Aligned_cols=210  Identities=22%  Similarity=0.377  Sum_probs=176.2

Q ss_pred             hhHHHHhcC----chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHH
Q 022132            3 SITKLMQRG----HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYF   75 (302)
Q Consensus         3 ~~~~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i   75 (302)
                      |+|.++.+.    +|..|.-+++.++|||+|+|+++|...     ..+|||+|||. |+|.++++..  ..++.-...++
T Consensus       296 AVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyM  370 (1157)
T KOG4278|consen  296 AVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYM  370 (1157)
T ss_pred             ehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCeEEEEecccCccHHHHHHHhchhhcchhHHHHH
Confidence            445555554    889999999999999999999999987     78999999986 8999999863  45677788899


Q ss_pred             HHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCccccccc---ccccCchhhhhCCCCCCCchh
Q 022132           76 LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV---TRWYRAPELLLNSSDYTAAID  152 (302)
Q Consensus        76 ~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~---~~~y~aPE~~~~~~~~~~~~D  152 (302)
                      +.||.+|++||...+++||||...|+|+..+..+|+.|||+++......+. ...|   ..-|.|||.+.- ..++.++|
T Consensus       371 AtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAy-NtFSiKSD  448 (1157)
T KOG4278|consen  371 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAY-NTFSIKSD  448 (1157)
T ss_pred             HHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-cccCccCcccccCcccccc-cccccchh
Confidence            999999999999999999999999999999999999999999987655432 2222   345999998843 44899999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHH
Q 022132          153 VWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV  231 (302)
Q Consensus       153 iwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  231 (302)
                      ||+||+++|++.+ |-.||+|-+..+.+..+-+..+-                             +...++++.+-+|+
T Consensus       449 VWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM-----------------------------~~PeGCPpkVYeLM  499 (1157)
T KOG4278|consen  449 VWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM-----------------------------DGPEGCPPKVYELM  499 (1157)
T ss_pred             hHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc-----------------------------cCCCCCCHHHHHHH
Confidence            9999999999986 78999999888877766543221                             11237899999999


Q ss_pred             HHccCCCCCCCCCHHHH
Q 022132          232 EKMLTFDPRQRITVEDA  248 (302)
Q Consensus       232 ~~~L~~dP~~R~t~~el  248 (302)
                      +.||+++|.+||+++|+
T Consensus       500 raCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  500 RACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             HHHhcCCcccCccHHHH
Confidence            99999999999999987

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=4.5e-33  Score=269.21  Aligned_cols=212  Identities=16%  Similarity=0.207  Sum_probs=152.7

Q ss_pred             hHHHHHHhcCC-CCccccceeeCCCCCC--CCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           15 RSSCFDTWIMK-TSVVAIRDIIPPPQRE--SFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        15 ~E~~il~~l~h-~niv~l~~~~~~~~~~--~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      +...-.+.+.| +||+++++.|......  ....++.++|+++++|.+++.. ...+++..+..++.||+.||+|||++|
T Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g  100 (793)
T PLN00181         21 FCTDGSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG  100 (793)
T ss_pred             cCCCccchhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            34445677777 7999999998443211  1246788899999999999975 356999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCC-------------------EEEeecccccccCCCC-----------------cccccccccc
Q 022132           91 VLHRDLKPSNLLLNANCD-------------------LKICDFGLARVTSETD-----------------FMTEYVVTRW  134 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~-------------------~kl~dfg~~~~~~~~~-----------------~~~~~~~~~~  134 (302)
                      |+||||||+|||++..|.                   +|++|||+++......                 ......+|++
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999965444                   5555555554211000                 0011357888


Q ss_pred             cCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccc
Q 022132          135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ  214 (302)
Q Consensus       135 y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (302)
                      |+|||.+.+. .++.++|||||||++|||++|.+|+.....  ....+.... .|.                        
T Consensus       181 Y~APE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~~------------------------  232 (793)
T PLN00181        181 YTSPEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LPP------------------------  232 (793)
T ss_pred             eEChhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cCh------------------------
Confidence            9999998654 489999999999999999999888743211  111111100 000                        


Q ss_pred             cccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          215 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       215 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                          ......+...+++.+||++||.+|||+.|+|+||||....
T Consensus       233 ----~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        233 ----QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             ----hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence                0001234567899999999999999999999999998753

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-32  Score=241.62  Aligned_cols=214  Identities=21%  Similarity=0.326  Sum_probs=176.4

Q ss_pred             HhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~   84 (302)
                      ..+..|.+|+++|.+|+||||+.+++++..+     ..+++++||++ |+|.+++.++  ..+.......|+.||++|++
T Consensus       577 ~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgma  651 (807)
T KOG1094|consen  577 NARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMA  651 (807)
T ss_pred             hHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHH
Confidence            3456899999999999999999999999988     88999999997 8999999887  33455667779999999999


Q ss_pred             HHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCCCCCchhHHHHHHHHH
Q 022132           85 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        85 ~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~  161 (302)
                      ||.+.+++|||+.+.|+|++.++++||+|||.++..-..+.   ....+....|+|+|.+.-++ ++.++|+|++|+++|
T Consensus       652 YLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlw  730 (807)
T KOG1094|consen  652 YLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLW  730 (807)
T ss_pred             HHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHH
Confidence            99999999999999999999999999999999985433321   22345567899999987554 999999999999999


Q ss_pred             HHH--hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC
Q 022132          162 ELM--DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       162 ~ll--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      |++  +...||....+.+.....-..+..++.                      .-.....+-++..+.+++.+|+..|-
T Consensus       731 E~~~~C~e~Py~~lt~e~vven~~~~~~~~~~----------------------~~~l~~P~~cp~~lyelml~Cw~~es  788 (807)
T KOG1094|consen  731 EVFMLCREQPYSQLTDEQVVENAGEFFRDQGR----------------------QVVLSRPPACPQGLYELMLRCWRRES  788 (807)
T ss_pred             HHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc----------------------ceeccCCCcCcHHHHHHHHHHhchhh
Confidence            985  678999877777766655554444332                      22333444678889999999999999


Q ss_pred             CCCCCHHHHh
Q 022132          240 RQRITVEDAL  249 (302)
Q Consensus       240 ~~R~t~~ell  249 (302)
                      .+|||++++-
T Consensus       789 ~~RPsFe~lh  798 (807)
T KOG1094|consen  789 EQRPSFEQLH  798 (807)
T ss_pred             hcCCCHHHHH
Confidence            9999999983

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.7e-32  Score=222.61  Aligned_cols=210  Identities=22%  Similarity=0.423  Sum_probs=172.3

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ....|..+..+- +||.+|-++.+|...     +.+++|.||.+ |+|--.+...+.++++.++.+...|+.||.|||+.
T Consensus       296 wvqtek~vfe~asn~pflvglhscfqte-----srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r  370 (593)
T KOG0695|consen  296 WVQTEKHVFEQASNNPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER  370 (593)
T ss_pred             hHHhhHHHHHhccCCCeEEehhhhhccc-----ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc
Confidence            344688888777 899999999999998     89999999996 68876666677899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccc-cCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||++||+|.+|++++.+|.+||+|+|.|+. ..+.+..+.++||+.|.|||++.+. .|+..+|.|+||++|++|..|+.
T Consensus       371 giiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrs  449 (593)
T KOG0695|consen  371 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRS  449 (593)
T ss_pred             CeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCC
Confidence            999999999999999999999999999975 4556677889999999999999654 59999999999999999999999


Q ss_pred             CCCCC--Ch-----HHH-HHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          169 LFPGR--DH-----VHQ-LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       169 pf~~~--~~-----~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      ||+..  +.     .+. .+.|.+.                           ..   .....+|-.+..+++..|++||.
T Consensus       450 pfdivgm~n~d~ntedylfqvilek---------------------------qi---riprslsvkas~vlkgflnkdp~  499 (593)
T KOG0695|consen  450 PFDIVGMDNPDMNTEDYLFQVILEK---------------------------QI---RIPRSLSVKASHVLKGFLNKDPK  499 (593)
T ss_pred             CcceecCCCcccchhHHHHHHHhhh---------------------------cc---cccceeehhhHHHHHHhhcCCcH
Confidence            99521  11     111 1111110                           00   11113556678899999999999


Q ss_pred             CCC------CHHHHhcCCCcCCc
Q 022132          241 QRI------TVEDALAHPYLGSL  257 (302)
Q Consensus       241 ~R~------t~~ell~h~~~~~~  257 (302)
                      +|.      ..+++-.|+||+.+
T Consensus       500 erlgc~~~~g~~dik~h~ffr~i  522 (593)
T KOG0695|consen  500 ERLGCRPQTGFSDIKSHAFFRSI  522 (593)
T ss_pred             HhcCCCcccchhhhhcchhhhhC
Confidence            996      46899999999865

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.98  E-value=2.9e-33  Score=252.10  Aligned_cols=214  Identities=22%  Similarity=0.356  Sum_probs=185.2

Q ss_pred             HhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~   85 (302)
                      .++..|..|..|+-|+.||||++|-++.+..     ..+.||+|||+ |+|..+|+++ +.++..++.-+++.|+.|++|
T Consensus       672 kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks-----~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkY  746 (996)
T KOG0196|consen  672 KQRRDFLSEASIMGQFDHPNIIRLEGVVTKS-----KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKY  746 (996)
T ss_pred             HHHhhhhhhhhhcccCCCCcEEEEEEEEecC-----ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHH
Confidence            4577899999999999999999999999887     88999999997 8999999864 779999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc-c-ccc--ccccccCchhhhhCCCCCCCchhHHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-M-TEY--VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~-~~~--~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~  161 (302)
                      |-+.|++||||.+.|||++.+..+|+.|||+++...+... . +..  .-...|.|||.+.. .+++.++|+||+|++||
T Consensus       747 Lsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmW  825 (996)
T KOG0196|consen  747 LSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMW  825 (996)
T ss_pred             HhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEE
Confidence            9999999999999999999999999999999997755431 1 111  12456999999954 45999999999999999


Q ss_pred             HHH-hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          162 ELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       162 ~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      |.+ .|..||-...+.+.+..+.+..+-|++-                             ++|..+-+|+..||++|-.
T Consensus       826 EVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm-----------------------------DCP~aL~qLMldCWqkdR~  876 (996)
T KOG0196|consen  826 EVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM-----------------------------DCPAALYQLMLDCWQKDRN  876 (996)
T ss_pred             EecccCCCcccccchHHHHHHHHhccCCCCCC-----------------------------CCcHHHHHHHHHHHHHHhh
Confidence            976 5999999999999998888877766542                             7888999999999999999


Q ss_pred             CCCCHHHHhc--CCCcCC
Q 022132          241 QRITVEDALA--HPYLGS  256 (302)
Q Consensus       241 ~R~t~~ell~--h~~~~~  256 (302)
                      .||++.++++  +..+.+
T Consensus       877 ~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  877 RRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             cCCCHHHHHHHHHHHhcC
Confidence            9999999887  344443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.98  E-value=4.4e-32  Score=229.83  Aligned_cols=243  Identities=26%  Similarity=0.419  Sum_probs=179.2

Q ss_pred             HhcCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..=.+...|+.+|..+ .+.||+++.+++...     +.+.+|+||++. +..++...   ++...++.+++.++.||++
T Consensus        76 s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn-----d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~  147 (418)
T KOG1167|consen   76 SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN-----DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAH  147 (418)
T ss_pred             cCchHHHHHHHHHHHhccchhhhcchhhhccC-----CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhh
Confidence            3344677999999999 789999999999988     899999999984 77777654   7799999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecC-CCEEEeeccccccc----------C-------C----C--------------------
Q 022132           86 IHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVT----------S-------E----T--------------------  123 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~----------~-------~----~--------------------  123 (302)
                      +|++||+||||||+|++.+.. +.-.|+|||++...          +       .    .                    
T Consensus       148 ~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~  227 (418)
T KOG1167|consen  148 LHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCN  227 (418)
T ss_pred             hhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccC
Confidence            999999999999999999865 67899999998510          0       0    0                    


Q ss_pred             ----CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChHHHhhhh
Q 022132          124 ----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF-PGRDHVHQLRLLIELIGTPSEAELGFLN  198 (302)
Q Consensus       124 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (302)
                          .......||+.|+|||++...+.-+.++||||.|+|+..++++..|| ...++.+.+..+....|...-.......
T Consensus       228 ~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~  307 (418)
T KOG1167|consen  228 DGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALP  307 (418)
T ss_pred             CCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcC
Confidence                00012357999999999998888899999999999999999988776 4556666666666555432222111110


Q ss_pred             Hh-----------HHHHhhhcccc-------ccc---cccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          199 EN-----------AKKYICQLPRY-------QRQ---SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       199 ~~-----------~~~~~~~~~~~-------~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                      ..           ..+....+...       ...   .........+..+.+|+.+||..||.+|.|++|+|.||||...
T Consensus       308 g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  308 GRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             CceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence            00           00000000000       001   1111222345689999999999999999999999999999954


Q ss_pred             c
Q 022132          258 H  258 (302)
Q Consensus       258 ~  258 (302)
                      .
T Consensus       388 ~  388 (418)
T KOG1167|consen  388 D  388 (418)
T ss_pred             h
Confidence            3

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=237.95  Aligned_cols=209  Identities=22%  Similarity=0.339  Sum_probs=175.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..|++|+.++..|+|||+++||++..+      ....||||++. |+|.+.|.+  ...|-......++.||+.|+.||.
T Consensus       156 ddflrEas~M~~L~H~hliRLyGvVl~------qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe  229 (1039)
T KOG0199|consen  156 DDFLREASHMLKLQHPHLIRLYGVVLD------QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE  229 (1039)
T ss_pred             HHHHHHHHHHHhccCcceeEEeeeecc------chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh
Confidence            478999999999999999999999987      46789999997 899999986  457888999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCccccc----ccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY----VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~----~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      +++++|||+...|+++-....+||+|||+.+..+........    .-...|+|||.+... .++.++|+|++||++|||
T Consensus       230 skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEM  308 (1039)
T KOG0199|consen  230 SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEM  308 (1039)
T ss_pred             hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhh
Confidence            999999999999999999989999999999987765433221    124459999999654 499999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          164 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       164 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      ++ |..||.|....+.+..+-+.-.                             ....+.++.++-+++.+||..+|.+|
T Consensus       309 FtyGEePW~G~~g~qIL~~iD~~er-----------------------------LpRPk~csedIY~imk~cWah~paDR  359 (1039)
T KOG0199|consen  309 FTYGEEPWVGCRGIQILKNIDAGER-----------------------------LPRPKYCSEDIYQIMKNCWAHNPADR  359 (1039)
T ss_pred             hccCCCCCCCCCHHHHHHhcccccc-----------------------------CCCCCCChHHHHHHHHHhccCCcccc
Confidence            97 8899999998877766542211                             12223678899999999999999999


Q ss_pred             CCHHHHhcCCCcC
Q 022132          243 ITVEDALAHPYLG  255 (302)
Q Consensus       243 ~t~~ell~h~~~~  255 (302)
                      ||+..+.+.-+..
T Consensus       360 ptFsair~~~~l~  372 (1039)
T KOG0199|consen  360 PTFSAIREDLVLA  372 (1039)
T ss_pred             ccHHHHHHhHHHH
Confidence            9999987554443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=4.4e-30  Score=232.70  Aligned_cols=228  Identities=18%  Similarity=0.280  Sum_probs=156.2

Q ss_pred             chhhHHHHHHhcCCCCc-----cccceeeCCCCC---CCCCcEEEEEecCC-ccHHHHHHcC------------------
Q 022132           12 HFVRSSCFDTWIMKTSV-----VAIRDIIPPPQR---ESFNDVYIAYELMD-TDLHQIIRSN------------------   64 (302)
Q Consensus        12 ~~~~E~~il~~l~h~ni-----v~l~~~~~~~~~---~~~~~~~lv~e~~~-~~L~~~l~~~------------------   64 (302)
                      .+..|+.++.+++|.++     +++++++.....   ...+..++|+||++ ++|.+++...                  
T Consensus       218 ~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l  297 (507)
T PLN03224        218 TGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKI  297 (507)
T ss_pred             hhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCch
Confidence            44568888888876554     677777764321   11256899999997 6998887531                  


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCccc--ccccccccC
Q 022132           65 ------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT--EYVVTRWYR  136 (302)
Q Consensus        65 ------~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~y~  136 (302)
                            ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..........  ...+++.|+
T Consensus       298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~  377 (507)
T PLN03224        298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS  377 (507)
T ss_pred             hhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence                  124567889999999999999999999999999999999999999999999986543322222  223478899


Q ss_pred             chhhhhCCCC-------------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCChHHH
Q 022132          137 APELLLNSSD-------------------Y--TAAIDVWSVGCIFMELMDRKP-LFPGRDHVHQLRLLIELIGTPSEAEL  194 (302)
Q Consensus       137 aPE~~~~~~~-------------------~--~~~~DiwslG~i~~~ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~  194 (302)
                      |||.+.....                   +  ....|+||+||++++|++|.. ||.+......   ..+.... .    
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~~~-~----  449 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQYDN-D----  449 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhccc-h----
Confidence            9998753221                   1  134799999999999999875 6643321110   0000000 0    


Q ss_pred             hhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC---CCCCCHHHHhcCCCcCC
Q 022132          195 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP---RQRITVEDALAHPYLGS  256 (302)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~R~t~~ell~h~~~~~  256 (302)
                         ......+...     ...+ ..++..++..+||+.+||..+|   .+|+|++|+|+||||..
T Consensus       450 ---~~~~r~~~~~-----~~~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        450 ---LNRWRMYKGQ-----KYDF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ---HHHHHhhccc-----CCCc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence               0000000000     0011 1345678899999999999876   68999999999999964

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=6.2e-31  Score=203.47  Aligned_cols=169  Identities=27%  Similarity=0.418  Sum_probs=140.1

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHH----HcCCCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII----RSNQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l----~~~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ++..+|+.+.... .+|.+|.+|+.+...     .++++.||.|+.+|..+.    .+++.++|..+-+|+..++.||.|
T Consensus        89 ~r~L~dldi~~r~~~CPf~V~FyGa~~re-----gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~  163 (282)
T KOG0984|consen   89 KRLLMDLDIIMRTVDCPFTVHFYGALFRE-----GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEF  163 (282)
T ss_pred             HHHHHhhhhhccCCCCCeEEEeehhhhcc-----ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHH
Confidence            3556788877777 789999999998887     899999999998886554    457889999999999999999999


Q ss_pred             HHhC-CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCC---CCCCCchhHHHHHHHHH
Q 022132           86 IHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        86 LH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~i~~  161 (302)
                      ||++ .++|||+||+|||++.+|++|+||||.+....+.--.+-..|-..|+|||.+...   ..|+.++||||||+++.
T Consensus       164 L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmi  243 (282)
T KOG0984|consen  164 LHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMI  243 (282)
T ss_pred             HHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhh
Confidence            9976 7999999999999999999999999999766544333334566679999998432   24789999999999999


Q ss_pred             HHHhCCCCCCCC-ChHHHHHHHHH
Q 022132          162 ELMDRKPLFPGR-DHVHQLRLLIE  184 (302)
Q Consensus       162 ~ll~g~~pf~~~-~~~~~~~~~~~  184 (302)
                      ||.+++.||+.. ...+++...++
T Consensus       244 ElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  244 EMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhhhccccccccCCHHHHHHHHhc
Confidence            999999999754 44556655554

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-30  Score=238.43  Aligned_cols=207  Identities=26%  Similarity=0.433  Sum_probs=169.4

Q ss_pred             hcCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHH
Q 022132            9 QRGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEE   70 (302)
Q Consensus         9 ~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~   70 (302)
                      ..+.+..|+.+++.+ +||||+.+++++..+     +.+++|+||+. |+|..+++.++                .++..
T Consensus       344 ~~~~~~~El~~m~~~g~H~niv~llG~~t~~-----~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~  418 (609)
T KOG0200|consen  344 EKKDLMSELNVLKELGKHPNIVNLLGACTQD-----GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTK  418 (609)
T ss_pred             HHHHHHHHHHHHHHhcCCcchhhheeeeccC-----CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHH
Confidence            345778999999999 799999999999986     89999999997 89999998755                48899


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCccc--ccc--cccccCchhhhhCCCC
Q 022132           71 HCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT--EYV--VTRWYRAPELLLNSSD  146 (302)
Q Consensus        71 ~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~--~~~~y~aPE~~~~~~~  146 (302)
                      ....+.+||+.|++||++..++|||+-+.||+++.+..+||+|||+++.........  ...  ....|+|||.+.. ..
T Consensus       419 dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~  497 (609)
T KOG0200|consen  419 DLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RV  497 (609)
T ss_pred             HHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-Cc
Confidence            999999999999999999999999999999999999999999999998654432221  122  2345999999966 56


Q ss_pred             CCCchhHHHHHHHHHHHHh-CCCCCCCCC-hHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCC
Q 022132          147 YTAAIDVWSVGCIFMELMD-RKPLFPGRD-HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH  224 (302)
Q Consensus       147 ~~~~~DiwslG~i~~~ll~-g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (302)
                      ++.++||||+|+++||+++ |..||++-. ..+.+..+.+ ...                            .+....++
T Consensus       498 ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~-G~r----------------------------~~~P~~c~  548 (609)
T KOG0200|consen  498 FTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE-GNR----------------------------MEQPEHCS  548 (609)
T ss_pred             ccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc-CCC----------------------------CCCCCCCC
Confidence            9999999999999999987 899998854 3333332221 111                            12223678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          225 PSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       225 ~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      +++-++++.||+.+|.+||++.++..
T Consensus       549 ~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  549 DEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            89999999999999999999998865

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=3.9e-30  Score=204.96  Aligned_cols=166  Identities=23%  Similarity=0.329  Sum_probs=127.0

Q ss_pred             ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCccccccccc
Q 022132           55 TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR  133 (302)
Q Consensus        55 ~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  133 (302)
                      |+|.+++.. ++++++..++.++.|++.||+|||+.|      ||+||+++.++.+++  ||.+......    ...++.
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence            689999986 456999999999999999999999999      999999999999999  9998765443    226789


Q ss_pred             ccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccc
Q 022132          134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ  212 (302)
Q Consensus       134 ~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  212 (302)
                      .|+|||++.+. .++.++||||+||++|+|++|.+||...... ..+..+...........                   
T Consensus        69 ~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  128 (176)
T smart00750       69 YFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD-------------------  128 (176)
T ss_pred             cccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc-------------------
Confidence            99999999654 4899999999999999999999999655432 22222222111100000                   


Q ss_pred             cccccccCCCCCH--HHHHHHHHccCCCCCCCCCHHHHhcCCCcCC
Q 022132          213 RQSFTEKFPNVHP--SAIDLVEKMLTFDPRQRITVEDALAHPYLGS  256 (302)
Q Consensus       213 ~~~~~~~~~~~~~--~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  256 (302)
                      .    .....++.  .+.+++.+||..||.+|||+.+++.|+|+..
T Consensus       129 ~----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      129 R----SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             c----ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            0    00001222  6899999999999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=4.2e-30  Score=254.34  Aligned_cols=212  Identities=18%  Similarity=0.268  Sum_probs=151.8

Q ss_pred             hhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hC
Q 022132           14 VRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH---SA   89 (302)
Q Consensus        14 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH---~~   89 (302)
                      ..|+.++++++||||+++++++...     +..|+||||++ |+|.+++..   +++..+..++.|++.|++|||   +.
T Consensus       731 ~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~  802 (968)
T PLN00113        731 SSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSP  802 (968)
T ss_pred             HHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCC
Confidence            4679999999999999999999887     78999999997 799999863   889999999999999999999   66


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      +|+|||+||+||+++.++..++. +|.......   .....++..|+|||.+.+ ..++.++||||+||++|||++|+.|
T Consensus       803 ~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p  877 (968)
T PLN00113        803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSP  877 (968)
T ss_pred             CeecCCCCHHhEEECCCCceEEE-ecccccccc---CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCC
Confidence            99999999999999998887775 554433221   122367889999998854 4589999999999999999999999


Q ss_pred             CCCCChH-HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 FPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |...... ...............         ......  +.... .. ........++.+++.+||+.||.+|||++|+
T Consensus       878 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~--~~~~~-~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ev  944 (968)
T PLN00113        878 ADAEFGVHGSIVEWARYCYSDCH---------LDMWID--PSIRG-DV-SVNQNEIVEVMNLALHCTATDPTARPCANDV  944 (968)
T ss_pred             CCcccCCCCcHHHHHHHhcCccc---------hhheeC--ccccC-CC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHH
Confidence            8532110 000000000000000         000000  00000 00 0000112357789999999999999999999


Q ss_pred             hcC
Q 022132          249 LAH  251 (302)
Q Consensus       249 l~h  251 (302)
                      ++.
T Consensus       945 l~~  947 (968)
T PLN00113        945 LKT  947 (968)
T ss_pred             HHH
Confidence            874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-31  Score=233.65  Aligned_cols=215  Identities=25%  Similarity=0.379  Sum_probs=179.1

Q ss_pred             hhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022132           13 FVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV   91 (302)
Q Consensus        13 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i   91 (302)
                      ...|+-+++.++||||+.+++.+.-.     ..++++||||+ |+|.+...-.+++++.++.++++..+.|++|||+.|-
T Consensus        59 iqqei~~~~dc~h~nivay~gsylr~-----dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk  133 (829)
T KOG0576|consen   59 IQQEIGMLRDCRHPNIVAYFGSYLRR-----DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGK  133 (829)
T ss_pred             cccceeeeecCCCcChHHHHhhhhhh-----cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCc
Confidence            45799999999999999999999887     88999999998 6999988888999999999999999999999999999


Q ss_pred             eecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhh--CCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           92 LHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        92 ~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      +|||||-.||++++.|.+|+.|||.+...+. -.....+.||++|+|||+-.  ....|...+|+|++|+...++-.-++
T Consensus       134 ~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqp  213 (829)
T KOG0576|consen  134 IHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQP  213 (829)
T ss_pred             ccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCC
Confidence            9999999999999999999999999865543 34567789999999999852  23458899999999999999987777


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |-........+....+..-.|+.                         .+.....++.+-+|++.+|.++|++|||++.+
T Consensus       214 plfdlhpmr~l~LmTkS~~qpp~-------------------------lkDk~kws~~fh~fvK~altknpKkRptaekl  268 (829)
T KOG0576|consen  214 PLFDLHPMRALFLMTKSGFQPPT-------------------------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKL  268 (829)
T ss_pred             cccccchHHHHHHhhccCCCCCc-------------------------ccCCccchHHHHHHHHHHhcCCCccCCChhhh
Confidence            76555544444333332222221                         12223567789999999999999999999999


Q ss_pred             hcCCCcCCc
Q 022132          249 LAHPYLGSL  257 (302)
Q Consensus       249 l~h~~~~~~  257 (302)
                      |.|||+.+.
T Consensus       269 L~h~fvs~~  277 (829)
T KOG0576|consen  269 LQHPFVSQT  277 (829)
T ss_pred             eeceeeccc
Confidence            999999864

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-30  Score=226.50  Aligned_cols=153  Identities=22%  Similarity=0.379  Sum_probs=141.0

Q ss_pred             hhhHHHHHHhcC---CCCccccceeeCCCCCCCCCcEEEEEecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           13 FVRSSCFDTWIM---KTSVVAIRDIIPPPQRESFNDVYIAYELMD-T-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        13 ~~~E~~il~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      .--||.||..++   |+||+|++++|++.     +.+|++||.-+ | +|.++++-+.+++|.+++.|++||+.|+++||
T Consensus       613 Vp~EIqIla~l~~~sH~NIlKlLdfFEdd-----d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh  687 (772)
T KOG1152|consen  613 VPSEIQILATLNKHSHENILKLLDFFEDD-----DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH  687 (772)
T ss_pred             cchhHHHHHHhhhcCccchhhhhheeecC-----CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc
Confidence            346999999998   99999999999998     89999999987 4 99999999999999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +.||+|||||-+|+.++.+|.+||+|||.+.....+ ....++||..|.|||++.+.+..+..-|||++|+++|.++...
T Consensus       688 ~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyke  766 (772)
T KOG1152|consen  688 DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKE  766 (772)
T ss_pred             ccCceecccccccEEEecCCeEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEecc
Confidence            999999999999999999999999999998766544 3566799999999999987777789999999999999999999


Q ss_pred             CCCC
Q 022132          168 PLFP  171 (302)
Q Consensus       168 ~pf~  171 (302)
                      .||.
T Consensus       767 npyy  770 (772)
T KOG1152|consen  767 NPYY  770 (772)
T ss_pred             CCCc
Confidence            8885

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=6.6e-28  Score=196.27  Aligned_cols=176  Identities=35%  Similarity=0.629  Sum_probs=154.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.+.|++|+++++++...     ...++++|+++ ++|.+++... ..++...+..++.+++.++++||+
T Consensus        36 ~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  110 (215)
T cd00180          36 EELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS  110 (215)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3588999999999999999999999987     88999999998 7999998765 578999999999999999999999


Q ss_pred             CCceecCCCCCCEEEec-CCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           89 ANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      .|++|+||+|.||+++. ++.++|+|||.+....... ......+...|++||.+......+.++|+|++|++++++   
T Consensus       111 ~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---  187 (215)
T cd00180         111 NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---  187 (215)
T ss_pred             CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---
Confidence            99999999999999999 8999999999987654332 123345677899999885543578999999999999998   


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                                                                                ..+.+++.+|+..||++||+++
T Consensus       188 ----------------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~  209 (215)
T cd00180         188 ----------------------------------------------------------PELKDLIRKMLQKDPEKRPSAK  209 (215)
T ss_pred             ----------------------------------------------------------HHHHHHHHHHhhCCcccCcCHH
Confidence                                                                      1477899999999999999999


Q ss_pred             HHhcCC
Q 022132          247 DALAHP  252 (302)
Q Consensus       247 ell~h~  252 (302)
                      ++++|+
T Consensus       210 ~l~~~~  215 (215)
T cd00180         210 EILEHL  215 (215)
T ss_pred             HHhhCC
Confidence            999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=4.3e-29  Score=230.85  Aligned_cols=221  Identities=27%  Similarity=0.361  Sum_probs=174.5

Q ss_pred             hhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 022132           13 FVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVL   92 (302)
Q Consensus        13 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~   92 (302)
                      +..|+.+-..+.|||++.....+.+.     ...+-+||||+++|...+...+.++...+..++.|++.||+|||+.||.
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Gia  442 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEI-----DGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLA  442 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhc-----ccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCce
Confidence            45678888889999999988888876     4455559999999999999887899999999999999999999999999


Q ss_pred             ecCCCCCCEEEecCCCEEEeecccccccCCC-----CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           93 HRDLKPSNLLLNANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        93 H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |||+|++|++++.+|.+||+|||.+....-.     ......+|+..|+|||++.+........||||.|+++..|++|+
T Consensus       443 hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~  522 (601)
T KOG0590|consen  443 HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR  522 (601)
T ss_pred             eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence            9999999999999999999999998653321     33456789999999999987775567899999999999999999


Q ss_pred             CCCCCCChHHHHH-HHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          168 PLFPGRDHVHQLR-LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       168 ~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .||......+... .....                      ...............++...+.+|.+||++||.+|.|++
T Consensus       523 ~~Wk~a~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~  580 (601)
T KOG0590|consen  523 FPWKVAKKSDNSFKTNNYS----------------------DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIE  580 (601)
T ss_pred             Cccccccccccchhhhccc----------------------cccccccChHHHHHhchhhHHHHHHHHccCChhheecHH
Confidence            9996443322210 00000                      000000111122235677889999999999999999999


Q ss_pred             HHhcCCCcCCccCC
Q 022132          247 DALAHPYLGSLHDI  260 (302)
Q Consensus       247 ell~h~~~~~~~~~  260 (302)
                      ++++.+||+.....
T Consensus       581 ~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  581 QILNDEWIRSIECC  594 (601)
T ss_pred             HHhhChHhhhcceE
Confidence            99999999987643

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-27  Score=202.84  Aligned_cols=228  Identities=21%  Similarity=0.258  Sum_probs=167.4

Q ss_pred             HhcCchhhHHHHHHhc--CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWI--MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l--~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~   84 (302)
                      ..++.|..|..|++..  +|+||+++++.-...+.. ...+++|++|.+ |+|.++|..+ .+++....+++..++.||+
T Consensus       244 ~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa  321 (534)
T KOG3653|consen  244 QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLA  321 (534)
T ss_pred             HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHH
Confidence            3556788888887766  899999999876554322 357999999986 8999999874 6899999999999999999


Q ss_pred             HHHhC---------CceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCCC----
Q 022132           85 YIHSA---------NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYT----  148 (302)
Q Consensus        85 ~LH~~---------~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~----  148 (302)
                      |||+-         .|+|||||..|||+..+++.-|+|||+|......   ......+||..|||||++.+..++.    
T Consensus       322 ~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~A  401 (534)
T KOG3653|consen  322 HLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDA  401 (534)
T ss_pred             HhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHH
Confidence            99963         4999999999999999999999999999765432   2334478999999999997765554    


Q ss_pred             -CchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC--CCC
Q 022132          149 -AAIDVWSVGCIFMELMDRKPLFP-GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVH  224 (302)
Q Consensus       149 -~~~DiwslG~i~~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  224 (302)
                       .+.||||+|.++|||++...-+. +..+.-++.-..+.-..|+.+.+...--.    .+     .+..++..+.  ...
T Consensus       402 fkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~----kK-----~RP~~p~~W~~h~~~  472 (534)
T KOG3653|consen  402 FKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVR----KK-----QRPKIPDAWRKHAGM  472 (534)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHh----hc-----cCCCChhhhhcCccH
Confidence             47999999999999998775553 33333333333344445555444322110    01     1111222221  123


Q ss_pred             HHHHHHHHHccCCCCCCCCCHH
Q 022132          225 PSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       225 ~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .-+++.+..||+.||..|.|+.
T Consensus       473 ~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  473 AVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             HHHHHHHHHHcCCchhhhhhhH
Confidence            4689999999999999999984

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9.4e-27  Score=198.62  Aligned_cols=217  Identities=17%  Similarity=0.249  Sum_probs=155.7

Q ss_pred             cCchhhHHHHHHhc--CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWI--MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        10 ~~~~~~E~~il~~l--~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+.||.+|++..  +|+||+.+.+.-..+ .+.+..+|+|++|-+ |+|+++|.. ..++.+...+++..+++||++|
T Consensus       247 E~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHL  324 (513)
T KOG2052|consen  247 ERSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHL  324 (513)
T ss_pred             hhhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHH
Confidence            34667888887775  999999988865443 345567999999998 899999987 6799999999999999999999


Q ss_pred             HhC--------CceecCCCCCCEEEecCCCEEEeecccccccCCC-----CcccccccccccCchhhhhCCCCC-----C
Q 022132           87 HSA--------NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDY-----T  148 (302)
Q Consensus        87 H~~--------~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~-----~  148 (302)
                      |..        .|+|||||+.||+|..+|.+-|+|+|+|....+.     ......+||..|||||++...-+.     -
T Consensus       325 H~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesy  404 (513)
T KOG2052|consen  325 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESY  404 (513)
T ss_pred             HHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhh
Confidence            953        3999999999999999999999999998654332     234567899999999999544321     1


Q ss_pred             CchhHHHHHHHHHHHHhC----------CCCCCCCChHH-HHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccccc
Q 022132          149 AAIDVWSVGCIFMELMDR----------KPLFPGRDHVH-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT  217 (302)
Q Consensus       149 ~~~DiwslG~i~~~ll~g----------~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (302)
                      ..+||||||.++||++..          ++||.+..+.+ ....+.++...                     +..+++++
T Consensus       405 k~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv---------------------~~~RP~ip  463 (513)
T KOG2052|consen  405 KRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCV---------------------QKLRPNIP  463 (513)
T ss_pred             hHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceee---------------------cccCCCCC
Confidence            369999999999998632          46775432211 11111111100                     00111122


Q ss_pred             ccCCCCC--HHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          218 EKFPNVH--PSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       218 ~~~~~~~--~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      ..|...+  ..+..+++.||..||.-|.||--+-
T Consensus       464 nrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  464 NRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence            2222211  2467799999999999999986553

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=3.8e-27  Score=213.89  Aligned_cols=205  Identities=21%  Similarity=0.279  Sum_probs=168.4

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..++.+|+.++..+.|||+++|++++..+      .+-||++|++ |+|.++++. +.++-.+....|..||++|+.|||
T Consensus       742 s~e~LdeAl~masldHpnl~RLLgvc~~s------~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe  815 (1177)
T KOG1025|consen  742 SIELLDEALRMASLDHPNLLRLLGVCMLS------TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE  815 (1177)
T ss_pred             hHHHHHHHHHHhcCCCchHHHHhhhcccc------hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            45788999999999999999999999885      4889999998 899999975 468889999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCccccc---ccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .++++||||-..|+||..-..+|+.|||+++...........   .....|+|-|.+.. ..++.++||||+||++||++
T Consensus       816 ~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElm  894 (1177)
T KOG1025|consen  816 EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELM  894 (1177)
T ss_pred             hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHH
Confidence            999999999999999999999999999999876654322221   22345888887754 45899999999999999998


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      | |..|+.+....+.-..+.+..+                             ....|..+-++--++.+||..|++.||
T Consensus       895 TFGa~Py~gi~~~eI~dlle~geR-----------------------------LsqPpiCtiDVy~~mvkCwmid~~~rp  945 (1177)
T KOG1025|consen  895 TFGAKPYDGIPAEEIPDLLEKGER-----------------------------LSQPPICTIDVYMVMVKCWMIDADSRP  945 (1177)
T ss_pred             hcCCCccCCCCHHHhhHHHhcccc-----------------------------CCCCCCccHHHHHHHHHHhccCcccCc
Confidence            7 9999988765544333222111                             123346778899999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      +++++..
T Consensus       946 ~fkel~~  952 (1177)
T KOG1025|consen  946 TFKELAE  952 (1177)
T ss_pred             cHHHHHH
Confidence            9998865

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-27  Score=192.01  Aligned_cols=219  Identities=22%  Similarity=0.343  Sum_probs=162.2

Q ss_pred             HhcCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      .+-+.|.||...-=.| .|-||+.-|++-....    +.+.+++||++ |+|..-+...| +-+...+.++.|+++|+.|
T Consensus        62 tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~----d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~f  136 (378)
T KOG1345|consen   62 TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS----DAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEF  136 (378)
T ss_pred             hhHHHHHHHhccceeeccchhhhHHHHHHhhcC----ceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHH
Confidence            3445778887765556 6899999888765542    67889999998 89998887644 7789999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEec--CCCEEEeecccccccCCCCcccccccccccCchhhhhCCC----CCCCchhHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCI  159 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~i  159 (302)
                      ||+.+++|||||.+||||-.  ..++||||||.++..+...  ...-....|.+||+.....    ...+.+|+|.||++
T Consensus       137 MHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi  214 (378)
T KOG1345|consen  137 MHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGII  214 (378)
T ss_pred             hhccchhhcccccceEEEecCCccEEEeeecccccccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeee
Confidence            99999999999999999843  3569999999998776542  2223456699999874322    24678999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC
Q 022132          160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       160 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      ++.+++|++||......           .++-..          +..... -.....+..|..+++.+..+.++-|.++|
T Consensus       215 ~f~cltG~~PWQka~~~-----------d~~Y~~----------~~~w~~-rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~  272 (378)
T KOG1345|consen  215 FFYCLTGKFPWQKASIM-----------DKPYWE----------WEQWLK-RKNPALPKKFNPFSEKALRLFKKSLTPRF  272 (378)
T ss_pred             eeeeecCCCcchhhhcc-----------CchHHH----------HHHHhc-ccCccCchhhcccCHHHHHHHHHhcCCcc
Confidence            99999999999522111           111111          111110 01124567778899999999999999999


Q ss_pred             CCC---CCHHHHhcCCCcC
Q 022132          240 RQR---ITVEDALAHPYLG  255 (302)
Q Consensus       240 ~~R---~t~~ell~h~~~~  255 (302)
                      .+|   -++.......|..
T Consensus       273 ~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  273 KDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             cccchhHHHHHHHHHHHHH
Confidence            999   5666555555654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=7.7e-26  Score=186.59  Aligned_cols=159  Identities=36%  Similarity=0.642  Sum_probs=139.6

Q ss_pred             hcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~-l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..+.+.+|+..++.++|+|++++++++...     ...++++|++++ +|.+++..... +++..+..++.+++.++.+|
T Consensus        40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l  114 (225)
T smart00221       40 QREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYL  114 (225)
T ss_pred             HHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            345777899999999999999999999887     789999999986 99999987666 89999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      |+.|++|+|++|.||+++.++.++|+|||.+.......  ......++..|++||.+.....++.++|+|++|+++++|+
T Consensus       115 h~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~  194 (225)
T smart00221      115 HSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELL  194 (225)
T ss_pred             HhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHH
Confidence            99999999999999999999999999999987655432  3344567788999998743445678999999999999999


Q ss_pred             hCCCCCCC
Q 022132          165 DRKPLFPG  172 (302)
Q Consensus       165 ~g~~pf~~  172 (302)
                      +|+.||.+
T Consensus       195 ~g~~pf~~  202 (225)
T smart00221      195 WGPEPFSG  202 (225)
T ss_pred             HCCCCccc
Confidence            99999977

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=2.8e-25  Score=187.03  Aligned_cols=205  Identities=17%  Similarity=0.244  Sum_probs=167.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHH-----c---CCCCCHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR-----S---NQALSEEHCQYFLYQILRG   82 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~-----~---~~~l~~~~~~~i~~qll~~   82 (302)
                      .+..|--++.-..|||+.++.++.....    ...++++.+++ |+|..++.     +   ...++..++..++.|+..|
T Consensus       333 ~~L~es~lly~~sH~nll~V~~V~ie~~----~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~a  408 (563)
T KOG1024|consen  333 LLLQESMLLYGASHPNLLSVLGVSIEDY----ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMA  408 (563)
T ss_pred             HHHHHHHHHhcCcCCCccceeEEEeecc----CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHH
Confidence            4556777788888999999999887642    67889999998 89999997     2   1357778889999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCccc---ccccccccCchhhhhCCCCCCCchhHHHHHHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT---EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  159 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  159 (302)
                      ++|||+.|++|.||...|++|++.-++||+|=.+++..-+.++..   .......|||||.+.. ..|+.++|+||||++
T Consensus       409 m~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVl  487 (563)
T KOG1024|consen  409 MEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVL  487 (563)
T ss_pred             HHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHH
Confidence            999999999999999999999999999999988887655443322   1223556999999965 459999999999999


Q ss_pred             HHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCC
Q 022132          160 FMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       160 ~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  238 (302)
                      +|||.+ |+.|+..-++.+....+.+..+.                             ...-++|+++..++.-||..+
T Consensus       488 lWELmtlg~~PyaeIDPfEm~~ylkdGyRl-----------------------------aQP~NCPDeLf~vMacCWall  538 (563)
T KOG1024|consen  488 LWELMTLGKLPYAEIDPFEMEHYLKDGYRL-----------------------------AQPFNCPDELFTVMACCWALL  538 (563)
T ss_pred             HHHHHhcCCCCccccCHHHHHHHHhcccee-----------------------------cCCCCCcHHHHHHHHHHHhcC
Confidence            999986 99999888877776666543221                             111278999999999999999


Q ss_pred             CCCCCCHHHHhc
Q 022132          239 PRQRITVEDALA  250 (302)
Q Consensus       239 P~~R~t~~ell~  250 (302)
                      |.+||+.+++..
T Consensus       539 peeRPsf~Qlv~  550 (563)
T KOG1024|consen  539 PEERPSFSQLVI  550 (563)
T ss_pred             cccCCCHHHHHH
Confidence            999999999854

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=8.6e-24  Score=178.69  Aligned_cols=198  Identities=22%  Similarity=0.327  Sum_probs=146.8

Q ss_pred             CCCCccccceeeCCCCC----------------------CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHH
Q 022132           24 MKTSVVAIRDIIPPPQR----------------------ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR   81 (302)
Q Consensus        24 ~h~niv~l~~~~~~~~~----------------------~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~   81 (302)
                      +|||||++..+|.++.+                      ....++|+||..+..+|.+++-.+ ..+.....-++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHH
Confidence            69999999998866421                      223569999999999999999774 4677788889999999


Q ss_pred             HHHHHHhCCceecCCCCCCEEEe--cC--CCEEEeecccccccCCC----C---cccccccccccCchhhhhCCCC----
Q 022132           82 GLKYIHSANVLHRDLKPSNLLLN--AN--CDLKICDFGLARVTSET----D---FMTEYVVTRWYRAPELLLNSSD----  146 (302)
Q Consensus        82 ~l~~LH~~~i~H~dikp~Nil~~--~~--~~~kl~dfg~~~~~~~~----~---~~~~~~~~~~y~aPE~~~~~~~----  146 (302)
                      |+.|||++||.|||+|.+||++.  ++  ..+.+.|||+|-.....    .   ......|.-..+|||+.-....    
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            99999999999999999999983  33  34799999998543221    1   1123346677899998743221    


Q ss_pred             -CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCH
Q 022132          147 -YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP  225 (302)
Q Consensus       147 -~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (302)
                       .-.++|.|+.|.+.||++....||.+......                            ....++...++.....+++
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L----------------------------~~r~Yqe~qLPalp~~vpp  484 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL----------------------------DTRTYQESQLPALPSRVPP  484 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccccchhee----------------------------chhhhhhhhCCCCcccCCh
Confidence             12589999999999999999999976432110                            0111222333444557899


Q ss_pred             HHHHHHHHccCCCCCCCCCHH---HHhc
Q 022132          226 SAIDLVEKMLTFDPRQRITVE---DALA  250 (302)
Q Consensus       226 ~~~~li~~~L~~dP~~R~t~~---ell~  250 (302)
                      .+++++..+|+.||++|+++.   .+|+
T Consensus       485 ~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  485 VARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            999999999999999999864   4554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=7.4e-22  Score=171.32  Aligned_cols=226  Identities=30%  Similarity=0.500  Sum_probs=175.0

Q ss_pred             cCchhhHHHHHHhcCCC-CccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKT-SVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~-niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qll~~l~   84 (302)
                      ...+.+|+.+++.+.|+ +++++++.+...     ...+++++++. +++.+.+....   .++......++.|++.++.
T Consensus        41 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  115 (384)
T COG0515          41 VERFLREIQILASLNHPPNIVKLYDFFQDE-----GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE  115 (384)
T ss_pred             HHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHH
Confidence            44688999999999888 799999999555     55899999997 58887777654   7999999999999999999


Q ss_pred             HHHhCCceecCCCCCCEEEecCC-CEEEeecccccccCCCC-------cccccccccccCchhhhhCC--CCCCCchhHH
Q 022132           85 YIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD-------FMTEYVVTRWYRAPELLLNS--SDYTAAIDVW  154 (302)
Q Consensus        85 ~LH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~~Diw  154 (302)
                      ++|+.|++|||+||+||+++..+ .++++|||.+.......       ......++..|+|||.+.+.  ...+...|+|
T Consensus       116 ~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~  195 (384)
T COG0515         116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIW  195 (384)
T ss_pred             HHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHH
Confidence            99999999999999999999988 69999999987544332       34667889999999998663  4678999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCC-ChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          155 SVGCIFMELMDRKPLFPGRDH---VHQLRLLIELIGTP-SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       155 slG~i~~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      |+|+++++++.|..||.....   .............+ .....                  .....   ......+.++
T Consensus       196 s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~---~~~~~~~~~~  254 (384)
T COG0515         196 SLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL------------------SPSNP---ELISKAASDL  254 (384)
T ss_pred             HHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccccc------------------Ccccc---chhhHHHHHH
Confidence            999999999999999877664   23333333222222 00000                  00000   1223578899


Q ss_pred             HHHccCCCCCCCCCHHHHhcCCCcCCccCCC
Q 022132          231 VEKMLTFDPRQRITVEDALAHPYLGSLHDIS  261 (302)
Q Consensus       231 i~~~L~~dP~~R~t~~ell~h~~~~~~~~~~  261 (302)
                      +.+++..+|..|.+..+...+++........
T Consensus       255 ~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~  285 (384)
T COG0515         255 LKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE  285 (384)
T ss_pred             HHHHHhcCchhcCCHHHHhhchHhhCccccc
Confidence            9999999999999999999987776654433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=7.4e-24  Score=188.59  Aligned_cols=201  Identities=21%  Similarity=0.411  Sum_probs=172.1

Q ss_pred             chhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      +...|-.++..++ ||.+++++-.+..+     .++|+++++.. |+|...+.+...+++.....+...++-+++++|+.
T Consensus        42 ~t~~er~il~~~~~~~f~v~lhyafqt~-----~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l  116 (612)
T KOG0603|consen   42 HTKQERIILAFVHNTPFLVKLHYAFQTD-----GKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL  116 (612)
T ss_pred             ccccHHHHHhhccCCCceeeeeeeeccc-----cchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh
Confidence            5667889999995 99999999999998     89999999996 59999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+|||+|++||+++.+|.+++.|||.++..-.....   +||..|||||++.   ....++|.||+|+++++|++|..|
T Consensus       117 ~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~p  190 (612)
T KOG0603|consen  117 GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLP  190 (612)
T ss_pred             HHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCC
Confidence            9999999999999999999999999998765444222   8899999999985   257899999999999999999999


Q ss_pred             CCCCChHHHHHHHHH-HhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC----
Q 022132          170 FPGRDHVHQLRLLIE-LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT----  244 (302)
Q Consensus       170 f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----  244 (302)
                      |.+    +....|.+ .++.|.                               .++..+++++..++..+|..|.-    
T Consensus       191 f~~----~~~~~Il~~~~~~p~-------------------------------~l~~~a~~~~~~l~~r~p~nrLg~~~~  235 (612)
T KOG0603|consen  191 FGG----DTMKRILKAELEMPR-------------------------------ELSAEARSLFRQLFKRNPENRLGAGPD  235 (612)
T ss_pred             Cch----HHHHHHhhhccCCch-------------------------------hhhHHHHHHHHHHHhhCHHHHhccCcc
Confidence            977    44444443 222221                               45678999999999999999985    


Q ss_pred             -HHHHhcCCCcCCcc
Q 022132          245 -VEDALAHPYLGSLH  258 (302)
Q Consensus       245 -~~ell~h~~~~~~~  258 (302)
                       +.|+++|+||++..
T Consensus       236 ~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  236 GVDEIKQHEFFQSID  250 (612)
T ss_pred             hhHHHhccchheeee
Confidence             47999999998764

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=6.8e-24  Score=198.27  Aligned_cols=203  Identities=24%  Similarity=0.380  Sum_probs=150.5

Q ss_pred             hhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 022132           14 VRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLH   93 (302)
Q Consensus        14 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H   93 (302)
                      .+|++ ....++||.+.+..+....     ..-|||-+|...+|++.+..+.-+..-+.+.|++||+.||..+|..||+|
T Consensus        70 L~~ik-~~l~~~pn~lPfqk~~~t~-----kAAylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcH  143 (1431)
T KOG1240|consen   70 LEEIK-FALMKAPNCLPFQKVLVTD-----KAAYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCH  143 (1431)
T ss_pred             HHHHH-HHhhcCCcccchHHHHHhh-----HHHHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccc
Confidence            34555 5666999999998887776     78999999999999999998888899999999999999999999999999


Q ss_pred             cCCCCCCEEEecCCCEEEeeccccccc--CCC--C----cccccccccccCchhhhhCCC----------CCCCchhHHH
Q 022132           94 RDLKPSNLLLNANCDLKICDFGLARVT--SET--D----FMTEYVVTRWYRAPELLLNSS----------DYTAAIDVWS  155 (302)
Q Consensus        94 ~dikp~Nil~~~~~~~kl~dfg~~~~~--~~~--~----~~~~~~~~~~y~aPE~~~~~~----------~~~~~~Diws  155 (302)
                      ||||.+|||++.=.-+.|+||..-++.  .+.  .    .+.....-.+|.|||.+....          ..+++.||||
T Consensus       144 GDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS  223 (1431)
T KOG1240|consen  144 GDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFS  223 (1431)
T ss_pred             cccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhh
Confidence            999999999999889999999765432  111  1    111122334699999986522          1467899999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHc
Q 022132          156 VGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  234 (302)
Q Consensus       156 lG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (302)
                      +||+++|+++ |.|||.    ..++-...  -+.  ..                   ......+..  -+..++.+|..|
T Consensus       224 ~GCViaELf~Eg~PlF~----LSQL~aYr--~~~--~~-------------------~~e~~Le~I--ed~~~Rnlil~M  274 (1431)
T KOG1240|consen  224 AGCVIAELFLEGRPLFT----LSQLLAYR--SGN--AD-------------------DPEQLLEKI--EDVSLRNLILSM  274 (1431)
T ss_pred             hhHHHHHHHhcCCCccc----HHHHHhHh--ccC--cc-------------------CHHHHHHhC--cCccHHHHHHHH
Confidence            9999999976 899993    11110000  000  00                   000000000  123688999999


Q ss_pred             cCCCCCCCCCHHHHhcC
Q 022132          235 LTFDPRQRITVEDALAH  251 (302)
Q Consensus       235 L~~dP~~R~t~~ell~h  251 (302)
                      ++.||++|.+|++.|+.
T Consensus       275 i~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  275 IQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HccCchhccCHHHHHHh
Confidence            99999999999999986

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=7.9e-21  Score=159.21  Aligned_cols=161  Identities=20%  Similarity=0.275  Sum_probs=109.1

Q ss_pred             EEEEEecCCccHHHHHHc---CC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           46 VYIAYELMDTDLHQIIRS---NQ----ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        46 ~~lv~e~~~~~L~~~l~~---~~----~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                      .+++|+.+.++|.+++.-   ..    .+.......+..|++..+++||+.|++|+||+|+|++++.+|.+.|+||+...
T Consensus       114 ~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~  193 (288)
T PF14531_consen  114 RFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLV  193 (288)
T ss_dssp             EEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEE
T ss_pred             hhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHe
Confidence            478899999999888652   11    23344456667999999999999999999999999999999999999998876


Q ss_pred             ccCCCCcccccccccccCchhhhhCC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 022132          119 VTSETDFMTEYVVTRWYRAPELLLNS-------SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE  191 (302)
Q Consensus       119 ~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  191 (302)
                      ..+.....  ...+..|.|||.....       ..++.+.|.|+||+++|.|++|..||.........            
T Consensus       194 r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~------------  259 (288)
T PF14531_consen  194 RAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADP------------  259 (288)
T ss_dssp             ETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTS------------
T ss_pred             ecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccc------------
Confidence            66544222  3445779999987443       23688999999999999999999999644321000            


Q ss_pred             HHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          192 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                                           ...+.... ++|..+++||+++|++||.+|
T Consensus       260 ---------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  260 ---------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ---------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ---------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence                                 00223333 678899999999999999988

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=1.6e-19  Score=157.37  Aligned_cols=209  Identities=17%  Similarity=0.132  Sum_probs=155.9

Q ss_pred             chhhHHHHHHhcCC----CCccccceeeC-CCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMK----TSVVAIRDIIP-PPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus        12 ~~~~E~~il~~l~h----~niv~l~~~~~-~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~   84 (302)
                      .+..|..++..+..    +++.++++... ..     ..-|+||+.++.+|.++....  +.++...+..++.|++.+|+
T Consensus        62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~-----~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~  136 (322)
T KOG1164|consen   62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE-----DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALE  136 (322)
T ss_pred             cchhHHHHHHHHhhhcCCCCCCEEEEeccCCC-----ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHH
Confidence            57789999999973    68999999885 44     778999999999999988543  68999999999999999999


Q ss_pred             HHHhCCceecCCCCCCEEEecC-----CCEEEeeccccc--ccC-CC-------Cc-ccccccccccCchhhhhCCCCCC
Q 022132           85 YIHSANVLHRDLKPSNLLLNAN-----CDLKICDFGLAR--VTS-ET-------DF-MTEYVVTRWYRAPELLLNSSDYT  148 (302)
Q Consensus        85 ~LH~~~i~H~dikp~Nil~~~~-----~~~kl~dfg~~~--~~~-~~-------~~-~~~~~~~~~y~aPE~~~~~~~~~  148 (302)
                      +||+.|++||||||+|++++..     ..+.|.|||+++  ... ..       .. .....||..|+|+....+.. .+
T Consensus       137 ~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~  215 (322)
T KOG1164|consen  137 DLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QG  215 (322)
T ss_pred             HHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cC
Confidence            9999999999999999999865     359999999998  311 11       11 22355999999999886554 79


Q ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHH
Q 022132          149 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  228 (302)
Q Consensus       149 ~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (302)
                      .+.|+||++.++.+++.|..||.+...................                         .......+..+.
T Consensus       216 r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~  270 (322)
T KOG1164|consen  216 RRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLT-------------------------DRFGDLKPEEFA  270 (322)
T ss_pred             CchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcc-------------------------ccccCCChHHHH
Confidence            9999999999999999999999765533222222111100000                         001123445666


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcC
Q 022132          229 DLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       229 ~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      ++...+-..+...+|-...+...
T Consensus       271 ~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  271 KILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHHHHhhccCCcCCCCHHHHHHH
Confidence            77776666888888877666543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.82  E-value=8.8e-20  Score=147.52  Aligned_cols=200  Identities=15%  Similarity=0.210  Sum_probs=155.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      +.|..|.--|+.+.||||+.+++.+..+     .++.++..||+ |+|+.++....  -.+..++.+++.+++.|.+|||
T Consensus       232 rdfneefp~lrifshpnilpvlgacnsp-----pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflh  306 (448)
T KOG0195|consen  232 RDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLH  306 (448)
T ss_pred             chhhhhCcceeeecCCchhhhhhhccCC-----CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHh
Confidence            4678899999999999999999999988     88999999998 89999998653  3667788999999999999999


Q ss_pred             hCC--ceecCCCCCCEEEecCCCEEEe--ecccccccCCCCcccccccccccCchhhhhCCCC--CCCchhHHHHHHHHH
Q 022132           88 SAN--VLHRDLKPSNLLLNANCDLKIC--DFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFM  161 (302)
Q Consensus        88 ~~~--i~H~dikp~Nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~i~~  161 (302)
                      +..  |.--.+....++++++.+.+|.  |--++-.      ......++.|++||.+.....  .-.++|+|||+++++
T Consensus       307 slep~ipr~~lns~hvmidedltarismad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillw  380 (448)
T KOG0195|consen  307 SLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLW  380 (448)
T ss_pred             hcchhhhhhhcccceEEecchhhhheecccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHH
Confidence            985  4444688889999998666554  3222111      122355788999999965543  246899999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       162 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      |+.+...||......+.-.++.-.-                            .-....|++++.+..|+.-|+..||.+
T Consensus       381 el~trevpfadlspmecgmkialeg----------------------------lrv~ippgis~hm~klm~icmnedpgk  432 (448)
T KOG0195|consen  381 ELNTREVPFADLSPMECGMKIALEG----------------------------LRVHIPPGISRHMNKLMNICMNEDPGK  432 (448)
T ss_pred             HhhccccccccCCchhhhhhhhhcc----------------------------ccccCCCCccHHHHHHHHHHhcCCCCc
Confidence            9999999998877665433332100                            012344688899999999999999999


Q ss_pred             CCCHHHHh
Q 022132          242 RITVEDAL  249 (302)
Q Consensus       242 R~t~~ell  249 (302)
                      ||.++.++
T Consensus       433 rpkfdmiv  440 (448)
T KOG0195|consen  433 RPKFDMIV  440 (448)
T ss_pred             CCCcceeh
Confidence            99887653

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=7.2e-20  Score=162.85  Aligned_cols=203  Identities=23%  Similarity=0.303  Sum_probs=153.9

Q ss_pred             HHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCC
Q 022132           20 DTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANV-LHRDL   96 (302)
Q Consensus        20 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~~i-~H~di   96 (302)
                      |+++.|.|+.++++...+.     ...++|.+||. |+|.+.+.. ...++......+++.++.|++|||...| .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence            4678999999999999998     88999999998 899999986 4678889999999999999999998866 99999


Q ss_pred             CCCCEEEecCCCEEEeecccccccCC---CCcccccccccccCchhhhhCCC--C----CCCchhHHHHHHHHHHHHhCC
Q 022132           97 KPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSS--D----YTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        97 kp~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~--~----~~~~~DiwslG~i~~~ll~g~  167 (302)
                      ++.|++++..-.+|+.|||+......   ...........-|.|||.+....  .    .+.+.|+||+|++++++++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999876532   11122223455699999986531  1    367899999999999999999


Q ss_pred             CCCCCCChHH----HHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          168 PLFPGRDHVH----QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       168 ~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      .||.......    .+..+.+....+.                      ++.... ....++++..++..||..+|.+||
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~~~~----------------------rP~i~~-~~e~~~~l~~l~~~cw~e~P~~rP  212 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGSNPF----------------------RPSIEL-LNELPPELLLLVARCWEEIPEKRP  212 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCCCCc----------------------Ccchhh-hhhcchHHHHHHHHhcccChhhCc
Confidence            9997533221    2211111011111                      011110 113455789999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      +++.+-.
T Consensus       213 s~~~i~~  219 (484)
T KOG1023|consen  213 SIEQIRS  219 (484)
T ss_pred             cHHHHHh
Confidence            9988744

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=5.3e-20  Score=161.17  Aligned_cols=175  Identities=26%  Similarity=0.458  Sum_probs=131.0

Q ss_pred             CcEEEEEecCC-ccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           44 NDVYIAYELMD-TDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        44 ~~~~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      ..+||.|++|. ++|.+++..+   ...+......++.|+..|++|   +|.+|+|+||.||++..+..++|+|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            35899999997 7999999743   346678899999999999999   9999999999999999999999999999865


Q ss_pred             cCCCC-------cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 022132          120 TSETD-------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSE  191 (302)
Q Consensus       120 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~  191 (302)
                      .....       ..+...||..|++||.+.+ ..|+.++||||||+|+++++. -...|      +........      
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~~d~------  472 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQF------ERIATLTDI------  472 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHH------HHHHhhhhh------
Confidence            44332       4566789999999999965 459999999999999999986 22222      111111000      


Q ss_pred             HHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCc
Q 022132          192 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  254 (302)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~  254 (302)
                                          ....++..+-.-.+.-.+|+.+||.+.|.+||++.+.--|+|.
T Consensus       473 --------------------r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  473 --------------------RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             --------------------hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                                0011111111122445689999999999999988887777765

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=6.9e-19  Score=140.50  Aligned_cols=146  Identities=14%  Similarity=0.033  Sum_probs=109.5

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+++|++| +|+++++++++         +..|++|||+.| +|.+....      . ...++.|++.+|+++|++
T Consensus        47 l~~rE~~iL~~L~~~~~vP~ll~~---------~~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~  110 (218)
T PRK12274         47 LARREALALRQLDGLPRTPRLLHW---------DGRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRC  110 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCCEEEEE---------cCEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHC
Confidence            467899999999 45889999885         236899999876 67654321      1 135788999999999999


Q ss_pred             CceecCC-CCCCEEEecCCCEEEeecccccccCCCCcc--------------cccccccccCchhhhhCCCCCC-CchhH
Q 022132           90 NVLHRDL-KPSNLLLNANCDLKICDFGLARVTSETDFM--------------TEYVVTRWYRAPELLLNSSDYT-AAIDV  153 (302)
Q Consensus        90 ~i~H~di-kp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~-~~~Di  153 (302)
                      ||+|||| ||+||+++.+|.++|+|||++.........              ....+++.|++|+...-....+ .+.+.
T Consensus       111 GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w  190 (218)
T PRK12274        111 GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELW  190 (218)
T ss_pred             cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHH
Confidence            9999999 799999999999999999999755433210              0112466678887653332233 56677


Q ss_pred             HHHHHHHHHHHhCCCCCCCC
Q 022132          154 WSVGCIFMELMDRKPLFPGR  173 (302)
Q Consensus       154 wslG~i~~~ll~g~~pf~~~  173 (302)
                      ++.|+-+|.++|+..|+-+.
T Consensus       191 ~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        191 FATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHhcchHHHHHhccCCcccc
Confidence            88899999999999887443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.79  E-value=2.5e-19  Score=167.77  Aligned_cols=169  Identities=27%  Similarity=0.410  Sum_probs=131.9

Q ss_pred             ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC-----------
Q 022132           55 TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-----------  123 (302)
Q Consensus        55 ~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-----------  123 (302)
                      |+-.+.++..++++.+-        +.+++|||+-||+|||+||+|.+|+.-|.+|++|||+++.+...           
T Consensus       136 gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~  207 (1205)
T KOG0606|consen  136 GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE  207 (1205)
T ss_pred             chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence            44444554444554443        67899999999999999999999999999999999998653221           


Q ss_pred             -----CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhh
Q 022132          124 -----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN  198 (302)
Q Consensus       124 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (302)
                           -.....++|+.|.|||++...+ |+..+|.|++|+|+|+.+-|+.||.|....+.+...+.-...          
T Consensus       208 k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~----------  276 (1205)
T KOG0606|consen  208 KDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE----------  276 (1205)
T ss_pred             HHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc----------
Confidence                 0123458999999999997554 899999999999999999999999999888776655542211          


Q ss_pred             HhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC---CHHHHhcCCCcCCccC
Q 022132          199 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSLHD  259 (302)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~ell~h~~~~~~~~  259 (302)
                                       |.+.-..++++++++|.++|+.+|..|.   .+-++.+|+||+.+.-
T Consensus       277 -----------------wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw  323 (1205)
T KOG0606|consen  277 -----------------WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW  323 (1205)
T ss_pred             -----------------ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence                             1122235788999999999999999996   5678899999997643

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=3e-19  Score=145.42  Aligned_cols=131  Identities=14%  Similarity=0.240  Sum_probs=99.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCC---CCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRES---FNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~---~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      .+.+|+..+.++.||+|..+.+++.......   .+..+++|||++| +|.++.    .+++.    .+.+++.++..+|
T Consensus        81 ~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH  152 (232)
T PRK10359         81 YYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLH  152 (232)
T ss_pred             HHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHH
Confidence            3679999999999999999999977543211   2468999999986 887773    23433    4669999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      +.|++|||++|+||+++.+| ++|+|||......+....            ..+.-...+..++|+||||+++...
T Consensus       153 ~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        153 QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHH
Confidence            99999999999999999998 999999987654322111            1121122356789999999987764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=8.4e-19  Score=153.10  Aligned_cols=116  Identities=22%  Similarity=0.251  Sum_probs=89.6

Q ss_pred             CchhhHHHHHHhcCCCCccc-cceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVA-IRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~-l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+++|++++|+|++. +++    .     +..|+||||++| +|.. +..   ..   ...++.|++.||.|||+
T Consensus        66 ~~~~~E~~iL~~L~h~~iv~~l~~----~-----~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~  129 (365)
T PRK09188         66 HLAAREIRALKTVRGIGVVPQLLA----T-----GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHR  129 (365)
T ss_pred             HHHHHHHHHHHhccCCCCCcEEEE----c-----CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHH
Confidence            34789999999999999985 443    1     457999999975 6752 211   11   14678999999999999


Q ss_pred             CCceecCC-CCCCEEEecCCCEEEeecccccccCCCCc---------ccccccccccCchhhhh
Q 022132           89 ANVLHRDL-KPSNLLLNANCDLKICDFGLARVTSETDF---------MTEYVVTRWYRAPELLL  142 (302)
Q Consensus        89 ~~i~H~di-kp~Nil~~~~~~~kl~dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~  142 (302)
                      .||+|||| ||+||+++.++.++|+|||+++.......         .....++..|+|||.+.
T Consensus       130 ~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        130 AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             CCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99999999 99999999999999999999975443211         12345677789999874

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=2.4e-18  Score=136.93  Aligned_cols=162  Identities=20%  Similarity=0.280  Sum_probs=135.2

Q ss_pred             CchhhHHHHHHhcCC-CCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMK-TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~-~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ++...|.++++.|++ ..|..+..+..+.     ..-.+|||.++.+|.+++. ..++++...+.-++-|++.-++|+|.
T Consensus        55 pqL~yEskvY~iL~~g~GiP~i~~y~~e~-----~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~  129 (341)
T KOG1163|consen   55 PQLLYESKVYRILQGGVGIPHIRHYGTEK-----DYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL  129 (341)
T ss_pred             cchhHHHHHHHHhccCCCCchhhhhcccc-----ccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh
Confidence            366789999999965 8899999998887     7888999999999988886 34689999999999999999999999


Q ss_pred             CCceecCCCCCCEEEec---CCCEEEeecccccccCCC--------CcccccccccccCchhhhhCCCCCCCchhHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG  157 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  157 (302)
                      .+++||||||+|+|+.-   ...+.++|||+++..-+.        .......||..|.+--...+.. -+.+.|+=|+|
T Consensus       130 r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvg  208 (341)
T KOG1163|consen  130 RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVG  208 (341)
T ss_pred             hccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhc
Confidence            99999999999999863   367999999999753221        2234457899999987775544 47889999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHH
Q 022132          158 CIFMELMDRKPLFPGRDHVHQ  178 (302)
Q Consensus       158 ~i~~~ll~g~~pf~~~~~~~~  178 (302)
                      .++.+..-|..||.|......
T Consensus       209 YvLmYfnrG~LPWQglka~tk  229 (341)
T KOG1163|consen  209 YVLMYFNRGSLPWQGLKAATK  229 (341)
T ss_pred             ceeeeeecCCCcccccchhhH
Confidence            999999999999988765443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.74  E-value=7.1e-17  Score=134.11  Aligned_cols=172  Identities=15%  Similarity=0.226  Sum_probs=139.9

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~-~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ++...|.+.++.| ..++|..+|-+-...     .+-.+|+|+++.+|.+++. ..++++.+.+.-++.|++.-++++|+
T Consensus        68 PQLrdEYr~YKlL~g~~GIP~vYYFGqeG-----~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~  142 (449)
T KOG1165|consen   68 PQLRDEYRTYKLLGGTEGIPQVYYFGQEG-----KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE  142 (449)
T ss_pred             chHHHHHHHHHHHcCCCCCCceeeecccc-----chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh
Confidence            3556799999999 569999988877665     6777999999998888886 45689999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecC-----CCEEEeecccccccCCC--------CcccccccccccCchhhhhCCCCCCCchhHHH
Q 022132           89 ANVLHRDLKPSNLLLNAN-----CDLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS  155 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~-----~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  155 (302)
                      +.+++|||||+|+||..-     ..+.++|||+|+..-+.        ....+..||..||+--..++.. -+.+.|.=|
T Consensus       143 k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEa  221 (449)
T KOG1165|consen  143 KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEA  221 (449)
T ss_pred             cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHH
Confidence            999999999999999753     44899999999754332        2234567899999988877665 588999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCC
Q 022132          156 VGCIFMELMDRKPLFPGRD---HVHQLRLLIELIGT  188 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~---~~~~~~~~~~~~~~  188 (302)
                      ||-++.+.|-|..||.|..   ..+-+.+|-+.-..
T Consensus       222 LGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~  257 (449)
T KOG1165|consen  222 LGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS  257 (449)
T ss_pred             hhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence            9999999999999998764   34455555544433

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=2.1e-17  Score=134.08  Aligned_cols=103  Identities=17%  Similarity=0.206  Sum_probs=82.8

Q ss_pred             cCchhhHHHHHHhc-----CCCCccccceeeCCCCCCCCCcEE-EEEecCC---ccHHHHHHcCCCCCHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWI-----MKTSVVAIRDIIPPPQRESFNDVY-IAYELMD---TDLHQIIRSNQALSEEHCQYFLYQIL   80 (302)
Q Consensus        10 ~~~~~~E~~il~~l-----~h~niv~l~~~~~~~~~~~~~~~~-lv~e~~~---~~L~~~l~~~~~l~~~~~~~i~~qll   80 (302)
                      .+.+.+|+.+++.+     .||||+++++++.++.  +.+.++ +|+||++   ++|.+++.. +.+++.  ..++.|++
T Consensus        40 ~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L  114 (210)
T PRK10345         40 DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLL  114 (210)
T ss_pred             HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHH
Confidence            44688999999999     5799999999998862  113444 7899965   699999976 456666  35688888


Q ss_pred             HHH-HHHHhCCceecCCCCCCEEEecC----CCEEEeecccc
Q 022132           81 RGL-KYIHSANVLHRDLKPSNLLLNAN----CDLKICDFGLA  117 (302)
Q Consensus        81 ~~l-~~LH~~~i~H~dikp~Nil~~~~----~~~kl~dfg~~  117 (302)
                      .++ +|||+++|+||||||+||+++..    +.++|+|++.+
T Consensus       115 ~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        115 KKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            888 99999999999999999999743    47999995433

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.72  E-value=2.3e-17  Score=132.49  Aligned_cols=99  Identities=15%  Similarity=0.220  Sum_probs=80.1

Q ss_pred             hHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCce
Q 022132           15 RSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI-HSANVL   92 (302)
Q Consensus        15 ~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L-H~~~i~   92 (302)
                      +|+.++..+.++++.....+..       ...++||||++| ++.......+.++...+..++.|++.+|.+| |+.||+
T Consensus        68 ~E~~~l~~l~~~~v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~gii  140 (190)
T cd05147          68 KEMRNLKRLVTAGIPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLV  140 (190)
T ss_pred             HHHHHHHHHHHCCCCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            4999999999888754443322       223899999986 5544434457899999999999999999999 799999


Q ss_pred             ecCCCCCCEEEecCCCEEEeecccccccC
Q 022132           93 HRDLKPSNLLLNANCDLKICDFGLARVTS  121 (302)
Q Consensus        93 H~dikp~Nil~~~~~~~kl~dfg~~~~~~  121 (302)
                      ||||||+||+++ ++.++|+|||++....
T Consensus       141 HrDlkP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         141 HADLSEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             cCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence            999999999998 5789999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.7e-18  Score=160.71  Aligned_cols=215  Identities=24%  Similarity=0.365  Sum_probs=170.1

Q ss_pred             chhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHH-HcCC-CCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQII-RSNQ-ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l-~~~~-~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      +...|..+-+.+. |+|++++++.....     ...+++++|.. +++...+ .... ..+......++.|+..++.|+|
T Consensus        66 ~i~~e~~~~~~~s~h~n~~~~~~~~~~~-----~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H  140 (601)
T KOG0590|consen   66 HIDTETDIQKKLSKHSNTVHMIEPSSSP-----RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLH  140 (601)
T ss_pred             hcCccccccccccccccccccCCccCCC-----cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccC
Confidence            3445777778885 99999999999888     88999999975 5888887 5544 6778888999999999999999


Q ss_pred             -hCCceecCCCCCCEEEecCC-CEEEeecccccccCC----CCccccccc-ccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           88 -SANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSE----TDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        88 -~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~----~~~~~~~~~-~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                       ..++.|+|++|+|.+++..+ .+++.|||++.....    .......+| +..|.|||...+........|+||+|+++
T Consensus       141 ~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l  220 (601)
T KOG0590|consen  141 PENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVL  220 (601)
T ss_pred             cccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccc
Confidence             99999999999999999999 999999999875443    233345567 99999999997766678999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      ..+++|..|+..........  .                       .........-...+...+....+++.++|..+|.
T Consensus       221 ~~~~~g~~p~~~~~~~~~~~--~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~  275 (601)
T KOG0590|consen  221 SAMLTGELPWDFPSRKDGRY--S-----------------------SWKSNKGRFTQLPWNSISDQAHDLLHKILKENPS  275 (601)
T ss_pred             cccccCCCCccccccccccc--e-----------------------eecccccccccCccccCChhhhhcccccccCCch
Confidence            99999999985443222000  0                       0000000001223446778899999999999999


Q ss_pred             CCCCHHHHhcCCCcCC
Q 022132          241 QRITVEDALAHPYLGS  256 (302)
Q Consensus       241 ~R~t~~ell~h~~~~~  256 (302)
                      .|.+.+++-.+||+..
T Consensus       276 ~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  276 NRLSIEELKLDNWLSS  291 (601)
T ss_pred             hccccccccccccccc
Confidence            9999999999999998

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.69  E-value=1.6e-16  Score=127.94  Aligned_cols=101  Identities=17%  Similarity=0.161  Sum_probs=81.9

Q ss_pred             hhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCcc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 022132           13 FVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-AN   90 (302)
Q Consensus        13 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~-~~   90 (302)
                      +.+|+..+.++.|+++.....+...       ..|+||||++|. +.........++......++.|++.++.+||+ .|
T Consensus        66 ~~~E~~~l~~l~~~~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g  138 (190)
T cd05145          66 AEKEFRNLKRLYEAGVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG  138 (190)
T ss_pred             HHHHHHHHHHHHhCCCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            3578999999999988555444332       237999999863 43332334678889999999999999999999 99


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTS  121 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  121 (302)
                      |+||||||+||+++ ++.++|+|||++....
T Consensus       139 ivHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         139 LVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            99999999999999 8899999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=1.1e-16  Score=132.93  Aligned_cols=205  Identities=20%  Similarity=0.228  Sum_probs=145.5

Q ss_pred             HHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC--ce
Q 022132           20 DTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSAN--VL   92 (302)
Q Consensus        20 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~~LH~~~--i~   92 (302)
                      |-++.|.||++.+.|+.+...++...+.+++||+. |++.++|++    ...+.....++|+.||+.||.|||+..  |+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            45567999999999999887656678899999997 899999874    356889999999999999999999996  99


Q ss_pred             ecCCCCCCEEEecCCCEEEeeccccc--c---cCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           93 HRDLKPSNLLLNANCDLKICDFGLAR--V---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        93 H~dikp~Nil~~~~~~~kl~dfg~~~--~---~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |++++.+.|++..+|-+|++.-.-..  .   ...........+.+.|.+||.- ...+.+.++|||++|....+|..+.
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHHHHHHhe
Confidence            99999999999999988887432111  0   0111112233456778898854 2234567899999999999997665


Q ss_pred             CC-CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          168 PL-FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       168 ~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .- -.+......-..+.+.+                                 +..-.+.-++++.+||+..|..||++.
T Consensus       280 iq~tnseS~~~~ee~ia~~i---------------------------------~~len~lqr~~i~kcl~~eP~~rp~ar  326 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANVI---------------------------------IGLENGLQRGSITKCLEGEPNGRPDAR  326 (458)
T ss_pred             eccCCCcceeehhhhhhhhe---------------------------------eeccCccccCcCcccccCCCCCCcchh
Confidence            32 11111111111111100                                 001112345689999999999999999


Q ss_pred             HHhcCCCcCCcc
Q 022132          247 DALAHPYLGSLH  258 (302)
Q Consensus       247 ell~h~~~~~~~  258 (302)
                      +++.||..-..+
T Consensus       327 ~llfHpllfeVh  338 (458)
T KOG1266|consen  327 LLLFHPLLFEVH  338 (458)
T ss_pred             hhhcCceeeecc
Confidence            999999876554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=7e-16  Score=146.85  Aligned_cols=146  Identities=21%  Similarity=0.264  Sum_probs=121.8

Q ss_pred             HHHHHHhcC---CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022132           16 SSCFDTWIM---KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV   91 (302)
Q Consensus        16 E~~il~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i   91 (302)
                      -.+++.+|+   -+.|+.+...+.-.     +.-++|+||.+ |+|.+++...+.+++..+..+..|++..|+.||..||
T Consensus       741 ~~q~~~RLk~~~~~~~~~~~~a~~~~-----~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~I  815 (974)
T KOG1166|consen  741 CLQVMERLKPQMLPSIMHISSAHVFQ-----NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGI  815 (974)
T ss_pred             hHHHHHhhchhhhcchHHHHHHHccC-----CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcce
Confidence            344555555   25566666666655     77889999998 8999999988999999999999999999999999999


Q ss_pred             eecCCCCCCEEEec-------CCCEEEeecccccc---cCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHH
Q 022132           92 LHRDLKPSNLLLNA-------NCDLKICDFGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        92 ~H~dikp~Nil~~~-------~~~~kl~dfg~~~~---~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~  161 (302)
                      ||+||||+|+++..       ..-++|+|||.+-.   ..+...+...++|..+-.+|...+ ..|+-.+|.|.++.+++
T Consensus       816 IHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h  894 (974)
T KOG1166|consen  816 IHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVH  894 (974)
T ss_pred             ecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHH
Confidence            99999999999953       34599999999854   334456677788999999998854 55999999999999999


Q ss_pred             HHHhCC
Q 022132          162 ELMDRK  167 (302)
Q Consensus       162 ~ll~g~  167 (302)
                      .||.|+
T Consensus       895 ~mLFG~  900 (974)
T KOG1166|consen  895 VMLFGK  900 (974)
T ss_pred             HHHHHH
Confidence            999886

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.58  E-value=1e-14  Score=119.39  Aligned_cols=100  Identities=27%  Similarity=0.343  Sum_probs=86.3

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.++..+.|++++....++...     +..+++|||++| +|.+.+.....    ....++.+++.+|.+||+
T Consensus        43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~  113 (211)
T PRK14879         43 RERTRREARIMSRARKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHS  113 (211)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHh
Confidence            34677899999999999988777776665     678899999975 99988865332    788899999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      .|++|+|++|.||+++ ++.++++|||.+..
T Consensus       114 ~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879        114 AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999999999 78899999998865

>smart00090 RIO RIO-like kinase

Probab=99.56  E-value=9.6e-15  Score=121.30  Aligned_cols=101  Identities=15%  Similarity=0.114  Sum_probs=79.2

Q ss_pred             hhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 022132           13 FVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-   90 (302)
Q Consensus        13 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~-   90 (302)
                      +.+|+.+++++.+. .+.+..++..      +..++||||++| +|.........++...+..++.|++.++.+||+.| 
T Consensus        97 ~~~E~~~L~~L~~~-~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~  169 (237)
T smart00090       97 AEKEFRNLQRLYEA-GVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGE  169 (237)
T ss_pred             HHHHHHHHHHHHhc-CCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCC
Confidence            56899999999753 3333333322      234799999987 56555444456777778899999999999999999 


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTS  121 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  121 (302)
                      ++|+||||+||+++ ++.++|+|||.+...+
T Consensus       170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      170 LVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            99999999999999 8899999999886544

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=2.2e-14  Score=119.36  Aligned_cols=103  Identities=20%  Similarity=0.227  Sum_probs=81.7

Q ss_pred             CchhhHHHHHHhcCCCCc--cccceeeCCCCCCCCCcEEEEEecCCc--cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSV--VAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~--~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..+.+|+.++..+.|++|  ++.+++...... .....++|||+++|  +|.+++.. .++++..    +.|++.+|.+|
T Consensus        85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~-~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~l  158 (239)
T PRK01723         85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG-LFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARF  158 (239)
T ss_pred             hHHHHHHHHHHHHHhCCCCCceeEeeeeeecC-cceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHH
Confidence            457789999999998775  667776544311 11234599999985  88888765 4566553    57899999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      |+.||+|+||||.||+++.++.++|+|||.+..
T Consensus       159 H~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        159 HDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            999999999999999999989999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.54  E-value=2.4e-14  Score=116.16  Aligned_cols=98  Identities=23%  Similarity=0.328  Sum_probs=79.8

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..++.+|+.+++.+.|+++....-++...     +..++||||++ ++|.+.+.....       .++.+++.+|.+||+
T Consensus        41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~  108 (199)
T TIGR03724        41 RERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHK  108 (199)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHH
Confidence            35667899999999988765544444444     55789999997 588887754321       789999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeeccccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVT  120 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  120 (302)
                      .|++|+|++|.||+++ ++.++++|||.+...
T Consensus       109 ~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724       109 AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999999999999999 889999999988653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=1e-14  Score=130.32  Aligned_cols=209  Identities=25%  Similarity=0.229  Sum_probs=162.1

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCC-CCHHHHHHHHHHHHH----HHHH
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR----GLKY   85 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-l~~~~~~~i~~qll~----~l~~   85 (302)
                      .=.+|+...+.+ .|+|.++.+..+...     +..|+=+|+|+.+|..+...... ++...++..+.+...    ||.+
T Consensus       163 ~k~~~~~s~~~i~~~~~~v~~~~~~e~~-----~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~  237 (524)
T KOG0601|consen  163 RKLREFLSHHKIDSHENPVRDSPAWEGS-----GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSH  237 (524)
T ss_pred             cccchhhcccccCccccccccCcccccC-----CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccc
Confidence            334677777777 589999977777776     89999999999999999876555 888999999999999    9999


Q ss_pred             HHhCCceecCCCCCCEEEecC-CCEEEeecccccccCCCCccc------ccccccccCchhhhhCCCCCCCchhHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETDFMT------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGC  158 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  158 (302)
                      +|+.+++|.|++|.||+...+ ...+++|||....+++.....      ...+...|++||...  ..++...|++++|-
T Consensus       238 ~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~--~l~~~~~di~sl~e  315 (524)
T KOG0601|consen  238 LHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN--GLATFASDIFSLGE  315 (524)
T ss_pred             cCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc--cccchHhhhcchhh
Confidence            999999999999999999999 889999999988777654222      124567799999884  34799999999999


Q ss_pred             HHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccC
Q 022132          159 IFMELMDRKPLFPGR--DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  236 (302)
Q Consensus       159 i~~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  236 (302)
                      ++.+..+|..+...+  +...++....                               ...+.....+..+...+..|++
T Consensus       316 v~l~~~l~~~~~~~g~~~~W~~~r~~~-------------------------------ip~e~~~~~s~~l~~~~~~~~d  364 (524)
T KOG0601|consen  316 VILEAILGSHLPSVGKNSSWSQLRQGY-------------------------------IPLEFCEGGSSSLRSVTSQMLD  364 (524)
T ss_pred             hhHhhHhhcccccCCCCCCcccccccc-------------------------------CchhhhcCcchhhhhHHHHhcC
Confidence            999988776544322  2111111100                               0012222455667779999999


Q ss_pred             CCCCCCCCHHHHhcCCCcCCcc
Q 022132          237 FDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       237 ~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      .+|-.|+++..+++|+++.+..
T Consensus       365 ~~~~~~~~~q~~~~l~~i~s~~  386 (524)
T KOG0601|consen  365 EDPRLRLTAQILTALNVIHSKL  386 (524)
T ss_pred             cchhhhhHHHHHhccccccchh
Confidence            9999999999999999998643

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.54  E-value=2.9e-14  Score=132.48  Aligned_cols=96  Identities=19%  Similarity=0.257  Sum_probs=83.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+++++.++|++++....+....     ...++||||++ ++|.+++.        ....++.+++.+|.+||+.
T Consensus       381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~  447 (535)
T PRK09605        381 ERTRAEARLLSEARRAGVPTPVIYDVDP-----EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA  447 (535)
T ss_pred             HHHHHHHHHHHhhcccCCCeeEEEEEeC-----CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC
Confidence            4678999999999999998877766665     56789999997 59988875        3567899999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeeccccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVT  120 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  120 (302)
                      |++|||+||+||++ .++.++|+|||+++..
T Consensus       448 giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        448 GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999999999 5778999999998654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.53  E-value=1.7e-13  Score=124.04  Aligned_cols=142  Identities=19%  Similarity=0.344  Sum_probs=112.5

Q ss_pred             hhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCc
Q 022132           13 FVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH-SANV   91 (302)
Q Consensus        13 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH-~~~i   91 (302)
                      ..+-++-|+.++||||+++++.+..+     ++.|+|+|.+.. |..++..   ++...+..-++||+.||.||| ..++
T Consensus        56 ~~~A~k~lKtlRHP~Il~yL~t~e~~-----~~~ylvTErV~P-l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~l  126 (690)
T KOG1243|consen   56 AKRAVKRLKTLRHPNILSYLDTTEEE-----GTLYLVTERVRP-LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNL  126 (690)
T ss_pred             HHHHHHHhhhccCchhhhhhhhhccc-----CceEEEeecccc-HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCe
Confidence            45677889999999999999999998     899999999863 4444443   348889999999999999997 6789


Q ss_pred             eecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           92 LHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        92 ~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      +|+++..+.|+|+..|..+|++|..+....... .......--.|..|+....   -....|.|.|||++++++.|
T Consensus       127 vHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  127 VHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             eeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence            999999999999999999999998875433222 1222333344777775522   22568999999999999988

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.45  E-value=6e-14  Score=132.18  Aligned_cols=201  Identities=24%  Similarity=0.348  Sum_probs=156.8

Q ss_pred             CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q 022132           24 MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL  102 (302)
Q Consensus        24 ~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil  102 (302)
                      .+|.++...--+...     ...++|++|++ ++|...+...+..+.+..+..+..+..++++||+..+.|+|++|.|++
T Consensus       862 ~~P~v~~~~~s~~~r-----sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l  936 (1205)
T KOG0606|consen  862 RSPAVVRSFPSFPCR-----SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLL  936 (1205)
T ss_pred             CCCceecccCCCCCC-----CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchh
Confidence            345555444333333     67999999996 699999998888899999999999999999999999999999999999


Q ss_pred             EecCCCEEEeecccccccCCC--------------------------------CcccccccccccCchhhhhCCCCCCCc
Q 022132          103 LNANCDLKICDFGLARVTSET--------------------------------DFMTEYVVTRWYRAPELLLNSSDYTAA  150 (302)
Q Consensus       103 ~~~~~~~kl~dfg~~~~~~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~  150 (302)
                      ...+|..++.|||.....+..                                .......+|+.|.+||...+.. .+..
T Consensus       937 ~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ 1015 (1205)
T KOG0606|consen  937 IAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSA 1015 (1205)
T ss_pred             hcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCc
Confidence            999999999999833211100                                0122345788999999987665 6889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          151 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       151 ~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      +|.|+.|+++++.++|.+||......+....+...                           ..+|..-....+..+.++
T Consensus      1016 ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~---------------------------~~~~p~g~~~~s~~aq~~ 1068 (1205)
T KOG0606|consen 1016 ADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNR---------------------------DIPWPEGPEEGSYEAQDL 1068 (1205)
T ss_pred             chhhhhhhhhhhhhcCCCCCCCcchhhhhhccccC---------------------------CCCCCCCccccChhhhhh
Confidence            99999999999999999999877766555433321                           122333333567889999


Q ss_pred             HHHccCCCCCCCCCHH---HHhcCCCcCCc
Q 022132          231 VEKMLTFDPRQRITVE---DALAHPYLGSL  257 (302)
Q Consensus       231 i~~~L~~dP~~R~t~~---ell~h~~~~~~  257 (302)
                      +...|..+|.+|..+.   ++-.|+||+..
T Consensus      1069 ~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1069 INRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             hhhhhccCchhccCcccccccccCCccCCC
Confidence            9999999999999887   99999999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.38  E-value=1.2e-12  Score=106.05  Aligned_cols=94  Identities=19%  Similarity=0.163  Sum_probs=74.4

Q ss_pred             hhhHHHHHHhcCCCC--ccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           13 FVRSSCFDTWIMKTS--VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        13 ~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      +.+|+.++..+.|++  +++.++   .      +..++||||++| +|.....      ......++.+++.++.++|+.
T Consensus        80 ~~~E~~~l~~l~~~~i~v~~~~~---~------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~  144 (198)
T cd05144          80 AQKEFAALKALYEEGFPVPKPID---W------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKH  144 (198)
T ss_pred             HHHHHHHHHHHHHcCCCCCceee---c------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHC
Confidence            568999999998875  333332   1      345899999986 6655432      134567889999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS  121 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  121 (302)
                      |++|+||+|.||+++.++.++|+|||.+....
T Consensus       145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999999999999985543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.30  E-value=8.8e-12  Score=95.95  Aligned_cols=96  Identities=22%  Similarity=0.241  Sum_probs=81.9

Q ss_pred             chhhHHHHHHhcCC--CCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           12 HFVRSSCFDTWIMK--TSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        12 ~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      .+.+|+.+++.+.|  .++++++.+....     +..|++|||++| .+...       +......++.+++.+++.||.
T Consensus        37 ~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~  104 (155)
T cd05120          37 DREREVAILQLLARKGLPVPKVLASGESD-----GWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQ  104 (155)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhC
Confidence            68899999999976  5899998888776     789999999986 34322       556777889999999999998


Q ss_pred             C---CceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           89 A---NVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        89 ~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      .   +++|+|++|.||+++..+.++++|||.+..
T Consensus       105 ~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120         105 LPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            5   699999999999999989999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=2.2e-11  Score=94.32  Aligned_cols=102  Identities=22%  Similarity=0.340  Sum_probs=78.5

Q ss_pred             hHHHHhcCchhhHHHHHHhcCCC--CccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHH
Q 022132            4 ITKLMQRGHFVRSSCFDTWIMKT--SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQIL   80 (302)
Q Consensus         4 ~~~~~~~~~~~~E~~il~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll   80 (302)
                      |+.-..+.+..+|.+++..+.--  +.+-++++.  +     +...|+|||++| .|.+.+...       ...++..+=
T Consensus        37 LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~-----~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG  102 (204)
T COG3642          37 LDEKLRRERTRREARILAKAREAGVPVPIVYDVD--P-----DNGLIVMEYIEGELLKDALEEA-------RPDLLREVG  102 (204)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--C-----CCCEEEEEEeCChhHHHHHHhc-------chHHHHHHH
Confidence            45556677888999999999654  444455544  3     456799999987 667788764       245566677


Q ss_pred             HHHHHHHhCCceecCCCCCCEEEecCCCEEEeeccccccc
Q 022132           81 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT  120 (302)
Q Consensus        81 ~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  120 (302)
                      ..+.-||.+||+|+|++++||+++.++ +.++|||++...
T Consensus       103 ~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642         103 RLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             HHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            777889999999999999999998765 999999998643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.28  E-value=2.3e-11  Score=97.20  Aligned_cols=101  Identities=15%  Similarity=0.183  Sum_probs=77.2

Q ss_pred             CchhhHHHHHHhcCC--CCccccceeeCCCCCCCCCcEEEEEecCCcc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-
Q 022132           11 GHFVRSSCFDTWIMK--TSVVAIRDIIPPPQRESFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYI-   86 (302)
Q Consensus        11 ~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qll~~l~~L-   86 (302)
                      ....+|++.|+++..  -++++++++         ..-++||||++++ +.....+...++.+....+..+++.++..| 
T Consensus        71 ~wa~kE~r~L~rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~  141 (197)
T cd05146          71 MWAEKEMHNLKRMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLY  141 (197)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHH
Confidence            345589999999953  677777764         2345999999863 322222223566667788889999999998 


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccC
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS  121 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  121 (302)
                      |+.|++|+|+++.||+++ ++.+.++|||.+....
T Consensus       142 H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         142 KECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HhCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            899999999999999997 4689999999876554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=2.9e-12  Score=116.58  Aligned_cols=155  Identities=22%  Similarity=0.340  Sum_probs=113.2

Q ss_pred             HHHHHHHHHHHHhC-CceecCCCCCCEEEecCCCEEEeecccccccCCCCc----------ccccccccccCchhhhhCC
Q 022132           76 LYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----------MTEYVVTRWYRAPELLLNS  144 (302)
Q Consensus        76 ~~qll~~l~~LH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~  144 (302)
                      +.++..|+.|+|.. +++|++|.|++|.++..|..||+.|+++........          .........|.|||.+.+ 
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-  183 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-  183 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-
Confidence            44556899999965 899999999999999999999999998865443211          011123556999999866 


Q ss_pred             CCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCC
Q 022132          145 SDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV  223 (302)
Q Consensus       145 ~~~~~~~DiwslG~i~~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (302)
                      ...+.++|++|+||.+|.+. .|+..+.+..............+.+.                          ......+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~--------------------------~~~s~~~  237 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA--------------------------FGYSNNL  237 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc--------------------------ccccccC
Confidence            44789999999999999988 56666655443322222111111100                          0111378


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          224 HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       224 ~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                      ++++++=+.++|..++..||++.+++..|||...
T Consensus       238 p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  238 PSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             cHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence            8999999999999999999999999999999864

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.18  E-value=9.8e-11  Score=93.93  Aligned_cols=74  Identities=20%  Similarity=0.251  Sum_probs=58.0

Q ss_pred             cEEEEEecCCc-cHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCEEEeecccccccC
Q 022132           45 DVYIAYELMDT-DLH-QIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARVTS  121 (302)
Q Consensus        45 ~~~lv~e~~~~-~L~-~~l~~~~~l~~~~~~~i~~qll~~l~~LH~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  121 (302)
                      ..++||||+++ ++. ..+... .. ...+..++.+++.++.++|. .||+|+||+|+||+++ ++.++++|||.+....
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            35899999986 211 111111 11 16788899999999999999 9999999999999999 8899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.17  E-value=3.5e-10  Score=95.33  Aligned_cols=107  Identities=13%  Similarity=0.126  Sum_probs=84.4

Q ss_pred             hhhHHHHHHhcCC--CCccccceeeCCCCCCCCCcEEEEEecCCc--cHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHH
Q 022132           13 FVRSSCFDTWIMK--TSVVAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRS--NQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        13 ~~~E~~il~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~--~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      +.+|...+..|..  -..++++++...........-++|||++++  +|.+++..  ..+.+......++.++...+.-|
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L  154 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM  154 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            7899999999954  444556666654322222567899999986  78888863  24566778889999999999999


Q ss_pred             HhCCceecCCCCCCEEEec-------CCCEEEeecccccc
Q 022132           87 HSANVLHRDLKPSNLLLNA-------NCDLKICDFGLARV  119 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~-------~~~~kl~dfg~~~~  119 (302)
                      |..||+|+|+++.||+++.       ++.+.++||+.+..
T Consensus       155 H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        155 HAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            9999999999999999975       46799999998753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.16  E-value=3e-10  Score=92.50  Aligned_cols=111  Identities=18%  Similarity=0.243  Sum_probs=91.6

Q ss_pred             HhcCchhhHHHHHHhcCC--CCccccceeeCCCCCCCCCcEEEEEecCCc--cHHHHHHcCCCCCHHHHHHHHHHHHHHH
Q 022132            8 MQRGHFVRSSCFDTWIMK--TSVVAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGL   83 (302)
Q Consensus         8 ~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~--~L~~~l~~~~~l~~~~~~~i~~qll~~l   83 (302)
                      .....+.+|...+..|..  -..++.+++........ ..-++|+|++++  +|.+++.....++......++.++...+
T Consensus        53 ~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   53 LRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLI  131 (206)
T ss_pred             ccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHH
Confidence            456678899999999954  44667777776643222 456899999985  7999998755578888899999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEecCC---CEEEeecccccc
Q 022132           84 KYIHSANVLHRDLKPSNLLLNANC---DLKICDFGLARV  119 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~~~---~~kl~dfg~~~~  119 (302)
                      +-||.+||+|+|+++.|||++.++   .+.++||+.++.
T Consensus       132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999999887   899999997754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.15  E-value=3e-10  Score=87.88  Aligned_cols=113  Identities=21%  Similarity=0.266  Sum_probs=86.4

Q ss_pred             hhHHHHhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc--cHHHHHHcC--CCCCHHHHHHHHHH
Q 022132            3 SITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRSN--QALSEEHCQYFLYQ   78 (302)
Q Consensus         3 ~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~--~L~~~l~~~--~~l~~~~~~~i~~q   78 (302)
                      +|+.-.++++..+|++.|.++.--.|.--.=++.+.     ..-.|+|||++|  ++.+++.+.  ..-+......++..
T Consensus        47 ~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-----~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~  121 (229)
T KOG3087|consen   47 ALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-----YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARR  121 (229)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-----CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHH
Confidence            456677888999999999999654444333344444     556699999998  899988753  22333444788899


Q ss_pred             HHHHHHHHHhCCceecCCCCCCEEEecCCC---EEEeeccccccc
Q 022132           79 ILRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVT  120 (302)
Q Consensus        79 ll~~l~~LH~~~i~H~dikp~Nil~~~~~~---~kl~dfg~~~~~  120 (302)
                      |-+.+.-||.++|+|+|++.+||++..++.   +.++|||++...
T Consensus       122 iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  122 IGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999999999999999999999999976643   589999998543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.11  E-value=2.7e-09  Score=94.61  Aligned_cols=182  Identities=17%  Similarity=0.206  Sum_probs=130.0

Q ss_pred             HHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC--ccHHHHHHc---------------CCCCCHHHHHHHHHH
Q 022132           16 SSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRS---------------NQALSEEHCQYFLYQ   78 (302)
Q Consensus        16 E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~--~~L~~~l~~---------------~~~l~~~~~~~i~~q   78 (302)
                      -+++.+++.|+|+|++.++|... ..+...+.+|++|++  ++|.++.-.               +...++..+|.++.|
T Consensus       323 lve~wkkl~h~NvV~frevf~t~-tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q  401 (655)
T KOG3741|consen  323 LVEAWKKLCHTNVVPFREVFLTY-TFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ  401 (655)
T ss_pred             HHHHHHHhccCceeehhhhhhhh-ccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence            46788999999999999999854 233367999999997  588877632               124778999999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHH
Q 022132           79 ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC  158 (302)
Q Consensus        79 ll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  158 (302)
                      +..||.++|+.|+.-+-+.|.+|+++++.+++|...|......+..           .+|  +.    -..+-|.-.||.
T Consensus       402 LtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-----------~~~--le----~~Qq~D~~~lG~  464 (655)
T KOG3741|consen  402 LTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-----------TEP--LE----SQQQNDLRDLGL  464 (655)
T ss_pred             HHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-----------Ccc--hh----HHhhhhHHHHHH
Confidence            9999999999999999999999999998888888777765544332           111  21    124568999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCC
Q 022132          159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       159 i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  238 (302)
                      +++.|.+|..--...+.....  ..+                                 ...+.++.+++++|.-....+
T Consensus       465 ll~aLAt~~~ns~~~d~~~~s--~~~---------------------------------~I~~~yS~D~rn~v~yl~s~~  509 (655)
T KOG3741|consen  465 LLLALATGTENSNRTDSTQSS--HLT---------------------------------RITTTYSTDLRNVVEYLESLN  509 (655)
T ss_pred             HHHHHhhcccccccccchHHH--HHH---------------------------------HhhhhhhHHHHHHHHHHHhcC
Confidence            999999996321111111110  011                                 111255667777887777777


Q ss_pred             CCCCCCHHHHhcC
Q 022132          239 PRQRITVEDALAH  251 (302)
Q Consensus       239 P~~R~t~~ell~h  251 (302)
                      +.. -++.+++.+
T Consensus       510 ~~~-ksI~~llp~  521 (655)
T KOG3741|consen  510 FRE-KSIQDLLPM  521 (655)
T ss_pred             ccc-ccHHHHHHH
Confidence            775 677777664

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.07  E-value=2.1e-10  Score=91.30  Aligned_cols=105  Identities=23%  Similarity=0.236  Sum_probs=70.5

Q ss_pred             HHHhcCchhhHHHHHHhcCCC--CccccceeeCCCCCCCCCcEEEEEecCC--ccHHHHHHcCCCCCHHHHHHHHHHHHH
Q 022132            6 KLMQRGHFVRSSCFDTWIMKT--SVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILR   81 (302)
Q Consensus         6 ~~~~~~~~~~E~~il~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~~~~~~i~~qll~   81 (302)
                      ....+....+|.+.|.++..-  ++++++++..         -.|||||++  |.....+... .++.+....++.+++.
T Consensus        48 ~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~---------~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~  117 (188)
T PF01163_consen   48 RYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR---------NVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILE  117 (188)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET---------TEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC---------CEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHH
Confidence            344556778999999999765  6777776542         249999998  6333333321 1224556677888888


Q ss_pred             HHHH-HHhCCceecCCCCCCEEEecCCCEEEeecccccccC
Q 022132           82 GLKY-IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS  121 (302)
Q Consensus        82 ~l~~-LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  121 (302)
                      .+.. +|+.||+|+|+++.||+++.+ .+.++|||.+....
T Consensus       118 ~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  118 EIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             HHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             HHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            5555 689999999999999999987 89999999876544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.06  E-value=6.2e-11  Score=106.40  Aligned_cols=208  Identities=20%  Similarity=0.198  Sum_probs=149.2

Q ss_pred             hcCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus         9 ~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ++..-..|+.+...+ .|.+++..+..+..-     ...|+=.|||. +++...+.-...+++...+.+..|++.++.++
T Consensus       308 ~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-----r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i  382 (524)
T KOG0601|consen  308 SDIFSLGEVILEAILGSHLPSVGKNSSWSQL-----RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVI  382 (524)
T ss_pred             hhhcchhhhhHhhHhhcccccCCCCCCcccc-----ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccc
Confidence            344455788888888 689999988888776     77889999996 45544443334688999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecC-CCEEEeecccccccCCCCcccccccccccC-chhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYR-APELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      |+..++|+|++|+||++..+ +..+++|||+.....-.  .........+. ..|++.....+..+.|++|||..+.+.+
T Consensus       383 ~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~  460 (524)
T KOG0601|consen  383 HSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAI  460 (524)
T ss_pred             cchhhhcccccccceeeccchhhhhcccccccccccee--cccccccccccccchhhccccccccccccccccccccccc
Confidence            99999999999999999886 77899999987542111  11112233333 3555656666889999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|.+.-........   +.                              .......+.....+..+.+.|..+|+..|++
T Consensus       461 ~~~~ls~~~~~~~~---i~------------------------------~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l  507 (524)
T KOG0601|consen  461 TGSPLSESGVQSLT---IR------------------------------SGDTPNLPGLKLQLQVLLKVMINPDRKRRPS  507 (524)
T ss_pred             cCcccCccccccee---ee------------------------------cccccCCCchHHhhhhhhhhhcCCccccchh
Confidence            88754322211100   00                              0001112233467788999999999999999


Q ss_pred             HHHHhcCCCcCC
Q 022132          245 VEDALAHPYLGS  256 (302)
Q Consensus       245 ~~ell~h~~~~~  256 (302)
                      +.++..|.-|..
T Consensus       508 ~~~l~~~~~~~~  519 (524)
T KOG0601|consen  508 AVELSLHSEFYR  519 (524)
T ss_pred             hhhhcccchhhh
Confidence            999999887654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.04  E-value=7e-09  Score=89.96  Aligned_cols=193  Identities=12%  Similarity=0.116  Sum_probs=127.7

Q ss_pred             cEEEEEecCCc--cHHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeeccc
Q 022132           45 DVYIAYELMDT--DLHQIIR------SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL  116 (302)
Q Consensus        45 ~~~lv~e~~~~--~L~~~l~------~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~  116 (302)
                      .+.+.|+.+.|  ....++.      +.....+....+..+.++.+.+.||..|..-+|+.++|+|+++++.+.|.|=..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            37788998864  4444443      224578999999999999999999999999999999999999999999998654


Q ss_pred             ccccCCCCcccccccccccCchhhhh----CCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCh
Q 022132          117 ARVTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSE  191 (302)
Q Consensus       117 ~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~i~~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~  191 (302)
                      -............++...|++||...    -+...+...|.|.||+++++++.| +.||.|-....       -...|.+
T Consensus       164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~-------~ap~p~E  236 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS-------DAPNPLE  236 (637)
T ss_pred             eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccC-------CCCCcch
Confidence            44434444455668899999999753    111246789999999999999875 89997542110       0011111


Q ss_pred             HHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCC--CCCCCCHH
Q 022132          192 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD--PRQRITVE  246 (302)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d--P~~R~t~~  246 (302)
                      ..+.......  ..++-+.....+..--+.-+++++..+..+|+..-  +.-|||++
T Consensus       237 ~~Ia~g~f~y--a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         237 TDIAHGRFAY--ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             hhhhcceeee--chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            1111100000  00111111222223333457888999999998743  56899875

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.02  E-value=6.7e-10  Score=87.53  Aligned_cols=92  Identities=21%  Similarity=0.233  Sum_probs=68.4

Q ss_pred             chhhHHHHHHhcCCCCc-cccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSV-VAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.+++.+.+.++ .+++....       ...++||||++| ++...        ......++.+++.+|+.||+.
T Consensus        38 ~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~  102 (170)
T cd05151          38 NRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSS  102 (170)
T ss_pred             CHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCC
Confidence            46789999999965554 45555432       234799999986 44322        111234578999999999999


Q ss_pred             Cc-----eecCCCCCCEEEecCCCEEEeecccccc
Q 022132           90 NV-----LHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        90 ~i-----~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      ++     +|+|++|.||+++ ++.++++|||.+..
T Consensus       103 ~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151         103 PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            85     9999999999999 67899999998743

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.97  E-value=2e-09  Score=97.41  Aligned_cols=104  Identities=18%  Similarity=0.254  Sum_probs=72.8

Q ss_pred             chhhHHHHHHhcC----CCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHH-HHH
Q 022132           12 HFVRSSCFDTWIM----KTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILR-GLK   84 (302)
Q Consensus        12 ~~~~E~~il~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qll~-~l~   84 (302)
                      .|.+|...+.++.    |.+-+.+-.++.+-.    +..++||||++| +|.+..... ...+   ...++.+++. .+.
T Consensus       199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~  271 (437)
T TIGR01982       199 DLRREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLN  271 (437)
T ss_pred             CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHH
Confidence            5677777777763    333444444554321    446899999975 777665421 1222   2345555555 467


Q ss_pred             HHHhCCceecCCCCCCEEEecCCCEEEeecccccccCC
Q 022132           85 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE  122 (302)
Q Consensus        85 ~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~  122 (302)
                      .+|..|++|+|++|.||+++.+|.++++|||++...++
T Consensus       272 ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       272 QVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            89999999999999999999999999999999876543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK09902 hypothetical protein; Provisional

Probab=98.90  E-value=1.7e-08  Score=81.07  Aligned_cols=110  Identities=17%  Similarity=0.104  Sum_probs=86.8

Q ss_pred             hcCchhhHHHHHHhcCC--CCccccceeeCCCCCCCCCcEEEEEecCC--ccHHHHHHcC--CCCCHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMK--TSVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRSN--QALSEEHCQYFLYQILRG   82 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~--~~L~~~l~~~--~~l~~~~~~~i~~qll~~   82 (302)
                      ..+.|.+|+..|++|..  -.++++. ++........-.-+||+|-++  .+|.+++...  .+.+......++.++..+
T Consensus        62 g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~  140 (216)
T PRK09902         62 GRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALA  140 (216)
T ss_pred             CchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHH
Confidence            46688999999999954  3356665 333222223355789999998  4999998663  356788888999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEecCCC--EEEeecccccc
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARV  119 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~  119 (302)
                      ++-||..|+.|+|+-+.||+++.+|.  +.++||..++.
T Consensus       141 ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        141 FKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             HHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            99999999999999999999987777  99999987654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.84  E-value=8.8e-09  Score=94.60  Aligned_cols=100  Identities=15%  Similarity=0.317  Sum_probs=67.6

Q ss_pred             chhhHHHHHHhcC----CCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHH--HHcCC----CCCHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIM----KTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQI--IRSNQ----ALSEEHCQYFLYQIL   80 (302)
Q Consensus        12 ~~~~E~~il~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~--l~~~~----~l~~~~~~~i~~qll   80 (302)
                      .+.+|..-+.++.    +.+.+.+-.++.+-.    +.-++||||++| .+.++  +...+    .+.+..+..++.|++
T Consensus       202 D~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        202 DLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             CHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence            4455555544442    344455555554421    456799999985 77654  33333    355555666666665


Q ss_pred             HHHHHHHhCCceecCCCCCCEEEecCC----CEEEeecccccccCC
Q 022132           81 RGLKYIHSANVLHRDLKPSNLLLNANC----DLKICDFGLARVTSE  122 (302)
Q Consensus        81 ~~l~~LH~~~i~H~dikp~Nil~~~~~----~~kl~dfg~~~~~~~  122 (302)
                             ..|++|+|++|.||+++.+|    .++++|||++...++
T Consensus       278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   58999999999999999988    999999999876544

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.67  E-value=5.8e-08  Score=93.73  Aligned_cols=202  Identities=16%  Similarity=0.214  Sum_probs=143.4

Q ss_pred             hHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 022132           15 RSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLH   93 (302)
Q Consensus        15 ~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H   93 (302)
                      .|+..+....|+|+..++.+-......+ --..+..++|. .++...+..-+.++....+.+..++++|++++|+....|
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~  309 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEH  309 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence            4777788889999999999987763211 12334556776 488888888889999999999999999999999997666


Q ss_pred             cCCCCC---CEEEecCCCEEEe--ecccccccCCCCcccccccccccCchhhhhCCC-CCCCchhHHHHHHHHHHHHhCC
Q 022132           94 RDLKPS---NLLLNANCDLKIC--DFGLARVTSETDFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        94 ~dikp~---Nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      .-+..+   +-.++.++....+  ||+..+.............+..+.++|...... ..+...|+|.+|.....+..|.
T Consensus       310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~  389 (1351)
T KOG1035|consen  310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGE  389 (1351)
T ss_pred             eEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcC
Confidence            655555   3344556666666  888877766655555555666788888764332 1233479999999999998876


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCC-HHHHHHHHHccCCCCCCCCCHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH-PSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+-....      ...+                                  ..+..+ ....+.+.+|+.-++++|+++.
T Consensus       390 ~i~~~~~------~~~~----------------------------------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~  429 (1351)
T KOG1035|consen  390 DISEKSA------VPVS----------------------------------LLDVLSTSELLDALPKCLDEDSEERLSAL  429 (1351)
T ss_pred             ccccccc------chhh----------------------------------hhccccchhhhhhhhhhcchhhhhccchh
Confidence            4421100      0000                                  001111 1577889999999999999999


Q ss_pred             HHhcCCCcCCc
Q 022132          247 DALAHPYLGSL  257 (302)
Q Consensus       247 ell~h~~~~~~  257 (302)
                      +++.|+|.+..
T Consensus       430 ~ll~~~f~~~~  440 (1351)
T KOG1035|consen  430 ELLTHPFLRFP  440 (1351)
T ss_pred             hhhhchhcccc
Confidence            99999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.65  E-value=1.1e-07  Score=78.05  Aligned_cols=106  Identities=18%  Similarity=0.232  Sum_probs=76.4

Q ss_pred             CchhhHHHHHHhcCC--CCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMK--TSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|..+++.+.+  .++.+++.+.....  ..+..++||||++| ++...+.. ..++.+....++.+++.+|..||
T Consensus        40 ~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH  116 (223)
T cd05154          40 HDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALH  116 (223)
T ss_pred             ccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHh
Confidence            467799999999965  44677777765531  11367899999986 55443321 34666666677777777777776


Q ss_pred             h--------------------------------------------------------CCceecCCCCCCEEEec--CCCE
Q 022132           88 S--------------------------------------------------------ANVLHRDLKPSNLLLNA--NCDL  109 (302)
Q Consensus        88 ~--------------------------------------------------------~~i~H~dikp~Nil~~~--~~~~  109 (302)
                      +                                                        ..++|+|+.|.||+++.  ++.+
T Consensus       117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~  196 (223)
T cd05154         117 SVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVV  196 (223)
T ss_pred             CCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEE
Confidence            3                                                        23689999999999998  5668


Q ss_pred             EEeecccccc
Q 022132          110 KICDFGLARV  119 (302)
Q Consensus       110 kl~dfg~~~~  119 (302)
                      .++||+.+..
T Consensus       197 ~iID~e~~~~  206 (223)
T cd05154         197 AVLDWELATL  206 (223)
T ss_pred             EEEecccccc
Confidence            9999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.64  E-value=9e-08  Score=78.93  Aligned_cols=100  Identities=20%  Similarity=0.188  Sum_probs=74.5

Q ss_pred             hcCchhhHHHHHHhcCCC--CccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMKT--SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ++....+|..+|..|...  .+++.++.         +.-.+||||++| .|...     +++.+....++..|++-+..
T Consensus       152 sRl~A~rEf~~L~~L~~~G~~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~  217 (304)
T COG0478         152 SRLAAEREFEALQRLYPEGVKVPKPIAW---------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRK  217 (304)
T ss_pred             HHHHHHHHHHHHHHhhhcCCCCCCcccc---------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHH
Confidence            445667899999998654  66666554         344599999998 33322     23455566667777777777


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCC
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE  122 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~  122 (302)
                      .-..|++|+|+++-||+++.+|.+.++||--+...+.
T Consensus       218 ~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~~~h  254 (304)
T COG0478         218 AYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVPISH  254 (304)
T ss_pred             HHHcCccccCCchheEEEecCCCEEEEeCcccccCCC
Confidence            7799999999999999999999999999977655443

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.58  E-value=2e-07  Score=75.20  Aligned_cols=104  Identities=18%  Similarity=0.266  Sum_probs=67.3

Q ss_pred             HHhcCchhhHHHHHHhcCCCCccccce---eeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHH
Q 022132            7 LMQRGHFVRSSCFDTWIMKTSVVAIRD---IIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRG   82 (302)
Q Consensus         7 ~~~~~~~~~E~~il~~l~h~niv~l~~---~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~   82 (302)
                      +.......+++..+..+....+..+-+   +..-....-....+++|||++| .|.+...    +++.    +...+.++
T Consensus        76 f~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~  147 (229)
T PF06176_consen   76 FFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEA  147 (229)
T ss_pred             HhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHH
Confidence            334445567777666665444433333   2222211111445689999987 5554421    3332    34567778


Q ss_pred             HHHHHhCCceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      +.-||+.|+.|+|.+|.|++++.++ ++++||+..+.
T Consensus       148 ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  148 IKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             HHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence            9999999999999999999998654 99999986543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=98.32  E-value=3.9e-06  Score=75.20  Aligned_cols=173  Identities=20%  Similarity=0.237  Sum_probs=116.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV   91 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i   91 (302)
                      .+.--..+++.+.|+|+..++++-..+.    ....+|+|+++.+|.+.+..+. +-.....              .+|+
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~~--------------~~~~   88 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESLL--------------AHGV   88 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhhc--------------cccc
Confidence            3445578889999999999999887653    4488999999999999987654 2222111              1222


Q ss_pred             eecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022132           92 LHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  171 (302)
Q Consensus        92 ~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~  171 (302)
                      .|-     |       .++.+|     ..          .|. |  |      ...++++||||+|.++.++..|...+.
T Consensus        89 ~~~-----~-------~~~~td-----~~----------~t~-~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   89 LHL-----N-------IIYITD-----HF----------LTK-Y--P------SPIGPKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             cee-----h-------hhhccc-----cc----------ccc-C--C------CCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence            221     1       122222     00          000 1  1      012359999999999999999998888


Q ss_pred             CCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          172 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      ..........+.+....+.+.....+.....                  -.++..++++..+|+-..|..||...++..+
T Consensus       133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~------------------~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~  194 (725)
T KOG1093|consen  133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQ------------------LLADKKRLPLLKKCLWLEPIIRPLPMELSKR  194 (725)
T ss_pred             HHHHHHHHHHHHHhccCchhHHHHHHHHHHH------------------HhhhHhHHHHhccCCccccccccchhHHhcC
Confidence            7777777777777666655443332222100                  0345568899999999999999999999999


Q ss_pred             CCcCCc
Q 022132          252 PYLGSL  257 (302)
Q Consensus       252 ~~~~~~  257 (302)
                      +-|...
T Consensus       195 ~i~~ev  200 (725)
T KOG1093|consen  195 CSFTEV  200 (725)
T ss_pred             ccHHHH
Confidence            999765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.22  E-value=3.1e-07  Score=83.79  Aligned_cols=207  Identities=18%  Similarity=0.158  Sum_probs=136.7

Q ss_pred             hhHHHHHHhcCCCC-ccccceeeCCCCCCCCCcEEEEEecCCcc--HHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           14 VRSSCFDTWIMKTS-VVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQII-RSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        14 ~~E~~il~~l~h~n-iv~l~~~~~~~~~~~~~~~~lv~e~~~~~--L~~~l-~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .-++++|.+++||| .+..++-+...     ...+++++++++.  ..... .....+..-+...+.+.-+.++++||+.
T Consensus       281 rl~~eLLdK~n~P~~~v~~~~d~~~E-----~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~  355 (829)
T KOG0576|consen  281 RLAIELLDKVNNPNPVVRYLEDYDGE-----DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS  355 (829)
T ss_pred             HHHHHHHHHccCCCCcccccccCCcc-----cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccc
Confidence            45889999999999 44444444443     6789999999743  22111 1112344455666777778899999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      .=+|+|    ||+..+ +..+.++|+...............+++.++|||+..+.. +....|.|++|.-..+|.-|.+|
T Consensus       356 ~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  356 YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             cccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCC
Confidence            878888    666554 678999999887766665566778899999999885544 78889999999877788878777


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      -...-..      ...++.+..  ...+..             ...+...+      -.++...|+..-|-.|++...++
T Consensus       430 r~~P~~~------~~~~g~~p~--s~~L~~-------------~~aw~~~~------~~~~~~~~~~g~P~~pkv~mgac  482 (829)
T KOG0576|consen  430 RSSPPAV------LPMIGNGPN--SPMLTD-------------KSAWSPVF------HRDFPAPCLNGLPPTPKVHMGAC  482 (829)
T ss_pred             CCCCccc------cCCCCCCCC--ccccch-------------hhhcCccc------ccCCcccccCCCCCCCcchhhHH
Confidence            5331000      000010000  000000             00011111      11467889999999999999999


Q ss_pred             cCCCcCCcc
Q 022132          250 AHPYLGSLH  258 (302)
Q Consensus       250 ~h~~~~~~~  258 (302)
                      .|.+|+.+.
T Consensus       483 fsKvfngCp  491 (829)
T KOG0576|consen  483 FSKVFNGCP  491 (829)
T ss_pred             HHHHhccCc
Confidence            999998763

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.08  E-value=1.5e-05  Score=63.71  Aligned_cols=95  Identities=15%  Similarity=0.099  Sum_probs=75.8

Q ss_pred             hHHHHHHhcCC-CCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 022132           15 RSSCFDTWIMK-TSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQI---IRSNQALSEEHCQYFLYQILRGLKYIHS-   88 (302)
Q Consensus        15 ~E~~il~~l~h-~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~---l~~~~~l~~~~~~~i~~qll~~l~~LH~-   88 (302)
                      .|.-+++.+.+ +++++++|++        +++ +|.||.+ +++...   +......++..+..++.++++.+.+|+. 
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C--------G~~-~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC--------GRF-YVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC--------CCE-EEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            58889999966 7999999998        333 6889987 444311   1111235899999999999999999997 


Q ss_pred             --CCceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           89 --ANVLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        89 --~~i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                        ..+.-.|++++|+.++++|.++++|.+.+.
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence              358889999999999999999999998664

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.03  E-value=2.4e-05  Score=64.12  Aligned_cols=99  Identities=14%  Similarity=0.125  Sum_probs=68.7

Q ss_pred             chhhHHHHHHhcC--CCCccccceeeCCCCCCCCCcEEEEEecCCcc--HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIM--KTSVVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~--L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      +..+|+.-|+++.  +-.+++-+.+.         +-.+|||+++..  -.=.|.. -+++.+....+..+++..+.-|-
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~  183 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLY  183 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHH
Confidence            4446777677663  33444444443         344999999843  1111111 23444477788889999988887


Q ss_pred             h-CCceecCCCCCCEEEecCCCEEEeecccccccC
Q 022132           88 S-ANVLHRDLKPSNLLLNANCDLKICDFGLARVTS  121 (302)
Q Consensus        88 ~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  121 (302)
                      . .|++|+||+..|||+. ++.+.++|||-+....
T Consensus       184 ~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         184 KEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            7 8999999999999999 8899999999876544

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.92  E-value=5.9e-05  Score=62.29  Aligned_cols=101  Identities=16%  Similarity=0.150  Sum_probs=60.3

Q ss_pred             chhhHHHHHHhcCCCC--ccccceeeCCCCCCCCCcEEEEEecCCcc--HHHHH---------------------HcC--
Q 022132           12 HFVRSSCFDTWIMKTS--VVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQII---------------------RSN--   64 (302)
Q Consensus        12 ~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~~--L~~~l---------------------~~~--   64 (302)
                      ...+|.++++.+..-.  +.+.+++..+.     +..++|||+++|.  +...+                     +.-  
T Consensus        38 ~i~~E~~~l~~l~~~glpvP~~~~~~~~~-----~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~  112 (226)
T TIGR02172        38 TIKREFDASRKVFSLGIPTPHPFDLVEDG-----GRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC  112 (226)
T ss_pred             HHHHHHHHHHHHHHcCCCCCceEEEEecC-----CeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC
Confidence            4578999999996443  57788887666     6678999999873  11111                     000  


Q ss_pred             CCCCHHH-HHHHHHH----------HHHH-HHHHH----hCCceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           65 QALSEEH-CQYFLYQ----------ILRG-LKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        65 ~~l~~~~-~~~i~~q----------ll~~-l~~LH----~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                      ....... ...+-.+          +... ..+|.    ...++|+|+.|.||+++.++ +.++||+.+.
T Consensus       113 ~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       113 DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            0011000 0011000          1111 12222    12478999999999999888 9999998774

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.88  E-value=8.8e-05  Score=62.02  Aligned_cols=29  Identities=21%  Similarity=0.187  Sum_probs=25.8

Q ss_pred             CceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                      .++|+|+.|.||+++.++...|+||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            48999999999999988778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.65  E-value=1.8e-05  Score=79.17  Aligned_cols=152  Identities=15%  Similarity=0.093  Sum_probs=113.5

Q ss_pred             hHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           15 RSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        15 ~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .|..-++...|+++...+.-..+.+.   ...|.+++|+. |.+.+.+.++    ..+...-+-....+.+.+..-.|+.
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s---~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSES---TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCC---hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            34445666789999887776666533   67889999986 7999998753    3444444444444446677776654


Q ss_pred             ---C--ceecCCCCCCEEEecCCCEEEeeccccc-ccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           90 ---N--VLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        90 ---~--i~H~dikp~Nil~~~~~~~kl~dfg~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                         |  -+|+++++-|.++..+..++++++|+.+ ............+++.|++|+..... .++.++|+|..|+-+|..
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~i-k~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEI-KFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHH-hhhhHHHHHHHHHHHHHH
Confidence               2  6899999999999999999999999998 33334455666788899999987443 467789999999999998


Q ss_pred             HhCCCCC
Q 022132          164 MDRKPLF  170 (302)
Q Consensus       164 l~g~~pf  170 (302)
                      -.|..+|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8777766

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.64  E-value=0.00055  Score=55.09  Aligned_cols=94  Identities=17%  Similarity=0.239  Sum_probs=71.8

Q ss_pred             cCchhhHHHHHHhcC------CCCccccceeeCCCCCCCCCcEEEEEecC---Cc----cHHHHHHcCCCCCHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIM------KTSVVAIRDIIPPPQRESFNDVYIAYELM---DT----DLHQIIRSNQALSEEHCQYFL   76 (302)
Q Consensus        10 ~~~~~~E~~il~~l~------h~niv~l~~~~~~~~~~~~~~~~lv~e~~---~~----~L~~~l~~~~~l~~~~~~~i~   76 (302)
                      .+...+|+.-+.++.      +.+|.+++++..++     -...+|+|.+   +|    +|.+++.. +.++. .....+
T Consensus        55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L  127 (199)
T PF10707_consen   55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETN-----LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQAL  127 (199)
T ss_pred             hHHHHHHHHHHHHHhhccCCcccccccEeEEEecC-----CceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHH
Confidence            456778888888887      78999999999988     6788899886   23    88888865 45666 433333


Q ss_pred             HHHHHHHHHHHhCCceecCCCCCCEEEecCC----CEEEee
Q 022132           77 YQILRGLKYIHSANVLHRDLKPSNLLLNANC----DLKICD  113 (302)
Q Consensus        77 ~qll~~l~~LH~~~i~H~dikp~Nil~~~~~----~~kl~d  113 (302)
                         -+-.++|-..+|+.+|++|.||++...+    .+.|+|
T Consensus       128 ---~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  128 ---DEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             ---HHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence               3446688899999999999999996542    477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.54  E-value=0.00061  Score=62.73  Aligned_cols=111  Identities=15%  Similarity=0.262  Sum_probs=72.6

Q ss_pred             HHHhcCchhhHHHHHHhcC----CCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHH--HHcCCCCCHHHHHHHHHH
Q 022132            6 KLMQRGHFVRSSCFDTWIM----KTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQI--IRSNQALSEEHCQYFLYQ   78 (302)
Q Consensus         6 ~~~~~~~~~~E~~il~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~--l~~~~~l~~~~~~~i~~q   78 (302)
                      .+...-.+.+|..-+.+++    ...=+++-.+|++-+    +.-.++|||++| .+.+.  +++ ..++.+.+...+.+
T Consensus       201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~  275 (517)
T COG0661         201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVR  275 (517)
T ss_pred             HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHH
Confidence            3444456777877777774    233445566665532    456699999987 55555  333 33553333222222


Q ss_pred             HHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC
Q 022132           79 ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET  123 (302)
Q Consensus        79 ll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~  123 (302)
                      +  -+..+=..|++|.|.+|.||+++.+|.+.+.|||.....++.
T Consensus       276 ~--f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         276 A--FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             H--HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            2  123334489999999999999999999999999998766543

>PLN02876 acyl-CoA dehydrogenase

Probab=97.46  E-value=0.00071  Score=66.58  Aligned_cols=43  Identities=9%  Similarity=0.039  Sum_probs=32.1

Q ss_pred             chhhHHHHHHhcC-CCCc--cccceeeCCCCCCCCCcEEEEEecCCcc
Q 022132           12 HFVRSSCFDTWIM-KTSV--VAIRDIIPPPQRESFNDVYIAYELMDTD   56 (302)
Q Consensus        12 ~~~~E~~il~~l~-h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~~   56 (302)
                      .+.+|+.+++.+. |+++  ++++.++.+...  .+..|+||||++|.
T Consensus        84 ~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v--~G~~flVME~v~G~  129 (822)
T PLN02876         84 AVEREYQVLRALGEHTDVPVPKVYCLCTDASV--IGTAFYIMEYLEGR  129 (822)
T ss_pred             HHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc--CCCceEEEEecCCc
Confidence            5679999999995 7765  777777765421  24678999999863

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.31  E-value=0.00092  Score=55.57  Aligned_cols=31  Identities=35%  Similarity=0.479  Sum_probs=25.8

Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      .+++|+|+.+.||+++.++...|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3589999999999998766567999997743

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.24  E-value=0.0025  Score=58.74  Aligned_cols=105  Identities=21%  Similarity=0.299  Sum_probs=64.7

Q ss_pred             cCchhhHHHHH----HhcCCCC---ccccceeeCCCCCCCCCcEEEEEecCCc----cHHHHHHcCCCCCHHHHHHHHHH
Q 022132           10 RGHFVRSSCFD----TWIMKTS---VVAIRDIIPPPQRESFNDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQ   78 (302)
Q Consensus        10 ~~~~~~E~~il----~~l~h~n---iv~l~~~~~~~~~~~~~~~~lv~e~~~~----~L~~~l~~~~~l~~~~~~~i~~q   78 (302)
                      .=.|.+|.+--    +.+.|-+   =|.+-.++++-+    ..-.++||||+|    ++ +.+.+.+ ++...+   +..
T Consensus       238 ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~~i---~~~  308 (538)
T KOG1235|consen  238 ELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDL-DAIDKRG-ISPHDI---LNK  308 (538)
T ss_pred             hcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCH-HHHHHcC-CCHHHH---HHH
Confidence            33444554433    3344555   223444554432    456799999986    55 4555543 454433   333


Q ss_pred             HHHH-HHHHHhCCceecCCCCCCEEEec----CCCEEEeecccccccCCC
Q 022132           79 ILRG-LKYIHSANVLHRDLKPSNLLLNA----NCDLKICDFGLARVTSET  123 (302)
Q Consensus        79 ll~~-l~~LH~~~i~H~dikp~Nil~~~----~~~~kl~dfg~~~~~~~~  123 (302)
                      +.++ ++-+=..|++|+|-+|.||+++.    ++.+.+.|||+....++.
T Consensus       309 l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  309 LVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            3333 22233578999999999999984    678999999998776644

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.21  E-value=0.0014  Score=53.87  Aligned_cols=30  Identities=33%  Similarity=0.595  Sum_probs=20.8

Q ss_pred             CCceecCCCCCCEEEe-cCCCEEEeeccccc
Q 022132           89 ANVLHRDLKPSNLLLN-ANCDLKICDFGLAR  118 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~-~~~~~kl~dfg~~~  118 (302)
                      .+++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             cEEEEeccccccceeeeccceeEEEecccce
Confidence            3599999999999999 66667899998763

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.50  E-value=0.0051  Score=52.83  Aligned_cols=97  Identities=16%  Similarity=0.198  Sum_probs=65.1

Q ss_pred             cCchhhHHHHHHhcC-CCC-ccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIM-KTS-VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        10 ~~~~~~E~~il~~l~-h~n-iv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      +-...+|+..|+.|. |-. +++.+         +.+.-++|||++.| .|.++-.   ..+...   +...+..-+.-|
T Consensus       154 Rlaa~kEfafmkaL~e~gfpVPkpi---------D~~RH~Vvmelv~g~Pl~~v~~---v~d~~~---ly~~lm~~Iv~l  218 (465)
T KOG2268|consen  154 RLAATKEFAFMKALYERGFPVPKPI---------DHNRHCVVMELVDGYPLRQVRH---VEDPPT---LYDDLMGLIVRL  218 (465)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCcc---------cccceeeHHHhhcccceeeeee---cCChHH---HHHHHHHHHHHH
Confidence            334557777777773 321 22222         23556799999986 6655432   122333   344555556778


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccC
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS  121 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  121 (302)
                      -.+|++|+|+.--||+++.++.++++||--+...+
T Consensus       219 a~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  219 ANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             HHcCceecccchheeEEecCCCEEEeechHhhccC
Confidence            89999999999999999999999999997654443

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.32  E-value=0.015  Score=50.72  Aligned_cols=105  Identities=17%  Similarity=0.301  Sum_probs=72.8

Q ss_pred             CcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCCCEEEeecccccccCC
Q 022132           44 NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE  122 (302)
Q Consensus        44 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~  122 (302)
                      -..|++|++-++++.-.    ..-..+++..++.+-+..+.-+.+. ..-||++...||+++ +|.+.|+||-+++...+
T Consensus       299 ~y~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~  373 (488)
T COG5072         299 LYLYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYS  373 (488)
T ss_pred             eEEEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccC
Confidence            56888999988776533    2345778888888888877777765 589999999999999 99999999999985443


Q ss_pred             CCcccccccccccCchhhhhCCCCCCCchhHHHHHHH
Q 022132          123 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  159 (302)
Q Consensus       123 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  159 (302)
                      .....    ....--|-.+.|.  -+..-+||-+.-.
T Consensus       374 q~~is----y~rldhp~lF~G~--dd~QFeIYrlMr~  404 (488)
T COG5072         374 QGIIS----YNRLDHPDLFNGV--DDYQFEIYRLMRR  404 (488)
T ss_pred             Cceee----ccccCchhhhcCc--cceeeeHHHHHHH
Confidence            32211    1123334444322  3566777775443

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.15  E-value=0.038  Score=47.81  Aligned_cols=33  Identities=24%  Similarity=0.494  Sum_probs=29.3

Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE  122 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~  122 (302)
                      .++|+|+.+.|++++.++.+-++||+.+....+
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            489999999999999999999999999876544

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.70  E-value=0.038  Score=44.99  Aligned_cols=86  Identities=14%  Similarity=0.174  Sum_probs=56.7

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ++-|..+.+++.++.  .|+++..-       +.-.+.++.|+|-.           ........+... +.+|.-.|+.
T Consensus       102 ~~~y~nky~v~Armh--GilrL~ND-------n~~~yGvIlE~Cy~-----------~~i~~~N~i~ag-i~~L~~fH~~  160 (308)
T PF07387_consen  102 DALYFNKYRVFARMH--GILRLKND-------NNYKYGVILERCYK-----------IKINFSNFITAG-IKDLMDFHSE  160 (308)
T ss_pred             hhhhhhhhhHHHHhh--heeEeecC-------CCceeEEEEeeccC-----------cccchhHHHHHh-HHHHHHhhcc
Confidence            345566777777664  35555521       12578899999862           111111122222 4667888843


Q ss_pred             --CceecCCCCCCEEEecCCCEEEeeccc
Q 022132           90 --NVLHRDLKPSNLLLNANCDLKICDFGL  116 (302)
Q Consensus        90 --~i~H~dikp~Nil~~~~~~~kl~dfg~  116 (302)
                        +..|+|..|+||+-+..|.+||.|-+.
T Consensus       161 ~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  161 NQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             CCCeecCCCChhheeecCCCCEEecChhh
Confidence              699999999999999999999999764

The function of this family is unknown.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.58  E-value=0.019  Score=47.52  Aligned_cols=29  Identities=28%  Similarity=0.439  Sum_probs=25.9

Q ss_pred             CceecCCCCCCEEEec-CCCEEEeeccccc
Q 022132           90 NVLHRDLKPSNLLLNA-NCDLKICDFGLAR  118 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~-~~~~kl~dfg~~~  118 (302)
                      +++|+|+.+.||+++. ++.+.++||..|.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            5999999999999998 5789999998764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.50  E-value=0.035  Score=48.08  Aligned_cols=29  Identities=24%  Similarity=0.423  Sum_probs=25.4

Q ss_pred             CCceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                      .+++|+|+.+.||+++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47999999999999987 678999998663

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=95.47  E-value=0.025  Score=48.97  Aligned_cols=30  Identities=33%  Similarity=0.526  Sum_probs=26.9

Q ss_pred             CCceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                      .+++|+|+.+.|++++.++...|+||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            579999999999999988877899998774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=95.39  E-value=0.059  Score=42.29  Aligned_cols=92  Identities=17%  Similarity=0.217  Sum_probs=64.6

Q ss_pred             CchhhHHHHHHhcCCCCccc-cceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVA-IRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~-l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+..|.++|..++..++-. +|.+-.+         ++.|||+.| .|.+.-...   +.+    -+..+++.---|-.
T Consensus        60 ~~l~kEakiLeil~g~~~~p~vy~yg~~---------~i~me~i~G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~  123 (201)
T COG2112          60 RNLEKEAKILEILAGEGVTPEVYFYGED---------FIRMEYIDGRPLGKLEIGG---DRK----HLLRVLEKAYKLDR  123 (201)
T ss_pred             hhHHHHHHHHHHhhhcCCCceEEEechh---------hhhhhhhcCcchhhhhhcc---cHH----HHHHHHHHHHHHHH
Confidence            35668999999998877644 5554433         356999987 777664321   222    34556677666888


Q ss_pred             CCceecCCC-CCCEEEecCCCEEEeeccccc
Q 022132           89 ANVLHRDLK-PSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        89 ~~i~H~dik-p~Nil~~~~~~~kl~dfg~~~  118 (302)
                      .||-|+.++ |...++..++.+.|+||..|+
T Consensus       124 ~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112         124 LGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            899999987 555555556699999999886

>PRK05231 homoserine kinase; Provisional

Probab=95.33  E-value=0.038  Score=48.09  Aligned_cols=30  Identities=30%  Similarity=0.357  Sum_probs=25.9

Q ss_pred             CCceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                      .|+||+|+.|.||+++.+....++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            379999999999999976556899999774

>PTZ00384 choline kinase; Provisional

Probab=95.30  E-value=0.093  Score=46.92  Aligned_cols=29  Identities=28%  Similarity=0.252  Sum_probs=24.1

Q ss_pred             CCceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                      ...||.|+.+.||+.+. +.+.++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence            46899999999998764 469999998764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=95.19  E-value=0.099  Score=42.10  Aligned_cols=89  Identities=21%  Similarity=0.277  Sum_probs=63.4

Q ss_pred             chhhHHHHHHhcC---CCCc--cccceeeCCCC-------------CCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHH
Q 022132           12 HFVRSSCFDTWIM---KTSV--VAIRDIIPPPQ-------------RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQ   73 (302)
Q Consensus        12 ~~~~E~~il~~l~---h~ni--v~l~~~~~~~~-------------~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~   73 (302)
                      .|..|-+...+|+   +.++  ++++++..-+.             ........||.||....-        .++...  
T Consensus       100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~--  169 (207)
T PF13095_consen  100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD--  169 (207)
T ss_pred             hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhH--
Confidence            6777888777774   4566  99999985431             012234678999887432        344444  


Q ss_pred             HHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccc
Q 022132           74 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  117 (302)
Q Consensus        74 ~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~  117 (302)
                        +.+|++-+..+|+.||+-+|+++.|..     .-+|+|||.+
T Consensus       170 --~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  170 --IPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             --HHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence              456777788899999999999999998     3489999864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.18  E-value=0.041  Score=47.51  Aligned_cols=29  Identities=34%  Similarity=0.438  Sum_probs=25.9

Q ss_pred             CceecCCCCCCEEEecC----CCEEEeeccccc
Q 022132           90 NVLHRDLKPSNLLLNAN----CDLKICDFGLAR  118 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~----~~~kl~dfg~~~  118 (302)
                      ++||+|+.+.||+++.+    +.+.++||..|.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            58999999999999985    889999998774

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.14  E-value=0.02  Score=45.54  Aligned_cols=30  Identities=30%  Similarity=0.423  Sum_probs=25.9

Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTS  121 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  121 (302)
                      .+|+|+.|.|++++++| ++++||+.+....
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gD  108 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDGD  108 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccCCC
Confidence            69999999999998877 9999999885443

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=95.13  E-value=0.037  Score=47.60  Aligned_cols=30  Identities=30%  Similarity=0.386  Sum_probs=26.6

Q ss_pred             CCceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                      .+++|+|+.|.|++++.++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            479999999999999988777999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.99  E-value=0.043  Score=46.53  Aligned_cols=51  Identities=27%  Similarity=0.354  Sum_probs=38.8

Q ss_pred             HHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           69 EEHCQYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        69 ~~~~~~i~~qll~~l~~LH~~--~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      ...+...+..+-.++.-.+..  -+||+|+.|+|++.++.+.+.|+||..|..
T Consensus       131 ~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         131 NHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             hHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            334444555555566666655  589999999999999989999999987754

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=94.38  E-value=0.1  Score=41.99  Aligned_cols=32  Identities=25%  Similarity=0.387  Sum_probs=26.0

Q ss_pred             hCCceecCCCCCCEEEecCC-----CEEEeecccccc
Q 022132           88 SANVLHRDLKPSNLLLNANC-----DLKICDFGLARV  119 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~-----~~kl~dfg~~~~  119 (302)
                      ...++|||+.+.|+++..++     .+.++||..+..
T Consensus       119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             ceEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            34699999999999998653     589999987743

subfamily of choline kinases

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.31  E-value=0.17  Score=44.56  Aligned_cols=100  Identities=16%  Similarity=0.156  Sum_probs=68.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH-SA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH-~~   89 (302)
                      +...|++-|++++...| ++-.-+.-.     ++ .+||++++. ....-..+.-.++...+..+-.|++.-+.-|- .+
T Consensus       212 WAEKE~RNLkRl~~aGI-P~PePIlLk-----~h-VLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c  284 (520)
T KOG2270|consen  212 WAEKEMRNLKRLNNAGI-PCPEPILLK-----NH-VLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC  284 (520)
T ss_pred             HHHHHHHHHHHHHhcCC-CCCCceeee-----cc-eEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh
Confidence            45578888888877664 333333332     33 499999984 21111123346777777777777777766664 66


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      +++|.||+--|+|+- +|.+.++|.+-+..
T Consensus       285 ~LVHADLSEfN~Lyh-dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  285 RLVHADLSEFNLLYH-DGKLYIIDVSQSVE  313 (520)
T ss_pred             ceeccchhhhhheEE-CCEEEEEEcccccc
Confidence            999999999999985 56899999986643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=94.24  E-value=0.037  Score=46.58  Aligned_cols=30  Identities=30%  Similarity=0.414  Sum_probs=26.1

Q ss_pred             CceecCCCCCCEEEecCCCEEEeeccccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVT  120 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  120 (302)
                      .++|+|+.|.||+++.++ +.++||+.+...
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence            489999999999999877 789999887543

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.21  E-value=0.032  Score=45.47  Aligned_cols=29  Identities=38%  Similarity=0.677  Sum_probs=20.7

Q ss_pred             CceecCCCCCCEEE-ecCCCEEEeeccccc
Q 022132           90 NVLHRDLKPSNLLL-NANCDLKICDFGLAR  118 (302)
Q Consensus        90 ~i~H~dikp~Nil~-~~~~~~kl~dfg~~~  118 (302)
                      .++|+|+.|.||++ +.++.++++||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            48999999999999 888999999998774

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.12  E-value=0.085  Score=45.77  Aligned_cols=30  Identities=20%  Similarity=0.232  Sum_probs=27.3

Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      ++||+|+.+.|+++++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999987743

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=93.72  E-value=0.11  Score=45.42  Aligned_cols=28  Identities=36%  Similarity=0.644  Sum_probs=25.5

Q ss_pred             ceecCCCCCCEEEecCCC-EEEeeccccc
Q 022132           91 VLHRDLKPSNLLLNANCD-LKICDFGLAR  118 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~-~kl~dfg~~~  118 (302)
                      +||+|+.|.||+++.+.. ..++||+.|.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999999885 8999999773

>PLN02236 choline kinase

Probab=93.60  E-value=0.11  Score=45.84  Aligned_cols=29  Identities=24%  Similarity=0.486  Sum_probs=25.5

Q ss_pred             CceecCCCCCCEEEec-CCCEEEeeccccc
Q 022132           90 NVLHRDLKPSNLLLNA-NCDLKICDFGLAR  118 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~-~~~~kl~dfg~~~  118 (302)
                      .++|+|+++.||+++. ++.+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            5899999999999986 4679999998774

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=93.53  E-value=0.15  Score=44.27  Aligned_cols=59  Identities=24%  Similarity=0.271  Sum_probs=36.6

Q ss_pred             EEEEecCCc-----cHHHHHHcCCCCCHHHHHHHHHHHHHHHH---HHH-hCCceecCCCCCCEEEec
Q 022132           47 YIAYELMDT-----DLHQIIRSNQALSEEHCQYFLYQILRGLK---YIH-SANVLHRDLKPSNLLLNA  105 (302)
Q Consensus        47 ~lv~e~~~~-----~L~~~l~~~~~l~~~~~~~i~~qll~~l~---~LH-~~~i~H~dikp~Nil~~~  105 (302)
                      -+|++++-+     ++....+-+-..-.+-++.++.||+.-.-   .|- -.+.+|-||||+|||+-+
T Consensus       247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd  314 (434)
T PF05445_consen  247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFD  314 (434)
T ss_pred             EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEec
Confidence            378887643     33333333222335668888888865331   122 336999999999999853

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=92.04  E-value=0.11  Score=44.25  Aligned_cols=31  Identities=26%  Similarity=0.541  Sum_probs=25.7

Q ss_pred             CceecCCCCCCEEEecCCC-EEEeeccccccc
Q 022132           90 NVLHRDLKPSNLLLNANCD-LKICDFGLARVT  120 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~-~kl~dfg~~~~~  120 (302)
                      .++|+|++|.||+++.++. ..|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997555 579999987543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PHA03111 Ser/Thr kinase; Provisional

Probab=92.03  E-value=0.94  Score=39.44  Aligned_cols=61  Identities=25%  Similarity=0.235  Sum_probs=39.0

Q ss_pred             EEEEEecCCc-----cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCceecCCCCCCEEEecC
Q 022132           46 VYIAYELMDT-----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNAN  106 (302)
Q Consensus        46 ~~lv~e~~~~-----~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH----~~~i~H~dikp~Nil~~~~  106 (302)
                      --+|++..-+     ++....+.+-.--.+-++.++.||+.-.-.+-    -.+.+|.||||+|||+-+.
T Consensus       250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            3478887642     34344433322335678889999876443332    2369999999999999554

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=91.57  E-value=0.3  Score=42.78  Aligned_cols=29  Identities=34%  Similarity=0.487  Sum_probs=25.3

Q ss_pred             ceecCCCCCCEEEec-CCCEEEeecccccc
Q 022132           91 VLHRDLKPSNLLLNA-NCDLKICDFGLARV  119 (302)
Q Consensus        91 i~H~dikp~Nil~~~-~~~~kl~dfg~~~~  119 (302)
                      +||+|+.+.||+++. ++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975 47899999988743

>PRK11768 serine/threonine protein kinase; Provisional

Probab=91.47  E-value=0.31  Score=42.61  Aligned_cols=28  Identities=32%  Similarity=0.433  Sum_probs=23.7

Q ss_pred             CCceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                      .+++|+|+.+.||+++ + .+.++||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            3689999999999995 4 57899999763

>PRK06148 hypothetical protein; Provisional

Probab=91.07  E-value=0.35  Score=49.02  Aligned_cols=31  Identities=35%  Similarity=0.529  Sum_probs=25.9

Q ss_pred             CCceecCCCCCCEEEecCC--CE-EEeecccccc
Q 022132           89 ANVLHRDLKPSNLLLNANC--DL-KICDFGLARV  119 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~--~~-kl~dfg~~~~  119 (302)
                      .+++|+|+.+.||+++.++  .+ -|+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999999875  44 5999998743

>PRK06149 hypothetical protein; Provisional

Probab=89.95  E-value=0.41  Score=48.36  Aligned_cols=31  Identities=19%  Similarity=0.289  Sum_probs=25.3

Q ss_pred             hCCceecCCCCCCEEEecCC--C---EEEeeccccc
Q 022132           88 SANVLHRDLKPSNLLLNANC--D---LKICDFGLAR  118 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~--~---~kl~dfg~~~  118 (302)
                      ..|++|+|+.+.||+++.+.  .   ..|+|||.+.
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            35799999999999998652  3   4899999764

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=89.78  E-value=0.59  Score=40.06  Aligned_cols=29  Identities=34%  Similarity=0.554  Sum_probs=24.2

Q ss_pred             ceecCCCCCCEEEecC--C---CEEEeecccccc
Q 022132           91 VLHRDLKPSNLLLNAN--C---DLKICDFGLARV  119 (302)
Q Consensus        91 i~H~dikp~Nil~~~~--~---~~kl~dfg~~~~  119 (302)
                      ++|||+..+||++..+  |   .++++||..++.
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~  250 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY  250 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeeccccccC
Confidence            8999999999999765  3   589999987643

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK14559 putative protein serine/threonine phosphatase; Provisional

Probab=88.97  E-value=1.2  Score=42.50  Aligned_cols=84  Identities=18%  Similarity=0.163  Sum_probs=67.1

Q ss_pred             CCCccccceeeCCCCCCCCCcEEEEEecCC--ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q 022132           25 KTSVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL  102 (302)
Q Consensus        25 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil  102 (302)
                      +.||.++|+++...     +.-.+++|+.+  ..|.+..... .++.-...+|+.||+.-=.-|...|++..=+.++|+.
T Consensus       179 ~~~iP~v~~~~~~~-----~~~i~Lle~~~~~~~l~~~w~~~-~~~~l~~l~Wl~q~~~LW~~l~~~~~~~sll~~~nlr  252 (645)
T PRK14559        179 PTEIPKIHDAWQDG-----DLQVILLEDRSHWQPLLDLWQDQ-TLPTLQILYWLNQMTQLWKALEPWGCCQSLLELENLR  252 (645)
T ss_pred             cccCcchheeecCC-----CCcEEEeCCCCCCchHHHHhhhc-CCcHHHHHHHHHHHHHHHHHHHhcCeehhccchhhee
Confidence            35599999999886     55568888886  3676666542 4567889999999999999999999999999999999


Q ss_pred             EecCCCEEEeec
Q 022132          103 LNANCDLKICDF  114 (302)
Q Consensus       103 ~~~~~~~kl~df  114 (302)
                      |+.+..+.|..|
T Consensus       253 v~~~~~~~l~~l  264 (645)
T PRK14559        253 VDEDQTLGLQQL  264 (645)
T ss_pred             eCCCceehHhhh
Confidence            986665555554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	302
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-86
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-85
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-85
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-85
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-85
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-85
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-85
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-85
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-85
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-85
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-85
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-85
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-85
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-85
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-84
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-84
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-84
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-84
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-84
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-84
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-84
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-83
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-83
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-82
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-76
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-76
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-76
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-75
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-75
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-70
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-70
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-70
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-70
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-70
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-70
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-70
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-70
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-70
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-70
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-70
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-70
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-70
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-70
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-70
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-70
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-70
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-70
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-70
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-70
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-70
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-70
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-70
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-70
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-70
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-70
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-70
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-70
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-70
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-70
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-70
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-70
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-70
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-70
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-70
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-69
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-69
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-69
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-69
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-69
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-69
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-69
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-69
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-69
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-69
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-69
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-69
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-69
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-69
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-69
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-69
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-69
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-69
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-69
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-69
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-69
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-69
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-68
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-68
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-68
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-67
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-66
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-62
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-62
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-62
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-55
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-55
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-55
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-55
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-55
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-55
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-54
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-54
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-54
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-54
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-54
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-54
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-54
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-54
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-54
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-54
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-54
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-54
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-54
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-54
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-54
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-54
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-54
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-54
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-54
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		7e-54
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-54
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-53
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-53
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-53
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-53
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-53
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-53
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-52
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-50
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-50
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-50
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-50
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-49
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-45
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-42
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-42
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-41
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-41
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-41
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-41
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-41
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-41
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-41
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-41
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-41
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-41
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-41
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-41
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-40
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-40
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-40
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-40
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-40
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-40
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-40
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-40
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-40
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-40
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-40
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-40
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-40
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-40
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-40
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-40
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-40
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-40
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-40
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-40
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-40
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-40
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-40
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-40
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-40
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-40
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-40
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-39
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-39
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-39
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-39
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-39
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-39
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-39
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-39
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-39
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-39
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-39
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-39
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-38
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-38
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-38
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-38
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-38
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-38
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-38
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-38
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-38
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-38
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-38
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-38
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-38
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-38
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-38
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-37
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-36
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-36
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-35
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-34
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-34
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-34
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-32
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-32
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-31
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-30
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-30
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-30
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-30
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-29
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		7e-27
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		7e-27
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-27
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-27
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		7e-27
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-27
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-27
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-27
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-26
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-26
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-26
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-26
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-26
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-26
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-26
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-26
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-26
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-26
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-26
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-26
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-26
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-26
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-26
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-26
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-26
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-26
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-26
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-26
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-26
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-26
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-26
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-26
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-26
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-26
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-24
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-24
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-24
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-24
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-24
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-24
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-23
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-22
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-22
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-22
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-22
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-21
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-21
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-20
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		8e-20
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-19
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-19
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-19
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-19
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-19
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-19
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-19
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-19
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-19
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-19
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-19
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-19
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-19
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-19
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-19
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-19
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-18
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-18
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-18
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-18
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-18
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-18
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-18
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-18
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-18
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-18
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-18
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-18
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-18
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-18
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-18
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-18
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-18
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-18
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-18
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-18
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-18
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-18
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-18
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-18
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-18
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-18
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-18
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-18
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-18
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-18
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-17
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-17
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-17
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-17
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-17
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-17
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-17
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-17
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-17
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-17
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-17
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-17
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-17
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-17
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-17
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-17
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-17
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-17
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-17
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-17
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-17
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-17
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-17
3soa_A	444	Full-Length Human Camkii Length = 444		5e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-17
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-17
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		8e-17
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-16
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-16
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-16
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-16
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-16
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-16
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-16
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-16
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-16
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-16
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-16
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-16
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-16
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-16
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-15
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-15
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-15
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-15
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-15
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-15
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-15
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-15
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-14
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-14
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-14
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-14
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-14
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-14
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-13
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-13
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-13
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-13
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-13
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-13
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-13
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-13
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-13
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-13
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-13
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-13
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-13
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-13
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-13
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-13
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-13
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		6e-13
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-13
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-13
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-13
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-13
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-13
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-13
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-13
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-13
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-12
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		7e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-12
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-12
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-12
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		9e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-12
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		9e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-11
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-11
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		9e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-10
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-10
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-10
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		4e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-10
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-09
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-07
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-07
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-07
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-07
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		9e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-06

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  313 bits (802), Expect = 8e-86,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 198/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 142
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 143 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPS 322
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 323 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 361

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  312 bits (799), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 198/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 142
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 143 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 322
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 323 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 361

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  311 bits (798), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 198/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 138
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 318
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 319 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 357

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  311 bits (798), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 198/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 145
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 325
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 326 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 364

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  311 bits (798), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 198/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 146
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 147 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 267 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 326
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 327 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 365

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  311 bits (798), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 198/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 137
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 138 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 258 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 317
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 318 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 356

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  311 bits (798), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 198/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 144
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 325 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  311 bits (798), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 198/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 140
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 141 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 320
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  311 bits (798), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 198/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 148
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 149 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 269 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 328
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 329 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 367

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  311 bits (798), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 198/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 140
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 141 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 320
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  311 bits (798), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 198/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 144
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 325 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  311 bits (797), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 198/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 160
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 161 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 340
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 341 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 379

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  310 bits (795), Expect = 5e-85,   Method: Compositional matrix adjust.
 Identities = 149/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL+++++  Q LS +H  YFLYQILRGLKYI
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKC-QHLSNDHICYFLYQILRGLKYI 144
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 325 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  310 bits (794), Expect = 7e-85,   Method: Compositional matrix adjust.
 Identities = 148/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 138
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+P + +L   +N  A
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 318
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 319 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 357

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  308 bits (790), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 148/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 142
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 143 HSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPS 322
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 323 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 361

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  308 bits (789), Expect = 3e-84,   Method: Compositional matrix adjust.
 Identities = 148/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 140
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 320
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  308 bits (788), Expect = 3e-84,   Method: Compositional matrix adjust.
 Identities = 148/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 144
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 325 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  308 bits (788), Expect = 3e-84,   Method: Compositional matrix adjust.
 Identities = 148/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 140
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 320
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  308 bits (788), Expect = 3e-84,   Method: Compositional matrix adjust.
 Identities = 148/279 (53%), Positives = 197/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 144
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 325 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  306 bits (785), Expect = 7e-84,   Method: Compositional matrix adjust.
 Identities = 147/279 (52%), Positives = 196/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 144
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+ E V TRWYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 325 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  306 bits (785), Expect = 7e-84,   Method: Compositional matrix adjust.
 Identities = 147/279 (52%), Positives = 196/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 145
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+ E V TRWYRAPE++L
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 325
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 326 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 364

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  304 bits (779), Expect = 3e-83,   Method: Compositional matrix adjust.
 Identities = 147/279 (52%), Positives = 196/279 (70%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 140
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN   DLKI DFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 320
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  303 bits (777), Expect = 5e-83,   Method: Compositional matrix adjust.
 Identities = 146/279 (52%), Positives = 194/279 (69%), Gaps = 6/279 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I DII  P  E   DVY+   LM  DL++++++ Q LS +H  YFLYQILRGLKYI
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYI 160
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE++L
Sbjct: 161 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D S
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 340
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           DEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 341 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 379

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  302 bits (774), Expect = 1e-82,   Method: Compositional matrix adjust.
 Identities = 144/276 (52%), Positives = 198/276 (71%), Gaps = 6/276 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +V+ IRDI+     E+  DVYI  +LM+TDL+++++S Q LS +H  YFLYQILRGLKYI
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ-LSNDHICYFLYQILRGLKYI 160
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVT----SETDFMTEYVVTRWYRAPELLL 142
           HSANVLHRDLKPSNLL+N  CDLKICDFGLAR+       T F+TE V TRWYRAPE++L
Sbjct: 161 HSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNENA 201
           NS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKA 280
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           + Y+  LP   + ++ + FP     A+DL+++MLTF+P +RITVE+ALAHPYL   +D +
Sbjct: 281 RNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPT 340
Query: 262 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           DEPV   PF+F  E   L + ++KELI+QE   F P
Sbjct: 341 DEPVAEEPFTFAMELDDLPKERLKELIFQETARFQP 376

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  283 bits (723), Expect = 1e-76,   Method: Compositional matrix adjust.
 Identities = 143/285 (50%), Positives = 195/285 (68%), Gaps = 18/285 (6%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I +I  P   E+FN+VYI  ELM TDLH++I S Q LS++H QYF+YQ LR +K +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVL 128
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----------TSETDFMTEYVVTRWY 135
           H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR+           T +   MTEYV TRWY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWY 188
Query: 136 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-SEAEL 194
           RAPE++L S+ Y+ A+DVWS GCI  EL  R+P+FPGRD+ HQL L+  +IGTP S+ +L
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 195 GFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
             + +  A++YI  LP Y      + FP V+P  IDL+++ML FDP +RIT ++AL HPY
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 254 LGSLHDISD----EPVCMSPFSFDFEQHALTEGQMKELIYQEALA 294
           L + HD +D    EP+  S F FD  + ALT   +K+LI+ E  +
Sbjct: 309 LQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS 353

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  282 bits (722), Expect = 1e-76,   Method: Compositional matrix adjust.
 Identities = 142/273 (52%), Positives = 191/273 (69%), Gaps = 9/273 (3%)
Query: 27  SVVAIRDIIPP--PQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 84
           +++AI+DI+ P  P  E F  VY+  +LM++DLHQII S+Q L+ EH +YFLYQ+LRGLK
Sbjct: 114 NIIAIKDILRPTVPYGE-FKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 172
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETD---FMTEYVVTRWYRAPE 139
           Y+HSA V+HRDLKPSNLL+N NC+LKI DFG+AR   TS  +   FMTEYV TRWYRAPE
Sbjct: 173 YMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 140 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN- 198
           L+L+  +YT AID+WSVGCIF E++ R+ LFPG+++VHQL+L++ ++GTPS A +  +  
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292
Query: 199 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 258
           E  + YI  LP  Q   +   +P     A+ L+ +ML F+P  RI+   AL HP+L   H
Sbjct: 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352
Query: 259 DISDEPVCMSPFSFDFEQHALTEGQMKELIYQE 291
           D  DEP C  PF F F++ ALT  ++KE I  E
Sbjct: 353 DPDDEPDCAPPFDFAFDREALTRERIKEAIVAE 385

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  282 bits (721), Expect = 2e-76,   Method: Compositional matrix adjust.
 Identities = 142/273 (52%), Positives = 191/273 (69%), Gaps = 9/273 (3%)
Query: 27  SVVAIRDIIPP--PQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 84
           +++AI+DI+ P  P  E F  VY+  +LM++DLHQII S+Q L+ EH +YFLYQ+LRGLK
Sbjct: 115 NIIAIKDILRPTVPYGE-FKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 173
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETD---FMTEYVVTRWYRAPE 139
           Y+HSA V+HRDLKPSNLL+N NC+LKI DFG+AR   TS  +   FMTEYV TRWYRAPE
Sbjct: 174 YMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 140 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN- 198
           L+L+  +YT AID+WSVGCIF E++ R+ LFPG+++VHQL+L++ ++GTPS A +  +  
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 293
Query: 199 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 258
           E  + YI  LP  Q   +   +P     A+ L+ +ML F+P  RI+   AL HP+L   H
Sbjct: 294 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 353
Query: 259 DISDEPVCMSPFSFDFEQHALTEGQMKELIYQE 291
           D  DEP C  PF F F++ ALT  ++KE I  E
Sbjct: 354 DPDDEPDCAPPFDFAFDREALTRERIKEAIVAE 386

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  280 bits (715), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 142/285 (49%), Positives = 194/285 (68%), Gaps = 18/285 (6%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I +I  P   E+FN+VYI  ELM TDLH++I S Q LS++H QYF+YQ LR +K +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVL 128
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----------TSETDFMTEYVVTRWY 135
           H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR+           T +   MTE V TRWY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWY 188
Query: 136 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-SEAEL 194
           RAPE++L S+ Y+ A+DVWS GCI  EL  R+P+FPGRD+ HQL L+  +IGTP S+ +L
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 195 GFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
             + +  A++YI  LP Y      + FP V+P  IDL+++ML FDP +RIT ++AL HPY
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 254 LGSLHDISD----EPVCMSPFSFDFEQHALTEGQMKELIYQEALA 294
           L + HD +D    EP+  S F FD  + ALT   +K+LI+ E  +
Sbjct: 309 LQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS 353

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  279 bits (714), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 141/285 (49%), Positives = 194/285 (68%), Gaps = 18/285 (6%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ I +I  P   E+FN+VYI  ELM TDLH++I S Q LS++H QYF+YQ LR +K +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVL 128
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----------TSETDFMTEYVVTRWY 135
           H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR+           T +   M E+V TRWY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 136 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-SEAEL 194
           RAPE++L S+ Y+ A+DVWS GCI  EL  R+P+FPGRD+ HQL L+  +IGTP S+ +L
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 195 GFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
             + +  A++YI  LP Y      + FP V+P  IDL+++ML FDP +RIT ++AL HPY
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 254 LGSLHDISD----EPVCMSPFSFDFEQHALTEGQMKELIYQEALA 294
           L + HD +D    EP+  S F FD  + ALT   +K+LI+ E  +
Sbjct: 309 LQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS 353

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  263 bits (672), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 179/274 (65%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN+ 
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNAM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  263 bits (671), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 134/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   PF   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPFDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  262 bits (669), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 179/274 (65%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 147
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWM 205
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 264
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 325 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  262 bits (669), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  261 bits (668), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 152
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 210
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 269
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 270 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 329
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 330 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 362

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  261 bits (668), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 146
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 204
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 263
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 264 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 323
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 324 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  261 bits (668), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 151
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 209
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 268
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 269 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 328
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 329 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 361

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  261 bits (668), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 152
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 210
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 269
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 270 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 329
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 330 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 362

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  261 bits (668), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 152
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 210
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 269
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 270 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 329
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 330 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 362

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  261 bits (668), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 147
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 205
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 264
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 325 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  261 bits (668), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 150
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 151 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 208
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 209 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 267
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 268 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 327
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 328 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 360

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  261 bits (668), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  261 bits (668), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 160
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 218
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 277
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 278 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 337
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 338 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 370

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 163
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 221
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 280
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 281 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 340
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 341 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 373

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 159
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 217
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 276
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 277 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 336
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 337 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 369

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 142
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 200
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 259
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 260 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 319
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 320 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 142
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 200
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 259
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 260 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 319
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 320 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 159
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 217
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 276
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 277 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 336
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 337 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 369

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 137
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 195
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 254
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 255 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 314
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 315 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 347

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 145
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 203
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 262
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 263 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 322
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 323 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 139
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 140 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 197
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 198 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 256
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 257 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 316
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 317 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 349

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  261 bits (667), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 160
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 218
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 277
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 278 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 337
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 338 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 370

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  261 bits (667), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 131/273 (47%), Positives = 177/273 (64%), Gaps = 6/273 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 145
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 203
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+A+ Y
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 263
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DEP
Sbjct: 264 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 323
Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           V   P+   FE   L   + K L Y E ++F P
Sbjct: 324 VA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  261 bits (667), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  261 bits (667), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 142
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 200
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 259
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 260 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 319
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 320 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  261 bits (667), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 146
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 204
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 263
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 264 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 323
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 324 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  261 bits (666), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 131/273 (47%), Positives = 177/273 (64%), Gaps = 6/273 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 194
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+A+ Y
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DEP
Sbjct: 255 IQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314
Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           V   P+   FE   L   + K L Y E ++F P
Sbjct: 315 VA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  261 bits (666), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 131/273 (47%), Positives = 177/273 (64%), Gaps = 6/273 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 138
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 139 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 196
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+A+ Y
Sbjct: 197 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 256
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DEP
Sbjct: 257 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 316
Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           V   P+   FE   L   + K L Y E ++F P
Sbjct: 317 VA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 348

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  261 bits (666), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 146
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 204
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 263
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 264 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 323
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 324 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  261 bits (666), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 131/273 (47%), Positives = 177/273 (64%), Gaps = 6/273 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 194
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+A+ Y
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DEP
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314
Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           V   P+   FE   L   + K L Y E ++F P
Sbjct: 315 VA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  261 bits (666), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 137
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 195
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 254
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 255 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 314
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 315 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 347

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  260 bits (664), Expect = 7e-70,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI D+GLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  260 bits (664), Expect = 7e-70,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 147
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWM 205
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 264
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+    E   L   + K L Y E ++F P
Sbjct: 325 PVA-DPYDQSLESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  259 bits (663), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P    FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPTDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  259 bits (663), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 163
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  YV TRWYRAPE++LN  
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGYVATRWYRAPEIMLNWM 221
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 280
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 281 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 340
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 341 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 373

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  259 bits (662), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P    FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPRDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  259 bits (662), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 130/273 (47%), Positives = 177/273 (64%), Gaps = 6/273 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  + L+++H Q+ +YQILRGLKY
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK-LTDDHVQFLIYQILRGLKY 136
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 194
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+A+ Y
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DEP
Sbjct: 255 IQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314
Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           V   P+   FE   L   + K L Y E ++F P
Sbjct: 315 VA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  259 bits (661), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P    FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPQDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  259 bits (661), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI  FGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  259 bits (661), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 178/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 147
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWM 205
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 264
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+    E   L   + K L Y E ++F P
Sbjct: 325 PVA-DPYDQSSESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI D GLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT  V TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGXVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  258 bits (660), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI D GLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  258 bits (659), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 146
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 204
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 263
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 264 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 323
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 324 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  258 bits (659), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  258 bits (659), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 142
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 200
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 259
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 260 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 319
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 320 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  258 bits (659), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI D GLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  258 bits (658), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 131/274 (47%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  +V TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  258 bits (658), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 131/274 (47%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  +V TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  258 bits (658), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 151
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 209
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 268
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 269 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 328
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 329 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 361

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  258 bits (658), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 129/273 (47%), Positives = 176/273 (64%), Gaps = 6/273 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  +V TRWYRAPE++LN  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIMLNWM 194
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+A+ Y
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DEP
Sbjct: 255 IQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314
Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           V   P+   FE   L   + K L Y E ++F P
Sbjct: 315 VA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  258 bits (658), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 145
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 203
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 262
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 263 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 322
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 323 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  257 bits (657), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 128/271 (47%), Positives = 177/271 (65%), Gaps = 6/271 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P    E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 169
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 227
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
            Y   +D+WSVGCI  EL+  + LFPG DH++QL+ ++ L GTP  + +  + +  A+ Y
Sbjct: 228 HYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNY 287
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  LP+  +++F + F   +P A+DL+EKML  D  +RIT  +ALAHPY    HD  DEP
Sbjct: 288 INSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDEP 347
Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAF 295
               P+   FE   L   + K L Y+E  +F
Sbjct: 348 ES-EPYDQSFESRQLEIEEWKRLTYEEVCSF 377

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  257 bits (657), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 145
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++LN  
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWM 203
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 262
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 263 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 322
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 323 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  257 bits (656), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 132/274 (48%), Positives = 177/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DF LAR T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  256 bits (654), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 131/274 (47%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKY
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 160
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M   V TRWYRAPE++LN  
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGXVATRWYRAPEIMLNWM 218
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 277
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 278 YIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 337
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+   FE   L   + K L Y E ++F P
Sbjct: 338 PVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 370

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  256 bits (653), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 131/274 (47%), Positives = 176/274 (64%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  E FNDVY+   LM  DL+ I++S Q L+++H Q+ +YQILRGLKY
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQILRGLKY 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA+++HRDLKPSNL +N + +LKI DFGL R T   D MT YV TRWYRAPE++LN  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD--DEMTGYVATRWYRAPEIMLNWM 198
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAKK 203
            Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E+A+ 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSESARN 257
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DE
Sbjct: 258 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
           PV   P+    E   L   + K L Y E ++F P
Sbjct: 318 PVA-DPYDQSLESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  253 bits (647), Expect = 8e-68,   Method: Compositional matrix adjust.
 Identities = 127/273 (46%), Positives = 176/273 (64%), Gaps = 6/273 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P    E F++VY+   LM  DL+ I++  QALS+EH Q+ +YQ+LRGLKY
Sbjct: 80  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKY 138
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA ++HRDLKPSN+ +N +C+L+I DFGLAR   E   MT YV TRWYRAPE++LN  
Sbjct: 139 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWM 196
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
            Y   +D+WSVGCI  EL+  K LFPG D++ QL+ ++E++GTPS   L  + +E+A+ Y
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 256
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  LP   ++  +  F   +P AIDL+ +ML  D  QR++  +ALAH Y    HD  DEP
Sbjct: 257 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 316
Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
               P+    E    T  + KEL YQE L+F P
Sbjct: 317 EA-EPYDESVEAKERTLEEWKELTYQEVLSFKP 348

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  250 bits (638), Expect = 8e-67,   Method: Compositional matrix adjust.
 Identities = 126/271 (46%), Positives = 175/271 (64%), Gaps = 6/271 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P    E F++VY+   LM  DL+ I++S QALS+EH Q+ +YQ+LRGLKY
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS-QALSDEHVQFLVYQLLRGLKY 146
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA ++HRDLKPSN+ +N + +L+I DFGLAR   E   MT YV TRWYRAPE++LN  
Sbjct: 147 IHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWM 204
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
            Y   +D+WSVGCI  EL+  K LFPG D++ QL+ ++E++GTPS   L  + +E+A+ Y
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  LP   ++  +  F   +P AIDL+ +ML  D  QR++  +ALAH Y    HD  DEP
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324
Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAF 295
               P+    E    T  + KEL YQE L+F
Sbjct: 325 EA-EPYDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  247 bits (631), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 125/271 (46%), Positives = 174/271 (64%), Gaps = 6/271 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P    E F++VY+   LM  DL+ I++  QALS+EH Q+ +YQ+LRGLKY
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKY 146
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA ++HRDLKPSN+ +N + +L+I DFGLAR   E   MT YV TRWYRAPE++LN  
Sbjct: 147 IHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWM 204
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKY 204
            Y   +D+WSVGCI  EL+  K LFPG D++ QL+ ++E++GTPS   L  + +E+A+ Y
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  LP   ++  +  F   +P AIDL+ +ML  D  QR++  +ALAH Y    HD  DEP
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324
Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAF 295
               P+    E    T  + KEL YQE L+F
Sbjct: 325 EA-EPYDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  235 bits (599), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 120/273 (43%), Positives = 164/273 (60%), Gaps = 6/273 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P     +F D Y+    M TDL +I+      SEE  QY +YQ+L+GLKY
Sbjct: 102 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GMEFSEEKIQYLVYQMLKGLKY 159
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA V+HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++L+  
Sbjct: 160 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWM 217
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN-AKKY 204
            Y   +D+WSVGCI  E++  K LF G+D++ QL  ++++ G P    +  LN+  AK Y
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 277
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  LP+  R+ FT+ FP   P A DL+EKML  D  +R+T   AL HP+     D  +E 
Sbjct: 278 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEET 337
Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
               PF    E   LT  + K+ IY+E + F+P
Sbjct: 338 EAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 370

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  234 bits (598), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 120/273 (43%), Positives = 164/273 (60%), Gaps = 6/273 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P     +F D Y+    M TDL +I+      SEE  QY +YQ+L+GLKY
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GLKFSEEKIQYLVYQMLKGLKY 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IHSA V+HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++L+  
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWM 199
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN-AKKY 204
            Y   +D+WSVGCI  E++  K LF G+D++ QL  ++++ G P    +  LN+  AK Y
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 259
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           I  LP+  R+ FT+ FP   P A DL+EKML  D  +R+T   AL HP+     D  +E 
Sbjct: 260 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEET 319
Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
               PF    E   LT  + K+ IY+E + F+P
Sbjct: 320 EAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  233 bits (594), Expect = 9e-62,   Method: Compositional matrix adjust.
 Identities = 119/274 (43%), Positives = 171/274 (62%), Gaps = 8/274 (2%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V+ + D+  P +  + F D Y+    M TDL ++++ ++ L E+  Q+ +YQ+L+GL+Y
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRY 143
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           IH+A ++HRDLKP NL +N +C+LKI DFGLAR       M   VVTRWYRAPE++LN  
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MXGXVVTRWYRAPEVILNWM 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-PSEAELGFLNENAKKY 204
            YT  +D+WSVGCI  E++  K LF G DH+ QL+ ++++ GT P+E      ++ AK Y
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           +  LP  +++ F     N  P A++L+EKML  D  QR+T  +ALAHPY  SLHD  DEP
Sbjct: 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 321
Query: 265 -VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
            V     SFD     L E   K + Y+E L+F P
Sbjct: 322 QVQKYDDSFDDVDRTLDE--WKRVTYKEVLSFKP 353

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  212 bits (539), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 115/283 (40%), Positives = 166/283 (58%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 206 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  211 bits (537), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 115/283 (40%), Positives = 166/283 (58%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 206 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  210 bits (534), Expect = 8e-55,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 170/283 (60%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 142
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 203 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 261
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 262 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 321
Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 322 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 362

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  210 bits (534), Expect = 9e-55,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 170/283 (60%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 179
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 240 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358
Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 359 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 399

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  210 bits (534), Expect = 9e-55,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 170/283 (60%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 142
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 203 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 261
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 262 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 321
Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 322 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 362

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  210 bits (534), Expect = 9e-55,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 165/283 (58%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLVGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 206 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  210 bits (534), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 170/283 (60%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 179
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 240 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358
Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 359 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 399

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 170/283 (60%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 170/283 (60%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 170/283 (60%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 140
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 141 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 200
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 201 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 259
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 260 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 319
Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 320 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 360

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 170/283 (60%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 135
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 196 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 254
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 255 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 314
Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 315 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 355

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 170/283 (60%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 134
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 195 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313
Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 314 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 354

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 170/283 (60%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 135
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 196 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 254
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 255 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 314
Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 315 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 355

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 165/283 (58%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 142
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    + Y+
Sbjct: 203 -YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 261
Query: 206 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 262 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 322 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 362

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 165/283 (58%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 206 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 115/283 (40%), Positives = 167/283 (59%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 146
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 147 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 206
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 207 -YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 265
Query: 206 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 266 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 325
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 326 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 366

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 165/283 (58%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 206 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  208 bits (530), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 115/283 (40%), Positives = 167/283 (59%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 135
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 196 -YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 254
Query: 206 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 255 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 314
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 315 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 355

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  208 bits (530), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 114/283 (40%), Positives = 165/283 (58%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260
Query: 206 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  208 bits (529), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 113/283 (39%), Positives = 169/283 (59%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  208 bits (529), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 113/283 (39%), Positives = 169/283 (59%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  208 bits (529), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 113/283 (39%), Positives = 169/283 (59%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKH 134
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 195 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313
Query: 254 LGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 314 INVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 354

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  207 bits (528), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 115/283 (40%), Positives = 169/283 (59%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I  +  L  E   Y LYQ+L G+K+
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--HMELDHERMSYLLYQMLCGIKH 139
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR  S    MT YVVTR+YRAPE++L   
Sbjct: 140 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMG 199
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  EL+    +F G DH+ Q   +IE +GTPS   +  L    + Y+
Sbjct: 200 -YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV 258
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P Y   +F E FP+ + PS           A DL+ KML  DP +RI+V++AL HPY
Sbjct: 259 ENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPY 318
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D ++    P  +     +  +HA+ E   KELIY+E +
Sbjct: 319 ITVWYDPAEAEAPPPQIYDAQLEEREHAIEE--WKELIYKEVM 359

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  207 bits (527), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 113/283 (39%), Positives = 164/283 (57%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLVGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVG I  E++    LFPG DH+ Q   +IE +GTPS   +  L    + Y+
Sbjct: 202 -YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 206 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  207 bits (527), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 115/283 (40%), Positives = 169/283 (59%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I  +  L  E   Y LYQ+L G+K+
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--HMELDHERMSYLLYQMLCGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR       MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y A +D+WSVGCI  EL+    +F G DH+ Q   +IE +GTPS   +  L    + Y+
Sbjct: 202 -YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV 260
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y    F E FP+ + PS           A DL+ KML  DP +RI+V++AL HPY
Sbjct: 261 ENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPY 320
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D ++    P  +     +  +HA+ E   KELIY+E +
Sbjct: 321 ITVWYDPAEAEAPPPQIYDAQLEEREHAIEE--WKELIYKEVM 361

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  207 bits (526), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 118/332 (35%), Positives = 173/332 (52%), Gaps = 61/332 (18%)
Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           VV + DI+ P   E F+++Y+  E+ D+D  ++ R+   L+E H +  LY +L G+KY+H
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH 173
Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTS--------------ETDF-------- 125
           SA +LHRDLKP+N L+N +C +K+CDFGLAR                 E D         
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233
Query: 126 ------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----------DRKP 168
                 +T +VVTRWYRAPEL+L   +YT AIDVWS+GCIF EL+           DR P
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
Query: 169 LFPG--------------------RDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQ 207
           LFPG                    R +  QL ++  ++GTPSE ++  L  E+AK+YI  
Sbjct: 294 LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI 353
Query: 208 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCM 267
            P+ +     E+FP     AI L+++ML F+P +RIT+ + LAHP+   +     E    
Sbjct: 354 FPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNAT 413
Query: 268 SPFSFDFEQ-HALTEGQMKELIYQEALAFNPE 298
                 F     + E Q++    +E   ++PE
Sbjct: 414 EKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  206 bits (525), Expect = 9e-54,   Method: Compositional matrix adjust.
 Identities = 113/283 (39%), Positives = 164/283 (57%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLVGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVG I  E++    LFPG DH+ Q   +IE +GTPS   +  L    + Y+
Sbjct: 202 -YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 206 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  206 bits (525), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 170/284 (59%), Gaps = 23/284 (8%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNS 144
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR T+ T FM E  VVTR+YRAPE++L  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMEPEVVTRYYRAPEVILGM 200
Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
             Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP  A +  L    + Y
Sbjct: 201 G-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNY 259
Query: 205 ICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHP 252
           +   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 253 YLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           Y+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 320 YINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 112/283 (39%), Positives = 164/283 (57%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 143
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  M  +VVTR+YRAPE++L   
Sbjct: 144 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG 203
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    + Y+
Sbjct: 204 -YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 262
Query: 206 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 263 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 322
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 323 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 363

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  205 bits (522), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 113/283 (39%), Positives = 164/283 (57%), Gaps = 21/283 (7%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT  VVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260
Query: 206 CQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 254 LGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  204 bits (520), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 112/280 (40%), Positives = 167/280 (59%), Gaps = 24/280 (8%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLCGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 254 LGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +D +           D  +H + E   KELIY+E +
Sbjct: 321 INVWYDPA------XXXXXDEREHTIEE--WKELIYKEVM 352

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  204 bits (518), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 113/324 (34%), Positives = 176/324 (54%), Gaps = 53/324 (16%)
Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++ + D+I P     F+++YI  E+ D+DL ++ ++   L+EEH +  LY +L G  +IH
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146
Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF--------------------- 125
            + ++HRDLKP+N LLN +C +K+CDFGLAR + SE D                      
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 126 -MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----------DRKPLFPG- 172
            +T +VVTRWYRAPEL+L   +YT +ID+WS GCIF EL+           +R PLFPG 
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266
Query: 173 ----------------RDHVHQLRLLIELIGTPSEAELGFLNE-NAKKYICQLPRYQRQS 215
                           + +  QL ++  +IGTP+E +L  +N+    KYI   P  +  +
Sbjct: 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326
Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFE 275
             +K+P++    I+L+E ML F+P +RIT++ AL HPYL  +     E          F+
Sbjct: 327 LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD 386
Query: 276 Q-HALTEGQMKELIYQEALAFNPE 298
               L+E Q++ +  +E  +F+PE
Sbjct: 387 DWMVLSETQLRYIFLKEVQSFHPE 410

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  203 bits (517), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 117/284 (41%), Positives = 169/284 (59%), Gaps = 23/284 (8%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNS 144
           +HSA ++HRDLKPSN+++ ++C LKI DFGLAR T+ T FM E  VVTR+YRAPE++L  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMEPEVVTRYYRAPEVILGM 200
Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
             Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y
Sbjct: 201 G-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 205 ICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDALAHP 252
           +   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 253 YLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           Y+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 320 YINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  201 bits (511), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 111/280 (39%), Positives = 165/280 (58%), Gaps = 26/280 (9%)
Query: 27  SVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K+
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 141
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+
Sbjct: 202 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 206 CQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDALAHPY 253
              P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL HPY
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 254 LGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 293
           +   +              D  +H + E   KELIY+E +
Sbjct: 321 INVWY--------XXXXXXDEREHTIEE--WKELIYKEVM 350

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  196 bits (499), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 157/273 (57%), Gaps = 4/273 (1%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKY 85
           +++ +RDI    +  + + +Y+  ELM TDL Q+I   +  +S +H QYF+Y IL GL  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +H A V+HRDL P N+LL  N D+ ICDF LAR  +     T YV  RWYRAPEL++   
Sbjct: 150 LHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFK 209
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS-EAELGFLNENAKKY 204
            +T  +D+WS GC+  E+ +RK LF G    +QL  ++E++GTP  E  + F + +A+ Y
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDY 269
Query: 205 I-CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           +   L     +++T   P   P A+DL+ KML F+P++RI+ E AL HPY  SL D  D 
Sbjct: 270 LRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDL 329
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFN 296
              +S   F F++       M ++   E   FN
Sbjct: 330 TEGLSE-RFHFDESVTDVYDMHKIFTAEVERFN 361

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  196 bits (498), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 106/273 (38%), Positives = 157/273 (57%), Gaps = 4/273 (1%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKY 85
           +++ +RDI    +  + + +Y+  ELM TDL Q+I   +  +S +H QYF+Y IL GL  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +H A V+HRDL P N+LL  N D+ ICDF LAR  +     T YV  RWYRAPEL++   
Sbjct: 150 LHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFK 209
Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS-EAELGFLNENAKKY 204
            +T  +D+WS GC+  E+ +RK LF G    +QL  ++E++GTP  E  + F + +A+ Y
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDY 269
Query: 205 I-CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
           +   L     +++T   P   P A+DL+ KML F+P++RI+ E AL HPY  SL D  D 
Sbjct: 270 LRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDL 329
Query: 264 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFN 296
              +S   F F++       M ++   E   FN
Sbjct: 330 TEGLSE-RFHFDESVTDVYDMHKIFTAEVERFN 361

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  195 bits (495), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 116/331 (35%), Positives = 181/331 (54%), Gaps = 64/331 (19%)
Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++ + D+I P     F+++YI  E+ D+DL ++ ++   L+E+H +  LY +L G K+IH
Sbjct: 89  IIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIH 148
Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF--------------------- 125
            + ++HRDLKP+N LLN +C +KICDFGLAR + S+ D                      
Sbjct: 149 ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKN 208
Query: 126 ----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----------DRKPLF 170
               +T +VVTRWYRAPEL+L   +YT +ID+WS GCIF EL+           +R PLF
Sbjct: 209 LKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLF 268
Query: 171 PGR-------DH----VH------QLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQ 212
           PG        DH    VH      QL ++  +IGTP E +L  +  +   KYI   P   
Sbjct: 269 PGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRD 328
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG-----SLHDISDEPVCM 267
               ++K+ ++    IDL+E ML F+ ++RIT++ AL+HPYL      +L + S E + +
Sbjct: 329 GIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLENFSTEKIIL 388
Query: 268 SPFSFDFEQHALTEGQMKELIYQEALAFNPE 298
            PF    +   L+E Q++ +  +E  +F+ +
Sbjct: 389 -PFD---DWMVLSETQLRYIFLKEIQSFHAD 415

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  193 bits (491), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 103/235 (43%), Positives = 145/235 (61%), Gaps = 20/235 (8%)
Query: 43  FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
            N VYI  E M+TDL  ++     L EEH + F+YQ+LRGLKYIHSANVLHRDLKP+NL 
Sbjct: 94  LNSVYIVQEYMETDLANVLEQGPLL-EEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF 152
Query: 103 LNA-NCDLKICDFGLARVT----SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           +N  +  LKI DFGLAR+     S    ++E +VT+WYR+P LLL+ ++YT AID+W+ G
Sbjct: 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212
Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
           CIF E++  K LF G   + Q++L++E I    E       E+ ++ +  +P Y R   T
Sbjct: 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE-------EDRQELLSVIPVYIRNDMT 265
Query: 218 EK-------FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
           E         P +   A+D +E++LTF P  R+T E+AL+HPY+       DEP+
Sbjct: 266 EPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI 320

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  192 bits (487), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 107/290 (36%), Positives = 169/290 (58%), Gaps = 47/290 (16%)
Query: 45  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           DVY+ ++ M+TDLH +IR+N  L   H QY +YQ+++ +KY+HS  +LHRD+KPSN+LLN
Sbjct: 85  DVYLVFDYMETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN 143
Query: 105 ANCDLKICDFGLAR---------------VTSETD-------FMTEYVVTRWYRAPELLL 142
           A C +K+ DFGL+R               +   T+        +T+YV TRWYRAPE+LL
Sbjct: 144 AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL 203
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN---- 198
            S+ YT  ID+WS+GCI  E++  KP+FPG   ++QL  +I +I  PS  ++  +     
Sbjct: 204 GSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFA 263
Query: 199 ----ENAKKYICQLPRYQRQSFTEKFPN----VHPS------AIDLVEKMLTFDPRQRIT 244
               E+ K+ +      +R  FT K+ N    ++P       A+DL++K+L F+P +RI+
Sbjct: 264 KTMIESLKEKVEIRQSNKRDIFT-KWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322
Query: 245 VEDALAHPYLGSLHDISDEPVCMSPFSF---DFEQHALTEGQMKELIYQE 291
             DAL HP++   H+ ++EP C    +    D  +H++ +   + L+Y E
Sbjct: 323 ANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDD--YRNLVYSE 370

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  177 bits (449), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 100/251 (39%), Positives = 142/251 (56%), Gaps = 12/251 (4%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKY 85
           ++V + DII      +   + + +E +D DL Q +      ++  + + FL+Q+LRGL Y
Sbjct: 61  NIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNS 144
            H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T      VVT WYR P++LL S
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFL-NENAK 202
           +DY+  ID+W VGCIF E+   +PLFPG     QL  +  ++GTP+E    G L NE  K
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235
Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD-IS 261
            Y    P+Y+ ++     P +     DL+ K+L F+ R RI+ EDA+ HP+  SL + I 
Sbjct: 236 TY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH 293
Query: 262 DEPVCMSPFSF 272
             P   S F+ 
Sbjct: 294 KLPDTTSIFAL 304

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  168 bits (425), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 82/212 (38%), Positives = 125/212 (58%), Gaps = 2/212 (0%)
Query: 48  IAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           + +E M+ DL +++  N+  L +   + +LYQ+LRG+ + H   +LHRDLKP NLL+N++
Sbjct: 96  LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD 155
Query: 107 CDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             LK+ DFGLAR         T  VVT WYRAP++L+ S  Y+ ++D+WS+GCIF E++ 
Sbjct: 156 GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
Query: 166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP 225
            KPLFPG     QL  +  ++GTP+  E   + E           ++++ ++   P    
Sbjct: 216 GKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQ 275
Query: 226 SAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
             IDL+  ML FDP +RI+  DA+ HPY   L
Sbjct: 276 EGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  168 bits (425), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 82/212 (38%), Positives = 125/212 (58%), Gaps = 2/212 (0%)
Query: 48  IAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           + +E M+ DL +++  N+  L +   + +LYQ+LRG+ + H   +LHRDLKP NLL+N++
Sbjct: 96  LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD 155
Query: 107 CDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             LK+ DFGLAR         T  VVT WYRAP++L+ S  Y+ ++D+WS+GCIF E++ 
Sbjct: 156 GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
Query: 166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP 225
            KPLFPG     QL  +  ++GTP+  E   + E           ++++ ++   P    
Sbjct: 216 GKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQ 275
Query: 226 SAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
             IDL+  ML FDP +RI+  DA+ HPY   L
Sbjct: 276 EGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 70  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 243
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 244 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 70  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 243
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 244 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 235
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLS 117
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 235
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  164 bits (414), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 235
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  164 bits (414), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  164 bits (414), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 64  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 178
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 237
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  163 bits (413), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 67  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 240
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 241 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 95/241 (39%), Positives = 133/241 (55%), Gaps = 28/241 (11%)
Query: 26  TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLK 84
           +++V + D+I   +R     + + +E +D DL +++      L     + FL Q+L G+ 
Sbjct: 60  SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT WYRAP++L+ 
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
           S  Y+  ID+WSVGCIF E+++  PLFPG     QL  +  ++GTP          N+K 
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP----------NSKN 224
Query: 204 Y--ICQLPRYQRQSFT--EKFP------NVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
           +  + +LP+Y   +FT  E  P       +  S IDL+ KML  DP QRIT + AL H Y
Sbjct: 225 WPNVTELPKYD-PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
Query: 254 L 254
Sbjct: 284 F 284

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 95/241 (39%), Positives = 133/241 (55%), Gaps = 28/241 (11%)
Query: 26  TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLK 84
           +++V + D+I   +R     + + +E +D DL +++      L     + FL Q+L G+ 
Sbjct: 60  SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT WYRAP++L+ 
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
           S  Y+  ID+WSVGCIF E+++  PLFPG     QL  +  ++GTP          N+K 
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTP----------NSKN 224
Query: 204 Y--ICQLPRYQRQSFT--EKFP------NVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
           +  + +LP+Y   +FT  E  P       +  S IDL+ KML  DP QRIT + AL H Y
Sbjct: 225 WPNVTELPKYD-PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
Query: 254 L 254
Sbjct: 284 F 284

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +D DL + + ++    +     + +L+Q+L+GL 
Sbjct: 66  NIVKLLDVI-----HTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 239
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 66  NIVKLLDVI-----HTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 121 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 239
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 64  NIVKLLDVI-----HTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 237
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 94/241 (39%), Positives = 133/241 (55%), Gaps = 28/241 (11%)
Query: 26  TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLK 84
           +++V + D+I   +R     + + +E +D DL +++      L     + FL Q+L G+ 
Sbjct: 60  SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT WYRAP++L+ 
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
           S  Y+  ID+WSVGCIF E+++  PLFPG     QL  +  ++GTP          N+K 
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP----------NSKN 224
Query: 204 Y--ICQLPRYQRQSFT--EKFP------NVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
           +  + +LP+Y   +FT  E  P       +  S IDL+ KML  DP QRIT + AL H Y
Sbjct: 225 WPNVTELPKYD-PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
Query: 254 L 254
Sbjct: 284 F 284

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 67  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 181
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 240
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 241 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 65  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 238
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 239 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 235
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 66  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 239
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 65  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 238
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 239 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 235
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 64  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 237
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 65  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 120 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 238
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 239 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 66  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 239
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L+GL 
Sbjct: 65  NIVKLLDVI-----HTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 238
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 239 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 64  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 237
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 64  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 237
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L+GL 
Sbjct: 66  NIVKLLDVI-----HTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 239
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 93/251 (37%), Positives = 138/251 (54%), Gaps = 23/251 (9%)
Query: 14  VRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHC 72
           +R  C    +   ++V + D++      S   + + +E  D DL +   S N  L  E  
Sbjct: 49  LREICLLKELKHKNIVRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIV 103
Query: 73  QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVV 131
           + FL+Q+L+GL + HS NVLHRDLKP NLL+N N +LK+ DFGLAR         +  VV
Sbjct: 104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV 163
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPS 190
           T WYR P++L  +  Y+ +ID+WS GCIF EL +  +PLFPG D   QL+ +  L+GTP+
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPT 223
Query: 191 EAELGFLNENAKKYICQLPRYQ-------RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
           E +           + +LP Y+         S     P ++ +  DL++ +L  +P QRI
Sbjct: 224 EEQW--------PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275
Query: 244 TVEDALAHPYL 254
           + E+AL HPY 
Sbjct: 276 SAEEALQHPYF 286

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  161 bits (407), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 132/231 (57%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L+GL 
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL 
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 235
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  160 bits (406), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L+GL 
Sbjct: 66  NIVKLLDVI-----HTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 239
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  160 bits (406), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 131/231 (56%), Gaps = 9/231 (3%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           ++V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L+GL 
Sbjct: 63  NIVKLLDVI-----HTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLN 143
           + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE+LL 
Sbjct: 118 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  +   
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPD 236
Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 92/251 (36%), Positives = 138/251 (54%), Gaps = 23/251 (9%)
Query: 14  VRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHC 72
           +R  C    +   ++V + D++      S   + + +E  D DL +   S N  L  E  
Sbjct: 49  LREICLLKELKHKNIVRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIV 103
Query: 73  QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVV 131
           + FL+Q+L+GL + HS NVLHRDLKP NLL+N N +LK+ +FGLAR         +  VV
Sbjct: 104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV 163
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPS 190
           T WYR P++L  +  Y+ +ID+WS GCIF EL +  +PLFPG D   QL+ +  L+GTP+
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223
Query: 191 EAELGFLNENAKKYICQLPRYQ-------RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
           E +           + +LP Y+         S     P ++ +  DL++ +L  +P QRI
Sbjct: 224 EEQW--------PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275
Query: 244 TVEDALAHPYL 254
           + E+AL HPY 
Sbjct: 276 SAEEALQHPYF 286

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 142 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 319
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 320 TARLTPLEACAHSFFDELRD 339

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 193 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 370
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 371 TARLTPLEACAHSFFDELRD 390

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 150 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 327
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 328 TARLTPLEACAHSFFDELRD 347

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 152 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 329
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 330 TARLTPLEACAHSFFDELRD 349

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 326 TARLTPLEACAHSFFDELRD 345

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 119 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 179 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 238
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 239 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 296
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 297 TARLTPLEACAHSFFDELRD 316

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 127 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 304
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 305 TARLTPLEACAHSFFDELRD 324

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++    P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--AFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 74/187 (39%), Positives = 117/187 (62%), Gaps = 4/187 (2%)
Query: 73  QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVV 131
           + ++YQ+LR L YIHS  + HRD+KP NLLL+     LK+ DFG A++    +     + 
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC 203
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 191
           +R+YRAPEL+  +++YT  ID+WS GC+  ELM  +PLFPG   + QL  +I+++GTPS 
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263
Query: 192 AELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALA 250
            ++  +N N  ++  + P+ +   F++ F P   P AIDL+ ++L + P  R+T  +AL 
Sbjct: 264 EQIKTMNPNYMEH--KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 251 HPYLGSL 257
           HP+   L
Sbjct: 322 HPFFDEL 328

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 122 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 299
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 300 TARLTPLEACAHSFFDELRD 319

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 115 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 175 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 234
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 235 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 292
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 293 TARLTPLEACAHSFFDELRD 312

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 326 TARLTPLEACAHSFFDELRD 345

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 126 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 303
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 304 TARLTPLEACAHSFFDELRD 323

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 126 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 303
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 304 TARLTPLEACAHSFFDELRD 323

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 142/232 (61%), Gaps = 6/232 (2%)
Query: 32  RDIIPPPQRESFNDVYIAY--ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA 89
           + +I  P +  + +V + Y  + +   L   IRS +++       ++YQ+ R + +IHS 
Sbjct: 101 KSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160
Query: 90  NVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYT 148
            + HRD+KP NLL+N+  + LK+CDFG A+    ++     + +R+YRAPEL+L +++YT
Sbjct: 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYT 220
Query: 149 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL 208
            +ID+WS+GC+F EL+  KPLF G   + QL  +I+++GTP++ ++  +N +  +   + 
Sbjct: 221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE--VRF 278
Query: 209 PRYQRQSFTEKFPNVHPS-AIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 259
           P  + + + +  P   PS AIDL+E++L ++P  RI   +A+AHP+   L +
Sbjct: 279 PTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 133 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 310
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 311 TARLTPLEACAHSFFDELRD 330

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 118 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 178 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 237
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 238 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 295
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 296 TARLTPLEACAHSFFDELRD 315

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 121/200 (60%), Gaps = 4/200 (2%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 120
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 121 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 239
            +I+++GTP+  ++  +N N  ++    P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--AFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 240 RQRITVEDALAHPYLGSLHD 259
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 92/238 (38%), Positives = 137/238 (57%), Gaps = 16/238 (6%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLK 84
           +VV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LRGL 
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 144
           ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+LL S
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
           S Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E       E+  + 
Sbjct: 195 S-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------EDWPRD 246
Query: 205 ICQLPRYQRQSFT----EKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
           +  LPR    S +    EKF  ++     DL+ K LTF+P +RI+   AL+HPY   L
Sbjct: 247 VA-LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 92/238 (38%), Positives = 137/238 (57%), Gaps = 16/238 (6%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLK 84
           +VV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LRGL 
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 144
           ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+LL S
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
           S Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E       E+  + 
Sbjct: 195 S-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------EDWPRD 246
Query: 205 ICQLPRYQRQSFT----EKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
           +  LPR    S +    EKF  ++     DL+ K LTF+P +RI+   AL+HPY   L
Sbjct: 247 VA-LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 91/235 (38%), Positives = 136/235 (57%), Gaps = 16/235 (6%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLK 84
           +VV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LRGL 
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 144
           ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+LL S
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
           S Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E       E+  + 
Sbjct: 195 S-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------EDWPRD 246
Query: 205 ICQLPRYQRQSFT----EKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +  LPR    S +    EKF  ++     DL+ K LTF+P +RI+   AL+HPY 
Sbjct: 247 VA-LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 86/243 (35%), Positives = 137/243 (56%), Gaps = 24/243 (9%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN------QALSEEHCQYFLYQIL 80
           ++V + D+I      + N + + +E MD DL + + S       + L     +YF +Q+L
Sbjct: 64  NIVRLYDVI-----HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 81  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 139
           +GL + H   +LHRDLKP NLL+N    LK+ DFGLAR      +  +  VVT WYRAP+
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 140 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEA------E 193
           +L+ S  Y+ +ID+WS GCI  E++  KPLFPG +   QL+L+ +++GTP+E+      +
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238
Query: 194 LGFLNENAKKYICQLPRYQRQSFT--EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
           L   N N ++   + PR  RQ      K P +  + +D +  +L  +P  R++ + AL H
Sbjct: 239 LPKYNPNIQQ---RPPRDLRQVLQPHTKEP-LDGNLMDFLHGLLQLNPDMRLSAKQALHH 294
Query: 252 PYL 254
           P+ 
Sbjct: 295 PWF 297

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 76/220 (34%), Positives = 126/220 (57%), Gaps = 3/220 (1%)
Query: 46  VYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           +++ +E  D T LH++ R  + + E   +   +Q L+ + + H  N +HRD+KP N+L+ 
Sbjct: 77  LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT 136
Query: 105 ANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            +  +K+CDFG AR+ T  +D+  + V TRWYR+PELL+  + Y   +DVW++GC+F EL
Sbjct: 137 KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAEL 196
Query: 164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE-KFPN 222
           +   PL+PG+  V QL L+ + +G          + N      ++P  +     E KFPN
Sbjct: 197 LSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPN 256
Query: 223 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 262
           +   A+ L++  L  DP +R+T E  L HPY  ++ +I D
Sbjct: 257 ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  148 bits (373), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 83/221 (37%), Positives = 121/221 (54%), Gaps = 16/221 (7%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +++ + ++ M+TDL  II+ N   L+  H + ++   L+GL+Y+H   +LHRDLKP+NLL
Sbjct: 85  SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL 144
Query: 103 LNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
           L+ N  LK+ DFGLA+   S        VVTRWYRAPELL  +  Y   +D+W+VGCI  
Sbjct: 145 LDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA 204
Query: 162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR-QSFT--- 217
           EL+ R P  PG   + QL  + E +GTP+E +           +C LP Y   +SF    
Sbjct: 205 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW--------PDMCSLPDYVTFKSFPGIP 256
Query: 218 --EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
               F       +DL++ +  F+P  RIT   AL   Y  +
Sbjct: 257 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  144 bits (363), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 84/230 (36%), Positives = 123/230 (53%), Gaps = 6/230 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           +VV + D+    + +    V + +E +D DL   +       L  E  +  + Q LRGL 
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 144
           ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +T  VVT WYRAPE+LL S
Sbjct: 135 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQS 194
Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
           + Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +      +    
Sbjct: 195 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD---WPRDVSLP 250
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
               P    +      P +  S   L+ +MLTF+P +RI+   AL H YL
Sbjct: 251 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/230 (36%), Positives = 122/230 (53%), Gaps = 6/230 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           +VV + D+    + +    V + +E +D DL   +       L  E  +  + Q LRGL 
Sbjct: 67  NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 126
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 144
           ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +   VVT WYRAPE+LL S
Sbjct: 127 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQS 186
Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
           + Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +      +    
Sbjct: 187 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD---WPRDVSLP 242
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
               P    +      P +  S   L+ +MLTF+P +RI+   AL H YL
Sbjct: 243 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/230 (36%), Positives = 122/230 (53%), Gaps = 6/230 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           +VV + D+    + +    V + +E +D DL   +       L  E  +  + Q LRGL 
Sbjct: 67  NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 126
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 144
           ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +   VVT WYRAPE+LL S
Sbjct: 127 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQS 186
Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
           + Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +      +    
Sbjct: 187 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD---WPRDVSLP 242
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
               P    +      P +  S   L+ +MLTF+P +RI+   AL H YL
Sbjct: 243 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/230 (36%), Positives = 122/230 (53%), Gaps = 6/230 (2%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLK 84
           +VV + D+    + +    V + +E +D DL   +       L  E  +  + Q LRGL 
Sbjct: 67  NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 126
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 144
           ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +   VVT WYRAPE+LL S
Sbjct: 127 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQS 186
Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
           + Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +      +    
Sbjct: 187 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD---WPRDVSLP 242
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
               P    +      P +  S   L+ +MLTF+P +RI+   AL H YL
Sbjct: 243 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 74/213 (34%), Positives = 119/213 (55%), Gaps = 7/213 (3%)
Query: 47  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           Y+ +E +D T L  +      L  +  Q +L+QI+ G+ + HS N++HRD+KP N+L++ 
Sbjct: 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ 159
Query: 106 NCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  +K+CDFG AR + +  +   + V TRWYRAPELL+    Y  A+DVW++GC+  E+ 
Sbjct: 160 SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219
Query: 165 DRKPLFPGRDHVHQLRLLIELIGT--PSEAELGFLNENAKKYICQLPRY-QRQSFTEKFP 221
             +PLFPG   + QL  ++  +G   P   EL   N+N      +LP   +R+    ++P
Sbjct: 220 MGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL--FNKNPVFAGVRLPEIKEREPLERRYP 277
Query: 222 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +    IDL +K L  DP +R    + L H + 
Sbjct: 278 KLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 113/196 (57%), Gaps = 13/196 (6%)
Query: 73  QYFLYQILRGLKYIH--SANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEY 129
           + FL+Q++R +  +H  S NV HRD+KP N+L+N A+  LK+CDFG A+  S ++    Y
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 189
           + +R+YRAPEL+  +  YT A+D+WSVGCIF E+M  +P+F G +   QL  ++ ++G P
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251
Query: 190 SEAELGFLNENAKKYICQLPRYQRQS------FTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
           S   L  LN +       +  Y  +       F++        A DL+  +L + P +R+
Sbjct: 252 SREVLRKLNPSHT----DVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307
Query: 244 TVEDALAHPYLGSLHD 259
              +AL HPY   LHD
Sbjct: 308 KPYEALCHPYFDELHD 323

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 75/228 (32%), Positives = 117/228 (51%), Gaps = 32/228 (14%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           +++ +E  + DL + +  N  +S    + FLYQ++ G+ + HS   LHRDLKP NLLL+ 
Sbjct: 108 LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV 167
Query: 106 NCD-----LKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           +       LKI DFGLAR         T  ++T WYR PE+LL S  Y+ ++D+WS+ CI
Sbjct: 168 SDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACI 227
Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
           + E++ + PLFPG   + QL  + E++G P        ++     +  LP ++     + 
Sbjct: 228 WAEMLMKTPLFPGDSEIDQLFKIFEVLGLP--------DDTTWPGVTALPDWK-----QS 274
Query: 220 FPNVHPSAIDLV-------------EKMLTFDPRQRITVEDALAHPYL 254
           FP      +  V               ML  DP +RI+ ++AL HPY 
Sbjct: 275 FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 117/229 (51%), Gaps = 12/229 (5%)
Query: 38  PQRESFNDVYIAYELMDTDLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHR 94
           P       +Y+ ++  + DL  ++ +      LSE   +  +  +L GL YIH   +LHR
Sbjct: 92  PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIHRNKILHR 149
Query: 95  DLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVVTRWYRAPELLLNSSDYTA 149
           D+K +N+L+  +  LK+ DFGLAR       S+ +     VVT WYR PELLL   DY  
Sbjct: 150 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGP 209
Query: 150 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 209
            ID+W  GCI  E+  R P+  G    HQL L+ +L G+ +      ++        +L 
Sbjct: 210 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 269
Query: 210 RYQRQSFTEKFPNV--HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           + Q++   ++       P A+DL++K+L  DP QRI  +DAL H +  S
Sbjct: 270 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 318

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 117/229 (51%), Gaps = 12/229 (5%)
Query: 38  PQRESFNDVYIAYELMDTDLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHR 94
           P       +Y+ ++  + DL  ++ +      LSE   +  +  +L GL YIH   +LHR
Sbjct: 91  PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIHRNKILHR 148
Query: 95  DLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVVTRWYRAPELLLNSSDYTA 149
           D+K +N+L+  +  LK+ DFGLAR       S+ +     VVT WYR PELLL   DY  
Sbjct: 149 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGP 208
Query: 150 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 209
            ID+W  GCI  E+  R P+  G    HQL L+ +L G+ +      ++        +L 
Sbjct: 209 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 268
Query: 210 RYQRQSFTEKFPNV--HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           + Q++   ++       P A+DL++K+L  DP QRI  +DAL H +  S
Sbjct: 269 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 117/229 (51%), Gaps = 12/229 (5%)
Query: 38  PQRESFNDVYIAYELMDTDLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHR 94
           P       +Y+ ++  + DL  ++ +      LSE   +  +  +L GL YIH   +LHR
Sbjct: 92  PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIHRNKILHR 149
Query: 95  DLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVVTRWYRAPELLLNSSDYTA 149
           D+K +N+L+  +  LK+ DFGLAR       S+ +     VVT WYR PELLL   DY  
Sbjct: 150 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGP 209
Query: 150 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 209
            ID+W  GCI  E+  R P+  G    HQL L+ +L G+ +      ++        +L 
Sbjct: 210 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 269
Query: 210 RYQRQSFTEKFPNV--HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           + Q++   ++       P A+DL++K+L  DP QRI  +DAL H +  S
Sbjct: 270 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 318

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  128 bits (321), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 75/221 (33%), Positives = 116/221 (52%), Gaps = 12/221 (5%)
Query: 46  VYIAYELMDTDLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +Y+ ++  + DL  ++ +      LSE   +  +  +L GL YIH   +LHRD+K +N+L
Sbjct: 100 IYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIHRNKILHRDMKAANVL 157
Query: 103 LNANCDLKICDFGLARV-----TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           +  +  LK+ DFGLAR       S+ +     VVT WYR PELLL   DY   ID+W  G
Sbjct: 158 ITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAG 217
Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
           CI  E+  R P+  G    HQL L+ +L G+ +      ++        +L + Q++   
Sbjct: 218 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 277
Query: 218 EKFPNV--HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           ++       P A+DL++K+L  DP QRI  +DAL H +  S
Sbjct: 278 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 318

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  124 bits (310), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 84/247 (34%), Positives = 129/247 (52%), Gaps = 42/247 (17%)
Query: 46  VYIAYELMDTDLHQIIRSNQA---------LSEEHCQYFLYQILRGLKYIHSANVLHRDL 96
           V++ ++  + DL  II+ ++A         L     +  LYQIL G+ Y+H+  VLHRDL
Sbjct: 95  VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 154
Query: 97  KPSNLLLNANCD----LKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYT 148
           KP+N+L+         +KI D G AR+ +        +   VVT WYRAPELLL +  YT
Sbjct: 155 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 214
Query: 149 AAIDVWSVGCIFMELMDRKPLFPGRD---------HVHQLRLLIELIGTPSEAELGFLNE 199
            AID+W++GCIF EL+  +P+F  R          H  QL  +  ++G P++ +     E
Sbjct: 215 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDW----E 270
Query: 200 NAKK---YICQLPRYQRQSFTE----KFPNVHP-----SAIDLVEKMLTFDPRQRITVED 247
           + KK   +   +  ++R ++T     K+   H       A  L++K+LT DP +RIT E 
Sbjct: 271 DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330
Query: 248 ALAHPYL 254
           A+  PY 
Sbjct: 331 AMQDPYF 337

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 66  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 124
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 142 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 201
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 183
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 202 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 261
Query: 184 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 229
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 262 KVLGTDG------LNAYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 314
Query: 230 LVEKMLTFDPRQRITVEDALAHPYL 254
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 315 FLDKLLRYDHQERLTALEAMTHPYF 339

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 138/244 (56%), Gaps = 26/244 (10%)
Query: 26  TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           T+++ + D +  P  ++   V+    + +TD  Q+    Q L++   ++++Y++L+ L Y
Sbjct: 93  TNIIKLIDTVKDPVSKTPALVFEY--INNTDFKQLY---QILTDFDIRFYMYELLKALDY 147
Query: 86  IHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 144
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 148 CHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDY 207
Query: 145 SDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
             Y  ++D+WS+GC+   ++  R+P F G+D+  QL  + +++GT  E   G+L    KK
Sbjct: 208 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYL----KK 261
Query: 204 Y-----------ICQLPRYQRQSF--TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA 250
           Y           + Q  R + ++F  +E    V P A+DL++K+L +D +QR+T ++A+ 
Sbjct: 262 YHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAME 321
Query: 251 HPYL 254
           HPY 
Sbjct: 322 HPYF 325

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 45  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 158
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 148 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 208 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 242
Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 45  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 87  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 146
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 158
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 147 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 206
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 207 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 241
Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 242 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 138/244 (56%), Gaps = 26/244 (10%)
Query: 26  TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           T+++ + D +  P  ++   V+    + +TD  Q+    Q L++   ++++Y++L+ L Y
Sbjct: 98  TNIIKLIDTVKDPVSKTPALVFEY--INNTDFKQLY---QILTDFDIRFYMYELLKALDY 152
Query: 86  IHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 144
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 153 CHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDY 212
Query: 145 SDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
             Y  ++D+WS+GC+   ++  R+P F G+D+  QL  + +++GT  E   G+L    KK
Sbjct: 213 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYL----KK 266
Query: 204 Y-----------ICQLPRYQRQSF--TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA 250
           Y           + Q  R + ++F  +E    V P A+DL++K+L +D +QR+T ++A+ 
Sbjct: 267 YHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAME 326
Query: 251 HPYL 254
           HPY 
Sbjct: 327 HPYF 330

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 45  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 158
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 148 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 208 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 242
Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 45  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 94  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 153
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 158
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 154 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 213
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 214 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 248
Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 249 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 45  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 158
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 148 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 208 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 242
Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 66  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 124
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 183
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 184 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 229
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 230 LVEKMLTFDPRQRITVEDALAHPYL 254
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 66  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 124
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 183
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 184 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 229
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 230 LVEKMLTFDPRQRITVEDALAHPYL 254
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 66  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 124
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 183
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 184 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 229
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 230 LVEKMLTFDPRQRITVEDALAHPYL 254
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 66  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 124
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 183
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 184 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 229
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 230 LVEKMLTFDPRQRITVEDALAHPYL 254
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 66  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 124
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 183
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 184 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 229
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 242 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 294
Query: 230 LVEKMLTFDPRQRITVEDALAHPYL 254
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 295 FLDKLLRYDHQERLTALEAMTHPYF 319

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 66  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 124
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 183
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 184 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 229
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 230 LVEKMLTFDPRQRITVEDALAHPYL 254
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 66  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 124
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 183
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 184 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 229
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 230 LVEKMLTFDPRQRITVEDALAHPYL 254
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 66  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 124
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 183
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 184 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 229
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 242 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 294
Query: 230 LVEKMLTFDPRQRITVEDALAHPYL 254
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 295 FLDKLLRYDHQERLTALEAMTHPYF 319

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 66  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 124
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 123 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 182
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 183
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 183 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 242
Query: 184 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 229
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 243 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 295
Query: 230 LVEKMLTFDPRQRITVEDALAHPYL 254
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 296 FLDKLLRYDHQERLTALEAMTHPYF 320

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 113/216 (52%), Gaps = 31/216 (14%)
Query: 45  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 227 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 286
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 158
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 287 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 346
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           I    +   P  P  +H  Q+ L  ++    +  +  F+                    E
Sbjct: 347 ILFICLSGYP--PFSEHRTQVSLKDQI----TSGKYNFI-------------------PE 381
Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 382 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 113/216 (52%), Gaps = 31/216 (14%)
Query: 45  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 272
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 158
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 273 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           I    +   P  P  +H  Q+ L  ++    +  +  F+                    E
Sbjct: 333 ILFICLSGYP--PFSEHRTQVSLKDQI----TSGKYNFI-------------------PE 367
Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N+L++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 252 PYL 254
           PY 
Sbjct: 322 PYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 252 PYL 254
           PY 
Sbjct: 322 PYF 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQL---RQTLTDYDIRFYMYEILKALDYC 147
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 252 PYL 254
           PY 
Sbjct: 322 PYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 252 PYL 254
           PY 
Sbjct: 322 PYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 252 PYL 254
           PY 
Sbjct: 322 PYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 252 PYL 254
           PY 
Sbjct: 322 PYF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 98  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 152
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 153 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 266
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 267 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 326
Query: 252 PYL 254
           PY 
Sbjct: 327 PYF 329

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 252 PYL 254
           PY 
Sbjct: 322 PYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 252 PYL 254
           PY 
Sbjct: 322 PYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 92  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 146
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 260
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 252 PYL 254
           PY 
Sbjct: 321 PYF 323

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 91  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 145
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 259
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319
Query: 252 PYL 254
           PY 
Sbjct: 320 PYF 322

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 92  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 146
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 260
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 252 PYL 254
           PY 
Sbjct: 321 PYF 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 252 PYL 254
           PY 
Sbjct: 322 PYF 324

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 252 PYL 254
           PY 
Sbjct: 322 PYF 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 87  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 205 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 252 PYL 254
           PY 
Sbjct: 322 PYF 324

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/245 (31%), Positives = 120/245 (48%), Gaps = 38/245 (15%)
Query: 44  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           N + + +EL+  +L+++I+ N  Q  S    + F + IL+ L  +H   ++H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 102 LLN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           LL       +K+ DFG +    E   +   + +R+YRAPE++L +  Y   ID+WS+GCI
Sbjct: 232 LLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCI 288
Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ--LPRY------ 211
             EL+   PL PG D   QL  +IEL+G PS+  L   ++ AK ++     PRY      
Sbjct: 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD-ASKRAKNFVSXKGYPRYCTVTTL 347
Query: 212 -----------QRQSFTEKFPNVH-----------PSAIDLVEKMLTFDPRQRITVEDAL 249
                       R+      P              P  +D +++ L +DP  R+T   AL
Sbjct: 348 SDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407
Query: 250 AHPYL 254
            HP+L
Sbjct: 408 RHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/245 (31%), Positives = 120/245 (48%), Gaps = 38/245 (15%)
Query: 44  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           N + + +EL+  +L+++I+ N  Q  S    + F + IL+ L  +H   ++H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 102 LLN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           LL       +K+ DFG +    E   +   + +R+YRAPE++L +  Y   ID+WS+GCI
Sbjct: 232 LLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCI 288
Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ--LPRY------ 211
             EL+   PL PG D   QL  +IEL+G PS+  L   ++ AK ++     PRY      
Sbjct: 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD-ASKRAKNFVSXKGYPRYCTVTTL 347
Query: 212 -----------QRQSFTEKFPNVH-----------PSAIDLVEKMLTFDPRQRITVEDAL 249
                       R+      P              P  +D +++ L +DP  R+T   AL
Sbjct: 348 SDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407
Query: 250 AHPYL 254
            HP+L
Sbjct: 408 RHPWL 412

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
            ++Y   EL D    +II+  +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL
Sbjct: 100 GELYTGGELFD----EIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            +   +CD+KI DFGL+    +   M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 155 ESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVIL 212
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
             L+   P F G++    L+            E G       KY   LP+++        
Sbjct: 213 YILLSGTPPFYGKNEYDILK----------RVETG-------KYAFDLPQWR-------- 247
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             +   A DL+ KMLTF P  RIT    L HP++
Sbjct: 248 -TISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 38/245 (15%)
Query: 44  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           N + + +EL+  +L+++I+ N  Q  S    + F + IL+ L  +H   ++H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 102 LLN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           LL       +K+ DFG +    E   +   + +R+YRAPE++L +  Y   ID+WS+GCI
Sbjct: 232 LLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRAPEVILGAR-YGMPIDMWSLGCI 288
Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ--LPRY------ 211
             EL+   PL PG D   QL  +IEL+G P +  L   ++ AK ++     PRY      
Sbjct: 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLD-ASKRAKNFVSXKGYPRYCTVTTL 347
Query: 212 -----------QRQSFTEKFPNVH-----------PSAIDLVEKMLTFDPRQRITVEDAL 249
                       R+      P              P  +D +++ L +DP  R+T   AL
Sbjct: 348 SDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407
Query: 250 AHPYL 254
            HP+L
Sbjct: 408 RHPWL 412

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  107 bits (267), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
            ++Y   EL D    +II+  +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL
Sbjct: 100 GELYTGGELFD----EIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            +   +CD+KI DFGL+    +   M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 155 ESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVIL 212
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
             L+   P F G++    L+            E G       KY   LP+++        
Sbjct: 213 YILLSGTPPFYGKNEYDILK----------RVETG-------KYAFDLPQWR-------- 247
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             +   A DL+ KMLTF P  RIT    L HP++
Sbjct: 248 -TISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
            ++Y   EL D    +II+  +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL
Sbjct: 100 GELYTGGELFD----EIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            +   +CD+KI DFGL+    +   M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 155 ESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVIL 212
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
             L+   P F G++    L+            E G       KY   LP+++        
Sbjct: 213 YILLSGTPPFYGKNEYDILK----------RVETG-------KYAFDLPQWR-------- 247
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             +   A DL+ KMLTF P  RIT    L HP++
Sbjct: 248 -TISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 36/211 (17%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA- 105
           Y   EL D  +H++       +E      + Q+L G+ Y+H  N++HRDLKP NLLL + 
Sbjct: 118 YKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 106 --NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
             +  +KI DFGL+ V      M E + T +Y APE+L     Y    DVWS+G I   L
Sbjct: 173 EKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL--RKKYDEKCDVWSIGVILFIL 230
Query: 164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV 223
           +   P F G+     LR          + E G       KY    P ++         NV
Sbjct: 231 LAGYPPFGGQTDQEILR----------KVEKG-------KYTFDSPEWK---------NV 264
Query: 224 HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              A DL+++ML FD ++RI+ + AL HP++
Sbjct: 265 SEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
            +VY   EL D      I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 128 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 182
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            +   + +++I DFGL+     +  M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 183 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 240
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 241 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 276
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             V  SA DL+ KMLT+ P  RI+  DAL H ++
Sbjct: 277 --VSESAKDLIRKMLTYVPSMRISARDALDHEWI 308

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
            +VY   EL D      I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 129 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 183
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            +   + +++I DFGL+     +  M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 184 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 241
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 242 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 277
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             V  SA DL+ KMLT+ P  RI+  DAL H ++
Sbjct: 278 --VSESAKDLIRKMLTYVPSMRISARDALDHEWI 309

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
            +VY   EL D      I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 105 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            +   + +++I DFGL+     +  M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 217
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 218 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 253
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             V  SA DL+ KMLT+ P  RI+  DAL H ++
Sbjct: 254 --VSESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
            +VY   EL D      I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 111 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 165
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            +   + +++I DFGL+     +  M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 166 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 223
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 224 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 259
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             V  SA DL+ KMLT+ P  RI+  DAL H ++
Sbjct: 260 --VSESAKDLIRKMLTYVPSMRISARDALDHEWI 291

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           ES + +++ ++LM   +L   +    ALSE+  +  +  +L  + ++H+ N++HRDLKP 
Sbjct: 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPE 229
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD-----YTAAIDVW 154
           N+LL+ N  +++ DFG +      + + E   T  Y APE+L  S D     Y   +D+W
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289
Query: 155 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ 214
           + G I   L+   P F  R  +  LR+++E                  +Y    P +  +
Sbjct: 290 ACGVILFTLLAGSPPFWHRRQILMLRMIME-----------------GQYQFSSPEWDDR 332
Query: 215 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           S T K         DL+ ++L  DP  R+T E AL HP+ 
Sbjct: 333 SSTVK---------DLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
            +VY   EL D      I S +  SE      + Q+L G+ Y H   ++HRDLKP NLLL
Sbjct: 105 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLL 159
Query: 104 NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            +   + +++I DFGL+     +    + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 217
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 218 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 253
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             V  SA DL+ K LT+ P  RI+  DAL H ++
Sbjct: 254 --VSESAKDLIRKXLTYVPSXRISARDALDHEWI 285

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 116/258 (44%), Gaps = 53/258 (20%)
Query: 45  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           +VY   EL D     I+R  Q  SE      + Q+L G  Y+H  N++HRDLKP NLLL 
Sbjct: 84  EVYRGGELFD---EIILR--QKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLE 138
Query: 105 ANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
           +      +KI DFGL+        M E + T +Y APE+L     Y    DVWS G I  
Sbjct: 139 SKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVILY 196
Query: 162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 221
            L+   P F G+                ++ E+             L R ++  F+   P
Sbjct: 197 ILLCGYPPFGGQ----------------TDQEI-------------LKRVEKGKFSFDPP 227
Query: 222 N---VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHA 278
           +   V   A  LV+ MLT++P +RI+ E+AL HP++           C    + D  +HA
Sbjct: 228 DWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKF--------CSQKHT-DVGKHA 278
Query: 279 LTE--GQMKELIYQEALA 294
           LT   G MK+    + LA
Sbjct: 279 LTGALGNMKKFQSSQKLA 296

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 117/253 (46%), Gaps = 40/253 (15%)
Query: 41  ESFNDVYIAYELMDTDLHQIIRSNQAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           E    + I +EL+    +  I+ N  L    +H +   YQI + + ++HS  + H DLKP
Sbjct: 87  EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKP 146
Query: 99  SNLLLNA-------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 139
            N+L                      N D+K+ DFG A  T + +  +  V TR YRAPE
Sbjct: 147 ENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPE 204
Query: 140 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-------TPSEA 192
           ++L +  ++   DVWS+GCI +E      +FP  D    L ++  ++G         +  
Sbjct: 205 VIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRK 263
Query: 193 ELGFLNE--------NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT 244
              F ++        +A +Y+ +  +  ++ F       H    DL++KML +DP +RIT
Sbjct: 264 RKYFHHDRLDWDEHSSAGRYVSRACKPLKE-FMLSQDVEHERLFDLIQKMLEYDPAKRIT 322
Query: 245 VEDALAHPYLGSL 257
           + +AL HP+   L
Sbjct: 323 LREALKHPFFDLL 335

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 48/250 (19%)
Query: 48  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL-LN 104
           IA+EL+  +  + ++ N  Q     H ++  YQ+   L+++H   + H DLKP N+L +N
Sbjct: 108 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 167
Query: 105 A------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           +                  N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 168 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 224
Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSEA-----------EL 194
           +    DVWS+GCI  E      LF   ++   L ++ +++G  PS             + 
Sbjct: 225 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 284
Query: 195 GFL---NENAKKYI---CQ-LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 247
           G +   N +  +Y+   C+ L  Y  Q   E     H    DL+ +ML FDP QRIT+ +
Sbjct: 285 GLVWDENSSDGRYVKENCKPLKSYMLQDSLE-----HVQLFDLMRRMLEFDPAQRITLAE 339
Query: 248 ALAHPYLGSL 257
           AL HP+   L
Sbjct: 340 ALLHPFFAGL 349

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 118/252 (46%), Gaps = 42/252 (16%)
Query: 44  ND-VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           ND V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  NL
Sbjct: 93  NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 152
Query: 102 LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GCI 
Sbjct: 153 FLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 211
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFT 217
             L+  KP F                      E   L E     KK    +P++      
Sbjct: 212 YTLLVGKPPF----------------------ETSCLKETYLRIKKNEYSIPKH------ 243
Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV-CMS-PFSFDFE 275
                ++P A  L++KML  DP  R T+ + L   +  S +  +  P+ C++ P  F   
Sbjct: 244 -----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 298
Query: 276 QHALTEGQMKEL 287
             +L     K L
Sbjct: 299 PSSLDPSNRKPL 310

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 47  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           Y+ ++L+   +L + I + +  SE    + ++QIL  + +IH  +++HRDLKP NLLL +
Sbjct: 106 YLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLAS 165
Query: 106 NCD---LKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
            C    +K+ DFGLA  V  E      +  T  Y +PE+L     Y   +D+W+ G I  
Sbjct: 166 KCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDIWACGVI-- 222
Query: 162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 221
                              L I L+G P      F +E+  K   Q+        + ++ 
Sbjct: 223 -------------------LYILLVGYPP-----FWDEDQHKLYQQIKAGAYDFPSPEWD 258
Query: 222 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            V P A +L+ +MLT +P +RIT + AL HP++
Sbjct: 259 TVTPEAKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 48/250 (19%)
Query: 48  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL-LN 104
           IA+EL+  +  + ++ N  Q     H ++  YQ+   L+++H   + H DLKP N+L +N
Sbjct: 131 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 190
Query: 105 A------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           +                  N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 191 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 247
Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSEA-----------EL 194
           +    DVWS+GCI  E      LF   ++   L ++ +++G  PS             + 
Sbjct: 248 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 307
Query: 195 GFL---NENAKKYI---CQ-LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 247
           G +   N +  +Y+   C+ L  Y  Q   E     H    DL+ +ML FDP QRIT+ +
Sbjct: 308 GLVWDENSSDGRYVKENCKPLKSYMLQDSLE-----HVQLFDLMRRMLEFDPAQRITLAE 362
Query: 248 ALAHPYLGSL 257
           AL HP+   L
Sbjct: 363 ALLHPFFAGL 372

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 101/216 (46%), Gaps = 42/216 (19%)
Query: 45  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           +VY   EL D     I+R  Q  SE      + Q+L G  Y+H  N++HRDLKP NLLL 
Sbjct: 101 EVYRGGELFD---EIILR--QKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLE 155
Query: 105 ANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
           +      +KI DFGL+        M E + T +Y APE+L     Y    DVWS G I  
Sbjct: 156 SKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVILY 213
Query: 162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 221
            L+   P F G+                ++ E+             L R ++  F+   P
Sbjct: 214 ILLCGYPPFGGQ----------------TDQEI-------------LKRVEKGKFSFDPP 244
Query: 222 N---VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +   V   A  LV+ MLT++P +RI+ E+AL HP++
Sbjct: 245 DWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 118/252 (46%), Gaps = 42/252 (16%)
Query: 44  ND-VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           ND V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  NL
Sbjct: 89  NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 148
Query: 102 LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GCI 
Sbjct: 149 FLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 207
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFT 217
             L+  KP F                      E   L E     KK    +P++      
Sbjct: 208 YTLLVGKPPF----------------------ETSCLKETYLRIKKNEYSIPKH------ 239
Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV-CMS-PFSFDFE 275
                ++P A  L++KML  DP  R T+ + L   +  S +  +  P+ C++ P  F   
Sbjct: 240 -----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPXFSIA 294
Query: 276 QHALTEGQMKEL 287
             +L     K L
Sbjct: 295 PSSLDPSNRKPL 306

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 48/250 (19%)
Query: 48  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL-LN 104
           IA+EL+  +  + ++ N  Q     H ++  YQ+   L+++H   + H DLKP N+L +N
Sbjct: 99  IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158
Query: 105 A------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           +                  N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 215
Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSEA-----------EL 194
           +    DVWS+GCI  E      LF   ++   L ++ +++G  PS             + 
Sbjct: 216 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 275
Query: 195 GFL---NENAKKYI---CQ-LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 247
           G +   N +  +Y+   C+ L  Y  Q   E     H    DL+ +ML FDP QRIT+ +
Sbjct: 276 GLVWDENSSDGRYVKENCKPLKSYMLQDSLE-----HVQLFDLMRRMLEFDPAQRITLAE 330
Query: 248 ALAHPYLGSL 257
           AL HP+   L
Sbjct: 331 ALLHPFFAGL 340

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 116/253 (45%), Gaps = 40/253 (15%)
Query: 41  ESFNDVYIAYELMDTDLHQIIRSNQAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           E    + I +EL+    +  I+ N  L    +H +   YQI + + ++HS  + H DLKP
Sbjct: 87  EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKP 146
Query: 99  SNLLLNA-------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 139
            N+L                      N D+K+ DFG A  T + +  +  V  R YRAPE
Sbjct: 147 ENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVXXRHYRAPE 204
Query: 140 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-------TPSEA 192
           ++L +  ++   DVWS+GCI +E      +FP  D    L ++  ++G         +  
Sbjct: 205 VIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRK 263
Query: 193 ELGFLNE--------NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT 244
              F ++        +A +Y+ +  +  ++ F       H    DL++KML +DP +RIT
Sbjct: 264 RKYFHHDRLDWDEHSSAGRYVSRACKPLKE-FMLSQDVEHERLFDLIQKMLEYDPAKRIT 322
Query: 245 VEDALAHPYLGSL 257
           + +AL HP+   L
Sbjct: 323 LREALKHPFFDLL 335

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 118/252 (46%), Gaps = 42/252 (16%)
Query: 44  ND-VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           ND V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  NL
Sbjct: 89  NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 148
Query: 102 LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GCI 
Sbjct: 149 FLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 207
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFT 217
             L+  KP F                      E   L E     KK    +P++      
Sbjct: 208 YTLLVGKPPF----------------------ETSCLKETYLRIKKNEYSIPKH------ 239
Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV-CMS-PFSFDFE 275
                ++P A  L++KML  DP  R T+ + L   +  S +  +  P+ C++ P  F   
Sbjct: 240 -----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 294
Query: 276 QHALTEGQMKEL 287
             +L     K L
Sbjct: 295 PSSLDPSNRKPL 306

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 118/252 (46%), Gaps = 42/252 (16%)
Query: 44  ND-VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           ND V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  NL
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 172
Query: 102 LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GCI 
Sbjct: 173 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 231
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFT 217
             L+  KP F                      E   L E     KK    +P++      
Sbjct: 232 YTLLVGKPPF----------------------ETSCLKETYLRIKKNEYSIPKH------ 263
Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV-CMS-PFSFDFE 275
                ++P A  L++KML  DP  R T+ + L   +  S +  +  P+ C++ P  F   
Sbjct: 264 -----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 318
Query: 276 QHALTEGQMKEL 287
             +L     K L
Sbjct: 319 PSSLDPSNRKPL 330

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 118/252 (46%), Gaps = 42/252 (16%)
Query: 44  ND-VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           ND V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  NL
Sbjct: 111 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 170
Query: 102 LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GCI 
Sbjct: 171 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 229
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFT 217
             L+  KP F                      E   L E     KK    +P++      
Sbjct: 230 YTLLVGKPPF----------------------ETSCLKETYLRIKKNEYSIPKH------ 261
Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV-CMS-PFSFDFE 275
                ++P A  L++KML  DP  R T+ + L   +  S +  +  P+ C++ P  F   
Sbjct: 262 -----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 316
Query: 276 QHALTEGQMKEL 287
             +L     K L
Sbjct: 317 PSSLDPSNRKPL 328

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 36/238 (15%)
Query: 23  IMKTSVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 81
           I   ++VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L 
Sbjct: 73  IKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 82  GLKYIHSANVLHRDLKPSNLL---LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 138
            +KY+H   ++HRDLKP NLL   L+ +  + I DFGL+++      ++    T  Y AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 198
           E+L     Y+ A+D WS+G I                       I L G P      F +
Sbjct: 188 EVLAQKP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYD 220
Query: 199 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           EN  K   Q+ + + +  +  + ++  SA D +  ++  DP +R T E AL HP++  
Sbjct: 221 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 36/238 (15%)
Query: 23  IMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 81
           I   ++VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L 
Sbjct: 73  IKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 82  GLKYIHSANVLHRDLKPSNLL---LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 138
            +KY+H   ++HRDLKP NLL   L+ +  + I DFGL+++      ++    T  Y AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 198
           E+L     Y+ A+D WS+G I                       I L G P      F +
Sbjct: 188 EVLAQKP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYD 220
Query: 199 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           EN  K   Q+ + + +  +  + ++  SA D +  ++  DP +R T E AL HP++  
Sbjct: 221 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 36/238 (15%)
Query: 23  IMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 81
           I   ++VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L 
Sbjct: 73  IKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 82  GLKYIHSANVLHRDLKPSNLL---LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 138
            +KY+H   ++HRDLKP NLL   L+ +  + I DFGL+++      ++    T  Y AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 198
           E+L     Y+ A+D WS+G I                       I L G P      F +
Sbjct: 188 EVLAQKP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYD 220
Query: 199 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           EN  K   Q+ + + +  +  + ++  SA D +  ++  DP +R T E AL HP++  
Sbjct: 221 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 36/238 (15%)
Query: 23  IMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 81
           I   ++VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L 
Sbjct: 73  IKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 82  GLKYIHSANVLHRDLKPSNLL---LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 138
            +KY+H   ++HRDLKP NLL   L+ +  + I DFGL+++      ++    T  Y AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 198
           E+L     Y+ A+D WS+G I                       I L G P      F +
Sbjct: 188 EVLAQKP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYD 220
Query: 199 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           EN  K   Q+ + + +  +  + ++  SA D +  ++  DP +R T E AL HP++  
Sbjct: 221 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 114/232 (49%), Gaps = 36/232 (15%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           ++V + D I   Q ESF+  Y+ ++L+   +L + I + +  SE    + + QIL  + Y
Sbjct: 66  NIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 86  IHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 142
            HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VL 179
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 202
               Y+  +D+W+ G I                     L I L+G P      F +E+  
Sbjct: 180 KKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWDEDQH 213
Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++
Sbjct: 214 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 114/232 (49%), Gaps = 36/232 (15%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           ++V + D I   Q ESF+  Y+ ++L+   +L + I + +  SE    + + QIL  + Y
Sbjct: 89  NIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 143
Query: 86  IHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 142
            HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VL 202
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 202
               Y+  +D+W+ G I                     L I L+G P      F +E+  
Sbjct: 203 KKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWDEDQH 236
Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++
Sbjct: 237 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 114/232 (49%), Gaps = 36/232 (15%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           ++V + D I   Q ESF+  Y+ ++L+   +L + I + +  SE    + + QIL  + Y
Sbjct: 65  NIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 86  IHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 142
            HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VL 178
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 202
               Y+  +D+W+ G I                     L I L+G P      F +E+  
Sbjct: 179 KKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWDEDQH 212
Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++
Sbjct: 213 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 114/232 (49%), Gaps = 36/232 (15%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           ++V + D I   Q ESF+  Y+ ++L+   +L + I + +  SE    + + QIL  + Y
Sbjct: 66  NIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 86  IHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 142
            HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE +L
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VL 179
Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 202
               Y+  +D+W+ G I                     L I L+G P      F +E+  
Sbjct: 180 KKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWDEDQH 213
Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++
Sbjct: 214 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 112/232 (48%), Gaps = 41/232 (17%)
Query: 44  ND-VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           ND V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  NL
Sbjct: 87  NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146
Query: 102 LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
            LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GCI 
Sbjct: 147 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 205
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFT 217
             L+  KP F                      E   L E     KK    +P++      
Sbjct: 206 YTLLVGKPPF----------------------ETSCLKETYLRIKKNEYSIPKH------ 237
Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV-CMS 268
                ++P A  L++KML  DP  R T+ + L   +  S +  +  P+ C++
Sbjct: 238 -----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLT 284

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 110/237 (46%), Gaps = 29/237 (12%)
Query: 41  ESFND---VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL 96
           E F+D    ++  EL++  +L + I+  +  SE    Y + +++  + ++H   V+HRDL
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDL 132
Query: 97  KPSNLLL---NANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAID 152
           KP NLL    N N ++KI DFG AR+   +   +     T  Y APE LLN + Y  + D
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQNGYDESCD 191
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   ++  +  F   D        +E++    + +  F  E  K          
Sbjct: 192 LWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK---------- 241
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSP 269
                    NV   A DL++ +LT DP +R+ +     + +L     +S  P+ M+P
Sbjct: 242 ---------NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPL-MTP 288

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 107/238 (44%), Gaps = 36/238 (15%)
Query: 23  IMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 81
           I   ++VA+ DI   P     N +Y+  +L+   +L   I      +E+     + Q+L 
Sbjct: 77  IKHENIVALEDIYESP-----NHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD 131
Query: 82  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 138
            + Y+H   ++HRDLKP NLL    +    + I DFGL+++  + D M+    T  Y AP
Sbjct: 132 AVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAP 191
Query: 139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 198
           E+L     Y+ A+D WS+G I                       I L G P      F +
Sbjct: 192 EVLAQKP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYD 224
Query: 199 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           EN  K   Q+ + + +  +  + ++  SA D +  ++  DP +R T E A  HP++  
Sbjct: 225 ENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAG 282

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 177 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 235
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 236 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 265
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 233 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 262
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 233 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 262
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 177 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 235
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 236 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 265
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 173 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 231
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 232 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 261
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 100/221 (45%), Gaps = 42/221 (19%)
Query: 46  VYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           VY+  ELM     L +I+R  +  SE    + L+ I + ++Y+HS  V+HRDLKPSN+L 
Sbjct: 96  VYLVTELMRGGELLDKILR-QKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILY 154
Query: 104 -----NANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
                N  C L+ICDFG A+ + +E   +     T  + APE +L    Y    D+WS+G
Sbjct: 155 VDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLKRQGYDEGCDIWSLG 212
Query: 158 C-IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
             ++  L    P   G               TP E                L R     F
Sbjct: 213 ILLYTMLAGYTPFANGPSD------------TPEEI---------------LTRIGSGKF 245
Query: 217 TEKFPN---VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           T    N   V  +A DLV KML  DP QR+T +  L HP++
Sbjct: 246 TLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 233 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 262
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 94  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 153
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 154 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 212
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 213 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 242
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 243 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 275

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 233 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 262
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 121 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 180
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 181 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 239
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 240 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 269
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 270 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 302

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 100/221 (45%), Gaps = 42/221 (19%)
Query: 46  VYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           VY+  ELM     L +I+R  +  SE    + L+ I + ++Y+HS  V+HRDLKPSN+L 
Sbjct: 96  VYLVTELMRGGELLDKILR-QKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILY 154
Query: 104 -----NANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
                N  C L+ICDFG A+ + +E   +     T  + APE +L    Y    D+WS+G
Sbjct: 155 VDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLKRQGYDEGCDIWSLG 212
Query: 158 C-IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
             ++  L    P   G               TP E                L R     F
Sbjct: 213 ILLYTMLAGYTPFANGPSD------------TPEEI---------------LTRIGSGKF 245
Query: 217 TEKFPN---VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           T    N   V  +A DLV KML  DP QR+T +  L HP++
Sbjct: 246 TLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 93  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 152
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 153 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 211
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 212 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 241
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 242 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 274

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 109/240 (45%), Gaps = 35/240 (14%)
Query: 10  RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSE 69
           +G   R   +   +    ++ + D+I     +S +++ +  E    +L   I     +SE
Sbjct: 48  QGRIEREISYLRLLRHPHIIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSE 102
Query: 70  EHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY 129
           +  + F  QI+  ++Y H   ++HRDLKP NLLL+ + ++KI DFGL+ + ++ +F+   
Sbjct: 103 QEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 162
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 189
             +  Y APE++         +DVWS G I   ++ R+  F                   
Sbjct: 163 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF------------------- 203
Query: 190 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
            +  +  L +N    +  LP++           + P A  L+++ML  +P  RI++ + +
Sbjct: 204 DDESIPVLFKNISNGVYTLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIM 252

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 112/234 (47%), Gaps = 37/234 (15%)
Query: 26  TSVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLK 84
           +++V + D I     E F+  Y+ ++L+   +L + I + +  SE    + + QIL  + 
Sbjct: 63  SNIVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 117
Query: 85  YIHSANVLHRDLKPSNLLLNANCD---LKICDFGLA-RVTSETDFMTEYVVTRWYRAPEL 140
           + H   V+HRDLKP NLLL + C    +K+ DFGLA  V  +      +  T  Y +PE+
Sbjct: 118 HCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV 177
Query: 141 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 200
           L   + Y   +D+W+ G I                     L I L+G P      F +E+
Sbjct: 178 LRKEA-YGKPVDIWACGVI---------------------LYILLVGYPP-----FWDED 210
Query: 201 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             K   Q+        + ++  V P A +L+ +MLT +P +RIT  +AL HP++
Sbjct: 211 QHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 173 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 231
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 232 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 261
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 91  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 150
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 151 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 209
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 210 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 239
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 240 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 272

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 92  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 151
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 152 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 210
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 211 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 240
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSS-DLWALGCIIYQLVAGLPPF 234
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +       +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEGLIFAKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 109/240 (45%), Gaps = 35/240 (14%)
Query: 10  RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSE 69
           +G   R   +   +    ++ + D+I     +S +++ +  E    +L   I     +SE
Sbjct: 52  QGRIEREISYLRLLRHPHIIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSE 106
Query: 70  EHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY 129
           +  + F  QI+  ++Y H   ++HRDLKP NLLL+ + ++KI DFGL+ + ++ +F+   
Sbjct: 107 QEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 166
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 189
             +  Y APE++         +DVWS G I   ++ R+  F                   
Sbjct: 167 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF------------------- 207
Query: 190 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
            +  +  L +N    +  LP++           + P A  L+++ML  +P  RI++ + +
Sbjct: 208 DDESIPVLFKNISNGVYTLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIM 256

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 98  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 157
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 158 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 216
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F EKF    P A DL
Sbjct: 217 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 246
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 247 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 279

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 35/222 (15%)
Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++ + D+I     +S +++ +  E    +L   I     +SE+  + F  QI+  ++Y H
Sbjct: 76  IIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 130
Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDY 147
              ++HRDLKP NLLL+ + ++KI DFGL+ + ++ +F+     +  Y APE++      
Sbjct: 131 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 190
Query: 148 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ 207
              +DVWS G I   ++ R+  F                    +  +  L +N    +  
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFKNISNGVYT 231
Query: 208 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
           LP++           + P A  L+++ML  +P  RI++ + +
Sbjct: 232 LPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIM 262

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 39/216 (18%)
Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           VY+  E+     L ++ +  +A++E   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 105 ANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + D+KI DFGLA ++  + +   +   T  Y APE+L     ++  +D+WS+GCI   L
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL 235
Query: 164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFTEKF 220
           +  KP F                      E   L E     KK    +PR+         
Sbjct: 236 LVGKPPF----------------------ETSCLKETYIRIKKNEYSVPRH--------- 264
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
             ++P A  L+ +ML  DP  R +V + L   +  S
Sbjct: 265 --INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 36/224 (16%)
Query: 44  NDVYIAYELMDTDL----HQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKP 98
            DV+I  ELMDT L     Q+I   Q + E+        I++ L+++HS  +V+HRD+KP
Sbjct: 123 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 182
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWS 155
           SN+L+NA   +K+CDFG++    ++   T     + Y APE +   LN   Y+   D+WS
Sbjct: 183 SNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWS 242
Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           +G   +EL               LR   +  GTP +     + E +       P+     
Sbjct: 243 LGITMIELA-------------ILRFPYDSWGTPFQQLKQVVEEPS-------PQLPADK 282
Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 259
           F+ +F       +D   + L  + ++R T  + + HP+  +LH+
Sbjct: 283 FSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFF-TLHE 318

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 35/222 (15%)
Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++ + D+I     +S +++ +  E    +L   I     +SE+  + F  QI+  ++Y H
Sbjct: 75  IIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 129
Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDY 147
              ++HRDLKP NLLL+ + ++KI DFGL+ + ++ +F+     +  Y APE++      
Sbjct: 130 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 189
Query: 148 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ 207
              +DVWS G I   ++ R+  F                    +  +  L +N    +  
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFKNISNGVYT 230
Query: 208 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
           LP++           + P A  L+++ML  +P  RI++ + +
Sbjct: 231 LPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIM 261

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 40/210 (19%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I DFG 
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 117 ARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 173
           A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F   
Sbjct: 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSS-DLWALGCIIYQLVAGLPPFRAG 237
Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
           +     + +I+L                              F EKF    P A DLVEK
Sbjct: 238 NEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDLVEK 267
Query: 234 MLTFDPRQRITVEDA------LAHPYLGSL 257
           +L  D  +R+  E+        AHP+  S+
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 39/216 (18%)
Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           VY+  E+     L ++ +  +A++E   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 101 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 160
Query: 105 ANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + D+KI DFGLA ++  + +   +   T  Y APE+L     ++  +D+WS+GCI   L
Sbjct: 161 DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL 219
Query: 164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFTEKF 220
           +  KP F                      E   L E     KK    +PR+         
Sbjct: 220 LVGKPPF----------------------ETSCLKETYIRIKKNEYSVPRH--------- 248
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
             ++P A  L+ +ML  DP  R +V + L   +  S
Sbjct: 249 --INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 282

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +       +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEGLIFAKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 37/228 (16%)
Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++ + D+I  P      D+ +  E    +L   I   + ++E+  + F  QI+  ++Y H
Sbjct: 71  IIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH 125
Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDY 147
              ++HRDLKP NLLL+ N ++KI DFGL+ + ++ +F+     +  Y APE++      
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 148 TAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
              +DVWS G + ++ L+ R P     + +  L                F   N+  Y+ 
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPF--DDEFIPNL----------------FKKVNSCVYV- 226
Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +P +           + P A  L+ +M+  DP QRIT+++    P+ 
Sbjct: 227 -MPDF-----------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           VY+  E+     L ++ +  +A++E   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 105 ANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + D+KI DFGLA ++  + +       T  Y APE+L     ++  +D+WS+GCI   L
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL 235
Query: 164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFTEKF 220
           +  KP F                      E   L E     KK    +PR+         
Sbjct: 236 LVGKPPF----------------------ETSCLKETYIRIKKNEYSVPRH--------- 264
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
             ++P A  L+ +ML  DP  R +V + L   +  S
Sbjct: 265 --INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           VY+  E+     L ++ +  +A++E   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 105 ANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + D+KI DFGLA ++  + +       T  Y APE+L     ++  +D+WS+GCI   L
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL 235
Query: 164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFTEKF 220
           +  KP F                      E   L E     KK    +PR+         
Sbjct: 236 LVGKPPF----------------------ETSCLKETYIRIKKNEYSVPRH--------- 264
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
             ++P A  L+ +ML  DP  R +V + L   +  S
Sbjct: 265 --INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 110/238 (46%), Gaps = 39/238 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E ++      I ++  ++EE        +LR L Y+H+  V+HRD+K  ++LL
Sbjct: 115 DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL 174
Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
            ++  +K+ DFG  A+V+ E       V T ++ APE +++   Y   +D+WS+G + +E
Sbjct: 175 TSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIE 233
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 222
           ++D +P                           + NE       Q  R  R S   +  +
Sbjct: 234 MIDGEP--------------------------PYFNEPP----LQAMRRIRDSLPPRVKD 263
Query: 223 VHPSAIDL---VEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQH 277
           +H  +  L   ++ ML  +P QR T ++ L HP+L     ++  P C+ P    +  H
Sbjct: 264 LHKVSSVLRGFLDLMLVREPSQRATAQELLGHPFL----KLAGPPSCIVPLMRQYRHH 317

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 47  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           Y+ ++L+   +L + I + +  SE    + + QIL  + + H   V+HRDLKP NLLL +
Sbjct: 97  YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLAS 156
Query: 106 ---NCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
                 +K+ DFGLA  V  E      +  T  Y +PE+L     Y   +D+W+ G I  
Sbjct: 157 KLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVI-- 213
Query: 162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 221
                              L I L+G P      F +E+  +   Q+        + ++ 
Sbjct: 214 -------------------LYILLVGYPP-----FWDEDQHRLYQQIKAGAYDFPSPEWD 249
Query: 222 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            V P A DL+ KMLT +P +RIT  +AL HP++
Sbjct: 250 TVTPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 107/220 (48%), Gaps = 40/220 (18%)
Query: 46  VYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           VY+  ELM     L +I+R  +  SE      L+ I + ++Y+H+  V+HRDLKPSN+L 
Sbjct: 91  VYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149
Query: 104 ---NANCD-LKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
              + N + ++ICDFG A+ + +E   +     T  + APE +L    Y AA D+WS+G 
Sbjct: 150 VDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGV 208
Query: 159 -IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE--AELGFLNENAKKYICQLPRYQRQS 215
            ++  L    P   G D             TP E  A +G     + K+          S
Sbjct: 209 LLYTMLTGYTPFANGPDD------------TPEEILARIG-----SGKF----------S 241
Query: 216 FTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +  + N V  +A DLV KML  DP QR+T    L HP++
Sbjct: 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 44  NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +D+++  E +   +L   I  N  L E+  +    QIL G+ Y H   V+HRDLKP N+L
Sbjct: 89  SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL 148
Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
           L+A+ + KI DFGL+ + S+ +F+     +  Y APE++         +D+WS G I   
Sbjct: 149 LDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYA 208
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 222
           L+     F   DHV  L                       K IC    Y  Q        
Sbjct: 209 LLCGTLPFDD-DHVPTLF----------------------KKICDGIFYTPQY------- 238
Query: 223 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           ++PS I L++ ML  DP +R T++D   H + 
Sbjct: 239 LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 47  YIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           ++ ++LM   +L   +     LSE+  +  +  +L  +  +H  N++HRDLKP N+LL+ 
Sbjct: 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 159
Query: 106 NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIF 160
           + ++K+ DFG +      + + E   T  Y APE++      N   Y   +D+WS G I 
Sbjct: 160 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
             L+   P F  R  +  LR+++                 +  Y    P +   S T K 
Sbjct: 220 YTLLAGSPPFWHRKQMLMLRMIM-----------------SGNYQFGSPEWDDYSDTVK- 261
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                   DLV + L   P++R T E+ALAHP+ 
Sbjct: 262 --------DLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 47  YIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           ++ ++LM   +L   +     LSE+  +  +  +L  +  +H  N++HRDLKP N+LL+ 
Sbjct: 87  FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 146
Query: 106 NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIF 160
           + ++K+ DFG +      + + E   T  Y APE++      N   Y   +D+WS G I 
Sbjct: 147 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 206
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
             L+   P F  R  +  LR+++                 +  Y    P +   S T K 
Sbjct: 207 YTLLAGSPPFWHRKQMLMLRMIM-----------------SGNYQFGSPEWDDYSDTVK- 248
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                   DLV + L   P++R T E+ALAHP+ 
Sbjct: 249 --------DLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 123/257 (47%), Gaps = 45/257 (17%)
Query: 44  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSA--NVLHRDLKPS 99
           N + + +E++  +L+ ++R+   + +S    + F  Q+   L ++ +   +++H DLKP 
Sbjct: 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 188
Query: 100 NLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+G
Sbjct: 189 NILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLG 245
Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP-------- 209
           CI +E+   +PLF G + V Q+  ++E++G P  A +      A+K+  +LP        
Sbjct: 246 CILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AHILDQAPKARKFFEKLPDGTWNLKK 304
Query: 210 -----RYQRQSFTEKFPNV-----------------HPSA-----IDLVEKMLTFDPRQR 242
                R  +   T K  N+                 H  A      DL+ +ML +DP+ R
Sbjct: 305 TKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364
Query: 243 ITVEDALAHPYLGSLHD 259
           I    AL H +     D
Sbjct: 365 IQPYYALQHSFFKKTAD 381

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 46  VYIAYELMD-TDL-HQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
           +Y+ +E MD  DL  +I++   A    SE    +++ QIL  L+Y H  N++HRD+KP N
Sbjct: 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPEN 160
Query: 101 LLLNA---NCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           +LL +   +  +K+ DFG+A    E+  +    V T  + APE ++    Y   +DVW  
Sbjct: 161 VLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGC 219
Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           G I   L               L   +   GT      G +    K      PR      
Sbjct: 220 GVILFIL---------------LSGCLPFYGTKERLFEGIIKGKYK----MNPR------ 254
Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             ++ ++  SA DLV +ML  DP +RITV +AL HP+L
Sbjct: 255 --QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPAFVAPE-IVNYEPLGLEAD 199
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 123/257 (47%), Gaps = 45/257 (17%)
Query: 44  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSA--NVLHRDLKPS 99
           N + + +E++  +L+ ++R+   + +S    + F  Q+   L ++ +   +++H DLKP 
Sbjct: 110 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 169
Query: 100 NLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+G
Sbjct: 170 NILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLG 226
Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP-------- 209
           CI +E+   +PLF G + V Q+  ++E++G P  A +      A+K+  +LP        
Sbjct: 227 CILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AHILDQAPKARKFFEKLPDGTWNLKK 285
Query: 210 -----RYQRQSFTEKFPNV-----------------HPSA-----IDLVEKMLTFDPRQR 242
                R  +   T K  N+                 H  A      DL+ +ML +DP+ R
Sbjct: 286 TKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 345
Query: 243 ITVEDALAHPYLGSLHD 259
           I    AL H +     D
Sbjct: 346 IQPYYALQHSFFKKTAD 362

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 83  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 142
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 198
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 199 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 232
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 40/223 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 153 VWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY 211
           +WS+G I ++ L    P                           FL +  ++ +  +   
Sbjct: 200 MWSIGVITYILLSGASP---------------------------FLGDTKQETLANVSAV 232
Query: 212 QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 233 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 83  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 142
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 198
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 199 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 232
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 125/260 (48%), Gaps = 51/260 (19%)
Query: 44  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSA--NVLHRDLKPS 99
           N + + +E++  +L+ ++R+   + +S    + F  Q+   L ++ +   +++H DLKP 
Sbjct: 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 188
Query: 100 NLLLNANCD-----LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 154
           N+LL   C+     +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+W
Sbjct: 189 NILL---CNPKRXAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMW 242
Query: 155 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP----- 209
           S+GCI +E+   +PLF G + V Q+  ++E++G P  A +      A+K+  +LP     
Sbjct: 243 SLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AHILDQAPKARKFFEKLPDGTWN 301
Query: 210 --------RYQRQSFTEKFPNV-----------------HPSA-----IDLVEKMLTFDP 239
                   R  +   T K  N+                 H  A      DL+ +ML +DP
Sbjct: 302 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361
Query: 240 RQRITVEDALAHPYLGSLHD 259
           + RI    AL H +     D
Sbjct: 362 KTRIQPYYALQHSFFKKTAD 381

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 84  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 143
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAID 152
           N +LL+ N     +KI DFGLA    + DF  E+     T  + APE ++N        D
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEAD 199
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS+G I   L+                       +P      FL +  ++ +  +    
Sbjct: 200 MWSIGVITYILLSG--------------------ASP------FLGDTKQETLANVSAVN 233
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 37/233 (15%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           ++V + D I     E F+  Y+ ++L+   +L + I + +  SE    + + QIL  + +
Sbjct: 64  NIVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 86  IHSANVLHRDLKPSNLLL---NANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELL 141
            H   ++HRDLKP NLLL   +    +K+ DFGLA  V  +      +  T  Y +PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 142 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 201
                Y   +D+W+ G I                     L I L+G P      F +E+ 
Sbjct: 179 -RKDPYGKPVDMWACGVI---------------------LYILLVGYPP-----FWDEDQ 211
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   Q+        + ++  V P A DL+ KMLT +P +RIT  +AL HP++
Sbjct: 212 HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 37/233 (15%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           ++V + D I     E F+  Y+ ++L+   +L + I + +  SE    + + QIL  + +
Sbjct: 64  NIVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 86  IHSANVLHRDLKPSNLLL---NANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELL 141
            H   ++HRDLKP NLLL   +    +K+ DFGLA  V  +      +  T  Y +PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 142 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 201
                Y   +D+W+ G I                     L I L+G P      F +E+ 
Sbjct: 179 -RKDPYGKPVDMWACGVI---------------------LYILLVGYPP-----FWDEDQ 211
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +   Q+        + ++  V P A DL+ KMLT +P +RIT  +AL HP++
Sbjct: 212 HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 39/231 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
            ++++  E +       I S   L+EE        +L+ L Y+H+  V+HRD+K  ++LL
Sbjct: 115 EELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL 174
Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +  +K+ DFG  A+++ +       V T ++ APE +++ S Y   +D+WS+G + +E
Sbjct: 175 TLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPE-VISRSLYATEVDIWSLGIMVIE 233
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 222
           ++D +P +     V  ++ L                              R S   K  N
Sbjct: 234 MVDGEPPYFSDSPVQAMKRL------------------------------RDSPPPKLKN 263
Query: 223 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 270
            H   P   D +E+ML  DP++R T ++ L HP+L      +  P C+ P 
Sbjct: 264 SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ----TGLPECLVPL 310

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 47  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           Y+ ++L+   +L + I + +  SE    + + QIL  + + H   V+HR+LKP NLLL +
Sbjct: 86  YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLAS 145
Query: 106 ---NCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
                 +K+ DFGLA  V  E      +  T  Y +PE+L     Y   +D+W+ G I  
Sbjct: 146 KLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVI-- 202
Query: 162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 221
                              L I L+G P      F +E+  +   Q+        + ++ 
Sbjct: 203 -------------------LYILLVGYPP-----FWDEDQHRLYQQIKAGAYDFPSPEWD 238
Query: 222 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            V P A DL+ KMLT +P +RIT  +AL HP++
Sbjct: 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 40/213 (18%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 119 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 178
Query: 114 FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 179 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 237
Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
              +     + +I+L                              F   F    P A DL
Sbjct: 238 RAGNEYLIFQKIIKL---------------------------EYDFPAAF---FPKARDL 267
Query: 231 VEKMLTFDPRQRITVEDA------LAHPYLGSL 257
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 268 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 300

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 36/224 (16%)
Query: 44  NDVYIAYELMDTDL----HQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKP 98
            DV+I  ELMDT L     Q+I   Q + E+        I++ L+++HS  +V+HRD+KP
Sbjct: 79  GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWS 155
           SN+L+NA   +K+CDFG++    +          + Y APE +   LN   Y+   D+WS
Sbjct: 139 SNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198
Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           +G   +EL               LR   +  GTP +     + E +       P+     
Sbjct: 199 LGITMIELA-------------ILRFPYDSWGTPFQQLKQVVEEPS-------PQLPADK 238
Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 259
           F+ +F       +D   + L  + ++R T  + + HP+  +LH+
Sbjct: 239 FSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFF-TLHE 274

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 116/246 (47%), Gaps = 40/246 (16%)
Query: 48  IAYELMDTDLHQIIRSNQALSE--EHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL-LN 104
           I++EL+       ++ N  L       ++  +Q+ + +K++H   + H DLKP N+L +N
Sbjct: 113 ISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVN 172
Query: 105 ANCDL------------------KICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           ++ +L                  ++ DFG A  T + +  +  V TR YRAPE++L    
Sbjct: 173 SDYELTYNLEKKRDERSVKSTAVRVVDFGSA--TFDHEHHSTIVSTRHYRAPEVILELG- 229
Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSE-------------A 192
           ++   DVWS+GCI  E      LF   D+   L ++  ++G  PS               
Sbjct: 230 WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRG 289
Query: 193 ELGF-LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
            L +  N +A +Y+ +  +  R+  T +    H    DL+E ML ++P +R+T+ +AL H
Sbjct: 290 RLDWDENTSAGRYVRENCKPLRRYLTSE-AEEHHQLFDLIESMLEYEPAKRLTLGEALQH 348
Query: 252 PYLGSL 257
           P+   L
Sbjct: 349 PFFARL 354

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 47  YIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           ++ ++LM   +L   +     LSE+  +  +  +L  +  +H  N++HRDLKP N+LL+ 
Sbjct: 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 159
Query: 106 NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIF 160
           + ++K+ DFG +      + +     T  Y APE++      N   Y   +D+WS G I 
Sbjct: 160 DMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
             L+   P F  R  +  LR+++                 +  Y    P +   S T K 
Sbjct: 220 YTLLAGSPPFWHRKQMLMLRMIM-----------------SGNYQFGSPEWDDYSDTVK- 261
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                   DLV + L   P++R T E+ALAHP+ 
Sbjct: 262 --------DLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 107 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+  + +TE   T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 167 ETTSHNSLTEPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 215
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 233
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 216 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 258
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
           +L  +P QR+T+ + + HP++     +   P+
Sbjct: 259 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 108/219 (49%), Gaps = 38/219 (17%)
Query: 41  ESFNDVYIAYELM-DTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           E  N VY+  E+  + ++++ +++  +  SE   ++F++QI+ G+ Y+HS  +LHRDL  
Sbjct: 81  EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTL 140
Query: 99  SNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
           SNLLL  N ++KI DFGLA   ++  E  +      T  Y +PE+   S+ +    DVWS
Sbjct: 141 SNLLLTRNMNIKIADFGLATQLKMPHEKHY--TLCGTPNYISPEIATRSA-HGLESDVWS 197
Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           +GC+F  L+  +P F      + L  ++                        L  Y+  S
Sbjct: 198 LGCMFYTLLIGRPPFDTDTVKNTLNKVV------------------------LADYEMPS 233
Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           F      +   A DL+ ++L  +P  R+++   L HP++
Sbjct: 234 F------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 221 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 280
Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 281 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 339
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 222
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 340 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 369
Query: 223 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLG 255
           +H   PS    ++++L  DP QR T  + L HP+L 
Sbjct: 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 405

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 105/220 (47%), Gaps = 40/220 (18%)
Query: 46  VYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           VY+  EL      L +I+R  +  SE      L+ I + ++Y+H+  V+HRDLKPSN+L 
Sbjct: 91  VYVVTELXKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149
Query: 104 ---NANCD-LKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
              + N + ++ICDFG A+ + +E   +     T  + APE +L    Y AA D+WS+G 
Sbjct: 150 VDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPE-VLERQGYDAACDIWSLGV 208
Query: 159 -IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE--AELGFLNENAKKYICQLPRYQRQS 215
            ++  L    P   G D             TP E  A +G     + K+          S
Sbjct: 209 LLYTXLTGYTPFANGPDD------------TPEEILARIG-----SGKF----------S 241
Query: 216 FTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +  + N V  +A DLV K L  DP QR+T    L HP++
Sbjct: 242 LSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 144 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 203
Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 204 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 262
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 222
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 263 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 292
Query: 223 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           +H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 114 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 173
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 174 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 222
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 233
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 223 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 265
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
           +L  +P QR+T+ + + HP++     +   P+
Sbjct: 266 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 297

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 115 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 174
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 175 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 223
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 233
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 224 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 266
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 268
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 267 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 301

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 123 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 182
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 183 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 231
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 233
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 232 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 274
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
           +L  +P QR+T+ + + HP++     +   P+
Sbjct: 275 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 306

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 113 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 172
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 173 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 221
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 233
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 222 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 264
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 268
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 265 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 299

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 99  DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 158
Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 159 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 217
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 222
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 218 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 247
Query: 223 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           +H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 248 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 284

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 30/193 (15%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARVTS 121
           + +SE      + QIL G+ Y+H  N++H DLKP N+LL++     D+KI DFG++R   
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185
Query: 122 ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 181
               + E + T  Y APE +LN    T A D+W++G I   L+     F G D       
Sbjct: 186 HACELREIMGTPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED------- 237
Query: 182 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ 241
                             N + Y+  + +       E F +V   A D ++ +L  +P +
Sbjct: 238 ------------------NQETYL-NISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEK 278
Query: 242 RITVEDALAHPYL 254
           R T E  L+H +L
Sbjct: 279 RPTAEICLSHSWL 291

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 101 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 160
Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 161 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 219
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 222
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 220 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 249
Query: 223 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLG 255
           +H   PS    ++++L  DP QR T  + L HP+L 
Sbjct: 250 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 285

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 217
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 233
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 218 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 260
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 268
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 261 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 295

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 37/233 (15%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ +++I   P      ++ +  EL+   +L   I      SE      + QIL  + Y
Sbjct: 109 NIIKLKEIFETP-----TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 86  IHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 142
           +H   ++HRDLKP NLL      +  LKI DFGL+++      M     T  Y APE+L 
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR 223
Query: 143 NSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 201
             + Y   +D+WSVG I ++ L   +P +  R      R ++                N 
Sbjct: 224 GCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----------------NC 266
Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           + Y    P +   S   K         DLV K++  DP++R+T   AL HP++
Sbjct: 267 EYYFIS-PWWDEVSLNAK---------DLVRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 108 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 167
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 168 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 216
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 233
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 217 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 259
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
           +L  +P QR+T+ + + HP++     +   P+
Sbjct: 260 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 291

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 107 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 167 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 215
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 233
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 216 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 258
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
           +L  +P QR+T+ + + HP++     +   P+
Sbjct: 259 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 90  DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 149
Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 150 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 208
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 222
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 209 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 238
Query: 223 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           +H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 94  DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 153
Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 154 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 212
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 222
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 213 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 242
Query: 223 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           +H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 243 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 279

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 41  ESFNDVYIAYELMDTD--LHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHRD 95
           E ++++YI  E  +    L +I+ +    +ALSE +    + Q++  L Y HS +V+H+D
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKD 149
Query: 96  LKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAID 152
           LKP N+L    + +  +KI DFGLA +    +  T    T  Y APE+     D T   D
Sbjct: 150 LKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF--KRDVTFKCD 207
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +WS G +   L+     F G                        L E  +K   + P Y 
Sbjct: 208 IWSAGVVMYFLLTGCLPFTGTS----------------------LEEVQQKATYKEPNYA 245
Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                E  P + P A+DL+++MLT DP +R +    L H + 
Sbjct: 246 ----VECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 261
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 233
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 262 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 304
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 268
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 305 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 339

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 217
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 233
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 218 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 260
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 268
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 261 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 295

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 159 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 218
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 219 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 267
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 233
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 268 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 310
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 268
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 311 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 345

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 31/182 (17%)
Query: 76  LYQILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVT 132
           + QIL G+ Y+H  N++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + T
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 133 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEA 192
            +Y APE+L     Y    DVWS G I   L+   P F G++    ++ +          
Sbjct: 212 AYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV---------- 259
Query: 193 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
                 E  K Y           F + + N+   A +L++ MLT+D  +R T E+AL   
Sbjct: 260 ------EKGKYYF---------DFND-WKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303
Query: 253 YL 254
           ++
Sbjct: 304 WI 305

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   TE   T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 77/133 (57%), Gaps = 5/133 (3%)
Query: 42  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 99
           S  ++ I  E MD   L Q+++  + + EE        +LRGL Y+   + ++HRD+KPS
Sbjct: 85  SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPS 144
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+L+N+  ++K+CDFG++    ++     +V TR Y APE  L  + Y+   D+WS+G  
Sbjct: 145 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMAPE-RLQGTHYSVQSDIWSMGLS 202
Query: 160 FMEL-MDRKPLFP 171
            +EL + R P+ P
Sbjct: 203 LVELAVGRYPIPP 215

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 44  NDVYIAYELMDT-DLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
            D++I  E      +  IIR  N+ L+E+     L   L+GL+Y+H    +HRD+K  N+
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNI 156
Query: 102 LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
           LLN     K+ DFG+A ++T         + T ++ APE ++    Y    D+WS+G   
Sbjct: 157 LLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPE-VIQEIGYNCVADIWSLGITA 215
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
           +E+ + KP +     +H +R +  +   P                 + P     +FT   
Sbjct: 216 IEMAEGKPPYA---DIHPMRAIFMIPTNPPPT-------------FRKPELWSDNFT--- 256
Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
                   D V++ L   P QR T    L HP++ S   +S
Sbjct: 257 --------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 103/236 (43%), Gaps = 37/236 (15%)
Query: 23  IMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 81
           I   ++V + DI      ES    Y+  +L+   +L   I      +E+     + Q+L 
Sbjct: 63  IKHENIVTLEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS 117
Query: 82  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 138
            +KY+H   ++HRDLKP NLL      N  + I DFGL+++  +   M+    T  Y AP
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM-EQNGIMSTACGTPGYVAP 176
Query: 139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 198
           E+L     Y+ A+D WS+G I                       I L G P      F  
Sbjct: 177 EVLAQKP-YSKAVDCWSIGVI---------------------TYILLCGYPP-----FYE 209
Query: 199 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           E   K   ++     +  +  + ++  SA D +  +L  DP +R T E AL+HP++
Sbjct: 210 ETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 46  VYIAYELMD-TDL-HQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
           +Y+ +E MD  DL  +I++   A    SE    +++ QIL  L+Y H  N++HRD+KP  
Sbjct: 103 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 162
Query: 101 LLLNA---NCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           +LL +   +  +K+  FG+A    E+  +    V T  + APE ++    Y   +DVW  
Sbjct: 163 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGC 221
Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           G I   L               L   +   GT      G +    K      PR      
Sbjct: 222 GVILFIL---------------LSGCLPFYGTKERLFEGIIKGKYK----MNPR------ 256
Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             ++ ++  SA DLV +ML  DP +RITV +AL HP+L
Sbjct: 257 --QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 44  NDVYIAYELMDTDL----HQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKP 98
            DV+I  EL DT L     Q+I   Q + E+        I++ L+++HS  +V+HRD+KP
Sbjct: 106 GDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 165
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWS 155
           SN+L+NA   +K CDFG++    +          + Y APE +   LN   Y+   D+WS
Sbjct: 166 SNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWS 225
Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           +G   +EL               LR   +  GTP +     + E +       P+     
Sbjct: 226 LGITXIELA-------------ILRFPYDSWGTPFQQLKQVVEEPS-------PQLPADK 265
Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 259
           F+ +F       +D   + L  + ++R T  +   HP+  +LH+
Sbjct: 266 FSAEF-------VDFTSQCLKKNSKERPTYPELXQHPFF-TLHE 301

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 46  VYIAYELMD-TDL-HQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
           +Y+ +E MD  DL  +I++   A    SE    +++ QIL  L+Y H  N++HRD+KP  
Sbjct: 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 160
Query: 101 LLLNA---NCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           +LL +   +  +K+  FG+A    E+  +    V T  + APE ++    Y   +DVW  
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGC 219
Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           G I   L               L   +   GT      G +    K      PR      
Sbjct: 220 GVILFIL---------------LSGCLPFYGTKERLFEGIIKGKYK----MNPR------ 254
Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             ++ ++  SA DLV +ML  DP +RITV +AL HP+L
Sbjct: 255 --QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T+   T  Y  PE ++    +   +D+WS+G 
Sbjct: 138 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 195
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 196 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 225
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 226 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T+   T  Y  PE ++    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 199
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T+   T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T+   T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 103 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 162
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 163 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 220
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 221 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 250
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 251 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 97/185 (52%), Gaps = 21/185 (11%)
Query: 76  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM-TEYVVTRW 134
           L +IL+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T +
Sbjct: 126 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 185
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
           + APE++  S+ Y +  D+WS+G   +EL   +P  P  D +H +R+L  +        +
Sbjct: 186 WMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNPPTLV 241
Query: 195 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           G   ++ K++I         +   K P+  P+A +L+        + +  V+++    YL
Sbjct: 242 GDFTKSFKEFI--------DACLNKDPSFRPTAKELL--------KHKFIVKNSKKTSYL 285
Query: 255 GSLHD 259
             L D
Sbjct: 286 TELID 290

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 141 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 198
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 199 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 228
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 229 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 93/189 (49%), Gaps = 31/189 (16%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           L E +    L +IL+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T   
Sbjct: 113 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 172
Query: 127 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 185
              +V T ++ APE++  S+ Y    D+WS+G   +EL   +P  P  D +H +R+L  +
Sbjct: 173 RNXFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVLFLI 228
Query: 186 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 245
              P  +      +++K +                        + VE  L  DPR R T 
Sbjct: 229 ---PKNSPPTLEGQHSKPF-----------------------KEFVEACLNKDPRFRPTA 262
Query: 246 EDALAHPYL 254
           ++ L H ++
Sbjct: 263 KELLKHKFI 271

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 199
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 94  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 153
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 154 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 211
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 212 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 241
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 242 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 42  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 99
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 94  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 153
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 154 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 211
Query: 160 FMEL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
            +E+ + R P+  G   +    LL  ++  P                   P+     F+ 
Sbjct: 212 LVEMAVGRYPIGSGSGSMAIFELLDYIVNEPP------------------PKLPSGVFSL 253
Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +F        D V K L  +P +R  ++  + H ++
Sbjct: 254 EFQ-------DFVNKCLIKNPAERADLKQLMVHAFI 282

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +N +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 141 ENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 198
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +   P F                              A  Y     R  R  FT 
Sbjct: 199 LCYEFLVGMPPF-----------------------------EAHTYQETYRRISRVEFT- 228
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +  QR+T+ + L HP++
Sbjct: 229 -FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 76  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 135
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 136 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 193
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 194 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 223
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 224 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 74  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 133
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 134 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 191
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 192 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 221
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 222 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T    T  Y  PE  +    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-XIEGRXHDEKVDLWSLGV 199
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 107/238 (44%), Gaps = 39/238 (16%)
Query: 23  IMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 81
           ++  +V+ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL 
Sbjct: 72  VLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 82  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRA 137
           G+ Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +         T  + A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 138 PELLLNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 196
           PE ++N        D+WS+G I ++ L    P                           F
Sbjct: 187 PE-IVNYEPLGLEADMWSIGVITYILLSGASP---------------------------F 218
Query: 197 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           L +  ++ +  +         E F +    A D + K+L  + R+R+T+++AL HP++
Sbjct: 219 LGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/136 (36%), Positives = 73/136 (53%), Gaps = 12/136 (8%)
Query: 46  VYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSAN-----VLHRD 95
           +YI  E  +  DL  +I    +  Q L EE     + Q+   LK  H  +     VLHRD
Sbjct: 82  LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 96  LKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 154
           LKP+N+ L+   ++K+ DFGLAR+ + + DF  E+V T +Y +PE  +N   Y    D+W
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPE-QMNRMSYNEKSDIW 200
Query: 155 SVGCIFMELMDRKPLF 170
           S+GC+  EL    P F
Sbjct: 201 SLGCLLYELCALMPPF 216

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 31/203 (15%)
Query: 59  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN--CDLKICDFGL 116
           +I   +  +SE     ++ Q   GLK++H  +++H D+KP N++        +KI DFGL
Sbjct: 138 RIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 117 ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV 176
           A   +  + +     T  + APE++ +        D+W++G +   L+     F G D +
Sbjct: 198 ATKLNPDEIVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256
Query: 177 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE-KFPNVHPSAIDLVEKML 235
             L                   +N K+  C         F E  F +V P A D ++ +L
Sbjct: 257 ETL-------------------QNVKR--CDW------EFDEDAFSSVSPEAKDFIKNLL 289
Query: 236 TFDPRQRITVEDALAHPYLGSLH 258
             +PR+R+TV DAL HP+L   H
Sbjct: 290 QKEPRKRLTVHDALEHPWLKGDH 312

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 39/237 (16%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + DI      E+  DV +  EL+   +L   +   ++L+E+    FL QIL G+ Y
Sbjct: 69  NIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 86  IHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 141
           +HS  + H DLKP N++L      N  +K+ DFG+A      +       T  + APE +
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-I 182
Query: 142 LNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 200
           +N        D+WS+G I ++ L    P                           FL E 
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSGASP---------------------------FLGET 215
Query: 201 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
            ++ +  +         E F N    A D + ++L  DP++R+T+  +L H ++ ++
Sbjct: 216 KQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 3/106 (2%)
Query: 68  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFM 126
           +E+   ++  QIL GLKY+H   ++HRD+K  N+L+N     LKI DFG ++  +  +  
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 127 TE-YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           TE +  T  Y APE++      Y  A D+WS+GC  +E+   KP F
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 116/233 (49%), Gaps = 38/233 (16%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VV + +++  P  +    +Y+ +EL++      + + + LSE+  +++   +++G++Y+
Sbjct: 97  NVVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYL 153
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSS 145
           H   ++HRD+KPSNLL+  +  +KI DFG++     +D  ++  V T  + APE L  + 
Sbjct: 154 HYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR 213
Query: 146 DY--TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
                 A+DVW++G                     + L   + G     +  F++E   +
Sbjct: 214 KIFSGKALDVWAMG---------------------VTLYCFVFG-----QCPFMDE---R 244
Query: 204 YICQLPRYQRQS--FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +C   + + Q+  F ++ P++     DL+ +ML  +P  RI V +   HP++
Sbjct: 245 IMCLHSKIKSQALEFPDQ-PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 37/237 (15%)
Query: 23  IMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 81
           ++  +V+ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL 
Sbjct: 72  VLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 82  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRA 137
           G+ Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +         T  + A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 138 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 197
           PE ++N        D+WS+G I   L+                       +P      FL
Sbjct: 187 PE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP------FL 219
Query: 198 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +  ++ +  +         E F +    A D + K+L  + R+R+T+++AL HP++
Sbjct: 220 GDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 37/237 (15%)
Query: 23  IMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 81
           ++  +V+ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL 
Sbjct: 72  VLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 82  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRA 137
           G+ Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +         T  + A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 138 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 197
           PE ++N        D+WS+G I   L+                       +P      FL
Sbjct: 187 PE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP------FL 219
Query: 198 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +  ++ +  +         E F +    A D + K+L  + R+R+T+++AL HP++
Sbjct: 220 GDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 3/106 (2%)
Query: 68  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFM 126
           +E+   ++  QIL GLKY+H   ++HRD+K  N+L+N     LKI DFG ++  +  +  
Sbjct: 106 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 165
Query: 127 TE-YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
           TE +  T  Y APE++      Y  A D+WS+GC  +E+   KP F
Sbjct: 166 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 123
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 103 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 162
Query: 124 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 183
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 163 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 217
Query: 184 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
           ELI          + E       + PR            + P A  L+  +L  DP+QR+
Sbjct: 218 ELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDPKQRL 251

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 32/184 (17%)
Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-V 119
           +   +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +  
Sbjct: 101 LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 160
Query: 120 TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 179
            S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH    
Sbjct: 161 ISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-- 217
Query: 180 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 239
             L ELI          + E       + PR            + P A  L+  +L  DP
Sbjct: 218 --LFELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDP 249
Query: 240 RQRI 243
           +QR+
Sbjct: 250 KQRL 253

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 103 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 162
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +    +   T  Y  PE ++    +   +D+WS+G 
Sbjct: 163 ENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 220
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 221 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 250
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 251 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 123
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 124 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 183
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 160 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 184 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
           ELI          + E       + PR            + P A  L+  +L  DP+QR+
Sbjct: 215 ELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 123
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 124 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 183
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 160 ATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 184 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
           ELI          + E       + PR            + P A  L+  +L  DP+QR+
Sbjct: 215 ELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 37/237 (15%)
Query: 23  IMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 81
           ++  +V+ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL 
Sbjct: 72  VLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 82  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRA 137
           G+ Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +         T  + A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 138 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 197
           PE ++N        D+WS+G I   L+                       +P      FL
Sbjct: 187 PE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP------FL 219
Query: 198 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +  ++ +  +         E F      A D + K+L  + R+R+T+++AL HP++
Sbjct: 220 GDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 32/184 (17%)
Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-V 119
           +   +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +  
Sbjct: 96  LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155
Query: 120 TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 179
            S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH    
Sbjct: 156 ISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-- 212
Query: 180 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 239
             L ELI          + E       + PR            + P A  L+  +L  DP
Sbjct: 213 --LFELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDP 244
Query: 240 RQRI 243
           +QR+
Sbjct: 245 KQRL 248

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 123
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 124 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 183
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 160 ATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 184 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
           ELI          + E       + PR            + P A  L+  +L  DP+QR+
Sbjct: 215 ELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 123
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 124 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 183
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 160 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 184 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
           ELI          + E       + PR            + P A  L+  +L  DP+QR+
Sbjct: 215 ELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 41  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+ Y+H+  + H DLKP 
Sbjct: 85  ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE 144
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
           N +LL+ N     +K+ DFGLA    +         T  + APE ++N        D+WS
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 203
Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           +G I   L+                       +P      FL +  ++ +  +       
Sbjct: 204 IGVITYILLSG--------------------ASP------FLGDTKQETLANITAVSYDF 237
Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             E F      A D + K+L  + R+R+T+++AL HP++
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +    +   T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 34/205 (16%)
Query: 55  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 114
           TDL +  + N  L EE   Y   +ILRGL ++H   V+HRD+K  N+LL  N ++K+ DF
Sbjct: 115 TDLIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173
Query: 115 GL-ARVTSETDFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMDRKPL 169
           G+ A++         ++ T ++ APE++    +    Y    D+WS+G   +E+ +  P 
Sbjct: 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP- 232
Query: 170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 229
            P  D +H +R L  +   P+                  PR + + +++KF +       
Sbjct: 233 -PLCD-MHPMRALFLIPRNPA------------------PRLKSKKWSKKFQS------- 265
Query: 230 LVEKMLTFDPRQRITVEDALAHPYL 254
            +E  L  +  QR   E  + HP++
Sbjct: 266 FIESCLVKNHSQRPATEQLMKHPFI 290

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 69/122 (56%), Gaps = 3/122 (2%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L + I S+  LS +    F  QIL G+K+ H   ++HRD+KP N+L+++N  LKI DFG+
Sbjct: 98  LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI 157
Query: 117 ARVTSETDFM-TEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
           A+  SET    T +V+ T  Y +PE     +      D++S+G +  E++  +P F G  
Sbjct: 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGET 216
Query: 175 HV 176
            V
Sbjct: 217 AV 218

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 79  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 138
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI +FG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 139 ENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 196
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 197 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 226
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 227 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E         I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+  + +T    T +Y APE +L    Y  + D WS+G I   L+   P          
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYP---------- 261
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 233
                     P  +  G       K   +  +Y+       FPN   S +      L+  
Sbjct: 262 ----------PFYSNHGLAISPGXKTRIRXGQYE-------FPNPEWSEVSEEVKXLIRN 304
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 268
           +L  +P QR T+ +   HP++     +   P+  S
Sbjct: 305 LLKTEPTQRXTITEFXNHPWIXQSTKVPQTPLHTS 339

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI +FG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 41  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+ Y+H+  + H DLKP 
Sbjct: 85  ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE 144
Query: 100 N-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
           N +LL+ N     +K+ DFGLA    +         T  + APE ++N        D+WS
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 203
Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           +G I   L+                       +P      FL +  ++ +  +       
Sbjct: 204 IGVITYILLSG--------------------ASP------FLGDTKQETLANITAVSYDF 237
Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             E F      A D + K+L  + R+R+T+++AL HP++
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 79  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 138
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 139 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 196
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 197 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 226
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 227 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG +   + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 138 ENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPE-MIEGRMHDEKVDLWSLGV 195
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 196 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 225
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 226 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++     ++++ ++      E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 199
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 138 ENLLLGSAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 195
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 196 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 225
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 226 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 73/134 (54%), Gaps = 9/134 (6%)
Query: 42  SFND---VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D   +Y+  E M   D+   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +N +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 141 ENLLLGSNGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 198
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +   P F                              A  Y     R  R  FT 
Sbjct: 199 LCYEFLVGMPPF-----------------------------EAHTYQETYRRISRVEFT- 228
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +  QR+T+ + L HP++
Sbjct: 229 -FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 73/134 (54%), Gaps = 9/134 (6%)
Query: 42  SFND---VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D   +Y+  E M   D+   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKP 136
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQDTYKRISRVEFT- 224
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 39/237 (16%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + DI      E+  DV +  EL+   +L   +   ++L+E+    FL QIL G+ Y
Sbjct: 90  NIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 144
Query: 86  IHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 141
           +HS  + H DLKP N++L      N  +K+ DFG+A      +       T  + APE +
Sbjct: 145 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-I 203
Query: 142 LNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 200
           +N        D+WS+G I ++ L    P                           FL E 
Sbjct: 204 VNYEPLGLEADMWSIGVITYILLSGASP---------------------------FLGET 236
Query: 201 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
            ++ +  +         E F N    A D + ++L  DP++R+ +  +L H ++ ++
Sbjct: 237 KQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAI 293

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 71/136 (52%), Gaps = 12/136 (8%)
Query: 46  VYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIH-----SANVLHRD 95
           +YI  E  +  DL  +I    +  Q L EE     + Q+   LK  H        VLHRD
Sbjct: 82  LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 96  LKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 154
           LKP+N+ L+   ++K+ DFGLAR+ + +T F   +V T +Y +PE  +N   Y    D+W
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE-QMNRMSYNEKSDIW 200
Query: 155 SVGCIFMELMDRKPLF 170
           S+GC+  EL    P F
Sbjct: 201 SLGCLLYELCALMPPF 216

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 71/136 (52%), Gaps = 12/136 (8%)
Query: 46  VYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIH-----SANVLHRD 95
           +YI  E  +  DL  +I    +  Q L EE     + Q+   LK  H        VLHRD
Sbjct: 82  LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 96  LKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 154
           LKP+N+ L+   ++K+ DFGLAR+ + +T F   +V T +Y +PE  +N   Y    D+W
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE-QMNRMSYNEKSDIW 200
Query: 155 SVGCIFMELMDRKPLF 170
           S+GC+  EL    P F
Sbjct: 201 SLGCLLYELCALMPPF 216

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 39/234 (16%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +++ + DI      E+  DV +  EL+   +L   +   ++L+E+    FL QIL G+ Y
Sbjct: 76  NIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 130
Query: 86  IHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 141
           +HS  + H DLKP N++L      N  +K+ DFG+A      +       T  + APE +
Sbjct: 131 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-I 189
Query: 142 LNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 200
           +N        D+WS+G I ++ L    P                           FL E 
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP---------------------------FLGET 222
Query: 201 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            ++ +  +         E F N    A D + ++L  DP++R+ +  +L H ++
Sbjct: 223 KQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 78/143 (54%), Gaps = 20/143 (13%)
Query: 57  LHQIIRSNQALSEEHCQYF--LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 114
           L+ +I S + L+++  +Y+    QIL  L YIHS  ++HRDLKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 115 GLAR---------------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           GLA+               +   +D +T  + T  Y A E+L  +  Y   ID++S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220
Query: 160 FMELMDRKPLFPGRDHVHQLRLL 182
           F E++   P   G + V+ L+ L
Sbjct: 221 FFEMI--YPFSTGMERVNILKKL 241

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 78/143 (54%), Gaps = 20/143 (13%)
Query: 57  LHQIIRSNQALSEEHCQYF--LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 114
           L+ +I S + L+++  +Y+    QIL  L YIHS  ++HRDLKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 115 GLAR---------------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           GLA+               +   +D +T  + T  Y A E+L  +  Y   ID++S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220
Query: 160 FMELMDRKPLFPGRDHVHQLRLL 182
           F E++   P   G + V+ L+ L
Sbjct: 221 FFEMI--YPFSTGMERVNILKKL 241

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 89  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 148
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 92/223 (41%), Gaps = 42/223 (18%)
Query: 41  ESFNDVYIAYEL-MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E   D+Y+  EL    +L + +   +   E      +  +L  + Y H  NV HRDLKP 
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPE 135
Query: 100 NLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           N L    + +  LK+ DFGLA        M   V T +Y +P++L     Y    D WS 
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPECDEWSA 193
Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           G +   L+   P F                  P++ E+             + + +  +F
Sbjct: 194 GVMMYVLLCGYPPF----------------SAPTDXEV-------------MLKIREGTF 224
Query: 217 TEKFP-----NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           T  FP     NV P A  L+ ++LT  P+QRIT   AL H + 
Sbjct: 225 T--FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 92/223 (41%), Gaps = 42/223 (18%)
Query: 41  ESFNDVYIAYEL-MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E   D+Y+  EL    +L + +   +   E      +  +L  + Y H  NV HRDLKP 
Sbjct: 93  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPE 152
Query: 100 NLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           N L    + +  LK+ DFGLA        M   V T +Y +P++L     Y    D WS 
Sbjct: 153 NFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPECDEWSA 210
Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           G +   L+   P F                  P++ E+             + + +  +F
Sbjct: 211 GVMMYVLLCGYPPF----------------SAPTDXEV-------------MLKIREGTF 241
Query: 217 TEKFP-----NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           T  FP     NV P A  L+ ++LT  P+QRIT   AL H + 
Sbjct: 242 T--FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 282

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 3/112 (2%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L   I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 116 LA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 75/133 (56%), Gaps = 5/133 (3%)
Query: 42  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS 99
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+     ++HRD+KPS
Sbjct: 137 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 196
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 197 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 254
Query: 160 FMEL-MDRKPLFP 171
            +E+ + R P+ P
Sbjct: 255 LVEMAVGRYPIPP 267

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175
Query: 127 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 168
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +P
Sbjct: 176 RNXFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEP 217

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 75/133 (56%), Gaps = 5/133 (3%)
Query: 42  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS 99
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+     ++HRD+KPS
Sbjct: 102 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 161
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 162 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 219
Query: 160 FMEL-MDRKPLFP 171
            +E+ + R P+ P
Sbjct: 220 LVEMAVGRYPIPP 232

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 62/107 (57%), Gaps = 5/107 (4%)
Query: 64  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 123
            + L E       +  L+GL Y+HS N++HRD+K  N+LL+    +K+ DFG A + +  
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207
Query: 124 DFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKP 168
           +    +V T ++ APE++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 208 N---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 127 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 168
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +P
Sbjct: 161 RNXFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEP 202

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 121 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 180
Query: 127 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 168
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +P
Sbjct: 181 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEP 222

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 127 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 168
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +P
Sbjct: 161 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEP 202

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 43  FNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           F+D    Y +++     ++++ ++      E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPE-MIEGRMHDEKVDLWSLGV 199
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 219 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 42  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 99
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 78  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 137
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+L+N+  ++K+CDFG++    + +   E+V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 138 NILVNSRGEIKLCDFGVSGQLID-EMANEFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 195
Query: 160 FMEL-MDRKPLFP 171
            +E+ + R P  P
Sbjct: 196 LVEMAVGRYPRPP 208

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 42  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 99
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 160 FMEL-MDRKPLFP 171
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 62/107 (57%), Gaps = 5/107 (4%)
Query: 64  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 123
            + L E       +  L+GL Y+HS N++HRD+K  N+LL+    +K+ DFG A + +  
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 124 DFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKP 168
           +    +V T ++ APE++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 169 N---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 117 ARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 175
           A         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  F  R  
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 176 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 235
             +                   N+  K+ + +    Q  ++ +KF    P++ D  E +L
Sbjct: 395 KVE-------------------NKELKQRVLE----QAVTYPDKF---SPASKDFCEALL 428
Query: 236 TFDPRQRITVEDA 248
             DP +R+   D 
Sbjct: 429 QKDPEKRLGFRDG 441

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 117 ARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 175
           A         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  F  R  
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 176 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 235
             +                   N+  K+ + +    Q  ++ +KF    P++ D  E +L
Sbjct: 395 KVE-------------------NKELKQRVLE----QAVTYPDKF---SPASKDFCEALL 428
Query: 236 TFDPRQRITVEDA 248
             DP +R+   D 
Sbjct: 429 QKDPEKRLGFRDG 441

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 117 ARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 175
           A         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  F  R  
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 176 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 235
             +                   N+  K+ + +    Q  ++ +KF    P++ D  E +L
Sbjct: 395 KVE-------------------NKELKQRVLE----QAVTYPDKF---SPASKDFCEALL 428
Query: 236 TFDPRQRITVEDA 248
             DP +R+   D 
Sbjct: 429 QKDPEKRLGFRDG 441

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 42  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 99
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 160 FMEL-MDRKPLFP 171
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 35/192 (18%)
Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR- 118
           +   +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL + 
Sbjct: 101 LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 160
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
              +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH   
Sbjct: 161 GIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--- 216
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD 238
              L ELI          + E       + PR            + P A  L+  +L  D
Sbjct: 217 -EKLFELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKD 249
Query: 239 PRQRI--TVEDA 248
           P+QR+    EDA
Sbjct: 250 PKQRLGGGSEDA 261

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLAG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 42  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 99
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 160 FMEL-MDRKPLFP 171
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 35/192 (18%)
Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR- 118
           +   +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL + 
Sbjct: 100 LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 159
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
              +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH   
Sbjct: 160 GIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--- 215
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD 238
              L ELI          + E       + PR            + P A  L+  +L  D
Sbjct: 216 -EKLFELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKD 248
Query: 239 PRQRI--TVEDA 248
           P+QR+    EDA
Sbjct: 249 PKQRLGGGSEDA 260

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 90/188 (47%), Gaps = 35/188 (18%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSE 122
           +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +
Sbjct: 243 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302
Query: 123 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 182
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L
Sbjct: 303 GATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL 357
Query: 183 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 242
            ELI          + E       + PR            + P A  L+  +L  DP+QR
Sbjct: 358 FELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKDPKQR 391
Query: 243 I--TVEDA 248
           +    EDA
Sbjct: 392 LGGGSEDA 399

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 90/188 (47%), Gaps = 35/188 (18%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSE 122
           +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +
Sbjct: 246 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 305
Query: 123 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 182
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L
Sbjct: 306 GATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL 360
Query: 183 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 242
            ELI          + E       + PR            + P A  L+  +L  DP+QR
Sbjct: 361 FELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKDPKQR 394
Query: 243 I--TVEDA 248
           +    EDA
Sbjct: 395 LGGGSEDA 402

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 90/188 (47%), Gaps = 35/188 (18%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSE 122
           +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +
Sbjct: 103 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 162
Query: 123 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 182
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L
Sbjct: 163 GATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL 217
Query: 183 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 242
            ELI          + E       + PR            + P A  L+  +L  DP+QR
Sbjct: 218 FELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKDPKQR 251
Query: 243 I--TVEDA 248
           +    EDA
Sbjct: 252 LGGGSEDA 259

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF---PGRDH 175
            T++    T    T +Y APE +L    Y  + D+WS+G I   L+   P F    G+  
Sbjct: 180 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237
Query: 176 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 235
              ++  I L       + GF N                    ++  V   A  L+  +L
Sbjct: 238 SPGMKRRIRL------GQYGFPN-------------------PEWSEVSEDAKQLIRLLL 272
Query: 236 TFDPRQRITVEDALAHPYLGSLHDISDEPV 265
             DP +R+T+   + HP++     +   P+
Sbjct: 273 KTDPTERLTITQFMNHPWINQSMVVPQTPL 302

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 117 ARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 175
           A         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  F  R  
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 176 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 235
             +                   N+  K+ + +    Q  ++ +KF    P++ D  E +L
Sbjct: 395 KVE-------------------NKELKQRVLE----QAVTYPDKF---SPASKDFCEALL 428
Query: 236 TFDPRQRITVEDA 248
             DP +R+   D 
Sbjct: 429 QKDPEKRLGFRDG 441

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 101 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF---PGRDH 175
            T++    T    T +Y APE +L    Y  + D+WS+G I   L+   P F    G+  
Sbjct: 161 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 218
Query: 176 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 235
              ++  I L       + GF N                    ++  V   A  L+  +L
Sbjct: 219 SPGMKRRIRL------GQYGFPN-------------------PEWSEVSEDAKQLIRLLL 253
Query: 236 TFDPRQRITVEDALAHPYLGSLHDISDEPV 265
             DP +R+T+   + HP++     +   P+
Sbjct: 254 KTDPTERLTITQFMNHPWINQSMVVPQTPL 283

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 42  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 99
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 160 FMEL-MDRKPLFP 171
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 42  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 99
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 160 FMEL-MDRKPLFP 171
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 80/147 (54%), Gaps = 3/147 (2%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +  +K+ DFG  A++T E    +E V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 208
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTP 189
           +++ +P +   + +  L  LI   GTP
Sbjct: 209 MIEGEPPYLNENPLRAL-YLIATNGTP 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 73/134 (54%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NL+++    +K+ DFGLA RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIKVTDFGLAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLXG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 115/235 (48%), Gaps = 42/235 (17%)
Query: 42  SFNDVYIAYELMDTDLHQIIRSNQ---ALSEEHCQYFLYQILR--------GLKYIHS-A 89
           ++++VYI YE M+ D   I++ ++    L + +  +   Q+++           YIH+  
Sbjct: 114 NYDEVYIIYEYMEND--SILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171
Query: 90  NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-----TRWYRAPELLLNS 144
           N+ HRD+KPSN+L++ N  +K+ DFG      E+++M +  +     T  +  PE   N 
Sbjct: 172 NICHRDVKPSNILMDKNGRVKLSDFG------ESEYMVDKKIKGSRGTYEFMPPEFFSNE 225
Query: 145 SDYTAA-IDVWSVG-CIFMELMDRKPLFPGRDHVHQLRL-LIELIGTPSEAELGF-LNEN 200
           S Y  A +D+WS+G C+++   +  P          L++ L+EL        + + L+ N
Sbjct: 226 SSYNGAKVDIWSLGICLYVMFYNVVPF--------SLKISLVELFNNIRTKNIEYPLDRN 277
Query: 201 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG 255
              Y    P   ++S T     +    ID ++  L  +P +RIT EDAL H +L 
Sbjct: 278 HFLY----PLTNKKS-TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 75/140 (53%), Gaps = 3/140 (2%)
Query: 52  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 111
           L   DL   +      +EE  +++L ++  GL ++HS  +++RDLKP N+LL+    +K+
Sbjct: 112 LRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKL 171
Query: 112 CDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
            DFGL++   + +     +  T  Y APE ++N   ++ + D WS G +  E++     F
Sbjct: 172 TDFGLSKEAIDHEKKAYSFCGTVEYMAPE-VVNRQGHSHSADWWSYGVLMFEMLTGSLPF 230
Query: 171 PGRDHVHQLRLLIEL-IGTP 189
            G+D    + L+++  +G P
Sbjct: 231 QGKDRKETMTLILKAKLGMP 250

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 8/138 (5%)
Query: 40  RESFNDVYIAYELMD----TDLHQIIRSNQAL--SEEHCQYFLYQILRGLKYIHSANVLH 93
           RESF +    Y +MD     DL + I + + +   E+    +  QI   LK++H   +LH
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 94  RDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAID 152
           RD+K  N+ L  +  +++ DFG+ARV + T +     + T +Y +PE+  N   Y    D
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP-YNNKSD 207
Query: 153 VWSVGCIFMELMDRKPLF 170
           +W++GC+  EL   K  F
Sbjct: 208 IWALGCVLYELCTLKHAF 225

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 123 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 178
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 179 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 234
Query: 166 RKPLF 170
             P F
Sbjct: 235 GYPPF 239

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 74/142 (52%), Gaps = 5/142 (3%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           N  ++   L   DL   I+S          ++  +I+ GL+++HS  +++RDLK  N+LL
Sbjct: 93  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 152
Query: 104 NANCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
           + +  +KI DFG+ +     D  T E+  T  Y APE+LL    Y  ++D WS G +  E
Sbjct: 153 DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYE 211
Query: 163 LMDRKPLFPGRDH---VHQLRL 181
           ++  +  F G+D     H +R+
Sbjct: 212 MLIGQSPFHGQDEEELFHSIRM 233

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 70/127 (55%), Gaps = 7/127 (5%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           +F D    + +MD     +L  ++R +Q       +++  ++   L+Y+HS ++++RDLK
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133
Query: 98  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           P N+LL+ N  +KI DFG A+   +  +      T  Y APE ++++  Y  +ID WS G
Sbjct: 134 PENILLDKNGHIKITDFGFAKYVPDVTYXL--CGTPDYIAPE-VVSTKPYNKSIDWWSFG 190
Query: 158 CIFMELM 164
            +  E++
Sbjct: 191 ILIYEML 197

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 63/111 (56%), Gaps = 5/111 (4%)
Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RV 119
           +R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++    +K+ DFG A RV
Sbjct: 133 LRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV 192
Query: 120 TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
              T  +     T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 193 KGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 109 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQ 164
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 165 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 220
Query: 166 RKPLF 170
             P F
Sbjct: 221 GYPPF 225

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 143 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 198
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 199 GYIQVTDFGFAKRVKGATWTLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 254
Query: 166 RKPLF 170
             P F
Sbjct: 255 GYPPF 259

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 40/230 (17%)
Query: 28  VVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           ++ +  +I  P      D ++  E +   +L   I  +  + E   +    QIL  + Y 
Sbjct: 73  IIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           H   V+HRDLKP N+LL+A+ + KI DFGL+ + S+ +F+ +   +  Y APE++     
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187
Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-PSEAE-LGFLNENAKKY 204
               +D+WS G I   L                     L GT P + E +  L +  +  
Sbjct: 188 AGPEVDIWSCGVILYAL---------------------LCGTLPFDDEHVPTLFKKIRGG 226
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +  +P Y  +S              L+  ML  DP +R T++D   H + 
Sbjct: 227 VFYIPEYLNRSVAT-----------LLMHMLQVDPLKRATIKDIREHEWF 265

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 76/143 (53%), Gaps = 20/143 (13%)
Query: 57  LHQIIRSNQALSEEHCQYF--LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 114
           L+ +I S + L+++  +Y+    QIL  L YIHS  ++HR+LKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDF 160
Query: 115 GLAR---------------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           GLA+               +   +D +T  + T  Y A E+L  +  Y   ID +S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGII 220
Query: 160 FMELMDRKPLFPGRDHVHQLRLL 182
           F E +   P   G + V+ L+ L
Sbjct: 221 FFEXI--YPFSTGXERVNILKKL 241

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 73/134 (54%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NL+++    +++ DFGLA RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIQVTDFGLAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 75/140 (53%), Gaps = 3/140 (2%)
Query: 52  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 111
           L   DL   +      +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+
Sbjct: 108 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 167
Query: 112 CDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
            DFGL++ + + +     +  T  Y APE ++N   +T + D WS G +  E++     F
Sbjct: 168 TDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 171 PGRDHVHQLRLLIEL-IGTP 189
            G+D    + ++++  +G P
Sbjct: 227 QGKDRKETMTMILKAKLGMP 246

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 41  ESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           ES ND+ +  E +D      +II  +  L+E     F+ QI  G++++H   +LH DLKP
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKP 215
Query: 99  SNLL-LNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
            N+L +N +   +KI DFGLAR     + +     T  + APE++ N    +   D+WSV
Sbjct: 216 ENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSV 274
Query: 157 GCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           G I +M L    P                           FL +N  + +  +   +   
Sbjct: 275 GVIAYMLLSGLSP---------------------------FLGDNDAETLNNILACRWDL 307
Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             E+F ++   A + + K+L  +   RI+  +AL HP+L
Sbjct: 308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     +E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 190 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 245
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 246 GVLIYEMAAGYPPF 259

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  ++  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYQMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 75/140 (53%), Gaps = 3/140 (2%)
Query: 52  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 111
           L   DL   +      +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+
Sbjct: 109 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 168
Query: 112 CDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
            DFGL++ + + +     +  T  Y APE ++N   +T + D WS G +  E++     F
Sbjct: 169 TDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPF 227
Query: 171 PGRDHVHQLRLLIEL-IGTP 189
            G+D    + ++++  +G P
Sbjct: 228 QGKDRKETMTMILKAKLGMP 247

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 96/246 (39%), Gaps = 59/246 (23%)
Query: 66  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETD 124
           +LS +  + ++  + + LK IH   ++HRD+KPSN L N       + DFGLA+ T +T 
Sbjct: 113 SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172
Query: 125 F-----------------------------MTEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
                                         +     T  +RAPE+L    + T AID+WS
Sbjct: 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232
Query: 156 VGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC--QLPRYQ 212
            G IF+ L+  R P +   D +  L  ++ + G  S   +       K  +C  ++P   
Sbjct: 233 AGVIFLSLLSGRYPFYKASDDLTALAQIMTIRG--SRETIQAAKTFGKSILCSKEVPAQD 290
Query: 213 RQSFTEKFPNVHPSAIDLVEKM------------------------LTFDPRQRITVEDA 248
            +   E+   +  S   L   +                        L  +P  RIT E+A
Sbjct: 291 LRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEA 350
Query: 249 LAHPYL 254
           L HP+ 
Sbjct: 351 LLHPFF 356

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 75/140 (53%), Gaps = 3/140 (2%)
Query: 52  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 111
           L   DL   +      +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+
Sbjct: 108 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 167
Query: 112 CDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 170
            DFGL++ + + +     +  T  Y APE ++N   +T + D WS G +  E++     F
Sbjct: 168 TDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 171 PGRDHVHQLRLLIEL-IGTP 189
            G+D    + ++++  +G P
Sbjct: 227 QGKDRKETMTMILKAKLGMP 246

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 40/230 (17%)
Query: 28  VVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           ++ +  +I  P      D ++  E +   +L   I  +  + E   +    QIL  + Y 
Sbjct: 73  IIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           H   V+HRDLKP N+LL+A+ + KI DFGL+ + S+ +F+     +  Y APE++     
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-PSEAE-LGFLNENAKKY 204
               +D+WS G I   L                     L GT P + E +  L +  +  
Sbjct: 188 AGPEVDIWSCGVILYAL---------------------LCGTLPFDDEHVPTLFKKIRGG 226
Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +  +P Y  +S              L+  ML  DP +R T++D   H + 
Sbjct: 227 VFYIPEYLNRSVAT-----------LLMHMLQVDPLKRATIKDIREHEWF 265

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 81/153 (52%), Gaps = 8/153 (5%)
Query: 44  NDVYIAYELMDT-DLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           N++ I  EL D  DL ++I+      + + E     +  Q+   L+++HS  V+HRD+KP
Sbjct: 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKP 164
Query: 99  SNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           +N+ + A   +K+ D GL R  +S+T      V T +Y +PE  ++ + Y    D+WS+G
Sbjct: 165 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLG 223
Query: 158 CIFMELMD-RKPLFPGRDHVHQLRLLIELIGTP 189
           C+  E+   + P +  + +++ L   IE    P
Sbjct: 224 CLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 256

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 46/255 (18%)
Query: 43  FNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
           ++ + + +E +   L++II  N       E  + +  +IL+ L Y+   ++ H DLKP N
Sbjct: 108 YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPEN 167
Query: 101 LLLN-------------------------ANCDLKICDFGLARVTSETDFMTEYVVTRWY 135
           +LL+                          +  +K+ DFG A  T ++D+    + TR Y
Sbjct: 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQY 225
Query: 136 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSEAEL 194
           RAPE++LN   +  + D+WS GC+  EL     LF   +H+  L ++  +I   P     
Sbjct: 226 RAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
Query: 195 GFLNENAKKYI----CQLPRYQRQSFTEKFPNV-----------HPSAIDLVEKMLTFDP 239
                N  KY+     +L   +  S      +V           H    D +  +L  DP
Sbjct: 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344
Query: 240 RQRITVEDALAHPYL 254
             R +  + L H +L
Sbjct: 345 TLRPSPAELLKHKFL 359

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 143 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 198
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 199 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 254
Query: 166 RKPLF 170
             P F
Sbjct: 255 GYPPF 259

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NL+++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE+++ S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIII-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 162 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 217
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 218 GVLIYEMAAGYPPF 231

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 79/147 (53%), Gaps = 3/147 (2%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 91  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 150
Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +  +K+ DFG  A++T E    +  V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 151 GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 209
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTP 189
           +++ +P +   + +  L  LI   GTP
Sbjct: 210 MIEGEPPYLNENPLRAL-YLIATNGTP 235

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 79/147 (53%), Gaps = 3/147 (2%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +  +K+ DFG  A++T E    +  V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 208
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTP 189
           +++ +P +   + +  L  LI   GTP
Sbjct: 209 MIEGEPPYLNENPLRAL-YLIATNGTP 234

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 18  CFDTWIMKT----SVVAIRDIIPPPQRESFNDV-YIAYELMDT-DLHQIIRSNQ---ALS 68
           C +  IMK     +VV+ R++    Q+ + ND+  +A E  +  DL + +   +    L 
Sbjct: 61  CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 120
Query: 69  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL---KICDFGLARVTSETDF 125
           E   +  L  I   L+Y+H   ++HRDLKP N++L         KI D G A+   + + 
Sbjct: 121 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 126 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFP 171
            TE+V T  Y APE LL    YT  +D WS G +  E +   +P  P
Sbjct: 181 CTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 18  CFDTWIMKT----SVVAIRDIIPPPQRESFNDV-YIAYELMDT-DLHQIIRSNQ---ALS 68
           C +  IMK     +VV+ R++    Q+ + ND+  +A E  +  DL + +   +    L 
Sbjct: 60  CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 69  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL---KICDFGLARVTSETDF 125
           E   +  L  I   L+Y+H   ++HRDLKP N++L         KI D G A+   + + 
Sbjct: 120 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 126 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFP 171
            TE+V T  Y APE LL    YT  +D WS G +  E +   +P  P
Sbjct: 180 CTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 79/147 (53%), Gaps = 3/147 (2%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +  +K+ DFG  A++T E    +  V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 208
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTP 189
           +++ +P +   + +  L  LI   GTP
Sbjct: 209 MIEGEPPYLNENPLRAL-YLIATNGTP 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 154
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 155 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 210
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 211 GVLIYEMAAGYPPF 224

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 117 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 172
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 173 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 228
Query: 166 RKPLF 170
             P F
Sbjct: 229 GYPPF 233

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 73/142 (51%), Gaps = 5/142 (3%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           N  ++   L   DL   I+S          ++  +I+ GL+++HS  +++RDLK  N+LL
Sbjct: 92  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 104 NANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
           + +  +KI DFG+ +     D  T  +  T  Y APE+LL    Y  ++D WS G +  E
Sbjct: 152 DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYE 210
Query: 163 LMDRKPLFPGRDH---VHQLRL 181
           ++  +  F G+D     H +R+
Sbjct: 211 MLIGQSPFHGQDEEELFHSIRM 232

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 73/129 (56%), Gaps = 11/129 (8%)
Query: 46  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           V I  EL++   L Q+++    L E+   Y+L Q L GL+Y+HS  +LH D+K  N+LL+
Sbjct: 160 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 219
Query: 105 ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 156
           ++     +CDFG A V  + D + + ++T  Y        APE++L  S   A +DVWS 
Sbjct: 220 SDGSHAALCDFGHA-VCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSS 277
Query: 157 GCIFMELMD 165
            C+ + +++
Sbjct: 278 CCMMLHMLN 286

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T  Y AP ++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPAIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NL+++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           D   H          E    ++  +I  GL+ +H   +++RDLKP N+LL+ +  ++I D
Sbjct: 270 DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISD 329
Query: 114 FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 173
            GLA    E   +   V T  Y APE++ N   YT + D W++GC+  E++       G+
Sbjct: 330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQ 382
Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
               Q +  I+              E  ++ + ++P    + ++E+F    P A  L  +
Sbjct: 383 SPFQQRKKKIK-------------REEVERLVKEVP----EEYSERF---SPQARSLCSQ 422
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
           +L  DP +R+           GS  ++ + P+
Sbjct: 423 LLCKDPAERLGCRG-------GSAREVKEHPL 447

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 54  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 113
           D   H          E    ++  +I  GL+ +H   +++RDLKP N+LL+ +  ++I D
Sbjct: 270 DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISD 329
Query: 114 FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 173
            GLA    E   +   V T  Y APE++ N   YT + D W++GC+  E++       G+
Sbjct: 330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQ 382
Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
               Q +  I+              E  ++ + ++P    + ++E+F    P A  L  +
Sbjct: 383 SPFQQRKKKIK-------------REEVERLVKEVP----EEYSERF---SPQARSLCSQ 422
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
           +L  DP +R+           GS  ++ + P+
Sbjct: 423 LLCKDPAERLGCRG-------GSAREVKEHPL 447

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 11/145 (7%)
Query: 46  VYIAYELM-DTDLHQIIRSNQALSEEHCQY--FLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +YI  E M    L   ++S++   +   +   F  QI  G+ +I   N +HRDL+ +N+L
Sbjct: 84  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 143
Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVT---RWYRAPELLLNSSDYTAAIDVWSVGCI 159
           ++A+   KI DFGLARV  + ++          +W  APE  +N   +T   DVWS G +
Sbjct: 144 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIKSDVWSFGIL 201
Query: 160 FMELM--DRKPLFPGRDHVHQLRLL 182
            ME++   R P +PG  +   +R L
Sbjct: 202 LMEIVTYGRIP-YPGMSNPEVIRAL 225

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 23/199 (11%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL 169
Query: 127 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 186
            E+  +  Y APEL          +DVWS+G I   L+     F G++            
Sbjct: 170 DEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------ 217
Query: 187 GTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
                  L  L E   +   ++P Y     ++  +KF  ++PS    +E+++  D    +
Sbjct: 218 -------LKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNV 269
Query: 244 TVEDALAHPYLGSLHDISD 262
             ED    PY+  L D  D
Sbjct: 270 GHEDDELKPYVEPLPDYKD 288

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 73/129 (56%), Gaps = 11/129 (8%)
Query: 46  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           V I  EL++   L Q+++    L E+   Y+L Q L GL+Y+HS  +LH D+K  N+LL+
Sbjct: 141 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 200
Query: 105 ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 156
           ++     +CDFG A V  + D + + ++T  Y        APE++L  S   A +DVWS 
Sbjct: 201 SDGSHAALCDFGHA-VCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSS 258
Query: 157 GCIFMELMD 165
            C+ + +++
Sbjct: 259 CCMMLHMLN 267

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 11/145 (7%)
Query: 46  VYIAYELM-DTDLHQIIRSNQALSEEHCQY--FLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +YI  E M    L   ++S++   +   +   F  QI  G+ +I   N +HRDL+ +N+L
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316
Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVT---RWYRAPELLLNSSDYTAAIDVWSVGCI 159
           ++A+   KI DFGLARV  + ++          +W  APE  +N   +T   DVWS G +
Sbjct: 317 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIKSDVWSFGIL 374
Query: 160 FMELM--DRKPLFPGRDHVHQLRLL 182
            ME++   R P +PG  +   +R L
Sbjct: 375 LMEIVTYGRIP-YPGMSNPEVIRAL 398

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 66/120 (55%), Gaps = 3/120 (2%)
Query: 52  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 111
           L+  DL   ++ N    EE  + F+ +++  L Y+ +  ++HRD+KP N+LL+ +  + I
Sbjct: 97  LLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHI 156
Query: 112 CDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELM-DRKP 168
            DF +A +      +T    T+ Y APE+  +   + Y+ A+D WS+G    EL+  R+P
Sbjct: 157 TDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 107 CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 165
             +++ DFG A RV   T  +     T    APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 166 RKPLF 170
             P F
Sbjct: 234 GYPPF 238

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 47  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N+L++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISA 151
Query: 106 NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 162 ELMDRKPLFPG 172
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 66/113 (58%), Gaps = 9/113 (7%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 116 LARVTSETDFMTEY----VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 162 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 217
Query: 157 GCIFMELMDRKPLF 170
           G +  E+    P F
Sbjct: 218 GVLIYEMAAGYPPF 231

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 66/113 (58%), Gaps = 9/113 (7%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 277 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 336
Query: 116 LARVTSETDFMTEY----VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 337 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 66/113 (58%), Gaps = 9/113 (7%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 116 LARVTSETDFMTEY----VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 66/113 (58%), Gaps = 9/113 (7%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 116 LARVTSETDFMTEY----VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           LA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 79/147 (53%), Gaps = 3/147 (2%)
Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +++++  E +       + +   + E        + L+ L+++HS  V+HR++K  N+LL
Sbjct: 91  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILL 150
Query: 104 NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +  +K+ DFG  A++T E    +  V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 151 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 209
Query: 163 LMDRKPLFPGRDHVHQLRLLIELIGTP 189
           +++ +P +   + +  L  LI   GTP
Sbjct: 210 MIEGEPPYLNENPLRAL-YLIATNGTP 235

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 65/117 (55%), Gaps = 3/117 (2%)
Query: 59  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 118
           Q+ R    + +  C ++L +I   L ++H   +++RDLKP N++LN    +K+ DFGL +
Sbjct: 111 QLEREGIFMEDTAC-FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 119 VTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
            +     +T  +  T  Y APE+L+ S  +  A+D WS+G +  +++   P F G +
Sbjct: 170 ESIHDGTVTHXFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 65/117 (55%), Gaps = 3/117 (2%)
Query: 59  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 118
           Q+ R    + +  C ++L +I   L ++H   +++RDLKP N++LN    +K+ DFGL +
Sbjct: 111 QLEREGIFMEDTAC-FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 119 VTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
            +     +T  +  T  Y APE+L+ S  +  A+D WS+G +  +++   P F G +
Sbjct: 170 ESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 109/239 (45%), Gaps = 57/239 (23%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQY--------FLYQILRGLKYIHSANVLHRDLK 97
           +YIA EL + +L  ++ S + +S+E+ +          L QI  G+ ++HS  ++HRDLK
Sbjct: 84  LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 98  PSNLLLNA-------------NCDLKICDFGLARV--TSETDFMTEY---VVTRWYRAPE 139
           P N+L++              N  + I DFGL +   + ++ F T       T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202
Query: 140 LLLNSSD------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 193
           LL  S++       T +ID++S+GC+F  ++  K   P  D   +   +I   G  S  E
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILS-KGKHPFGDKYSRESNIIR--GIFSLDE 259
Query: 194 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
           +  L++ +                     +   A DL+ +M+  DP +R T    L HP
Sbjct: 260 MKCLHDRS---------------------LIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 35/233 (15%)
Query: 44  NDVYIAYELMDTDLHQIIRS-----NQALSEEHCQYFLYQILRGLKYI-HSANVLHRDLK 97
            D +I  ELM T   +  +      +  + EE         ++ L ++  +  ++HRD+K
Sbjct: 94  GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153
Query: 98  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD---YTAAIDVW 154
           PSN+LL+ + ++K+CDFG++    ++   T     R Y APE +  S+    Y    DVW
Sbjct: 154 PSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213
Query: 155 SVGCIFMELMDRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 213
           S+G    EL   +  +P  + V  QL  +++  G P                 QL   + 
Sbjct: 214 SLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPP----------------QLSNSEE 255
Query: 214 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           + F+       PS I+ V   LT D  +R   ++ L HP++    + + E  C
Sbjct: 256 REFS-------PSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVAC 301

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 96  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155
Query: 116 LARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 156 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 210
Query: 175 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 234
                    +++G+    +     +N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 211 ---------DIVGSSDNPD-----QNTEDYLFQV-ILEKQIRIPRSLSVKAASV--LKSF 253
Query: 235 LTFDPRQRI------TVEDALAHPYLGSLH-DISDEPVCMSPFS 271
           L  DP++R+         D   HP+  ++  D+ ++   + PF 
Sbjct: 254 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFK 297

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 41  ESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           E  N++ + YE M       ++   +  +SE+    ++ Q+ +GL ++H  N +H DLKP
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 283
Query: 99  SNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
            N++     + +LK+ DFGL         +     T  + APE +          D+WSV
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSV 342
Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           G +   L+     F G +    LR +        ++    ++E+ K              
Sbjct: 343 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK-------------- 388
Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                       D + K+L  DP  R+T+  AL HP+L
Sbjct: 389 ------------DFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 41  ESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           E  N++ + YE M       ++   +  +SE+    ++ Q+ +GL ++H  N +H DLKP
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 177
Query: 99  SNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
            N++     + +LK+ DFGL         +     T  + APE +          D+WSV
Sbjct: 178 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSV 236
Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           G +   L+     F G +    LR +        ++    ++E+ K              
Sbjct: 237 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK-------------- 282
Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                       D + K+L  DP  R+T+  AL HP+L
Sbjct: 283 ------------DFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 108/223 (48%), Gaps = 30/223 (13%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 107 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 166
Query: 116 LARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 167 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 221
Query: 175 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 234
                    +++G+         ++N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 222 ---------DIVGSSDNP-----DQNTEDYLFQVI-LEKQIRIPRSMSVKAASV--LKSF 264
Query: 235 LTFDPRQRI------TVEDALAHPYLGSLH-DISDEPVCMSPF 270
           L  DP++R+         D   HP+  ++  D+ ++   + PF
Sbjct: 265 LNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF 307

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 108/223 (48%), Gaps = 30/223 (13%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 92  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 151
Query: 116 LARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 152 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 206
Query: 175 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 234
                    +++G+         ++N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 207 ---------DIVGSSDNP-----DQNTEDYLFQVI-LEKQIRIPRSLSVKAASV--LKSF 249
Query: 235 LTFDPRQRI------TVEDALAHPYLGSLH-DISDEPVCMSPF 270
           L  DP++R+         D   HP+  ++  D+ ++   + PF
Sbjct: 250 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF 292

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 23/199 (11%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL 169
Query: 127 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 186
             +  +  Y APEL          +DVWS+G I   L+     F G++            
Sbjct: 170 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------ 217
Query: 187 GTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
                  L  L E   +   ++P Y     ++  +KF  ++PS    +E+++  D    +
Sbjct: 218 -------LKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNV 269
Query: 244 TVEDALAHPYLGSLHDISD 262
             ED    PY+  L D  D
Sbjct: 270 GHEDDELKPYVAPLPDYKD 288

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 108/223 (48%), Gaps = 30/223 (13%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 116 LARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 199 MCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 253
Query: 175 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 234
                    +++G+         ++N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 254 ---------DIVGSSDNP-----DQNTEDYLFQVI-LEKQIRIPRSLSVKAASV--LKSF 296
Query: 235 LTFDPRQRI------TVEDALAHPYLGSLH-DISDEPVCMSPF 270
           L  DP++R+         D   HP+  ++  D+ ++   + PF
Sbjct: 297 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF 339

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 47  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 106 NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 162 ELMDRKPLFPG 172
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 47  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 106 NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 162 ELMDRKPLFPG 172
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 47  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 106 NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 162 ELMDRKPLFPG 172
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 44/206 (21%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLL---NANCDLK--ICDFGLAR--VTSETDFMT 127
            L Q   GL ++HS N++HRDLKP N+L+   NA+  +K  I DFGL +        F  
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 128 EYVV--TRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 183
              V  T  + APE+L      + T  +D++S GC+F  ++       G+    Q  +L+
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242
Query: 184 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
                            A    C  P        EK  +V   A +L+EKM+  DP++R 
Sbjct: 243 ----------------GACSLDCLHP--------EKHEDV--IARELIEKMIAMDPQKRP 276
Query: 244 TVEDALAHPYLGSL-------HDISD 262
           + +  L HP+  SL        D+SD
Sbjct: 277 SAKHVLKHPFFWSLEKQLQFFQDVSD 302

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 47  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 106 NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 162 ELMDRKPLFPG 172
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 47  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 109 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 168
Query: 106 NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 169 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 227
Query: 162 ELMDRKPLFPG 172
           E++  +P F G
Sbjct: 228 EVLTGEPPFTG 238

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 123 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 182
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 183 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 231

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 53/235 (22%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQY--------FLYQILRGLKYIHSANVLHRDLK 97
           +YIA EL + +L  ++ S + +S+E+ +          L QI  G+ ++HS  ++HRDLK
Sbjct: 102 LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 160
Query: 98  PSNLLLNA-------------NCDLKICDFGLARV--TSETDF---MTEYVVTRWYRAPE 139
           P N+L++              N  + I DFGL +   + +  F   +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 140 LLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 197
           LL  S+    T +ID++S+GC+F  ++  K   P  D   +   +I   G  S  E+  L
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILS-KGKHPFGDKYSRESNIIR--GIFSLDEMKCL 277
Query: 198 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
           ++ +                     +   A DL+ +M+  DP +R T    L HP
Sbjct: 278 HDRS---------------------LIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 195 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 53/235 (22%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQY--------FLYQILRGLKYIHSANVLHRDLK 97
           +YIA EL + +L  ++ S + +S+E+ +          L QI  G+ ++HS  ++HRDLK
Sbjct: 102 LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 160
Query: 98  PSNLLLNA-------------NCDLKICDFGLARV--TSETDF---MTEYVVTRWYRAPE 139
           P N+L++              N  + I DFGL +   + +  F   +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 140 LLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 197
           LL  S+    T +ID++S+GC+F  ++  K   P  D   +   +I   G  S  E+  L
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILS-KGKHPFGDKYSRESNIIR--GIFSLDEMKCL 277
Query: 198 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
           ++ +                     +   A DL+ +M+  DP +R T    L HP
Sbjct: 278 HDRS---------------------LIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 23/199 (11%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL 169
Query: 127 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 186
             +  +  Y APEL          +DVWS+G I   L+     F G++            
Sbjct: 170 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------ 217
Query: 187 GTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
                  L  L E   +   ++P Y     ++  +KF  ++PS    +E+++  D    +
Sbjct: 218 -------LKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNV 269
Query: 244 TVEDALAHPYLGSLHDISD 262
             ED    PY+  L D  D
Sbjct: 270 GHEDDELKPYVEPLPDYKD 288

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 160 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 160 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 23/199 (11%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +
Sbjct: 103 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL 162
Query: 127 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 186
             +  +  Y APEL          +DVWS+G I   L+     F G++            
Sbjct: 163 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------ 210
Query: 187 GTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
                  L  L E   +   ++P Y     ++  +KF  ++PS    +E+++  D    +
Sbjct: 211 -------LKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNV 262
Query: 244 TVEDALAHPYLGSLHDISD 262
             ED    PY+  L D  D
Sbjct: 263 GHEDDELKPYVEPLPDYKD 281

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 35/87 (40%), Positives = 50/87 (57%), Gaps = 1/87 (1%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 137
           QI +G+ YIHS  ++HRDLKPSN+ L     +KI DFGL          T    T  Y +
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 203
Query: 138 PELLLNSSDYTAAIDVWSVGCIFMELM 164
           PE  ++S DY   +D++++G I  EL+
Sbjct: 204 PE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 23/199 (11%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL 169
Query: 127 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 186
             +  +  Y APEL          +DVWS+G I   L+     F G++            
Sbjct: 170 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------ 217
Query: 187 GTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
                  L  L E   +   ++P Y     ++  +KF  ++PS    +E+++  D    +
Sbjct: 218 -------LKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNV 269
Query: 244 TVEDALAHPYLGSLHDISD 262
             ED    PY+  L D  D
Sbjct: 270 GHEDDELKPYVEPLPDYKD 288

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 158
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 159 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 207

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 208 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 256

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 125
           L+E   Q    Q L  L Y+H   ++HRDLK  N+L   + D+K+ DFG+ A+ T     
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 126 MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 181
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+ +   + P    ++ +R+
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 182 LIELIGT--PSEAELGFLNENAKKYI 205
           L+++  +  P+ A+    + N K ++
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFL 274

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 125
           L+E   Q    Q L  L Y+H   ++HRDLK  N+L   + D+K+ DFG+ A+ T     
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 191
Query: 126 MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 181
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+ +   + P    ++ +R+
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 182 LIELIGT--PSEAELGFLNENAKKYI 205
           L+++  +  P+ A+    + N K ++
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFL 274

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 114
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 74/142 (52%), Gaps = 15/142 (10%)
Query: 46  VYIAYELM-DTDLHQIIRSNQALSEEHCQY--FLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +YI  E M    L   ++S++   +   +   F  QI  G+ +I   N +HRDL+ +N+L
Sbjct: 251 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 310
Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
           ++A+   KI DFGLARV ++          +W  APE  +N   +T   DVWS G + ME
Sbjct: 311 VSASLVCKIADFGLARVGAK-------FPIKW-TAPE-AINFGSFTIKSDVWSFGILLME 361
Query: 163 LM--DRKPLFPGRDHVHQLRLL 182
           ++   R P +PG  +   +R L
Sbjct: 362 IVTYGRIP-YPGMSNPEVIRAL 382

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 108/241 (44%), Gaps = 40/241 (16%)
Query: 46  VYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLL 102
           V + +E++  +L  +I+   ++ +   + +    Q+L GL Y+H    ++H D+KP N+L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 103 LNAN------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           +           +KI D G A    E    T  + TR YR+PE+LL +  +    D+WS 
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWST 221
Query: 157 GCIFMELMDRKPLF-PGRDHVH-----QLRLLIELIGT-PSEAELGFLNENAK------- 202
            C+  EL+    LF P   H +      +  +IEL+G  PS     +L  N K       
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS-----YLLRNGKYTRTFFN 276
Query: 203 -----KYICQLPRYQRQS-FTEKFPNVHPSA---IDLVEKMLTFDPRQRITVEDALAHPY 253
                + I +L  +  +   TEK+      A    D +  ML  DPR+R      + HP+
Sbjct: 277 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 336
Query: 254 L 254
           L
Sbjct: 337 L 337

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 125
           L+E   Q    Q L  L Y+H   ++HRDLK  N+L   + D+K+ DFG+ A+ T     
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 126 MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 181
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+ +   + P    ++ +R+
Sbjct: 192 RDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 182 LIELIGT--PSEAELGFLNENAKKYI 205
           L+++  +  P+ A+    + N K ++
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFL 274

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 23/199 (11%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +
Sbjct: 110 MKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL 169
Query: 127 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 186
             +     Y APEL          +DVWS+G I   L+     F G++            
Sbjct: 170 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------ 217
Query: 187 GTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 243
                  L  L E   +   ++P Y     ++  +KF  ++PS    +E+++  D    +
Sbjct: 218 -------LKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNV 269
Query: 244 TVEDALAHPYLGSLHDISD 262
             ED    PY+  L D  D
Sbjct: 270 GHEDDELKPYVEPLPDYKD 288

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 108/241 (44%), Gaps = 40/241 (16%)
Query: 46  VYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLL 102
           V + +E++  +L  +I+   ++ +   + +    Q+L GL Y+H    ++H D+KP N+L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 103 LNAN------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           +           +KI D G A    E    T  + TR YR+PE+LL +  +    D+WS 
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWST 221
Query: 157 GCIFMELMDRKPLF-PGRDHVH-----QLRLLIELIGT-PSEAELGFLNENAK------- 202
            C+  EL+    LF P   H +      +  +IEL+G  PS     +L  N K       
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS-----YLLRNGKYTRTFFN 276
Query: 203 -----KYICQLPRYQRQS-FTEKFPNVHPSA---IDLVEKMLTFDPRQRITVEDALAHPY 253
                + I +L  +  +   TEK+      A    D +  ML  DPR+R      + HP+
Sbjct: 277 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 336
Query: 254 L 254
           L
Sbjct: 337 L 337

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 56/108 (51%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +    +
Sbjct: 108 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 167
Query: 127 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
             +  +  Y APEL          +DVWS+G I   L+     F G++
Sbjct: 168 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 55/104 (52%), Gaps = 2/104 (1%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICD 113
           +L++ I +    SE+  ++F  Q+L G+ Y HS  + HRDLK  N LL+ +    LKICD
Sbjct: 102 ELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD 161
Query: 114 FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           FG ++ +         V T  Y APE+LL         DVWS G
Sbjct: 162 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCG 205

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 64  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 123
           ++ L+E   Q    Q+L  L ++HS  ++HRDLK  N+L+    D+++ DFG++    +T
Sbjct: 111 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170
Query: 124 -DFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
                 ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P    ++ 
Sbjct: 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 227
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 232
           +R+L+++  +     L        K+  +   + + +  +K P   PSA  L+E
Sbjct: 228 MRVLLKIAKSDPPTLL-----TPSKWSVEFRDFLKIAL-DKNPETRPSAAQLLE 275

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +    +
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170
Query: 127 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
             +     Y APEL          +DVWS+G I   L+     F G++
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L++ ++ +    E+    F+ ++   L Y H   V+HRD+KP NLL+    +LKI DFG
Sbjct: 100 ELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159
Query: 116 LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF--PGR 173
            + V + +        T  Y  PE ++    +   +D+W  G +  E +   P F  P  
Sbjct: 160 WS-VHAPSLRRRXMCGTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217
Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
              H+  + ++L   P      FL++ +K                          DL+ K
Sbjct: 218 TETHRRIVNVDLKFPP------FLSDGSK--------------------------DLISK 245
Query: 234 MLTFDPRQRITVEDALAHPYLGS 256
           +L + P QR+ ++  + HP++ +
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVKA 268

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L++ ++ +    E+    F+ ++   L Y H   V+HRD+KP NLL+    +LKI DFG
Sbjct: 101 ELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 160
Query: 116 LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF--PGR 173
            + V + +        T  Y  PE ++    +   +D+W  G +  E +   P F  P  
Sbjct: 161 WS-VHAPSLRRRXMCGTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 218
Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
              H+  + ++L   P      FL++ +K                          DL+ K
Sbjct: 219 TETHRRIVNVDLKFPP------FLSDGSK--------------------------DLISK 246
Query: 234 MLTFDPRQRITVEDALAHPYLGS 256
           +L + P QR+ ++  + HP++ +
Sbjct: 247 LLRYHPPQRLPLKGVMEHPWVKA 269

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 64  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 123
           ++ L+E   Q    Q+L  L ++HS  ++HRDLK  N+L+    D+++ DFG++    +T
Sbjct: 103 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 162
Query: 124 -DFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
                 ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P    ++ 
Sbjct: 163 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 219
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 232
           +R+L+++  +     L        K+  +   + + +  +K P   PSA  L+E
Sbjct: 220 MRVLLKIAKSDPPTLL-----TPSKWSVEFRDFLKIAL-DKNPETRPSAAQLLE 267

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 108/239 (45%), Gaps = 57/239 (23%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQY--------FLYQILRGLKYIHSANVLHRDLK 97
           +YIA EL + +L  ++ S + +S+E+ +          L QI  G+ ++HS  ++HRDLK
Sbjct: 84  LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 98  PSNLLLNA-------------NCDLKICDFGLARV--TSETDF---MTEYVVTRWYRAPE 139
           P N+L++              N  + I DFGL +   + +  F   +     T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 202
Query: 140 LLLNSSD------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 193
           LL  S++       T +ID++S+GC+F  ++  K   P  D   +   +I   G  S  E
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILS-KGKHPFGDKYSRESNIIR--GIFSLDE 259
Query: 194 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
           +  L++ +                     +   A DL+ +M+  DP +R T    L HP
Sbjct: 260 MKCLHDRS---------------------LIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 2/107 (1%)
Query: 69  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 128
           E   +++  +I   L Y+HS N+++RDLKP N+LL++   + + DFGL +   E +  T 
Sbjct: 138 EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS 197
Query: 129 -YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
            +  T  Y APE +L+   Y   +D W +G +  E++   P F  R+
Sbjct: 198 TFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 29/225 (12%)
Query: 47  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-- 103
           Y+ +E M    +   I   +  +E      +  +   L ++H+  + HRDLKP N+L   
Sbjct: 87  YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH 146
Query: 104 -NANCDLKICDFGLARVTS--------ETDFMTEYVVTRWYRAPELL----LNSSDYTAA 150
            N    +KICDFGL              T  +     +  Y APE++      +S Y   
Sbjct: 147 PNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 151 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 210
            D+WS+G I   L+   P F GR             G+    + G      +  + +  +
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGR------------CGSDCGWDRGEACPACQNMLFESIQ 254
Query: 211 YQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             +  F +K + ++  +A DL+ K+L  D +QR++    L HP++
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 56/108 (51%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           + E+  +    QI+  ++Y H   ++HRDLK  NLLL+ + ++KI DFG +   +  + +
Sbjct: 111 MKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKL 170
Query: 127 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 174
             +  +  Y APEL          +DVWS+G I   L+     F G++
Sbjct: 171 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 34/193 (17%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNAN--CDLKICDFGLAR-----VTSETDFMT 127
            + QI   L Y+H+  + HRD+KP N L + N   ++K+ DFGL++        E   MT
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 128 EYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 186
               T ++ APE+L  +++ Y    D WS G +   L+     FPG +    +  ++   
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-- 290
Query: 187 GTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE 246
                          KK   + P Y   S         P A DL+  +L  +  +R    
Sbjct: 291 ---------------KKLCFENPNYNVLS---------PLARDLLSNLLNRNVDERFDAM 326
Query: 247 DALAHPYLGSLHD 259
            AL HP++    D
Sbjct: 327 RALQHPWISQFSD 339

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 12/173 (6%)
Query: 1   MHSITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQI 60
           +  IT++ Q   F+R       +   +V+A+  I+ PP  E    V + Y +   DL Q 
Sbjct: 57  LSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP--EGLPHVLLPY-MCHGDLLQF 113
Query: 61  IRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV 119
           IRS Q   + +    F  Q+ RG++Y+     +HRDL   N +L+ +  +K+ DFGLAR 
Sbjct: 114 IRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173
Query: 120 TSETDFMT------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 166
             + ++ +        +  +W       L +  +T   DVWS G +  EL+ R
Sbjct: 174 ILDREYYSVQQHRHARLPVKWTALES--LQTYRFTTKSDVWSFGVLLWELLTR 224

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 67/152 (44%), Gaps = 24/152 (15%)
Query: 18  CFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFL 76
           CF T+I  T                  DV+IA ELM T   ++ +  Q  + E       
Sbjct: 89  CFGTFITNT------------------DVFIAMELMGTCAEKLKKRMQGPIPERILGKMT 130
Query: 77  YQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWY 135
             I++ L Y+     V+HRD+KPSN+LL+    +K+CDFG++    +            Y
Sbjct: 131 VAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAY 190
Query: 136 RAPELL----LNSSDYTAAIDVWSVGCIFMEL 163
            APE +        DY    DVWS+G   +EL
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 36/195 (18%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETD 124
            SE+  ++F  Q++ G+ Y H+  V HRDLK  N LL+ +    LKICDFG ++ +    
Sbjct: 112 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 171
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 184
                V T  Y APE+LL         DVWS G                     + L + 
Sbjct: 172 QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------------VTLYVM 210
Query: 185 LIGT-----PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 239
           L+G      P E       +N +K I ++     Q     + ++ P    L+ ++   DP
Sbjct: 211 LVGAYPFEDPEEP------KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADP 262
Query: 240 RQRITVEDALAHPYL 254
            +RI++ +   H + 
Sbjct: 263 AKRISIPEIRNHEWF 277

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 36/195 (18%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETD 124
            SE+  ++F  Q++ G+ Y H+  V HRDLK  N LL+ +    LKICDFG ++ +    
Sbjct: 111 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 170
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 184
                V T  Y APE+LL         DVWS G                     + L + 
Sbjct: 171 QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------------VTLYVM 209
Query: 185 LIGT-----PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 239
           L+G      P E       +N +K I ++     Q     + ++ P    L+ ++   DP
Sbjct: 210 LVGAYPFEDPEEP------KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADP 261
Query: 240 RQRITVEDALAHPYL 254
            +RI++ +   H + 
Sbjct: 262 AKRISIPEIRNHEWF 276

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 103/249 (41%), Gaps = 39/249 (15%)
Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLY--QILRGLK 84
           +V+ + D++     E    +Y+  E     + +++ S        CQ   Y  Q++ GL+
Sbjct: 67  NVIQLVDVL---YNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAPELL 141
           Y+HS  ++H+D+KP NLLL     LKI   G+A      +  D       +  ++ PE+ 
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 142 LNSSDYTA-AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 200
                ++   +D+WS G     +      F G D++++   L E IG  S A  G     
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYK---LFENIGKGSYAIPG----- 234
Query: 201 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 260
                                +  P   DL++ ML ++P +R ++     H +    H  
Sbjct: 235 ---------------------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273
Query: 261 SDEPVCMSP 269
           ++ PV + P
Sbjct: 274 AEAPVPIPP 282

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 6/112 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  QI  G+ YI   N +HRDL+ +N+L++ +   KI DFGLARV  + ++         
Sbjct: 115 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 174
Query: 133 -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHVHQLRLL 182
            +W  APE  +N   +T   DVWS G +  E++    + +PGR +   +  L
Sbjct: 175 IKW-TAPE-AINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTAL 224

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 68  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT 127
            E+  +    QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + + 
Sbjct: 111 KEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLD 170
Query: 128 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG 187
            +     Y APEL          +DVWS+G I   L+     F G++             
Sbjct: 171 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------- 217
Query: 188 TPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT 244
                 L  L E   +   ++P Y     ++  +KF  ++PS    +E++   D    + 
Sbjct: 218 ------LKELRERVLRGKYRIPFYXSTDCENLLKKFLILNPSKRGTLEQIXK-DRWXNVG 270
Query: 245 VEDALAHPYLGSLHDISD 262
            ED    PY+  L D  D
Sbjct: 271 HEDDELKPYVEPLPDYKD 288

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 90/186 (48%), Gaps = 29/186 (15%)
Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-- 118
           +   +  +E   Q ++ +I+  L+++H   +++RD+K  N+LL++N  + + DFGL++  
Sbjct: 150 LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH 177
           V  ET+   ++  T  Y AP+++    S +  A+D WS+G +  EL+     F       
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF------- 262
Query: 178 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTF 237
                        + E     E +++ +   P Y ++        +   A DL++++L  
Sbjct: 263 -----------TVDGEKNSQAEISRRILKSEPPYPQE--------MSALAKDLIQRLLMK 303
Query: 238 DPRQRI 243
           DP++R+
Sbjct: 304 DPKKRL 309

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
            L  I  G+KY+ + N +HRDL   N+L+N+N   K+ DFGL+RV  E D    Y  +  
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGG 210
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
               RW  APE  ++   +T+A DVWS G +  E+M
Sbjct: 211 KIPIRW-TAPE-AISYRKFTSASDVWSFGIVMWEVM 244

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 269
Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 270 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 298

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 151 YQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 210
Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 211 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 239

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 153 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 212
Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 213 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 241

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 156 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 215
Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 216 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 244

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+       R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPV 223
Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 46  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           V I  EL++   L Q+I+    L E+   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184
Query: 105 ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 156
           ++     +CDFG A +  + D + + ++T  Y        APE+++      A +D+WS 
Sbjct: 185 SDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSS 242
Query: 157 GCIFMELMD 165
            C+ + +++
Sbjct: 243 CCMMLHMLN 251

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 46  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           V I  EL++   L Q+I+    L E+   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 141 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 200
Query: 105 ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 156
           ++     +CDFG A +  + D + + ++T  Y        APE+++      A +D+WS 
Sbjct: 201 SDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSS 258
Query: 157 GCIFMELMD 165
            C+ + +++
Sbjct: 259 CCMMLHMLN 267

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 46  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           V I  EL++   L Q+I+    L E+   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 139 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 198
Query: 105 ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 156
           ++     +CDFG A +  + D + + ++T  Y        APE+++      A +D+WS 
Sbjct: 199 SDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSS 256
Query: 157 GCIFMELMD 165
            C+ + +++
Sbjct: 257 CCMMLHMLN 265

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 82/180 (45%), Gaps = 27/180 (15%)
Query: 72  CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD------- 124
           C +   QI   ++++HS  ++HRDLKPSN+    +  +K+ DFGL     + +       
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 125 ------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
                   T  V T+ Y +PE +  +S Y+  +D++S+G I  EL     L+P    + +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMER 233
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD 238
           +R L ++        L F     +KY C+      Q      P   P AI+++E  +  D
Sbjct: 234 VRTLTDV------RNLKFPPLFTQKYPCEY--VMVQDMLSPSPMERPEAINIIENAVFED 285

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 84/215 (39%), Gaps = 57/215 (26%)
Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 118
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 178
            T+                         Y  + D+WS+G I   L+   P          
Sbjct: 169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYP---------- 196
Query: 179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 233
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 197 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 239
Query: 234 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 268
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 240 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 274

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 130
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL 232
Query: 131 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 172
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 233 PVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 273

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 130
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 225
Query: 131 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 172
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 226 PVKWM-APESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 266

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 130
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 232
Query: 131 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 172
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 233 PVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 273

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 130
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 227
Query: 131 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 172
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 228 PVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 268

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 59/112 (52%), Gaps = 6/112 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  QI  G+ YI   N +HRDL+ +N+L++ +   KI DFGLARV  + ++         
Sbjct: 114 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 173
Query: 133 -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHVHQLRLL 182
            +W  APE  +N   +T   +VWS G +  E++    + +PGR +   +  L
Sbjct: 174 IKW-TAPE-AINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSAL 223

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 167 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221
Query: 107 CDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +KICDFGLAR +  + D++ +    +  +W  APE + +   YT   DVWS G +  E
Sbjct: 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 279
Query: 163 L 163
           +
Sbjct: 280 I 280

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 107 CDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +KICDFGLAR +  + D++ +    +  +W  APE + +   YT   DVWS G +  E
Sbjct: 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 242
Query: 163 L 163
           +
Sbjct: 243 I 243

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 70/126 (55%), Gaps = 11/126 (8%)
Query: 42  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           S  + ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+
Sbjct: 116 SKRNEFVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 102 LLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           LL+    +KICDFGLAR +  + D++ +    +  +W  APE + +   YT   DVWS G
Sbjct: 171 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFG 228
Query: 158 CIFMEL 163
            +  E+
Sbjct: 229 VLLWEI 234

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 130
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 131 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 172
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 210 PVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 250

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 70/126 (55%), Gaps = 11/126 (8%)
Query: 42  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           S  + ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+
Sbjct: 116 SKRNEFVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 102 LLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           LL+    +KICDFGLAR +  + D++ +    +  +W  APE + +   YT   DVWS G
Sbjct: 171 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFG 228
Query: 158 CIFMEL 163
            +  E+
Sbjct: 229 VLLWEI 234

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D   +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D   +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 134
           YQ+ RG++Y+ S   +HRDL   N+L+  N  ++I DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 135 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 36/195 (18%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETD 124
            SE+  ++F  Q++ G+ Y H+  V HRDLK  N LL+ +    LKIC FG ++ +    
Sbjct: 112 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHS 171
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 184
              + V T  Y APE+LL         DVWS G                     + L + 
Sbjct: 172 QPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------------VTLYVM 210
Query: 185 LIGT-----PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 239
           L+G      P E       +N +K I ++     Q     + ++ P    L+ ++   DP
Sbjct: 211 LVGAYPFEDPEEP------KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADP 262
Query: 240 RQRITVEDALAHPYL 254
            +RI++ +   H + 
Sbjct: 263 AKRISIPEIRNHEWF 277

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 61/122 (50%), Gaps = 4/122 (3%)
Query: 46  VYIAYELMDTD-LHQII--RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           ++I  E  D   L Q I  R  + L +        QI +G+ YIHS  +++RDLKPSN+ 
Sbjct: 95  LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154
Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
           L     +KI DFGL               T  Y +PE  ++S DY   +D++++G I  E
Sbjct: 155 LVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAE 213
Query: 163 LM 164
           L+
Sbjct: 214 LL 215

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 36/195 (18%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETD 124
            SE+  ++F  Q++ G+ Y H+  V HRDLK  N LL+ +    LKI DFG ++ +    
Sbjct: 112 FSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHS 171
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 184
                V T  Y APE+LL         DVWS G                     + L + 
Sbjct: 172 QPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------------VTLYVM 210
Query: 185 LIGT-----PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 239
           L+G      P E       +N +K I ++     Q     + ++ P    L+ ++   DP
Sbjct: 211 LVGAYPFEDPEEP------KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADP 262
Query: 240 RQRITVEDALAHPYL 254
            +RI++ +   H + 
Sbjct: 263 AKRISIPEIRNHEWF 277

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 8/171 (4%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           L E      L ++L GL+Y+H    +HRD+K  N+LL  +  ++I DFG++   +    +
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177
Query: 127 TE------YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
           T       +V T  + APE++     Y    D+WS G   +EL       P   +     
Sbjct: 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKV 235
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 231
           L++ L   P   E G  ++   K   +  R       +K P   P+A +L+
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 8/171 (4%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           L E      L ++L GL+Y+H    +HRD+K  N+LL  +  ++I DFG++   +    +
Sbjct: 113 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 172
Query: 127 TE------YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
           T       +V T  + APE++     Y    D+WS G   +EL       P   +     
Sbjct: 173 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKV 230
Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 231
           L++ L   P   E G  ++   K   +  R       +K P   P+A +L+
Sbjct: 231 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 29/225 (12%)
Query: 47  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-- 103
           Y+ +E M    +   I   +  +E      +  +   L ++H+  + HRDLKP N+L   
Sbjct: 87  YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH 146
Query: 104 -NANCDLKICDFGLARVTS--------ETDFMTEYVVTRWYRAPELL----LNSSDYTAA 150
            N    +KICDF L              T  +     +  Y APE++      +S Y   
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 151 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 210
            D+WS+G I   L+   P F GR             G+    + G      +  + +  +
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGR------------CGSDCGWDRGEACPACQNMLFESIQ 254
Query: 211 YQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             +  F +K + ++  +A DL+ K+L  D +QR++    L HP++
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 69/126 (54%), Gaps = 11/126 (8%)
Query: 42  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           S  + ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+
Sbjct: 116 SKRNEFVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 102 LLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           LL+    +KICDFGLAR +  + D + +    +  +W  APE + +   YT   DVWS G
Sbjct: 171 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFG 228
Query: 158 CIFMEL 163
            +  E+
Sbjct: 229 VLLWEI 234

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 11/121 (9%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 107 CDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +KICDFGLAR +  + D + +    +  +W  APE + +   YT   DVWS G +  E
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 242
Query: 163 L 163
           +
Sbjct: 243 I 243

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 69/126 (54%), Gaps = 11/126 (8%)
Query: 42  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           S  + ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+
Sbjct: 116 SKRNEFVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 102 LLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           LL+    +KICDFGLAR +  + D + +    +  +W  APE + +   YT   DVWS G
Sbjct: 171 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFG 228
Query: 158 CIFMEL 163
            +  E+
Sbjct: 229 VLLWEI 234

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 73/146 (50%), Gaps = 3/146 (2%)
Query: 41  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           ++ + +Y   E ++  DL   I+      E    ++  +I  GL ++H   +++RDLK  
Sbjct: 90  QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLD 149
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           N++L++   +KI DFG+ +        T E+  T  Y APE++     Y  ++D W+ G 
Sbjct: 150 NVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQP-YGKSVDWWAYGV 208
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIE 184
           +  E++  +P F G D     + ++E
Sbjct: 209 LLYEMLAGQPPFDGEDEDELFQSIME 234

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 36/195 (18%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETD 124
            SE+  ++F  Q++ G+ Y H+  V HRDLK  N LL+ +    LKIC FG ++ +    
Sbjct: 112 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHS 171
Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 184
                V T  Y APE+LL         DVWS G                     + L + 
Sbjct: 172 QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------------VTLYVM 210
Query: 185 LIGT-----PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 239
           L+G      P E       +N +K I ++     Q     + ++ P    L+ ++   DP
Sbjct: 211 LVGAYPFEDPEEP------KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADP 262
Query: 240 RQRITVEDALAHPYL 254
            +RI++ +   H + 
Sbjct: 263 AKRISIPEIRNHEWF 277

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 41  ESFNDVYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           ES  ++ + +E +   D+ + I ++   L+E     +++Q+   L+++HS N+ H D++P
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130
Query: 99  SNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
            N++     +  +KI +FG AR     D          Y APE+  +    TA  D+WS+
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT-DMWSL 189
Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           G +   L+    + P                        FL E  ++ I  +   +    
Sbjct: 190 GTLVYVLLS--GINP------------------------FLAETNQQIIENIMNAEYTFD 223
Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            E F  +   A+D V+++L  + + R+T  +AL HP+L
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 87  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 145
Query: 106 NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 152
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 146 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 205
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 206 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 244
Query: 213 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 254
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 245 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 106 NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 152
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 162 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 222 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 260
Query: 213 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 254
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 261 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 106 NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 152
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           VWS+GCI   +   K  F  +  ++Q+  L  +I    E E                   
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIE------------------- 288
Query: 213 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 254
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 289 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 125
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 126 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 255 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 293

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 11/169 (6%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           +Y+  E M       + SN  + E+  +++  +++  L  IHS  ++HRD+KP N+LL+ 
Sbjct: 150 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK 209
Query: 106 NCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIF 160
           +  LK+ DFG      ET  +     V T  Y +PE+L +      Y    D WSVG   
Sbjct: 210 HGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 269
Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGT---PSEAELGFLNENAKKYIC 206
            E++     F     V     +++   +   P +AE   ++++AK  IC
Sbjct: 270 FEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAE---ISKHAKNLIC 315

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 83  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 141
Query: 106 NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 152
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 142 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 201
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 202 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 240
Query: 213 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 254
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 241 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 106 NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 152
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           VWS+GCI   +   K  F  +  ++Q+  L  +I    E E                   
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIE------------------- 288
Query: 213 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 254
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 289 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 84  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 142
Query: 106 NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 152
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 202
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 203 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 241
Query: 213 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 254
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 242 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 125
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 126 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 257 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 125
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 126 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 250 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 288

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 124
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 125 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 125
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 126 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 248 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 286

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 124
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 125 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 238

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 124
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 125 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 124
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 125 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 124
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 125 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 237

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 69/126 (54%), Gaps = 11/126 (8%)
Query: 42  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           S  + ++ Y+    DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+
Sbjct: 127 SKRNEFVPYKEAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 181
Query: 102 LLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           LL+    +KICDFGLAR +  + D++ +    +  +W  APE + +   YT   DVWS G
Sbjct: 182 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFG 239
Query: 158 CIFMEL 163
            +  E+
Sbjct: 240 VLLWEI 245

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 11/121 (9%)
Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
           ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 107 CDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
             +KICDFGLAR +  + D + +    +  +W  APE + +   YT   DVWS G +  E
Sbjct: 185 NVVKICDFGLARDIYKDPDXVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 242
Query: 163 L 163
           +
Sbjct: 243 I 243

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 106/270 (39%), Gaps = 74/270 (27%)
Query: 57  LHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNAN-------- 106
           L  II+SN Q L     +  + Q+L+GL Y+H+   ++H D+KP N+LL+ N        
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191
Query: 107 -----------------------------------------CDLKICDFGLARVTSETDF 125
                                                      +KI D G A    +   
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--H 249
Query: 126 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-------GRDHVHQ 178
            TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF         RD  H 
Sbjct: 250 FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH- 307
Query: 179 LRLLIELIG-TPSEAELG-------FLNENAKKYICQL-PRYQRQSFTEKFPNVHPSA-- 227
           + L+IEL+G  P +  +        F  +   K+I +L P    +   EK+      A  
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367
Query: 228 -IDLVEKMLTFDPRQRITVEDALAHPYLGS 256
             D +  ML   P +R T  + L HP+L S
Sbjct: 368 FTDFLLPMLELIPEKRATAAECLRHPWLNS 397

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 124
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 125 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 286

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 124
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 125 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 124
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 125 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 230

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 125
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D 
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 126 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 205 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 431 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 467

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 125
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 141 LTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 200
Query: 126 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 201 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 239

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 106/270 (39%), Gaps = 74/270 (27%)
Query: 57  LHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNAN-------- 106
           L  II+SN Q L     +  + Q+L+GL Y+H+   ++H D+KP N+LL+ N        
Sbjct: 116 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 175
Query: 107 -----------------------------------------CDLKICDFGLARVTSETDF 125
                                                      +KI D G A    +   
Sbjct: 176 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--H 233
Query: 126 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-------GRDHVHQ 178
            TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF         RD  H 
Sbjct: 234 FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH- 291
Query: 179 LRLLIELIG-TPSEAELG-------FLNENAKKYICQL-PRYQRQSFTEKFPNVHPSA-- 227
           + L+IEL+G  P +  +        F  +   K+I +L P    +   EK+      A  
Sbjct: 292 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 351
Query: 228 -IDLVEKMLTFDPRQRITVEDALAHPYLGS 256
             D +  ML   P +R T  + L HP+L S
Sbjct: 352 FTDFLLPMLELIPEKRATAAECLRHPWLNS 381

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 130
           + +Q+ RG++++ S   +HRDL   N+LL+ N  +KICDFGLAR +    D++ +    +
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 131 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
             +W  APE + +   Y+   DVWS G +  E+
Sbjct: 264 PLKWM-APESIFDKI-YSTKSDVWSYGVLLWEI 294

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 61/128 (47%), Gaps = 11/128 (8%)
Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           V I  E M+   L   +R N    +       L  I  G+KY+   N +HRDL   N+L+
Sbjct: 109 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV 168
Query: 104 NANCDLKICDFGLARVTSE-------TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           N+N   K+ DFGL+R   +       T  +   +  RW  APE  +    +T+A DVWS 
Sbjct: 169 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPE-AIQYRKFTSASDVWSY 226
Query: 157 GCIFMELM 164
           G +  E+M
Sbjct: 227 GIVMWEVM 234

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 178
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 179 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 39/230 (16%)
Query: 47  YIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           Y+ +E L    +   I+  +  +E      +  +   L ++H+  + HRDLKP N+L  +
Sbjct: 87  YLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCES 146
Query: 106 N---CDLKICDF----GLARVTSETDFMTEYVVT----RWYRAPELLLNSSD----YTAA 150
                 +KICDF    G+    S T   T  + T      Y APE++   +D    Y   
Sbjct: 147 PEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKR 206
Query: 151 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 210
            D+WS+G +   ++   P F G                   A+ G+ +      +CQ   
Sbjct: 207 CDLWSLGVVLYIMLSGYPPFVGH----------------CGADCGW-DRGEVCRVCQNKL 249
Query: 211 YQR-QSFTEKFPN-----VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           ++  Q    +FP+     +   A DL+ K+L  D +QR++    L HP++
Sbjct: 250 FESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 174
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 175 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 211

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 170
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 171 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 207

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 172
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 173 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 209

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 43/223 (19%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 106 NCDLKICDFGLARVTSETDFMT---EYVVTRWYRAPELLLNSSD----------YTAAID 152
           +  LK+ DFG+A               V T  Y  PE + + S            +   D
Sbjct: 162 DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 222 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 260
Query: 213 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 254
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 261 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 127 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 186
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 187 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 223

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW 178
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 179 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 124
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 125 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
              +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 182
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 183 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 219

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 73/146 (50%), Gaps = 3/146 (2%)
Query: 41  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           ++ + +Y   E ++  DL   I+      E H  ++  +I  GL ++ S  +++RDLK  
Sbjct: 91  QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 150
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           N++L++   +KI DFG+ +        T+ +  T  Y APE++     Y  ++D W+ G 
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP-YGKSVDWWAFGV 209
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIE 184
           +  E++  +  F G D     + ++E
Sbjct: 210 LLYEMLAGQAPFEGEDEDELFQSIME 235

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 125
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D 
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 126 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 205 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
            L  I  G++Y+     +HRDL   N+L+N+N   K+ DFGL+RV  E D    Y  T  
Sbjct: 150 MLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI-EDDPEAVYTTTGG 208
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
               RW  APE  +    +T+A DVWS G +  E+M
Sbjct: 209 KIPVRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVM 242

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 112 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 171
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 172 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 208

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 122 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 181
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 182 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 218

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 75/137 (54%), Gaps = 9/137 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 134
           Q  RG+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 116 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 175
Query: 135 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS-E 191
           + APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  S  
Sbjct: 176 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLS 232
Query: 192 AELGFLNENAKKYICQL 208
            +L  +  N  K + +L
Sbjct: 233 PDLSKVRSNCPKRMKRL 249

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 73/146 (50%), Gaps = 3/146 (2%)
Query: 41  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           ++ + +Y   E ++  DL   I+      E H  ++  +I  GL ++ S  +++RDLK  
Sbjct: 412 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 471
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           N++L++   +KI DFG+ +        T+ +  T  Y APE++     Y  ++D W+ G 
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP-YGKSVDWWAFGV 530
Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIE 184
           +  E++  +  F G D     + ++E
Sbjct: 531 LLYEMLAGQAPFEGEDEDELFQSIME 556

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGLARV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGK 211
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 59/113 (52%), Gaps = 13/113 (11%)
Query: 75  FLYQILRGLKYIHS---ANVLHRDLKPSNLLLN--------ANCDLKICDFGLARVTSET 123
           +  QI RG+ Y+H      ++HRDLK SN+L+         +N  LKI DFGLAR    T
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169
Query: 124 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV 176
             M+      W  APE++  +S ++   DVWS G +  EL+  +  F G D +
Sbjct: 170 TKMSAAGAYAWM-APEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL  +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGL R+  + ++          +W
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW 348
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 349 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 385

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 46  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 106 NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 152
           +  LK+ DFG+A ++  +T  + +   V    Y  PE + + S            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           VWS+GCI   +   K  F  +  ++Q+  L  +I    E E                   
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIE------------------- 288
Query: 213 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 254
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 289 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 43  FNDVYIAYELMDTD-LHQIIRSNQAL---SEEHCQYFLYQILRGLKYIHSAN---VLHRD 95
            N V +  E  +   L+ ++   + L   +  H   +  Q  +G+ Y+HS     ++HRD
Sbjct: 72  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 96  LKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 154
           LKP NLLL A    LKICDFG A        MT    +  + APE +   S+Y+   DV+
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTA--CDIQTHMTNNKGSAAWMAPE-VFEGSNYSEKCDVF 188
Query: 155 SVGCIFMELMDRKPLF 170
           S G I  E++ R+  F
Sbjct: 189 SWGIILWEVITRRKPF 204

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 63  SNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARVT 120
           + + L E       Y + +G+ Y+H+ N  ++HRDLK  NLL++    +K+CDFGL+R+ 
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 189
Query: 121 SETDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +     ++    T  + APE+L +      + DV+S G I  EL
Sbjct: 190 ASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWEL 232

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 58/104 (55%), Gaps = 4/104 (3%)
Query: 63  SNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARVT 120
           + + L E       Y + +G+ Y+H+ N  ++HR+LK  NLL++    +K+CDFGL+R+ 
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189
Query: 121 SETDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           + T   ++    T  + APE+L +      + DV+S G I  EL
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWEL 232

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 70/134 (52%), Gaps = 18/134 (13%)
Query: 39  QRESFNDVYIAYELM-----DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLH 93
           +RE F++  I YE       + DL+        L+ E    F YQ+ +G++++   + +H
Sbjct: 143 KREKFSEDEIEYENQKRLEEEEDLN-------VLTFEDLLCFAYQVAKGMEFLEFKSCVH 195
Query: 94  RDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTA 149
           RDL   N+L+     +KICDFGLAR + S+++++      +  +W  APE L     YT 
Sbjct: 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKW-MAPESLFEGI-YTI 253
Query: 150 AIDVWSVGCIFMEL 163
             DVWS G +  E+
Sbjct: 254 KSDVWSYGILLWEI 267

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 43  FNDVYIAYELMDTD-LHQIIRSNQAL---SEEHCQYFLYQILRGLKYIHSAN---VLHRD 95
            N V +  E  +   L+ ++   + L   +  H   +  Q  +G+ Y+HS     ++HRD
Sbjct: 71  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 96  LKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 154
           LKP NLLL A    LKICDFG A        MT    +  + APE +   S+Y+   DV+
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTA--CDIQTHMTNNKGSAAWMAPE-VFEGSNYSEKCDVF 187
Query: 155 SVGCIFMELMDRKPLF 170
           S G I  E++ R+  F
Sbjct: 188 SWGIILWEVITRRKPF 203

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 107/268 (39%), Gaps = 72/268 (26%)
Query: 57  LHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNA--------- 105
           L  II+SN Q L     +  + Q+L+GL Y+HS   ++H D+KP N+L+           
Sbjct: 126 LKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMA 185
Query: 106 -----------------------------------NCD---LKICDFGLARVTSETDFMT 127
                                              N D   +KI D G A    +    T
Sbjct: 186 AEATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHK--HFT 243
Query: 128 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-------GRDHVHQLR 180
           E + TR YR+ E+L+ +  Y+   D+WS  C+  EL     LF         RD  H + 
Sbjct: 244 EDIQTRQYRSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDH-IA 301
Query: 181 LLIELIGT-PSEAELG------FLNENAK-KYICQL-PRYQRQSFTEKFPNVHPSA---I 228
            +IEL+G+ P    L       F N   + ++I +L P        EK+   H  A    
Sbjct: 302 HIIELLGSIPRHFALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFT 361
Query: 229 DLVEKMLTFDPRQRITVEDALAHPYLGS 256
           D +  ML   P +R +  + L HP+L S
Sbjct: 362 DFLIPMLEMVPEKRASAGECLRHPWLNS 389

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+   + +HRDL   N+L+N+N   K+ DFG++RV     E  + T    
Sbjct: 136 MLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 195
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  APE +     +T+A DVWS G +  E+M
Sbjct: 196 IPIRWT-APEAIAYRK-FTSASDVWSYGIVMWEVM 228

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + +           +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 181
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 53/107 (49%), Gaps = 16/107 (14%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT-------------S 121
           F   I  G+ Y+HS N++HRDL   N L+  N ++ + DFGLAR+               
Sbjct: 113 FAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 122 ETDFMTEYVVTR--WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 166
           + D    Y V    ++ APE ++N   Y   +DV+S G +  E++ R
Sbjct: 173 KPDRKKRYTVVGNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + +           +W
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 172
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 172 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 208

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 196
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 197 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 193 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 150 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 210 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 242

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 136 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 195
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 196 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 125 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 184
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 185 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 221

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 183 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 215

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 14/106 (13%)
Query: 72  CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF------ 125
           C +   QI   ++++HS  ++HRDLKPSN+    +  +K+ DFGL     + +       
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 126 -MTEY------VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            M  Y      V T+ Y +PE  ++ ++Y+  +D++S+G I  EL+
Sbjct: 226 PMPAYATHXGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 183 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 215

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 130 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 189
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 190 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 231

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 182
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 183 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 219

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKW 176
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 157 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 216
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 217 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 135 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 194
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 195 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 140 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  +PE +     +T+A DVWS G +  E+M
Sbjct: 200 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVM 232

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 126 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 185
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 186 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 222

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 156 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 215
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 216 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HR+L+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 113 QIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 172
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 173 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 209

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 118 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 177
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 178 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 119 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 178
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 179 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 215

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 6/102 (5%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           Q+  G+ YI   N +HRDL+ +N+L+      KI DFGLAR+  + +           +W
Sbjct: 113 QVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW 172
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDH 175
             APE  L    +T   DVWS G +  EL+ +  + +PG ++
Sbjct: 173 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNN 212

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+   + +HRDL   N+L+N+N   K+ DFG++RV     E  + T    
Sbjct: 121 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 180
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  APE +     +T+A DVWS G +  E+M
Sbjct: 181 IPIRWT-APEAIAYRK-FTSASDVWSYGIVMWEVM 213

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 125
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR +  + D+
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY 200
Query: 126 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 201 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 239

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 134
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 172
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+   + +HRDL   N+L+N+N   K+ DFG++RV     E  + T    
Sbjct: 115 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 174
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  APE +     +T+A DVWS G +  E+M
Sbjct: 175 IPIRWT-APEAIAYRK-FTSASDVWSYGIVMWEVM 207

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 65/119 (54%), Gaps = 10/119 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 133
           Q  RG+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 134 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS 190
           W  APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  S
Sbjct: 188 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGS 242

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 9/97 (9%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-------TSETDFMT 127
            L  I  G++Y+   + +HRDL   N+L+N+N   K+ DFGL+R         +ET  + 
Sbjct: 123 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG 182
Query: 128 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
             +  RW  APE +     +T+A D WS G +  E+M
Sbjct: 183 GKIPIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVM 217

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/98 (39%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           F  QI  G+ Y+HS + +HR+L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 122 FAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 178
Query: 134 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
                  WY APE L     Y A+ DVWS G    EL+
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 65/119 (54%), Gaps = 10/119 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 133
           Q  RG+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 134 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS 190
           W  APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  S
Sbjct: 188 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGS 242

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 198
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 199 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 136 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 195
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 196 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 143 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 202
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 203 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 257 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-------TDFMT 127
            L  I  G+KY+   N +HR L   N+L+N+N   K+ DFGL+R   +       T  + 
Sbjct: 114 MLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173
Query: 128 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
             +  RW  APE  +    +T+A DVWS G +  E+M
Sbjct: 174 GKIPIRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVM 208

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGA 198
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 199 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 61/141 (43%), Gaps = 3/141 (2%)
Query: 41  ESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E    +Y+  EL    L Q   +   +L E     +L   L  L ++HS  ++H D+KP+
Sbjct: 127 EEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPA 186
Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+ L      K+ DFGL                  Y APELL  S  Y  A DV+S+G  
Sbjct: 187 NIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS--YGTAADVFSLGLT 244
Query: 160 FMELMDRKPLFPGRDHVHQLR 180
            +E+     L  G +   QLR
Sbjct: 245 ILEVACNMELPHGGEGWQQLR 265

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 82  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAP 138
           G+ ++H  + +HRD+K +N+LL+     KI DFGLAR +   ++T   +  V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204
Query: 139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKP 168
           E L    + T   D++S G + +E++   P
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 9/104 (8%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + +  + +  T  
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGA 196
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 171
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 197 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--Y 129
            L  I  G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    
Sbjct: 129 MLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 188
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           +  RW  APE +     +T+A DVWS G +  E++
Sbjct: 189 IPIRW-TAPEAIA-FRKFTSASDVWSYGIVMWEVV 221

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 456 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 515
Query: 117 AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 162
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 516 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 564

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 457 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 516
Query: 117 AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 162
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 517 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 565

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 58/105 (55%), Gaps = 6/105 (5%)
Query: 63  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTS 121
           +N  LS     +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + +
Sbjct: 157 ANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 122 ETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +++++ +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 217 DSNYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEI 259

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 55/92 (59%), Gaps = 5/92 (5%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRW 134
           Q  +G+ Y+H+ N++HRD+K +N+ L+    +KI DFGLA V S    +  + +   +  
Sbjct: 140 QTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 135 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 164
           + APE+  + +++ ++   DV+S G +  ELM
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM 231

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-------TDFMT 127
            L  I  G++Y+   + +HRDL   N+L+N+N   K+ DFGL+R   E       T  + 
Sbjct: 121 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 128 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
             +  RW  APE +     +T+A D WS G +  E+M
Sbjct: 181 GKIPIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVM 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           F  QI  G+ Y+H+ + +HR+L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 122 FAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 178
Query: 134 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
                  WY APE L     Y A+ DVWS G    EL+
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +   ETD     V    
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDR 189
Query: 134 -----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
                WY APE L+ S  Y A+ DVWS G    EL+
Sbjct: 190 DSPVFWY-APECLMQSKFYIAS-DVWSFGVTLHELL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +   ETD     V    
Sbjct: 119 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDR 177
Query: 134 -----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
                WY APE L+ S  Y A+ DVWS G    EL+
Sbjct: 178 DSPVFWY-APECLMQSKFYIAS-DVWSFGVTLHELL 211

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 82  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAP 138
           G+ ++H  + +HRD+K +N+LL+     KI DFGLAR +   ++T      V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204
Query: 139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKP 168
           E L    + T   D++S G + +E++   P
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 117 AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 162
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 117 AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 162
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 50/97 (51%), Gaps = 11/97 (11%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           F  QI  G+ Y+H+ + +HRDL   N+LL+ +  +KI DFGLA+   E      Y V   
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EXYRVRED 196
Query: 134 ------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
                 WY APE L     Y A+ DVWS G    EL+
Sbjct: 197 GDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 171
Query: 117 AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 162
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 172 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 220

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 50/98 (51%), Gaps = 13/98 (13%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           F  QI  G+ Y+H+ + +HR L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 117 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 173
Query: 134 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
                  WY APE L     Y A+ DVWS G    EL+
Sbjct: 174 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELL 209

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 117 AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 162
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 212

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 50/98 (51%), Gaps = 13/98 (13%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           F  QI  G+ Y+H+ + +HR L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 116 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 172
Query: 134 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
                  WY APE L     Y A+ DVWS G    EL+
Sbjct: 173 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELL 208

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 117 AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 162
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 158 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 206

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 117 AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 162
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 202

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 92  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 151
Query: 117 AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 162
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 152 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 200

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 46  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS   +HRD+KP N+LL+
Sbjct: 149 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 207
Query: 105 ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 159
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 208 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 160 FMELM 164
             E++
Sbjct: 268 LYEML 272

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 46  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS   +HRD+KP N+LL+
Sbjct: 149 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 207
Query: 105 ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 159
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 208 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 160 FMELM 164
             E++
Sbjct: 268 LYEML 272

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 46  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS   +HRD+KP N+LL+
Sbjct: 144 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202
Query: 105 ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 159
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 160 FMELM 164
             E++
Sbjct: 263 LYEML 267

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 134
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 114 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 135 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 164
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 205

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 134
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 135 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 164
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
            L  +  G++Y+     +HRDL   N+L+++N   K+ DFGL+RV  E D    Y  T  
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTGG 214
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
               RW  APE +   + +++A DVWS G +  E++
Sbjct: 215 KIPIRWT-APEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 134
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 135 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 164
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 6/105 (5%)
Query: 63  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTS 121
           +N   S     +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + +
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 122 ETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +++++ +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 217 DSNYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEI 259

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 134
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 135 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 164
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 134
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 135 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 164
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 86/200 (43%), Gaps = 34/200 (17%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           +L++ ++ +    E+     + ++   L Y H   V+HRD+KP NLLL    +LKI DFG
Sbjct: 109 ELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFG 168
Query: 116 LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 175
            + V + +        T  Y  PE ++    +   +D+W +G +  EL+   P F    H
Sbjct: 169 WS-VHAPSLRRKTMCGTLDYLPPE-MIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASH 226
Query: 176 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPS-AIDLVEKM 234
               R ++++                                 KFP   P+ A DL+ K+
Sbjct: 227 NETYRRIVKV-------------------------------DLKFPASVPTGAQDLISKL 255
Query: 235 LTFDPRQRITVEDALAHPYL 254
           L  +P +R+ +    AHP++
Sbjct: 256 LRHNPSERLPLAQVSAHPWV 275

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT----EYVVTR 133
           QI  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R    TD+        +  R
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLF 170
           W   PE ++    +T   DVWS G I  E+    ++P F
Sbjct: 201 WM-PPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 134
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 139 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 135 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 164
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 230

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 134
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 135 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 164
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 231

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 13/94 (13%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 133
           QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++        +Y V R    
Sbjct: 122 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQ 178
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L+ + ++   DVWS G +  EL
Sbjct: 179 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 13/94 (13%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 133
           QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++        +Y V R    
Sbjct: 123 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQ 179
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L+ + ++   DVWS G +  EL
Sbjct: 180 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 82  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAP 138
           G+ ++H  + +HRD+K +N+LL+     KI DFGLAR +   ++    +  V T  Y AP
Sbjct: 136 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKP 168
           E L    + T   D++S G + +E++   P
Sbjct: 196 EAL--RGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 66/140 (47%), Gaps = 20/140 (14%)
Query: 51  ELMDTDLHQIIRSNQALSEEHCQYFL---YQILRGLKYIHSAN--VLHRDLKPSNLLLNA 105
           EL    L + ++  ++     C   L   YQ  R ++++H     ++HRDLK  NLLL+ 
Sbjct: 114 ELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173
Query: 106 NCDLKICDFGLARVTS---------ETDFMTEYVVTR----WYRAPELLLNSSDYTAA-- 150
              +K+CDFG A   S         +   + E  +TR     YR PE++   S++     
Sbjct: 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK 233
Query: 151 IDVWSVGCIFMELMDRKPLF 170
            D+W++GCI   L  R+  F
Sbjct: 234 QDIWALGCILYLLCFRQHPF 253

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 6/103 (5%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 123
           + LS     +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + +++
Sbjct: 161 EQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 220
Query: 124 DFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +++ +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 221 NYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEI 261

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTR 133
            L+Q+  G+KY+   N +HRDL   N+LL      KI DFGL++     D + T     +
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           W   + APE  +N   +++  DVWS G    E +
Sbjct: 175 WPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEAL 207

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 13/94 (13%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 133
           QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++        +Y V R    
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQ 191
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L+ + ++   DVWS G +  EL
Sbjct: 192 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 6/104 (5%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 124
           +AL+      F +QI +G++Y+   +++HRDL   N+L+     +KI DFGL+R   E D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 125 FMTE----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
              +     +  +W  A E L +   YT   DVWS G +  E++
Sbjct: 205 SXVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 246

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 13/97 (13%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     E+   + 
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFKVKE 175
Query: 134 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
                  WY APE  L  S ++ A DVWS G +  EL
Sbjct: 176 PGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 210

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 117 ARV--TSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
           ++     E  +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 158 SKALRADENXYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 206

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 6/104 (5%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 124
           +AL+      F +QI +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 125 FMTE----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
              +     +  +W  A E L +   YT   DVWS G +  E++
Sbjct: 205 SXVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 246

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 60/115 (52%), Gaps = 12/115 (10%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   I+ ++   E   +++  +I+  L ++H   +++RDLK  N+LL+     K+ DFG
Sbjct: 110 DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 169
Query: 116 LAR------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           + +      VT+ T     +  T  Y APE +L    Y  A+D W++G +  E++
Sbjct: 170 MCKEGICNGVTTAT-----FCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEML 218

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 82  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAP 138
           G+ ++H  + +HRD+K +N+LL+     KI DFGLAR +   ++       V T  Y AP
Sbjct: 139 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198
Query: 139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKP 168
           E L    + T   D++S G + +E++   P
Sbjct: 199 EAL--RGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 8/105 (7%)
Query: 65  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 124
           +AL+      F +QI +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 125 FMTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELM 164
               YV     R P   +         YT   DVWS G +  E++
Sbjct: 205 ---SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 13/94 (13%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 133
           QI +G++Y+ +   +HR+L   N+L+     +KI DFGL +V  +     EY   +    
Sbjct: 123 QICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD---KEYYKVKEPGE 179
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 180 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 211

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 61  IRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV 119
           +R N+  L  +    +  QI +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR+
Sbjct: 109 VRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARL 168
Query: 120 --TSETDFMTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
               ET++  +   V  +W     +L     +T   DVWS G    ELM
Sbjct: 169 LDIDETEYHADGGKVPIKWMALESILRRR--FTHQSDVWSYGVTVWELM 215

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-----LARVTS 121
           L+E+   + L  I RGL+ IH+    HRDLKP+N+LL       + D G        V  
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 122 ETDFMT--EYVVTRW---YRAPELLLNSSDYT--AAIDVWSVGCIFMELM 164
               +T  ++   R    YRAPEL    S        DVWS+GC+   +M
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 52  LMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 109
           +++TD    I ++ A  LS +   +F   + RG+ Y+     +HRDL   N+L+  N   
Sbjct: 112 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 171
Query: 110 KICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           KI DFGL+R        T   +  RW       LN S YT   DVWS G +  E++
Sbjct: 172 KIADFGLSRGQEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 52  LMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 109
           +++TD    I ++ A  LS +   +F   + RG+ Y+     +HRDL   N+L+  N   
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181
Query: 110 KICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           KI DFGL+R        T   +  RW       LN S YT   DVWS G +  E++
Sbjct: 182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 209
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 210 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 241

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 213

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 124 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 183
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 184 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 117 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 176
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 177 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 208

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 125 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 184
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 185 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 126 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 185
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 186 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 217

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---Y 129
           +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + ++++++ +    
Sbjct: 164 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 223
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 224 LPVKWM-APESIFDCV-YTVQSDVWSYGILLWEI 255

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 213

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 179 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 123 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 182
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 183 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 214

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 179 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 210

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---Y 129
           +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + ++++++ +    
Sbjct: 162 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 221
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 222 LPVKWM-APESIFDCV-YTVQSDVWSYGILLWEI 253

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 137 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 197 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 228

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 118 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 177
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 178 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 209

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 213

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 28/109 (25%), Positives = 52/109 (47%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   I  +  L E    Y   Q++  + Y+   +++HRD+K  N+++  +  +K+ DFG
Sbjct: 116 DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175
Query: 116 LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            A           +  T  Y APE+L+ +      +++WS+G     L+
Sbjct: 176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 133
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 137 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 197 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 228

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---Y 129
           +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + ++++++ +    
Sbjct: 156 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 215
Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 216 LPVKWM-APESIFDCV-YTVQSDVWSYGILLWEI 247

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTR 133
            L+Q+  G+KY+   N +HR+L   N+LL      KI DFGL++     D + T     +
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           W   + APE  +N   +++  DVWS G    E +
Sbjct: 501 WPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEAL 533

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 45  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           D Y+  +L    L  + +    L EE  +++L +++  +  +H  + +HRD+KP N+L++
Sbjct: 154 DYYVGGDL----LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 209
Query: 105 ANCDLKICDFG--LARVTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVG- 157
            N  +++ DFG  L  +   T   +  V T  Y +PE+L         Y    D WS+G 
Sbjct: 210 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGV 269
Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
           C++  L    P +           L+E  G               K +    R+Q   F 
Sbjct: 270 CMYEMLYGETPFYA--------ESLVETYG---------------KIMNHKERFQ---FP 303
Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLGSLHDISDEPVCMSPF 270
            +  +V  +A DL+ +++     +  +  +ED   HP+   + D  +   C +P+
Sbjct: 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI-DWDNIRNCEAPY 357

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 133
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 132 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 134 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 164
           W  APE+  + + + Y+   DV++ G +  ELM
Sbjct: 192 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELM 223

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 133
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 134 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 164
           W  APE+  + + + Y+   DV++ G +  ELM
Sbjct: 200 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELM 231

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 133
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 134 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 164
           W  APE+  + + + Y+   DV++ G +  ELM
Sbjct: 172 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 64/129 (49%), Gaps = 7/129 (5%)
Query: 46  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A+V+HRDL   N L+
Sbjct: 77  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLV 136
Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 160
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 137 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 194
Query: 161 MELMDRKPL 169
            E+     +
Sbjct: 195 WEVFSEGKI 203

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 52  LMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 109
           +++TD    I ++ A  LS +   +F   + RG+ Y+     +HR+L   N+L+  N   
Sbjct: 119 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVA 178
Query: 110 KICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           KI DFGL+R        T   +  RW       LN S YT   DVWS G +  E++
Sbjct: 179 KIADFGLSRGQEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
            L  +  G++Y+     +HRDL   N+L+++N   K+ DFGL+RV  E D       T  
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAXTTTGG 214
Query: 133 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
               RW  APE +   + +++A DVWS G +  E++
Sbjct: 215 KIPIRWT-APEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 126
           L++    +   QI  G+ Y+ S + +HRDL   N L+  N  +KI DFG++R    TD+ 
Sbjct: 125 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 184
Query: 127 T----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
                  +  RW   PE ++    +T   DVWS+G +  E+
Sbjct: 185 RVGGHTMLPIRWM-PPESIM-YRKFTTESDVWSLGVVLWEI 223

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           W  APE L +   +T + D+WS G +  E+
Sbjct: 197 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 224

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 184
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 206 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 255

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           W  APE L +   +T + D+WS G +  E+
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 184
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 206 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 255

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 4/111 (3%)
Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL--LNANCDLKICD 113
           DL   I     L E   + F  Q++  +++ HS  V+HRD+K  N+L  L   C  K+ D
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC-AKLID 183
Query: 114 FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           FG   +  +  + T++  TR Y  PE +     +     VWS+G +  +++
Sbjct: 184 FGSGALLHDEPY-TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 137 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 184
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 197 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 246

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 184
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 200 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 249

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 184
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 193 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 242

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 136 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 184
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 196 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 245

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 184
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 199 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 248

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 184
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 199 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 248

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 13/94 (13%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 133
           QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++        +  V R    
Sbjct: 119 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDXXVVREPGQ 175
Query: 134 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               WY APE  L+ + ++   DVWS G +  EL
Sbjct: 176 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 168 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 227
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 184
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 228 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 277

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 6/90 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 133
           Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     D+      + +  R
Sbjct: 182 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR 241
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           W     +  N   YT   DVW+ G +  E+
Sbjct: 242 WMPPESIFYNR--YTTESDVWAYGVVLWEI 269

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 132
           F+  I  G++Y+ S N +HRDL   N +L  +  + + DFGL+R     D+  +   +  
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 133 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 166
             +W     L  N   YT   DVW+ G    E+M R
Sbjct: 202 PVKWLALESLADNL--YTVHSDVWAFGVTMWEIMTR 235

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 81  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---WYRA 137
           RGL Y+H+  ++HRD+K  N+LL+ N   KI DFG+++  +E D      V +    Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 138 PELLLNSSDYTAAIDVWSVGCIFMELM 164
           PE  +     T   DV+S G +  E++
Sbjct: 210 PEYFIKGR-LTEKSDVYSFGVVLFEVL 235

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 131
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 556 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 118 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 178 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 214

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 151 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 210
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 211 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 247

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 127 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 186
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 187 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 223

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 45  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           D Y+  +L    L  + +    L E+  ++++ +++  +  IH  + +HRD+KP N+LL+
Sbjct: 170 DYYVGGDL----LTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD 225
Query: 105 ANCDLKICDFGLARVTSETDFMTEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG- 157
            N  +++ DFG     ++   +   V   T  Y +PE+L    D    Y    D WS+G 
Sbjct: 226 VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGV 285
Query: 158 CIFMELMDRKPLF 170
           C++  L    P +
Sbjct: 286 CMYEMLYGETPFY 298

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 45  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           D Y+  +L    L  + +    L E+  ++++ +++  +  IH  + +HRD+KP N+LL+
Sbjct: 154 DYYVGGDL----LTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD 209
Query: 105 ANCDLKICDFGLARVTSETDFMTEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG- 157
            N  +++ DFG     ++   +   V   T  Y +PE+L    D    Y    D WS+G 
Sbjct: 210 VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGV 269
Query: 158 CIFMELMDRKPLF 170
           C++  L    P +
Sbjct: 270 CMYEMLYGETPFY 282

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           W  APE L +   +T + D+WS G +  E+
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           W  APE L +   +T + D+WS G +  E+
Sbjct: 195 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 121 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 180
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 181 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 217

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 215

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           W  APE L +   +T + D+WS G +  E+
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 123 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 182
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 183 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 219

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 220

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 118 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 178 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 142 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 201
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 202 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 238

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 220

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 220

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 215

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 46  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 77  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 136
Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 160
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 137 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 194
Query: 161 MELMDRKPL 169
            E+     +
Sbjct: 195 WEVFSEGKI 203

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 131
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 119 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 178
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 179 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 184
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 200 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 249

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 131
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 118 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 177
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 178 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 46  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 97  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 156
Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 160
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 157 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 214
Query: 161 MELMDRKPL 169
            E+     +
Sbjct: 215 WEVFSEGKI 223

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 46  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 80  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 139
Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 160
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 140 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 197
Query: 161 MELMDRKPL 169
            E+     +
Sbjct: 198 WEVFSEGKI 206

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAK 171
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 172 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDPSQVYELL 223

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 131
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 144 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 203
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 204 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 131
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 181 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 131
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 173 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 203

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 171
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 172 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDPSQVYELL 223

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 46  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 75  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 134
Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 160
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 135 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 192
Query: 161 MELMDRKPL 169
            E+     +
Sbjct: 193 WEVFSEGKI 201

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 131
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 171 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 207

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 8/123 (6%)
Query: 46  VYIAYELM-DTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +YI  EL+   D    +R+  A L  +     +     G++Y+ S   +HRDL   N L+
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV 246
Query: 104 NANCDLKICDFGLARVTSETDFMT----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
                LKI DFG++R  ++  +        V  +W  APE  LN   Y++  DVWS G +
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW-TAPE-ALNYGRYSSESDVWSFGIL 304
Query: 160 FME 162
             E
Sbjct: 305 LWE 307

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 131
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 79  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWY 135
           +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R      ET  +      RW 
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRW- 187
Query: 136 RAPELLLNSSDYTAAIDVWSVGCIFMEL 163
             PE+L+ S  +++  D+W+ G +  E+
Sbjct: 188 SPPEVLMYSK-FSSKSDIWAFGVLMWEI 214

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 171
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 172 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDPSQVYELL 223

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 131 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 184
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 191 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 240

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 4/130 (3%)
Query: 46  VYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           +Y+   L++  DL   +R    L+       + QI   L   H+A   HRD+KP N+L++
Sbjct: 109 LYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168
Query: 105 ANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
           A+    + DFG+A  T++     +   V T +Y APE   + S  T   D++++ C+  E
Sbjct: 169 ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPE-RFSESHATYRADIYALTCVLYE 227
Query: 163 LMDRKPLFPG 172
            +   P + G
Sbjct: 228 CLTGSPPYQG 237

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 8/106 (7%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 134 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAK 192
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRD 174
           +   + APE L  ++ ++   DVW+ G +  E+      P +PG D
Sbjct: 193 FPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSP-YPGID 236

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 116 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 174
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 175 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 226

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 178
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 178
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 4/87 (4%)
Query: 81  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRA 137
           RGL Y+H+  ++HRD+K  N+LL+ N   KI DFG+++  +E   T        T  Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 138 PELLLNSSDYTAAIDVWSVGCIFMELM 164
           PE  +     T   DV+S G +  E++
Sbjct: 210 PEYFIKGR-LTEKSDVYSFGVVLFEVL 235

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 178
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 79  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW---Y 135
           +  G+ Y+  A V+HRDL   N L+  N  +K+ DFG+ R   +  + T    T++   +
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 171
Query: 136 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 169
            +PE + + S Y++  DVWS G +  E+     +
Sbjct: 172 ASPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HRDL   N  +  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 184
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 193 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 242

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 131
           + YQ+   L Y+ S   +HRD+   N+L++A   +K+ DFGL+R   ++ +       + 
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 556 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 128 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 186
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 187 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 238

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 175
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 176 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 227

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 175
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 176 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 227

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 178
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 177
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 178 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 178
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 58/118 (49%), Gaps = 7/118 (5%)
Query: 58  HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 117
           H + R+  +L       +  QI + + Y+ S N +HRD+   N+L+ +   +K+ DFGL+
Sbjct: 113 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 172
Query: 118 RVTSETDFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLF 170
           R   + D+    V     +W  +PE  +N   +T A DVW       E++   ++P F
Sbjct: 173 RYIEDEDYYKASVTRLPIKWM-SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HR+L   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           W  APE L +   +T + D+WS G +  E+
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 58/118 (49%), Gaps = 7/118 (5%)
Query: 58  HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 117
           H + R+  +L       +  QI + + Y+ S N +HRD+   N+L+ +   +K+ DFGL+
Sbjct: 97  HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 156
Query: 118 RVTSETDFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLF 170
           R   + D+    V     +W  +PE  +N   +T A DVW       E++   ++P F
Sbjct: 157 RYIEDEDYYKASVTRLPIKW-MSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 133
           +I  G+ Y+++   +HR+L   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           W  APE L +   +T + D+WS G +  E+
Sbjct: 199 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 226

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 58/118 (49%), Gaps = 7/118 (5%)
Query: 58  HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 117
           H + R+  +L       +  QI + + Y+ S N +HRD+   N+L+ +   +K+ DFGL+
Sbjct: 101 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
Query: 118 RVTSETDFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLF 170
           R   + D+    V     +W  +PE  +N   +T A DVW       E++   ++P F
Sbjct: 161 RYIEDEDYYKASVTRLPIKW-MSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 131
           + YQ+   L Y+ S   +HRD+   N+L++A   +K+ DFGL+R   ++ +       + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 73  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 127
           QY L    QI  G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 114 QYLLNWCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 173
Query: 128 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 174 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 210

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 133
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 134 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 182
           +   + APE L   + ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 60/124 (48%), Gaps = 10/124 (8%)
Query: 46  VYIAYELM-DTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +YI  EL+   D    +R+  A L  +     +     G++Y+ S   +HRDL   N L+
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV 246
Query: 104 NANCDLKICDFGLAR-----VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
                LKI DFG++R     V + +  + + V  +W  APE  LN   Y++  DVWS G 
Sbjct: 247 TEKNVLKISDFGMSREEADGVXAASGGLRQ-VPVKWT-APE-ALNYGRYSSESDVWSFGI 303
Query: 159 IFME 162
           +  E
Sbjct: 304 LLWE 307

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 131
           + YQ+   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++         + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLP 175
Query: 132 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            +W  APE  +N   +T+A DVW  G    E++
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 7/99 (7%)
Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVV 131
           +L++ + GLK  H   + HRD+K  N+LL  N    I DFGLA               V 
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 132 TRWYRAPELLLNSSDYTA----AIDVWSVGCIFMELMDR 166
           TR Y APE+L  + ++       ID++++G +  EL  R
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 79  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV---TRWY 135
           +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW 
Sbjct: 109 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW- 167
Query: 136 RAPELLLNSSDYTAAIDVWSVGCIFMEL 163
            +P  +L  S +++  D+W+ G +  E+
Sbjct: 168 -SPPEVLMYSKFSSKSDIWAFGVLMWEI 194

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 59/117 (50%), Gaps = 8/117 (6%)
Query: 51  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 110
           ++  TD  + ++S  AL      + + QI  G++Y+ S +V+H+DL   N+L+    ++K
Sbjct: 111 DVGSTDDDRTVKS--ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 168
Query: 111 ICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           I D GL R     D+        +  RW  APE ++    ++   D+WS G +  E+
Sbjct: 169 ISDLGLFREVYAADYYKLLGNSLLPIRWM-APEAIMYGK-FSIDSDIWSYGVVLWEV 223

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 59/117 (50%), Gaps = 8/117 (6%)
Query: 51  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 110
           ++  TD  + ++S  AL      + + QI  G++Y+ S +V+H+DL   N+L+    ++K
Sbjct: 128 DVGSTDDDRTVKS--ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 185
Query: 111 ICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           I D GL R     D+        +  RW  APE ++    ++   D+WS G +  E+
Sbjct: 186 ISDLGLFREVYAADYYKLLGNSLLPIRWM-APEAIMYGK-FSIDSDIWSYGVVLWEV 240
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	302
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-178
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-173
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-172
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-169
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-168
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-168
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-167
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-165
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-162
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-160
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-157
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-156
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-141
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-140
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-138
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-136
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-125
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-106
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-96
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-92
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-91
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-91
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-91
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-90
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-90
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-89
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-88
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-87
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-87
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-85
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-75
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-53
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-50
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-50
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-50
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-49
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-49
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-48
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-48
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-46
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-46
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-46
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-45
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-45
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-44
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-44
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-43
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-43
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-42
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-42
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-41
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-41
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-41
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-41
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-41
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-40
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-40
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-40
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-40
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-40
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-40
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-40
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-40
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-40
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-40
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-40
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-40
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-39
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-39
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-39
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-39
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-39
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-39
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-38
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-38
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-38
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-38
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-38
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-37
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-37
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-37
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-37
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-36
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-36
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-36
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-35
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-35
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-34
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-34
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-33
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-33
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-33
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-32
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-31
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-31
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-30
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-30
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-30
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-29
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-29
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-29
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-29
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-29
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-29
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-29
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-28
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-28
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-27
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-26
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-26
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-25
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-25
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-24
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-24
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-24
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-23
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-23
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-23
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-23
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-22
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-21
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-21
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-20
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-20
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-18
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-18
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-18
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-17
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-17
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-17
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-17
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-17
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-17
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-16
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-15
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-15
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-15
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-14
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-14
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-13
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-13
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-13
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-13
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-12
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-06

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  494 bits (1275), Expect = e-178
 Identities = 149/278 (53%), Positives = 197/278 (70%), Gaps = 6/278 (2%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLKYIH
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH 145

Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPELLLN 143
           SANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++LN
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAK 202
           S  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L  + N  A+
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 265

Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 262
            Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D SD
Sbjct: 266 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325

Query: 263 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           EP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 326 EPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  483 bits (1246), Expect = e-173
 Identities = 103/272 (37%), Positives = 153/272 (56%), Gaps = 4/272 (1%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYI 86
           ++ +RDI    +  + + +Y+  ELM TDL Q+I   +  +S +H QYF+Y IL GL  +
Sbjct: 91  ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL 150

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           H A V+HRDL P N+LL  N D+ ICDF LAR  +     T YV  RWYRAPEL++    
Sbjct: 151 HEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKG 210

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
           +T  +D+WS GC+  E+ +RK LF G    +QL  ++E++GTP   ++    + +A+ Y+
Sbjct: 211 FTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYL 270

Query: 206 -CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
              L     +++T   P   P A+DL+ KML F+P++RI+ E AL HPY  SL D  D  
Sbjct: 271 RNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT 330

Query: 265 VCMSPFSFDFEQHALTEGQMKELIYQEALAFN 296
                  F F++       M ++   E   FN
Sbjct: 331 EG-LSERFHFDESVTDVYDMHKIFTAEVERFN 361

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  478 bits (1233), Expect = e-172
 Identities = 140/284 (49%), Positives = 192/284 (67%), Gaps = 18/284 (6%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++ I +I  P   E+FN+VYI  ELM TDLH++I + Q LS++H QYF+YQ LR +K +H
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLH 129

Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARV-----------TSETDFMTEYVVTRWYR 136
            +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR+           T +   M E+V TRWYR
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189

Query: 137 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-SEAELG 195
           APE++L S+ Y+ A+DVWS GCI  EL  R+P+FPGRD+ HQL L+  +IGTP S+ +L 
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249

Query: 196 FL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            + +  A++YI  LP Y      + FP V+P  IDL+++ML FDP +RIT ++AL HPYL
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

Query: 255 GSLHDISDEPVC----MSPFSFDFEQHALTEGQMKELIYQEALA 294
            + HD +DEP       S F FD  + ALT   +K+LI+ E  +
Sbjct: 310 QTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS 353

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  472 bits (1218), Expect = e-169
 Identities = 117/277 (42%), Positives = 170/277 (61%), Gaps = 6/277 (2%)

Query: 28  VVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           V+ + D+  P    + F D Y+    M TDL ++++  + L E+  Q+ +YQ+L+GL+YI
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYI 144

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           H+A ++HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++LN   
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTGYVVTRWYRAPEVILNWMR 202

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
           YT  +D+WSVGCI  E++  K LF G DH+ QL+ ++++ GTP    +  L ++ AK Y+
Sbjct: 203 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 262

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
             LP  +++ F     N  P A++L+EKML  D  QR+T  +ALAHPY  SLHD  DEP 
Sbjct: 263 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 322

Query: 266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 302
               +   F+    T  + K + Y+E L+F P  +  
Sbjct: 323 V-QKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLG 358

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  473 bits (1218), Expect = e-168
 Identities = 109/328 (33%), Positives = 171/328 (52%), Gaps = 53/328 (16%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++ + D+I P     F+++YI  E+ D+DL ++ ++   L+EEH +  LY +L G  +IH
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146

Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-----------------------ETD 124
            + ++HRDLKP+N LLN +C +K+CDFGLAR  +                          
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206

Query: 125 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----------DRKPLFPG- 172
            +T +VVTRWYRAPEL+L   +YT +ID+WS GCIF EL+           +R PLFPG 
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266

Query: 173 ----------------RDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQS 215
                           + +  QL ++  +IGTP+E +L  +      KYI   P  +  +
Sbjct: 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326

Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFE 275
             +K+P++    I+L+E ML F+P +RIT++ AL HPYL  +     E          F+
Sbjct: 327 LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD 386

Query: 276 Q-HALTEGQMKELIYQEALAFNPEYRQQ 302
               L+E Q++ +  +E  +F+PE    
Sbjct: 387 DWMVLSETQLRYIFLKEVQSFHPELVIP 414

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  470 bits (1211), Expect = e-168
 Identities = 131/277 (47%), Positives = 177/277 (63%), Gaps = 6/277 (2%)

Query: 28  VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           V+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKYI
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYI 148

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN   
Sbjct: 149 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWMH 206

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
           Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+A+ YI
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
             L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DEPV
Sbjct: 267 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 326

Query: 266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 302
              P+    E   L   + K L Y E ++F P    Q
Sbjct: 327 A-DPYDQSLESRDLLIDEWKSLTYDEVISFVPPPLDQ 362

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  468 bits (1206), Expect = e-167
 Identities = 119/272 (43%), Positives = 163/272 (59%), Gaps = 6/272 (2%)

Query: 28  VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           V+ + D+  P     +F D Y+    M TDL +I+      SEE  QY +YQ+L+GLKYI
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKYI 142

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSA V+HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++L+   
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMH 200

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYI 205
           Y   +D+WSVGCI  E++  K LF G+D++ QL  ++++ G P    +  L ++ AK YI
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 260

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
             LP+  R+ FT+ FP   P A DL+EKML  D  +R+T   AL HP+     D  +E  
Sbjct: 261 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETE 320

Query: 266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
              PF    E   LT  + K+ IY+E + F+P
Sbjct: 321 AQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  466 bits (1202), Expect = e-165
 Identities = 115/336 (34%), Positives = 172/336 (51%), Gaps = 61/336 (18%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           VV + DI+ P   E F+++Y+  E+ D+D  ++ R+   L+E H +  LY +L G+KY+H
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH 173

Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----------------------- 124
           SA +LHRDLKP+N L+N +C +K+CDFGLAR     +                       
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233

Query: 125 -----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----------DRKP 168
                 +T +VVTRWYRAPEL+L   +YT AIDVWS+GCIF EL+           DR P
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293

Query: 169 LFPGRD--------------------HVHQLRLLIELIGTPSEAELGFL-NENAKKYICQ 207
           LFPG                      +  QL ++  ++GTPSE ++  L  E+AK+YI  
Sbjct: 294 LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI 353

Query: 208 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCM 267
            P+ +     E+FP     AI L+++ML F+P +RIT+ + LAHP+   +     E    
Sbjct: 354 FPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNAT 413

Query: 268 SPFSFDFE-QHALTEGQMKELIYQEALAFNPEYRQQ 302
                 F     + E Q++    +E   ++PE +  
Sbjct: 414 EKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPEIQLP 449

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  455 bits (1172), Expect = e-162
 Identities = 102/315 (32%), Positives = 164/315 (52%), Gaps = 44/315 (13%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           +V + +++      +  DVY+ ++ M+TDLH +IR+   L   H QY +YQ+++ +KY+H
Sbjct: 71  IVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLH 126

Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARV----------------------TSETDF 125
           S  +LHRD+KPSN+LLNA C +K+ DFGL+R                         +   
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186

Query: 126 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 185
           +T+YV TRWYRAPE+LL S+ YT  ID+WS+GCI  E++  KP+FPG   ++QL  +I +
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246

Query: 186 IGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKF----------------PNVHPSAI 228
           I  PS  ++  + +  AK  I  L        + K                  + +  A+
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306

Query: 229 DLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHA-LTEGQMKEL 287
           DL++K+L F+P +RI+  DAL HP++   H+ ++EP C    +     +   +    + L
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNL 366

Query: 288 IYQEALAFNPEYRQQ 302
           +Y E      E    
Sbjct: 367 VYSEISRRKRELISN 381

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  449 bits (1157), Expect = e-160
 Identities = 111/289 (38%), Positives = 161/289 (55%), Gaps = 17/289 (5%)

Query: 28  VVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           ++ + ++  P    E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 143

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262

Query: 207 QLPRYQRQSFTEKFPNVH------------PSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL HPY+
Sbjct: 263 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322

Query: 255 GSLHDISDEPVCM-SPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 302
              +D S+             ++   T  + KELIY+E +     +   
Sbjct: 323 NVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEHHHHHH 371

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  446 bits (1149), Expect = e-157
 Identities = 110/289 (38%), Positives = 166/289 (57%), Gaps = 17/289 (5%)

Query: 28  VVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           ++++ ++  P    E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L G+K++
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 180

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 239

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299

Query: 207 QLPRYQRQSFTEKFPNVH------------PSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             P+Y   +F + FP+                A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

Query: 255 GSLHDISDE-PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 302
              +D ++        +    ++   T  + KELIY+E +    + +  
Sbjct: 360 NVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNG 408

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  437 bits (1125), Expect = e-156
 Identities = 103/252 (40%), Positives = 147/252 (58%), Gaps = 15/252 (5%)

Query: 28  VVAIRDIIPPPQR---------ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQ 78
           +V + +I+ P               N VYI  E M+TDL  ++     L EEH + F+YQ
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFMYQ 128

Query: 79  ILRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTS----ETDFMTEYVVTR 133
           +LRGLKYIHSANVLHRDLKP+NL +N  +  LKI DFGLAR+          ++E +VT+
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 193
           WYR+P LLL+ ++YT AID+W+ GCIF E++  K LF G   + Q++L++E I    E +
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248

Query: 194 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
              L      YI        +  T+  P +   A+D +E++LTF P  R+T E+AL+HPY
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308

Query: 254 LGSLHDISDEPV 265
           +       DEP+
Sbjct: 309 MSIYSFPMDEPI 320

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  402 bits (1036), Expect = e-141
 Identities = 83/280 (29%), Positives = 138/280 (49%), Gaps = 16/280 (5%)

Query: 28  VVAIRDIIPPPQRESFNDVY--IAYELMDTDLHQIIRS----NQALSEEHCQYFLYQILR 81
           +V ++            D+Y  +  E +   LH+  R+      A      + FL+Q++R
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140

Query: 82  GLKYIH--SANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 138
            +  +H  S NV HRD+KP N+L+N A+  LK+CDFG A+  S ++    Y+ +R+YRAP
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAP 200

Query: 139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 198
           EL+  +  YT A+D+WSVGCIF E+M  +P+F G +   QL  ++ ++G PS   L  LN
Sbjct: 201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260

Query: 199 -ENAKKYICQLPRYQ-RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
             +    +           F++        A DL+  +L + P +R+   +AL HPY   
Sbjct: 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320

Query: 257 LHDISDE-----PVCMSPFSFDFEQHALTEGQMKELIYQE 291
           LHD + +      +    F F   +  +     K  + ++
Sbjct: 321 LHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  401 bits (1031), Expect = e-140
 Identities = 82/283 (28%), Positives = 155/283 (54%), Gaps = 21/283 (7%)

Query: 36  PPPQRESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANV 91
                     + +  E +   LH++++    S +++       ++YQ+ R + +IHS  +
Sbjct: 103 VIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI 162

Query: 92  LHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAA 150
            HRD+KP NLL+N+  + LK+CDFG A+    ++    Y+ +R+YRAPEL+L +++YT +
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPS 222

Query: 151 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 210
           ID+WS+GC+F EL+  KPLF G   + QL  +I+++GTP++ ++  +N +  +   + P 
Sbjct: 223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV--RFPT 280

Query: 211 YQRQSFTEKFPNVHPS-AIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSP 269
            + + + +  P   PS AIDL+E++L ++P  RI   +A+AHP+   L +  +  V  + 
Sbjct: 281 LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNS 340

Query: 270 -------------FSFDFEQHALTEGQMKELIYQEALAFNPEY 299
                        F+F   + ++  G +   I  +  + N ++
Sbjct: 341 NFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFSPNYKH 383

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  395 bits (1018), Expect = e-138
 Identities = 83/285 (29%), Positives = 150/285 (52%), Gaps = 12/285 (4%)

Query: 28  VVAIRDIIPPP-QRESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRG 82
           +V +R       +++    + +  + +   ++++ R    + Q L   + + ++YQ+ R 
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168

Query: 83  LKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELL 141
           L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R+YRAPEL+
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 228

Query: 142 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 201
             ++DYT++IDVWS GC+  EL+  +P+FPG   V QL  +I+++GTP+  ++  +N N 
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288

Query: 202 KKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 260
            ++  + P+ +   +T+ F P   P AI L  ++L + P  R+T  +A AH +   L D 
Sbjct: 289 TEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346

Query: 261 SDEP--VCMSPFSFDFEQHALTE-GQMKELIYQEALAFNPEYRQQ 302
           + +      +P  F+F    L+    +  ++              
Sbjct: 347 NVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTP 391

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  390 bits (1004), Expect = e-136
 Identities = 85/276 (30%), Positives = 148/276 (53%), Gaps = 13/276 (4%)

Query: 28  VVAIRDIIPPP-QRESFNDVYIAYELMDTDLHQIIRS----NQALSEEHCQYFLYQILRG 82
           VV ++        ++    + +  E +   +++  R      Q +     + ++YQ+LR 
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153

Query: 83  LKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELL 141
           L YIHS  + HRD+KP NLLL+     LK+ DFG A++    +    Y+ +R+YRAPEL+
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELI 213

Query: 142 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 201
             +++YT  ID+WS GC+  ELM  +PLFPG   + QL  +I+++GTPS  ++  +N N 
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273

Query: 202 KKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD- 259
            ++  + P+ +   F++ F P   P AIDL+ ++L + P  R+T  +AL HP+   L   
Sbjct: 274 MEH--KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331

Query: 260 ---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEA 292
              + +       F++  E+ ++    +  L+ Q A
Sbjct: 332 EARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHA 367

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  359 bits (924), Expect = e-125
 Identities = 67/241 (27%), Positives = 131/241 (54%), Gaps = 14/241 (5%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y H
Sbjct: 93  IITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 147

Query: 88  SANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           S  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++   
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207

Query: 147 YTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAE-LGFLN-ENAKK 203
           Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT    + +   N E   +
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267

Query: 204 YICQLPRYQRQSFTEKFPN-----VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 258
           +   L R+ R+ +     +     V P A+D ++K+L +D + R+T  +A+ HPY  ++ 
Sbjct: 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327

Query: 259 D 259
            
Sbjct: 328 K 328

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  311 bits (798), Expect = e-106
 Identities = 75/253 (29%), Positives = 129/253 (50%), Gaps = 9/253 (3%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDL-HQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +V + ++           +++ +E  D  + H++ R  + + E   +   +Q L+ + + 
Sbjct: 64  LVNLLEVFR-----RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 145
           H  N +HRD+KP N+L+  +  +K+CDFG AR+ T  +D+  + V TRWYR+PELL+  +
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKY 204
            Y   +DVW++GC+F EL+   PL+PG+  V QL L+ + +G         F        
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238

Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
           +        +    KFPN+   A+ L++  L  DP +R+T E  L HPY  ++ +I D  
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLA 298

Query: 265 VCMS-PFSFDFEQ 276
                P    + Q
Sbjct: 299 KEHDKPAENLYFQ 311

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  286 bits (733), Expect = 3e-96
 Identities = 70/229 (30%), Positives = 119/229 (51%), Gaps = 8/229 (3%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 86
           +V + ++            Y+ +E +D  +   +      L  +  Q +L+QI+ G+ + 
Sbjct: 86  LVNLLEVCK-----KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 145
           HS N++HRD+KP N+L++ +  +K+CDFG AR   +  +   + V TRWYRAPELL+   
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y  A+DVW++GC+  E+   +PLFPG   + QL  ++  +G          N+N     
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260

Query: 206 CQLPRYQ-RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
            +LP  + R+    ++P +    IDL +K L  DP +R    + L H +
Sbjct: 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  273 bits (700), Expect = 8e-92
 Identities = 87/229 (37%), Positives = 121/229 (52%), Gaps = 10/229 (4%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 86
           +V + D+I      +   + + +E +D DL +++      L     + FL Q+L G+ Y 
Sbjct: 62  IVKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 145
           H   VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT WYRAP++L+ S 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKY 204
            Y+  ID+WSVGCIF E+++  PLFPG     QL  +  ++GTP+             KY
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV--TELPKY 234

Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
                 Y+   +      +  S IDL+ KML  DP QRIT + AL H Y
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  273 bits (700), Expect = 2e-91
 Identities = 83/229 (36%), Positives = 122/229 (53%), Gaps = 8/229 (3%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKY 85
           VV + D+    + +    V + +E +D DL   +       L  E  +  + Q LRGL +
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +T  VVT WYRAPE+LL S+
Sbjct: 136 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST 195

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKY 204
            Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +       +  + 
Sbjct: 196 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD--VSLPRG 252

Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
               P    +      P +  S   L+ +MLTF+P +RI+   AL H Y
Sbjct: 253 --AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  272 bits (699), Expect = 4e-91
 Identities = 86/253 (33%), Positives = 129/253 (50%), Gaps = 14/253 (5%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKY 85
           VV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LRGL +
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+LL SS
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKY 204
            Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E +          + 
Sbjct: 196 -YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD--VALPRQ 252

Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
                    Q   +   ++     DL+ K LTF+P +RI+   AL+HPY        D  
Sbjct: 253 --AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF------QDLE 304

Query: 265 VCMSPFSFDFEQH 277
            C           
Sbjct: 305 RCKENLDSHLPPS 317

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  271 bits (696), Expect = 9e-91
 Identities = 85/234 (36%), Positives = 132/234 (56%), Gaps = 11/234 (4%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 86
           +V++ D+I      S   + + +E M+ DL +++      L +   + +LYQ+LRG+ + 
Sbjct: 81  IVSLIDVIH-----SERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 145
           H   +LHRDLKP NLL+N++  LK+ DFGLAR         T  VVT WYRAP++L+ S 
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLN-ENAKK 203
            Y+ ++D+WS+GCIF E++  KPLFPG     QL  +  ++GTP+  E          K+
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255

Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
                  ++++ ++   P      IDL+  ML FDP +RI+  DA+ HPY   L
Sbjct: 256 R--TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  269 bits (691), Expect = 7e-90
 Identities = 97/259 (37%), Positives = 142/259 (54%), Gaps = 15/259 (5%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 86
           +V + DII      +   + + +E +D DL Q +      ++  + + FL+Q+LRGL Y 
Sbjct: 62  IVTLHDIIH-----TEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 145
           H   VLHRDLKP NLL+N   +LK+ DFGLAR  +  T      VVT WYR P++LL S+
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST 176

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLN-ENAKK 203
           DY+  ID+W VGCIF E+   +PLFPG     QL  +  ++GTP+E    G L+ E  K 
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236

Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL----HD 259
           Y    P+Y+ ++     P +     DL+ K+L F+ R RI+ EDA+ HP+  SL    H 
Sbjct: 237 Y--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK 294

Query: 260 ISDEPVCMSPFSFDFEQHA 278
           + D     +      ++ A
Sbjct: 295 LPDTTSIFALKEIQLQKEA 313

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  270 bits (692), Expect = 1e-89
 Identities = 78/230 (33%), Positives = 121/230 (52%), Gaps = 13/230 (5%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 86
           ++ + D          +++ + ++ M+TDL  II+  +  L+  H + ++   L+GL+Y+
Sbjct: 74  IIGLLDAFG-----HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 145
           H   +LHRDLKP+NLLL+ N  LK+ DFGLA+   S     T  VVTRWYRAPELL  + 
Sbjct: 129 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 188

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLN-ENAKK 203
            Y   +D+W+VGCI  EL+ R P  PG   + QL  + E +GTP+E +     +  +   
Sbjct: 189 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 248

Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
           +      +        F       +DL++ +  F+P  RIT   AL   Y
Sbjct: 249 F----KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  266 bits (681), Expect = 2e-88
 Identities = 75/238 (31%), Positives = 126/238 (52%), Gaps = 15/238 (6%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++ ++ +I        + +++ +E  + DL + +  N  +S    + FLYQ++ G+ + H
Sbjct: 95  IIELKSVIH-----HNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149

Query: 88  SANVLHRDLKPSNLLLNANCD-----LKICDFGLARV-TSETDFMTEYVVTRWYRAPELL 141
           S   LHRDLKP NLLL+ +       LKI DFGLAR         T  ++T WYR PE+L
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209

Query: 142 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNEN 200
           L S  Y+ ++D+WS+ CI+ E++ + PLFPG   + QL  + E++G P +    G     
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV--TA 267

Query: 201 AKKYICQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
              +    P+++ ++        +    +DL+  ML  DP +RI+ ++AL HPY    
Sbjct: 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  261 bits (670), Expect = 4e-87
 Identities = 90/241 (37%), Positives = 131/241 (54%), Gaps = 25/241 (10%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI 86
           +V + D++      S   + + +E  D DL +   S N  L  E  + FL+Q+L+GL + 
Sbjct: 63  IVRLHDVLH-----SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSS 145
           HS NVLHRDLKP NLL+N N +LK+ +FGLAR         +  VVT WYR P++L  + 
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 146 DYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKK 203
            Y+ +ID+WS GCIF EL +  +PLFPG D   QL+ +  L+GTP+E +           
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM------- 230

Query: 204 YICQLPRY-------QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
              +LP Y          S     P ++ +  DL++ +L  +P QRI+ E+AL HPY   
Sbjct: 231 --TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

Query: 257 L 257
            
Sbjct: 289 F 289

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  262 bits (673), Expect = 9e-87
 Identities = 82/268 (30%), Positives = 129/268 (48%), Gaps = 18/268 (6%)

Query: 27  SVVAIRDII---PPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRG 82
           +VV + +I      P       +Y+ ++  + DL  ++ +     +    +  +  +L G
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136

Query: 83  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-----VTSETDFMTEYVVTRWYRA 137
           L YIH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +  T  VVT WYR 
Sbjct: 137 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196

Query: 138 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GF 196
           PELLL   DY   ID+W  GCI  E+  R P+  G    HQL L+ +L G+ +       
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 256

Query: 197 LN-ENAKKYICQLPRYQRQSFTEKFPNVH--PSAIDLVEKMLTFDPRQRITVEDALAHPY 253
            N E  +K   +L + Q++   ++       P A+DL++K+L  DP QRI  +DAL H +
Sbjct: 257 DNYELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314

Query: 254 LGSL---HDISDEPVCMSPFSFDFEQHA 278
             S     D+           F++    
Sbjct: 315 FWSDPMPSDLKGMLSTHLTSMFEYLAPP 342

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  258 bits (662), Expect = 1e-85
 Identities = 79/250 (31%), Positives = 131/250 (52%), Gaps = 20/250 (8%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN------QALSEEHCQYFLYQILR 81
           +V + D+I      + N + + +E MD DL + + S       + L     +YF +Q+L+
Sbjct: 65  IVRLYDVIH-----TENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 82  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPEL 140
           GL + H   +LHRDLKP NLL+N    LK+ DFGLAR      +  +  VVT WYRAP++
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179

Query: 141 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNE 199
           L+ S  Y+ +ID+WS GCI  E++  KPLFPG +   QL+L+ +++GTP+E+        
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV--T 237

Query: 200 NAKKYICQLPRYQRQSFTEKF-----PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              KY   + +   +   +         +  + +D +  +L  +P  R++ + AL HP+ 
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

Query: 255 GSLHDISDEP 264
              +  +   
Sbjct: 298 AEYYHHASMG 307

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  236 bits (603), Expect = 1e-75
 Identities = 80/263 (30%), Positives = 127/263 (48%), Gaps = 43/263 (16%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS---------NQALSEEHCQYFLYQ 78
           V++++ +           V++ ++  + DL  II+             L     +  LYQ
Sbjct: 80  VISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 79  ILRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLAR-----VTSETDFMTEY 129
           IL G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR     +    D     
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV- 195

Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD---------HVHQLR 180
           VVT WYRAPELLL +  YT AID+W++GCIF EL+  +P+F  R          H  QL 
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255

Query: 181 LLIELIGTPSEAEL-GFLNENAKKYICQLPRYQRQSFT---------EKFPNVHPSAIDL 230
            +  ++G P++ +      +   ++   +  ++R ++T         +        A  L
Sbjct: 256 RIFNVMGFPADKDWEDI--KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313

Query: 231 VEKMLTFDPRQRITVEDALAHPY 253
           ++K+LT DP +RIT E A+  PY
Sbjct: 314 LQKLLTMDPIKRITSEQAMQDPY 336

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  177 bits (452), Expect = 5e-53
 Identities = 71/240 (29%), Positives = 116/240 (48%), Gaps = 36/240 (15%)

Query: 48  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN- 104
           + +EL+  +L+++I+ N  Q  S    + F + IL+ L  +H   ++H DLKP N+LL  
Sbjct: 176 MTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ 235

Query: 105 -ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
                +K+ DFG +    E   +  Y+ +R+YRAPE++L +  Y   ID+WS+GCI  EL
Sbjct: 236 QGRSGIKVIDFGSS--CYEHQRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAEL 292

Query: 164 MDRKPLFPGRDHVHQLRLLIELIGTPSE--------AELGFLNENA-------------- 201
           +   PL PG D   QL  +IEL+G PS+        A+    ++                
Sbjct: 293 LTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSV 352

Query: 202 -------KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                  ++   + P   R+          P  +D +++ L +DP  R+T   AL HP+L
Sbjct: 353 VLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  169 bits (431), Expect = 3e-50
 Identities = 62/247 (25%), Positives = 111/247 (44%), Gaps = 43/247 (17%)

Query: 48  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLL 103
           + +E++  +L+ ++R+   + +S    + F  Q+   L ++ +   +++H DLKP N+LL
Sbjct: 133 LVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL 192

Query: 104 --NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
                  +KI DFG +        + +Y+ +R+YR+PE+LL    Y  AID+WS+GCI +
Sbjct: 193 CNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILV 249

Query: 162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSE--------AELGFLNENAKKY--------- 204
           E+   +PLF G + V Q+  ++E++G P          A   F       +         
Sbjct: 250 EMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGK 309

Query: 205 -----------------ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 247
                                P  +R   +      +    DL+ +ML +DP+ RI    
Sbjct: 310 REYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369

Query: 248 ALAHPYL 254
           AL H + 
Sbjct: 370 ALQHSFF 376

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  169 bits (429), Expect = 3e-50
 Identities = 54/234 (23%), Positives = 96/234 (41%), Gaps = 30/234 (12%)

Query: 48  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN 104
           + +E++  +L  +I+    + +   + +    Q+L GL Y+H    ++H D+KP N+L+ 
Sbjct: 107 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166

Query: 105 ANCD------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
                     +KI D G A      +  T  + TR YR+PE+LL +  +    D+WS  C
Sbjct: 167 IVDSPENLIQIKIADLGNA--CWYDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTAC 223

Query: 159 IFMELMDRKPLFPGRD------HVHQLRLLIELIGTPSE--------AELGFLNENAKKY 204
           +  EL+    LF   +          +  +IEL+G                F +    + 
Sbjct: 224 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 283

Query: 205 ICQLPRYQRQSFTEKFPNV----HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           I +L  +  +    +             D +  ML  DPR+R      + HP+L
Sbjct: 284 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  167 bits (425), Expect = 9e-50
 Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 38/242 (15%)

Query: 48  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN- 104
           IA+EL+  +  + ++ N  Q     H ++  YQ+   L+++H   + H DLKP N+L   
Sbjct: 99  IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158

Query: 105 ------------------ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
                              N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 215

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS--------------EA 192
           +    DVWS+GCI  E      LF   ++   L ++ +++G                 + 
Sbjct: 216 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 275

Query: 193 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
            L +   ++     +      +S+  +    H    DL+ +ML FDP QRIT+ +AL HP
Sbjct: 276 GLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHP 335

Query: 253 YL 254
           + 
Sbjct: 336 FF 337

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  167 bits (424), Expect = 1e-49
 Identities = 68/254 (26%), Positives = 115/254 (45%), Gaps = 43/254 (16%)

Query: 40  RESF---NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHR 94
            E F     + I +EL+    +  I+ N       +H +   YQI + + ++HS  + H 
Sbjct: 83  LEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHT 142

Query: 95  DLKPSNLLLN-------------------ANCDLKICDFGLARVTSETDFMTEYVVTRWY 135
           DLKP N+L                      N D+K+ DFG A  T + +  +  V TR Y
Sbjct: 143 DLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHY 200

Query: 136 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL- 194
           RAPE++L    ++   DVWS+GCI +E      +FP  D    L ++  ++G   +  + 
Sbjct: 201 RAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259

Query: 195 ----------GFLN----ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR 240
                       L+     +A +Y+ +  +  ++    +    H    DL++KML +DP 
Sbjct: 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE-HERLFDLIQKMLEYDPA 318

Query: 241 QRITVEDALAHPYL 254
           +RIT+ +AL HP+ 
Sbjct: 319 KRITLREALKHPFF 332

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  166 bits (422), Expect = 3e-49
 Identities = 57/250 (22%), Positives = 103/250 (41%), Gaps = 46/250 (18%)

Query: 48  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN- 104
           + +E +   L++II  N       E  + +  +IL+ L Y+   ++ H DLKP N+LL+ 
Sbjct: 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172

Query: 105 ------------------------ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPEL 140
                                    +  +K+ DFG A  T ++D+    + TR YRAPE+
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEV 230

Query: 141 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE--------- 191
           +LN   +  + D+WS GC+  EL     LF   +H+  L ++  +I    +         
Sbjct: 231 ILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKT 289

Query: 192 AELGFLNENAKKYICQLP-------RYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT 244
               ++N++  K             ++ ++         H    D +  +L  DP  R +
Sbjct: 290 NGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS 349

Query: 245 VEDALAHPYL 254
             + L H +L
Sbjct: 350 PAELLKHKFL 359

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  164 bits (417), Expect = 1e-48
 Identities = 36/261 (13%), Positives = 69/261 (26%), Gaps = 34/261 (13%)

Query: 2   HSITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII 61
            S  +   R   +  S     +   S      + P     +  +  +       DL  + 
Sbjct: 122 ESPEEARDRRRLLLPSD---AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178

Query: 62  R-------SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 114
                                  Q++R    + S  ++H    P NL +  +  L + D 
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238

Query: 115 GLARVTSETDFMTEYVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 173
                           V   Y   E L  +++ +T A++ W +G     +      F   
Sbjct: 239 SALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296

Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
               +       +  P    L F                          +      L+ +
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAF---------------------GSCTPLPDFVKTLIGR 335

Query: 234 MLTFDPRQRITVEDALAHPYL 254
            L FD R+R+   +A+  P  
Sbjct: 336 FLNFDRRRRLLPLEAMETPEF 356

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  161 bits (409), Expect = 9e-48
 Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 41/227 (18%)

Query: 41  ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
            +   +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N
Sbjct: 98  ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 157

Query: 101 LLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSD----------Y 147
            L+  +  LK+ DFG+A        +      V T  Y  PE + + S            
Sbjct: 158 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216

Query: 148 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ 207
           +   DVWS+GCI   +   K  F      +Q+  L  +I                 +  +
Sbjct: 217 SPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAII--------------DPNHEIE 260

Query: 208 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            P                   D+++  L  DP+QRI++ + LAHPY+
Sbjct: 261 FP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  161 bits (409), Expect = 1e-46
 Identities = 57/241 (23%), Positives = 90/241 (37%), Gaps = 45/241 (18%)

Query: 41  ESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           +     YIA EL    L + +     A         L Q   GL ++HS N++HRDLKP 
Sbjct: 88  KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPH 147

Query: 100 NLLL-----NANCDLKICDFGLARV----TSETDFMTEYVVTRWYRAPELLLNSSD--YT 148
           N+L+     +      I DFGL +            +    T  + APE+L        T
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPT 207

Query: 149 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL 208
             +D++S GC+F  ++       G+    Q  +L+                 A       
Sbjct: 208 YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL----------------GACSL---- 247

Query: 209 PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY-------LGSLHDIS 261
                        +    A +L+EKM+  DP++R + +  L HP+       L    D+S
Sbjct: 248 ------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVS 301

Query: 262 D 262
           D
Sbjct: 302 D 302

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  158 bits (401), Expect = 3e-46
 Identities = 54/276 (19%), Positives = 101/276 (36%), Gaps = 43/276 (15%)

Query: 41  ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
            +   +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N
Sbjct: 79  ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 138

Query: 101 LLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSD----------Y 147
            L+  +  LK+ DFG+A        +      V T  Y  PE + + S            
Sbjct: 139 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 197

Query: 148 TAAIDVWSVGCIFMELMDRKPLFPG-RDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           +   DVWS+GCI   +   K  F    + + +L  +I+                   +  
Sbjct: 198 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----------------PNHEI 240

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 266
           + P                   D+++  L  DP+QRI++ + LAHPY+       ++   
Sbjct: 241 EFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 289

Query: 267 MSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 302
            +     +    L        I + A      Y   
Sbjct: 290 GTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGG 325

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  156 bits (397), Expect = 4e-46
 Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 47/241 (19%)

Query: 32  RDIIPPPQRESFNDVYIAYELMDT-DLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA 89
             + P    +  + ++I  E  +   L+ +I S N     +       QIL  L YIHS 
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135

Query: 90  NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---------------DFMTEYVVTRW 134
            ++HRDLKP N+ ++ + ++KI DFGLA+    +               D +T  + T  
Sbjct: 136 GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAM 195

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
           Y A E+L  +  Y   ID++S+G IF E++   P   G + V+ L+ L            
Sbjct: 196 YVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL------------ 241

Query: 195 GFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
                          R     F   F  N       ++  ++  DP +R      L   +
Sbjct: 242 ---------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286

Query: 254 L 254
           L
Sbjct: 287 L 287

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  155 bits (393), Expect = 2e-45
 Identities = 52/218 (23%), Positives = 77/218 (35%), Gaps = 37/218 (16%)

Query: 41  ESF---NDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL 96
           +++     +Y+  EL    L Q       +L E     +L   L  L ++HS  ++H D+
Sbjct: 124 QAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDV 183

Query: 97  KPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           KP+N+ L      K+ DFGL                  Y APELL     Y  A DV+S+
Sbjct: 184 KPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSL 241

Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           G   +E+     L  G +   QLR                          +         
Sbjct: 242 GLTILEVACNMELPHGGEGWQQLR--------------------QGYLPPEFT------- 274

Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                 +      ++  ML  DP+ R T E  LA P L
Sbjct: 275 ----AGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  156 bits (396), Expect = 4e-45
 Identities = 52/272 (19%), Positives = 94/272 (34%), Gaps = 41/272 (15%)

Query: 44  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
             +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+
Sbjct: 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 188

Query: 104 NANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSD----------YTAA 150
             +  LK+ DFG+A        +      V    Y  PE + + S            +  
Sbjct: 189 V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK 247

Query: 151 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 210
            DVWS+GCI   +   K  F    +       I                    +  + P 
Sbjct: 248 SDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID----------------PNHEIEFP- 290

Query: 211 YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 270
                             D+++  L  DP+QRI++ + LAHPY+       ++    +  
Sbjct: 291 ----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 340

Query: 271 SFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 302
              +    L        I + A      Y   
Sbjct: 341 EMKYVLGQLVGLNSPNSILKAAKTLYEHYSGG 372

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  152 bits (385), Expect = 1e-44
 Identities = 48/239 (20%), Positives = 80/239 (33%), Gaps = 40/239 (16%)

Query: 19  FDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQII--RSNQALSEEHCQYF 75
              W                 +     ++I  E  D   L Q I  R  + L +      
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKC--LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127

Query: 76  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWY 135
             QI +G+ YIHS  +++RDLKPSN+ L     +KI DFGL          T    T  Y
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187

Query: 136 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG 195
            +PE + +   Y   +D++++G I  EL+             +       +         
Sbjct: 188 MSPEQISSQD-YGKEVDLYALGLILAELL--HVCDTA----FETSKFFTDL--------- 231

Query: 196 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                           +    ++ F         L++K+L+  P  R    + L    +
Sbjct: 232 ----------------RDGIISDIFD---KKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  150 bits (381), Expect = 9e-44
 Identities = 56/244 (22%), Positives = 105/244 (43%), Gaps = 44/244 (18%)

Query: 23  IMKT-----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFL 76
           I++      +++ ++D       E+    ++ ++LM   +L   +     LSE+  +  +
Sbjct: 76  ILRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYR 136
             +L  +  +H  N++HRDLKP N+LL+ + ++K+ DFG +      + + E   T  Y 
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 190

Query: 137 APELLLNSSD-----YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 191
           APE++  S +     Y   +D+WS G I                     +   L G+P  
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVI---------------------MYTLLAGSPP- 228

Query: 192 AELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALA 250
               F +      + ++       F      +   +  DLV + L   P++R T E+ALA
Sbjct: 229 ----FWHRKQML-MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283

Query: 251 HPYL 254
           HP+ 
Sbjct: 284 HPFF 287

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  152 bits (386), Expect = 2e-43
 Identities = 75/243 (30%), Positives = 118/243 (48%), Gaps = 43/243 (17%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
           I+K      ++ I++       ++  D YI  ELM+  +L   +  N+ L E  C+ + Y
Sbjct: 193 ILKKLNHPCIIKIKNFF-----DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRW 134
           Q+L  ++Y+H   ++HRDLKP N+LL++   +C +KI DFG +++  ET  M     T  
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 306

Query: 135 YRAPELLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEA 192
           Y APE+L++     Y  A+D WS+G I                     L I L G P   
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVI---------------------LFICLSGYPP-- 343

Query: 193 ELGFLNENAKKYICQLPRYQRQSFT-EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
              F     +  +       + +F  E +  V   A+DLV+K+L  DP+ R T E+AL H
Sbjct: 344 ---FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400

Query: 252 PYL 254
           P+L
Sbjct: 401 PWL 403

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  148 bits (377), Expect = 6e-43
 Identities = 76/260 (29%), Positives = 121/260 (46%), Gaps = 43/260 (16%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
           I+K      ++ I++       ++  D YI  ELM+  +L   +  N+ L E  C+ + Y
Sbjct: 68  ILKKLNHPCIIKIKNFF-----DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRW 134
           Q+L  ++Y+H   ++HRDLKP N+LL++   +C +KI DFG +++  ET  M     T  
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 181

Query: 135 YRAPELLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEA 192
           Y APE+L++     Y  A+D WS+G I                     L I L G P   
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVI---------------------LFICLSGYPP-- 218

Query: 193 ELGFLNENAKKYICQLPRYQRQSF-TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
              F     +  +       + +F  E +  V   A+DLV+K+L  DP+ R T E+AL H
Sbjct: 219 ---FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275

Query: 252 PYLGSLHDISDEPVCMSPFS 271
           P+L            +S  +
Sbjct: 276 PWLQDEDMKRKFQDLLSEEN 295

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  148 bits (375), Expect = 3e-42
 Identities = 59/247 (23%), Positives = 105/247 (42%), Gaps = 54/247 (21%)

Query: 23  IMKT-----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFL 76
           I++       ++ + D       ES + +++ ++LM   +L   +    ALSE+  +  +
Sbjct: 152 ILRQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM 206

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYR 136
             +L  + ++H+ N++HRDLKP N+LL+ N  +++ DFG +      + + E   T  Y 
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYL 266

Query: 137 APELLLNSSD-----YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-- 189
           APE+L  S D     Y   +D+W+ G I                     L   L G+P  
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVI---------------------LFTLLAGSPPF 305

Query: 190 ---SEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITV 245
               +  +        +Y           F+     +   +  DL+ ++L  DP  R+T 
Sbjct: 306 WHRRQILM-LRMIMEGQY----------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTA 354

Query: 246 EDALAHP 252
           E AL HP
Sbjct: 355 EQALQHP 361

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  147 bits (373), Expect = 4e-42
 Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 37/222 (16%)

Query: 40  RESF---NDVYIAYELMDT-DLHQII--RSNQALSEEHCQYFLYQILRGLKYIHSANVLH 93
           RESF     +YI  +  +  DL + I  +      E+    +  QI   LK++H   +LH
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148

Query: 94  RDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-TRWYRAPELLLNSSDYTAAID 152
           RD+K  N+ L  +  +++ DFG+ARV + T  +    + T +Y +PE+  N   Y    D
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP-YNNKSD 207

Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           +W++GC+  EL   K  F      +    L+  I                     +    
Sbjct: 208 IWALGCVLYELCTLKHAFEAGSMKN----LVLKI--------------ISGSFPPVS--- 246

Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                    +       LV ++   +PR R +V   L   ++
Sbjct: 247 --------LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  144 bits (365), Expect = 1e-41
 Identities = 63/257 (24%), Positives = 109/257 (42%), Gaps = 53/257 (20%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
           I++     +++ + DI      E+  DV +  EL+   +L   +   ++L+E+    FL 
Sbjct: 61  ILREIRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK 115

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTR 133
           QIL G+ Y+HS  + H DLKP N++L      N  +K+ DFG+A      +       T 
Sbjct: 116 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP 175

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP---- 189
            + APE ++N        D+WS+G I                       I L G      
Sbjct: 176 EFVAPE-IVNYEPLGLEADMWSIGVI---------------------TYILLSGASPFLG 213

Query: 190 -SEAELGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVED 247
            ++ E    N +A  Y           F E+ F N    A D + ++L  DP++R+T+  
Sbjct: 214 ETKQET-LTNISAVNY----------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQ 262

Query: 248 ALAHPYLGSLHDISDEP 264
           +L H ++ ++   +   
Sbjct: 263 SLEHSWIKAIRRRNVRG 279

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  142 bits (361), Expect = 5e-41
 Identities = 65/251 (25%), Positives = 99/251 (39%), Gaps = 43/251 (17%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
           IMK+    +++ + +       E   D+Y+  EL    +L + +   +   E      + 
Sbjct: 59  IMKSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK 113

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRW 134
            +L  + Y H  NV HRDLKP N L    + +  LK+ DFGLA        M   V T +
Sbjct: 114 DVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPY 173

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
           Y +P++L     Y    D WS G +                     + + L G P     
Sbjct: 174 YVSPQVLEGL--YGPECDEWSAGVM---------------------MYVLLCGYPP---- 206

Query: 195 GFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
            F      + +    R    +F EK + NV P A  L+ ++LT  P+QRIT   AL H +
Sbjct: 207 -FSAPTDSE-VMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264

Query: 254 LGSLHDISDEP 264
                  S   
Sbjct: 265 FEKQLSSSPRN 275

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  143 bits (363), Expect = 7e-41
 Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 50/239 (20%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDT-DL-HQII-RSNQALSEEHCQYFLYQILRGLK 84
           V+ + ++      E+ +++ +  E     ++    +    + +SE      + QIL G+ 
Sbjct: 91  VINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY 145

Query: 85  YIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 141
           Y+H  N++H DLKP N+LL       D+KI DFG++R       + E + T  Y APE +
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE-I 204

Query: 142 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAELGF 196
           LN    T A D+W++G I                       + L  T         E  +
Sbjct: 205 LNYDPITTATDMWNIGII---------------------AYMLLTHTSPFVGEDNQET-Y 242

Query: 197 LNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           LN +               ++E+ F +V   A D ++ +L  +P +R T E  L+H +L
Sbjct: 243 LNISQVNV----------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  143 bits (362), Expect = 8e-41
 Identities = 63/247 (25%), Positives = 105/247 (42%), Gaps = 53/247 (21%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
           I++     +V+ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ 
Sbjct: 68  ILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK 122

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTR 133
           QIL G+ Y+H+  + H DLKP N++L         +K+ DFGLA    +         T 
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP---- 189
            + APE ++N        D+WS+G I                       I L G      
Sbjct: 183 EFVAPE-IVNYEPLGLEADMWSIGVI---------------------TYILLSGASPFLG 220

Query: 190 -SEAELGFLNENAKKYICQLPRYQRQSFT-EKFPNVHPSAIDLVEKMLTFDPRQRITVED 247
            ++ E    N  +  Y           F  E F +    A D + K+L  + R+R+T+++
Sbjct: 221 DTKQET-LANITSVSY----------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQE 269

Query: 248 ALAHPYL 254
           AL HP++
Sbjct: 270 ALRHPWI 276

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  142 bits (360), Expect = 8e-41
 Identities = 63/239 (26%), Positives = 110/239 (46%), Gaps = 42/239 (17%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
           I +     ++V + D I     +  +  Y+ ++L+   +L + I + +  SE    + + 
Sbjct: 58  ICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ 112

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRW 134
           QIL  + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  
Sbjct: 113 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG 172

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
           Y +PE +L    Y+  +D+W+ G I                     L I L+G P     
Sbjct: 173 YLSPE-VLKKDPYSKPVDIWACGVI---------------------LYILLVGYPP---- 206

Query: 195 GFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
            F +E+  +   Q+       +    +  V P A  L++ MLT +P++RIT + AL  P
Sbjct: 207 -FWDEDQHRLYAQIKAGAY-DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  141 bits (359), Expect = 1e-40
 Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 56/247 (22%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMD-----TDLHQIIRSNQALSEEHCQ 73
           ++K+    +++ I ++      E ++++YI  E  +       +       +ALSE +  
Sbjct: 73  VLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127

Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYV 130
             + Q++  L Y HS +V+H+DLKP N+L    + +  +KI DFGLA +    +  T   
Sbjct: 128 ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA 187

Query: 131 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP- 189
            T  Y APE+     D T   D+WS G +                     +   L G   
Sbjct: 188 GTALYMAPEVF--KRDVTFKCDIWSAGVV---------------------MYFLLTGCLP 224

Query: 190 ----SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 245
               S  E+       K+           ++  +   + P A+DL+++MLT DP +R + 
Sbjct: 225 FTGTSLEEV-QQKATYKEP----------NYAVECRPLTPQAVDLLKQMLTKDPERRPSA 273

Query: 246 EDALAHP 252
              L H 
Sbjct: 274 AQVLHHE 280

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  146 bits (370), Expect = 1e-40
 Identities = 68/251 (27%), Positives = 106/251 (42%), Gaps = 43/251 (17%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLY 77
           ++K     +++ + +       E     Y+  E+    +L   I S +  SE      + 
Sbjct: 79  LLKQLDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 133

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRW 134
           Q+L G+ Y+H   ++HRDLKP NLLL   + + +++I DFGL+     +  M + + T +
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY 193

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
           Y APE+L     Y    DVWS G I                     L I L G P     
Sbjct: 194 YIAPEVL--HGTYDEKCDVWSTGVI---------------------LYILLSGCP----- 225

Query: 195 GFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
            F   N    I +     + +F    +  V  SA DL+ KMLT+ P  RI+  DAL H +
Sbjct: 226 PFNGANEYD-ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284

Query: 254 LGSLHDISDEP 264
           + +        
Sbjct: 285 IQTYTKEQISV 295

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  146 bits (370), Expect = 2e-40
 Identities = 67/241 (27%), Positives = 106/241 (43%), Gaps = 43/241 (17%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLY 77
           ++K     +++ + D       E   + Y+  E     +L   I      +E      + 
Sbjct: 89  VLKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK 143

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRW 134
           Q+L G+ Y+H  N++HRDLKP NLLL     +  +KI DFGL+ V      M E + T +
Sbjct: 144 QVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY 203

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
           Y APE+L     Y    DVWS+G I   L+   P F G+                     
Sbjct: 204 YIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTD------------------- 242

Query: 195 GFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
                   + I +     + +F    + NV   A DL+++ML FD ++RI+ + AL HP+
Sbjct: 243 --------QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294

Query: 254 L 254
           +
Sbjct: 295 I 295

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  142 bits (360), Expect = 2e-40
 Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 53/247 (21%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLY 77
           I+K     +V+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL 
Sbjct: 67  ILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTR 133
           QIL G+ Y+HS  + H DLKP N++L         +KI DFGLA      +       T 
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP---- 189
            + APE ++N        D+WS+G I                       I L G      
Sbjct: 182 EFVAPE-IVNYEPLGLEADMWSIGVI---------------------TYILLSGASPFLG 219

Query: 190 -SEAELGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVED 247
            ++ E    N +A  Y           F ++ F N    A D + ++L  DP++R+T++D
Sbjct: 220 DTKQET-LANVSAVNY----------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268

Query: 248 ALAHPYL 254
           +L HP++
Sbjct: 269 SLQHPWI 275

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  142 bits (360), Expect = 2e-40
 Identities = 48/241 (19%), Positives = 91/241 (37%), Gaps = 49/241 (20%)

Query: 34  IIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSA 89
           +           +YI  +L    +L   +    +L       C +   QI   ++++HS 
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183

Query: 90  NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-------------MTEYVVTRWYR 136
            ++HRDLKPSN+    +  +K+ DFGL     + +               T  V T+ Y 
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243

Query: 137 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 196
           +PE  ++ ++Y+  +D++S+G I  EL                     L    ++ E   
Sbjct: 244 SPE-QIHGNNYSHKVDIFSLGLILFEL---------------------LYSFSTQMERVR 281

Query: 197 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
           +  + +             F   F   +P    +V+ ML+  P +R    D + +    +
Sbjct: 282 IITDVRNLK----------FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

Query: 257 L 257
           L
Sbjct: 332 L 332

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  144 bits (365), Expect = 2e-40
 Identities = 63/260 (24%), Positives = 103/260 (39%), Gaps = 62/260 (23%)

Query: 41  ESFNDVYIAYELMDTDLHQIIRSNQ-------ALSEEHCQYFLYQILRGLKYIHSANVLH 93
            +   +YIA EL + +L  ++ S            E +    L QI  G+ ++HS  ++H
Sbjct: 79  TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIH 138

Query: 94  RDLKPSNLLL-------------NANCDLKICDFGLARV-----TSETDFMTEYVVTRWY 135
           RDLKP N+L+               N  + I DFGL +      +S    +     T  +
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198

Query: 136 RAPELLLNSSD------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 189
           RAPELL  S++       T +ID++S+GC+F  ++ +     G  +  +           
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----------- 247

Query: 190 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
                     N  + I  L   +         ++   A DL+ +M+  DP +R T    L
Sbjct: 248 ---------SNIIRGIFSLDEMKC----LHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294

Query: 250 AHPY-------LGSLHDISD 262
            HP        L  L  +SD
Sbjct: 295 RHPLFWPKSKKLEFLLKVSD 314

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  141 bits (358), Expect = 3e-40
 Identities = 43/253 (16%), Positives = 87/253 (34%), Gaps = 31/253 (12%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ---ALSEEHCQY 74
           ++K     ++V +  I    +  +     +  E      L+ ++        L E     
Sbjct: 60  VLKKLNHKNIVKLFAIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARVTSETDFMTEYV 130
            L  ++ G+ ++    ++HR++KP N++     D     K+ DFG AR   + +      
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176

Query: 131 VTRWYRAPELLLNSSD-------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 183
            T  Y  P++   +         Y A +D+WS+G  F         F   +   + + ++
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

Query: 184 ELI--GTPSEAELGF--LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 239
             I  G PS A  G          +   +P     S       +      ++  +L  D 
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-----RGLQVLLTPVLANILEADQ 291

Query: 240 RQRITVEDALAHP 252
            +    +   A  
Sbjct: 292 EKCWGFDQFFAET 304

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  140 bits (356), Expect = 3e-40
 Identities = 72/239 (30%), Positives = 106/239 (44%), Gaps = 43/239 (17%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
           ++K     +++ + +I+     E  +  YI  EL    +L   I   +  SE      + 
Sbjct: 74  LLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK 128

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRW 134
           Q+  G+ Y+H  N++HRDLKP N+LL     +CD+KI DFGL+    +   M + + T +
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
           Y APE+L  +  Y    DVWS G I                     L I L GTP     
Sbjct: 189 YIAPEVLRGT--YDEKCDVWSAGVI---------------------LYILLSGTPP---- 221

Query: 195 GFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
            F  +N    I +     + +F    +  +   A DL+ KMLTF P  RIT    L HP
Sbjct: 222 -FYGKNEYD-ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  142 bits (361), Expect = 3e-40
 Identities = 63/250 (25%), Positives = 116/250 (46%), Gaps = 40/250 (16%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
           I +     ++V + D I     +  +  Y+ ++L+   +L + I + +  SE    + + 
Sbjct: 81  ICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ 135

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRW 134
           QIL  + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG 195

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
           Y +PE +L    Y+  +D+W+ G I                     L I L+G P     
Sbjct: 196 YLSPE-VLKKDPYSKPVDIWACGVI---------------------LYILLVGYPP---- 229

Query: 195 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            F +E+  +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++
Sbjct: 230 -FWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

Query: 255 GSLHDISDEP 264
            +   ++   
Sbjct: 289 CNRERVASAI 298

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  142 bits (360), Expect = 4e-40
 Identities = 63/247 (25%), Positives = 105/247 (42%), Gaps = 53/247 (21%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
           I++     +++ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ 
Sbjct: 68  ILRQVLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK 122

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTR 133
           QIL G+ Y+H+  + H DLKP N++L         +K+ DFGLA    +         T 
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP---- 189
            + APE ++N        D+WS+G I                       I L G      
Sbjct: 183 EFVAPE-IVNYEPLGLEADMWSIGVI---------------------TYILLSGASPFLG 220

Query: 190 -SEAELGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVED 247
            ++ E    N  A  Y           F E+ F      A D + K+L  + R+R+T+++
Sbjct: 221 DTKQET-LANITAVSY----------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQE 269

Query: 248 ALAHPYL 254
           AL HP++
Sbjct: 270 ALRHPWI 276

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  140 bits (356), Expect = 4e-40
 Identities = 47/226 (20%), Positives = 86/226 (38%), Gaps = 49/226 (21%)

Query: 46  VYIAYELMDT-DLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           +YI  +L    +L   +     +       C +   QI   ++++HS  ++HRDLKPSN+
Sbjct: 90  LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNI 149

Query: 102 LLNANCDLKICDFGLARVTSETDFM-------------TEYVVTRWYRAPELLLNSSDYT 148
               +  +K+ DFGL     + +               T  V T+ Y +PE +  +S Y+
Sbjct: 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YS 208

Query: 149 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL 208
             +D++S+G I  EL+   P     + V  L  +                          
Sbjct: 209 HKVDIFSLGLILFELL--YPFSTQMERVRTLTDV-------------------------- 240

Query: 209 PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              +   F   F   +P    +V+ ML+  P +R    + + +   
Sbjct: 241 ---RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  141 bits (358), Expect = 4e-40
 Identities = 52/246 (21%), Positives = 104/246 (42%), Gaps = 52/246 (21%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMD-TDLH-QIIRSNQALSEEHCQYFL 76
           I+      +++ + +       ES  ++ + +E +   D+  +I  S   L+E     ++
Sbjct: 54  ILNIARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYV 108

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRW 134
           +Q+   L+++HS N+ H D++P N++     +  +KI +FG AR     D          
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE 168

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP----- 189
           Y APE +      + A D+WS+G +                     + + L G       
Sbjct: 169 YYAPE-VHQHDVVSTATDMWSLGTL---------------------VYVLLSGINPFLAE 206

Query: 190 SEAELGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDA 248
           +  ++   N    +Y          +F E+ F  +   A+D V+++L  + + R+T  +A
Sbjct: 207 TNQQI-IENIMNAEY----------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

Query: 249 LAHPYL 254
           L HP+L
Sbjct: 256 LQHPWL 261

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  139 bits (353), Expect = 6e-40
 Identities = 60/231 (25%), Positives = 95/231 (41%), Gaps = 46/231 (19%)

Query: 40  RESFND-----VYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSA 89
            +   D     +YI  E  +  DL  +I    +  Q L EE     + Q+   LK  H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 90  N-----VLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLN 143
           +     VLHRDLKP+N+ L+   ++K+ DFGLAR+   +T F   +V T +Y +PE +  
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
            S Y    D+WS+GC+  EL    P F       +L   I                  + 
Sbjct: 191 MS-YNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIR-----------------EG 231

Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              ++P                   +++ +ML      R +VE+ L +P +
Sbjct: 232 KFRRIP-----------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  141 bits (358), Expect = 1e-39
 Identities = 57/257 (22%), Positives = 102/257 (39%), Gaps = 52/257 (20%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMD-TDLH-QIIRSNQALSEEHCQYFL 76
           IM       ++ + D       E   ++ +  E +   +L  +I   +  +SE     ++
Sbjct: 101 IMNQLHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 155

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRW 134
            Q   GLK++H  +++H D+KP N++        +KI DFGLA   +  + +     T  
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 215

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP----- 189
           + APE +++        D+W++G +                       + L G       
Sbjct: 216 FAAPE-IVDREPVGFYTDMWAIGVL---------------------GYVLLSGLSPFAGE 253

Query: 190 SEAELGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDA 248
            + E    N     +           F E  F +V P A D ++ +L  +PR+R+TV DA
Sbjct: 254 DDLET-LQNVKRCDW----------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302

Query: 249 LAHPYLGSLHDISDEPV 265
           L HP+L   H      +
Sbjct: 303 LEHPWLKGDHSNLTSRI 319

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  143 bits (362), Expect = 2e-39
 Identities = 62/250 (24%), Positives = 114/250 (45%), Gaps = 41/250 (16%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLY 77
           ++K+    +++ + D+      E     Y+  E  +  +L + I +     E      + 
Sbjct: 99  LLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRW 134
           QIL G+ Y+H  N++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + T +
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY 213

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
           Y APE+L     Y    DVWS G I   L+   P F G++     + +I+ +    + + 
Sbjct: 214 YIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQND----QDIIKKV---EKGKY 264

Query: 195 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            F                       + N+   A +L++ MLT+D  +R T E+AL   ++
Sbjct: 265 YFD-------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305

Query: 255 GSLHDISDEP 264
               +  ++ 
Sbjct: 306 KKYANNINKS 315

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  142 bits (361), Expect = 2e-39
 Identities = 72/241 (29%), Positives = 108/241 (44%), Gaps = 43/241 (17%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLY 77
           ++K     +++ + +I+     E  +  YI  EL    +L   I   +  SE      + 
Sbjct: 74  LLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK 128

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRW 134
           Q+  G+ Y+H  N++HRDLKP N+LL     +CD+KI DFGL+    +   M + + T +
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
           Y APE+L  +  Y    DVWS G I                     L I L GTP     
Sbjct: 189 YIAPEVLRGT--YDEKCDVWSAGVI---------------------LYILLSGTP----- 220

Query: 195 GFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
            F  +N    I +     + +F    +  +   A DL+ KMLTF P  RIT    L HP+
Sbjct: 221 PFYGKNEYD-ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

Query: 254 L 254
           +
Sbjct: 280 I 280

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  139 bits (352), Expect = 4e-39
 Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 41/241 (17%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
           ++      +++ +++I      E+  ++ +  EL+   +L   I      SE      + 
Sbjct: 101 VLLRLSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK 155

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRW 134
           QIL  + Y+H   ++HRDLKP NLL      +  LKI DFGL+++      M     T  
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG 215

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
           Y APE+L   + Y   +D+WSVG I                       I L G       
Sbjct: 216 YCAPEILRGCA-YGPEVDMWSVGII---------------------TYILLCGFEP---- 249

Query: 195 GFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 253
            F +E   +++ +        F    +  V  +A DLV K++  DP++R+T   AL HP+
Sbjct: 250 -FYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308

Query: 254 L 254
           +
Sbjct: 309 V 309

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  139 bits (351), Expect = 5e-39
 Identities = 52/245 (21%), Positives = 92/245 (37%), Gaps = 35/245 (14%)

Query: 19  FDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLH-QIIRSNQALSEEHCQYFLY 77
            D   +       +  +   + +         E ++  +H      +    E+     + 
Sbjct: 116 LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLARV-----TSETDFMTEYV 130
           QI   L Y+H+  + HRD+KP N L   N + ++K+ DFGL++        E   MT   
Sbjct: 176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235

Query: 131 VTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 189
            T ++ APE+L  +++ Y    D WS G +   L+     FPG +        I  +   
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND----ADTISQV--- 288

Query: 190 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
              +L F                       +  + P A DL+  +L  +  +R     AL
Sbjct: 289 LNKKLCFE-------------------NPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329

Query: 250 AHPYL 254
            HP++
Sbjct: 330 QHPWI 334

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  138 bits (349), Expect = 9e-39
 Identities = 61/258 (23%), Positives = 108/258 (41%), Gaps = 30/258 (11%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +V + ++            ++  EL++  +L + I+  +  SE    Y + +++  + ++
Sbjct: 68  IVKLHEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 87  HSANVLHRDLKPSNLLL---NANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLL 142
           H   V+HRDLKP NLL    N N ++KI DFG AR    +   +     T  Y APE LL
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LL 181

Query: 143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 202
           N + Y  + D+WS+G I   ++  +  F   D        +E++    + +  F  E   
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA-- 239

Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 262
                            + NV   A DL++ +LT DP +R+ +     + +L     +S 
Sbjct: 240 -----------------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS 282

Query: 263 EPVCMSPFSFDFEQHALT 280
            P+              T
Sbjct: 283 NPLMTPDILGSSGAAVHT 300

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  138 bits (350), Expect = 1e-38
 Identities = 62/246 (25%), Positives = 105/246 (42%), Gaps = 52/246 (21%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLH-QIIRSNQALSEEHCQYFL 76
           +M      +++ + D       ES ND+ +  E +D  +L  +II  +  L+E     F+
Sbjct: 139 VMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFM 193

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRW 134
            QI  G++++H   +LH DLKP N+L        +KI DFGLAR     + +     T  
Sbjct: 194 KQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE 253

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP----- 189
           + APE ++N    +   D+WSVG I                       + L G       
Sbjct: 254 FLAPE-VVNYDFVSFPTDMWSVGVI---------------------AYMLLSGLSPFLGD 291

Query: 190 SEAELGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDA 248
           ++AE    N  A ++             ++ F ++   A + + K+L  +   RI+  +A
Sbjct: 292 NDAET-LNNILACRW----------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA 340

Query: 249 LAHPYL 254
           L HP+L
Sbjct: 341 LKHPWL 346

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  137 bits (348), Expect = 2e-38
 Identities = 63/244 (25%), Positives = 103/244 (42%), Gaps = 35/244 (14%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           ++ ++D+      +    VY+  ELM   +L   I   +  SE      L+ I + ++Y+
Sbjct: 78  IITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132

Query: 87  HSANVLHRDLKPSNLLLNANCD----LKICDFGLAR-VTSETDFMTEYVVTRWYRAPELL 141
           H+  V+HRDLKPSN+L          ++ICDFG A+ + +E   +     T  + APE+L
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192

Query: 142 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 201
                Y AA D+WS+G +   ++     F          +L   IG     +        
Sbjct: 193 ERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL-ARIG---SGKFSLSGGY- 246

Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
                             + +V  +A DLV KML  DP QR+T    L HP++     + 
Sbjct: 247 ------------------WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288

Query: 262 DEPV 265
              +
Sbjct: 289 QYQL 292

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  137 bits (346), Expect = 2e-38
 Identities = 70/251 (27%), Positives = 109/251 (43%), Gaps = 35/251 (13%)

Query: 41  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E  + V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  
Sbjct: 111 EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 170

Query: 100 NLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           NL LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GC
Sbjct: 171 NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGC 229

Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           I   L+  KP F                               KK    +P++       
Sbjct: 230 IMYTLLVGKPPFETSCLKETYL-------------------RIKKNEYSIPKH------- 263

Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL--GSLHDISDEPVCMSPFSFDFEQ 276
               ++P A  L++KML  DP  R T+ + L   +   G +           P  F    
Sbjct: 264 ----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAP 319

Query: 277 HALTEGQMKEL 287
            +L     K L
Sbjct: 320 SSLDPSNRKPL 330

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  137 bits (347), Expect = 3e-38
 Identities = 66/258 (25%), Positives = 107/258 (41%), Gaps = 52/258 (20%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMD-TDL-HQIIR---SNQALSEEHCQ 73
           I        +V + +        S   +Y+ +E MD  DL  +I++   +    SE    
Sbjct: 79  ICHMLKHPHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133

Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR-VTSETDFMTEY 129
           +++ QIL  L+Y H  N++HRD+KP  +LL     +  +K+  FG+A  +          
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193

Query: 130 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 189
           V T  + APE ++    Y   +DVW  G I                     L I L G  
Sbjct: 194 VGTPHFMAPE-VVKREPYGKPVDVWGCGVI---------------------LFILLSGCL 231

Query: 190 SEAELGFLNENAKKY--ICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVE 246
                 F     + +  I +  +Y       + + ++  SA DLV +ML  DP +RITV 
Sbjct: 232 P-----FYGTKERLFEGIIKG-KY---KMNPRQWSHISESAKDLVRRMLMLDPAERITVY 282

Query: 247 DALAHPYLGSLHDISDEP 264
           +AL HP+L      + + 
Sbjct: 283 EALNHPWLKERDRYAYKI 300

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  136 bits (344), Expect = 3e-38
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 36/224 (16%)

Query: 40  RESF---NDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSANV 91
             SF   N++ I  EL D  DL ++I    +  + + E     +  Q+   L+++HS  V
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157

Query: 92  LHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAA 150
           +HRD+KP+N+ + A   +K+ D GL R  +S+T      V T +Y +PE +  +  Y   
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFK 216

Query: 151 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 210
            D+WS+GC+  E+   +  F G      L  L + I                   C  P 
Sbjct: 217 SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQ-----------------CDYPP 257

Query: 211 YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                ++E+          LV   +  DP +R  V         
Sbjct: 258 LPSDHYSEEL-------RQLVNMCINPDPEKRPDVTYVYDVAKR 294

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  136 bits (344), Expect = 4e-38
 Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 30/239 (12%)

Query: 46  VYIAYELMDTD--LHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           + I  E M+      +I  R +QA +E      +  I   ++++HS N+ HRD+KP NLL
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160

Query: 103 L---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
                 +  LK+ DFG A+ T++    T    T +Y APE+L     Y  + D+WS+G I
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEK-YDKSCDMWSLGVI 218

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
              L+   P F           +   I      + GF N                     
Sbjct: 219 MYILLCGFPPFYSNTGQAISPGMKRRIR---LGQYGFPNPE------------------- 256

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHA 278
           +  V   A  L+  +L  DP +R+T+   + HP++     +   P+  +    + + H 
Sbjct: 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW 315

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  136 bits (345), Expect = 1e-37
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 29/227 (12%)

Query: 44  NDVYIAYELMD--TDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
             + I  E +D      +I  R +QA +E      +  I   ++Y+HS N+ HRD+KP N
Sbjct: 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 191

Query: 101 LLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           LL      N  LK+ DFG A+ T+  + +T    T +Y APE+L     Y  + D+WS+G
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLG 250

Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
            I   L+   P F     +     +   I      +  F N                   
Sbjct: 251 VIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQYEFPNPE----------------- 290

Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEP 264
             +  V      L+  +L  +P QR+T+ + + HP++     +   P
Sbjct: 291 --WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  139 bits (351), Expect = 1e-37
 Identities = 55/246 (22%), Positives = 95/246 (38%), Gaps = 52/246 (21%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMD-TDL-HQIIRSNQALSEEHCQYFL 76
            M      ++V + D       E  N++ + YE M   +L  ++   +  +SE+    ++
Sbjct: 207 TMSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 261

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRW 134
            Q+ +GL ++H  N +H DLKP N++     + +LK+ DFGL         +     T  
Sbjct: 262 RQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 321

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP----- 189
           + APE +          D+WSVG +                       I L G       
Sbjct: 322 FAAPE-VAEGKPVGYYTDMWSVGVL---------------------SYILLSGLSPFGGE 359

Query: 190 SEAELGFLNENAKKYICQLPRYQRQSFT-EKFPNVHPSAIDLVEKMLTFDPRQRITVEDA 248
           ++ E    N  +  +          +     F  +     D + K+L  DP  R+T+  A
Sbjct: 360 NDDET-LRNVKSCDW----------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408

Query: 249 LAHPYL 254
           L HP+L
Sbjct: 409 LEHPWL 414

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  133 bits (337), Expect = 2e-37
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 35/240 (14%)

Query: 41  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E  + V++  EL     L ++ +  +AL+E   +Y+L QI+ G +Y+H   V+HRDLK  
Sbjct: 85  EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 144

Query: 100 NLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           NL LN + ++KI DFGLA +V  + +       T  Y APE +L+   ++  +DVWS+GC
Sbjct: 145 NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGC 203

Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           I   L+  KP F                               KK    +P++       
Sbjct: 204 IMYTLLVGKPPFETSCLKETYL-------------------RIKKNEYSIPKH------- 237

Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL--GSLHDISDEPVCMSPFSFDFEQ 276
               ++P A  L++KML  DP  R T+ + L   +   G +           P  F    
Sbjct: 238 ----INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAP 293

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  132 bits (334), Expect = 9e-37
 Identities = 67/244 (27%), Positives = 104/244 (42%), Gaps = 49/244 (20%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
           ++K     ++V + DI      ES    Y+  +L+   +L   I      +E+     + 
Sbjct: 59  VLKKIKHENIVTLEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ 113

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRW 134
           Q+L  +KY+H   ++HRDLKP NLL      N  + I DFGL+++  +   M+    T  
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM-EQNGIMSTACGTPG 172

Query: 135 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP---SE 191
           Y APE+L     Y+ A+D WS+G I                       I L G P    E
Sbjct: 173 YVAPEVLAQKP-YSKAVDCWSIGVI---------------------TYILLCGYPPFYEE 210

Query: 192 AELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALA 250
            E     +       +   Y    F   F  ++  SA D +  +L  DP +R T E AL+
Sbjct: 211 TESKLFEK------IKEGYY---EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261

Query: 251 HPYL 254
           HP++
Sbjct: 262 HPWI 265

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  134 bits (340), Expect = 2e-36
 Identities = 67/255 (26%), Positives = 105/255 (41%), Gaps = 49/255 (19%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLY 77
           I +     ++V + D I           Y+ ++L+   +L + I + +  SE    + + 
Sbjct: 63  ICRLLKHPNIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ 117

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR-VTSETDFMTEYVVTR 133
           QIL  + + H   V+HR+LKP NLLL        +K+ DFGLA  V  E      +  T 
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP---S 190
            Y +PE+L     Y   +D+W+ G I                     L I L+G P    
Sbjct: 178 GYLSPEVLRKDP-YGKPVDLWACGVI---------------------LYILLVGYPPFWD 215

Query: 191 EAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
           E +     +       +   Y    F       V P A DL+ KMLT +P +RIT  +AL
Sbjct: 216 EDQHRLYQQ------IKAGAY---DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEAL 266

Query: 250 AHPYLGSLHDISDEP 264
            HP++     ++   
Sbjct: 267 KHPWISHRSTVASCM 281

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  130 bits (329), Expect = 3e-36
 Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 45/216 (20%)

Query: 44  NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
             VY+  E      +++ ++      E+    ++ ++   L Y HS  V+HRD+KP NLL
Sbjct: 82  TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 141

Query: 103 LNANCDLKICDFGLARVTSETDFMT-----EYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           L +  +LKI DFG +     +         +Y+       PE ++    +   +D+WS+G
Sbjct: 142 LGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPE-MIEGRMHDEKVDLWSLG 194

Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
            +  E +  KP F    +    +                             R  R  F 
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYK-----------------------------RISRVEF- 224

Query: 218 EKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
             FP+ V   A DL+ ++L  +P QR  + + L HP
Sbjct: 225 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  129 bits (327), Expect = 5e-36
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 44/220 (20%)

Query: 41  ESFNDVYIA--Y----ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHR 94
           E  N VY+        E+       +    +  SE   ++F++QI+ G+ Y+HS  +LHR
Sbjct: 81  EDSNYVYLVLEMCHNGEMNR----YLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136

Query: 95  DLKPSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDV 153
           DL  SNLLL  N ++KI DFGLA ++    +       T  Y +PE +   S +    DV
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATRSAHGLESDV 195

Query: 154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 213
           WS+GC+F  L+  +P F      + L                              +   
Sbjct: 196 WSLGCMFYTLLIGRPPFDTDTVKNTLN-----------------------------KVVL 226

Query: 214 QSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
             +  + P+ +   A DL+ ++L  +P  R+++   L HP
Sbjct: 227 ADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  132 bits (333), Expect = 6e-36
 Identities = 43/252 (17%), Positives = 87/252 (34%), Gaps = 31/252 (12%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ---ALSEEHCQY 74
           ++K     ++V +  I    +  +     +  E      L+ ++        L E     
Sbjct: 60  VLKKLNHKNIVKLFAIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116

Query: 75  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARVTSETDFMTEYV 130
            L  ++ G+ ++    ++HR++KP N++     D     K+ DFG AR   + +      
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176

Query: 131 VTRWYRAPELLLNSSD-------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 183
            T  Y  P++   +         Y A +D+WS+G  F         F   +   + + ++
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

Query: 184 ELI--GTPSEAELGF--LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 239
             I  G PS A  G          +   +P     S       +      ++  +L  D 
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-----RGLQVLLTPVLANILEADQ 291

Query: 240 RQRITVEDALAH 251
            +    +   A 
Sbjct: 292 EKCWGFDQFFAE 303

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  129 bits (326), Expect = 8e-36
 Identities = 45/235 (19%), Positives = 84/235 (35%), Gaps = 59/235 (25%)

Query: 44  NDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           + + I  E  +   L   I    R      E   +  L Q+ RGL+YIHS +++H D+KP
Sbjct: 84  DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKP 143

Query: 99  SNLLLNAN-------------------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 139
           SN+ ++                        KI D G     S             + A E
Sbjct: 144 SNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE---EGDSRFLANE 200

Query: 140 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 199
           +L  +  +    D++++    +     +PL    D  H++R                   
Sbjct: 201 VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR------------------- 241

Query: 200 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             +  + ++P    Q  +++F        +L++ M+  DP +R +    + H  L
Sbjct: 242 --QGRLPRIP----QVLSQEF-------TELLKVMIHPDPERRPSAMALVKHSVL 283

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  134 bits (338), Expect = 1e-35
 Identities = 65/255 (25%), Positives = 99/255 (38%), Gaps = 19/255 (7%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFND-VYIAYELMDT-DLHQIIRSNQ---ALSEEHCQ 73
           IMK     +VV+ R++    Q+ + ND   +A E  +  DL + +   +    L E   +
Sbjct: 65  IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124

Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYV 130
             L  I   L+Y+H   ++HRDLKP N++L         KI D G A+   + +  TE+V
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184

Query: 131 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS 190
            T  Y APELL     YT  +D WS G +  E +     F       Q    +    +  
Sbjct: 185 GTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE-KSNE 242

Query: 191 EAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA 250
              +      A K+   LP     S               ++ ML +  RQR T      
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILA-----GKLERWLQCMLMWHQRQRGTDPQNPN 297

Query: 251 HPYLGSLHDISDEPV 265
                +L  I    +
Sbjct: 298 VGCFQALDSILSLKL 312

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  130 bits (329), Expect = 1e-35
 Identities = 29/243 (11%), Positives = 66/243 (27%), Gaps = 54/243 (22%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTD-------LHQIIRSNQALSEEHCQYFLYQI 79
               +  +    +       +  Y  M ++       L     ++++L          Q+
Sbjct: 156 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 215

Query: 80  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 139
           +R L  +H   ++H  L+P +++L+    + +  F                V+R +  PE
Sbjct: 216 IRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVSRGFEPPE 272

Query: 140 LL----------LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 189
           L              +  T + D W++G +   +            +     +       
Sbjct: 273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC--- 329

Query: 190 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
                                           N+      L+E  L +    R+    A+
Sbjct: 330 -------------------------------KNIPQPVRALLEGFLRYPKEDRLLPLQAM 358

Query: 250 AHP 252
             P
Sbjct: 359 ETP 361

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  129 bits (326), Expect = 3e-35
 Identities = 46/198 (23%), Positives = 78/198 (39%), Gaps = 23/198 (11%)

Query: 62  RSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVT 120
                +  +  +  +  +L    YIH+  N+ HRD+KPSN+L++ N  +K+ DFG +   
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202

Query: 121 SETDFMT-----EYVVTRWYRAPELLLNSSDY-TAAIDVWSVGCIFMELMDRKPLFPGRD 174
            +          E++       PE   N S Y  A +D+WS+G     +      F  + 
Sbjct: 203 VDKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256

Query: 175 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 234
            + +L   I          + +           L     +  T     +    ID ++  
Sbjct: 257 SLVELFNNI------RTKNIEY----PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF 306

Query: 235 LTFDPRQRITVEDALAHP 252
           L  +P +RIT EDAL H 
Sbjct: 307 LRKNPAERITSEDALKHE 324

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  125 bits (317), Expect = 2e-34
 Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 38/235 (16%)

Query: 44  NDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKP 98
            DV+I  ELMDT       Q+I   Q + E+        I++ L+++HS  +V+HRD+KP
Sbjct: 79  GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138

Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE---LLLNSSDYTAAIDVWS 155
           SN+L+NA   +K+CDFG++    +          + Y APE     LN   Y+   D+WS
Sbjct: 139 SNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198

Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           +G   +EL   +  FP        + L +++  PS                  P+     
Sbjct: 199 LGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS------------------PQLPADK 238

Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 270
           F+ +F       +D   + L  + ++R T  + + HP+         +   ++ F
Sbjct: 239 FSAEF-------VDFTSQCLKKNSKERPTYPELMQHPF---FTLHESKGTDVASF 283

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  125 bits (317), Expect = 3e-34
 Identities = 51/231 (22%), Positives = 79/231 (34%), Gaps = 44/231 (19%)

Query: 39  QRESFNDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSANVLH 93
           +R + ++ ++         L   I         L+E+   + L  I RGL+ IH+    H
Sbjct: 98  ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAH 157

Query: 94  RDLKPSNLLLNANCDLKICDFGLARV------TSETDFMTEYVVTR----WYRAPELLLN 143
           RDLKP+N+LL       + D G           S      +    +     YRAPEL   
Sbjct: 158 RDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSV 217

Query: 144 SS--DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 201
            S        DVWS+GC+   +M  +  +           L                   
Sbjct: 218 QSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---------------VQN 262

Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
           +  I Q PR+              +   L+  M+T DP QR  +   L+  
Sbjct: 263 QLSIPQSPRH------------SSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  123 bits (312), Expect = 1e-33
 Identities = 56/243 (23%), Positives = 109/243 (44%), Gaps = 50/243 (20%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYE------LMDTDLHQIIRSNQALSEEHC 72
           I+K     +VV + +++  P  +    +Y+ +E      +M+      + + + LSE+  
Sbjct: 89  ILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVME------VPTLKPLSEDQA 139

Query: 73  QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV- 131
           +++   +++G++Y+H   ++HRD+KPSNLL+  +  +KI DFG++     +D +    V 
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVG 199

Query: 132 TRWYRAPELLLNSS-DYT-AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 189
           T  + APE L  +   ++  A+DVW++G      +  +  F   + +  L   I      
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKI------ 252

Query: 190 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
                       K    + P           P++     DL+ +ML  +P  RI V +  
Sbjct: 253 ------------KSQALEFPDQ---------PDIAEDLKDLITRMLDKNPESRIVVPEIK 291

Query: 250 AHP 252
            HP
Sbjct: 292 LHP 294

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  123 bits (310), Expect = 1e-33
 Identities = 46/202 (22%), Positives = 79/202 (39%), Gaps = 44/202 (21%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L++ ++ +    E+    F+ ++   L Y H   V+HRD+KP NLL+    +LKI DFG 
Sbjct: 101 LYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW 160

Query: 117 ARVTSETDFMT-----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP 171
           +         T     +Y+       PE ++    +   +D+W  G +  E +   P F 
Sbjct: 161 SVHAPSLRRRTMCGTLDYL------PPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

Query: 172 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN-VHPSAIDL 230
              H          I      +L                        KFP  +   + DL
Sbjct: 214 SPSHTE----THRRI---VNVDL------------------------KFPPFLSDGSKDL 242

Query: 231 VEKMLTFDPRQRITVEDALAHP 252
           + K+L + P QR+ ++  + HP
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHP 264

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  123 bits (312), Expect = 1e-33
 Identities = 55/242 (22%), Positives = 91/242 (37%), Gaps = 34/242 (14%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           V+ + +       E  +  Y+ +E M    +   I   +  +E      +  +   L ++
Sbjct: 73  VLELIEFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127

Query: 87  HSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRW--------Y 135
           H+  + HRDLKP N+L    N    +KICDF L          +               Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 136 RAPELLLNSSD----YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 191
            APE++   S+    Y    D+WS+G I   L+   P  P                 P+ 
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP--PFVGRCGSDCGWDRGEACPAC 245

Query: 192 AELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALA 250
             + F +    KY           F +K   ++  +A DL+ K+L  D +QR++    L 
Sbjct: 246 QNMLFESIQEGKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295

Query: 251 HP 252
           HP
Sbjct: 296 HP 297

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  125 bits (315), Expect = 2e-33
 Identities = 27/239 (11%), Positives = 62/239 (25%), Gaps = 47/239 (19%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-------NQALSEEHCQYFLYQI 79
               +  +    +       +  Y  M ++L             +++L          Q+
Sbjct: 161 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 220

Query: 80  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRA 137
           +R L  +H   ++H  L+P +++L+    + +  F        +               A
Sbjct: 221 IRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTA 280

Query: 138 PELLL----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 193
             +L     + +  T A D W++G     +            +     +           
Sbjct: 281 ERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC------- 333

Query: 194 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
                                       N+      L+E  L +    R+    A+  P
Sbjct: 334 ---------------------------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 365

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  121 bits (306), Expect = 2e-32
 Identities = 43/212 (20%), Positives = 84/212 (39%), Gaps = 35/212 (16%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFG 115
           L Q+I+    L E+   Y+L Q L GL+Y+H+  +LH D+K  N+LL+++     +CDFG
Sbjct: 137 LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG 196

Query: 116 LARVTSE-----TDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 169
            A          +    +Y+  T  + APE+++      A +D+WS  C+ + +++    
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHP 255

Query: 170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 229
           +       +  L +  I +                  ++P           P+  P    
Sbjct: 256 WT---QYFRGPLCL-KIASEPPPIR------------EIP-----------PSCAPLTAQ 288

Query: 230 LVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
            +++ L  +P  R +  +              
Sbjct: 289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  118 bits (297), Expect = 1e-31
 Identities = 52/241 (21%), Positives = 86/241 (35%), Gaps = 50/241 (20%)

Query: 44  NDVYIAYELMDTD--LHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
             + I  E +D      +I  R +QA +E      +  I   ++Y+HS N+ HRD+KP N
Sbjct: 88  KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 147

Query: 101 LLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           LL      N  LK+ DFG                     A E       Y  + D+WS+G
Sbjct: 148 LLYTSKRPNAILKLTDFGF--------------------AKETTGEK--YDKSCDMWSLG 185

Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
            I   L+   P F     +     +   I      +  F N                   
Sbjct: 186 VIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQYEFPNPE----------------- 225

Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQH 277
             +  V      L+  +L  +P QR+T+ + + HP++     +   P+  S    + ++ 
Sbjct: 226 --WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKER 283

Query: 278 A 278
            
Sbjct: 284 W 284

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  117 bits (294), Expect = 7e-31
 Identities = 57/274 (20%), Positives = 115/274 (41%), Gaps = 42/274 (15%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
           IMK     ++V + ++I     E+   +Y+  E     ++   + ++  + E+  +    
Sbjct: 67  IMKILNHPNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR 121

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 137
           QI+  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +    +  +     Y A
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA 181

Query: 138 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 197
           PEL          +DVWS+G I   L+     F G  ++ +LR  +              
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERV-------------- 226

Query: 198 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
                +   ++P Y           +     +L+++ L  +P +R T+E  +   ++ + 
Sbjct: 227 ----LRGKYRIPFY-----------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271

Query: 258 HDISDEPVCMSPFSFDFEQHALTEGQMKELIYQE 291
           H+  +    + P     +Q  +    M  + Y +
Sbjct: 272 HEEDELKPFVEPELDISDQKRID--IMVGMGYSQ 303

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  116 bits (292), Expect = 1e-30
 Identities = 45/229 (19%), Positives = 79/229 (34%), Gaps = 47/229 (20%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           V+ + D       E+     +  E      DL   I     L E   + F  Q++  +++
Sbjct: 100 VIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154

Query: 86  IHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 144
            HS  V+HRD+K  N+L++      K+ DFG   +  +  +   +  TR Y  PE +   
Sbjct: 155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWISRH 213

Query: 145 SDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
             +     VWS+G + +  +    P F     +                          +
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIP-FERDQEI-------------------------LE 247

Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
                P +           V P    L+ + L   P  R ++E+ L  P
Sbjct: 248 AELHFPAH-----------VSPDCCALIRRCLAPKPSSRPSLEEILLDP 285

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  115 bits (290), Expect = 2e-30
 Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 32/217 (14%)

Query: 44  NDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNL 101
            DV+IA ELM T   ++  R    + E         I++ L Y+     V+HRD+KPSN+
Sbjct: 97  TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156

Query: 102 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE----LLLNSSDYTAAIDVWSVG 157
           LL+    +K+CDFG++    +            Y APE          DY    DVWS+G
Sbjct: 157 LLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216

Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
              +EL   +  +          +L +++                     LP +    F+
Sbjct: 217 ISLVELATGQFPYKNCKTD--FEVLTKVLQEEPP---------------LLPGHMG--FS 257

Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             F          V+  LT D R+R      L H ++
Sbjct: 258 GDF-------QSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  116 bits (292), Expect = 3e-30
 Identities = 48/227 (21%), Positives = 95/227 (41%), Gaps = 18/227 (7%)

Query: 44  NDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNL 101
            ++ I  E MD   L Q+++    + E+        +++GL Y+     ++HRD+KPSN+
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163

Query: 102 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
           L+N+  ++K+CDFG++    ++   + +V TR Y +PE  L  + Y+   D+WS+G   +
Sbjct: 164 LVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 221

Query: 162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ----SFT 217
           E+   +   P  D      +    +   +           +         +         
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281

Query: 218 EKFPNVHP----------SAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +   N  P             D V K L  +P +R  ++  + H ++
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  115 bits (289), Expect = 4e-30
 Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 33/220 (15%)

Query: 44  NDVYIAYELMDTDLHQIIRS-----NQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLK 97
            D +I  ELM T   +  +      +  + EE         ++ L ++     ++HRD+K
Sbjct: 94  GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153

Query: 98  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVW 154
           PSN+LL+ + ++K+CDFG++    ++   T     R Y APE +    +   Y    DVW
Sbjct: 154 PSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213

Query: 155 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ 214
           S+G    EL   +  +P  + V      +             +  +  +    L   + +
Sbjct: 214 SLGITLYELATGRFPYPKWNSVFDQLTQV-------------VKGDPPQ----LSNSEER 256

Query: 215 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            F+  F       I+ V   LT D  +R   ++ L HP++
Sbjct: 257 EFSPSF-------INFVNLCLTKDESKRPKYKELLKHPFI 289

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  114 bits (288), Expect = 6e-30
 Identities = 54/234 (23%), Positives = 103/234 (44%), Gaps = 39/234 (16%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQ 78
            +K      ++ + D+I      +  D+ +  E    +L   I   + ++E+  + F  Q
Sbjct: 62  YLKLLRHPHIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQ 116

Query: 79  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 138
           I+  ++Y H   ++HRDLKP NLLL+ N ++KI DFGL+ + ++ +F+     +  Y AP
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP 176

Query: 139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 198
           E++         +DVWS G +   ++  +  F   + +  L   +               
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKV--------------- 220

Query: 199 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
                 +  +P +           + P A  L+ +M+  DP QRIT+++    P
Sbjct: 221 ---NSCVYVMPDF-----------LSPGAQSLIRRMIVADPMQRITIQEIRRDP 260

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  113 bits (285), Expect = 1e-29
 Identities = 49/228 (21%), Positives = 87/228 (38%), Gaps = 45/228 (19%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           V+ + D       E  +   +  E  +   DL   I    AL EE  + F +Q+L  +++
Sbjct: 110 VIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164

Query: 86  IHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 144
            H+  VLHRD+K  N+L++ N  +LK+ DFG   +  +T +   +  TR Y  PE +   
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYH 223

Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 204
             +  +  VWS+G +  +++     F   + + + ++                       
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV----------------------- 260

Query: 205 ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
                +            V      L+   L   P  R T E+   HP
Sbjct: 261 --FFRQR-----------VSSECQHLIRWCLALRPSDRPTFEEIQNHP 295

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  114 bits (286), Expect = 1e-29
 Identities = 54/248 (21%), Positives = 93/248 (37%), Gaps = 55/248 (22%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMD----TDLHQII--RSNQALSEEHCQYFLYQILR 81
           +V         + ES         L +      +  +    S   LS +      YQ  R
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147

Query: 82  GLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARV---------TSETDFMTEYV 130
            ++++H     ++HRDLK  NLLL+    +K+CDFG A           +++   + E  
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 131 VTR----WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 184
           +TR     YR PE+  L ++       D+W++GCI   L  R+  F              
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED------------ 255

Query: 185 LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT 244
                  A+L  +N    KY   +P +  Q               L+  ML  +P +R++
Sbjct: 256 ------GAKLRIVN---GKY--SIPPHDTQY---------TVFHSLIRAMLQVNPEERLS 295

Query: 245 VEDALAHP 252
           + + +   
Sbjct: 296 IAEVVHQL 303

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  114 bits (287), Expect = 2e-29
 Identities = 62/279 (22%), Positives = 100/279 (35%), Gaps = 73/279 (26%)

Query: 48  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN 104
           + +E++   L + I  +  Q L     +  + Q+L+GL Y+H+   ++H D+KP N+LL+
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181

Query: 105 AN-------------------------------------------------CDLKICDFG 115
            N                                                   +KI D G
Sbjct: 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG 241

Query: 116 LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD- 174
            A    +    TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF     
Sbjct: 242 NACWVHKHF--TEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSG 298

Query: 175 -----HVHQLRLLIELIGTP-------SEAELGFLNENAK-KYICQLPRYQRQSFTEKFP 221
                    + L+IEL+G          +    F  +    K+I +L  +       +  
Sbjct: 299 EEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY 358

Query: 222 NV----HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 256
                      D +  ML   P +R T  + L HP+L S
Sbjct: 359 EWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  111 bits (281), Expect = 3e-29
 Identities = 58/235 (24%), Positives = 98/235 (41%), Gaps = 40/235 (17%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
            +K      ++ +  +I      +  D ++  E +   +L   I  +  + E   +    
Sbjct: 64  NLKLFRHPHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ 118

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 137
           QIL  + Y H   V+HRDLKP N+LL+A+ + KI DFGL+ + S+ +F+     +  Y A
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA 178

Query: 138 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 197
           PE++         +D+WS G I   L+     F   +HV  L   I              
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKI-------------- 223

Query: 198 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
               +  +  +P Y           ++ S   L+  ML  DP +R T++D   H 
Sbjct: 224 ----RGGVFYIPEY-----------LNRSVATLLMHMLQVDPLKRATIKDIREHE 263

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  112 bits (281), Expect = 3e-29
 Identities = 40/215 (18%), Positives = 86/215 (40%), Gaps = 34/215 (15%)

Query: 44  NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSN 100
             + +  ELM +  L   ++  + +  +  + +  QIL+GL+++H+    ++HRDLK  N
Sbjct: 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDN 161

Query: 101 LLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           + +      +KI D GLA +   + F    + T  + APE+      Y  ++DV++ G  
Sbjct: 162 IFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMY--EEKYDESVDVYAFGMC 218

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
            +E+   +  +    +  Q+       G    +         K                 
Sbjct: 219 MLEMATSEYPYSECQNAAQI-YRRVTSGVKPASFDKVAIPEVK----------------- 260

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                    +++E  +  +  +R +++D L H + 
Sbjct: 261 ---------EIIEGCIRQNKDERYSIKDLLNHAFF 286

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  112 bits (282), Expect = 7e-29
 Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 38/238 (15%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLY 77
             ++    ++V  +++I      +   + I  E     +L++ I +    SE+  ++F  
Sbjct: 69  NHRSLRHPNIVRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ 123

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWY 135
           Q+L G+ Y HS  + HRDLK  N LL  +    LKICDFG ++ +         V T  Y
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 183

Query: 136 RAPELLLNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
            APE+LL         DVWS G   ++ L+   P F   +     R  I+ I        
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPRDYRKTIQRI-------- 234

Query: 195 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
                        +P   R S         P    L+ ++   DP  RI++ +   H 
Sbjct: 235 -------LSVKYSIPDDIRIS---------PECCHLISRIFVADPATRISIPEIKTHS 276

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  111 bits (279), Expect = 8e-29
 Identities = 50/258 (19%), Positives = 100/258 (38%), Gaps = 45/258 (17%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELM---DTDLHQIIRSNQALSEEHCQYF 75
           +++     +V+ + D++     E    +Y+  E       ++   +   +         +
Sbjct: 59  LLRRLRHKNVIQLVDVL---YNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGY 114

Query: 76  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVT 132
             Q++ GL+Y+HS  ++H+D+KP NLLL     LKI   G+A      +  D       +
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174

Query: 133 RWYRAPELLLNSSDYT-AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 191
             ++ PE+      ++   +D+WS G     +      F G D++++L   I        
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENI-------- 225

Query: 192 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
                      K    +P               P   DL++ ML ++P +R ++     H
Sbjct: 226 ----------GKGSYAIPGD-----------CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264

Query: 252 PYLGSLHDISDEPVCMSP 269
            +    H  ++ PV + P
Sbjct: 265 SWFRKKHPPAEAPVPIPP 282

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  111 bits (280), Expect = 9e-29
 Identities = 46/238 (19%), Positives = 88/238 (36%), Gaps = 47/238 (19%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFL 76
           I+      +++ + DI      E+     +  E   +  DL   I  +  L E    Y  
Sbjct: 82  ILSRVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF 136

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYR 136
            Q++  + Y+   +++HRD+K  N+++  +  +K+ DFG A           +  T  Y 
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYC 196

Query: 137 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 196
           APE+L+ +      +++WS+G     L+  +  F   +                EA +  
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------VEAAI-- 241

Query: 197 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                       P             V    + LV  +L   P +R T+E  +  P++
Sbjct: 242 ----------HPPYL-----------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  110 bits (278), Expect = 9e-29
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 33/204 (16%)

Query: 57  LHQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKIC 112
           L  ++RS       +E+   ++  QIL GLKY+H   ++HRD+K  N+L+N  +  LKI 
Sbjct: 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKIS 165

Query: 113 DFGLARVTSETDFMTEYVV-TRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLF 170
           DFG ++  +  +  TE    T  Y APE++      Y  A D+WS+GC  +E+   KP F
Sbjct: 166 DFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
                       +  +G               K   ++P            ++   A   
Sbjct: 226 YELGEPQA---AMFKVGM-------------FKVHPEIP-----------ESMSAEAKAF 258

Query: 231 VEKMLTFDPRQRITVEDALAHPYL 254
           + K    DP +R    D L   +L
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFL 282

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  110 bits (277), Expect = 1e-28
 Identities = 57/245 (23%), Positives = 94/245 (38%), Gaps = 54/245 (22%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIA--Y----ELMDTDLHQIIRSNQALSEEHC 72
           I K     +VV              N  Y+   Y    EL D      I  +  + E   
Sbjct: 58  INKMLNHENVVKFYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDA 107

Query: 73  QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT 132
           Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA V        E ++ 
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLN 165

Query: 133 RW-----YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG 187
           +      Y APELL     +   +DVWS G +   ++  +   P        +   +   
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSD--- 220

Query: 188 TPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 247
                                   +++++   +  +  + + L+ K+L  +P  RIT+ D
Sbjct: 221 ----------------------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPD 258

Query: 248 ALAHP 252
                
Sbjct: 259 IKKDR 263

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  109 bits (274), Expect = 5e-28
 Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 34/197 (17%)

Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 120
           I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA V 
Sbjct: 96  IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155

Query: 121 SETDFMTEYVVTRW-----YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 175
                  E ++ +      Y APELL     +   +DVWS G +   ++  +   P    
Sbjct: 156 --RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQP 211

Query: 176 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 235
               +   +                           +++++   +  +  + + L+ K+L
Sbjct: 212 SDSCQEYSD-------------------------WKEKKTYLNPWKKIDSAPLALLHKIL 246

Query: 236 TFDPRQRITVEDALAHP 252
             +P  RIT+ D     
Sbjct: 247 VENPSARITIPDIKKDR 263

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  106 bits (267), Expect = 3e-27
 Identities = 36/204 (17%), Positives = 76/204 (37%), Gaps = 31/204 (15%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + I  +  +   L+  + +++     +       Q  RG+ Y+H+ +++HRDLK +N+ L
Sbjct: 94  LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL 153

Query: 104 NANCDLKICDFGLARV---TSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGC 158
           + +  +KI DFGLA      S +    +   +  + APE++       Y+   DV++ G 
Sbjct: 154 HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGI 213

Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  ELM  +  +                    +  +  +                   ++
Sbjct: 214 VLYELMTGQLPYSNI--------------NNRDQIIEMVGRG----------SLSPDLSK 249

Query: 219 KFPNVHPSAIDLVEKMLTFDPRQR 242
              N       L+ + L     +R
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDER 273

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  107 bits (270), Expect = 1e-26
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 31/213 (14%)

Query: 41  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
            + +D+++  E +   +L   I  N  L E+  +    QIL G+ Y H   V+HRDLKP 
Sbjct: 86  STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPE 145

Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+LL+A+ + KI DFGL+ + S+ +F+     +  Y APE++         +D+WS G I
Sbjct: 146 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVI 205

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
              L+     F   DHV  L   I                     I   P+Y        
Sbjct: 206 LYALLCGTLPFDD-DHVPTLFKKI------------------CDGIFYTPQY-------- 238

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
              ++PS I L++ ML  DP +R T++D   H 
Sbjct: 239 ---LNPSVISLLKHMLQVDPMKRATIKDIREHE 268

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  105 bits (265), Expect = 2e-26
 Identities = 45/205 (21%), Positives = 87/205 (42%), Gaps = 30/205 (14%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   ++ N    EE  + F+ +++  L Y+ +  ++HRD+KP N+LL+ +  + I DF 
Sbjct: 101 DLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFN 160

Query: 116 LARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGR 173
           +A +      +T    T+ Y APE+  +   + Y+ A+D WS+G    EL+  +  +  R
Sbjct: 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220

Query: 174 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 233
                 + ++          + +            P                  + L++K
Sbjct: 221 SS-TSSKEIVHTF---ETTVVTY------------P-----------SAWSQEMVSLLKK 253

Query: 234 MLTFDPRQRI-TVEDALAHPYLGSL 257
           +L  +P QR   + D    PY+  +
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYMNDI 278

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  103 bits (259), Expect = 4e-26
 Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 41/218 (18%)

Query: 44  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           +++++  E +     TD    + +   + E        + L+ L+++HS  V+HRD+K  
Sbjct: 90  DELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145

Query: 100 NLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           N+LL  +  +K+ DFG  A++T E    +  V T ++ APE++     Y   +D+WS+G 
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGI 204

Query: 159 IFMELMDRKPLFPGRDHVHQLR--LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           + +E+++ +P  P  +  + LR   LI   GTP       L    K              
Sbjct: 205 MAIEMIEGEP--PYLN-ENPLRALYLIATNGTPE------LQNPEK-------------L 242

Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +  F        D + + L  D  +R + ++ L H +L
Sbjct: 243 SAIF-------RDFLNRCLEMDVEKRGSAKELLQHQFL 273

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  103 bits (260), Expect = 4e-26
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 54/209 (25%)

Query: 61  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 120
           IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+V 
Sbjct: 121 IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

Query: 121 SETDFMT---------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP 171
           S               +YV      +PELL        + D+W++GCI  +L+   P F 
Sbjct: 181 SPESKQARANSFVGTAQYV------SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR 233

Query: 172 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDL 230
             +      L+ + I                +Y               FP    P A DL
Sbjct: 234 AGNE----YLIFQKI-------------IKLEY--------------DFPEKFFPKARDL 262

Query: 231 VEKMLTFDPRQRIT------VEDALAHPY 253
           VEK+L  D  +R+            AHP+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  103 bits (260), Expect = 5e-26
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 41/218 (18%)

Query: 44  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
            ++++  E +     TD    I S   L+EE        +L+ L Y+H+  V+HRD+K  
Sbjct: 115 EELWVLMEFLQGGALTD----IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSD 170

Query: 100 NLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           ++LL  +  +K+ DFG  A+++ +       V T ++ APE++   S Y   +D+WS+G 
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGI 229

Query: 159 IFMELMDRKPLFPGRDHVHQLR--LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           + +E++D +P  P       ++    +     P       L  + K              
Sbjct: 230 MVIEMVDGEP--PYFS-DSPVQAMKRLRDSPPPK------LKNSHK-------------V 267

Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +           D +E+ML  DP++R T ++ L HP+L
Sbjct: 268 SPVL-------RDFLERMLVRDPQERATAQELLDHPFL 298

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (258), Expect = 8e-26
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 39/218 (17%)

Query: 44  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
            D++I  E       +D+ ++   N+ L+E+     L   L+GL+Y+H    +HRD+K  
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAG 154

Query: 100 NLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           N+LLN     K+ DFG+  ++T         + T ++ APE++     Y    D+WS+G 
Sbjct: 155 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGI 213

Query: 159 IFMELMDRKPLFPGRDHVHQLR--LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
             +E+ + KP  P  D +H +R   +I     P+        +                +
Sbjct: 214 TAIEMAEGKP--PYAD-IHPMRAIFMIPTNPPPT------FRKPEL-------------W 251

Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           ++ F        D V++ L   P QR T    L HP++
Sbjct: 252 SDNF-------TDFVKQCLVKSPEQRATATQLLQHPFV 282

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  103 bits (258), Expect = 8e-26
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 38/220 (17%)

Query: 44  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           + +++  E       TDL +  +    L EE   Y   +ILRGL ++H   V+HRD+K  
Sbjct: 100 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 158

Query: 100 NLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVW 154
           N+LL  N ++K+ DFG+ A++         ++ T ++ APE++       + Y    D+W
Sbjct: 159 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 218

Query: 155 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ 214
           S+G   +E+ +  P  P  D +H +R L  +   P+                  PR + +
Sbjct: 219 SLGITAIEMAEGAP--PLCD-MHPMRALFLIPRNPA------------------PRLKSK 257

Query: 215 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +++KF          +E  L  +  QR   E  + HP++
Sbjct: 258 KWSKKF-------QSFIESCLVKNHSQRPATEQLMKHPFI 290

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (258), Expect = 2e-25
 Identities = 47/243 (19%), Positives = 85/243 (34%), Gaps = 36/243 (14%)

Query: 44  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           N++++    M      DL         ++E    Y L  +L+ L YIH    +HR +K S
Sbjct: 99  NELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKAS 157

Query: 100 NLLLNANCDLKICDFGLA--------RVTSETDFMTEYVVTRWYRAPELLL-NSSDYTAA 150
           ++L++ +  + +              R     DF    V    + +PE+L  N   Y A 
Sbjct: 158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 217

Query: 151 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE--------LIGTPSEAELGFLNENAK 202
            D++SVG    EL +    F     +   ++L+E        L+ T +          ++
Sbjct: 218 SDIYSVGITACELANGHVPF---KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSR 274

Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAI-----------DLVEKMLTFDPRQRITVEDALAH 251
                       + T +  N    +              VE+ L  +P  R +    L H
Sbjct: 275 SVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334

Query: 252 PYL 254
            + 
Sbjct: 335 SFF 337

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  101 bits (254), Expect = 3e-25
 Identities = 38/144 (26%), Positives = 60/144 (41%), Gaps = 18/144 (12%)

Query: 46  VYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +    E +    L  II+S            F   I  G+ Y+HS N++HRDL   N L+
Sbjct: 82  LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV 141

Query: 104 NANCDLKICDFGLARVTSETDF---------------MTEYVVTRWYRAPELLLNSSDYT 148
             N ++ + DFGLAR+  +                      V   ++ APE++   S Y 
Sbjct: 142 RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YD 200

Query: 149 AAIDVWSVGCIFMELMDRKPLFPG 172
             +DV+S G +  E++ R    P 
Sbjct: 201 EKVDVFSFGIVLCEIIGRVNADPD 224

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  101 bits (253), Expect = 6e-25
 Identities = 62/254 (24%), Positives = 107/254 (42%), Gaps = 37/254 (14%)

Query: 44  NDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +  ++  E        ++  ++  L E       +  L+GL Y+HS N++HRD+K  N+L
Sbjct: 127 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 186

Query: 103 LNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCI 159
           L+    +K+ DFG  + +     F    V T ++ APE++L      Y   +DVWS+G  
Sbjct: 187 LSEPGLVKLGDFGSASIMAPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 242

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
            +EL +RKP  P   +++ +  L   I             N        P  Q   ++E 
Sbjct: 243 CIELAERKP--P-LFNMNAMSALY-HIAQ-----------NES------PALQSGHWSEY 281

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD-EPVCMSPFSFDFEQHA 278
           F        + V+  L   P+ R T E  L H ++      +    +         E   
Sbjct: 282 F-------RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDN 334

Query: 279 LTEGQMKELIYQEA 292
           L   +MK++++QEA
Sbjct: 335 LQYRKMKKILFQEA 348

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  100 bits (250), Expect = 6e-25
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 15/138 (10%)

Query: 47  YIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN---VLHRDLKPSNLL 102
            +  E      L++++   + +  +    +  QI RG+ Y+H      ++HRDLK SN+L
Sbjct: 82  CLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140

Query: 103 LN--------ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 154
           +         +N  LKI DFGLAR    T  M+      W  APE ++ +S ++   DVW
Sbjct: 141 ILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW-MAPE-VIRASMFSKGSDVW 198

Query: 155 SVGCIFMELMDRKPLFPG 172
           S G +  EL+  +  F G
Sbjct: 199 SYGVLLWELLTGEVPFRG 216

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (250), Expect = 1e-24
 Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 30/212 (14%)

Query: 51  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 110
           +++   + +    +  L E      L ++L GL+Y+H    +HRD+K  N+LL  +  ++
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161

Query: 111 ICDFGLARVTSETDFMTE------YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           I DFG++   +    +T       +V T  + APE++     Y    D+WS G   +EL 
Sbjct: 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221

Query: 165 DRKPLFPGRDHVHQLR--LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 222
                +        ++  +L      PS        E  KKY                  
Sbjct: 222 TGAAPY---HKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKY----------G------- 261

Query: 223 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              S   ++   L  DP +R T  + L H + 
Sbjct: 262 --KSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  100 bits (250), Expect = 1e-24
 Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 11/139 (7%)

Query: 42  SFNDVYIAYELMDT-DLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSAN---VLHR 94
             N V +  E  +   L+ ++   +     +  H   +  Q  +G+ Y+HS     ++HR
Sbjct: 70  CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129

Query: 95  DLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDV 153
           DLKP NLLL A    LKICDFG A        MT    +  + APE +   S+Y+   DV
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE-VFEGSNYSEKCDV 186

Query: 154 WSVGCIFMELMDRKPLFPG 172
           +S G I  E++ R+  F  
Sbjct: 187 FSWGIILWEVITRRKPFDE 205

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  100 bits (250), Expect = 1e-24
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 8/129 (6%)

Query: 51  ELMD-TDLHQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN 104
           E +    L++++  + A   L E       Y + +G+ Y+H+ N  ++HR+LK  NLL++
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD 173

Query: 105 ANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
               +K+CDFGL+R+ + T         T  + APE +L         DV+S G I  EL
Sbjct: 174 KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWEL 232

Query: 164 MDRKPLFPG 172
              +  +  
Sbjct: 233 ATLQQPWGN 241

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 99.3 bits (248), Expect = 2e-24
 Identities = 48/222 (21%), Positives = 96/222 (43%), Gaps = 42/222 (18%)

Query: 44  NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
             ++I  E         +  ++  ++ L+E   Q    Q+L  L ++HS  ++HRDLK  
Sbjct: 89  GKLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAG 146

Query: 100 NLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVW 154
           N+L+    D+++ DFG+ A+          ++ T ++ APE+++      + Y    D+W
Sbjct: 147 NVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 206

Query: 155 SVGCIFMELMDRKPLFPGRDHVHQLR--LLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           S+G   +E+   +P  P  + ++ +R  L I     P+      L   +K          
Sbjct: 207 SLGITLIEMAQIEP--PHHE-LNPMRVLLKIAKSDPPT------LLTPSK---------- 247

Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              ++ +F        D ++  L  +P  R +    L HP++
Sbjct: 248 ---WSVEF-------RDFLKIALDKNPETRPSAAQLLEHPFV 279

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 98.5 bits (246), Expect = 2e-24
 Identities = 29/132 (21%), Positives = 57/132 (43%), Gaps = 12/132 (9%)

Query: 51  ELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL--- 103
           E +   DL+  +      +        +  I  G++Y+ + N  ++HRDL+  N+ L   
Sbjct: 101 EFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL 160

Query: 104 --NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIF 160
             NA    K+ DFGL++ +  +  ++  +    + APE +    + YT   D +S   I 
Sbjct: 161 DENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218

Query: 161 MELMDRKPLFPG 172
             ++  +  F  
Sbjct: 219 YTILTGEGPFDE 230

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  101 bits (252), Expect = 4e-24
 Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 36/210 (17%)

Query: 51  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 110
           ++    ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++
Sbjct: 271 DIR-YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR 329

Query: 111 ICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 169
           I D GLA         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  
Sbjct: 330 ISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP 388

Query: 170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAI 228
           F  R    + + L + +          L +                    +P    P++ 
Sbjct: 389 FRARGEKVENKELKQRV----------LEQA-----------------VTYPDKFSPASK 421

Query: 229 DLVEKMLTFDPRQRI-----TVEDALAHPY 253
           D  E +L  DP +R+     + +    HP 
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 98.1 bits (244), Expect = 1e-23
 Identities = 33/230 (14%), Positives = 63/230 (27%), Gaps = 57/230 (24%)

Query: 44  NDVYIAYELMD-TDLHQIIR-----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           N   +  EL     L   I        + + +     F  ++L  ++ +H   ++H D+K
Sbjct: 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIK 199

Query: 98  PSNLLLN-----------ANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAPELLLN 143
           P N +L             +  L + D G +   ++  +    T    T  ++  E+L N
Sbjct: 200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN 259

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              +   ID + V      ++    +                            NE  + 
Sbjct: 260 KP-WNYQIDYFGVAATVYCMLFGTYMK-------------------------VKNEGGEC 293

Query: 204 YICQ-LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
                  R        +F             ML       +   D L   
Sbjct: 294 KPEGLFRRLPHLDMWNEF----------FHVMLNIPDCHHLPSLDLLRQK 333

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 97.0 bits (242), Expect = 2e-23
 Identities = 34/142 (23%), Positives = 61/142 (42%), Gaps = 17/142 (11%)

Query: 47  YIAYELMDT-DLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
            I   L     L+ ++R     L     +    +I++G+ Y+H+  +LH+DLK  N+  +
Sbjct: 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD 164

Query: 105 ANCDLKICDFGLARVTSETDFMTEY----VVTRWYR--APELLLNSSD--------YTAA 150
            N  + I DFGL  ++             +   W    APE++   S         ++  
Sbjct: 165 -NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH 223

Query: 151 IDVWSVGCIFMELMDRKPLFPG 172
            DV+++G I+ EL  R+  F  
Sbjct: 224 SDVFALGTIWYELHAREWPFKT 245

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 98.8 bits (246), Expect = 3e-23
 Identities = 42/168 (25%), Positives = 69/168 (41%), Gaps = 10/168 (5%)

Query: 27  SVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           S+V I + +    R      YI  E +    L +     Q L       +L +IL  L Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSY 197

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HS  +++ DLKP N++L     LK+ D G     +   ++     T  ++APE++    
Sbjct: 198 LHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRTGP 253

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 193
             T A D+++VG     L    P   G  +V  L     ++ T     
Sbjct: 254 --TVATDIYTVGRTLAALTLDLPTRNG-RYVDGLPEDDPVLKTYDSYG 298

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 97.0 bits (242), Expect = 3e-23
 Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 52/226 (23%)

Query: 42  SFNDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168

Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDV 153
           P NLL++    +++ DFG A RV   T  +    E +      APE++L+   Y  A+D 
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL------APEIILS-KGYNKAVDW 221

Query: 154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 213
           W++G +  E+    P F     +     + E I          ++               
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ----IYEKI----------VSGKV------------ 255

Query: 214 QSFTEKFP-NVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 253
                +FP +      DL+  +L  D  +R       V D   H +
Sbjct: 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.4 bits (245), Expect = 4e-23
 Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 35/204 (17%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337

Query: 116 LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 175
           LA   S+       V T  Y APE+L     Y ++ D +S+GC+  +L+     F     
Sbjct: 338 LACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH-- 394

Query: 176 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKM 234
                       T  + E+        +    +          + P +  P    L+E +
Sbjct: 395 -----------KTKDKHEI-------DRMTLTMA--------VELPDSFSPELRSLLEGL 428

Query: 235 LTFDPRQRI-----TVEDALAHPY 253
           L  D  +R+       ++    P+
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPF 452

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 94.2 bits (235), Expect = 9e-23
 Identities = 21/129 (16%), Positives = 45/129 (34%), Gaps = 11/129 (8%)

Query: 51  ELMDT-DLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNA 105
             M    L+ ++       + +     F   + RG+ ++H+    +    L   +++++ 
Sbjct: 89  HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE 148

Query: 106 NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMEL 163
           +   +I    +         M       W  APE L          + D+WS   +  EL
Sbjct: 149 DMTARISMADVKFSFQSPGRMYAP---AWV-APEALQKKPEDTNRRSADMWSFAVLLWEL 204

Query: 164 MDRKPLFPG 172
           + R+  F  
Sbjct: 205 VTREVPFAD 213

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 97.2 bits (242), Expect = 9e-23
 Identities = 46/196 (23%), Positives = 80/196 (40%), Gaps = 34/196 (17%)

Query: 64  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 123
                E    ++  +I  GL+ +H   +++RDLKP N+LL+ +  ++I D GLA    E 
Sbjct: 280 QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339

Query: 124 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 183
             +   V T  Y APE++ N   YT + D W++GC+  E++  +  F  R    +   + 
Sbjct: 340 QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

Query: 184 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQR 242
            L+                               E++     P A  L  ++L  DP +R
Sbjct: 399 RLV----------KEVP-----------------EEYSERFSPQARSLCSQLLCKDPAER 431

Query: 243 I-----TVEDALAHPY 253
           +     +  +   HP 
Sbjct: 432 LGCRGGSAREVKEHPL 447

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 94.0 bits (234), Expect = 2e-22
 Identities = 33/128 (25%), Positives = 55/128 (42%), Gaps = 19/128 (14%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA--------NVLHRDLKPSNLLLNANCD 108
           L+  ++    L    C   +  I  GL ++H           + HRDLK  N+L+  N  
Sbjct: 93  LYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151

Query: 109 LKICDFGLARVTSETDFMTEYVV-----TRWYRAPELL-----LNSSDYTAAIDVWSVGC 158
             I D GLA + S++    +        T+ Y APE+L     ++  D    +D+W+ G 
Sbjct: 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211

Query: 159 IFMELMDR 166
           +  E+  R
Sbjct: 212 VLWEVARR 219

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 94.2 bits (235), Expect = 2e-22
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 43/205 (20%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   I+S          ++  +I+ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 104 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163

Query: 116 LARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 169
           + +     + M     T        Y APE+LL    Y  ++D WS G +  E++  +  
Sbjct: 164 MCK-----ENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP 217

Query: 170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 229
           F G+D       L   I            +N        PR+           +   A D
Sbjct: 218 FHGQDE----EELFHSI----------RMDNPF-----YPRW-----------LEKEAKD 247

Query: 230 LVEKMLTFDPRQRI-TVEDALAHPY 253
           L+ K+   +P +R+    D   HP 
Sbjct: 248 LLVKLFVREPEKRLGVRGDIRQHPL 272

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 93.5 bits (233), Expect = 2e-22
 Identities = 37/129 (28%), Positives = 62/129 (48%), Gaps = 4/129 (3%)

Query: 47  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
           Y+   L++  DL  ++R    L+       + QI   L   H+A   HRD+KP N+L++A
Sbjct: 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA 169

Query: 106 NCDLKICDFGLARVTSETDF-MTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           +    + DFG+A  T++         V T +Y APE     S  T   D++++ C+  E 
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYEC 228

Query: 164 MDRKPLFPG 172
           +   P + G
Sbjct: 229 LTGSPPYQG 237

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 93.2 bits (232), Expect = 3e-22
 Identities = 50/189 (26%), Positives = 90/189 (47%), Gaps = 31/189 (16%)

Query: 67  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 125
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+  ++T     
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175

Query: 126 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 185
              +V T ++ APE++  S  Y +  D+WS+G   +EL   +P  P  + +H +++L   
Sbjct: 176 RNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEP--PHSE-LHPMKVL--- 228

Query: 186 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 245
                     FL          +P+    +    +        + VE  L  +P  R T 
Sbjct: 229 ----------FL----------IPKNNPPTLEGNYS---KPLKEFVEACLNKEPSFRPTA 265

Query: 246 EDALAHPYL 254
           ++ L H ++
Sbjct: 266 KELLKHKFI 274

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 92.6 bits (231), Expect = 7e-22
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 50/225 (22%)

Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           +F D    + +MD     +L  ++R +Q       +++  ++   L+Y+HS ++++RDLK
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133

Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDV 153
           P N+LL+ N  +KI DFG A  V   T  +    +Y+      APE++     Y  +ID 
Sbjct: 134 PENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI------APEVVST-KPYNKSIDW 186

Query: 154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 213
           WS G +  E++     F   +         E I     AEL F            P +  
Sbjct: 187 WSFGILIYEMLAGYTPFYDSNT----MKTYEKI---LNAELRF------------PPF-- 225

Query: 214 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 253
                     +    DL+ +++T D  QR+       ED   HP+
Sbjct: 226 ---------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 92.5 bits (230), Expect = 1e-21
 Identities = 33/128 (25%), Positives = 49/128 (38%), Gaps = 19/128 (14%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--------VLHRDLKPSNLLLNANCD 108
           L+  ++S   L  +      Y  + GL ++H+          + HRDLK  N+L+  N  
Sbjct: 122 LYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180

Query: 109 LKICDFGLARV-----TSETDFMTEYVVTRWYRAPELL-----LNSSDYTAAIDVWSVGC 158
             I D GLA                 V T+ Y  PE+L      N        D++S G 
Sbjct: 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240

Query: 159 IFMELMDR 166
           I  E+  R
Sbjct: 241 ILWEVARR 248

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 91.5 bits (228), Expect = 1e-21
 Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 9/148 (6%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +V++ D       E  +  Y+  E ++   L + I S+  LS +    F  QIL G+K+ 
Sbjct: 73  IVSMID-----VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVV-TRWYRAPELLLNS 144
           H   ++HRD+KP N+L+++N  LKI DFG+A+  SET    T +V+ T  Y +PE     
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK-G 186

Query: 145 SDYTAAIDVWSVGCIFMELMDRKPLFPG 172
                  D++S+G +  E++  +P F G
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNG 214

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 41/205 (20%), Positives = 80/205 (39%), Gaps = 35/205 (17%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L  + +    L EE  +++L +++  +  +H  + +HRD+KP N+L++ N  +++ DFG 
Sbjct: 162 LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221

Query: 117 A-RVTSETDFMTEYVV-TRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMDRKPLF 170
             ++  +    +   V T  Y +PE+L         Y    D WS+G    E++  +  F
Sbjct: 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

Query: 171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 230
                V         I                     +   +R  F  +  +V  +A DL
Sbjct: 282 YAESLVE----TYGKI---------------------MNHKERFQFPTQVTDVSENAKDL 316

Query: 231 VEKMLTFDPRQRITVEDAL---AHP 252
           + +++      R+          HP
Sbjct: 317 IRRLIC-SREHRLGQNGIEDFKKHP 340

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 91.1 bits (227), Expect = 3e-21
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 54/215 (25%)

Query: 51  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 110
           EL      Q+ R      E+   ++L +I   L ++H   +++RDLKP N++LN    +K
Sbjct: 107 ELF----MQLEREGI-FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK 161

Query: 111 ICDFGLARVTSETDFMT-------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 163
           + DFGL + +     +T       EY+      APE+L+  S +  A+D WS+G +  ++
Sbjct: 162 LTDFGLCKESIHDGTVTHTFCGTIEYM------APEILMR-SGHNRAVDWWSLGALMYDM 214

Query: 164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV 223
           +   P F G +     +  I+ I          L          LP Y           +
Sbjct: 215 LTGAPPFTGENR----KKTIDKI----------LKCKLN-----LPPY-----------L 244

Query: 224 HPSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 253
              A DL++K+L  +   R+        +  AHP+
Sbjct: 245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 90.7 bits (226), Expect = 4e-21
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 52/214 (24%)

Query: 51  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 110
           EL     H  +   +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +K
Sbjct: 91  ELF---FH--LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK 145

Query: 111 ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           I DFGL +     + +++    +       Y APE+L + +DY  A+D W +G +  E+M
Sbjct: 146 ITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 199

Query: 165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 224
             +  F  +DH      L ELI          L E  +      PR            + 
Sbjct: 200 CGRLPFYNQDH----ERLFELI----------LMEEIR-----FPRT-----------LS 229

Query: 225 PSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 253
           P A  L+  +L  DP+QR+       ++ + H +
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 90.7 bits (226), Expect = 4e-21
 Identities = 44/198 (22%), Positives = 86/198 (43%), Gaps = 49/198 (24%)

Query: 68  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT 127
           +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+ DFGL++ + + +   
Sbjct: 124 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183

Query: 128 -------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 180
                  EY+      APE++     +T + D WS G +  E++     F G+D     +
Sbjct: 184 YSFCGTVEYM------APEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDR----K 232

Query: 181 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR 240
             + +I          L          +P++           + P A  L+  +   +P 
Sbjct: 233 ETMTMI----------LKAKLG-----MPQF-----------LSPEAQSLLRMLFKRNPA 266

Query: 241 QRI-----TVEDALAHPY 253
            R+      VE+   H +
Sbjct: 267 NRLGAGPDGVEEIKRHSF 284

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 90.8 bits (226), Expect = 4e-21
 Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 53/215 (24%)

Query: 51  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 110
           +LM      I +S +   E   +++  +I+  L ++H   +++RDLK  N+LL+     K
Sbjct: 110 DLM----FHIQKSRR-FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164

Query: 111 ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           + DFG+ +     + +   V T        Y APE+L     Y  A+D W++G +  E++
Sbjct: 165 LADFGMCK-----EGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEML 218

Query: 165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 224
                F   +       L E I          LN+         P +           +H
Sbjct: 219 CGHAPFEAENE----DDLFEAI----------LNDEVV-----YPTW-----------LH 248

Query: 225 PSAIDLVEKMLTFDPRQRI------TVEDALAHPY 253
             A  +++  +T +P  R+           L HP+
Sbjct: 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 91.3 bits (227), Expect = 4e-21
 Identities = 39/208 (18%), Positives = 77/208 (37%), Gaps = 37/208 (17%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 116
           L  + +  + +  E  +++L +I+  +  +H    +HRD+KP N+LL+    +++ DFG 
Sbjct: 149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208

Query: 117 A-RVTSETDFMTEYVV-TRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMDRKP 168
             ++ ++    +   V T  Y +PE+L        +  Y    D W++G    E+   + 
Sbjct: 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

Query: 169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI 228
            F               I                     +   +  S       V   A 
Sbjct: 269 PFYADSTAE----TYGKI---------------------VHYKEHLSLPLVDEGVPEEAR 303

Query: 229 DLVEKMLTFDPRQRITVEDAL---AHPY 253
           D ++++L   P  R+    A     HP+
Sbjct: 304 DFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 90.0 bits (224), Expect = 8e-21
 Identities = 45/211 (21%), Positives = 95/211 (45%), Gaps = 39/211 (18%)

Query: 51  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 110
           EL       + +  +  +E   Q ++ +I+  L+++H   +++RD+K  N+LL++N  + 
Sbjct: 145 ELF----THLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 199

Query: 111 ICDFGLAR--VTSETDFMTEYVVTRWYRAPELLL-NSSDYTAAIDVWSVGCIFMELMDRK 167
           + DFGL++  V  ET+   ++  T  Y AP+++    S +  A+D WS+G +  EL+   
Sbjct: 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

Query: 168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSA 227
             F      +    +   I    ++E  +            P+            +   A
Sbjct: 260 SPFTVDGEKNSQAEISRRI---LKSEPPY------------PQE-----------MSALA 293

Query: 228 IDLVEKMLTFDPRQRI-----TVEDALAHPY 253
            DL++++L  DP++R+       ++   H +
Sbjct: 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 89.2 bits (222), Expect = 9e-21
 Identities = 37/132 (28%), Positives = 69/132 (52%), Gaps = 6/132 (4%)

Query: 46  VYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
            YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150

Query: 105 ANCDLKICDFGLAR-VTSETDFMTE--YVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
           A   +K+ DFG+AR +    + +T+   V+ T  Y +PE         A  DV+S+GC+ 
Sbjct: 151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVL 209

Query: 161 MELMDRKPLFPG 172
            E++  +P F G
Sbjct: 210 YEVLTGEPPFTG 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 89.2 bits (222), Expect = 2e-20
 Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 52/214 (24%)

Query: 51  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 110
           +LM    + I +  +   E H  ++  +I  GL ++ S  +++RDLK  N++L++   +K
Sbjct: 107 DLM----YHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 161

Query: 111 ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           I DFG+ +     + + + V T+       Y APE++     Y  ++D W+ G +  E++
Sbjct: 162 IADFGMCK-----ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEML 215

Query: 165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 224
             +  F G D       L + I          +  N        P+            + 
Sbjct: 216 AGQAPFEGEDE----DELFQSI----------MEHNVA-----YPKS-----------MS 245

Query: 225 PSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 253
             A+ + + ++T  P +R+        D   H +
Sbjct: 246 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 88.7 bits (220), Expect = 2e-20
 Identities = 30/128 (23%), Positives = 49/128 (38%), Gaps = 19/128 (14%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA--------NVLHRDLKPSNLLLNANCD 108
           L   +     ++ E           GL ++H           + HRDLK  N+L+  N  
Sbjct: 127 LFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185

Query: 109 LKICDFGLARVTSETDFMTEYVV-----TRWYRAPELLLNSS-----DYTAAIDVWSVGC 158
             I D GLA          +        T+ Y APE+L +S      +     D++++G 
Sbjct: 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245

Query: 159 IFMELMDR 166
           +F E+  R
Sbjct: 246 VFWEIARR 253

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 88.2 bits (219), Expect = 2e-20
 Identities = 42/155 (27%), Positives = 62/155 (40%), Gaps = 18/155 (11%)

Query: 57  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA----------NVLHRDLKPSNLLLNAN 106
           L   +++N  +S     +    + RGL Y+H             + HRD+K  N+LL  N
Sbjct: 109 LSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167

Query: 107 CDLKICDFGLARV---TSETDFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCI 159
               I DFGLA               V TR Y APE+L        D    ID++++G +
Sbjct: 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 194
             EL  R     G    + L    E+   PS  ++
Sbjct: 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDM 262

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 88.6 bits (220), Expect = 5e-20
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 43/210 (20%)

Query: 51  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDL 109
           EL     H  +   +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +
Sbjct: 234 ELF---FH--LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 288

Query: 110 KICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 168
           KI DFGL +    +   M  +  T  Y APE+L + +DY  A+D W +G +  E+M  + 
Sbjct: 289 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRL 347

Query: 169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI 228
            F  +DH      L ELI          L E  +      PR            + P A 
Sbjct: 348 PFYNQDH----EKLFELI----------LMEEIR-----FPRT-----------LGPEAK 377

Query: 229 DLVEKMLTFDPRQRI-----TVEDALAHPY 253
            L+  +L  DP+QR+       ++ + H +
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 88.1 bits (219), Expect = 5e-20
 Identities = 48/213 (22%), Positives = 86/213 (40%), Gaps = 51/213 (23%)

Query: 51  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 110
           EL     H  ++  +   E   +++  +I   L Y+HS N+++RDLKP N+LL++   + 
Sbjct: 125 ELF---YH--LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179

Query: 111 ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           + DFGL +     + +     T        Y APE+L     Y   +D W +G +  E++
Sbjct: 180 LTDFGLCK-----ENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEML 233

Query: 165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 224
              P F  R+       + + I          LN+  +     L              + 
Sbjct: 234 YGLPPFYSRNT----AEMYDNI----------LNKPLQ-----LKPN-----------IT 263

Query: 225 PSAIDLVEKMLTFDPRQRI----TVEDALAHPY 253
            SA  L+E +L  D  +R+       +  +H +
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.8 bits (218), Expect = 9e-20
 Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 40/223 (17%)

Query: 42  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           +F D    Y +M+     DL  ++  N  + E+  +++  +++  L  IHS   +HRD+K
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195

Query: 98  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVV-TRWYRAPELLLN---SSDYTAAID 152
           P N+LL+ +  LK+ DFG   ++  E     +  V T  Y +PE+L +      Y    D
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255

Query: 153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
            WSVG    E+                     L+G        F  ++      ++  ++
Sbjct: 256 WWSVGVFLYEM---------------------LVGDTP-----FYADSLVGTYSKIMNHK 289

Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHP 252
                    ++   A +L+   LT D   R+    VE+   H 
Sbjct: 290 NSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHL 331

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.5 bits (219), Expect = 9e-20
 Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 52/214 (24%)

Query: 51  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 110
           +LM    + I +  +   E H  ++  +I  GL ++ S  +++RDLK  N++L++   +K
Sbjct: 428 DLM----YHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482

Query: 111 ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           I DFG+ +     + + + V T+       Y APE++     Y  ++D W+ G +  E++
Sbjct: 483 IADFGMCK-----ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEML 536

Query: 165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 224
             +  F G D       L + I          +  N        P+            + 
Sbjct: 537 AGQAPFEGEDE----DELFQSI----------MEHNVA-----YPKS-----------MS 566

Query: 225 PSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 253
             A+ + + ++T  P +R+        D   H +
Sbjct: 567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 47/215 (21%), Positives = 89/215 (41%), Gaps = 49/215 (22%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 96  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155

Query: 116 LARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 169
           + +     + +     T        Y APE+L    DY  ++D W++G +  E+M  +  
Sbjct: 156 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 209

Query: 170 FPGRDHVHQLR-----LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 224
           F                L ++I          L +  +     +PR            + 
Sbjct: 210 FDIVGSSDNPDQNTEDYLFQVI----------LEKQIR-----IPRS-----------LS 243

Query: 225 PSAIDLVEKMLTFDPRQRI------TVEDALAHPY 253
             A  +++  L  DP++R+         D   HP+
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 85.5 bits (212), Expect = 4e-19
 Identities = 47/215 (21%), Positives = 89/215 (41%), Gaps = 49/215 (22%)

Query: 56  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 115
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198

Query: 116 LARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 169
           + +     + +     T        Y APE+L    DY  ++D W++G +  E+M  +  
Sbjct: 199 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 252

Query: 170 FPGRDHVHQLR-----LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 224
           F                L ++I          L +  +     +PR            + 
Sbjct: 253 FDIVGSSDNPDQNTEDYLFQVI----------LEKQIR-----IPRS-----------LS 286

Query: 225 PSAIDLVEKMLTFDPRQRI------TVEDALAHPY 253
             A  +++  L  DP++R+         D   HP+
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 82.7 bits (205), Expect = 1e-18
 Identities = 34/127 (26%), Positives = 63/127 (49%), Gaps = 12/127 (9%)

Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
             +  E+ +   L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL 
Sbjct: 92  WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 151

Query: 105 ANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVG 157
                KI DFGL++     +    Y          +WY APE  +N   +++  DVWS G
Sbjct: 152 TQHYAKISDFGLSKALRADE--NYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFG 207

Query: 158 CIFMELM 164
            +  E  
Sbjct: 208 VLMWEAF 214

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 82.8 bits (205), Expect = 2e-18
 Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 20/155 (12%)

Query: 23  IMKT----SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFL 76
           I+K      +V  R +   P R+S   + +  E + +  L   ++ ++A L       + 
Sbjct: 77  ILKALHSDFIVKYRGVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---- 132
            QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++         YVV     
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK--DYYVVREPGQ 191

Query: 133 ---RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
               WY APE L ++  ++   DVWS G +  EL 
Sbjct: 192 SPIFWY-APESLSDNI-FSRQSDVWSFGVVLYELF 224

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 81.9 bits (203), Expect = 3e-18
 Identities = 37/128 (28%), Positives = 53/128 (41%), Gaps = 13/128 (10%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + +  EL     L   +R +Q          +  Q+  G+ Y+ S   +HRDL   NLLL
Sbjct: 95  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 154

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
                +KI DFGL R   + D    YV+         W  APE  L +  ++ A D W  
Sbjct: 155 ATRDLVKIGDFGLMRALPQND--DHYVMQEHRKVPFAWC-APE-SLKTRTFSHASDTWMF 210

Query: 157 GCIFMELM 164
           G    E+ 
Sbjct: 211 GVTLWEMF 218

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 82.3 bits (204), Expect = 3e-18
 Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 12/127 (9%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           V +  +LM    L   +R ++  +  ++   +  QI +G+ Y+    ++HRDL   N+L+
Sbjct: 91  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 157
                +KI DFGLA++    +   EY         +W  A E  +    YT   DVWS G
Sbjct: 151 KTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM-ALE-SILHRIYTHQSDVWSYG 206

Query: 158 CIFMELM 164
               ELM
Sbjct: 207 VTVWELM 213

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 82.0 bits (203), Expect = 3e-18
 Identities = 35/128 (27%), Positives = 59/128 (46%), Gaps = 13/128 (10%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + +  E +    L   ++ ++  +       +  QI +G++Y+ +   +HRDL   N+L+
Sbjct: 88  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 147

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
                +KI DFGL +V  +      + V         WY APE L  S  ++ A DVWS 
Sbjct: 148 ENENRVKIGDFGLTKVLPQDK--EFFKVKEPGESPIFWY-APESLTESK-FSVASDVWSF 203

Query: 157 GCIFMELM 164
           G +  EL 
Sbjct: 204 GVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 81.7 bits (202), Expect = 5e-18
 Identities = 36/128 (28%), Positives = 59/128 (46%), Gaps = 13/128 (10%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + +  E +    L   ++ ++  +       +  QI +G++Y+ +   +HRDL   N+L+
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 178

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
                +KI DFGL +V  +      Y V         WY APE L  S  ++ A DVWS 
Sbjct: 179 ENENRVKIGDFGLTKVLPQDK--EYYKVKEPGESPIFWY-APESLTESK-FSVASDVWSF 234

Query: 157 GCIFMELM 164
           G +  EL 
Sbjct: 235 GVVLYELF 242

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 80.3 bits (199), Expect = 7e-18
 Identities = 34/138 (24%), Positives = 62/138 (44%), Gaps = 18/138 (13%)

Query: 46  VYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +YI  E +    L   +RS+ + L         Y +  G+ ++ S   +HRDL   N L+
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV 137

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
           + +  +K+ DFG+ R   +     +YV +       +W  APE+      Y++  DVW+ 
Sbjct: 138 DRDLCVKVSDFGMTRYVLD----DQYVSSVGTKFPVKWS-APEVFHYFK-YSSKSDVWAF 191

Query: 157 GCIFMELMD--RKPLFPG 172
           G +  E+    + P +  
Sbjct: 192 GILMWEVFSLGKMP-YDL 208

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 80.3 bits (199), Expect = 9e-18
 Identities = 36/122 (29%), Positives = 56/122 (45%), Gaps = 6/122 (4%)

Query: 46  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +YI  E M    L   +RS     L  +    F   +   ++Y+   N +HRDL   N+L
Sbjct: 90  LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 149

Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
           ++ +   K+ DFGL +  S T    +  V +W  APE L     ++   DVWS G +  E
Sbjct: 150 VSEDNVAKVSDFGLTKEASSTQDTGKLPV-KWT-APEALREKK-FSTKSDVWSFGILLWE 206

Query: 163 LM 164
           + 
Sbjct: 207 IY 208

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 80.8 bits (200), Expect = 9e-18
 Identities = 37/128 (28%), Positives = 60/128 (46%), Gaps = 13/128 (10%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + +  E + +  L + +  N+  ++ +    +  QI +G+ Y+ S   +HRDL   N+L+
Sbjct: 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 159

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
            +   +KI DFGL +          Y V         WY APE L+ S  +  A DVWS 
Sbjct: 160 ESEHQVKIGDFGLTKAIETDK--EYYTVKDDRDSPVFWY-APECLMQSK-FYIASDVWSF 215

Query: 157 GCIFMELM 164
           G    EL+
Sbjct: 216 GVTLHELL 223

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 47/245 (19%), Positives = 89/245 (36%), Gaps = 42/245 (17%)

Query: 63  SNQALSEEHCQYFLYQILRGLKYIHSA---------NVLHRDLKPSNLLLNANCDLKICD 113
           S             + + RGL Y+H+           + HRDL   N+L+  +    I D
Sbjct: 104 SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163

Query: 114 FGLARVTSETDF---------MTEYVVTRWYRAPELLLNS------SDYTAAIDVWSVGC 158
           FGL+   +                 V T  Y APE+L  +            +D++++G 
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223

Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN--ENAKKYICQLPRYQRQSF 216
           I+ E+  R       + V + ++         + E+G     E+ +  + +    QR  F
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQM-------AFQTEVGNHPTFEDMQVLVSR--EKQRPKF 274

Query: 217 TEKFPNVHPSAIDLVEKMLTF----DPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSF 272
            E +   +  A+  +++ +      D   R+T + A     +  L  I +    +SP + 
Sbjct: 275 PEAWKE-NSLAVRSLKETIEDCWDQDAEARLTAQXAEE--RMAELMMIWERNKSVSPTAH 331

Query: 273 DFEQH 277
               H
Sbjct: 332 HHHHH 336

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 80.0 bits (198), Expect = 1e-17
 Identities = 36/128 (28%), Positives = 59/128 (46%), Gaps = 13/128 (10%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + +  E+     LH+ +   +  +   +    L+Q+  G+KY+   N +HRDL   N+LL
Sbjct: 84  LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL 143

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
                 KI DFGL++     D  + Y          +WY APE  +N   +++  DVWS 
Sbjct: 144 VNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE-CINFRKFSSRSDVWSY 199

Query: 157 GCIFMELM 164
           G    E +
Sbjct: 200 GVTMWEAL 207

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 79.6 bits (197), Expect = 1e-17
 Identities = 33/128 (25%), Positives = 58/128 (45%), Gaps = 15/128 (11%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + +  E M+   L   +R+ +   + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 78  ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 137

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
             N  +K+ DFG+ R   +     +Y  +       +W  +PE+   S  Y++  DVWS 
Sbjct: 138 GENQVIKVSDFGMTRFVLD----DQYTSSTGTKFPVKWA-SPEVFSFSR-YSSKSDVWSF 191

Query: 157 GCIFMELM 164
           G +  E+ 
Sbjct: 192 GVLMWEVF 199

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 35/125 (28%), Positives = 56/125 (44%), Gaps = 8/125 (6%)

Query: 46  VYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           +YI  EL+   D    +R+    L  +     +     G++Y+ S   +HRDL   N L+
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV 246

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT----RWYRAPELLLNSSDYTAAIDVWSVGCI 159
                LKI DFG++R  ++  +     +     +W  APE L     Y++  DVWS G +
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APEALNYGR-YSSESDVWSFGIL 304

Query: 160 FMELM 164
             E  
Sbjct: 305 LWETF 309

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 37/125 (29%), Positives = 56/125 (44%), Gaps = 8/125 (6%)

Query: 46  VYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +YI  E M    L   ++    + L          QI  G+ Y+   N +HRDL+ +N+L
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 395

Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVT---RWYRAPELLLNSSDYTAAIDVWSVGCI 159
           +  N   K+ DFGLAR+  + ++          +W  APE       +T   DVWS G +
Sbjct: 396 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APE-AALYGRFTIKSDVWSFGIL 453

Query: 160 FMELM 164
             EL 
Sbjct: 454 LTELT 458

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 37/125 (29%), Positives = 56/125 (44%), Gaps = 8/125 (6%)

Query: 46  VYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +YI  E M    L   ++    + L          QI  G+ Y+   N +HRDL+ +N+L
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312

Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVT---RWYRAPELLLNSSDYTAAIDVWSVGCI 159
           +  N   K+ DFGLAR+  + ++          +W  APE       +T   DVWS G +
Sbjct: 313 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APE-AALYGRFTIKSDVWSFGIL 370

Query: 160 FMELM 164
             EL 
Sbjct: 371 LTELT 375

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 80.1 bits (198), Expect = 2e-17
 Identities = 31/128 (24%), Positives = 58/128 (45%), Gaps = 14/128 (10%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + +  + +    L   +R ++  L  +    +  QI +G+ Y+    ++HR+L   N+LL
Sbjct: 89  LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL 148

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
            +   +++ DFG+A +    D   + ++        +W  A E +     YT   DVWS 
Sbjct: 149 KSPSQVQVADFGVADLLPPDD---KQLLYSEAKTPIKWM-ALESIHFGK-YTHQSDVWSY 203

Query: 157 GCIFMELM 164
           G    ELM
Sbjct: 204 GVTVWELM 211

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 79.2 bits (196), Expect = 2e-17
 Identities = 36/128 (28%), Positives = 61/128 (47%), Gaps = 15/128 (11%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           V+I  EL    +L   ++  +  L       + YQ+   L Y+ S   +HRD+   N+L+
Sbjct: 90  VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 149

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
           ++N  +K+ DFGL+R   ++     Y          +W  APE  +N   +T+A DVW  
Sbjct: 150 SSNDCVKLGDFGLSRYMEDST----YYKASKGKLPIKWM-APE-SINFRRFTSASDVWMF 203

Query: 157 GCIFMELM 164
           G    E++
Sbjct: 204 GVCMWEIL 211

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 79.2 bits (196), Expect = 3e-17
 Identities = 38/129 (29%), Positives = 57/129 (44%), Gaps = 16/129 (12%)

Query: 46  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
            YI  E M   +L   +R    Q +S     Y   QI   ++Y+   N +HRDL   N L
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143

Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWS 155
           +  N  +K+ DFGL+R+    D    Y          +W  APE L  +  ++   DVW+
Sbjct: 144 VGENHLVKVADFGLSRLM-TGD---TYTAHAGAKFPIKWT-APESLAYNK-FSIKSDVWA 197

Query: 156 VGCIFMELM 164
            G +  E+ 
Sbjct: 198 FGVLLWEIA 206

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 37/127 (29%), Positives = 57/127 (44%), Gaps = 6/127 (4%)

Query: 41  ESFNDVYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           E    +YI  E M    L   +RS     L  +    F   +   ++Y+   N +HRDL 
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316

Query: 98  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
             N+L++ +   K+ DFGL +  S T    +  V +W  APE L     ++   DVWS G
Sbjct: 317 ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KWT-APEALREKK-FSTKSDVWSFG 373

Query: 158 CIFMELM 164
            +  E+ 
Sbjct: 374 ILLWEIY 380

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 78.8 bits (195), Expect = 3e-17
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 15/128 (11%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           ++I  E M    L   +R  +     +        +   ++Y+ S   LHRDL   N L+
Sbjct: 94  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 153

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
           N    +K+ DFGL+R   +     EY  +       RW   PE+L+ S  +++  D+W+ 
Sbjct: 154 NDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWS-PPEVLMYSK-FSSKSDIWAF 207

Query: 157 GCIFMELM 164
           G +  E+ 
Sbjct: 208 GVLMWEIY 215

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 78.9 bits (195), Expect = 5e-17
 Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 12/127 (9%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           V +  +LM    L   +R ++  +  ++   +  QI +G+ Y+    ++HRDL   N+L+
Sbjct: 91  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 157
                +KI DFGLA++    +   EY         +W  A E  +    YT   DVWS G
Sbjct: 151 KTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM-ALE-SILHRIYTHQSDVWSYG 206

Query: 158 CIFMELM 164
               ELM
Sbjct: 207 VTVWELM 213

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 79.8 bits (197), Expect = 5e-17
 Identities = 36/129 (27%), Positives = 57/129 (44%), Gaps = 16/129 (12%)

Query: 46  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
            YI  E M   +L   +R    Q +S     Y   QI   ++Y+   N +HR+L   N L
Sbjct: 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL 350

Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWS 155
           +  N  +K+ DFGL+R+ +       Y          +W  APE  L  + ++   DVW+
Sbjct: 351 VGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWT-APE-SLAYNKFSIKSDVWA 404

Query: 156 VGCIFMELM 164
            G +  E+ 
Sbjct: 405 FGVLLWEIA 413

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 80.0 bits (197), Expect = 6e-17
 Identities = 35/128 (27%), Positives = 59/128 (46%), Gaps = 13/128 (10%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + +  E+     LH+ +   +  +   +    L+Q+  G+KY+   N +HR+L   N+LL
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL 469

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
                 KI DFGL++     D  + Y          +WY APE  +N   +++  DVWS 
Sbjct: 470 VNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE-CINFRKFSSRSDVWSY 525

Query: 157 GCIFMELM 164
           G    E +
Sbjct: 526 GVTMWEAL 533

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 79.4 bits (196), Expect = 7e-17
 Identities = 43/129 (33%), Positives = 63/129 (48%), Gaps = 16/129 (12%)

Query: 46  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +YI  E M    L   ++S+            F  QI  G+ +I   N +HRDL+ +N+L
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316

Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWS 155
           ++A+   KI DFGLARV  +     EY          +W  APE +   S +T   DVWS
Sbjct: 317 VSASLVCKIADFGLARVIED----NEYTAREGAKFPIKWT-APEAINFGS-FTIKSDVWS 370

Query: 156 VGCIFMELM 164
            G + ME++
Sbjct: 371 FGILLMEIV 379

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 78.1 bits (193), Expect = 8e-17
 Identities = 39/127 (30%), Positives = 57/127 (44%), Gaps = 13/127 (10%)

Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 104
           + +  E +    L   +  +  +       F  QI  G+ Y+H+ + +HRDL   N+LL+
Sbjct: 110 LQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168

Query: 105 ANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVG 157
            +  +KI DFGLA+   E      Y V         WY APE L     +  A DVWS G
Sbjct: 169 NDRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFWY-APECLKEYK-FYYASDVWSFG 224

Query: 158 CIFMELM 164
               EL+
Sbjct: 225 VTLYELL 231

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 78.1 bits (193), Expect = 9e-17
 Identities = 44/127 (34%), Positives = 63/127 (49%), Gaps = 11/127 (8%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           + I  E M+   L + +R      S       L  I  G+KY+ + N +HRDL   N+L+
Sbjct: 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV 180

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 157
           N+N   K+ DFGL+RV  E D    Y  +      RW  APE +     +T+A DVWS G
Sbjct: 181 NSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT-APEAISYRK-FTSASDVWSFG 237

Query: 158 CIFMELM 164
            +  E+M
Sbjct: 238 IVMWEVM 244

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 77.6 bits (192), Expect = 1e-16
 Identities = 37/125 (29%), Positives = 61/125 (48%), Gaps = 8/125 (6%)

Query: 46  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +YI  E M+   L   +++     L+         QI  G+ +I   N +HRDL+ +N+L
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141

Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           ++     KI DFGLAR+  + ++          +W  APE  +N   +T   DVWS G +
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT-APE-AINYGTFTIKSDVWSFGIL 199

Query: 160 FMELM 164
             E++
Sbjct: 200 LTEIV 204

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 77.2 bits (191), Expect = 1e-16
 Identities = 34/128 (26%), Positives = 57/128 (44%), Gaps = 15/128 (11%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
            +I  EL    +L   +  N+  L       +  QI + + Y+ S N +HRD+   N+L+
Sbjct: 87  TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV 146

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
            +   +K+ DFGL+R   + D    Y          +W  +PE  +N   +T A DVW  
Sbjct: 147 ASPECVKLGDFGLSRYIEDED----YYKASVTRLPIKWM-SPE-SINFRRFTTASDVWMF 200

Query: 157 GCIFMELM 164
                E++
Sbjct: 201 AVCMWEIL 208

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 43/127 (33%), Positives = 60/127 (47%), Gaps = 11/127 (8%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           V I  E M+   L   +R + A  +       L  I  G+KY+     +HRDL   N+L+
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI 180

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 157
           N+N   K+ DFGL RV  E D    Y         RW  +PE  +    +T+A DVWS G
Sbjct: 181 NSNLVCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWT-SPE-AIAYRKFTSASDVWSYG 237

Query: 158 CIFMELM 164
            +  E+M
Sbjct: 238 IVLWEVM 244

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 36/128 (28%), Positives = 61/128 (47%), Gaps = 15/128 (11%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
           V+I  EL    +L   ++  +  L       + YQ+   L Y+ S   +HRD+   N+L+
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 524

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 156
           ++N  +K+ DFGL+R   ++     Y          +W  APE  +N   +T+A DVW  
Sbjct: 525 SSNDCVKLGDFGLSRYMEDST----YYKASKGKLPIKWM-APE-SINFRRFTSASDVWMF 578

Query: 157 GCIFMELM 164
           G    E++
Sbjct: 579 GVCMWEIL 586

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 76.5 bits (189), Expect = 3e-16
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 13/149 (8%)

Query: 46  VYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
            ++    M   DL Q IRS  +  + +    F  Q+ RG++Y+     +HRDL   N +L
Sbjct: 98  PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 157
           + +  +K+ DFGLAR   + ++ +           +W  A E L     +T   DVWS G
Sbjct: 158 DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-ALESLQTYR-FTTKSDVWSFG 215

Query: 158 CIFMELMD--RKPLFPGRDHVHQLRLLIE 184
            +  EL+     P +   D       L +
Sbjct: 216 VLLWELLTRGAPP-YRHIDPFDLTHFLAQ 243

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 76.2 bits (188), Expect = 3e-16
 Identities = 27/142 (19%), Positives = 51/142 (35%), Gaps = 16/142 (11%)

Query: 46  VYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
             +  E +    L   ++ N+  ++         Q+   + ++    ++H ++   N+LL
Sbjct: 87  NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILL 146

Query: 104 NANCDL--------KICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
               D         K+ D G++      D + E +   W   PE + N  +   A D WS
Sbjct: 147 IREEDRKTGNPPFIKLSDPGISITVLPKDILQERI--PWV-PPECIENPKNLNLATDKWS 203

Query: 156 VGCIFMELMD--RKPLFPGRDH 175
            G    E+     KP     D 
Sbjct: 204 FGTTLWEICSGGDKP-LSALDS 224

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 76.6 bits (189), Expect = 3e-16
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 11/127 (8%)

Query: 46  VYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
             I  E M+   L   +R++    +       L  +  G++Y+     +HRDL   N+L+
Sbjct: 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV 184

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 157
           ++N   K+ DFGL+RV  E D    Y  T      RW  APE  +    +++A DVWS G
Sbjct: 185 DSNLVCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWT-APE-AIAFRTFSSASDVWSFG 241

Query: 158 CIFMELM 164
            +  E++
Sbjct: 242 VVMWEVL 248

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 12/122 (9%)

Query: 50  YELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 109
              ++ +          L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232

Query: 110 KICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFME 162
           KICDFGLAR   +     +YV         +W  APE + +   YT   DVWS G +  E
Sbjct: 233 KICDFGLARDIYKDP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 287

Query: 163 LM 164
           + 
Sbjct: 288 IF 289

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 73.8 bits (182), Expect = 2e-15
 Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 13/149 (8%)

Query: 46  VYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
             +    M   DL   IR+     + +    F  Q+ +G+KY+ S   +HRDL   N +L
Sbjct: 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML 161

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 157
           +    +K+ DFGLAR   + ++ + +  T      +W  A E L     +T   DVWS G
Sbjct: 162 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-ALESLQTQK-FTTKSDVWSFG 219

Query: 158 CIFMELMDR--KPLFPGRDHVHQLRLLIE 184
            +  ELM R   P +P  +       L++
Sbjct: 220 VLLWELMTRGAPP-YPDVNTFDITVYLLQ 247

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 74.0 bits (182), Expect = 4e-15
 Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 13/149 (8%)

Query: 46  VYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 103
             +    M   DL   IR+     + +    F  Q+ +G+K++ S   +HRDL   N +L
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 225

Query: 104 NANCDLKICDFGLARVTSETDFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVG 157
           +    +K+ DFGLAR   + +F + +  T      +W  A E L     +T   DVWS G
Sbjct: 226 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALESLQTQK-FTTKSDVWSFG 283

Query: 158 CIFMELMDR--KPLFPGRDHVHQLRLLIE 184
            +  ELM R   P +P  +       L++
Sbjct: 284 VLLWELMTRGAPP-YPDVNTFDITVYLLQ 311

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 73.1 bits (180), Expect = 5e-15
 Identities = 42/109 (38%), Positives = 51/109 (46%), Gaps = 12/109 (11%)

Query: 63  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 122
              AL  E    F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR    
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 123 TDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
                 YVV        +W  APE + N   YT   DVWS G    EL 
Sbjct: 198 DS---NYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGIFLWELF 241

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 73.0 bits (180), Expect = 6e-15
 Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 10/100 (10%)

Query: 81  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-----Y 135
            G+ ++H  + +HRD+K +N+LL+     KI DFGLAR + +       + +R      Y
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--QTVMTSRIVGTTAY 201

Query: 136 RAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRD 174
            APE L    + T   D++S G + +E++     +   R+
Sbjct: 202 MAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 72.7 bits (179), Expect = 8e-15
 Identities = 35/114 (30%), Positives = 51/114 (44%), Gaps = 12/114 (10%)

Query: 58  HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 117
                +N   S     +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLA
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211

Query: 118 RVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
           R          Y+V        +W  APE + +   YT   DVWS G +  E+ 
Sbjct: 212 RDIMNDS---NYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIF 260

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 72.0 bits (177), Expect = 1e-14
 Identities = 41/161 (25%), Positives = 65/161 (40%), Gaps = 22/161 (13%)

Query: 40  RESFNDVYIAYELMDT-DLHQIIRSN------QALSEEHCQYFLYQILRGLKYIHSANVL 92
           +       +    M   DLH  + ++        L  +    F+  I  G++Y+ S N +
Sbjct: 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFI 159

Query: 93  HRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSS 145
           HRDL   N +L  +  + + DFGL+R     D    Y          +W  A E L ++ 
Sbjct: 160 HRDLAARNCMLAEDMTVCVADFGLSRKIYSGD---YYRQGCASKLPVKWL-ALESLADNL 215

Query: 146 DYTAAIDVWSVGCIFMELMDR--KPLFPGRDHVHQLRLLIE 184
            YT   DVW+ G    E+M R   P + G ++      LI 
Sbjct: 216 -YTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAEIYNYLIG 254

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 38/154 (24%), Positives = 63/154 (40%), Gaps = 22/154 (14%)

Query: 47  YIAYELMDT-DLHQIIRSN------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
            +    M   DLH  +  +      + +  +    F+  I  G++Y+ + N LHRDL   
Sbjct: 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR 176

Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAID 152
           N +L  +  + + DFGL++     D    Y          +W  A E L +   YT+  D
Sbjct: 177 NCMLRDDMTVCVADFGLSKKIYSGD---YYRQGRIAKMPVKWI-AIESLADRV-YTSKSD 231

Query: 153 VWSVGCIFMELMDR--KPLFPGRDHVHQLRLLIE 184
           VW+ G    E+  R   P +PG  +      L+ 
Sbjct: 232 VWAFGVTMWEIATRGMTP-YPGVQNHEMYDYLLH 264

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 71.1 bits (175), Expect = 3e-14
 Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 12/109 (11%)

Query: 63  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 122
               L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR   +
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 123 TDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
                +YV         +W  APE + +   YT   DVWS G +  E+ 
Sbjct: 201 DP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIF 244

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 70.8 bits (174), Expect = 4e-14
 Identities = 37/137 (27%), Positives = 58/137 (42%), Gaps = 23/137 (16%)

Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQ----------YFLYQILRGLKYIHSANVLHR 94
             +  ELM   DL   +RS +     +                +I  G+ Y+++   +HR
Sbjct: 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 162

Query: 95  DLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDY 147
           DL   N ++  +  +KI DFG+ R   ETD+   Y          RW  +PE L +   +
Sbjct: 163 DLAARNCMVAEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWM-SPESLKDGV-F 217

Query: 148 TAAIDVWSVGCIFMELM 164
           T   DVWS G +  E+ 
Sbjct: 218 TTYSDVWSFGVVLWEIA 234

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 70.8 bits (174), Expect = 4e-14
 Identities = 37/109 (33%), Positives = 52/109 (47%), Gaps = 12/109 (11%)

Query: 63  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 122
               L+ E    F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR    
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 123 TDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
                 YVV        +W  APE L     YT   DVWS G +  E+ 
Sbjct: 225 DS---NYVVRGNARLPVKWM-APESLFEGI-YTIKSDVWSYGILLWEIF 268

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 70.5 bits (173), Expect = 6e-14
 Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 29/143 (20%)

Query: 46  VYIAYELMDT-DLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS 88
           +Y+  E     +L + +R+                 + ++ +      YQ+ RG++Y+ S
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221

Query: 89  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 141
              +HRDL   N+L+  N  +KI DFGLAR  +  D    Y  T       +W  APE L
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWM-APEAL 277

Query: 142 LNSSDYTAAIDVWSVGCIFMELM 164
            +   YT   DVWS G +  E+ 
Sbjct: 278 FDRV-YTHQSDVWSFGVLMWEIF 299

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 69.5 bits (171), Expect = 7e-14
 Identities = 33/143 (23%), Positives = 59/143 (41%), Gaps = 29/143 (20%)

Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQ----------------YFLYQILRGLKYIHS 88
           + + +      DLH+ +      S+                    + + QI  G++Y+ S
Sbjct: 87  LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 146

Query: 89  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 141
            +V+H+DL   N+L+    ++KI D GL R     D    Y +        RW  APE +
Sbjct: 147 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD---YYKLLGNSLLPIRWM-APEAI 202

Query: 142 LNSSDYTAAIDVWSVGCIFMELM 164
           +    ++   D+WS G +  E+ 
Sbjct: 203 MYGK-FSIDSDIWSYGVVLWEVF 224

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 69.6 bits (171), Expect = 9e-14
 Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 29/143 (20%)

Query: 46  VYIAYELMDT-DLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS 88
           +Y+  E     +L + +R+                 + ++ +      YQ+ RG++Y+ S
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175

Query: 89  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 141
              +HRDL   N+L+  N  +KI DFGLAR  +  D    Y  T       +W  APE L
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWM-APEAL 231

Query: 142 LNSSDYTAAIDVWSVGCIFMELM 164
            +   YT   DVWS G +  E+ 
Sbjct: 232 FDRV-YTHQSDVWSFGVLMWEIF 253

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 12/98 (12%)

Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT- 132
              YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D    Y  T 
Sbjct: 195 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID---YYKKTT 251

Query: 133 ------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
                 +W  APE L +   YT   DVWS G +  E+ 
Sbjct: 252 NGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIF 287

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 40/143 (27%), Positives = 63/143 (44%), Gaps = 29/143 (20%)

Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQ----------------YFLYQILRGLKYIHS 88
           + + +E M   DL++ +R++   +                     +   QI  G+ Y+ S
Sbjct: 92  LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 151

Query: 89  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 141
            + +HRDL   N L+ AN  +KI DFG++R    TD+   Y V        RW   PE +
Sbjct: 152 QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWM-PPESI 207

Query: 142 LNSSDYTAAIDVWSVGCIFMELM 164
           +    +T   DVWS G I  E+ 
Sbjct: 208 MYRK-FTTESDVWSFGVILWEIF 229

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 37/142 (26%), Positives = 60/142 (42%), Gaps = 28/142 (19%)

Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQ---------------YFLYQILRGLKYIHSA 89
           + + +E M   DL++ +RS+   ++                       Q+  G+ Y+   
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177

Query: 90  NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLL 142
           + +HRDL   N L+     +KI DFG++R    TD+   Y V        RW   PE +L
Sbjct: 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWM-PPESIL 233

Query: 143 NSSDYTAAIDVWSVGCIFMELM 164
               +T   DVWS G +  E+ 
Sbjct: 234 YRK-FTTESDVWSFGVVLWEIF 254

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 12/109 (11%)

Query: 63  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 122
             +AL+      F +QI +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 123 TDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 164
            D    YV         +W  A E L +   YT   DVWS G +  E++
Sbjct: 203 ED---SYVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 246

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 31/113 (27%), Positives = 55/113 (48%), Gaps = 13/113 (11%)

Query: 81  RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW--- 134
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++    D    +V T     
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---THVTTAVRGT 198

Query: 135 --YRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIE 184
             + APE L  +   +   DV+  G + +EL+  ++     R       +L++
Sbjct: 199 IGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 68.1 bits (167), Expect = 3e-13
 Identities = 40/143 (27%), Positives = 59/143 (41%), Gaps = 32/143 (22%)

Query: 46  VYIAYELMDT-DLHQIIRSNQALSEEHCQ----------------YFLYQILRGLKYIHS 88
           +Y+A E     +L   +R ++ L  +                   +F   + RG+ Y+  
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160

Query: 89  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 141
              +HRDL   N+L+  N   KI DFGL+R     +    YV         RW  A E L
Sbjct: 161 KQFIHRDLAARNILVGENYVAKIADFGLSR---GQE---VYVKKTMGRLPVRWM-AIESL 213

Query: 142 LNSSDYTAAIDVWSVGCIFMELM 164
             S  YT   DVWS G +  E++
Sbjct: 214 NYSV-YTTNSDVWSYGVLLWEIV 235

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 67.2 bits (165), Expect = 5e-13
 Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 19/106 (17%)

Query: 81  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-----Y 135
           RGL Y+H+  ++HRD+K  N+LL+ N   KI DFG+++  +E D    ++ T       Y
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD--QTHLSTVVKGTLGY 207

Query: 136 RAPE-----LLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDH 175
             PE      L   S      DV+S G +  E++  R  +      
Sbjct: 208 IDPEYFIKGRLTEKS------DVYSFGVVLFEVLCARSAIVQSLPR 247

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 66.6 bits (163), Expect = 9e-13
 Identities = 34/137 (24%), Positives = 52/137 (37%), Gaps = 23/137 (16%)

Query: 46  VYIAYELMDT-DLHQIIRSN-------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
            +I  ELM   DL   +R          +L+     +    I  G +Y+   + +HRD+ 
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 167

Query: 98  PSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDY 147
             N LL         KI DFG+AR      +   Y          +W   PE  +    +
Sbjct: 168 ARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRKGGCAMLPVKWM-PPEAFMEGI-F 222

Query: 148 TAAIDVWSVGCIFMELM 164
           T+  D WS G +  E+ 
Sbjct: 223 TSKTDTWSFGVLLWEIF 239

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 34/137 (24%), Positives = 52/137 (37%), Gaps = 23/137 (16%)

Query: 46  VYIAYELMDT-DLHQIIRSN-------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
            +I  ELM   DL   +R          +L+     +    I  G +Y+   + +HRD+ 
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208

Query: 98  PSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDY 147
             N LL         KI DFG+AR      +   Y          +W   PE  +    +
Sbjct: 209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKGGCAMLPVKWM-PPEAFMEGI-F 263

Query: 148 TAAIDVWSVGCIFMELM 164
           T+  D WS G +  E+ 
Sbjct: 264 TSKTDTWSFGVLLWEIF 280

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.3 bits (158), Expect = 3e-12
 Identities = 36/227 (15%), Positives = 69/227 (30%), Gaps = 27/227 (11%)

Query: 36  PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHR 94
             P     + ++I  E     +       +  S    +  L+Q+   L    ++    HR
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHR 186

Query: 95  DLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 154
           DL   N+LL      K+      + ++                  L ++  DYT +    
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC-------------GLQVSIIDYTLSRLER 233

Query: 155 SVGCIFMELMDRKPLFPGRDHVHQL---RLLIELIGTPSEAELGFLNENAKKYICQL--- 208
               +F ++   + LF G D  +Q    RL+ +           + N     Y+      
Sbjct: 234 DGIVVFCDVSMDEDLFTG-DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK 292

Query: 209 -PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              ++ +  T     +     +    ML F      +  D L    L
Sbjct: 293 QMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 29/91 (31%), Positives = 39/91 (42%), Gaps = 12/91 (13%)

Query: 74  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT- 132
               Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     D    Y    
Sbjct: 178 CIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---YYKADG 234

Query: 133 ------RWYRAPELLLNSSDYTAAIDVWSVG 157
                 RW   PE +  +  YT   DVW+ G
Sbjct: 235 NDAIPIRWM-PPESIFYNR-YTTESDVWAYG 263

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 64.0 bits (156), Expect = 5e-12
 Identities = 23/217 (10%), Positives = 51/217 (23%), Gaps = 60/217 (27%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           V  + D++      +     +  E +    L ++  +  + S       +  +       
Sbjct: 93  VARVLDVV-----HTRAGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAA 145

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           H A V      PS + ++ + D+ +                                  D
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAYPATM---------------------------PD 178

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI-ELIGTPSEAELGFLNENAKKYI 205
                D+  +G     L+  +   P       L     +  G P E              
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE-------------- 224

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 242
              P            ++      +  + +  D   R
Sbjct: 225 ---PADID-------RDIPFQISAVAARSVQGDGGIR 251

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.8 bits (140), Expect = 9e-10
 Identities = 22/74 (29%), Positives = 37/74 (50%), Gaps = 2/74 (2%)

Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-A 105
           ++  E +  DL +I   N    +        ++L  L+YIH    +H D+K +NLLL   
Sbjct: 128 FMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187

Query: 106 NCD-LKICDFGLAR 118
           N D + + D+GL+ 
Sbjct: 188 NPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 21/43 (48%), Positives = 28/43 (65%), Gaps = 2/43 (4%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLN-ANCD-LKICDFGLAR 118
           +IL  L+YIH    +H D+K SNLLLN  N D + + D+GLA 
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 11/72 (15%), Positives = 28/72 (38%), Gaps = 4/72 (5%)

Query: 51  ELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD 108
             +   L   +  +    LSE        ++L  L+++H    +H ++   N+ ++    
Sbjct: 138 PSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ 197

Query: 109 LKI--CDFGLAR 118
            ++    +G A 
Sbjct: 198 SQVTLAGYGFAF 209

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 16/46 (34%), Positives = 29/46 (63%), Gaps = 5/46 (10%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLL--NANCDLKIC---DFGLAR 118
           Q++  ++Y+HS N+++RD+KP N L+    N   ++    DF LA+
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 48.5 bits (116), Expect = 8e-07
 Identities = 23/76 (30%), Positives = 38/76 (50%), Gaps = 4/76 (5%)

Query: 47  YIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
            +  EL+   L  +    ++  S +       Q++  ++YIHS N +HRD+KP N L+  
Sbjct: 81  VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140

Query: 106 NCD---LKICDFGLAR 118
                 + I DFGLA+
Sbjct: 141 GKKGNLVYIIDFGLAK 156

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 13/46 (28%), Positives = 25/46 (54%), Gaps = 5/46 (10%)

Query: 78  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLK-----ICDFGLAR 118
           Q+L  ++ IH  ++++RD+KP N L+            + DFG+ +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 46.5 bits (110), Expect = 5e-06
 Identities = 21/76 (27%), Positives = 39/76 (51%), Gaps = 4/76 (5%)

Query: 47  YIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 105
            +  +L+   L  +    ++ LS +       Q++  ++++HS + LHRD+KP N L+  
Sbjct: 79  VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138

Query: 106 NCD---LKICDFGLAR 118
                 + I DFGLA+
Sbjct: 139 GRRANQVYIIDFGLAK 154

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	302
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.76
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.6
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.31
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.06
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.84
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.82
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.76
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.25
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.17
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.16
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.16
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.71
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.63
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.04
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.01
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.92
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.53
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.29
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.07
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	95.62
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.57
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	94.08
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	93.75
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	93.23
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	91.93
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	91.41
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	90.49
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	90.03
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.0
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.38
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.25
3mes_A	424	Choline kinase; malaria, structural genomics, stru	84.74

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-63  Score=439.59  Aligned_cols=289  Identities=48%  Similarity=0.867  Sum_probs=256.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCC-CCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      +.+.+|+.+|+.++|||||++++++.... -...+++|||||||+|+|.+++.+++++++..++.+++||+.||+|||++
T Consensus        98 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~  177 (398)
T 4b99_A           98 KRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA  177 (398)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            45779999999999999999999987653 23347899999999999999999989999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC-----CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-----TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ||+||||||+|||++.+|.+||+|||+|+....     .......+||+.|+|||++.+...++.++||||+|||+|+|+
T Consensus       178 ~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell  257 (398)
T 4b99_A          178 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML  257 (398)
T ss_dssp             TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence            999999999999999999999999999976432     223456789999999999987777899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhh-hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      +|.+||.+.+..+++..+....+.|+...+... ......+....+.....++...++.++++++|||.+||++||.+||
T Consensus       258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~  337 (398)
T 4b99_A          258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI  337 (398)
T ss_dssp             HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred             HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc
Confidence            999999999999999999999999998776554 3334555666777777788888999999999999999999999999


Q ss_pred             CHHHHhcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccChhh
Q 022132          244 TVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY  299 (302)
Q Consensus       244 t~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (302)
                      |++|+|+||||+...++.+++.+..++.+.++...++.++++++|+.|+..|+++.
T Consensus       338 ta~e~L~Hp~f~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~k~~i~~ei~~~~~~r  393 (398)
T 4b99_A          338 SAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARR  393 (398)
T ss_dssp             CHHHHTTSGGGTTTCCGGGSCCCSSCCCCHHHHSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHhcCHhhCcCCCCccccCCCCCCCCccchhhcCHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999999999999999999999998753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.7e-58  Score=387.84  Aligned_cols=211  Identities=24%  Similarity=0.477  Sum_probs=177.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ..+.+|+.++++++||||+++++++.+.     +.+|+|||||+|+|.+++.+++++++..++.++.||+.||+|||++|
T Consensus        58 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~  132 (275)
T 3hyh_A           58 GRIEREISYLRLLRHPHIIKLYDVIKSK-----DEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK  132 (275)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3578999999999999999999999988     89999999999999999999999999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      |+||||||+||+++.++.+||+|||+|+...........+||+.|+|||++.+...++.++||||+||++|+|++|++||
T Consensus       133 IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF  212 (275)
T 3hyh_A          133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF  212 (275)
T ss_dssp             CCCCCCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCC
Confidence            99999999999999999999999999987766666667899999999999976665678999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      .+.+.......+.+..  +                            .....+|+++++||.+||++||.+|||++|+|+
T Consensus       213 ~~~~~~~~~~~i~~~~--~----------------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          213 DDESIPVLFKNISNGV--Y----------------------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCSSHHHHHHHHHHTC--C----------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCC--C----------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            8887666555544311  0                            111357899999999999999999999999999


Q ss_pred             CCCcCC
Q 022132          251 HPYLGS  256 (302)
Q Consensus       251 h~~~~~  256 (302)
                      ||||+.
T Consensus       263 hpw~k~  268 (275)
T 3hyh_A          263 DDWFKV  268 (275)
T ss_dssp             CHHHHT
T ss_pred             Cccccc
Confidence            999974

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-56  Score=389.06  Aligned_cols=215  Identities=23%  Similarity=0.458  Sum_probs=187.5

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+|+.++|||||+++++|.+.     +.+|||||||+ |+|.+++.+ +++++..++.++.||+.||+|||+
T Consensus       115 ~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~  188 (346)
T 4fih_A          115 RELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA  188 (346)
T ss_dssp             GGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34678999999999999999999999988     89999999997 699998876 579999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||+||||||+|||++.+|.+||+|||+|+..... ......+||+.|+|||++.+ ..|+.++||||+||++|+|++|.
T Consensus       189 ~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~  267 (346)
T 4fih_A          189 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGE  267 (346)
T ss_dssp             TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999999999999876443 44567799999999999854 45899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+..+.+..+......                           ....++.+|+++++||.+||++||.+|||++|
T Consensus       268 ~PF~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e  320 (346)
T 4fih_A          268 PPYFNEPPLKAMKMIRDNLPP---------------------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE  320 (346)
T ss_dssp             CTTTTSCHHHHHHHHHHSSCC---------------------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCCCcCHHHHHHHHHcCCCC---------------------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            999988877776665442111                           01122367899999999999999999999999


Q ss_pred             HhcCCCcCCcc
Q 022132          248 ALAHPYLGSLH  258 (302)
Q Consensus       248 ll~h~~~~~~~  258 (302)
                      +|+||||+...
T Consensus       321 ~l~Hp~~~~~~  331 (346)
T 4fih_A          321 LLKHPFLAKAG  331 (346)
T ss_dssp             HTTCGGGGGCC
T ss_pred             HhcCHhhcCCC
Confidence            99999998743

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-56  Score=384.18  Aligned_cols=211  Identities=28%  Similarity=0.485  Sum_probs=186.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+++|++++|||||+++++|.+.     +.+|+|||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++|
T Consensus        78 ~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~  152 (311)
T 4aw0_A           78 YVTRERDVMSRLDHPFFVKLYFTFQDD-----EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG  152 (311)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            577999999999999999999999988     89999999997 699999998899999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |+||||||+|||++.+|.+||+|||+|+.....   ......+||+.|+|||++.+. .++.++||||+||++|+|++|.
T Consensus       153 IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~  231 (311)
T 4aw0_A          153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGL  231 (311)
T ss_dssp             EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSS
T ss_pred             CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999865432   334567899999999999764 4899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+..+.+..+.+.-  +                            .....+|+++++||.+||++||.+|||++|
T Consensus       232 ~PF~~~~~~~~~~~i~~~~--~----------------------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e  281 (311)
T 4aw0_A          232 PPFRAGNEGLIFAKIIKLE--Y----------------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEE  281 (311)
T ss_dssp             CSSCCSSHHHHHHHHHHTC--C----------------------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGG
T ss_pred             CCCCCCCHHHHHHHHHcCC--C----------------------------CCCcccCHHHHHHHHHHccCCHhHCcChHH
Confidence            9999988777776665411  0                            111367899999999999999999999988


Q ss_pred             ------HhcCCCcCCcc
Q 022132          248 ------ALAHPYLGSLH  258 (302)
Q Consensus       248 ------ll~h~~~~~~~  258 (302)
                            +++||||+++.
T Consensus       282 ~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          282 MEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             GTCHHHHHTSGGGTTCC
T ss_pred             HcCCHHHHCCCCcCCCC
Confidence                  58999998753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.1e-56  Score=386.58  Aligned_cols=226  Identities=22%  Similarity=0.336  Sum_probs=190.6

Q ss_pred             chhHHHHhcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHH
Q 022132            2 HSITKLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQIL   80 (302)
Q Consensus         2 ~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll   80 (302)
                      .|||++..+....+|+.+++.++|||||++++++.+.     +.+|||||||+ |+|.+++.+.+++++..+..++.||+
T Consensus        86 vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~  160 (336)
T 4g3f_A           86 CAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREG-----PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL  160 (336)
T ss_dssp             EEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHH
T ss_pred             EEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHH
Confidence            3677777677777999999999999999999999987     89999999997 69999999888999999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCCEEEecCC-CEEEeecccccccCCCC------cccccccccccCchhhhhCCCCCCCchhH
Q 022132           81 RGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD------FMTEYVVTRWYRAPELLLNSSDYTAAIDV  153 (302)
Q Consensus        81 ~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  153 (302)
                      .||+|||++||+||||||+|||++.+| .+||+|||+|+......      .....+||+.|+|||++.+ ..++.++||
T Consensus       161 ~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~Di  239 (336)
T 4g3f_A          161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDI  239 (336)
T ss_dssp             HHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT-CCCCTHHHH
T ss_pred             HHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC-CCCCcHHHH
Confidence            999999999999999999999999987 59999999998654321      1233579999999999965 458999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHH
Q 022132          154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  233 (302)
Q Consensus       154 wslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  233 (302)
                      ||+||++|+|++|.+||.+.+....+..+...                           ..++.+..+.+++.+.+||.+
T Consensus       240 wSlGvilyemltG~~Pf~~~~~~~~~~~i~~~---------------------------~~~~~~~~~~~s~~~~~li~~  292 (336)
T 4g3f_A          240 WSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE---------------------------PPPIREIPPSCAPLTAQAIQE  292 (336)
T ss_dssp             HHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS---------------------------CCGGGGSCTTSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC---------------------------CCCchhcCccCCHHHHHHHHH
Confidence            99999999999999999877655444444321                           112233455789999999999


Q ss_pred             ccCCCCCCCCCHHHH-------------hcCCCcCCccCC
Q 022132          234 MLTFDPRQRITVEDA-------------LAHPYLGSLHDI  260 (302)
Q Consensus       234 ~L~~dP~~R~t~~el-------------l~h~~~~~~~~~  260 (302)
                      ||++||.+|||+.|+             |+|||+.....+
T Consensus       293 ~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          293 GLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             HccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            999999999999997             679999887654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.6e-55  Score=388.88  Aligned_cols=215  Identities=23%  Similarity=0.458  Sum_probs=187.7

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+|+.++|||||+++++|.+.     +.+|||||||+ |+|.+++.. +.+++..+..++.||+.||+|||+
T Consensus       192 ~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~  265 (423)
T 4fie_A          192 RELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA  265 (423)
T ss_dssp             GGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34577999999999999999999999987     89999999997 699999876 569999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||+||||||+|||++.+|.+||+|||+|+..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.
T Consensus       266 ~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~  344 (423)
T 4fie_A          266 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGE  344 (423)
T ss_dssp             TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999999999999865443 44567799999999999854 45899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+..+.+..+.....                           +....+..+|+++++||.+||++||.+|||++|
T Consensus       345 ~PF~~~~~~~~~~~i~~~~~---------------------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e  397 (423)
T 4fie_A          345 PPYFNEPPLKAMKMIRDNLP---------------------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE  397 (423)
T ss_dssp             CTTTTSCHHHHHHHHHHSCC---------------------------CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCCCcCHHHHHHHHHcCCC---------------------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            99998887777666544211                           111233478999999999999999999999999


Q ss_pred             HhcCCCcCCcc
Q 022132          248 ALAHPYLGSLH  258 (302)
Q Consensus       248 ll~h~~~~~~~  258 (302)
                      +|+||||+...
T Consensus       398 ll~Hp~~~~~~  408 (423)
T 4fie_A          398 LLKHPFLAKAG  408 (423)
T ss_dssp             HTTCGGGGGCC
T ss_pred             HhcCHHhcCCC
Confidence            99999998743

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.4e-56  Score=379.55  Aligned_cols=211  Identities=21%  Similarity=0.402  Sum_probs=180.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+|++++|||||++++++.+.     +.+|+|||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++
T Consensus        71 ~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~  145 (304)
T 3ubd_A           71 VRTKMERDILVEVNHPFIVKLHYAFQTE-----GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL  145 (304)
T ss_dssp             C------CCCCCCCCTTEECEEEEEEET-----TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577899999999999999999999987     89999999997 69999999889999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+|||++.+|.+||+|||+|+.... .......+||+.|+|||++.+. .++.++||||+||++|+|++|.+
T Consensus       146 ~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~  224 (304)
T 3ubd_A          146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTL  224 (304)
T ss_dssp             TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCC
Confidence            999999999999999999999999999986433 3345567899999999999654 48999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT----  244 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----  244 (302)
                      ||.+.+..+.+..+.+..  +                            .....+|+++++||++||++||.+|||    
T Consensus       225 PF~~~~~~~~~~~i~~~~--~----------------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~  274 (304)
T 3ubd_A          225 PFQGKDRKETMTMILKAK--L----------------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPD  274 (304)
T ss_dssp             SSCCSSHHHHHHHHHHCC--C----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTT
T ss_pred             CCCCcCHHHHHHHHHcCC--C----------------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcC
Confidence            999988877776665411  0                            112367899999999999999999998    


Q ss_pred             -HHHHhcCCCcCCc
Q 022132          245 -VEDALAHPYLGSL  257 (302)
Q Consensus       245 -~~ell~h~~~~~~  257 (302)
                       ++|+++||||+.+
T Consensus       275 ~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          275 GVEEIKRHSFFSTI  288 (304)
T ss_dssp             THHHHHTSGGGTTC
T ss_pred             CHHHHHcCccccCC
Confidence             5899999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.9e-56  Score=385.46  Aligned_cols=211  Identities=24%  Similarity=0.407  Sum_probs=184.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+|++++|||||++++++.+.     +.+|||||||+ |+|.+++...  ..+++..++.|+.||+.||+|||
T Consensus        68 ~~~~~E~~il~~l~HpnIV~~~~~~~~~-----~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH  142 (350)
T 4b9d_A           68 EESRREVAVLANMKHPNIVQYRESFEEN-----GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH  142 (350)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999987     89999999997 6999999754  45799999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ++||+||||||+|||++.+|.+||+|||+|+..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|
T Consensus       143 ~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG  221 (350)
T 4b9d_A          143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTL  221 (350)
T ss_dssp             HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHS
T ss_pred             HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHC
Confidence            999999999999999999999999999999876543 22345689999999999965 4589999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+..+.+..+.....                             ......+|+++++||.+||++||.+|||++
T Consensus       222 ~~PF~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~  272 (350)
T 4b9d_A          222 KHAFEAGSMKNLVLKIISGSF-----------------------------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVN  272 (350)
T ss_dssp             SCSCCCSSHHHHHHHHHHTCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCcCHHHHHHHHHcCCC-----------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHH
Confidence            999999888777766654211                             112236889999999999999999999999


Q ss_pred             HHhcCCCcCC
Q 022132          247 DALAHPYLGS  256 (302)
Q Consensus       247 ell~h~~~~~  256 (302)
                      |+|+||||+.
T Consensus       273 e~l~hp~~~~  282 (350)
T 4b9d_A          273 SILEKGFIAK  282 (350)
T ss_dssp             HHHTSHHHHT
T ss_pred             HHhcCHHhhc
Confidence            9999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.8e-54  Score=387.18  Aligned_cols=291  Identities=38%  Similarity=0.743  Sum_probs=247.0

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+.+|+.+|+.++||||+++++++........+.+|+||||++++|.+++.....+++..++.++.||+.||+|||++
T Consensus        69 ~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~  148 (432)
T 3n9x_A           69 CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES  148 (432)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34678999999999999999999999886555557899999999999999999888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC-----------------------cccccccccccCchhhhhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----------------------FMTEYVVTRWYRAPELLLNSSD  146 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~  146 (302)
                      ||+||||||+||+++.++.+||+|||+++......                       .....++|+.|+|||++.....
T Consensus       149 givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~  228 (432)
T 3n9x_A          149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN  228 (432)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSC
T ss_pred             CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCC
Confidence            99999999999999999999999999997654321                       2356788999999999766677


Q ss_pred             CCCchhHHHHHHHHHHHHh-----------CCCCCCCCC-----------------hHHHHHHHHHHhCCCChHHHhhh-
Q 022132          147 YTAAIDVWSVGCIFMELMD-----------RKPLFPGRD-----------------HVHQLRLLIELIGTPSEAELGFL-  197 (302)
Q Consensus       147 ~~~~~DiwslG~i~~~ll~-----------g~~pf~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~-  197 (302)
                      ++.++||||+||++++|++           |.++|.+.+                 ..+++..+.+.+|.|+...+... 
T Consensus       229 ~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~  308 (432)
T 3n9x_A          229 YTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN  308 (432)
T ss_dssp             CCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhcc
Confidence            9999999999999999997           566666654                 46789999999999999887765 


Q ss_pred             hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccCCCCCCCCCCCCCcchhh-
Q 022132          198 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQ-  276 (302)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~-  276 (302)
                      ......+....+......+...++.+++++++||++||++||.+|||++|+|+||||+.++....++.+..++...++. 
T Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~  388 (432)
T 3n9x_A          309 KPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDW  388 (432)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTT
T ss_pred             CHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhc
Confidence            4456666666777777777888889999999999999999999999999999999999999888887776655554443 


Q ss_pred             cccCHHHHHHHHHHHHHccChhhh
Q 022132          277 HALTEGQMKELIYQEALAFNPEYR  300 (302)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~  300 (302)
                      ..++.++++++++.|+.+|+|..+
T Consensus       389 ~~~~~~~~~~~~~~e~~~~~~~~~  412 (432)
T 3n9x_A          389 MVLSETQLRYIFLKEVQSFHPELV  412 (432)
T ss_dssp             CCCCHHHHHHHHHHHHHHHCTTCC
T ss_pred             ccCCHHHHHHHHHHHHHHhCcccc
Confidence            579999999999999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.5e-55  Score=372.72  Aligned_cols=215  Identities=20%  Similarity=0.353  Sum_probs=178.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..|.+|+.++++++|||||+++++|.+... +.+.+|||||||+ |+|.+++.+.+.+++..+..++.||+.||+|||++
T Consensus        70 ~~~~~E~~il~~l~HpnIV~~~~~~~~~~~-~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~  148 (290)
T 3fpq_A           70 QRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR  148 (290)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEEEET-TEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEeeccC-CCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            468899999999999999999999865311 1157999999997 69999999888999999999999999999999999


Q ss_pred             C--ceecCCCCCCEEEec-CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           90 N--VLHRDLKPSNLLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        90 ~--i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |  |+||||||+|||++. +|.+||+|||+|+.... ......+||+.|+|||++.+  .++.++|||||||++|+|++|
T Consensus       149 ~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg  225 (290)
T 3fpq_A          149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATS  225 (290)
T ss_dssp             SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHC
Confidence            9  999999999999985 78999999999976443 34456789999999998853  489999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+....+...+.....|.                           ...+..++++++||.+||++||.+|||++
T Consensus       226 ~~Pf~~~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~  278 (290)
T 3fpq_A          226 EYPYSECQNAAQIYRRVTSGVKPA---------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIK  278 (290)
T ss_dssp             SCTTTTCSSHHHHHHHHTTTCCCG---------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             CCCCCCCCcHHHHHHHHHcCCCCC---------------------------CCCccCCHHHHHHHHHHccCChhHCcCHH
Confidence            999987665544333222111110                           11125678999999999999999999999


Q ss_pred             HHhcCCCcCC
Q 022132          247 DALAHPYLGS  256 (302)
Q Consensus       247 ell~h~~~~~  256 (302)
                      |+|+||||+.
T Consensus       279 e~l~Hp~~~~  288 (290)
T 3fpq_A          279 DLLNHAFFQE  288 (290)
T ss_dssp             HHHTSGGGC-
T ss_pred             HHhcCccccC
Confidence            9999999975

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-53  Score=375.98  Aligned_cols=285  Identities=41%  Similarity=0.784  Sum_probs=244.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCC-CCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.... ......+|+||||++++|.+++.. +.+++..+..++.||+.||+|||++
T Consensus        69 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~  147 (367)
T 1cm8_A           69 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA  147 (367)
T ss_dssp             HHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            45779999999999999999999998763 234467899999999999999987 5799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.+||+|||+++.....  .....+|+.|+|||++.+...++.++||||+||++++|++|.+|
T Consensus       148 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  225 (367)
T 1cm8_A          148 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL  225 (367)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CccccCcCHHHEEEcCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999999876543  34567899999999998756689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhh-hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |.+.+..+++..+.+..+.|+...+... ......+....+......+...++..++.+++||.+||+.||.+|||++|+
T Consensus       226 f~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~  305 (367)
T 1cm8_A          226 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA  305 (367)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHH
Confidence            9999999999999999999998877655 445666777778777788888889999999999999999999999999999


Q ss_pred             hcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccChhh
Q 022132          249 LAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY  299 (302)
Q Consensus       249 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (302)
                      |+||||+.+.++.+++.+. ++...++....+.++|++++|.|+..|+|..
T Consensus       306 l~hp~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (367)
T 1cm8_A          306 LAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKPPR  355 (367)
T ss_dssp             HHSGGGTTTC------CCC-CCCCC-----CCHHHHHHHHHHHHHTCCC--
T ss_pred             hcChHHHhhcCCccCCCCC-CCCCChhhhcCCHHHHHHHHHHHHHHhcccc
Confidence            9999999998888777654 6777778889999999999999999999874

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-53  Score=387.17  Aligned_cols=291  Identities=40%  Similarity=0.760  Sum_probs=245.5

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+.+|+.+|+.++||||+++++++......+.+.+|+||||++++|.+++...+.+++..++.++.||+.||+|||+.
T Consensus        96 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~  175 (458)
T 3rp9_A           96 CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA  175 (458)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            34678999999999999999999999776545557899999999999999999888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC----------------------------CcccccccccccCchhhh
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET----------------------------DFMTEYVVTRWYRAPELL  141 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~  141 (302)
                      ||+||||||+|||++.++.+||+|||+++.....                            ......++|+.|+|||++
T Consensus       176 ~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~  255 (458)
T 3rp9_A          176 GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI  255 (458)
T ss_dssp             TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHH
T ss_pred             CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHh
Confidence            9999999999999999999999999999765322                            123455789999999988


Q ss_pred             hCCCCCCCchhHHHHHHHHHHHHh-----------CCCCCCCCC--------------------hHHHHHHHHHHhCCCC
Q 022132          142 LNSSDYTAAIDVWSVGCIFMELMD-----------RKPLFPGRD--------------------HVHQLRLLIELIGTPS  190 (302)
Q Consensus       142 ~~~~~~~~~~DiwslG~i~~~ll~-----------g~~pf~~~~--------------------~~~~~~~~~~~~~~~~  190 (302)
                      .....++.++|||||||++|+|++           |.++|.+.+                    ..+++..+.+.+|.|+
T Consensus       256 ~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~  335 (458)
T 3rp9_A          256 LLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS  335 (458)
T ss_dssp             TTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCC
T ss_pred             hCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCC
Confidence            666679999999999999999998           788887765                    3678899999999999


Q ss_pred             hHHHhhh-hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccCCCCCCCCCCC
Q 022132          191 EAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSP  269 (302)
Q Consensus       191 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~~~~  269 (302)
                      ...+... ......+....+......+...++..++++++||++||.+||.+|||++|+|+||||+.++....++.+..+
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~  415 (458)
T 3rp9_A          336 EEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEK  415 (458)
T ss_dssp             HHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSC
T ss_pred             HHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCC
Confidence            9887765 445666667777777778888899999999999999999999999999999999999999877776665554


Q ss_pred             CCcch-hhcccCHHHHHHHHHHHHHccChhhh
Q 022132          270 FSFDF-EQHALTEGQMKELIYQEALAFNPEYR  300 (302)
Q Consensus       270 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (302)
                      ....+ +...++..++++.++.|+..|+|...
T Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~  447 (458)
T 3rp9_A          416 VRLPFNDWMNMDEPQLRYAFVKEIQRYHPEIQ  447 (458)
T ss_dssp             CCCSSCTTSCCCHHHHHHHHHHHHTTTCTTCC
T ss_pred             CCCCccccccCCHHHHHHHHHHHHHHhCcccc
Confidence            44433 33678999999999999999998653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.2e-53  Score=374.07  Aligned_cols=286  Identities=45%  Similarity=0.833  Sum_probs=238.4

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCC-CCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++||||+++++++.... ....+.+|+|+||++++|.+++.. +.+++..+..++.||+.||+|||+
T Consensus        72 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~  150 (367)
T 2fst_X           72 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS  150 (367)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            346779999999999999999999997653 233467899999999999998876 679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      +||+||||||+||+++.++.++|+|||+++.....  .....+|..|+|||++.+...++.++||||+||++++|++|.+
T Consensus       151 ~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  228 (367)
T 2fst_X          151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT  228 (367)
T ss_dssp             TTCCCCCCCGGGEEECTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCeeeCCCCHhhEEECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999999765433  3456789999999999775678999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhh-hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      ||.+.+...++..+.+.++.|....+... ......+....+......+...++..++.+++||.+||++||.+|||++|
T Consensus       229 pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e  308 (367)
T 2fst_X          229 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ  308 (367)
T ss_dssp             SCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHH
Confidence            99999999999999999999998877665 34455666667777777788888899999999999999999999999999


Q ss_pred             HhcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccChhh
Q 022132          248 ALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY  299 (302)
Q Consensus       248 ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (302)
                      +|+||||+.+..+.+++.+. ++....+...+..+++++++|.|+.+|+|..
T Consensus       309 ~L~hp~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  359 (367)
T 2fst_X          309 ALAHAYFAQYHDPDDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVPPP  359 (367)
T ss_dssp             HHTSGGGTTTCCGGGCCCCC-CCCGGGSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred             HhcChhhhhccCCCCCCCCC-CCCcchhhccCCHHHHHHHHHHHHHHhccCc
Confidence            99999999998887777654 7788888889999999999999999998864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.7e-53  Score=383.44  Aligned_cols=287  Identities=39%  Similarity=0.705  Sum_probs=230.7

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++||||+++++++..... +..+++|+||||++++|.+.+..  .+++..++.++.||+.||+|||+
T Consensus       105 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~  182 (464)
T 3ttj_A          105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS  182 (464)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHH
Confidence            3467799999999999999999999987642 34568999999999999888864  59999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      .||+||||||+||+++.++.+||+|||+++..+.........+|+.|+|||++.+. .++.++||||+||++++|++|.+
T Consensus       183 ~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~  261 (464)
T 3ttj_A          183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKI  261 (464)
T ss_dssp             TTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999999877766556778899999999999765 58999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCC------------CHHHHHHHHHccC
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLT  236 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~L~  236 (302)
                      ||.+.+..+++..+.+.++.|....+.........+....+......+...++..            ++++++||.+||+
T Consensus       262 pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~  341 (464)
T 3ttj_A          262 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV  341 (464)
T ss_dssp             SSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred             CCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcC
Confidence            9999999999999999999999998888777777777776666665555555443            5679999999999


Q ss_pred             CCCCCCCCHHHHhcCCCcCCccCCCCCCC-CCCCCCcchhhcccCHHHHHHHHHHHHHccChhh
Q 022132          237 FDPRQRITVEDALAHPYLGSLHDISDEPV-CMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY  299 (302)
Q Consensus       237 ~dP~~R~t~~ell~h~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (302)
                      +||.+|||++|+|+||||+.+.++.+... ....+....+....+.++++++++.|++.++...
T Consensus       342 ~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  405 (464)
T 3ttj_A          342 IDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKT  405 (464)
T ss_dssp             SSTTTSCCHHHHHTSTTTGGGCCHHHHSCCC-----------CCCHHHHHHHHHHHHHC-----
T ss_pred             CChhhCCCHHHHhcChhhhhccCcccccCCCCccCCcchhhccCCHHHHHHHHHHHHHHhhhcc
Confidence            99999999999999999998876554322 2234555667788899999999999999877654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.5e-53  Score=374.68  Aligned_cols=238  Identities=28%  Similarity=0.461  Sum_probs=187.1

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.+|+.+ +||||++++++|.+.     +++|+|||||+ |+|.+++.   .+++..++.++.||+.||+|||++
T Consensus        65 ~~~~E~~~l~~~~~h~nIv~l~~~~~~~-----~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~  136 (361)
T 4f9c_A           65 RIAAELQCLTVAGGQDNVMGVKYCFRKN-----DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF  136 (361)
T ss_dssp             HHHHHHHHHHHTCSBTTBCCCSEEEEET-----TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhcCCCCCceEEEEEEEC-----CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            467899999999 799999999999987     89999999997 69999984   599999999999999999999999


Q ss_pred             CceecCCCCCCEEEecC-CCEEEeecccccccCCCC-----------------------------cccccccccccCchh
Q 022132           90 NVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETD-----------------------------FMTEYVVTRWYRAPE  139 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~-----------------------------~~~~~~~~~~y~aPE  139 (302)
                      ||+||||||+|||++.+ +.+||+|||+|+...+..                             .....+||+.|+|||
T Consensus       137 gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE  216 (361)
T 4f9c_A          137 GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE  216 (361)
T ss_dssp             TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred             CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence            99999999999999987 799999999997543221                             123457999999999


Q ss_pred             hhhCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChHHHhhhh-------------------H
Q 022132          140 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLF-PGRDHVHQLRLLIELIGTPSEAELGFLN-------------------E  199 (302)
Q Consensus       140 ~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~  199 (302)
                      ++.+...++.++||||+||++|+|++|++|| .+.+..+++..+....|.+.........                   .
T Consensus       217 ~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  296 (361)
T 4f9c_A          217 VLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCE  296 (361)
T ss_dssp             HHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHH
T ss_pred             HHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHH
Confidence            9987777899999999999999999999888 5667778999999888865443322110                   0


Q ss_pred             hHHHHhhhcccc-----ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          200 NAKKYICQLPRY-----QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       200 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                      .........+..     ......+.++.+|++++|||++||++||.+|+|++|+|+||||+++
T Consensus       297 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          297 RLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             hhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            000000000100     0011223456789999999999999999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.5e-52  Score=368.13  Aligned_cols=289  Identities=52%  Similarity=0.947  Sum_probs=248.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ..+.+|+.++++++||||+++++++..........+|+||||++++|.+++.. +.+++..+..++.||+.||+|||++|
T Consensus        70 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~  148 (364)
T 3qyz_A           70 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN  148 (364)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45779999999999999999999998765444568999999999999999976 46999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |+||||||+||+++.++.++|+|||.+.......    ......+|+.|+|||++.+...++.++||||+||++++|++|
T Consensus       149 ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  228 (364)
T 3qyz_A          149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN  228 (364)
T ss_dssp             EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred             eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHC
Confidence            9999999999999999999999999997654321    234457899999999987777789999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhh-hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      .+||.+.+..+.+..+...++.|....+... ......+....+.....++...++.+++++.+||.+||++||.+|||+
T Consensus       229 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  308 (364)
T 3qyz_A          229 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV  308 (364)
T ss_dssp             SCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH
Confidence            9999999999999999999999998877654 333445555566666667777888999999999999999999999999


Q ss_pred             HHHhcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccChhhh
Q 022132          246 EDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR  300 (302)
Q Consensus       246 ~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (302)
                      +|+|+||||+.+..+..++....++.++.+...++.++++++++.|+..|+|+.|
T Consensus       309 ~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~  363 (364)
T 3qyz_A          309 EQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR  363 (364)
T ss_dssp             HHHHTSGGGTTTCCGGGSCCCSSCCCCC-----CCHHHHHHHHHHHTGGGCC---
T ss_pred             HHHhcCcchhhccCcccccCCCCcCCcccccccCCHHHHHHHHHHHHHHhhhhcC
Confidence            9999999999998888888888899998888999999999999999999999876

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-52  Score=372.93  Aligned_cols=288  Identities=36%  Similarity=0.686  Sum_probs=231.8

Q ss_pred             cCchhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.+. ||||+++++++.....   ..+|+||||++++|.+++.. +.+++..+..++.||+.||+|||+
T Consensus        52 ~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~  127 (388)
T 3oz6_A           52 AQRTFREIMILTELSGHENIVNLLNVLRADND---RDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHS  127 (388)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS---SCEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCCCeeeeEEecCCC---CEEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            345679999999996 9999999999976421   57999999999999999987 579999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCC----------------------CCcccccccccccCchhhhhCCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE----------------------TDFMTEYVVTRWYRAPELLLNSSD  146 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~  146 (302)
                      .||+||||||+||+++.++.++|+|||+++....                      .......++|+.|+|||++.+...
T Consensus       128 ~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  207 (388)
T 3oz6_A          128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTK  207 (388)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCC
T ss_pred             CCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCC
Confidence            9999999999999999999999999999975432                      122344678999999999977667


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHh-HHHHhhhcccc---cccccccc---
Q 022132          147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN-AKKYICQLPRY---QRQSFTEK---  219 (302)
Q Consensus       147 ~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~---  219 (302)
                      ++.++||||+||++++|++|.+||.+.+...++..+...++.|....+...... ...+....+..   ....+...   
T Consensus       208 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (388)
T 3oz6_A          208 YTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTK  287 (388)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHH
T ss_pred             CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcc
Confidence            899999999999999999999999999999999999999999998766543211 11111111100   01111111   


Q ss_pred             ----------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccCCCCCCCCCCCCCcchh-hcccCHHHHHHHH
Q 022132          220 ----------FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFE-QHALTEGQMKELI  288 (302)
Q Consensus       220 ----------~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  288 (302)
                                ....++++++||.+||++||.+|||++|+|+||||+.+.++..++.+...+...+. ....+.+++++++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (388)
T 3oz6_A          288 WKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLV  367 (388)
T ss_dssp             HHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHH
T ss_pred             hhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHH
Confidence                      12678999999999999999999999999999999999998888888777766554 4578899999999


Q ss_pred             HHHHHccChhhhc
Q 022132          289 YQEALAFNPEYRQ  301 (302)
Q Consensus       289 ~~~~~~~~~~~~~  301 (302)
                      |.|+..+++..++
T Consensus       368 ~~~~~~~~~~~~~  380 (388)
T 3oz6_A          368 YSEISRRKRELIS  380 (388)
T ss_dssp             HHHHHHHHHHHTC
T ss_pred             HHHHHHhhhhhhh
Confidence            9999998886653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.9e-50  Score=354.75  Aligned_cols=283  Identities=43%  Similarity=0.776  Sum_probs=241.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++..... .....+|+||||++++|.+.+.  ..+++..+..++.||+.||+|||++
T Consensus        86 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~  163 (371)
T 4exu_A           86 KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSA  163 (371)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            467799999999999999999999987632 2223459999999999998874  4599999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.++|+|||.+......  .....+|+.|+|||++.+...++.++|||||||++++|++|.+|
T Consensus       164 ~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  241 (371)
T 4exu_A          164 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL  241 (371)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CCcCCCcCHHHeEECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999999765443  34557899999999997656689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhh-HhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |.+.+..+.+..+....+.|......... .....+....+......+...++..++.+.+||.+||++||.+|||++|+
T Consensus       242 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  321 (371)
T 4exu_A          242 FKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA  321 (371)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH
Confidence            99999999999999999999888766553 33444555556666666777778899999999999999999999999999


Q ss_pred             hcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccCh
Q 022132          249 LAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  297 (302)
Q Consensus       249 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (302)
                      |+||||+.+..+..+.....++....+....+.+++++.++.|+.+|.|
T Consensus       322 l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (371)
T 4exu_A          322 LTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  370 (371)
T ss_dssp             HTSGGGTTTCCGGGCCCCSSCCCCTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred             hcCcccccCCCcccccccccCcCcchhhcccchHHHHHHHHHHHHhccc
Confidence            9999999988777776667778777778889999999999999999986

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-50  Score=345.97  Aligned_cols=210  Identities=19%  Similarity=0.283  Sum_probs=172.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..|.+|+.++++++|||||++++++..      +.+|||||||+ |+|.+++.. .+++++..+..|+.||+.||+|||+
T Consensus        77 ~~f~~E~~il~~l~HpNIV~l~g~~~~------~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~  150 (307)
T 3omv_A           77 QAFRNEVAVLRKTRHVNILLFMGYMTK------DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA  150 (307)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECS------SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEC------CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            468899999999999999999998854      56899999997 799999975 4679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCC--CCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~i~~~l  163 (302)
                      +||+||||||+|||++.++.+||+|||+|+.....   ......+||+.|+|||++.+.  ..++.++|||||||++|||
T Consensus       151 ~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~El  230 (307)
T 3omv_A          151 KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYEL  230 (307)
T ss_dssp             TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHH
T ss_pred             CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHH
Confidence            99999999999999999999999999999765432   233456899999999998643  3589999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|++||.+.+....+..+......+                        .......+.+++.+.+|+.+||+.||.+||
T Consensus       231 ltg~~Pf~~~~~~~~~~~~~~~~~~~------------------------p~~~~~~~~~~~~l~~li~~cl~~dP~~RP  286 (307)
T 3omv_A          231 MTGELPYSHINNRDQIIFMVGRGYAS------------------------PDLSKLYKNCPKAMKRLVADCVKKVKEERP  286 (307)
T ss_dssp             HHSSCTTTTCCCHHHHHHHHHTTCCC------------------------CCSTTSCTTSCHHHHHHHHHHTCSSSTTSC
T ss_pred             HHCCCCCCCCChHHHHHHHHhcCCCC------------------------CCcccccccchHHHHHHHHHHcCCCHhHCc
Confidence            99999998877666555444321111                        112233457889999999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |+.|+++
T Consensus       287 s~~ei~~  293 (307)
T 3omv_A          287 LFPQILS  293 (307)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9998754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.4e-51  Score=351.78  Aligned_cols=216  Identities=22%  Similarity=0.371  Sum_probs=163.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCC-------CCCCcEEEEEecCC-ccHHHHHHcCCC---CCHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQR-------ESFNDVYIAYELMD-TDLHQIIRSNQA---LSEEHCQYFLYQI   79 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~-------~~~~~~~lv~e~~~-~~L~~~l~~~~~---l~~~~~~~i~~ql   79 (302)
                      ..+.+|+.+|++++|||||++++++.+...       .....+|+|||||+ |+|.+++...+.   .++..+..++.||
T Consensus        48 ~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi  127 (299)
T 4g31_A           48 EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI  127 (299)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHH
Confidence            467899999999999999999999875421       11135899999996 699999987654   3456789999999


Q ss_pred             HHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-------------cccccccccccCchhhhhCCCC
Q 022132           80 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-------------FMTEYVVTRWYRAPELLLNSSD  146 (302)
Q Consensus        80 l~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~  146 (302)
                      +.||+|||++||+||||||+|||++.+|.+||+|||+|+......             .....+||+.|+|||++.+ ..
T Consensus       128 ~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~  206 (299)
T 4g31_A          128 AEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NS  206 (299)
T ss_dssp             HHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTT-CC
T ss_pred             HHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CC
Confidence            999999999999999999999999999999999999997654321             1234579999999999865 45


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHH
Q 022132          147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPS  226 (302)
Q Consensus       147 ~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (302)
                      ++.++|||||||++|+|++   ||.+.  .+....+........+                          ..++..++.
T Consensus       207 y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~~~~~~~p--------------------------~~~~~~~~~  255 (299)
T 4g31_A          207 YSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTDVRNLKFP--------------------------PLFTQKYPC  255 (299)
T ss_dssp             CCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHHHHTTCCC--------------------------HHHHHHCHH
T ss_pred             CCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHHHhcCCCC--------------------------CCCcccCHH
Confidence            8999999999999999996   66432  2222222222111111                          111134567


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          227 AIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       227 ~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      +.+||.+||++||.+|||+.|+|+||||+.+.
T Consensus       256 ~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          256 EYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            88999999999999999999999999998764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.3e-50  Score=346.71  Aligned_cols=211  Identities=22%  Similarity=0.358  Sum_probs=179.7

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------------CCCCHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------------QALSEEHCQYF   75 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------------~~l~~~~~~~i   75 (302)
                      .+.|.+|+.+|++++|||||++++++.+.     +.+|||||||+ |+|.+++.+.             ..+++..+..+
T Consensus        59 ~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i  133 (299)
T 4asz_A           59 RKDFHREAELLTNLQHEHIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI  133 (299)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEeeC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Confidence            34688999999999999999999999987     88999999997 7999999764             36999999999


Q ss_pred             HHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchh
Q 022132           76 LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAID  152 (302)
Q Consensus        76 ~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~D  152 (302)
                      +.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+......   ......||+.|+|||++.+. .++.++|
T Consensus       134 ~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~D  212 (299)
T 4asz_A          134 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESD  212 (299)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHH
T ss_pred             HHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhh
Confidence            9999999999999999999999999999999999999999997654332   22334689999999999755 4899999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHH
Q 022132          153 VWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV  231 (302)
Q Consensus       153 iwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  231 (302)
                      ||||||++|||++ |++||.+.+..+.+..+.....                             ....+.+|+++.+|+
T Consensus       213 VwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~-----------------------------~~~p~~~~~~~~~li  263 (299)
T 4asz_A          213 VWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-----------------------------LQRPRTCPQEVYELM  263 (299)
T ss_dssp             HHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC-----------------------------CCCCTTCCHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCccchHHHHHHH
Confidence            9999999999998 8999998887776665543111                             111236789999999


Q ss_pred             HHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          232 EKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       232 ~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                      .+||+.||.+|||++++  ++|++.+
T Consensus       264 ~~cl~~dP~~RPs~~~i--~~~L~~~  287 (299)
T 4asz_A          264 LGCWQREPHMRKNIKGI--HTLLQNL  287 (299)
T ss_dssp             HHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred             HHHcCCChhHCcCHHHH--HHHHHHH
Confidence            99999999999999999  4566654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.5e-50  Score=357.12  Aligned_cols=284  Identities=39%  Similarity=0.705  Sum_probs=223.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCC-CCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.... ......+|+||||++++|.+.+.  ..+++..+..++.||+.||+|||++
T Consensus        69 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~  146 (371)
T 2xrw_A           69 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA  146 (371)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC
Confidence            45779999999999999999999998763 23345899999999999999986  3589999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.++|+|||++.............+|..|+|||++.+. .++.++||||+||++++|++|.+|
T Consensus       147 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p  225 (371)
T 2xrw_A          147 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL  225 (371)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999999876655445567889999999999654 489999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCC------------CHHHHHHHHHccCC
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTF  237 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~L~~  237 (302)
                      |.+.+....+..+.+.++.|....+.........+....+.+....+...++..            ++.+++||.+||++
T Consensus       226 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~  305 (371)
T 2xrw_A          226 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI  305 (371)
T ss_dssp             SCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcC
Confidence            999999999999999999998887776666665555555554444333333221            56799999999999


Q ss_pred             CCCCCCCHHHHhcCCCcCCccCCCCCCCC-CCCCCcchhhcccCHHHHHHHHHHHHHccCh
Q 022132          238 DPRQRITVEDALAHPYLGSLHDISDEPVC-MSPFSFDFEQHALTEGQMKELIYQEALAFNP  297 (302)
Q Consensus       238 dP~~R~t~~ell~h~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (302)
                      ||.+|||++|+|+||||+.+.++...... ........++...+.++|++++|.++..|+-
T Consensus       306 dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (371)
T 2xrw_A          306 DASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEH  366 (371)
T ss_dssp             SGGGSCCHHHHHHSHHHHTTCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHHHHHCC
T ss_pred             ChhhCCCHHHHhCCcchhhhcCccccCCCCCCCCChhhccccCcHHHHHHHHHHHHHHHhh
Confidence            99999999999999999987664432211 1223345566788999999999999998874

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-50  Score=375.31  Aligned_cols=220  Identities=24%  Similarity=0.396  Sum_probs=192.3

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.+|+.++||||++++++|.+.     +.+|||||||+ |+|.+++.. .+.+++..++.++.||+.||+|||
T Consensus       198 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH  272 (573)
T 3uto_A          198 KETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH  272 (573)
T ss_dssp             HHHHHHHHHHHHHTCCTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34677999999999999999999999988     89999999996 699999964 468999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecC--CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNAN--CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||+||||||+|||++.+  +.+||+|||+|+...........+||+.|+|||++.+. .++.++||||+||++|+|++
T Consensus       273 ~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~  351 (573)
T 3uto_A          273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLS  351 (573)
T ss_dssp             HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHH
T ss_pred             HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHH
Confidence            9999999999999999854  89999999999988776666778899999999999654 58999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+..+.+..+......+.                          ...++.+|+++++||++||++||.+|||+
T Consensus       352 G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~  405 (573)
T 3uto_A          352 GLSPFGGENDDETLRNVKSCDWNMD--------------------------DSAFSGISEDGKDFIRKLLLADPNTRMTI  405 (573)
T ss_dssp             SCCSSCCSSHHHHHHHHHTTCCCCC--------------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             CCCCCCCcCHHHHHHHHHhCCCCCC--------------------------cccccCCCHHHHHHHHHHccCChhHCcCH
Confidence            9999999988877766654222111                          22345789999999999999999999999


Q ss_pred             HHHhcCCCcCCccCCC
Q 022132          246 EDALAHPYLGSLHDIS  261 (302)
Q Consensus       246 ~ell~h~~~~~~~~~~  261 (302)
                      +|+|+||||+....+.
T Consensus       406 ~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          406 HQALEHPWLTPGNAPG  421 (573)
T ss_dssp             HHHHHSTTTSCCCCTT
T ss_pred             HHHhcCcCcCCCCCCC
Confidence            9999999999765443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.6e-49  Score=348.36  Aligned_cols=283  Identities=43%  Similarity=0.775  Sum_probs=238.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++..... .....+|+||||++++|.+++.  ..+++..+..++.||+.||+|||++
T Consensus        68 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~  145 (353)
T 3coi_A           68 KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSA  145 (353)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            456789999999999999999999987631 1223569999999999988875  3599999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.++|+|||++......  .....++..|+|||.+.+...++.++||||+||++++|++|.+|
T Consensus       146 ~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p  223 (353)
T 3coi_A          146 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL  223 (353)
T ss_dssp             TCCCSSCCGGGEEECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CcccCCCCHHHEeECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999999765433  34457899999999987656689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhh-HhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |.+.+..+.+..+....+.|......... .....+....+......+...++..++.+.+||.+||+.||.+|||++++
T Consensus       224 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  303 (353)
T 3coi_A          224 FKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA  303 (353)
T ss_dssp             SBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            99999999999999999999887766553 33344445555555556667777899999999999999999999999999


Q ss_pred             hcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccCh
Q 022132          249 LAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  297 (302)
Q Consensus       249 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (302)
                      |+||||+....+..++....++....+...++.++|++.|+.|+..|.|
T Consensus       304 l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 3coi_A          304 LTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  352 (353)
T ss_dssp             HTSGGGTTTCCGGGCCCCSSCCCCTTTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred             hcCcchhhccCccccccCCCCCccchhhccCCHHHHHHHHHHHHHhhcc
Confidence            9999999988776666666778777788899999999999999999876

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.5e-49  Score=341.66  Aligned_cols=242  Identities=36%  Similarity=0.688  Sum_probs=207.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++.+.     +.+|+||||++++|.+.+... ..+++..+..++.||+.||+|||+.|
T Consensus        65 ~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  139 (311)
T 3niz_A           65 TAIREISLLKELHHPNIVSLIDVIHSE-----RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR  139 (311)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECCS-----SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHcCCCCEeeeeeEEccC-----CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            567999999999999999999999887     889999999999999998764 45999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.++|+|||++...+.. .......+|..|+|||++.+...++.++||||+||++++|++|.+|
T Consensus       140 ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  219 (311)
T 3niz_A          140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL  219 (311)
T ss_dssp             EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999999865433 2334557899999999997766789999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+..+.+..+....+.+....+....................++....+.+++++.+||.+||++||.+|||++|+|
T Consensus       220 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  299 (311)
T 3niz_A          220 FPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM  299 (311)
T ss_dssp             CCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             CCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            99999999999999999998877665544332222223333444556666778999999999999999999999999999


Q ss_pred             cCCCcCCcc
Q 022132          250 AHPYLGSLH  258 (302)
Q Consensus       250 ~h~~~~~~~  258 (302)
                      +||||+...
T Consensus       300 ~hp~f~~~~  308 (311)
T 3niz_A          300 NHPYFKDLD  308 (311)
T ss_dssp             TSGGGTTSC
T ss_pred             cCcccccCC
Confidence            999999854

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.1e-50  Score=346.29  Aligned_cols=207  Identities=23%  Similarity=0.361  Sum_probs=171.0

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC---------------CCCCHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN---------------QALSEEHCQ   73 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---------------~~l~~~~~~   73 (302)
                      ...|.+|+.+|++++|||||++++++.+.     +.+|||||||+ |+|.+++.+.               +++++..+.
T Consensus        87 ~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~  161 (329)
T 4aoj_A           87 RQDFQREAELLTMLQHQHIVRFFGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL  161 (329)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHH
Confidence            34688999999999999999999999987     88999999997 7999999753               469999999


Q ss_pred             HHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCc
Q 022132           74 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAA  150 (302)
Q Consensus        74 ~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~  150 (302)
                      .|+.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.+
T Consensus       162 ~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~  240 (329)
T 4aoj_A          162 AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTE  240 (329)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHH
T ss_pred             HHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCcc
Confidence            999999999999999999999999999999999999999999998654332   2344578999999999865 458999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHH
Q 022132          151 IDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID  229 (302)
Q Consensus       151 ~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (302)
                      +|||||||++|||++ |++||.+.+..+.+..+......                             ...+.+++++.+
T Consensus       241 sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~-----------------------------~~p~~~~~~~~~  291 (329)
T 4aoj_A          241 SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL-----------------------------ERPRACPPEVYA  291 (329)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCC-----------------------------CCCTTCCHHHHH
T ss_pred             ccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCcccccHHHHH
Confidence            999999999999998 89999988877766555431111                             112367899999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcC
Q 022132          230 LVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       230 li~~~L~~dP~~R~t~~ell~h  251 (302)
                      |+.+||+.||.+|||++|++++
T Consensus       292 li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          292 IMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHHcCcChhHCcCHHHHHHH
Confidence            9999999999999999999764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.1e-50  Score=372.04  Aligned_cols=209  Identities=25%  Similarity=0.389  Sum_probs=176.4

Q ss_pred             HHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 022132           16 SSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHR   94 (302)
Q Consensus        16 E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~   94 (302)
                      ++.+++.++|||||+++++|.+.     +.+|+|||||. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||
T Consensus       242 ~l~ll~~~~HP~IV~l~~~f~~~-----~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHR  316 (689)
T 3v5w_A          242 MLSLVSTGDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR  316 (689)
T ss_dssp             HHHHHSSSCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             HHHHHhhCCCCCEeEEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            35666777899999999999998     89999999996 6999999988999999999999999999999999999999


Q ss_pred             CCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022132           95 DLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  174 (302)
Q Consensus        95 dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~  174 (302)
                      ||||+|||++.+|.+||+|||+|+...... ....+||+.|+|||++.+...|+.++|+|||||++|+|++|.+||.+.+
T Consensus       317 DLKPeNILld~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~  395 (689)
T 3v5w_A          317 DLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  395 (689)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred             CCchHHeEEeCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999998765443 4567899999999999665568999999999999999999999997643


Q ss_pred             hHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHh
Q 022132          175 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDAL  249 (302)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell  249 (302)
                      ..............+                           ....+.+|+++++||.+||++||.+|++     ++|++
T Consensus       396 ~~~~~~i~~~i~~~~---------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          396 TKDKHEIDRMTLTMA---------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             CCCHHHHHHHHHHCC---------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             hHHHHHHHHhhcCCC---------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            222111111100000                           1122368999999999999999999998     79999


Q ss_pred             cCCCcCCc
Q 022132          250 AHPYLGSL  257 (302)
Q Consensus       250 ~h~~~~~~  257 (302)
                      +||||+++
T Consensus       449 ~HpfF~~i  456 (689)
T 3v5w_A          449 ESPFFRSL  456 (689)
T ss_dssp             TSGGGTTC
T ss_pred             cCccccCC
Confidence            99999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.6e-49  Score=353.18  Aligned_cols=284  Identities=31%  Similarity=0.579  Sum_probs=224.3

Q ss_pred             hhHHHHhcCch-hhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHH----cCCCCCHHHHHHHH
Q 022132            3 SITKLMQRGHF-VRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFL   76 (302)
Q Consensus         3 ~~~~~~~~~~~-~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~   76 (302)
                      |+|++..+..+ .+|+.+++.++||||+++++++..... .+...+|+||||+++++...+.    ....+++..++.++
T Consensus        68 aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  147 (394)
T 4e7w_A           68 AIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM  147 (394)
T ss_dssp             EEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHH
T ss_pred             EEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHH
Confidence            34444444444 489999999999999999999965421 2224588999999987766654    35789999999999


Q ss_pred             HHHHHHHHHHHhCCceecCCCCCCEEEe-cCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHH
Q 022132           77 YQILRGLKYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS  155 (302)
Q Consensus        77 ~qll~~l~~LH~~~i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  155 (302)
                      .||+.||+|||++||+||||||+||+++ .++.+||+|||+++............+|+.|+|||++.+...++.++||||
T Consensus       148 ~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS  227 (394)
T 4e7w_A          148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWS  227 (394)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred             HHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHH
Confidence            9999999999999999999999999999 789999999999987665555566788999999999977667899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC-CCCHHHHHHHHHc
Q 022132          156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKM  234 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~  234 (302)
                      +||++|+|++|.+||.+.+..+.+..+.+.++.|....+.........  ...+.....++...++ ..++++.+||.+|
T Consensus       228 lG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  305 (394)
T 4e7w_A          228 TGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME--HKFPQIRPHPFSKVFRPRTPPDAIDLISRL  305 (394)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS--SCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh--hccccccCCcHHHhccccCCHHHHHHHHHH
Confidence            999999999999999999999999999999999998877654432211  1233333344444443 4889999999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCcCCccCCCCCC----CCCCCCCcchhhcccCHHHHHHHH
Q 022132          235 LTFDPRQRITVEDALAHPYLGSLHDISDEP----VCMSPFSFDFEQHALTEGQMKELI  288 (302)
Q Consensus       235 L~~dP~~R~t~~ell~h~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  288 (302)
                      |++||.+|||+.|+++||||+.++......    .....+++..++.....+.+..++
T Consensus       306 L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (394)
T 4e7w_A          306 LEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLV  363 (394)
T ss_dssp             CCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHHHHTCGGGHHHHS
T ss_pred             hCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHHhhcCHHHHHhhc
Confidence            999999999999999999999887654332    223345565555555555555444

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.1e-48  Score=342.26  Aligned_cols=283  Identities=49%  Similarity=0.860  Sum_probs=233.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ..+.+|+.+++.++||||+++++++........+..|+||||++++|.+++.. +.+++..+..++.|++.||+|||++|
T Consensus        54 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~  132 (353)
T 2b9h_A           54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN  132 (353)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            35678999999999999999999987754444578999999999999999887 57999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC-----------cccccccccccCchhhhhCCCCCCCchhHHHHHHH
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  159 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  159 (302)
                      |+||||||+||+++.++.++|+|||++.......           ......+|..|+|||++.+...++.++|||||||+
T Consensus       133 ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i  212 (353)
T 2b9h_A          133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCI  212 (353)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHH
T ss_pred             eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHH
Confidence            9999999999999999999999999987654221           12234679999999998766678999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhh--hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCC
Q 022132          160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL--NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTF  237 (302)
Q Consensus       160 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  237 (302)
                      +++|++|.+||.+.+....+..+....+.|........  ......+....+......+...++.+++.+.+||.+||+.
T Consensus       213 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  292 (353)
T 2b9h_A          213 LAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF  292 (353)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCc
Confidence            99999999999999999999999998888764332221  2223344455555556666777788999999999999999


Q ss_pred             CCCCCCCHHHHhcCCCcCCccCCCCCCCC----CCCCCcchhhcccCHHHHHHHHHHHHHc
Q 022132          238 DPRQRITVEDALAHPYLGSLHDISDEPVC----MSPFSFDFEQHALTEGQMKELIYQEALA  294 (302)
Q Consensus       238 dP~~R~t~~ell~h~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (302)
                      ||.+|||++|+|+||||+....+..++..    ...++++.....++.++++++++.|+++
T Consensus       293 dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (353)
T 2b9h_A          293 DPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS  353 (353)
T ss_dssp             SGGGSCCHHHHHTSGGGTTTCCTTSSCCCCCCCGGGGGGGCCSSCCCHHHHHHHHHHHHTC
T ss_pred             CcccCCCHHHHhcCccccccCCcccccccCCCCcceeeecchhhcCCHHHHHHHHHHHhhC
Confidence            99999999999999999988766544322    2235566677889999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-49  Score=342.32  Aligned_cols=206  Identities=18%  Similarity=0.327  Sum_probs=176.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQ   73 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~   73 (302)
                      +.|.+|+.++++++|||||++++++...     +.+|+|||||+ |+|.+++..+                ..+++..+.
T Consensus        74 ~~f~~E~~il~~l~HpNIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~  148 (308)
T 4gt4_A           74 EEFRHEAMLRARLQHPNVVCLLGVVTKD-----QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV  148 (308)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCcceEEEEC-----CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHH
Confidence            3688999999999999999999999887     88999999997 7999999643                358999999


Q ss_pred             HHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCCCCc
Q 022132           74 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAA  150 (302)
Q Consensus        74 ~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~  150 (302)
                      .++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....   .......||+.|+|||++.+. .++.+
T Consensus       149 ~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~k  227 (308)
T 4gt4_A          149 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSID  227 (308)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCcc
Confidence            99999999999999999999999999999999999999999999764332   233456789999999999755 48999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHH
Q 022132          151 IDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID  229 (302)
Q Consensus       151 ~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (302)
                      +|||||||++|||++ |.+||.+.+..+.+..+.+....                             ...+.+|+.+.+
T Consensus       228 sDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~-----------------------------~~p~~~~~~~~~  278 (308)
T 4gt4_A          228 SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL-----------------------------PCPDDCPAWVYA  278 (308)
T ss_dssp             HHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCC-----------------------------CCCTTCCHHHHH
T ss_pred             chhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCcccchHHHHH
Confidence            999999999999998 89999988877665554431111                             112367889999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcC
Q 022132          230 LVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       230 li~~~L~~dP~~R~t~~ell~h  251 (302)
                      |+.+||+.||.+|||++|++++
T Consensus       279 li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          279 LMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.9e-48  Score=341.83  Aligned_cols=285  Identities=36%  Similarity=0.676  Sum_probs=225.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++..........+|+||||++|+|.+.+... ..+++..+..++.||+.||.|||++
T Consensus        74 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  153 (362)
T 3pg1_A           74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA  153 (362)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            467899999999999999999999965443334689999999999999998764 4799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.++|+|||++.............++..|+|||++.+...++.++||||+||++++|++|.+|
T Consensus       154 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  233 (362)
T 3pg1_A          154 GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL  233 (362)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence            99999999999999999999999999998665555556678899999999987656689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhH-hHHHHh-hhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNE-NAKKYI-CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      |.+.+....+..+....+.|.......... ....+. ..........+....+..++.+.+||.+||++||.+|||++|
T Consensus       234 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  313 (362)
T 3pg1_A          234 FRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ  313 (362)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence            999999999999999999998776554322 122222 222233334455666788999999999999999999999999


Q ss_pred             HhcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccC
Q 022132          248 ALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFN  296 (302)
Q Consensus       248 ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (302)
                      +|+||||+++..+.+... ...-.+.......+..++.++++.|+.+|+
T Consensus       314 ll~hp~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~  361 (362)
T 3pg1_A          314 ALRHPYFESLFDPLDLTE-GLSERFHFDESVTDVYDMHKIFTAEVERFN  361 (362)
T ss_dssp             HHTSGGGTTTCCGGGGTT-TCCCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred             HHcCchhhhccCcccccc-ccccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence            999999999876554332 222333445577888999999999998876

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=339.21  Aligned_cols=245  Identities=37%  Similarity=0.701  Sum_probs=206.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+||||++++|.+++... ..+++..++.++.||+.||+|||+.|
T Consensus        46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~  120 (324)
T 3mtl_A           46 TAIREVSLLKDLKHANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK  120 (324)
T ss_dssp             CCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            567899999999999999999999887     889999999999999998764 46999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.++|+|||++...... .......+|..|+|||++.+...++.++||||+||++++|++|.+|
T Consensus       121 ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  200 (324)
T 3mtl_A          121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL  200 (324)
T ss_dssp             EEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998765432 2334457799999999997766789999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+..+.+..+....+.|....+..............+...........+.+++++.+||.+||++||.+|||++|+|
T Consensus       201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  280 (324)
T 3mtl_A          201 FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM  280 (324)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             CCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence            99999999999999999999888776554333323333444444455566678899999999999999999999999999


Q ss_pred             cCCCcCCccCCC
Q 022132          250 AHPYLGSLHDIS  261 (302)
Q Consensus       250 ~h~~~~~~~~~~  261 (302)
                      +||||.+.....
T Consensus       281 ~hp~f~~~~~~~  292 (324)
T 3mtl_A          281 KHPFFLSLGERI  292 (324)
T ss_dssp             TSGGGGGGCSTT
T ss_pred             cChhhhhccccc
Confidence            999999876544

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-47  Score=334.08  Aligned_cols=215  Identities=21%  Similarity=0.378  Sum_probs=188.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...+++++..+..++.||+.||+|||++
T Consensus        59 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~  133 (328)
T 3fe3_A           59 QKLFREVRIMKILNHPNIVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK  133 (328)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3567999999999999999999999887     89999999996 69999998888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.++|+|||++............+||+.|+|||++.+....+.++||||+||++++|++|.+|
T Consensus       134 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  213 (328)
T 3fe3_A          134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP  213 (328)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence            99999999999999999999999999998766665566778999999999997766556899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+.......+.....                              .....+++++.+||++||..||.+|||++|++
T Consensus       214 f~~~~~~~~~~~i~~~~~------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil  263 (328)
T 3fe3_A          214 FDGQNLKELRERVLRGKY------------------------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM  263 (328)
T ss_dssp             SCCSSHHHHHHHHHHCCC------------------------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHT
T ss_pred             CCCCCHHHHHHHHHhCCC------------------------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            998876665554433110                              11125788999999999999999999999999


Q ss_pred             cCCCcCCccCC
Q 022132          250 AHPYLGSLHDI  260 (302)
Q Consensus       250 ~h~~~~~~~~~  260 (302)
                      +||||+.....
T Consensus       264 ~h~~~~~~~~~  274 (328)
T 3fe3_A          264 KDRWINAGHEE  274 (328)
T ss_dssp             TCTTTTTTCTT
T ss_pred             cCHhhcCCCcc
Confidence            99999976543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.4e-48  Score=329.74  Aligned_cols=239  Identities=37%  Similarity=0.670  Sum_probs=198.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+||||++++|.+++... +.+++..+..++.||+.||+|||++|
T Consensus        46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  120 (288)
T 1ob3_A           46 TTIREISILKELKHSNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR  120 (288)
T ss_dssp             HHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHhcCCCCEeeeeeEEccC-----CeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            566899999999999999999999887     889999999999999999764 67999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.++|+|||++...... .......+|..|+|||++.+...++.++||||+||++++|++|.+|
T Consensus       121 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  200 (288)
T 1ob3_A          121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL  200 (288)
T ss_dssp             CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998765432 2234457899999999997666689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+..+.+..+....+.+....+...... ..+..........++....+.+++.+.+||.+||+.||.+|||++|+|
T Consensus       201 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  279 (288)
T 1ob3_A          201 FPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL  279 (288)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS-TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             CCCCCHHHHHHHHHHHHCCCChhhchhhhcc-cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            9999999999999998888776554432211 111112222233345555667899999999999999999999999999


Q ss_pred             cCCCcCC
Q 022132          250 AHPYLGS  256 (302)
Q Consensus       250 ~h~~~~~  256 (302)
                      +||||++
T Consensus       280 ~hp~f~~  286 (288)
T 1ob3_A          280 EHAYFKE  286 (288)
T ss_dssp             TSGGGGC
T ss_pred             cCcchhh
Confidence            9999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2e-48  Score=340.18  Aligned_cols=208  Identities=24%  Similarity=0.363  Sum_probs=173.3

Q ss_pred             CchhhHHHHHHhcCC-CCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHH
Q 022132           11 GHFVRSSCFDTWIMK-TSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHC   72 (302)
Q Consensus        11 ~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~   72 (302)
                      +.|.+|+.+|+++.| ||||++++++....    +.+|||||||+ |+|.+++.+.                ..+++..+
T Consensus       112 ~~~~~E~~il~~l~hhpnIV~l~g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~  187 (353)
T 4ase_A          112 RALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL  187 (353)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHH
T ss_pred             HHHHHHHHHHHHcCCCCcEEEEEEEEEecC----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHH
Confidence            468899999999965 99999999987642    57999999997 7999999753                34899999


Q ss_pred             HHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCC
Q 022132           73 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTA  149 (302)
Q Consensus        73 ~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~  149 (302)
                      ..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+......   ......+|+.|+|||++.+. .++.
T Consensus       188 ~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~  266 (353)
T 4ase_A          188 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTI  266 (353)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCH
T ss_pred             HHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCC
Confidence            9999999999999999999999999999999999999999999998654332   23345789999999999765 4899


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHH
Q 022132          150 AIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  228 (302)
Q Consensus       150 ~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (302)
                      ++|||||||++|||++ |.+||.+.+....+...+.....+                            ...+.+++++.
T Consensus       267 ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~----------------------------~~p~~~~~~~~  318 (353)
T 4ase_A          267 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------------------------RAPDYTTPEMY  318 (353)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC----------------------------CCCTTCCHHHH
T ss_pred             cccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCC----------------------------CCCccCCHHHH
Confidence            9999999999999998 999998876544443333221111                            11235789999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcC
Q 022132          229 DLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       229 ~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +++.+||+.||.+|||++|+++|
T Consensus       319 ~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          319 QTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCcChhHCcCHHHHHHH
Confidence            99999999999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.1e-48  Score=345.89  Aligned_cols=258  Identities=33%  Similarity=0.633  Sum_probs=209.1

Q ss_pred             hhHHHHhcCch-hhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHH----cCCCCCHHHHHHHH
Q 022132            3 SITKLMQRGHF-VRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFL   76 (302)
Q Consensus         3 ~~~~~~~~~~~-~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~   76 (302)
                      |||++..+..+ .+|+.+++.++||||+++++++..... .+...+++||||++++|.+.+.    ....+++..++.++
T Consensus        83 aiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~  162 (420)
T 1j1b_A           83 AIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM  162 (420)
T ss_dssp             EEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHH
T ss_pred             EEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHH
Confidence            55655554444 489999999999999999999864321 1223477999999998877764    35789999999999


Q ss_pred             HHHHHHHHHHHhCCceecCCCCCCEEEecC-CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHH
Q 022132           77 YQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS  155 (302)
Q Consensus        77 ~qll~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  155 (302)
                      .||+.||+|||++||+||||||+||+++.+ +.+||+|||+++............+|+.|+|||++.+...++.++||||
T Consensus       163 ~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS  242 (420)
T 1j1b_A          163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWS  242 (420)
T ss_dssp             HHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHH
T ss_pred             HHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHH
Confidence            999999999999999999999999999965 5689999999987655555566788999999999976666899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccC-CCCCHHHHHHHHHc
Q 022132          156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKM  234 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~  234 (302)
                      +||++|+|++|.+||.+.+..+++..+.+.++.|....+.........+  ..+.....++...+ +..++++++||.+|
T Consensus       243 lG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~  320 (420)
T 1j1b_A          243 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRL  320 (420)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHh
Confidence            9999999999999999999999999999999999987765443221111  22223333333333 46789999999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCcCCccCCCC
Q 022132          235 LTFDPRQRITVEDALAHPYLGSLHDISD  262 (302)
Q Consensus       235 L~~dP~~R~t~~ell~h~~~~~~~~~~~  262 (302)
                      |++||.+|||+.|+|+||||+.++....
T Consensus       321 L~~dP~~R~t~~e~l~hp~f~~~~~~~~  348 (420)
T 1j1b_A          321 LEYTPTARLTPLEACAHSFFDELRDPNV  348 (420)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred             ccCChhHCCCHHHHhCCHhhcccccccc
Confidence            9999999999999999999998876543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.2e-47  Score=332.88  Aligned_cols=247  Identities=32%  Similarity=0.633  Sum_probs=200.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC------CCCCHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN------QALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~------~~l~~~~~~~i~~qll~~l~~   85 (302)
                      .+.+|+.++++++||||+++++++...     +.+|+||||++++|.+++...      ..+++..+..++.||+.||+|
T Consensus        49 ~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~  123 (317)
T 2pmi_A           49 TAIREISLMKELKHENIVRLYDVIHTE-----NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF  123 (317)
T ss_dssp             HHHHHHHHHTTCCBTTBCCEEEEECCT-----TEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCcceEEEEEEEC-----CeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHH
Confidence            567899999999999999999999987     899999999999999998653      459999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ||+.||+||||||+||+++.++.++|+|||++...... .......+|..|+|||++.+...++.++|||||||++|+|+
T Consensus       124 lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  203 (317)
T 2pmi_A          124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI  203 (317)
T ss_dssp             HHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             HHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999765432 23345678999999999976666899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccc-----ccccCCCCCHHHHHHHHHccCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS-----FTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      +|.+||.+.+....+..+.+..+.+....+....... .+...........     .......+++++.+||.+||++||
T Consensus       204 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  282 (317)
T 2pmi_A          204 TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP-KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNP  282 (317)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT-TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSG
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh-hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCc
Confidence            9999999999999999999999988766554332110 0000000000000     011223578899999999999999


Q ss_pred             CCCCCHHHHhcCCCcCCccCCCCCC
Q 022132          240 RQRITVEDALAHPYLGSLHDISDEP  264 (302)
Q Consensus       240 ~~R~t~~ell~h~~~~~~~~~~~~~  264 (302)
                      .+|||++|+|+||||+.+.......
T Consensus       283 ~~Rpt~~e~l~hp~f~~~~~~~~~~  307 (317)
T 2pmi_A          283 DMRLSAKQALHHPWFAEYYHHASMG  307 (317)
T ss_dssp             GGSCCHHHHTTSGGGGGGCC-----
T ss_pred             ccCCCHHHHhCChhhhcccchhhcc
Confidence            9999999999999999987654443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.8e-48  Score=342.21  Aligned_cols=255  Identities=31%  Similarity=0.627  Sum_probs=208.5

Q ss_pred             hhHHHHhcC-chhhHHHHHHhcCCCCccccceeeCCCCC---------------------------------CCCCcEEE
Q 022132            3 SITKLMQRG-HFVRSSCFDTWIMKTSVVAIRDIIPPPQR---------------------------------ESFNDVYI   48 (302)
Q Consensus         3 ~~~~~~~~~-~~~~E~~il~~l~h~niv~l~~~~~~~~~---------------------------------~~~~~~~l   48 (302)
                      |||++..+. ...+|+.+++.++||||+++++++.....                                 .+...+++
T Consensus        36 AiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  115 (383)
T 3eb0_A           36 ALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV  115 (383)
T ss_dssp             EEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEE
T ss_pred             EEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEE
Confidence            455554443 34589999999999999999999855321                                 22255899


Q ss_pred             EEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEe-cCCCEEEeecccccccCCC
Q 022132           49 AYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSET  123 (302)
Q Consensus        49 v~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~  123 (302)
                      ||||++++|.+.+.    ..+.+++..++.++.||+.||+|||+.||+||||||+||+++ .++.++|+|||++......
T Consensus       116 v~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  195 (383)
T 3eb0_A          116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS  195 (383)
T ss_dssp             EECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC
Confidence            99999998877765    457899999999999999999999999999999999999998 5789999999999876666


Q ss_pred             CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHH
Q 022132          124 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK  203 (302)
Q Consensus       124 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (302)
                      .......+|+.|+|||++.+...++.++||||+||++++|++|.+||.+.+..+.+..+...++.|+...+.........
T Consensus       196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~  275 (383)
T 3eb0_A          196 EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE  275 (383)
T ss_dssp             SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--
T ss_pred             CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc
Confidence            55667788999999999877666899999999999999999999999999999999999999999998876554332211


Q ss_pred             HhhhccccccccccccCC-CCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccC
Q 022132          204 YICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  259 (302)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  259 (302)
                        ...+......+...++ ..++++.+||.+||++||.+|||+.|+|+||||+.++.
T Consensus       276 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          276 --VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             --CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             --ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence              1222333333333333 47899999999999999999999999999999987654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.7e-47  Score=326.78  Aligned_cols=242  Identities=36%  Similarity=0.657  Sum_probs=199.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++.+.     +.+|+||||+++++.+.+.. .+.+++..++.++.||+.||+|||++
T Consensus        46 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~  120 (292)
T 3o0g_A           46 SSALREICLLKELKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR  120 (292)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3566899999999999999999999887     89999999999988887765 57899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||.+...+.. .......+|..|+|||++.+...++.++||||+||++++|++|..
T Consensus       121 ~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~  200 (292)
T 3o0g_A          121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR  200 (292)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSC
T ss_pred             CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999999765433 334556789999999999776668999999999999999997655


Q ss_pred             C-CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          169 L-FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       169 p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      | |.+.+..+.+..+....+.|....+........ +................+.+++.+++||++||+.||.+|||++|
T Consensus       201 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  279 (292)
T 3o0g_A          201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD-YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE  279 (292)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT-CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc-ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHH
Confidence            5 778888889999999999888776544322110 00000001122334455678999999999999999999999999


Q ss_pred             HhcCCCcCCcc
Q 022132          248 ALAHPYLGSLH  258 (302)
Q Consensus       248 ll~h~~~~~~~  258 (302)
                      +|+||||+.+.
T Consensus       280 ~l~hp~f~~~~  290 (292)
T 3o0g_A          280 ALQHPYFSDFC  290 (292)
T ss_dssp             HHTSGGGTTC-
T ss_pred             HhcCcccccCC
Confidence            99999998754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=331.49  Aligned_cols=242  Identities=36%  Similarity=0.611  Sum_probs=201.1

Q ss_pred             chhhHHHHHHhcC---CCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIM---KTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~--l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+|+.+++.++   ||||+++++++..........+++||||++++|.+++.....  +++..+..++.||+.||+||
T Consensus        57 ~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~l  136 (308)
T 3g33_A           57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL  136 (308)
T ss_dssp             HHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            4668888888775   999999999998763322236899999999999999987644  99999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |++||+||||||+||+++.++.++|+|||++.............+|+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus       137 H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g  215 (308)
T 3g33_A          137 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRR  215 (308)
T ss_dssp             HHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTS
T ss_pred             HHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhC
Confidence            99999999999999999999999999999998776665566778899999999997654 89999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+....+..+.+..+.+....+........   ...+.....+.....+.+++.+.+||.+||++||.+|||+.
T Consensus       216 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  292 (308)
T 3g33_A          216 KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR---GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF  292 (308)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCG---GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccc---cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHH
Confidence            999999999999999999998887765432211100   11222223344555678899999999999999999999999


Q ss_pred             HHhcCCCcCCc
Q 022132          247 DALAHPYLGSL  257 (302)
Q Consensus       247 ell~h~~~~~~  257 (302)
                      |+|+||||+..
T Consensus       293 e~l~h~~~~~~  303 (308)
T 3g33_A          293 RALQHSYLHKD  303 (308)
T ss_dssp             HHHTSTTC---
T ss_pred             HHhcCccccCC
Confidence            99999999874

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.7e-47  Score=332.65  Aligned_cols=214  Identities=27%  Similarity=0.470  Sum_probs=187.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..+..++.||+.||.|||++|
T Consensus        61 ~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  135 (361)
T 2yab_A           61 EIEREVSILRQVLHPNIITLHDVYENR-----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK  135 (361)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCcCCCcEEEEEEeC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999999999999887     89999999995 799999998889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCC----CEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           91 VLHRDLKPSNLLLNANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |+||||||+||+++.++    .++|+|||++.............||+.|+|||++.+ ..++.++||||+||++|+|++|
T Consensus       136 ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g  214 (361)
T 2yab_A          136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSG  214 (361)
T ss_dssp             EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhC
Confidence            99999999999998876    799999999987766555566789999999999854 4589999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+....+..+.........                          ..++.+++.+++||.+||.+||.+|||++
T Consensus       215 ~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~  268 (361)
T 2yab_A          215 ASPFLGDTKQETLANITAVSYDFDE--------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQ  268 (361)
T ss_dssp             CCSSCCSSHHHHHHHHHTTCCCCCH--------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCc--------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHH
Confidence            9999988877766655432211111                          22346788999999999999999999999


Q ss_pred             HHhcCCCcCCc
Q 022132          247 DALAHPYLGSL  257 (302)
Q Consensus       247 ell~h~~~~~~  257 (302)
                      |+|+||||+..
T Consensus       269 e~l~hp~~~~~  279 (361)
T 2yab_A          269 EALRHPWITPV  279 (361)
T ss_dssp             HHHTSTTTSCS
T ss_pred             HHhcCcCcCCC
Confidence            99999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.9e-47  Score=330.22  Aligned_cols=242  Identities=31%  Similarity=0.641  Sum_probs=192.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      ..+.+|+.++++++||||+++++++...     +.+|+||||++++|.+++...+.+++..++.++.||+.||+|||++|
T Consensus        78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~  152 (329)
T 3gbz_A           78 GTAIREVSLLKELQHRNIIELKSVIHHN-----HRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR  152 (329)
T ss_dssp             --CHHHHHHGGGCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHcCCCCcceEEEEEecC-----CEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3577999999999999999999999987     89999999999999999999889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEe-----cCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           91 VLHRDLKPSNLLLN-----ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        91 i~H~dikp~Nil~~-----~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      |+||||||+||+++     .++.++|+|||++...... .......+|..|+|||++.+...++.++|||||||++++|+
T Consensus       153 ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  232 (329)
T 3gbz_A          153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML  232 (329)
T ss_dssp             CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence            99999999999995     4455999999999765432 23345577999999999977666899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccC-CCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      +|.+||.+.+..+.+..+....+.|....+....... .+....+......+.... ..+++++.+||.+||++||.+||
T Consensus       233 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  311 (329)
T 3gbz_A          233 MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP-DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI  311 (329)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST-TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh-hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCC
Confidence            9999999999999999999999888776543322110 001111111111111111 12678999999999999999999


Q ss_pred             CHHHHhcCCCcCCcc
Q 022132          244 TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 t~~ell~h~~~~~~~  258 (302)
                      |++|+|+||||+...
T Consensus       312 t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          312 SAKNALEHPYFSHND  326 (329)
T ss_dssp             CHHHHHTSGGGSSSC
T ss_pred             CHHHHhCCcccCCCC
Confidence            999999999998753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=322.37  Aligned_cols=247  Identities=30%  Similarity=0.620  Sum_probs=196.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++...     +..++||||+++ +|.+++...+.+++..+..++.|++.||+|||+.
T Consensus        47 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~  121 (311)
T 4agu_A           47 KIALREIRMLKQLKHPNLVNLLEVFRRK-----RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH  121 (311)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCccchhheeecC-----CeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3567899999999999999999999887     889999999985 7777877778899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++||||+||++++|++|.+
T Consensus       122 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~  201 (311)
T 4agu_A          122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP  201 (311)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999999765532 334456789999999999776678999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccc-ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      ||.+.+..+....+.+..+.....................+.. ...+....++.+++++.+||.+||++||.+|||++|
T Consensus       202 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  281 (311)
T 4agu_A          202 LWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ  281 (311)
T ss_dssp             SCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHH
Confidence            9999999999998888888777654433322111111111111 112334455688999999999999999999999999


Q ss_pred             HhcCCCcCCccCCCC
Q 022132          248 ALAHPYLGSLHDISD  262 (302)
Q Consensus       248 ll~h~~~~~~~~~~~  262 (302)
                      +|+||||+......+
T Consensus       282 ll~hp~f~~~~~~~~  296 (311)
T 4agu_A          282 LLHHPYFENIREIED  296 (311)
T ss_dssp             HHTSGGGTTCC----
T ss_pred             HhcChHHHhccCHHH
Confidence            999999998765543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-46  Score=327.84  Aligned_cols=243  Identities=33%  Similarity=0.610  Sum_probs=203.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++++|.+.+... ..+++..+..++.|++.||+|||++
T Consensus        57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  131 (346)
T 1ua2_A           57 RTALREIKLLQELSHPNIIGLLDAFGHK-----SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH  131 (346)
T ss_dssp             THHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhhCCCCCCCeEEEEEeeC-----CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4577999999999999999999999887     889999999999999998764 4699999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.++|+|||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+
T Consensus       132 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  211 (346)
T 1ua2_A          132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP  211 (346)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            9999999999999999999999999999765432 334456789999999999766668999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||.+.+..+.+..+....+.+....+........ + .........++...++..++++++||.+||+.||.+|||++|+
T Consensus       212 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  289 (346)
T 1ua2_A          212 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD-Y-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA  289 (346)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT-C-CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             CCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc-c-ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence            9999999999999999998887665443211000 0 0011112223344556788999999999999999999999999


Q ss_pred             hcCCCcCCccCC
Q 022132          249 LAHPYLGSLHDI  260 (302)
Q Consensus       249 l~h~~~~~~~~~  260 (302)
                      |+||||+....+
T Consensus       290 l~h~~f~~~~~~  301 (346)
T 1ua2_A          290 LKMKYFSNRPGP  301 (346)
T ss_dssp             HTSGGGTSSSCC
T ss_pred             hcChhhhcCCCC
Confidence            999999875443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9e-46  Score=322.32  Aligned_cols=214  Identities=29%  Similarity=0.457  Sum_probs=185.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++|
T Consensus        60 ~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~  134 (326)
T 2y0a_A           60 DIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ  134 (326)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            477999999999999999999999887     89999999996 699999988889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCC----CEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           91 VLHRDLKPSNLLLNANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |+||||||+||+++.++    .++|+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus       135 ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g  213 (326)
T 2y0a_A          135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSG  213 (326)
T ss_dssp             EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHS
T ss_pred             eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHC
Confidence            99999999999998887    799999999987665545566789999999999854 4589999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+....+..+........                          ...++..++.+.+||.+||+.||.+|||++
T Consensus       214 ~~pf~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  267 (326)
T 2y0a_A          214 ASPFLGDTKQETLANVSAVNYEFE--------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQ  267 (326)
T ss_dssp             CCSSCCSSHHHHHHHHHHTCCCCC--------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             cCCCCCCCHHHHHHHHHhcCCCcC--------------------------ccccccCCHHHHHHHHHHccCChhhCCCHH
Confidence            999988877666555443221111                          112246788999999999999999999999


Q ss_pred             HHhcCCCcCCc
Q 022132          247 DALAHPYLGSL  257 (302)
Q Consensus       247 ell~h~~~~~~  257 (302)
                      |+|+||||+..
T Consensus       268 e~l~hp~~~~~  278 (326)
T 2y0a_A          268 DSLQHPWIKPK  278 (326)
T ss_dssp             HHHHSTTTSCC
T ss_pred             HHhcCCCccCC
Confidence            99999999863

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.6e-46  Score=327.89  Aligned_cols=211  Identities=25%  Similarity=0.467  Sum_probs=182.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV   91 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i   91 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+||||++|+|.+++...+.+++..+..++.||+.||+|||+.||
T Consensus        55 ~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  129 (336)
T 3h4j_B           55 RVEREISYLKLLRHPHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI  129 (336)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            577999999999999999999999987     889999999999999999888899999999999999999999999999


Q ss_pred             eecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022132           92 LHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  171 (302)
Q Consensus        92 ~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~  171 (302)
                      +||||||+||+++.++.++|+|||++............+||+.|+|||++.+....+.++||||+||++|+|++|.+||.
T Consensus       130 vH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~  209 (336)
T 3h4j_B          130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD  209 (336)
T ss_dssp             CCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSB
T ss_pred             EecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999999877666666677899999999998665544789999999999999999999997


Q ss_pred             CCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          172 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +........                              ..........+.+++.+.+||++||+.||.+|||++|+++|
T Consensus       210 ~~~~~~~~~------------------------------~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          210 DEFIPNLFK------------------------------KVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CSSSTTCBC------------------------------CCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CccHHHHHH------------------------------HHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            543211100                              00001112223578999999999999999999999999999


Q ss_pred             CCcCCc
Q 022132          252 PYLGSL  257 (302)
Q Consensus       252 ~~~~~~  257 (302)
                      |||+..
T Consensus       260 p~~~~~  265 (336)
T 3h4j_B          260 PWFNVN  265 (336)
T ss_dssp             HHHHTT
T ss_pred             hhhccC
Confidence            999863

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=334.44  Aligned_cols=247  Identities=32%  Similarity=0.570  Sum_probs=188.9

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC---------CCCCHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---------QALSEEHCQYFLYQILRG   82 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qll~~   82 (302)
                      .+.+|+.+|+.++||||+++++++.....   ..+|+||||++++|.+++...         ..+++..++.++.||+.|
T Consensus        64 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  140 (405)
T 3rgf_A           64 SACREIALLRELKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG  140 (405)
T ss_dssp             HHHHHHHHHHHCCCTTBCCCCEEEEETTT---TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCeeeEeeEEecCCC---CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHH
Confidence            57799999999999999999999954211   789999999999999888632         259999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEE----ecCCCEEEeecccccccCCC----CcccccccccccCchhhhhCCCCCCCchhHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVW  154 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~----~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  154 (302)
                      |+|||+.||+||||||+||++    +.++.++|+|||++......    .......+|..|+|||++.+...++.++|||
T Consensus       141 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  220 (405)
T 3rgf_A          141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  220 (405)
T ss_dssp             HHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHH
T ss_pred             HHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhH
Confidence            999999999999999999999    67789999999999765432    2234567899999999997766689999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHhCCCChHHHhhhhHhH--HHHhhhcccc--ccc----ccc
Q 022132          155 SVGCIFMELMDRKPLFPGRDH---------VHQLRLLIELIGTPSEAELGFLNENA--KKYICQLPRY--QRQ----SFT  217 (302)
Q Consensus       155 slG~i~~~ll~g~~pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~--~~~----~~~  217 (302)
                      ||||++|+|++|.+||.+...         .+++..+.+.++.|....|.......  ..........  ...    ...
T Consensus       221 SlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (405)
T 3rgf_A          221 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME  300 (405)
T ss_dssp             HHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHh
Confidence            999999999999999976654         57889999999999887665442211  1111111000  000    011


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccCCC
Q 022132          218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  261 (302)
Q Consensus       218 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~  261 (302)
                      ......++.+.+||.+||++||.+|||++|+|+||||.....+.
T Consensus       301 ~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          301 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             TTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred             hcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence            12223477899999999999999999999999999998765443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-46  Score=323.19  Aligned_cols=216  Identities=22%  Similarity=0.388  Sum_probs=187.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +.+|+||||++ ++|.+++... ..+++..+..++.||+.||+|||+
T Consensus        46 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~  120 (321)
T 1tki_A           46 VLVKKEISILNIARHRNILHLHESFESM-----EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS  120 (321)
T ss_dssp             HHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999887     89999999997 5999999765 479999999999999999999999


Q ss_pred             CCceecCCCCCCEEEec--CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           89 ANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      +||+||||||+||+++.  ++.++|+|||++.............+|+.|+|||++.+. .++.++||||+||++|+|++|
T Consensus       121 ~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g  199 (321)
T 1tki_A          121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSG  199 (321)
T ss_dssp             TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHS
T ss_pred             CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhC
Confidence            99999999999999987  789999999999877665555667789999999998654 478999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+....+..+......+..                          ..++.+++++.+||.+||..||.+|||++
T Consensus       200 ~~pf~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~  253 (321)
T 1tki_A          200 INPFLAETNQQIIENIMNAEYTFDE--------------------------EAFKEISIEAMDFVDRLLVKERKSRMTAS  253 (321)
T ss_dssp             SCTTCCSSHHHHHHHHHHTCCCCCH--------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred             CCCCcCCCHHHHHHHHHcCCCCCCh--------------------------hhhccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            9999988877766666543222221                          22346789999999999999999999999


Q ss_pred             HHhcCCCcCCcc
Q 022132          247 DALAHPYLGSLH  258 (302)
Q Consensus       247 ell~h~~~~~~~  258 (302)
                      |+|+||||+...
T Consensus       254 e~l~hp~~~~~~  265 (321)
T 1tki_A          254 EALQHPWLKQKI  265 (321)
T ss_dssp             HHHHSHHHHSCG
T ss_pred             HHhcChhhccCc
Confidence            999999998643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-45  Score=320.89  Aligned_cols=210  Identities=26%  Similarity=0.448  Sum_probs=183.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++|
T Consensus        51 ~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~  125 (337)
T 1o6l_A           51 HTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD  125 (337)
T ss_dssp             HHHHHHHHHHSCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCcCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            567899999999999999999999987     89999999996 699999988888999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.+|.++|+|||++.... ........+||+.|+|||++.+. .++.++|+|||||++|+|++|.+|
T Consensus       126 ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~P  204 (337)
T 1o6l_A          126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLP  204 (337)
T ss_dssp             CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCC
Confidence            9999999999999999999999999997532 33345567899999999998654 589999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----C
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----T  244 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t  244 (302)
                      |.+.+.......+....                              ......+++++.+||.+||+.||.+||     |
T Consensus       205 f~~~~~~~~~~~i~~~~------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~  254 (337)
T 1o6l_A          205 FYNQDHERLFELILMEE------------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD  254 (337)
T ss_dssp             SCCSSHHHHHHHHHHCC------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTT
T ss_pred             CCCCCHHHHHHHHHcCC------------------------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCC
Confidence            98877666555443310                              011125789999999999999999999     9


Q ss_pred             HHHHhcCCCcCCc
Q 022132          245 VEDALAHPYLGSL  257 (302)
Q Consensus       245 ~~ell~h~~~~~~  257 (302)
                      ++|+++||||...
T Consensus       255 ~~ei~~h~~f~~~  267 (337)
T 1o6l_A          255 AKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHHHTSGGGTTC
T ss_pred             HHHHHcCCCcCCC
Confidence            9999999999865

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.5e-45  Score=324.12  Aligned_cols=251  Identities=31%  Similarity=0.538  Sum_probs=196.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCC---CCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQR---ESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      .+.+|+.+++.++||||+++++++.....   ...+.+|+||||++++|.+.+... ..+++..+..++.||+.||+|||
T Consensus        62 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH  141 (351)
T 3mi9_A           62 TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH  141 (351)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45689999999999999999999987421   112579999999999999888764 67999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCC-----CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-----TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      ++||+||||||+||+++.++.++|+|||++.....     ........+|+.|+|||++.+...++.++|||||||++++
T Consensus       142 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e  221 (351)
T 3mi9_A          142 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE  221 (351)
T ss_dssp             HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHH
T ss_pred             HCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHH
Confidence            99999999999999999999999999999876442     2223445779999999999776668999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC--CCCHHHHHHHHHccCCCCC
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~  240 (302)
                      |++|.+||.+.+.......+....+.+....+...........................  ..++.+.+||.+||++||.
T Consensus       222 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  301 (351)
T 3mi9_A          222 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA  301 (351)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGG
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChh
Confidence            99999999999999999999998888776654432211000000000000000000000  1367899999999999999


Q ss_pred             CCCCHHHHhcCCCcCCccCCCC
Q 022132          241 QRITVEDALAHPYLGSLHDISD  262 (302)
Q Consensus       241 ~R~t~~ell~h~~~~~~~~~~~  262 (302)
                      +|||++|+|+||||.+...+..
T Consensus       302 ~R~t~~e~l~hp~f~~~~~~~~  323 (351)
T 3mi9_A          302 QRIDSDDALNHDFFWSDPMPSD  323 (351)
T ss_dssp             GSCCHHHHHTSGGGGSSSCCCC
T ss_pred             hCCCHHHHhCCCCcCCCCCccc
Confidence            9999999999999987554443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=319.37  Aligned_cols=253  Identities=42%  Similarity=0.720  Sum_probs=202.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCC---------CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQR---------ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR   81 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~---------~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~   81 (302)
                      ..+.+|+.+++.++||||+++++++.....         ...+.+|+||||++|+|.+++.. +++++..++.++.|++.
T Consensus        53 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~  131 (320)
T 2i6l_A           53 KHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLR  131 (320)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHH
Confidence            467799999999999999999999865321         22368999999999999999865 67999999999999999


Q ss_pred             HHHHHHhCCceecCCCCCCEEEe-cCCCEEEeecccccccCCC----CcccccccccccCchhhhhCCCCCCCchhHHHH
Q 022132           82 GLKYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  156 (302)
Q Consensus        82 ~l~~LH~~~i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  156 (302)
                      ||+|||++||+||||||+||+++ .++.++|+|||.+......    .......++..|+|||.+.+...++.++|||||
T Consensus       132 ~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  211 (320)
T 2i6l_A          132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA  211 (320)
T ss_dssp             HHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHH
T ss_pred             HHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhH
Confidence            99999999999999999999998 4678999999999765422    223345678899999998776678999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccC
Q 022132          157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  236 (302)
Q Consensus       157 G~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  236 (302)
                      ||++++|++|.+||.+.+....+..+......+..............+..........++....+.+++.+++||.+||+
T Consensus       212 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  291 (320)
T 2i6l_A          212 GCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILT  291 (320)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSC
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcC
Confidence            99999999999999999988888888888777766655444332222222222223344455667889999999999999


Q ss_pred             CCCCCCCCHHHHhcCCCcCCccCCCCCC
Q 022132          237 FDPRQRITVEDALAHPYLGSLHDISDEP  264 (302)
Q Consensus       237 ~dP~~R~t~~ell~h~~~~~~~~~~~~~  264 (302)
                      .||.+|||++|+|+||||+....+..++
T Consensus       292 ~dP~~Rpt~~ell~hp~~~~~~~p~~~~  319 (320)
T 2i6l_A          292 FSPMDRLTAEEALSHPYMSIYSFPMDEP  319 (320)
T ss_dssp             SSGGGSCCHHHHHTSHHHHTTCC-----
T ss_pred             CCccccCCHHHHhCCcccccccCccCCC
Confidence            9999999999999999999876555443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=331.51  Aligned_cols=215  Identities=28%  Similarity=0.457  Sum_probs=185.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +..|+||||+. |+|.+.+...+.+++..+..++.||+.||+|||++
T Consensus        55 ~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~  129 (444)
T 3soa_A           55 QKLEREARICRLLKHPNIVRLHDSISEE-----GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM  129 (444)
T ss_dssp             HHHHHHHHHHHHCCBTTBCCEEEEEECS-----SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCcCCCeEEEEEEEC-----CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577999999999999999999999987     89999999996 69999999889999999999999999999999999


Q ss_pred             CceecCCCCCCEEEe---cCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           90 NVLHRDLKPSNLLLN---ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ||+||||||+||+++   .++.+||+|||++...... .......||+.|+|||++.+ ..++.++||||+||++|+|++
T Consensus       130 givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~  208 (444)
T 3soa_A          130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLV  208 (444)
T ss_dssp             TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHH
T ss_pred             CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHh
Confidence            999999999999998   4578999999999765543 23345689999999999854 458999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+.......+.......+                          ...++.+++.+.+||.+||+.||.+|||+
T Consensus       209 G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpta  262 (444)
T 3soa_A          209 GYPPFWDEDQHRLYQQIKAGAYDFP--------------------------SPEWDTVTPEAKDLINKMLTINPSKRITA  262 (444)
T ss_dssp             SSCSCCCSSHHHHHHHHHHTCCCCC--------------------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CCCCCCCccHHHHHHHHHhCCCCCC--------------------------ccccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            9999988887766665554221111                          12234788999999999999999999999


Q ss_pred             HHHhcCCCcCCc
Q 022132          246 EDALAHPYLGSL  257 (302)
Q Consensus       246 ~ell~h~~~~~~  257 (302)
                      .|+|+||||+..
T Consensus       263 ~e~L~hp~~~~~  274 (444)
T 3soa_A          263 AEALKHPWISHR  274 (444)
T ss_dssp             HHHHHSCTTHHH
T ss_pred             HHHhcCccccCC
Confidence            999999999753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.7e-45  Score=324.91  Aligned_cols=214  Identities=28%  Similarity=0.476  Sum_probs=184.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++.+.     +..|+||||+. ++|.+.+...+.+++..+..++.||+.||+|||++|
T Consensus        74 ~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~  148 (362)
T 2bdw_A           74 KLEREARICRKLQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG  148 (362)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            577899999999999999999999987     89999999997 599999988889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecC---CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           91 VLHRDLKPSNLLLNAN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        91 i~H~dikp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |+||||||+||+++.+   +.++|+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus       149 ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~  227 (362)
T 2bdw_A          149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGY  227 (362)
T ss_dssp             CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCC
Confidence            9999999999999865   45999999999877655555567899999999998654 5899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+.......+.......+                          ...++.+++.+.+||.+||+.||.+|||+++
T Consensus       228 ~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  281 (362)
T 2bdw_A          228 PPFWDEDQHRLYAQIKAGAYDYP--------------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQ  281 (362)
T ss_dssp             CSSCCSSHHHHHHHHHHTCCCCC--------------------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHhCCCCCC--------------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            99988877666555543211111                          1122357889999999999999999999999


Q ss_pred             HhcCCCcCCc
Q 022132          248 ALAHPYLGSL  257 (302)
Q Consensus       248 ll~h~~~~~~  257 (302)
                      +|+||||...
T Consensus       282 ~l~hp~~~~~  291 (362)
T 2bdw_A          282 ALKVPWICNR  291 (362)
T ss_dssp             HTTSHHHHTH
T ss_pred             HhcCcccCCC
Confidence            9999999763

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1e-45  Score=326.26  Aligned_cols=219  Identities=26%  Similarity=0.398  Sum_probs=168.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ |+|.+++...+++++..++.++.||+.||+|||++
T Consensus        61 ~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~  135 (361)
T 3uc3_A           61 ENVQREIINHRSLRHPNIVRFKEVILTP-----THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM  135 (361)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEeeC-----CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3567999999999999999999999987     88999999996 69999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCC--EEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           90 NVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      ||+||||||+||+++.++.  ++|+|||+++............+|+.|+|||++.+....+.++||||+||++|+|++|.
T Consensus       136 ~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  215 (361)
T 3uc3_A          136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA  215 (361)
T ss_dssp             TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSS
T ss_pred             CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCC
Confidence            9999999999999987765  99999999875544444556689999999999976654445599999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.............+....                       .. ......+++.+++||.+||++||.+|||++|
T Consensus       216 ~Pf~~~~~~~~~~~~~~~~~~~~-----------------------~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e  271 (361)
T 3uc3_A          216 YPFEDPEEPRDYRKTIQRILSVK-----------------------YS-IPDDIRISPECCHLISRIFVADPATRISIPE  271 (361)
T ss_dssp             CSCC----CCCHHHHHHHHHTTC-----------------------CC-CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             CCCCCCccHHHHHHHHHHHhcCC-----------------------CC-CCCcCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            99976543222222221110000                       00 0011257889999999999999999999999


Q ss_pred             HhcCCCcCCcc
Q 022132          248 ALAHPYLGSLH  258 (302)
Q Consensus       248 ll~h~~~~~~~  258 (302)
                      +++||||....
T Consensus       272 ll~hp~f~~~~  282 (361)
T 3uc3_A          272 IKTHSWFLKNL  282 (361)
T ss_dssp             HHTSHHHHTTC
T ss_pred             HHhCcchhcCC
Confidence            99999997653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=324.86  Aligned_cols=211  Identities=19%  Similarity=0.364  Sum_probs=179.8

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|..+++.+ +||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||+
T Consensus        68 ~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~  142 (353)
T 3txo_A           68 ECTMTEKRILSLARNHPFLTQLFCCFQTP-----DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD  142 (353)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCceeeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3566899999998 799999999999987     89999999997 6999999888899999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||+||||||+||+++.+|.++|+|||+++... ........+||+.|+|||++.+. .++.++|+|||||++|+|++|.
T Consensus       143 ~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~  221 (353)
T 3txo_A          143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGH  221 (353)
T ss_dssp             TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCC
Confidence            999999999999999999999999999997533 22334556899999999998654 4899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH--
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV--  245 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--  245 (302)
                      +||.+.+..+....+.....                              .....+++++.+||++||++||.+||++  
T Consensus       222 ~Pf~~~~~~~~~~~i~~~~~------------------------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~  271 (353)
T 3txo_A          222 APFEAENEDDLFEAILNDEV------------------------------VYPTWLHEDATGILKSFMTKNPTMRLGSLT  271 (353)
T ss_dssp             CSSCCSSHHHHHHHHHHCCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGG
T ss_pred             CCCCCCCHHHHHHHHHcCCC------------------------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcc
Confidence            99999887777666654110                              1112478899999999999999999998  


Q ss_pred             ----HHHhcCCCcCCc
Q 022132          246 ----EDALAHPYLGSL  257 (302)
Q Consensus       246 ----~ell~h~~~~~~  257 (302)
                          +|+++||||+.+
T Consensus       272 ~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          272 QGGEHAILRHPFFKEI  287 (353)
T ss_dssp             GTCTHHHHTSGGGTTC
T ss_pred             cCCHHHHhhCCcccCC
Confidence                899999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.7e-45  Score=321.77  Aligned_cols=252  Identities=31%  Similarity=0.544  Sum_probs=203.3

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCC--CCCCcEEEEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQR--ESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~--~~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      .+.+|+..++.++||||+++++++.....  .....+++||||++++|...+.    ....+++..+..++.|++.||.|
T Consensus        65 ~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~  144 (360)
T 3e3p_A           65 RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC  144 (360)
T ss_dssp             HHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            45677788888999999999999965421  1113488999999988776554    45789999999999999999999


Q ss_pred             HH--hCCceecCCCCCCEEEec-CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           86 IH--SANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        86 LH--~~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      ||  +.||+||||||+||+++. ++.++|+|||++.............+|..|+|||++.+...++.++|||||||++|+
T Consensus       145 lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~e  224 (360)
T 3e3p_A          145 LHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE  224 (360)
T ss_dssp             HTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             HhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHH
Confidence            99  999999999999999997 899999999999877666555667889999999998766668999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC----CCCHHHHHHHHHccCCC
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP----NVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~d  238 (302)
                      |++|.+||.+.+....+..+....+.|....+..........  ........++...++    ..++.+.+||.+||++|
T Consensus       225 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  302 (360)
T 3e3p_A          225 MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDV--DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL  302 (360)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCG--GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSS
T ss_pred             HHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhc--cccccccCCcccccchhhccccHHHHHHHHHHhccC
Confidence            999999999999999999999999999887665443221111  011111122222222    36788999999999999


Q ss_pred             CCCCCCHHHHhcCCCcCCccCCCCCCC
Q 022132          239 PRQRITVEDALAHPYLGSLHDISDEPV  265 (302)
Q Consensus       239 P~~R~t~~ell~h~~~~~~~~~~~~~~  265 (302)
                      |.+|||+.|+|+||||++...+.....
T Consensus       303 P~~Rpt~~e~l~hp~f~~~~~~~~~~~  329 (360)
T 3e3p_A          303 PEERMKPYEALCHPYFDELHDPATKLP  329 (360)
T ss_dssp             GGGSCCHHHHTTSGGGGGGGCTTCCCT
T ss_pred             ccccCCHHHHhcCccccccCCccccCC
Confidence            999999999999999999876655433

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4e-45  Score=316.96  Aligned_cols=209  Identities=22%  Similarity=0.439  Sum_probs=183.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|..+++.++||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++
T Consensus        51 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~  125 (318)
T 1fot_A           51 EHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK  125 (318)
T ss_dssp             HHHHHHHHHHHSCCBTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhhCCCCCCceEeEEEEeC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3566899999999999999999999987     89999999997 69999999888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.+|.++|+|||++......  ....+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+|
T Consensus       126 ~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p  202 (318)
T 1fot_A          126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTP  202 (318)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             CccccCCChheEEEcCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCC
Confidence            9999999999999999999999999999876543  345678999999999865 4489999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----C
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----T  244 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t  244 (302)
                      |.+.+.......+.....                              ...+.+++++.++|.+||..||.+||     +
T Consensus       203 f~~~~~~~~~~~i~~~~~------------------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~  252 (318)
T 1fot_A          203 FYDSNTMKTYEKILNAEL------------------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG  252 (318)
T ss_dssp             TCCSSHHHHHHHHHHCCC------------------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTT
T ss_pred             CCCCCHHHHHHHHHhCCC------------------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCC
Confidence            988877666655543110                              11135788999999999999999999     9


Q ss_pred             HHHHhcCCCcCCc
Q 022132          245 VEDALAHPYLGSL  257 (302)
Q Consensus       245 ~~ell~h~~~~~~  257 (302)
                      ++|+++||||+..
T Consensus       253 ~~~i~~hp~f~~~  265 (318)
T 1fot_A          253 TEDVKNHPWFKEV  265 (318)
T ss_dssp             THHHHTSGGGSSC
T ss_pred             HHHHhcCccccCC
Confidence            9999999999865

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.5e-45  Score=313.34  Aligned_cols=213  Identities=20%  Similarity=0.379  Sum_probs=181.9

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++... .+++..+..++.|++.||+|||++|
T Consensus        63 ~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~  136 (297)
T 3fxz_A           63 LIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ  136 (297)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            467899999999999999999999987     88999999995 7999999774 6999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.++|+|||++...... .......+|+.|+|||.+.+. .++.++||||+||++|+|++|.+|
T Consensus       137 i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p  215 (297)
T 3fxz_A          137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPP  215 (297)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998765443 234456789999999998655 489999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+.......+.......                           ......+++.+.+||.+||+.||.+|||++|+|
T Consensus       216 f~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  268 (297)
T 3fxz_A          216 YLNENPLRALYLIATNGTPE---------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL  268 (297)
T ss_dssp             TTTSCHHHHHHHHHHHCSCC---------------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             CCCCCHHHHHHHHHhCCCCC---------------------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            98887666554443321110                           011125788899999999999999999999999


Q ss_pred             cCCCcCCcc
Q 022132          250 AHPYLGSLH  258 (302)
Q Consensus       250 ~h~~~~~~~  258 (302)
                      +||||+...
T Consensus       269 ~h~~~~~~~  277 (297)
T 3fxz_A          269 QHQFLKIAK  277 (297)
T ss_dssp             TCGGGGGCC
T ss_pred             hChhhcccC
Confidence            999998743

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2e-44  Score=313.51  Aligned_cols=245  Identities=35%  Similarity=0.615  Sum_probs=202.1

Q ss_pred             chhhHHHHHHhc---CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWI---MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~il~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+|+.+++.+   +||||+++++++..........+++||||++++|.+++...  ..+++..+..++.||+.||.||
T Consensus        57 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l  136 (326)
T 1blx_A           57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL  136 (326)
T ss_dssp             THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence            566899888887   89999999999873211122789999999999999999864  3499999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |+.||+||||||+||+++.++.++|+|||.+.............++..|+|||.+.+. .++.++|||||||++++|++|
T Consensus       137 H~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g  215 (326)
T 1blx_A          137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRR  215 (326)
T ss_dssp             HHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHS
T ss_pred             HHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcC
Confidence            9999999999999999999999999999999776554445566789999999998654 489999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+....+..+.+..+.|....+........   .........+.....+.+++.+.+||.+||..||.+|||++
T Consensus       216 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  292 (326)
T 1blx_A          216 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY  292 (326)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHHHcCCCCcccCccccccch---hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHH
Confidence            999999999999999999888887665432211100   11112223344555678899999999999999999999999


Q ss_pred             HHhcCCCcCCccCC
Q 022132          247 DALAHPYLGSLHDI  260 (302)
Q Consensus       247 ell~h~~~~~~~~~  260 (302)
                      |+++||||+.....
T Consensus       293 e~l~hp~~~~~~~~  306 (326)
T 1blx_A          293 SALSHPYFQDLERC  306 (326)
T ss_dssp             HHHTSGGGTTCCCC
T ss_pred             HHhcCccccccchh
Confidence            99999999987543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.5e-45  Score=332.67  Aligned_cols=212  Identities=28%  Similarity=0.474  Sum_probs=186.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ |+|.+++.+++.+++..+..++.||+.||+|||++
T Consensus        61 ~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~  135 (476)
T 2y94_A           61 GKIRREIQNLKLFRHPHIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH  135 (476)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577999999999999999999999887     89999999995 69999999888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.++|+|||++............+||+.|+|||++.+....+.++||||+||++|+|++|.+|
T Consensus       136 givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~P  215 (476)
T 2y94_A          136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP  215 (476)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCC
Confidence            99999999999999999999999999998776665566778999999999997665457899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+.......+.....                              .....+++.+.+||++||+.||.+|||++|++
T Consensus       216 f~~~~~~~~~~~i~~~~~------------------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil  265 (476)
T 2y94_A          216 FDDDHVPTLFKKICDGIF------------------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIR  265 (476)
T ss_dssp             SCCSSSHHHHHHHHTTCC------------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             CCCCCHHHHHHHHhcCCc------------------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            988876665554433110                              11125788999999999999999999999999


Q ss_pred             cCCCcCCc
Q 022132          250 AHPYLGSL  257 (302)
Q Consensus       250 ~h~~~~~~  257 (302)
                      +||||+..
T Consensus       266 ~hp~~~~~  273 (476)
T 2y94_A          266 EHEWFKQD  273 (476)
T ss_dssp             TCHHHHTT
T ss_pred             hCHHhhhc
Confidence            99999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.9e-45  Score=318.89  Aligned_cols=240  Identities=30%  Similarity=0.596  Sum_probs=194.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++...     +.+|+||||+++ +|.+++...+.+++..+..++.||+.||+|||+.|
T Consensus        70 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  144 (331)
T 4aaa_A           70 IAMREIKLLKQLRHENLVNLLEVCKKK-----KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN  144 (331)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHhhCCCCCEeeEEEEeecC-----CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            466899999999999999999999887     889999999985 66666666778999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|||||||++++|++|.+|
T Consensus       145 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  224 (331)
T 4aaa_A          145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL  224 (331)
T ss_dssp             CCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999999764432 2334557899999999997665689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccc-ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |.+.+..+.+..+....+.........+...........+.. ...+....++.+++.+.+||.+||+.||.+|||++|+
T Consensus       225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el  304 (331)
T 4aaa_A          225 FPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL  304 (331)
T ss_dssp             CCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred             CCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH
Confidence            999999999999998888877655443322211111111111 1223445556789999999999999999999999999


Q ss_pred             hcCCCcCC
Q 022132          249 LAHPYLGS  256 (302)
Q Consensus       249 l~h~~~~~  256 (302)
                      |+||||+.
T Consensus       305 l~hp~f~~  312 (331)
T 4aaa_A          305 LHHDFFQM  312 (331)
T ss_dssp             GGSHHHHG
T ss_pred             hcCchhcc
Confidence            99999976

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8e-45  Score=319.03  Aligned_cols=209  Identities=22%  Similarity=0.377  Sum_probs=183.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++
T Consensus        86 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~  160 (350)
T 1rdq_E           86 EHTLNEKRILQAVNFPFLVKLEFSFKDN-----SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL  160 (350)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3567899999999999999999999987     89999999995 79999999888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.+|.++|+|||++......  ....+||+.|+|||++.+. .++.++|+|||||++|+|++|.+|
T Consensus       161 ~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~P  237 (350)
T 1rdq_E          161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPP  237 (350)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcccccCccceEEECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCC
Confidence            9999999999999999999999999999876543  3456889999999998654 489999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----  244 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----  244 (302)
                      |.+.+.......+....  +                            .....+++.+.+||.+||+.||.+||+     
T Consensus       238 f~~~~~~~~~~~i~~~~--~----------------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~  287 (350)
T 1rdq_E          238 FFADQPIQIYEKIVSGK--V----------------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNG  287 (350)
T ss_dssp             SCCSSHHHHHHHHHHCC--C----------------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTT
T ss_pred             CCCCCHHHHHHHHHcCC--C----------------------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCC
Confidence            98887766665554310  0                            111257899999999999999999998     


Q ss_pred             HHHHhcCCCcCCc
Q 022132          245 VEDALAHPYLGSL  257 (302)
Q Consensus       245 ~~ell~h~~~~~~  257 (302)
                      ++|+++||||+..
T Consensus       288 ~~ei~~h~~f~~~  300 (350)
T 1rdq_E          288 VNDIKNHKWFATT  300 (350)
T ss_dssp             THHHHTSGGGTTC
T ss_pred             HHHHHhCcCcCCC
Confidence            9999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.2e-45  Score=321.71  Aligned_cols=214  Identities=22%  Similarity=0.419  Sum_probs=181.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++.+.     +.+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++|
T Consensus        61 ~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g  135 (384)
T 4fr4_A           61 NVFKELQIMQGLEHPFLVNLWYSFQDE-----EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR  135 (384)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            567899999999999999999999987     89999999995 699999998889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhC--CCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |+||||||+||+++.+|.++|+|||++............+||+.|+|||++.+  ...++.++|+|||||++|+|++|.+
T Consensus       136 ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~  215 (384)
T 4fr4_A          136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR  215 (384)
T ss_dssp             EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             ceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCC
Confidence            99999999999999999999999999987766666677889999999999864  2347899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC-HHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-VED  247 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-~~e  247 (302)
                      ||.+...............                           ........+++.+.+||.+||+.||.+||+ +++
T Consensus       216 Pf~~~~~~~~~~~~~~~~~---------------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~  268 (384)
T 4fr4_A          216 PYHIRSSTSSKEIVHTFET---------------------------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSD  268 (384)
T ss_dssp             SSCCCTTSCHHHHHHHHHH---------------------------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHH
T ss_pred             CCCCCCCccHHHHHHHHhh---------------------------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHH
Confidence            9975432211111110000                           001112367889999999999999999998 999


Q ss_pred             HhcCCCcCCc
Q 022132          248 ALAHPYLGSL  257 (302)
Q Consensus       248 ll~h~~~~~~  257 (302)
                      +++||||+.+
T Consensus       269 l~~hp~f~~~  278 (384)
T 4fr4_A          269 VQNFPYMNDI  278 (384)
T ss_dssp             HHTSGGGTTC
T ss_pred             HHcChhhhcC
Confidence            9999999865

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2e-44  Score=313.17  Aligned_cols=214  Identities=27%  Similarity=0.465  Sum_probs=185.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||+|||+.|
T Consensus        61 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~  135 (321)
T 2a2a_A           61 EIEREVSILRQVLHHNVITLHDVYENR-----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK  135 (321)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEecC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            477999999999999999999999887     89999999996 699999998888999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCC----CEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           91 VLHRDLKPSNLLLNANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |+||||||+||+++.++    .++|+|||++.............+++.|+|||.+.+ ..++.++|||||||++++|++|
T Consensus       136 ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g  214 (321)
T 2a2a_A          136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSG  214 (321)
T ss_dssp             EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHS
T ss_pred             eecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHC
Confidence            99999999999999887    799999999987766555566678999999999854 4589999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||.+.+..+.+..+........                          ...++..++.+.+||.+||+.||.+|||++
T Consensus       215 ~~pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  268 (321)
T 2a2a_A          215 ASPFLGDTKQETLANITSVSYDFD--------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQ  268 (321)
T ss_dssp             CCSSCCSSHHHHHHHHHTTCCCCC--------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHhcccccC--------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHH
Confidence            999988877666555443221111                          112236788999999999999999999999


Q ss_pred             HHhcCCCcCCc
Q 022132          247 DALAHPYLGSL  257 (302)
Q Consensus       247 ell~h~~~~~~  257 (302)
                      |+++||||+..
T Consensus       269 e~l~hp~~~~~  279 (321)
T 2a2a_A          269 EALRHPWITPV  279 (321)
T ss_dssp             HHHHSTTTSCS
T ss_pred             HHhcCccccCC
Confidence            99999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-44  Score=308.05  Aligned_cols=216  Identities=27%  Similarity=0.433  Sum_probs=187.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++...+.+++..+..++.|++.||+|||++
T Consensus        51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  125 (277)
T 3f3z_A           51 DRFKQEIEIMKSLDHPNIIRLYETFEDN-----TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL  125 (277)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecC-----CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577899999999999999999999887     88999999996 59999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEE---ecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           90 NVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        90 ~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ||+||||||+||++   +.++.++|+|||.+.............+|+.|+|||.+.+  .++.++||||+||++++|++|
T Consensus       126 ~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g  203 (277)
T 3f3z_A          126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCG  203 (277)
T ss_dssp             TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHS
T ss_pred             CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHC
Confidence            99999999999999   7889999999999987766655666789999999999853  389999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||.+.+.......+.......+..                          .+..+++.+.++|.+||++||.+|||+.
T Consensus       204 ~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~  257 (277)
T 3f3z_A          204 YPPFSAPTDSEVMLKIREGTFTFPEK--------------------------DWLNVSPQAESLIRRLLTKSPKQRITSL  257 (277)
T ss_dssp             SCSSCCSSHHHHHHHHHHCCCCCCHH--------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHhCCCCCCch--------------------------hhhcCCHHHHHHHHHHccCChhhCcCHH
Confidence            99999887776666555432222211                          1236788999999999999999999999


Q ss_pred             HHhcCCCcCCccC
Q 022132          247 DALAHPYLGSLHD  259 (302)
Q Consensus       247 ell~h~~~~~~~~  259 (302)
                      ++|+||||+....
T Consensus       258 ~~l~h~~~~~~~~  270 (277)
T 3f3z_A          258 QALEHEWFEKQLS  270 (277)
T ss_dssp             HHTTSHHHHHHHC
T ss_pred             HHhcCHHHhcccc
Confidence            9999999987543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.6e-44  Score=321.31  Aligned_cols=220  Identities=21%  Similarity=0.391  Sum_probs=177.7

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|..+++++ +||||+++++++.+.     +.+|+||||++ |+|..++...+.+++..++.++.||+.||+|||+
T Consensus        97 ~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~  171 (396)
T 4dc2_A           97 DWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE  171 (396)
T ss_dssp             CHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCcCeeEEEEEEC-----CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3467899999988 899999999999987     89999999996 6999999888899999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccc-cCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||+||||||+||+++.+|.+||+|||+++. ..........+||+.|+|||++.+. .++.++|+|||||++|+|++|.
T Consensus       172 ~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~  250 (396)
T 4dc2_A          172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGR  250 (396)
T ss_dssp             TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999999975 3333445667899999999999654 5899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH--
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV--  245 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--  245 (302)
                      +||.+.........       ....   .......   ..        .....+.+++++++||++||++||.+|||+  
T Consensus       251 ~Pf~~~~~~~~~~~-------~~~~---~~~~~i~---~~--------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~  309 (396)
T 4dc2_A          251 SPFDIVGSSDNPDQ-------NTED---YLFQVIL---EK--------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHP  309 (396)
T ss_dssp             CSSTTTTC-------------CCHH---HHHHHHH---HC--------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCST
T ss_pred             CCCcccccccccch-------hhHH---HHHHHHh---cc--------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCC
Confidence            99965432111000       0000   0000000   00        011223678999999999999999999985  


Q ss_pred             ----HHHhcCCCcCCc
Q 022132          246 ----EDALAHPYLGSL  257 (302)
Q Consensus       246 ----~ell~h~~~~~~  257 (302)
                          +|+++||||+.+
T Consensus       310 ~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          310 QTGFADIQGHPFFRNV  325 (396)
T ss_dssp             TTHHHHHHHSTTTTTC
T ss_pred             CCCHHHHhcCccccCC
Confidence                899999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.4e-44  Score=323.35  Aligned_cols=239  Identities=31%  Similarity=0.568  Sum_probs=194.2

Q ss_pred             CchhhHHHHHHhc------CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWI------MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRG   82 (302)
Q Consensus        11 ~~~~~E~~il~~l------~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~~   82 (302)
                      ..+.+|+.+++.+      +|+||+++++++...     +.+++||||++++|.+++....  .+++..+..++.||+.|
T Consensus       138 ~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~a  212 (429)
T 3kvw_A          138 RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-----NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC  212 (429)
T ss_dssp             HHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-----CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHH
Confidence            3566788998888      567999999999887     8999999999999999998653  59999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEecCCC--EEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      |+|||+.||+||||||+||+++.++.  ++|+|||++......  .....+|+.|+|||++.+.. ++.++|||||||++
T Consensus       213 L~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il  289 (429)
T 3kvw_A          213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCIL  289 (429)
T ss_dssp             HHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHH
T ss_pred             HHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhCCC-CCchHHHHhHHHHH
Confidence            99999999999999999999999887  999999999765433  34567899999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhc--ccc---------------------------
Q 022132          161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL--PRY---------------------------  211 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---------------------------  211 (302)
                      |+|++|.+||.+.+..+.+..+.+.++.|+...+...... ..+....  +.+                           
T Consensus       290 ~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (429)
T 3kvw_A          290 AELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA-KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPP  368 (429)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH-HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECST
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh-hhccCCCCCcccccccccccccccccccccchhhccCCc
Confidence            9999999999999999999999999999988765433221 1111100  000                           


Q ss_pred             cccccccc-CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          212 QRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       212 ~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      ....+... ....++.+++||++||++||.+|||++|+|+||||+...
T Consensus       369 ~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          369 ESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             TCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred             cchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence            00001111 123478899999999999999999999999999998743

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8e-45  Score=318.20  Aligned_cols=210  Identities=23%  Similarity=0.398  Sum_probs=182.5

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|..+++.+ +||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..+..++.||+.||+|||++
T Consensus        63 ~~~~E~~il~~~~~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~  137 (345)
T 1xjd_A           63 CTMVEKRVLSLAWEHPFLTHMFCTFQTK-----ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK  137 (345)
T ss_dssp             HHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCCCCcEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            466899999988 999999999999987     89999999996 69999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.+|.++|+|||+++.... .......+||+.|+|||++.+. .++.++|+|||||++|+|++|.+
T Consensus       138 ~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~  216 (345)
T 1xjd_A          138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQS  216 (345)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCC
Confidence            999999999999999999999999999975432 2334566899999999998654 48999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH-H
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE-D  247 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-e  247 (302)
                      ||.+.+.......+...  .+                            .....+++++++||.+||+.||.+|||+. +
T Consensus       217 Pf~~~~~~~~~~~i~~~--~~----------------------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~  266 (345)
T 1xjd_A          217 PFHGQDEEELFHSIRMD--NP----------------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGD  266 (345)
T ss_dssp             SSCCSSHHHHHHHHHHC--CC----------------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSC
T ss_pred             CCCCCCHHHHHHHHHhC--CC----------------------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHH
Confidence            99988776665555331  00                            11125788999999999999999999998 9


Q ss_pred             HhcCCCcCCc
Q 022132          248 ALAHPYLGSL  257 (302)
Q Consensus       248 ll~h~~~~~~  257 (302)
                      +++||||+..
T Consensus       267 i~~hp~f~~~  276 (345)
T 1xjd_A          267 IRQHPLFREI  276 (345)
T ss_dssp             GGGSGGGTTC
T ss_pred             HHcCccccCC
Confidence            9999999876

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.9e-44  Score=314.06  Aligned_cols=212  Identities=23%  Similarity=0.422  Sum_probs=176.2

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+
T Consensus        65 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~  139 (327)
T 3a62_A           65 TAHTKAERNILEEVKHPFIVDLIYAFQTG-----GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ  139 (327)
T ss_dssp             ------HHHHHHHCCCTTBCCEEEEEECS-----SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCccceeEEEEcC-----CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34577899999999999999999999887     89999999996 6999999888889999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||+||||||+||+++.++.++|+|||++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus       140 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~  218 (327)
T 3a62_A          140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGA  218 (327)
T ss_dssp             TTCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCC
Confidence            9999999999999999999999999999875332 2334456789999999998654 4799999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC----
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI----  243 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----  243 (302)
                      +||.+.+.......+.....                              ...+.+++.+.+||.+||..||.+||    
T Consensus       219 ~pf~~~~~~~~~~~i~~~~~------------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~  268 (327)
T 3a62_A          219 PPFTGENRKKTIDKILKCKL------------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGP  268 (327)
T ss_dssp             CSCCCSSHHHHHHHHHHTCC------------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSST
T ss_pred             CCCCCCCHHHHHHHHHhCCC------------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCC
Confidence            99998877666555543110                              11235788999999999999999999    


Q ss_pred             -CHHHHhcCCCcCCc
Q 022132          244 -TVEDALAHPYLGSL  257 (302)
Q Consensus       244 -t~~ell~h~~~~~~  257 (302)
                       |++++++||||+..
T Consensus       269 ~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          269 GDAGEVQAHPFFRHI  283 (327)
T ss_dssp             TTHHHHHHSGGGSSC
T ss_pred             CCHHHHHcCCcccCC
Confidence             89999999999865

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=321.30  Aligned_cols=216  Identities=25%  Similarity=0.418  Sum_probs=184.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +.+|+||||++ ++|.+++... ..+++..+..++.||+.||+|||+
T Consensus        93 ~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~  167 (387)
T 1kob_A           93 YTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE  167 (387)
T ss_dssp             HHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCCCeEEEEEEeC-----CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3677999999999999999999999887     89999999996 6999998764 479999999999999999999999


Q ss_pred             CCceecCCCCCCEEEec--CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           89 ANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      +||+||||||+||+++.  ++.++|+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus       168 ~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg  246 (387)
T 1kob_A          168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSG  246 (387)
T ss_dssp             TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHS
T ss_pred             CCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhC
Confidence            99999999999999974  47799999999987766555556689999999999865 4489999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+....+..+......                          .....+..+++++.+||.+||+.||.+|||++
T Consensus       247 ~~Pf~~~~~~~~~~~i~~~~~~--------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~  300 (387)
T 1kob_A          247 LSPFAGEDDLETLQNVKRCDWE--------------------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVH  300 (387)
T ss_dssp             CCSSCCSSHHHHHHHHHHCCCC--------------------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHhCCCC--------------------------CCccccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            9999988776655544331110                          01223446889999999999999999999999


Q ss_pred             HHhcCCCcCCcc
Q 022132          247 DALAHPYLGSLH  258 (302)
Q Consensus       247 ell~h~~~~~~~  258 (302)
                      |+|+||||+...
T Consensus       301 ell~hp~~~~~~  312 (387)
T 1kob_A          301 DALEHPWLKGDH  312 (387)
T ss_dssp             HHHTSTTTSSCC
T ss_pred             HHhhCccccCCc
Confidence            999999998743

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.3e-44  Score=322.30  Aligned_cols=246  Identities=18%  Similarity=0.256  Sum_probs=177.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...  +.+++..+..++.||+.||+|||
T Consensus        71 ~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH  145 (389)
T 3gni_B           71 TFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH  145 (389)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEeEEEEEC-----CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            4566899999999999999999999987     89999999997 6999999765  67999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCC--------CcccccccccccCchhhhhCC-CCCCCchhHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGC  158 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~  158 (302)
                      ++||+||||||+||+++.++.++|+|||.+......        .......+|..|+|||++.+. ..++.++|||||||
T Consensus       146 ~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  225 (389)
T 3gni_B          146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI  225 (389)
T ss_dssp             HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHH
T ss_pred             hCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHH
Confidence            999999999999999999999999999987543211        122334788899999999653 45899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhC--------CCChHHHhhhhHh--------HHHHhhhccccccccccccCCC
Q 022132          159 IFMELMDRKPLFPGRDHVHQLRLLIELIG--------TPSEAELGFLNEN--------AKKYICQLPRYQRQSFTEKFPN  222 (302)
Q Consensus       159 i~~~ll~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~  222 (302)
                      ++|+|++|.+||.+.+....+..+.....        .+...........        ........+.....+.......
T Consensus       226 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
T 3gni_B          226 TACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRT  305 (389)
T ss_dssp             HHHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------
T ss_pred             HHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccc
Confidence            99999999999988765554433322110        0000000000000        0000000000111112223446


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccCCC
Q 022132          223 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  261 (302)
Q Consensus       223 ~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~  261 (302)
                      +++.+++||++||++||.+|||++|+|+||||+.+....
T Consensus       306 ~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~~  344 (389)
T 3gni_B          306 FSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA  344 (389)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---C
T ss_pred             cCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhcc
Confidence            789999999999999999999999999999999876543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-44  Score=324.15  Aligned_cols=217  Identities=21%  Similarity=0.379  Sum_probs=186.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|..+++.++||||+++++++.+.     +.+|+||||+. |+|.+++.. .+.+++..++.++.||+.||+|||+
T Consensus       119 ~~~~~E~~il~~~~hp~Iv~l~~~~~~~-----~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~  193 (437)
T 4aw2_A          119 ACFREERDVLVNGDSKWITTLHYAFQDD-----NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ  193 (437)
T ss_dssp             CCHHHHHHHHHHSCTTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3578999999999999999999999987     89999999995 799999987 5789999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhC----CCCCCCchhHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~i~~~  162 (302)
                      +||+||||||+||+++.+|.+||+|||+++.......  ....+||+.|+|||++..    ...++.++||||+||++|+
T Consensus       194 ~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~e  273 (437)
T 4aw2_A          194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE  273 (437)
T ss_dssp             TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHH
T ss_pred             CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHH
Confidence            9999999999999999999999999999976543322  234679999999999862    4458999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC-
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ-  241 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~-  241 (302)
                      |++|.+||.+.+..+.+..+.....                         ...++...+.+++++++||++||..+|.+ 
T Consensus       274 lltG~~Pf~~~~~~~~~~~i~~~~~-------------------------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~  328 (437)
T 4aw2_A          274 MLYGETPFYAESLVETYGKIMNHKE-------------------------RFQFPTQVTDVSENAKDLIRRLICSREHRL  328 (437)
T ss_dssp             HHHSSCTTCCSSHHHHHHHHHTHHH-------------------------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCT
T ss_pred             HHhCCCCCCCCChhHHHHhhhhccc-------------------------cccCCcccccCCHHHHHHHHHHhccccccc
Confidence            9999999999888777766653210                         01122233468999999999999999888 


Q ss_pred             -CCCHHHHhcCCCcCCc
Q 022132          242 -RITVEDALAHPYLGSL  257 (302)
Q Consensus       242 -R~t~~ell~h~~~~~~  257 (302)
                       |++++|+++||||+..
T Consensus       329 ~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          329 GQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             TTTTTHHHHTSGGGTTC
T ss_pred             CCCCHHHHhCCCccCCC
Confidence             9999999999999865

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.4e-44  Score=314.40  Aligned_cols=216  Identities=25%  Similarity=0.399  Sum_probs=179.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++...+.+++..+..++.||+.||+|||+.
T Consensus        50 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~  124 (323)
T 3tki_A           50 ENIKKEICINKMLNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI  124 (323)
T ss_dssp             -CHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            5678999999999999999999999987     89999999996 59999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ||+||||||+||+++.++.++|+|||++......   .......||+.|+|||++.+....+.++|||||||++|+|++|
T Consensus       125 givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  204 (323)
T 3tki_A          125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  204 (323)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999754322   2234567899999999997665457899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||.+.+.............                           .....+..+++.+.+||.+||+.||.+|||++
T Consensus       205 ~~pf~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  257 (323)
T 3tki_A          205 ELPWDQPSDSCQEYSDWKEKK---------------------------TYLNPWKKIDSAPLALLHKILVENPSARITIP  257 (323)
T ss_dssp             SCSCSSSCTTSHHHHHHHTTC---------------------------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CCCCCCCchHHHHHHHHhccc---------------------------ccCCccccCCHHHHHHHHHHccCChhhCcCHH
Confidence            999976654322111111000                           00111235788999999999999999999999


Q ss_pred             HHhcCCCcCCcc
Q 022132          247 DALAHPYLGSLH  258 (302)
Q Consensus       247 ell~h~~~~~~~  258 (302)
                      |+++||||+...
T Consensus       258 eil~h~~~~~~~  269 (323)
T 3tki_A          258 DIKKDRWYNKPL  269 (323)
T ss_dssp             HHTTCTTTTCCC
T ss_pred             HHhhChhhcccc
Confidence            999999998754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.1e-44  Score=315.48  Aligned_cols=210  Identities=20%  Similarity=0.369  Sum_probs=182.5

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|..+++.+ +||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++
T Consensus        66 ~~~~E~~~l~~~~~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~  140 (353)
T 2i0e_A           66 CTMVEKRVLALPGKPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK  140 (353)
T ss_dssp             HHHHHHHHHTCTTCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCEEeeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            466899999988 899999999999987     89999999996 69999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.+|.++|+|||++.... ........+||+.|+|||++.+. .++.++|+|||||++|+|++|.+
T Consensus       141 givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~  219 (353)
T 2i0e_A          141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQA  219 (353)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSC
T ss_pred             CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCC
Confidence            99999999999999999999999999997532 23334566899999999998654 48999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----  243 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----  243 (302)
                      ||.+.+.......+....                              ....+.+++++.+||.+||..||.+||     
T Consensus       220 Pf~~~~~~~~~~~i~~~~------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~  269 (353)
T 2i0e_A          220 PFEGEDEDELFQSIMEHN------------------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPE  269 (353)
T ss_dssp             SSCCSSHHHHHHHHHHCC------------------------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTT
T ss_pred             CCCCCCHHHHHHHHHhCC------------------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCC
Confidence            999888776666555411                              011126789999999999999999999     


Q ss_pred             CHHHHhcCCCcCCc
Q 022132          244 TVEDALAHPYLGSL  257 (302)
Q Consensus       244 t~~ell~h~~~~~~  257 (302)
                      +++++++||||+..
T Consensus       270 ~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          270 GERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHHHHTSGGGTTC
T ss_pred             CHHHHhcCccccCC
Confidence            47999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.3e-44  Score=314.57  Aligned_cols=219  Identities=21%  Similarity=0.405  Sum_probs=176.1

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|..+++++ +||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++
T Consensus        55 ~~~~E~~~l~~~~~hp~iv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~  129 (345)
T 3a8x_A           55 WVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER  129 (345)
T ss_dssp             HHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCccCeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            467899999998 899999999999887     89999999996 69999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.+|.++|+|||+++... ........+||+.|+|||++.+. .++.++|+|||||++|+|++|.+
T Consensus       130 ~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~  208 (345)
T 3a8x_A          130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRS  208 (345)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999997532 23344566899999999998654 58999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH---
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV---  245 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---  245 (302)
                      ||...........       ...   .......   ...     .   ......+++.+++||.+||+.||.+|||+   
T Consensus       209 pf~~~~~~~~~~~-------~~~---~~~~~~i---~~~-----~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~  267 (345)
T 3a8x_A          209 PFDIVGSSDNPDQ-------NTE---DYLFQVI---LEK-----Q---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQ  267 (345)
T ss_dssp             TTTTTTC--------------CH---HHHHHHH---HHC-----C---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTT
T ss_pred             CcCCccccccccc-------ccH---HHHHHHH---HcC-----C---CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCc
Confidence            9965322110000       000   0000000   000     0   01123678999999999999999999995   


Q ss_pred             ---HHHhcCCCcCCc
Q 022132          246 ---EDALAHPYLGSL  257 (302)
Q Consensus       246 ---~ell~h~~~~~~  257 (302)
                         +|+++||||+..
T Consensus       268 ~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          268 TGFADIQGHPFFRNV  282 (345)
T ss_dssp             THHHHHHTSGGGTTC
T ss_pred             CCHHHHhcCCccCCC
Confidence               899999999875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-44  Score=323.19  Aligned_cols=215  Identities=23%  Similarity=0.330  Sum_probs=184.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +.+|+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++
T Consensus       114 ~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~  187 (410)
T 3v8s_A          114 AFFWEERDIMAFANSPWVVQLFYAFQDD-----RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSM  187 (410)
T ss_dssp             STHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4577999999999999999999999987     89999999995 699999876 4699999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCC---CCCchhHHHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~---~~~~~DiwslG~i~~~ll  164 (302)
                      ||+||||||+||+++.+|.+||+|||++.......  .....+||+.|+|||++.+...   ++.++|+|||||++|+|+
T Consensus       188 givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell  267 (410)
T 3v8s_A          188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML  267 (410)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHH
T ss_pred             CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHH
Confidence            99999999999999999999999999997655432  2345689999999999965432   678999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC--C
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--R  242 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R  242 (302)
                      +|.+||.+.+.......+........                          ....+.+++++++||.+||..+|.+  |
T Consensus       268 ~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~p~~~~~s~~~~~li~~lL~~~~~rlgR  321 (410)
T 3v8s_A          268 VGDTPFYADSLVGTYSKIMNHKNSLT--------------------------FPDDNDISKEAKNLICAFLTDREVRLGR  321 (410)
T ss_dssp             HSSCTTCCSSHHHHHHHHHTHHHHCC--------------------------CCTTCCCCHHHHHHHHHHSSCGGGCTTS
T ss_pred             hCCCCCCCCChhhHHHHHHhcccccc--------------------------CCCcccccHHHHHHHHHHccChhhhCCC
Confidence            99999999888777766654211000                          0011367899999999999999988  9


Q ss_pred             CCHHHHhcCCCcCCc
Q 022132          243 ITVEDALAHPYLGSL  257 (302)
Q Consensus       243 ~t~~ell~h~~~~~~  257 (302)
                      +|++|+++||||+..
T Consensus       322 ~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          322 NGVEEIKRHLFFKND  336 (410)
T ss_dssp             SCHHHHHTSGGGCCS
T ss_pred             CCHHHHhcCccccCC
Confidence            999999999999874

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=318.50  Aligned_cols=218  Identities=28%  Similarity=0.443  Sum_probs=168.1

Q ss_pred             hcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ....+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||
T Consensus        91 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH  165 (349)
T 2w4o_A           91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH  165 (349)
T ss_dssp             --------CHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCcceeeeEecC-----CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            345677899999999999999999999887     88999999996 699999998888999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEec---CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      +.||+||||||+||+++.   ++.++|+|||++.............+|+.|+|||.+.+. .++.++|||||||++|+|+
T Consensus       166 ~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell  244 (349)
T 2w4o_A          166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILL  244 (349)
T ss_dssp             HTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHH
T ss_pred             HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHH
Confidence            999999999999999975   889999999999876655445566789999999998654 4899999999999999999


Q ss_pred             hCCCCCCCCChHH-HHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 DRKPLFPGRDHVH-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      +|..||.+..... ....+.+...                          ......++.++..+.+||++||+.||.+||
T Consensus       245 ~g~~pf~~~~~~~~~~~~i~~~~~--------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  298 (349)
T 2w4o_A          245 CGFEPFYDERGDQFMFRRILNCEY--------------------------YFISPWWDEVSLNAKDLVRKLIVLDPKKRL  298 (349)
T ss_dssp             HSSCTTCCTTCHHHHHHHHHTTCC--------------------------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred             hCCCCCCCCcccHHHHHHHHhCCC--------------------------ccCCchhhhCCHHHHHHHHHHccCChhhCc
Confidence            9999997766544 2222221100                          011122346889999999999999999999


Q ss_pred             CHHHHhcCCCcCCcc
Q 022132          244 TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 t~~ell~h~~~~~~~  258 (302)
                      |+.|+|+||||....
T Consensus       299 t~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          299 TTFQALQHPWVTGKA  313 (349)
T ss_dssp             CHHHHHHSTTTTSTT
T ss_pred             CHHHHhcCcccCCCc
Confidence            999999999998743

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.1e-45  Score=321.40  Aligned_cols=217  Identities=26%  Similarity=0.398  Sum_probs=186.3

Q ss_pred             hcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ....+.+|+.++++++||||+++++++...     +.+|+||||++ ++|.+.+... ..+++..+..++.||+.||+||
T Consensus       129 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L  203 (373)
T 2x4f_A          129 DKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM  203 (373)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            345678999999999999999999999987     88999999996 6999888654 5799999999999999999999


Q ss_pred             HhCCceecCCCCCCEEE--ecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      |+.||+||||||+||++  +.++.++|+|||++.............+|+.|+|||++.+ ..++.++|||||||++++|+
T Consensus       204 H~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell  282 (373)
T 2x4f_A          204 HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLL  282 (373)
T ss_dssp             HHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHH
T ss_pred             HHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHH
Confidence            99999999999999999  4567899999999987766555556679999999998854 45789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|.+||.+.+....+..+......+.                          ...++.+++.+++||.+||++||.+|||
T Consensus       283 tg~~pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps  336 (373)
T 2x4f_A          283 SGLSPFLGDNDAETLNNILACRWDLE--------------------------DEEFQDISEEAKEFISKLLIKEKSWRIS  336 (373)
T ss_dssp             HSSCTTCCSSHHHHHHHHHHTCCCSC--------------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             hCCCCCCCCCHHHHHHHHHhccCCCC--------------------------hhhhccCCHHHHHHHHHHcCCChhhCCC
Confidence            99999998887776666554221111                          1233468899999999999999999999


Q ss_pred             HHHHhcCCCcCCc
Q 022132          245 VEDALAHPYLGSL  257 (302)
Q Consensus       245 ~~ell~h~~~~~~  257 (302)
                      ++|+|+||||+..
T Consensus       337 ~~e~l~hp~~~~~  349 (373)
T 2x4f_A          337 ASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHHSHHHHCH
T ss_pred             HHHHhcCcCcCCC
Confidence            9999999999875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.6e-44  Score=304.75  Aligned_cols=217  Identities=27%  Similarity=0.470  Sum_probs=186.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++...     +..|+||||++ ++|.+.+...+.+++..+..++.|++.||+|||++
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  124 (284)
T 3kk8_A           50 QKLEREARICRKLQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN  124 (284)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHcCCCCcCeEEEEEEcC-----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3567899999999999999999999887     88999999997 59999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCC---EEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           90 NVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ||+||||||+||+++.++.   ++|+|||.+.............+++.|+|||.+.+. .++.++||||+|+++++|++|
T Consensus       125 ~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g  203 (284)
T 3kk8_A          125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVG  203 (284)
T ss_dssp             TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHS
T ss_pred             CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHC
Confidence            9999999999999986655   999999999877666555667889999999998654 479999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||.+.+.......+........                          ...+..+++.+.+||.+||++||.+|||++
T Consensus       204 ~~pf~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  257 (284)
T 3kk8_A          204 YPPFWDEDQHRLYAQIKAGAYDYP--------------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITAD  257 (284)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCCC--------------------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CCCCCCCchhHHHHHHHhccccCC--------------------------chhhcccCHHHHHHHHHHcccChhhCCCHH
Confidence            999988876666555443221111                          122346789999999999999999999999


Q ss_pred             HHhcCCCcCCccC
Q 022132          247 DALAHPYLGSLHD  259 (302)
Q Consensus       247 ell~h~~~~~~~~  259 (302)
                      |+|+||||+....
T Consensus       258 ~~l~h~~~~~~~~  270 (284)
T 3kk8_A          258 QALKVPWICNRER  270 (284)
T ss_dssp             HHTTSHHHHSCCC
T ss_pred             HHhcCccccCChh
Confidence            9999999987543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3e-44  Score=330.26  Aligned_cols=216  Identities=26%  Similarity=0.448  Sum_probs=188.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++.+.     +.+|+|||||+ |+|.+.+...+.+++..+..++.||+.||+|||+.
T Consensus        91 ~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~  165 (504)
T 3q5i_A           91 EEIYNEISLLKSLDHPNIIKLFDVFEDK-----KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH  165 (504)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577899999999999999999999987     89999999996 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCC---CEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           90 NVLHRDLKPSNLLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ||+||||||+||+++.++   .++|+|||++.............||+.|+|||++.  ..++.++||||+||++|+|++|
T Consensus       166 ~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g  243 (504)
T 3q5i_A          166 NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCG  243 (504)
T ss_dssp             TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhC
Confidence            999999999999998776   69999999998776665566778999999999985  3489999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+....+..+.........                          ..++.+++.+++||++||++||.+|||++
T Consensus       244 ~~pf~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~  297 (504)
T 3q5i_A          244 YPPFGGQNDQDIIKKVEKGKYYFDF--------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAE  297 (504)
T ss_dssp             SCSSCCSSHHHHHHHHHHCCCCCCH--------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCc--------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHH
Confidence            9999998877766665542211111                          12246889999999999999999999999


Q ss_pred             HHhcCCCcCCccC
Q 022132          247 DALAHPYLGSLHD  259 (302)
Q Consensus       247 ell~h~~~~~~~~  259 (302)
                      |+|+||||+....
T Consensus       298 e~l~h~~~~~~~~  310 (504)
T 3q5i_A          298 EALNSRWIKKYAN  310 (504)
T ss_dssp             HHHTSHHHHHTCC
T ss_pred             HHhcCHhhhhchh
Confidence            9999999987653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2e-44  Score=330.07  Aligned_cols=214  Identities=31%  Similarity=0.545  Sum_probs=183.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++.+.     +.+|+|||||. ++|.+.+...+.+++..+..++.||+.||.|||++|
T Consensus        67 ~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~  141 (486)
T 3mwu_A           67 TILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN  141 (486)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCcCeEEEEEEcC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            567999999999999999999999987     89999999996 699999988889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEe---cCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           91 VLHRDLKPSNLLLN---ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        91 i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |+||||||+||+++   .++.++|+|||++.............+|+.|+|||++.+  .++.++||||+||++|+|++|.
T Consensus       142 ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~  219 (486)
T 3mwu_A          142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGT  219 (486)
T ss_dssp             CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSS
T ss_pred             eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999995   456799999999987666555566789999999999854  4899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+..+.+..+........                          ...++.+++.+++||.+||++||.+|||+.+
T Consensus       220 ~pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~  273 (486)
T 3mwu_A          220 PPFYGKNEYDILKRVETGKYAFD--------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQ  273 (486)
T ss_dssp             CSSCCSSHHHHHHHHHHTCCCSC--------------------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHhCCCCCC--------------------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            99998887776665544221111                          1122367889999999999999999999999


Q ss_pred             HhcCCCcCCcc
Q 022132          248 ALAHPYLGSLH  258 (302)
Q Consensus       248 ll~h~~~~~~~  258 (302)
                      +|+||||+...
T Consensus       274 ~l~hp~~~~~~  284 (486)
T 3mwu_A          274 CLEHPWIQKYS  284 (486)
T ss_dssp             HHHCHHHHHTC
T ss_pred             HhcCHhhccCc
Confidence            99999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.9e-44  Score=329.61  Aligned_cols=214  Identities=31%  Similarity=0.535  Sum_probs=186.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +.+|+|||||. |+|.+.+.....+++..+..++.||+.||+|||++
T Consensus        81 ~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  155 (494)
T 3lij_A           81 SKLLEEVAVLKLLDHPNIMKLYDFFEDK-----RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH  155 (494)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577899999999999999999999987     89999999997 69999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecC---CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           90 NVLHRDLKPSNLLLNAN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ||+||||||+||+++..   +.++|+|||++.............||+.|+|||++.  ..++.++||||+||++|+|++|
T Consensus       156 ~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g  233 (494)
T 3lij_A          156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAG  233 (494)
T ss_dssp             TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhC
Confidence            99999999999999764   559999999998776665566778999999999884  3489999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+....+..+........                          ...++.+++.+++||++||++||.+|||++
T Consensus       234 ~~pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~  287 (494)
T 3lij_A          234 YPPFGGQTDQEILRKVEKGKYTFD--------------------------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQ  287 (494)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCCC--------------------------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHhCCCCCC--------------------------chhcccCCHHHHHHHHHHCCCChhhCccHH
Confidence            999998887776665554222211                          122346889999999999999999999999


Q ss_pred             HHhcCCCcCCc
Q 022132          247 DALAHPYLGSL  257 (302)
Q Consensus       247 ell~h~~~~~~  257 (302)
                      ++|+||||+..
T Consensus       288 e~l~hp~~~~~  298 (494)
T 3lij_A          288 QALEHPWIKEM  298 (494)
T ss_dssp             HHHTCHHHHHH
T ss_pred             HHhcCcccccC
Confidence            99999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.3e-44  Score=315.73  Aligned_cols=236  Identities=24%  Similarity=0.389  Sum_probs=189.8

Q ss_pred             CchhhHHHHHHhcC-----CCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIM-----KTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGL   83 (302)
Q Consensus        11 ~~~~~E~~il~~l~-----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~~l   83 (302)
                      ..+.+|+.+++.+.     ||||+++++++...     +.+|+||||++++|.+++....  .+++..+..++.||+.||
T Consensus        76 ~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL  150 (360)
T 3llt_A           76 RSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-----DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKAL  150 (360)
T ss_dssp             HHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHhcccCCCCCCeecccceeeEC-----CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence            45668999999997     99999999999887     8999999999999999998653  599999999999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEec-------------------------CCCEEEeecccccccCCCCcccccccccccCch
Q 022132           84 KYIHSANVLHRDLKPSNLLLNA-------------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP  138 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~-------------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP  138 (302)
                      +|||++||+||||||+||+++.                         ++.++|+|||++......  .....+|+.|+||
T Consensus       151 ~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aP  228 (360)
T 3llt_A          151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAP  228 (360)
T ss_dssp             HHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCH
T ss_pred             HHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCc
Confidence            9999999999999999999975                         788999999999765443  3456789999999


Q ss_pred             hhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccccc-
Q 022132          139 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT-  217 (302)
Q Consensus       139 E~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  217 (302)
                      |++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++..................... ...++ 
T Consensus       229 E~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~p~  306 (360)
T 3llt_A          229 EVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDEL-KLAWPE  306 (360)
T ss_dssp             HHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTT-EECTTT
T ss_pred             HHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccc-eecCcc
Confidence            999654 489999999999999999999999999999999998888888777655433221110000000000 00000 


Q ss_pred             ----------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcC
Q 022132          218 ----------------EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  255 (302)
Q Consensus       218 ----------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  255 (302)
                                      ......++.+.+||.+||++||.+|||++|+|+||||+
T Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          307 NASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             TCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             cccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence                            00012347788999999999999999999999999995

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.2e-44  Score=313.45  Aligned_cols=222  Identities=24%  Similarity=0.438  Sum_probs=160.6

Q ss_pred             CchhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.+. ||||+++++++.+.     +..|+||||++ ++|.+++...+.+++..+..++.||+.||+|||+
T Consensus        50 ~~~~~e~~~l~~l~~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~  124 (325)
T 3kn6_A           50 ANTQKEITALKLCEGHPNIVKLHEVFHDQ-----LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD  124 (325)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHhcCCCCeeEEEEEEEcC-----CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            45678999999996 99999999999987     89999999997 5999999998899999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCC---CEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANC---DLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~---~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      +||+||||||+||+++.++   .++|+|||++...... .......+|..|+|||++.+. .++.++||||+||++++|+
T Consensus       125 ~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll  203 (325)
T 3kn6_A          125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTML  203 (325)
T ss_dssp             TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------C-CCCHHHHHHHHHHHHHHHH
T ss_pred             CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHH
Confidence            9999999999999998766   7999999999765432 233456789999999998544 4899999999999999999


Q ss_pred             hCCCCCCCCChHHH---HHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          165 DRKPLFPGRDHVHQ---LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       165 ~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      +|.+||.+.+....   ...+...+...                      ........++.+++++++||.+||++||.+
T Consensus       204 ~g~~pf~~~~~~~~~~~~~~~~~~i~~~----------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~  261 (325)
T 3kn6_A          204 SGQVPFQSHDRSLTCTSAVEIMKKIKKG----------------------DFSFEGEAWKNVSQEAKDLIQGLLTVDPNK  261 (325)
T ss_dssp             HSSCTTC-------CCCHHHHHHHHTTT----------------------CCCCCSHHHHTSCHHHHHHHHHHHCCCTTT
T ss_pred             hCCCCCCCCccccccccHHHHHHHHHcC----------------------CCCCCcccccCCCHHHHHHHHHHCCCChhH
Confidence            99999976543211   00111111000                      000011122367899999999999999999


Q ss_pred             CCCHHHHhcCCCcCCccCC
Q 022132          242 RITVEDALAHPYLGSLHDI  260 (302)
Q Consensus       242 R~t~~ell~h~~~~~~~~~  260 (302)
                      |||++|+++||||+.....
T Consensus       262 Rpt~~ell~h~w~~~~~~~  280 (325)
T 3kn6_A          262 RLKMSGLRYNEWLQDGSQL  280 (325)
T ss_dssp             CCCTTTSTTCGGGCTTCCC
T ss_pred             CCCHHHHhcChhhccCccC
Confidence            9999999999999875443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.1e-44  Score=314.92  Aligned_cols=214  Identities=29%  Similarity=0.475  Sum_probs=176.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +.+|+||||++ ++|.+.+..    ...+++..+..++.||+.||+|
T Consensus        71 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~  145 (351)
T 3c0i_A           71 EDLKREASICHMLKHPHIVELLETYSSD-----GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY  145 (351)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999999887     89999999997 699887754    2458999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCC---EEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~---~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~  161 (302)
                      ||++||+||||||+||+++.++.   ++|+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|
T Consensus       146 lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~  224 (351)
T 3c0i_A          146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILF  224 (351)
T ss_dssp             HHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHH
T ss_pred             HHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHH
Confidence            99999999999999999987654   9999999997765443 23456789999999998654 4899999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       162 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      +|++|.+||.+.. ......+........                          ...++.+++.+.+||.+||..||.+
T Consensus       225 ~ll~g~~pf~~~~-~~~~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~  277 (351)
T 3c0i_A          225 ILLSGCLPFYGTK-ERLFEGIIKGKYKMN--------------------------PRQWSHISESAKDLVRRMLMLDPAE  277 (351)
T ss_dssp             HHHHSSCSSCSSH-HHHHHHHHHTCCCCC--------------------------HHHHTTSCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHCCCCCCCcH-HHHHHHHHcCCCCCC--------------------------ccccccCCHHHHHHHHHHCCCChhH
Confidence            9999999997753 222222222111111                          1122467889999999999999999


Q ss_pred             CCCHHHHhcCCCcCCc
Q 022132          242 RITVEDALAHPYLGSL  257 (302)
Q Consensus       242 R~t~~ell~h~~~~~~  257 (302)
                      |||+.++|+||||+..
T Consensus       278 R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          278 RITVYEALNHPWLKER  293 (351)
T ss_dssp             SCCHHHHHTSHHHHTH
T ss_pred             CcCHHHHhcChhhcCC
Confidence            9999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.4e-44  Score=330.99  Aligned_cols=215  Identities=30%  Similarity=0.498  Sum_probs=187.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++...     +.+|+||||+. ++|.+.+...+.+++..+..++.||+.||+|||++|
T Consensus        72 ~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  146 (484)
T 3nyv_A           72 SLLREVQLLKQLDHPNIMKLYEFFEDK-----GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK  146 (484)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            577999999999999999999999987     89999999996 699999998899999999999999999999999999


Q ss_pred             ceecCCCCCCEEE---ecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           91 VLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        91 i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |+||||||+||++   +.++.++|+|||++.............+|+.|+|||++.+  .++.++||||+||++|+|++|.
T Consensus       147 ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~  224 (484)
T 3nyv_A          147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGC  224 (484)
T ss_dssp             CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCC
Confidence            9999999999999   5678999999999987766555566789999999999864  4899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+..+.+..+........                          ...++.+++.+++||++||++||.+|||++|
T Consensus       225 ~pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e  278 (484)
T 3nyv_A          225 PPFNGANEYDILKKVEKGKYTFE--------------------------LPQWKKVSESAKDLIRKMLTYVPSMRISARD  278 (484)
T ss_dssp             CSSCCSSHHHHHHHHHHCCCCCC--------------------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCC--------------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence            99998887776666544221111                          1122367889999999999999999999999


Q ss_pred             HhcCCCcCCccC
Q 022132          248 ALAHPYLGSLHD  259 (302)
Q Consensus       248 ll~h~~~~~~~~  259 (302)
                      +|+||||+....
T Consensus       279 ~l~h~~~~~~~~  290 (484)
T 3nyv_A          279 ALDHEWIQTYTK  290 (484)
T ss_dssp             HHTSHHHHHHTC
T ss_pred             HhhChhhccccc
Confidence            999999987643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.7e-44  Score=304.06  Aligned_cols=211  Identities=27%  Similarity=0.432  Sum_probs=171.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+.+..    ...+++..+..++.||+.||+||
T Consensus        66 ~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L  140 (285)
T 3is5_A           66 QIEAEIEVLKSLDHPNIIKIFEVFEDY-----HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF  140 (285)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCchHHhHHHheecC-----CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            567899999999999999999999887     88999999997 599988853    46899999999999999999999


Q ss_pred             HhCCceecCCCCCCEEE---ecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      |+.||+||||||+||++   +.++.++|+|||++.............++..|+|||.+.  ..++.++|||||||++++|
T Consensus       141 H~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~l  218 (285)
T 3is5_A          141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFL  218 (285)
T ss_dssp             HHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHH
T ss_pred             HhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHH
Confidence            99999999999999999   456889999999998765555556677899999999884  3478999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|..||.+.+............                           ..........++.+.+||.+||+.||.+||
T Consensus       219 l~g~~pf~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  271 (285)
T 3is5_A          219 LTGCLPFTGTSLEEVQQKATYKE---------------------------PNYAVECRPLTPQAVDLLKQMLTKDPERRP  271 (285)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHCC---------------------------CCCCC--CCCCHHHHHHHHHHTCSCTTTSC
T ss_pred             HhCCCCCCCCCHHHHHhhhccCC---------------------------cccccccCcCCHHHHHHHHHHccCChhhCc
Confidence            99999998877555433322210                           011111224788999999999999999999


Q ss_pred             CHHHHhcCCCcCC
Q 022132          244 TVEDALAHPYLGS  256 (302)
Q Consensus       244 t~~ell~h~~~~~  256 (302)
                      |++|+|+||||++
T Consensus       272 s~~e~l~hp~f~~  284 (285)
T 3is5_A          272 SAAQVLHHEWFKQ  284 (285)
T ss_dssp             CHHHHHTSGGGGC
T ss_pred             CHHHHhcCHHhhc
Confidence            9999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.3e-43  Score=313.40  Aligned_cols=215  Identities=27%  Similarity=0.510  Sum_probs=185.1

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++++ +||||+++++++...     +..|+||||++ ++|.+++.....+++..+..++.||+.||.|||+
T Consensus       144 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~  218 (365)
T 2y7j_A          144 EATRRETHILRQVAGHPHIITLIDSYESS-----SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA  218 (365)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEEBS-----SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCEeEEEEEEeeC-----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4567899999999 899999999999887     89999999997 5999999887889999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCC-----CCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS-----SDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~i~~~l  163 (302)
                      .||+|+||||+||+++.+|.++|+|||++.............+|+.|+|||.+.+.     ..++.++|||||||++|+|
T Consensus       219 ~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el  298 (365)
T 2y7j_A          219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL  298 (365)
T ss_dssp             TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHH
T ss_pred             CCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHH
Confidence            99999999999999999999999999999877665555667899999999998632     2478899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|.+||.+.+.......+......+..                          ..+...++.+.+||.+||+.||.+||
T Consensus       299 l~g~~pf~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~Rp  352 (365)
T 2y7j_A          299 LAGSPPFWHRRQILMLRMIMEGQYQFSS--------------------------PEWDDRSSTVKDLISRLLQVDPEARL  352 (365)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHTCCCCCH--------------------------HHHSSSCHHHHHHHHHHSCSSTTTSC
T ss_pred             HHCCCCCCCCCHHHHHHHHHhCCCCCCC--------------------------cccccCCHHHHHHHHHHcCCChhHCc
Confidence            9999999887766655554432221111                          11236788999999999999999999


Q ss_pred             CHHHHhcCCCcCC
Q 022132          244 TVEDALAHPYLGS  256 (302)
Q Consensus       244 t~~ell~h~~~~~  256 (302)
                      |++++|+||||+.
T Consensus       353 s~~ell~hp~f~r  365 (365)
T 2y7j_A          353 TAEQALQHPFFER  365 (365)
T ss_dssp             CHHHHHHSGGGCC
T ss_pred             CHHHHhcCcccCC
Confidence            9999999999973

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.9e-44  Score=325.59  Aligned_cols=211  Identities=26%  Similarity=0.438  Sum_probs=175.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~-   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ |+|.+++...+.+++..+..++.||+.||+|||+ 
T Consensus       193 ~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~  267 (446)
T 4ejn_A          193 AHTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE  267 (446)
T ss_dssp             --------CCCCCSCTTSCCEEEEEEET-----TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCeEeeEEEEEeeC-----CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence            4667899999999999999999999887     88999999997 5999999888899999999999999999999998 


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      .||+||||||+||+++.++.++|+|||++.... .........||+.|+|||++.+. .++.++|||||||++++|++|.
T Consensus       268 ~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~  346 (446)
T 4ejn_A          268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR  346 (446)
T ss_dssp             TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCC
Confidence            999999999999999999999999999987533 23334567899999999998654 4899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC----
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI----  243 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----  243 (302)
                      +||.+.+.......+.....                              ...+.+++.+.+||.+||++||.+||    
T Consensus       347 ~Pf~~~~~~~~~~~i~~~~~------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~  396 (446)
T 4ejn_A          347 LPFYNQDHEKLFELILMEEI------------------------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGS  396 (446)
T ss_dssp             CSSCCSSHHHHHHHHHHCCC------------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCST
T ss_pred             CCCCCCCHHHHHHHHHhCCC------------------------------CCCccCCHHHHHHHHHHcccCHHHhCCCCC
Confidence            99988877666555443110                              11125788999999999999999999    


Q ss_pred             -CHHHHhcCCCcCCc
Q 022132          244 -TVEDALAHPYLGSL  257 (302)
Q Consensus       244 -t~~ell~h~~~~~~  257 (302)
                       |++|+++||||+..
T Consensus       397 ~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          397 EDAKEIMQHRFFAGI  411 (446)
T ss_dssp             TTHHHHHTSGGGTTC
T ss_pred             CCHHHHHhCccccCC
Confidence             99999999999976

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.6e-45  Score=325.17  Aligned_cols=228  Identities=26%  Similarity=0.396  Sum_probs=174.8

Q ss_pred             hhHHHHhcCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHH
Q 022132            3 SITKLMQRGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQ   78 (302)
Q Consensus         3 ~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~q   78 (302)
                      |||.+.....+.+|+.++.++ +||||+++++++.... .+.+.+|+||||++ |+|.+++...+  .+++..+..++.|
T Consensus        91 AiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~q  169 (400)
T 1nxk_A           91 ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS  169 (400)
T ss_dssp             EEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHH
T ss_pred             EEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHH
Confidence            556665556778999998655 8999999999986511 01167999999997 69999998753  5999999999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCCEEEec---CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHH
Q 022132           79 ILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS  155 (302)
Q Consensus        79 ll~~l~~LH~~~i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  155 (302)
                      |+.||+|||++||+||||||+||+++.   ++.+||+|||++............++|+.|+|||++.+ ..++.++||||
T Consensus       170 i~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws  248 (400)
T 1nxk_A          170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWS  248 (400)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCC-CCSSSHHHHHH
T ss_pred             HHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHH
Confidence            999999999999999999999999997   78899999999987665555566788999999999854 45899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHH
Q 022132          156 VGCIFMELMDRKPLFPGRDHVH----QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV  231 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  231 (302)
                      |||++|+|++|.+||.+.+...    ....+..  +.                        .......+..+++++.+||
T Consensus       249 lG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~--~~------------------------~~~~~~~~~~~s~~~~~li  302 (400)
T 1nxk_A          249 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--GQ------------------------YEFPNPEWSEVSEEVKMLI  302 (400)
T ss_dssp             HHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH--TC------------------------CCCCTTTTTTSCHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCccccccHHHHHHHHc--Cc------------------------ccCCCcccccCCHHHHHHH
Confidence            9999999999999997654321    1111110  00                        0000122346889999999


Q ss_pred             HHccCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          232 EKMLTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       232 ~~~L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      ++||+.||.+|||++|+++||||....
T Consensus       303 ~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          303 RNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             HHHCCCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999999999998654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=8.3e-44  Score=311.00  Aligned_cols=206  Identities=20%  Similarity=0.340  Sum_probs=179.3

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-T-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.+++.++||||+++++++...     +.+++||||++ | +|.+++...+.+++..+..++.||+.||+|||+.
T Consensus        75 ~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  149 (335)
T 3dls_A           75 KVTLEIAILSRVEHANIIKVLDIFENQ-----GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK  149 (335)
T ss_dssp             EEEHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEeeC-----CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            677899999999999999999999887     89999999985 5 9999999988999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.++|+|||++.............+|+.|+|||++.+....+.++|||||||++|+|++|..|
T Consensus       150 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  229 (335)
T 3dls_A          150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP  229 (335)
T ss_dssp             TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCc
Confidence            99999999999999999999999999998776665566678999999999997665458899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |......                                    ..........+++.+.+||.+||++||.+|||+++++
T Consensus       230 f~~~~~~------------------------------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell  273 (335)
T 3dls_A          230 FCELEET------------------------------------VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLV  273 (335)
T ss_dssp             CSSGGGG------------------------------------TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hhhHHHH------------------------------------HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence            9542110                                    0000111224788999999999999999999999999


Q ss_pred             cCCCcCCcc
Q 022132          250 AHPYLGSLH  258 (302)
Q Consensus       250 ~h~~~~~~~  258 (302)
                      +||||++..
T Consensus       274 ~hp~~~~~~  282 (335)
T 3dls_A          274 TDPWVTQPV  282 (335)
T ss_dssp             HCTTTTCCC
T ss_pred             cCccccCCc
Confidence            999998743

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=317.05  Aligned_cols=217  Identities=20%  Similarity=0.307  Sum_probs=182.9

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|..++..++||||+++++++.+.     +.+|+||||+. |+|.+++.+. ..+++..++.++.||+.||+|||
T Consensus       105 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-----~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH  179 (412)
T 2vd5_A          105 VSCFREERDVLVNGDRRWITQLHFAFQDE-----NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH  179 (412)
T ss_dssp             GCCHHHHHHHHHHSCTTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999987     89999999995 7999999864 47999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhC------CCCCCCchhHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLN------SSDYTAAIDVWSVGCI  159 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~i  159 (302)
                      ++||+||||||+||+++.+|.+||+|||++........  ....+||+.|+|||++..      ...++.++|+|||||+
T Consensus       180 ~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvi  259 (412)
T 2vd5_A          180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF  259 (412)
T ss_dssp             HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHH
T ss_pred             HCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHH
Confidence            99999999999999999999999999999976554322  234579999999999863      3457899999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC
Q 022132          160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       160 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      +|+|++|.+||.+.+..+.+..+.......                         .++.....+++++++||++||. +|
T Consensus       260 lyelltG~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~p~~~~~~s~~~~dli~~lL~-~p  313 (412)
T 2vd5_A          260 AYEMFYGQTPFYADSTAETYGKIVHYKEHL-------------------------SLPLVDEGVPEEARDFIQRLLC-PP  313 (412)
T ss_dssp             HHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-------------------------CCC----CCCHHHHHHHHTTSS-CG
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhcccCc-------------------------CCCccccCCCHHHHHHHHHHcC-Ch
Confidence            999999999999888777766665321000                         0111123688999999999999 99


Q ss_pred             CCC---CCHHHHhcCCCcCCc
Q 022132          240 RQR---ITVEDALAHPYLGSL  257 (302)
Q Consensus       240 ~~R---~t~~ell~h~~~~~~  257 (302)
                      .+|   ++++|+++||||+.+
T Consensus       314 ~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          314 ETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             GGCTTTTTHHHHHTSGGGTTC
T ss_pred             hhcCCCCCHHHHhcCCCcCCC
Confidence            998   599999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.6e-44  Score=311.92  Aligned_cols=220  Identities=27%  Similarity=0.435  Sum_probs=179.9

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ....+|+.++.++ +||||+++++++.+.     +.+|+||||++ |+|.+.+...+.+++..+..++.||+.||+|||+
T Consensus        60 ~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~  134 (342)
T 2qr7_A           60 RDPTEEIEILLRYGQHPNIITLKDVYDDG-----KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA  134 (342)
T ss_dssp             CCCHHHHHHHHHHTTSTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CChHHHHHHHHHhcCCCCcCeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3566899999999 899999999999887     89999999996 6999999988899999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecC----CCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNAN----CDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~----~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      +||+||||||+||++..+    +.++|+|||++...... ......++|+.|+|||++.+. .++.++|||||||++|+|
T Consensus       135 ~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el  213 (342)
T 2qr7_A          135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTM  213 (342)
T ss_dssp             TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHH
T ss_pred             CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHH
Confidence            999999999999998543    35999999999765433 334556789999999998654 378899999999999999


Q ss_pred             HhCCCCCCCCC---hHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          164 MDRKPLFPGRD---HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       164 l~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      ++|.+||.+..   .......+....                          .......++.+++.+++||++||..||.
T Consensus       214 l~g~~Pf~~~~~~~~~~~~~~i~~~~--------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~  267 (342)
T 2qr7_A          214 LTGYTPFANGPDDTPEEILARIGSGK--------------------------FSLSGGYWNSVSDTAKDLVSKMLHVDPH  267 (342)
T ss_dssp             HHSSCSSCSSTTSCHHHHHHHHHHCC--------------------------CCCCSTTTTTSCHHHHHHHHHHTCSSTT
T ss_pred             hcCCCCCCCCCcCCHHHHHHHHccCC--------------------------cccCccccccCCHHHHHHHHHHCCCChh
Confidence            99999997632   222222222100                          0011123357889999999999999999


Q ss_pred             CCCCHHHHhcCCCcCCccCCCC
Q 022132          241 QRITVEDALAHPYLGSLHDISD  262 (302)
Q Consensus       241 ~R~t~~ell~h~~~~~~~~~~~  262 (302)
                      +|||++++++||||..+.....
T Consensus       268 ~R~t~~~il~hp~~~~~~~~~~  289 (342)
T 2qr7_A          268 QRLTAALVLRHPWIVHWDQLPQ  289 (342)
T ss_dssp             TSCCHHHHTTSHHHHTGGGSCC
T ss_pred             HCcCHHHHhcCCeecCcccccc
Confidence            9999999999999988765443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=308.47  Aligned_cols=213  Identities=23%  Similarity=0.461  Sum_probs=175.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++.....   +.+|+||||++ ++|.+++ ..+++++..+..++.||+.||+|||++
T Consensus        81 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~  156 (298)
T 2zv2_A           81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQ  156 (298)
T ss_dssp             CHHHHHHHHHHTCCCTTBCCEEEEEECSSS---SEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcCCC---CEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            567899999999999999999999987421   78999999997 5777654 346799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCC--CCCchhHHHHHHHHHHHHhC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~i~~~ll~g  166 (302)
                      ||+||||||+||+++.++.++|+|||++...... .......+|+.|+|||.+.+...  ++.++|||||||++|+|++|
T Consensus       157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             CeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            9999999999999999999999999999765443 23345678999999999865432  36789999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||.+.+.......+.....                           . ....+.+++++.+||.+||+.||.+|||++
T Consensus       237 ~~pf~~~~~~~~~~~~~~~~~---------------------------~-~~~~~~~~~~l~~li~~~l~~dp~~R~s~~  288 (298)
T 2zv2_A          237 QCPFMDERIMCLHSKIKSQAL---------------------------E-FPDQPDIAEDLKDLITRMLDKNPESRIVVP  288 (298)
T ss_dssp             SCSSCCSSHHHHHHHHHHCCC---------------------------C-CCSSSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             CCCCCCccHHHHHHHHhcccC---------------------------C-CCCccccCHHHHHHHHHHhhcChhhCCCHH
Confidence            999987765444333222100                           0 011236789999999999999999999999


Q ss_pred             HHhcCCCcC
Q 022132          247 DALAHPYLG  255 (302)
Q Consensus       247 ell~h~~~~  255 (302)
                      |+++||||+
T Consensus       289 e~l~hp~~~  297 (298)
T 2zv2_A          289 EIKLHPWVT  297 (298)
T ss_dssp             HHTTCHHHH
T ss_pred             HHhcCcccc
Confidence            999999996

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.2e-44  Score=315.66  Aligned_cols=211  Identities=22%  Similarity=0.426  Sum_probs=176.6

Q ss_pred             CchhhHHHH-HHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCF-DTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|..+ ++.++||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||+
T Consensus        83 ~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~  157 (373)
T 2r5t_A           83 KHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS  157 (373)
T ss_dssp             --------CCBCCCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            355667666 5778999999999999987     89999999997 6999999888889999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||+||||||+||+++.+|.++|+|||+++... ........+||+.|+|||++.+. .++.++|+|||||++|+|++|.
T Consensus       158 ~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~  236 (373)
T 2r5t_A          158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGL  236 (373)
T ss_dssp             TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCC
Confidence            999999999999999999999999999997633 33345567899999999998654 5899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH--
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV--  245 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--  245 (302)
                      +||.+.+.......+....                              ....+.+++.+++||.+||+.||.+||++  
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~------------------------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          237 PPFYSRNTAEMYDNILNKP------------------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             CTTCCSBHHHHHHHHHHSC------------------------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             CCCCCCCHHHHHHHHHhcc------------------------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            9999887776666554310                              01123678999999999999999999986  


Q ss_pred             --HHHhcCCCcCCc
Q 022132          246 --EDALAHPYLGSL  257 (302)
Q Consensus       246 --~ell~h~~~~~~  257 (302)
                        +++++||||+..
T Consensus       287 ~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          287 DFMEIKSHVFFSLI  300 (373)
T ss_dssp             THHHHHTSGGGTTC
T ss_pred             CHHHHhCCccccCC
Confidence              699999999865

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.9e-43  Score=307.88  Aligned_cols=242  Identities=26%  Similarity=0.527  Sum_probs=187.3

Q ss_pred             CchhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++ ||||+++++++.....   ...++||||++ ++|.+++.   .+++..+..++.||+.||+|||+
T Consensus        75 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~  148 (330)
T 3nsz_A           75 KKIKREIKILENLRGGPNIITLADIVKDPVS---RTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHS  148 (330)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---CCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCEEEeeeeeccCCC---CceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHh
Confidence            46779999999996 9999999999987422   77999999997 68888875   48999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCC-CEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||+||||||+||+++.++ .++|+|||++.............++..|+|||.+.+...++.++|||||||++++|++|.
T Consensus       149 ~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  228 (330)
T 3nsz_A          149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK  228 (330)
T ss_dssp             TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999777 899999999987665555566788999999999977567899999999999999999999


Q ss_pred             CCCC-CCChHHHHHHHHHHhCCCChHHHhhhhH--hHHHHhhhcccccccccccc-----CCCCCHHHHHHHHHccCCCC
Q 022132          168 PLFP-GRDHVHQLRLLIELIGTPSEAELGFLNE--NAKKYICQLPRYQRQSFTEK-----FPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       168 ~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP  239 (302)
                      .||. +.+....+..+....+.+..........  ....+...........+...     ...+++.+++||.+||++||
T Consensus       229 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  308 (330)
T 3nsz_A          229 EPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH  308 (330)
T ss_dssp             SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSG
T ss_pred             CCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCc
Confidence            9884 5556667776666665432211110000  00000000011111111111     12378999999999999999


Q ss_pred             CCCCCHHHHhcCCCcCCcc
Q 022132          240 RQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       240 ~~R~t~~ell~h~~~~~~~  258 (302)
                      .+|||++|+|+||||++..
T Consensus       309 ~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          309 QSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             GGSCCHHHHHTSGGGTTCC
T ss_pred             ccCCCHHHHhcCccHhhhc
Confidence            9999999999999999865

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.7e-44  Score=302.99  Aligned_cols=212  Identities=23%  Similarity=0.396  Sum_probs=179.3

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+.+...+.+++..+..++.||+.||+|||+
T Consensus        53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~  127 (279)
T 3fdn_A           53 EHQLRREVEIQSHLRHPNILRLYGYFHDA-----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS  127 (279)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHcCCCCCCcchhheEecC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34577899999999999999999999887     88999999997 6999999887889999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      .||+||||||+||+++.++.++|+|||++...... ......++..|+|||.+.+ ..++.++||||+|+++++|++|..
T Consensus       128 ~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~  205 (279)
T 3fdn_A          128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKP  205 (279)
T ss_dssp             TTCEECCCCGGGEEECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCEecccCChHhEEEcCCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCC
Confidence            99999999999999999999999999988654433 2344578999999999864 447899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||.+.+.......+.....                              .....+++.+.+||.+||+.||.+|||++|+
T Consensus       206 p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  255 (279)
T 3fdn_A          206 PFEANTYQETYKRISRVEF------------------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREV  255 (279)
T ss_dssp             TTCCSSHHHHHHHHHHTCC------------------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CCCCCcHHHHHHHHHhCCC------------------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHH
Confidence            9988776665554433111                              1112477899999999999999999999999


Q ss_pred             hcCCCcCCcc
Q 022132          249 LAHPYLGSLH  258 (302)
Q Consensus       249 l~h~~~~~~~  258 (302)
                      ++||||+...
T Consensus       256 l~h~~~~~~~  265 (279)
T 3fdn_A          256 LEHPWITANS  265 (279)
T ss_dssp             HHCHHHHHHC
T ss_pred             hhCccccCCc
Confidence            9999998754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-43  Score=311.46  Aligned_cols=211  Identities=24%  Similarity=0.385  Sum_probs=180.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~-~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+||||+.|+|.+.+. ..+.+++..+..++.|++.||+|||++
T Consensus        99 ~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  173 (348)
T 1u5q_A           99 QDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH  173 (348)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3577999999999999999999999887     8999999999999998885 457899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhC--CCCCCCchhHHHHHHHHHHHHhCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      ||+||||||+||+++.++.++|+|||++......   ....+|+.|+|||++.+  ...++.++|||||||++++|++|.
T Consensus       174 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~  250 (348)
T 1u5q_A          174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  250 (348)
T ss_dssp             TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999999765433   34578999999999853  345789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+....+..+.... .+                           .......++.+.+||.+||+.||.+|||+++
T Consensus       251 ~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~  302 (348)
T 1u5q_A          251 PPLFNMNAMSALYHIAQNE-SP---------------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV  302 (348)
T ss_dssp             CTTTTSCHHHHHHHHHHSC-CC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCChHHHHHHHHhcC-CC---------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence            9998877655544333211 00                           0112357889999999999999999999999


Q ss_pred             HhcCCCcCCc
Q 022132          248 ALAHPYLGSL  257 (302)
Q Consensus       248 ll~h~~~~~~  257 (302)
                      +++||||...
T Consensus       303 ll~h~~~~~~  312 (348)
T 1u5q_A          303 LLKHRFVLRE  312 (348)
T ss_dssp             HTTCHHHHSC
T ss_pred             HhhChhhhcc
Confidence            9999999764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-43  Score=308.77  Aligned_cols=216  Identities=26%  Similarity=0.430  Sum_probs=179.8

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..+.+|+.+++.+ +||||+++++++...     +.+|+||||+. ++|.+++..  .+.+++..+..++.||+.||+||
T Consensus        73 ~~~~~e~~~l~~l~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~L  147 (327)
T 3lm5_A           73 AEILHEIAVLELAKSCPRVINLHEVYENT-----SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL  147 (327)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCEEEEEEEEEeC-----CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            3567899999999 569999999999887     88999999997 599998854  36799999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEec---CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      |+.||+||||||+||+++.   ++.++|+|||++.............+++.|+|||.+.+. .++.++|||||||++++|
T Consensus       148 H~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l  226 (327)
T 3lm5_A          148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYML  226 (327)
T ss_dssp             HHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHH
T ss_pred             HHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHH
Confidence            9999999999999999987   789999999999877655555566899999999998544 589999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|..||.+.+.......+........                          ...++.+++.+.+||.+||+.||.+||
T Consensus       227 l~g~~pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rp  280 (327)
T 3lm5_A          227 LTHTSPFVGEDNQETYLNISQVNVDYS--------------------------EETFSSVSQLATDFIQSLLVKNPEKRP  280 (327)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHTCCCCC--------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred             HhCCCCCCCCCchHHHHHHHhcccccC--------------------------chhhcccCHHHHHHHHHHcCCChhhCc
Confidence            999999988887766555544322211                          223346788999999999999999999


Q ss_pred             CHHHHhcCCCcCCcc
Q 022132          244 TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 t~~ell~h~~~~~~~  258 (302)
                      |++++|+||||+.+.
T Consensus       281 t~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          281 TAEICLSHSWLQQWD  295 (327)
T ss_dssp             CHHHHTTCGGGCCCC
T ss_pred             CHHHHhCCHhhcccc
Confidence            999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.8e-43  Score=301.68  Aligned_cols=218  Identities=26%  Similarity=0.475  Sum_probs=186.1

Q ss_pred             cCchhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.+++++. ||||+++++++...     +..|+||||++ ++|.+++..+..+++..+..++.||+.||+|||
T Consensus        67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH  141 (298)
T 1phk_A           67 REATLKEVDILRKVSGHPNIIQLKDTYETN-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH  141 (298)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeeeeeeccC-----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            346779999999995 99999999999887     89999999997 699999988888999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhh-----CCCCCCCchhHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwslG~i~~~  162 (302)
                      +.|++|+||+|+||+++.++.++|+|||.+.............++..|+|||++.     ....++.++|||||||++++
T Consensus       142 ~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~  221 (298)
T 1phk_A          142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT  221 (298)
T ss_dssp             HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred             HCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHH
Confidence            9999999999999999999999999999998766555556667899999999985     23457889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      |++|..||.+.+.......+........                          ...++.++..+.++|.+||+.||.+|
T Consensus       222 l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~R  275 (298)
T 1phk_A          222 LLAGSPPFWHRKQMLMLRMIMSGNYQFG--------------------------SPEWDDYSDTVKDLVSRFLVVQPQKR  275 (298)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHTCCCCC--------------------------TTTGGGSCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHCCCCCcCccHHHHHHHHhcCCcccC--------------------------cccccccCHHHHHHHHHHccCCcccC
Confidence            9999999988776655554443211111                          01123578899999999999999999


Q ss_pred             CCHHHHhcCCCcCCcc
Q 022132          243 ITVEDALAHPYLGSLH  258 (302)
Q Consensus       243 ~t~~ell~h~~~~~~~  258 (302)
                      ||++++|+||||++..
T Consensus       276 ps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          276 YTAEEALAHPFFQQYV  291 (298)
T ss_dssp             CCHHHHTTSGGGCTTC
T ss_pred             CCHHHHHhChHhhhcc
Confidence            9999999999998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6e-44  Score=329.35  Aligned_cols=212  Identities=26%  Similarity=0.437  Sum_probs=179.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+|+.++||||+++++++.+.     +.+|+||||++ |+|.+++...+  .+++..++.++.||+.||+|||
T Consensus       229 ~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH  303 (576)
T 2acx_A          229 AMALNEKQILEKVNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH  303 (576)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCEeeEEEEEeeC-----CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999987     89999999995 79999998654  4999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      ++||+||||||+||+++.+|.++|+|||++............+||+.|+|||++.+. .++.++|+|||||++|+|++|.
T Consensus       304 ~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~  382 (576)
T 2acx_A          304 RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQ  382 (576)
T ss_dssp             HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSS
T ss_pred             HCCEeccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999999877655555567899999999998654 4899999999999999999999


Q ss_pred             CCCCCCCh---HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-
Q 022132          168 PLFPGRDH---VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-  243 (302)
Q Consensus       168 ~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-  243 (302)
                      +||.+.+.   ...+.......  +                           ......+++++++||.+||+.||.+|| 
T Consensus       383 ~PF~~~~~~~~~~~i~~~i~~~--~---------------------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g  433 (576)
T 2acx_A          383 SPFQQRKKKIKREEVERLVKEV--P---------------------------EEYSERFSPQARSLCSQLLCKDPAERLG  433 (576)
T ss_dssp             CSSSCSSSCCCHHHHHHHHHHC--C---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred             CCCcccccchhHHHHHHHhhcc--c---------------------------ccCCccCCHHHHHHHHHhccCCHHHcCC
Confidence            99987542   11111111100  0                           011236789999999999999999999 


Q ss_pred             ----CHHHHhcCCCcCCc
Q 022132          244 ----TVEDALAHPYLGSL  257 (302)
Q Consensus       244 ----t~~ell~h~~~~~~  257 (302)
                          |++|+++||||+..
T Consensus       434 ~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          434 CRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             CSSSHHHHHHTSGGGTTC
T ss_pred             CCCCCHHHHHhChhhccC
Confidence                89999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-43  Score=306.95  Aligned_cols=231  Identities=23%  Similarity=0.348  Sum_probs=170.1

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.+++++ +||||+++++++.+.     +.+|+||||++ ++|.+++...+.+++..+..++.||+.||+|||++
T Consensus        56 ~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~  130 (316)
T 2ac3_A           56 RVFREVEMLYQCQGHRNVLELIEFFEEE-----DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK  130 (316)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            567899999996 799999999999887     89999999997 79999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCC---EEEeecccccccCCC--------CcccccccccccCchhhhhCC----CCCCCchhHH
Q 022132           90 NVLHRDLKPSNLLLNANCD---LKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNS----SDYTAAIDVW  154 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~---~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Diw  154 (302)
                      ||+||||||+||+++.++.   ++|+|||++......        .......+|..|+|||++.+.    ..++.++|||
T Consensus       131 ~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  210 (316)
T 2ac3_A          131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLW  210 (316)
T ss_dssp             TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHH
T ss_pred             CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccH
Confidence            9999999999999988766   999999998654321        112334689999999998641    2368899999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHc
Q 022132          155 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  234 (302)
Q Consensus       155 slG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (302)
                      ||||++|+|++|.+||.+....+.....    ................   ...    .......++.+++.+++||.+|
T Consensus       211 slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~i~---~~~----~~~~~~~~~~~~~~~~~li~~~  279 (316)
T 2ac3_A          211 SLGVILYILLSGYPPFVGRCGSDCGWDR----GEACPACQNMLFESIQ---EGK----YEFPDKDWAHISCAAKDLISKL  279 (316)
T ss_dssp             HHHHHHHHHHHSSCSCCCCCCSCSCC--------CCHHHHHHHHHHHH---HCC----CCCCHHHHTTSCHHHHHHHHHH
T ss_pred             hHHHHHHHHHHCCCCCcccccccccccc----cccchhHHHHHHHHHh---ccC----cccCchhcccCCHHHHHHHHHH
Confidence            9999999999999999765421100000    0000000000000000   000    0001112246788999999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          235 LTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       235 L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      |+.||.+|||++|+|+||||+...
T Consensus       280 L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          280 LVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             SCSSTTTSCCHHHHHHSTTCC---
T ss_pred             hhCChhhCCCHHHHhcChhhcCCC
Confidence            999999999999999999998754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.4e-43  Score=300.74  Aligned_cols=217  Identities=26%  Similarity=0.452  Sum_probs=181.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++...     +..|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.
T Consensus        53 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~  127 (283)
T 3bhy_A           53 EEIEREVNILREIRHPNIITLHDIFENK-----TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK  127 (283)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCeeehhheecCC-----CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3577999999999999999999999887     88999999996 79999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCC----CEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           90 NVLHRDLKPSNLLLNANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      |++||||||+||+++.++    .++|+|||.+.............++..|+|||.+.+ ..++.++|+||||+++++|++
T Consensus       128 ~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~  206 (283)
T 3bhy_A          128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLS  206 (283)
T ss_dssp             TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHH
T ss_pred             CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHH
Confidence            999999999999998877    799999999987665544555678999999999854 448999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||.+.+.......+........                          ...++..++.+.++|.+||..||.+|||+
T Consensus       207 g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~  260 (283)
T 3bhy_A          207 GASPFLGETKQETLTNISAVNYDFD--------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTI  260 (283)
T ss_dssp             SSCTTCCSSHHHHHHHHHTTCCCCC--------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             CCCCCCCcchHHHHHHhHhcccCCc--------------------------chhcccCCHHHHHHHHHHccCCHhHCcCH
Confidence            9999988776655544432111111                          12224678899999999999999999999


Q ss_pred             HHHhcCCCcCCccC
Q 022132          246 EDALAHPYLGSLHD  259 (302)
Q Consensus       246 ~ell~h~~~~~~~~  259 (302)
                      .++++||||+..+.
T Consensus       261 ~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          261 AQSLEHSWIKAIRR  274 (283)
T ss_dssp             HHHHHCHHHHHHHH
T ss_pred             HHHHhCHHHHHHHH
Confidence            99999999987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.3e-43  Score=303.73  Aligned_cols=213  Identities=26%  Similarity=0.456  Sum_probs=180.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+.|
T Consensus        88 ~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~  161 (321)
T 2c30_A           88 LLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG  161 (321)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999999999999887     88999999996 699988765 57999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.++|+|||++...... .......||..|+|||.+.+ ..++.++|||||||++++|++|.+|
T Consensus       162 ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p  240 (321)
T 2c30_A          162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPP  240 (321)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998765443 23345678999999999854 4589999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+.......+..... +.                          ......+++.+.++|.+||+.||.+|||+++++
T Consensus       241 f~~~~~~~~~~~~~~~~~-~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  293 (321)
T 2c30_A          241 YFSDSPVQAMKRLRDSPP-PK--------------------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELL  293 (321)
T ss_dssp             TTTSCHHHHHHHHHHSSC-CC--------------------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCCCCHHHHHHHHhcCCC-CC--------------------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence            988776655444332110 00                          011125678999999999999999999999999


Q ss_pred             cCCCcCCcc
Q 022132          250 AHPYLGSLH  258 (302)
Q Consensus       250 ~h~~~~~~~  258 (302)
                      +||||.+..
T Consensus       294 ~hp~~~~~~  302 (321)
T 2c30_A          294 DHPFLLQTG  302 (321)
T ss_dssp             TSGGGGGCC
T ss_pred             cChhhccCC
Confidence            999998643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.7e-44  Score=308.30  Aligned_cols=225  Identities=17%  Similarity=0.252  Sum_probs=156.6

Q ss_pred             hHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC----
Q 022132           15 RSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA----   89 (302)
Q Consensus        15 ~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~----   89 (302)
                      +|+..+.+++|||||++++++..... ....+|||||||+ |+|.+++.. .+++++.+..++.|++.||+|||++    
T Consensus        46 ~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~  123 (303)
T 3hmm_A           46 AEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGT  123 (303)
T ss_dssp             HHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCST
T ss_pred             HHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhc
Confidence            46666678899999999999976421 1136899999997 799999986 4699999999999999999999987    


Q ss_pred             ----CceecCCCCCCEEEecCCCEEEeecccccccCCCC-----cccccccccccCchhhhhCCC-----CCCCchhHHH
Q 022132           90 ----NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSS-----DYTAAIDVWS  155 (302)
Q Consensus        90 ----~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Diws  155 (302)
                          ||+||||||+|||++.++.+||+|||+++......     .....+||+.|+|||++.+..     .++.++||||
T Consensus       124 ~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS  203 (303)
T 3hmm_A          124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA  203 (303)
T ss_dssp             TCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHH
T ss_pred             cCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhh
Confidence                99999999999999999999999999997654332     123457999999999986532     2567999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC--CCCHHHHHHHHH
Q 022132          156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEK  233 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~  233 (302)
                      |||++|||++|.+||........... ......+.....       ......  ...+..++..+.  ..+..+.+|+.+
T Consensus       204 ~Gvvl~El~tg~~~~~~~~~~~~p~~-~~~~~~~~~~~~-------~~~~~~--~~~rp~~p~~~~~~~~~~~l~~li~~  273 (303)
T 3hmm_A          204 MGLVFWEIARRCSIGGIHEDYQLPYY-DLVPSDPSVEEM-------RKVVCE--QKLRPNIPNRWQSCEALRVMAKIMRE  273 (303)
T ss_dssp             HHHHHHHHHHTBCBTTBCCCCCCTTT-TTSCSSCCHHHH-------HHHHTT--SCCCCCCCGGGGSSHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHCCCCCCccccccccch-hcccccchHHHH-------HHHHhc--ccCCCCCCccccchHHHHHHHHHHHH
Confidence            99999999999887753321100000 000000000000       000000  000001111111  123468899999


Q ss_pred             ccCCCCCCCCCHHHHhcC
Q 022132          234 MLTFDPRQRITVEDALAH  251 (302)
Q Consensus       234 ~L~~dP~~R~t~~ell~h  251 (302)
                      ||+.||.+|||+.|+++.
T Consensus       274 cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          274 CWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TCCSSGGGSCCHHHHHHH
T ss_pred             HcccCHhHCcCHHHHHHH
Confidence            999999999999999863

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1e-43  Score=319.48  Aligned_cols=215  Identities=32%  Similarity=0.566  Sum_probs=170.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+|++++||||+++++++..      +..|+||||++ ++|.+.+...+.+++..+..++.||+.||+|||++
T Consensus       185 ~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~  258 (419)
T 3i6u_A          185 LNVETEIEILKKLNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN  258 (419)
T ss_dssp             CCHHHHHHHHHHCCCTTBCCCCEEEES------SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEec------CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            357899999999999999999999854      56899999996 69999998888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCC---CEEEeecccccccCCCCcccccccccccCchhhhhC--CCCCCCchhHHHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ||+||||||+||+++.++   .+||+|||++...+.........||+.|+|||++.+  ...++.++|||||||++|+|+
T Consensus       259 ~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~ll  338 (419)
T 3i6u_A          259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL  338 (419)
T ss_dssp             TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHH
T ss_pred             CccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHH
Confidence            999999999999997554   599999999988776655666789999999999853  345788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|.+||.+......+.........                         ......++.+++.+.+||.+||+.||.+|||
T Consensus       339 tg~~pf~~~~~~~~~~~~i~~~~~-------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps  393 (419)
T 3i6u_A          339 SGYPPFSEHRTQVSLKDQITSGKY-------------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFT  393 (419)
T ss_dssp             HSSCSSCCCSSSCCHHHHHHTTCC-------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred             HCCCCCCCCcchHHHHHHHhcCCC-------------------------CCCchhhcccCHHHHHHHHHHccCChhHCcC
Confidence            999999765433222221111100                         1112233467899999999999999999999


Q ss_pred             HHHHhcCCCcCC
Q 022132          245 VEDALAHPYLGS  256 (302)
Q Consensus       245 ~~ell~h~~~~~  256 (302)
                      ++|+|+||||+.
T Consensus       394 ~~e~l~hp~~~~  405 (419)
T 3i6u_A          394 TEEALRHPWLQD  405 (419)
T ss_dssp             HHHHHHSGGGCC
T ss_pred             HHHHhCCcccCC
Confidence            999999999976

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.6e-43  Score=300.70  Aligned_cols=211  Identities=25%  Similarity=0.401  Sum_probs=173.3

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||+|||++|
T Consensus        57 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  131 (276)
T 2h6d_A           57 KIKREIQNLKLFRHPHIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM  131 (276)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHhcCCCCCEeEEEEEEecC-----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            567899999999999999999999887     89999999996 699999988788999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      ++|+||+|+||+++.++.++|+|||.+.............++..|+|||.+.+....+.++|+||||+++++|++|..||
T Consensus       132 i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  211 (276)
T 2h6d_A          132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF  211 (276)
T ss_dssp             SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999987665544556678999999999876554468999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      .+.+.......+.....                              .....++..+.++|.+||+.||.+|||++++++
T Consensus       212 ~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          212 DDEHVPTLFKKIRGGVF------------------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CCSSHHHHHHHHHHCCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcHHHHHHHhhcCcc------------------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            87765554443322100                              011256789999999999999999999999999


Q ss_pred             CCCcCCc
Q 022132          251 HPYLGSL  257 (302)
Q Consensus       251 h~~~~~~  257 (302)
                      ||||++.
T Consensus       262 h~~~~~~  268 (276)
T 2h6d_A          262 HEWFKQD  268 (276)
T ss_dssp             SHHHHTT
T ss_pred             ChhhccC
Confidence            9999764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-43  Score=310.74  Aligned_cols=218  Identities=22%  Similarity=0.395  Sum_probs=177.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--------------------------
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--------------------------   63 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--------------------------   63 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +..|+||||++ |+|.+++..                          
T Consensus        73 ~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (345)
T 3hko_A           73 ERIKTEVRLMKKLHHPNIARLYEVYEDE-----QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE  147 (345)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceeehhhccC-----CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccc
Confidence            4677899999999999999999999887     88999999996 799998852                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC--CEEEeecccccccCCC----
Q 022132           64 --------------NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDFGLARVTSET----  123 (302)
Q Consensus        64 --------------~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~----  123 (302)
                                    ...+++..++.++.||+.||+|||+.||+||||||+||+++.++  .++|+|||++......    
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~  227 (345)
T 3hko_A          148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE  227 (345)
T ss_dssp             HHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-
T ss_pred             cccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccc
Confidence                          11246788999999999999999999999999999999998776  8999999999754321    


Q ss_pred             -CcccccccccccCchhhhhCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhH
Q 022132          124 -DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA  201 (302)
Q Consensus       124 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (302)
                       .......+|+.|+|||.+.+. ..++.++|||||||++++|++|..||.+.+..+....+.........          
T Consensus       228 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------  297 (345)
T 3hko_A          228 YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN----------  297 (345)
T ss_dssp             -------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS----------
T ss_pred             cccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC----------
Confidence             123456789999999998643 45789999999999999999999999988877766655542211111          


Q ss_pred             HHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccC
Q 022132          202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  259 (302)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  259 (302)
                                      ..+..+++.+.+||.+||+.||.+|||+.++|+||||+.+..
T Consensus       298 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          298 ----------------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             ----------------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             ----------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence                            112247889999999999999999999999999999998653

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.8e-43  Score=299.81  Aligned_cols=212  Identities=22%  Similarity=0.433  Sum_probs=182.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.
T Consensus        59 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~  133 (284)
T 2vgo_A           59 HQLRREIEIQSHLRHPNILRMYNYFHDR-----KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER  133 (284)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcCCCCCEeeEEEEEEcC-----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577999999999999999999999887     89999999996 59999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+. .++.++||||||+++++|++|..|
T Consensus       134 ~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  211 (284)
T 2vgo_A          134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPP  211 (284)
T ss_dssp             TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-BCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             CceecCCCHHHEEEcCCCCEEEecccccccCcccc-cccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCC
Confidence            99999999999999999999999999986654332 3445789999999998654 478999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+.......+....                              ....+.++..+.++|.+||..||.+|||+++++
T Consensus       212 f~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  261 (284)
T 2vgo_A          212 FDSPSHTETHRRIVNVD------------------------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVM  261 (284)
T ss_dssp             TCCSSHHHHHHHHHTTC------------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CCCCCHhHHHHHHhccc------------------------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHh
Confidence            98776655444332210                              011235788999999999999999999999999


Q ss_pred             cCCCcCCccC
Q 022132          250 AHPYLGSLHD  259 (302)
Q Consensus       250 ~h~~~~~~~~  259 (302)
                      +||||+....
T Consensus       262 ~h~~~~~~~~  271 (284)
T 2vgo_A          262 EHPWVKANSR  271 (284)
T ss_dssp             TCHHHHHHCC
T ss_pred             hCHHHHhhcc
Confidence            9999987543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=303.99  Aligned_cols=207  Identities=26%  Similarity=0.305  Sum_probs=168.3

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+..+..+ +||||+++++++...     +.+|+||||++++|.+.+.. ...+++..+..++.||+.||+|||+.
T Consensus       102 ~~~~e~~~~~~~~~h~~iv~l~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  176 (311)
T 3p1a_A          102 RKLAEVGSHEKVGQHPCCVRLEQAWEEG-----GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ  176 (311)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEEeC-----CEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            445566666666 999999999999887     89999999999999998875 45699999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.+||+|||++...+.........||+.|+|||++.+  .++.++||||+||++++|++|..|
T Consensus       177 ~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~  254 (311)
T 3p1a_A          177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMEL  254 (311)
T ss_dssp             TEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCC
T ss_pred             CEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999999987766555556678999999998864  489999999999999999999766


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      +.+......   +..  +..                          .....+.+++.+.+||.+||++||.+|||++|+|
T Consensus       255 ~~~~~~~~~---~~~--~~~--------------------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell  303 (311)
T 3p1a_A          255 PHGGEGWQQ---LRQ--GYL--------------------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALL  303 (311)
T ss_dssp             CSSHHHHHH---HTT--TCC--------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCCccHHHH---Hhc--cCC--------------------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            644322111   100  000                          0111236788999999999999999999999999


Q ss_pred             cCCCcCC
Q 022132          250 AHPYLGS  256 (302)
Q Consensus       250 ~h~~~~~  256 (302)
                      +||||++
T Consensus       304 ~hp~~~~  310 (311)
T 3p1a_A          304 ALPVLRQ  310 (311)
T ss_dssp             TSGGGSC
T ss_pred             hCccccC
Confidence            9999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.8e-43  Score=305.73  Aligned_cols=216  Identities=29%  Similarity=0.437  Sum_probs=184.2

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++||||+++++++.+.     +.+|+||||++ ++|.+++...+.+++..+..++.||+.||+|||+
T Consensus        85 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (335)
T 2owb_A           85 REKMSMEISIHRSLAHQHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR  159 (335)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            44677899999999999999999999887     88999999997 6999999887889999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||+||||||+||+++.++.++|+|||++...... .......++..|+|||.+.+. .++.++|||||||++|+|++|.
T Consensus       160 ~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~  238 (335)
T 2owb_A          160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGK  238 (335)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCc
Confidence            99999999999999999999999999999765422 233455789999999998654 4789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      .||.+.........+....                              ......+++.+.+||.+||+.||.+|||++|
T Consensus       239 ~pf~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  288 (335)
T 2owb_A          239 PPFETSCLKETYLRIKKNE------------------------------YSIPKHINPVAASLIQKMLQTDPTARPTINE  288 (335)
T ss_dssp             CTTCCSSHHHHHHHHHHTC------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred             CCCCCCCHHHHHHHHhcCC------------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            9998776555443332210                              0111257789999999999999999999999


Q ss_pred             HhcCCCcCCccCCC
Q 022132          248 ALAHPYLGSLHDIS  261 (302)
Q Consensus       248 ll~h~~~~~~~~~~  261 (302)
                      +++||||.+...+.
T Consensus       289 ll~~~~~~~~~~~~  302 (335)
T 2owb_A          289 LLNDEFFTSGYIPA  302 (335)
T ss_dssp             GGGSHHHHTSCCCS
T ss_pred             HhcCccccCCCccc
Confidence            99999998765444

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.1e-42  Score=303.65  Aligned_cols=240  Identities=28%  Similarity=0.505  Sum_probs=191.2

Q ss_pred             CchhhHHHHHHhcCCCC------ccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTS------VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRG   82 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~n------iv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qll~~   82 (302)
                      ..+.+|+.+++.++|++      ++++++++...     +.+|+||||++++|.+++...+  ++++..+..++.||+.|
T Consensus        56 ~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~  130 (339)
T 1z57_A           56 EAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-----GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKS  130 (339)
T ss_dssp             HHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-----CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHH
Confidence            45678999999998765      99999999887     8999999999999999998765  68999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEec-------------------CCCEEEeecccccccCCCCcccccccccccCchhhhhC
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNA-------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN  143 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~-------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  143 (302)
                      |+|||++||+||||||+||+++.                   ++.++|+|||.+......  .....+|..|+|||++.+
T Consensus       131 l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~  208 (339)
T 1z57_A          131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA  208 (339)
T ss_dssp             HHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT
T ss_pred             HHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC
Confidence            99999999999999999999987                   668999999999765433  345578999999999865


Q ss_pred             CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhH---------------HHHhhhc
Q 022132          144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA---------------KKYICQL  208 (302)
Q Consensus       144 ~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~  208 (302)
                      . .++.++|||||||++++|++|.+||.+.+..+....+....+.++...+.......               ..+....
T Consensus       209 ~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
T 1z57_A          209 L-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA  287 (339)
T ss_dssp             S-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHH
T ss_pred             C-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhc
Confidence            4 48999999999999999999999999999888888888888877665443221100               0000000


Q ss_pred             cccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccC
Q 022132          209 PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  259 (302)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  259 (302)
                      . ..........+..++.+.+||.+||+.||.+|||++|+++||||+..+.
T Consensus       288 ~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          288 C-KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             C-CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred             C-cchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHhc
Confidence            0 0000011111223567999999999999999999999999999987653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.7e-43  Score=299.34  Aligned_cols=217  Identities=29%  Similarity=0.435  Sum_probs=183.8

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++...+.+++..+..++.|++.||+|||+
T Consensus        59 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  133 (294)
T 2rku_A           59 REKMSMEISIHRSLAHQHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR  133 (294)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeeeeeeccC-----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            44677899999999999999999999887     88999999997 6999999887889999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      .|++||||||+||+++.++.++|+|||.+...... .......++..|+|||.+.+. .++.++|+||+|+++++|++|.
T Consensus       134 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~  212 (294)
T 2rku_A          134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGK  212 (294)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999998765422 233445789999999998654 4789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      .||.+....+....+....                              ......+++.+.++|.+||+.||.+|||+++
T Consensus       213 ~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  262 (294)
T 2rku_A          213 PPFETSCLKETYLRIKKNE------------------------------YSIPKHINPVAASLIQKMLQTDPTARPTINE  262 (294)
T ss_dssp             CTTCCSSHHHHHHHHHTTC------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred             CCCCCCCHHHHHHHHhhcc------------------------------CCCccccCHHHHHHHHHHcccChhhCcCHHH
Confidence            9998776554433322100                              0112257889999999999999999999999


Q ss_pred             HhcCCCcCCccCCCC
Q 022132          248 ALAHPYLGSLHDISD  262 (302)
Q Consensus       248 ll~h~~~~~~~~~~~  262 (302)
                      +++||||.+...+..
T Consensus       263 ll~~~~~~~~~~~~~  277 (294)
T 2rku_A          263 LLNDEFFTSGYIPAR  277 (294)
T ss_dssp             GGGSHHHHTSCCCSC
T ss_pred             HhhChheecCCcCCC
Confidence            999999987654443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.1e-43  Score=303.10  Aligned_cols=216  Identities=32%  Similarity=0.567  Sum_probs=177.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...      .+|+||||++ ++|.+++...+.+++..+..++.||+.||+|||++
T Consensus        60 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  133 (322)
T 2ycf_A           60 LNVETEIEILKKLNHPCIIKIKNFFDAE------DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN  133 (322)
T ss_dssp             -CHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhHHHHHHHHHhCCCCCCceEeeEEcCC------ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3578999999999999999999998663      4899999996 59999998888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCC---EEEeecccccccCCCCcccccccccccCchhhhh--CCCCCCCchhHHHHHHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ||+||||||+||+++.++.   ++|+|||++.............++..|+|||++.  +...++.++|||||||++|+|+
T Consensus       134 ~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~  213 (322)
T 2ycf_A          134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL  213 (322)
T ss_dssp             TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHH
T ss_pred             CeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence            9999999999999987654   9999999998766554444567899999999974  3455789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|.+||.+......+.........                         ......+..+++.+.+||.+||..||.+|||
T Consensus       214 ~g~~pf~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps  268 (322)
T 2ycf_A          214 SGYPPFSEHRTQVSLKDQITSGKY-------------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFT  268 (322)
T ss_dssp             HSSCSSCSTTCSSCHHHHHHHTCC-------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred             hCCCCCcccchHHHHHHHHHhCcc-------------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCC
Confidence            999999765433222211111100                         0111223467889999999999999999999


Q ss_pred             HHHHhcCCCcCCc
Q 022132          245 VEDALAHPYLGSL  257 (302)
Q Consensus       245 ~~ell~h~~~~~~  257 (302)
                      ++++|+||||+..
T Consensus       269 ~~~~l~h~~~~~~  281 (322)
T 2ycf_A          269 TEEALRHPWLQDE  281 (322)
T ss_dssp             HHHHHTSGGGCCH
T ss_pred             HHHHhhCcCcCCH
Confidence            9999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.8e-43  Score=305.22  Aligned_cols=214  Identities=24%  Similarity=0.379  Sum_probs=171.8

Q ss_pred             CchhhHHHHHHhcCC--CCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMK--TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++|  |||+++++++...     +.+|+|||+.+++|.+++...+.+++..+..++.||+.||+|||+
T Consensus        52 ~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~  126 (343)
T 3dbq_A           52 DSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ  126 (343)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhhhcCCceEEEeeeEeeC-----CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            457789999999976  9999999999987     899999998889999999998999999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhC----------CCCCCCchhHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLN----------SSDYTAAIDVWS  155 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~----------~~~~~~~~Diws  155 (302)
                      .||+||||||+||+++ ++.++|+|||++.......   ......||+.|+|||.+.+          ...++.++||||
T Consensus       127 ~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diws  205 (343)
T 3dbq_A          127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS  205 (343)
T ss_dssp             TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHH
T ss_pred             CCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHH
Confidence            9999999999999997 6789999999997654332   2335578999999999854          245788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHc
Q 022132          156 VGCIFMELMDRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  234 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (302)
                      |||++++|++|.+||.+.... ..+..+.   ...                         .........+..+.+||.+|
T Consensus       206 lG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~-------------------------~~~~~~~~~~~~l~~li~~~  257 (343)
T 3dbq_A          206 LGCILYYMTYGKTPFQQIINQISKLHAII---DPN-------------------------HEIEFPDIPEKDLQDVLKCC  257 (343)
T ss_dssp             HHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CTT-------------------------SCCCCCCCSCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCcchhhhhHHHHHHHHh---cCC-------------------------cccCCcccCCHHHHHHHHHH
Confidence            999999999999999764332 1111111   100                         00111224567899999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          235 LTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       235 L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      |+.||.+|||+.|+|+||||+...
T Consensus       258 L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          258 LKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             TCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             cCCChhHCCCHHHHHhCccccccC
Confidence            999999999999999999998643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.8e-43  Score=301.22  Aligned_cols=213  Identities=26%  Similarity=0.403  Sum_probs=163.9

Q ss_pred             hhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           13 FVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        13 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      +.++...++.++||||+++++++...     +..|+||||++++|.+++.    ..+.+++..+..++.|++.||+|||+
T Consensus        53 ~~~~~~~~~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  127 (290)
T 3fme_A           53 LMDLDISMRTVDCPFTVTFYGALFRE-----GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS  127 (290)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECS-----SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCeEEEEeeeeecc-----CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            33455557888999999999999987     8899999999999877765    35789999999999999999999999


Q ss_pred             C-CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhh---hCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 A-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      + ||+||||||+||+++.++.++|+|||.+.............+++.|+|||.+   .....++.++||||+||++++|+
T Consensus       128 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~  207 (290)
T 3fme_A          128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA  207 (290)
T ss_dssp             HSCCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHH
T ss_pred             cCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHH
Confidence            8 9999999999999999999999999999876655445556789999999997   24455789999999999999999


Q ss_pred             hCCCCCCCCChH-HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 DRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      +|..||...... ..+....... .+                           ......+++.+.++|.+||+.||.+||
T Consensus       208 ~g~~p~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp  259 (290)
T 3fme_A          208 ILRFPYDSWGTPFQQLKQVVEEP-SP---------------------------QLPADKFSAEFVDFTSQCLKKNSKERP  259 (290)
T ss_dssp             HTSCSSCCCSCHHHHHHHHHHSC-CC---------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HCCCCccccCchHHHHHHHhccC-CC---------------------------CcccccCCHHHHHHHHHHhhcChhhCc
Confidence            999999764332 2222222110 00                           011135788999999999999999999


Q ss_pred             CHHHHhcCCCcCCcc
Q 022132          244 TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 t~~ell~h~~~~~~~  258 (302)
                      |++|+++||||+...
T Consensus       260 t~~e~l~hp~f~~~~  274 (290)
T 3fme_A          260 TYPELMQHPFFTLHE  274 (290)
T ss_dssp             CHHHHTTSHHHHHHH
T ss_pred             CHHHHHhCcccccCc
Confidence            999999999998643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.6e-43  Score=301.23  Aligned_cols=214  Identities=28%  Similarity=0.460  Sum_probs=182.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||+|||+.
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~  125 (304)
T 2jam_A           51 SSLENEIAVLKKIKHENIVTLEDIYEST-----THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN  125 (304)
T ss_dssp             -HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCeeehhhhcccC-----CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4577999999999999999999999887     89999999996 69999998878899999999999999999999999


Q ss_pred             CceecCCCCCCEEE---ecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           90 NVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        90 ~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ||+||||||+||++   +.++.++|+|||.+...... ......++..|+|||.+.+ ..++.++|||||||++++|++|
T Consensus       126 ~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g  203 (304)
T 2jam_A          126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCG  203 (304)
T ss_dssp             TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHS
T ss_pred             CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHC
Confidence            99999999999999   77899999999998765433 2344568999999999854 4589999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+.......+.+.....                          ....++.+++.+.+||.+||..||.+|||++
T Consensus       204 ~~pf~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  257 (304)
T 2jam_A          204 YPPFYEETESKLFEKIKEGYYEF--------------------------ESPFWDDISESAKDFICHLLEKDPNERYTCE  257 (304)
T ss_dssp             SCTTTTSCHHHHHHHHHHCCCCC--------------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCC--------------------------CccccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            99998877666555444311110                          0122346789999999999999999999999


Q ss_pred             HHhcCCCcCCc
Q 022132          247 DALAHPYLGSL  257 (302)
Q Consensus       247 ell~h~~~~~~  257 (302)
                      ++|+||||+..
T Consensus       258 ~~l~h~~~~~~  268 (304)
T 2jam_A          258 KALSHPWIDGN  268 (304)
T ss_dssp             HHHTSHHHHSS
T ss_pred             HHhcCccccCC
Confidence            99999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-42  Score=297.81  Aligned_cols=215  Identities=20%  Similarity=0.352  Sum_probs=176.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++..... +.+.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.
T Consensus        70 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~  148 (290)
T 1t4h_A           70 QRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR  148 (290)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEEESS-SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeeeccccC-CCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC
Confidence            457789999999999999999999865321 1267999999996 69999998878899999999999999999999999


Q ss_pred             C--ceecCCCCCCEEEe-cCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           90 N--VLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        90 ~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |  |+||||||+||+++ .++.++|+|||++...... ......+++.|+|||.+.  ..++.++||||+||++++|++|
T Consensus       149 ~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g  225 (290)
T 1t4h_A          149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATS  225 (290)
T ss_dssp             SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHh--ccCCCcchHHHHHHHHHHHHhC
Confidence            9  99999999999997 7899999999999755433 234557899999999885  3489999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||.+................+                           .......++.+.++|.+||+.||.+|||++
T Consensus       226 ~~pf~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  278 (290)
T 1t4h_A          226 EYPYSECQNAAQIYRRVTSGVKP---------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIK  278 (290)
T ss_dssp             SCTTTTCSSHHHHHHHHTTTCCC---------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             CCCCCCcCcHHHHHHHHhccCCc---------------------------cccCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            99998765544433222111111                           011125678899999999999999999999


Q ss_pred             HHhcCCCcCC
Q 022132          247 DALAHPYLGS  256 (302)
Q Consensus       247 ell~h~~~~~  256 (302)
                      |+|+||||+.
T Consensus       279 ell~h~~f~~  288 (290)
T 1t4h_A          279 DLLNHAFFQE  288 (290)
T ss_dssp             HHHTSGGGC-
T ss_pred             HHhhCccccc
Confidence            9999999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-42  Score=328.97  Aligned_cols=210  Identities=20%  Similarity=0.372  Sum_probs=184.1

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|..++..+ +||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||+.
T Consensus       387 ~~~~E~~~l~~~~~~~~i~~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~  461 (674)
T 3pfq_A          387 CTMVEKRVLALPGKPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK  461 (674)
T ss_dssp             HHHHHHHHHTCTTCCTTBCCEEEECBCS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhccCCCeEEEEEEEEEeC-----CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            466899999988 799999999999987     89999999996 69999999888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccC-CCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+|||++.+|.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+
T Consensus       462 gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~  540 (674)
T 3pfq_A          462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQA  540 (674)
T ss_dssp             SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred             CeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCC
Confidence            99999999999999999999999999997532 3334556789999999999854 458999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH---
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV---  245 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---  245 (302)
                      ||.+.+..+.+..+....                              ....+.+++++++||++||++||.+||++   
T Consensus       541 Pf~~~~~~~~~~~i~~~~------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~  590 (674)
T 3pfq_A          541 PFEGEDEDELFQSIMEHN------------------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPE  590 (674)
T ss_dssp             SSCCSSHHHHHHHHHSSC------------------------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTT
T ss_pred             CCCCCCHHHHHHHHHhCC------------------------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCC
Confidence            999988777766665311                              01123678999999999999999999997   


Q ss_pred             --HHHhcCCCcCCc
Q 022132          246 --EDALAHPYLGSL  257 (302)
Q Consensus       246 --~ell~h~~~~~~  257 (302)
                        +|+++||||+.+
T Consensus       591 ~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          591 GERDIKEHAFFRYI  604 (674)
T ss_dssp             HHHHHHSSGGGSSC
T ss_pred             cHHHHhcCccccCC
Confidence              999999999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.3e-42  Score=307.23  Aligned_cols=238  Identities=27%  Similarity=0.518  Sum_probs=188.9

Q ss_pred             chhhHHHHHHhcC-CCC-----ccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIM-KTS-----VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGL   83 (302)
Q Consensus        12 ~~~~E~~il~~l~-h~n-----iv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~~l   83 (302)
                      .+.+|+.+++.++ |++     |+++++++...     +.+|+||||++++|.+++...  +.+++..+..++.|++.||
T Consensus        96 ~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al  170 (382)
T 2vx3_A           96 QAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-----NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL  170 (382)
T ss_dssp             HHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcccccceeEEEeeeeeccC-----CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHH
Confidence            4567899999884 554     89999999887     899999999999999999865  4699999999999999999


Q ss_pred             HHHH--hCCceecCCCCCCEEEe--cCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHH
Q 022132           84 KYIH--SANVLHRDLKPSNLLLN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  159 (302)
Q Consensus        84 ~~LH--~~~i~H~dikp~Nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  159 (302)
                      .|||  +.||+||||||+||+++  .++.+||+|||++...+..  .....+|+.|+|||++.+. .++.++|||||||+
T Consensus       171 ~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~i  247 (382)
T 2vx3_A          171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCI  247 (382)
T ss_dssp             HHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHH
T ss_pred             HHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc--cccccCCccccChHHHcCC-CCCcHHHHHHHHHH
Confidence            9999  57999999999999995  4678999999999876543  3456789999999999655 48999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccc-----------------ccccccC--
Q 022132          160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR-----------------QSFTEKF--  220 (302)
Q Consensus       160 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~--  220 (302)
                      +++|++|.+||.+.+..+.+..+....+.|+...+..... ...+....+....                 ..+...+  
T Consensus       248 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (382)
T 2vx3_A          248 LVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK-ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGV  326 (382)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT-HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTT
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH-HHHHHHhccccccccccccccccccCCcchhhHHHHhhc
Confidence            9999999999999999999999999999888765543221 1222222111100                 0000000  


Q ss_pred             ---------CC-------CCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          221 ---------PN-------VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       221 ---------~~-------~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                               ..       .++.+++||.+||++||.+|||++|+|+||||+...
T Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          327 ETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             cccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence                     00       013789999999999999999999999999998754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=298.32  Aligned_cols=221  Identities=19%  Similarity=0.372  Sum_probs=180.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++.....   +..|+||||++++|.+.+..  .+.+++..+..++.||+.||+|||+
T Consensus        51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~  127 (305)
T 2wtk_C           51 ANVKKEIQLLRRLRHKNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS  127 (305)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEECC------CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999854321   68999999999888888875  4679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCC-CCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~i~~~ll  164 (302)
                      +||+||||||+||+++.++.++|+|||.+......   .......++..|+|||++.+.. ..+.++|||||||++++|+
T Consensus       128 ~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~  207 (305)
T 2wtk_C          128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNIT  207 (305)
T ss_dssp             TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHH
T ss_pred             CCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHH
Confidence            99999999999999999999999999998765422   2234456899999999986433 2367999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|..||.+.+.......+....                              ......+++.+.+||.+||+.||.+|||
T Consensus       208 ~g~~p~~~~~~~~~~~~i~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps  257 (305)
T 2wtk_C          208 TGLYPFEGDNIYKLFENIGKGS------------------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFS  257 (305)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHCC------------------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCC
T ss_pred             hCCCCCCCchHHHHHHHHhcCC------------------------------CCCCCccCHHHHHHHHHHccCChhhCCC
Confidence            9999998876555444332210                              0112357889999999999999999999


Q ss_pred             HHHHhcCCCcCCccCCCCCC
Q 022132          245 VEDALAHPYLGSLHDISDEP  264 (302)
Q Consensus       245 ~~ell~h~~~~~~~~~~~~~  264 (302)
                      ++|+++||||+........+
T Consensus       258 ~~~ll~~~~~~~~~~~~~~~  277 (305)
T 2wtk_C          258 IRQIRQHSWFRKKHPPAEAP  277 (305)
T ss_dssp             HHHHHHSHHHHSCCCC-CCC
T ss_pred             HHHHhcCcccccCCCCcCCC
Confidence            99999999998876554433

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.7e-42  Score=318.70  Aligned_cols=211  Identities=23%  Similarity=0.402  Sum_probs=177.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +.+|+||||++ |+|.+++...    ..+++..++.++.||+.||+|
T Consensus       230 ~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~  304 (543)
T 3c4z_A          230 QGAMVEKKILAKVHSRFIVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH  304 (543)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEeeEEEEEeeC-----CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999887     88999999997 6999998763    469999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc-ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ||++||+||||||+||+++.+|.+||+|||++........ ....+||+.|+|||++.+ ..++.++|+|||||++|+|+
T Consensus       305 LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyell  383 (543)
T 3c4z_A          305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMI  383 (543)
T ss_dssp             HHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHH
T ss_pred             HHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHH
Confidence            9999999999999999999999999999999987654432 344589999999999965 45899999999999999999


Q ss_pred             hCCCCCCCCCh----HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          165 DRKPLFPGRDH----VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       165 ~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      +|.+||.+.+.    ......+...                              .....+.+++.+.+||++||++||.
T Consensus       384 tG~~PF~~~~~~~~~~~~~~~i~~~------------------------------~~~~p~~~s~~~~~li~~lL~~dP~  433 (543)
T 3c4z_A          384 AARGPFRARGEKVENKELKQRVLEQ------------------------------AVTYPDKFSPASKDFCEALLQKDPE  433 (543)
T ss_dssp             HSSCSSCCTTCCCCHHHHHHHHHHC------------------------------CCCCCTTSCHHHHHHHHHHSCSSGG
T ss_pred             hCCCCCCCCccchhHHHHHHHHhhc------------------------------ccCCCcccCHHHHHHHHHhccCCHh
Confidence            99999977532    2222222110                              0011236789999999999999999


Q ss_pred             CCCC-----HHHHhcCCCcCCc
Q 022132          241 QRIT-----VEDALAHPYLGSL  257 (302)
Q Consensus       241 ~R~t-----~~ell~h~~~~~~  257 (302)
                      +||+     ++++++||||+..
T Consensus       434 ~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          434 KRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             GSCCCBTTBSHHHHTSGGGTTC
T ss_pred             HCCCCcccCHHHHHcCccccCC
Confidence            9996     5899999999974

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.6e-43  Score=296.46  Aligned_cols=215  Identities=26%  Similarity=0.425  Sum_probs=178.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++.....+++..+..++.|++.||+|||++
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~  124 (276)
T 2yex_A           50 ENIKKEICINKMLNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI  124 (276)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4567899999999999999999999887     88999999997 59999998778899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |++|+||+|+||+++.++.++|+|||.+......   .......++..|+|||.+.+....+.++|||||||++++|++|
T Consensus       125 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  204 (276)
T 2yex_A          125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  204 (276)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhC
Confidence            9999999999999999999999999998754322   2234557899999999986655457799999999999999999


Q ss_pred             CCCCCCCChHHH-HHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          167 KPLFPGRDHVHQ-LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       167 ~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      ..||.+...... ......   .                         ......++.+++.+.+||.+||+.||.+|||+
T Consensus       205 ~~p~~~~~~~~~~~~~~~~---~-------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  256 (276)
T 2yex_A          205 ELPWDQPSDSCQEYSDWKE---K-------------------------KTYLNPWKKIDSAPLALLHKILVENPSARITI  256 (276)
T ss_dssp             SCCCSCSCTTSHHHHHHHT---T-------------------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CCCCCCCchHHHHHHHhhh---c-------------------------ccccCchhhcCHHHHHHHHHHCCCCchhCCCH
Confidence            999976654321 111110   0                         00011123578899999999999999999999


Q ss_pred             HHHhcCCCcCCcc
Q 022132          246 EDALAHPYLGSLH  258 (302)
Q Consensus       246 ~ell~h~~~~~~~  258 (302)
                      +|+++||||+...
T Consensus       257 ~~il~~~~~~~~~  269 (276)
T 2yex_A          257 PDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHTTCTTTTCCC
T ss_pred             HHHhcCccccChh
Confidence            9999999998754

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.7e-43  Score=311.25  Aligned_cols=241  Identities=26%  Similarity=0.413  Sum_probs=185.7

Q ss_pred             CchhhHHHHHHhcC--------CCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIM--------KTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL   80 (302)
Q Consensus        11 ~~~~~E~~il~~l~--------h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll   80 (302)
                      ..+.+|+.+++.+.        ||||+++++++..... ....+|+||||++++|.+.+...  +.+++..++.++.||+
T Consensus        78 ~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~  156 (397)
T 1wak_A           78 ETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV-NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL  156 (397)
T ss_dssp             HHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET-TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC-CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHH
Confidence            45778999999995        7889999999973211 11689999999999888888654  5699999999999999


Q ss_pred             HHHHHHHhC-CceecCCCCCCEEEecCC-------------------------------------------------CEE
Q 022132           81 RGLKYIHSA-NVLHRDLKPSNLLLNANC-------------------------------------------------DLK  110 (302)
Q Consensus        81 ~~l~~LH~~-~i~H~dikp~Nil~~~~~-------------------------------------------------~~k  110 (302)
                      .||+|||++ ||+||||||+||+++.++                                                 .++
T Consensus       157 ~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k  236 (397)
T 1wak_A          157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK  236 (397)
T ss_dssp             HHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEE
T ss_pred             HHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceE
Confidence            999999998 999999999999998775                                                 799


Q ss_pred             EeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHH
Q 022132          111 ICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD------HVHQLRLLIE  184 (302)
Q Consensus       111 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~------~~~~~~~~~~  184 (302)
                      |+|||.+......  .....+|..|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+      ....+..+..
T Consensus       237 l~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  313 (397)
T 1wak_A          237 IADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE  313 (397)
T ss_dssp             ECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHH
T ss_pred             ecccccccccccc--CccCCCCCcccCChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHH
Confidence            9999999766543  34557899999999997654 8999999999999999999999997655      5667888888


Q ss_pred             HhCCCChHHHhhhhHhHHHHhhhccccccc----c------cc---ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          185 LIGTPSEAELGFLNENAKKYICQLPRYQRQ----S------FT---EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~------~~---~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      ..+.++...+....... .+..........    +      +.   ......++.+++||.+||++||.+|||++|+|+|
T Consensus       314 ~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          314 LLGKVPRKLIVAGKYSK-EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             HHCSCCHHHHHHCTTGG-GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             hcCCCChHHhhcccccc-cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            88887765442211110 000000000000    0      00   0011234578999999999999999999999999


Q ss_pred             CCcCC
Q 022132          252 PYLGS  256 (302)
Q Consensus       252 ~~~~~  256 (302)
                      |||++
T Consensus       393 p~~~~  397 (397)
T 1wak_A          393 PWLNS  397 (397)
T ss_dssp             GGGGC
T ss_pred             ccccC
Confidence            99974

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.3e-42  Score=307.81  Aligned_cols=214  Identities=23%  Similarity=0.372  Sum_probs=173.0

Q ss_pred             CchhhHHHHHHhcC--CCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIM--KTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.+.  ||||+++++++...     +.+|+|||+.+++|.+++...+.+++..+..++.||+.||.|||+
T Consensus        99 ~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-----~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~  173 (390)
T 2zmd_A           99 DSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ  173 (390)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHcccCCCeEEEEEEEEecC-----CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            45789999999996  59999999999887     789999998788999999988899999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCC----------CCCCCchhHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNS----------SDYTAAIDVWS  155 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------~~~~~~~Diws  155 (302)
                      .||+||||||+||+++ ++.+||+|||++.......   ......||+.|+|||++.+.          ..++.++||||
T Consensus       174 ~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwS  252 (390)
T 2zmd_A          174 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS  252 (390)
T ss_dssp             TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHH
T ss_pred             CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHH
Confidence            9999999999999995 5899999999997654332   23456799999999998642          35789999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHc
Q 022132          156 VGCIFMELMDRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  234 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (302)
                      |||++|+|++|.+||.+.... ..+..+.   ....                         ........+..+.+||.+|
T Consensus       253 lGvil~ell~G~~Pf~~~~~~~~~~~~~~---~~~~-------------------------~~~~~~~~~~~~~~li~~~  304 (390)
T 2zmd_A          253 LGCILYYMTYGKTPFQQIINQISKLHAII---DPNH-------------------------EIEFPDIPEKDLQDVLKCC  304 (390)
T ss_dssp             HHHHHHHHHHSSCTTTTCCCHHHHHHHHH---CTTS-------------------------CCCCCCCSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCcchhhhHHHHHHHHHh---Cccc-------------------------cCCCCccchHHHHHHHHHH
Confidence            999999999999999765432 2222111   1000                         0011123467899999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          235 LTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       235 L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      |+.||.+|||+.|+|+||||+...
T Consensus       305 L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          305 LKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             TCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             cccChhhCCCHHHHhhCcCccccC
Confidence            999999999999999999998644

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.4e-43  Score=297.02  Aligned_cols=211  Identities=28%  Similarity=0.485  Sum_probs=156.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++...     +..|+||||++ ++|.+++... +.+++..+..++.|++.||+|||+
T Consensus        56 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  130 (278)
T 3cok_A           56 QRVQNEVKIHCQLKHPSILELYNYFEDS-----NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS  130 (278)
T ss_dssp             HHHHHHHHHHTTBCCTTBCCEEEEEECS-----SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeEeEEEEEccC-----CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999887     88999999996 6999999865 679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      .|++||||||+||+++.++.++|+|||.+...... .......++..|+|||.+.+. .++.++|+||+||++++|++|.
T Consensus       131 ~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~  209 (278)
T 3cok_A          131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGR  209 (278)
T ss_dssp             TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSS
T ss_pred             CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999998765432 223345688999999988544 4789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||...+.......+.                        .     .. ......++.++.++|.+||+.||.+|||+++
T Consensus       210 ~p~~~~~~~~~~~~~~------------------------~-----~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  259 (278)
T 3cok_A          210 PPFDTDTVKNTLNKVV------------------------L-----AD-YEMPSFLSIEAKDLIHQLLRRNPADRLSLSS  259 (278)
T ss_dssp             CSSCCCSCC-----CC------------------------S-----SC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCCCChhHHHHHHHHh------------------------h-----cc-cCCccccCHHHHHHHHHHcccCHhhCCCHHH
Confidence            9997654332211100                        0     00 0112357889999999999999999999999


Q ss_pred             HhcCCCcCCc
Q 022132          248 ALAHPYLGSL  257 (302)
Q Consensus       248 ll~h~~~~~~  257 (302)
                      +++||||...
T Consensus       260 ~l~h~~~~~~  269 (278)
T 3cok_A          260 VLDHPFMSRN  269 (278)
T ss_dssp             HTTSTTTC--
T ss_pred             HhcCccccCC
Confidence            9999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-42  Score=296.49  Aligned_cols=214  Identities=31%  Similarity=0.545  Sum_probs=181.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++...     +.+|+||||+. ++|.+.+...+.+++..+..++.||+.||.|||+.|
T Consensus        67 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  141 (287)
T 2wei_A           67 TILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN  141 (287)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhccCCCccEEEEEEeCC-----CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            567899999999999999999999887     88999999996 699999987788999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecC---CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           91 VLHRDLKPSNLLLNAN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        91 i~H~dikp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      ++|+||+|+||+++.+   +.++|+|||++.............++..|+|||.+.+  .++.++||||||+++++|++|.
T Consensus       142 i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~  219 (287)
T 2wei_A          142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGT  219 (287)
T ss_dssp             CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCC
Confidence            9999999999999764   4699999999987665554555678999999998854  3789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+.......+........                          ...+..+++.+.++|.+||..||.+|||+++
T Consensus       220 ~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  273 (287)
T 2wei_A          220 PPFYGKNEYDILKRVETGKYAFD--------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQ  273 (287)
T ss_dssp             CSSCCSSHHHHHHHHHHCCCCCC--------------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCC--------------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHH
Confidence            99988776655444433111000                          1122367889999999999999999999999


Q ss_pred             HhcCCCcCCcc
Q 022132          248 ALAHPYLGSLH  258 (302)
Q Consensus       248 ll~h~~~~~~~  258 (302)
                      +|+||||+.+.
T Consensus       274 ll~hp~~~~~~  284 (287)
T 2wei_A          274 CLEHPWIQKYS  284 (287)
T ss_dssp             HHHSHHHHHHC
T ss_pred             HhcCHHHhccc
Confidence            99999998754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5e-42  Score=301.47  Aligned_cols=239  Identities=28%  Similarity=0.507  Sum_probs=190.3

Q ss_pred             cCchhhHHHHHHhcCCCC------ccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTS------VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILR   81 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~n------iv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qll~   81 (302)
                      ...+.+|+.+++.++|++      ++.+++++...     +.+|+||||++++|.+.+...  ..+++..+..++.||+.
T Consensus        60 ~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~  134 (355)
T 2eu9_A           60 REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-----GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH  134 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-----CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHH
Confidence            345678999999998766      89999999887     899999999999999888765  47999999999999999


Q ss_pred             HHHHHHhCCceecCCCCCCEEE-------------------ecCCCEEEeecccccccCCCCcccccccccccCchhhhh
Q 022132           82 GLKYIHSANVLHRDLKPSNLLL-------------------NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL  142 (302)
Q Consensus        82 ~l~~LH~~~i~H~dikp~Nil~-------------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  142 (302)
                      ||+|||++||+||||||+||++                   +.++.++|+|||++......  .....+|..|+|||++.
T Consensus       135 ~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~  212 (355)
T 2eu9_A          135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVIL  212 (355)
T ss_dssp             HHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHT
T ss_pred             HHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeee
Confidence            9999999999999999999999                   67889999999999765433  34557899999999996


Q ss_pred             CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhH---------------HHHh-h
Q 022132          143 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA---------------KKYI-C  206 (302)
Q Consensus       143 ~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~-~  206 (302)
                      +. .++.++|||||||++|+|++|.+||.+.+....+..+....+.++...........               ..+. .
T Consensus       213 ~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (355)
T 2eu9_A          213 EL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE  291 (355)
T ss_dssp             TC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHH
T ss_pred             cC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccc
Confidence            54 48999999999999999999999999999888888888888877765443221100               0000 0


Q ss_pred             hccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      .....  ..........++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus       292 ~~~~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          292 NCKPL--KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             HCCCG--GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             cCCcc--cccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence            00000  000000112245789999999999999999999999999999764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8e-43  Score=300.12  Aligned_cols=225  Identities=21%  Similarity=0.364  Sum_probs=168.0

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--------CCCCCHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--------NQALSEEHCQYFLYQIL   80 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--------~~~l~~~~~~~i~~qll   80 (302)
                      ...+.+|+.++++++||||+++++++...     +..|+||||++ ++|.+++..        .+.+++..+..++.||+
T Consensus        57 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~  131 (303)
T 2vwi_A           57 MDELLKEIQAMSQCHHPNIVSYYTSFVVK-----DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL  131 (303)
T ss_dssp             ---------CCCCCCCTTBCCEEEEEESS-----SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCEeeEEEEEeec-----CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHH
Confidence            35677999999999999999999999887     78999999995 699999863        46699999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC------CcccccccccccCchhhhhCCCCCCCchhHH
Q 022132           81 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVW  154 (302)
Q Consensus        81 ~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  154 (302)
                      .||.|||+.|++||||+|+||+++.++.++|+|||.+......      .......++..|+|||.+.+...++.++|||
T Consensus       132 ~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~  211 (303)
T 2vwi_A          132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW  211 (303)
T ss_dssp             HHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHH
T ss_pred             HHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHH
Confidence            9999999999999999999999999999999999998654322      1223456899999999986544579999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHc
Q 022132          155 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  234 (302)
Q Consensus       155 slG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (302)
                      ||||++++|++|..||.+............  ..+...                  ............+++.+.++|.+|
T Consensus       212 slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~------------------~~~~~~~~~~~~~~~~~~~li~~~  271 (303)
T 2vwi_A          212 SFGITAIELATGAAPYHKYPPMKVLMLTLQ--NDPPSL------------------ETGVQDKEMLKKYGKSFRKMISLC  271 (303)
T ss_dssp             HHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--SSCCCT------------------TC-----CCCCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCccCchhhHHHHHhc--cCCCcc------------------ccccccchhhhhhhHHHHHHHHHH
Confidence            999999999999999987665443322211  110000                  000011233456789999999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCcCCccC
Q 022132          235 LTFDPRQRITVEDALAHPYLGSLHD  259 (302)
Q Consensus       235 L~~dP~~R~t~~ell~h~~~~~~~~  259 (302)
                      |+.||.+|||++++++||||+....
T Consensus       272 l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          272 LQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             CCSSGGGSCCHHHHHTSTTC-----
T ss_pred             ccCChhhCcCHHHHhhChhhhcCCC
Confidence            9999999999999999999987653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.6e-44  Score=315.83  Aligned_cols=211  Identities=16%  Similarity=0.234  Sum_probs=166.1

Q ss_pred             CchhhHH---HHHHhcCCCCccccc-------eeeCCCCCC-------CCC-----cEEEEEecCCccHHHHHHcCCCCC
Q 022132           11 GHFVRSS---CFDTWIMKTSVVAIR-------DIIPPPQRE-------SFN-----DVYIAYELMDTDLHQIIRSNQALS   68 (302)
Q Consensus        11 ~~~~~E~---~il~~l~h~niv~l~-------~~~~~~~~~-------~~~-----~~~lv~e~~~~~L~~~l~~~~~l~   68 (302)
                      ..+.+|+   ++++.++||||++++       +++.+....       +.+     ..|+||||++|+|.+++...+.++
T Consensus       118 ~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~  197 (377)
T 3byv_A          118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS  197 (377)
T ss_dssp             HHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccc
Confidence            4567899   556666899999999       555543110       001     389999999999999998655555


Q ss_pred             H-------HHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhh
Q 022132           69 E-------EHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL  141 (302)
Q Consensus        69 ~-------~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~  141 (302)
                      +       ..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...+..  .....| ..|+|||++
T Consensus       198 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~  274 (377)
T 3byv_A          198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR--VVSSVS-RGFEPPELE  274 (377)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCE--EECCCC-TTCCCHHHH
T ss_pred             cccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCCc--ccCCCC-cCccChhhh
Confidence            5       888889999999999999999999999999999999999999999999865432  344566 899999999


Q ss_pred             hCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccc
Q 022132          142 LNS----------SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY  211 (302)
Q Consensus       142 ~~~----------~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (302)
                      .+.          ..++.++|||||||++|+|++|.+||.+.+.....                                
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~--------------------------------  322 (377)
T 3byv_A          275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS--------------------------------  322 (377)
T ss_dssp             HHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS--------------------------------
T ss_pred             cccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch--------------------------------
Confidence            765          24899999999999999999999999654321110                                


Q ss_pred             ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          212 QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                        .......+.+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       323 --~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          323 --EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             --GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             --hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence              011122347889999999999999999999999999999998754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-42  Score=305.23  Aligned_cols=216  Identities=19%  Similarity=0.343  Sum_probs=176.1

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.+ +||||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+
T Consensus       103 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~  177 (355)
T 1vzo_A          103 EHTRTERQVLEHIRQSPFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK  177 (355)
T ss_dssp             GGCCCHHHHHHHHHTCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHccCCCceeEEEEEEeeC-----ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4577899999999 799999999999887     88999999997 6999999888889999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC--CcccccccccccCchhhhhCC-CCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +||+||||||+||+++.++.++|+|||+++.....  .......+|..|+|||.+.+. ..++.++|||||||++|+|++
T Consensus       178 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~  257 (355)
T 1vzo_A          178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT  257 (355)
T ss_dssp             TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred             CCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH
Confidence            99999999999999999999999999998754322  223345789999999998653 346889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC--
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI--  243 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~--  243 (302)
                      |..||...........+....                  ...        .....+.+++.+.+||.+||..||.+||  
T Consensus       258 g~~pf~~~~~~~~~~~~~~~~------------------~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~  311 (355)
T 1vzo_A          258 GASPFTVDGEKNSQAEISRRI------------------LKS--------EPPYPQEMSALAKDLIQRLLMKDPKKRLGC  311 (355)
T ss_dssp             SSCTTSCTTSCCCHHHHHHHH------------------HHC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             CCCCCccCCccchHHHHHHHH------------------hcc--------CCCCCcccCHHHHHHHHHHhhhCHHHhcCC
Confidence            999997543211111111100                  000        0112236788999999999999999999  


Q ss_pred             ---CHHHHhcCCCcCCc
Q 022132          244 ---TVEDALAHPYLGSL  257 (302)
Q Consensus       244 ---t~~ell~h~~~~~~  257 (302)
                         |++|+++||||+..
T Consensus       312 ~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          312 GPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             STTTHHHHHTSGGGTTC
T ss_pred             CCCCHHHHHcCcchhcC
Confidence               99999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.4e-42  Score=292.60  Aligned_cols=208  Identities=22%  Similarity=0.279  Sum_probs=170.5

Q ss_pred             cCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGL   83 (302)
Q Consensus        10 ~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~~l   83 (302)
                      ...+.+|+.++..+ +||||+++++++.+.     +.+|+||||++ ++|.+++...    +.+++..+..++.||+.||
T Consensus        54 ~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al  128 (289)
T 1x8b_A           54 EQNALREVYAHAVLGQHSHVVRYFSAWAED-----DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL  128 (289)
T ss_dssp             HHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHH
Confidence            34677899999999 999999999999887     89999999996 5999999764    6799999999999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEecC-------------------CCEEEeecccccccCCCCcccccccccccCchhhhhCC
Q 022132           84 KYIHSANVLHRDLKPSNLLLNAN-------------------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS  144 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~~-------------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  144 (302)
                      +|||++||+||||||+||+++.+                   ..++|+|||.+......   ....++..|+|||.+.+.
T Consensus       129 ~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~  205 (289)
T 1x8b_A          129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQEN  205 (289)
T ss_dssp             HHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTC
T ss_pred             HHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCC
Confidence            99999999999999999999844                   47999999998776543   234589999999999766


Q ss_pred             CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCC
Q 022132          145 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH  224 (302)
Q Consensus       145 ~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (302)
                      ..++.++|||||||++++|++|.+|+.......   .+..                             .......+.++
T Consensus       206 ~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~-----------------------------~~~~~~~~~~~  253 (289)
T 1x8b_A          206 YTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIRQ-----------------------------GRLPRIPQVLS  253 (289)
T ss_dssp             CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HHHT-----------------------------TCCCCCSSCCC
T ss_pred             CCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HHHc-----------------------------CCCCCCCcccC
Confidence            556789999999999999999998775432211   1110                             01112233678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          225 PSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       225 ~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                      +.+.++|.+||+.||.+|||++++++||||.+.
T Consensus       254 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          254 QEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            999999999999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.4e-42  Score=294.54  Aligned_cols=216  Identities=21%  Similarity=0.378  Sum_probs=175.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++.. .+.+++..+..++.||+.||.|||+
T Consensus        61 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  135 (302)
T 2j7t_A           61 EDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS  135 (302)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECC------CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc
Confidence            3577899999999999999999999887     88999999997 589888764 5679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhh----CCCCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~i~~~l  163 (302)
                      .|++||||||+||+++.++.++|+|||++...... .......++..|+|||.+.    ....++.++|||||||++++|
T Consensus       136 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l  215 (302)
T 2j7t_A          136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM  215 (302)
T ss_dssp             TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHH
T ss_pred             CCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHH
Confidence            99999999999999999999999999987532211 1123456889999999984    345578999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|.+||.+.+.......+..... +.                          ......++..+.++|.+||..||.+||
T Consensus       216 ~~g~~p~~~~~~~~~~~~~~~~~~-~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rp  268 (302)
T 2j7t_A          216 AQIEPPHHELNPMRVLLKIAKSDP-PT--------------------------LLTPSKWSVEFRDFLKIALDKNPETRP  268 (302)
T ss_dssp             HHSSCTTTTSCHHHHHHHHHHSCC-CC--------------------------CSSGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred             hcCCCCCccCCHHHHHHHHhccCC-cc--------------------------cCCccccCHHHHHHHHHHcccChhhCC
Confidence            999999988776555443332110 00                          001124678899999999999999999


Q ss_pred             CHHHHhcCCCcCCcc
Q 022132          244 TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 t~~ell~h~~~~~~~  258 (302)
                      |++++++||||+...
T Consensus       269 s~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          269 SAAQLLEHPFVSSIT  283 (302)
T ss_dssp             CHHHHTTSTTTTTCC
T ss_pred             CHHHHhcChHHhhhc
Confidence            999999999998754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.6e-42  Score=298.47  Aligned_cols=215  Identities=22%  Similarity=0.358  Sum_probs=167.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCC--------------------------------------------------
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQR--------------------------------------------------   40 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~--------------------------------------------------   40 (302)
                      ..+.+|+.++++++||||+++++++.+...                                                  
T Consensus        49 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  128 (332)
T 3qd2_B           49 EKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQ  128 (332)
T ss_dssp             HHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-----------------------------------------
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccccccc
Confidence            467899999999999999999999855321                                                  


Q ss_pred             --CCCCcEEEEEecCC-ccHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeec
Q 022132           41 --ESFNDVYIAYELMD-TDLHQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF  114 (302)
Q Consensus        41 --~~~~~~~lv~e~~~-~~L~~~l~~~~~---l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~df  114 (302)
                        .....+|+||||++ ++|.+++.....   .++..+..++.||+.||+|||++||+||||||+||+++.++.++|+||
T Consensus       129 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Df  208 (332)
T 3qd2_B          129 PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF  208 (332)
T ss_dssp             ---CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeec
Confidence              11134899999997 599999987543   556678999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCC-------------cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 022132          115 GLARVTSETD-------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  181 (302)
Q Consensus       115 g~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~  181 (302)
                      |++.......             ......+|+.|+|||.+.+. .++.++||||+||++++|++|..|+.     .....
T Consensus       209 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~  282 (332)
T 3qd2_B          209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM-----ERVRI  282 (332)
T ss_dssp             TTCEECSCC--------------CCCSCC-CGGGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHH
T ss_pred             CcccccccchhhccccccccccccccccCCCcCccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh-----HHHHH
Confidence            9997655431             22345789999999998654 48999999999999999999876641     11111


Q ss_pred             HHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          182 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                      .........                          +..++..++.+.+||.+||+.||.+|||++|+|+||||+++
T Consensus       283 ~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          283 ITDVRNLKF--------------------------PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHHHHTTCC--------------------------CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             HHHhhccCC--------------------------CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            111111110                          11112345778999999999999999999999999999863

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-42  Score=306.27  Aligned_cols=239  Identities=20%  Similarity=0.326  Sum_probs=178.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||+|||+.
T Consensus        76 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~  150 (360)
T 3eqc_A           76 NQIIRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK  150 (360)
T ss_dssp             HHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            4678999999999999999999999887     88999999996 59999999888899999999999999999999996


Q ss_pred             -CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 -NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 -~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                       ||+||||||+||+++.++.++|+|||++...... ......++..|+|||++.+. .++.++|||||||++++|++|..
T Consensus       151 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~  228 (360)
T 3eqc_A          151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRY  228 (360)
T ss_dssp             HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSC
T ss_pred             CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999998654322 23345789999999998654 58999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhh---hH-------------hHHHHhhhccccccccccccCCCCCHHHHHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFL---NE-------------NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE  232 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  232 (302)
                      ||...+.......................   ..             .............  ........++.++.+||.
T Consensus       229 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~  306 (360)
T 3eqc_A          229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVN  306 (360)
T ss_dssp             CSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHH
T ss_pred             CCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHH
Confidence            99887655443222111100000000000   00             0000000000000  001111246889999999


Q ss_pred             HccCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          233 KMLTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       233 ~~L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      +||++||.+|||++|+|+||||+...
T Consensus       307 ~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          307 KCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             HHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             HHhhcChhhCCCHHHHhhChHhhcch
Confidence            99999999999999999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=293.69  Aligned_cols=214  Identities=26%  Similarity=0.421  Sum_probs=178.9

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~-~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++. ....+++..+..++.|++.||.|||+.
T Consensus        70 ~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  144 (314)
T 3com_A           70 EIIKEISIMQQCDSPHVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM  144 (314)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            567899999999999999999999887     88999999997 59999986 457899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      |++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+. .++.++|||||||++++|++|..
T Consensus       145 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~  223 (314)
T 3com_A          145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKP  223 (314)
T ss_dssp             TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999999765433 223455789999999998654 48899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||.+.+.......+.... .+                          .......+++.+.+||.+||..||.+|||++++
T Consensus       224 p~~~~~~~~~~~~~~~~~-~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~l  276 (314)
T 3com_A          224 PYADIHPMRAIFMIPTNP-PP--------------------------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQL  276 (314)
T ss_dssp             TTTTSCHHHHHHHHHHSC-CC--------------------------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCCChHHHHHHHhcCC-Cc--------------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            998776554433222110 00                          001112467899999999999999999999999


Q ss_pred             hcCCCcCCcc
Q 022132          249 LAHPYLGSLH  258 (302)
Q Consensus       249 l~h~~~~~~~  258 (302)
                      ++||||+...
T Consensus       277 l~~~~~~~~~  286 (314)
T 3com_A          277 LQHPFVRSAK  286 (314)
T ss_dssp             TTSHHHHTCC
T ss_pred             HhCHHHhcCC
Confidence            9999998743

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.2e-43  Score=301.35  Aligned_cols=220  Identities=21%  Similarity=0.356  Sum_probs=176.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++...... ....|+||||++ ++|.+++...+.+++..+..++.||+.||+|||++|
T Consensus        58 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  136 (311)
T 3ork_A           58 RFRREAQNAAALNHPAIVAVYDTGEAETPA-GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG  136 (311)
T ss_dssp             HHHHHHTTCCCCCCTTBCCEEEEEEEEETT-EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHcCCCCCcceEEEeeeccCCC-CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            577999999999999999999998765211 134699999996 699999988888999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC----CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |+||||||+||+++.++.++|+|||++......    .......||..|+|||.+.+. .++.++|||||||++|+|++|
T Consensus       137 ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g  215 (311)
T 3ork_A          137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTG  215 (311)
T ss_dssp             CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhC
Confidence            999999999999999999999999998765432    122345689999999999654 489999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||.+.+..............+                          .....+.+++++.++|.+||+.||.+||++.
T Consensus       216 ~~pf~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~  269 (311)
T 3ork_A          216 EPPFTGDSPVSVAYQHVREDPIP--------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTA  269 (311)
T ss_dssp             SCSCCCSSHHHHHHHHHHCCCCC--------------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred             CCCCCCCChHHHHHHHhcCCCCC--------------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhH
Confidence            99998887665544443321111                          1122346889999999999999999999999


Q ss_pred             HHhcCCCcCCccC
Q 022132          247 DALAHPYLGSLHD  259 (302)
Q Consensus       247 ell~h~~~~~~~~  259 (302)
                      +++.|+|++....
T Consensus       270 ~~l~~~l~~~~~~  282 (311)
T 3ork_A          270 AEMRADLVRVHNG  282 (311)
T ss_dssp             HHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcC
Confidence            9999999986543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.1e-42  Score=302.38  Aligned_cols=230  Identities=24%  Similarity=0.345  Sum_probs=180.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHH------HHc--CCCCCHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQI------IRS--NQALSEEHCQYFLYQILR   81 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~------l~~--~~~l~~~~~~~i~~qll~   81 (302)
                      ..+.+|+.++++++||||+++++++...     +.+|+||||+++ +|.++      +..  ...+++..+..++.|++.
T Consensus        88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~  162 (348)
T 2pml_X           88 DDFKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLN  162 (348)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHH
Confidence            5678999999999999999999999887     899999999975 99988      655  578999999999999999


Q ss_pred             HHHHHHh-CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCC-chhHHHHHHH
Q 022132           82 GLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTA-AIDVWSVGCI  159 (302)
Q Consensus        82 ~l~~LH~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DiwslG~i  159 (302)
                      ||.|||+ .||+||||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+...++. ++||||+||+
T Consensus       163 ~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~i  241 (348)
T 2pml_X          163 SFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC  241 (348)
T ss_dssp             HHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHH
T ss_pred             HHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHH
Confidence            9999999 99999999999999999999999999999765443 3455678999999999876544555 9999999999


Q ss_pred             HHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCC
Q 022132          160 FMELMDRKPLFPGRDH-VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       160 ~~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  238 (302)
                      +++|++|.+||.+.+. ......+.......+.....           ..............+.+++.+.+||.+||+.|
T Consensus       242 l~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  310 (348)
T 2pml_X          242 LYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNH-----------FLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN  310 (348)
T ss_dssp             HHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSS-----------STTTTCC--------CCCHHHHHHHHHHCCSS
T ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhh-----------hhccccccccccchhhcCHHHHHHHHHHccCC
Confidence            9999999999987766 44333332210000000000           00000000111222468899999999999999


Q ss_pred             CCCCCCHHHHhcCCCcCCc
Q 022132          239 PRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       239 P~~R~t~~ell~h~~~~~~  257 (302)
                      |.+|||++|+++||||+..
T Consensus       311 P~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          311 PAERITSEDALKHEWLADT  329 (348)
T ss_dssp             GGGSCCHHHHHTSGGGTTC
T ss_pred             hhhCCCHHHHhcCccccCC
Confidence            9999999999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-41  Score=301.23  Aligned_cols=247  Identities=23%  Similarity=0.378  Sum_probs=186.5

Q ss_pred             cCchhhHHHHHHhcC-----------CCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc--CCCCCHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIM-----------KTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFL   76 (302)
Q Consensus        10 ~~~~~~E~~il~~l~-----------h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~   76 (302)
                      ...+.+|+.++++++           ||||+++++++..... +...+++||||++++|.+++..  .+.+++..+..++
T Consensus        59 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~  137 (373)
T 1q8y_A           59 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP-NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS  137 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET-TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHH
T ss_pred             hhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCC-CCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHH
Confidence            345678999999886           8999999999986421 1147999999999999999976  3569999999999


Q ss_pred             HHHHHHHHHHHhC-CceecCCCCCCEEEecC------CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCC
Q 022132           77 YQILRGLKYIHSA-NVLHRDLKPSNLLLNAN------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTA  149 (302)
Q Consensus        77 ~qll~~l~~LH~~-~i~H~dikp~Nil~~~~------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  149 (302)
                      .||+.||+|||++ ||+||||||+||+++.+      +.++|+|||++......  .....+|..|+|||++.+.. ++.
T Consensus       138 ~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~  214 (373)
T 1q8y_A          138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGC  214 (373)
T ss_dssp             HHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCT
T ss_pred             HHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCc
Confidence            9999999999998 99999999999999543      47999999999766543  34457899999999997654 899


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccc------cc--
Q 022132          150 AIDVWSVGCIFMELMDRKPLFPGRD------HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR------QS--  215 (302)
Q Consensus       150 ~~DiwslG~i~~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~--  215 (302)
                      ++|||||||++|+|++|.+||.+.+      ....+..+...++.++...+...... ..+.........      .+  
T Consensus       215 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  293 (373)
T 1q8y_A          215 GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYT-RTFFNSRGLLRNISKLKFWPLE  293 (373)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTH-HHHBCC--CBSSCCCCCBCCHH
T ss_pred             hHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchh-hhhcCCcchhcccccccccchh
Confidence            9999999999999999999998654      55677888888888776544322111 011000000000      00  


Q ss_pred             --cc---ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccCCC
Q 022132          216 --FT---EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  261 (302)
Q Consensus       216 --~~---~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~  261 (302)
                        ..   ...+..++.+.+||.+||+.||.+|||++|+|+||||+......
T Consensus       294 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  344 (373)
T 1q8y_A          294 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME  344 (373)
T ss_dssp             HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCT
T ss_pred             hhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCcc
Confidence              00   01113456789999999999999999999999999999865443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.7e-41  Score=293.10  Aligned_cols=211  Identities=24%  Similarity=0.406  Sum_probs=168.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA---LSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---l~~~~~~~i~~qll~~l~~LH   87 (302)
                      .+.+|+.++++++||||+++++++...     +.+|+||||++ ++|.+++...+.   +++..+..++.||+.||+|||
T Consensus        80 ~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  154 (309)
T 3p86_A           80 EFLREVAIMKRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH  154 (309)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECST-----TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEEC-----CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            577999999999999999999999887     78999999996 599999987653   999999999999999999999


Q ss_pred             hCC--ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           88 SAN--VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        88 ~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      +.|  |+||||||+||+++.++.++|+|||++...... .......+|..|+|||.+.+. .++.++|||||||++|+|+
T Consensus       155 ~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell  233 (309)
T 3p86_A          155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELA  233 (309)
T ss_dssp             TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHH
T ss_pred             cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHH
Confidence            999  999999999999999999999999998754433 223456789999999998654 4799999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|..||.+.+.......+......                            ......+++.+.+||.+||..||.+|||
T Consensus       234 tg~~Pf~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps  285 (309)
T 3p86_A          234 TLQQPWGNLNPAQVVAAVGFKCKR----------------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPS  285 (309)
T ss_dssp             HCCCTTTTSCHHHHHHHHHHSCCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             hCCCCCCCCCHHHHHHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcC
Confidence            999999887766554433221111                            1122367899999999999999999999


Q ss_pred             HHHHhc--CCCcCC
Q 022132          245 VEDALA--HPYLGS  256 (302)
Q Consensus       245 ~~ell~--h~~~~~  256 (302)
                      ++++++  .+++++
T Consensus       286 ~~~ll~~L~~~~~~  299 (309)
T 3p86_A          286 FATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHHHHh
Confidence            999988  555554

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.4e-41  Score=291.23  Aligned_cols=211  Identities=24%  Similarity=0.367  Sum_probs=178.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++.. +++++..+..++.|++.||.|||+.
T Consensus        65 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~  138 (303)
T 3a7i_A           65 EDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE  138 (303)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577899999999999999999999887     88999999997 599998865 6799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|||||||++++|++|.+
T Consensus       139 ~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~  217 (303)
T 3a7i_A          139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEP  217 (303)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCC
Confidence            99999999999999999999999999997654432 23455789999999998654 47899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||...+.......+...                             ........++..+.+||.+||+.||.+|||++++
T Consensus       218 p~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  268 (303)
T 3a7i_A          218 PHSELHPMKVLFLIPKN-----------------------------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL  268 (303)
T ss_dssp             TTTTSCHHHHHHHHHHS-----------------------------CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CCCCcCHHHHHHHhhcC-----------------------------CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            99877655443332210                             0011223678899999999999999999999999


Q ss_pred             hcCCCcCCc
Q 022132          249 LAHPYLGSL  257 (302)
Q Consensus       249 l~h~~~~~~  257 (302)
                      ++||||...
T Consensus       269 l~~~~~~~~  277 (303)
T 3a7i_A          269 LKHKFILRN  277 (303)
T ss_dssp             TTCHHHHHH
T ss_pred             hhChhhhcC
Confidence            999999763

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.8e-41  Score=287.52  Aligned_cols=215  Identities=25%  Similarity=0.402  Sum_probs=173.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      .+.+|+.+++.++||||+++++++...     +..++||||++ ++|.+++...   ..+++..+..++.|++.||+|||
T Consensus        65 ~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  139 (295)
T 2clq_A           65 PLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH  139 (295)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999887     88999999996 6999999764   35679999999999999999999


Q ss_pred             hCCceecCCCCCCEEEec-CCCEEEeecccccccCCC-CcccccccccccCchhhhhCC-CCCCCchhHHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~i~~~ll  164 (302)
                      +.|++|+||+|+||+++. ++.++|+|||.+...... .......++..|+|||.+.+. ..++.++|||||||++++|+
T Consensus       140 ~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~  219 (295)
T 2clq_A          140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA  219 (295)
T ss_dssp             HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHH
T ss_pred             hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHH
Confidence            999999999999999998 899999999998765432 223455789999999998643 23688999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|..||..................                           .......+++.+.++|.+||+.||.+|||
T Consensus       220 ~g~~pf~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps  272 (295)
T 2clq_A          220 TGKPPFYELGEPQAAMFKVGMFKV---------------------------HPEIPESMSAEAKAFILKCFEPDPDKRAC  272 (295)
T ss_dssp             HTSCTTGGGSSHHHHHHHHHHHCC---------------------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCC
T ss_pred             HCCCCccCCCchhHHHHhhccccc---------------------------cccccccCCHHHHHHHHHHccCChhhCCC
Confidence            999999654433221111110000                           01122367889999999999999999999


Q ss_pred             HHHHhcCCCcCCcc
Q 022132          245 VEDALAHPYLGSLH  258 (302)
Q Consensus       245 ~~ell~h~~~~~~~  258 (302)
                      ++++|+||||+...
T Consensus       273 ~~~ll~~~~~~~~~  286 (295)
T 2clq_A          273 ANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHHTSGGGCC--
T ss_pred             HHHHhcChhhhhcc
Confidence            99999999998754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=294.71  Aligned_cols=219  Identities=22%  Similarity=0.371  Sum_probs=172.5

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCC-CCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.+++++ +||||+++++++..... ...+.+|+||||++ ++|.+++...  ..+++..+..++.||+.||.|
T Consensus        65 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~  144 (326)
T 2x7f_A           65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH  144 (326)
T ss_dssp             HHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH
Confidence            4677999999999 89999999999976431 11368999999997 5999999764  579999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhC----CCCCCCchhHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~i~  160 (302)
                      ||+.||+|+||||+||+++.++.++|+|||++...... .......++..|+|||.+..    ...++.++|||||||++
T Consensus       145 lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il  224 (326)
T 2x7f_A          145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA  224 (326)
T ss_dssp             HHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHH
T ss_pred             HHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHH
Confidence            99999999999999999999999999999998765432 22344578999999999852    34478999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      ++|++|.+||.+.+.......+.... .+                           ......+++.+.+||.+||..||.
T Consensus       225 ~~l~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~  276 (326)
T 2x7f_A          225 IEMAEGAPPLCDMHPMRALFLIPRNP-AP---------------------------RLKSKKWSKKFQSFIESCLVKNHS  276 (326)
T ss_dssp             HHHHHSSCTTTTSCHHHHHHHHHHSC-CC---------------------------CCSCSCSCHHHHHHHHHHCCSSGG
T ss_pred             HHHHhCCCCCCCCcHHHHHHHhhcCc-cc---------------------------cCCccccCHHHHHHHHHHhccChh
Confidence            99999999998776554443322110 00                           011235788999999999999999


Q ss_pred             CCCCHHHHhcCCCcCCc
Q 022132          241 QRITVEDALAHPYLGSL  257 (302)
Q Consensus       241 ~R~t~~ell~h~~~~~~  257 (302)
                      +|||++++++||||+..
T Consensus       277 ~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          277 QRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             GSCCHHHHHTSHHHHCC
T ss_pred             hCCCHHHHhhChHHhhC
Confidence            99999999999999863

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.5e-41  Score=298.19  Aligned_cols=205  Identities=25%  Similarity=0.384  Sum_probs=171.6

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHH
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQ   73 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~   73 (302)
                      .+.+|+.+++.+ +||||+++++++...     +.+|+||||++ |+|.+++...+                .+++..+.
T Consensus       132 ~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (370)
T 2psq_A          132 DLVSEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV  206 (370)
T ss_dssp             HHHHHHHHHHHSCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEeeEEEEEccC-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHH
Confidence            578999999999 899999999999887     88999999997 59999998643                48999999


Q ss_pred             HHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCc
Q 022132           74 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAA  150 (302)
Q Consensus        74 ~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~  150 (302)
                      .++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......   ......++..|+|||++.+. .++.+
T Consensus       207 ~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~  285 (370)
T 2psq_A          207 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQ  285 (370)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHH
T ss_pred             HHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcH
Confidence            999999999999999999999999999999999999999999997654332   22334567889999998654 48999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHH
Q 022132          151 IDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID  229 (302)
Q Consensus       151 ~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (302)
                      +|||||||++|+|++ |.+||.+.+..+....+....                             .......+++.+.+
T Consensus       286 ~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~  336 (370)
T 2psq_A          286 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-----------------------------RMDKPANCTNELYM  336 (370)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------------------------CCCCCTTSCHHHHH
T ss_pred             HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-----------------------------CCCCCCCCCHHHHH
Confidence            999999999999998 999998776554433322110                             01122367889999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcC
Q 022132          230 LVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       230 li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +|.+||+.||.+|||+.|++++
T Consensus       337 li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          337 MMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999863

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.5e-41  Score=289.06  Aligned_cols=215  Identities=28%  Similarity=0.423  Sum_probs=176.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.++++++||||+++++++.....   +.+|+||||++ ++|.+++...    ..+++..+..++.|++.||+|
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~  126 (279)
T 2w5a_A           50 QMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE  126 (279)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEEGGG---TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCeEEEEEecCCC---ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHH
Confidence            457799999999999999999998854211   68999999997 5999998753    459999999999999999999


Q ss_pred             HHhCC-----ceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHH
Q 022132           86 IHSAN-----VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  159 (302)
Q Consensus        86 LH~~~-----i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  159 (302)
                      ||+.|     |+||||||+||+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|||||||+
T Consensus       127 lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~i  205 (279)
T 2w5a_A          127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCL  205 (279)
T ss_dssp             HHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHH
T ss_pred             HhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHH
Confidence            99999     9999999999999999999999999987654332 22345688999999998654 47899999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC
Q 022132          160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       160 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      +++|++|.+||.+.+.......+.....                             ......+++.+.++|.+||+.||
T Consensus       206 l~~l~~g~~p~~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p  256 (279)
T 2w5a_A          206 LYELCALMPPFTAFSQKELAGKIREGKF-----------------------------RRIPYRYSDELNEIITRMLNLKD  256 (279)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHTCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSG
T ss_pred             HHHHHHCCCCCcccCHHHHHHHHhhccc-----------------------------ccCCcccCHHHHHHHHHHcCCCc
Confidence            9999999999988776554443332110                             11123578899999999999999


Q ss_pred             CCCCCHHHHhcCCCcCCcc
Q 022132          240 RQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       240 ~~R~t~~ell~h~~~~~~~  258 (302)
                      .+|||++|+++|+|+....
T Consensus       257 ~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          257 YHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             GGSCCHHHHHTSTTCCGGG
T ss_pred             ccCCCHHHHHhChhhhhhc
Confidence            9999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.6e-41  Score=289.97  Aligned_cols=216  Identities=25%  Similarity=0.378  Sum_probs=173.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++...     +.+|+||||++ ++|.+++...+++++..+..++.|++.||+|||++
T Consensus        56 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~  130 (294)
T 4eqm_A           56 KRFEREVHNSSQLSHQNIVSMIDVDEED-----DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM  130 (294)
T ss_dssp             HHHHHHHHHHTTCCBTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCCCceEEEeeeeC-----CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4678999999999999999999999887     89999999997 59999999888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      ||+||||||+||+++.++.++|+|||++.......  ......+|+.|+|||.+.+. .++.++||||+||++|+|++|.
T Consensus       131 ~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~  209 (294)
T 4eqm_A          131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGE  209 (294)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSS
T ss_pred             CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999997654332  22345689999999998654 4789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+............ .+.                        ......+.+++.+.++|.+||.+||.+||+..+
T Consensus       210 ~pf~~~~~~~~~~~~~~~~-~~~------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~  264 (294)
T 4eqm_A          210 PPFNGETAVSIAIKHIQDS-VPN------------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQ  264 (294)
T ss_dssp             CSSCSSCHHHHHHHHHSSC-CCC------------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHH
T ss_pred             CCCCCCChHHHHHHHhhcc-CCC------------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHH
Confidence            9998877655433322110 000                        011233468899999999999999999996666


Q ss_pred             HhcCCCcCCc
Q 022132          248 ALAHPYLGSL  257 (302)
Q Consensus       248 ll~h~~~~~~  257 (302)
                      .+.+.|..-.
T Consensus       265 ~l~~~l~~~~  274 (294)
T 4eqm_A          265 EMKDDLSSVL  274 (294)
T ss_dssp             HHHHHHHTSS
T ss_pred             HHHHHHHHHH
Confidence            6666665443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=297.75  Aligned_cols=233  Identities=16%  Similarity=0.237  Sum_probs=173.3

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      .+.+|+.+++.++||||+++++++.....   ..+|+||||++ ++|.+++....   .+++..+..++.||+.||+|||
T Consensus        53 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH  129 (319)
T 4euu_A           53 VQMREFEVLKKLNHKNIVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR  129 (319)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECTTT---CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCcceEEEEeecCCC---ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            46699999999999999999999977522   57899999996 79999998643   3999999999999999999999


Q ss_pred             hCCceecCCCCCCEEE----ecCCCEEEeecccccccCCCCcccccccccccCchhhhhC-------CCCCCCchhHHHH
Q 022132           88 SANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN-------SSDYTAAIDVWSV  156 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Diwsl  156 (302)
                      +.||+||||||+||++    +.++.++|+|||++.............+|..|+|||++..       ...++.++|||||
T Consensus       130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl  209 (319)
T 4euu_A          130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI  209 (319)
T ss_dssp             HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHH
T ss_pred             HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHH
Confidence            9999999999999999    6777899999999987766655566789999999999852       3457899999999


Q ss_pred             HHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHH
Q 022132          157 GCIFMELMDRKPLFPGRDH----VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE  232 (302)
Q Consensus       157 G~i~~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  232 (302)
                      ||++|+|++|..||.....    ...+..+...  .|. ..+.................  .........++..+.++|+
T Consensus       210 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~p~-~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~ll~  284 (319)
T 4euu_A          210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG--KPS-GAISGVQKAENGPIDWSGDM--PVSCSLSRGLQVLLTPVLA  284 (319)
T ss_dssp             HHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH--CCT-TCCEEEECSTTCCEEEESSC--CTTCSSCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC--CCc-ccchhhhcccCCccccCccC--CcccccchhHHHHhHHHHH
Confidence            9999999999999965432    2233322221  111 11000000000000000000  0000111134567899999


Q ss_pred             HccCCCCCCCCCHHHHhcCC
Q 022132          233 KMLTFDPRQRITVEDALAHP  252 (302)
Q Consensus       233 ~~L~~dP~~R~t~~ell~h~  252 (302)
                      +||++||.+|||++|+|+||
T Consensus       285 ~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          285 NILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHSCCCTTTSCCHHHHHHHH
T ss_pred             HhccCChhhhccHHHhhhcc
Confidence            99999999999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.4e-41  Score=285.50  Aligned_cols=206  Identities=19%  Similarity=0.314  Sum_probs=173.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++.+.     +..|+||||++ ++|.+++.. .+.+++..+..++.|++.||+|||+
T Consensus        50 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~  124 (269)
T 4hcu_A           50 EDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE  124 (269)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecC-----CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh
Confidence            3578999999999999999999999887     78999999996 699999975 4569999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      .||+||||||+||+++.++.++|+|||++.......  ......++..|+|||.+.+. .++.++|+||+||++++|++ 
T Consensus       125 ~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~  203 (269)
T 4hcu_A          125 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSE  203 (269)
T ss_dssp             TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcC
Confidence            999999999999999999999999999997654321  22334557789999998654 48999999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+.......+......                             ......++.+.+++.+||+.||.+|||+
T Consensus       204 g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  254 (269)
T 4hcu_A          204 GKIPYENRSNSEVVEDISTGFRL-----------------------------YKPRLASTHVYQIMNHCWRERPEDRPAF  254 (269)
T ss_dssp             SCCTTTTCCHHHHHHHHHTTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCCHHHHHHHHhcCccC-----------------------------CCCCcCCHHHHHHHHHHccCCcccCcCH
Confidence            99999888776655544331111                             1112468899999999999999999999


Q ss_pred             HHHhcC
Q 022132          246 EDALAH  251 (302)
Q Consensus       246 ~ell~h  251 (302)
                      +++++|
T Consensus       255 ~~ll~~  260 (269)
T 4hcu_A          255 SRLLRQ  260 (269)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.9e-41  Score=293.75  Aligned_cols=205  Identities=20%  Similarity=0.296  Sum_probs=171.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++... +.+++..+..++.||+.||+|||+
T Consensus        95 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~  169 (325)
T 3kul_A           95 RDFLSEASIMGQFDHPNIIRLEGVVTRG-----RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD  169 (325)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECGG-----GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999877     88999999996 6999999754 689999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .||+||||||+||+++.++.++|+|||++.......    ......+|..|+|||.+.+. .++.++|||||||++++|+
T Consensus       170 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell  248 (325)
T 3kul_A          170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVL  248 (325)
T ss_dssp             TTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHH
T ss_pred             CCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999997654331    12233456789999998654 4899999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |..||.+.+.......+......+                             ....+++.+.+||.+||..||.+||
T Consensus       249 ~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rp  299 (325)
T 3kul_A          249 AYGERPYWNMTNRDVISSVEEGYRLP-----------------------------APMGCPHALHQLMLDCWHKDRAQRP  299 (325)
T ss_dssp             TTSCCTTTTSCHHHHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             cCCCCCcccCCHHHHHHHHHcCCCCC-----------------------------CCCCcCHHHHHHHHHHccCChhhCc
Confidence            8 999998887766555443321111                             1236788999999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |++++++
T Consensus       300 s~~eil~  306 (325)
T 3kul_A          300 RFSQIVS  306 (325)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.5e-42  Score=304.84  Aligned_cols=225  Identities=14%  Similarity=0.149  Sum_probs=157.8

Q ss_pred             CchhhHHHHHHhc--CCCCccccc-------eeeCCCCCC------------CCCcEEEEEecCCccHHHHHHcC-CCCC
Q 022132           11 GHFVRSSCFDTWI--MKTSVVAIR-------DIIPPPQRE------------SFNDVYIAYELMDTDLHQIIRSN-QALS   68 (302)
Q Consensus        11 ~~~~~E~~il~~l--~h~niv~l~-------~~~~~~~~~------------~~~~~~lv~e~~~~~L~~~l~~~-~~l~   68 (302)
                      ..+.+|+.+++.+  +||||++++       +++......            ....+|+||||++++|.+++... ..++
T Consensus       107 ~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~  186 (371)
T 3q60_A          107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV  186 (371)
T ss_dssp             HHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCC
T ss_pred             HHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccc
Confidence            3556785555555  699988855       444332111            01448999999999999999863 3445


Q ss_pred             HHHH------HHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhh
Q 022132           69 EEHC------QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL  142 (302)
Q Consensus        69 ~~~~------~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  142 (302)
                      ...+      ..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...+...  ....++..|+|||++.
T Consensus       187 ~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~  264 (371)
T 3q60_A          187 FRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLN  264 (371)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHT
T ss_pred             hhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhcc
Confidence            5555      6777999999999999999999999999999999999999999998765432  2456679999999996


Q ss_pred             CC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC
Q 022132          143 NS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP  221 (302)
Q Consensus       143 ~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (302)
                      +. ..++.++|||||||++|+|++|.+||.+......             ..+.       .. ...............+
T Consensus       265 ~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------------~~~~-------~~-~~~~~~~~~~~~~~~~  323 (371)
T 3q60_A          265 ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK-------------GSWK-------RP-SLRVPGTDSLAFGSCT  323 (371)
T ss_dssp             CSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT-------------TCCC-------BC-CTTSCCCCSCCCTTSS
T ss_pred             CCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc-------------cchh-------hh-hhhhccccccchhhcc
Confidence            41 3589999999999999999999999976532100             0000       00 0000000011112234


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          222 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       222 ~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      .+++.+.+||.+||++||.+|||++++|+||||+...
T Consensus       324 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          324 PLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             CCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            7899999999999999999999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=299.55  Aligned_cols=211  Identities=19%  Similarity=0.251  Sum_probs=175.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------QALSEEHCQYFLYQILRG   82 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qll~~   82 (302)
                      ..+.+|+.++++++||||+++++++...     +..|+||||++ |+|.+++...       ..+++..+..++.||+.|
T Consensus       119 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a  193 (367)
T 3l9p_A          119 LDFLMEALIISKFNHQNIVRCIGVSLQS-----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG  193 (367)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEecC-----CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHH
Confidence            3578999999999999999999999887     78899999995 6999999753       359999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEecCC---CEEEeecccccccCC---CCcccccccccccCchhhhhCCCCCCCchhHHHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNANC---DLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  156 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~~~---~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  156 (302)
                      |+|||++||+||||||+||+++.+|   .++|+|||+++....   ........+|..|+|||++.+. .++.++|||||
T Consensus       194 L~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvwsl  272 (367)
T 3l9p_A          194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSF  272 (367)
T ss_dssp             HHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHH
T ss_pred             HHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHH
Confidence            9999999999999999999999555   499999999974321   2223345678899999998655 48999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHcc
Q 022132          157 GCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  235 (302)
Q Consensus       157 G~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  235 (302)
                      ||++++|++ |.+||.+.+.......+......                             .....+++.+.+||.+||
T Consensus       273 G~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~~l  323 (367)
T 3l9p_A          273 GVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-----------------------------DPPKNCPGPVYRIMTQCW  323 (367)
T ss_dssp             HHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHT
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCccCCHHHHHHHHHHc
Confidence            999999998 99999888766655444331111                             112367889999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCcCC
Q 022132          236 TFDPRQRITVEDALAHPYLGS  256 (302)
Q Consensus       236 ~~dP~~R~t~~ell~h~~~~~  256 (302)
                      +.||.+|||+++++++.++-.
T Consensus       324 ~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          324 QHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHHHHHHh
Confidence            999999999999999887643

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=305.88  Aligned_cols=215  Identities=27%  Similarity=0.333  Sum_probs=165.1

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+|+++ +||||+++++++.+.     +.+|+|||||+|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus        62 ~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-----~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  136 (432)
T 3p23_A           62 SFADREVQLLRESDEHPNVIRYFCTEKDR-----QFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS  136 (432)
T ss_dssp             EECHHHHHHHHHSCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCcCeEEEEEecC-----CEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH
Confidence            3567999999999 899999999999887     8899999999999999998653 45666778999999999999999


Q ss_pred             CCceecCCCCCCEEEec-----CCCEEEeecccccccCCC----CcccccccccccCchhhhhC--CCCCCCchhHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNA-----NCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVG  157 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~-----~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG  157 (302)
                      +||+||||||+||+++.     ...++|+|||++......    .......||+.|+|||++.+  ...++.++||||+|
T Consensus       137 ~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG  216 (432)
T 3p23_A          137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG  216 (432)
T ss_dssp             TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHH
T ss_pred             CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHH
Confidence            99999999999999953     235889999999765432    22345678999999999864  34467899999999


Q ss_pred             HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccC
Q 022132          158 CIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  236 (302)
Q Consensus       158 ~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  236 (302)
                      |++++|++ |.+||.......... +   .+.....                       ........+..+.+||.+||+
T Consensus       217 ~il~ellt~g~~pf~~~~~~~~~~-~---~~~~~~~-----------------------~~~~~~~~~~~~~~li~~~L~  269 (432)
T 3p23_A          217 CVFYYVISEGSHPFGKSLQRQANI-L---LGACSLD-----------------------CLHPEKHEDVIARELIEKMIA  269 (432)
T ss_dssp             HHHHHHHTTSCBTTBSTTTHHHHH-H---TTCCCCT-----------------------TSCTTCHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHcCCCCCcchhhHHHHHH-H---hccCCcc-----------------------ccCccccccHHHHHHHHHHHh
Confidence            99999999 999996554332211 1   1110000                       000001234568899999999


Q ss_pred             CCCCCCCCHHHHhcCCCcCCc
Q 022132          237 FDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       237 ~dP~~R~t~~ell~h~~~~~~  257 (302)
                      .||.+|||++++++||||...
T Consensus       270 ~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          270 MDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             SSGGGSCCHHHHHTSTTTCCH
T ss_pred             CCHhhCCCHHHHHhCccccCh
Confidence            999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.4e-41  Score=292.84  Aligned_cols=217  Identities=24%  Similarity=0.340  Sum_probs=164.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCC-ccHHHHHHcCC------CCCHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRSNQ------ALSEEHCQYFLYQILRG   82 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~-~~L~~~l~~~~------~l~~~~~~~i~~qll~~   82 (302)
                      ..+.+|+.++++++||||+++++++..... ......++||||+. ++|.+++....      .+++..+..++.||+.|
T Consensus        70 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~a  149 (323)
T 3qup_A           70 EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG  149 (323)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHH
Confidence            467899999999999999999999987632 11223599999997 59999986432      69999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  159 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  159 (302)
                      |+|||++||+||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+. .++.++|||||||+
T Consensus       150 l~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~i  228 (323)
T 3qup_A          150 MEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVT  228 (323)
T ss_dssp             HHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHH
T ss_pred             HHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHH
Confidence            999999999999999999999999999999999997654332   12234457789999998654 48999999999999


Q ss_pred             HHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCC
Q 022132          160 FMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       160 ~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  238 (302)
                      +++|++ |.+||.+.+.......+.....                             ....+.+++.+.+||.+||+.|
T Consensus       229 l~ell~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~d  279 (323)
T 3qup_A          229 MWEIMTRGQTPYAGIENAEIYNYLIGGNR-----------------------------LKQPPECMEEVYDLMYQCWSAD  279 (323)
T ss_dssp             HHHHHTTSCCTTTTCCGGGHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHTTCSS
T ss_pred             HHHHHhCCCCCccccChHHHHHHHhcCCC-----------------------------CCCCCccCHHHHHHHHHHccCC
Confidence            999999 9999988776555444332110                             1122367889999999999999


Q ss_pred             CCCCCC-------HHHHhcCCCcCCc
Q 022132          239 PRQRIT-------VEDALAHPYLGSL  257 (302)
Q Consensus       239 P~~R~t-------~~ell~h~~~~~~  257 (302)
                      |.+|||       ++++++|||+...
T Consensus       280 p~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          280 PKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             GGGSCCHHHHHHHHHHHHHC------
T ss_pred             hhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            999999       7889999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2e-42  Score=302.47  Aligned_cols=234  Identities=24%  Similarity=0.353  Sum_probs=156.0

Q ss_pred             hhHHHHhcCchhhHHHH-HHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHH
Q 022132            3 SITKLMQRGHFVRSSCF-DTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQ   78 (302)
Q Consensus         3 ~~~~~~~~~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~q   78 (302)
                      |||.+.......+|+.. ++.++||||+++++++..... +...+|+||||++ |+|.+++...+  .+++..+..++.|
T Consensus        58 avK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~q  136 (336)
T 3fhr_A           58 ALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHH-GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD  136 (336)
T ss_dssp             EEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHH
T ss_pred             EEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccC-CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHH
Confidence            44444444445555554 455699999999999976311 1156999999997 59999998753  6999999999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCCEEEec---CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHH
Q 022132           79 ILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS  155 (302)
Q Consensus        79 ll~~l~~LH~~~i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  155 (302)
                      |+.||+|||++||+||||||+||+++.   ++.++|+|||++...... ......+++.|+|||.+.+ ..++.++||||
T Consensus       137 l~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~s  214 (336)
T 3fhr_A          137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWS  214 (336)
T ss_dssp             HHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCC-CCCCchhhHHH
Confidence            999999999999999999999999976   455999999999765533 2345577999999998844 44788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHcc
Q 022132          156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  235 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  235 (302)
                      |||++++|++|.+||.+................                      .........+..+++.+.+||.+||
T Consensus       215 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~li~~~L  272 (336)
T 3fhr_A          215 LGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL----------------------GQYGFPNPEWSEVSEDAKQLIRLLL  272 (336)
T ss_dssp             HHHHHHHHHHSSCCC-------------------------------------------CCCTTTSTTCCHHHHHHHHHHS
T ss_pred             HHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc----------------------cccccCchhhccCCHHHHHHHHHHC
Confidence            999999999999999765433221111110000                      0000011223467899999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCcCCccCCC
Q 022132          236 TFDPRQRITVEDALAHPYLGSLHDIS  261 (302)
Q Consensus       236 ~~dP~~R~t~~ell~h~~~~~~~~~~  261 (302)
                      +.||.+|||++|+|+||||+......
T Consensus       273 ~~dP~~Rpt~~ell~hp~~~~~~~~~  298 (336)
T 3fhr_A          273 KTDPTERLTITQFMNHPWINQSMVVP  298 (336)
T ss_dssp             CSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred             CCChhHCcCHHHHhcCccccccccCC
Confidence            99999999999999999998765433

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.2e-41  Score=285.86  Aligned_cols=206  Identities=17%  Similarity=0.280  Sum_probs=174.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++.. .+.+++..+..++.|++.||+|||+
T Consensus        64 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~  138 (283)
T 3gen_A           64 DEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES  138 (283)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCEeeEEEEEecC-----CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999999887     88999999995 799999976 5679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      +||+||||||+||+++.++.++|+|||.+.......  ......++..|+|||.+.+.. ++.++||||+|+++++|++ 
T Consensus       139 ~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~  217 (283)
T 3gen_A          139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSL  217 (283)
T ss_dssp             TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTT
T ss_pred             CCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhC
Confidence            999999999999999999999999999997654321  122334567899999986554 8999999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+.......+.......                             .....++.+.++|.+||+.||.+|||+
T Consensus       218 g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~  268 (283)
T 3gen_A          218 GKMPYERFTNSETAEHIAQGLRLY-----------------------------RPHLASEKVYTIMYSCWHEKADERPTF  268 (283)
T ss_dssp             TCCTTTTSCHHHHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             CCCCccccChhHHHHHHhcccCCC-----------------------------CCCcCCHHHHHHHHHHccCChhHCcCH
Confidence            999998887666555444321111                             112467899999999999999999999


Q ss_pred             HHHhcC
Q 022132          246 EDALAH  251 (302)
Q Consensus       246 ~ell~h  251 (302)
                      +++++|
T Consensus       269 ~~ll~~  274 (283)
T 3gen_A          269 KILLSN  274 (283)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5e-41  Score=284.22  Aligned_cols=206  Identities=18%  Similarity=0.286  Sum_probs=172.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++...     +..|+||||++ ++|.+++... ..+++..+..++.|++.||+|||+
T Consensus        48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~  122 (268)
T 3sxs_A           48 DEFFQEAQTMMKLSHPKLVKFYGVCSKE-----YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES  122 (268)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEccC-----CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999999887     88999999996 6899999764 459999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      .||+||||||+||+++.++.++|+|||.+........  .....++..|+|||.+.+.. ++.++||||+|+++++|++ 
T Consensus       123 ~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~  201 (268)
T 3sxs_A          123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSL  201 (268)
T ss_dssp             TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTT
T ss_pred             CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcC
Confidence            9999999999999999999999999999976544321  22334567799999986544 7899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+.......+......                             ......++.+.+++.+||+.||.+|||+
T Consensus       202 g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~  252 (268)
T 3sxs_A          202 GKMPYDLYTNSEVVLKVSQGHRL-----------------------------YRPHLASDTIYQIMYSCWHELPEKRPTF  252 (268)
T ss_dssp             TCCTTTTSCHHHHHHHHHTTCCC-----------------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             CCCCccccChHHHHHHHHcCCCC-----------------------------CCCCcChHHHHHHHHHHcCCChhhCcCH
Confidence            99999887766554443321110                             1112467889999999999999999999


Q ss_pred             HHHhcC
Q 022132          246 EDALAH  251 (302)
Q Consensus       246 ~ell~h  251 (302)
                      ++++++
T Consensus       253 ~~ll~~  258 (268)
T 3sxs_A          253 QQLLSS  258 (268)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.7e-41  Score=290.84  Aligned_cols=206  Identities=25%  Similarity=0.410  Sum_probs=176.4

Q ss_pred             CchhhHHHHHHhcC--CCCccccceeeCCCCCCCCCcEEEEEecCC--ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIM--KTSVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        11 ~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..+.+|+.+++.++  ||||+++++++...     +..++|||++.  ++|.+++...+.+++..+..++.||+.||+||
T Consensus        91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~L  165 (320)
T 3a99_A           91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC  165 (320)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECS-----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHhhccCCCCceEEEEEEecC-----CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            56778999999996  59999999999987     88999999996  69999998888999999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEe-cCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           87 HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      |+.||+||||||+||+++ .++.++|+|||++....... .....++..|+|||.+.+....+.++|||||||++++|++
T Consensus       166 H~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~  244 (320)
T 3a99_A          166 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC  244 (320)
T ss_dssp             HHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred             HHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHH
Confidence            999999999999999999 77899999999998765432 3445789999999998766645788999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||...+.      +..  +.                            ......+++.+.+||.+||+.||.+|||+
T Consensus       245 g~~pf~~~~~------~~~--~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~  288 (320)
T 3a99_A          245 GDIPFEHDEE------IIR--GQ----------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTF  288 (320)
T ss_dssp             SSCSCCSHHH------HHH--CC----------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCChhh------hhc--cc----------------------------ccccccCCHHHHHHHHHHccCChhhCcCH
Confidence            9999964321      000  00                            01123678899999999999999999999


Q ss_pred             HHHhcCCCcCCcc
Q 022132          246 EDALAHPYLGSLH  258 (302)
Q Consensus       246 ~ell~h~~~~~~~  258 (302)
                      +++++||||+...
T Consensus       289 ~~ll~hp~~~~~~  301 (320)
T 3a99_A          289 EEIQNHPWMQDVL  301 (320)
T ss_dssp             HHHHTSGGGSSCC
T ss_pred             HHHhcCHhhcCcc
Confidence            9999999998754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-40  Score=287.66  Aligned_cols=214  Identities=24%  Similarity=0.372  Sum_probs=170.1

Q ss_pred             CchhhHHHHHHhcC--CCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIM--KTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++  ||||+++++++...     +.+|+|||+.+++|.+++...+.+++..+..++.|++.||.|||+
T Consensus        71 ~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  145 (313)
T 3cek_A           71 DSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ  145 (313)
T ss_dssp             HHHHHHHHHHHHHGGGCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccCCceEEEEEEeecC-----CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            45779999999996  59999999999887     889999998889999999988899999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCC----------CCCCCchhHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNS----------SDYTAAIDVWS  155 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------~~~~~~~Diws  155 (302)
                      .||+||||||+||+++ ++.++|+|||++.......   ......++..|+|||.+.+.          ..++.++||||
T Consensus       146 ~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~s  224 (313)
T 3cek_A          146 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS  224 (313)
T ss_dssp             TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHH
T ss_pred             CCceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHH
Confidence            9999999999999996 4899999999987654332   22345689999999998642          35788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHc
Q 022132          156 VGCIFMELMDRKPLFPGRDHVH-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  234 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (302)
                      |||++++|++|..||....... .+..+.   ...                         .........+..+.++|.+|
T Consensus       225 lG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~-------------------------~~~~~~~~~~~~l~~li~~~  276 (313)
T 3cek_A          225 LGCILYYMTYGKTPFQQIINQISKLHAII---DPN-------------------------HEIEFPDIPEKDLQDVLKCC  276 (313)
T ss_dssp             HHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CTT-------------------------SCCCCCCCSCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCchhhHHHHHHHHHHHH---hcc-------------------------cccCCcccchHHHHHHHHHH
Confidence            9999999999999997654322 111111   000                         00011224578899999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          235 LTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       235 L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      |+.||.+|||++|+|+||||+...
T Consensus       277 l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          277 LKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             TCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             ccCCcccCcCHHHHhcCccccCCC
Confidence            999999999999999999998754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=295.45  Aligned_cols=206  Identities=24%  Similarity=0.379  Sum_probs=174.4

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHC   72 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~   72 (302)
                      ..+.+|+.+++.+ +||||+++++++...     +.+|+||||++ |+|.+++....                .+++..+
T Consensus       119 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  193 (382)
T 3tt0_A          119 SDLISEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL  193 (382)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHH
T ss_pred             HHHHHHHHHHHHhcCCchhhhheeeeccC-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHH
Confidence            4577999999999 999999999999887     78999999996 59999998653                4999999


Q ss_pred             HHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCCCC
Q 022132           73 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTA  149 (302)
Q Consensus        73 ~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~  149 (302)
                      ..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++......   .......++..|+|||.+.+. .++.
T Consensus       194 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~  272 (382)
T 3tt0_A          194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTH  272 (382)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCH
T ss_pred             HHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCc
Confidence            999999999999999999999999999999999999999999999765433   223344567889999998654 4899


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHH
Q 022132          150 AIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  228 (302)
Q Consensus       150 ~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (302)
                      ++|||||||++++|++ |..||.+.+..+....+.....                             ......+++.+.
T Consensus       273 ~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~  323 (382)
T 3tt0_A          273 QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR-----------------------------MDKPSNCTNELY  323 (382)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-----------------------------CCCCSSCCHHHH
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCccCCHHHH
Confidence            9999999999999999 9999988776655444332111                             111236788999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcC
Q 022132          229 DLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       229 ~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +||.+||+.||.+|||++|++++
T Consensus       324 ~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          324 MMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.7e-41  Score=289.43  Aligned_cols=213  Identities=24%  Similarity=0.353  Sum_probs=163.3

Q ss_pred             hhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-Cc
Q 022132           14 VRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA-NV   91 (302)
Q Consensus        14 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~~-~i   91 (302)
                      ..+..+++.++||||+++++++...     +.+|+||||+++.+..+... .+.+++..+..++.|++.||.|||+. |+
T Consensus        72 ~~~~~~~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i  146 (318)
T 2dyl_A           72 MDLDVVLKSHDCPYIVQCFGTFITN-----TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV  146 (318)
T ss_dssp             HHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHhcCCCceeeEEEEEecC-----CcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence            3455567888999999999999887     89999999997777666643 57899999999999999999999995 99


Q ss_pred             eecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhC----CCCCCCchhHHHHHHHHHHHHhCC
Q 022132           92 LHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        92 ~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +|+||||+||+++.++.++|+|||++.............++..|+|||.+..    ...++.++||||+||++++|++|.
T Consensus       147 ~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~  226 (318)
T 2dyl_A          147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ  226 (318)
T ss_dssp             CCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSS
T ss_pred             EeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCC
Confidence            9999999999999999999999999976655444455678999999999852    345788999999999999999999


Q ss_pred             CCCCCCCh-HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          168 PLFPGRDH-VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       168 ~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .||..... ...+..+...  .+                         +.......+++++.++|.+||+.||.+|||++
T Consensus       227 ~pf~~~~~~~~~~~~~~~~--~~-------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  279 (318)
T 2dyl_A          227 FPYKNCKTDFEVLTKVLQE--EP-------------------------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYN  279 (318)
T ss_dssp             CTTTTCCSHHHHHHHHHHS--CC-------------------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             CCCCCCCccHHHHHHHhcc--CC-------------------------CCCCccCCCCHHHHHHHHHHccCChhHCcCHH
Confidence            99976433 3333322221  00                         00111225789999999999999999999999


Q ss_pred             HHhcCCCcCCcc
Q 022132          247 DALAHPYLGSLH  258 (302)
Q Consensus       247 ell~h~~~~~~~  258 (302)
                      ++++||||+...
T Consensus       280 ~ll~h~~~~~~~  291 (318)
T 2dyl_A          280 KLLEHSFIKRYE  291 (318)
T ss_dssp             HHTTSHHHHHHH
T ss_pred             HHhhCHHHHhcc
Confidence            999999998754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.8e-41  Score=294.03  Aligned_cols=208  Identities=24%  Similarity=0.370  Sum_probs=171.4

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC----------------------
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA----------------------   66 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----------------------   66 (302)
                      ..+.+|+.+++++ +||||+++++++....    ..+++||||++ |+|.+++.....                      
T Consensus        70 ~~~~~E~~~l~~l~~hpniv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (359)
T 3vhe_A           70 RALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI  145 (359)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSTT----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------
T ss_pred             HHHHHHHHHHHhhcCCcceeeeeeeeecCC----CceEEEEEecCCCcHHHHHHhccccccccccccchhhccccccccc
Confidence            3578999999999 8999999999998752    45899999997 599999986543                      


Q ss_pred             --------------------------------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q 022132           67 --------------------------------------------LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL  102 (302)
Q Consensus        67 --------------------------------------------l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil  102 (302)
                                                                  +++..+..++.||+.||+|||++||+||||||+||+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIl  225 (359)
T 3vhe_A          146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  225 (359)
T ss_dssp             --------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             chhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEE
Confidence                                                        899999999999999999999999999999999999


Q ss_pred             EecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 022132          103 LNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  178 (302)
Q Consensus       103 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~  178 (302)
                      ++.++.++|+|||++.......   ......+|..|+|||++.+. .++.++|||||||++|+|++ |.+||.+......
T Consensus       226 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  304 (359)
T 3vhe_A          226 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  304 (359)
T ss_dssp             ECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             EcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH
Confidence            9999999999999997653321   23345678889999998654 48999999999999999998 9999987765444


Q ss_pred             HHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          179 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      ..........+                            ......++.+.+++.+||+.||.+|||++|+++|
T Consensus       305 ~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          305 FCRRLKEGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            33333221111                            1123578899999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.8e-41  Score=285.09  Aligned_cols=204  Identities=24%  Similarity=0.376  Sum_probs=160.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++..      +..|+||||++ ++|.+++... ..+++..+..++.|++.||+|||+
T Consensus        61 ~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  134 (281)
T 1mp8_A           61 EKFLQEALTMRQFDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES  134 (281)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECS------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCccceEEEEEcc------CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            457899999999999999999999853      57899999997 5999999865 479999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      .||+||||||+||+++.++.++|+|||++........  .....++..|+|||.+.+. .++.++|||||||++++|++ 
T Consensus       135 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~  213 (281)
T 1mp8_A          135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMH  213 (281)
T ss_dssp             TTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTT
T ss_pred             CCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhc
Confidence            9999999999999999999999999999976544321  2234556789999998654 48999999999999999996 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+..+....+.....                             ....+.+++.+.++|.+||+.||.+|||+
T Consensus       214 g~~pf~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~  264 (281)
T 1mp8_A          214 GVKPFQGVKNNDVIGRIENGER-----------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRF  264 (281)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCcCCHHHHHHHHHcCCC-----------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence            9999987766554443322100                             11224678999999999999999999999


Q ss_pred             HHHhc
Q 022132          246 EDALA  250 (302)
Q Consensus       246 ~ell~  250 (302)
                      .++++
T Consensus       265 ~~l~~  269 (281)
T 1mp8_A          265 TELKA  269 (281)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-40  Score=288.56  Aligned_cols=206  Identities=22%  Similarity=0.327  Sum_probs=171.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC-----------------------
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA-----------------------   66 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----------------------   66 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...+.                       
T Consensus        71 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (314)
T 2ivs_A           71 RDLLSEFNVLKQVNHPHVIKLYGACSQD-----GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER  145 (314)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------C
T ss_pred             HHHHHHHHHHhhCCCCceeeEEEEEecC-----CceEEEEeecCCCCHHHHHHHHhhccCCccccccccccccccccccc
Confidence            3577899999999999999999999887     88999999997 799999986543                       


Q ss_pred             -CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhh
Q 022132           67 -LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLL  142 (302)
Q Consensus        67 -l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~  142 (302)
                       +++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.
T Consensus       146 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  225 (314)
T 2ivs_A          146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF  225 (314)
T ss_dssp             EECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc
Confidence             8999999999999999999999999999999999999999999999999997654332   123345677899999986


Q ss_pred             CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC
Q 022132          143 NSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP  221 (302)
Q Consensus       143 ~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (302)
                      +. .++.++|||||||++++|++ |..||.+.+.......+....                             ......
T Consensus       226 ~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~  275 (314)
T 2ivs_A          226 DH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH-----------------------------RMERPD  275 (314)
T ss_dssp             HC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------------------------CCCCCT
T ss_pred             CC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC-----------------------------cCCCCc
Confidence            54 47999999999999999999 999998776544333222110                             011223


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          222 NVHPSAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       222 ~~~~~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      .+++.+.++|.+||+.||.+|||+++++++
T Consensus       276 ~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          276 NCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            678999999999999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.2e-41  Score=291.84  Aligned_cols=207  Identities=24%  Similarity=0.298  Sum_probs=171.3

Q ss_pred             cCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHH
Q 022132           10 RGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEH   71 (302)
Q Consensus        10 ~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~   71 (302)
                      ...+.+|+.+++++ +||||+++++++...     +.+|+||||++ ++|.+++...+                .+++..
T Consensus        69 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (327)
T 1fvr_A           69 HRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ  143 (327)
T ss_dssp             -CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHH
T ss_pred             HHHHHHHHHHHHhccCCCchhhhceeeeeC-----CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHH
Confidence            34678899999999 999999999999887     88999999996 69999998654                799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCch
Q 022132           72 CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAI  151 (302)
Q Consensus        72 ~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  151 (302)
                      +..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.............++..|+|||.+.+. .++.++
T Consensus       144 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~  222 (327)
T 1fvr_A          144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNS  222 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHH
T ss_pred             HHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchh
Confidence            9999999999999999999999999999999999999999999998754433333445667889999998654 478999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          152 DVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       152 DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      |||||||++++|++ |.+||.+.+.......+....                             .......+++.+.+|
T Consensus       223 Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~l  273 (327)
T 1fvr_A          223 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-----------------------------RLEKPLNCDDEVYDL  273 (327)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-----------------------------CCCCCTTBCHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC-----------------------------CCCCCCCCCHHHHHH
Confidence            99999999999998 999998877554433322100                             011123578899999


Q ss_pred             HHHccCCCCCCCCCHHHHhcC
Q 022132          231 VEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       231 i~~~L~~dP~~R~t~~ell~h  251 (302)
                      |.+||..||.+|||+++++++
T Consensus       274 i~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          274 MRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.5e-41  Score=302.93  Aligned_cols=215  Identities=27%  Similarity=0.367  Sum_probs=162.3

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCC-------HHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALS-------EEHCQYFLYQILRGL   83 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~-------~~~~~~i~~qll~~l   83 (302)
                      .+.+|+.+++++ +||||+++++++.+.     +.+|+|||||+|+|.+++...+...       +..+..++.||+.||
T Consensus        54 ~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL  128 (434)
T 2rio_A           54 IALMEIKLLTESDDHPNVIRYYCSETTD-----RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV  128 (434)
T ss_dssp             HHHHHHHHHHHHTTSTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccCCCCcCeEEEEEecC-----CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHH
Confidence            467899999987 899999999999887     8899999999999999998754332       234567999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEecC-------------CCEEEeecccccccCCCC-----cccccccccccCchhhhhC--
Q 022132           84 KYIHSANVLHRDLKPSNLLLNAN-------------CDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLN--  143 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~~-------------~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--  143 (302)
                      +|||++||+||||||+||+++.+             +.++|+|||++.......     ......||+.|+|||++.+  
T Consensus       129 ~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  208 (434)
T 2rio_A          129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESN  208 (434)
T ss_dssp             HHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCC
T ss_pred             HHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccc
Confidence            99999999999999999999764             479999999998654432     1234578999999999865  


Q ss_pred             ----CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccc
Q 022132          144 ----SSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE  218 (302)
Q Consensus       144 ----~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (302)
                          ...++.++|||||||++++|++ |..||.+......  .+........                   ..  ..  .
T Consensus       209 ~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~i~~~~~~~~-------------------~~--~~--~  263 (434)
T 2rio_A          209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLD-------------------EM--KC--L  263 (434)
T ss_dssp             TTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--HHHHTCCCCC-------------------CC--TT--C
T ss_pred             ccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--HHhcCCCCcc-------------------cc--cc--c
Confidence                2457899999999999999998 9999976544321  1111100000                   00  00  0


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCC
Q 022132          219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  256 (302)
Q Consensus       219 ~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  256 (302)
                      ..+.+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       264 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          264 HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            00123568999999999999999999999999999964

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.3e-40  Score=286.91  Aligned_cols=209  Identities=15%  Similarity=0.201  Sum_probs=170.6

Q ss_pred             cCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.+++.+ +||||+++++++...     +..|+||||++++|.+++.. .+.+++..+..++.||+.||+|||
T Consensus        48 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  122 (330)
T 2izr_A           48 APQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH  122 (330)
T ss_dssp             SCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34678999999999 999999999999887     88999999998899999986 478999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCC-----EEEeecccccccCCCCc--------ccccccccccCchhhhhCCCCCCCchhHH
Q 022132           88 SANVLHRDLKPSNLLLNANCD-----LKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLNSSDYTAAIDVW  154 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~-----~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  154 (302)
                      +.||+||||||+||+++.++.     ++|+|||++........        .....||..|+|||++.+ ..++.++|||
T Consensus       123 ~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~  201 (330)
T 2izr_A          123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLE  201 (330)
T ss_dssp             HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHH
T ss_pred             hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHH
Confidence            999999999999999998887     99999999976543221        245678999999999865 4489999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHH
Q 022132          155 SVGCIFMELMDRKPLFPGRDHV---HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV  231 (302)
Q Consensus       155 slG~i~~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  231 (302)
                      ||||++|+|++|.+||.+.+..   ..+..+.......+                         ........+ .+.+++
T Consensus       202 slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~p-~~~~li  255 (330)
T 2izr_A          202 ALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-------------------------IEVLCENFP-EMATYL  255 (330)
T ss_dssp             HHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-------------------------HHHHTTTCH-HHHHHH
T ss_pred             HHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-------------------------HHHHhccCh-HHHHHH
Confidence            9999999999999999875432   22222222110000                         011112334 899999


Q ss_pred             HHccCCCCCCCCCHHHHhc
Q 022132          232 EKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       232 ~~~L~~dP~~R~t~~ell~  250 (302)
                      ..||..||.+|||++++++
T Consensus       256 ~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          256 RYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHhCCCCCCCCHHHHHH
Confidence            9999999999999988876

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.1e-41  Score=286.26  Aligned_cols=202  Identities=14%  Similarity=0.236  Sum_probs=167.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++...     +..|+||||++ ++|.+++...+. +++..+..++.||+.||+|||+
T Consensus        57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~  131 (289)
T 4fvq_A           57 ESFFEAASMMSKLSHKHLVLNYGVCVCG-----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE  131 (289)
T ss_dssp             HHHHHHHHHHHTSCCTTBCCEEEEECCT-----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEEEeC-----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            4678999999999999999999999987     78899999997 699999987654 9999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCC--------EEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCD--------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      +||+||||||+||+++.++.        ++|+|||.+......   ....++..|+|||.+.+...++.++||||+||++
T Consensus       132 ~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il  208 (289)
T 4fvq_A          132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTL  208 (289)
T ss_dssp             TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHH
T ss_pred             CCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHH
Confidence            99999999999999999887        999999998654432   3345788899999997646689999999999999


Q ss_pred             HHHHhC-CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC
Q 022132          161 MELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       161 ~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      ++|++| .+||...+...........                               .......++.+.++|.+||+.||
T Consensus       209 ~el~~g~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dp  257 (289)
T 4fvq_A          209 WEICSGGDKPLSALDSQRKLQFYEDR-------------------------------HQLPAPKAAELANLINNCMDYEP  257 (289)
T ss_dssp             HHHHTTTCCTTTTSCHHHHHHHHHTT-------------------------------CCCCCCSSCTTHHHHHHHSCSSG
T ss_pred             HHHHcCCCCCccccchHHHHHHhhcc-------------------------------CCCCCCCCHHHHHHHHHHcCCCh
Confidence            999994 5666555443332221110                               01112456789999999999999


Q ss_pred             CCCCCHHHHhcC
Q 022132          240 RQRITVEDALAH  251 (302)
Q Consensus       240 ~~R~t~~ell~h  251 (302)
                      .+|||+++++++
T Consensus       258 ~~Rps~~~ll~~  269 (289)
T 4fvq_A          258 DHRPSFRAIIRD  269 (289)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hHCcCHHHHHHH
Confidence            999999999984

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.7e-41  Score=287.17  Aligned_cols=217  Identities=25%  Similarity=0.364  Sum_probs=164.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCC--------CCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQR--------ESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQIL   80 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~--------~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll   80 (302)
                      ..+.+|+.++++++||||+++++++.+...        .+.+.+|+||||++ ++|.+++... ..+++..+..++.|++
T Consensus        47 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~  126 (303)
T 1zy4_A           47 STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL  126 (303)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHH
Confidence            457789999999999999999998865311        12367999999996 6999999854 4688999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC---------------CcccccccccccCchhhhhCCC
Q 022132           81 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---------------DFMTEYVVTRWYRAPELLLNSS  145 (302)
Q Consensus        81 ~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~  145 (302)
                      .||+|||++||+||||||+||+++.++.++|+|||.+......               .......++..|+|||.+.+..
T Consensus       127 ~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  206 (303)
T 1zy4_A          127 EALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG  206 (303)
T ss_dssp             HHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCS
T ss_pred             HHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCC
Confidence            9999999999999999999999999999999999998754321               1223456889999999997665


Q ss_pred             CCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCC
Q 022132          146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDH-VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH  224 (302)
Q Consensus       146 ~~~~~~DiwslG~i~~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (302)
                      .++.++||||+||++|+|++   ||..... ......+....                          ...........+
T Consensus       207 ~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~  257 (303)
T 1zy4_A          207 HYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVS--------------------------IEFPPDFDDNKM  257 (303)
T ss_dssp             CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTT--------------------------CCCCTTCCTTTS
T ss_pred             CCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccc--------------------------cccCccccccch
Confidence            68999999999999999998   4432211 11111111000                          000011223567


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHhcCCCcCC
Q 022132          225 PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  256 (302)
Q Consensus       225 ~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  256 (302)
                      +.+.++|.+||+.||.+|||++++++||||..
T Consensus       258 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          258 KVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            78999999999999999999999999999975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=291.05  Aligned_cols=216  Identities=12%  Similarity=0.095  Sum_probs=170.7

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ...+.+|+.+++.++||||+++++++.... .+.+.+|+||||++++|.+++...+.+++..+..++.||+.||+|||+.
T Consensus        92 ~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~  170 (345)
T 2v62_A           92 KKDCIKKWIERKQLDYLGIPLFYGSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN  170 (345)
T ss_dssp             CHHHHHHHHHHHTCSCCCCCCEEEEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhHHHHHHHhhccccccCcceeeccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            335778899999999999999999987721 1117899999999889999998777899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCC--CEEEeecccccccCCC--------CcccccccccccCchhhhhCCCCCCCchhHHHHHHH
Q 022132           90 NVLHRDLKPSNLLLNANC--DLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  159 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  159 (302)
                      ||+||||||+||+++.++  .++|+|||+++.....        .......+|..|+|||.+.+. .++.++|||||||+
T Consensus       171 ~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~i  249 (345)
T 2v62_A          171 EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYC  249 (345)
T ss_dssp             TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHH
T ss_pred             CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHH
Confidence            999999999999999887  9999999999754322        112445789999999998654 48999999999999


Q ss_pred             HHHHHhCCCCCCCC-ChHHHHHHHH-HHhCCCChHHHhhhhHhHHHHhhhccccccccccccC--CCCCHHHHHHHHHcc
Q 022132          160 FMELMDRKPLFPGR-DHVHQLRLLI-ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF--PNVHPSAIDLVEKML  235 (302)
Q Consensus       160 ~~~ll~g~~pf~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L  235 (302)
                      +|+|++|..||.+. .......... ......+..                       .....  ..+++.+.++|.+||
T Consensus       250 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l  306 (345)
T 2v62_A          250 MLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQS-----------------------VLKWAPSGSSCCEIAQFLVCAH  306 (345)
T ss_dssp             HHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHH-----------------------HHHHSCTTSCCHHHHHHHHHHH
T ss_pred             HHHHHhCCCCccccccccHHHHHHHHhhcccccHH-----------------------HHhhccccccHHHHHHHHHHHh
Confidence            99999999999643 2222222111 111111100                       00111  167889999999999


Q ss_pred             CCCCCCCCCHHHHhc
Q 022132          236 TFDPRQRITVEDALA  250 (302)
Q Consensus       236 ~~dP~~R~t~~ell~  250 (302)
                      ..||.+|||++++++
T Consensus       307 ~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          307 SLAYDEKPNYQALKK  321 (345)
T ss_dssp             TCCTTCCCCHHHHHH
T ss_pred             hcCcccCCCHHHHHH
Confidence            999999999999987

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.7e-40  Score=280.95  Aligned_cols=211  Identities=13%  Similarity=0.140  Sum_probs=173.6

Q ss_pred             hcCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus         9 ~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ....+.+|+.+++.+ +|+|++++++++...     ...|+||||++++|.+++... .++++..+..++.||+.||+||
T Consensus        48 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l  122 (298)
T 1csn_A           48 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI  122 (298)
T ss_dssp             TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC-----ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH
Confidence            345678999999999 899999999999877     889999999999999999864 4699999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCC-----EEEeecccccccCCCC--------cccccccccccCchhhhhCCCCCCCchhH
Q 022132           87 HSANVLHRDLKPSNLLLNANCD-----LKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDV  153 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~-----~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  153 (302)
                      |++||+||||||+||+++.++.     ++|+|||++.......        ......+|..|+|||.+.+. .++.++||
T Consensus       123 H~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di  201 (298)
T 1csn_A          123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDL  201 (298)
T ss_dssp             HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHH
T ss_pred             HhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHH
Confidence            9999999999999999987776     9999999997654332        23455789999999998654 48999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          154 WSVGCIFMELMDRKPLFPGRD---HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       154 wslG~i~~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      |||||++++|++|..||.+.+   ....+..+......                         .+.....+.+++.+.++
T Consensus       202 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~l~~l  256 (298)
T 1csn_A          202 EALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-------------------------TPLRELCAGFPEEFYKY  256 (298)
T ss_dssp             HHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-------------------------SCHHHHTTTSCHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC-------------------------ccHHHHHhhCcHHHHHH
Confidence            999999999999999998753   22223222221111                         11122334688999999


Q ss_pred             HHHccCCCCCCCCCHHHHhc
Q 022132          231 VEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       231 i~~~L~~dP~~R~t~~ell~  250 (302)
                      +.+||+.||.+|||++++++
T Consensus       257 i~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          257 MHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHhcCCcccCCCHHHHHH
Confidence            99999999999999999876

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-40  Score=290.36  Aligned_cols=205  Identities=21%  Similarity=0.304  Sum_probs=171.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC------------------------C
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN------------------------Q   65 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------~   65 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...                        .
T Consensus        95 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (343)
T 1luf_A           95 ADFQREAALMAEFDNPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP  169 (343)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------C
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEccC-----CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCC
Confidence            3578999999999999999999999887     88999999997 5999999763                        5


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhh
Q 022132           66 ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLL  142 (302)
Q Consensus        66 ~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~  142 (302)
                      .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......   .......++..|+|||.+.
T Consensus       170 ~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  249 (343)
T 1luf_A          170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF  249 (343)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc
Confidence            7999999999999999999999999999999999999999999999999998754332   1223456788899999986


Q ss_pred             CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC
Q 022132          143 NSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP  221 (302)
Q Consensus       143 ~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (302)
                      +.. ++.++|||||||++|+|++ |..||.+.+.......+....                             ......
T Consensus       250 ~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~  299 (343)
T 1luf_A          250 YNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-----------------------------ILACPE  299 (343)
T ss_dssp             HCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----------------------------CCCCCT
T ss_pred             cCC-cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC-----------------------------cCCCCC
Confidence            544 8999999999999999998 999998877655444332210                             011223


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          222 NVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       222 ~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      .+++.+.++|.+||+.||.+|||+.++++
T Consensus       300 ~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          300 NCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            67889999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.2e-40  Score=285.26  Aligned_cols=208  Identities=25%  Similarity=0.345  Sum_probs=172.8

Q ss_pred             cCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC------------------CCCH
Q 022132           10 RGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ------------------ALSE   69 (302)
Q Consensus        10 ~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------------------~l~~   69 (302)
                      ...+.+|+.+++++ +||||+++++++...     +..|+||||++ |+|.+++....                  .+++
T Consensus        70 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (313)
T 1t46_A           70 REALMSELKVLSYLGNHMNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL  144 (313)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCH
T ss_pred             HHHHHHHHHHHhhcccCCCeeeEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCH
Confidence            34678999999999 999999999999887     78999999996 59999997653                  4899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc---ccccccccccCchhhhhCCCC
Q 022132           70 EHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSD  146 (302)
Q Consensus        70 ~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~  146 (302)
                      ..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++........   .....++..|+|||.+.+. .
T Consensus       145 ~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~  223 (313)
T 1t46_A          145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-V  223 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-C
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-C
Confidence            99999999999999999999999999999999999999999999999976544321   2334567789999998654 4


Q ss_pred             CCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCH
Q 022132          147 YTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP  225 (302)
Q Consensus       147 ~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (302)
                      ++.++|||||||++++|++ |.+||.+................+                            ......++
T Consensus       224 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~  275 (313)
T 1t46_A          224 YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM----------------------------LSPEHAPA  275 (313)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC----------------------------CCCTTSCH
T ss_pred             CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC----------------------------CCcccCCH
Confidence            8999999999999999998 999998776544433333211110                            11235788


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          226 SAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       226 ~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      .+.++|.+||+.||.+|||+++++++
T Consensus       276 ~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          276 EMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            99999999999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-40  Score=295.28  Aligned_cols=206  Identities=21%  Similarity=0.340  Sum_probs=170.9

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.++++++||||+++++++...     +.+|+||||++ |+|.+++... ..+++..+..++.|++.||+|||
T Consensus       156 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH  230 (377)
T 3cbl_A          156 KAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE  230 (377)
T ss_dssp             HTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            35788999999999999999999999887     78999999996 7999999764 46999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc---cccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      ++||+||||||+||+++.++.+||+|||+++........   ....++..|+|||.+... .++.++|||||||++++|+
T Consensus       231 ~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~  309 (377)
T 3cbl_A          231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETF  309 (377)
T ss_dssp             HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHH
T ss_pred             HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999999999999765433211   122346779999998654 4789999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |..||.+.+.......+......                             .....+++.+.+||.+||+.||.+||
T Consensus       310 t~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rp  360 (377)
T 3cbl_A          310 SLGASPYPNLSNQQTREFVEKGGRL-----------------------------PCPELCPDAVFRLMEQCWAYEPGQRP  360 (377)
T ss_dssp             TTSCCSSTTSCHHHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             hCCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCCchhCc
Confidence            8 99999887765544333211100                             11225788999999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |++++++
T Consensus       361 s~~~i~~  367 (377)
T 3cbl_A          361 SFSTIYQ  367 (377)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999975

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-40  Score=289.48  Aligned_cols=208  Identities=24%  Similarity=0.352  Sum_probs=171.7

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-----------------------
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-----------------------   65 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------------------   65 (302)
                      ..+.+|+.+++++ +||||+++++++...     +.+|+||||++ |+|.+++....                       
T Consensus        93 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (344)
T 1rjb_A           93 EALMSELKMMTQLGSHENIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN  167 (344)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEeeC-----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccc
Confidence            3577999999999 999999999999887     78999999996 69999998643                       


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhh
Q 022132           66 ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLL  142 (302)
Q Consensus        66 ~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~  142 (302)
                      .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......   ......+|..|+|||.+.
T Consensus       168 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  247 (344)
T 1rjb_A          168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF  247 (344)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc
Confidence            37999999999999999999999999999999999999999999999999997554332   123345678899999986


Q ss_pred             CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC
Q 022132          143 NSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP  221 (302)
Q Consensus       143 ~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (302)
                      +. .++.++|||||||++++|++ |..||.+................                            .....
T Consensus       248 ~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~  298 (344)
T 1rjb_A          248 EG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK----------------------------MDQPF  298 (344)
T ss_dssp             HC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC----------------------------CCCCT
T ss_pred             cC-CCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCC----------------------------CCCCC
Confidence            54 48999999999999999998 99999877644433333221100                            01123


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHhcCC
Q 022132          222 NVHPSAIDLVEKMLTFDPRQRITVEDALAHP  252 (302)
Q Consensus       222 ~~~~~~~~li~~~L~~dP~~R~t~~ell~h~  252 (302)
                      ..++.+.+||.+||+.||.+|||+++++++.
T Consensus       299 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          299 YATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            5788999999999999999999999999854

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.5e-41  Score=293.36  Aligned_cols=217  Identities=24%  Similarity=0.382  Sum_probs=155.4

Q ss_pred             chhhHHH-HHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSC-FDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-----NQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        12 ~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-----~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      .+.+|+. +++.++||||+++++++...     +..|+||||++++|.+++..     ...+++..+..++.|++.||.|
T Consensus        66 ~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~  140 (327)
T 3aln_A           66 QLLMDLDVVMRSSDCPYIVQFYGALFRE-----GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH  140 (327)
T ss_dssp             HHHHHHHHHHSSCCCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCcEeeeeeEEEeC-----CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHH
Confidence            4455655 67778999999999999987     89999999999999888863     5789999999999999999999


Q ss_pred             HHhC-CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhh---CCCCCCCchhHHHHHHHHH
Q 022132           86 IHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL---NSSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        86 LH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~i~~  161 (302)
                      ||+. ||+||||||+||+++.++.++|+|||++.............++..|+|||.+.   ....++.++|||||||+++
T Consensus       141 lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~  220 (327)
T 3aln_A          141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY  220 (327)
T ss_dssp             HHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHH
T ss_pred             HhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHH
Confidence            9999 99999999999999999999999999997765544444557899999999983   2344789999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccc-cccCCCCCHHHHHHHHHccCCCCC
Q 022132          162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF-TEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       162 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      +|++|..||.+.......  +    .                   .........+ ......+++.+.+||.+||+.||.
T Consensus       221 ~l~~g~~pf~~~~~~~~~--~----~-------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  275 (327)
T 3aln_A          221 ELATGRFPYPKWNSVFDQ--L----T-------------------QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDES  275 (327)
T ss_dssp             HHHHSCCCSSCC-------------C-------------------CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHCCCCCCCcchHHHH--H----H-------------------HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChh
Confidence            999999999764321100  0    0                   0000000011 112236789999999999999999


Q ss_pred             CCCCHHHHhcCCCcCCcc
Q 022132          241 QRITVEDALAHPYLGSLH  258 (302)
Q Consensus       241 ~R~t~~ell~h~~~~~~~  258 (302)
                      +|||++++++||||....
T Consensus       276 ~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          276 KRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             GSCCHHHHTTSHHHHHHH
T ss_pred             hCcCHHHHHhChHHHHhH
Confidence            999999999999998654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=286.19  Aligned_cols=208  Identities=21%  Similarity=0.343  Sum_probs=170.5

Q ss_pred             hcCchhhHHHHHHhc----CCCCccccceeeCCCCCCCCCcEEEEEec-CC-ccHHHHHHcCCCCCHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWI----MKTSVVAIRDIIPPPQRESFNDVYIAYEL-MD-TDLHQIIRSNQALSEEHCQYFLYQILRG   82 (302)
Q Consensus         9 ~~~~~~~E~~il~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~-~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~   82 (302)
                      ....+.+|+.+++++    +||||+++++++...     +..++|||| +. ++|.+++...+.+++..+..++.||+.|
T Consensus        77 ~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~  151 (312)
T 2iwi_A           77 DSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA  151 (312)
T ss_dssp             --CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC-----CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Confidence            445677899999999    899999999999887     789999999 54 7999999888889999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEe-cCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~  161 (302)
                      |+|||+.||+||||||+||+++ .++.++|+|||++....... .....++..|+|||.+.+....+.++|||||||+++
T Consensus       152 l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~  230 (312)
T 2iwi_A          152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLY  230 (312)
T ss_dssp             HHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHH
T ss_pred             HHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHH
Confidence            9999999999999999999999 78999999999988765432 345578999999999876554456899999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       162 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      +|++|..||.+...      +..                      ..        ......+++.+.++|.+||+.||.+
T Consensus       231 ~l~~g~~pf~~~~~------~~~----------------------~~--------~~~~~~~~~~~~~li~~~l~~~p~~  274 (312)
T 2iwi_A          231 DMVCGDIPFERDQE------ILE----------------------AE--------LHFPAHVSPDCCALIRRCLAPKPSS  274 (312)
T ss_dssp             HHHHSSCSCCSHHH------HHH----------------------TC--------CCCCTTSCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHCCCCCCChHH------Hhh----------------------hc--------cCCcccCCHHHHHHHHHHccCChhh
Confidence            99999999964311      000                      00        0112367889999999999999999


Q ss_pred             CCCHHHHhcCCCcCCcc
Q 022132          242 RITVEDALAHPYLGSLH  258 (302)
Q Consensus       242 R~t~~ell~h~~~~~~~  258 (302)
                      |||++|+++||||+...
T Consensus       275 Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          275 RPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             SCCHHHHHHSTTTCC--
T ss_pred             CcCHHHHhcChhhcCch
Confidence            99999999999998754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.1e-40  Score=288.27  Aligned_cols=205  Identities=20%  Similarity=0.254  Sum_probs=168.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++..      +..++||||+. |+|.+++... +.+++..+..++.||+.||+|||+
T Consensus        60 ~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  133 (325)
T 3kex_A           60 QAVTDHMLAIGSLDHAHIVRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE  133 (325)
T ss_dssp             CSCCHHHHHHHTCCCTTBCCEEEEECB------SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEcC------CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            467789999999999999999999863      57999999997 7999999864 579999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      .||+||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+.. ++.++|||||||++|+|++
T Consensus       134 ~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~  212 (325)
T 3kex_A          134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMT  212 (325)
T ss_dssp             TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHh
Confidence            999999999999999999999999999998654332   233455677899999996544 8999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |..||.+.........+.....                             .......++++.++|.+||..||.+|||
T Consensus       213 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps  263 (325)
T 3kex_A          213 FGAEPYAGLRLAEVPDLLEKGER-----------------------------LAQPQICTIDVYMVMVKCWMIDENIRPT  263 (325)
T ss_dssp             TSCCTTTTSCTTHHHHHHHTTCB-----------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCC
T ss_pred             CCCCCccccCHHHHHHHHHcCCC-----------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcC
Confidence             9999987765544333321100                             1111245678999999999999999999


Q ss_pred             HHHHhcC
Q 022132          245 VEDALAH  251 (302)
Q Consensus       245 ~~ell~h  251 (302)
                      +.+++++
T Consensus       264 ~~el~~~  270 (325)
T 3kex_A          264 FKELANE  270 (325)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5e-40  Score=283.94  Aligned_cols=213  Identities=23%  Similarity=0.369  Sum_probs=171.0

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.++++++||||+++++++.+.     +..|+||||++ ++|.+++.. .+.+++..+..++.|++.||+|||
T Consensus        51 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH  125 (310)
T 3s95_A           51 QRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH  125 (310)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            44678999999999999999999999987     88999999996 599999986 578999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcc---------------cccccccccCchhhhhCCCCCCCchh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM---------------TEYVVTRWYRAPELLLNSSDYTAAID  152 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~~D  152 (302)
                      +.||+||||||+||+++.++.++|+|||.+.........               ....||+.|+|||.+.+ ..++.++|
T Consensus       126 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D  204 (310)
T 3s95_A          126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVD  204 (310)
T ss_dssp             HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHH
T ss_pred             hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHH
Confidence            999999999999999999999999999999765432211               14578999999999865 45899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHH
Q 022132          153 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE  232 (302)
Q Consensus       153 iwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  232 (302)
                      |||+||++++|++|..||.........              .   .........          ....+.+++.+.+++.
T Consensus       205 i~slG~~l~el~~g~~~~~~~~~~~~~--------------~---~~~~~~~~~----------~~~~~~~~~~l~~li~  257 (310)
T 3s95_A          205 VFSFGIVLCEIIGRVNADPDYLPRTMD--------------F---GLNVRGFLD----------RYCPPNCPPSFFPITV  257 (310)
T ss_dssp             HHHHHHHHHHHHHTCCSSTTTSCBCTT--------------S---SBCHHHHHH----------HTCCTTCCTTHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCcchhhhHHH--------------H---hhhhhcccc----------ccCCCCCCHHHHHHHH
Confidence            999999999999999998643211000              0   000000000          0112367889999999


Q ss_pred             HccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          233 KMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       233 ~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                      +||+.||.+|||++++++  ++..+
T Consensus       258 ~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          258 RCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             HHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             HHccCChhhCcCHHHHHH--HHHHH
Confidence            999999999999999987  55554

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.9e-40  Score=287.70  Aligned_cols=205  Identities=21%  Similarity=0.285  Sum_probs=168.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++...      ..++|+||+. |+|.+++.. .+.+++..+..++.||+.||+|||+
T Consensus        62 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~  135 (327)
T 3poz_A           62 KEILDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED  135 (327)
T ss_dssp             HHHHHHHHHHHHCCBTTBCCEEEEEESS------SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEEecC------CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            4678999999999999999999999874      4788889886 799999976 4679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +||+||||||+||+++.++.++|+|||+++......   ......+|..|+|||.+.+. .++.++|||||||++|+|++
T Consensus       136 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt  214 (327)
T 3poz_A          136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             CCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHh
Confidence            999999999999999999999999999997654332   12234557789999998754 48999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |..||.+.+.......+.....                             ....+..+..+.+++.+||+.||.+|||
T Consensus       215 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps  265 (327)
T 3poz_A          215 FGSKPYDGIPASEISSILEKGER-----------------------------LPQPPICTIDVYMIMVKCWMIDADSRPK  265 (327)
T ss_dssp             TSCCTTTTCCGGGHHHHHHTTCC-----------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCC
T ss_pred             cCCCCccCCCHHHHHHHHHcCCC-----------------------------CCCCccCCHHHHHHHHHHcCCChhhCCC
Confidence             9999987765443332221110                             1112357789999999999999999999


Q ss_pred             HHHHhcC
Q 022132          245 VEDALAH  251 (302)
Q Consensus       245 ~~ell~h  251 (302)
                      +.+++++
T Consensus       266 ~~ell~~  272 (327)
T 3poz_A          266 FRELIIE  272 (327)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.3e-40  Score=292.21  Aligned_cols=205  Identities=21%  Similarity=0.325  Sum_probs=161.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++...     +.+|+||||++ ++|.+++... ..+++..+..++.||+.||+|||+
T Consensus        91 ~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  165 (373)
T 2qol_A           91 RDFLGEASIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD  165 (373)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999887     88999999995 7999999865 479999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .||+||||||+||+++.++.+||+|||++.......    ......++..|+|||.+.+. .++.++|||||||++++|+
T Consensus       166 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ell  244 (373)
T 2qol_A          166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVM  244 (373)
T ss_dssp             TTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHH
T ss_pred             CCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHH
Confidence            999999999999999999999999999997654321    11222346779999998654 4899999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |..||.+.+..+....+......                             .....++..+.+++.+||+.||.+||
T Consensus       245 t~g~~P~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dp~~RP  295 (373)
T 2qol_A          245 SYGERPYWEMSNQDVIKAVDEGYRL-----------------------------PPPMDCPAALYQLMLDCWQKDRNNRP  295 (373)
T ss_dssp             TTC-CTTTTCCHHHHHHHHHTTEEC-----------------------------CCCTTCBHHHHHHHHHHTCSSGGGSC
T ss_pred             hCCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCccccHHHHHHHHHHhCcChhhCc
Confidence            7 99999877765544433221111                             11125678999999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |++++++
T Consensus       296 s~~~i~~  302 (373)
T 2qol_A          296 KFEQIVS  302 (373)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999876

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=291.85  Aligned_cols=222  Identities=9%  Similarity=0.118  Sum_probs=173.5

Q ss_pred             hhHHHHhcCchhhHHHHHHhcCCCCccccc---------------eeeCCCCCCCCCcEEEEEecCCccHHHHHHcC--C
Q 022132            3 SITKLMQRGHFVRSSCFDTWIMKTSVVAIR---------------DIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--Q   65 (302)
Q Consensus         3 ~~~~~~~~~~~~~E~~il~~l~h~niv~l~---------------~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~   65 (302)
                      |+|....+..+.+|+.++++++||||++++               +++...    .+.+|+||||++++|.+++...  +
T Consensus        79 avK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~  154 (352)
T 2jii_A           79 SLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQ----DKYRFLVLPSLGRSLQSALDVSPKH  154 (352)
T ss_dssp             EEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEET----TTEEEEEEECCCEEHHHHHHHSGGG
T ss_pred             EEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccC----CcEEEEEecCCCcCHHHHHHhCCcC
Confidence            455566667889999999999999999844               444331    1789999999988999999876  7


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC--CEEEeecccccccCCCC--------ccccccccccc
Q 022132           66 ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDFGLARVTSETD--------FMTEYVVTRWY  135 (302)
Q Consensus        66 ~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y  135 (302)
                      .+++..+..++.||+.||+|||++||+||||||+||+++.++  .++|+|||++.......        ......+|..|
T Consensus       155 ~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y  234 (352)
T 2jii_A          155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEF  234 (352)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccc
Confidence            899999999999999999999999999999999999999998  89999999997544321        12344789999


Q ss_pred             CchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHH-HhCCCChHHHhhhhHhHHHHhhhcccccc
Q 022132          136 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQLRLLIE-LIGTPSEAELGFLNENAKKYICQLPRYQR  213 (302)
Q Consensus       136 ~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (302)
                      +|||.+.+. .++.++|||||||++|+|++|..||.+.. ....+..... ....+.                   ... 
T Consensus       235 ~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------~~~-  293 (352)
T 2jii_A          235 ISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPG-------------------PFV-  293 (352)
T ss_dssp             CCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCC-------------------CEE-
T ss_pred             cCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChh-------------------hhh-
Confidence            999998654 48999999999999999999999997654 2222222211 111110                   000 


Q ss_pred             ccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          214 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       214 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                       .....+..+++.+.+||.+||+.||.+|||++++++
T Consensus       294 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          294 -GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             -CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             -hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence             000112257899999999999999999999999977

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.7e-40  Score=280.21  Aligned_cols=206  Identities=21%  Similarity=0.318  Sum_probs=167.6

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.+++.++||||+++++++..      +..|+||||++ ++|.+++... ..+++..+..++.|++.||+|||
T Consensus        57 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH  130 (281)
T 3cc6_A           57 KEKFMSEAVIMKNLDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE  130 (281)
T ss_dssp             HHHHHHHHHHHHHHCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEcC------CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999865      45689999997 6999999754 56999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||+||||||+||+++.++.++|+|||.+.......  ......++..|+|||.+.+. .++.++|||||||++++|++
T Consensus       131 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt  209 (281)
T 3cc6_A          131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILS  209 (281)
T ss_dssp             HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             HCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHh
Confidence            9999999999999999999999999999987654332  12334567789999998644 48999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |..||...+.......+......                             .....+++.+.++|.+||..||.+|||
T Consensus       210 ~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps  260 (281)
T 3cc6_A          210 FGKQPFFWLENKDVIGVLEKGDRL-----------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPR  260 (281)
T ss_dssp             TTCCTTTTSCGGGHHHHHHHTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCcccCChHHHHHHHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHccCCchhCcC
Confidence             99999766655444333221111                             112257889999999999999999999


Q ss_pred             HHHHhcC
Q 022132          245 VEDALAH  251 (302)
Q Consensus       245 ~~ell~h  251 (302)
                      ++|++++
T Consensus       261 ~~ell~~  267 (281)
T 3cc6_A          261 FTELVCS  267 (281)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.1e-40  Score=277.70  Aligned_cols=206  Identities=19%  Similarity=0.304  Sum_probs=172.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++...     +..|+||||++ ++|.+++... +.+++..+..++.|++.||+|||+
T Consensus        48 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  122 (267)
T 3t9t_A           48 EDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE  122 (267)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh
Confidence            4678999999999999999999999887     78999999996 6999999764 568999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      .|++||||||+||+++.++.++|+|||.+.......  ......++..|+|||.+.+. .++.++|+||+|+++++|++ 
T Consensus       123 ~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~  201 (267)
T 3t9t_A          123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSE  201 (267)
T ss_dssp             TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhcc
Confidence            999999999999999999999999999987654321  12334567789999998654 47999999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+.......+.....                             .......++.+.+++.+||+.||.+|||+
T Consensus       202 g~~p~~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~  252 (267)
T 3t9t_A          202 GKIPYENRSNSEVVEDISTGFR-----------------------------LYKPRLASTHVYQIMNHCWRERPEDRPAF  252 (267)
T ss_dssp             SCCTTTTCCHHHHHHHHHTTCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCCHHHHHHHHhcCCc-----------------------------CCCCccCcHHHHHHHHHHccCChhhCcCH
Confidence            8999988776655444332110                             01112467899999999999999999999


Q ss_pred             HHHhcC
Q 022132          246 EDALAH  251 (302)
Q Consensus       246 ~ell~h  251 (302)
                      ++++++
T Consensus       253 ~~ll~~  258 (267)
T 3t9t_A          253 SRLLRQ  258 (267)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.7e-40  Score=284.96  Aligned_cols=205  Identities=23%  Similarity=0.360  Sum_probs=172.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------QALSEEHCQYFLYQIL   80 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qll   80 (302)
                      .+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++...          ..+++..+..++.||+
T Consensus        74 ~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  148 (322)
T 1p4o_A           74 EFLNEASVMKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA  148 (322)
T ss_dssp             HHHHHHHHGGGCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCEeeeEEEEccC-----CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHH
Confidence            577999999999999999999999887     78999999997 6999998752          4579999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHH
Q 022132           81 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG  157 (302)
Q Consensus        81 ~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  157 (302)
                      .||+|||++||+||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+. .++.++||||||
T Consensus       149 ~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG  227 (322)
T 1p4o_A          149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFG  227 (322)
T ss_dssp             HHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHH
T ss_pred             HHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHH
Confidence            99999999999999999999999999999999999987554332   12334567889999998654 489999999999


Q ss_pred             HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccC
Q 022132          158 CIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  236 (302)
Q Consensus       158 ~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  236 (302)
                      |++++|++ |.+||.+.+.......+....                             .......+++.+.++|.+||+
T Consensus       228 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~  278 (322)
T 1p4o_A          228 VVLWEIATLAEQPYQGLSNEQVLRFVMEGG-----------------------------LLDKPDNCPDMLFELMRMCWQ  278 (322)
T ss_dssp             HHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTC
T ss_pred             HHHHHHHhcCCCccccCCHHHHHHHHHcCC-----------------------------cCCCCCCCCHHHHHHHHHHcC
Confidence            99999999 899998877655544333210                             011223678899999999999


Q ss_pred             CCCCCCCCHHHHhcC
Q 022132          237 FDPRQRITVEDALAH  251 (302)
Q Consensus       237 ~dP~~R~t~~ell~h  251 (302)
                      .||.+|||+.|++++
T Consensus       279 ~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          279 YNPKMRPSFLEIISS  293 (322)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CCcccCcCHHHHHHH
Confidence            999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7e-40  Score=283.34  Aligned_cols=211  Identities=19%  Similarity=0.273  Sum_probs=164.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHH------cCCCCCHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR------SNQALSEEHCQYFLYQILRGL   83 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~------~~~~l~~~~~~~i~~qll~~l   83 (302)
                      ..+.+|+.++++++||||+++++++......+....|+||||++ ++|.+++.      ..+.+++..+..++.||+.||
T Consensus        81 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL  160 (313)
T 3brb_A           81 EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM  160 (313)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHH
Confidence            35779999999999999999999998764333346799999997 69999984      335799999999999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           84 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      .|||++||+||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+. .++.++|||||||++
T Consensus       161 ~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il  239 (313)
T 3brb_A          161 EYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTM  239 (313)
T ss_dssp             HHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHH
T ss_pred             HHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHH
Confidence            99999999999999999999999999999999987654331   12334567789999998654 489999999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC
Q 022132          161 MELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       161 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      ++|++ |.+||.+.+.......+.....                             ......+++.+.++|.+||..||
T Consensus       240 ~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp  290 (313)
T 3brb_A          240 WEIATRGMTPYPGVQNHEMYDYLLHGHR-----------------------------LKQPEDCLDELYEIMYSCWRTDP  290 (313)
T ss_dssp             HHHHTTSCCSSTTCCGGGHHHHHHTTCC-----------------------------CCCBTTCCHHHHHHHHHTTCSSG
T ss_pred             HHHHhcCCCCCccCCHHHHHHHHHcCCC-----------------------------CCCCccccHHHHHHHHHHcCCCh
Confidence            99999 9999987765544433322110                             11123678899999999999999


Q ss_pred             CCCCCHHHHhcC
Q 022132          240 RQRITVEDALAH  251 (302)
Q Consensus       240 ~~R~t~~ell~h  251 (302)
                      .+|||+++++++
T Consensus       291 ~~Rps~~~l~~~  302 (313)
T 3brb_A          291 LDRPTFSVLRLQ  302 (313)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hhCcCHHHHHHH
Confidence            999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=284.32  Aligned_cols=206  Identities=21%  Similarity=0.321  Sum_probs=166.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++...     +.+|+||||++ ++|.+++... +.+++..+..++.||+.||+|||+
T Consensus        91 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  165 (333)
T 1mqb_A           91 VDFLGEAGIMGQFSHHNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN  165 (333)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEecC-----CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3577999999999999999999999887     88999999997 5999999764 679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .||+||||||+||+++.++.++|+|||.+.......    ......++..|+|||.+.+. .++.++|||||||++++|+
T Consensus       166 ~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell  244 (333)
T 1mqb_A          166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVM  244 (333)
T ss_dssp             TTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHH
T ss_pred             CCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHH
Confidence            999999999999999999999999999997654321    11223456789999998654 4899999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |..||.+.+.......+......                             .....+++.+.++|.+||+.||.+||
T Consensus       245 t~g~~pf~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp  295 (333)
T 1mqb_A          245 TYGERPYWELSNHEVMKAINDGFRL-----------------------------PTPMDCPSAIYQLMMQCWQQERARRP  295 (333)
T ss_dssp             TTSCCTTTTCCHHHHHHHHHTTCCC-----------------------------CCCTTCBHHHHHHHHHHTCSSTTTSC
T ss_pred             cCCCCCcccCCHHHHHHHHHCCCcC-----------------------------CCcccCCHHHHHHHHHHcCCChhhCc
Confidence            8 99999887765554443321111                             11225788999999999999999999


Q ss_pred             CHHHHhcC
Q 022132          244 TVEDALAH  251 (302)
Q Consensus       244 t~~ell~h  251 (302)
                      |+.+++++
T Consensus       296 s~~~l~~~  303 (333)
T 1mqb_A          296 KFADIVSI  303 (333)
T ss_dssp             CHHHHHHH
T ss_pred             CHHHHHHH
Confidence            99999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.3e-39  Score=278.60  Aligned_cols=210  Identities=20%  Similarity=0.289  Sum_probs=163.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||++++++...      +..++||||++ ++|.+++.. ...+++..+..++.|++.||+|||+
T Consensus        65 ~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~  138 (289)
T 3og7_A           65 QAFKNEVGVLRKTRHVNILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA  138 (289)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECS------SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCcEEEEEeeccC------CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            457899999999999999999997643      56899999997 699999854 4679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCC---CCcccccccccccCchhhhhC--CCCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i~~~l  163 (302)
                      .||+||||||+||+++.++.++|+|||++.....   ........++..|+|||.+..  ...++.++|||||||++++|
T Consensus       139 ~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el  218 (289)
T 3og7_A          139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL  218 (289)
T ss_dssp             TTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHH
T ss_pred             CCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHH
Confidence            9999999999999999999999999999875432   222344568999999999852  34578899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|..||.+................+.                        .+......+++.+.+||.+||+.||.+||
T Consensus       219 ~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  274 (289)
T 3og7_A          219 MTGQLPYSNINNRDQIIEMVGRGSLSP------------------------DLSKVRSNCPKRMKRLMAECLKKKRDERP  274 (289)
T ss_dssp             HHSSCTTSSCCCHHHHHHHHHHTSCCC------------------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHCCCCccccchHHHHHHHhcccccCc------------------------chhhccccCCHHHHHHHHHHccCChhhCC
Confidence            999999988776665544443222111                        11223346789999999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |++++++
T Consensus       275 s~~ell~  281 (289)
T 3og7_A          275 SFPRILA  281 (289)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-39  Score=279.30  Aligned_cols=204  Identities=20%  Similarity=0.276  Sum_probs=170.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++. .     +..|+||||++ ++|.+++...+.+++..+..++.||+.||+|||+.
T Consensus        63 ~~~~~e~~~l~~l~h~~i~~~~~~~~-~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~  136 (291)
T 1xbb_A           63 DELLAEANVMQQLDNPYIVRMIGICE-A-----ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES  136 (291)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEE-S-----SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEC-C-----CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            45779999999999999999999993 3     67899999997 69999999888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCc----ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ||+||||||+||+++.++.++|+|||++........    .....++..|+|||.+.+. .++.++||||||+++++|++
T Consensus       137 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~  215 (291)
T 1xbb_A          137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFS  215 (291)
T ss_dssp             TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHT
T ss_pred             CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHh
Confidence            999999999999999999999999999876543321    1223456789999998654 47889999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |..||.+.+.......+....                             .....+.+++.+.++|.+||+.||.+|||
T Consensus       216 ~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps  266 (291)
T 1xbb_A          216 YGQKPYRGMKGSEVTAMLEKGE-----------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPG  266 (291)
T ss_dssp             TTCCSSTTCCHHHHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             cCCCCCCCCCHHHHHHHHHcCC-----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence             999998877655443332210                             01122367889999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      +.++++
T Consensus       267 ~~~l~~  272 (291)
T 1xbb_A          267 FAAVEL  272 (291)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999976

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.8e-40  Score=279.31  Aligned_cols=205  Identities=23%  Similarity=0.371  Sum_probs=172.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.++++++||||+++++++...     +.+|+||||++ ++|.+++...  ..+++..+..++.|++.||+|||
T Consensus        54 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH  128 (288)
T 3kfa_A           54 EEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE  128 (288)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH
Confidence            3577999999999999999999999887     88999999997 6999999863  45999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||+||||||+||+++.++.++|+|||.+.......  ......++..|+|||.+.+. .++.++||||||+++++|++
T Consensus       129 ~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~  207 (288)
T 3kfa_A          129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIAT  207 (288)
T ss_dssp             HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999999997655432  22334567789999998654 48999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.+.......+.....                             ......+++.+.+|+.+||..||.+|||
T Consensus       208 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps  258 (288)
T 3kfa_A          208 YGMSPYPGIDLSQVYELLEKDYR-----------------------------MERPEGCPEKVYELMRACWQWNPSDRPS  258 (288)
T ss_dssp             TSCCSSTTCCGGGHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHhccCC-----------------------------CCCCCCCCHHHHHHHHHHhCCChhhCcC
Confidence             9999987765544333322110                             1122367889999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++++++
T Consensus       259 ~~~~~~  264 (288)
T 3kfa_A          259 FAEIHQ  264 (288)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999976

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.9e-40  Score=277.19  Aligned_cols=205  Identities=24%  Similarity=0.341  Sum_probs=162.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++. .+.+++..+..++.|++.||+|||++
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~  124 (271)
T 3dtc_A           51 ENVRQEAKLFAMLKHPNIIALRGVCLKE-----PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDE  124 (271)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECCC-------CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHhcCCCCEeeEEEEEecC-----CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3577899999999999999999999887     78999999996 68888875 46899999999999999999999999


Q ss_pred             C---ceecCCCCCCEEEec--------CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHH
Q 022132           90 N---VLHRDLKPSNLLLNA--------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC  158 (302)
Q Consensus        90 ~---i~H~dikp~Nil~~~--------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  158 (302)
                      |   |+||||||+||+++.        ++.++|+|||.+....... .....++..|+|||.+.+. .++.++||||+|+
T Consensus       125 ~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~  202 (271)
T 3dtc_A          125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGV  202 (271)
T ss_dssp             SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHH
T ss_pred             CCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHH
Confidence            9   999999999999986        6789999999997654432 2345789999999998654 4899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCC
Q 022132          159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       159 i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  238 (302)
                      ++++|++|..||.+.+.............                            .......+++.+.+++.+||+.|
T Consensus       203 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~  254 (271)
T 3dtc_A          203 LLWELLTGEVPFRGIDGLAVAYGVAMNKL----------------------------ALPIPSTCPEPFAKLMEDCWNPD  254 (271)
T ss_dssp             HHHHHHHCCCTTTTSCHHHHHHHHHTSCC----------------------------CCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHhhhcCCC----------------------------CCCCCcccCHHHHHHHHHHhcCC
Confidence            99999999999987765544332221100                            01112367889999999999999


Q ss_pred             CCCCCCHHHHhcC
Q 022132          239 PRQRITVEDALAH  251 (302)
Q Consensus       239 P~~R~t~~ell~h  251 (302)
                      |.+|||++|++++
T Consensus       255 p~~Rps~~e~l~~  267 (271)
T 3dtc_A          255 PHSRPSFTNILDQ  267 (271)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             cccCcCHHHHHHH
Confidence            9999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.4e-39  Score=284.11  Aligned_cols=205  Identities=25%  Similarity=0.388  Sum_probs=172.3

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHH
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQ   73 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~   73 (302)
                      .+.+|+.+++.+ +||||+++++++...     +.+|+||||++ ++|.+++....                .+++..+.
T Consensus        86 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (334)
T 2pvf_A           86 DLVSEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV  160 (334)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCEeeEEEEEccC-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHH
Confidence            577999999999 999999999999887     88999999996 59999998653                38999999


Q ss_pred             HHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCc
Q 022132           74 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAA  150 (302)
Q Consensus        74 ~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~  150 (302)
                      .++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+. .++.+
T Consensus       161 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~  239 (334)
T 2pvf_A          161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQ  239 (334)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHH
T ss_pred             HHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChH
Confidence            999999999999999999999999999999999999999999997655432   12334567789999998654 47899


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHH
Q 022132          151 IDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID  229 (302)
Q Consensus       151 ~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (302)
                      +|||||||++++|++ |..||.+.+.......+.....                             ......+++.+.+
T Consensus       240 ~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~  290 (334)
T 2pvf_A          240 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR-----------------------------MDKPANCTNELYM  290 (334)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC-----------------------------CCCCTTCCHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC-----------------------------CCCCccCCHHHHH
Confidence            999999999999999 9999988776555443332111                             1112367889999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcC
Q 022132          230 LVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       230 li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +|.+||..||.+|||+++++++
T Consensus       291 li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          291 MMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.2e-40  Score=288.90  Aligned_cols=218  Identities=16%  Similarity=0.117  Sum_probs=166.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+..++.++||||+++++++..... +....|+||||++++|.+++... +.+++..+..++.||+.||+|||+.|
T Consensus        94 ~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~  172 (364)
T 3op5_A           94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKN-GKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE  172 (364)
T ss_dssp             HHHHHHHHHTTCSCCCSCCEEEEEEEEET-TEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHhhccCCCCCeEEeeeeeccC-CcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34566677777889999999999876421 12568999999988999999875 68999999999999999999999999


Q ss_pred             ceecCCCCCCEEEe--cCCCEEEeecccccccCCCC--------cccccccccccCchhhhhCCCCCCCchhHHHHHHHH
Q 022132           91 VLHRDLKPSNLLLN--ANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        91 i~H~dikp~Nil~~--~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~  160 (302)
                      |+||||||+||+++  .++.++|+|||+++......        ......||..|+|||.+.+. .++.++|||||||++
T Consensus       173 iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l  251 (364)
T 3op5_A          173 YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCM  251 (364)
T ss_dssp             EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHH
T ss_pred             eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHH
Confidence            99999999999999  88999999999997543321        11334589999999998654 489999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      |+|++|..||.+................          .........       .+  ....+++.+.+++..||..||.
T Consensus       252 ~el~~g~~Pf~~~~~~~~~~~~~~~~~~----------~~~~~~~~~-------~~--~~~~~~~~~~~li~~cl~~~p~  312 (364)
T 3op5_A          252 IQWLTGHLPWEDNLKDPKYVRDSKIRYR----------ENIASLMDK-------CF--PAANAPGEIAKYMETVKLLDYT  312 (364)
T ss_dssp             HHHHHSCCTTGGGTTCHHHHHHHHHHHH----------HCHHHHHHH-------HS--CTTCCCHHHHHHHHHHHTCCTT
T ss_pred             HHHHhCCCCccccccCHHHHHHHHHHhh----------hhHHHHHHH-------hc--ccccCHHHHHHHHHHHhcCCCC
Confidence            9999999999854322222211111000          000000000       00  0136788999999999999999


Q ss_pred             CCCCHHHHhc
Q 022132          241 QRITVEDALA  250 (302)
Q Consensus       241 ~R~t~~ell~  250 (302)
                      +|||++++++
T Consensus       313 ~RP~~~~l~~  322 (364)
T 3op5_A          313 EKPLYENLRD  322 (364)
T ss_dssp             CCCCHHHHHH
T ss_pred             CCCCHHHHHH
Confidence            9999999876

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-39  Score=295.25  Aligned_cols=204  Identities=22%  Similarity=0.346  Sum_probs=168.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.++++++||||+++++++....    +.+|+||||++ |+|.+++...+  .+++..+..++.||+.||+|||
T Consensus       231 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH  306 (450)
T 1k9a_A          231 QAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE  306 (450)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999987652    47999999996 69999998654  3799999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-C
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-R  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g  166 (302)
                      ++||+||||||+||+++.++.+||+|||+++.....  .....++..|+|||.+.+. .++.++|||||||++++|++ |
T Consensus       307 ~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g  383 (450)
T 1k9a_A          307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFG  383 (450)
T ss_dssp             HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTT
T ss_pred             hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999999755433  2233567889999999654 48999999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ..||.+.+..+....+.....                             ....+.+++.+.++|.+||+.||.+|||+.
T Consensus       384 ~~P~~~~~~~~~~~~i~~~~~-----------------------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~  434 (450)
T 1k9a_A          384 RVPYPRIPLKDVVPRVEKGYK-----------------------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFL  434 (450)
T ss_dssp             CCSSTTSCTTTHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence            999987765544433321100                             112236789999999999999999999999


Q ss_pred             HHhc
Q 022132          247 DALA  250 (302)
Q Consensus       247 ell~  250 (302)
                      +++.
T Consensus       435 ~l~~  438 (450)
T 1k9a_A          435 QLRE  438 (450)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.2e-39  Score=278.28  Aligned_cols=206  Identities=22%  Similarity=0.321  Sum_probs=167.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++....    +..|+||||++ ++|.+++.. ...+++..+..++.|++.||+|||+
T Consensus        71 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~  146 (298)
T 3f66_A           71 SQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS  146 (298)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEECCSS----SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeEEEcCC----CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            45779999999999999999999865532    67899999997 599999976 4568999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC-----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      +||+||||||+||+++.++.++|+|||.+.......     ......++..|+|||.+.+. .++.++||||+||++++|
T Consensus       147 ~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l  225 (298)
T 3f66_A          147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWEL  225 (298)
T ss_dssp             TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHH
T ss_pred             CCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHH
Confidence            999999999999999999999999999997654322     22334567789999998654 489999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          164 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       164 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      ++ |.+||.+.+..+....+.....                             ......+++.+.+++.+||+.||.+|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~R  276 (298)
T 3f66_A          226 MTRGAPPYPDVNTFDITVYLLQGRR-----------------------------LLQPEYCPDPLYEVMLKCWHPKAEMR  276 (298)
T ss_dssp             HTTSCCSSTTSCTTTHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             HhCCCCCCccCCHHHHHHHHhcCCC-----------------------------CCCCccCCHHHHHHHHHHcCCChhhC
Confidence            99 7788876665444333322111                             11122567899999999999999999


Q ss_pred             CCHHHHhc
Q 022132          243 ITVEDALA  250 (302)
Q Consensus       243 ~t~~ell~  250 (302)
                      ||++++++
T Consensus       277 ps~~ell~  284 (298)
T 3f66_A          277 PSFSELVS  284 (298)
T ss_dssp             CCHHHHHH
T ss_pred             cCHHHHHH
Confidence            99999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=283.89  Aligned_cols=204  Identities=22%  Similarity=0.290  Sum_probs=163.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++...      ..++|+||+. |+|.+++.. .+.+++..+..++.||+.||+|||+
T Consensus        62 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  135 (327)
T 3lzb_A           62 KEILDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED  135 (327)
T ss_dssp             HHHHHHHHHHTTCCBTTBCCCCEEEESS------SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeeEEEEEEecC------CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            3577899999999999999999999874      4788888886 799999976 4679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +||+||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+. .++.++|||||||++|+|++
T Consensus       136 ~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~  214 (327)
T 3lzb_A          136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             TTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999997654332   22334557789999999754 48999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.+.......+.....                             ....+..++++.++|.+||..||.+|||
T Consensus       215 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps  265 (327)
T 3lzb_A          215 FGSKPYDGIPASEISSILEKGER-----------------------------LPQPPICTIDVYMIMRKCWMIDADSRPK  265 (327)
T ss_dssp             TSCCTTTTCCGGGHHHHHHTTCC-----------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCccCCHHHHHHHHHHcCCChhHCcC
Confidence             9999987765544333322111                             1112357889999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++|+++
T Consensus       266 ~~ell~  271 (327)
T 3lzb_A          266 FRELII  271 (327)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9.9e-40  Score=284.82  Aligned_cols=206  Identities=21%  Similarity=0.295  Sum_probs=170.1

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--------------CCCCCHHHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--------------NQALSEEHCQY   74 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--------------~~~l~~~~~~~   74 (302)
                      ..+.+|+.+++.+ +||||+++++++...     +.+|+||||++ |+|.+++..              ...+++..+..
T Consensus        94 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (333)
T 2i1m_A           94 EALMSELKIMSHLGQHENIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH  168 (333)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEecC-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHH
Confidence            4578999999999 899999999999887     78999999997 599999864              24689999999


Q ss_pred             HHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCch
Q 022132           75 FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAI  151 (302)
Q Consensus        75 i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~  151 (302)
                      ++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+. .++.++
T Consensus       169 ~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~  247 (333)
T 2i1m_A          169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQS  247 (333)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHH
T ss_pred             HHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHH
Confidence            99999999999999999999999999999999999999999997543321   12334567789999998654 489999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          152 DVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       152 DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      |||||||++++|++ |.+||.+................+                            ......++.+.++
T Consensus       248 Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~l  299 (333)
T 2i1m_A          248 DVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM----------------------------AQPAFAPKNIYSI  299 (333)
T ss_dssp             HHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHH
Confidence            99999999999998 999998766544433333221110                            1112467899999


Q ss_pred             HHHccCCCCCCCCCHHHHhc
Q 022132          231 VEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       231 i~~~L~~dP~~R~t~~ell~  250 (302)
                      |.+||+.||.+|||++++++
T Consensus       300 i~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          300 MQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccChhhCcCHHHHHH
Confidence            99999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=278.14  Aligned_cols=206  Identities=19%  Similarity=0.273  Sum_probs=171.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++..      +..|+||||++ ++|.+++.. ...+++..+..++.|++.||.|||+
T Consensus        55 ~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  128 (287)
T 1u59_A           55 EEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE  128 (287)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEecC------CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH
Confidence            457799999999999999999999943      56999999997 599999864 3569999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc----ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .||+||||||+||+++.++.++|+|||++........    .....++..|+|||.+.+. .++.++|||||||++++|+
T Consensus       129 ~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell  207 (287)
T 1u59_A          129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEAL  207 (287)
T ss_dssp             TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHH
T ss_pred             CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHH
Confidence            9999999999999999999999999999976543321    2233457889999998644 4789999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |..||.+.+..+....+....                             .....+.+++.+.++|.+||..||.+||
T Consensus       208 t~g~~p~~~~~~~~~~~~i~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp  258 (287)
T 1u59_A          208 SYGQKPYKKMKGPEVMAFIEQGK-----------------------------RMECPPECPPELYALMSDCWIYKWEDRP  258 (287)
T ss_dssp             TTSCCTTTTCCTHHHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred             cCCCCCcccCCHHHHHHHHhcCC-----------------------------cCCCCCCcCHHHHHHHHHHcCCChhhCc
Confidence            8 999998877655444332210                             0112236789999999999999999999


Q ss_pred             CHHHHhcCC
Q 022132          244 TVEDALAHP  252 (302)
Q Consensus       244 t~~ell~h~  252 (302)
                      |+.+++++.
T Consensus       259 s~~~l~~~l  267 (287)
T 1u59_A          259 DFLTVEQRM  267 (287)
T ss_dssp             CHHHHHHHH
T ss_pred             CHHHHHHHH
Confidence            999999863

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.6e-40  Score=284.30  Aligned_cols=211  Identities=19%  Similarity=0.257  Sum_probs=173.8

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------QALSEEHCQYFLYQILRG   82 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qll~~   82 (302)
                      ..+.+|+.++++++||||+++++++...     +..|+||||++ ++|.+++...       ..+++..+..++.||+.|
T Consensus        78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a  152 (327)
T 2yfx_A           78 LDFLMEALIISKFNHQNIVRCIGVSLQS-----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG  152 (327)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhCCCCCCCeEEEEEcCC-----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHH
Confidence            3678899999999999999999999987     78899999995 7999999865       348999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEec---CCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCCCCchhHHHH
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  156 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  156 (302)
                      |.|||+.||+||||||+||+++.   +..++|+|||++......   .......++..|+|||.+.+. .++.++|||||
T Consensus       153 l~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~sl  231 (327)
T 2yfx_A          153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSF  231 (327)
T ss_dssp             HHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHH
T ss_pred             HHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHH
Confidence            99999999999999999999984   446999999998754322   122344668889999998654 48999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHcc
Q 022132          157 GCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  235 (302)
Q Consensus       157 G~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  235 (302)
                      ||++++|++ |.+||.+.+.......+.....                             ......+++.+.++|.+||
T Consensus       232 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l  282 (327)
T 2yfx_A          232 GVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR-----------------------------MDPPKNCPGPVYRIMTQCW  282 (327)
T ss_dssp             HHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHT
T ss_pred             HHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC-----------------------------CCCCCCCCHHHHHHHHHHh
Confidence            999999998 9999988776554443322110                             1112367889999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCcCC
Q 022132          236 TFDPRQRITVEDALAHPYLGS  256 (302)
Q Consensus       236 ~~dP~~R~t~~ell~h~~~~~  256 (302)
                      +.||.+|||+++++++.|+-.
T Consensus       283 ~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          283 QHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCChhhCcCHHHHHHHHHHHh
Confidence            999999999999999988754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.7e-39  Score=274.85  Aligned_cols=205  Identities=14%  Similarity=0.220  Sum_probs=170.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.++++++||||+++++++.....   +.+++||||++ ++|.+++...+  .+++..+..++.|++.||+|||
T Consensus        52 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH  128 (271)
T 3kmu_A           52 RDFNEECPRLRIFSHPNVLPVLGACQSPPA---PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH  128 (271)
T ss_dssp             HHHHHHGGGGCCCSCTTEECEEEEECTTTS---SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhcCCCchhheEEEEccCCC---CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh
Confidence            468899999999999999999999977532   67899999997 69999998765  4899999999999999999999


Q ss_pred             hCC--ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCC--CCCchhHHHHHHHHHHH
Q 022132           88 SAN--VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        88 ~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~i~~~l  163 (302)
                      +.|  ++||||||+||+++.++.++++|||++.....    ....+|+.|+|||.+.+...  ++.++|||||||++++|
T Consensus       129 ~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el  204 (271)
T 3kmu_A          129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWEL  204 (271)
T ss_dssp             TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHH
T ss_pred             cCCCceecCCCccceEEEcCCcceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHH
Confidence            999  99999999999999999999999988654332    23467899999999865432  23379999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|..||.+.+..............                            ....+.+++.+.++|.+||+.||.+||
T Consensus       205 ~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp  256 (271)
T 3kmu_A          205 VTREVPFADLSNMEIGMKVALEGLR----------------------------PTIPPGISPHVSKLMKICMNEDPAKRP  256 (271)
T ss_dssp             HHCSCTTTTSCHHHHHHHHHHSCCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HhCCCCccccChHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence            9999999887766554443321111                            112236789999999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |++++++
T Consensus       257 s~~~il~  263 (271)
T 3kmu_A          257 KFDMIVP  263 (271)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.3e-39  Score=295.71  Aligned_cols=204  Identities=25%  Similarity=0.396  Sum_probs=171.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.++++++||||+++++++..      +.+|+||||+. |+|.+++...  ..+++..+..++.||+.||+|||
T Consensus       228 ~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH  301 (454)
T 1qcf_A          228 EAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE  301 (454)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEEeC------CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999863      67899999996 6999999753  36899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||+||||||+||+++.++.+||+|||+++......  ......++..|+|||++... .++.++|||||||++++|++
T Consensus       302 ~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t  380 (454)
T 1qcf_A          302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVT  380 (454)
T ss_dssp             HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHh
Confidence            9999999999999999999999999999998654321  12233456789999998654 48999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.+..+....+......+                             ....+++.+.+||.+||..||.+|||
T Consensus       381 ~g~~P~~~~~~~~~~~~i~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~dp~~RPt  431 (454)
T 1qcf_A          381 YGRIPYPGMSNPEVIRALERGYRMP-----------------------------RPENCPEELYNIMMRCWKNRPEERPT  431 (454)
T ss_dssp             TSCCSSTTCCHHHHHHHHHHTCCCC-----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CCCCCCHHHHHHHHHHccCChhHCcC
Confidence             999999887766655544321111                             11267889999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      +++++.
T Consensus       432 ~~~i~~  437 (454)
T 1qcf_A          432 FEYIQS  437 (454)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999976

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-39  Score=276.90  Aligned_cols=206  Identities=25%  Similarity=0.341  Sum_probs=167.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++.+..    +..++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+
T Consensus        67 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  142 (298)
T 3pls_A           67 EAFLREGLLMRGLNHPNVLALIGIMLPPE----GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE  142 (298)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEECCSS----SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEecCC----CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            46779999999999999999999998762    34589999985 799999986 4678999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-----CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      +||+||||||+||+++.++.++|+|||++......     .......++..|+|||.+.+. .++.++||||+||++++|
T Consensus       143 ~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l  221 (298)
T 3pls_A          143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWEL  221 (298)
T ss_dssp             TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHH
T ss_pred             CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHH
Confidence            99999999999999999999999999999754332     222345678889999998544 489999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          164 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       164 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      ++ |.+||.+.+.......+.....                             .......++.+.+++.+||+.||.+|
T Consensus       222 ~~g~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~R  272 (298)
T 3pls_A          222 LTRGAPPYRHIDPFDLTHFLAQGRR-----------------------------LPQPEYCPDSLYQVMQQCWEADPAVR  272 (298)
T ss_dssp             HHTSCCTTTTSCGGGHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             hhCCCCCCccCCHHHHHHHhhcCCC-----------------------------CCCCccchHHHHHHHHHHccCChhhC
Confidence            99 5566665554443333222111                             11123578899999999999999999


Q ss_pred             CCHHHHhc
Q 022132          243 ITVEDALA  250 (302)
Q Consensus       243 ~t~~ell~  250 (302)
                      ||++++++
T Consensus       273 ps~~~ll~  280 (298)
T 3pls_A          273 PTFRVLVG  280 (298)
T ss_dssp             CCHHHHHH
T ss_pred             cCHHHHHH
Confidence            99999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.8e-39  Score=280.97  Aligned_cols=207  Identities=24%  Similarity=0.377  Sum_probs=170.4

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC----------------CCHHHHH
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA----------------LSEEHCQ   73 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----------------l~~~~~~   73 (302)
                      .+.+|+.+++++ +||||+++++++....    +.+|+||||++ ++|.+++.....                +++..+.
T Consensus        76 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (316)
T 2xir_A           76 ALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI  151 (316)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHH
T ss_pred             HHHHHHHHHHhcccCCCeeeEEEEEecCC----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHH
Confidence            577999999999 7999999999987752    56999999997 599999987544                8999999


Q ss_pred             HHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCc
Q 022132           74 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAA  150 (302)
Q Consensus        74 ~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~  150 (302)
                      .++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+. .++.+
T Consensus       152 ~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~  230 (316)
T 2xir_A          152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQ  230 (316)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHH
T ss_pred             HHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccch
Confidence            999999999999999999999999999999999999999999997654322   12344567889999998654 48999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHH
Q 022132          151 IDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID  229 (302)
Q Consensus       151 ~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (302)
                      +|||||||++++|++ |..||.+................                            .......++.+.+
T Consensus       231 ~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~  282 (316)
T 2xir_A          231 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR----------------------------MRAPDYTTPEMYQ  282 (316)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC----------------------------CCCCTTCCHHHHH
T ss_pred             hHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc----------------------------CCCCCCCCHHHHH
Confidence            999999999999998 99999876644333322221111                            1112357889999


Q ss_pred             HHHHccCCCCCCCCCHHHHhcC
Q 022132          230 LVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       230 li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +|.+||+.||.+|||++++++|
T Consensus       283 li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          283 TMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999975

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.9e-40  Score=281.10  Aligned_cols=223  Identities=18%  Similarity=0.297  Sum_probs=165.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++.....   ..+|+||||++ ++|.+++...+ .+++..+..++.|++.||+|||+
T Consensus        56 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  132 (295)
T 3ugc_A           56 RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT  132 (295)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECHHHH---TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCCC---CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc
Confidence            357799999999999999999999865421   56899999995 69999998654 59999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .||+||||||+||+++.++.++|+|||++.......    ......++..|+|||.+.+. .++.++||||+||++++|+
T Consensus       133 ~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~  211 (295)
T 3ugc_A          133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELF  211 (295)
T ss_dssp             TTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHH
T ss_pred             CCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999997654331    22334567779999998655 4899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|..||......     .....+.........  .........      .........+++.+.++|.+||+.||.+|||
T Consensus       212 ~g~~~~~~~~~~-----~~~~~~~~~~~~~~~--~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  278 (295)
T 3ugc_A          212 TYIEKSKSPPAE-----FMRMIGNDKQGQMIV--FHLIELLKN------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPS  278 (295)
T ss_dssp             HTTCTTCSHHHH-----HHHHHCTTCCTHHHH--HHHHHHHHT------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred             hcccccCCChHH-----HHhhhcCccccchhH--HHHHHHHhc------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCC
Confidence            999998543211     111122211111100  000000000      0111223467899999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++|+++
T Consensus       279 ~~el~~  284 (295)
T 3ugc_A          279 FRDLAL  284 (295)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-39  Score=279.80  Aligned_cols=207  Identities=24%  Similarity=0.346  Sum_probs=163.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++...     +.+|+||||++ ++|.+++...+.+++..+..++.|++.||+|||+.
T Consensus        79 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~  153 (309)
T 2h34_A           79 TRMQREARTAGRLQEPHVVPIHDFGEID-----GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA  153 (309)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhhcCCCCeeEEEEEEeeC-----CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4577899999999999999999999887     89999999997 59999998888899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      ||+||||||+||+++.++.++|+|||++.......  ......++..|+|||.+.+ ..++.++||||||+++++|++|.
T Consensus       154 ~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~  232 (309)
T 2h34_A          154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGS  232 (309)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSS
T ss_pred             cCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCC
Confidence            99999999999999999999999999987654332  2334568899999999854 45789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-CHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-TVE  246 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-t~~  246 (302)
                      .||.+.+..... .....  .                        ........+.+++.+.++|.+||+.||.+|| |++
T Consensus       233 ~pf~~~~~~~~~-~~~~~--~------------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~  285 (309)
T 2h34_A          233 PPYQGDQLSVMG-AHINQ--A------------------------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCG  285 (309)
T ss_dssp             CSSCSCHHHHHH-HHHHS--C------------------------CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHH
T ss_pred             CCCCCchHHHHH-HHhcc--C------------------------CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHH
Confidence            999776543221 11110  0                        0011223357888999999999999999999 788


Q ss_pred             HHhc
Q 022132          247 DALA  250 (302)
Q Consensus       247 ell~  250 (302)
                      ++++
T Consensus       286 ~l~~  289 (309)
T 2h34_A          286 DLSA  289 (309)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8775

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.8e-39  Score=297.50  Aligned_cols=205  Identities=22%  Similarity=0.379  Sum_probs=171.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.++++++||||+++++++...     +.+|+||||+. |+|.+++...  ..+++..+..++.||+.||+|||
T Consensus       261 ~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH  335 (495)
T 1opk_A          261 EEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE  335 (495)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEeeEEEEEecC-----CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999887     78999999997 7999999853  46999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||+||||||+||+++.++.+||+|||+++.......  .....++..|+|||.+... .++.++|||||||++++|++
T Consensus       336 ~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t  414 (495)
T 1opk_A          336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIAT  414 (495)
T ss_dssp             HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHT
T ss_pred             hCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHh
Confidence            99999999999999999999999999999986543321  2233456789999998654 48999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.+.......+.....                             ......+++.+.+||.+||+.||.+|||
T Consensus       415 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs  465 (495)
T 1opk_A          415 YGMSPYPGIDLSQVYELLEKDYR-----------------------------MERPEGCPEKVYELMRACWQWNPSDRPS  465 (495)
T ss_dssp             TSCCSSTTCCGGGHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCCCCCHHHHHHHHHHcCcChhHCcC
Confidence             9999988765544433221110                             1122367889999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++++++
T Consensus       466 ~~el~~  471 (495)
T 1opk_A          466 FAEIHQ  471 (495)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999976

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.6e-40  Score=286.47  Aligned_cols=228  Identities=20%  Similarity=0.228  Sum_probs=168.3

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~-   89 (302)
                      .+.+|+.++++++||||+++++++...... ...+|+||||++ |+|.+++.. +.+++..+..++.|++.||+|||+. 
T Consensus        64 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~  141 (322)
T 3soc_A           64 QNEYEVYSLPGMKHENILQFIGAEKRGTSV-DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDI  141 (322)
T ss_dssp             HHHHHHHTSTTCCCTTBCCEEEEEEEECSS-SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCE
T ss_pred             HHHHHHHHHhcCCCCCchhhcceeccCCCC-CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhc
Confidence            445689999999999999999999875211 146899999996 599999977 4599999999999999999999999 


Q ss_pred             ---------CceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCC----CCCCchhH
Q 022132           90 ---------NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSS----DYTAAIDV  153 (302)
Q Consensus        90 ---------~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~----~~~~~~Di  153 (302)
                               ||+||||||+||+++.++.+||+|||++.......   ......+|..|+|||++.+..    .++.++||
T Consensus       142 ~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di  221 (322)
T 3soc_A          142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM  221 (322)
T ss_dssp             EEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHH
T ss_pred             cccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchh
Confidence                     99999999999999999999999999997654332   233457899999999986532    24568899


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC--CCCHHHHHHH
Q 022132          154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLV  231 (302)
Q Consensus       154 wslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li  231 (302)
                      |||||++|+|++|.+||.+................+....+....         ........+...+.  ..++.+.+||
T Consensus       222 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li  292 (322)
T 3soc_A          222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVV---------VHKKKRPVLRDYWQKHAGMAMLCETI  292 (322)
T ss_dssp             HHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHH---------TTSCCCCCCCGGGGSSHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhh---------hcccCCCCccccccccchHHHHHHHH
Confidence            999999999999999997654332222222222222222111100         00000111111111  1234599999


Q ss_pred             HHccCCCCCCCCCHHHHhc
Q 022132          232 EKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       232 ~~~L~~dP~~R~t~~ell~  250 (302)
                      .+||+.||.+|||++|+++
T Consensus       293 ~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          293 EECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHH
Confidence            9999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-39  Score=288.55  Aligned_cols=207  Identities=21%  Similarity=0.317  Sum_probs=160.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++....    +..|+||||++ ++|.+++... ..+++..+..++.||+.||+|||+
T Consensus       135 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  210 (373)
T 3c1x_A          135 SQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS  210 (373)
T ss_dssp             HHHHHHHTTSTTCCCTTBCCCCEEECCCS----SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEcCC----CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            45789999999999999999999876542    67899999997 5999999864 468999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC-----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      +||+||||||+||+++.++.+||+|||+++......     ......++..|+|||.+.+. .++.++|||||||++|+|
T Consensus       211 ~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el  289 (373)
T 3c1x_A          211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWEL  289 (373)
T ss_dssp             TTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHH
T ss_pred             CCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHH
Confidence            999999999999999999999999999997543321     12334567789999998654 489999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          164 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       164 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      ++ |.+||.+.+..+....+.....                             ......+++.+.+++.+||+.||.+|
T Consensus       290 lt~~~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~p~~~~~~l~~li~~cl~~dp~~R  340 (373)
T 3c1x_A          290 MTRGAPPYPDVNTFDITVYLLQGRR-----------------------------LLQPEYCPDPLYEVMLKCWHPKAEMR  340 (373)
T ss_dssp             HTTSCCSCTTSCSSCHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             HhCcCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCCCCCHHHHHHHHHHcCCChhhC
Confidence            99 7889976654433322221000                             01123578899999999999999999


Q ss_pred             CCHHHHhcC
Q 022132          243 ITVEDALAH  251 (302)
Q Consensus       243 ~t~~ell~h  251 (302)
                      ||+++++++
T Consensus       341 Ps~~ell~~  349 (373)
T 3c1x_A          341 PSFSELVSR  349 (373)
T ss_dssp             CCHHHHHHH
T ss_pred             cCHHHHHHH
Confidence            999999874

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.4e-40  Score=283.69  Aligned_cols=214  Identities=24%  Similarity=0.369  Sum_probs=162.9

Q ss_pred             hhHHHHhcCchhhHHHHH-HhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHH
Q 022132            3 SITKLMQRGHFVRSSCFD-TWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQ   78 (302)
Q Consensus         3 ~~~~~~~~~~~~~E~~il-~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~q   78 (302)
                      |+|.+.....+.+|+.++ +..+||||+++++++.... .+.+.+|+||||++ ++|.+++...+  .+++..+..++.|
T Consensus        47 aiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~q  125 (299)
T 3m2w_A           47 ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS  125 (299)
T ss_dssp             EEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHH
T ss_pred             EEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHH
Confidence            556565666788999998 5559999999999987610 01178999999997 59999998754  6999999999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCCEEEec---CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHH
Q 022132           79 ILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS  155 (302)
Q Consensus        79 ll~~l~~LH~~~i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  155 (302)
                      |+.||+|||+.||+||||||+||+++.   ++.++|+|||++.....                      ..++.++||||
T Consensus       126 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~----------------------~~~~~~~Diws  183 (299)
T 3m2w_A          126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG----------------------EKYDKSCDMWS  183 (299)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT----------------------CGGGGHHHHHH
T ss_pred             HHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc----------------------ccCCchhhHHH
Confidence            999999999999999999999999998   78899999998854331                      23678999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHcc
Q 022132          156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  235 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  235 (302)
                      +||++++|++|.+||.+.+...........                      ............+..+++.+.+||.+||
T Consensus       184 lG~il~el~tg~~pf~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l  241 (299)
T 3m2w_A          184 LGVIMYILLCGYPPFYSNHGLAISPGMKTR----------------------IRMGQYEFPNPEWSEVSEEVKMLIRNLL  241 (299)
T ss_dssp             HHHHHHHHHHSSCSCCC-------CCSCCS----------------------SCTTCCSSCHHHHTTSCHHHHHHHHHHT
T ss_pred             HHHHHHHHHHCCCCCCCCcchhhhHHHHHH----------------------HhhccccCCchhcccCCHHHHHHHHHHc
Confidence            999999999999999765432211000000                      0000000011122467899999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCcCCccCCC
Q 022132          236 TFDPRQRITVEDALAHPYLGSLHDIS  261 (302)
Q Consensus       236 ~~dP~~R~t~~ell~h~~~~~~~~~~  261 (302)
                      +.||.+|||++|+++||||+......
T Consensus       242 ~~dP~~Rps~~e~l~hp~~~~~~~~~  267 (299)
T 3m2w_A          242 KTEPTQRMTITEFMNHPWIMQSTKVP  267 (299)
T ss_dssp             CSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred             ccChhhCCCHHHHhcChhhcccccCC
Confidence            99999999999999999998765433

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-39  Score=277.07  Aligned_cols=204  Identities=21%  Similarity=0.336  Sum_probs=161.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.++++++||||+++++++....    +.+|+||||+++ +|.+++...+  .+++..+..++.|++.||+|||
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH  134 (278)
T 1byg_A           59 QAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE  134 (278)
T ss_dssp             HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEcCC----CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH
Confidence            35778999999999999999999976542    579999999974 9999997653  3899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-C
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-R  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g  166 (302)
                      +.|++||||||+||+++.++.++|+|||.+......  .....++..|+|||.+.+. .++.++||||||+++++|++ |
T Consensus       135 ~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g  211 (278)
T 1byg_A          135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFG  211 (278)
T ss_dssp             HTTCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred             hCCccccCCCcceEEEeCCCcEEEeecccccccccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999998765433  2234567889999998654 48999999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+..+....+...                             ........+++.+.++|.+||+.||.+|||+.
T Consensus       212 ~~p~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  262 (278)
T 1byg_A          212 RVPYPRIPLKDVVPRVEKG-----------------------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFL  262 (278)
T ss_dssp             CCSCTTSCGGGHHHHHTTT-----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCCHHHHHHHHhcC-----------------------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHH
Confidence            9999776544333222110                             00112236789999999999999999999999


Q ss_pred             HHhc
Q 022132          247 DALA  250 (302)
Q Consensus       247 ell~  250 (302)
                      ++++
T Consensus       263 ~l~~  266 (278)
T 1byg_A          263 QLRE  266 (278)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9976

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.9e-39  Score=303.80  Aligned_cols=204  Identities=20%  Similarity=0.281  Sum_probs=170.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++..      +.+++||||+. |+|.+++...+.+++..+..++.||+.||+|||++
T Consensus       415 ~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~  488 (635)
T 4fl3_A          415 DELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES  488 (635)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            468899999999999999999999964      46899999997 69999999888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ||+||||||+||+++.++.+||+|||+++......    ......++..|+|||++.+. .++.++|||||||++|+|++
T Consensus       489 ~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt  567 (635)
T 4fl3_A          489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFS  567 (635)
T ss_dssp             TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999997654332    12333456789999999654 48999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |..||.+.+..+....+.....                             ......+++++.+||.+||+.||.+|||
T Consensus       568 ~G~~Pf~~~~~~~~~~~i~~~~~-----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs  618 (635)
T 4fl3_A          568 YGQKPYRGMKGSEVTAMLEKGER-----------------------------MGCPAGCPREMYDLMNLCWTYDVENRPG  618 (635)
T ss_dssp             TTCCSSTTCCHHHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcC
Confidence             9999988877665544432111                             1112367889999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++++++
T Consensus       619 ~~~l~~  624 (635)
T 4fl3_A          619 FAAVEL  624 (635)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.2e-39  Score=274.28  Aligned_cols=211  Identities=16%  Similarity=0.160  Sum_probs=168.0

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~-~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++|++++..+..+....    +..|+||||++++|.+++. ..+.+++..+..++.||+.||+|||+
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  123 (296)
T 3uzp_A           48 HPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS  123 (296)
T ss_dssp             CCHHHHHHHHHHHHTTSTTCCCEEEEEEET----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcCCCCCccccccCCC----CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            346789999999999988777666664431    7889999999999999997 35679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEe---cCCCEEEeecccccccCCCCc--------ccccccccccCchhhhhCCCCCCCchhHHHHH
Q 022132           89 ANVLHRDLKPSNLLLN---ANCDLKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG  157 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  157 (302)
                      +||+||||||+||+++   .++.++|+|||.+........        .....++..|+|||.+.+. .++.++||||||
T Consensus       124 ~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG  202 (296)
T 3uzp_A          124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLG  202 (296)
T ss_dssp             TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHH
T ss_pred             CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHH
Confidence            9999999999999994   889999999999976544321        2455789999999998654 489999999999


Q ss_pred             HHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHc
Q 022132          158 CIFMELMDRKPLFPGRDHV---HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  234 (302)
Q Consensus       158 ~i~~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (302)
                      |++++|++|..||.+.+..   ..+..+......                         .+.....+.+++.+.+++.+|
T Consensus       203 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~l~~li~~~  257 (296)
T 3uzp_A          203 YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-------------------------TPIEVLCKGYPSEFATYLNFC  257 (296)
T ss_dssp             HHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-------------------------SCHHHHTTTSCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-------------------------CchHHHHhhCCHHHHHHHHHH
Confidence            9999999999999764321   122222211000                         011122246789999999999


Q ss_pred             cCCCCCCCCCHHHHhc
Q 022132          235 LTFDPRQRITVEDALA  250 (302)
Q Consensus       235 L~~dP~~R~t~~ell~  250 (302)
                      |+.||.+|||++++++
T Consensus       258 l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          258 RSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTSCTTCCCCHHHHHH
T ss_pred             HhcCcCcCCCHHHHHH
Confidence            9999999999999887

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3e-39  Score=274.82  Aligned_cols=204  Identities=22%  Similarity=0.357  Sum_probs=169.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.++||||+++++++..      +..|+||||++ ++|.+++....  .+++..+..++.|++.||+|||
T Consensus        53 ~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH  126 (279)
T 1qpc_A           53 DAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE  126 (279)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCcceEEEEEcC------CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357799999999999999999999864      56899999995 69999987542  6999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||+||||||+||+++.++.++|+|||.+.......  ......++..|+|||.+.+. .++.++|||||||++++|++
T Consensus       127 ~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~  205 (279)
T 1qpc_A          127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVT  205 (279)
T ss_dssp             HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHT
T ss_pred             HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHh
Confidence            9999999999999999999999999999997665432  12234557789999998644 47899999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.+..+....+.....                             ......+++.+.+++.+||..||.+|||
T Consensus       206 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps  256 (279)
T 1qpc_A          206 HGRIPYPGMTNPEVIQNLERGYR-----------------------------MVRPDNCPEELYQLMRLCWKERPEDRPT  256 (279)
T ss_dssp             TTCCSSTTCCHHHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCcccCHHHHHHHHhcccC-----------------------------CCCcccccHHHHHHHHHHhccChhhCCC
Confidence             9999988776655443322110                             0112367889999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++++++
T Consensus       257 ~~~l~~  262 (279)
T 1qpc_A          257 FDYLRS  262 (279)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.3e-39  Score=275.04  Aligned_cols=211  Identities=23%  Similarity=0.276  Sum_probs=171.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCC-----------CCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQ-----------RESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFL   76 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~-----------~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~   76 (302)
                      ..+.+|+.+++.++||||+++++++....           ....+.+|+||||++ ++|.+++...  ..+++..+..++
T Consensus        49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~  128 (284)
T 2a19_B           49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF  128 (284)
T ss_dssp             GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH
Confidence            46779999999999999999999885410           011256899999998 5999999753  679999999999


Q ss_pred             HHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHH
Q 022132           77 YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  156 (302)
Q Consensus        77 ~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  156 (302)
                      .||+.||.|||+.||+|+||||+||+++.++.++|+|||.+.............++..|+|||.+.+. .++.++|||||
T Consensus       129 ~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~sl  207 (284)
T 2a19_B          129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYAL  207 (284)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHH
T ss_pred             HHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHH
Confidence            99999999999999999999999999999999999999999876655555566789999999998654 47999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccC
Q 022132          157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  236 (302)
Q Consensus       157 G~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  236 (302)
                      ||++++|++|..|+....      .....+.                  .          ....+.+++.+.++|.+||+
T Consensus       208 G~il~~l~~~~~~~~~~~------~~~~~~~------------------~----------~~~~~~~~~~~~~li~~~l~  253 (284)
T 2a19_B          208 GLILAELLHVCDTAFETS------KFFTDLR------------------D----------GIISDIFDKKEKTLLQKLLS  253 (284)
T ss_dssp             HHHHHHHHSCCSSHHHHH------HHHHHHH------------------T----------TCCCTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHHHhcCCcchhHH------HHHHHhh------------------c----------ccccccCCHHHHHHHHHHcc
Confidence            999999999998863110      0000000                  0          00112578899999999999


Q ss_pred             CCCCCCCCHHHHhcCCCcCC
Q 022132          237 FDPRQRITVEDALAHPYLGS  256 (302)
Q Consensus       237 ~dP~~R~t~~ell~h~~~~~  256 (302)
                      .||.+|||+.|++++.+.-.
T Consensus       254 ~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          254 KKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             SSGGGSCCHHHHHHHHHHHT
T ss_pred             CChhhCcCHHHHHHHHHHHh
Confidence            99999999999999987643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-38  Score=271.93  Aligned_cols=203  Identities=19%  Similarity=0.318  Sum_probs=165.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++.+.     .  ++||||++ ++|.+.+... ..+++..+..++.|++.||+|||+
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~  140 (287)
T 4f0f_A           68 QEFQREVFIMSNLNHPNIVKLYGLMHNP-----P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN  140 (287)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEETTT-----T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCchhhheeecCC-----C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh
Confidence            4677999999999999999999999765     3  69999997 7998888654 579999999999999999999999


Q ss_pred             CC--ceecCCCCCCEEEecCCC-----EEEeecccccccCCCCcccccccccccCchhhhhC-CCCCCCchhHHHHHHHH
Q 022132           89 AN--VLHRDLKPSNLLLNANCD-----LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIF  160 (302)
Q Consensus        89 ~~--i~H~dikp~Nil~~~~~~-----~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~i~  160 (302)
                      .|  |+||||||+||+++.++.     ++|+|||++......  .....++..|+|||.+.. ...++.++||||+||++
T Consensus       141 ~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l  218 (287)
T 4f0f_A          141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL  218 (287)
T ss_dssp             SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHH
T ss_pred             CCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHH
Confidence            99  999999999999988776     999999999755433  345678999999998843 33468899999999999


Q ss_pred             HHHHhCCCCCCCCChHHH--HHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCC
Q 022132          161 MELMDRKPLFPGRDHVHQ--LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       161 ~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  238 (302)
                      |+|++|..||.+.+....  ...+.. .+.                           .......+++.+.++|.+||+.|
T Consensus       219 ~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~l~~li~~~l~~d  270 (287)
T 4f0f_A          219 YTILTGEGPFDEYSYGKIKFINMIRE-EGL---------------------------RPTIPEDCPPRLRNVIELCWSGD  270 (287)
T ss_dssp             HHHHHSSCTTTTCCCCHHHHHHHHHH-SCC---------------------------CCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHcCCCCCccccccHHHHHHHHhc-cCC---------------------------CCCCCcccCHHHHHHHHHHhcCC
Confidence            999999999976553322  111111 000                           01122367889999999999999


Q ss_pred             CCCCCCHHHHhc
Q 022132          239 PRQRITVEDALA  250 (302)
Q Consensus       239 P~~R~t~~ell~  250 (302)
                      |.+|||++++++
T Consensus       271 p~~Rps~~~ll~  282 (287)
T 4f0f_A          271 PKKRPHFSYIVK  282 (287)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             hhhCcCHHHHHH
Confidence            999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.3e-38  Score=272.88  Aligned_cols=212  Identities=16%  Similarity=0.152  Sum_probs=169.0

Q ss_pred             hcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ....+.+|+.+++.++|++++..+..+....    +..++||||++++|.+++.. .+.+++..+..++.||+.||+|||
T Consensus        47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  122 (296)
T 4hgt_A           47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH  122 (296)
T ss_dssp             -CCCHHHHHHHHHHHTTSTTCCCEEEEEEET----TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHhcCCCCCCeeeeecCCC----CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3457889999999999888777776664431    78899999999999999974 467999999999999999999999


Q ss_pred             hCCceecCCCCCCEEE---ecCCCEEEeecccccccCCCC--------cccccccccccCchhhhhCCCCCCCchhHHHH
Q 022132           88 SANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  156 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  156 (302)
                      ++||+||||||+||++   +.++.++|+|||++.......        ......+|..|+|||.+.+. .++.++||||+
T Consensus       123 ~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~sl  201 (296)
T 4hgt_A          123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESL  201 (296)
T ss_dssp             HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHH
T ss_pred             HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHH
Confidence            9999999999999999   788999999999997654332        22355789999999998654 48999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHH
Q 022132          157 GCIFMELMDRKPLFPGRDHV---HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  233 (302)
Q Consensus       157 G~i~~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  233 (302)
                      ||++++|++|..||.+.+..   ..+..+.....                         ..+.....+.+++.+.++|.+
T Consensus       202 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~l~~li~~  256 (296)
T 4hgt_A          202 GYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-------------------------STPIEVLCKGYPSEFATYLNF  256 (296)
T ss_dssp             HHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-------------------------HSCHHHHTTTSCHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-------------------------cchhhhhhccCCHHHHHHHHH
Confidence            99999999999999765422   11111111100                         001122234678899999999


Q ss_pred             ccCCCCCCCCCHHHHhc
Q 022132          234 MLTFDPRQRITVEDALA  250 (302)
Q Consensus       234 ~L~~dP~~R~t~~ell~  250 (302)
                      ||+.||.+|||++++++
T Consensus       257 ~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          257 CRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHTSCTTCCCCHHHHHH
T ss_pred             HHhcCCCCCCCHHHHHH
Confidence            99999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2e-39  Score=279.73  Aligned_cols=219  Identities=20%  Similarity=0.293  Sum_probs=169.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS---NQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~---~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..+.+|+.++++++||||+++++++...     +..|+||||++ ++|.+++..   ..++++..+..++.|++.||+||
T Consensus        75 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l  149 (307)
T 2nru_A           75 QQFDQEIKVMAKCQHENLVELLGFSSDG-----DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL  149 (307)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeEEEEEEEecC-----CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            3577999999999999999999999887     88999999995 799999873   45699999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      |+.||+||||||+||+++.++.++|+|||.+.......   ......++..|+|||.+.+  .++.++|||||||++++|
T Consensus       150 H~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l  227 (307)
T 2nru_A          150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEI  227 (307)
T ss_dssp             HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHH
T ss_pred             hcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHH
Confidence            99999999999999999999999999999987654321   1234568999999998853  378999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|.+||.+.........+..........        ...+       ............+..+.+++.+||+.||.+||
T Consensus       228 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp  292 (307)
T 2nru_A          228 ITGLPAVDEHREPQLLLDIKEEIEDEEKT--------IEDY-------IDKKMNDADSTSVEAMYSVASQCLHEKKNKRP  292 (307)
T ss_dssp             HHCCCSBCTTBSSSBTTHHHHHHHTTSCC--------HHHH-------SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHCCCCcccCcchHHHHHHHHHhhhhhhh--------hhhh-------ccccccccchHHHHHHHHHHHHHcCCCcccCc
Confidence            99999997655433222222211110000        0000       00001111112346789999999999999999


Q ss_pred             CHHHHhcC
Q 022132          244 TVEDALAH  251 (302)
Q Consensus       244 t~~ell~h  251 (302)
                      |+++++++
T Consensus       293 s~~~l~~~  300 (307)
T 2nru_A          293 DIKKVQQL  300 (307)
T ss_dssp             CHHHHHHH
T ss_pred             CHHHHHHH
Confidence            99999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.1e-39  Score=291.54  Aligned_cols=210  Identities=25%  Similarity=0.369  Sum_probs=169.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.++++++||||+++++++..      +.+|+||||++ |+|.+++..  ...+++..+..++.||+.||+|||
T Consensus       224 ~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH  297 (452)
T 1fmk_A          224 EAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE  297 (452)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEcC------CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            367899999999999999999999865      46899999996 699999964  356999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||+||||||+||+++.++.+||+|||+++......  ......++..|+|||.+... .++.++|||||||++++|++
T Consensus       298 ~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t  376 (452)
T 1fmk_A          298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTT  376 (452)
T ss_dssp             HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHh
Confidence            9999999999999999999999999999997654322  12233456789999998654 48999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+....+....+......                             ...+.+++.+.++|.+||+.||.+|||
T Consensus       377 ~g~~P~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt  427 (452)
T 1fmk_A          377 KGRVPYPGMVNREVLDQVERGYRM-----------------------------PCPPECPESLHDLMCQCWRKEPEERPT  427 (452)
T ss_dssp             TTCCSSTTCCHHHHHHHHHTTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHccCChhhCcC
Confidence             99999888766655444321111                             112367889999999999999999999


Q ss_pred             HHHHhc--CCCcCC
Q 022132          245 VEDALA--HPYLGS  256 (302)
Q Consensus       245 ~~ell~--h~~~~~  256 (302)
                      ++++++  ..++..
T Consensus       428 ~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          428 FEYLQAFLEDYFTS  441 (452)
T ss_dssp             HHHHHHHHHTTTSC
T ss_pred             HHHHHHHHHHHhcc
Confidence            999987  355544

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.7e-39  Score=282.09  Aligned_cols=218  Identities=22%  Similarity=0.313  Sum_probs=168.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----ALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++....    .+++..+..++.|++.||+||
T Consensus        81 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l  155 (321)
T 2qkw_B           81 EFETEIETLSFCRHPHLVSLIGFCDER-----NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL  155 (321)
T ss_dssp             HHHHHHHGGGSCCCTTBCCEEEECCCT-----TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEcCC-----CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHh
Confidence            577999999999999999999999887     88999999997 69999886542    589999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      |++||+||||||+||+++.++.++|+|||++......   .......++..|+|||.+.+. .++.++|||||||++++|
T Consensus       156 H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el  234 (321)
T 2qkw_B          156 HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEV  234 (321)
T ss_dssp             HHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHH
T ss_pred             cCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHH
Confidence            9999999999999999999999999999998764332   223345689999999998654 489999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHH---HHHhCCCChHHHhhhhHhHHHHhhhccccccccc-cccCCCCCHHHHHHHHHccCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLL---IELIGTPSEAELGFLNENAKKYICQLPRYQRQSF-TEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      ++|..||.+..........   ......                 ........... ....+..+..+.+++.+||+.||
T Consensus       235 l~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  297 (321)
T 2qkw_B          235 LCARSAIVQSLPREMVNLAEWAVESHNN-----------------GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS  297 (321)
T ss_dssp             HHCCTTCSCSSSSSCCCHHHHTHHHHTT-----------------TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSG
T ss_pred             HhCCCcccccCcHHHHHHHHHhhhcccc-----------------ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCc
Confidence            9999999765422111000   000000                 00000000000 11112345678999999999999


Q ss_pred             CCCCCHHHHhcCC
Q 022132          240 RQRITVEDALAHP  252 (302)
Q Consensus       240 ~~R~t~~ell~h~  252 (302)
                      .+|||++|++++.
T Consensus       298 ~~Rps~~ell~~L  310 (321)
T 2qkw_B          298 EDRPSMGDVLWKL  310 (321)
T ss_dssp             GGSCCHHHHHHHH
T ss_pred             ccCcCHHHHHHHH
Confidence            9999999999754

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.7e-39  Score=278.77  Aligned_cols=206  Identities=21%  Similarity=0.288  Sum_probs=167.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++...     +.+++||||++ ++|.+++...+ .+++..+..++.||+.||+|||+
T Consensus        74 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~  148 (319)
T 2y4i_B           74 KAFKREVMAYRQTRHENVVLFMGACMSP-----PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA  148 (319)
T ss_dssp             CCCCTTGGGGTTCCCTTBCCCCEEEECS-----SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCEeEEEEEEecC-----CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4678999999999999999999999987     78999999997 69999998654 79999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCC------CCcccccccccccCchhhhhC--------CCCCCCchhHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE------TDFMTEYVVTRWYRAPELLLN--------SSDYTAAIDVW  154 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~Diw  154 (302)
                      .|++||||||+||+++ ++.++|+|||++.....      ........++..|+|||.+.+        ...++.++|||
T Consensus       149 ~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~  227 (319)
T 2y4i_B          149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF  227 (319)
T ss_dssp             TTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHH
T ss_pred             CCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHH
Confidence            9999999999999998 67999999998765421      122334468899999999864        23478899999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHc
Q 022132          155 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  234 (302)
Q Consensus       155 slG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (302)
                      ||||++++|++|..||.+.........+..... +                           ......++..+.+++.+|
T Consensus       228 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~l~~li~~~  279 (319)
T 2y4i_B          228 ALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK-P---------------------------NLSQIGMGKEISDILLFC  279 (319)
T ss_dssp             HHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC-C---------------------------CCCCSSCCTTHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC-C---------------------------CCCcCCCCHHHHHHHHHH
Confidence            999999999999999987776554433322100 0                           001125678899999999


Q ss_pred             cCCCCCCCCCHHHHhc
Q 022132          235 LTFDPRQRITVEDALA  250 (302)
Q Consensus       235 L~~dP~~R~t~~ell~  250 (302)
                      |..||.+|||++++++
T Consensus       280 l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          280 WAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HCSSTTTSCCHHHHHH
T ss_pred             hcCChhhCcCHHHHHH
Confidence            9999999999999987

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.2e-39  Score=281.98  Aligned_cols=223  Identities=20%  Similarity=0.294  Sum_probs=168.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++.....   +.+|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||+
T Consensus        69 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~  145 (327)
T 3lxl_A           69 RDFQREIQILKALHSDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS  145 (327)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECSSS---CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCceeEEEEEEecCCC---ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            357899999999999999999999875322   67999999995 799999976 4569999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .||+||||||+||+++.++.++|+|||.+.......    ......++..|+|||.+.+. .++.++|||||||++++|+
T Consensus       146 ~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll  224 (327)
T 3lxl_A          146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELF  224 (327)
T ss_dssp             TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHH
T ss_pred             CCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHH
Confidence            999999999999999999999999999997654332    22344577889999998654 4789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|..||.........     .......  ...... ......      ........+.+++.+.+||.+||+.||.+|||
T Consensus       225 ~g~~p~~~~~~~~~~-----~~~~~~~--~~~~~~-~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps  290 (327)
T 3lxl_A          225 TYCDKSCSPSAEFLR-----MMGCERD--VPALSR-LLELLE------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPS  290 (327)
T ss_dssp             TTTCGGGSHHHHHHH-----HCC------CCHHHH-HHHHHH------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             hCCCCCccccchhhh-----hcccccc--cccHHH-HHHHhh------cccCCCCCCcccHHHHHHHHHHcCCChhhCcC
Confidence            999998643322110     0000000  000000 000000      00111223467899999999999999999999


Q ss_pred             HHHHhcC
Q 022132          245 VEDALAH  251 (302)
Q Consensus       245 ~~ell~h  251 (302)
                      +++++++
T Consensus       291 ~~ell~~  297 (327)
T 3lxl_A          291 FSALGPQ  297 (327)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999653

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.5e-39  Score=281.48  Aligned_cols=221  Identities=20%  Similarity=0.274  Sum_probs=168.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----ALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+|+.+++.++||||+++++++...     +..++||||++ ++|.+++....    .+++..+..++.|++.||+||
T Consensus        73 ~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l  147 (326)
T 3uim_A           73 QFQTEVEMISMAVHRNLLRLRGFCMTP-----TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL  147 (326)
T ss_dssp             HHHHHHHGGGTCCCTTBCCCCEEECCS-----SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccCCCccceEEEEecC-----CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999999999999999887     78899999996 59999998643    499999999999999999999


Q ss_pred             HhC---CceecCCCCCCEEEecCCCEEEeecccccccCCC--CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHH
Q 022132           87 HSA---NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  161 (302)
Q Consensus        87 H~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~  161 (302)
                      |+.   ||+||||||+||+++.++.++|+|||++......  .......+|..|+|||.+.+.. ++.++||||+||+++
T Consensus       148 H~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~  226 (326)
T 3uim_A          148 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLL  226 (326)
T ss_dssp             HHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHH
T ss_pred             HhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHH
Confidence            999   9999999999999999999999999999765432  2234455899999999986544 799999999999999


Q ss_pred             HHHhCCCCCCCCC-----hHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccc-cccCCCCCHHHHHHHHHcc
Q 022132          162 ELMDRKPLFPGRD-----HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF-TEKFPNVHPSAIDLVEKML  235 (302)
Q Consensus       162 ~ll~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L  235 (302)
                      +|++|.+||....     ...............                 .......... ....+..+..+.+++.+||
T Consensus       227 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  289 (326)
T 3uim_A          227 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-----------------KLEALVDVDLQGNYKDEEVEQLIQVALLCT  289 (326)
T ss_dssp             HHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC-----------------CSTTSSCTTCTTSCCHHHHHHHHHHHHHHT
T ss_pred             HHHhCCCcccccccccccchhHHHHHHHHhhch-----------------hhhhhcChhhccccCHHHHHHHHHHHHHHh
Confidence            9999999995210     000000000000000                 0000000000 0011123467999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCcC
Q 022132          236 TFDPRQRITVEDALAHPYLG  255 (302)
Q Consensus       236 ~~dP~~R~t~~ell~h~~~~  255 (302)
                      +.||.+|||++|+++|-.-.
T Consensus       290 ~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          290 QSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             CSCGGGSCCHHHHHHHHHTS
T ss_pred             CcCCccCCCHHHHHHHhcCc
Confidence            99999999999999976543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=282.53  Aligned_cols=212  Identities=22%  Similarity=0.372  Sum_probs=152.9

Q ss_pred             cCchhhHHHHHHhcC-CCCccccceeeCCCC---CCCCCcEEEEEecCCccHHHHHHc---CCCCCHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIM-KTSVVAIRDIIPPPQ---RESFNDVYIAYELMDTDLHQIIRS---NQALSEEHCQYFLYQILRG   82 (302)
Q Consensus        10 ~~~~~~E~~il~~l~-h~niv~l~~~~~~~~---~~~~~~~~lv~e~~~~~L~~~l~~---~~~l~~~~~~~i~~qll~~   82 (302)
                      ...+.+|+.+++++. ||||+++++++....   ..+...+++||||++|+|.+++..   .+.+++..+..++.||+.|
T Consensus        69 ~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~  148 (337)
T 3ll6_A           69 NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA  148 (337)
T ss_dssp             HHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHH
Confidence            346789999999995 999999999984321   122267999999999999998864   5679999999999999999


Q ss_pred             HHHHHhCC--ceecCCCCCCEEEecCCCEEEeecccccccCCCCcc-------------cccccccccCchhhhh--CCC
Q 022132           83 LKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM-------------TEYVVTRWYRAPELLL--NSS  145 (302)
Q Consensus        83 l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-------------~~~~~~~~y~aPE~~~--~~~  145 (302)
                      |+|||+.|  |+||||||+||+++.++.++|+|||++.........             ....++..|+|||++.  ...
T Consensus       149 l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  228 (337)
T 3ll6_A          149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF  228 (337)
T ss_dssp             HHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTS
T ss_pred             HHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccC
Confidence            99999999  999999999999999999999999999765543211             1345889999999883  234


Q ss_pred             CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCH
Q 022132          146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP  225 (302)
Q Consensus       146 ~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (302)
                      .++.++|||||||++++|++|..||.+.........   ...                             .......++
T Consensus       229 ~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~~-----------------------------~~~~~~~~~  276 (337)
T 3ll6_A          229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG---KYS-----------------------------IPPHDTQYT  276 (337)
T ss_dssp             CSSHHHHHHHHHHHHHHHHHSSCCC---------------CC-----------------------------CCTTCCSSG
T ss_pred             CCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC---ccc-----------------------------CCcccccch
Confidence            478899999999999999999999965433211110   000                             011124567


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHhcCCC
Q 022132          226 SAIDLVEKMLTFDPRQRITVEDALAHPY  253 (302)
Q Consensus       226 ~~~~li~~~L~~dP~~R~t~~ell~h~~  253 (302)
                      .+.+||.+||+.||.+|||++|++++..
T Consensus       277 ~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          277 VFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             GGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            8999999999999999999999998743

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.1e-38  Score=274.32  Aligned_cols=222  Identities=20%  Similarity=0.338  Sum_probs=168.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~-~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+++.++||||+++++++.....   +.+|+||||++ ++|.+++. ....+++..+..++.|++.||+|||+
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~  144 (302)
T 4e5w_A           68 ADLKKEIEILRNLYHENIVKYKGICTEDGG---NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS  144 (302)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEC------CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeEEecCCC---ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc
Confidence            357789999999999999999999987532   56899999996 59999995 45679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .||+||||||+||+++.++.++|+|||++.......    ......++..|+|||.+.+. .++.++||||+||++++|+
T Consensus       145 ~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~  223 (302)
T 4e5w_A          145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELL  223 (302)
T ss_dssp             TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHH
T ss_pred             CCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHH
Confidence            999999999999999999999999999997655432    23345677889999998654 4789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          165 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       165 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      +|..|+...     ........+.........   ........      .......+.+++.+.+||.+||+.||.+|||
T Consensus       224 ~g~~p~~~~-----~~~~~~~~~~~~~~~~~~---~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  289 (302)
T 4e5w_A          224 TYCDSDSSP-----MALFLKMIGPTHGQMTVT---RLVNTLKE------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTS  289 (302)
T ss_dssp             TTTCGGGSH-----HHHHHHHHCSCCGGGHHH---HHHHHHHT------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred             HccCCCcch-----hhHHhhccCCcccccCHH---HHHHHHhc------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Confidence            999886322     112222222222111100   00000000      0111223468899999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++++++
T Consensus       290 ~~~ll~  295 (302)
T 4e5w_A          290 FQNLIE  295 (302)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=273.06  Aligned_cols=202  Identities=26%  Similarity=0.386  Sum_probs=158.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..+.+|+.++++++||||+++++++.+       ..|+||||++ ++|.+++...+   .++...+..++.|++.||+||
T Consensus        46 ~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~L  118 (307)
T 2eva_A           46 KAFIVELRQLSRVNHPNIVKLYGACLN-------PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL  118 (307)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999998863       3789999996 69999998754   478999999999999999999


Q ss_pred             Hh---CCceecCCCCCCEEEecCCC-EEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           87 HS---ANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        87 H~---~~i~H~dikp~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      |+   +||+||||||+||+++.++. ++|+|||.+......  .....++..|+|||.+.+ ..++.++|||||||++++
T Consensus       119 H~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~e  195 (307)
T 2eva_A          119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWE  195 (307)
T ss_dssp             HTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHH
T ss_pred             HhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHH
Confidence            99   89999999999999998887 799999998765433  234468999999999865 458999999999999999


Q ss_pred             HHhCCCCCCCCChHHH-HHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          163 LMDRKPLFPGRDHVHQ-LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      |++|..||........ ...... .+                           ......+.+++.+.+++.+||+.||.+
T Consensus       196 l~~g~~p~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~  247 (307)
T 2eva_A          196 VITRRKPFDEIGGPAFRIMWAVH-NG---------------------------TRPPLIKNLPKPIESLMTRCWSKDPSQ  247 (307)
T ss_dssp             HHHTCCTTTTTCSSHHHHHHHHH-TT---------------------------CCCCCBTTCCHHHHHHHHHHTCSSGGG
T ss_pred             HHHCCCCchhhCccHHHHHHHHh-cC---------------------------CCCCcccccCHHHHHHHHHHhcCChhh
Confidence            9999999975432211 110000 00                           011223467889999999999999999


Q ss_pred             CCCHHHHhc
Q 022132          242 RITVEDALA  250 (302)
Q Consensus       242 R~t~~ell~  250 (302)
                      |||++++++
T Consensus       248 Rps~~ell~  256 (307)
T 2eva_A          248 RPSMEEIVK  256 (307)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999988

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.6e-39  Score=274.64  Aligned_cols=205  Identities=20%  Similarity=0.287  Sum_probs=168.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++...      ..++||||+. ++|.+++... +.+++..+..++.|++.||.|||+
T Consensus        66 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~  139 (291)
T 1u46_A           66 DDFIREVNAMHSLDHRNLIRLYGVVLTP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES  139 (291)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcccEEEEEccC------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh
Confidence            4677999999999999999999999874      4889999997 6999998753 579999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc----ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      .|++|+||||+||+++.++.++|+|||++........    .....++..|+|||.+.+. .++.++||||||+++++|+
T Consensus       140 ~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~  218 (291)
T 1u46_A          140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMF  218 (291)
T ss_dssp             TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHH
T ss_pred             CCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHH
Confidence            9999999999999999999999999999876543321    2234567789999998654 4789999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |.+||.+.+.......+......                            ......+++.+.++|.+||..||.+||
T Consensus       219 ~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp  270 (291)
T 1u46_A          219 TYGQEPWIGLNGSQILHKIDKEGER----------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRP  270 (291)
T ss_dssp             TTSCCTTTTCCHHHHHHHHHTSCCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             hCCCCCcccCCHHHHHHHHHccCCC----------------------------CCCCcCcCHHHHHHHHHHccCCcccCc
Confidence            9 99999888766554443321100                            111236788999999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |+.++++
T Consensus       271 s~~~l~~  277 (291)
T 1u46_A          271 TFVALRD  277 (291)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999987

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=297.39  Aligned_cols=204  Identities=19%  Similarity=0.278  Sum_probs=167.2

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++..      +.+|+||||++ |+|.+++.. ...+++..+..++.||+.||+|||+
T Consensus       381 ~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~  454 (613)
T 2ozo_A          381 EEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE  454 (613)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            367899999999999999999999965      45999999997 699999875 3569999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc----ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      +||+||||||+||+++.++.+||+|||+++.......    .....++..|+|||++.+. .++.++|||||||++|+|+
T Consensus       455 ~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ell  533 (613)
T 2ozo_A          455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEAL  533 (613)
T ss_dssp             TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHH
T ss_pred             CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999976543211    1223345789999998654 4899999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |..||.+.+..+....+.....                             ....+.+++.+.++|.+||..||.+||
T Consensus       534 t~G~~Pf~~~~~~~~~~~i~~~~~-----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RP  584 (613)
T 2ozo_A          534 SYGQKPYKKMKGPEVMAFIEQGKR-----------------------------MECPPECPPELYALMSDCWIYKWEDRP  584 (613)
T ss_dssp             TTSCCTTTTCCSHHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSC
T ss_pred             HCCCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCCcCCHHHHHHHHHHcCCChhHCc
Confidence            8 9999998877665544432110                             112236789999999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |++++++
T Consensus       585 s~~~l~~  591 (613)
T 2ozo_A          585 DFLTVEQ  591 (613)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999854

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.6e-40  Score=304.85  Aligned_cols=271  Identities=21%  Similarity=0.251  Sum_probs=189.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCC-CCCCCcEEEEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQ-RESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.+++.++||||+++++++.... ....+..|+||||++ |+|.+++....   .+++..+..++.|++.||+|
T Consensus        57 ~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~y  136 (676)
T 3qa8_A           57 ERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY  136 (676)
T ss_dssp             HHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHH
Confidence            45778999999999999999999987632 122377899999995 69999998644   69999999999999999999


Q ss_pred             HHhCCceecCCCCCCEEEecCCC---EEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           86 IHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        86 LH~~~i~H~dikp~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      ||+.||+||||||+||+++.++.   ++|+|||.+.............++..|+|||.+.+ ..++.++||||+||++|+
T Consensus       137 LHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLye  215 (676)
T 3qa8_A          137 LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFE  215 (676)
T ss_dssp             HHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHH
T ss_pred             HHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHH
Confidence            99999999999999999997765   89999999987766655666789999999999854 458999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccc-c-ccccccCCCCCHHHHHHHHHccCCCCC
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ-R-QSFTEKFPNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~li~~~L~~dP~  240 (302)
                      |++|..||.+......+.....   ............     ......+. . .......+.+++.+.++|.+||.+||.
T Consensus       216 LltG~~Pf~~~~~~~~~~~~i~---~~~~~~~~~~~~-----l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~  287 (676)
T 3qa8_A          216 CITGFRPFLPNWQPVQWHGKVR---EKSNEHIVVYDD-----LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQR  287 (676)
T ss_dssp             HHSSCSSCCSSCHHHHSSTTCC---------CCSCCC-----CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC
T ss_pred             HHHCCCCCCcccchhhhhhhhh---cccchhhhhhhh-----hccccccccccCCchhhchhhhHHHHHHHHHHccCCHh
Confidence            9999999976543322110000   000000000000     00000000 0 001112224567899999999999999


Q ss_pred             CCCCHHHHhcCCCcCCccCCCCCCCC------CCCCCcchhhcccCHHHHHHHHHH
Q 022132          241 QRITVEDALAHPYLGSLHDISDEPVC------MSPFSFDFEQHALTEGQMKELIYQ  290 (302)
Q Consensus       241 ~R~t~~ell~h~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~  290 (302)
                      +|||++++++||||+.+.........      ......-......+..++++.+..
T Consensus       288 kRPTa~elL~hp~F~~l~~iL~~kil~~f~~~~~~~~~~~i~~~~tl~~l~~~i~~  343 (676)
T 3qa8_A          288 QRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQ  343 (676)
T ss_dssp             ---CCTTCCCCTTHHHHHHHHCCCEEECCCSSSSCCCEEECCTTCCHHHHHHHHHT
T ss_pred             hCcCHHHHhcCHHHHHHHHHHhccccccccccccccceeecCCCccHHHHHHHHHH
Confidence            99999999999999877543332211      001111122345566777776664

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=293.52  Aligned_cols=232  Identities=17%  Similarity=0.258  Sum_probs=169.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..+.+|+.++++++||||+++++++.....   ...|+||||++ |+|.+++....   .+++..+..++.||+.||+||
T Consensus        52 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L  128 (396)
T 4eut_A           52 DVQMREFEVLKKLNHKNIVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL  128 (396)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECTTT---CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCeEEEeeccCCC---CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            345699999999999999999999987522   57899999996 69999997543   399999999999999999999


Q ss_pred             HhCCceecCCCCCCEEE----ecCCCEEEeecccccccCCCCcccccccccccCchhhhhCC-------CCCCCchhHHH
Q 022132           87 HSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS-------SDYTAAIDVWS  155 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~Diws  155 (302)
                      |+.||+||||||+||++    +.++.++|+|||++.............+|..|+|||++.+.       ..++.++||||
T Consensus       129 H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwS  208 (396)
T 4eut_A          129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS  208 (396)
T ss_dssp             HHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHH
T ss_pred             HHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHH
Confidence            99999999999999999    67777999999999876665555567799999999998542       33678999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHH
Q 022132          156 VGCIFMELMDRKPLFPGRD----HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV  231 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  231 (302)
                      |||++|+|++|..||.+..    ..+.+..+..  +.|. ..+.................  .........++..+.++|
T Consensus       209 lG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~p~-~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~~l~~ll  283 (396)
T 4eut_A          209 IGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPS-GAISGVQKAENGPIDWSGDM--PVSCSLSRGLQVLLTPVL  283 (396)
T ss_dssp             HHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--SCCT-TCCEEEECSTTCCEEEESSC--CTTCSSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--CCCc-ccchhheeccCCCcccCccC--CcccccchHHHhhchHHH
Confidence            9999999999999996432    2233333222  2221 11110000000000000000  000011113456789999


Q ss_pred             HHccCCCCCCCCCHHHHhc
Q 022132          232 EKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       232 ~~~L~~dP~~R~t~~ell~  250 (302)
                      ++||++||.+|||++++++
T Consensus       284 ~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          284 ANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHHSCCCTTTSCCHHHHHH
T ss_pred             HHhhccChhhhccHHHHHH
Confidence            9999999999999999855

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.8e-39  Score=277.57  Aligned_cols=221  Identities=20%  Similarity=0.285  Sum_probs=168.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.+...   ..+|+||||++ ++|.+++... .+++..+..++.||+.||+|||+.
T Consensus        78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~  153 (318)
T 3lxp_A           78 SGWKQEIDILRTLYHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ  153 (318)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEETTT---TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCcchhhEEEEEecCCC---ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            357899999999999999999999987422   67999999997 6999999764 599999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ||+||||||+||+++.++.++|+|||.+.......    ......++..|+|||.+.+.. ++.++|||||||++++|++
T Consensus       154 ~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~  232 (318)
T 3lxp_A          154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLT  232 (318)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred             CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999998665432    223445778899999986544 7899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||......     .....+........   ........      ..........+++.+.+||.+||+.||.+|||+
T Consensus       233 g~~p~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  298 (318)
T 3lxp_A          233 HCDSSQSPPTK-----FLELIGIAQGQMTV---LRLTELLE------RGERLPRPDKCPAEVYHLMKNCWETEASFRPTF  298 (318)
T ss_dssp             TTCGGGSHHHH-----HHHHHCSCCHHHHH---HHHHHHHH------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCcccccchh-----hhhhhcccccchhH---HHHHHHHh------cccCCCCCccccHHHHHHHHHHcCCCcccCcCH
Confidence            99998543211     11111111111000   00000000      011112234678999999999999999999999


Q ss_pred             HHHhc
Q 022132          246 EDALA  250 (302)
Q Consensus       246 ~ell~  250 (302)
                      +++++
T Consensus       299 ~ell~  303 (318)
T 3lxp_A          299 ENLIP  303 (318)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.1e-38  Score=272.63  Aligned_cols=208  Identities=25%  Similarity=0.396  Sum_probs=158.8

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLK   84 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~   84 (302)
                      ...+.+|+.+++.++||||+++++++...     +..|+||||++ ++|.+++..    ...+++..+..++.|++.||.
T Consensus        76 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~  150 (310)
T 2wqm_A           76 RADCIKEIDLLKQLNHPNVIKYYASFIED-----NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE  150 (310)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHH
Confidence            34577999999999999999999999887     89999999997 499998864    567999999999999999999


Q ss_pred             HHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           85 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        85 ~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      |||+.|++||||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+. .++.++|||||||++++|
T Consensus       151 ~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l  229 (310)
T 2wqm_A          151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEM  229 (310)
T ss_dssp             HHHHTTCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHH
T ss_pred             HHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHH
Confidence            999999999999999999999999999999998765433 223345688999999998654 489999999999999999


Q ss_pred             HhCCCCCCCCChH-HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          164 MDRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       164 l~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      ++|..||.+.... ..+.........+                           ......+++.+.++|.+||+.||.+|
T Consensus       230 ~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~R  282 (310)
T 2wqm_A          230 AALQSPFYGDKMNLYSLCKKIEQCDYP---------------------------PLPSDHYSEELRQLVNMCINPDPEKR  282 (310)
T ss_dssp             HHSSCTTC---CCHHHHHHHHHTTCSC---------------------------CCCTTTSCHHHHHHHHHHTCSSGGGS
T ss_pred             HhCCCCCcccchhHHHHHHHhhcccCC---------------------------CCcccccCHHHHHHHHHHcCCChhhC
Confidence            9999999754321 1111111100000                           01113578899999999999999999


Q ss_pred             CCHHHHhc
Q 022132          243 ITVEDALA  250 (302)
Q Consensus       243 ~t~~ell~  250 (302)
                      ||++++++
T Consensus       283 ps~~~il~  290 (310)
T 2wqm_A          283 PDVTYVYD  290 (310)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHHH
Confidence            99999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=293.63  Aligned_cols=210  Identities=25%  Similarity=0.368  Sum_probs=173.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..|.+|+.++++++||||+++++++..      +.+|+||||+. |+|.+++..  ...+++..+..++.||+.||+|||
T Consensus       307 ~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH  380 (535)
T 2h8h_A          307 EAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE  380 (535)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEee------ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            368899999999999999999999865      46899999997 699999964  356999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||+||||||+||+++.++.+||+|||+++......  ......++..|+|||.+... .++.++|||||||++|+|++
T Consensus       381 ~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t  459 (535)
T 2h8h_A          381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTT  459 (535)
T ss_dssp             HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTT
T ss_pred             hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999999997654321  12233456789999998654 48999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |..||.+....+.+..+......                             ...+.++..+.+||.+||+.||.+|||
T Consensus       460 ~g~~P~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt  510 (535)
T 2h8h_A          460 KGRVPYPGMVNREVLDQVERGYRM-----------------------------PCPPECPESLHDLMCQCWRKEPEERPT  510 (535)
T ss_dssp             TTCCSSTTCCHHHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence             99999888766655444321111                             112367889999999999999999999


Q ss_pred             HHHHhcC--CCcCC
Q 022132          245 VEDALAH--PYLGS  256 (302)
Q Consensus       245 ~~ell~h--~~~~~  256 (302)
                      ++++++.  .++..
T Consensus       511 ~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          511 FEYLQAFLEDYFTS  524 (535)
T ss_dssp             HHHHHHHHHTSSCC
T ss_pred             HHHHHHHHHHHhhc
Confidence            9999873  45443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.6e-38  Score=296.11  Aligned_cols=204  Identities=24%  Similarity=0.375  Sum_probs=169.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++.+      +.+|+||||++ |+|.+++... ..+++..+..++.|++.||+|||+
T Consensus       436 ~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~  509 (656)
T 2j0j_A          436 EKFLQEALTMRQFDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES  509 (656)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEec------CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            467899999999999999999999854      56899999997 7999999864 479999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      +||+||||||+||+++.++.++|+|||++........  .....++..|+|||.+.+. .++.++||||+||++++|++ 
T Consensus       510 ~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~  588 (656)
T 2j0j_A          510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMH  588 (656)
T ss_dssp             TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHc
Confidence            9999999999999999999999999999976544321  2234556789999998654 58999999999999999997 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+..+....+......                             ...+.+++.+.++|.+||..||.+|||+
T Consensus       589 g~~Pf~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~  639 (656)
T 2j0j_A          589 GVKPFQGVKNNDVIGRIENGERL-----------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRF  639 (656)
T ss_dssp             SCCTTTTCCHHHHHHHHHHTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCccccHHHHHHHHHHcCCChhHCcCH
Confidence            99999988776665544331111                             1223678899999999999999999999


Q ss_pred             HHHhc
Q 022132          246 EDALA  250 (302)
Q Consensus       246 ~ell~  250 (302)
                      .++++
T Consensus       640 ~el~~  644 (656)
T 2j0j_A          640 TELKA  644 (656)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99975

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.6e-39  Score=277.29  Aligned_cols=214  Identities=23%  Similarity=0.324  Sum_probs=165.5

Q ss_pred             hcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGL   83 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l   83 (302)
                      ....+.+|+.+++.++||||+++++++.... ...+..|+||||+. ++|.+++..    ...+++..+..++.||+.||
T Consensus        69 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L  147 (317)
T 2buj_A           69 DREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL  147 (317)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence            3446789999999999999999999997321 11268999999997 599998875    57799999999999999999


Q ss_pred             HHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc----------ccccccccccCchhhhhCCC--CCCCch
Q 022132           84 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----------MTEYVVTRWYRAPELLLNSS--DYTAAI  151 (302)
Q Consensus        84 ~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~  151 (302)
                      +|||++||+||||||+||+++.++.++|+|||.+........          .....++..|+|||.+.+..  .++.++
T Consensus       148 ~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  227 (317)
T 2buj_A          148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT  227 (317)
T ss_dssp             HHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHH
T ss_pred             HHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchh
Confidence            999999999999999999999999999999998765432110          12234688999999885432  258899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          152 DVWSVGCIFMELMDRKPLFPGRDHVH-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       152 DiwslG~i~~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      |||||||++++|++|..||....... ......                      ...      ......+.+++.+.++
T Consensus       228 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------------------~~~------~~~~~~~~~~~~l~~l  279 (317)
T 2buj_A          228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV----------------------QNQ------LSIPQSPRHSSALWQL  279 (317)
T ss_dssp             HHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH----------------------HCC--------CCCCTTSCHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCChhhhhcccchhhHHh----------------------hcc------CCCCccccCCHHHHHH
Confidence            99999999999999999994210000 000000                      000      0001123678899999


Q ss_pred             HHHccCCCCCCCCCHHHHhcC
Q 022132          231 VEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       231 i~~~L~~dP~~R~t~~ell~h  251 (302)
                      |.+||+.||.+|||+++++++
T Consensus       280 i~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          280 LNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhhcChhhCCCHHHHHHH
Confidence            999999999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.2e-38  Score=269.44  Aligned_cols=216  Identities=21%  Similarity=0.295  Sum_probs=161.2

Q ss_pred             CchhhHHHHHHh--cCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTW--IMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~--l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|..++..  ++||||+++++++.... .....+|+||||++ |+|.+++.. ..+++..+..++.|++.||+|||
T Consensus        45 ~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH  122 (301)
T 3q4u_A           45 KSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLH  122 (301)
T ss_dssp             HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHH
Confidence            345577788777  79999999999865431 11267999999997 699999965 57999999999999999999999


Q ss_pred             --------hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc-----ccccccccccCchhhhhCCCC-----CCC
Q 022132           88 --------SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-----MTEYVVTRWYRAPELLLNSSD-----YTA  149 (302)
Q Consensus        88 --------~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~-----~~~  149 (302)
                              +.||+||||||+||+++.++.++|+|||++........     .....+|..|+|||.+.+...     ++.
T Consensus       123 ~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  202 (301)
T 3q4u_A          123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYK  202 (301)
T ss_dssp             SCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHH
T ss_pred             HhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCc
Confidence                    99999999999999999999999999999875443321     233478999999999865432     346


Q ss_pred             chhHHHHHHHHHHHHhC----------CCCCCCCCh----HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccc
Q 022132          150 AIDVWSVGCIFMELMDR----------KPLFPGRDH----VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS  215 (302)
Q Consensus       150 ~~DiwslG~i~~~ll~g----------~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (302)
                      ++||||+||++|+|++|          .+||.....    ..............                   +..   +
T Consensus       203 ~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~---~  260 (301)
T 3q4u_A          203 RVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR-------------------PNI---P  260 (301)
T ss_dssp             HHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-------------------CCC---C
T ss_pred             hhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCC-------------------CCC---C
Confidence            89999999999999999          888854321    11111111100000                   000   0


Q ss_pred             ccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       216 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      ........++.+.+|+.+||+.||.+|||++++++
T Consensus       261 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          261 NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            00001124567999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.2e-37  Score=281.88  Aligned_cols=210  Identities=16%  Similarity=0.189  Sum_probs=166.6

Q ss_pred             cCchhhHHHHHHhcCCC-CccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKT-SVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~-niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.+++.+.|+ ++..+..++...     +..++||||++++|.+++.. .+.+++..+..++.||+.||+|||
T Consensus        46 ~~~~~~E~~il~~L~~~~~i~~i~~~~~~~-----~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH  120 (483)
T 3sv0_A           46 HPQLLYESKIYRILQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH  120 (483)
T ss_dssp             SCCHHHHHHHHHHTTTSTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhcCCCCCCeEEEEEeeC-----CEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45688999999999775 455555555554     78999999999999999974 568999999999999999999999


Q ss_pred             hCCceecCCCCCCEEE---ecCCCEEEeecccccccCCCCc--------ccccccccccCchhhhhCCCCCCCchhHHHH
Q 022132           88 SANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  156 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  156 (302)
                      ++||+||||||+|||+   +.++.++|+|||++........        .....+|..|+|||.+.+. .++.++|||||
T Consensus       121 ~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSl  199 (483)
T 3sv0_A          121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESL  199 (483)
T ss_dssp             HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHH
T ss_pred             HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHH
Confidence            9999999999999999   5889999999999976543321        2256789999999998654 48999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHH
Q 022132          157 GCIFMELMDRKPLFPGRDHV---HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  233 (302)
Q Consensus       157 G~i~~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  233 (302)
                      ||++|+|++|..||.+....   ..+..+......                         .........++.++.+||..
T Consensus       200 Gvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------------------------~~~~~l~~~~p~~l~~li~~  254 (483)
T 3sv0_A          200 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-------------------------TSIEALCRGYPTEFASYFHY  254 (483)
T ss_dssp             HHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-------------------------SCHHHHHTTSCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-------------------------ccHHHHhcCCcHHHHHHHHH
Confidence            99999999999999875432   222222211100                         01112223678899999999


Q ss_pred             ccCCCCCCCCCHHHHhc
Q 022132          234 MLTFDPRQRITVEDALA  250 (302)
Q Consensus       234 ~L~~dP~~R~t~~ell~  250 (302)
                      ||..||.+||+++++++
T Consensus       255 cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          255 CRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHTCCTTCCCCHHHHHH
T ss_pred             HhcCChhhCcCHHHHHH
Confidence            99999999999988765

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=270.68  Aligned_cols=222  Identities=18%  Similarity=0.283  Sum_probs=167.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.+++.++||||+++++++.....   ..+++||||++ ++|.+++... ..+++..+..++.||+.||++||+.
T Consensus        88 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  164 (326)
T 2w1i_A           88 DFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK  164 (326)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEECC-------CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEEecCC---CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            57799999999999999999999876522   57899999996 5999999865 5699999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCc----ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ||+||||||+||+++.++.++|+|||++........    .....++..|+|||.+.+. .++.++|||||||++++|++
T Consensus       165 ~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t  243 (326)
T 2w1i_A          165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFT  243 (326)
T ss_dssp             TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHH
T ss_pred             CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999999976554321    2234567779999998654 47899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |..||.....     ......+........  ...........      ......+.+++.+.++|.+||..||.+|||+
T Consensus       244 g~~~~~~~~~-----~~~~~~~~~~~~~~~--~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  310 (326)
T 2w1i_A          244 YIEKSKSPPA-----EFMRMIGNDKQGQMI--VFHLIELLKNN------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSF  310 (326)
T ss_dssp             TTCGGGSHHH-----HHHHHHCTTCCTHHH--HHHHHHHHHTT------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             cCCCCCCCHH-----HHHHhhccccchhhh--HHHHHHHhhcC------CCCCCCCcccHHHHHHHHHHcCCChhhCcCH
Confidence            9998853211     111122222111100  00000000000      0011234678999999999999999999999


Q ss_pred             HHHhc
Q 022132          246 EDALA  250 (302)
Q Consensus       246 ~ell~  250 (302)
                      .++++
T Consensus       311 ~el~~  315 (326)
T 2w1i_A          311 RDLAL  315 (326)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99985

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=276.67  Aligned_cols=235  Identities=19%  Similarity=0.252  Sum_probs=160.2

Q ss_pred             chhhHHHH--HHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           12 HFVRSSCF--DTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        12 ~~~~E~~i--l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      .+..|..+  ++.++||||+++++.+......+...+|+||||++ |+|.+++... ..++..+..++.||+.||+|||+
T Consensus        51 ~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~  129 (336)
T 3g2f_A           51 NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHT  129 (336)
T ss_dssp             HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHh
Confidence            33444444  45589999999998654322222267899999995 6999999764 45899999999999999999999


Q ss_pred             C---------CceecCCCCCCEEEecCCCEEEeecccccccCCC---------CcccccccccccCchhhhhCC------
Q 022132           89 A---------NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---------DFMTEYVVTRWYRAPELLLNS------  144 (302)
Q Consensus        89 ~---------~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~------  144 (302)
                      .         ||+||||||+||+++.++.++|+|||++......         .......||..|+|||++.+.      
T Consensus       130 ~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  209 (336)
T 3g2f_A          130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDX  209 (336)
T ss_dssp             CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGH
T ss_pred             hhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccc
Confidence            9         9999999999999999999999999999765432         122345689999999998653      


Q ss_pred             CCCCCchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHh-CCCChHHHhhhhHhHHHHhhhccccccccccccCC-
Q 022132          145 SDYTAAIDVWSVGCIFMELMDRKPLF-PGRDHVHQLRLLIELI-GTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-  221 (302)
Q Consensus       145 ~~~~~~~DiwslG~i~~~ll~g~~pf-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  221 (302)
                      ..++.++|||||||++|+|++|..|| .+.............. ..|.........         ........+...++ 
T Consensus       210 ~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~  280 (336)
T 3g2f_A          210 ESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV---------SREKQRPKFPEAWKE  280 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHH---------TTSCCCCCCCTTCCC
T ss_pred             cccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhh---------cccccCCCCCccccc
Confidence            23457899999999999999996554 3332211111111111 112111111000         00001111122111 


Q ss_pred             --CCCHHHHHHHHHccCCCCCCCCCHHHHhc------CCCcCC
Q 022132          222 --NVHPSAIDLVEKMLTFDPRQRITVEDALA------HPYLGS  256 (302)
Q Consensus       222 --~~~~~~~~li~~~L~~dP~~R~t~~ell~------h~~~~~  256 (302)
                        ..++.+.+||.+||+.||.+|||++|+++      ++|-+.
T Consensus       281 ~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          281 NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence              13457999999999999999999999954      566554

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.2e-37  Score=270.13  Aligned_cols=200  Identities=16%  Similarity=0.188  Sum_probs=161.1

Q ss_pred             chhhHHHHHHhcC---CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-----CCCCCHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIM---KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-----NQALSEEHCQYFLYQILRG   82 (302)
Q Consensus        12 ~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qll~~   82 (302)
                      .+.+|+.+++.++   |+||+++++++...     +..|+||||++ |+|.+++..     .+.+++..+..++.||+.|
T Consensus       110 ~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~  184 (365)
T 3e7e_A          110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQ-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM  184 (365)
T ss_dssp             HHHHHHHHHHHSCGGGGGGBCCEEEEEECS-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhhhhhhhhhhhheeeecC-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHH
Confidence            5678888888887   89999999999987     88999999997 799999973     5679999999999999999


Q ss_pred             HHHHHhCCceecCCCCCCEEEec-----------CCCEEEeecccccccC---CCCcccccccccccCchhhhhCCCCCC
Q 022132           83 LKYIHSANVLHRDLKPSNLLLNA-----------NCDLKICDFGLARVTS---ETDFMTEYVVTRWYRAPELLLNSSDYT  148 (302)
Q Consensus        83 l~~LH~~~i~H~dikp~Nil~~~-----------~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~  148 (302)
                      |+|||++||+||||||+||+++.           ++.+||+|||++....   .........||..|+|||++.+.. ++
T Consensus       185 L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~  263 (365)
T 3e7e_A          185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WN  263 (365)
T ss_dssp             HHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BS
T ss_pred             HHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CC
Confidence            99999999999999999999998           8999999999996432   233445567999999999996544 89


Q ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHH
Q 022132          149 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  228 (302)
Q Consensus       149 ~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (302)
                      .++|||||||++|+|++|..||.......                                ......+...  ..+..+.
T Consensus       264 ~~~DiwslG~il~elltg~~pf~~~~~~~--------------------------------~~~~~~~~~~--~~~~~~~  309 (365)
T 3e7e_A          264 YQIDYFGVAATVYCMLFGTYMKVKNEGGE--------------------------------CKPEGLFRRL--PHLDMWN  309 (365)
T ss_dssp             THHHHHHHHHHHHHHHHSSCCCEEEETTE--------------------------------EEECSCCTTC--SSHHHHH
T ss_pred             ccccHHHHHHHHHHHHhCCCccccCCCCc--------------------------------eeechhcccc--CcHHHHH
Confidence            99999999999999999999985332100                                0000000000  2345788


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcC
Q 022132          229 DLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       229 ~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +++..||+.+|.+|++..+.+.+
T Consensus       310 ~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          310 EFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             HHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             HHHHHHcCCCCCCcchHHHHHHH
Confidence            99999999999999765544443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.3e-39  Score=283.00  Aligned_cols=210  Identities=15%  Similarity=0.167  Sum_probs=154.5

Q ss_pred             CchhhHHHHHHhcC--------------------------CCCccccceeeCCCC--------CCCCCcEEEEEecCC-c
Q 022132           11 GHFVRSSCFDTWIM--------------------------KTSVVAIRDIIPPPQ--------RESFNDVYIAYELMD-T   55 (302)
Q Consensus        11 ~~~~~E~~il~~l~--------------------------h~niv~l~~~~~~~~--------~~~~~~~~lv~e~~~-~   55 (302)
                      ..+.+|+.+++.++                          ||||+++++++.+..        ..+.+.+|+||||+. |
T Consensus        68 ~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g  147 (336)
T 2vuw_A           68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG  147 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCC
T ss_pred             HHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCC
Confidence            45678999999986                          566666666665410        001278999999985 5


Q ss_pred             cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEecCC--------------------CEEEeec
Q 022132           56 DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNANC--------------------DLKICDF  114 (302)
Q Consensus        56 ~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH-~~~i~H~dikp~Nil~~~~~--------------------~~kl~df  114 (302)
                      ++.+.+.+ +.+++..++.++.||+.||+||| ++||+||||||+|||++.++                    .+||+||
T Consensus       148 ~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DF  226 (336)
T 2vuw_A          148 IDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDY  226 (336)
T ss_dssp             EETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCC
T ss_pred             ccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeec
Confidence            55555543 67899999999999999999999 99999999999999999987                    8999999


Q ss_pred             ccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChH
Q 022132          115 GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVH-QLRLLIELIGTPSEA  192 (302)
Q Consensus       115 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i-~~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~  192 (302)
                      |+++.....    ...||+.|+|||++.+..  +.++||||+|++ .++++.|..||.+..... ....+.....     
T Consensus       227 G~a~~~~~~----~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-----  295 (336)
T 2vuw_A          227 TLSRLERDG----IVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT-----  295 (336)
T ss_dssp             TTCBEEETT----EEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC-----
T ss_pred             cccEecCCC----cEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc-----
Confidence            999876543    347899999999986443  889999998777 667888999884321111 1111111000     


Q ss_pred             HHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh-cCCCcC
Q 022132          193 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL-AHPYLG  255 (302)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell-~h~~~~  255 (302)
                                        .........++.+++++++||++||++|     |++|+| +||||+
T Consensus       296 ------------------~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          296 ------------------FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             ------------------CSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             ------------------cCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence                              0011111122346788999999999987     999999 999995

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.9e-36  Score=264.78  Aligned_cols=215  Identities=17%  Similarity=0.251  Sum_probs=163.9

Q ss_pred             CchhhHHHHHHh--cCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTW--IMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~--l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|..+++.  ++||||+++++++..... ....+|+||||++ |+|.+++.. ..+++..+..++.|++.||+|||
T Consensus        79 ~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH  156 (342)
T 1b6c_B           79 RSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLH  156 (342)
T ss_dssp             HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH
Confidence            456789999988  799999999999987621 1237999999997 599999976 46999999999999999999999


Q ss_pred             --------hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC-----cccccccccccCchhhhhCCCCC-----CC
Q 022132           88 --------SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDY-----TA  149 (302)
Q Consensus        88 --------~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~-----~~  149 (302)
                              +.||+||||||+||+++.++.++|+|||++.......     ......++..|+|||.+.+....     +.
T Consensus       157 ~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  236 (342)
T 1b6c_B          157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK  236 (342)
T ss_dssp             CCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHH
T ss_pred             HHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCC
Confidence                    8999999999999999999999999999987654432     22445789999999998654322     26


Q ss_pred             chhHHHHHHHHHHHHhC----------CCCCCCCCh----HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccc
Q 022132          150 AIDVWSVGCIFMELMDR----------KPLFPGRDH----VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS  215 (302)
Q Consensus       150 ~~DiwslG~i~~~ll~g----------~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (302)
                      ++|||||||++|+|++|          ..||.....    ...+........                        ....
T Consensus       237 ~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~  292 (342)
T 1b6c_B          237 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK------------------------LRPN  292 (342)
T ss_dssp             HHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC------------------------CCCC
T ss_pred             cccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHH------------------------hCCC
Confidence            89999999999999999          677754421    111111110000                        0000


Q ss_pred             ccccC--CCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          216 FTEKF--PNVHPSAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       216 ~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +...+  ...+..+.+|+.+||+.||.+|||+++++++
T Consensus       293 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          293 IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            01100  1234578999999999999999999999875

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-37  Score=277.22  Aligned_cols=209  Identities=14%  Similarity=0.160  Sum_probs=160.4

Q ss_pred             chhhHHHHHHhcCC-CCcccccee---------------------eCCCCCCCCCcEEEEEecCCccHHHHHHc------
Q 022132           12 HFVRSSCFDTWIMK-TSVVAIRDI---------------------IPPPQRESFNDVYIAYELMDTDLHQIIRS------   63 (302)
Q Consensus        12 ~~~~E~~il~~l~h-~niv~l~~~---------------------~~~~~~~~~~~~~lv~e~~~~~L~~~l~~------   63 (302)
                      .+.+|+.+++.+.| +|...+..+                     +..........++++|++++++|.+++..      
T Consensus       124 ~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~  203 (413)
T 3dzo_A          124 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS  203 (413)
T ss_dssp             HHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccc
Confidence            46689999999977 332221111                     11111111246889999999999998841      


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhh
Q 022132           64 -NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL  142 (302)
Q Consensus        64 -~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  142 (302)
                       .+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..+..  .....| ..|+|||++.
T Consensus       204 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~  280 (413)
T 3dzo_A          204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTA  280 (413)
T ss_dssp             TSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhh
Confidence             345788899999999999999999999999999999999999999999999998765544  344566 8999999984


Q ss_pred             ---------CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccc
Q 022132          143 ---------NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR  213 (302)
Q Consensus       143 ---------~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (302)
                               ....++.++|||||||++|+|++|..||.+.+.....                                  
T Consensus       281 ~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~----------------------------------  326 (413)
T 3dzo_A          281 ERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS----------------------------------  326 (413)
T ss_dssp             HHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS----------------------------------
T ss_pred             ccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH----------------------------------
Confidence                     3334778999999999999999999999765421110                                  


Q ss_pred             ccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          214 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       214 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                      .......+.+++.+.+||.+||+.||.+|||+.++++||||+.+
T Consensus       327 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          327 EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             GGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            00111223678999999999999999999999999999999865

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-36  Score=265.62  Aligned_cols=213  Identities=21%  Similarity=0.277  Sum_probs=157.6

Q ss_pred             chhhHHHHHHhc--CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           12 HFVRSSCFDTWI--MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        12 ~~~~E~~il~~l--~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      .+.+|..++..+  +||||+++++++..... ..+.+|+||||++ |+|.+++.. ..+++..+..++.|++.||+|||+
T Consensus        75 ~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~  152 (337)
T 3mdy_A           75 SWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHT  152 (337)
T ss_dssp             HHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHS
T ss_pred             hhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH
Confidence            345566666655  89999999999876521 2257999999996 599999976 469999999999999999999999


Q ss_pred             C--------CceecCCCCCCEEEecCCCEEEeecccccccCCCCc-----ccccccccccCchhhhhCCCCCCC------
Q 022132           89 A--------NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-----MTEYVVTRWYRAPELLLNSSDYTA------  149 (302)
Q Consensus        89 ~--------~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~------  149 (302)
                      .        ||+||||||+||+++.++.++|+|||++........     .....+|..|+|||++.+.. ...      
T Consensus       153 ~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~  231 (337)
T 3mdy_A          153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYI  231 (337)
T ss_dssp             CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHH
T ss_pred             hhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCcc
Confidence            9        999999999999999999999999999865443221     12457899999999986544 333      


Q ss_pred             chhHHHHHHHHHHHHhC----------CCCCCCCCh----HHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccc
Q 022132          150 AIDVWSVGCIFMELMDR----------KPLFPGRDH----VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS  215 (302)
Q Consensus       150 ~~DiwslG~i~~~ll~g----------~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (302)
                      ++|||||||++|+|++|          ..||.....    ............                        ....
T Consensus       232 ~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~  287 (337)
T 3mdy_A          232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK------------------------LRPS  287 (337)
T ss_dssp             HHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC------------------------CCCC
T ss_pred             ccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhc------------------------cCcc
Confidence            39999999999999999          666643321    111111110000                        0000


Q ss_pred             ccc--cCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          216 FTE--KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       216 ~~~--~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +..  ....+++.+.++|.+||+.||.+|||+++++++
T Consensus       288 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          288 FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            000  011345679999999999999999999999875

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.8e-36  Score=284.88  Aligned_cols=201  Identities=25%  Similarity=0.353  Sum_probs=160.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++......+....|+||||++ ++|.+++..  .+++..+..++.||+.||.|||++|
T Consensus       125 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g  202 (681)
T 2pzi_A          125 MAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG  202 (681)
T ss_dssp             HHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            5679999999999999999999998763222123799999997 588887654  7999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      |+||||||+||+++.+ .+||+|||++......   ....||+.|+|||++.+.  .+.++|||||||++++|++|.+||
T Consensus       203 iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~  276 (681)
T 2pzi_A          203 LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTR  276 (681)
T ss_dssp             EECCCCSGGGEEECSS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEE
T ss_pred             CeecccChHHeEEeCC-cEEEEecccchhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCC
Confidence            9999999999999875 8999999999876543   445789999999998653  488999999999999999999988


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      .+....          +.+...                      +    ....++.+.++|.+||++||.+||+..+++.
T Consensus       277 ~~~~~~----------~~~~~~----------------------~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  320 (681)
T 2pzi_A          277 NGRYVD----------GLPEDD----------------------P----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS  320 (681)
T ss_dssp             TTEECS----------SCCTTC----------------------H----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             cccccc----------cccccc----------------------c----ccccCHHHHHHHhhhccCChhhCCCHHHHHH
Confidence            643110          000000                      0    0023567899999999999999999999998


Q ss_pred             CCCcCC
Q 022132          251 HPYLGS  256 (302)
Q Consensus       251 h~~~~~  256 (302)
                      |+|+..
T Consensus       321 ~~l~~~  326 (681)
T 2pzi_A          321 AQLTGV  326 (681)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            888754

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=8.7e-34  Score=242.18  Aligned_cols=182  Identities=13%  Similarity=0.059  Sum_probs=146.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++...     +..|+||||++ ++|.+++.. + .....+..++.||+.||+|||++
T Consensus        76 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~  148 (286)
T 3uqc_A           76 QETLSRTLRLSRIDKPGVARVLDVVHTR-----AGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRA  148 (286)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCCcceeeEEEEEC-----CcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHC
Confidence            4678999999999999999999999887     88999999997 699999864 3 46667889999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.+|.++|++++                   |++        .++.++|||||||++|+|++|..|
T Consensus       149 givH~Dikp~NIll~~~g~~kl~~~~-------------------~~~--------~~~~~~Di~slG~il~elltg~~P  201 (286)
T 3uqc_A          149 GVALSIDHPSRVRVSIDGDVVLAYPA-------------------TMP--------DANPQDDIRGIGASLYALLVNRWP  201 (286)
T ss_dssp             TCCCCCCSGGGEEEETTSCEEECSCC-------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEEC
T ss_pred             CCccCCCCcccEEEcCCCCEEEEecc-------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCC
Confidence            99999999999999999999998543                   222        268899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+....+....                       ..............+.+++.+.++|.+||+.||.+| |++|++
T Consensus       202 f~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~  257 (286)
T 3uqc_A          202 LPEAGVRSGLAPAE-----------------------RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLL  257 (286)
T ss_dssp             SCCCSBCCCSEECC-----------------------BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHH
T ss_pred             CCcCCcchhhHHHH-----------------------HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHH
Confidence            97764321100000                       000001112223445789999999999999999999 999998


Q ss_pred             c
Q 022132          250 A  250 (302)
Q Consensus       250 ~  250 (302)
                      +
T Consensus       258 ~  258 (286)
T 3uqc_A          258 N  258 (286)
T ss_dssp             H
T ss_pred             H
Confidence            7

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=6.2e-34  Score=264.13  Aligned_cols=148  Identities=17%  Similarity=0.166  Sum_probs=115.6

Q ss_pred             cCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...|.+|+.+|+++ .|+||+++++++++.     +.+||||||++| +|.+++...+++++..   |+.||+.||+|||
T Consensus       285 ~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~-----~~~yLVMEyv~G~~L~d~i~~~~~l~~~~---I~~QIl~AL~ylH  356 (569)
T 4azs_A          285 KYELHNEIKFLTQPPAGFDAPAVLAHGENA-----QSGWLVMEKLPGRLLSDMLAAGEEIDREK---ILGSLLRSLAALE  356 (569)
T ss_dssp             HHHHHHHHHHHHSCCTTCCCCCEEEEEECS-----SEEEEEEECCCSEEHHHHHHTTCCCCHHH---HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCeeEEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhCCCCCHHH---HHHHHHHHHHHHH
Confidence            34688999999999 799999999999998     899999999975 9999999999998764   7899999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      ++||+||||||+|||++.+|.+||+|||+++..... ......+||+.|+|||++.+  .+..++|+||+|++.+.+.++
T Consensus       357 ~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          357 KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTT
T ss_pred             HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccc
Confidence            999999999999999999999999999999765433 34556789999999999854  357789999999998877555


Q ss_pred             C
Q 022132          167 K  167 (302)
Q Consensus       167 ~  167 (302)
                      .
T Consensus       435 ~  435 (569)
T 4azs_A          435 W  435 (569)
T ss_dssp             H
T ss_pred             c
Confidence            4

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=6.3e-25  Score=202.61  Aligned_cols=147  Identities=18%  Similarity=0.287  Sum_probs=120.7

Q ss_pred             hcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ....+.+|+.++++++||||+++..+....     +..|+||||++ ++|.+++..        +..++.|++.||+|||
T Consensus       382 ~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH  448 (540)
T 3en9_A          382 RKSRTAREARYLALVKDFGIPAPYIFDVDL-----DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLH  448 (540)
T ss_dssp             HHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHH
Confidence            345688999999999999999554444444     56799999997 799999865        6689999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCc--------ccccccccccCchhhhhCC-CCCCCchhHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGC  158 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~  158 (302)
                      ++||+||||||+||+++.  .+||+|||+++.......        .....+|+.|+|||++... ..|+..+|+||.++
T Consensus       449 ~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl  526 (540)
T 3en9_A          449 KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIIL  526 (540)
T ss_dssp             HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHH
T ss_pred             HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHH
Confidence            999999999999999998  999999999987654321        2356789999999998541 23677889999988


Q ss_pred             HHHHHHhCCCCC
Q 022132          159 IFMELMDRKPLF  170 (302)
Q Consensus       159 i~~~ll~g~~pf  170 (302)
                      -..+.+.++.+|
T Consensus       527 ~~l~~v~~r~rY  538 (540)
T 3en9_A          527 ELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHTCSCC
T ss_pred             HHHHHHHhcccc
Confidence            888777766655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.76  E-value=2.8e-19  Score=151.77  Aligned_cols=104  Identities=19%  Similarity=0.143  Sum_probs=85.3

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+++.++  | +++++++..      +..|+||||++ ++|.+ +.      ......++.|++.||.+||+
T Consensus       148 ~~~~~~E~~~l~~l~--~-~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~  211 (282)
T 1zar_A          148 IRSARNEFRALQKLQ--G-LAVPKVYAW------EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYH  211 (282)
T ss_dssp             HHHHHHHHHHHHHTT--T-SSSCCEEEE------ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcc--C-CCcCeEEec------cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHH
Confidence            446789999999999  5 777776643      55799999997 59987 32      12345799999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL  142 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  142 (302)
                      .||+||||||+||+++ ++.++|+|||++..            +..+.|||.+.
T Consensus       212 ~giiHrDlkp~NILl~-~~~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          212 RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             TTEECSCCSTTSEEEE-TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             CCCEeCCCCHHHEEEE-CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence            9999999999999999 99999999999853            33468888773

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.60  E-value=4.3e-16  Score=130.48  Aligned_cols=95  Identities=16%  Similarity=0.152  Sum_probs=77.3

Q ss_pred             chhhHHHHHHhcCCCCc--cccceeeCCCCCCCCCcEEEEEecCCc------cHHHHHHcCCCCCHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSV--VAIRDIIPPPQRESFNDVYIAYELMDT------DLHQIIRSNQALSEEHCQYFLYQILRGL   83 (302)
Q Consensus        12 ~~~~E~~il~~l~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~------~L~~~l~~~~~l~~~~~~~i~~qll~~l   83 (302)
                      .+.+|+.+|+.+.|+++  +.+++.         +..++||||+++      +|.+....   .++..+..++.|++.||
T Consensus       116 ~~~~E~~~l~~l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l  183 (258)
T 1zth_A          116 WTEKEFRNLERAKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENV  183 (258)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHH
Confidence            57799999999988864  333331         356899999952      77776433   23557788999999999


Q ss_pred             HHHH-hCCceecCCCCCCEEEecCCCEEEeeccccccc
Q 022132           84 KYIH-SANVLHRDLKPSNLLLNANCDLKICDFGLARVT  120 (302)
Q Consensus        84 ~~LH-~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  120 (302)
                      .+|| +.||+||||||+||+++.  .++|+|||+|...
T Consensus       184 ~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          184 KRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999 999999999999999988  8999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.31  E-value=6.9e-13  Score=116.05  Aligned_cols=69  Identities=17%  Similarity=0.212  Sum_probs=55.6

Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC----------EEEeec
Q 022132           46 VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD----------LKICDF  114 (302)
Q Consensus        46 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~----------~kl~df  114 (302)
                      .+|||||++| +|.++.      +.+....++.||+.+|.+||++||+||||||.|||++.+|.          +.|+||
T Consensus       186 ~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~  259 (397)
T 4gyi_A          186 HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXF  259 (397)
T ss_dssp             TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCC
T ss_pred             ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEe
Confidence            3699999986 665432      22344678899999999999999999999999999988763          899999


Q ss_pred             cccccc
Q 022132          115 GLARVT  120 (302)
Q Consensus       115 g~~~~~  120 (302)
                      +-+...
T Consensus       260 ~Q~V~~  265 (397)
T 4gyi_A          260 PQMVSM  265 (397)
T ss_dssp             TTCEET
T ss_pred             CCcccC
Confidence            976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.06  E-value=3.2e-10  Score=94.69  Aligned_cols=99  Identities=15%  Similarity=0.103  Sum_probs=79.4

Q ss_pred             cCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.+++.+ .+..+.+++++....     +..|+||||++| +|.+.+.     +......++.++..+|..||
T Consensus        53 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH  122 (263)
T 3tm0_A           53 TYDVEREKDMMLWLEGKLPVPKVLHFERHD-----GWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFH  122 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeEEEEEecC-----CceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHh
Confidence            34678999999999 467888999988765     789999999987 7766521     22234467889999999999


Q ss_pred             h-----------------------------------------------------------CCceecCCCCCCEEEecCCC
Q 022132           88 S-----------------------------------------------------------ANVLHRDLKPSNLLLNANCD  108 (302)
Q Consensus        88 ~-----------------------------------------------------------~~i~H~dikp~Nil~~~~~~  108 (302)
                      +                                                           .+++|+|++|.||+++.++.
T Consensus       123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~  202 (263)
T 3tm0_A          123 SIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV  202 (263)
T ss_dssp             HSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEE
T ss_pred             CCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcE
Confidence            8                                                           45899999999999987655


Q ss_pred             EEEeeccccc
Q 022132          109 LKICDFGLAR  118 (302)
Q Consensus       109 ~kl~dfg~~~  118 (302)
                      +.|+||+.+.
T Consensus       203 ~~lIDwe~a~  212 (263)
T 3tm0_A          203 SGFIDLGRSG  212 (263)
T ss_dssp             EEECCCTTCE
T ss_pred             EEEEEchhcc
Confidence            6799998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.84  E-value=9e-09  Score=89.94  Aligned_cols=107  Identities=14%  Similarity=0.201  Sum_probs=82.9

Q ss_pred             cCchhhHHHHHHhcC--CCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIM--KTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        10 ~~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ...+.+|+.+++.+.  +..+++++.++.+..  ..+..|+||||++| .+.+.  ....++......++.++..+|..|
T Consensus        80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~L  155 (359)
T 3dxp_A           80 AHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAM  155 (359)
T ss_dssp             --CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHH
Confidence            457789999999996  456888988887652  12458999999986 44321  113477888899999999999999


Q ss_pred             Hh----------------------------------------------------------CCceecCCCCCCEEEecCCC
Q 022132           87 HS----------------------------------------------------------ANVLHRDLKPSNLLLNANCD  108 (302)
Q Consensus        87 H~----------------------------------------------------------~~i~H~dikp~Nil~~~~~~  108 (302)
                      |+                                                          .+++|+|+++.||+++.++.
T Consensus       156 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~  235 (359)
T 3dxp_A          156 HTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP  235 (359)
T ss_dssp             HHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS
T ss_pred             hCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC
Confidence            97                                                          35899999999999997753


Q ss_pred             --EEEeeccccccc
Q 022132          109 --LKICDFGLARVT  120 (302)
Q Consensus       109 --~kl~dfg~~~~~  120 (302)
                        +.|+||+.+...
T Consensus       236 ~v~~viDwe~a~~g  249 (359)
T 3dxp_A          236 RVLAVLDWELSTLG  249 (359)
T ss_dssp             CEEEECCCTTCEEE
T ss_pred             cEEEEECccccccC
Confidence              689999988643

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.82  E-value=1e-08  Score=85.14  Aligned_cols=95  Identities=15%  Similarity=0.218  Sum_probs=71.6

Q ss_pred             CchhhHHHHHHhcCCCC--ccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTS--VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..+.+|+.+++.+.+.+  +.+++++....     +..|+||||++| +| . .   ...+.   ..++.++...|..||
T Consensus        58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~~~~v~e~i~G~~l-~-~---~~~~~---~~~~~~l~~~l~~lh  124 (264)
T 1nd4_A           58 NELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLLGEVPGQDL-L-S---SHLAP---AEKVSIMADAMRRLH  124 (264)
T ss_dssp             SCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEEECCSSEET-T-T---SCCCH---HHHHHHHHHHHHHHT
T ss_pred             hhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CCCEEEEEecCCccc-C-c---CcCCH---hHHHHHHHHHHHHHh
Confidence            45679999999995434  56688887765     679999999986 55 3 1   11222   246677778888888


Q ss_pred             hCC----------------------------------------------------------ceecCCCCCCEEEecCCCE
Q 022132           88 SAN----------------------------------------------------------VLHRDLKPSNLLLNANCDL  109 (302)
Q Consensus        88 ~~~----------------------------------------------------------i~H~dikp~Nil~~~~~~~  109 (302)
                      +..                                                          ++|+|++|.||+++.++.+
T Consensus       125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~  204 (264)
T 1nd4_A          125 TLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFS  204 (264)
T ss_dssp             TSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEE
T ss_pred             CCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEE
Confidence            653                                                          9999999999999877666


Q ss_pred             EEeeccccc
Q 022132          110 KICDFGLAR  118 (302)
Q Consensus       110 kl~dfg~~~  118 (302)
                      .|+||+.+.
T Consensus       205 ~liD~~~a~  213 (264)
T 1nd4_A          205 GFIDCGRLG  213 (264)
T ss_dssp             EECCCTTCE
T ss_pred             EEEcchhcc
Confidence            799999874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.76  E-value=1e-08  Score=87.53  Aligned_cols=156  Identities=15%  Similarity=0.181  Sum_probs=98.0

Q ss_pred             CchhhHHHHHHhc-CCCC--ccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTS--VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..+.+|..+|+.+ .+..  +.+++......  ......|+||++++| +|.....  ..++.+....++.++...++.|
T Consensus        55 ~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~L  130 (304)
T 3sg8_A           55 TNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSEL  130 (304)
T ss_dssp             HHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHH
Confidence            4577899999998 4433  34444443322  112345899999987 5544332  2477888888888888888888


Q ss_pred             Hh----------------------------------------------------------CCceecCCCCCCEEEec--C
Q 022132           87 HS----------------------------------------------------------ANVLHRDLKPSNLLLNA--N  106 (302)
Q Consensus        87 H~----------------------------------------------------------~~i~H~dikp~Nil~~~--~  106 (302)
                      |+                                                          ..++|+|++|.||+++.  .
T Consensus       131 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~  210 (304)
T 3sg8_A          131 HSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKN  210 (304)
T ss_dssp             HHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTT
T ss_pred             HcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCC
Confidence            86                                                          13799999999999998  4


Q ss_pred             CCEEEeecccccccCCCCcccccccccccCchhhhh----CCCC---------CCCchhHHHHHHHHHHHHhCCCCC
Q 022132          107 CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL----NSSD---------YTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus       107 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~---------~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      +.+.++||+.+.................-.+|+...    ....         .....+.|++|.+++.+.+|.++|
T Consensus       211 ~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          211 TICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             EEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            567899999886543211000000000001222110    0000         112368999999999999998766

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.17  E-value=4.5e-05  Score=60.62  Aligned_cols=98  Identities=19%  Similarity=0.160  Sum_probs=66.3

Q ss_pred             cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCEEEeecccccccCCCCccccccccc
Q 022132           56 DLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR  133 (302)
Q Consensus        56 ~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  133 (302)
                      +|.++|.. +.+++++++|.+++|.+.+|.-+-. ..-..+=+.|..|++..+|.+.+.+ +.+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            89999974 5799999999999999999877622 2222344567899999999988874 2111           1122


Q ss_pred             ccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132          134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus       134 ~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      .+.|||...  ...+.+.=|||||+++|.-+-..
T Consensus       102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A          102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             -----CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             CCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence            366787652  23567889999999999988544

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.16  E-value=8.5e-06  Score=67.88  Aligned_cols=99  Identities=16%  Similarity=0.272  Sum_probs=72.0

Q ss_pred             chhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|..+|+.+. +--+.+++++..+.     +..|+|||+++| ++.+.....    ......+..++...|..||+.
T Consensus        65 ~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~  135 (272)
T 4gkh_A           65 DVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSI  135 (272)
T ss_dssp             HHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCC
Confidence            4668999999994 44477888888776     788999999987 666554331    222334556666666666641


Q ss_pred             ----------------------------------------------------------CceecCCCCCCEEEecCCCEEE
Q 022132           90 ----------------------------------------------------------NVLHRDLKPSNLLLNANCDLKI  111 (302)
Q Consensus        90 ----------------------------------------------------------~i~H~dikp~Nil~~~~~~~kl  111 (302)
                                                                                .++|+|+.+.||+++.++.+-|
T Consensus       136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~v  215 (272)
T 4gkh_A          136 PVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGC  215 (272)
T ss_dssp             CGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEE
T ss_pred             CcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEE
Confidence                                                                      2689999999999998777789


Q ss_pred             eecccccc
Q 022132          112 CDFGLARV  119 (302)
Q Consensus       112 ~dfg~~~~  119 (302)
                      +||+.+..
T Consensus       216 iDwe~a~~  223 (272)
T 4gkh_A          216 IDVGRVGI  223 (272)
T ss_dssp             CCCTTCEE
T ss_pred             EECccccc
Confidence            99998743

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.16  E-value=1.6e-05  Score=67.72  Aligned_cols=105  Identities=16%  Similarity=0.214  Sum_probs=71.1

Q ss_pred             CchhhHHHHHHhcCCC---CccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKT---SVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~---niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..+.+|..+|+.+.+.   .+.+++.+....    .+..|+|||+++| ++....-  ..++......+..++...|..|
T Consensus        54 ~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~----~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~L  127 (306)
T 3tdw_A           54 DELNKEIQLLPLLVGCVKVNIPQYVYIGKRS----DGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNEL  127 (306)
T ss_dssp             HHHHHHHHHHHHHTTTCSSBCCCEEEEEECT----TSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCCeEeecccC----CCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHH
Confidence            3577999999999652   356666665422    1567899999987 5554321  2345555555556665555555


Q ss_pred             HhC------------------------------------------------------------CceecCCCCCCEEEec-
Q 022132           87 HSA------------------------------------------------------------NVLHRDLKPSNLLLNA-  105 (302)
Q Consensus        87 H~~------------------------------------------------------------~i~H~dikp~Nil~~~-  105 (302)
                      |+.                                                            .++|+|++|.||+++. 
T Consensus       128 H~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~  207 (306)
T 3tdw_A          128 SAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLN  207 (306)
T ss_dssp             HHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTT
T ss_pred             hcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecC
Confidence            542                                                            3599999999999987 


Q ss_pred             --CCCE-EEeecccccccC
Q 022132          106 --NCDL-KICDFGLARVTS  121 (302)
Q Consensus       106 --~~~~-kl~dfg~~~~~~  121 (302)
                        ++.+ .|+||+.+....
T Consensus       208 ~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          208 SRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             CSSCCEEEECCCTTCEEEC
T ss_pred             CCCCceEEEEehhhcCCCC
Confidence              4554 899999876543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.63  E-value=4.2e-05  Score=66.38  Aligned_cols=31  Identities=16%  Similarity=0.269  Sum_probs=26.0

Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            4699999999999999644579999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.04  E-value=0.0016  Score=57.23  Aligned_cols=32  Identities=19%  Similarity=0.348  Sum_probs=26.4

Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeeccccccc
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVT  120 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  120 (302)
                      ...++|||+.+.||+++.+ .+.++||..+...
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G  257 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG  257 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence            3569999999999999876 4899999877543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.01  E-value=0.0035  Score=53.61  Aligned_cols=33  Identities=27%  Similarity=0.425  Sum_probs=27.9

Q ss_pred             CCceecCCCCCCEEEecC----CCEEEeecccccccC
Q 022132           89 ANVLHRDLKPSNLLLNAN----CDLKICDFGLARVTS  121 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~----~~~kl~dfg~~~~~~  121 (302)
                      .+++|||+.+.||+++.+    +.+.|+||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            469999999999999874    679999999886543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.92  E-value=0.0024  Score=53.81  Aligned_cols=30  Identities=20%  Similarity=0.248  Sum_probs=25.3

Q ss_pred             CceecCCCCCCEEEecCCCEEEeeccccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVT  120 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  120 (302)
                      .++|+|+.+.||+ ..++.+.++||..+...
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            3899999999999 66678999999887543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.53  E-value=0.0041  Score=53.12  Aligned_cols=30  Identities=27%  Similarity=0.394  Sum_probs=27.1

Q ss_pred             CCceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                      .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888889999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=95.62  E-value=0.046  Score=46.27  Aligned_cols=39  Identities=10%  Similarity=0.101  Sum_probs=31.3

Q ss_pred             chhhHHHHHHhcC---CCCccccceeeCCCCCCCCCcEEEEEecCCc
Q 022132           12 HFVRSSCFDTWIM---KTSVVAIRDIIPPPQRESFNDVYIAYELMDT   55 (302)
Q Consensus        12 ~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~   55 (302)
                      .+.+|...|+.+.   ...+++++++....     +..|+|||+++|
T Consensus        74 ~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~~lvme~l~G  115 (312)
T 3jr1_A           74 MFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHSFLLLEALNK  115 (312)
T ss_dssp             HHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEEEEEEECCCC
T ss_pred             HHHHHHHHHHHHHhhCCCCcceEEEEeecC-----CceEEEEEeccC
Confidence            4678999999994   25688888887665     789999999975

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.57  E-value=0.011  Score=52.25  Aligned_cols=34  Identities=12%  Similarity=0.304  Sum_probs=29.1

Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccC
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS  121 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  121 (302)
                      +...++|+|++|.||+++.++ +.++||+.+....
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~  263 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP  263 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence            456799999999999998876 9999999886543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=94.08  E-value=0.024  Score=47.99  Aligned_cols=31  Identities=29%  Similarity=0.309  Sum_probs=26.1

Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      .+++|+|+.+.||+++.++.+.++||+.+..
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            3699999999999999876568999987743

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=93.75  E-value=0.058  Score=45.67  Aligned_cols=30  Identities=27%  Similarity=0.279  Sum_probs=25.5

Q ss_pred             CCceecCCCCCCEEEecCCCEEEeeccccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVT  120 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  120 (302)
                      .+++|+|+++.||+++ + .+.++||+.+...
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            4589999999999998 4 8999999877543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=93.23  E-value=0.074  Score=45.49  Aligned_cols=32  Identities=19%  Similarity=0.320  Sum_probs=27.8

Q ss_pred             CCceecCCCCCCEEEecCCCEEEeeccccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVT  120 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  120 (302)
                      .+++|+|+.+.||+++.++.+.++||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            36999999999999998888999999877543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=91.93  E-value=0.16  Score=43.89  Aligned_cols=29  Identities=28%  Similarity=0.595  Sum_probs=24.2

Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      +++|+|+.+.||+++.++ +.++||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            599999999999998654 89999987753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=91.41  E-value=0.18  Score=45.12  Aligned_cols=33  Identities=18%  Similarity=0.182  Sum_probs=23.6

Q ss_pred             hhHHHHHHhcCCCCc-cccceeeCCCCCCCCCcEEEEEecCCc
Q 022132           14 VRSSCFDTWIMKTSV-VAIRDIIPPPQRESFNDVYIAYELMDT   55 (302)
Q Consensus        14 ~~E~~il~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~~~~   55 (302)
                      .+|..+++.+...++ .++++++.       +.  +|+||++|
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~-------~G--~v~e~I~G  185 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFT-------NG--RIEEFMDG  185 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEET-------TE--EEEECCCS
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeC-------Ce--EEEEeeCC
Confidence            489999999965444 56777762       21  49999975

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=90.49  E-value=0.11  Score=46.05  Aligned_cols=30  Identities=33%  Similarity=0.458  Sum_probs=24.1

Q ss_pred             CceecCCCCCCEEEecC----------------------------CCEEEeecccccc
Q 022132           90 NVLHRDLKPSNLLLNAN----------------------------CDLKICDFGLARV  119 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~----------------------------~~~kl~dfg~~~~  119 (302)
                      .++|+|+.+.||+++.+                            +.+.++||..+..
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            48999999999999875                            6789999987643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=90.03  E-value=0.17  Score=44.06  Aligned_cols=99  Identities=16%  Similarity=0.213  Sum_probs=62.0

Q ss_pred             chhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCCc-cHH--------------HHHH---cC-----CCC
Q 022132           12 HFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLH--------------QIIR---SN-----QAL   67 (302)
Q Consensus        12 ~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~--------------~~l~---~~-----~~l   67 (302)
                      ...+|..+++.+. +.-..++++++..      +   +||||++| +|.              +.+.   .-     +..
T Consensus        99 ~~~rE~~vl~~L~~~gv~P~ll~~~~~------g---~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~  169 (379)
T 3feg_A           99 SLVLESVMFAILAERSLGPQLYGVFPE------G---RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEP  169 (379)
T ss_dssp             HHHHHHHHHHHHHHTTSSCCEEEEETT------E---EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSC
T ss_pred             HHHHHHHHHHHHHhcCCCCeEEEEcCC------c---cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            3458999999994 4334667766532      1   89999975 211              1111   10     112


Q ss_pred             C--HHHHHHHHHHHHH-------------------HHHHHH----hC----CceecCCCCCCEEEecC----CCEEEeec
Q 022132           68 S--EEHCQYFLYQILR-------------------GLKYIH----SA----NVLHRDLKPSNLLLNAN----CDLKICDF  114 (302)
Q Consensus        68 ~--~~~~~~i~~qll~-------------------~l~~LH----~~----~i~H~dikp~Nil~~~~----~~~kl~df  114 (302)
                      .  ...+..++.++-.                   .+..|.    ..    .++|+|+.+.||+++.+    +.+.++||
T Consensus       170 ~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDw  249 (379)
T 3feg_A          170 HWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDF  249 (379)
T ss_dssp             CHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCC
T ss_pred             ccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEec
Confidence            2  4566666655432                   123332    22    49999999999999876    78999999


Q ss_pred             ccccc
Q 022132          115 GLARV  119 (302)
Q Consensus       115 g~~~~  119 (302)
                      ..+..
T Consensus       250 E~a~~  254 (379)
T 3feg_A          250 EYSSY  254 (379)
T ss_dssp             TTCEE
T ss_pred             ccCCc
Confidence            88743

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.00  E-value=1.7  Score=34.34  Aligned_cols=113  Identities=14%  Similarity=0.153  Sum_probs=75.8

Q ss_pred             CCCCccccceeeCCCCCCCCCcEEEEEecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q 022132           24 MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-T-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL  101 (302)
Q Consensus        24 ~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Ni  101 (302)
                      .||+++.. .+-.+.     +.+.+.++.-+ + ++..+    +.++......++.+|+....++  ..=+|--+.|+|+
T Consensus        43 ~~~~Fl~~-~I~e~e-----D~v~~~y~~~~~~~~f~~i----k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELR-----DSFQIHYDINDNHTPFDNI----KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECS-----SEEEEEECCCTTSEEGGGG----GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGE
T ss_pred             cCCcccce-EEEEcc-----cEEEEEEEcCcccCCHHHH----HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceE
Confidence            47888766 455554     66666666654 2 55543    3478899999999998876444  3346677999999


Q ss_pred             EEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132          102 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus       102 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      +++.++.+++.-.|.....                +|.      ..+...-.-.+-|++..+++++..|
T Consensus       111 ~f~~~~~p~i~~RGik~~l----------------~P~------~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVV----------------DPL------PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             EECTTSCEEESCCEETTTB----------------SCC------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             EEcCCCCEEEEEccCccCC----------------CCC------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999999977754222                121      1222333445788888889888776

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.38  E-value=0.3  Score=42.78  Aligned_cols=29  Identities=28%  Similarity=0.403  Sum_probs=24.6

Q ss_pred             ceecCCCCCCEEEe------cCCCEEEeecccccc
Q 022132           91 VLHRDLKPSNLLLN------ANCDLKICDFGLARV  119 (302)
Q Consensus        91 i~H~dikp~Nil~~------~~~~~kl~dfg~~~~  119 (302)
                      ++|+|+.+.||++.      .++.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            78999999999993      457799999988753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.25  E-value=8.3  Score=30.46  Aligned_cols=113  Identities=17%  Similarity=0.190  Sum_probs=72.9

Q ss_pred             CCCCccccceeeCCCCCCCCCcEEEEEecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q 022132           24 MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-T-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL  101 (302)
Q Consensus        24 ~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Ni  101 (302)
                      .||++  -..+-.+.     +.+.+.++.-+ + ++..+    ..++......++.+|+.... -|...-+|--+.|+||
T Consensus        48 ~~~~f--~~~I~~~e-----D~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSE-----DEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECS-----SEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeC-----CEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceE
Confidence            56777  33333443     56667666653 2 66644    24788899898888877554 1234556778999999


Q ss_pred             EEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132          102 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus       102 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      +++.++.+++.-.|.-...                +|..      .+...-.-++-|++..++.++.-|
T Consensus       116 ~f~~~~~p~i~hRGi~~~l----------------pP~e------~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKESL----------------PPDE------WDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             EECTTCCEEESCCEETTTB----------------SSCS------CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             EEeCCCcEEEEEcCCcccC----------------CCCC------CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999999987764322                2210      122222345778888888877665

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=84.74  E-value=0.47  Score=41.90  Aligned_cols=29  Identities=24%  Similarity=0.544  Sum_probs=25.6

Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      .++|+|+.+.||+ +.++.+.++||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4899999999999 7788999999988753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	302
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-76
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-68
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-65
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-60
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-59
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-56
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-53
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-53
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-52
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-50
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-50
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-49
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-48
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-47
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-47
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-47
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-46
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-44
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-42
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-37
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-33
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-33
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-32
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-32
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-31
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-31
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-31
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-30
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-30
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-29
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-29
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-29
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-29
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-28
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-28
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-27
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-27
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-26
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-26
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-26
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-25
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-24
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-24
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-24
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-15

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (597), Expect = 3e-76
 Identities = 146/278 (52%), Positives = 193/278 (69%), Gaps = 6/278 (2%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 87
           ++ I DII  P  E   DVY+   LM  DL++++++   LS +H  YFLYQILRGLKYIH
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 126

Query: 88  SANVLHRDLKPSNLLLNANCDLKICDFGLARV----TSETDFMTEYVVTRWYRAPELLLN 143
           SANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE++LN
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAK 202
           S  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N  A+
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246

Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 262
            Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D SD
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306

Query: 263 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 300
           EP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 307 EPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 344

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 5e-68
 Identities = 117/272 (43%), Positives = 170/272 (62%), Gaps = 6/272 (2%)

Query: 28  VVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           V+ + D+  P    + F D Y+    M TDL ++++ ++ L E+  Q+ +YQ+L+GL+YI
Sbjct: 79  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYI 137

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           H+A ++HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++LN   
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMR 195

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-PSEAELGFLNENAKKYI 205
           YT  +D+WSVGCI  E++  K LF G DH+ QL+ ++++ GT P+E      ++ AK Y+
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
             LP  +++ F     N  P A++L+EKML  D  QR+T  +ALAHPY  SLHD  DEP 
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 315

Query: 266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
               +   F+    T  + K + Y+E L+F P
Sbjct: 316 V-QKYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 1e-65
 Identities = 130/272 (47%), Positives = 174/272 (63%), Gaps = 6/272 (2%)

Query: 28  VVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           V+ + D+  P    E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILRGLKYI
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYI 137

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSA+++HRDLKPSNL +N +C+LKI DFGLAR T +   MT YV TRWYRAPE++LN   
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMH 195

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKYI 205
           Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L    +E+A+ YI
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPV 265
             L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD  DEPV
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 315

Query: 266 CMSPFSFDFEQHALTEGQMKELIYQEALAFNP 297
              P+   FE   L   + K L Y E ++F P
Sbjct: 316 A-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 8e-60
 Identities = 83/272 (30%), Positives = 149/272 (54%), Gaps = 13/272 (4%)

Query: 28  VVAIRDII-PPPQRESFNDVYIAYELMDTDLHQII----RSNQALSEEHCQYFLYQILRG 82
           +V +R       +++    + +  + +   ++++     R+ Q L   + + ++YQ+ R 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 83  LKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 141
           L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R+YRAPEL+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194

Query: 142 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 201
             ++DYT++IDVWS GC+  EL+  +P+FPG   V QL  +I+++GTP+  ++  +N N 
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254

Query: 202 KKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD- 259
            ++  + P+ +   +T+ F P   P AI L  ++L + P  R+T  +A AH +   L D 
Sbjct: 255 TEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312

Query: 260 ---ISDEPVCMSPFSFDFEQHALTEGQMKELI 288
              + +     + F+F  ++ +        LI
Sbjct: 313 NVKLPNGRDTPALFNFTTQELSSNPPLATILI 344

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 6e-59
 Identities = 109/280 (38%), Positives = 163/280 (58%), Gaps = 17/280 (6%)

Query: 28  VVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           ++++ ++  P    E F DVY+  ELMD +L Q+I+       E   Y LYQ+L G+K++
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--DHERMSYLLYQMLCGIKHL 135

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 146
           HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++L    
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 194

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
           Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    + Y+ 
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254

Query: 207 QLPRYQRQSFTEKFPN------------VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             P+Y   +F + FP+                A DL+ KML  DP +RI+V+DAL HPY+
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

Query: 255 GSLHDISDEPVC-MSPFSFDFEQHALTEGQMKELIYQEAL 293
              +D ++        +    ++   T  + KELIY+E +
Sbjct: 315 NVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-56
 Identities = 78/228 (34%), Positives = 119/228 (52%), Gaps = 6/228 (2%)

Query: 44  NDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +++ + ++ M+TD    I  ++  L+  H + ++   L+GL+Y+H   +LHRDLKP+NLL
Sbjct: 73  SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL 132

Query: 103 LNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
           L+ N  LK+ DFGLA+   S     T  VVTRWYRAPELL  +  Y   +D+W+VGCI  
Sbjct: 133 LDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA 192

Query: 162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 221
           EL+ R P  PG   + QL  + E +GTP+E +  + +  +         +        F 
Sbjct: 193 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ--WPDMCSLPDYVTFKSFPGIPLHHIFS 250

Query: 222 NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSP 269
                 +DL++ +  F+P  RIT   AL   Y  +       P C  P
Sbjct: 251 AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG--PTPGCQLP 296

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-53
 Identities = 83/232 (35%), Positives = 126/232 (54%), Gaps = 6/232 (2%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELM--DTDLHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           VV + D+    + +    + + +E +  D   +        +  E  +  ++Q+LRGL +
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131

Query: 86  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           +HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+LL SS
Sbjct: 132 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 191

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYI 205
            Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E +      +     
Sbjct: 192 -YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED---WPRDVALPR 247

Query: 206 CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
                   Q   +   ++     DL+ K LTF+P +RI+   AL+HPY   L
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 2e-53
 Identities = 57/243 (23%), Positives = 107/243 (44%), Gaps = 23/243 (9%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +V            S  ++ I  E MD   L Q+++    + E+        +++GL Y+
Sbjct: 66  IVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 87  HSAN-VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
              + ++HRD+KPSN+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  +
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGT 178

Query: 146 DYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQLRLLIELIGTPSE-----------AE 193
            Y+   D+WS+G   +E+   +   P  D    +L    ++ G  +E             
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238

Query: 194 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPS--AIDLVEKMLTFDPRQRITVEDALAH 251
              ++      I +L  Y       K P+   S    D V K L  +P +R  ++  + H
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298

Query: 252 PYL 254
            ++
Sbjct: 299 AFI 301

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-53
 Identities = 76/235 (32%), Positives = 116/235 (49%), Gaps = 8/235 (3%)

Query: 36  PPPQRESFNDVYIAYELMDTDLHQI-IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHR 94
             P       +Y+ ++  + DL  +        +    +  +  +L GL YIH   +LHR
Sbjct: 82  ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHR 141

Query: 95  DLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVVTRWYRAPELLLNSSDYTA 149
           D+K +N+L+  +  LK+ DFGLAR       S+ +  T  VVT WYR PELLL   DY  
Sbjct: 142 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP 201

Query: 150 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 209
            ID+W  GCI  E+  R P+  G    HQL L+ +L G+ +      ++        +L 
Sbjct: 202 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 261

Query: 210 RYQRQSFTEKFPN--VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 262
           + Q++   ++       P A+DL++K+L  DP QRI  +DAL H +  S    SD
Sbjct: 262 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 316

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-52
 Identities = 82/222 (36%), Positives = 126/222 (56%), Gaps = 4/222 (1%)

Query: 41  ESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
            + N +Y+ +E +  DL + + ++    +     + +L+Q+L+GL + HS  VLHRDLKP
Sbjct: 71  HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130

Query: 99  SNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
            NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL    Y+ A+D+WS+G
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190

Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
           CIF E++ R+ LFPG   + QL  +   +GTP E        +   Y    P++ RQ F+
Sbjct: 191 CIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG-VTSMPDYKPSFPKWARQDFS 249

Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 259
           +  P +      L+ +ML +DP +RI+ + ALAHP+   +  
Sbjct: 250 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  171 bits (433), Expect = 3e-52
 Identities = 83/215 (38%), Positives = 109/215 (50%), Gaps = 2/215 (0%)

Query: 41  ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
                V +   L       +      L     + FL Q+L G+ Y H   VLHRDLKP N
Sbjct: 71  TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQN 130

Query: 101 LLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           LL+N   +LKI DFGLAR         T  +VT WYRAP++L+ S  Y+  ID+WSVGCI
Sbjct: 131 LLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
           F E+++  PLFPG     QL  +  ++GTP+      + E   KY      Y+   +   
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE-LPKYDPNFTVYEPLPWESF 249

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              +  S IDL+ KML  DP QRIT + AL H Y 
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 2e-50
 Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 31/215 (14%)

Query: 44  NDVYIAYELMDTDLH-QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           N  Y+  E          I  +  + E   Q F +Q++ G+ Y+H   + HRD+KP NLL
Sbjct: 76  NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 135

Query: 103 LNANCDLKICDFGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           L+   +LKI DFGLA V    +    + +   T  Y APELL     +   +DVWS G +
Sbjct: 136 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 195

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
              ++  +  +       Q     +                           +++++   
Sbjct: 196 LTAMLAGELPWDQPSDSCQEYSDWK---------------------------EKKTYLNP 228

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
           +  +  + + L+ K+L  +P  RIT+ D     + 
Sbjct: 229 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  165 bits (418), Expect = 4e-50
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 32/220 (14%)

Query: 41  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+    ++ ++LM   +L   +     LSE+  +  +  +L  +  +H  N++HRDLKP 
Sbjct: 80  ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE 139

Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVW 154
           N+LL+ + ++K+ DFG +      + + E   T  Y APE++      N   Y   +D+W
Sbjct: 140 NILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 199

Query: 155 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ 214
           S G I   L+   P F  R  +  LR+++                               
Sbjct: 200 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG------------------------ 235

Query: 215 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             + ++ +   +  DLV + L   P++R T E+ALAHP+ 
Sbjct: 236 --SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (419), Expect = 7e-50
 Identities = 57/253 (22%), Positives = 103/253 (40%), Gaps = 35/253 (13%)

Query: 44  NDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +  ++  E    +    +    + L E       +  L+GL Y+HS N++HRD+K  N+L
Sbjct: 88  HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147

Query: 103 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIF 160
           L+    +K+ DFG A + +       +V T ++ APE++L   +  Y   +DVWS+G   
Sbjct: 148 LSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204

Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
           +EL +RKP     + +  L  +                             Q +S   + 
Sbjct: 205 IELAERKPPLFNMNAMSALYHIA----------------------------QNESPALQS 236

Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD-EPVCMSPFSFDFEQHAL 279
            +      + V+  L   P+ R T E  L H ++      +    +         E   L
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNL 296

Query: 280 TEGQMKELIYQEA 292
              +MK++++QEA
Sbjct: 297 QYRKMKKILFQEA 309

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 6e-49
 Identities = 80/222 (36%), Positives = 114/222 (51%), Gaps = 3/222 (1%)

Query: 40  RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
                   +               N  L  E  + FL+Q+L+GL + HS NVLHRDLKP 
Sbjct: 71  HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ 130

Query: 100 NLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           NLL+N N +LK+ +FGLAR         +  VVT WYR P++L  +  Y+ +ID+WS GC
Sbjct: 131 NLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 190

Query: 159 IFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
           IF EL    +PLFPG D   QL+ +  L+GTP+E +   + +    Y          S  
Sbjct: 191 IFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDYKPYPMYPATTSLV 249

Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 259
              P ++ +  DL++ +L  +P QRI+ E+AL HPY      
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 9e-49
 Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 33/215 (15%)

Query: 41  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
                VY+  E      +++ ++      E+    ++ ++   L Y HS  V+HRD+KP 
Sbjct: 76  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 135

Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           NLLL +  +LKI DFG +     +   T    T  Y  PE++     +   +D+WS+G +
Sbjct: 136 NLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEGRM-HDEKVDLWSLGVL 193

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
             E +  KP F    +    + +  +  T                               
Sbjct: 194 CYEFLVGKPPFEANTYQETYKRISRVEFTFP----------------------------- 224

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 3e-48
 Identities = 46/218 (21%), Positives = 87/218 (39%), Gaps = 34/218 (15%)

Query: 44  NDVYIAYELMDTDL--HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           N+++I  E          ++   + L+E   Q    Q L  L Y+H   ++HRDLK  N+
Sbjct: 82  NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNI 141

Query: 102 LLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSV 156
           L   + D+K+ DFG++   T        ++ T ++ APE+++  +     Y    DVWS+
Sbjct: 142 LFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 201

Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           G   +E+ + +P     + +  L  + +                      + P       
Sbjct: 202 GITLIEMAEIEPPHHELNPMRVLLKIAK---------------------SEPPTL----- 235

Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             +      +  D ++K L  +   R T    L HP++
Sbjct: 236 -AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  161 bits (408), Expect = 8e-48
 Identities = 53/241 (21%), Positives = 92/241 (38%), Gaps = 36/241 (14%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKY 85
           +V + D       E  N++ + YE M       ++   +  +SE+    ++ Q+ +GL +
Sbjct: 85  LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139

Query: 86  IHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 143
           +H  N +H DLKP N++     + +LK+ DFGL         +     T  + APE+   
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
                   D+WSVG +   L+     F G +    LR +        +            
Sbjct: 200 KP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------------ 246

Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
                           F  +     D + K+L  DP  R+T+  AL HP+L   +    +
Sbjct: 247 --------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 292

Query: 264 P 264
            
Sbjct: 293 S 293

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  160 bits (405), Expect = 1e-47
 Identities = 65/240 (27%), Positives = 133/240 (55%), Gaps = 16/240 (6%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           ++ + DI+   +        + +E ++ TD  Q+ ++   L++   ++++Y+IL+ L Y 
Sbjct: 92  IITLADIV---KDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYC 145

Query: 87  HSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 145
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205

Query: 146 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNENAK 202
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT    +    +  E   
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 203 KYICQLPRYQRQSF-----TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 257
           ++   L R+ R+ +     +E    V P A+D ++K+L +D + R+T  +A+ HPY  ++
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 7e-47
 Identities = 58/225 (25%), Positives = 89/225 (39%), Gaps = 41/225 (18%)

Query: 41  ESFNDVYIAYELMD-TDLHQII----RSNQALSEEHCQYFLYQILRGLKYIH-----SAN 90
            +   +YI  E  +  DL  +I    +  Q L EE     + Q+   LK  H        
Sbjct: 75  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 134

Query: 91  VLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTA 149
           VLHRDLKP+N+ L+   ++K+ DFGLAR +  +T F   +V T +Y +PE +   S Y  
Sbjct: 135 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNE 193

Query: 150 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 209
             D+WS+GC+  EL    P F           + E                         
Sbjct: 194 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------------------------- 228

Query: 210 RYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                 F            +++ +ML      R +VE+ L +P +
Sbjct: 229 ----GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 9e-47
 Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 30/256 (11%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQII--RSNQALSEEHCQYFLYQILRGLK 84
           +V I D+           + I  E +D  +L   I  R +QA +E      +  I   ++
Sbjct: 67  IVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125

Query: 85  YIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 141
           Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y APE +
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-V 184

Query: 142 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 201
           L    Y  + D+WS+G I   L+   P F     +     +   I               
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI--------------- 229

Query: 202 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 261
           +    + P         ++  V      L+  +L  +P QR+T+ + + HP++     + 
Sbjct: 230 RMGQYEFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282

Query: 262 DEPVCMSPFSFDFEQH 277
             P+  S    + ++ 
Sbjct: 283 QTPLHTSRVLKEDKER 298

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  157 bits (397), Expect = 4e-46
 Identities = 56/248 (22%), Positives = 104/248 (41%), Gaps = 36/248 (14%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKY 85
           ++ + D       E   ++ +  E +   +L   I +    +SE     ++ Q   GLK+
Sbjct: 88  LINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142

Query: 86  IHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 143
           +H  +++H D+KP N++        +KI DFGLA   +  + +     T  + APE +++
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVD 201

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
                   D+W++G +   L+     F G D +  L+ +        E            
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE------------ 249

Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 263
                         + F +V P A D ++ +L  +PR+R+TV DAL HP+L   H     
Sbjct: 250 --------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTS 295

Query: 264 PVCMSPFS 271
            +  S ++
Sbjct: 296 RIPSSRYN 303

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 5e-46
 Identities = 54/266 (20%), Positives = 108/266 (40%), Gaps = 32/266 (12%)

Query: 41  ESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           ES  ++ + +E +   D+ + I ++   L+E     +++Q+   L+++HS N+ H D++P
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130

Query: 99  SNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
            N++     +  +KI +FG AR     D          Y APE+  +    + A D+WS+
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSL 189

Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           G +   L+     F    +   +  ++    T  E                         
Sbjct: 190 GTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE------------------------- 224

Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQ 276
            E F  +   A+D V+++L  + + R+T  +AL HP+L    +     V +         
Sbjct: 225 -EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV-IRTLKHRRYY 282

Query: 277 HALTEGQMKELIYQEALAFNPEYRQQ 302
           H L +  +  ++    ++     R Q
Sbjct: 283 HTLIKKDLNMVVSAARISCGGAIRSQ 308

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 7e-46
 Identities = 45/215 (20%), Positives = 93/215 (43%), Gaps = 29/215 (13%)

Query: 41  ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
              +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146

Query: 101 LLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           +LL  +  +K+ DFG    +T E    +  V T ++ APE++   + Y   +D+WS+G +
Sbjct: 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIM 205

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
            +E+++ +P +   + +  L  LI   GTP                            + 
Sbjct: 206 AIEMIEGEPPYLNENPLRALY-LIATNGTPEL--------------------------QN 238

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
              +     D + + L  D  +R + ++ L H +L
Sbjct: 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 3e-44
 Identities = 40/215 (18%), Positives = 87/215 (40%), Gaps = 34/215 (15%)

Query: 44  NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPSN 100
             + +  ELM +  L   ++  + +  +  + +  QIL+GL+++H+    ++HRDLK  N
Sbjct: 85  KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDN 144

Query: 101 LLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           + +      +KI D GLA +     F    + T  + APE+      Y  ++DV++ G  
Sbjct: 145 IFITGPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY--EEKYDESVDVYAFGMC 201

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
            +E+   +  +    +  Q+   +     P+  +                          
Sbjct: 202 MLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD-------------------------- 235

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                P   +++E  +  +  +R +++D L H + 
Sbjct: 236 -KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (380), Expect = 5e-44
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 36/231 (15%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
           +VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L  +KY+
Sbjct: 69  IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123

Query: 87  HSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 143
           H   ++HRDLKP NLL    + +  + I DFGL+++      ++    T  Y APE+L  
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 183

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
              Y+ A+D WS+G I   L+   P F   +       +++                   
Sbjct: 184 KP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS------------ 230

Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
                           + ++  SA D +  ++  DP +R T E AL HP++
Sbjct: 231 --------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 4e-42
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 46/240 (19%)

Query: 28  VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 86
            V +         +    +Y         +L + IR   +  E   +++  +I+  L+Y+
Sbjct: 70  FVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 87  HSANVLHRDLKPSNLLLNANCDLKICDFGLARV---TSETDFMTEYVVTRWYRAPELLLN 143
           H   ++HRDLKP N+LLN +  ++I DFG A+V    S+      +V T  Y +PELL  
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 144 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 203
            S    + D+W++GCI  +L+   P F   +     + +I+L     E            
Sbjct: 185 KS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE------------ 231

Query: 204 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA------LAHPYLGSL 257
                                P A DLVEK+L  D  +R+  E+        AHP+  S+
Sbjct: 232 ------------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-42
 Identities = 40/218 (18%), Positives = 85/218 (38%), Gaps = 31/218 (14%)

Query: 41  ESFNDVYIAYELMD-TDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
            +   + I  +  + + L+  +   +             Q  +G+ Y+H+ +++HRDLK 
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKS 132

Query: 99  SNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLL--NSSDYTAAIDV 153
           +N+ L+ +  +KI DFGLA V S    +    +   +  + APE++   + + Y+   DV
Sbjct: 133 NNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDV 192

Query: 154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 213
           ++ G +  ELM  +  +   ++  Q+  ++                           Y  
Sbjct: 193 YAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------------------------GYLS 228

Query: 214 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
              ++   N   +   L+ + L     +R      LA 
Sbjct: 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 6e-40
 Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 40/214 (18%)

Query: 44  NDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           +   +  E  +   DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+
Sbjct: 82  DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 141

Query: 102 LLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 160
           L++ N  +LK+ DFG   +  +T   T++  TR Y  PE +     +  +  VWS+G + 
Sbjct: 142 LIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200

Query: 161 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 220
            +++     F   + + + ++                                       
Sbjct: 201 YDMVCGDIPFEHDEEIIRGQVFFR------------------------------------ 224

Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             V      L+   L   P  R T E+   HP++
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 7e-39
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 32/219 (14%)

Query: 41  ESFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           E+  DV +  EL+    L   +   ++L+EE    FL QIL G+ Y+HS  + H DLKP 
Sbjct: 83  ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 142

Query: 100 NLLLN----ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
           N++L         +KI DFGLA      +       T  + APE++ N        D+WS
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWS 201

Query: 156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           +G I   L+     F G      L  +  +     +                        
Sbjct: 202 IGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------------------------ 237

Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
             E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 238 --EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  134 bits (338), Expect = 2e-37
 Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 34/220 (15%)

Query: 41  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
            + + +    +LM+  DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+
Sbjct: 77  HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA 136

Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+LL+ +  ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+
Sbjct: 137 NILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 195

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
             +L+     F       +  +                            R       E 
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEID---------------------------RMTLTMAVEL 228

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYL 254
             +  P    L+E +L  D  +R+       ++    P+ 
Sbjct: 229 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-37
 Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 34/217 (15%)

Query: 41  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           ++  +++   E ++  DL   I+S          ++  +I+ GL+++HS  +++RDLK  
Sbjct: 73  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 132

Query: 100 NLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           N+LL+ +  +KI DFG+ +           +  T  Y APE+LL    Y  ++D WS G 
Sbjct: 133 NILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGV 191

Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
           +  E++  +  F G+D                                      R     
Sbjct: 192 LLYEMLIGQSPFHGQDEEELF------------------------------HSIRMDNPF 221

Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVE-DALAHPYL 254
               +   A DL+ K+   +P +R+ V  D   HP  
Sbjct: 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (311), Expect = 2e-34
 Identities = 43/214 (20%), Positives = 73/214 (34%), Gaps = 34/214 (15%)

Query: 41  ESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           E    +YI  E M    L   +RS     L  +    F   +   ++Y+   N +HRDL 
Sbjct: 71  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 130

Query: 98  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
             N+L++ +   K+ DFGL +  S T       +   + APE L     ++   DVWS G
Sbjct: 131 ARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFG 187

Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
            +  E+     +   R  +  +   +E                 K Y    P        
Sbjct: 188 ILLWEIYSFGRVPYPRIPLKDVVPRVE-----------------KGYKMDAP-------- 222

Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
                  P+  ++++     D   R +       
Sbjct: 223 ---DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 1e-33
 Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 38/218 (17%)

Query: 44  NDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           + +    E  +   L   +   +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+
Sbjct: 78  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137

Query: 103 LNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 161
           L+ +  +KI DFGL +   S+   M  +  T  Y APE+L + +DY  A+D W +G +  
Sbjct: 138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMY 196

Query: 162 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP 221
           E+M  +  F  +DH                               + P            
Sbjct: 197 EMMCGRLPFYNQDHERLFE-------------------LILMEEIRFP-----------R 226

Query: 222 NVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL 254
            + P A  L+  +L  DP+QR+       ++ + H + 
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 1e-33
 Identities = 35/223 (15%), Positives = 85/223 (38%), Gaps = 35/223 (15%)

Query: 41  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           ++   +++  + ++  +L   +   +  +E   Q ++ +I+  L+++H   +++RD+K  
Sbjct: 99  QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 158

Query: 100 NLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           N+LL++N  + + DFGL++                  +     +    S +  A+D WS+
Sbjct: 159 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218

Query: 157 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
           G +  EL+     F      +    +   I                              
Sbjct: 219 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------------------------- 253

Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL 254
                 +   A DL++++L  DP++R+       ++   H + 
Sbjct: 254 -PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  121 bits (304), Expect = 3e-33
 Identities = 43/219 (19%), Positives = 82/219 (37%), Gaps = 32/219 (14%)

Query: 39  QRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 97
           +  +    YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+K
Sbjct: 79  ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVK 138

Query: 98  PSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDV 153
           P+N++++A   +K+ DFG+AR  +++          + T  Y +PE     S   A  DV
Sbjct: 139 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDV 197

Query: 154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 213
           +S+GC+  E++  +P F G   V      +     P                        
Sbjct: 198 YSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS---------------------- 235

Query: 214 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 252
                +   +      +V K L  +P  R      +   
Sbjct: 236 ----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  120 bits (302), Expect = 2e-32
 Identities = 57/274 (20%), Positives = 102/274 (37%), Gaps = 28/274 (10%)

Query: 6   KLMQRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ 65
           KL+QR +   ++  D+      +  +              +       +         ++
Sbjct: 61  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 120

Query: 66  ALSEEHCQYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNAN------CDLKICDFGLAR 118
            +   + +    Q+L GL Y+H    ++H D+KP N+L+           +KI D G A 
Sbjct: 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

Query: 119 VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD---- 174
              E       + TR YR+PE+LL +  +    D+WS  C+  EL+    LF   +    
Sbjct: 181 WYDEHYTN--SIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237

Query: 175 --HVHQLRLLIELIGTPSEAEL--------GFLNENAKKYICQLPRYQRQSFTEK----F 220
                 +  +IEL+G      L         F +    + I +L  +  +    +     
Sbjct: 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297

Query: 221 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 254
            +      D +  ML  DPR+R      + HP+L
Sbjct: 298 KDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 331

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 3e-32
 Identities = 52/225 (23%), Positives = 78/225 (34%), Gaps = 38/225 (16%)

Query: 42  SFNDVYIAYELMD---TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
           S   +YI  E M            + + L          QI  G+ Y+   N +HRDL+ 
Sbjct: 82  SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 141

Query: 99  SNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
           +N+L+  N   K+ DFGLAR+  + ++           + APE  L    +T   DVWS 
Sbjct: 142 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSF 200

Query: 157 GCIFMEL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           G +  EL    +  +PG  +   L  +      P                          
Sbjct: 201 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP------------------------ 236

Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA--HPYLGSLH 258
                P    S  DL+ +    +P +R T E   A    Y  S  
Sbjct: 237 -----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (295), Expect = 1e-31
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 39/220 (17%)

Query: 41  ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           +    +++  + ++  +L  ++R +Q       +++  ++   L+Y+HS ++++RDLKP 
Sbjct: 74  QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPE 133

Query: 100 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           N+LL+ N  +KI DFG A+   +         T  Y APE ++++  Y  +ID WS G +
Sbjct: 134 NILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGIL 190

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
             E++     F   + +     ++        AEL F                       
Sbjct: 191 IYEMLAGYTPFYDSNTMKTYEKIL-------NAELRFP---------------------- 221

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL 254
            P  +    DL+ +++T D  QR+       ED   HP+ 
Sbjct: 222 -PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 5e-31
 Identities = 48/239 (20%), Positives = 79/239 (33%), Gaps = 57/239 (23%)

Query: 41  ESFNDVYIAYELMD-TDLHQIIRSNQ-----------------------ALSEEHCQYFL 76
                +Y+ +E     DL   +RS +                        L+ E    F 
Sbjct: 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 170

Query: 77  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTR 133
           YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR               +  
Sbjct: 171 YQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230

Query: 134 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEA 192
            + APE L     YT   DVWS G +  E+       +PG         LI+        
Sbjct: 231 KWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ-------- 281

Query: 193 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
                      +    P                    +++    FD R+R +  +  + 
Sbjct: 282 ---------NGFKMDQP-----------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  116 bits (292), Expect = 5e-31
 Identities = 42/213 (19%), Positives = 77/213 (36%), Gaps = 38/213 (17%)

Query: 47  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 106
            +   +   ++   +R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177

Query: 107 CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 166
             +++ DFG A+             T    APE++L+   Y  A+D W++G +  E+   
Sbjct: 178 GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAG 234

Query: 167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPS 226
            P F     +                                             +    
Sbjct: 235 YPPFFADQPIQIY------------------------------EKIVSGKVRFPSHFSSD 264

Query: 227 AIDLVEKMLTFDPRQRI-----TVEDALAHPYL 254
             DL+  +L  D  +R       V D   H + 
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-30
 Identities = 46/230 (20%), Positives = 84/230 (36%), Gaps = 43/230 (18%)

Query: 43  FNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
                +  E+ +   L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+
Sbjct: 79  AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV 138

Query: 102 LLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           LL      KI DFGL++     +      T       + APE +     +++  DVWS G
Sbjct: 139 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFG 197

Query: 158 CIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
            +  E     +  + G        +L                   K      P       
Sbjct: 198 VLMWEAFSYGQKPYRGMKGSEVTAMLE------------------KGERMGCP------- 232

Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSLHDISDE 263
                       DL+    T+D   R     VE  L + Y    +D+ +E
Sbjct: 233 ----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY----YDVVNE 274

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 4e-30
 Identities = 41/227 (18%), Positives = 79/227 (34%), Gaps = 28/227 (12%)

Query: 42  SFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA--------NVL 92
           ++  +++  +  +   L   +     ++ E           GL ++H           + 
Sbjct: 72  TWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130

Query: 93  HRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSS-- 145
           HRDLK  N+L+  N    I D GLA                 V T+ Y APE+L +S   
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190

Query: 146 ---DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 202
              +     D++++G +F E+  R  +  G    +QL     +   PS  E+       +
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEM-------R 242

Query: 203 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
           K +C+           +          ++ +    +   R+T     
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 2e-29
 Identities = 41/220 (18%), Positives = 73/220 (33%), Gaps = 40/220 (18%)

Query: 44  NDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
             + +  E+     LH+ +    + +   +    L+Q+  G+KY+   N +HRDL   N+
Sbjct: 81  EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 140

Query: 102 LLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           LL      KI DFGL++     D      +       + APE + N   +++  DVWS G
Sbjct: 141 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYG 199

Query: 158 CIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 216
               E +   +  +        +  +                             ++   
Sbjct: 200 VTMWEALSYGQKPYKKMKGPEVMAFI-----------------------------EQGKR 230

Query: 217 TEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPY 253
            E  P   P    L+     +    R     VE  +   Y
Sbjct: 231 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 3e-29
 Identities = 47/223 (21%), Positives = 78/223 (34%), Gaps = 41/223 (18%)

Query: 44  NDVYIAYELMDTDL---HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
             +YI  E M+           S   L+         QI  G+ +I   N +HRDL+ +N
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139

Query: 101 LLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           +L++     KI DFGLAR+  + ++           + APE + N   +T   DVWS G 
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 198

Query: 159 IFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
           +  E++   +  +PG  +   ++ L                             +R    
Sbjct: 199 LLTEIVTHGRIPYPGMTNPEVIQNL-----------------------------ERGYRM 229

Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 260
            +  N       L+       P  R T +   +      L D 
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSV-----LEDF 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 3e-29
 Identities = 36/212 (16%), Positives = 66/212 (31%), Gaps = 34/212 (16%)

Query: 44  NDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
             + +  EL    + L ++ +            +  Q+  G+ Y+ S   +HRDL   NL
Sbjct: 83  PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL 142

Query: 102 LLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           LL     +KI DFGL R   + D    M E+    +       L +  ++ A D W  G 
Sbjct: 143 LLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGV 202

Query: 159 IFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
              E+    +  + G +    L  + +                                 
Sbjct: 203 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERL---------------------------- 234

Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
            +  +      +++ +     P  R T     
Sbjct: 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 8e-29
 Identities = 46/199 (23%), Positives = 68/199 (34%), Gaps = 29/199 (14%)

Query: 53  MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 112
            D        +   LS +   +F   + RG+ Y+     +HRDL   N+L+  N   KI 
Sbjct: 110 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169

Query: 113 DFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 172
           DFGL+R        T   +   + A E  LN S YT   DVWS G +  E++        
Sbjct: 170 DFGLSRGQEVYVKKTMGRLPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228

Query: 173 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 232
                +L                       + + Q  R       EK  N      DL+ 
Sbjct: 229 GMTCAELY----------------------EKLPQGYRL------EKPLNCDDEVYDLMR 260

Query: 233 KMLTFDPRQRITVEDALAH 251
           +     P +R +    L  
Sbjct: 261 QCWREKPYERPSFAQILVS 279

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 4e-28
 Identities = 36/216 (16%), Positives = 70/216 (32%), Gaps = 35/216 (16%)

Query: 41  ESFNDVYIAYELM--DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
                ++I  E M     L+ +         +        +   ++Y+ S   LHRDL  
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 128

Query: 99  SNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 156
            N L+N    +K+ DFGL+R   + ++           +  PE+L+ S  +++  D+W+ 
Sbjct: 129 RNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAF 187

Query: 157 GCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 215
           G +  E+    K  +    +                             I Q  R  R  
Sbjct: 188 GVLMWEIYSLGKMPYERFTNSETAEH-----------------------IAQGLRLYRP- 223

Query: 216 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
                         ++         +R T +  L++
Sbjct: 224 -----HLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (267), Expect = 8e-28
 Identities = 36/215 (16%), Positives = 64/215 (29%), Gaps = 34/215 (15%)

Query: 39  QRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
                    +++  + T           LS         Q+  G+ Y+     +HRDL  
Sbjct: 109 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168

Query: 99  SNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWS 155
            N L+  N  +KI DFGL+R     D+        +   +  PE +  +  YT   DVW+
Sbjct: 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWA 227

Query: 156 VGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ 214
            G +  E+       + G  H   +  + +                              
Sbjct: 228 YGVVLWEIFSYGLQPYYGMAHEEVIYYVRD-----------------------------G 258

Query: 215 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
           +      N      +L+    +  P  R +     
Sbjct: 259 NILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 2e-27
 Identities = 39/212 (18%), Positives = 70/212 (33%), Gaps = 33/212 (15%)

Query: 44  NDVYIAYELMDT-DLHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
             + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N 
Sbjct: 73  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 132

Query: 102 LLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           L+  N  +K+ DFG+ R   +      T       + +PE+  + S Y++  DVWS G +
Sbjct: 133 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVL 191

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
             E+     +        ++   I                    +    PR         
Sbjct: 192 MWEVFSEGKIPYENRSNSEVVEDIS-----------------TGFRLYKPR--------- 225

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
                     ++       P  R      L  
Sbjct: 226 --LASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 3e-27
 Identities = 46/257 (17%), Positives = 86/257 (33%), Gaps = 41/257 (15%)

Query: 44  NDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           + V +  +LM     L  +      +  ++   +  QI +G+ Y+    ++HRDL   N+
Sbjct: 83  STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 142

Query: 102 LLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 158
           L+     +KI DFGLA++    +         V   + A E +L+   YT   DVWS G 
Sbjct: 143 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGV 201

Query: 159 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 218
              ELM             ++  ++E                            +     
Sbjct: 202 TVWELMTFGSKPYDGIPASEISSILE----------------------------KGERLP 233

Query: 219 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH-------PYLGSLHDISDEPVCMSPFS 271
           + P        ++ K    D   R    + +         P    +    +     SP  
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTD 293

Query: 272 FDFEQHALTEGQMKELI 288
            +F +  + E  M +++
Sbjct: 294 SNFYRALMDEEDMDDVV 310

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 1e-26
 Identities = 44/212 (20%), Positives = 79/212 (37%), Gaps = 33/212 (15%)

Query: 44  NDVYIAYELM--DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
           N V+I  EL         +     +L       + YQ+   L Y+ S   +HRD+   N+
Sbjct: 80  NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 139

Query: 102 LLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
           L+++N  +K+ DFGL+R   ++ +   ++  +   + APE + N   +T+A DVW  G  
Sbjct: 140 LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVC 198

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
             E++            + +   I                            +       
Sbjct: 199 MWEILMHGVKPFQGVKNNDVIGRI----------------------------ENGERLPM 230

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
            PN  P+   L+ K   +DP +R    +  A 
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  103 bits (257), Expect = 2e-26
 Identities = 41/210 (19%), Positives = 70/210 (33%), Gaps = 32/210 (15%)

Query: 44  NDVYIAYELMD---TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 100
              YI  E M       +    + Q +S     Y   QI   ++Y+   N +HRDL   N
Sbjct: 86  PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145

Query: 101 LLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 159
            L+  N  +K+ DFGL+R +T +T                  L  + ++   DVW+ G +
Sbjct: 146 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 205

Query: 160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 219
             E+            + Q+  L+E                 K Y  + P          
Sbjct: 206 LWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRMERP---------- 238

Query: 220 FPNVHPSAIDLVEKMLTFDPRQRITVEDAL 249
                    +L+     ++P  R +  +  
Sbjct: 239 -EGCPEKVYELMRACWQWNPSDRPSFAEIH 267

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  103 bits (257), Expect = 2e-26
 Identities = 33/225 (14%), Positives = 65/225 (28%), Gaps = 38/225 (16%)

Query: 44  NDVYIAYELMDTDLHQI-IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 102
           +   +  EL+   L  +    ++  S +       Q++  ++YIHS N +HRD+KP N L
Sbjct: 76  DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL 135

Query: 103 ---LNANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAI 151
                    + I DFGLA+   +                 T  Y +    L   + +   
Sbjct: 136 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRD 194

Query: 152 DVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY 211
           D+ S+G + M        + G     + +                      KY     + 
Sbjct: 195 DLESLGYVLMYFNLGSLPWQGLKAATKRQ----------------------KYERISEKK 232

Query: 212 QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPY 253
                              +    +     +     +     + +
Sbjct: 233 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  102 bits (255), Expect = 4e-26
 Identities = 39/219 (17%), Positives = 68/219 (31%), Gaps = 37/219 (16%)

Query: 41  ESFNDVYIAYELMDTDLHQII--RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 98
                V I  E M+         +++   +       L  I  G+KY+   N +HRDL  
Sbjct: 97  TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAA 156

Query: 99  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-----NSSDYTAAIDV 153
            N+L+N+N   K+ DFGL+R   +      Y      + P             +T+A DV
Sbjct: 157 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDV 216

Query: 154 WSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 212
           WS G +  E+M   +  +    +   +  + +    P                       
Sbjct: 217 WSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP--------------------- 255

Query: 213 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
                    +   +   L+      D   R      +  
Sbjct: 256 --------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 4e-26
 Identities = 46/232 (19%), Positives = 83/232 (35%), Gaps = 50/232 (21%)

Query: 41  ESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGL 83
           +    + +  E     +L   +RS +                 L+ EH   + +Q+ +G+
Sbjct: 88  KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 147

Query: 84  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPEL 140
           +++ S   +HRDL   N+LL+    +KICDFGLAR   +        +  +   + APE 
Sbjct: 148 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 207

Query: 141 LLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 199
           + +   YT   DVWS G +  E+       +PG     +    ++               
Sbjct: 208 IFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--------------- 251

Query: 200 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
             +    + P               P     +      +P QR T  + + H
Sbjct: 252 --EGTRMRAP-----------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  101 bits (252), Expect = 1e-25
 Identities = 29/216 (13%), Positives = 63/216 (29%), Gaps = 37/216 (17%)

Query: 41  ESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 99
           +      +  +L+   L  ++    +  S +       Q+L  ++ IH  ++++RD+KP 
Sbjct: 71  QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD 130

Query: 100 NLLLNANC-----DLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSD 146
           N L+          + + DFG+ +   +                 T  Y +    L   +
Sbjct: 131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-RE 189

Query: 147 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC 206
            +   D+ ++G +FM  +     + G                           N +KY  
Sbjct: 190 QSRRDDLEALGHVFMYFLRGSLPWQGLKAA----------------------TNKQKYER 227

Query: 207 QLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 242
              + Q     E            +           
Sbjct: 228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 2e-25
 Identities = 46/237 (19%), Positives = 80/237 (33%), Gaps = 41/237 (17%)

Query: 44  NDVYIAYELM--DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 101
             + I  E M        +   +   S       L  I  G+KY+ + N +HRDL   N+
Sbjct: 82  KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 141

Query: 102 LLNANCDLKICDFGLARVTSE----TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 157
           L+N+N   K+ DFGL+RV  +    T   +   +   + APE +      +A+ DVWS G
Sbjct: 142 LVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS-DVWSFG 200

Query: 158 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 217
            +  E+M            H++   I                                  
Sbjct: 201 IVMWEVMTYGERPYWELSNHEVMKAI----------------------------NDGFRL 232

Query: 218 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDF 274
               +   +   L+ +    +  +R    D ++      L  +   P  +   + DF
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI-----LDKLIRAPDSLKTLA-DF 283

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 1e-24
 Identities = 49/232 (21%), Positives = 81/232 (34%), Gaps = 51/232 (21%)

Query: 41  ESFNDVYIAYELMD-TDLHQIIR----------------SNQALSEEHCQYFLYQILRGL 83
                +Y+  E     +L + ++                  + LS +      YQ+ RG+
Sbjct: 89  TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 148

Query: 84  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAPEL 140
           +Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +     +   + APE 
Sbjct: 149 EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA 208

Query: 141 LLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 199
           L +   YT   DVWS G +  E+       +PG                          E
Sbjct: 209 LFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------------------VE 244

Query: 200 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
              K + +  R       +K  N       ++       P QR T +  +  
Sbjct: 245 ELFKLLKEGHRM------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.7 bits (245), Expect = 1e-24
 Identities = 53/230 (23%), Positives = 78/230 (33%), Gaps = 54/230 (23%)

Query: 44  NDVYIAYELMD-TDLHQIIRSNQ------------------ALSEEHCQYFLYQILRGLK 84
               +  E     DL   +R  +                  AL  E    F YQ+ +G+ 
Sbjct: 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159

Query: 85  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV---TSETDFMTEYVVTRWYRAPELL 141
           ++ S N +HRDL   N+LL      KICDFGLAR     S         +   + APE +
Sbjct: 160 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219

Query: 142 LNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 200
            N   YT   DVWS G    EL       +PG     +   +I                 
Sbjct: 220 FNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI----------------- 261

Query: 201 AKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDAL 249
                       ++ F    P +      D+++     DP +R T +  +
Sbjct: 262 ------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (241), Expect = 5e-24
 Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 45/223 (20%)

Query: 44  NDVYIAYELMD-TDLHQIIRSNQ----------ALSEEHCQYFLYQILRGLKYIHSANVL 92
               +  ELM   DL   +RS +            S         +I  G+ Y+++   +
Sbjct: 96  QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155

Query: 93  HRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTA 149
           HRDL   N ++  +  +KI DFG+ R   ETD+     + ++   + +PE L +   +T 
Sbjct: 156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTT 214

Query: 150 AIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL 208
             DVWS G +  E+    +  + G  +   LR ++E                        
Sbjct: 215 YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------------------------ 250

Query: 209 PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
                    +K  N      +L+     ++P+ R +  + ++ 
Sbjct: 251 -----GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.0 bits (238), Expect = 1e-23
 Identities = 41/218 (18%), Positives = 72/218 (33%), Gaps = 36/218 (16%)

Query: 41  ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQ--YFLYQILRGLKYIHSANVLHRDLKP 98
            S     +    M     +    N+  +        F  Q+ +G+K++ S   +HRDL  
Sbjct: 99  RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAA 158

Query: 99  SNLLLNANCDLKICDFGLARVTSETDF-----MTEYVVTRWYRAPELLLNSSDYTAAIDV 153
            N +L+    +K+ DFGLAR   + +F      T   +   + A E L     +T   DV
Sbjct: 159 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDV 217

Query: 154 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 213
           WS G +  ELM R        +   +                        Y+ Q  R  +
Sbjct: 218 WSFGVLLWELMTRGAPPYPDVNTFDIT----------------------VYLLQGRRLLQ 255

Query: 214 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 251
                          +++ K        R +  + ++ 
Sbjct: 256 PE------YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 70.6 bits (172), Expect = 3e-15
 Identities = 21/133 (15%), Positives = 44/133 (33%), Gaps = 20/133 (15%)

Query: 35  IPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHR 94
           +  P+  ++    +  EL+D      +R       E+    L  IL  +   +   ++H 
Sbjct: 74  LAVPKVYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMILEEVAKFYHRGIVHG 127

Query: 95  DLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTA 149
           DL   N+L++    + I DF  +    E             +  ++           Y  
Sbjct: 128 DLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS--------RTYRT 178

Query: 150 AIDVWSVGCIFME 162
             D+ S     ++
Sbjct: 179 EKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	302
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.72
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.89
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.37
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.67
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.86
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.17
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	91.68

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-56  Score=389.05  Aligned_cols=282  Identities=42%  Similarity=0.800  Sum_probs=238.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+|++++|||||+++++|..... ....++|+||||++++|..+... +++++..++.++.||+.||+|||++|
T Consensus        63 ~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~  141 (346)
T d1cm8a_          63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG  141 (346)
T ss_dssp             HHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            57799999999999999999999987642 33457899999998888887765 57999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      |+||||||+||+++.++.++++|||.+......  .....+|+.|+|||++.+...++.++||||+||++|+|++|.+||
T Consensus       142 IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf  219 (346)
T d1cm8a_         142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF  219 (346)
T ss_dssp             EECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             CcccccCcchhhcccccccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC
Confidence            999999999999999999999999999876544  456689999999999987777899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhhh-HhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      .+.+....+..+....+.++...+.... .....+....+......+...+++.++++++||++||++||.+|||++|+|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL  299 (346)
T d1cm8a_         220 KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL  299 (346)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence            9999999999999999999988766553 334445556666677777888889999999999999999999999999999


Q ss_pred             cCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccCh
Q 022132          250 AHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  297 (302)
Q Consensus       250 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (302)
                      +||||+...+..+++.. ..+....+....+.+++++++|.|+++|+|
T Consensus       300 ~Hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~e~k~~~~~e~~~~~~  346 (346)
T d1cm8a_         300 AHPYFESLHDTEDEPQV-QKYDDSFDDVDRTLDEWKRVTYKEVLSFKP  346 (346)
T ss_dssp             HSGGGTTTC------CC-CCCCCC-----CCHHHHHHHHHHHHHTCCC
T ss_pred             cChhhCcCCCccccccC-CCCCCchhhhhcCHHHHHHHHHHHhhcCCC
Confidence            99999998877776654 355666677788999999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-55  Score=380.19  Aligned_cols=288  Identities=51%  Similarity=0.942  Sum_probs=244.0

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV   91 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i   91 (302)
                      .+.+|+.+|++++||||+++++++..........+|+++++++|+|.+++.. +++++..++.++.||+.||+|||++||
T Consensus        52 ~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~i  130 (345)
T d1pmea_          52 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV  130 (345)
T ss_dssp             HHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            5779999999999999999999998764444456888888888999999976 479999999999999999999999999


Q ss_pred             eecCCCCCCEEEecCCCEEEeecccccccCCC----CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           92 LHRDLKPSNLLLNANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        92 ~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||||||+|||++.++.+||+|||++......    .......+|+.|+|||++.....++.++||||+||++++|++|.
T Consensus       131 iHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~  210 (345)
T d1pmea_         131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR  210 (345)
T ss_dssp             ECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCC
Confidence            99999999999999999999999998754332    22455678999999999876677899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhh-hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      +||.+.+..+.........+.+........ ...........+.....++...++.+++.+++||.+||++||.+|||++
T Consensus       211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~  290 (345)
T d1pmea_         211 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE  290 (345)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHH
Confidence            999999999999999999988887755433 3334445555666666677788889999999999999999999999999


Q ss_pred             HHhcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccChhhh
Q 022132          247 DALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR  300 (302)
Q Consensus       247 ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (302)
                      |+|+||||+....+.+++....++.++.+..+++.+++++++++|...++|-+|
T Consensus       291 e~L~hpf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~e~~~~~~~~~  344 (345)
T d1pmea_         291 QALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR  344 (345)
T ss_dssp             HHHTSGGGTTTCCGGGSCCCSSCC--------CCHHHHHHHHHHHSGGGSTTTC
T ss_pred             HHhcCHhhccCCCCccCccccCccCCChhhhhCCHHHHHHHHHHHHHhcCCCCC
Confidence            999999999998888888888888888888899999999999999999999887

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=371.47  Aligned_cols=241  Identities=32%  Similarity=0.595  Sum_probs=202.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l-~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++...     +++|+||||+++++...+ ..++.+++..++.++.||+.||+|||++
T Consensus        45 ~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~  119 (299)
T d1ua2a_          45 RTALREIKLLQELSHPNIIGLLDAFGHK-----SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH  119 (299)
T ss_dssp             THHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEeeeccC-----CceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc
Confidence            3577999999999999999999999988     889999999986554444 4567899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.++.+||+|||.+...... ......++|+.|+|||++.+...++.++||||+||++|+|++|.+
T Consensus       120 ~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~  199 (299)
T d1ua2a_         120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP  199 (299)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcC
Confidence            9999999999999999999999999999765543 334456799999999999777778999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      ||.+.+..+++..+.+.++.|....+.......  ...........++...++..++++++||.+||++||.+|||++|+
T Consensus       200 pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~  277 (299)
T d1ua2a_         200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP--DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA  277 (299)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST--TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             CCCCCCHHHHHHHHHHhcCCCChhhccchhccc--hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            999999999999999999998876543221110  001111222334455667889999999999999999999999999


Q ss_pred             hcCCCcCCcc
Q 022132          249 LAHPYLGSLH  258 (302)
Q Consensus       249 l~h~~~~~~~  258 (302)
                      |+||||++..
T Consensus       278 L~Hp~f~~~p  287 (299)
T d1ua2a_         278 LKMKYFSNRP  287 (299)
T ss_dssp             HTSGGGTSSS
T ss_pred             hCCHhhCCCC
Confidence            9999998744

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-55  Score=367.70  Aligned_cols=216  Identities=25%  Similarity=0.401  Sum_probs=181.4

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.++++++||||+++++++.+.     +.+|+|||||+ |+|.+++.+++.+++..++.++.||+.||+|||+
T Consensus        47 ~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~  121 (271)
T d1nvra_          47 PENIKKEICINKMLNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG  121 (271)
T ss_dssp             --CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEeeeeccC-----ceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999987     89999999997 6999999888899999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +||+||||||+||+++.++.+||+|||+|+.....   ......+||+.|+|||++.+...++.++||||+||++|+|++
T Consensus       122 ~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~  201 (271)
T d1nvra_         122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA  201 (271)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred             cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh
Confidence            99999999999999999999999999999865322   234566899999999999766655788999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |++||.+...............                           .....++.+|+++++||.+||+.||.+|||+
T Consensus       202 G~~pf~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~  254 (271)
T d1nvra_         202 GELPWDQPSDSCQEYSDWKEKK---------------------------TYLNPWKKIDSAPLALLHKILVENPSARITI  254 (271)
T ss_dssp             SSCSCSSSSTTSHHHHHHHTTC---------------------------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CCCCCCCCChHHHHHHHHhcCC---------------------------CCCCccccCCHHHHHHHHHHcCCChhHCcCH
Confidence            9999976654322221111000                           0111223678899999999999999999999


Q ss_pred             HHHhcCCCcCCc
Q 022132          246 EDALAHPYLGSL  257 (302)
Q Consensus       246 ~ell~h~~~~~~  257 (302)
                      +|+|+||||+..
T Consensus       255 ~eil~hpwf~~~  266 (271)
T d1nvra_         255 PDIKKDRWYNKP  266 (271)
T ss_dssp             HHHTTCTTTTCC
T ss_pred             HHHhcCHhhCcC
Confidence            999999999753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-55  Score=365.54  Aligned_cols=209  Identities=23%  Similarity=0.406  Sum_probs=183.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+++.++||||+++++++.+.     +.+|+|||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++
T Consensus        51 ~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~  125 (263)
T d2j4za1          51 HQLRREVEIQSHLRHPNILRLYGYFHDA-----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK  125 (263)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhcCCCCCCeEEEEEEEC-----CEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3577899999999999999999999987     89999999997 69999999888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.++.+||+|||++...... ......||+.|+|||++.+. .++.++||||+||++|+|++|.+|
T Consensus       126 ~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~P  203 (263)
T d2j4za1         126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPP  203 (263)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             CeeeeeeccccceecCCCCEeecccceeeecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCC
Confidence            9999999999999999999999999999765543 23456899999999999654 489999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+..+.+..+.+.-                              ....+.+|+++++||.+||++||.+|||++|+|
T Consensus       204 f~~~~~~~~~~~i~~~~------------------------------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil  253 (263)
T d2j4za1         204 FEANTYQETYKRISRVE------------------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVL  253 (263)
T ss_dssp             TCCSSHHHHHHHHHTTC------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCHHHHHHHHHcCC------------------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence            98887766655443210                              011125789999999999999999999999999


Q ss_pred             cCCCcCC
Q 022132          250 AHPYLGS  256 (302)
Q Consensus       250 ~h~~~~~  256 (302)
                      +||||++
T Consensus       254 ~hp~~~~  260 (263)
T d2j4za1         254 EHPWITA  260 (263)
T ss_dssp             TCHHHHH
T ss_pred             cCcCcCC
Confidence            9999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=371.73  Aligned_cols=284  Identities=46%  Similarity=0.854  Sum_probs=241.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+|++++||||+++++++..... ++.+.+|+++++++|+|.+++.. +++++..++.++.||+.||+|||++
T Consensus        62 ~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~  140 (348)
T d2gfsa1          62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA  140 (348)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC
Confidence            357799999999999999999999976532 23355677776667899998865 5799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.+|.++++|||.+......  .....|+..|+|||.+.+...++.++||||+||++|+|++|.+|
T Consensus       141 giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~p  218 (348)
T d2gfsa1         141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL  218 (348)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CCcccccCCccccccccccccccccchhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCC
Confidence            9999999999999999999999999998765433  34567899999999987777789999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhh-hHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                      |.+.+.......+....+.+........ ..................+...+..+++++++||++||++||.+|||++|+
T Consensus       219 F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el  298 (348)
T d2gfsa1         219 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  298 (348)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence            9999999999999999998887766554 333444455555666666777778899999999999999999999999999


Q ss_pred             hcCCCcCCccCCCCCCCCCCCCCcchhhcccCHHHHHHHHHHHHHccChh
Q 022132          249 LAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE  298 (302)
Q Consensus       249 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (302)
                      |+||||+++.++..+++ ..++..+++....+.+++++++++|+.+|+|-
T Consensus       299 L~Hp~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~k~~~~~e~~~~~p~  347 (348)
T d2gfsa1         299 LAHAYFAQYHDPDDEPV-ADPYDQSFESRDLLIDEWKSLTYDEVISFVPP  347 (348)
T ss_dssp             HTSGGGTTTCCTTSCCC-CCCCCCGGGGCCCCHHHHHHHHHHHHHTCCCC
T ss_pred             hcCHhhCCCCCCccCCC-CCCCCCcccchhcCHHHHHHHHHHHhhccCCC
Confidence            99999999988887775 45788888999999999999999999999873

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-53  Score=366.13  Aligned_cols=215  Identities=27%  Similarity=0.488  Sum_probs=172.2

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ...+.+|+.+|++++||||+++++++.+.     +.+|+|||||+ |+|.+++...+.+++..+..++.||+.||+|||+
T Consensus        51 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~  125 (307)
T d1a06a_          51 EGSMENEIAVLHKIKHPNIVALDDIYESG-----GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD  125 (307)
T ss_dssp             ----CHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhh
Confidence            34677999999999999999999999987     89999999997 7999999998999999999999999999999999


Q ss_pred             CCceecCCCCCCEEEe---cCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLN---ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +||+||||||+||++.   .++.+||+|||+++...........+||+.|+|||++.+. .++.++||||+||++|+|++
T Consensus       126 ~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~  204 (307)
T d1a06a_         126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLC  204 (307)
T ss_dssp             TTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHH
T ss_pred             ceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHh
Confidence            9999999999999995   4789999999999877666666677899999999998654 58999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+.......+......+                          .....+.+|+++++||.+||++||.+|||+
T Consensus       205 g~~Pf~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~  258 (307)
T d1a06a_         205 GYPPFYDENDAKLFEQILKAEYEF--------------------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTC  258 (307)
T ss_dssp             SSCSCCCSSHHHHHHHHHTTCCCC--------------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             CCCCCCCCCHHHHHHHHhccCCCC--------------------------CCccccCCCHHHHHHHHHHccCCHhHCcCH
Confidence            999999887776665554321111                          112334789999999999999999999999


Q ss_pred             HHHhcCCCcCC
Q 022132          246 EDALAHPYLGS  256 (302)
Q Consensus       246 ~ell~h~~~~~  256 (302)
                      +|+|+||||++
T Consensus       259 ~eil~hp~~~~  269 (307)
T d1a06a_         259 EQALQHPWIAG  269 (307)
T ss_dssp             HHHHHSTTTTS
T ss_pred             HHHhcCHhhCC
Confidence            99999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=360.64  Aligned_cols=211  Identities=20%  Similarity=0.396  Sum_probs=182.9

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++.+.     +.+|+|||||+ |+|.+++.+ +.+++..++.++.||+.||+|||++|
T Consensus        63 ~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~  136 (293)
T d1yhwa1          63 LIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ  136 (293)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            477999999999999999999999987     89999999997 699988776 57999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.+|.+||+|||+++..... ......+||+.|+|||++.+ ..++.++||||+||++|+|++|.+|
T Consensus       137 iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~P  215 (293)
T d1yhwa1         137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPP  215 (293)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCC
Confidence            999999999999999999999999999875433 34556689999999999965 4589999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+....+..+..... +.                          ....+.+|+.+++||.+||++||.+|||++|+|
T Consensus       216 f~~~~~~~~~~~~~~~~~-~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil  268 (293)
T d1yhwa1         216 YLNENPLRALYLIATNGT-PE--------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL  268 (293)
T ss_dssp             TTTSCHHHHHHHHHHHCS-CC--------------------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             CCCCCHHHHHHHHHhCCC-CC--------------------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            988887766655543211 11                          011235788999999999999999999999999


Q ss_pred             cCCCcCC
Q 022132          250 AHPYLGS  256 (302)
Q Consensus       250 ~h~~~~~  256 (302)
                      +||||+.
T Consensus       269 ~Hp~~~~  275 (293)
T d1yhwa1         269 QHQFLKI  275 (293)
T ss_dssp             TCGGGGG
T ss_pred             cCHhhCC
Confidence            9999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=366.58  Aligned_cols=280  Identities=40%  Similarity=0.721  Sum_probs=220.8

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+|++++||||++++++|..... +..+++|+|||||.+++.+.+.  ..+++..++.++.||+.||+|||++|
T Consensus        62 ~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~g  139 (355)
T d2b1pa1          62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG  139 (355)
T ss_dssp             HHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcc
Confidence            57799999999999999999999976542 3447899999999998887764  56999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      |+||||||+||+++.++.++++|||.++..+.........+|+.|+|||++.+. .++.++||||+||++++|++|++||
T Consensus       140 iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF  218 (355)
T d2b1pa1         140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILF  218 (355)
T ss_dssp             CCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCC
Confidence            999999999999999999999999999887776667777899999999999664 5899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCC------------CCCHHHHHHHHHccCCC
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP------------NVHPSAIDLVEKMLTFD  238 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~L~~d  238 (302)
                      .+.+.......+....+.+....+..............+..........++            ..++++++||++||++|
T Consensus       219 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d  298 (355)
T d2b1pa1         219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID  298 (355)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred             CCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCC
Confidence            999999999999999999999888777666666655554444333332221            23568999999999999


Q ss_pred             CCCCCCHHHHhcCCCcCCccCCCCC-CCCCCCCCcchhhcccCHHHHHHHHHHHHHc
Q 022132          239 PRQRITVEDALAHPYLGSLHDISDE-PVCMSPFSFDFEQHALTEGQMKELIYQEALA  294 (302)
Q Consensus       239 P~~R~t~~ell~h~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (302)
                      |.+||||+|+|+||||+...++... ......++.+.++...+.++|+++|+.|+++
T Consensus       299 P~~R~ta~elL~Hpw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (355)
T d2b1pa1         299 PAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN  355 (355)
T ss_dssp             TTTSCCHHHHHTSTTTGGGCCHHHHTCCCC-------CCCCCCHHHHHHHHHHHHHC
T ss_pred             hhHCcCHHHHhcCcccCCCCCcccccCCCCCCCCcchhhhhcCHHHHHHHHHHHhcC
Confidence            9999999999999999987543322 2223455667788899999999999999874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=360.70  Aligned_cols=244  Identities=35%  Similarity=0.683  Sum_probs=209.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+++|++++||||+++++++.+.     +.+|+||||+++++.+.+..  .+.+++..++.++.||+.||+|||+
T Consensus        46 ~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~  120 (298)
T d1gz8a_          46 STAIREISLLKELNHPNIVKLLDVIHTE-----NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS  120 (298)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCcEEEeccccccc-----cceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc
Confidence            4677999999999999999999999987     89999999999887777643  4679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||+||||||+||+++.++.+||+|||.|+..... .......+|+.|+|||++.....++.++||||+||++|+|++|+
T Consensus       121 ~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~  200 (298)
T d1gz8a_         121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR  200 (298)
T ss_dssp             TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCC
Confidence            99999999999999999999999999999766433 34556689999999999877776789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+..+.+..+....+.|....+..... ........+......+....+.+++++++||++||++||.+|||++|
T Consensus       201 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~e  279 (298)
T d1gz8a_         201 ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS-MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA  279 (298)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHHhcCCCchhhcccccc-ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            99999999999999999998888765543322 22223334444455556667788999999999999999999999999


Q ss_pred             HhcCCCcCCccCC
Q 022132          248 ALAHPYLGSLHDI  260 (302)
Q Consensus       248 ll~h~~~~~~~~~  260 (302)
                      +|+||||+....+
T Consensus       280 ll~H~ff~~~~~p  292 (298)
T d1gz8a_         280 ALAHPFFQDVTKP  292 (298)
T ss_dssp             HHTSGGGTTCCCC
T ss_pred             HhCCHhhccCCCC
Confidence            9999999887543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-53  Score=359.97  Aligned_cols=214  Identities=22%  Similarity=0.389  Sum_probs=181.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      +.+.+|+.+|++++||||+++++++.+.     +.+|+|||||+ |+|.+++.+ .+.+++..++.++.||+.||+|||+
T Consensus        54 ~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~  128 (288)
T d2jfla1          54 EDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD  128 (288)
T ss_dssp             GGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            5678999999999999999999999987     89999999997 699998764 5679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhC----CCCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~i~~~l  163 (302)
                      +||+||||||+||+++.++.+||+|||+|...... .......||+.|+|||++..    ...++.++||||+||++|+|
T Consensus       129 ~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyem  208 (288)
T d2jfla1         129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM  208 (288)
T ss_dssp             TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHH
T ss_pred             CCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHH
Confidence            99999999999999999999999999998654322 22345679999999999842    34478999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|.+||.+.+..+.+..+....  +                         +.....+.+|+++++||.+||++||.+||
T Consensus       209 ltg~~Pf~~~~~~~~~~~i~~~~--~-------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~  261 (288)
T d2jfla1         209 AEIEPPHHELNPMRVLLKIAKSE--P-------------------------PTLAQPSRWSSNFKDFLKKCLEKNVDARW  261 (288)
T ss_dssp             HHSSCTTTTSCGGGHHHHHHHSC--C-------------------------CCCSSGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred             hhCCCCCCCCCHHHHHHHHHcCC--C-------------------------CCCCccccCCHHHHHHHHHHccCChhHCc
Confidence            99999998887766655544311  0                         00111235789999999999999999999


Q ss_pred             CHHHHhcCCCcCC
Q 022132          244 TVEDALAHPYLGS  256 (302)
Q Consensus       244 t~~ell~h~~~~~  256 (302)
                      |++|+|+||||+.
T Consensus       262 t~~ell~hp~~~~  274 (288)
T d2jfla1         262 TTSQLLQHPFVTV  274 (288)
T ss_dssp             CHHHHTTSGGGCC
T ss_pred             CHHHHhcCcccCC
Confidence            9999999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7e-53  Score=366.89  Aligned_cols=218  Identities=24%  Similarity=0.395  Sum_probs=190.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~-~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.+|++++||||+++++++.+.     +.+|+|||||+ |+|.+++. ..+++++..+..++.||+.||+|||+
T Consensus        68 ~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~  142 (350)
T d1koaa2          68 ETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE  142 (350)
T ss_dssp             HHHHHHHHHHHHTCCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4577999999999999999999999987     89999999997 69999985 45679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEec--CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           89 ANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      +||+||||||+||+++.  ++.+||+|||+++..+.........||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus       143 ~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G  221 (350)
T d1koaa2         143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSG  221 (350)
T ss_dssp             TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHS
T ss_pred             cCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhC
Confidence            99999999999999964  578999999999887776666778899999999999754 489999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+..+.+..+......+.                          ...++.+|+++++||.+||++||.+|||++
T Consensus       222 ~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  275 (350)
T d1koaa2         222 LSPFGGENDDETLRNVKSCDWNMD--------------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIH  275 (350)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCSC--------------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHhCCCCCC--------------------------cccccCCCHHHHHHHHHHccCChhHCcCHH
Confidence            999999888777776654322211                          122346789999999999999999999999


Q ss_pred             HHhcCCCcCCccCC
Q 022132          247 DALAHPYLGSLHDI  260 (302)
Q Consensus       247 ell~h~~~~~~~~~  260 (302)
                      |+|+||||+....+
T Consensus       276 eil~hp~~~~~~~~  289 (350)
T d1koaa2         276 QALEHPWLTPGNAP  289 (350)
T ss_dssp             HHHHSTTTSCTTCC
T ss_pred             HHhcCcccCCCCCC
Confidence            99999999876543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=358.45  Aligned_cols=210  Identities=29%  Similarity=0.495  Sum_probs=181.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.++++++||||+++++++.+.     +.+|+|||||+ |+|.+++...+.+++..++.++.|++.||+|||++|
T Consensus        54 ~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~  128 (288)
T d1uu3a_          54 YVTRERDVMSRLDHPFFVKLYFTFQDD-----EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG  128 (288)
T ss_dssp             HHHHHHHHHHHCCSTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHcCCCCeeEEEEEEEEC-----CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc
Confidence            577999999999999999999999987     89999999997 699999998899999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      |+||||||+||+++.+|.++|+|||+|+..+..   ......+||+.|+|||++.+. .++.++||||+||++|+|++|.
T Consensus       129 iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~  207 (288)
T d1uu3a_         129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGL  207 (288)
T ss_dssp             EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSS
T ss_pred             EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCC
Confidence            999999999999999999999999999865432   233456799999999999654 4899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+.......+.+.-  +                            .....+++++++||++||++||.+|||++|
T Consensus       208 ~Pf~~~~~~~~~~~i~~~~--~----------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e  257 (288)
T d1uu3a_         208 PPFRAGNEYLIFQKIIKLE--Y----------------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEE  257 (288)
T ss_dssp             CSSCCSSHHHHHHHHHTTC--C----------------------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGG
T ss_pred             CCCCCcCHHHHHHHHHcCC--C----------------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            9999887776665544210  0                            111367899999999999999999999988


Q ss_pred             ------HhcCCCcCCc
Q 022132          248 ------ALAHPYLGSL  257 (302)
Q Consensus       248 ------ll~h~~~~~~  257 (302)
                            +++||||+++
T Consensus       258 ~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         258 MEGYGPLKAHPFFESV  273 (288)
T ss_dssp             GTCHHHHHTSGGGTTC
T ss_pred             HcCCHHHHcCCccCCC
Confidence                  5889999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=357.45  Aligned_cols=214  Identities=29%  Similarity=0.457  Sum_probs=187.4

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+|++++||||+++++++.+.     +.+|+|||||+ |+|.+++...+.+++..++.++.|++.||+|||+.|
T Consensus        59 ~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~  133 (293)
T d1jksa_          59 DIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ  133 (293)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc
Confidence            577999999999999999999999988     89999999997 699999988889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCC----CEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           91 VLHRDLKPSNLLLNANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |+||||||+||+++.++    .+|++|||++.............+|+.|+|||++.+ ..++.++||||+||++|+|++|
T Consensus       134 ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g  212 (293)
T d1jksa_         134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSG  212 (293)
T ss_dssp             EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHS
T ss_pred             eeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcC
Confidence            99999999999998776    499999999988766655667789999999999965 4589999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+..+.+..+........                          ...++++|+.+++||++||++||.+|||++
T Consensus       213 ~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~  266 (293)
T d1jksa_         213 ASPFLGDTKQETLANVSAVNYEFE--------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQ  266 (293)
T ss_dssp             SCSSCCSSHHHHHHHHHTTCCCCC--------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCCC--------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHH
Confidence            999998887777665543221111                          122346889999999999999999999999


Q ss_pred             HHhcCCCcCCc
Q 022132          247 DALAHPYLGSL  257 (302)
Q Consensus       247 ell~h~~~~~~  257 (302)
                      |+|+||||+..
T Consensus       267 eil~hp~~~~~  277 (293)
T d1jksa_         267 DSLQHPWIKPK  277 (293)
T ss_dssp             HHHHSTTTCC-
T ss_pred             HHhcCcccCCC
Confidence            99999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-53  Score=353.89  Aligned_cols=214  Identities=20%  Similarity=0.354  Sum_probs=177.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+++|++++||||+++++++.+... +...+|+|||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++
T Consensus        53 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~  131 (270)
T d1t4ha_          53 QRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR  131 (270)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEEESS-SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEeeccc-cCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC
Confidence            357899999999999999999999865321 1267999999997 69999999888999999999999999999999999


Q ss_pred             C--ceecCCCCCCEEEe-cCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           90 N--VLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        90 ~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |  |+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++.+  .++.++||||+||++|+|++|
T Consensus       132 ~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g  208 (270)
T d1t4ha_         132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATS  208 (270)
T ss_dssp             SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHC
Confidence            9  99999999999997 4789999999999764433 3456689999999998853  489999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      ++||.+......+...+.....|                           .......++++.+||.+||++||++|||++
T Consensus       209 ~~Pf~~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~  261 (270)
T d1t4ha_         209 EYPYSECQNAAQIYRRVTSGVKP---------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIK  261 (270)
T ss_dssp             SCTTTTCSSHHHHHHHHTTTCCC---------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             CCCCCCcccHHHHHHHHHcCCCC---------------------------cccCccCCHHHHHHHHHHccCCHhHCcCHH
Confidence            99998766554433222111010                           011125788999999999999999999999


Q ss_pred             HHhcCCCcC
Q 022132          247 DALAHPYLG  255 (302)
Q Consensus       247 ell~h~~~~  255 (302)
                      |+|+||||+
T Consensus       262 ell~Hp~fk  270 (270)
T d1t4ha_         262 DLLNHAFFQ  270 (270)
T ss_dssp             HHHTSGGGC
T ss_pred             HHhCCcccC
Confidence            999999995

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2e-52  Score=364.22  Aligned_cols=217  Identities=24%  Similarity=0.425  Sum_probs=189.8

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ...+.+|+.+|++++||||++++++|.+.     +.+|+|||||+ |+|.+.+... .++++..++.++.||+.||+|||
T Consensus        70 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH  144 (352)
T d1koba_          70 KYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH  144 (352)
T ss_dssp             HHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34677999999999999999999999987     89999999997 6999887654 47999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEe--cCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||+||||||+|||++  .++.+||+|||+|.............+|+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus       145 ~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyellt  223 (352)
T d1koba_         145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLS  223 (352)
T ss_dssp             HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHH
T ss_pred             HCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHh
Confidence            99999999999999998  568999999999988877666677789999999999865 458999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+....+..+......++                          ...++.+|+++++||.+||++||.+|||+
T Consensus       224 G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~  277 (352)
T d1koba_         224 GLSPFAGEDDLETLQNVKRCDWEFD--------------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTV  277 (352)
T ss_dssp             SCCSSCCSSHHHHHHHHHHCCCCCC--------------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             CCCCCCCCCHHHHHHHHHhCCCCCC--------------------------cccccCCCHHHHHHHHHHccCChhHCcCH
Confidence            9999999888777766654222111                          23345789999999999999999999999


Q ss_pred             HHHhcCCCcCCcc
Q 022132          246 EDALAHPYLGSLH  258 (302)
Q Consensus       246 ~ell~h~~~~~~~  258 (302)
                      +|+|+||||+...
T Consensus       278 ~eil~Hp~~~~~~  290 (352)
T d1koba_         278 HDALEHPWLKGDH  290 (352)
T ss_dssp             HHHHTSTTTSSCC
T ss_pred             HHHhcCHhhCCCc
Confidence            9999999998743

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-52  Score=362.64  Aligned_cols=258  Identities=32%  Similarity=0.604  Sum_probs=210.2

Q ss_pred             chhHHHHhcCc-hhhHHHHHHhcCCCCccccceeeCCCC-CCCCCcEEEEEecCCccHHHHH----HcCCCCCHHHHHHH
Q 022132            2 HSITKLMQRGH-FVRSSCFDTWIMKTSVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQII----RSNQALSEEHCQYF   75 (302)
Q Consensus         2 ~~~~~~~~~~~-~~~E~~il~~l~h~niv~l~~~~~~~~-~~~~~~~~lv~e~~~~~L~~~l----~~~~~l~~~~~~~i   75 (302)
                      .|||++..+.. ..+|+.+|++++||||++++++|.... ..+..++|+|||||++++...+    .....+++..++.+
T Consensus        48 vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i  127 (350)
T d1q5ka_          48 VAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY  127 (350)
T ss_dssp             EEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHH
T ss_pred             EEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHH
Confidence            36666655554 448999999999999999999986542 2233578999999998665554    34568999999999


Q ss_pred             HHHHHHHHHHHHhCCceecCCCCCCEEEecCC-CEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHH
Q 022132           76 LYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW  154 (302)
Q Consensus        76 ~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  154 (302)
                      +.||+.||+|||++||+||||||+|||++.++ .+||+|||++.............|+..|+|||.+.+...++.++|||
T Consensus       128 ~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIw  207 (350)
T d1q5ka_         128 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVW  207 (350)
T ss_dssp             HHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeec
Confidence            99999999999999999999999999999875 89999999998877666667778999999999987777789999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhcccccccccc-ccCCCCCHHHHHHHHH
Q 022132          155 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT-EKFPNVHPSAIDLVEK  233 (302)
Q Consensus       155 slG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~  233 (302)
                      |+||++|+|++|.+||.+.+..+.+..+.+.++.+....+..........  ..+.....++. ...+..++++.+||.+
T Consensus       208 SlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~dLl~~  285 (350)
T d1q5ka_         208 SAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSR  285 (350)
T ss_dssp             HHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC--CCCCCCCCCGGGTSCTTSCHHHHHHHHH
T ss_pred             ccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc--cccccccCchhhhcccCCCHHHHHHHHH
Confidence            99999999999999999999999999999999999987765443322111  12222222222 2335688999999999


Q ss_pred             ccCCCCCCCCCHHHHhcCCCcCCccCCC
Q 022132          234 MLTFDPRQRITVEDALAHPYLGSLHDIS  261 (302)
Q Consensus       234 ~L~~dP~~R~t~~ell~h~~~~~~~~~~  261 (302)
                      ||++||.+|||+.|+|+||||+...++.
T Consensus       286 mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  313 (350)
T d1q5ka_         286 LLEYTPTARLTPLEACAHSFFDELRDPN  313 (350)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             HccCChhHCcCHHHHhcCHhhccccCCC
Confidence            9999999999999999999999876543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-52  Score=358.68  Aligned_cols=211  Identities=24%  Similarity=0.350  Sum_probs=181.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      +.+.+|+.++++++||||+++++++.+.     +.+|+|||||.+ +|..++..++++++..++.++.||+.||.|||++
T Consensus        60 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~  134 (309)
T d1u5ra_          60 QDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH  134 (309)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999999999999887     899999999974 6666667778899999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCC--CCCCCchhHHHHHHHHHHHHhCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      ||+||||||+|||++.++.+||+|||++......   ....||+.|+|||++.+.  ..++.++|||||||++|+|++|.
T Consensus       135 ~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~  211 (309)
T d1u5ra_         135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  211 (309)
T ss_dssp             TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CEeccCCCcceEEECCCCCEEEeecccccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCC
Confidence            9999999999999999999999999999765443   456799999999998642  35789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+..+.+..+......+                            .....+|+.+++||.+||++||.+|||++|
T Consensus       212 ~Pf~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e  263 (309)
T d1u5ra_         212 PPLFNMNAMSALYHIAQNESPA----------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEV  263 (309)
T ss_dssp             CTTTTSCHHHHHHHHHHSCCCC----------------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHhCCCCC----------------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence            9998887766655544311100                            011257899999999999999999999999


Q ss_pred             HhcCCCcCCc
Q 022132          248 ALAHPYLGSL  257 (302)
Q Consensus       248 ll~h~~~~~~  257 (302)
                      +|+||||...
T Consensus       264 ll~Hp~~~~~  273 (309)
T d1u5ra_         264 LLKHRFVLRE  273 (309)
T ss_dssp             HTTCHHHHSC
T ss_pred             HHhCHHhcCC
Confidence            9999999763

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.7e-52  Score=350.20  Aligned_cols=216  Identities=25%  Similarity=0.467  Sum_probs=189.6

Q ss_pred             CchhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++ ||||+++++++.+.     +.+|+|||||+ |+|.+++..++++++..++.++.||+.||+|||+
T Consensus        54 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~  128 (277)
T d1phka_          54 EATLKEVDILRKVSGHPNIIQLKDTYETN-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK  128 (277)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEeecccC-----cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35779999999996 99999999999987     89999999996 6999999988899999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhC-----CCCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN-----SSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~i~~~l  163 (302)
                      +||+||||||+||+++.++.+||+|||++...+.........||..|+|||.+.+     ...++.++||||+||++|+|
T Consensus       129 ~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyem  208 (277)
T d1phka_         129 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL  208 (277)
T ss_dssp             TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred             cCCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhh
Confidence            9999999999999999999999999999988776656667789999999999853     23468899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|++||.+.+.......+.+.-..+.                          ....+++|+++++||.+||++||.+||
T Consensus       209 l~g~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~  262 (277)
T d1phka_         209 LAGSPPFWHRKQMLMLRMIMSGNYQFG--------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRY  262 (277)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHTCCCCC--------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSC
T ss_pred             ccCCCCCCCCCHHHHHHHHHhCCCCCC--------------------------CcccccCCHHHHHHHHHHccCChhHCc
Confidence            999999999887776666554211111                          112336889999999999999999999


Q ss_pred             CHHHHhcCCCcCCc
Q 022132          244 TVEDALAHPYLGSL  257 (302)
Q Consensus       244 t~~ell~h~~~~~~  257 (302)
                      |++|+|+||||+..
T Consensus       263 s~~eil~h~~~~~~  276 (277)
T d1phka_         263 TAEEALAHPFFQQY  276 (277)
T ss_dssp             CHHHHTTSGGGCTT
T ss_pred             CHHHHHcCHHHHHh
Confidence            99999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-52  Score=358.78  Aligned_cols=211  Identities=26%  Similarity=0.441  Sum_probs=186.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.+|+.++||||+++++++.+.     +.+|+|||||+ |+|.+++.+.+.++++.++.++.||+.||+|||++
T Consensus        50 ~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~  124 (337)
T d1o6la_          50 AHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR  124 (337)
T ss_dssp             HHHHHHHHHHHSCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEeeeccc-----cccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc
Confidence            3567999999999999999999999998     89999999997 69999999989999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+||+++.+|.+||+|||+|+.... .......+||+.|+|||++.+. .++.++|+||+||++|+|++|.+
T Consensus       125 ~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~  203 (337)
T d1o6la_         125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRL  203 (337)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCC
Confidence            999999999999999999999999999986533 4445667899999999998654 48999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC----
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT----  244 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----  244 (302)
                      ||.+.+.......+....                              ......+|+++++||++||++||.+|++    
T Consensus       204 pf~~~~~~~~~~~i~~~~------------------------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~  253 (337)
T d1o6la_         204 PFYNQDHERLFELILMEE------------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPS  253 (337)
T ss_dssp             SSCCSSHHHHHHHHHHCC------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTT
T ss_pred             CCCCcCHHHHHHHHhcCC------------------------------CCCCccCCHHHHHHHHhhccCCchhhcccccc
Confidence            999988766655544310                              0112368899999999999999999994    


Q ss_pred             -HHHHhcCCCcCCc
Q 022132          245 -VEDALAHPYLGSL  257 (302)
Q Consensus       245 -~~ell~h~~~~~~  257 (302)
                       ++|+++||||+..
T Consensus       254 ~~~eil~Hp~f~~i  267 (337)
T d1o6la_         254 DAKEVMEHRFFLSI  267 (337)
T ss_dssp             THHHHHTSGGGTTC
T ss_pred             cHHHHHcCcccccC
Confidence             9999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-53  Score=363.94  Aligned_cols=238  Identities=21%  Similarity=0.355  Sum_probs=178.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~-   88 (302)
                      ..+.+|+.+|++++|||||+++++|.+.     +.+|+|||||+ |+|.+++.+.+.+++..++.++.||+.||.|||+ 
T Consensus        49 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~  123 (322)
T d1s9ja_          49 NQIIRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK  123 (322)
T ss_dssp             HHHHHHGGGGGGCCCTTBCCEEEEEECS-----SEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            3577999999999999999999999988     89999999997 6999999988899999999999999999999997 


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      +||+||||||+|||++.+|.+||+|||+|...... .....+||+.|+|||++.+. .++.++||||+||++|+|++|+.
T Consensus       124 ~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~  201 (322)
T d1s9ja_         124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRY  201 (322)
T ss_dssp             HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCC
Confidence            59999999999999999999999999999865432 23456899999999999765 48999999999999999999999


Q ss_pred             CCCCCChHHH-HHHHHHHhCCCChHHHhhhh--Hh-------------HHHHhhhccccccccccccCCCCCHHHHHHHH
Q 022132          169 LFPGRDHVHQ-LRLLIELIGTPSEAELGFLN--EN-------------AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE  232 (302)
Q Consensus       169 pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  232 (302)
                      ||.+.+.... ........+.+.........  ..             ...............  ......|+++++||.
T Consensus       202 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~  279 (322)
T d1s9ja_         202 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVN  279 (322)
T ss_dssp             CSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCC--CCBTTBCHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCcc--CccccCCHHHHHHHH
Confidence            9987654332 22222212211110000000  00             000000000000000  011236789999999


Q ss_pred             HccCCCCCCCCCHHHHhcCCCcCCc
Q 022132          233 KMLTFDPRQRITVEDALAHPYLGSL  257 (302)
Q Consensus       233 ~~L~~dP~~R~t~~ell~h~~~~~~  257 (302)
                      +||++||.+|||++|+|+||||++.
T Consensus       280 ~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         280 KCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             HHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             HHcCCChhHCcCHHHHhhCHhhCcC
Confidence            9999999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=351.33  Aligned_cols=211  Identities=28%  Similarity=0.451  Sum_probs=168.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKY   85 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qll~~l~~   85 (302)
                      ..+.+|+.++++++||||+++++++.+...   +.+|+|||||+ |+|.+++.+    ++.+++..++.++.||+.||+|
T Consensus        48 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~---~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~y  124 (269)
T d2java1          48 QMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE  124 (269)
T ss_dssp             HHHHHHHHHTTSCCCTTBCCEEEEEEC-------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCEeeEEEEEEeCCC---CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHH
Confidence            357799999999999999999999875422   67999999997 699998853    4689999999999999999999


Q ss_pred             HHhCC-----ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHH
Q 022132           86 IHSAN-----VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  159 (302)
Q Consensus        86 LH~~~-----i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  159 (302)
                      ||+.|     |+||||||+||+++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus       125 lH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvi  203 (269)
T d2java1         125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCL  203 (269)
T ss_dssp             HHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHH
T ss_pred             HHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHH
Confidence            99976     999999999999999999999999999876543 33456789999999999854 458999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCC
Q 022132          160 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       160 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      +|+|++|.+||.+.+..+....+.+..                             +......+|+++.+||++||+.||
T Consensus       204 lyel~tg~~Pf~~~~~~~~~~~i~~~~-----------------------------~~~~~~~~s~~l~~li~~~L~~dp  254 (269)
T d2java1         204 LYELCALMPPFTAFSQKELAGKIREGK-----------------------------FRRIPYRYSDELNEIITRMLNLKD  254 (269)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHTC-----------------------------CCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHcCC-----------------------------CCCCCcccCHHHHHHHHHHcCCCh
Confidence            999999999999887766655544311                             111223678999999999999999


Q ss_pred             CCCCCHHHHhcCCCc
Q 022132          240 RQRITVEDALAHPYL  254 (302)
Q Consensus       240 ~~R~t~~ell~h~~~  254 (302)
                      .+|||++|+|+|||+
T Consensus       255 ~~Rps~~ell~hp~i  269 (269)
T d2java1         255 YHRPSVEEILENPLI  269 (269)
T ss_dssp             GGSCCHHHHHTSTTC
T ss_pred             hHCcCHHHHHhCCcC
Confidence            999999999999996

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=353.03  Aligned_cols=244  Identities=35%  Similarity=0.624  Sum_probs=202.0

Q ss_pred             chhhHHHHHHhc---CCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWI---MKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR--SNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        12 ~~~~E~~il~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~--~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      .+.+|+.+++.+   +||||++++++|..........+|++|||+++++.....  ....+++..++.++.|++.||+||
T Consensus        53 ~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yL  132 (305)
T d1blxa_          53 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL  132 (305)
T ss_dssp             THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            566899888877   799999999999754333336899999999876554443  346799999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |++||+||||||+|||++.++.+||+|||.+.............||+.|+|||++.+. .++.++||||+||++|+|++|
T Consensus       133 H~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g  211 (305)
T d1blxa_         133 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRR  211 (305)
T ss_dssp             HHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHS
T ss_pred             HhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHC
Confidence            9999999999999999999999999999999876666666778899999999998654 589999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+..+.+..+.+..+.|....+........   .........+.....+.+++.+++||++||++||.+|||++
T Consensus       212 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~  288 (305)
T d1blxa_         212 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY  288 (305)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHHhhCCCchhcccccccchh---hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence            999999999999999999999988765543211111   11122223344555667899999999999999999999999


Q ss_pred             HHhcCCCcCCccC
Q 022132          247 DALAHPYLGSLHD  259 (302)
Q Consensus       247 ell~h~~~~~~~~  259 (302)
                      |+|+||||+.+..
T Consensus       289 e~L~Hpff~~i~~  301 (305)
T d1blxa_         289 SALSHPYFQDLER  301 (305)
T ss_dssp             HHHTSGGGTTCCC
T ss_pred             HHhcChhhcCchh
Confidence            9999999998643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-51  Score=352.00  Aligned_cols=209  Identities=22%  Similarity=0.439  Sum_probs=185.3

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      ..+.+|+.++++++||||+++++++.+.     +.+|+|||||. |+|...+.....+++..++.++.||+.||+|||++
T Consensus        49 ~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~  123 (316)
T d1fota_          49 EHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK  123 (316)
T ss_dssp             HHHHHHHHHHHSCCBTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHhccCcChhheeeeEeeC-----CeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccC
Confidence            3577899999999999999999999988     89999999997 69999999989999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      ||+||||||+||+++.+|.+||+|||+++.....  ....+||+.|+|||++.+. .++.++||||+||++|+|++|.+|
T Consensus       124 ~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~P  200 (316)
T d1fota_         124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTP  200 (316)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             cEEccccCchheeEcCCCCEEEecCccceEeccc--cccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCC
Confidence            9999999999999999999999999999876544  3456899999999998654 489999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----C
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----T  244 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t  244 (302)
                      |.+.+..+....+...-.                              ...+.++++++++|.+||.+||.+|+     |
T Consensus       201 f~~~~~~~~~~~i~~~~~------------------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t  250 (316)
T d1fota_         201 FYDSNTMKTYEKILNAEL------------------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG  250 (316)
T ss_dssp             TCCSSHHHHHHHHHHCCC------------------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTT
T ss_pred             CCCcCHHHHHHHHHcCCC------------------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhh
Confidence            998887776666543110                              11236789999999999999999996     9


Q ss_pred             HHHHhcCCCcCCc
Q 022132          245 VEDALAHPYLGSL  257 (302)
Q Consensus       245 ~~ell~h~~~~~~  257 (302)
                      ++++++||||++.
T Consensus       251 ~~~il~Hp~f~~i  263 (316)
T d1fota_         251 TEDVKNHPWFKEV  263 (316)
T ss_dssp             THHHHTSGGGSSC
T ss_pred             HHHHHcCcccccC
Confidence            9999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.4e-51  Score=348.11  Aligned_cols=239  Identities=37%  Similarity=0.669  Sum_probs=201.3

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l-~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+|++++||||+++++++...     +..|++|||+++++...+ ...+.+++..++.++.||+.||+|||+.|
T Consensus        46 ~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  120 (286)
T d1ob3a_          46 TTIREISILKELKHSNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR  120 (286)
T ss_dssp             HHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCcEEeeeeecccC-----CceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc
Confidence            677999999999999999999999998     899999999997555554 55788999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCC-cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.+|++|||.+...+... ......+++.|+|||.+.+...++.++||||+||++++|++|++|
T Consensus       121 IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~p  200 (286)
T d1ob3a_         121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL  200 (286)
T ss_dssp             CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCC
Confidence            9999999999999999999999999997755432 234456889999999998777789999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 022132          170 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  249 (302)
Q Consensus       170 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell  249 (302)
                      |.+.+..+++..+....+.|....+...... .............+.....+.++++++|||++||++||++|||++|+|
T Consensus       201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell  279 (286)
T d1ob3a_         201 FPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL  279 (286)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS-TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             CCCCCHHHHHHHHHHhhCCCChhhccchhhh-hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            9999999999999999999887766543222 122223333344556666778999999999999999999999999999


Q ss_pred             cCCCcCC
Q 022132          250 AHPYLGS  256 (302)
Q Consensus       250 ~h~~~~~  256 (302)
                      +||||++
T Consensus       280 ~Hp~f~~  286 (286)
T d1ob3a_         280 EHAYFKE  286 (286)
T ss_dssp             TSGGGGC
T ss_pred             cCcccCc
Confidence            9999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.9e-51  Score=355.41  Aligned_cols=208  Identities=22%  Similarity=0.377  Sum_probs=184.5

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+++|+.++||||+++++++.+.     +.+|+||||+. |+|...+.+.+.+++..++.++.||+.||.|||++|
T Consensus        87 ~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~  161 (350)
T d1rdqe_          87 HTLNEKRILQAVNFPFLVKLEFSFKDN-----SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD  161 (350)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHcCCCcEeecccccccc-----cccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999999999999988     89999999996 699999988889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  170 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf  170 (302)
                      |+||||||+|||++.+|.+||+|||+|+.....  .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||
T Consensus       162 iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf  238 (350)
T d1rdqe_         162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPF  238 (350)
T ss_dssp             EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EecCcCCHHHcccCCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCC
Confidence            999999999999999999999999999876543  3456899999999999654 4899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CH
Q 022132          171 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TV  245 (302)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~  245 (302)
                      .+.+....+..+.....                              ...+.+++++.+||++||++||.+|+     |+
T Consensus       239 ~~~~~~~~~~~i~~~~~------------------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~  288 (350)
T d1rdqe_         239 FADQPIQIYEKIVSGKV------------------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGV  288 (350)
T ss_dssp             CCSSHHHHHHHHHHCCC------------------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTT
T ss_pred             CCcCHHHHHHHHhcCCC------------------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccH
Confidence            98887766665543211                              11236889999999999999999995     99


Q ss_pred             HHHhcCCCcCCc
Q 022132          246 EDALAHPYLGSL  257 (302)
Q Consensus       246 ~ell~h~~~~~~  257 (302)
                      +|+++||||++.
T Consensus       289 ~ell~Hp~f~~~  300 (350)
T d1rdqe_         289 NDIKNHKWFATT  300 (350)
T ss_dssp             HHHHTSGGGTTC
T ss_pred             HHHHcCccccCC
Confidence            999999999865

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-51  Score=352.02  Aligned_cols=213  Identities=22%  Similarity=0.408  Sum_probs=186.9

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|+.+|+.++||||++++++|.+.     +.+|+|||||+ |+|.+++...+ ++++..++.++.||+.||+|||++
T Consensus        47 ~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~  121 (321)
T d1tkia_          47 LVKKEISILNIARHRNILHLHESFESM-----EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH  121 (321)
T ss_dssp             HHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence            467999999999999999999999987     89999999997 59999998654 799999999999999999999999


Q ss_pred             CceecCCCCCCEEEecC--CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           90 NVLHRDLKPSNLLLNAN--CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      ||+||||||+||+++.+  +.++|+|||++.............+++.|+|||.+.+. .++.++||||+||++|+|++|.
T Consensus       122 ~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~  200 (321)
T d1tkia_         122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGI  200 (321)
T ss_dssp             TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSS
T ss_pred             CCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCC
Confidence            99999999999999854  57999999999887666656667889999999988544 4899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 022132          168 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  247 (302)
Q Consensus       168 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  247 (302)
                      +||.+.+..+.+..+.+....++.                          ..++.+|+++++||.+||++||.+|||++|
T Consensus       201 ~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e  254 (321)
T d1tkia_         201 NPFLAETNQQIIENIMNAEYTFDE--------------------------EAFKEISIEAMDFVDRLLVKERKSRMTASE  254 (321)
T ss_dssp             CTTCCSSHHHHHHHHHHTCCCCCH--------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHhCCCCCCh--------------------------hhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            999999888777776653322222                          223468899999999999999999999999


Q ss_pred             HhcCCCcCC
Q 022132          248 ALAHPYLGS  256 (302)
Q Consensus       248 ll~h~~~~~  256 (302)
                      +|+||||++
T Consensus       255 il~hp~~~~  263 (321)
T d1tkia_         255 ALQHPWLKQ  263 (321)
T ss_dssp             HHHSHHHHS
T ss_pred             HhcCHhhcc
Confidence            999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-50  Score=354.64  Aligned_cols=209  Identities=25%  Similarity=0.385  Sum_probs=177.5

Q ss_pred             HHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 022132           16 SSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHR   94 (302)
Q Consensus        16 E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i~H~   94 (302)
                      |+.+++.++||||+++++++.+.     +.+|+|||||+ |+|.+++.+++.+++..++.++.||+.||+|||++||+||
T Consensus        57 ~~~~l~~~~hpnIv~l~~~~~~~-----~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHr  131 (364)
T d1omwa3          57 MLSLVSTGDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR  131 (364)
T ss_dssp             HHHHHSSSCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHhcCCCCcEEEEEEEEEEC-----CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccce
Confidence            46677777899999999999988     89999999997 7999999988899999999999999999999999999999


Q ss_pred             CCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022132           95 DLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  174 (302)
Q Consensus        95 dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~  174 (302)
                      ||||+|||++.+|.+||+|||+|+...... .....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+
T Consensus       132 DlKP~NILl~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  210 (364)
T d1omwa3         132 DLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  210 (364)
T ss_dssp             CCSGGGEEECSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             eeccceeEEcCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999998765442 4456899999999999766668999999999999999999999998765


Q ss_pred             hHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHh
Q 022132          175 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDAL  249 (302)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-----~~ell  249 (302)
                      ..............                           .....+.+|+++++||.+||++||.+|||     ++|++
T Consensus       211 ~~~~~~~~~~~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil  263 (364)
T d1omwa3         211 TKDKHEIDRMTLTM---------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  263 (364)
T ss_dssp             SSCHHHHHHHSSSC---------------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHH
T ss_pred             HHHHHHHHHhcccC---------------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHH
Confidence            43322211111100                           11223368999999999999999999999     79999


Q ss_pred             cCCCcCCc
Q 022132          250 AHPYLGSL  257 (302)
Q Consensus       250 ~h~~~~~~  257 (302)
                      +||||++.
T Consensus       264 ~Hp~f~~i  271 (364)
T d1omwa3         264 ESPFFRSL  271 (364)
T ss_dssp             TSGGGTTC
T ss_pred             cCccccCC
Confidence            99999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-52  Score=359.10  Aligned_cols=233  Identities=26%  Similarity=0.378  Sum_probs=184.5

Q ss_pred             chhHHHHhcCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHH
Q 022132            2 HSITKLMQRGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLY   77 (302)
Q Consensus         2 ~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~   77 (302)
                      .|||++.....+.+|+.++.++ +||||++++++|.+... ..+.+|+|||||+ |+|.+++.++  ..+++..++.++.
T Consensus        40 vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~-~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~  118 (335)
T d2ozaa1          40 FALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK  118 (335)
T ss_dssp             EEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHH
T ss_pred             EEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc-CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHH
Confidence            3677777777888999997665 89999999999865211 1167999999997 6999999864  4799999999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCCEEEec---CCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHH
Q 022132           78 QILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW  154 (302)
Q Consensus        78 qll~~l~~LH~~~i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  154 (302)
                      ||+.||+|||++||+||||||+||+++.   .+.+||+|||+++............||+.|+|||++.+ ..++.++|||
T Consensus       119 qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~Diw  197 (335)
T d2ozaa1         119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMW  197 (335)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHH
T ss_pred             HHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcC-CCCCHHHHHH
Confidence            9999999999999999999999999985   46799999999987776666677889999999998854 4489999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHc
Q 022132          155 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  234 (302)
Q Consensus       155 slG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (302)
                      ||||++|+|++|.+||.+.+.......+...+....                      .......++.+|+++++||++|
T Consensus       198 SlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~----------------------~~~~~~~~~~~s~~~~~li~~~  255 (335)
T d2ozaa1         198 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----------------------YEFPNPEWSEVSEEVKMLIRNL  255 (335)
T ss_dssp             HHHHHHHHHTTSSCSCEETTCC--------CCCSCS----------------------SSCCTTHHHHSCHHHHHHHHHH
T ss_pred             hhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC----------------------CCCCCcccccCCHHHHHHHHHH
Confidence            999999999999999987665443333322111100                      0000011225788999999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCcCCcc
Q 022132          235 LTFDPRQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       235 L~~dP~~R~t~~ell~h~~~~~~~  258 (302)
                      |++||.+|||++|+|+||||....
T Consensus       256 L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         256 LKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             SCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             ccCChhHCcCHHHHHcCHHhhCCC
Confidence            999999999999999999997543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=342.26  Aligned_cols=210  Identities=23%  Similarity=0.398  Sum_probs=182.3

Q ss_pred             chhhHHHHHH-hcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           12 HFVRSSCFDT-WIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        12 ~~~~E~~il~-~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      .+.+|..++. .++||||+++++++.+.     +.+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++
T Consensus        48 ~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~  122 (320)
T d1xjda_          48 CTMVEKRVLSLAWEHPFLTHMFCTFQTK-----ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK  122 (320)
T ss_dssp             HHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCcEEEEEEEEccC-----CceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4567777765 67999999999999998     89999999997 69999999888999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCC-CCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  168 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~  168 (302)
                      ||+||||||+|||++.++.+||+|||+++.... ........||+.|+|||++.+. .++.++||||+||++|+|++|+.
T Consensus       123 ~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~  201 (320)
T d1xjda_         123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQS  201 (320)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCC
Confidence            999999999999999999999999999976543 3334556899999999999654 48999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH-H
Q 022132          169 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE-D  247 (302)
Q Consensus       169 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~-e  247 (302)
                      ||.+.+.......+..  +.|                            ...+.+|+++.+||++||++||.+|||+. +
T Consensus       202 PF~~~~~~~~~~~i~~--~~~----------------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~  251 (320)
T d1xjda_         202 PFHGQDEEELFHSIRM--DNP----------------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGD  251 (320)
T ss_dssp             SSCCSSHHHHHHHHHH--CCC----------------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSC
T ss_pred             CCCCCCHHHHHHHHHc--CCC----------------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHH
Confidence            9998887776655542  111                            11125789999999999999999999995 8


Q ss_pred             HhcCCCcCCc
Q 022132          248 ALAHPYLGSL  257 (302)
Q Consensus       248 ll~h~~~~~~  257 (302)
                      +++||||+++
T Consensus       252 l~~hpff~~~  261 (320)
T d1xjda_         252 IRQHPLFREI  261 (320)
T ss_dssp             GGGSGGGTTC
T ss_pred             HHhCchhccC
Confidence            9999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=335.40  Aligned_cols=206  Identities=25%  Similarity=0.419  Sum_probs=176.4

Q ss_pred             CchhhHHHHHHhcC--CCCccccceeeCCCCCCCCCcEEEEEecCC--ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIM--KTSVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus        11 ~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ..+.+|+.++++++  ||||+++++++.+.     +.+|+||||+.  +++.+++..++.+++..++.++.||+.||+||
T Consensus        52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-----~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~l  126 (273)
T d1xwsa_          52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC  126 (273)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECS-----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCccEEEEEEeeC-----CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            45779999999996  89999999999988     89999999996  48888988888999999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecC-CCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           87 HSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      |++||+||||||+||+++.+ +.+||+|||++...... ......||+.|+|||++.+...++.++||||+||++|+|++
T Consensus       127 H~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~  205 (273)
T d1xwsa_         127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC  205 (273)
T ss_dssp             HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred             HHCCCccccCcccceEEecCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh
Confidence            99999999999999999855 78999999999765443 34566899999999999776656788999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+.      +..  +.                            ....+.+|+++++||++||++||.+|||+
T Consensus       206 g~~Pf~~~~~------i~~--~~----------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~  249 (273)
T d1xwsa_         206 GDIPFEHDEE------IIR--GQ----------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTF  249 (273)
T ss_dssp             SSCSCCSHHH------HHH--CC----------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCchH------Hhh--cc----------------------------cCCCCCCCHHHHHHHHHHccCCHhHCcCH
Confidence            9999965321      110  00                            01123688999999999999999999999


Q ss_pred             HHHhcCCCcCCcc
Q 022132          246 EDALAHPYLGSLH  258 (302)
Q Consensus       246 ~ell~h~~~~~~~  258 (302)
                      +|+|+||||++..
T Consensus       250 ~eil~hp~~~~~~  262 (273)
T d1xwsa_         250 EEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHTSGGGSSCC
T ss_pred             HHHhcCHhhCCCC
Confidence            9999999998753

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-49  Score=338.09  Aligned_cols=246  Identities=31%  Similarity=0.543  Sum_probs=191.1

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCC---CCCCcEEEEEecCCccHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQR---ESFNDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~l-~~~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      .+.+|+.+|+.++||||+++++++.....   ...+.+|+||||+++++.... .....+++..++.++.||+.||.|||
T Consensus        55 ~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH  134 (318)
T d3blha1          55 TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH  134 (318)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhc
Confidence            36799999999999999999999876421   122579999999997666555 44578999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCC-----CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      ++||+||||||+||+++.++.++|+|||++...+..     .......+|+.|+|||++.+...++.++||||+||++++
T Consensus       135 ~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~e  214 (318)
T d3blha1         135 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE  214 (318)
T ss_dssp             HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             cCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeee
Confidence            999999999999999999999999999999755432     223445789999999999877678999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccC--CCCCHHHHHHHHHccCCCCC
Q 022132          163 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF--PNVHPSAIDLVEKMLTFDPR  240 (302)
Q Consensus       163 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~  240 (302)
                      |++|++||.+.+.......+....+.+..............................+  ...++.++|||.+||++||+
T Consensus       215 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~  294 (318)
T d3blha1         215 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA  294 (318)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTT
T ss_pred             HhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChh
Confidence            9999999999999999999999998887665443321111111011111111111111  02467899999999999999


Q ss_pred             CCCCHHHHhcCCCcCCc
Q 022132          241 QRITVEDALAHPYLGSL  257 (302)
Q Consensus       241 ~R~t~~ell~h~~~~~~  257 (302)
                      +|||++|+|+||||+..
T Consensus       295 ~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         295 QRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TSCCHHHHHHSGGGSSS
T ss_pred             HCcCHHHHHcChhhccC
Confidence            99999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=329.70  Aligned_cols=211  Identities=19%  Similarity=0.270  Sum_probs=173.5

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..|.+|+.++++++||||+++++++..      +.+|+|||||+ |+|.+++.. ..++++..+..++.||+.||+|||+
T Consensus        49 ~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~  122 (276)
T d1uwha_          49 QAFKNEVGVLRKTRHVNILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA  122 (276)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECS------SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeEEEec------cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            367799999999999999999998754      56899999998 699999975 4679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCC--CCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~i~~~l  163 (302)
                      +||+||||||+|||++.++.+||+|||+|+.....   .......||+.|+|||++...  ..++.++|||||||++|+|
T Consensus       123 ~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el  202 (276)
T d1uwha_         123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL  202 (276)
T ss_dssp             TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHH
T ss_pred             CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHH
Confidence            99999999999999999999999999999765432   233456789999999998643  3478999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          164 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       164 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      ++|+.||.+.+....+.........++                        ......+.+++.+.+||.+||+.||.+||
T Consensus       203 ~tg~~Pf~~~~~~~~~~~~~~~~~~~p------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RP  258 (276)
T d1uwha_         203 MTGQLPYSNINNRDQIIFMVGRGYLSP------------------------DLSKVRSNCPKAMKRLMAECLKKKRDERP  258 (276)
T ss_dssp             HHSSCTTTTCCCHHHHHHHHHHTSCCC------------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHCCCCCCCCChHHHHHHHHhcCCCCC------------------------cchhccccchHHHHHHHHHHcCCCHhHCc
Confidence            999999998877666555544322111                        12233446889999999999999999999


Q ss_pred             CHHHHhcC
Q 022132          244 TVEDALAH  251 (302)
Q Consensus       244 t~~ell~h  251 (302)
                      |++|++++
T Consensus       259 t~~~il~~  266 (276)
T d1uwha_         259 LFPQILAS  266 (276)
T ss_dssp             CHHHHHHH
T ss_pred             CHHHHHHH
Confidence            99999876

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=333.12  Aligned_cols=209  Identities=20%  Similarity=0.296  Sum_probs=174.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA   89 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~   89 (302)
                      +.+.+|+.++++++||||+++++++..      +..|+|||||+ |+|.+++...+.+++..+..++.||+.||+|||++
T Consensus        53 ~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~  126 (277)
T d1xbba_          53 DELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES  126 (277)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC
Confidence            368899999999999999999999854      46799999997 69999999989999999999999999999999999


Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ||+||||||+||+++.++.++|+|||+++......    ......+|+.|+|||.+.+. .++.++|||||||++|+|++
T Consensus       127 ~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt  205 (277)
T d1xbba_         127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFS  205 (277)
T ss_dssp             TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHT
T ss_pred             CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhh
Confidence            99999999999999999999999999997654332    12335678899999998654 48999999999999999997


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.+..+....+.+...                             ......+|+++.+||.+||+.||.+|||
T Consensus       206 ~g~~Pf~~~~~~~~~~~i~~~~~-----------------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs  256 (277)
T d1xbba_         206 YGQKPYRGMKGSEVTAMLEKGER-----------------------------MGCPAGCPREMYDLMNLCWTYDVENRPG  256 (277)
T ss_dssp             TTCCSSTTCCHHHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCcccCHHHHHHHHHHcCCCHhHCcC
Confidence             8999998876655444432110                             1112367899999999999999999999


Q ss_pred             HHHH---hcCCCcC
Q 022132          245 VEDA---LAHPYLG  255 (302)
Q Consensus       245 ~~el---l~h~~~~  255 (302)
                      ++++   |+|+|+.
T Consensus       257 ~~~i~~~L~~~~~~  270 (277)
T d1xbba_         257 FAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHHHHHHHHHHHH
T ss_pred             HHHHHHHhhCHHhh
Confidence            9998   4566654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-48  Score=329.54  Aligned_cols=242  Identities=34%  Similarity=0.610  Sum_probs=199.6

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+|+.++||||+++++++...     ...++|++++.+ +|..++...+.+++..++.++.|++.||+|||++|
T Consensus        47 ~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~  121 (292)
T d1unla_          47 SALREICLLKELKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN  121 (292)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcCcCCEEeeccccccc-----cceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC
Confidence            567999999999999999999999998     899999999975 77777788889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC-CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  169 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~~p  169 (302)
                      |+||||||+||+++.++.+||+|||.+...... .......++..|+|||.+.....++.++||||+||++++|++|..|
T Consensus       122 IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p  201 (292)
T d1unla_         122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred             EeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCC
Confidence            999999999999999999999999999876543 3344456778899999987766679999999999999999998876


Q ss_pred             -CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 022132          170 -FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  248 (302)
Q Consensus       170 -f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  248 (302)
                       |.+.+..+.+..+....+.+....+.......... ...............+.+++.+++||++||++||.+|||++|+
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~  280 (292)
T d1unla_         202 LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK-PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA  280 (292)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC-CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc-ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence             56777788888888888888776554332211100 0000111223444556788999999999999999999999999


Q ss_pred             hcCCCcCCccC
Q 022132          249 LAHPYLGSLHD  259 (302)
Q Consensus       249 l~h~~~~~~~~  259 (302)
                      |+||||+++..
T Consensus       281 L~Hp~f~~~~~  291 (292)
T d1unla_         281 LQHPYFSDFCP  291 (292)
T ss_dssp             TTSGGGSSCSC
T ss_pred             hcChhhcCCCC
Confidence            99999987654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-48  Score=331.21  Aligned_cols=206  Identities=21%  Similarity=0.323  Sum_probs=166.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      +.|.+|+.+|++++|||||++++++...     +.+|+|||||+ |+|.+++.. .+.+++..+..++.||+.||+|||+
T Consensus        72 ~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  146 (299)
T d1jpaa_          72 RDFLSEASIMGQFDHPNVIHLEGVVTKS-----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD  146 (299)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEeeC-----CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            4688999999999999999999999887     88999999997 699998876 4579999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCCc------ccccccccccCchhhhhCCCCCCCchhHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  162 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~  162 (302)
                      +||+||||||+|||++.++.+||+|||+++.......      .....+|..|+|||.+.+. .++.++|||||||++|+
T Consensus       147 ~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~e  225 (299)
T d1jpaa_         147 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWE  225 (299)
T ss_dssp             TTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHH
T ss_pred             CCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHH
Confidence            9999999999999999999999999999976543211      1224568899999998654 58999999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCC
Q 022132          163 LMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  241 (302)
Q Consensus       163 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  241 (302)
                      |++ |.+||.+.+..+.+..+......|                             ....+++.+.+|+.+||+.||.+
T Consensus       226 l~t~g~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~~P~~  276 (299)
T d1jpaa_         226 VMSYGERPYWDMTNQDVINAIEQDYRLP-----------------------------PPMDCPSALHQLMLDCWQKDRNH  276 (299)
T ss_dssp             HHTTSCCTTTTCCHHHHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSTTT
T ss_pred             HHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CCccchHHHHHHHHHHcCCCHhH
Confidence            997 899998887766655443321111                             12367889999999999999999


Q ss_pred             CCCHHHHhcC
Q 022132          242 RITVEDALAH  251 (302)
Q Consensus       242 R~t~~ell~h  251 (302)
                      |||++|++++
T Consensus       277 RPs~~ei~~~  286 (299)
T d1jpaa_         277 RPKFGQIVNT  286 (299)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999998874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1e-47  Score=332.69  Aligned_cols=242  Identities=27%  Similarity=0.527  Sum_probs=188.5

Q ss_pred             CchhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      +.+.+|+.+|+++. ||||++++++|.....   ..+|+|||||+ ++|...   .+.+++..++.++.||+.||+|||+
T Consensus        74 ~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~---~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~  147 (328)
T d3bqca1          74 KKIKREIKILENLRGGPNIITLADIVKDPVS---RTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHS  147 (328)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---CSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCCcEEEEEEEecCC---CceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhh
Confidence            46779999999995 9999999999975422   67999999998 577655   3579999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCC-CEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhCC
Q 022132           89 ANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  167 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g~  167 (302)
                      +||+||||||+|||++.++ .++|+|||+|.............+|+.|+|||.+.+...++.++||||+||++++|++|.
T Consensus       148 ~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~  227 (328)
T d3bqca1         148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK  227 (328)
T ss_dssp             TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             cccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCC
Confidence            9999999999999999765 589999999987776666677789999999999987777899999999999999999999


Q ss_pred             CCCCCC-ChHHHHHHHHHHhCCCChHHHhhhhHh--HHHHhhhccccccccc-----cccCCCCCHHHHHHHHHccCCCC
Q 022132          168 PLFPGR-DHVHQLRLLIELIGTPSEAELGFLNEN--AKKYICQLPRYQRQSF-----TEKFPNVHPSAIDLVEKMLTFDP  239 (302)
Q Consensus       168 ~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP  239 (302)
                      .||... +...+...+...++.+....+......  ...+...........+     ......++++++|||++||++||
T Consensus       228 ~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP  307 (328)
T d3bqca1         228 EPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH  307 (328)
T ss_dssp             SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSG
T ss_pred             CCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCCh
Confidence            998655 455666677776665443332211000  0001111111111111     11223478899999999999999


Q ss_pred             CCCCCHHHHhcCCCcCCcc
Q 022132          240 RQRITVEDALAHPYLGSLH  258 (302)
Q Consensus       240 ~~R~t~~ell~h~~~~~~~  258 (302)
                      .+|||++|+|+||||++..
T Consensus       308 ~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         308 QSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             GGSCCHHHHHTSGGGTTSC
T ss_pred             hHCcCHHHHhcCcccCCCC
Confidence            9999999999999998754

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=329.61  Aligned_cols=210  Identities=19%  Similarity=0.287  Sum_probs=176.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      +.|.+|+.+|++++||||+++++++..      +.+|+|||||+ |+|.+++.. ++.+++..+..++.||+.||+|||+
T Consensus        54 ~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~  127 (285)
T d1u59a_          54 EEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE  127 (285)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEeeeecc------CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            468899999999999999999999864      46899999997 699998764 4679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      +||+||||||+||+++.++.+||+|||+++......    ......+|..|+|||++... .++.++||||+||++|+|+
T Consensus       128 ~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~l  206 (285)
T d1u59a_         128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEAL  206 (285)
T ss_dssp             TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHH
T ss_pred             CCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHH
Confidence            999999999999999999999999999998655432    22345678899999998654 4899999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |.+||.+.+..+....+.+...                             ....+.+|+++.+||.+||+.||.+||
T Consensus       207 t~G~~Pf~~~~~~~~~~~i~~~~~-----------------------------~~~p~~~~~~l~~li~~cl~~~p~~RP  257 (285)
T d1u59a_         207 SYGQKPYKKMKGPEVMAFIEQGKR-----------------------------MECPPECPPELYALMSDCWIYKWEDRP  257 (285)
T ss_dssp             TTSCCTTTTCCTHHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred             hCCCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCc
Confidence            7 9999998877665554432110                             112246889999999999999999999


Q ss_pred             CHHHH---hcCCCcCC
Q 022132          244 TVEDA---LAHPYLGS  256 (302)
Q Consensus       244 t~~el---l~h~~~~~  256 (302)
                      |+.++   |+|+|++-
T Consensus       258 s~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         258 DFLTVEQRMRACYYSL  273 (285)
T ss_dssp             CHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHh
Confidence            99887   67888753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-48  Score=334.64  Aligned_cols=206  Identities=24%  Similarity=0.357  Sum_probs=174.0

Q ss_pred             chhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-----------------------CC
Q 022132           12 HFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-----------------------QA   66 (302)
Q Consensus        12 ~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----------------------~~   66 (302)
                      .+.+|+.+++++ +|||||++++++.+.     +.+|+|||||+ |+|.+++..+                       ..
T Consensus        86 ~~~~E~~~l~~l~~HpnIv~l~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (325)
T d1rjba_          86 ALMSELKMMTQLGSHENIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV  160 (325)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------
T ss_pred             HHHHHHHHHHHhcCCCcEeEEEEEEeeC-----CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCC
Confidence            577999999999 899999999999987     88999999997 7999999754                       24


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhC
Q 022132           67 LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLN  143 (302)
Q Consensus        67 l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~  143 (302)
                      +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+|+......   ......+|+.|+|||++.+
T Consensus       161 l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  240 (325)
T d1rjba_         161 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE  240 (325)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC
Confidence            8999999999999999999999999999999999999999999999999997654332   2334567999999999865


Q ss_pred             CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCC
Q 022132          144 SSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN  222 (302)
Q Consensus       144 ~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (302)
                      . .++.++|||||||++|+|++ |.+||.+.+....+..+......+                            .....
T Consensus       241 ~-~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~----------------------------~~p~~  291 (325)
T d1rjba_         241 G-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM----------------------------DQPFY  291 (325)
T ss_dssp             C-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC----------------------------CCCTT
T ss_pred             C-CCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC----------------------------CCCCc
Confidence            4 48999999999999999997 899998877655555444321111                            11236


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 022132          223 VHPSAIDLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       223 ~~~~~~~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +|+++.+||.+||+.||++|||++|+++|
T Consensus       292 ~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         292 ATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            78999999999999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-48  Score=323.30  Aligned_cols=207  Identities=19%  Similarity=0.315  Sum_probs=165.9

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      +..|.+|+.++++++||||+++++++...     +.+|+||||++ |+|.+++... ..++++.+..++.||+.||+|||
T Consensus        44 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH  118 (263)
T d1sm2a_          44 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE  118 (263)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcccccceeccC-----CceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh
Confidence            34688999999999999999999999887     88999999997 7999998754 66899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||+||||||+||+++.++.+||+|||+++......  ......||..|+|||++.+. .++.++||||+||++|+|++
T Consensus       119 ~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t  197 (263)
T d1sm2a_         119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFS  197 (263)
T ss_dssp             HTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             ccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHH
Confidence            9999999999999999999999999999997654432  22345688999999998654 58999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.+..+.+..+......                             ......++.+.+|+.+||+.||.+|||
T Consensus       198 ~~~~~~~~~~~~~~~~~i~~~~~~-----------------------------~~p~~~~~~l~~li~~cl~~~p~~Rps  248 (263)
T d1sm2a_         198 EGKIPYENRSNSEVVEDISTGFRL-----------------------------YKPRLASTHVYQIMNHCWKERPEDRPA  248 (263)
T ss_dssp             TSCCTTCSCCHHHHHHHHHHTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHhcCCC-----------------------------CCccccCHHHHHHHHHHccCCHhHCcC
Confidence             67778777666655554432111                             111256789999999999999999999


Q ss_pred             HHHHhcC
Q 022132          245 VEDALAH  251 (302)
Q Consensus       245 ~~ell~h  251 (302)
                      ++|+++|
T Consensus       249 ~~~il~~  255 (263)
T d1sm2a_         249 FSRLLRQ  255 (263)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999985

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=318.79  Aligned_cols=208  Identities=17%  Similarity=0.278  Sum_probs=177.4

Q ss_pred             hcCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ++..|.+|+.++++++||||+++++++.++     +.+|+||||++ |+|.+++.. ...+++..+..++.|++.||+||
T Consensus        42 ~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~L  116 (258)
T d1k2pa_          42 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL  116 (258)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHH
Confidence            345788999999999999999999999887     88999999996 788888664 46799999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           87 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      |+.||+||||||+||+++.++.+||+|||+++...+..  ......+|..|+|||.+.+.. ++.++||||+||++|+|+
T Consensus       117 H~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~  195 (258)
T d1k2pa_         117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIY  195 (258)
T ss_dssp             HHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHH
T ss_pred             hhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHH
Confidence            99999999999999999999999999999997654432  233456889999999987554 899999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |+.||.+.+..+....+.+....+                             .....++.+.+||++||+.||++||
T Consensus       196 t~g~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------~p~~~~~~l~~li~~cl~~dP~~RP  246 (258)
T d1k2pa_         196 SLGKMPYERFTNSETAEHIAQGLRLY-----------------------------RPHLASEKVYTIMYSCWHEKADERP  246 (258)
T ss_dssp             TTSCCTTTTSCHHHHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred             hcCCCCCCCCCHHHHHHHHHhCCCCC-----------------------------CcccccHHHHHHHHHHccCCHhHCc
Confidence            8 899999888776665554321111                             1125678999999999999999999


Q ss_pred             CHHHHhcC
Q 022132          244 TVEDALAH  251 (302)
Q Consensus       244 t~~ell~h  251 (302)
                      |++++++|
T Consensus       247 t~~eil~~  254 (258)
T d1k2pa_         247 TFKILLSN  254 (258)
T ss_dssp             CHHHHHHH
T ss_pred             CHHHHHHH
Confidence            99999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-47  Score=323.39  Aligned_cols=205  Identities=23%  Similarity=0.362  Sum_probs=169.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      +.+.+|+.+|++++||||+++++++.+.     +.+|+|||||+ |+|.+++...  ..+++..+..++.||+.||+|||
T Consensus        58 ~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH  132 (287)
T d1opja_          58 EEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE  132 (287)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEecCCccEeeC-----CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH
Confidence            3678999999999999999999999887     88999999997 7999998753  67899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||+||||||+|||++.++.+||+|||+++......  ......++..|+|||.+.+. .++.++||||+||++|+|++
T Consensus       133 ~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~  211 (287)
T d1opja_         133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIAT  211 (287)
T ss_dssp             HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHT
T ss_pred             HCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHh
Confidence            9999999999999999999999999999998755432  22334578899999998655 48999999999999999999


Q ss_pred             CCCC-CCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 RKPL-FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      |..| |.+.+.......+... ..                            ....+.+++.+.+||.+||+.||.+|||
T Consensus       212 ~~~p~~~~~~~~~~~~~i~~~-~~----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps  262 (287)
T d1opja_         212 YGMSPYPGIDLSQVYELLEKD-YR----------------------------MERPEGCPEKVYELMRACWQWNPSDRPS  262 (287)
T ss_dssp             TSCCSSTTCCHHHHHHHHHTT-CC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCcchHHHHHHHHhcC-CC----------------------------CCCCccchHHHHHHHHHHcCCCHhHCcC
Confidence            6554 5555444333222110 00                            1122367899999999999999999999


Q ss_pred             HHHHhc
Q 022132          245 VEDALA  250 (302)
Q Consensus       245 ~~ell~  250 (302)
                      ++|+++
T Consensus       263 ~~ei~~  268 (287)
T d1opja_         263 FAEIHQ  268 (287)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999976

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-48  Score=325.54  Aligned_cols=209  Identities=22%  Similarity=0.356  Sum_probs=173.3

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      .|.+|+.++++++||||+++++++.+      +.+|+||||++ |+|.+++...  .++++..+..++.||+.||+|||+
T Consensus        54 ~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~  127 (272)
T d1qpca_          54 AFLAEANLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE  127 (272)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCEeEEEeeecc------CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            58899999999999999999998854      56799999997 7999877543  369999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      +||+||||||+||+++.++.+||+|||+|+......  ......++..|+|||++.+. .++.++|||||||++|+|++ 
T Consensus       128 ~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~  206 (272)
T d1qpca_         128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTH  206 (272)
T ss_dssp             TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTT
T ss_pred             CCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhC
Confidence            999999999999999999999999999998765432  23445788899999998654 48999999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||...+..+.+..+......                             ...+.+++++.+|+.+||+.||.+|||+
T Consensus       207 ~~~~~~~~~~~~~~~~i~~~~~~-----------------------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~  257 (272)
T d1qpca_         207 GRIPYPGMTNPEVIQNLERGYRM-----------------------------VRPDNCPEELYQLMRLCWKERPEDRPTF  257 (272)
T ss_dssp             TCCSSTTCCHHHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCC-----------------------------CCcccChHHHHHHHHHHcCCCHhHCcCH
Confidence            56667666655554444321110                             1123678899999999999999999999


Q ss_pred             HHHhc--CCCcCC
Q 022132          246 EDALA--HPYLGS  256 (302)
Q Consensus       246 ~ell~--h~~~~~  256 (302)
                      +++++  ++||++
T Consensus       258 ~ei~~~L~~~fts  270 (272)
T d1qpca_         258 DYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHhhhhhhc
Confidence            99998  788754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.3e-47  Score=321.10  Aligned_cols=214  Identities=22%  Similarity=0.364  Sum_probs=170.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN   90 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~   90 (302)
                      .+.+|+.+++.++||||+++++++..... ....+|+||||++ ++|.+++...+++++..+..++.||+.||+|||++|
T Consensus        53 ~~~~E~~~l~~~~hpniv~~~~~~~~~~~-~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~  131 (277)
T d1o6ya_          53 RFRREAQNAAALNHPAIVAVYDTGEAETP-AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG  131 (277)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEEEECS-SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcCCCCCCcccceeeeccC-CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            57899999999999999999999976521 1145899999998 699999988889999999999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCCEEEeecccccccCCC----CcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHhC
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  166 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~g  166 (302)
                      |+||||||+||+++.++..+++|||.+......    .......||+.|+|||++.+ ..++.++||||+||++|+|++|
T Consensus       132 iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG  210 (277)
T d1o6ya_         132 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTG  210 (277)
T ss_dssp             EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHS
T ss_pred             ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhC
Confidence            999999999999999999999999988654322    23445678999999999865 4589999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC-CH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-TV  245 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-t~  245 (302)
                      .+||.+.+..+....+......                          +.....+.+|+.+.+||.+||++||.+|| |+
T Consensus       211 ~~Pf~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa  264 (277)
T d1o6ya_         211 EPPFTGDSPVSVAYQHVREDPI--------------------------PPSARHEGLSADLDAVVLKALAKNPENRYQTA  264 (277)
T ss_dssp             SCSCCCSSHHHHHHHHHHCCCC--------------------------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred             CCCCCCcCHHHHHHHHHhcCCC--------------------------CCchhccCCCHHHHHHHHHHccCCHhHCHhHH
Confidence            9999988777665554431111                          11233457899999999999999999999 55


Q ss_pred             HHHhcCCCc
Q 022132          246 EDALAHPYL  254 (302)
Q Consensus       246 ~ell~h~~~  254 (302)
                      +++ .|+|.
T Consensus       265 ~~l-~~~l~  272 (277)
T d1o6ya_         265 AEM-RADLV  272 (277)
T ss_dssp             HHH-HHHHH
T ss_pred             HHH-HHHHH
Confidence            555 45554

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=324.68  Aligned_cols=217  Identities=19%  Similarity=0.338  Sum_probs=180.2

Q ss_pred             CchhhHHHHHHhcCC-CCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMK-TSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++| |||+++++++.+.     ..+|++|||+. |+|.+.+...+.+++..++.++.||+.||+|||+
T Consensus        73 ~~~~~E~~il~~l~h~pnIv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~  147 (322)
T d1vzoa_          73 EHTRTERQVLEHIRQSPFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK  147 (322)
T ss_dssp             GGCCCHHHHHHHHHTCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCeEEEeeeeeccC-----CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhc
Confidence            467799999999966 8999999999988     89999999997 6999999988899999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCC--CcccccccccccCchhhhhCCC-CCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~i~~~ll~  165 (302)
                      +||+||||||+||+++.+|.++|+|||+++.....  .......+++.|+|||.+.+.. .++.++||||+||++|+|++
T Consensus       148 ~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt  227 (322)
T d1vzoa_         148 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT  227 (322)
T ss_dssp             TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred             CCEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh
Confidence            99999999999999999999999999999764332  3345567899999999996543 46889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC--
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI--  243 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~--  243 (302)
                      |..||.+.+.......+......                          .........++.+++||.+||++||.+||  
T Consensus       228 G~~PF~~~~~~~~~~~i~~~~~~--------------------------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~  281 (322)
T d1vzoa_         228 GASPFTVDGEKNSQAEISRRILK--------------------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGC  281 (322)
T ss_dssp             SSCTTSCTTSCCCHHHHHHHHHH--------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             CCCCCCCCCHHHHHHHHHHhccc--------------------------CCCCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence            99999876544333333221100                          00112236889999999999999999999  


Q ss_pred             ---CHHHHhcCCCcCCcc
Q 022132          244 ---TVEDALAHPYLGSLH  258 (302)
Q Consensus       244 ---t~~ell~h~~~~~~~  258 (302)
                         |++|+++||||++..
T Consensus       282 ~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         282 GPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             STTTHHHHHTSGGGTTCC
T ss_pred             CcccHHHHHcCHhhcCCC
Confidence               589999999998753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-47  Score=318.20  Aligned_cols=205  Identities=23%  Similarity=0.364  Sum_probs=163.7

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..+.+|+.++++++||||+++++++.+      +.+|+||||++ |+|.+++.. .+.+++..+..++.||+.||+|||+
T Consensus        53 ~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~  126 (273)
T d1mp8a_          53 EKFLQEALTMRQFDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES  126 (273)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECS------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEec------CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc
Confidence            468899999999999999999999954      57899999997 688887654 4679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-  165 (302)
                      +||+||||||+||+++.++.+||+|||+++......  ......+|+.|+|||++.+. .++.++|||||||++|+|++ 
T Consensus       127 ~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~  205 (273)
T d1mp8a_         127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMH  205 (273)
T ss_dssp             TTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTT
T ss_pred             cCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhc
Confidence            999999999999999999999999999997654332  23445678999999999654 48999999999999999997 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 022132          166 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  245 (302)
Q Consensus       166 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  245 (302)
                      |.+||.+.+..+.+..+.+...                             ....+.+|+.+.+||.+||+.||.+|||+
T Consensus       206 g~~P~~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~  256 (273)
T d1mp8a_         206 GVKPFQGVKNNDVIGRIENGER-----------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRF  256 (273)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCH
Confidence            8999988877665554432111                             12234788999999999999999999999


Q ss_pred             HHHhcC
Q 022132          246 EDALAH  251 (302)
Q Consensus       246 ~ell~h  251 (302)
                      +|+++|
T Consensus       257 ~ei~~~  262 (273)
T d1mp8a_         257 TELKAQ  262 (273)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-46  Score=313.73  Aligned_cols=205  Identities=21%  Similarity=0.327  Sum_probs=163.4

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..|.+|+.++++++|||||++++++...     +..++|||||. +++.+.+.. .+.+++..+..++.||+.||+|||+
T Consensus        54 ~~~~~E~~il~~l~H~nIv~~~g~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~  128 (283)
T d1mqba_          54 VDFLGEAGIMGQFSHHNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN  128 (283)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEeeeeEEEecC-----CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc
Confidence            3688999999999999999999999887     88999999997 578877764 4679999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      +||+||||||+|||++.++.+||+|||+++......    ......||..|+|||.+.+. .++.++|||||||++|+|+
T Consensus       129 ~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~  207 (283)
T d1mqba_         129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVM  207 (283)
T ss_dssp             TTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHH
T ss_pred             cccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHH
Confidence            999999999999999999999999999997654321    22334678899999998654 5899999999999999999


Q ss_pred             hC-CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 DR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      +| .+|+.+.+..+.+..+.+....                             .....+++.+.+||.+||+.||.+||
T Consensus       208 t~~~~~~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~~p~~RP  258 (283)
T d1mqba_         208 TYGERPYWELSNHEVMKAINDGFRL-----------------------------PTPMDCPSAIYQLMMQCWQQERARRP  258 (283)
T ss_dssp             TTSCCTTTTCCHHHHHHHHHTTCCC-----------------------------CCCTTCBHHHHHHHHHHTCSSTTTSC
T ss_pred             hCCCCccccCCHHHHHHHHhccCCC-----------------------------CCchhhHHHHHHHHHHHCcCCHhHCc
Confidence            85 5556555554444433221111                             11235788999999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |+.|+++
T Consensus       259 t~~eil~  265 (283)
T d1mqba_         259 KFADIVS  265 (283)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-46  Score=314.19  Aligned_cols=211  Identities=25%  Similarity=0.371  Sum_probs=169.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      ..|.+|+.++++++||||+++++++.+      +.+|+||||+. |+|..++..  .+.+++..+..++.||+.||+|||
T Consensus        57 ~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH  130 (285)
T d1fmka3          57 EAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE  130 (285)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcccCCEeEEEEEEec------CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh
Confidence            368899999999999999999999854      56799999997 688888753  357999999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCC--cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      ++||+||||||+||+++.++.+||+|||+++...+..  ......+|..|+|||.+... .++.++||||+||++|+|++
T Consensus       131 ~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t  209 (285)
T d1fmka3         131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTT  209 (285)
T ss_dssp             HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             hhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHh
Confidence            9999999999999999999999999999997654332  23345688999999999654 48999999999999999998


Q ss_pred             C-CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 R-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                      | .+|+.+....+.+..+......                             ...+.+++.+++||.+||+.||++|||
T Consensus       210 ~~~p~~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps  260 (285)
T d1fmka3         210 KGRVPYPGMVNREVLDQVERGYRM-----------------------------PCPPECPESLHDLMCQCWRKEPEERPT  260 (285)
T ss_dssp             TTCCSSTTCCHHHHHHHHHTTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHhcCCC-----------------------------CCCcccCHHHHHHHHHHcccCHhHCcC
Confidence            5 5666666665555544331111                             122367889999999999999999999


Q ss_pred             HHHHhc--CCCcCCc
Q 022132          245 VEDALA--HPYLGSL  257 (302)
Q Consensus       245 ~~ell~--h~~~~~~  257 (302)
                      ++++++  ++||+..
T Consensus       261 ~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         261 FEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHHHHHHTTTSCS
T ss_pred             HHHHHHHHhhhhcCC
Confidence            999988  8898764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=316.39  Aligned_cols=207  Identities=24%  Similarity=0.297  Sum_probs=174.2

Q ss_pred             cCchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHH
Q 022132           10 RGHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEH   71 (302)
Q Consensus        10 ~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~   71 (302)
                      ...+.+|+.+|+++ +||||+++++++.+.     +.+|+||||++ |+|.+++.+.                ..+++..
T Consensus        54 ~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~  128 (309)
T d1fvra_          54 HRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ  128 (309)
T ss_dssp             -CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHH
T ss_pred             HHHHHHHHHHHHhccCCCCEeeEEEEEecC-----CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHH
Confidence            44688999999999 799999999999987     89999999997 7999999754                5799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCch
Q 022132           72 CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAI  151 (302)
Q Consensus        72 ~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  151 (302)
                      +..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++............+|..|+|||.+.+. .++.++
T Consensus       129 ~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~s  207 (309)
T d1fvra_         129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNS  207 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHH
T ss_pred             HHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccC-CCCccc
Confidence            9999999999999999999999999999999999999999999999876655445566789999999999654 489999


Q ss_pred             hHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          152 DVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       152 DiwslG~i~~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      |||||||++|+|++| .+||.+.+..+.+..+.+...                             ......+++.+.+|
T Consensus       208 DvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~~~~l  258 (309)
T d1fvra_         208 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-----------------------------LEKPLNCDDEVYDL  258 (309)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC-----------------------------CCCCTTBCHHHHHH
T ss_pred             eeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-----------------------------CCCCccCCHHHHHH
Confidence            999999999999996 568887776665544322100                             11223678899999


Q ss_pred             HHHccCCCCCCCCCHHHHhcC
Q 022132          231 VEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       231 i~~~L~~dP~~R~t~~ell~h  251 (302)
                      |.+||+.||++|||++|++++
T Consensus       259 i~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         259 MRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-46  Score=309.84  Aligned_cols=205  Identities=20%  Similarity=0.338  Sum_probs=164.6

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH   87 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qll~~l~~LH   87 (302)
                      +.+.+|++++++++||||+++++++.+..    +.+|+||||++ |+|.+++.++  ..+++..+..++.||+.||.|||
T Consensus        45 ~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH  120 (262)
T d1byga_          45 QAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE  120 (262)
T ss_dssp             HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc
Confidence            46789999999999999999999986542    56899999996 7999999754  35899999999999999999999


Q ss_pred             hCCceecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh-C
Q 022132           88 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-R  166 (302)
Q Consensus        88 ~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~-g  166 (302)
                      +.+|+||||||+||+++.++.++++|||+++..+..  .....++..|+|||.+.+. .++.++|||||||++|+|++ |
T Consensus       121 ~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~  197 (262)
T d1byga_         121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFG  197 (262)
T ss_dssp             HTTCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred             cCceeccccchHhheecCCCCEeecccccceecCCC--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCC
Confidence            999999999999999999999999999999875543  3345678899999999765 48999999999999999998 7


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 022132          167 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  246 (302)
Q Consensus       167 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  246 (302)
                      .+||.+.+..+....+.+..                             .....+..++.+.+||++||+.||.+|||+.
T Consensus       198 ~~p~~~~~~~~~~~~i~~~~-----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~  248 (262)
T d1byga_         198 RVPYPRIPLKDVVPRVEKGY-----------------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFL  248 (262)
T ss_dssp             CCSCTTSCGGGHHHHHTTTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHcCC-----------------------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHH
Confidence            89998776555444432110                             1122336789999999999999999999999


Q ss_pred             HHhcC
Q 022132          247 DALAH  251 (302)
Q Consensus       247 ell~h  251 (302)
                      +++++
T Consensus       249 ~l~~~  253 (262)
T d1byga_         249 QLREQ  253 (262)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99873

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=315.71  Aligned_cols=205  Identities=21%  Similarity=0.285  Sum_probs=168.0

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      +.+.+|+.++++++||||+++++++.+.      ..++++||+. |+|.+.+.. ...+++..+..++.||+.||+|||+
T Consensus        56 ~~~~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~  129 (317)
T d1xkka_          56 KEILDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED  129 (317)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecC------CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3688999999999999999999999764      4667777764 788887765 4689999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHHh
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  165 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll~  165 (302)
                      +||+||||||+||+++.++.+||+|||+++......   ......||..|+|||.+.+. .++.++|||||||++|+|++
T Consensus       130 ~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t  208 (317)
T d1xkka_         130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMT  208 (317)
T ss_dssp             TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             cCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHH
Confidence            999999999999999999999999999998654332   22334679999999998765 48999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 022132          166 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  244 (302)
Q Consensus       166 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  244 (302)
                       |.+||.+.+..+....+......                             ...+.+++.+.+|+.+||+.||.+|||
T Consensus       209 ~g~~p~~~~~~~~~~~~i~~~~~~-----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs  259 (317)
T d1xkka_         209 FGSKPYDGIPASEISSILEKGERL-----------------------------PQPPICTIDVYMIMVKCWMIDADSRPK  259 (317)
T ss_dssp             TSCCTTTTSCGGGHHHHHHHTCCC-----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCcccCHHHHHHHHHhCCCChhhCcC
Confidence             89999887665544433321111                             112367889999999999999999999


Q ss_pred             HHHHhcC
Q 022132          245 VEDALAH  251 (302)
Q Consensus       245 ~~ell~h  251 (302)
                      +.|++.|
T Consensus       260 ~~eil~~  266 (317)
T d1xkka_         260 FRELIIE  266 (317)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-45  Score=311.74  Aligned_cols=208  Identities=24%  Similarity=0.361  Sum_probs=165.3

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHC   72 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~   72 (302)
                      ..+.+|..++.++ +|+||+.+++++....    +.+++|||||+ |+|.+++...                ..+++..+
T Consensus        61 ~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  136 (299)
T d1ywna1          61 RALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL  136 (299)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSTT----SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHH
T ss_pred             HHHHHHHHHHHhhcCCCeEEEeeeeeccCC----CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHH
Confidence            3567888888888 7899999999987652    67999999997 7999999753                34899999


Q ss_pred             HHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCCCC
Q 022132           73 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTA  149 (302)
Q Consensus        73 ~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~  149 (302)
                      ..++.||+.||+|||++||+||||||+||+++.++.+||+|||+|+.....   .......||+.|+|||++.+. .++.
T Consensus       137 ~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~  215 (299)
T d1ywna1         137 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTI  215 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCH
T ss_pred             HHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCc
Confidence            999999999999999999999999999999999999999999999754432   223456789999999999764 4899


Q ss_pred             chhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHH
Q 022132          150 AIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  228 (302)
Q Consensus       150 ~~DiwslG~i~~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (302)
                      ++||||+||++|+|++| .+||.+.+....+.........+                            ...+.+++++.
T Consensus       216 ~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~  267 (299)
T d1ywna1         216 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------------------------RAPDYTTPEMY  267 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC----------------------------CCCTTCCHHHH
T ss_pred             ccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC----------------------------CCCccCCHHHH
Confidence            99999999999999986 57888776555444433321111                            12236788999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhcC
Q 022132          229 DLVEKMLTFDPRQRITVEDALAH  251 (302)
Q Consensus       229 ~li~~~L~~dP~~R~t~~ell~h  251 (302)
                      +||.+||+.||.+|||++|+++|
T Consensus       268 ~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         268 QTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-45  Score=308.07  Aligned_cols=205  Identities=20%  Similarity=0.282  Sum_probs=169.9

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      +.|.+|+.++++++||||+++++++.+      +.+++|||||+ |++.+.+.. .+.+++..+..++.||+.||.|||+
T Consensus        56 ~~~~~Ei~~l~~l~H~nIv~~~g~~~~------~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~  129 (273)
T d1u46a_          56 DDFIREVNAMHSLDHRNLIRLYGVVLT------PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES  129 (273)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEee------cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh
Confidence            367899999999999999999999965      45789999997 688887754 4579999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  164 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~ll  164 (302)
                      +||+||||||+||+++.++.+||+|||+++......    ......++..|+|||.+.+. .++.++|||||||++|+|+
T Consensus       130 ~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~eml  208 (273)
T d1u46a_         130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMF  208 (273)
T ss_dssp             TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHH
T ss_pred             CCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHH
Confidence            999999999999999999999999999998764432    12334567889999999754 4899999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 022132          165 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  243 (302)
Q Consensus       165 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  243 (302)
                      + |.+||.+.+..+....+......                            ....+.+|+.+.+||.+||+.||++||
T Consensus       209 t~G~~Pf~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~dp~~RP  260 (273)
T d1u46a_         209 TYGQEPWIGLNGSQILHKIDKEGER----------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRP  260 (273)
T ss_dssp             TTSCCTTTTCCHHHHHHHHHTSCCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             hCCCCCCCCcCHHHHHHHHHhCCCC----------------------------CCCcccccHHHHHHHHHHcCCChhHCc
Confidence            7 89999988877766555431111                            112246789999999999999999999


Q ss_pred             CHHHHhc
Q 022132          244 TVEDALA  250 (302)
Q Consensus       244 t~~ell~  250 (302)
                      |++++++
T Consensus       261 t~~ei~~  267 (273)
T d1u46a_         261 TFVALRD  267 (273)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=306.22  Aligned_cols=205  Identities=25%  Similarity=0.388  Sum_probs=173.2

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHC   72 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~   72 (302)
                      ..+.+|..++.++ +||||+++++++.+.     +.+|+|||||+ |+|.+++...                ..+++..+
T Consensus        63 ~~~~~e~~~l~~~~~HpnIv~~~~~~~~~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~  137 (299)
T d1fgka_          63 SDLISEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL  137 (299)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHH
T ss_pred             HHHHHHHHHHHHhcCCCeEEecccccccC-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHH
Confidence            4677899999998 899999999999987     88999999997 7999999754                35899999


Q ss_pred             HHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCC
Q 022132           73 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTA  149 (302)
Q Consensus        73 ~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~  149 (302)
                      ..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......   ......+++.|+|||.+.+. .++.
T Consensus       138 ~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~  216 (299)
T d1fgka_         138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTH  216 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCH
T ss_pred             HHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCc
Confidence            9999999999999999999999999999999999999999999997654332   23446788899999998654 5899


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHH
Q 022132          150 AIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  228 (302)
Q Consensus       150 ~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (302)
                      ++|||||||++|+|++ |.+||.+.+.......+.+.. .                            ......+++.+.
T Consensus       217 k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~-~----------------------------~~~p~~~~~~l~  267 (299)
T d1fgka_         217 QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-R----------------------------MDKPSNCTNELY  267 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-C----------------------------CCCCSSCCHHHH
T ss_pred             hhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCC-C----------------------------CCCCccchHHHH
Confidence            9999999999999997 799998877665544332211 1                            111236789999


Q ss_pred             HHHHHccCCCCCCCCCHHHHhc
Q 022132          229 DLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       229 ~li~~~L~~dP~~R~t~~ell~  250 (302)
                      +||.+||++||.+|||++|+++
T Consensus       268 ~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         268 MMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHH
Confidence            9999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-44  Score=307.50  Aligned_cols=206  Identities=21%  Similarity=0.306  Sum_probs=172.5

Q ss_pred             cCchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-----------------------
Q 022132           10 RGHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-----------------------   65 (302)
Q Consensus        10 ~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------------------   65 (302)
                      ...+.+|+.+|++++||||+++++++...     +..+++|||++ |+|.+++....                       
T Consensus        60 ~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (301)
T d1lufa_          60 QADFQREAALMAEFDNPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP  134 (301)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------
T ss_pred             HHHHHHHHHHHHhcCCCCcccceeeeccC-----CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCC
Confidence            34688999999999999999999999887     88999999997 79999986432                       


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhh
Q 022132           66 -ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELL  141 (302)
Q Consensus        66 -~l~~~~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~  141 (302)
                       .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...+.   .......++..|+|||.+
T Consensus       135 ~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~  214 (301)
T d1lufa_         135 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI  214 (301)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH
Confidence             4889999999999999999999999999999999999999999999999999754332   223345678899999999


Q ss_pred             hCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccC
Q 022132          142 LNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF  220 (302)
Q Consensus       142 ~~~~~~~~~~DiwslG~i~~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (302)
                      .+. .++.++|||||||++|+|++|. +||.+.+..+.+..+.+..                             .....
T Consensus       215 ~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~-----------------------------~~~~p  264 (301)
T d1lufa_         215 FYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-----------------------------ILACP  264 (301)
T ss_dssp             HHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----------------------------CCCCC
T ss_pred             ccC-CCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC-----------------------------CCCCC
Confidence            754 4899999999999999999885 7898887776665543311                             11222


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 022132          221 PNVHPSAIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       221 ~~~~~~~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      ..+++++.+||.+||+.||.+|||+.|+++
T Consensus       265 ~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         265 ENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            367899999999999999999999999964

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=303.24  Aligned_cols=206  Identities=25%  Similarity=0.343  Sum_probs=173.8

Q ss_pred             CchhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCC------------------CCCHH
Q 022132           11 GHFVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ------------------ALSEE   70 (302)
Q Consensus        11 ~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------------------~l~~~   70 (302)
                      ..+.+|+.+++.+ +||||+++++++.+.     +.+|+|||||+ |+|.+++.+..                  .+++.
T Consensus        71 ~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~  145 (311)
T d1t46a_          71 EALMSELKVLSYLGNHMNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE  145 (311)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHH
T ss_pred             HHHHHHHHHHHhccCCCCEEEEEEEEeeC-----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHH
Confidence            3688999999999 799999999999887     88999999997 69999987543                  58999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCC---CcccccccccccCchhhhhCCCCC
Q 022132           71 HCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDY  147 (302)
Q Consensus        71 ~~~~i~~qll~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~  147 (302)
                      .+..++.||+.||+|||++|++||||||+||+++.++.++++|||.++.....   .......+|+.|+|||.+.+. .+
T Consensus       146 ~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~  224 (311)
T d1t46a_         146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VY  224 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CC
Confidence            99999999999999999999999999999999999999999999999865543   223446789999999999654 48


Q ss_pred             CCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHH
Q 022132          148 TAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPS  226 (302)
Q Consensus       148 ~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (302)
                      +.++|||||||++|+|++ |.+||.+.+....+..+...-..+                            ......++.
T Consensus       225 ~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~  276 (311)
T d1t46a_         225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM----------------------------LSPEHAPAE  276 (311)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC----------------------------CCCTTSCHH
T ss_pred             CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC----------------------------CCcccccHH
Confidence            999999999999999998 778887776655555544322111                            111257889


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHhc
Q 022132          227 AIDLVEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       227 ~~~li~~~L~~dP~~R~t~~ell~  250 (302)
                      +.+||.+||++||.+|||++++++
T Consensus       277 l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         277 MYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-43  Score=301.34  Aligned_cols=210  Identities=23%  Similarity=0.350  Sum_probs=176.7

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHH
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------QALSEEHCQYFLYQIL   80 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qll   80 (302)
                      .+.+|+.++++++||||+++++++...     ..+++||||+. |+|.+++...          ..+++..+..++.|++
T Consensus        69 ~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia  143 (308)
T d1p4oa_          69 EFLNEASVMKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA  143 (308)
T ss_dssp             HHHHHHHHGGGCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCEeeeeeEEecC-----CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHH
Confidence            578999999999999999999999887     88999999996 7999988642          3578999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCCEEEecCCCEEEeecccccccCCCC---cccccccccccCchhhhhCCCCCCCchhHHHHH
Q 022132           81 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG  157 (302)
Q Consensus        81 ~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  157 (302)
                      .||.|||+++|+||||||+|||++.++.+||+|||+++......   ......+++.|+|||.+.+.. ++.++||||+|
T Consensus       144 ~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G  222 (308)
T d1p4oa_         144 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFG  222 (308)
T ss_dssp             HHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHH
T ss_pred             HHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHH
Confidence            99999999999999999999999999999999999997554332   233446889999999986554 78999999999


Q ss_pred             HHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccC
Q 022132          158 CIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  236 (302)
Q Consensus       158 ~i~~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  236 (302)
                      |++++|++| .+||.+.+..+.+..+.+...                             ....+.+++.+.++|.+||+
T Consensus       223 ~il~El~t~~~~p~~~~~~~~~~~~i~~~~~-----------------------------~~~p~~~~~~l~~li~~cl~  273 (308)
T d1p4oa_         223 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-----------------------------LDKPDNCPDMLFELMRMCWQ  273 (308)
T ss_dssp             HHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTC
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC-----------------------------CCCcccchHHHHHHHHHHcC
Confidence            999999997 588988887776665543111                             11223678899999999999


Q ss_pred             CCCCCCCCHHHHhc------CCCcCC
Q 022132          237 FDPRQRITVEDALA------HPYLGS  256 (302)
Q Consensus       237 ~dP~~R~t~~ell~------h~~~~~  256 (302)
                      .||++|||++++++      +|+|++
T Consensus       274 ~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         274 YNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             SSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            99999999999998      565543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-43  Score=300.63  Aligned_cols=207  Identities=21%  Similarity=0.277  Sum_probs=166.1

Q ss_pred             CchhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022132           11 GHFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS   88 (302)
Q Consensus        11 ~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~LH~   88 (302)
                      ..|.+|++++++++||||+++++++....    +.+++|||||+ |+|.+++... ..+++..+..++.|++.||.|||+
T Consensus        73 ~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~  148 (311)
T d1r0pa_          73 SQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS  148 (311)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc
Confidence            56889999999999999999999976531    68999999997 6999988754 467888999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCEEEeecccccccCCCC-----cccccccccccCchhhhhCCCCCCCchhHHHHHHHHHHH
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  163 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i~~~l  163 (302)
                      .||+||||||+|||++.++.+||+|||+++......     ......+|..|+|||.+... .++.++||||||+++|+|
T Consensus       149 ~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El  227 (311)
T d1r0pa_         149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWEL  227 (311)
T ss_dssp             TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHH
T ss_pred             cCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHH
Confidence            999999999999999999999999999997654332     22335678999999998654 489999999999999999


Q ss_pred             HhCCCCCCCCC-hHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 022132          164 MDRKPLFPGRD-HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  242 (302)
Q Consensus       164 l~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  242 (302)
                      ++|..||.... ..+....+... ..                            ....+.+++.+.+||.+||+.||.+|
T Consensus       228 ~t~~~p~~~~~~~~~~~~~i~~g-~~----------------------------~~~p~~~~~~l~~li~~cl~~dP~~R  278 (311)
T d1r0pa_         228 MTRGAPPYPDVNTFDITVYLLQG-RR----------------------------LLQPEYCPDPLYEVMLKCWHPKAEMR  278 (311)
T ss_dssp             HTTSCCSCC------CHHHHHTT-CC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             HHCCCCCCCCCCHHHHHHHHHcC-CC----------------------------CCCcccCcHHHHHHHHHHcCCCHhHC
Confidence            99776665433 22222222110 00                            11123578899999999999999999


Q ss_pred             CCHHHHhcC
Q 022132          243 ITVEDALAH  251 (302)
Q Consensus       243 ~t~~ell~h  251 (302)
                      ||+.|+++|
T Consensus       279 Ps~~ei~~~  287 (311)
T d1r0pa_         279 PSFSELVSR  287 (311)
T ss_dssp             CCHHHHHHH
T ss_pred             cCHHHHHHH
Confidence            999999997

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-41  Score=286.37  Aligned_cols=220  Identities=15%  Similarity=0.152  Sum_probs=168.2

Q ss_pred             hcCchhhHHHHHHhcCCCCcccc-ceeeCCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMKTSVVAI-RDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h~niv~l-~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ....+.+|+.+++.++|+|++.. .+++.+.     +..++||||++++|.+.+.. .+.+++..+..++.|++.||+||
T Consensus        45 ~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~-----~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l  119 (299)
T d1ckia_          45 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEG-----DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI  119 (299)
T ss_dssp             TSCCHHHHHHHHHHSTTSTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHccCCCcccEEEEEEecC-----CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHH
Confidence            44578899999999987765554 5555555     78999999999988877754 56899999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEec---CCCEEEeecccccccCCCC--------cccccccccccCchhhhhCCCCCCCchhHHH
Q 022132           87 HSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWS  155 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  155 (302)
                      |++||+||||||+||+++.   +..++|+|||+|+......        ......||+.|+|||.+.+.. ++.++||||
T Consensus       120 H~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS  198 (299)
T d1ckia_         120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLES  198 (299)
T ss_dssp             HHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHH
T ss_pred             HHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEe
Confidence            9999999999999999863   4579999999998654321        234457899999999986544 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHHHHHcc
Q 022132          156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  235 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  235 (302)
                      |||++++|++|.+||.+.........+.....                      .....+.....+++|+++.++|.+||
T Consensus       199 lG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~p~~~~~li~~cl  256 (299)
T d1ckia_         199 LGYVLMYFNLGSLPWQGLKAATKRQKYERISE----------------------KKMSTPIEVLCKGYPSEFATYLNFCR  256 (299)
T ss_dssp             HHHHHHHHHHSSCTTCCCC-------HHHHHH----------------------HHHHSCHHHHTTTSCHHHHHHHHHHH
T ss_pred             cCHHHHHHHhCCCcccccchHHHHHHHHHhhc----------------------ccCCCChhHhccCCCHHHHHHHHHHc
Confidence            99999999999999987655443332221100                      00011122334578899999999999


Q ss_pred             CCCCCCCCCHH---HHhcCCCcCC
Q 022132          236 TFDPRQRITVE---DALAHPYLGS  256 (302)
Q Consensus       236 ~~dP~~R~t~~---ell~h~~~~~  256 (302)
                      ..||.+||+++   ++|+|+|.+.
T Consensus       257 ~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         257 SLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cCChhHCcCHHHHHHHHHHHHHHc
Confidence            99999999987   5577877644

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.5e-40  Score=280.45  Aligned_cols=211  Identities=13%  Similarity=0.141  Sum_probs=170.5

Q ss_pred             hcCchhhHHHHHHhcCC-CCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHH
Q 022132            9 QRGHFVRSSCFDTWIMK-TSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYI   86 (302)
Q Consensus         9 ~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qll~~l~~L   86 (302)
                      ....+.+|+++++.+.| +|++++++++...     ...|+||||++++|.+++... ..++...+..++.|++.||+||
T Consensus        43 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~l  117 (293)
T d1csna_          43 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI  117 (293)
T ss_dssp             TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHHHhcCCCCCCEEEEEeecC-----CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHH
Confidence            34567899999999965 9999999999887     899999999999999998764 5799999999999999999999


Q ss_pred             HhCCceecCCCCCCEEEec-----CCCEEEeecccccccCCC--------CcccccccccccCchhhhhCCCCCCCchhH
Q 022132           87 HSANVLHRDLKPSNLLLNA-----NCDLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNSSDYTAAIDV  153 (302)
Q Consensus        87 H~~~i~H~dikp~Nil~~~-----~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  153 (302)
                      |++||+||||||+||+++.     ++.++|+|||+|+.....        .......||+.|+|||.+.+ ..++.++||
T Consensus       118 H~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~Di  196 (293)
T d1csna_         118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDL  196 (293)
T ss_dssp             HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHH
T ss_pred             HHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHH
Confidence            9999999999999999974     578999999999764322        12334579999999999965 458999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccCCCCCHHHHHH
Q 022132          154 WSVGCIFMELMDRKPLFPGRDHVH---QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL  230 (302)
Q Consensus       154 wslG~i~~~ll~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (302)
                      |||||++|+|++|..||.+.....   ....+.....                         ..+..+..+++|+++.++
T Consensus       197 wSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-------------------------~~~~~~l~~~~p~~l~~i  251 (293)
T d1csna_         197 EALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-------------------------STPLRELCAGFPEEFYKY  251 (293)
T ss_dssp             HHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-------------------------HSCHHHHTTTSCHHHHHH
T ss_pred             HHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-------------------------CCChHHhcCCCCHHHHHH
Confidence            999999999999999998654322   2222221110                         011223345788999999


Q ss_pred             HHHccCCCCCCCCCHHHHhc
Q 022132          231 VEKMLTFDPRQRITVEDALA  250 (302)
Q Consensus       231 i~~~L~~dP~~R~t~~ell~  250 (302)
                      +..|+..+|++||+.+.+.+
T Consensus       252 i~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         252 MHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHhcCCcccCcCHHHHHH
Confidence            99999999999998776644

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-40  Score=291.22  Aligned_cols=243  Identities=23%  Similarity=0.352  Sum_probs=176.3

Q ss_pred             CchhhHHHHHHhcC-----------CCCccccceeeCCCCCCCCCcEEEEEecCC--ccHHHHH--HcCCCCCHHHHHHH
Q 022132           11 GHFVRSSCFDTWIM-----------KTSVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQII--RSNQALSEEHCQYF   75 (302)
Q Consensus        11 ~~~~~E~~il~~l~-----------h~niv~l~~~~~~~~~~~~~~~~lv~e~~~--~~L~~~l--~~~~~l~~~~~~~i   75 (302)
                      ..+.+|+++++.++           |+||+++++++.....   ...+++++++.  ++.....  .....+++..++.+
T Consensus        54 ~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i  130 (362)
T d1q8ya_          54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP---NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI  130 (362)
T ss_dssp             HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET---TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc---cceeeeeeecccccccccccccccccCCcHHHHHHH
Confidence            35678999998886           4789999998865421   55666666653  3443333  34468999999999


Q ss_pred             HHHHHHHHHHHHh-CCceecCCCCCCEEEecCCC------EEEeecccccccCCCCcccccccccccCchhhhhCCCCCC
Q 022132           76 LYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCD------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYT  148 (302)
Q Consensus        76 ~~qll~~l~~LH~-~~i~H~dikp~Nil~~~~~~------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  148 (302)
                      +.||+.||+|||+ .||+||||||+||+++.++.      ++++|||.+......  .....+|+.|+|||++.+.. ++
T Consensus       131 ~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~  207 (362)
T d1q8ya_         131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WG  207 (362)
T ss_dssp             HHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CC
T ss_pred             HHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc--cccccccccccChhhccccC-CC
Confidence            9999999999998 89999999999999987654      999999998765433  35567999999999987554 79


Q ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChHHHhhhhHhHHHHh-----hhccccccccc-
Q 022132          149 AAIDVWSVGCIFMELMDRKPLFPGRD------HVHQLRLLIELIGTPSEAELGFLNENAKKYI-----CQLPRYQRQSF-  216 (302)
Q Consensus       149 ~~~DiwslG~i~~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-  216 (302)
                      .++|+||+||++++|++|++||.+.+      ..+.+......++.++.............+.     .........++ 
T Consensus       208 ~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (362)
T d1q8ya_         208 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE  287 (362)
T ss_dssp             THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred             ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchh
Confidence            99999999999999999999996443      4456777788888877665433221111100     00000000000 


Q ss_pred             ------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCcCCccC
Q 022132          217 ------TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  259 (302)
Q Consensus       217 ------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  259 (302)
                            ....+..++.++|||.+||++||.+|||++|+|+||||+....
T Consensus       288 ~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~  336 (362)
T d1q8ya_         288 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG  336 (362)
T ss_dssp             HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred             hhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCC
Confidence                  0111134578999999999999999999999999999996543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-40  Score=283.46  Aligned_cols=224  Identities=17%  Similarity=0.222  Sum_probs=155.6

Q ss_pred             hHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-----
Q 022132           15 RSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-----   88 (302)
Q Consensus        15 ~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~-----   88 (302)
                      +|+..+++++||||+++++++.... .....+|+|||||. |+|.+++.+. .+++..+..++.|++.||+|||+     
T Consensus        46 ~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~  123 (303)
T d1vjya_          46 AEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGT  123 (303)
T ss_dssp             HHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCST
T ss_pred             HHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhh
Confidence            3444556789999999999998652 12246899999996 6999999874 69999999999999999999996     


Q ss_pred             ---CCceecCCCCCCEEEecCCCEEEeecccccccCCCC-----cccccccccccCchhhhhCCC-----CCCCchhHHH
Q 022132           89 ---ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSS-----DYTAAIDVWS  155 (302)
Q Consensus        89 ---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Diws  155 (302)
                         .||+||||||+||+++.++.+||+|||+++......     ......||+.|+|||.+.+..     .++.++||||
T Consensus       124 ~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S  203 (303)
T d1vjya_         124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA  203 (303)
T ss_dssp             TCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHH
T ss_pred             ccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhh
Confidence               599999999999999999999999999987654321     223467899999999985432     1456899999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHHhhhhHhHHHHhhhccccccccccccC--CCCCHHHHHHHHH
Q 022132          156 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF--PNVHPSAIDLVEK  233 (302)
Q Consensus       156 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~  233 (302)
                      |||++|+|++|.+||............ .....+......       ... .... .+..+...+  ...+..+.+|+.+
T Consensus       204 ~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-------~~~-~~~~-~~p~~~~~~~~~~~~~~l~~li~~  273 (303)
T d1vjya_         204 MGLVFWEIARRCSIGGIHEDYQLPYYD-LVPSDPSVEEMR-------KVV-CEQK-LRPNIPNRWQSCEALRVMAKIMRE  273 (303)
T ss_dssp             HHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCSSCCHHHHH-------HHH-TTSC-CCCCCCGGGGGCHHHHHHHHHHHT
T ss_pred             hHHHHHHHhhCCCCCCcccccccchhh-cccccchHHHHH-------HHH-hccc-cCCCCCcccCChHHHHHHHHHHHH
Confidence            999999999999887432211000000 000000000000       000 0000 000111111  1122458899999


Q ss_pred             ccCCCCCCCCCHHHHhc
Q 022132          234 MLTFDPRQRITVEDALA  250 (302)
Q Consensus       234 ~L~~dP~~R~t~~ell~  250 (302)
                      ||+.||.+|||+.|+++
T Consensus       274 cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         274 CWYANGAARLTALRIKK  290 (303)
T ss_dssp             TCCSSGGGSCCHHHHHH
T ss_pred             HcccCHhHCcCHHHHHH
Confidence            99999999999999976

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.72  E-value=8.5e-19  Score=138.36  Aligned_cols=128  Identities=16%  Similarity=0.087  Sum_probs=90.2

Q ss_pred             chhhHHHHHHhcCCCCccccceeeCCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022132           12 HFVRSSCFDTWIMKTSVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV   91 (302)
Q Consensus        12 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~~~i   91 (302)
                      ...+|...+.++.|++++..+++.        . .+++|||+++...      ..++...+..++.|++.++++||++||
T Consensus        60 ~~~~e~~~l~~l~~~~v~~~~~~~--------~-~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~gi  124 (191)
T d1zara2          60 SARNEFRALQKLQGLAVPKVYAWE--------G-NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGI  124 (191)
T ss_dssp             HHHHHHHHHHHTTTSSSCCEEEEE--------T-TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHccCCCcceEEEec--------C-CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCE
Confidence            345788999999999998887653        1 2699999986322      124556677899999999999999999


Q ss_pred             eecCCCCCCEEEecCCCEEEeecccccccCCCCcccccccccccCchhhhhCCCCCCCchhHHHHHH
Q 022132           92 LHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC  158 (302)
Q Consensus        92 ~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  158 (302)
                      +||||||+||+++.++ ++|+|||.+...+...... ........-.+-+  .+.|+.++|+||+.-
T Consensus       125 iHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~~-~l~rd~~~~~~~f--~r~y~~~~d~~s~~~  187 (191)
T d1zara2         125 VHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWRE-ILERDVRNIITYF--SRTYRTEKDINSAID  187 (191)
T ss_dssp             ECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHHH-HHHHHHHHHHHHH--HHHHCCCCCHHHHHH
T ss_pred             EEccCChhheeeeCCC-EEEEECCCcccCCCCCcHH-HHHHHHHHHHHHH--cCCCCCcccHHHHHH
Confidence            9999999999999664 8999999987655332111 0000000001222  134788899999754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.89  E-value=1.3e-05  Score=64.43  Aligned_cols=97  Identities=15%  Similarity=0.125  Sum_probs=64.7

Q ss_pred             chhhHHHHHHhcC-CCCccccceeeCCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 022132           12 HFVRSSCFDTWIM-KTSVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-   88 (302)
Q Consensus        12 ~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qll~~l~~LH~-   88 (302)
                      .+.+|..+++.+. +--+.+++++....     +..|+||++++| ++.+....     ......++.++...++.||+ 
T Consensus        55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~-----~~~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~  124 (263)
T d1j7la_          55 DVEREKDMMLWLEGKLPVPKVLHFERHD-----GWSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSI  124 (263)
T ss_dssp             CHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTS
T ss_pred             hHHHHHHHHHHHhccCCCCcEEEEEecC-----CceEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhcc
Confidence            5678999999884 44467788877666     788999999986 55433221     11111223333333444442 


Q ss_pred             ----------------------------------------------------------CCceecCCCCCCEEEecCCCEE
Q 022132           89 ----------------------------------------------------------ANVLHRDLKPSNLLLNANCDLK  110 (302)
Q Consensus        89 ----------------------------------------------------------~~i~H~dikp~Nil~~~~~~~k  110 (302)
                                                                                ..++|+|+.|.||++++++...
T Consensus       125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~  204 (263)
T d1j7la_         125 DISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSG  204 (263)
T ss_dssp             CCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEE
T ss_pred             CccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEE
Confidence                                                                      1278999999999999776667


Q ss_pred             Eeeccccc
Q 022132          111 ICDFGLAR  118 (302)
Q Consensus       111 l~dfg~~~  118 (302)
                      |+||+.+.
T Consensus       205 lIDwe~a~  212 (263)
T d1j7la_         205 FIDLGRSG  212 (263)
T ss_dssp             ECCCTTCE
T ss_pred             Eeechhcc
Confidence            99998774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.37  E-value=9.8e-05  Score=58.68  Aligned_cols=28  Identities=21%  Similarity=0.171  Sum_probs=24.8

Q ss_pred             ceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           91 VLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        91 i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                      ++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            7999999999999987667899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.67  E-value=0.0016  Score=55.08  Aligned_cols=30  Identities=20%  Similarity=0.296  Sum_probs=25.7

Q ss_pred             CceecCCCCCCEEEecCCCEEEeeccccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARVT  120 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  120 (302)
                      .++|||+.|.||+++.++ ++|+||..+...
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G  253 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYG  253 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence            589999999999998764 899999887543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.86  E-value=0.0051  Score=51.91  Aligned_cols=34  Identities=15%  Similarity=0.028  Sum_probs=24.6

Q ss_pred             hhhHHHHHHhc-CCCCccccceeeCCCCCCCCCcEEEEEecCCc
Q 022132           13 FVRSSCFDTWI-MKTSVVAIRDIIPPPQRESFNDVYIAYELMDT   55 (302)
Q Consensus        13 ~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~   55 (302)
                      ..+|..+++.+ .+.-..++++++..         ++|+||++|
T Consensus        91 r~~E~~i~~~ls~~gl~Pkll~~~~~---------g~I~efi~g  125 (395)
T d1nw1a_          91 LVAESVIFTLLSERHLGPKLYGIFSG---------GRLEEYIPS  125 (395)
T ss_dssp             HHHHHHHHHHHHHTTSSSCEEEEETT---------EEEECCCCE
T ss_pred             HHHHHHHHHHHHhCCCCCeEEEEcCC---------ceEEEEecc
Confidence            34799999998 44444678887743         488999875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.17  E-value=0.003  Score=51.52  Aligned_cols=30  Identities=30%  Similarity=0.344  Sum_probs=26.7

Q ss_pred             CCceecCCCCCCEEEecCCCEEEeeccccc
Q 022132           89 ANVLHRDLKPSNLLLNANCDLKICDFGLAR  118 (302)
Q Consensus        89 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~  118 (302)
                      .|++|+|+.++|++++.+...-++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988777999999773

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=91.68  E-value=0.096  Score=42.43  Aligned_cols=28  Identities=29%  Similarity=0.285  Sum_probs=23.1

Q ss_pred             CceecCCCCCCEEEecCCCEEEeecccccc
Q 022132           90 NVLHRDLKPSNLLLNANCDLKICDFGLARV  119 (302)
Q Consensus        90 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~  119 (302)
                      +++|+|+.+.||+++++  ..++||+.|..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            68999999999999743  46899998754